Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases

ABSTRACT

Methods of diagnosing or monitoring an autoimmune or chronic inflammatory disease, particularly SLE in a patient by detecting the expression level of one or more genes or surrogates derived therefrom in the patient are described. Diagnostic oligonucleotides for diagnosing or monitoring chronic inflammatory disease, particularly SLE infection and kits or systems containing the same are also described.

RELATED APPLICATIONS

This application is a Continuation-in-Part application of Ser. No.10/006,290 filed Oct. 22, 2001, which claims priority to U.S.provisional patent application No. 60/296,764 filed Jun. 8, 2001, bothof which are hereby incorporated by reference in their entirety.

FIELD OF THE INVENTION

This application is in the field of chronic inflammatory diseases. Inparticular, this invention relates to methods and compositions fordiagnosing or monitoring chronic inflammatory diseases.

BACKGROUND OF THE INVENTION

Many of the current shortcomings in diagnosis, prognosis, riskstratification and treatment of disease can be approached through theidentification of the molecular mechanisms underlying a disease andthrough the discovery of nucleotide sequences (or sets of nucleotidesequences) whose expression patterns predict the occurrence orprogression of disease states, or predict a patient's response to aparticular therapeutic intervention. In particular, identification ofnucleotide sequences and sets of nucleotide sequences with suchpredictive value from cells and tissues that are readily accessiblewould be extremely valuable. For example, peripheral blood is attainablefrom all patients and can easily be obtained at multiple time points atlow cost. This is a desirable contrast to most other cell and tissuetypes, which are less readily accessible, or accessible only throughinvasive and aversive procedures. In addition, the various cell typespresent in circulating blood are ideal for expression profilingexperiments as the many cell types in the blood specimen can be easilyseparated if desired prior to analysis of gene expression. While bloodprovides a very attractive substrate for the study of diseases usingexpression profiling techniques, and for the development of diagnostictechnologies and the identification of therapeutic targets, the value ofexpression profiling in blood samples rests on the degree to whichchanges in gene expression in these cell types are associated with apredisposition to, and pathogenesis and progression of a disease.

There is an extensive literature supporting the role of leukocytes,e.g., T-and B-lymphocytes, monocytes and granulocytes, includingneutrophils, in a wide range of disease processes, including such broadclasses as cardiovascular diseases, inflammatory, autoimmune andrheumatic diseases, infectious diseases, transplant rejection, cancerand malignancy, and endocrine diseases.

Of particular interest is the role of leukocytes and leukocyte geneexpression in chronic inflammatory diseases such as Systemic LupusErythematosis and Rheumatoid Arthritis. Systemic lupus erythematosis(SLE) and Rheumatoid Arthritis (RA) are chonic autoimmune andinflammatory disorders characterized by dysregulation of the immunesystem, which causes damage to a variety of organs. These diseasesclearly involve differential expression of genes in leukocytes.Diagnostic and disease monitoring tools are severly lacking for thesepatients and their physicians. Leukocyte expression profiling can beapplied to discover expression markers for SLE and RA and apply them aspatient management tools in the clinical setting. In addition,osteoarthirtis is a degenerative joint disease that can be confused withRA. This disease also involves leukocytes and expression profiling ofleukocytes associated with osteoarthritis may lead to the discovery ofnew diagnostic and therapeutic approaches to the disease.

The accuracy of technologies based on expression profiling for thediagnosis, prognosis, and monitoring of disease would be dramaticallyincreased if numerous differentially expressed nucleotide sequences,each with a measure of sensitivity and specificity for a disease inquestion, could be identified and assayed in a concerted manner. Usingthe expression of multiple genes (gene sets) for diagnostic applicationshelps overcome assay and population variability. In order to achievethis improved accuracy, the appropriate sets of nucleotide sequencesneed to be identified and validated against numerous samples incombination with relevant clinical data.

SUMMARY OF THE INVENTION

In order to meet these needs, the present invention identifies genes andgene sets that have clinical utility as diagnostic tools for themanagement of transplant recipients, lupus patients and patients with avariety of chronic inflammatory and autoimmune diseases. The presentinvention is thus directed to a method of diagnosing or monitoringchronic autoimmune or inflammatory disease in a patient. The method ofthe invention involves detecting in a patient expression of one or moregenes such as those genes depicted in Table 8 and Table 10A andsurrogates derived therefrom. Exemplary surrogates are provided in Table10C. The present invention is further directed to a method of diagnosingor monitoring an autoimmune or chronic inflammatory disease in a patientby detecting the expression level of one or more genes or surrogatesderived therefrom in said patient to diagnose or monitor the autoimmuneor chronic inflammatory disease in the patient wherein said genesinclude a nucleotide sequence selected from SEQ ID NO: 41; SEQ IDNO:328; SEQ ID NO:668; SEQ ID NO:855; SEQ ID NO:981; SEQ ID NO:1001; SEQID NO:1003; SEQ ID NO:1025; SEQ ID NO:1035; SEQ ID NO:1227; SEQ IDNO:1341; SEQ ID NO:1390; SEQ ID NO:1436; SEQ ID NO: 1535; SEQ ID NO:1750; SEQ ID NO:2102; SEQ ID NO:2331; SEQ ID NO:2386; SEQ ID NO:2412;SEQ ID NO:2560; SEQ ID NO:2648; SEQ ID NO:2895, SEQ ID NO:3249; SEQ IDNO:3305; SEQ ID NO:3541; SEQ ID NO:3692; SEQ ID NO:3701; SEQ ID NO:3741;SEQ ID NO:3825; SEQ ID NO:3827; SEQ ID NO:3832; SEQ ID NO:4149; SEQ IDNO:4400; SEQ ID NO:4601; SEQ ID NO:4604; SEQ ID NO:4631; SEQ ID NO:4637;SEQ ID NO:5067; SEQ ID NO:5074; SEQ ID NO:5468; SEQ ID NO:5531; SEQ IDNO:5607; SEQ ID NO:6382; SEQ ID NO:6956; SEQ ID NO:7238; SEQ ID NO:7330;SEQ ID NO:7641; SEQ ID NO:8015 and SEQ ID NO:8095.

In the method of the invention, the chronic inflammatory disease orautoimmune disease may be systemic lupus erythematosis (SLE).

In one format, expression is detecting by measuring RNA levels orprotein levels from the genes.

In the method of the invention, RNA may be isolated from the patientprior to detecting expression of a gene such as those depicted in Table10A. RNA levels may be detected by PCR, hybridization such ashybridization to an oligonucleotide. The nucleotide sequence may includecomprises DNA, cDNA, PNA, genomic DNA, or synthetic oligonucleotides.

In the methods of the invention, the RNA may be detected byhybridization to an oligonucleotide having a nucleotide sequenceselected from SEQ ID NO: 41; SEQ ID NO:328; SEQ ID NO:668; SEQ IDNO:855; SEQ ID NO:981; SEQ ID NO:1001; SEQ ID NO:1003; SEQ ID NO:1025;SEQ ID NO:1035; SEQ ID NO:1227; SEQ ID NO:1341; SEQ II) NO:1390; SEQ IDNO: 1436; SEQ ID NO:1535; SEQ ID NO:1750; SEQ ID NO:2102; SEQ IDNO:2331; SEQ ID NO:2386; SEQ ID NO:2412; SEQ ID NO:2560; SEQ ID NO:2648;SEQ ID NO:2895, SEQ ID NO:3249; SEQ ID NO:3305; SEQ ID NO:3541; SEQ IDNO:3692; SEQ ID NO:3701; SEQ ID NO:3741; SEQ ID NO:3825; SEQ ID NO:3827;SEQ ID NO:3832; SEQ ID NO:4149; SEQ ID NO:4400; SEQ ID NO:4601; SEQ IDNO:4604; SEQ ID NO:4631; SEQ ID NO:4637; SEQ ID NO:5067; SEQ ID NO:5074;SEQ ID NO:5468; SEQ ID NO:5531; SEQ ID NO:5607; SEQ ID NO:6382; SEQ IDNO:6956; SEQ ID NO:7238; SEQ ID NO:7330; SEQ ID NO:7641; SEQ ID NO:8015and SEQ ID NO:8095.

The present invention is further directed to a diagnosticoligonucleotide for detecting chronic or inflammatory disease whereinthe oligonucleotide has a nucleotide sequence selected from SEQ ID NO:4637. The diagnostic oligonucleotide of may include DNA, cDNA, PNA,genomic DNA, or synthetic oligonucleotides.

The present invention is further directed to a system or kit fordiagnosing or monitoring chronic inflammatory or autoimmune disease in apatient comprising an isolated DNA molecule wherein the isolated DNAmolecule detects expression of a gene listed in Table 10A. In the systemof the invention, the DNA molecules may be synthetic DNA, genomic DNA,PNA or cDNA. The isolated DNA molecule may be immobilized on an array.Such arrays may include a chip array, a plate array, a bead array, a pinarray, a membrane array, a solid surface array, a liquid array, anoligonucleotide array, polynucleotide array or a cDNA array, amicrotiter plate, a membrane and a chip.

The present invention is further directed to a system or detectingdifferential gene expression. In one format, the system has one or moreisolated DNA molecules wherein each isolated DNA molecule detectsexpression of a gene selected from the group of genes corresponding tothe oligonucleotides depicted in the Sequence Listing. It is understoodthat the DNA sequences and oligonucleotides of the invention may haveslightly different sequences than those identified herein. Such sequencevariations are understood to those of ordinary skill in the art to bevariations in the sequence which do not significantly affect the abilityof the sequences to detect gene expression.

The sequences encompassed by the invention have at least 40-50, 50-60,70-80, 80-85, 85-90, 90-95 or 95-100% sequence identity to the sequencesdisclosed herein. In some embodiments, DNA molecules are less than aboutany of the following lengths (in bases or base pairs): 10,000; 5,000;2500; 2000; 1500; 1250; 1000; 750; 500; 300; 250; 200; 175; 150; 125;100; 75; 50; 25; 10. In some embodiments, DNA molecule is greater thanabout any of the following lengths (in bases or base pairs): 10; 15; 20;25; 30; 40; 50; 60; 75; 100; 125; 150; 175; 200; 250; 300; 350; 400;500; 750; 1000; 2000; 5000; 7500; 10000; 20000; 50000. Alternately, aDNA molecule can be any of a range of sizes having an upper limit of10,000; 5,000; 2500; 2000; 1500; 1250; 1000; 750; 500; 300; 250; 200;175; 150; 125; 100; 75; 50; 25; or 10 and an independently selectedlower limit of 10; 15; 20; 25; 30; 40; 50; 60; 75; 100; 125; 150; 175;200; 250; 300; 350; 400; 500; 750; 1000; 2000; 5000; 7500 wherein thelower limit is less than the upper limit.

The gene expression system may be a candidate library, a diagnosticagent, a diagnostic oligonucleotide set or a diagnostic probe set. TheDNA molecules may be genomic DNA, protein nucleic acid (PNA), cDNA orsynthetic oligonucleotides.

In one format, the gene expression system is immobilized on an array.The array may be a chip array, a plate array, a bead array, a pin array,a membrane array, a solid surface array, a liquid array, anoligonucleotide array, a polynucleotide array, a cDNA array, amicrofilter plate, a membrane or a chip.

BRIEF DESCRIPTION OF THE SEQUENCE LISTING

A brief description of the sequence listing is given below. There are9090 entries. The Sequence Listing presents 50mer oligonucleotidesequences derived from human leukocyte, plant and viral genes. These arelisted as SEQ IDs 1-8143. The 50mer sequences and their sources are alsodisplayed in Table 8. Most of these 50mers were designed from sequencesof genes in Tables 2, 3A, B and C and the Sequence listing.

SEQ IDs 8144-8766 are the cDNA sequences derived from human leukocytesthat were not homologous to UniGene sequences or sequences found indbEST at the time they were searched. So me of these sequences matchhuman genomic sequences and are listed in Tables 3B and C. The remainingclones are putative cDNA sequences that contained less than 50% maskednucleotides when submitted to RepeatMasker, were longer than 147nucleotides, and did not have significant similarity to the UniGeneUnique database, dbEST, the NR nucleotide database of Genbank or theassembled human genome of Genbank.

SEQ IDs 8767-8770, 8828-8830 and 8832 are sequences that appear in thespecification (primer, masked sequences, exemplary sequences, etc.).

SEQ IDs 8845-8893 are the full length gene sequences for the genesidentified by an accession number in Table 10A.

SEQ IDs 8894-9085 are the primer sequences for lupus genes identified inTable 10B.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1: FIG. 1 is a schematic flow chart illustrating an instruction setfor characterization of the nucleotide sequence and/or the predictedprotein sequence of novel nucleotide sequences.

FIG. 2: FIG. 2 shows PCR Primer efficiency testing. A standard curve ofCt versus log of the starting RNA amount is shown for 2 g enes.

FIG. 3: FIG. 3 depicts a graph comparing the median backgroundsubtracted expression signals for various leukocyte reference RNAs.

FIG. 4: FIG. 4 depicts Diagnostic genes, gene sets and diagnosticalgorithms for Systemic Lupus Erythematosis are identified. FIG. 4Ashows the relative expression level of oligonucleotide and SEQ ID # 4637(Sialyltransferase 4A) between Lupus and control samples is shown. Thegene is identified as having a false detection rate for differentialexpression from the SAM algorithm of 0.5%. FIG. 4B shows the scaledratios (non log) for Sialyltransferase (SEQ ID # 4637) are given for thesamples in the analysis. The average ratio of each group along with thestandard deviation of the ratio is shown. The average fold change fromcontrol to Lupus is 1.48. FIG. 4C shows CART gene expression models fordiagnosis of SLE. For each model, the number of genes used, the relativecost with 10 fold cross validation, the SEQ ID, Locus accession number,the name and the position and values in the CART model are given. TheCART values given are the expression level thresholds for classificationof the sample as SLE after the node. For example, in the single genemodel II, the first node of the decision tree asks if expression of gene5067 is >0.103. If yes, the sample is placed in the lupus class. FIG. 4Dshows the sensitivity and specificity of Model 1. The sensitivity andspecificity are given for both the 2 and 3 gene models and both thetraining set and on cross validation. The relative cost is given forcross-validation. FIG. 4E shows the CART Model I, 2 genes. The modeluses 2 genes in a single node to classify samples as Lupus (Class 1) ornon-Lupus (Class 2). FIG. 4F shows CART Model 1, 3 genes. The model usesa second node to classify all samples correctly as lupus (class 1) ornon-lupus (class 2) for the training set.

FIG. 5: FIG. 5 shows endpoint testing of PCR primers. Electrophoresisand microfluidics are used to assess the product of gene specific PCRprimers. FIG. 5A is a β-GUS gel image. Lane 3 is the image for primersF178 and R242. Lanes 2 and 1 correspond to the no-template control and−RT control, respectively. FIG. 5B shows the electropherogram of β-GUSprimers F178 and R242, a graphical representation of Lane 3 from the gelimage. FIG. 5C shows a β-Actin gel image. Lane 3 is the image forprimers F75 and R178. Lanes 2 and 1 correspond to the no-templatecontrol and −RT control, respectively. FIG. 5D shows theelectropherogram of β-Actin primers F75 and R178, a graphicalrepresentation of Lave 3 from the gel image.

FIG. 6: FIG. 6 shows the validation of differential expression of a genediscovered using microarrays using Real-time PCR. FIG. 6A shows the Ctfor each patient sample on multiple assays is shown along with the Ct inthe R50 control RNA. Triangles represent −RT (reverse transcriptase)controls. FIG. 6B shows the fold difference between the expression ofGranzyme B and an Actin reference is shown for 3 samples from patientswith and without CMV disease.

BRIEF DESCRIPTION OF THE TABLES

Table 1: Table 1 lists some of the diseases or conditions amenable tostudy by leukocyte profiling.

Table 2: Table 2 describes genes and other nucleotide sequencesidentified using data mining of publically available publicationdatabases and nucleotide sequence databases. Corresponding Unigene(build 133) cluster numbers are listed with each gene or othernucleotide sequence.

Table 3A: Table 3A describes differentially expressed nucleotidesequences useful for the prediction of clinical outcomes. This tablecontains 4517 identified cDNAs and cDNA regions of genes that aremembers of a leukocyte candidate library, for use in measuring theexpression of nucleotide sequences that could subsequently be correlatedwith human clinical conditions. The regions of similarity were found bysearching three different databases for pair wise similarity usingblastn. The three databases were UniGene Unique build Mar. 30, 2001,file Hs.seq.uniq.Z; the downloadable database located at the websiteftp.ncbi.nlm.nih.com/blast/db/est human.Z with date Apr. 8, 2001 whichis a section of Genbank version 122; and the non-redundant section ofGenbank ver 123. The Hs.XXXXX numbers represent UniGene accessionnumbers from the Hs.seq.uniq.Z file of Mar. 30, 2001. The clonesequences are not in the sequence listing.

Table 3B: Table 3B describes Identified Genomic Regions that code fornovel mRNAs. The table contains 591 identified genomic regions that arehighly similar to the cDNA clones. Those regions that are within ˜100 to200 Kb of each other on the same contig are likely to represent exons ofthe same gene. The indicated clone is exemplary of the cDNA clones thatmatch the indicated genomic region. The “number clones” column indicateshow many clones were isolated from the libraries that are similar to theindicated region of the chromosome. The probability number is thelikelihood that region of similarity would occur by chance on a randomsequence. The Accession numbers are from the Mar. 15, 2001 build of thehuman genome. The file date for the downloaded data was Apr. 17, 2001.These sequences may prove useful for the prediction of clinicaloutcomes.

Table 3C: Table 3C describes 48 clones whose sequences align to two ormore non-contiguous sequences on the same assembled human contig ofgenomic sequence. The Accession numbers are from the Mar. 15, 2001 buildof the human genome. The file date for the downloaded data was Apr. 17,2001. The alignments of the clone and the contig are indicated in thetable. The start and stop offset of each matching region is indicated inthe table. The sequence of the clones themselves is included in thesequence listing. The alignments of these clones strongly suggest thatthey are novel nucleotide sequences. Furthermore, no EST or mRNAaligning to the clone was found in the database. These sequences mayprove useful for the prediction of clinical outcomes.

Table 4: Database mining. The Library Browser at the NCBI UniGene website was used to identify genes that are specifically expressed inleukocyte cell populations. The table lists the library name and type,the number of sequences in each library and the number used for thearray.

Table 5: Table 5 describes the nucleotide sequence databases used in thesequence analysis described herein.

Table 6: Table 6 describes the algorithms and software packages used forexon and polypeptide prediction used in the sequence analysis describedherein.

Table 7: Table 7 describes the databases and algorithms used for theprotein sequence analysis described herein.

Table 8: Table 8 provides a listing of all oligonucleotides designed forthe arrays and their associated genes. In this table, the sequence ID isgiven which corresponds to the sequence listing. The origin of thesequence for inclusion on the array is noted as coming from one of thecDNA libraries described in example 1, mining from databases asdescribed in examples 2 and 11 or identification from the publishedliterature. The unigene number, genebank accession and GI number arealso given for each sequence when known. These data were obtained fromthe Unigene unique database, build 137. The name of the gene associatedwith the accession number is noted. The sequence of these genes asavailable from the databases are hereby incorporated by reference intheir entirety. The strand is noted as −1 or 1, meaning that the probewas designed from the complement of the sequence (−1) or directly fromthe sequence (1). The nucleotide sequence of each probe is also given inthe Sequence Listing.

Table 9: Table 9 shows viral genes for arrays. Viral genomes were usedto design oligonucleotides for the microarrays. The accession numbersfor the viral genomes used are given, along with the gene name andlocation of the region used for oligonucleotide design.

Table 10A. Table 10A shows Lupus gene expression markers. This tablelists the oligonucleotides and associated genes identified as havingvalue for the diagnosis and monitoring of lupus. The first column givesthe SEQ ID that corresponds to the oligonuclotide in the sequencelisting. The origin of the sequence for inclusion on the array is notedas coming from one of the cDNA libraries described in example 1, miningfrom databases as described in examples 2 and 11 or identification fromthe published literature. The unigene number, genebank accession and GInumber are also given for each sequence when known. The SEQ ID for thesequence listing for the full-length genes corresponding to theaccession numbers in the table are also given (SEQ ID ACC). These datawere obtained from the Unigene unique database, build ###. The name ofthe gene associated with the accession number is noted. The strand isnoted as −1 or 1, meaning that the probe was designed from thecomplement of the sequence (−1) or directly from the sequence (1). Next,the nucleotide sequence of each probe is also given. For each gene, thefalse detection rate (FDR) from the significance analsysis described inexample 10 is given if applicable. Also, those genes that wereidentified by CART as a diagnostic gene are noted with the model andposition in the model (see example 10 and FIG. 5).

Table 10B. Table 10B shows primers for PCR. For each of the lupus geneexpression markers identified in Table 10A, 2 sets of PCR primer pairsare shown that were derived by the methods described in example 15. Themelting temperature (Tm) for each primer is shown, as is thecorresponding SEQ ID number for the primer in the sequence listing.

Table 10C. Table 10C shows surrogates for the lupus gene expressionmarkers disclosed herein. For some of the lupus marker genes identifiedin Table 10A, genes are identified by the SEQ ID number as surrogates.The surrogates are identified as such by the CART algorithm or byhierarchical clustering as detailed below.

Table 11: Table 11 describes kits useful for the practice of theinvention. Table 11A describes the contents of a kit useful for thediscovery of diagnostic nucleotide sets using microarrays. Table 11Bdescribes the contents of a kit useful for the application of diagnosticnucleotide sets using microarrays. Table 11C describes contents of a kituseful for the application of diagnostic nucleotide sets using real-timePCR.

DETAILED DESCRIPTION OF THE INVENTION

Definitions

Unless defined otherwise, all scientific and technical terms areunderstood to have the same meaning as commonly used in the art to whichthey pertain. For the purpose of the present invention, the followingterms are defined below.

In the context of the invention, the term “gene expression system”refers to any system, device or means to detect gene expression andincludes diagnostic agents, candidate libraries oligonucleotide,oligonucleotide sets or probe sets.

The terms “diagnostic oligonucleotide” or “diagnostic oligonucleotideset” generally refers to an oligonucleotide or to a set of two or moreoligonucleotides that, when evaluated for differential expression theircorresponding diagnostic genes, collectively yields predictive data.Such predictive data typically relates to diagnosis, prognosis,monitoring of therapeutic outcomes, and the like. In general, thecomponents of a diagnostic oligonucleotide or a diagnosticoligonucleotide set are distinguished from oligonucleotide sequencesthat are evaluated by analysis of the DNA to directly determine thegenotype of an individual as it correlates with a specified trait orphenotype, such as a disease, in that it is the pattern of expression ofthe components of the diagnostic oligonucleotide set, rather thanmutation or polymorphism of the DNA sequence that provides predictivevalue. It will be understood that a particular component (or member) ofa diagnostic oligonucleotide set can, in some cases, also present one ormore mutations, or polymorphisms that are amenable to direct genotypingby any of a variety of well known analysis methods, e.g., Southernblotting, RFLP, AFLP, SSCP, SNP, and the like.

A “diagnostic gene” is a gene whose expression is detected by adiagnostic oligonucleotide or diagnostic oligonucleotide set.

A “disease specific target oligonucleotide sequence” is a gene or otheroligonucleotide that encodes a polypeptide, most typically a protein, ora subunit of a multi-subunit protein that is a therapeutic target for adisease, or group of diseases.

A “candidate library” or a “candidate oligonucleotide library” refers toa collection of oligonucleotide sequences (or gene sequences) that byone or more criteria have an increased probability of being associatedwith a particular disease or group of diseases. The criteria can be, forexample, a differential expression pattern in a disease state or inactivated or resting leukocytes in vitro as reported in the scientificor technical literature, tissue specific expression as reported in asequence database, differential expression in a tissue or cell type ofinterest, or the like. Typically, a candidate library has at least 2members or components; more typically, the library has in excess ofabout 10, or about 100, or about 1000, or even more, members orcomponents.

The term “disease criterion” is used herein to designate an indicator ofa disease, such as a diagnostic factor, a prognostic factor, a factorindicated by a medical or family history, a genetic factor, or asymptom, as well as an overt or confirmed diagnosis of a diseaseassociated with several indicators such as those selected from the abovelist. A disease criterion includes data describing a patient's healthstatus, including retrospective or prospective health data, e.g. in theform of the patient's medical history, laboratory test results,diagnostic test result, clinical events, medications, lists, response(s)to treatment and risk factors, etc.

An autoimmune disorder is defined as a disease state in which apatient's immune system recognizes an antigen in that patient's organsor tissues as foreign and becomes activated. The activated immune cellscan then cause damage to the inciting organ or tissue or can damageother organs or tissues. In some cases, the disorder may be caused by adysregulation of the immune system cells, rather than by the recognitionas a self-antigen as foreign. Dysregulated immune cells can secreteinflammatory cytokines that cause systemic inflammation or they canrecognize self-antigens as foreign.

Examples of autoimmune diseases include: Autoimmune hepatitis, MultipleSclerosis, Myasthenia Gravis, Type I diabetes, Rheumatoid Arthritis,Psoriasis, Systemic Lupus Erythematosis, Hashimoto's Thyroiditis,Grave's disease, Ankylosing Spondylitis Sjogrens Disease, CRESTsyndrome, Scleroderma and many more.

Most of the autoimmune diseases are also chronic inflammatory diseases.This is defined as a disease process associated with long-term (>6months) activation of inflammatory cells (leukocytes). The chronicinflammation leads to damage of patient organs or tissues. Many diseasesare chronic inflammatory disorders, but are not know to have anautoimmune basis. For example, Atherosclerosis, Congestive HeartFailure, Crohn's disease, Ulcerative Colitis, Polyarteritis nodosa,Whipple's Disease, Primary Sclerosing Cholangitis and many more.

The terms “molecular signature” or “expression profile” refers to thecollection of expression values for a plurality (e.g., at least 2, butfrequently about 10, about 100, about 1000, or more) of members of acandidate library. In many cases, the molecular signature represents theexpression pattern for all of the nucleotide sequences in a library orarray of candidate or diagnostic nucleotide sequences or genes.Alternatively, the molecular signature represents the expression patternfor one or more subsets of the candidate library. The term“oligonucleotide” refers to two or more nucleotides. Nucleotides may beDNA or RNA, naturally occurring or synthetic.

The term “healthy individual,” as used herein, is relative to aspecified disease or disease criterion. That is, the individual does notexhibit the specified disease criterion or is not diagnosed with thespecified disease. It will be understood, that the individual inquestion, can, of course, exhibit symptoms, or possess various indicatorfactors for another disease.

Similarly, an “individual diagnosed with a disease” refers to anindividual diagnosed with a specified disease (or disease criterion).Such an individual may, or may not, also exhibit a disease criterionassociated with, or be diagnosed with another (related or unrelated)disease.

The term “monitoring” is used herein to describe the use of gene sets toprovide useful information about an individual or an individual's healthor disease status. “Monitoring” can include, determination of prognosis,risk-stratification, selection of drug therapy, assessment of ongoingdrug therapy, prediction of outcomes, determining response to therapy,diagnosis of a disease or disease complication, following progression ofa disease or providing any information relating to a patients healthstatus.

An “array” is a spatially or logically organized collection, e.g., ofoligonucleotide sequences or nucleotide sequence products such as RNA orproteins encoded by an oligonucleotide sequence. In some embodiments, anarray includes antibodies or other binding reagents specific forproducts of a candidate library.

When referring to a pattern of expression, a “qualitative” difference ingene expression refers to a difference that is not assigned a relativevalue. That is, such a difference is designated by an “all or nothing”valuation. Such an all or nothing variation can be, for example,expression above or below a threshold of detection (an on/off pattern ofexpression). Alternatively, a qualitative difference can refer toexpression of different types of expression products, e.g., differentalleles e.g., a mutant or polymorphic allele), variants (includingsequence variants as well as post-translationally modified variants),etc.

In contrast, a “quantitative” difference, when referring to a pattern ofgene expression, refers to a difference in expression that can beassigned a value on a graduated scale, (e.g., a 0-5 or 1-10 scale, a+−+++scale, a grade 1-grade 5 scale, or the like; it will be understoodthat the numbers selected for illustration are entirely arbitrary and inno-way are meant to be interpreted to limit the invention).

Gene Expression Systems and Methods of Detecting Gene Expression

The invention is directed to methods of detecting gene expression with agene expression system having one or more DNA molecules wherein the oneor more DNA molecules has a nucleotide sequence which detects expressionof a gene corresponding to the oligonucleotides depicted in the SequenceListing. In one format, the oligonucleotide detects expression of a genethat is differentially expressed in leukocytes. The gene expressionsystem may be a candidate library, a diagnostic agent, a diagnosticoligonucleotide set or a diagnostic probe set. The DNA molecules may begenomic DNA, RNA, protein nucleic acid (PNA), cDNA or syntheticoligonucleotides. Following the procedures taught herein, one canidentity sequences of interest for analyzing gene expression inleukocytes. Such sequences may be predictive of a disease state.

Diagnostic Oligonucleotides of the Invention

The invention relates to diagnostic oligonucleotides and diagnosticoligonucleotide set(s) comprising members of the leukocyte candidatelibrary listed in Table 2, Table 3 and Tables 8-10 in the SequenceListing, for which a correlation exists between the health status of anindividual, and the individual's expression of RNA or protein productscorresponding to the nucleotide sequence. In some instances, only oneoligonucleotide is necessary for such detection. Members of a diagnosticoligonucleotide set may be identified by any means capable of detectingexpression of RNA or protein products, including but not limited todifferential expression screening, PCR, RT-PCR, SAGE analysis,high-throughput sequencing, microarrays, liquid or other arrays,protein-based methods (e.g., western blotting, proteomics, and othermethods described herein), and data mining methods, as further describedherein.

In one embodiment, a diagnostic oligonucleotide set comprises at leasttwo oligonucleotide sequences listed in Table 2, Table 3 and Tables 8-10or the Sequence Listing which are differentially expressed in leukocytesin an individual with at least one disease criterion for at least oneleukocyte-implicated disease relative to the expression in individualwithout the at least one disease criterion, wherein expression of thetwo or more nucleotide sequences is correlated with at least one diseasecriterion, as described below.

In another embodiment, a diagnostic oligonucleotide set comprises atleast one oligonucleotide having an oligonucleotide sequence listed inTable 2, 3 and Tables 8-10, or the Sequence Listing which isdifferentially expressed, and further wherein the differentialexpression/correlation has not previously been described. In someembodiments, the diagnostic oligonucleotide set is immobilized on anarray.

In another embodiment, diagnostic oligonucleotides (or oligonucleotidesets) are related to the members of the leukocyte candidate librarylisted in Table 2, Table 3, Tables 8-10 and in the Sequence Listing, forwhich a correlation exists between the health status (or diseasecriterion) of an individual. The diagnostic oligonucleotides arepartially or totally contained in (or derived from) full-length genesequences (or predicted full-length gene sequences) for the members ofthe candidate library listed in Table 2, 3 and the Sequence Listing.This includes sequences from accession numbers and unigene numbers fromTable 8. Table 8 shows the accession and unigene number (when known) foreach oligonucleotide used on the 8134 gene leukocyte array described inexamples 11-13. In some cases, oligonucleotide sequences are designedfrom EST or Chromosomal sequences from a public database. In these casesthe full-length gene sequences may not be known. Full-length sequencesin these cases can be predicted using gene prediction algorithms(Examples 4-6). Alternatively the full-length can be determined bycloning and sequencing the full-length gene or genes that contain thesequence of interest using standard molecular biology approachesdescribed here. The same is true for olignonucleotides designed from oursequencing of cDNA libraries (see Examples 1-4) where the cDNA does notmatch any sequence in the public databases.

The diagnostic oligonucleotides may also be derived from other genesthat are coexpressed with the correlated sequence or full-length gene.Genes may share expression patterns because they are regulated in thesame molecular pathway. Because of the similarity of expression,behavior genes are identified as surrogates in that they can substitutefor a diagnostic gene in a diagnostic gene set. Example 10 demonstratesthe discovery of surrogates from the data and Table 10C and the sequencelisting identify and give the sequence for surrogates for lupusdiagnostic genes. Surrogate oligonucleotide and surrogateoligonucleotide sets can be utilized to detect expression of surrogategenes and thereby diagnose or monitor patients with a disease.

As used herein the term “gene cluster” or “cluster” refers to a group ofgenes related by expression pattern. In other words, a cluster of genesis a group of genes with similar regulation across different conditions,such as a patient having a chronic autoimmune or inflammatory disease ora patient without chronic autoimmune or inflammatory disease. Theexpression profile for each gene in a cluster should be correlated withthe expression profile of at least one other gene in that cluster.Correlation may be evaluated using a variety of statistical methods. Asused herein the term “surrogate” refers to a gene with an expressionprofile such that it can substitute for a diagnostic gene in adiagnostic assay. Such genes are often members of the same gene clusteras the diagnostic gene. For each member of a diagnostic gene set, a setof potential surrogates can be identified through identification ofgenes with similar expression patterns as described below.

Many statistical analyses produce a correlation coefficient to describethe relatedness between two gene expression patterns. Patterns may beconsidered correlated if the correlation coefficient is greater than orequal to 0.8. In preferred embodiments, the correlation coefficientshould be greater than 0.85, 0.9 or 0.95. Other statistical methodsproduce a measure of mutual information to describe the relatednessbetween two gene expression patterns. Patterns may be consideredcorrelated if the normalized mutual information value is greater than orequal to 0.7. In preferred embodiments, the normalized mutualinformation value should be greater than 0.8, 0.9 or 0.95. Patterns mayalso be considered similar if they cluster closely upon hierarchicalclustering of gene expression data (Eisen et al. 1998). Similar patternsmay be those genes that are among the 1, 2, 5, 10, 20, 50 or 100 nearestneighbors in a hierarchical clustering or have a similarity score (Eisenet al. 1998) of >0.5, 0.7, 0.8, 0.9, 0.95 or 0.99. Similar patterns mayalso be identified as those genes found to be surrogates in aclassification tree by CART (Breiman et al. 1994). Often, but notalways, members of a gene cluster have similar biological functions inaddition to similar gene expression patterns.

Correlated genes, clusters and surrogates are identified for thediagnostic genes of the invention. These surrogates may be used asdiagnostic genes in an assay instead of, or in addition to, thediagnostic genes for which they are surrogates.

The invention also provides diagnostic probe sets. It is understood thata probe includes any reagent capable of specifically identifying anucleotide sequence of the diagnostic nucleotide set, including but notlimited to amplified DNA, amplified RNA, cDNA, syntheticoligonucleotide, partial or full-length nucleic acid sequences. Inaddition, the probe may identify the protein product of a diagnosticnucleotide sequence, including, for example, antibodies and otheraffinity reagents.

It is also understood that each probe can correspond to one gene, ormultiple probes can correspond to one gene, or both, or one probe cancorrespond to more than one gene.

Homologs and variants of the disclosed nucleic acid molecules may beused in the present invention. Homologs and variants of these nucleicacid molecules will possess a relatively high degree of sequenceidentity when aligned using standard methods. The sequences encompassedby the invention have at least 40-50, 50-60, 70-80, 80-85, 85-90, 90-95or 95-100% sequence identity to the sequences disclosed herein.

It is understood that for expression profiling, variations in thedisclosed sequences will still permit detection of gene expression. Thedegree of sequence identity required to detect gene expression variesdepending on the length of the oligomer. For a 60 mer, (anoligonucleotide with 60 nucleotides) 6-8 random mutations or 6-8 randomdeletions in a 60 mer do not affect gene expression detection. Hughes, TR, et al. “Expression profiling using microarrays fabricated by anink-jet oligonucleotide synthesizer. Nature Biotechnology,19:343-347(2001). As the length of the DNA sequence is increased, thenumber of mutations or deletions permitted while still allowing geneexpression detection is increased.

As will be appreciated by those skilled in the art, the sequences of thepresent invention may contain sequencing errors. That is, there may beincorrect nucleotides, frameshifts, unknown nucleotides, or other typesof sequencing errors in any of the sequences; however, the correctsequences will fall within the homology and stringency definitionsherein.

The minimum length of an oligonucleotide probe necessary for specifichybridization in the human genome can be estimated using two approaches.The first method uses a statistical argument that the probe will beunique in the human genome by chance. Briefly, the number of independentperfect matches (Po) expected for an oligonucleotide of length L in agenome of complexity C can be calculated from the equation (Laird CD,Chromosoma 32:378 (1971):Po=(1/4)^(L)*2C

In the case of mammalian genomes, 2C=˜3.6×10⁹, and an oligonucleotide of14-15 nucleotides is expected to be represented only once in the genome.However, the distribution of nucleotides in the coding sequence ofmammalian genomes is nonrandom (Lathe, R. J. Mol. Biol. 183:1 (1985) andlonger oligonucleotides may be preferred in order to in increase thespecificity of hybridization. In practical terms, this works out toprobes that are 19-40 nucleotides long (Sambrook J et al., infra). Thesecond method for estimating the length of a specific probe is to use aprobe long enough to hybridize under the chosen conditions and use acomputer to search for that sequence or close matches to the sequence inthe human genome and choose a unique match. Probe sequences are chosenbased on the desired hybridization properties as described in Chapter 11of Sambrook et al, infra. The PRIMER3 program is useful for designingthese probes (S. Rozen and H. Skaletsky 1996,1997; Primer3 codeavailable at genome.wi.mit.edu/genome_softwarelother/primer3.html, thewebsite). The sequences of these probes are then compared pair wiseagainst a database of the human genome sequences using a program such asBLAST or MEGABLAST (Madden, T. L et al.(1996) Meth. Enzymol.266:131-141). Since most of the human genome is now contained in thedatabase, the number of matches will be determined. Probe sequences arechosen that are unique to the desired target sequence.

In some embodiments, a diagnostic oligonucleotide or oligonucleotideprobe set is immobilized on an array. The array is optionally comprisesone or more of: a chip array, a plate array, a bead array, a pin array,a membrane array, a solid surface array, a liquid array, anoligonucleotide array, a polynucleotide array or a cDNA array, amicrotiter plate, a pin array, a bead array, a membrane or a chip.

In some embodiments, the leukocyte-implicated disease is selected fromthe diseases listed in Table 1. In other embodiments, the disease isatherosclerosis or cardiac allograft rejection. In other embodiments,the disease is congestive heart failure, angina, myocardial infarction,chronic autoimmune and inflammatory diseases, systemic lupuserythematosis (SLE) and rheumatoid arthritis.

In some embodiments, diagnostic oligonucleotides of the invention areused as a diagnostic gene set in combination with genes that are know tobe associated with a disease state (“known markers”). The use of thediagnostic oligonucleotides in combination with the known markers canprovide information that is not obtainable through the known markersalone. The known markers include those identified by the prior artlisting provided.

General Molecular Biology References

In the context of the invention, nucleic acids and/or proteins aremanipulated according to well known molecular biology techniques.Detailed protocols for numerous such procedures are described in, e.g.,in Ausubel et al. Current Protocols in Molecular Biology (supplementedthrough 2000) John Wiley & Sons, New York (“Ausubel”); Sambrook et al.Molecular Cloning-A Laboratory Manual (2nd Ed.), Vol. 1-3, Cold SpringHarbor Laboratory, Cold Spring Harbor, N.Y., 1989 (“Sambrook”), andBerger and Kimmel Guide to Molecular Cloning Techniques, Methods inEnzymology volume 152 Academic Press, Inc., San Diego, Calif.(“Berger”).

In addition to the above references, protocols for in vitroamplification techniques, such as the polymerase chain reaction (PCR),the ligase chain reaction (LCR), Q-replicase amplification, and otherRNA polymerase mediated techniques (e.g., NASBA), useful e.g., foramplifying cDNA probes of the invention, are found in Mullis et al.(1987) U.S. Pat. No. 4,683,202; PCR Protocols A Guide to Methods andApplications (Innis et al. eds) Academic Press Inc. San Diego, Calif.(1990) (“Innis”); Amheim and Levinson (1990) C&EN 36; The Journal Of NIHResearch (1991) 3:81; Kwoh et al. (1989) Proc Natl Acad Sci USA 86,1173; Guatelli et al. (1990) Proc Natl Acad Sci USA 87:1874; Lomell etal. (1989) J Clin Chem 35:1826; Landegren et al. (1988) Science241:1077; Van Brunt (1990) Biotechnology 8:291; Wu and Wallace (1989)Gene 4: 560; Barringer et al. (1990) Gene 89:117, and Sooknanan andMalek (1995) Biotechnology 13:563. Additional methods, useful forcloning nucleic acids in the context of the present invention, includeWallace et al. U.S. Pat. No. 5,426,039. Improved methods of amplifyinglarge nucleic acids by PCR are summarized in Cheng et al. (1994) Nature369:684 and the references therein.

Certain polynucleotides of the invention, e.g., oligonucleotides can besynthesized utilizing various solid-phase strategies involvingmononucleotide- and/or trinucleotide-based phosphoramidite couplingchemistry. For example, nucleic acid sequences can be synthesized by thesequential addition of activated monomers and/or trimers to anelongating polynucleotide chain. See e.g., Caruthers, M. H. et al.(1992) Meth Enzymol 211:3.

In lieu of synthesizing the desired sequences, essentially any nucleicacid can be custom ordered from any of a variety of commercial sources,such as The Midland Certified Reagent Company (mcrc@oligos.com), TheGreat American Gene Company (genco.com), ExpressGen, Inc.(expressgen.com), Operon Technologies, Inc. (operon.com), and manyothers.

Similarly, commercial sources for nucleic acid and protein micro arraysare avaiable, and include, e.g., Agilent Technologies, Palo Alto, Calif.and Affymetrix, Santa Clara, Calif.

Candidate Library

Libraries of candidate genes that are differentially expressed inleukocytes are substrates for the identification and evaluation ofdiagnostic oligonucleotides and oligonucleotide sets and diseasespecific target nucleotide sequences.

The term leukocyte is used generically to refer to any nucleated bloodcell that is not a nucleated erythrocyte. More specifically, leukocytescan be subdivided into two broad classes. The first class includesgranulocytes, including, most prevalently, neutrophils, as well aseosinophils and basophils at low frequency. The second class, thenon-granular or mononuclear leukocytes, includes monocytes andlymphocytes (e.g., T cells and B cells). There is an extensiveliterature in the art implicating leukocytes, e.g., neutrophils,monocytes and lymphocytes in a wide variety of disease processes,including inflammatory and rheumatic diseases, neurodegenerativediseases (such as Alzheimer's dementia), cardiovascular disease,endocrine diseases, transplant rejection, malignancy and infectiousdiseases, and other diseases listed in Table 1. Mononuclear cells areinvolved in the chronic immune response, while granulocytes, which makeup approximately 60% of the leukocytes, have a non-specific andstereotyped response to acute inflammatory stimuli and often have a lifespan of only 24 hours.

In addition to their widespread involvement and/or implication innumerous disease related processes, leukocytes are particularlyattractive substrates for clinical and experimental evaluation for avariety of reasons. Most importantly, they are readily accessible at lowcost from essentially every potential subject. Collection is minimallyinvasive and associated with little pain, disability or recovery time.Collection can be performed by minimally trained personnel (e.g.,phlebotomists, medical technicians, etc.) in a variety of clinical andnon-clinical settings without significant technological expenditure.Additionally, leukocytes are renewable, and thus available at multipletime points for a single subject.

Assembly of Candidate Libraries

At least two conceptually distinct approaches to the assembly ofcandidate libraries exist. Either, or both, or other, approaches can befavorably employed. The method of assembling, or identifying, candidatelibraries is secondary to the criteria utilized for selectingappropriate library members. Most importantly, library members areassembled based on differential expression of RNA or protein products inleukocyte populations. More specifically, candidate nucleotide sequencesare induced or suppressed, or expressed at increased or decreased levelsin leukocytes from a subject with one or more disease or disease state(a disease criterion) relative to leukocytes from a subject lacking thespecified disease criterion. Alternatively, or in addition, librarymembers can be assembled from among nucleotide sequences that aredifferentially expressed in activated or resting leukocytes relative toother cell types.

Firstly, publication and sequence databases can be “mined” using avariety of search strategies. For example, currently availablescientific and medical publication databases such as Medline, CurrentContents, OMIM (online Mendelian inheritance in man) various Biologicaland Chemical Abstracts, Journal indexes, and the like can be searchedusing term or key-word searches, or by author, title, or other relevantsearch parameters. Many such databases are publicly available, and oneof skill is well versed in strategies and procedures for identifyingpublications and their contents, e.g., genes, other nucleotidesequences, descriptions, indications, expression pattern, etc. Numerousdatabases are available through the internet for free or bysubscription, see, e.g., the websites, ncbi.nlm.nih.gov/PubMed/;3.infotrieve.com/; isinet.com/; sciencemag.org/. Additional oralternative publication or citation databases are also available thatprovide identical or similar types of information, any of which arefavorably employed in the context of the invention. These databases canbe searched for publications describing differential gene expression inleukocytes between patients with and without diseases or conditionslisted in Table 1. We identified the nucleotide sequences listed inTable 2 and some of the sequences used to design oligonucleotides formicroarrays (sequence listing), using data mining methods.

Alternatively, a variety of publicly available and proprietary sequencedatabases (including GenBank, dbEST, UniGene, and TIGR and SAGEdatabases) including sequences corresponding to expressed nucleotidesequences, such as expressed sequence tags (ESTs) are available. Forexample, the Genbank™ website located at ncbi.nlm.nih.gov/Genbank/amongothers, can be readily accessed and searched via the internet. These andother sequence and clone database resources are currently available;however, any number of additional or alternative databases comprisingnucleotide sequence sequences, EST sequences, clone repositories, PCRprimer sequences, and the like corresponding to individual nucleotidesequence sequences are also suitable for the purposes of the invention.Nucleotide sequences can be identified that are only found in librariesderived from leukocytes or sub-populations of leukocytes, for examplesee Table 2 and Example 2.

Alternatively, the representation, or relative frequency, of anucleotide sequence may be determined in a leukocyte-derived nucleicacid library and compared to the representation of the sequence innon-leukocyte derived libraries. The representation of a nucleotidesequence correlates with the relative expression level of the nucleotidesequence in leukocytes and non-leukocytes. An oligonucleotide sequencethat has increased or decreased representation in a leukocyte-derivednucleic acid library relative to a non-leukocyte-derived libraries is acandidate for a leukocyte-specific gene.

Nucleotide sequences identified as having specificity to activated orresting leukocytes or to leukocytes from patients or patient sampleswith a variety of disease types can be isolated for use in a candidatelibrary for leukocyte expression profiling through a variety ofmechanisms. These include, but are not limited to, the amplification ofthe nucleotide sequence from RNA or DNA using nucleotide sequencespecific primers for PCR or RT-PCR, isolation of the nucleotide sequenceusing conventional cloning methods, the purchase of an IMAGE consortiumcDNA clone (EST) with complimentary sequence or from the same expressednucleotide sequence, design of oligonucleotides, preparation ofsynthetic nucleic acid sequence, or any other nucleic-acid based method.In addition, the protein product of the nucleotide sequence can beisolated or prepared, and represented in a candidate library, usingstandard methods in the art, as described further below.

While the above discussion related primarily to “genomics” approaches,it is appreciated that numerous, analogous “proteomics” approaches aresuitable to the present invention. For example, a differentiallyexpressed protein product can, for example, be detected using westernanalysis, two-dimensional gel analysis, chromatographic separation, massspectrometric detection, protein-fusion reporter constructs,colorometric assays, binding to a protein array, or by characterizationof polysomal mRNA. The protein is further characterized and thenucleotide sequence encoding the protein is identified using standardtechniques, e.g. by screening a cDNA library using a probe based onprotein sequence information.

The second approach involves the construction of a differentialexpression library by any of a variety of means. Any one or more ofdifferential screening, differential display or subtractivehybridization procedures, or other techniques that preferentiallyidentify, isolate or amplify differentially expressed nucleotidesequences can be employed to produce a library of differentiallyexpressed candidate nucleotide sequences, a subset of such a library, apartial library, or the like. Such methods are well known in the art.For example, peripheral blood leukocytes, (i.e., a mixed populationincluding lymphocytes, monocytes and neutrophils), from multiple donorsamples are pooled to prevent bias due to a single-donor's uniquegenotype. The pooled leukocytes are cultured in standard medium andstimulated with individual cytokines or growth factors e.g., with IL-2,IL-1, MCPI, TNFα, and/or IL8 according to well known procedures (see,e.g., Tough et al. (1999); Winston et al. (1999); Hansson et al.(1989)). Typically, leukocytes are recovered from Buffy coatpreparations produced by centrifugation of whole blood. Alternatively,mononuclear cells (monocytes and lymphocytes) can be obtained by densitygradient centrifugation of whole blood, or specific cell types (such asa T lymphocyte) can be isolated using affinity reagents to cell specificsurface markers. When affinity reagents are used to isolate specificcell types, it is desirable to isolate the cells using negativeselection to avoid activation of the desired cell type by binding of theantibody. Leukocytes may also be stimulated by incubation withionomycin, and phorbol myristate acetate (PMA). This stimulationprotocol is intended to non-specifically mimic “activation” of numerouspathways due to variety of disease conditions rather than to simulateany single disease condition or paradigm.

Using well-known subtractive hybridization procedures (as described in,e.g., U.S. Pat. Nos. 5,958,738; 5589,339; 5,827,658; 5,712,127;5,643,761) each of which are hereby incorporated by reference, a libraryis produced that is enriched for RNA species (messages) that aredifferentially expressed between test and control leukocyte populations.In some embodiments, the test population of leukocytes are simplystimulated as described above to emulate non-specific activation events,while in other embodiments the test population can be selected fromsubjects (or patients) with a specified disease or class of diseases.Typically, the control leukocyte population lacks the defining testcondition, e.g., stimulation, disease state, diagnosis, genotype, etc.Alternatively, the total RNA from control and test leukocyte populationsare prepared by established techniques, treated with DNAseI, andselected for messenger RNA with an intact 3′ end (i.e., polyA(+)messenger RNA) e.g., using commercially available kits according to themanufacturer's instructions e.g. Clontech. Double stranded cDNA issynthesized utilizing reverse transcriptase. Double stranded cDNA isthen cut with a first restriction enzyme (e.g., NlaIII, that cuts at therecognition site: CATG, and cuts the cDNA sequence at approximately 256bp intervals) that cuts the cDNA molecules into conveniently sizedfragments.

The cDNAs prepared from the test population of leukocytes are dividedinto (typically 2) “tester” pools, while cDNAs prepared from the controlpopulation of leukocytes are designated the “driver” pool. Typically,pooled populations of cells from multiple individual donors are utilizedand in the case of stimulated versus unstimulated cells, thecorresponding tester and driver pools for any single subtractionreaction are derived from the same donor pool.

A unique double-stranded adapter is ligated to each of the tester cDNApopulations using unphosphorylated primers so that only the sense strandis covalently linked to the adapter. An initial hybridization isperformed consisting of each of the tester pools of cDNA (each with itscorresponding adapter) and an excess of the driver cDNA. Typically, anexcess of about 10-100 fold driver relative to tester is employed,although significantly lower or higher ratios can be empiricallydetermined to provide more favorable results. The initial hybridizationresults in an initial normalization of the cDNAs such that high and lowabundance messages become more equally represented followinghybridization due to a failure of driver/tester hybrids to amplify.

A second hybridization involves pooling un-hybridized sequences frominitial hybridizations together with the addition of supplemental drivercDNA. In this step, the expressed sequences enriched in the two testerpools following the initial hybridization can hybridize. Hybridsresulting from the hybridization between members of each of the twotester pools are then recovered by amplification in a polymerase chainreaction (PCR) using primers specific for the unique adapters. Again,sequences originating in a tester pool that form hybrids with componentsof the driver pool are not amplified. Hybrids resulting between membersof the same tester pool are eliminated by the formation of “panhandles”between their common 5′ and 3′ ends. For additional details, see, e.g.,Lukyanov et al. (1997) Biochem Biophys Res Commun 230:285-8.

Typically, the tester and driver pools are designated in thealternative, such that the hybridization is performed in both directionsto ensure recovery of messenger RNAs that are differentially expressedin either a positive or negative manner (i.e., that are turned on orturned off, up-regulated or down-regulated). Accordingly, it will beunderstood that the designation of test and control populations is tosome extent arbitrary, and that a test population can just as easily becompared to leukocytes derived from a patient with the same of anotherdisease of interest.

If so desired, the efficacy of the process can be assessed by suchtechniques as semi-quantitative PCR of known (i.e., control) nucleotidesequences, of varying abundance such as β-actin. The resulting PCRproducts representing partial cDNAs of differentially expressednucleotide sequences are then cloned (i.e., ligated) into an appropriatevector (e.g., a commercially available TA cloning vector, such as pGEMfrom Promega) and, optionally, transformed into competent bacteria forselection and screening.

Either of the above approaches, or both in combination, or indeed, anyprocedure, which permits the assembly of a collection of nucleotidesequences that are expressed in leukocytes, is favorably employed toproduce the libraries of candidates useful for the identification ofdiagnostic nucleotide sets and disease specific target nucleotides ofthe invention. Additionally, any method that permits the assembly of acollection of nucleotides that are expressed in leukocytes andpreferentially associated with one or more disease or condition, whetheror not the nucleotide sequences are differentially expressed, isfavorably employed in the context of the invention. Typically, librariesof about 2,000-10,000 members are produced (although libraries in excessof 10,000 are not uncommon). Following additional evaluation procedures,as described below, the proportion of unique clones in the candidatelibrary can approximate 100%.

A candidate oligonucleotide sequence may be represented in a candidatelibrary by a full-length or partial nucleic acid sequence,deoxyribonucleic acid (DNA) sequence, cDNA sequence, RNA sequence,synthetic oligonucleotides, etc. The nucleic acid sequence can be atleast 19 nucleotides in length, at least 25 nucleotides, at least 40nucleotides, at least 100 nucleotides, or larger. Alternatively, theprotein product of a candidate nucleotide sequence may be represented ina candidate library using standard methods, as further described below.

Characterization of Candidate Oliponucleotide Sequences

The sequence of individual members (e.g., clones, partial sequencelisting in a database such as an EST, etc.) of the candidateoligonucleotide libraries is then determined by conventional sequencingmethods well known in the art, e.g., by the dideoxy-chain terminationmethod of Sanger et al. (1977) Proc Natl Acad Sci USA 74:5463-7; bychemical procedures, e.g., Maxam and Gilbert (1977) Proc Natl Acad SciUSA 74:560-4; or by polymerase chain reaction cycle sequencing methods,e.g., Olsen and Eckstein (1989) Nuc Acid Res 17:9613-20, DNA chip basedsequencing techniques or variations, including automated variations(e.g., as described in Hunkapiller et al. (1991) Science 254:59-67;Pease et al. (1994) Proc Natl Acad Sci USA 91:5022-6), thereof. Numerouskits for performing the above procedures are commercially available andwell known to those of skill in the art. Character strings correspondingto the resulting nucleotide sequences are then recorded (i.e., stored)in a database. Most commonly the character strings are recorded on acomputer readable medium for processing by a computational device.

Generally, to facilitate subsequent analysis, a custom algorithm isemployed to query existing databases in an ongoing fashion, to determinethe identity, expression pattern and potential function of theparticular members of a candidate library. The sequence is firstprocessed, by removing low quality sequence. Next the vector sequencesare identified and removed and sequence repeats are identified andmasked. The remaining sequence is then used in a Blast algorithm againstmultiple publicly available, and/or proprietary databases, e.g., NCBInucleotide, EST and protein databases, Unigene, and Human GenomeSequence. Sequences are also compared to all previously sequencedmembers of the candidate libraries to detect redundancy.

In some cases, sequences are of high quality, but do not match anysequence in the NCBI nr, human EST or Unigene databases. In this casethe sequence is queried against the human genomic sequence. If a singlechromosomal site is matched with a high degree of confidence, thatregion of genomic DNA is identified and subjected to further analysiswith a gene prediction program such as GRAIL. This analysis may lead tothe identification of a new gene in the genomic sequence. This sequencecan then be translated to identify the protein sequence that is encodedand that sequence can be further analyzed using tools such as Pfam,Blast P, or other protein structure prediction programs, as illustratedin Table 7. Typically, the above analysis is directed towards theidentification of putative coding regions, e.g., previously unidentifiedopen reading frames, confirming the presence of known coding sequences,and determining structural motifs or sequence similarities of thepredicted protein (i.e., the conceptual translation product) in relationto known sequences. In addition, it has become increasingly possible toassemble “virtual cDNAs” containing large portions of coding region,simply through the assembly of available expressed sequence tags (ESTs).In turn, these extended nucleic acid and amino acid sequences allow therapid expansion of substrate sequences for homology searches andstructural and functional motif characterization. The results of theseanalysis permits the categorization of sequences according to structuralcharacteristics, e.g., as structural proteins, proteins involved insignal transduction, cell surface or secreted proteins etc.

It is understood that full-length nucleotide sequences may also beidentified using conventional methods, for example, library screening,RT-PCR, chromosome walking, etc., as described in Sambrook and Ausubel,infra.

Candidate Nucleotide Library of the Invention

We identified members of a candidate nucleotide library that aredifferentially expressed in activated leukocytes and resting leukocytes.Accordingly, the invention provides the candidate leukocyte nucleotidelibrary comprising the nucleotide sequences listed in Table 2, Table 3,Tables 8-10 and in the Sequence Listing. In another embodiment, theinvention provides a candidate library comprising at least twonucleotide sequences listed in Table 2, Table 3, Tables 8-10 and theSequence Listing. In another embodiment, at least two nucleotidesequences are 18 nucleotides in length, at least 35 nucleotides, atleast 40 nucleotides or at least 100 nucleotides. In some embodiments,the nucleotide sequences comprises deoxyribonucleic acid (DNA) sequence,ribonucleic acid (RNA) sequence, synthetic oligonucleotide sequence, orgenomic DNA sequence. It is understood that the nucleotide sequences mayeach correspond to one gene, or that several nucleotide sequences maycorrespond to one gene, or that a single nucleotide sequence maycorrespond to multiple genes.

The invention also provides probes to the candidate nucleotide library.In one embodiment of the invention, the probes comprise at least twonucleotide sequences listed in Table 2, Table 3, Tables 8-10, or theSequence Listing which are differentially expressed in leukocytes in anindividual with a least one disease criterion for at least oneleukocyte-related disease and in leukocytes in an individual without theat least one disease criterion, wherein expression of the two or morenucleotide sequences is correlated with at least one disease criterion.It is understood that a probe may detect either the RNA expression orprotein product expression of the candidate nucleotide library.Alternatively, or in addition, a probe can detect a genotype associatedwith a candidate nucleotide sequence, as further described below. Inanother embodiment, the probes for the candidate nucleotide library areimmobilized on an array.

The candidate nucleotide library of the invention is useful inidentifying diagnostic nucleotide sets of the invention, as describedbelow. The candidate nucleotide sequences may be further characterized,and may be identified as a disease target nucleotide sequence and/or anovel nucleotide sequence, as described below. The candidate nucleotidesequences may also be suitable for use as imaging reagents, as describedbelow.

Generation of Expression Patterns

RNA, DNA or Protein Sample Procurement

Following identification or assembly of a library of differentiallyexpressed candidate nucleotide sequences, leukocyte expression profilescorresponding to multiple members of the candidate library are obtained.Leukocyte samples from one or more subjects are obtained by standardmethods. Most typically, these methods involve trans-cutaneous venoussampling of peripheral blood. While sampling of circulating leukocytesfrom whole blood from the peripheral vasculature is generally thesimplest, least invasive, and lowest cost alternative, it will beappreciated that numerous alternative sampling procedures exist, and arefavorably employed in some circumstances. No pertinent distinctionexists, in fact, between leukocytes sampled from the peripheralvasculature, and those obtained, e.g., from a central line, from acentral artery, or indeed from a cardiac catheter, or during a surgicalprocedure which accesses the central vasculature. In addition, otherbody fluids and tissues that are, at least in part, composed ofleukocytes are also desirable leukocyte samples. For example, fluidsamples obtained from the lung during bronchoscopy may be rich inleukocytes, and amenable to expression profiling in the context of theinvention, e.g., for the diagnosis, prognosis, or monitoring of lungtransplant rejection, inflammatory lung diseases or infectious lungdisease. Fluid samples from other tissues, e.g., obtained by endoscopyof the colon, sinuses, esophagus, stomach, small bowel, pancreatic duct,biliary tree, bladder, ureter, vagina, cervix or uterus, etc., are alsosuitable. Samples may also be obtained other sources containingleukocytes, e.g., from urine, bile, cerebrospinal fluid, feces, gastricor intestinal secretions, semen, or solid organ or joint biopsies.

Most frequently, mixed populations of leukocytes, such as are found inwhole blood are utilized in the methods of the present invention. Acrude separation, e.g., of mixed leukocytes from red blood cells, and/orconcentration, e.g., over a sucrose, percoll or ficoll gradient, or byother methods known in the art, can be employed to facilitate therecovery of RNA or protein expression products at sufficientconcentrations, and to reduce non-specific background. In someinstances, it can be desirable to purify sub-populations of leukocytes,and methods for doing so, such as density or affinity gradients, flowcytometry, Fluorescence Activated Cell Sorting (FACS), immuno-magneticseparation, “panning,” and the like, are described in the availableliterature and below.

Obtaining DNA, RNA and Protein Samples for Expression Profiling

A variety of techniques are available for the isolation of RNA fromwhole blood. Any technique that allows isolation of mRNA from cells (inthe presence or absence of rRNA and tRNA) can be utilized. In brief, onemethod that allows reliable isolation of total RNA suitable forsubsequent gene expression analysis is described as follows. Peripheralblood (either venous or arterial) is drawn from a subject, into one ormore sterile, endotoxin free, tubes containing an anticoagulant (e.g.,EDTA, citrate, heparin, etc.). Typically, the sample is divided into atleast two portions. One portion, e.g., of 5-8 ml of whole blood isfrozen and stored for future analysis, e.g., of DNA or protein. A secondportion, e.g., of approximately 8 ml whole blood is processed forisolation of total RNA by any of a variety of techniques as describedin, e.g, Sambook, Ausubel, below, as well as U.S. Pat. Nos: 5,728,822and 4,843,155.

Typically, a subject sample of mononuclear leukocytes obtained fromabout 8 ml of whole blood, a quantity readily available from an adulthuman subject under most circumstances, yields 5-20 μg of total RNA.This amount is ample, e.g., for labeling and hybridization to at leasttwo probe arrays. Labeled probes for analysis of expression patterns ofnucleotides of the candidate libraries are prepared from the subject'ssample of RNA using standard methods. In many cases, cDNA is synthesizedfrom total RNA using a polyT primer and labeled, e.g., radioactive orfluorescent, nucleotides. The resulting labeled cDNA is then hybridizedto probes corresponding to members of the candidate nucleotide library,and expression data is obtained for each nucleotide sequence in thelibrary. RNA isolated from subject samples (e.g., peripheral bloodleukocytes, or leukocytes obtained from other biological fluids andsamples) is next used for analysis of expression patterns of nucleotidesof the candidate libraries.

In some cases, however, the amount of RNA that is extracted from theleukocyte sample is limiting, and amplification of the RNA is desirable.Amplification may be accomplished by increasing the efficiency of probelabeling, or by amplifying the RNA sample prior to labeling. It isappreciated that care must be taken to select an amplification procedurethat does not introduce any bias (with respect to gene expressionlevels) during the amplification process.

Several methods are available that increase the signal from limitingamounts of RNA, e.g. use of the Clontech (Glass Fluorescent LabelingKit) or Stratagene (Fairplay Microarray Labeling Kit), or the Micromaxkit (New England Nuclear, Inc.). Alternatively, cDNA is synthesized fromRNA using a T7-polyT primer, in the absence of label, and DNA dendrimersfrom Genisphere (3DNA Submicro) are hybridized to the poly T sequence onthe primer, or to a different “capture sequence” which is complementaryto a fluorescently labeled sequence. Each 3DNA molecule has 250fluorescent molecules and therefore can strongly label each cDNA.

Alternatively, the RNA sample is amplified prior to labeling. Forexample, linear amplification may be performed, as described in U.S.Pat. No. 6,132,997. A T7-polyT primer is used to generate the cDNA copyof the RNA. A second DNA strand is then made to complete the substratefor amplification. The T7 promoter incorporated into the primer is usedby a T7 polymerase to produce numerous antisense copies of the originalRNA. Fluorescent dye labeled nucleotides are directly incorporated intothe RNA. Alternatively, amino allyl labeled nucleotides are incorporatedinto the RNA, and then fluorescent dyes are chemically coupled to theamino allyl groups, as described in Hughes et al. 2001. Other exemplarymethods for amplification are described below.

It is appreciated that the RNA isolated must contain RNA derived fromleukocytes, but may also contain RNA from other cell types to a variabledegree. Additionally, the isolated RNA may come from subsets ofleukocytes, e.g. monocytes and/or T-lymphocytes, as described above.Such consideration of cell type used for the derivation of RNA dependson the method of expression profiling used.

DNA samples may be obtained for analysis of the presence of DNAmutations, single nucleotide polymorphisms (SNPs), or otherpolymorphisms. DNA is isolated using standard techniques, e.g. Maniatus,supra.

Expression of products of candidate nucleotides may also be assessedusing proteomics. Protein(s) are detected in samples of patient serum orfrom leukocyte cellular protein. Serum is prepared by centrifugation ofwhole blood, using standard methods. Proteins present in the serum mayhave been produced from any of a variety of leukocytes and non-leukocytecells, and may include secreted proteins from leukocytes. Alternatively,leukocytes or a desired sub-population of leukocytes are prepared asdescribed above. Cellular protein is prepared from leukocyte samplesusing methods well known in the art, e.g., Trizol (Invitrogen LifeTechnologies, cat # 15596108; Chomczynski, P. and Sacchi, N. (1987)Anal. Biochem. 162, 156; Simms, D., Cizdziel, P. E., and Chomczynski, P.(1993) Focus® 15, 99; Chomczynski, P., Bowers-Finn, R., and Sabatini, L.(1987) J. of NIH Res. 6, 83; Chomczynski, P. (1993) Bio/Techniques 15,532; Bracete, A. M., Fox, D. K., and Simms, D. (1998) Focus 20, 82;Sewall, A. and McRae, S. (1998) Focus 20, 36; Anal Biochem 1984April;138(1):141-3, A method for the quantitative recovery of protein indilute solution in the presence of detergents and lipids; Wessel D,Flugge Ul. (1984) Anal Biochem. 1984 April;138(1):141-143.

Obtaining Expression Patterns

Expression patterns, or profiles, of a plurality of nucleotidescorresponding to members of the candidate library are then evaluated inone or more samples of leukocytes. Typically, the leukocytes are derivedfrom patient peripheral blood samples, although, as indicated above,many other sample sources are also suitable. These expression patternsconstitute a set of relative or absolute expression values for somenumber of RNAs or protein products corresponding to the plurality ofnucleotide sequences evaluated, which is referred to herein as thesubject's “expression profile” for those nucleotide sequences. Whileexpression patterns for as few as one independent member of thecandidate library can be obtained, it is generally preferable to obtainexpression patterns corresponding to a larger number of nucleotidesequences, e.g., about 2, about 5, about 10, about 20, about 50, about100, about 200, about 500, or about 1000, or more. The expressionpattern for each differentially expressed component member of thelibrary provides a finite specificity and sensitivity with respect topredictive value, e.g., for diagnosis, prognosis, monitoring, and thelike.

Clinical Studies, Data and Patient Groups

For the purpose of discussion, the term subject, or subject sample ofleukocytes, refers to an individual regardless of health and/or diseasestatus. A subject can be a patient, a study participant, a controlsubject, a screening subject, or any other class of individual from whoma leukocyte sample is obtained and assessed in the context of theinvention. Accordingly, a subject can be diagnosed with a disease, canpresent with one or more symptom of a disease, or a predisposing factor,such as a family (genetic) or medical history (medical) factor, for adisease, or the like. Alternatively, a subject can be healthy withrespect to any of the aforementioned factors or criteria. It will beappreciated that the term “healthy” as used herein, is relative to aspecified disease, or disease factor, or disease criterion, as the term“healthy” cannot be defined to correspond to any absolute evaluation orstatus. Thus, an individual defined as healthy with reference to anyspecified disease or disease criterion, can in fact be diagnosed withany other one or more disease, or exhibit any other one or more diseasecriterion.

Furthermore, while the discussion of the invention focuses, and isexemplified using human sequences and samples, the invention is equallyapplicable, through construction or selection of appropriate candidatelibraries, to non-human animals, such as laboratory animals, e.g., mice,rats, guinea pigs, rabbits; domesticated livestock, e.g., cows, horses,goats, sheep, chicken, etc.; and companion animals, e.g., dogs, cats,etc.

Methods for Obtaining Expression Data

Numerous methods for obtaining expression data are known, and any one ormore of these techniques, singly or in combination, are suitable fordetermining expression profiles in the context of the present invention.For example, expression patterns can be evaluated by northern analysis,PCR, RT-PCR, Taq Man analysis, FRET detection, monitoring one or moremolecular beacon, hybridization to an oligonucleotide array,hybridization to a cDNA array, hybridization to a polynucleotide array,hybridization to a liquid microarray, hybridization to a microelectricarray, molecular beacons, cDNA sequencing, clone hybridization, cDNAfragment fingerprinting, serial analysis of gene expression (SAGE),subtractive hybridization, differential display and/or differentialscreening (see, e.g., Lockhart and Winzeler (2000) Nature 405:827-836,and references cited therein).

For example, specific PCR primers are designed to a member(s) of acandidate nucleotide library. cDNA is prepared from subject sample RNAby reverse transcription from a poly-dT oligonucleotide primer, andsubjected to PCR. Double stranded cDNA may be prepared using primerssuitable for reverse transcription of the PCR product, followed byamplification of the cDNA using in vitro transcription. The product ofin vitro transcription is a sense-RNA corresponding to the originalmember(s) of the candidate library. PCR product may be also be evaluatedin a number of ways known in the art, including real-time assessmentusing detection of labeled primers, e.g. TaqMan or molecular beaconprobes. Technology platforms suitable for analysis of PCR productsinclude the ABI 7700, 5700, or 7000 Sequence Detection Systems (AppliedBiosystems, Foster City, Calif.), the MJ Research Opticon (MJ Research,Waltham, Mass.), the Roche Light Cycler (Roche Diagnositics,Indianapolis, Ind.), the Stratagene MX4000 (Stratagene, La Jolla,Calif.), and the Bio-Rad iCycler (Bio-Rad Laboratories, Hercules,Calif.). Alternatively, molecular beacons are used to detect presence ofa nucleic acid sequence in an unamplified RNA or cDNA sample, orfollowing amplification of the sequence using any method, e.g. IVT (InVitro transcription) or NASBA (nucleic acid sequence basedamplification). Molecular beacons are designed with sequencescomplementary to member(s) of a candidate nucleotide library, and arelinked to fluorescent labels. Each probe has a different fluorescentlabel with non-overlapping emission wavelengths. For example, expressionof ten genes may be assessed using ten different sequence-specificmolecular beacons.

Alternatively, or in addition, molecular beacons are used to assessexpression of multiple nucleotide sequences at once. Molecular beaconswith sequence complimentary to the members of a diagnostic nucleotideset are designed and linked to fluorescent labels. Each fluorescentlabel used must have a non-overlapping emission wavelength. For example,10 nucleotide sequences can be assessed by hybridizing 10 sequencespecific molecular beacons (each labeled with a different fluorescentmolecule) to an amplified or un-amplified RNA or cDNA sample. Such anassay bypasses the need for sample labeling procedures.

Alternatively, or in addition bead arrays can be used to assessexpression of multiple sequences at once (See, e.g, LabMAP 100, LuminexCorp, Austin, Tex.). Alternatively, or in addition electric arrays areused to assess expression of multiple sequences, as exemplified by thee-Sensor technology of Motorola (Chicago, Ill.) or Nanochip technologyof Nanogen (San Diego, Calif.)

Of course, the particular method elected will be dependent on suchfactors as quantity of RNA recovered, practitioner preference, availablereagents and equipment, detectors, and the like. Typically, however, theelected method(s) will be appropriate for processing the number ofsamples and probes of interest. Methods for high-throughput expressionanalysis are discussed below.

Alternatively, expression at the level of protein products of geneexpression is performed. For example, protein expression, in a sample ofleukocytes, can be evaluated by one or more method selected from among:western analysis, two-dimensional gel analysis, chromatographicseparation, mass spectrometric detection, protein-fusion reporterconstructs, calorimetric assays, binding to a protein array andcharacterization of polysomal mRNA. One particularly favorable approachinvolves binding of labeled protein expression products to an array ofantibodies specific for members of the candidate library. Methods forproducing and evaluating antibodies are widespread in the art, see,e.g., Coligan, supra; and Harlow and Lane (1989) Antibodies: ALaboratory Manual, Cold Spring Harbor Press, NY (“Harlow and Lane”).Additional details regarding a variety of immunological and immunoassayprocedures adaptable to the present invention by selection of antibodyreagents specific for the products of candidate nucleotide sequences canbe found in, e.g., Stites and Terr (eds.)(1991) Basic and ClinicalImmunology, 7^(th) ed., and Paul, supra. Another approach uses systemsfor performing desorption spectrometry. Commercially available systems,e.g., from Ciphergen Biosystems, Inc. (Fremont, Calif.) are particularlywell suited to quantitative analysis of protein expression. Indeed,Protein Chip(arrays (see, e.g., the website, ciphergen.com) used indesorption spectrometry approaches provide arrays for detection ofprotein expression. Alternatively, affinity reagents, (e.g., antibodies,small molecules, etc.) are developed that recognize epitopes of theprotein product. Affinity assays are used in protein array assays, e.g.to detect the presence or absence of particular proteins. Alternatively,affinity reagents are used to detect expression using the methodsdescribed above. In the case of a protein that is expressed on the cellsurface of leukocytes, labeled affinity reagents are bound topopulations of leukocytes, and leukocytes expressing the protein areidentified and counted using fluorescent activated cell sorting (FACS).

It is appreciated that the methods of expression evaluation discussedherein, although discussed in the context of discovery of diagnosticnucleotide sets, are also applicable for expression evaluation whenusing diagnostic nucleotide sets for, e.g. diagnosis of diseases, asfurther discussed below.

High Throughput Expression Assays

A number of suitable high throughput formats exist for evaluating geneexpression. Typically, the term high throughput refers to a format thatperforms at least about 100 assays, or at least about 500 assays, or atleast about 1000 assays, or at least about 5000 assays, or at leastabout 10,000 assays, or more per day. When enumerating assays, eitherthe number of samples or the number of candidate nucleotide sequencesevaluated can be considered. For example, a northern analysis of, e.g.,about 100 samples performed in a gridded array, e.g., a dot blot, usinga single probe corresponding to a candidate nucleotide sequence can beconsidered a high throughput assay. More typically, however, such anassay is performed as a series of duplicate blots, each evaluated with adistinct probe corresponding to a different member of the candidatelibrary. Alternatively, methods that simultaneously evaluate expressionof about 100 or more candidate nucleotide sequences in one or moresamples, or in multiple samples, are considered high throughput.

Numerous technological platforms for performing high throughputexpression analysis are known. Generally, such methods involve a logicalor physical array of either the subject samples, or the candidatelibrary, or both. Common array formats include both liquid and solidphase arrays. For example, assays employing liquid phase arrays, e.g.,for hybridization of nucleic acids, binding of antibodies or otherreceptors to ligand, etc., can be performed in multiwell, or microtiter,plates. Microtiter plates with 96, 384 or 1536 wells are widelyavailable, and even higher numbers of wells, e.g, 3456 and 9600 can beused. In general, the choice of microtiter plates is determined by themethods and equipment, e.g., robotic handling and loading systems, usedfor sample preparation and analysis. Exemplary systems include, e.g.,the ORCA™ system from Beckman-Coulter, Inc. (Fullerton, Calif.) and theZymate systems from Zymark Corporation (Hopkinton, Mass.).

Alternatively, a variety of solid phase arrays can favorably be employedin to determine expression patterns in the context of the invention.Exemplary formats include membrane or filter arrays (e.g,nitrocellulose, nylon), pin arrays, and bead arrays (e.g., in a liquid“slurry”). Typically, probes corresponding to nucleic acid or proteinreagents that specifically interact with (e.g., hybridize to or bind to)an expression product corresponding to a member of the candidate libraryare immobilized, for example by direct or indirect cross-linking, to thesolid support. Essentially any solid support capable of withstanding thereagents and conditions necessary for performing the particularexpression assay can be utilized. For example, functionalized glass,silicon, silicon dioxide, modified silicon, any of a variety ofpolymers, such as (poly)tetrafluoroethylene, (poly)vinylidenedifluoride,polystyrene, polycarbonate, or combinations thereof can all serve as thesubstrate for a solid phase array.

In a preferred embodiment, the array is a “chip” composed, e.g., of oneof the above-specified materials. Polynucleotide probes, e.g., RNA orDNA, such as cDNA, synthetic oligonucleotides, and the like, or bindingproteins such as antibodies, that specifically interact with expressionproducts of individual components of the candidate library are affixedto the chip in a logically ordered manner, i.e., in an array. Inaddition, any molecule with a specific affinity for either the sense oranti-sense sequence of the marker nucleotide sequence (depending on thedesign of the sample labeling), can be fixed to the array surfacewithout loss of specific affinity for the marker and can be obtained andproduced for array production, for example, proteins that specificallyrecognize the specific nucleic acid sequence of the marker, ribozymes,peptide nucleic acids (PNA), or other chemicals or molecules withspecific affinity.

Detailed discussion of methods for linking nucleic acids and proteins toa chip substrate, are found in, e.g., U.S. Pat. No. 5,143,854 “LargeScale Photolithographic Solid Phase Synthesis Of Polypeptides AndReceptor Binding Screening Thereof” to Pirrung et al., issued, Sep. 1,1992; U.S. Pat. No. 5,837,832 “Arrays Of Nucleic Acid Probes OnBiological Chips” to Chee et al., issued Nov. 17, 1998; U.S. Pat. No.6,087,112 “Arrays With Modified Oligonucleotide And PolynucleotideCompositions” to Dale, issued Jul. 11, 2000; U.S. Pat. No. 5,215,882“Method Of Immobilizing Nucleic Acid On A Solid Substrate For Use InNucleic Acid Hybridization Assays” to Bahl et al., issued Jun. 1, 1993;U.S. Pat. No. 5,707,807 “Molecular Indexing For Expressed Gene Analysis”to Kato, issued Jan. 13, 1998; U.S. Pat. No. 5,807,522 “Methods ForFabricating Microarrays Of Biological Samples” to Brown et al., issuedSep. 15, 1998; U.S. Pat. No. 5,958,342 “Jet Droplet Device” to Gamble etal., issued Sep. 28, 1999; U.S. Pat. No. 5,994,076 “Methods Of AssayingDifferential Expression” to Chenchik et al., issued Nov. 30, 1999; U.S.Pat. No. 6,004,755 “Quantitative Microarray Hybridization Assays” toWang, issued Dec. 21, 1999; U.S. Pat. No. 6,048,695 “Chemically ModifiedNucleic Acids And Method For Coupling Nucleic Acids To Solid Support” toBradley et al., issued Apr. 11, 2000; U.S. Pat. No. 6,060,240 “MethodsFor Measuring Relative Amounts Of Nucleic Acids In A Complex Mixture AndRetrieval Of Specific Sequences Therefrom” to Kamb et al., issued May 9,2000; U.S. Pat. No. 6,090,556 “Method For Quantitatively Determining TheExpression Of A Gene” to Kato, issued Jul. 18, 2000; and U.S. Pat. No.6,040,138 “Expression Monitoring By Hybridization To High DensityOligonucleotide Arrays” to Lockhart et al., issued Mar. 21, 2000 each ofwhich are hereby incorporated by reference in their entirety.

For example, cDNA inserts corresponding to candidate nucleotidesequences, in a standard TA cloning vector are amplified by a polymerasechain reaction for approximately 30-40 cycles. The amplified PCRproducts are then arrayed onto a glass support by any of a variety ofwell-known techniques, e.g., the VSLIPS™ technology described in U.S.Pat. No. 5,143,854. RNA, or cDNA corresponding to RNA, isolated from asubject sample of leukocytes is labeled, e.g., with a fluorescent tag,and a solution containing the RNA (or cDNA) is incubated underconditions favorable for hybridization, with the “probe” chip. Followingincubation, and washing to eliminate non-specific hybridization, thelabeled nucleic acid bound to the chip is detected qualitatively orquantitatively, and the resulting expression profile for thecorresponding candidate nucleotide sequences is recorded. It isappreciated that the probe used for diagnostic purposes may be identicalto the probe used during diagnostic nucleotide sequence discovery andvalidation. Alternatively, the probe sequence may be different than thesequence used in diagnostic nucleotide sequence discovery andvalidation. Multiple cDNAs from a nucleotide sequence that arenon-overlapping or partially overlapping may also be used.

In another approach, oligonucleotides corresponding to members of acandidate nucleotide library are synthesized and spotted onto an array.Alternatively, oligonucleotides are synthesized onto the array usingmethods known in the art, e.g. Hughes, et al. supra. The oligonucleotideis designed to be complementary to any portion of the candidatenucleotide sequence. In addition, in the context of expression analysisfor, e.g. diagnostic use of diagnostic nucleotide sets, anoligonucleotide can be designed to exhibit particular hybridizationcharacteristics, or to exhibit a particular specificity and/orsensitivity, as further described below.

Oligonucleotide probes are also prepared using the DNA sequenceinformation for the candidate genes identified by differentialhybridization screening (listed in Tables 3, 8-10 and the SequenceListing) and/or the sequence information for the genes identified bydatabase mining (listed in Table 2) is used to design complimentaryoligonucleotide probes. Oligo probes are designed on a contract basis byvarious companies (for example, Compugen, Mergen, Affymetrix, Telechem),or designed from the candidate sequences using a variety of parametersand algorithms as indicated at the websitegenome.wi.mit.edu/cgi-bin/primer/primer3.cgi. Briefly, the length of theoligonucleotide to be synthesized is determined, preferably at least 16nucleotides, generally 18-24 nucleotides, 24-70 nucleotides and, in somecircumstances, more than 70 nucleotides. The sequence analysisalgorithms and tools described above are applied to the sequences tomask repetitive elements, vector sequences and low complexity sequences.Oligonucleotides are selected that are specific to the candidatenucleotide sequence (based on a Blast n search of the oligonucleotidesequence in question against gene sequences databases, such as the HumanGenome Sequence, UniGene, dbEST or the non-redundant database at NCBI),and have <50% G content and 25-70% G+C content. Desired oligonucleotidesare synthesized using well-known methods and apparatus, or ordered froma company (for example Sigma). Oligonucleotides are spotted ontomicroarrays. Alternatively, oligonucleotides are synthesized directly onthe array surface, using a variety of techniques (Hughes et al. 2001,Yershov et al. 1996, Lockhart et al 1996).

Hybridization signal may be amplified using methods known in the art,and as described herein, for example use of the Clontech kit (GlassFluorescent Labeling Kit), Stratagene kit (Fairplay Microarray LabelingKit), the Micromax kit (New England Nuclear, Inc.), the Genisphere kit(3DNA Submicro), linear amplification, e.g. as described in U.S. Pat.No. 6,132,997 or described in Hughes, T R, et al., Nature Biotechnology,19:343-347 (2001) and/or Westin et al. Nat Biotech. 18:199-204. In somecases, amplification techniques do not increase signal intensity, butallow assays to be done with small amounts of RNA.

Alternatively, fluorescently labeled cDNA are hybridized directly to themicroarray using methods known in the art. For example, labeled cDNA aregenerated by reverse transcription using Cy3- and Cy5-conjugateddeoxynucleotides, and the reaction products purified using standardmethods. It is appreciated that the methods for signal amplification ofexpression data useful for identifying diagnostic nucleotide sets arealso useful for amplification of expression data for diagnosticpurposes.

Microarray expression may be detected by scanning the microarray with avariety of laser or CCD-based scanners, and extracting features withnumerous software packages, for example, Imagene (Biodiscovery), FeatureExtraction Software (Agilent), Scanalyze (Eisen, M. 1999. SCANALYZE UserManual; Stanford Univ., Stanford, Calif. Ver 2.32.), GenePix (AxonInstruments).

In another approach, hybridization to microelectric arrays is performed,e.g. as described in Umek et al (2001) J Mol Diagn. 3:74-84. An affinityprobe, e.g. DNA, is deposited on a metal surface. The metal surfaceunderlying each probe is connected to a metal wire and electrical signaldetection system. Unlabelled RNA or cDNA is hybridized to the array, oralternatively, RNA or cDNA sample is amplified before hybridization,e.g. by PCR. Specific hybridization of sample RNA or cDNA results ingeneration of an electrical signal, which is transmitted to a detector.See Westin (2000) Nat Biotech. 18:199-204 (describing anchored multiplexamplification of a microelectronic chip array); Edman (1997) NAR25:4907-14; Vignali (2000) J Immunol Methods 243:243-55.

In another approach, a microfluidics chip is used for RNA samplepreparation and analysis. This approach increases efficiency becausesample preparation and analysis are streamlined. Briefly, microfluidicsmay be used to sort specific leukocyte sub-populations prior to RNApreparation and analysis. Microfluidics chips are also useful for, e.g.,RNA preparation, and reactions involving RNA (reverse transcription,RT-PCR). Briefly, a small volume of whole, anti-coagulated blood isloaded onto a microfluidics chip, for example chips available fromCaliper (Mountain View, Calif.) or Nanogen (San Diego, Calif.) Amicrofluidics chip may contain channels and reservoirs in which cellsare moved and reactions are performed. Mechanical, electrical, magnetic,gravitational, centrifugal or other forces are used to move the cellsand to expose them to reagents. For example, cells of whole blood aremoved into a chamber containing hypotonic saline, which results inselective lysis of red blood cells after a 20-minute incubation. Next,the remaining cells (leukocytes) are moved into a wash chamber andfinally, moved into a chamber containing a lysis buffer such asguanidine isothyocyanate. The leukocyte cell lysate is further processedfor RNA isolation in the chip, or is then removed for furtherprocessing, for example, RNA extraction by standard methods.Alternatively, the microfluidics chip is a circular disk containingficoll or another density reagent. The blood sample is injected into thecenter of the disc, the disc is rotated at a speed that generates acentrifugal force appropriate for density gradient separation ofmononuclear cells, and the separated mononuclear cells are thenharvested for further analysis or processing.

It is understood that the methods of expression evaluation, above,although discussed in the context of discovery of diagnostic nucleotidesots, are also applicable for expression evaluation when usingdiagnostic nucleotide sets for, e.g. diagnosis of diseases, as furtherdiscussed below.

Evaluation of Expression Patterns

Expression patterns can be evaluated by qualitative and/or quantitativemeasures. Certain of the above described techniques for evaluating geneexpression (as RNA or protein products) yield data that arepredominantly qualitative in nature. That is, the methods detectdifferences in expression that classify expression into distinct modeswithout providing significant information regarding quantitative aspectsof expression. For example, a technique can be described as aqualitative technique if it detects the presence or absence ofexpression of a candidate nucleotide sequence, i.e., an on/off patternof expression. Alternatively, a qualitative technique measures thepresence (and/or absence) of different alleles, or variants, of a geneproduct.

In contrast, some methods provide data that characterize expression in aquantitative manner. That is, the methods relate expression on anumerical scale, e.g., a scale of 0-5, a scale of 1-10, a scale of+−+++, from grade 1 to grade 5, a grade from a to z, or the like. Itwill be understood that the numerical, and symbolic examples providedare arbitrary, and that any graduated scale (or any symbolicrepresentation of a graduated scale) can be employed in the context ofthe present invention to describe quantitative differences in nucleotidesequence expression. Typically, such methods yield informationcorresponding to a relative increase or decrease in expression.

Any method that yields either quantitative or qualitative expressiondata is suitable for evaluating expression of candidate nucleotidesequence in a subject sample of leukocytes. In some cases, e.g., whenmultiple methods are employed to determine expression patterns for aplurality of candidate nucleotide sequences, the recovered data, e.g.,the expression profile, for the nucleotide sequences is a combination ofquantitative and qualitative data.

In some applications, expression of the plurality of candidatenucleotide sequences is evaluated sequentially. This is typically thecase for methods that can be characterized as low- tomoderate-throughput. In contrast, as the throughput of the elected assayincreases, expression for the plurality of candidate nucleotidesequences in a sample or multiple samples of leukocytes, is assayedsimultaneously. Again, the methods (and throughput) are largelydetermined by the individual practitioner, although, typically, it ispreferable to employ methods that permit rapid, e.g. automated orpartially automated, preparation and detection, on a scale that istime-efficient and cost-effective.

It is understood that the preceding discussion, while directed at theassessment of expression of the members of candidate libraries, is alsoapplies to the assessment of the expression of members of diagnosticnucleotide sets, as further discussed below.

Genotyping

In addition to, or in conjunction with the correlation of expressionprofiles and clinical data, it is often desirable to correlateexpression patterns with the subject's genotype at one or more geneticloci or to correlate both expression profiles and genetic loci data withclinical data The selected loci can be, for example, chromosomal locicorresponding to one or more member of the candidate library,polymorphic alleles for marker loci, or alternative disease related loci(not contributing to the candidate library) known to be, or putativelyassociated with, a disease (or disease criterion). Indeed, it will beappreciated, that where a (polymorphic) allele at a locus is linked to adisease (or to a predisposition to a disease), the presence of theallele can itself be a disease criterion.

Numerous well known methods exist for evaluating the genotype of anindividual, including southern analysis, restriction fragment lengthpolymorphism (RFLP) analysis, polymerase chain reaction (PCR),amplification length polymorphism (AFLP) analysis, single strandedconformation polymorphism (SSCP) analysis, single nucleotidepolymorphism (SNP) analysis (e.g., via PCR, Taqman or molecularbeacons), among many other useful methods. Many such procedures arereadily adaptable to high throughput and/or automated (orsemi-automated) sample preparation and analysis methods. Most, can beperformed on nucleic acid samples recovered via simple procedures fromthe same sample of leukocytes as yielded the material for expressionprofiling. Exemplary techniques are described in, e.g., Sambrook, andAusubel, supra.

Identification of the Diagnostic Oligonucleotides and OligonucleotideSets of the Invention

Identification of diagnostic nucleotides and nucleotide sets and diseasespecific target nucleotide sequence proceeds by correlating theleukocyte expression profiles with data regarding the subject's healthstatus to produce a data set designated a “molecular signature.”Examples of data regarding a patient's health status, also termed“disease criteria(ion)”, is described below and in the Section titled“selected diseases,” below. Methods useful for correlation analysis arefurther described elsewhere in the specification.

Generally, relevant data regarding the subject's health status includesretrospective or prospective health data, e.g., in the form of thesubject's medical history, as provided by the subject, physician orthird party, such as, medical diagnoses, laboratory test results,diagnostic test results, clinical events, or medication lists, asfurther described below. Such data may include information regarding apatient's response to treatment and/or a particular medication and dataregarding the presence of previously characterized “risk factors.” Forexample, cigarette smoking and obesity are previously identified riskfactors for heart disease. Further examples of health statusinformation, including diseases and disease criteria, is described inthe section titled Selected diseases, below.

Typically, the data describes prior events and evaluations (i.e.,retrospective data). However, it is envisioned that data collectedsubsequent to the sampling (i.e., prospective data) can also becorrelated with the expression profile. The tissue sampled, e.g.,peripheral blood, bronchial lavage, etc., can be obtained at one or moremultiple time points and subject data is considered retrospective orprospective with respect to the time of sample procurement.

Data collected at multiple time points, called “longitudinal data”, isoften useful, and thus, the invention encompasses the analysis ofpatient data collected from the same patient at different time points.Analysis of paired samples, such as samples from a patient at differenttimes, allows identification of differences that are specificallyrelated to the disease state since the genetic variability specific tothe patient is controlled for by the comparison; Additionally, othervariables that exist between patients may be controlled for in this way,for example, the presence or absence of inflammatory diseases (e.g.,rheumatoid arthritis) the use of medications that may effect leukocytegene expression, the presence or absence of co-morbid conditions, etc.Methods for analysis of paired samples are further described below.Moreover, the analysis of a pattern of expression profiles (generated bycollecting multiple expression profiles) provides information relatingto changes in expression level over time, and may permit thedetermination of a rate of change, a trajectory, or an expression curve.Two longitudinal samples may provide information on the change inexpression of a gene over time, while three longitudinal samples may benecessary to determine the “trajectory” of expression of a gene. Suchinformation may be relevant to the diagnosis of a disease. For example,the expression of a gene may vary from individual to individual, but aclinical event, for example, a heart attack, may cause the level ofexpression to double in each patient. In this example, clinicallyinteresting information is gleaned from the change in expression level,as opposed to the absolute level of expression in each individual.

When a single patient sample is obtained, it may still be desirable tocompare the expression profile of that sample to some referenceexpression profile. In this case, one can determine the change ofexpression between the patient's sample and a reference expressionprofile that is appropriate for that patient and the medical conditionin question. For example, a reference expression profile can bedetermined for all patients without the disease criterion in questionwho have similar characteristics, such as age, sex, race, diagnoses etc.

Generally, small sample sizes of 1040 samples from 10-20 individuals areused to identify a diagnostic nucleotide set. Larger sample sizes aregenerally necessary to validate the diagnostic nucleotide set for use inlarge and varied patient populations, as further described below. Forexample, extension of gene expression correlations to varied ethnicgroups, demographic groups, nations, peoples or races may requireexpression correlation experiments on the population of interest.

Expression Reference Standards

Expression profiles derived from a patient (i.e., subjects diagnosedwith, or exhibiting symptoms of, or exhibiting a disease criterion, orunder a doctor's care for a disease) sample are compared to a control orstandard expression RNA to facilitate comparison of expression profiles(e.g. of a set of candidate nucleotide sequences) from a group ofpatients relative to each other (i.e., from one patient in the group toother patients in the group, or to patients in another group).

The reference RNA used should have desirable features of low cost andsimplicity of production on a large scale. Additionally, the referenceRNA should contain measurable amounts of as many of the genes of thecandidate library as possible.

For example, in one approach to identifying diagnostic nucleotide sets,expression profiles derived from patient samples are compared to aexpression reference “standard.” Standard expression reference can be,for example, RNA derived from resting cultured leukocytes orcommercially available reference RNA, such as Universal reference RNAfrom Stratagene. See Nature, V406, 8-17-00, p. 747-752. Use of anexpression reference standard is particularly useful when the expressionof large numbers of nucleotide sequences is assayed, e.g. in an array,and in certain other applications, e.g. qualitative PCR, RT-PCR, etc.,where it is desirable to compare a sample profile to a standard profile,and/or when large numbers of expression profiles, e.g. a patientpopulation, are to be compared. Generally, an expression referencestandard should be available in large quantities, should be a goodsubstrate for amplification and labeling reactions, and should becapable of detecting a large percentage of candidate nucleic acids usingsuitable expression profiling technology.

Alternatively, or in addition, the expression profile derived from apatient sample is compared with the expression of an internal referencecontrol gene, for example, β-actin or CD4. The relative expression ofthe profiled genes and the internal reference control gene (from thesame individual) is obtained. An internal reference control may also beused with a reference RNA. For example, an expression profile for “gene1” and the gene encoding CD4 can be determined in a patient sample andin a reference RNA. The expression of each gene can be expressed as the“relative” ratio of expression the gene in the patient sample comparedwith expression of the gene in the reference RNA. The expression ratio(sample/reference) for gene 1 may be divided by the expression rationfor CD4 (sample/reference) and thus the relative expression of gene 1 toCD4 is obtained.

The invention also provides a buffy coat control RNA useful forexpression profiling, and a method of using control RNA produced from apopulation of buffy coat cells, the white blood cell layer derived fromthe centrifugation of whole blood. Buffy coat contains all white bloodcells, including granulocytes, mononuclear cells and platelets. Theinvention also provides a method of preparing control RNA from buffycoat cells for use in expression profile analysis of leukocytes. Buffycoat fractions are obtained, e.g. from a blood bank or directly fromindividuals, preferably from a large number of individuals such thatbias from individual samples is avoided and so that the RNA samplerepresents an average expression of a healthy population. Buffy coatfractions from about 50 or about 100, or more individuals are preferred:10 ml buffy coat from each individual is used. Buffy coat samples aretreated with an erthythrocyte lysis buffer, so that erthythrocytes areselectively removed. The leukocytes of the buffy coat layer arecollected by centrifugation. Alternatively, the buffy cell sample can befurther enriched for a particular leukocyte sub-populations, e.g.mononuclear cells, T-lymphocytes, etc. To enrich for mononuclear cells,the buffy cell pellet, above, is diluted in PBS (phosphate bufferedsaline) and loaded onto a non-polystyrene tube containing a polysucroseand sodium diatrizoate solution adjusted to a density of 1.077+/−0.001g/ml. To enrich for T-lymphocytes, 45 ml of whole blood is treated withRosetteSep (Stem Cell Technologies), and incubated at room temperaturefor 20 minutes. The mixture is diluted with an equal volume of PBS plus2% FBS and mixed by inversion. 30 ml of diluted mixture is layered ontop of 15 ml DML medium (Stem Cell Technologies). The tube iscentrifuged at 1200×g, and the enriched cell layer at the plasma:mediuminterface is removed, washed with PBS+2% FBS, and cells collected bycentrifugation at 1200×g. The cell pellet is treated with 5 ml oferythrocyte lysis buffer (EL buffer, Qiagen) for 10 minutes on ice, andenriched T-lymphocytes are collected by centrifugation.

In addition or alternatively, the buffy cells (whole buffy coat orsub-population, e.g. mononuclear fraction) can be cultured in vitro andsubjected to stimulation with cytokines or activating chemicals such asphorbol esters or ionomycin. Such stimuli may increase expression ofnucleotide sequences that are expressed in activated immune cells andmight be of interest for leukocyte expression profiling experiments.

Following sub-population selection and/or further treatment, e.g.stimulation as described above, RNA is prepared using standard methods.For example, cells are pelleted and lysed with a phenol/guanidiniumthiocyanate and RNA is prepared. RNA can also be isolated using a silicagel-based purification column or the column method can be used on RNAisolated by the phenol/guanidinium thiocyanate method. RNA fromindividual buffy coat samples can be pooled during this process, so thatthe resulting reference RNA represents the RNA of many individuals andindividual bias is minimized or eliminated. In addition, a new batch ofbuffy coat reference RNA can be directly compared to the last batch toensure similar expression pattern from one batch to another, usingmethods of collecting and comparing expression profiles describedabove/below. One or more expression reference controls are used in anexperiment. For example, RNA derived from one or more of the followingsources can be used as controls for an experiment: stimulated orunstimulated whole buffy coat, stimulated or unstimulated peripheralmononuclear cells, or stimulated or unstimulated T-lymphocytes.

Alternatively, the expression reference standard can be derived from anysubject or class of subjects including healthy subjects or subjectsdiagnosed with the same or a different disease or disease criterion.Expression profiles from subjects in two or more distinct classes arecompared to determine which subset of nucleotide sequences in thecandidate library can best distinguish between the subject classes, asfurther discussed below. It will be appreciated that in the presentcontext, the term “distinct classes” is relevant to at least onedistinguishable criterion relevant to a disease of interest, a “diseasecriterion.” The classes can, of course, demonstrate significant overlap(or identity) with respect to other disease criteria, or with respect todisease diagnoses, prognoses, or the like. The mode of discoveryinvolves, e.g., comparing the molecular signature of different subjectclasses to each other (such as patient to control, patients with a firstdiagnosis to patients with a second diagnosis, etc.) or by comparing themolecular signatures of a single individual taken at different timepoints. The invention can be applied to a broad range of diseases,disease criteria, conditions and other clinical and/or epidemiologicalquestions, as further discussed above/below.

It is appreciated that while the present discussion pertains to the useof expression reference controls while identifying diagnostic nucleotidesets, expression reference controls are also useful during use ofdiagnostic nucleotide sets, e.g. use of a diagnostic nucleotide set fordiagnosis of a disease, as further described below.

Analysis of Expression Profiles

In order to facilitate ready access, e.g., for comparison, review,recovery, and/or modification, the molecular signatures/expressionprofiles are typically recorded in a database. Most typically, thedatabase is a relational database accessible by a computational device,although other formats, e.g., manually accessible indexed files ofexpression profiles as photographs, analogue or digital imagingreadouts, spreadsheets, etc. can be used. Further details regardingpreferred embodiments are provided below. Regardless of whether theexpression patterns initially recorded are analog or digital in natureand/or whether they represent quantitative or qualitative differences inexpression, the expression patterns, expression profiles (collectiveexpression patterns), and molecular signatures (correlated expressionpatterns) are stored digitally and accessed via a database. Typically,the database is compiled and maintained at a central facility, withaccess being available locally and/or remotely.

As additional samples are obtained, and their expression profilesdetermined and correlated with relevant subject data, the ensuingmolecular signatures are likewise recorded in the database. However,rather than each subsequent addition being added in an essentiallypassive manner in which the data from one sample has little relation todata from a second (prior or subsequent) sample, the algorithmsoptionally additionally query additional samples against the existingdatabase to further refine the association between a molecular signatureand disease criterion. Furthermore, the data set comprising the one (ormore) molecular signatures is optionally queried against an expandingset of additional or other disease criteria. The use of the database inintegrated systems and web embodiments is further described below.

Analysis of Expression Profile Data from Arrays

Expression data is analyzed using methods well known in the art,including the software packages Imagene (Biodiscovery, Marina del Rey,Calif.), Feature Extraction Software (Agilent, Palo Alto, Calif.), andScanalyze (Stanford University). In the discussion that follows, a“feature” refers to an individual spot of DNA on an array. Each gene maybe represented by more than one feature. For example, hybridizedmicroarrays are scanned and analyzed on an Axon Instruments scannerusing GenePix 3.0 software (Axon Instruments, Union City, Calif.). Thedata extracted by GenePix is used for all downstream quality control andexpression evaluation. The data is derived as follows. The data for allfeatures flagged as “not found” by the software is removed from thedataset for individual hybridizations. The “not found” flag by GenePixindicates that the software was unable to discriminate the feature fromthe background. Each feature is examined to determine the value of itssignal. The median pixel intensity of the background (B_(n)) issubtracted from the median pixel intensity of the feature (F_(n)) toproduce the background-subtracted signal (hereinafter, “BGSS”). The BGSSis divided by the standard deviation of the background pixels to providethe signal-to-noise ratio (hereinafter, “S/N”). Features with a SIN ofthree or greater in both the Cy3 channel (corresponding to the sampleRNA) and Cy5 channel (corresponding to the reference RNA) are used forfurther analysis (hereinafter denoted “useable features”).Alternatively, different SINs are used for selecting expression data foran analysis. For example, only expression data with signal to noiseratios >3 might be used in an analysis. Alternatively, features with S/Nvalues <3 may be flagged as such and included in the analysis. Suchflagged data sets include more values and may allow one to discoverexpression markers that would be missed otherwise. However, such datasets may have a higher variablilty than filtered data, which maydecrease significance of findings or performance of correlationstatistics.

For each usable feature (i), the expression level (e) is expressed asthe logarithm of the ratio (R) of the Background Subtracted Signal(hereinafter “BGSS”) for the Cy3 (sample RNA) channel divided by theBGSS for the Cy5 channel (reference RNA). This “log ratio” value is usedfor comparison to other experiments. $\begin{matrix}{R_{i} = \frac{{BGSS}_{sample}}{{BGSS}_{reference}}} & (0.1)\end{matrix}$  e _(i)=log r _(i)  (0.2)

Variation in signal across hybridizations may be caused by a number offactors affecting hybridization, DNA spotting, wash conditions, andlabeling efficiency.

A single reference RNA may be used with all of the experimental RNAs,permitting multiple comparisons in addition to individual comparisons.By comparing sample RNAs to the same reference, the gene expressionlevels from each sample are compared across arrays, permitting the useof a consistent denominator for our experimental ratios.

Scaling

The data may be scaled (normalized) to control for labeling andhybridization variability within the experiment, using methods known inthe art. Scaling is desirable because it facilitates the comparison ofdata between different experiments, patients, etc. Generally the BGSSare scaled to a factor such as the median, the mean, the trimmed mean,and percentile. Additional methods of scaling include: to scale between0 and 1, to subtract the mean, or to subtract the median.

Scaling is also performed by comparison to expression patterns obtainedusing a common reference RNA, as described in greater detail above. Aswith other scaling methods, the reference RNA facilitates multiplecomparisons of the expression data, e.g., between patients, betweensamples, etc. Use of a reference RNA provides a consistent denominatorfor experimental ratios.

In addition to the use of a reference RNA, individual expression levelsmay be adjusted to correct for differences in labeling efficiencybetween different hybridization experiments, allowing direct comparisonbetween experiments with different overall signal intensities, forexample. A scaling factor (α) may be used to adjust individualexpression levels as follows. The median of the scaling factor (α), forexample, BGSS, is determined for the set of all features with a S/Ngreater than three. Next, the BGSS_(i) (the BGSS for each feature “i”)is divided by the median for all features (α), generating a scaledratio. The scaled ration is used to determine the expression value forthe feature (e_(i)), or the log ratio. $\begin{matrix}{S_{i} = \frac{{BGSS}_{i}}{a}} & (0.3) \\{e_{i} = {\log\left( \frac{{Cy3S}_{i}}{C_{y}5S_{i}} \right)}} & (0.4)\end{matrix}$

In addition, or alternatively, control features are used to normalizethe data for labeling and hybridization variability within theexperiment. Control feature may be cDNA for genes from the plant,Arabidopsis thaliana, that are included when spotting the mini-array.Equal amounts of RNA complementary to control cDNAs are added to each ofthe samples before they were labeled. Using the signal from thesecontrol genes, a normalization constant (L) is determined according tothe following formula:$L_{j} = \frac{\frac{\sum\limits_{i = 1}^{N}{BGSS}_{j,i}}{N}}{\frac{\sum\limits_{j = 1}^{K}\frac{\sum\limits_{i = 1}^{N}{BGSS}_{j,i}}{N}}{K}}$where BGSS_(i) is the signal for a specific feature, N is the number ofA. thaliana control features, K is the number of hybridizations, andL_(j) is the normalization constant for each individual hybridization.

Using the formula above, the mean for all control features of aparticular hybridization and dye (e.g., Cy3) is calculated. The controlfeature means for all Cy3 hybridizations are averaged, and the controlfeature mean in one hybridization divided by the average of allhybridizations to generate a normalization constant for that particularCy3 hybridization (L_(j)), which is used as a in equation (0.3). Thesame normalization steps may be performed for Cy3 and Cy5 values.

Many additional methods for normalization exist and can be applied tothe data. In one method, the average ratio of Cy3 BGSS/Cy5 BGSS isdetermined for all features on an array. This ratio is then scaled tosome arbitrary number, such as 1 or some other number. The ratio foreach probe is then multiplied by the scaling factor required to bringthe average ratio to the chosen level. This is performed for each arrayin an analysis. Alternatively, the ratios are normalized to the averageratio across all arrays in an analysis.

If multiple features are used per gene sequence or oligonucleotide,these repeats can be used to derive an average expression value for eachgene. If some of the replicate features are of poor qualitay and don'tmeet requirements for analysis, the remaining features can be used torepresent the gene or gene sequence.

Correlation Analysis

Correlation analysis is performed to determine which array probes haveexpression behavior that best distinguishes or serves as markers forrelevant groups of samples representing a particular clinical condition.Correlation analysis, or comparison among samples representing differentdisease criteria (e.g., clinical conditions), is performed usingstandard statistical methods. Numerous algorithms are useful forcorrelation analysis of expression data, and the selection of algorithmsdepends in part on the data analysis to be performed. For example,algorithms can be used to identify the single most informative gene withexpression behavior that reliably classifies samples, or to identify allthe genes useful to classify samples. Alternatively, algorithms can beapplied that determine which set of 2 or more genes have collectiveexpression behavior that accurately classifies samples. The use ofmultiple expression markers for diagnostics may overcome the variabilityin expression of a gene between individuals, or overcome the variabilityintrinsic to the assay. Multiple expression markers may includeredundant markers (surrogates), in that two or more genes or probes mayprovide the same information with respect to diagnosis. This may occur,for example, when two or more genes or gene probes are coordinatelyexpressed. For diagnostic application, it may be appropriate to utilizea gene and one or more of its surrogates in the assay. This redundancymay overcome failures (technical or biological) of a single marker todistinguish samples. Alternatively, one or more surrogates may haveproperties that make them more suitable for assay development, such as ahigher baseline level of expression, better cell specificity, a higherfold change between sample groups or more specific sequence for thedesign of PCR primers or complimentary probes. It will be appreciatedthat while the discussion above pertains to the analysis of RNAexpression profiles the discussion is equally applicable to the analysisof profiles of proteins or other molecular markers.

Prior to analysis, expression profile data may be formatted or preparedfor analysis using methods known in the art. For example, often the logratio of scaled expression data for every array probe is calculatedusing the following formula:

log (Cy3 BGSS/Cy5 BGSS), where Cy3 signal corresponds to the expressionof the gene in the clinical sample, and Cy5 signal corresponds toexpression of the gene in the reference RNA.

Data may be further filtered depending on the specific analysis to bedone as noted below. For example, filtering may be aimed at selectingonly samples with expression above a certain level, or probes withvariability above a certain level between sample sets.

The following non-limiting discussion consider several statisticalmethods known in the art. Briefly, the t-test and ANOVA are used toidentify single genes with expression differences between or amongpopulations, respectively. Multivariate methods are used to identify aset of two or more genes for which expression discriminates between twodisease states more specifically than expression of any single gene.

t-test

The simplest measure of a difference between two groups is the Student'st test. See, e.g., Welsh et al. (2001) Proc Natl Acad Sci USA 98:1176-81(demonstrating the use of an unpaired Student's t-test for the discoveryof differential gene expression in ovarian cancer samples and controltissue samples). The t-test assumes equal variance and normallydistributed data. This test identifies the probability that there is adifference in expression of a single gene between two groups of samples.The number of samples within each group that is required to achievestatistical significance is dependent upon the variation among thesamples within each group. The standard formula for a t-test is:$\begin{matrix}{{{t\left( e_{i} \right)} = \frac{{\overset{\_}{e}}_{i,c} - {\overset{\_}{e}}_{i,t}}{\sqrt{\left( {s_{i,c}^{2}/n_{c}} \right) + \left( {s_{i,t}^{2}\text{/}n_{t}} \right)}}},} & (0.5)\end{matrix}$where ē_(i) is the difference between the mean expression level of genei in groups c and t, s_(i,c) is the variance of gene x in group c ands_(i,t) is the variance of gene x in group t. n_(c) and n_(t) are thenumbers of samples in groups c and t.

The combination of the t statistic and the degrees of freedom[min(n_(t), n_(c))−1] provides a p value, the probability of rejectingthe null hypothesis. A p-value of ≦0.01, signifying a 99 percentprobability the mean expression levels are different between the twogroups (a 1% chance that the mean expression levels are in fact notdifferent and that the observed difference occurred by statisticalchance), is often considered acceptable.

When performing tests on a large scale, for example, on a large datasetof about 8000 genes, a correction factor must be included to adjust forthe number of individual tests being performed. The most common andsimplest correction is the Bonferroni correction for multiple tests,which divides the p-value by the number of tests run. Using this test onan 8000 member dataset indicates that a p value of ≦0.00000125 isrequired to identify genes that are likely to be truly different betweenthe two test conditions.

Significance Analysis for Microarrays (SAM)

Significance analysis for microarrays (SAM) (Tusher 2001) is a methodthrough which genes with a correlation between their expression valuesand the response vector are statistically discovered and assigned astatistical significance. The ratio of false significant to significantgenes is the False Discovery Rate (FDR). This means that for eachthreshold there are a set of genes which are called significant, and theFDR gives a confidence level for this claim. If a gene is calleddifferentially expressed between 2 classes by SAM, with a FDR of 5%,there is a 95% chance that the gene is actually differentially expressedbetween the classes. SAM takes intoaccount the variability and largenumber of variables of microarrays. SAM will identiy genes that are mostglobally differentially expressed between the classes. Thus, importantgenes for identifying and classifying outlier samples or patients maynot be identified by SAM.

Wilcoxon's Signed Ranks Test

This method is non-parametric and is utilized for paired comparisons.See e.g., Sokal and Rohlf (1987) Introduction to Biostatistics 2^(nd)edition, WH Freeman, New York. At least 6 pairs are necessary to applythis statistic. This test is useful for analysis of paired expressiondata (for example, a set of patients who have had samples taken beforeand after administration of a pharmacologic agent).

ANOVA

Differences in gene expression across multiple related groups may beassessed using an Analysis of Variance (ANOVA), a method well known inthe art (Michelson and Schofield, 1996).

Multivariate Analysis

Many algorithms suitable for multivariate analysis are known in the art(Katz 1999). Generally, a set of two or more genes for which expressiondiscriminates between two disease states more specifically thanexpression of any single gene is identified by searching through thepossible combinations of genes using a criterion for discrimination, forexample the expression of gene X must increase from normal 300 percent,while the expression of genes Y and Z must decrease from normal by 75percent. Ordinarily, the search starts with a single gene, then adds thenext best fit at each step of the search. Alternatively, the searchstarts with all of the genes and genes that do not aid in thediscrimination are eliminated step-wise.

Paired Samples

Paired samples, or samples collected at different time-points from thesame patient, are often useful, as described above. For example, use ofpaired samples permits the reduction of variation due to geneticvariation among individuals. In addition, the use of paired samples hasa statistical significance in that data derived from paired samples canbe calculated in a different manner that recognizes the reducedvariability. For example, the formula for a t-test for paired samplesis: $\begin{matrix}{{t\left( e_{x} \right)} = \frac{{\overset{\_}{D}}_{{\overset{\_}{e}}_{x}}}{\sqrt{\frac{{\sum D^{2}} - {\left( {\sum D} \right)^{2}\text{/}b}}{b - 1}}}} & (0.5)\end{matrix}$where D is the difference between each set of paired samples and b isthe number of sample pairs. {overscore (D)} is the mean of thedifferences between the members of the pairs. In this test, only thedifferences between the paired samples are considered, then groupedtogether (as opposed to taking all possible differences between groups,as would be the case with an ordinary t-test). Additional statisticaltests useful with paired data, e.g., ANOVA and Wilcoxon's signed ranktest, are discussed above.

Diagnostic Classification

Once a discriminating set of genes is identified, the diagnosticclassifier (a mathematical function that assigns samples to diagnosticcategories based on expression data) is applied to unknown sampleexpression levels.

Methods that can be used for this analysis include the followingnon-limiting list:

CLEAVER is an algorithm used for classification of useful expressionprofile data See Raychaudhuri et al. (2001) Trends Biotechnol19:189-193. CLEAVER uses positive training samples (e.g., expressionprofiles from samples known to be derived from a particular patient orsample diagnostic category, disease or disease criteria), negativetraining samples (e.g., expression profiles from samples known not to bederived from a particular patient or sample diagnostic category, diseaseor disease criteria) and test samples (e.g., expression profilesobtained from a patient), and determines whether the test samplecorrelates with the particular disease or disease criteria, or does notcorrelate with a particular disease or disease criteria. CLEAVER alsogenerates a list of the 20 most predictive genes for classification.

Artificial neural networks (hereinafter, “ANN”) can be used to recognizepatterns in complex data sets and can discover expression criteria thatclassify samples into more than 2 groups. The use of artificial neuralnetworks for discovery of gene expression diagnostics for cancers usingexpression data generated by oligonucleotide expression microarrays isdemonstrated by Khan et al. (2001) Nature Med. 7:673-9. Khan found that96 genes provided 0% error rate in classification of the tumors. Themost important of these genes for classification was then determined bymeasuring the sensitivity of the classification to a change inexpression of each gene. Hierarchical clustering using the 96 genesresults in correct grouping of the cancers into diagnostic categories.

Golub uses cDNA microarrays and a distinction calculation to identifygenes with expression behavior that distinguishes myeloid and lymphoidleukemias. See Golub et al. (1999) Science 286:531-7. Self organizingmaps were used for new class discovery. Cross validation was done with a“leave one out” analysis. 50 genes were identified as useful markers.This was reduced to as few as 10 genes with equivalent diagnosticaccuracy.

Hierarchical and non-hierarchical clustering methods are also useful foridentifying groups of genes that correlate with a subset of clinicalsamples such as those with and without Lupus. Alizadeh used hierarchicalclustering as the primary tool to distinguish different types of diffuseB-cell lymphomas based on gene expression profile data. See Alizadeh etal. (2000) Nature 403:503-11. Alizadeh used hierarchical clustering asthe primary tool to distinguish different types of diffuse B-celllymphomas based on gene expression profile data. A cDNA array carrying17856 probes was used for these experiments, 96 samples were assessed on128 arrays, and a set of 380 genes was identified as being useful forsample classification.

Perou demonstrates the use of hierarchical clustering for the molecularclassification of breast tumor samples based on expression profile data.See Perou et al. (2000) Nature 406:747-52. In this work, a cDNA arraycarrying 8102 gene probes was used. 1753 of these genes were found tohave high variation between breast tumors and were used for theanalysis.

Hastie describes the use of gene shaving for discovery of expressionmarkers. Hastie et al. (2000) Genome Biol. 1(2):RESEARCH 0003.1-0003.21.The gene shaving algorithm identifies sets of genes with similar orcoherent expression patterns, but large variation across conditions (RNAsamples, sample classes, patient classes). In this manner, genes with atight expression pattern within a diagnostic group, but also with highvariability across the diagnoses are grouped together. The algorithmtakes advantage of both characteristics in one grouping step. Forexample, gene shaving can identify useful marker genes with co-regulatedexpression. Sets of useful marker genes can be reduced to a smaller set,with each gene providing some non-redundant value in classification.This algorithm was used on the data set described in Alizadeh et al.,supra, and the set of 380 informative gene markers was reduced to 234.

Supervised harvesting of expression trees (Hastie 2001) identifies genesor clusters that best distinguish one class from all the others on thedata set. The method is used to identify the genes/clusters that canbest separate one class versus all the others for datasets that includetwo or more classes or all classes from each other. This algorithm canbe used for discovery or testing of a diagnostic gene set.

CART is a decision tree classification algorithm (Breiman 1984). Fromgene expression and or other data, CART can develop a decision tree forthe classification of samples. Each node on the decision tree involves aquery about the expression level of one or more genes or variables.Samples that are above the threshold go down one branch of the decisiontree and samples that are not go down the other branch. See examples 10and 16 for further description of its use in classification analysis andexamples of its usefulness in discovering and implementing a diagnosticgene set. CART identifies surrogates for each splitter (genes that arethe next best substitute for a useful gene inclassification.

Once a set of genes and expression criteria for those genes have beenestablished for classification, cross validation is done. There are manyapproaches, including a 10 fold cross validation analysis in which 10%of the training samples are left out of the analysis and theclassification algorithm is built with the remaining 90%. The 10% arethen used as a test set for the algorithm. The process is repeated 10times with 10% of the samples being left out as a test set each time.Through this analysis, one can derive a cross validation error whichhelps estimate the robustness of the algorithm for use on prospective(test) samples.

Clinical data are gathered for every patient sample used for expressionanalysis. Clinical variables can be quantitative or non-quantitative. Aclinical variable that is quantitiative can be used as a variable forsignificance or classification analysis. Non-quantitative clinicalvariables, such as the sex of the patient, can also be used in asignificance analysis or classification analysis with some statisticaltool. It is appreciated that the most useful diagnostic gene set for acondition may be optimal when considered along with one or morepredictive clinical variables. Clinical data can also be used assupervising vectors for a correlation analysis. That is to say that theclinical data associated with each sample can be used to divide thesamples into meaningful diagnostic categories for analysis. For example,samples can be divided into 2 or more groups based on the presence orabsence of some diagnostic criterion (a). In addition, clinical data canbe utilized to select patients for a correlation analysis or to excludethem based on some undesirable characteristic, such as an ongoinginfection, a medicine or some other issue. Clincial data can also beused to assess the pre-test probability of an outcome. For example,patients who a re female a re much more likely to be diagnosed as havingsystemic lupus erythematosis than patients who are male.

Once a set of genes are identified that classify samples with acceptableaccuracy. These genes are validated as a set using new samples that werenot used to discover the ge ne set. These samples can be taken fromfrozen archieves from the discovery clinical study or can be taken fromnew patients prospectively. Validation using a “test set” of samples canbe done using expression profiling of the gene set with microarrays orusing real-time PCR for each gene on the test set samples.Alternatively, a different expression profiling technology can be used.

Validation and Accuracy of Diagnostic Nucleoside Sets

Prior to widespread application of the diagnostic probe sets of theinvention the predictive value of the probe set is validated. When thediagnostic probe set is discovered by microarray based expressionanalysis, the differential expression of the member genes may bevalidated by a less variable and more quantitive and accurate technologysuch as real time PCR. In this type of experiment the amplificationproduct is measured during the PCR reaction. This enables the researcherto observe the amplification before any reagent becomes rate limitingfor amplification. In kinetic PCR the measurement is of C_(T) (thresholdcycle) or C_(P) (crossing point). This measure ment (C_(T)=C_(p)) is thepoint at which an amplification curve crosses a threshold fluorescencevalue. The threshold is set to a point within the area where all of thereactions were in their linear phase of amplification. When measuringC_(T), a lower C_(T) value is indicative of a higher amount of startingmaterial since an earlier cycle number means the threshold was crossedmore quickly.

Several fluorescence methodologies are available to measureamplification product in real-time PCR. Taqman (Applied BioSystems,Foster City, Calif.) uses fluorescence resonance energy transfer (FRET)to inhibit signal from a probe until the probe is degraded by thesequence specific binding and Taq 3′exonuclease activity. MolecularBeacons (Stratagene, La Jolla, Calif.) also use FRET technology, wherebythe fluorescence is measured when a hairpin structure is relaxed by thespecific probe binding to the amplified DNA. The third commonly usedchemistry is Sybr Green, a DNA-binding dye (Molecular Probes, Eugene,Oreg.). The more amplified product that is produced, the higher thesignal. The Sybr Green method is sensitive to non-specific amplificationproducts, increasing the importance of primer design and selection.Other detection chemistries can also been used, such as ethedium bromideor other DNA-binding dyes and many modifications of the fluorescentdye/quencher dye Taqman chemistry, for example scorpions.

Real-time PCR validation can be done as described in Example 15.

Typically, the oligonucleotide sequence of each probe is confirmed, e.g.by DNA sequencing using an oligonucleotide-specific primer. Partialsequence obtained is generally sufficient to confirm the identity of theoligonucleotide probe. Alternatively, a complementary polynucleotide isfluorescently labeled and hybridized to the array, or to a differentarray containing a resynthesized version of the oligo nucleotide probe,and detection of the correct probe is confirmed.

Typically, validation is performed by statistically evaluating theaccuracy of the correspondence between the molecular signature for adiagnostic probe set and a selected indicator. For example, theexpression differential for a nucleotide sequence between two subjectclasses can be expressed as a simple ratio of relative expression. Theexpression of the nucleotide sequence in subjects with selectedindicator can be compared to the expression of that nucleotide sequencein subjects without the indicator, as described in the followingequations.ΣE _(x) ai/N=E _(x) Athe average expression of nucleotide sequence x in the members of groupA;ΣE _(x) bi/M=E _(x) Bthe average expression of nucleotide sequence x in the members of groupB;E _(x) A/E×B=ΔE _(x) ABthe average differential expression of nucleotide sequence x betweengroups A and B:where Σ indicates a sum; Ex is the expression of nucleotide sequence xrelative to a standard; ai are the individual members of group A, groupA has N members; bi are the individual members of group B, group B has Mmembers.

Individual components of a diagnostic probe set each have a definedsensitivity and specificity for distinguishing between subject groups.Such individual nucleotide sequences can be employed in concert as adiagnostic probe set to increase the sensitivity and specificity of theevaluation. The database of molecular signatures is queried byalgorithms to identify the set of nucleotide sequences (i.e.,corresponding to members of the probe set) with the highest averagedifferential expression between subject groups. Typically, as the numberof nucleotide sequences in the diagnostic probe set increases, so doesthe predictive value, that is, the sensitivity and specificity of theprobe set. When the probe sets are defined they may be used fordiagnosis and patient monitoring as discussed below. The diagnosticsensitivity and specificity of the probe sets for the defined use can bedetermined for a given probe set with specified expression levels asdemonstrated above. By altering the expression threshold required forthe use of each nucleotide sequence as a diagnostic, the sensitivity andspecificity of the probe set can be altered by the practitioner. Forexample, by lowering the magnitude of the expression differentialthreshold for each nucleotide sequence in the set, the sensitivity ofthe test will increase, but the specificity will decrease. As isapparent from the foregoing discussion, sensitivity and specificity areinversely related and the predictive accuracy of the probe set iscontinuous and dependent on the expression threshold set for eachnucleotide sequence. Although sensitivity and specificity tend to havean inverse relationship when expression thresholds are altered, bothparameters calf be increased as nucleotide sequences with predictivevalue are added to the diagnostic nucleotide set. In addition a singleor a few markers may not be reliable expression markers across apopulation of patients. This is because of the variability in expressionand measurement of expression that exists between measurements,individuals and individuals over time. Inclusion of a large number ofcandidate nucleotide sequences or large numbers of nucleotide sequencesin a diagnostic nucleotide set allows for this variability as not allnucleotide sequences need to meet a threshold for diagnosis. Generally,more markers are better than a single marker. If many markers are usedto make a diagnosis, the likelihood that all expression markers will notmeet some thresholds based upon random variability is low and thus thetest will give fewer false negatives. Surrogate markers are useful forthese purposes. These are markers or genes that are coordinatelyexpressed. Surrogate markers essential provide redundant infomation, butthis redundancy can improve accuracy by decreasing errors due to assayvariability.

It is appreciated that the desired diagnostic sensitivity andspecificity of the diagnostic nucleotide set may vary depending on theintended use of the set. For example, in certain uses, high specificityand high sensitivity are desired. For example, a diagnostic nucleotideset for predicting which patient population may experience side effectsmay require high sensitivity so as to avoid treating such patients. Inother settings, high sensitivity is desired, while reduced specificitymay be tolerated. For example, in the case of a beneficial treatmentwith few side effects, it may be important to identify as many patientsas possible (high sensitivity) who will respond to the drug, andtreatment of some patients who will not respond is tolerated. In othersettings, high specificity is desired and reduced sensitivity may betolerated. For example, when identifying patients for an early-phaseclinical trial, it is important to identify patients who may respond tothe particular treatment. Lower sensitivity is tolerated in this settingas it merely results in reduced patients who enroll in the study orrequires that more patients are screened for enrollment.

To discover and validate a gene set that can be applied to accuratelydiagnose or classify patients across the country or around the world, itis necessary to ensure that the gene set was developed and validatedusing samples that represent the types of patients that will beencountered in the clinical setting. For example, diverse ethnicity,drug usage and clinical practice patterns must all be represented in thediscovery and validation to ensure that the test works on this varietyof patients.

Selected Diseases

In principle, individual oligonucleotides and diagnostic oligonucleotidesets of the invention may be developed and applied to essentially anydisease, or disease criterion, as long as at least one subset ofoligonucleotide sequences is differentially expressed in samples derivedfrom one or more individuals with a disease criteria or disease and oneor more individuals without the disease criteria or disease, wherein theindividual may be the same individual sampled at different points intime, or the individuals may be different individuals (or populations ofindividuals). For example, the subset of oligonucleotide sequences maybe differentially expressed in the sampled tissues of subjects with thedisease or disease criterion (e.g., a patient with a disease or diseasecriteria) as compared to subjects without the disease or diseasecriterion (e.g., patients without a disease (control patients)).Alternatively, or in addition, the subset of oligonucleotide sequence(s)may be differentially expressed in different samples taken from the samepatient, e.g at different points in time, at different disease stages,before and after a treatment, in the presence or absence of a riskfactor, etc.

Expression profiles corresponding to oligonucleotides and sets ofoligonucleotide sequences that correlate not with a diagnosis, butrather with a particular aspect of a disease can also be used toidentify the diagnostic oligonucleotide sets and disease specific targetoligonucleotide sequences of the invention. For example, such an aspect,or disease criterion, can relate to a subject's medical or familyhistory, e.g., occurance of an autoimmune disease, childhood illness,cause of death of a parent or other relative, prior surgery or otherintervention, medications, laboratory values and results of diagnostictesting (radiology, pathology, etc.), symptoms (including onset and/orduration of symptoms), etc. Alternatively, the disease criterion canrelate to a diagnosis, e.g., chronic inflammatory disease such as lupus,rheumatoid arthritis, osteoarthritis, or prognosis (e.g., prediction offuture diagnoses, events or complications), e.g., renal failure fromlupus, joint replacement surgery for rheumatoid arthritis, rheumatoidarthritis or systemic lupus erythematosis disease activity or the like.In other cases, the disease criterion corresponds to a therapeuticoutcome, e.g., response to a medication, response to a surgery orphysical therapy for a joint. Alternatively, the disease criteriacorrespond with previously identified or classic risk factors and maycorrespond to prognosis or future disease diagnosis. As indicated above,a disease criterion can also correspond to genotype for one or moreloci. Disease criteria (including patient data) may be collected (andcompared) from the same patient at different points in time, fromdifferent patients, between patients with a disease (criterion) andpatients respresenting a control population, etc. Longitudinal data,i.e., data collected at different time points from an individual (orgroup of individuals) may be used for comparisons of samples obtainedfrom an individual (group of individuals) at different points in time,to permit identification of differences specifically related to thedisease state, and to obtain information relating to the change inexpression over time, including a rate of change or trajectory ofexpression over time. The usefulness of longitudinal data is furtherdiscussed in the section titled “Identification of diagnostic nucleotidesets of the invention”.

It is further understood that diagnostic oligonucleotides andoligonucleotide sets may be developed for use in diagnosing conditionsfor which there is no present means of diagnosis. For example, inrheumatoid arthritis, joint destruction is often well under way before apatient experience symptoms of the condition. A diagnostic nucleotide ornucleotide set may be developed that diagnoses rheumatic jointdestruction at an earlier stage than would be possible using presentmeans of diagnosis, which rely in part on the presentation of symptomsby a patient. Diagnostic nucleotide sets may also be developed toreplace or augment current diagnostic procedures. For example, the useof a diagnostic nucleotide or nucleotide set to diagnose lupus mayreplace or supplement the current diagnostic tests and strategies.

It is understood that the following discussion of diseases is exemplaryand non-limiting, and further that the general criteria discussed above,e.g. use of family medical history, are generally applicable to thespecific diseases discussed below.

In addition to leukocytes, as described throughout, the general methodis applicable to oligonucleotide sequences that are differentiallyexpressed in any subject tissue or cell type, by the collection andassessment of samples of that tissue or cell type. However, in manycases, collection of such samples presents significant technical ormedical problems given the current state of the art.

Systemic Lupus Erythematosis (SLE)

SLE is a chronic, systemic inflammatory disease characterized bydysregulation of the immune system, which affects up to 2 millionpatients in the US. Symptoms of SLE include rashes, joint pain, abnormalblood counts, renal dysfunction and damage, infections, CNS disorders,arthralgias and autoimmunity. Patients may also have early onsetatherosclerosis. The diagnosis of SLE is difficult to make withcertainty using current diagnostic tests and algorithms. Antibody testscan be specific for the disease, but often lack sensitivity. Clinicaldiagnosis may lack both high sensitivity and specificity. SLE is adisease that clearly involves differential gene expression in leukocytescompared to patients without the disease.

Diagnostic oligonucleotides and oligonucleotide sets are identified andvalidated for use in diagnosis and monitoring of SLE activity andprogression. Disease criteria correspond to clinical data, e.g. symptomrash, joint pain, malaise, rashes, blood counts (white and red), testsof renal function e.g. creatinine, blood urea nitrogen (hereinafter,“bun”) creative clearance, data obtained from laboratory tests,including complete blood counts with differentials, CRP, ESR, ANA, SerumIL6, Soluble CD40 ligand, LDL, HDL, Anti-DNA antibodies, rheumatoidfactor, C3, C4, serum creatinine and any medication levels, the need forpain medications, cumulative doses or immunosuppressive therapy,symptoms or any manifestation of carotid atherosclerosis (e.g.ultrasound diagnosis or any other manifestations of the disease), datafrom surgical procedures such as gross operative findings andpathological evaluation of resected tissues and biopsies (e.g., renal,CNS), information on pharmacological therapy and treatment changes,clinical diagnoses of disease “flare”, hospitalizations, death, responseto medications, quantitative joint exams, results from health assessmentquestionnaires (HAQs), and other clinical measures of patient symptomsand disability. In addition, disease criteria correspond to the clinicalscore known as SLEDAI (Bombadier C, Gladman D D, Urowitz M B, Caron D,Chang C H and the Committee on Prognosis Studies in SLE: Derivation ofthe SLEDAI for Lupus Patients. Arthritis Rheum 35:630-640, 1992.).Diagnostic nucleotide sets may be useful for diagnosis of SLE,monitoring disease progression including progressive renal dysfunction,carotid atherosclerosis and CNS dysfunction, and predicting occurrenceof side-effects, for example.

Rheumatoid Arthritis

Rheumatoid arthritis (RA) effects about two million patients in the USand is a chronic and debilitating inflammatory arthritis, particularlyinvolving pain and destruction of the joints. RA often goes undiagnosedbecause patients may have no pain, but the disease is activelydestroying the joint. Other patients are known to have RA, and aretreated to alleviate symptoms, but the rate of progression of jointdestruction can't easily be monitored. Drug therapy is available, butthe most effective medicines are toxic (e.g., steroids, methotrexate)and thus need to be used with caution. A new class of medications (TNFblockers) is very effective, but the drugs are expensive, have sideeffects, and not all patients respond. Side-effects are common andinclude immune suppression, toxicity to organ systems, allergy andmetabolic disturbances.

Diagnostic oligonucleotides and oligonucleotide sets of the inventionare developed and validated for use in diagnosis and treatment of RA.Disease criteria correspond to disease symptoms (e.g., joint pain, jointswelling and joint stiffness and any of the American College forRheumatology criteria for the diagnosis of RA, see Arnett et al (1988)Arthr. Rheum. 31:315-24), progression of joint destruction (e.g. asmeasured by serial hand radiographs, assessment of joint function andmobility), surgery, need for medication, additional diagnoses ofinflammatory and non-inflammatory conditions, and clinical laboratorymeasurements including complete blood counts with differentials, CRP,ESR, ANA, Serum IL6, Soluble CD40 ligand, LDL, HDL, Anti-DNA antibodies,rheumatoid factor, C3, C4, serum creatinine, death, hospitalization anddisability due to joint destruction. In addition, or alternatively,disease criteria correspond to response to drug therapy and presence orabsence of side-effects or measures of improvement exemplified by theAmerican College of Rheumatology “20%” and “50%” response/improvementrates. See Felson et al (1995) Arthr Rheum 38:531-37. Diagnosticnucleotide sets are identified that monitor and predict diseaseprogression including flaring (acute worsening of disease accompanied byjoint pain or other symptoms), response to drug treatment and likelihoodof side-effects.

In addition to peripheral leukocytes, surgical specimens of rheumatoidjoints can be used for leukocyte expression profiling experiments.Members of diagnostic nucleotide sets are candidates for leukocytetarget nucleotide sequences, e.g. as a candidate drug target forrheumatoid arthritis. Synovial specimens can be used for expressionprofiling or cells derived and sorted from that tissue (such as subsetsof leukocytes) can be used. Cells can be separated by fluorescenceactivated cell sorting or magnetic affinity reagent techniques or someother technique. Synovial specimens and blood can be obtained from thesame patient and gene expression can be compared between these 2 sampletypes.

Osteoarthritis

20-40 million patients in the US have osteoarthritis. Patient groups areheterogeneous, with a subset of patients having earlier onset, moreaggressive joint damage, involving more inflammation (leukocyteinfiltration). Leukocyte diagnostics can be used to distinguishosteoarthritis from rheumatoid arthritis and other differntialdiagnoses, define likelihood and degree of response to NSAID therapy(non-steroidal anti-inflammatory drugs) or other anti-inflammatorytherapies. Rate of progression of joint damage can also be assessed.Diagnostic nucleotide sets may be developed for use in selection andtitration of treatment therapies. Disease criteria correspond toresponse to therapy, and disease progression using certain therapies,response to medications, need for joint surgery, joint pain anddisability.

In addition to peripheral leukocytes, surgical specimens ofosteoarthritic joints can be used for leukocyte expression profilingexperiments. Diagnostic oligonucleotides and diagnostic oligonucleotidesets are candidates for leukocyte target nucleotide sequences, e.g. as acandidate drug target for osteoarthritis. Synovial specimens can be usedfor expression profiling or cells derived and sorted from that tissue(such as subsets of leukocytes) can be used. Cells can be separated byfluorescence activated cell sorting or magnetic affinity reagenttechniques or some other technique. Synovial specimens and blood can beobtained from the same patient and gene expression can be comparedbetween these 2 sample types.

In another example, diagnostic nucleotide sets ate developed andvalidated for use in diagnosis and therapy of peri-prostheticosteolysis. In this disease, a prosthetic joint such as a knee or hip isfound to loosen over time and requires repeat surgery. Loosening mayoccur in some patients due to an inflammatory response incited by theforeign material of the prosthesis. Disease criteria include jointloosening, radiographic evidence of peri-prosthetic osteolysis, need forrepeat surgery, response to pharmacological therapy, and/or histological(from biopsy or surgery) or biochemical (markers of bone metabolism suchas alkaline phosphatase) evidence of osteolysis. Tissues used forexpression profiling can include peripheral leukocytes or leukocytesubsets, periprosthetic tissue, or synovial fluid. In addition, genesets can be discovered using an in vitromodel of the disease in whichimmune cells are exposed to prosthesis materials such as cement ortitanium.

Pharmacogenomics

Pharmocogenomics is the study of the individual propensity to respond toa particular drug therapy (combination of therapies). In this context,response can mean whether a particular drug will work on a particularpatient, e.g. some patients respond to one drug but not to another drug.Response can also refer to the likelihood of successful treatment or theassessment of progress in treatment. Titration of drug therapy to aparticular patient is also included in this description, e.g. differentpatients can respond to different doses of a given medication. Thisaspect may be important when drugs with side-effects or interactionswith other drug therapies are contemplated.

Diagnostic oligonucleotides and oligonucleotide sets are developed andvalidated for use in assessing whether a patient will respond to aparticular therapy and/or monitoring response of a patient to drugtherapy(therapies). Disease criteria correspond to presence or absenceof clinical symptoms or clinical endpoints, presence of side-effects orinteraction with other drug(s). The diagnostic nucleotide set mayfurther comprise nucleotide sequences that are targets of drug treatmentor markers of active disease.

Diagnostic oligonucleotides and oligonucleotide sets are developed andvalidated for use in assessing whether a patient has a particular drugtoxicity or toxicity due to an environmental, work-related or otheragent. Such exposures of the patient may also be related to biologicalor biochemical agents used in warfare. Diagnostic oligonucleotides andoligonucleotide sets may allow early diagnosis of a toxicity or exposureor may monitor the severity and course of toxic responses.

Methods of Using Diagnostic Oligonucleotides and Oligonucleotide Sets.

The invention also provide methods of using the diagnosticoligonucleotides and oligonucleotide sets to: diagnose or monitordisease; assess severity of disease; predict future occurrence ofdisease; predict future complications of disease; determine diseaseprognosis; evaluate the patient's risk, or “stratify” a group ofpatients; assess response to current drug therapy; assess response tocurrent non-pharmacological therapy; determine the most appropriatemedication or treatment for the patient; predict whether a patient islikely to respond to a particular drug; and determine most appropriateadditional diagnostic testing for the patient, among other clinicallyand epidemiologically relevant applications.

The oligonucleotides and oligonucleotide sets of the invention can beutilized for a variety of purposes by physicians, healthcare workers,hospitals, laboratories, patients, companies and other institutions. Asindicated previously, essentially any disease, condition, or status forwhich at least one nucleotide sequence is differentially expressed inleukocyte populations (or sub-populations) can be evaluated, e.g.,diagnosed, monitored, etc. using the diagnostic nucleotide sets andmethods of the invention. In addition to assessing health status at anindividual level, the diagnostic nucleotide sets of the presentinvention are suitable for evaluating subjects at a “population level,”e.g., for epidemiological studies, or for population screening for acondition or disease.

Collection and Preparation of Sample

RNA, protein and/or DNA are prepared using methods well-known in theart, as further described herein. It is appreciated that subject samplescollected for use in the methods of the invention are generallycollected in a clinical setting, where delays may be introduced beforeRNA samples are prepared from the subject samples of whole blood, e.g.the blood sample may not be promptly delivered to the clinical lab forfurther processing. Further delay may be introduced in the clinical labsetting where multiple samples are generally being processed at anygiven time. For this reason, methods that feature lengthy incubations ofintact leukocytes at room temperature are not preferred, because theexpression profile of the leukocytes may change during this extendedtime period. For example, RNA can be isolated from whole blood using aphenol/guanidine isothiocyanate reagent or another direct whole-bloodlysis method, as described in, e.g., U.S. Pat. Nos. 5,346,994 and4,843,155. This method may be less preferred under certain circumstancesbecause the large majority of the RNA recovered from whole blood RNAextraction comes from erythrocytes since these cells outnumberleukocytes 1000:1. Care must be taken to ensure that the presence oferythrocyte RNA and protein does not introduce bias in the RNAexpression profile data or lead to inadequate sensitivity or specificityof probes.

Alternatively, intact leukocytes may be collected from whole blood usinga lysis buffer that selectively lyses erythrocytes, but not leukocytes,as described, e.g., in (U.S. Pat. Nos. 5,973,137, and 6,020,186). Intactleukocytes are then collected by centrifugation, and leukocyte RNA isisolated using standard protocols, as described herein. However, thismethod does not allow isolation of sub-populations of leukocytes, e.g.mononuclear cells, which may be desired. In addition, the expressionprofile may change during the lengthy incubation in lysis buffer,especially in a busy clinical lab where large numbers of samples arebeing prepared at any given time.

Alternatively, specific leukocyte cell types can be separated usingdensity gradient reagents (Boyum, A, 1968.). For example, mononuclearcells may be separated from whole blood using density gradientcentrifugation, as described, e.g., in U.S. Pat. Nos. 4,190,535,4,350,593, 4751001, 4818418, and 5053134. Blood is drawn directly into atube containing an anticoagulant and a density reagent (such as Ficollor Percoll). Centrifugation of this tube results in separation of bloodinto an erythrocyte and granulocyte layer, a mononuclear cellsuspension, and a plasma layer. The mononuclear cell layer is easilyremoved and the cells can be collected by centrifugation, lysed, andfrozen. Frozen samples are stable until RNA can be isolated. Densitycentrifugation, however, must be conducted at room temperature, and ifprocessing is unduly lengthy, such as in a busy clinical lab, theexpression profile may change.

The quality and quantity of each clinical RNA sample is desirablychecked before amplification and labeling for array hybridization, usingmethods known in the art. For example, one microliter of each sample maybe analyzed on a Bioanalyzer (Agilent 2100 Palo Alto, Calif. USA) usingan RNA 6000 nano LabChip (Caliper, Mountain View, Calif. USA). DegradedRNA is identified by the reduction of the 28S to 18S ribosomal RNA ratioand/or the presence of large quantities of RNA in the 25-100 nucleotiderange.

It is appreciated that the RNA sample for use with a diagnosticoligonucleotide or oligonucleotide set may be produced from the same ora different cell population, sub-population and/or cell type as used toidentify the diagnostic nucleotide set. For example, a diagnosticoligonucleotide or oligonucleotide set identified using RNA extractedfrom mononuclear cells may be suitable for analysis of RNA extractedfrom whole blood or mononuclear cells, depending on the particularcharacteristics of the members of the diagnostic nucleotide set.Generally, diagnostic oligonucleotides or oligonucleotide sets must betested and validated when used with RNA derived from a different cellpopulation, sub-population or cell type than that used when obtainingthe diagnostic gene set. Factors such as the cell-specific geneexpression of diagnostic nucleotide set members, redundancy of theinformation provided by members of the diagnostic nucleotide set,expression level of the member of the diagnostic nucleotide set, andcell-specific alteration of expression of a member of the diagnosticnucleotide set will contribute to the usefullness of a different RNAsource than that used when identifying the members of the diagnosticnucleotide set. It is appreciated that it may be desirable to assay RNAderived from whole blood, obviating the need to isolate particular celltypes from the blood.

Assessing Expression for Diagnostics

Expression profiles for the oligonucleotides or the set of diagnosticoligonucleotide sequences in a subject sample can be evaluated by anytechnique that determines the expression of each componentoligonucleotide sequence. Methods suitable for expression analysis areknown in the art, and numerous examples are discussed in the Sectionstitled “Methods of obtaining expression data” and “high throughputexpression Assays”, above.

In many cases, evaluation of expression profiles is most efficiently,and cost effectively, performed by analyzing RNA expression.Alternatively, the proteins encoded by each component of the diagnosticnucleotide set are detected for diagnostic purposes by any techniquecapable of determining protein expression, e.g., as described above.Expression profiles can be assessed in subject leukocyte sample usingthe same or different techniques as those used to identify and validatethe diagnostic oligonucleotide or oligonucleotide set. For example, adiagnostic nucleotide set identified as a subset of sequences on a cDNAmicroarray can be utilized for diagnostic (or prognostic, or monitoring,etc.) purposes on the same array from which they were identified.Alternatively, the diagnostic nucleotide sets for a given disease orcondition can be organized onto a dedicated sub-array for the indicatedpurpose. It is important to note that if diagnostic nucleotide sets arediscovered using one technology, e.g. RNA expression profiling, butapplied as a diagnostic using another technology, e.g. proteinexpression profiling, the nucleotide (or gene, or protein) sets mustgenerally be validated for diagnostic purposes with the new technology.In addition, it is appreciated that diagnostic nucleotide sets that aredeveloped for one use, e.g. to diagnose a particular disease, may laterbe found to be useful for a different application, e.g. to predict thelikelihood that the particular disease will occur. Generally, thediagnostic nucleotide set will need to be validated for use in thesecond circumstance. As discussed herein, the sequence of diagnosticnucleotide set members may be amplified from RNA or cDNA using methodsknown in the art providing specific amplification of the nucleotidesequences.

Identification of Novel Nucleotide Sequences that are DifferentiallyExpressed in Leukocytes

Novel nucleotide sequences that are differentially expressed inleukocytes are also part of the invention. Previously unidentified openreading frames maybe identified in a library of differentially expressedcandidate nucleotide sequences, as described above, and the DNA andpredicted protein sequence may be identified and characterized as notedabove. We identified unnamed (not previously described as correspondingto a gene, or an expressed gene) nucleotide sequences in our candidatenucleotide library, depicted in Table 3A, 3B AND 3C and the sequencelisting. Accordingly, further embodiments of the invention are theisolated nucleic acids described in Tables 3A and 3B AND 3C and in thesequence listing. The novel differentially expressed nucleotidesequences of the invention are useful in the diagnostic nucleotide setof the invention described above, and are further useful as members of adiagnostic nucleotide set immobilized on an array. The novel partialnucleotide sequences may be further characterized using sequence toolsand publically or privately accessible sequence databases, as is wellknown in the art: Novel differentially expressed nucleotide sequencesmay be identified as disease target nucleotide sequences, describedbelow. Novel nucleotide sequences may also be used as imaging reagent,as further described below.

As used herein, “novel nucleotide sequence” refers to (a) a nucleotidesequence containing at least one of the DNA sequences disclosed herein(as shown in FIGS. Table 3A, 3B a nd the sequence listing); (b) a anyDNA sequence that encodes the amino acid sequence encoded by the DNAsequences disclosed herein; (c) any DNA sequence that hybridizes to thecomplement of the coding sequences disclosed herein, contained withinthe coding region of the nucleotide sequence to which the DNA sequencesdisclosed herein (as shown in Table 3A, 3B AND 3C and the sequencelisting) belong, under highly stringent conditions, e.g., hybridizationto filter-bound DNA in 0.5 M NaHPO₄, 7% sodium dodecyl sulfate (SDS), 1mM EDTA at 65° C., and washing in 0.1×SSC/0.1% SDS at 68° C. (Ausubel F.M. et al., eds., 1989, Current Protocols in Molecular Biology, Vol. I,Green Publishing Associates, Inc., and John Wiley & sons, Inc., NewYork, at p. 2.10.3), (d) any DNA sequence that hybridizes to thecomplement of the coding sequences disclosed herein, (as shown in Table3A, 3B AND 3C and the sequence listing) contained within the codingregion of the nucleotide sequence to which DNA sequences disclosedherein (as shown in TABLES 3A, 3B and the sequence listing) belong,under less stringent conditions, such as moderately stringentconditions, e.g., washing in 0.2×SSC/0.1% SDS at 42° C. (Ausubel et al.,1989, supra), yet which still encodes a functionally equivalent geneproduct; and/or (e) any DNA sequence that is at least 90% identical, atleast 80% identical or at least 70% identical to the coding sequencesdisclosed herein (as shown in TABLES 3A, 3B AND 3C and the sequencelisting), wherein % identity is determined using standard algorithmsknown in the art.

The invention also includes nucleic acid molecules, preferably DNAmolecules, that hybridize to, and are therefore the complements of, theDNA sequences (a) through (c), in the preceding paragraph. Suchhybridization conditions may be highly stringent or less highlystringent, as described above. In instances wherein the nucleic acidmolecules are deoxyoligonucleotides (“oligos”), highly stringentconditions may refer, e.g., to washing in 6×SSC/0.05% sodiumpyrophosphate at 37° C. (for 14-base oligos), 48° C. (for 17-baseoligos), 55° C. (for 20-base oligos), and 60° C. (for 23-base oligos).These nucleic acid molecules may act as target nucleotide sequenceantisense molecules, useful, for example, in target nucleotide sequenceregulation and/or as antisense primers in amplification reactions oftarget nucleotide sequence nucleic acid sequences. Further, suchsequences may be used as part of ribozyme and/or triple helix sequences,also useful for target nucleotide sequence regulation. Still further,such molecules may be used as components of diagnostic methods wherebythe presence of a disease-causing allele, may be detected.

The Invention Also Encompasses Nucleic Acid Molecules Contained inFull-Length Gene Sequences That Are Related to Or Derived From SequencesIn Tables 2, 3, 8-10 and the Sequence Listing. One Sequence May Map toMore Than One Full-Length Gene.

The invention also encompasses (a) DNA vectors that contain any of theforegoing coding sequences and/or their complements (i.e., antisense);(b) DNA expression vectors that contain any of the foregoing codingsequences operatively associated with a regulatory element that directsthe expression of the coding sequences; and (c) genetically engineeredhost cells that contain any of the foregoing coding sequencesoperatively associated with a regulatory element that directs theexpression of the coding sequences in the host cell. As used herein,regulatory elements include but are not limited to inducible andnon-inducible promoters, enhancers, operators and other elements knownto those skilled in the art that drive and regulate expression. Theinvention includes fragments of any of the DNA sequences disclosedherein. Fragments of the DNA sequences may be at least 5, at least 10,at least 15, at least 19 nucleotides, at least 25 nucleotides, at least50 nucleotides, at least 100 nucleotides, at least 200, at least 500, orlarger.

In addition to the oligonucleotide sequences described above, homologuesand orthologs of such sequences, as may, for example be present in otherspecies, may be identified and may be readily isolated, without undueexperimentation, by molecular biological techniques well known in theart, as well as use of gene analysis tools described above, and e.g., inExample 4. Further, there may exist nucleotide sequences at othergenetic loci within the genome that encode proteins, which haveextensive homology to one or more domains of such gene products. Thesenucleotide sequences may also be identified via similar techniques.

For example, the isolated differentially expressed nucleotide sequencemay be labeled and used to screen a cDNA library constructed from mRNAobtained from the organism of interest. Hybridization conditions will beof a lower stringency when the cDNA library was derived from an organismdifferent from the type of organism from which the labeled sequence wasderived. Alternatively, the labeled fragment may be used to screen agenomic library derived from the organism of interest, again, usingappropriately stringent conditions. Such low stringency conditions willbe well known to those of skill in the art, and will vary predictablydepending on the specific organisms from which the library and thelabeled sequences are derived. For guidance regarding such conditionssee, for example, Sambrook et al., 1989, Molecular Cloning, A LaboratoryManual, Cold Springs Harbor Press, N.Y.; and Ausubel et al., 1989,Current Protocols in Molecular Biology, Green Publishing Associates andWiley Interscience, N.Y.

Protein Products

Novel nucleotide products include those proteins encoded by the novelnucleotide sequences described, above. Specifically, novel gene productsmay include polypeptides encoded by the novel nucleotide sequencescontained in the coding regions of the nucleotide sequences to which DNAsequences disclosed herein (in TABLES 3A, 3B and the sequence listing).

In addition, novel protein products of novel nucleotide sequences mayinclude proteins that represent functionally equivalent gene products.Such an equivalent novel gene product may contain deletions, additionsor substitutions of amino acid residues within the amino acid sequenceencoded by the novel nucleotide sequences described, above, but whichresult in a silent change, thus producing a functionally equivalentnovel nucleotide sequence product. Amino acid substitutions may be madeon the basis of similarity in polarity, charge, solubility,hydrophobicity, hydrophilicity, and/or the amphipathic nature of theresidues involved.

For example, nonpolar (hydrophobic) amino acids include alanine,leucine, isoleucine, valine, proline, phenylalanine, tryptophan, andmethionine; polar neutral amino acids include glycine, serine,threonine, cysteine, tyrosine, asparagine, and glutamine; positivelycharged (basic) amino acids include arginine, lysine, and histidine; andnegatively charged (acidic) amino acids include aspartic acid andglutamic acid. “Functionally equivalent”, as utilized herein, refers toa protein capable of exhibiting a substantially similar in vivo activityas the endogenous novel gene products encoded by the novel nucleotidedescribed, above.

The novel gene products (protein products of the novel nucleotidesequences) may be produced by recombinant DNA technology usingtechniques well known in the art. Methods which are well known to thoseskilled in the art can be used to construct expression vectorscontaining novel nucleotide sequence protein coding sequences andappropriate transcriptional/translational control signals. These methodsinclude, for example, in vitro recombinant DNA techniques, synthetictechniques and in vivo recombination/genetic recombination. See, forexample, the techniques described in Sambrook et al., 1989, supra, andAusubel et al., 1989, supra. Alternatively, RNA capable of encodingnovel nucleotide sequence protein sequences may be chemicallysynthesized using, for example, synthesizers. See, for example, thetechniques described in “Oligonucleotide Synthesis”, 1984, Gait, M. J.ed., IRL Press, Oxford, which is incorporated by reference herein in itsentirety. A variety of host-expression vector systems may be utilized toexpress the novel nucleotide sequence coding sequences of the invention.(Ruther et al., 1983, EMBO J. 2:1791; Inouyc & Inouye, 1985, NucleicAcids Res. 13:3101-3109; Van Heeke & Schuster, 1989, J. Biol. Chem.264:5503; Smith et al., 1983, J. Virol. 46: 584; Smith, U.S. Pat. No.4,215,051; Logan & Shenk, 1984, Proc. Natl. Acad. Sci. USA 81:3655-3659;Bittner et al., 1987, Methods in Enzymol. 153:516-544; Wigler, et al.,1977, Cell 11:223; Szybalska & Szybalski, 1962, Proc. Natl. Acad. Sci.USA 48:2026; Lowy, et al., 1980, Cell 22:817; Wigler, et al., 1980,Natl. Acad. Sci. USA 77:3567; O'Hare, et al., 1981, Proc. Natl. Acad.Sci. USA 78:1527; Mulligan & Berg, 1981, Proc. Natl. Acad. Sci. USA78:2072; Colberre-Garapin, et al., 1981, J. Mol. Biol. 150:1; Santerre,et al., 1984, Gene 30:147; Janknecht, et al., 1991, Proc. Natl. Acad.Sci. USA 88: 8972-8976

Where recombinant DNA technology is used to produce the protein encodedby the novel nucleotide sequence for such assay systems, it may beadvantageous to engineer fusion proteins that can facilitate labeling,immobilization and/or detection.

Indirect labeling involves the use of a protein, such as a labeledantibody, which specifically binds to the protein encoded by the novelnucleotide sequence. Such antibodies include but are not limited topolyclonal, monoclonal, chimeric, single chain, Fab fragments andfragments produced by an Fab expression library.

Antibodies

The invention also provides for antibodies to the protein encoded by thenovel nucleotide sequences. Described herein are methods for theproduction of antibodies capable of specifically recognizing one or morenovel nucleotide sequence epitopes. Such antibodies may include, but arenot limited to polyclonal antibodies, monoclonal antibodies (mAbs),humanized or chimeric antibodies, single chain antibodies, Fabfragments, F(ab′)2 fragments, fragments produced by a Fab expressionlibrary, anti-idiotypic (anti-Id) antibodies, and epitope-bindingfragments of any of the above. Such antibodies may be used, for example,in the detection of a novel nucleotide sequence in a biological sample,or, alternatively, as a method for the inhibition of abnormal geneactivity, for example, the inhibition of a disease target nucleotidesequence, as further described below. Thus, such antibodies may beutilized as part of cardiovascular or other disease treatment method,and/or may be used as part of diagnostic techniques whereby patients maybe tested for abnormal levels of novel nucleotide sequence encodedproteins, or for the presence of abnormal forms of the such proteins.

For the production of antibodies to a novel nucleotide sequence, varioushost animals may be immunized by injection with a novel protein encodedby the novel nucleotide sequence, or a portion thereof. Such hostanimals may include but are not limited to rabbits, mice, and rats, toname but a few. Various adjuvants may be used to increase theimmunological response, depending on the host species, including but notlimited to Freund's (complete and incomplete), mineral gels such asaluminum hydroxide, surface active substances such as lysolecithin,pluronic polyols, polyanions, peptides, oil emulsions, keyhole limpethemocyanin, dinitrophenol, and potentially useful human adjuvants suchas BCG (bacille Calmette-Guerin) and Corynebacterium parvum.

Polyclonal antibodies are heterogeneous populations of antibodymolecules derived from the sera of animals immunized with an antigen,such as novel gene product, or an antigenic functional derivativethereof. For the production of polyclonal antibodies, host animals suchas those described above, may be immunized by injection with novel geneproduct supplemented with adjuvants as also described above.

Monoclonal antibodies, which are homogeneous populations of antibodiesto a particular antigen, may be obtained by any technique which providesfor the production of antibody molecules by continuous cell lines inculture. These include, but are not limited to the hybridoma techniqueof Kohler and Milstein, (1975, Nature 256:495-497; and U.S. Pat. No.4,376,110), the human B-cell hybridoma technique (Kosbor et al., 1983,Immunology Today 4:72; Cole et al., 1983, Proc. Natl. Acad. Sci. USA80:2026-2030), and the EBV-hybridoma technique (Cole et al., 1985,Monoclonal Antibodies And Cancer Therapy, Alan R. Liss, Inc., pp.77-96). Such antibodies may be of any immunoglobulin class includingIgG, IgM, IgE, IgA, IgD and any subclass thereof. The hybridomaproducing the mAb of this invention may be cultivated in vitro or invivo.

In addition, techniques developed for the production of “chimericantibodies” (Morrison et al., 1984, Proc. Natl. Acad. Sci.,81:6851-6855; Neuberger et al., 1984, Nature, 312:604-608; Takeda etal., 1985, Nature, 314:452-454) by splicing the genes from a mouseantibody molecule of appropriate antigen specificity together with genesfrom a human antibody molecule of appropriate biological activity can beused. A chimeric antibody is a molecule in which different portions arederived from different animal species, such as those having a variableregion derived from a murine mAb and a human immunoglobulin constantregion.

Alternatively, techniques described for the production of single chainantibodies (U.S. Pat. No. 4,946,778; Bird, 1988, Science 242:423-426;Huston et al., 1988, Proc. Natl. Acad. Sci. USA 85:5879-5883; and Wardet al., 1989, Nature 334:544-546) can be adapted to produce novelnucleotide sequence-single chain antibodies. Single chain antibodies areformed by linking the heavy and light chain fragments of the Fv regionvia an amino acid bridge, resulting in a single chain polypeptide.

Antibody fragments which recognize specific epitopes may be generated byknown techniques For example, such fragments include but are not limitedto: the F(ab′)2 fragments which can be produced by pepsin digestion ofthe antibody molecule and the Fab fragments which can be generated byreducing the disulfide bridges of the F(ab′)2 fragments. Alternatively,Fab expression libraries may be constructed (Huse et al., 1989, Science,246:1275-1281) to allow rapid and easy identification of monoclonal Fabfragments with the desired specificity.

Disease Specific Target Oligonucleotide Sequences

The invention also provides disease specific target oligonucleotidesequences, and sets of disease specific target oligonucleotidesequences. The diagnostic oligonucleotide sets, subsets thereof, noveloligonucleotide sequences, and individual members of the diagnosticoligonucleotide sets identified as described above are also diseasespecific target oligonucleotide sequences. In particular, individualoligonucleotide sequences that are differentially regulated or havepredictive value that is strongly correlated with a disease or diseasecriterion are especially favorable as disease specific targetoligonucleotide sequences. Sets of genes that are co-regulated may alsobe identified as disease specific target oligonucleotide sets. Sucholigonucleotide sequences and/or oligonucleotide sequence products aretargets for modulation by a variety of agents and techniques. Forexample, disease specific target oligonucleotide sequences (or theproducts of such oligonucleotide sequences, or sets of disease specifictarget oligonucleotide sequences) can be inhibited or activated by,e.g., target specific monoclonal antibodies or small moleculeinhibitors, or delivery of the oligonucleotide sequence or gene productof the oligonucleotide sequence to patients. Also, sets of genes can beinhibited or activated by a variety of agents and techniques. Thespecific usefulness of the target oligonucleotide sequence(s) depends onthe subject groups from which they were discovered, and the disease ordisease criterion with which they correlate.

Kits

The present invention is optionally provided to a user as a kit.Typically, a kit contains one or more diagnostic nucleotide sets of theinvention. Alternatively, the kit contains the candidate nucleotidelibrary of the invention. Most often, the kit contains a diagnosticnucleotide probe set, or other subset of a candidate library, (e.g., asa cDNA, oligonucleotide or antibody microarray or reagents forperforming an assay on a diagnostic gene set using any expressionprofiling technology), packaged in a suitable container. The kit mayfurther comprise, one or more additional reagents, e.g., substrates,labels, primers, for labeling expression products, tubes and/or otheraccessories, reagents for collecting blood samples, buffers, e.g.,erythrocyte lysis buffer, leukocyte lysis buffer, hybridizationchambers, cover slips, etc., as well as a software package, e.g.,including the statistical methods of the invention, e.g., as describedabove, and a password and/or account number for accessing the compileddatabase. The kit optionally further comprises an instruction set oruser manual detailing preferred methods of using the diagnosticnucleotide sets in the methods of the invention.

This invention will be better understood by reference to the followingnon-limiting Examples:

Examples

Example 1: Generation of subtracted leukocyte candidate nucleotidelibrary

Example 2: Identification of nucleotide sequences for candidate libraryusing data mining techniques

Example 3: DNA Sequencing and Processing of raw sequence data

Example 4: Further sequence analysis of novel nucleotide sequencesidentified by subtractive hybridization screening

Example 5: Further sequence analysis of novel Clone 596H6

Example 6: Further sequence analysis of novel Clone 486E11

Example 7: Preparation of RNA from mononuclear cells for expressionprofiling

Example 8: Preparation of Universal Control RNA for use in leukocyteexpression profiling

Example 9: Identification of diagnostic oligonucleotide sets for use indiagnosis of rheumatoid arthritis

Example 10: Identification of diagnostic oligonucleotide sets fordiagnosis of Systemic Lupus Erythematosis

Example 11: Probe selection for a 24,000 feature Array.

Example 12: Design of oligonucleotide probes

Example 13: Production of an array of 8,000 spotted 50 meroligonucleotides.

Example 14: Amplification, labeling and hybridization of total RNA to anoligonucleotide microarray

Example 15: Real-time PCR validation of array expression results

Example 16: Correlation and classification analysis

EXAMPLES Example 1 Generation of Subtracted Leukocyte CandidateNucleotide Library

To produce a candidate nucleotide library with representatives from thespectrum of nucleotide sequences that are differentially expressed inleukocytes, subtracted hybridization libraries were produced from thefollowing cell types and conditions:

-   -   1. Buffy Coat leukocyte fractions—stimulated with ionomycin and        PMA    -   2. Buffy Coat leukocyte fractions—un-stimulated    -   3. Peripheral blood mononuclear cells stimulated with ionomycin        and PMA    -   4. Peripheral blood mononuclear cells—un-stimulated    -   5. T lymphocytes—stimulated with PMA and ionomycin    -   6. T lymphocytes—resting

Cells were obtained from multiple individuals to avoid introduction ofbias by using only one person as a cell source.

Buffy coats (platelets and leukocytes that are isolated from wholeblood) were purchased from Stanford Medical School Blood Center. Fourbuffy coats were used, each of which was derived from about 350 ml ofwhole blood from one donor individual 10 ml of buffy coat sample wasdrawn from the sample bag using a needle and syringe. 40 ml of Buffer EL(Qiagen) was added per 10 ml of buffy coat to lyse red blood cells. Thesample was placed on ice for 15 minutes, and cells were collected bycentrifugation at 2000 rpm for 10 minutes. The supernatant was decantedand the cell pellet was re-suspended in leukocyte growth mediasupplemented with DNase (LGM-3 from Clonetics supplemented with Dnase ata final concentration of 30 U/ml). Cell density was determined using ahemocytometer. Cells were plated in media at a density of 1×10⁶ cells/mlin a total volume of 30 ml in a T-75 flask (Corning). Half of the cellswere stimulated with ionomycin and phorbol myristate acetate (PMA) at afinal concentration of 1 μg/ml and 62 ng/ml, respectively. Cells wereincubated at 37° C. and at 5% CO₂ for 3 hours, then cells were scrapedoff the flask and collected into 50 ml tubes. Stimulated and restingcell populations were kept separate. Cells were centrifuged at 2000 rpmfor 10 minutes and the supernatant was removed. Cells were lysed in 6 mlof phenol/guanidine isothyocyanate (Trizol reagent, GibcoBRL),homogenized using a rotary homogenizer, and frozen at 80°. Total RNA andmRNA were isolated as described below.

Two frozen vials of 5×10⁶ pooled human peripheral blood mononuclearcells (PBMCs) were purchased from Clonetics (catalog number cc-2702).The cells were rapidly thawed in a 37° C. water bath and transferred toa 15 ml tube containing 10 ml of leukocyte growth media supplementedwith DNase (prepared as described above). Cells were centrifuged at 200μg for 10 minutes. The supernatant was removed and the cell pellet wasresuspended in LGM-3 media supplemented with DNase. Cell density wasdetermined using a hemocytometer. Cells were plated at a density of1×10⁶ cells/ml in a total volume of 30 ml in a T-75 flask (Corning).Half of the cells were stimulated with ionomycin and PMA at a finalconcentration of 1 μg/ml and 62 ng/ml, respectively. Cells wereincubated at 37° C. and at 5% CO₂ for 3 hours, then cells were scrapedoff the flask and collected into 50 ml tubes. Stimulated and restingcell populations were kept separate. Cells were centrifuged at 2000 rpmand the supernatant was removed. Cells were lysed in 6 ml ofphenol/guanidine isothyocyanate solution (TRIZOL reagent, GibcoBRL)),homogenized using a rotary homogenizer, and frozen at 80°. Total RNA andmRNA were isolated from these samples using the protocol describedbelow.

45 ml of whole blood was drawn from a peripheral vein of four healthyhuman subjects into tubes containing anticoagulant. 50 μl RosetteSep(Stem Cell Technologies) T-cell isolation cocktail per ml of blood wasadded, mixed well, and incubated for 20 minutes at room temperature. Themixture was diluted with an equal volume of PBS+2% fetal bovine serum(FBS) and mixed by inversion. 30 ml of diluted mixture sample waslayered on top of 15 ml DML medium (Stem Cell Technologies). The sampletube was centrifuged for 20 minutes at 1200×g at room temperature. Theenriched T-lymphocyte cell layer at the plasma: medium interface wasremoved. Enriched cells were washed with PBS+2% FBS and centrifuged at1200×g. The cell pellet was treated with 5 ml of erythrocyte lysisbuffer (EL buffer, Qiagen) for 10 minutes on ice. The sample wascentrifuged for 5 min at 1200 g. Cells were plated at a density of 1×10⁶cells/ml in a total volume of 30 ml in a T-75 flask (Corning). Half ofthe cells were stimulated with ionomycin and PMA at a finalconcentration of 1 μg/ml and 62 ng/ml, respectively. Cells wereincubated at 37° C. and at 5% CO₂ for 3 hours, then cells were scrapedoff the flask and collected into 50 ml tubes. Stimulated and restingcell populations were kept separate. Cells were centrifuged at 2000 rpmand the supernatant was removed. Cells were lysed in 6 ml ofphenol/guanidine isothyocyanate solution (TRIZOL reagent, GibcoBRL),homogenized using a rotary homogenizer, and frozen at 80°. Total RNA andmRNA were isolated as described below.

Total RNA and mRNA were isolated using the following procedure: thehomogenized samples were thawed and mixed by vortexing. Samples werelysed in a 1:0.2 mixture of Trizol and chloroform, respectively. Forsome samples, 6 ml of Trizol-chloroform was added. Variable amounts ofTrizol-chloroform was added to other samples. Following lysis, sampleswere centrifuged at 3000 g for 15 min at 4° C. The aqueous layer wasremoved into a clean tube and 4 volumes of Buffer RLT Qiagen) was addedfor every volume of aqueous layer. The samples were mixed thoroughly andtotal RNA was prepared from the sample by following the Qiagen Rneasymidi protocol for RNA cleanup (October 1999 protocol, Qiagen). For thefinal step, the RNA was eluted from the column twice with 250 μlRnase-free water. Total RNA was quantified using a spectrophotometer.Isolation of mRNA from total RNA sample was done using The Oligotex mRNAisolation protocol (Qiagen) was used to isolate mRNA from total RNA,according to the manufacturer's instructions (Qiagen, 7/99 version).mRNA was quantified by spectrophotometry.

Subtracted cDNA libraries were prepared using Clontech's PCR-Select cDNASubtraction Kit (protocol number PT-1117-1) as described in themanufacturer's protocol. The protocol calls for two sources of RNA perlibrary, designated “Driver” and “Tester.” The following 6 librarieswere made:

Library Driver RNA Tester RNA Buffy Coat Un-stimulated Buffy StimulatedBuffy Coat Stimulated Coat Buffy Coat Resting Stimulated Buffy CoatUn-stimulated Buffy Coat PBMC Stimulated Un-stimulated PBMCs StimulatedPBMCs PBMC Resting Stimulated PBMCs Un-stimulated PBMCs T-cellStimulated Un-stimulated T-cells Stimulated T-cells T-cell RestingStimulated T-cells Un-stimulated T-cells

The Clontech protocol results in the PCR amplification of cDNA products.The PCR products of the subtraction protocol were ligated to the pGEMT-easy bacterial vector as described by the vector manufacturer (Promega6/99 version). Ligated vector was transformed into competent bacteriausing well-known techniques, plated, and individual clones are picked,grown and stored as a glycerol stock at −80C. Plasmid DNA was isolatedfrom these bacteria by standard techniques and used for sequenceanalysis of the insert. Unique cDNA sequences were searched in theUnigene database (build 133), and Unigene cluster numbers wereidentified that corresponded to the DNA sequence of the cDNA. Unigenecluster numbers were recorded in an Excel spreadsheet.

Example 2 Identification of Nucleotide Sequences for Candidate LibraryUsing Data Mining Techniques

Existing and publicly available gene sequence databases were used toidentify candidate nucleotide sequences for leukocyte expressionprofiling. Genes and nucleotide sequences with specific expression inleukocytes, for example, lineage specific markers, or known differentialexpression in resting or activated leukocytes were identified. Suchnucleotide sequences are used in a leukocyte candidate nucleotidelibrary, alone or in combination with nucleotide sequences isolatedthrough cDNA library construction, as described above.

Leukocyte candidate nucleotide sequences were identified using threeprimary methods. First, the publically accessible publication databasePubMed was searched to identify nucleotide sequences with known specificor differential expression in leukocytes. Nucleotide sequences wereidentified that have been demonstrated to have differential expressionin peripheral blood leukocytes between subjects with and withoutparticular disease(s) selected from Table 1. Additionally, genes andgene sequences that were known to be specific or selective forleukocytes or sub-populations of leukocytes were identified in this way.

Next, two publicly available databases of DNA sequences, Unigene locatedon the website at ncbi.nlm.nih.gov/UniGene and BodyMap located on thewebsite at bodymap.ims.u-tokyo.ac.jp, were searched for sequenced DNAclones that showed specificity to leukocyte lineages, or subsets ofleukocytes, or resting or activated leukocytes.

The human Unigene database (build 133) was used to identify leukocytecandidate nucleotide sequences that were likely to be highly orexclusively expressed in leukocytes. We used the Library DifferentialDisplay utility of Unigene located on the website atncbi.nlm.nih.gov/UniGene/info/ddd.html, which uses statistical methods(The Fisher Exact Test) to identify nucleotide sequences that haverelative specificity for a chosen library or group of libraries relativeto each other. We compared the following human libraries from Unigenerelease 133:

-   -   546 NCI_CGAP_HSCI (399)    -   848 Human_mRNA_from_cd34+_stem_cells (122)    -   105 CD34+DIRECTIONAL (150)    -   3587 KRIBB_Human_CD4_intrathymic_T-cell-cDNA_library (134)    -   3586 KRIBB_Human_DP_intrathymic_T-cell_cDNA_library (179)    -   3585 KRIBB_Human_TN_intrathymic-T-cell_cDNA_library (127) 3586        323 Activated_T-cells_I (740)    -   376 Activated_T-cells_XX (1727)    -   327 Monocytes,_stimulated_II (110)    -   Proliferating_Erythroid_Cells_(LCB:ad_library) (665)    -   825 429 Macrophage_II (105)    -   387 Macrophage_I (137)    -   669 NCI_CGAP_CLL1 (11626)    -   129 Human_White_blood_cells (922)    -   1400 NIH_MGC_(—)2 (422)    -   55 Human_promyelocyte (1220)    -   1010 NCI_CGAP_CML1 (2541)    -   2217 NCI_CGAP_Sub7 (218)    -   1395 NCI_CGAP_Sub6 (2764)    -   4874 NIH_MGC_(—)48 (2524)

Sequences from these libraries were compared to sequences fromnon-leukocyte derived libraries in the Unigene database to identifygenes that had some specificity for the leukocyte-derived libraries.

BodyMap, like Unigene, contains cell-specific libraries that containpotentially useful information about genes that may serve aslineage-specific or leukocyte specific markers (Okubo et al. 1992). Wecompared three leukocyte specific libraries, Granulocyte, CD4 T cell,and CD8 T cell, with the other libraries. Nucleotide sequences that werefound in one or more of the leukocyte-specific libraries, but absent inthe others, were identified. Clones that were found exclusively in oneof the three leukocyte libraries were also included in a list ofnucleotide sequences that could serve as lineage-specific markers.

Next, the sequence of the nucleotide sequences identified in PubMed orBodyMap were searched in Unigene (version 133), and a human Unigenecluster number was identified for each nucleotide sequence. The clusternumber was recorded in a Microsoft Excel™ spreadsheet, and anon-redundant list of these clones was made by sorting the clones byUniGene number, and removing all redundant clones using Microsoft Excel™tools. The non-redundant list of UniGene cluster numbers was thencompared to the UniGene cluster numbers of the cDNAs identified usingsubtractive cDNA hybridization, as described above in Example 1 (listedin Table 3 and the sequence listing). Only UniGene clusters that werenot contained in the cDNA libraries were retained. Unigene clusterscorresponding to 1911 candidate nucleotide sequences for leukocyteexpression profiling were identified in this way and are listed in Table3 and the sequence listing.

DNA clones corresponding to each UniGene cluster number are obtained ina variety of ways. First, a cDNA clone with identical sequence to partof, or all of the identified UniGene cluster is bought from a commercialvendor or obtained from the IMAGE consortium located on the web atimage.llnl.gov/, the Integrated Molecular Analysis of Genomes and theirExpression. Alternatively, PCR primers are designed to amplify and cloneany portion of the nucleotide sequence from cDNA or genomic DNA usingwell-known techniques. Alternatively, the sequences of the identifiedUniGene clusters are used to design and synthesize oligonucleotideprobes for use in oligonucleotide microarray based expression profiling.

Example 3 DNA Sequencing and Processing of Raw Sequence Data

Clones of differentially expressed cDNAs (identified by subtractivehybridization, described above) were sequenced on an MJ ResearchBaseStation™ slab gel based fluorescent detection system, using BigDye™(Applied Biosystems, Foster City, Calif.) terminator chemistry was used(Heiner et al., Genome Res 1998 May;8(5):557-61).

The fluorescent profiles were analyzed using the Phred sequence analysisprogram (Ewing et al, (1998), Genome Research 8: 175-185). Analysis ofeach clone results in a one pass nucleotide sequence and a quality filecontaining a number for each base pair with a score based on theprobability that the determined base is correct. Each of the sequencefiles and its respective quality files were initially combined intosingle fasta format (Pearson, W R. Methods Mol. Biol. 2000;132:185-219),multi-sequence file with the appropriate labels for each clone in theheaders for subsequent automated analysis.

Initially, known sequences were analyzed by pair wise similaritysearching using the blastn option of the blastall program obtained fromthe National Center for Biological Information, National Library ofMedicine, National Institutes of Health (NCBI) to determine the qualityscore that produced accurate matching (Altschul SF,et al. J. Mol. Biol.1990 Oct. 5;215(3):403-10.). Empirically, it was determined that a rawscore of 8 was the minimum that contained useful information. Using asliding window average for 16 base pairs, an average score wasdetermined. The sequence was removed (trimmed) when the average scorefell below 8. Maximum reads were 950 nucleotides long.

Next, the sequences were compared by similarity matching against adatabase file containing the flanking vector sequences used to clone thecDNA, using the blastall program with the blastn option. All regions ofvector similarity were removed, or “trimmed” from the sequences of theclones using scripts in the GAWK programming language, a variation ofAWK (Aho AV et al, The Awk Programming Language (Addison-Wesley, ReadingMass., 1988); Robbins, AD, “Effective AWK Programming” (Free SoftwareFoundation, Boston Mass., 1997). It was found that the first 45 basepairs of all the sequences were related to vector; these sequences werealso trimmed and thus removed from consideration. The remainingsequences were then compared against the NCBI vector database (Kitts, P.A. et al. National Center for Biological Information, National Libraryof Medicine, National Institutes of Health, Manuscript in preparation(2001) using blastall with the blastn option. Any vector sequences thatwere found were removed from the sequences.

Messenger RNA contains repetitive elements that are found in genomicDNA. These repetitive elements lead to false positive results insimilarity searches of query mRNA sequences versus known mRNA and ESTdatabases. Additionally, regions of low information content (long runsof the same nucleotide, for example) also result in false positiveresults. These regions were masked using the program RepeatMasker2 foundon the website at repeatmasker.genome.washington.edu (Smit, AFA & Green,P “RepeatMasker” at the website atgenome.washington.edu/RM/RepeatMasker.html. The trimmed and masked fileswere then subjected to further sequence analysis.

Example 4 Further Sequence Analysis of Novel Nucleotide SequencesIdentified by Subtractive Hybridization Screening

cDNA sequences were further characterized using BLAST analysis. TheBLASTN program was used to compare the sequence of the fragment to theUniGene, dbEST, and nr databases at NCBI (GenBank release 123.0; seeTable 5). In the BLAST algorithm, the expect value for an alignment isused as the measure of its significance. First, the cDNA sequences werecompared to sequences in Unigene on the web at ncbi.nlm.nih.gov/UniGene.If no alignments were found with an expect value less than 10⁻²⁵, thesequence was compared to the sequences in the dbEST database usingBLASTN. If no alignments were found with an expect value less than10⁻²⁵, the sequence was compared to sequences in the nr database.

The BLAST analysis produced the following categories of results: a) asignificant match to a known or predicted human gene, b) a significantmatch to a nonhuman DNA sequence, such as vector DNA or E. coli DNA, c)a significant match to an unidentified GenBank entry (a sequence notpreviously identified or predicted to be an expressed sequence or agene), such as a cDNA clone, mRNA, or cosmid, or d) no significantalignments. If a match to a known or predicted human gene was found,analysis of the known or predicted protein product was performed asdescribed below. If a match to an unidentified GenBank entry was found,or if no significant alignments were found, the sequence was searchedagainst all known sequences in the human genome database located on theweb at ncbi.nlmm.nih.gov/genome/seq/page.cgi?F=HsBlast.html&&ORG=Hs, seeTable 5.

If many unknown sequences were to be analyzed with BLASTN, theclustering algorithm CAP2 (Contig Assembly Program, version 2) was usedto cluster them into longer, contiguous sequences before performing aBLAST search of the human genome. Sequences that can be grouped intocontigs are likely to be cDNA from expressed genes rather than vectorDNA, E. coli DNA or human chromosomal DNA from a noncoding region, anyof which could have been incorporated into the library. Clusteredsequences provide a longer query sequence for database comparisons withBLASTN, increasing the probability of finding a significant match to aknown gene. When a significant alignment was found, further analysis ofthe putative gene was performed, as described below. Otherwise, thesequence of the original cDNA fragment or the CAP2 contig is used todesign a probe for expression analysis and further approaches are takento identify the gene or predicted gene that corresponds to the cDNAsequence, including similarity searches of other databases, molecularcloning, and Rapid Amplification of cDNA Ends (RACE).

In some cases, the process of analyzing many unknown sequences withBLASTN was automated by using the BLAST network-client program blastcl3,which was downloaded from ftp://ncbi.nlm.nih.gov/blast/network/netblast.

When a cDNA sequence aligned to the sequence of one or more chromosomes,a large piece of the genomic region around the loci was used to predictthe gene containing the cDNA. To do this, the contig corresponding tothe mapped locus, as assembled by the RefSeq project at NCBI, wasdownloaded and cropped to include the region of alignment plus 100,000bases preceding it and 100,000 bases following it on the chromosome. Theresult was a segment 200 kb in length, plus the length of the alignment.This segment, designated a putative gene, was analyzed using an exonprediction algorithm to determine whether the alignment area of theunknown sequence was contained within a region predicted to betranscribed (see Table 6).

This putative gene was characterized as follows: all of the exonscomprising the putative gene and the introns between them were taken asa unit by noting the residue numbers on the 200 kb+ segment thatcorrespond to the first base of the first exon and the last base of thelast exon, as given in the data returned by the exon predictionalgorithm. The truncated sequence was compared to the UniGene, dbEST,and nr databases to search for alignments missed by searching with theinitial fragment.

The predicted amino acid sequence of the gene was also analyzed. Thepeptide sequence of the gene predicted from the exons was used inconjunction with numerous software tools for protein analysis (see Table7). These were used to classify or identify the peptide based onsimilarities to known proteins, as well as to predict physical,chemical, and biological properties of the peptides, including secondaryand tertiary structure, flexibility, hydrophobicity, antigenicity(hydrophilicity), common domains and motifs, and localization within thecell or tissues. The peptide sequence was compared to protein databases,including SWISS-PROT, TrEMBL, GenPept, PDB, PIR, PROSITE, ProDom,PROSITE, Blocks, PRINTS, and Pfam, using BLASTP and other algorithms todetemine similarities to known proteins or protein subunits.

Example 5 Further Sequence Analysis of Novel Clone 596H6

The sequence of clone 596H6 is provided below

ACTATATTTA GGCACCACTG CCATAAACTA CCAAAAAAAA AATGTAATTC 50 (SEQ IDNO:8767) CTAGAAGCTG TGAAGAATAG TAGTGTAGCT AAGCACGGTG TGTGGACAGT 100GGGACATCTG CCACCTGCAG TAGGTCTCTG CACTCCCAAA AGCAAATTAC 150 ATTGGCTTGAACTTCAGTAT GCCCGGTTCC ACCCTCCAGA AACTTTTGTG 200 TTCTTTGTAT AGAATTTAGGAACTTCTGAG GGCCACAAAT ACACACATTA 250 AAAAAGGTAG AATTTTTGAA GATAAGATTCTTCTAAAAAA GCTTCCCAAT 300 GCTTGAGTAG AAAGTATCAG TAGAGGTATC AAGGGAGGAGAGACTAGGTG 350 ACCACTAAAC TCCTTCAGAC TCTTAAAATT ACGATTCTTT TCTCAAAGGG400 GAAGAACGTC AGTGCAGCGA TCCCTTCACC TTTAGCTAAA GAATTGGACT 450GTGCTGCTCA AAATAAAGAT CAGTTGGAGG TANGATGTCC AAGACTGAAG 500 GTAAAGGACTAGTGCAAACT GAAAGTGATG GGGAAACAGA CCTACGTATG 550 GAAGCCATGT AGTGTTCTTCACAGGCTGCT GTTGACTGAA ATTCCTATCC 600 TCAAATTACT CTAGACTGAA GCTGCTTCCCTTCAGTGAGC AGCCTCTCCT 650 TCCAAGATTC TGGAAAGCAC ACCTGACTCC AAACAAAGACTTAGAGCCCT 700 GTGTCAGTGC TGCTGCTGCT TTTACCAGAT TCTCTAACCT TCCGGGTAGA750 AGAG

This sequence was used as input for a series of BLASTN searches. First,it was used to search the UniGene database, build 132 located on the webat ncbi.nlm.nih.gov/BLAST. No alignments were found with an expect valueless than the threshold value of 10⁻²⁵. A BLASTN search of the databasedbEST, release 041001, was then performed on the sequence and 21alignments were found (http://www.ncbi.nlm.nih.gov/BLAST/). Ten of thesehad expect values less than 10⁻²⁵, but all were matches to unidentifiedcDNA clones. Next, the sequence was used to run a BLASTN search of thenr database, release 123.0. No significant alignment to any sequence innr was found. Finally, a BLASTN search of the human genome was performedon the sequence located on the web atncbi.nlm.nih.gov/genome/seq/page.cgi?F=HsBlast.html&&ORG=Hs.

A single alignment to the genome was found on contig NT_(—)004698.3(e=0.0). The region of alignment on the contig was from base 1,821,298to base 1,822,054, and this region was found to be mapped to chromosome1, from base 105,552,694 to base 105,553,450. The sequence containingthe aligned region, plus 100 kilobases on each side of the alignedregion, was downloaded. Specifically, the sequence of chromosome 1 frombase 105,452,694 to 105,653,450 was downloaded from the website atncbi.nlm.nih.gov/cgi-bin/Entrez/seq_reg.cgi?chr=1&from=105452694&to=105653450.

This 200,757 bp segment of the chromosome was used to predict exons andtheir peptide products as follows. The sequence was used as input forthe Genscan algorithm located on the web at genes.mit.edu/GENSCAN.html,using the following Genscan settings:

-   -   Organism: vertebrate    -   Suboptimal exon cutoff: 10.00 (no suboptimal exons)    -   Print options: Predicted CDS and peptides

The region matching the sequence of clone 596H6 was known to span basenumbers 100,001 to 100,757 of the input sequence. An exon was predictedby the algorithm, with a probability of 0.695, covering bases 100,601 to101,094 (designated exon 4.14 of the fourth predicted gene). This exonwas part of a predicted cistron that is 24,195 bp in length. Thesequence corresponding to the cistron was noted and saved separatelyfrom the 200,757 bp segment. BLASTN searches of the Unigene, dbEST, andnr databases were performed on it.

At least 100 significant alignments to various regions of the sequencewere found in the dbEST database, although most appeared to be redundantrepresentations of a few exons. All matches were to unnamed cDNAs andmRNAs (unnamed cDNAs and mRNAs are cDNAs and mRNAs not previouslyidentified, or shown to correspond to a known or predicted human gene)from various tissue types. Most aligned to a single region on thesequence and spanned 500 bp or less, but several consisted of five orsix regions separated by gaps, suggesting the locations of exons in thegene. Several significant matches to entries in the UniGene databasewere found, as well, even after masking low-complexity regions and shortrepeats in the sequence. All matches were to unnamed cDNA clones.

At least 100 significant alignments were found in the nr database, aswell. A similarity to hypothetical protein FLJ22457 (UniGene clusterHs.238707) was found (e=0.0). The cDNA of this predicted protein hasbeen isolated from B lymphocytes located on the web atncbi.nlm.nih.gov/entrez/viewer.cgi?save=0&cmd=&cfm=on&f=1&view=gp&txt=0&val=13637988.

Other significant alignments were to unnamed cDNAs and mRNAs.

Using Genscan, the following 730 residue peptide sequence was predictedfrom the putative gene:

MDGLGRRLRA SLRLKRGHGG HWRLNEMPYM KHEFDGGPPQ DNSGEALKEP 50 SEQ ID NO:8768ERAQEHSLPN FAGGQHFFEY LLVVSLKKKR SEDDYEPIIT YQFPKRENLL 100 RGQQEEEERLLKAIPLFCFP DGNEWASLTE YPSLSCKTPG LLAALVVEKA 150 QPRTCCHASA PSAAPQARGPDAPSPAAGQA LPAGPGPRLP KVYCIISCIG 200 CFGLFSKILD EVEKRHQISM AVIYPFMQGLREAAFPAPGK TVTLKSFIPD 250 SGTEFISLTR PLDSHLEHVD FSSLLHCLSF EQILQIFASAVLERKIIFLA 300 EGLREEEKDV RDSTEVRGAG ECHGFQRKGN LGKQWGLCVE DSVKMGDNQR350 GTSCSTLSQC IHAAAALLYP FSWAHTYIPV VPESLLATVC CPTPFMVGVQ 400MRFQQEVMDS PMEEIQPQAE IKTVNPLGVY EERGPEKASL CLFQVLLVNL 450 CEGTFLMSVGDEKDILPPKL QDDILDSLGQ GINELKTAEQ INEHVSGPFV 500 QFFVKIVGHY ASYIKREANGQGHFQERSFC KALTSKTNRR FVKKFVKTQL 550 FSLFIQEAEK SKNPPAEVTQ VGNSSTCVVDTWLEAAATAL SHHYNIFNTE 600 HTLWSKGSAS LHEVCGHVRT RVKRKILFLY VSLAFTMGKSIFLVENKAMN 650 MTIKWTTSGR PGHGDMFGVI ESWGAAALLL LTGRVRDTGK SSSSTGHRAS700 KSLVWSQVCF PESWEERLLT EGKQLQSRVI

Multiple analyses were performed using this prediction. First, apairwise comparison of the sequence above and the sequence of FLJ22457,the hypothetical protein mentioned above, using BLASTP version 2.1.2located on the web at ncbi.nlm.nih.gov/BLAST, resulted in a match withan expect value of 0.0. The peptide sequence predicted from clone 596H6was longer and 19% of the region of alignment between the two resultedfrom gaps in hypothetical protein FLJ22457. The cause of the discrepancymight be alternative mRNA splicing, alternative post-translationalprocessing, or differences in the peptide-predicting algorithms used tocreate the two sequences, but the homology between the two issignificant.

BLASTP and TBLASTN were also used to search for sequence similarities inthe SWISS-PROT, TrEMBL, GenBank Translated, and PDB databases. Matchesto several proteins were found, among them a tumor cell suppressionprotein, HTS1. No matches aligned to the full length of the peptidesequence, however, suggesting that similarity is limited to a fewregions of the peptide.

TBLASTN produced matches to several proteins—both identified andtheoretical—but again, no matches aligned to the full length of thepeptide sequence. The best alignment was to the same hypotheticalprotein found in GenBank before (FLJ22457).

To discover similarities to protein families, comparisons of the domains(described above) were carried out using the Pfam and Blocks databases.A search of the Pfam database identified two regions of the peptidedomains as belonging the DENN protein family (e=2.1×10⁻³³). The humanDENN protein possesses an RGD cellular adhesion motif and aleucine-zipper-like motif associated with protein dimerization, andshows partial homology to the receptor binding domain of tumor necrosisfactor alpha DENN is virtually identical to MADD, a human MAPkinase-activating death domain protein that interacts with type I tumornecrosis factor receptor located on the web atsrs.ebi.ac.uk/srs6bin/cgi-bin/wgetz?-id+fS5n1GQsHf+−e+[INTERPRO:‘IPR001194’].The search of the Blocks database also revealed similarities betweenregions of the peptide sequence and known protein groups, but none witha satisfactory degree of confidence. In the Blocks scoring system,scores over 1,100 are likely to be relevant. The highest score of anymatch to the predicted peptide was 1,058.

The Prosite, ProDom, PRINTS databases (all publicly available) were usedto conduct further domain and motif analysis. The Prosite searchgenerated many recognized protein domains. A BLASTP search was performedto identify areas of similarity between the protein query sequence andPRINTS, a protein database of protein fingerprints, groups of motifsthat together form a characteristic signature of a protein family. Inthis case, no groups were found to align closely to any section of thesubmitted sequence. The same was true when the ProDom database wassearched with BLASTP.

A prediction of protein structure was done by performing a BLAST searchof the sequence against PDB, a database in which every member hastertiary structure information. No significant alignments were found bythis method. Secondary and super-secondary structure was examined usingthe Gamier algorithm. Although it is only considered to be 60-65%accurate, the algorithm provided information on the locations andlengths of alpha-helices, beta-sheets, turns and coils.

The antigenicity of the predicted peptide was modeled by graphinghydrophilicity vs. amino acid number. This produced a visualrepresentation of trends in hydrophilicity along the sequence. Manylocations in the sequence showed antigenicity and five sites hadantigenicity greater than 2. This information can be used in the designof affinity reagents to the protein.

Membrane-spanning regions were predicted by graphing hydrophobicity vs.amino acid number. Thirteen regions were found to be somewhathydrophobic. The algorithm TMpred predicted a model with 6 strongtransmembrane helices located on the web atch.embnet.orglsoftware/TMPRED_form.html.

NNPSL is a neural network algorithm developed by the Sanger Center. Ituses amino acid composition and sequence to predict cellular location.For the peptide sequence submitted, its first choice was mitochondrial(51.1% expected accuracy). Its second choice was cytoplasmic (91.4%expected accuracy).

Example 6 Further Sequence Analysis of Novel Clone 486E11

The sequence of clone 486E11 is provided below

TAAAAGCAGG CTGTGCACTA GGGACCTAGT GACCTTACTA GAAAAAACTC 50 SEQ ID NO:8769AAATTCTCTG AGCCACAAGT CCTCATGGGC AAAATGTAGA TACCACCACC 100 TAACCCTGCCAATTTCCTAT CATTGTGACT ATCAAATTAA ACCACAGGCA 150 GGAAGTTGCC TTGAAAACTTTTTATAGTGT ATATTACTGT TCACATAGAT 200 NAGCAATTAA CTTTACATAT ACCCGTTTTTAAAAGATCAG TCCTGTGATT 250 AAAAGTCTGG CTGCCCTAAT TCACTTCGAT TATACATTAGGTTAAAGCCA 300 TATAAAAGAG GCACTACGTC TTCGGAGAGA TGAATGGATA TTACAAGCAG350 TAATGTTGGC TTTGGAATAT ACACATAATG TCCACTTGAC CTCATCTATT 400TGACACAAAA TGTAAACTAA ATTATGAGCA TCATTAGATA CCTTGGCCTT 450 TTCAAATCACACAGGGTCCT AGATCTNNNN NNNNNNNNNN NNNNNNNNNN 500 NNNNNNNNNN NNNNNNNNNNNNNNNNNNNN NNNNNNNNAC TTTGGGATTC 550 CTATATCTTT GTCAGCTGTC AACTTCAGTGTTTTCAGGTT AAATTCTATC 600 CATAGTCATC CCAATATACC TGCTTTAGAT GATACAACCTTCAAAAGATC 650 CGCTCTTCCT CGTAAAAAGT GGAG

The BLASTN program was used to compare the sequence to the UniGene anddbEST databases. No significant alignments were found in either. It wasthen searched against the nr database and only alignments to unnamedgenomic DNA clones were found.

CAP2 was used to cluster a group of unknowns, including clone 486E11.The sequence for 486E11 was found to overlap others. These formed acontig of 1,010 residues, which is shown below:

CGGACAGGTA CCTAAAAGCA GGCTGTGCAC TAGGGACCTA GTGACCTTAC 50 SEQ ID NO:8832TAGAAAAAAC TCAAATTCTC TGAGCCACAA GTCCTCATGG GCAAAATGTA 100 GATACCACCACCTAACCCTG CCAATTTCCT ATCATTGTGA CTATCAAATT 150 AAACCACAGG CAGGAAGTTGCCTTGAAAAC TTTTTATAGT GTATATTACT 200 GTTCACATAG ATNAGCAATT AACTTTACATATACCCGTTT TTAAAAGATC 250 AGTCCTGTGA TTAAAAGTCT GGCTGCCCTA ATTCACTTCGATTATACATT 300 AGGTTAAAGC CATATAAAAG AGGCACTACG TCTTCGGAGA GATGAATGGA350 TATTACAAGC AGTAATTTTG GCTTTGGAAT ATACACATAA TGTCCACTTG 400ACCTCATCTA TTTGACACAA AATGTAAACT AAATTATGAG CATCATTAGA 450 TACCTTGGGCCTTTTCAAAT CACACAGGGT CCTAGATCTG NNNNNNNNNN 500 NNNNNNNNNN NNNNNNNNNNNNNNNNNNNN NNNNNNNNNN NNNNNNNNNN 550 NACTTTGGAT TCTTATATCT TTGTCAGCTGTCAACTTCAG TGTTTTCAGG 600 NTAAATTCTA TCCATAGTCA TCCCAATATA CCTGCTTTAGATGATACAAA 650 CTTCAAAAGA TCCGGCTCTC CCTCGTAAAA CGTGGAGGAC AGACATCAAG700 GGGGTTTTCT GAGTAAAGAA AGGCAACCGC TCGGCAAAAA CTCACCCTGG 750CACAACAGGA NCGAATATAT ACAGACGCTG ATTGAGCGTT TTGCTCCATC 800 TTCACTTCTGTTAAATGAAG ACATTGATAT CTAAAATGCT ATGAGTCTAA 850 CTTTGTAAAA TTAAAATAGATTTGTAGTTA TTTTTCAAAA TGAAATCGAA 900 AAGATACAAG TTTTGAAGGC AGTCTCTTTTTCCACCCTGC CCCTCTAGTG 950 TGTTTTACAC ACTTCTCTGG CCACTCCAAC AGGGAAGCTGGTCCAGGGCC 1000 ATTATACAGG

The sequence of the CAP2 contig was used in a BLAST search of the humangenome. 934 out of 1,010 residues aligned to a region of chromosome 21.A gap of 61 residues divided the aligned region into two smallerfragments. The sequence of this region, plus 100 kilobases on each sideof it, was downloaded and analyzed using the Genscan site at MIT locatedon the web at genes.mit.edu/GENSCAN.html, with the following settings:

-   -   Organism: vertebrate    -   Suboptimal exon cutoff: 1.00 (no suboptimal exons)    -   Print options; Predicted CDS and peptides

The fragment was found to fall within one of several predicted genes inthe chromosome region. The bases corresponding to the predicted gene,including its predicted introns, were saved as a separate file and usedto search GenBank again with BLASTN to find any ESTs or UniGene clustersidentified by portions of the sequence not included in the originalunknown fragment. The nr database contained no significant matches. Atleast 100 significant matches to various parts of the predicted genewere found in the dbEST database, but all of them were to unnamed cDNAclones. Comparison to UniGene produced fewer significant matches, butall matches were to unnamed cDNAs.

The peptide sequence predicted by Genscan was also saved. Multiple typesof analyses were performed on it using the resources mentioned in Table3. BLASTP and TBLASTN were used to search the TrEMBL protein databaselocated on the web at expasy.ch/sprot/) and the GenBank nr databaselocated on the web at ncbi.nlm.hih.gov/BLAST, which includes data fromthe SwissProt, PIR, PRF, and PDB databases. No significant matches werefound in any of these, so no gene identity or tertiary structure wasdiscovered.

The peptide sequence was also searched for similarity to known domainsand motifs using BLASTP with the Prositc, Blocks, Pfam, and ProDomdatabases. The searches produced no significant alignments to knowndomains. BLASTP comparison to the PRINTS database produced an alignmentto the P450 protein family, but with a low probability of accuracy(e=6.9).

Two methods were used to predict secondary structure—theGamier/Osguthorpe/Robson model and the Chou-Fasman model. The twomethods differed somewhat in their results, but both producedrepresentations of the peptide sequence with helical and sheet regionsand locations of turns.

Antigenicity was plotted as a graph with amino acid number in thesequence on the x-axis and hydrophilicity on the y-axis. Several areasof antigenicity were observed, but only one with antigenicity greaterthan 2. Hydrophobicity was plotted in the same way. Only one region,from approximately residue 135 to residue 150, had notablehydrophobicity. TMpreα, accessed through ExPASy, was used to predicttransmembrane helices. No regions of the peptide sequence were predictedwith reasonable confidence to be membrane-spanning helices.

NNPSL predicted that the putative protein would be found either in thenucleus (expected prediction accuracy=51.1%) or secreted from the cell(expected prediction accuracy=91.4%).

Example 7 Preparation of RNA from Mononuclear Cells for ExpressionProfiling

Blood was isolated from the subject for leukocyte expression profilingusing the following methods:

Two tubes were drawn per patient. Blood was drawn from either a standardperipheral venous blood draw or directly from a large-boreintra-arterial or intravenous catheter inserted in the femoral artery,femoral vein, subclavian vein or internal jugular vein. Care was takento avoid sample contamination with heparin from the intravascularcatheters, as heparin can interfere with subsequent RNA reactions.

For each tube, 8 ml of whole blood was drawn into a tube (CPT,Becton-Dickinson order #362753) containing the anticoagulant Citrate,25° C. density gradient solution (e.g. Ficoll, Percoll) and a polyestergel barrier that upon centrifugation was permeable to RBCs andgranulocytes but not to mononuclear cells. The tube was inverted severaltimes to mix the blood with the anticoagulant. The tubes werecentrifuged at 1750×g in a swing-out rotor at room temperature for 20minutes. The tubes were removed from the centrifuge and inverted 5-10times to mix the plasma with the mononuclear cells, while trapping theRBCs and the granulocytes beneath the gel barrier. Theplasma/mononuclear cell mix was decanted into a 15 ml tube and 5 ml ofphosphate-buffered saline (PBS) is added. The 15 ml tubes were spun for5 minutes at 1750×g to pellet the cells. The supernatant was discardedand 1.8 ml of RLT lysis buffer is added to the mononuclear cell pellet.The buffer and cells were pipetted up and down to ensure complete lysisof the pellet. The cell lysate was frozen and stored until it isconvenient to proceed with isolation of total RNA.

Total RNA was purified from the lysed mononuclear cells using the QiagenRneasy Miniprep kit, as directed by the manufacturer (10/99 version) fortotal RNA isolation, including homogenization (Qiashredder columns) andon-column DNase treatment. The purified RNA was eluted in SOul of water.

Some samples were prepared by a different protocol, as follows:

Two 8 ml blood samples were drawn from a peripheral vein into a tube(CPT, Becton-Dickinson order #362753) containing anticoagulant(Citrate), 25° C. density gradient solution (Ficoll) and a polyester gelbarrier that upon centrifugation is permeable to RBCs and granulocytesbut not to mononuclear cells. The mononuclear cells and plasma remainedabove the barrier while the RBCs and granulocytes were trapped below.The tube was inverted several times to mix the blood with theanticoagulant, and the tubes were subjected to centrifugation at 1750×gin a swing-out rotor at room temperature for 20 min. The tubes wereremoved from the centrifuge, and the clear plasma layer above the cloudymononuclear cell layer was aspirated and discarded. The cloudymononuclear cell layer was aspirated, with care taken to rinse all ofthe mononuclear cells from the surface of the gel barrier with PBS(phosphate buffered saline). Approximately 2 mls of mononuclear cellsuspension was transferred to a 2 ml microcentrifuge tube, andcentrifuged for 3 min. at 16,000 rpm in a microcentrifuge to pellet thecells. The supernatant was discarded and 1.8 ml of RLT lysis buffer(Qiagen) were added to the mononuclear cell pellet, which lysed thecells and inactivated Rnases. The cells and lysis buffer were pipettedup and down to ensure complete lysis of the pellet. Cell lysate wasfrozen and stored until it was convenient to proceed with isolation oftotal RNA.

RNA samples were isolated from 8 mL of whole blood. Yields ranged from 2ug to 20ug total RNA for 8 mL blood. A260/A280 spectrophotometric ratioswere between 1.6 and 2.0, indicating purity of sample. 2 ul of eachsample were run on an agarose gel in the presence of ethidium bromide.No degradation of the RNA sample and no DNA contamination were visible.

In some cases, specific subsets of mononuclear cells were isolated fromperipheral blood of human subjects. When this was done, the StemSep cellseparation kits (manual version 6.0.0) were used from StemCellTechnologies (Vancouver, Canada). This same protocol can be applied tothe isolation of T cells, CD4 T cells, CD8 T cells, B cells, monocytes,NK cells and other cells. Isolation of cell types using negativeselection with antibodies may be desirable to avoid activation of targetcells by antibodies.

Example 8 Preparation of Universal Control RNA for Use in LeukocyteExpression Profiling

Control RNA was prepared using total RNA from Buffy coats and/or totalRNA from enriched mononuclear cells isolated from Buffy coats, both withand without stimulation with ionomycin and PMA. The following controlRNAs were prepared:

-   Control 1: Buffy Coat Total RNA-   Control 2: Mononuclear cell Total RNA-   Control 3: Stimulated buffy coat Total RNA-   Control 4: Stimulated mononuclear Total RNA-   Control 5: 50% Buffy coat Total RNA/50% Stimulated buffy coat Total    RNA-   Control 6: 50% Mononuclear cell Total RNA/50% Stimulated Mononuclear    Total RNA.

Some samples were prepared using the following protocol: Buffy coatsfrom 38 individuals were obtained from Stanford Blood Center. Each buffycoat is derived from ˜350 mL whole blood from one individual. 10 mlbuffy coat was removed from the bag, and placed into a 50 ml tube. 40 mlof Buffer EL (Qiagen) was added, the tube was mixed and placed on icefor 15 minutes, then cells were pelleted by centrifugation at 2000×g for10 minutes at 4° C. The supernatant was decanted and the cell pellet wasre-suspended in 10 ml of Qiagen Buffer EL. The tube was then centrifugedat 2000×g for 10 minutes at 4° C. The cell pellet was then re-suspendedin 20 ml TRIZOL (GibcoBRL) per Buffy coat sample, the mixture wasshredded using a rotary homogenizer, and the lysate was then frozen at−80° C. prior to proceeding to RNA isolation.

Other control RNAs were prepared from enriched mononuclear cellsprepared from Buffy coats. Buffy coats from Stanford Blood Center wereobtained, as described above. 10 ml buffy coat was added to a 50 mlpolypropylene tube, and 10 ml of phosphate buffer saline (PBS) was addedto each tube. A polysucrose (5.7 g/dL) and sodium diatrizoate (9.0 g/dL)solution at a 1.077+/−0.0001 g/ml density solution of equal volume todiluted sample was prepared (Histopaque 1077, Sigma cat. no 1077-1).This and all subsequent steps were performed at room temperature. 15 mlof diluted buffy coat/PBS was layered on top of 15 ml of the histopaquesolution in a 50 ml tube. The tube was centrifuged at 400×g for 30minutes at room temperature. After centrifugation, the upper layer ofthe solution to within 0.5 cm of the opaque interface containing themononuclear cells was discarded. The opaque interface was transferredinto a clean centrifuge tube. An equal volume of PBS was added to eachtube and centrifiged at 350×g for 10 minutes at room temperature. Thesupernatant was discarded. 5 ml of Buffer EL (Qiagen) was used toresuspend the remaining cell pellet and the tube was centrifuged at2000×g for 10 minutes at room temperature. The supernatant wasdiscarded. The pellet was resuspended in 20 ml of TRIZOL (GibcoBRL) foreach individual buffy coat that was processed. The sample washomogenized using a rotary homogenizer and frozen at −80C until RNA wasisolated.

RNA was isolated from frozen lysed Buffy coat samples as follows: frozensamples were thawed, and 4 ml of chloroform was added to each buffy coatsample. The sample was mixed by vortexing and centrifuged at 2000×g for5 minutes. The aqueous layer was moved to new tube and then repurifiedby using the RNeasy Maxi RNA clean up kit, according to themanufacturer's instruction (Qiagen, PN 75162). The yield, purity andintegrity were assessed by spectrophotometer and gel electrophoresis.

Some samples were prepared by a different protocol, as follows. Thefurther use of RNA prepared using this protocol is described in Example14.

50 whole blood samples were randomly selected from consented blooddonors at the Stanford Medical School Blood Center. Each buffy coatsample was produced from ˜350 mL of an individual's donated blood. Thewhole blood sample was centrifuged at ˜4,400×g for 8 minutes at roomtemperature, resulting in three distinct layers: a top layer of plasma,a second layer of buffy coat, and a third layer of red blood cells. 25ml of the buffy coat fraction was obtained and diluted with an equalvolume of PBS (phosphate buffered saline). 30 ml of diluted buffy coatwas layered onto 15 ml of sodium diatrizoate solution adjusted to adensity of 1.077+/−0.001 g/ml (Histopaque 1077, Sigma) in a 50 mLplastic tube. The tube was spun at 800 g for 10 minutes at roomtemperature. The plasma layer was removed to the 30 ml mark on the tube,and the mononuclear cell layer removed into a new tube and washed withan equal volume of PBS, and collected by centrifugation at 2000 g for 10minutes at room temperature. The cell pellet was resuspended in 10 ml ofBuffer EL (Qiagen) by vortexing and incubated on ice for 10 minutes toremove any remaining erthythrocytes. The mononuclear cells were spun at2000 g for 10 minutes at 4 degrees Celsius. The cell pellet was lysed in25 ml of a phenol/guanidinium thiocyanate solution (TRIZOL Reagent,Invitrogen). The sample was homogenized using a PowerGene 5 rotaryhomogenizer (Fisher Scientific) and Omini disposable generator probes(Fisher Scientific). The Trizol lysate was frozen at −80 degrees C.until the next step.

The samples were thawed out and incubated at room temperature for 5minutes. 5 ml chloroform was added to each sample, mixed by vortexing,and incubated at room temperature for 3 minutes. The aqueous layers weretransferred to new 50 ml tubes. The aqueous layer containing total RNAwas further purified using the Qiagen RNeasy Maxi kit (PN 75162), perthe manufacturer's protocol (October 1999). The columns were elutedtwice with 1 ml Rnase-free water, with a minute incubation before eachspin. Quantity and quality of RNA was assessed using standard methods.Generally, RNA was isolated from batches of 10 buffy coats at a time,with an average yield per buffy coat of 870 μg, and an estimated totalyield of 43.5 mg total RNA with a 260/280 ratio of 1.56 and a 28S/18Sratio of 1.78.

Quality of the RNA was tested using the Agilent 2100 Bioanalyzer usingRNA 6000 microfluidics chips. Analysis of the electrophorgrams from theBioanalyzer for five different batches demonstrated the reproducibilityin quality between the batches.

Total RNA from all five batches were combined and mixed in a 50 ml tube,then aliquoted as follows: 2×10 ml aliquots in 15 ml tubes, and the restin 100 μl aliquots in 1.5 ml microcentrifuge tubes. The aliquots gavehighly reproducible results with respect to RNA purity, size andintegrity. The RNA was stored at −80° C.

Test Hybridization of Reference RNA.

When compared with BC38 and Stimulated mononuclear reference samples,the R50 performed as well, if not better than the other referencesamples as shown in FIG. 3.

In an analysis of hybridizations, where the R50 targets werefluorescently labeled with Cy-5 using methods described herein and theamplified and labeled aRNA was hybridized (as in example 14) to theolignoucleotide array described in example 13. The R50 detected 97.3% ofprobes with a Signal to Noise ratio (S/N) of greater than three and99.9% of probes with S/N greater one.

Example 9 Identification of Diagnostic Oligonucleotides andOligonucleotide Sets for Use in Monitoring Treatment and/or Progressionof Rheumatoid Arthritis

Rheumatoid arthritis (hereinafter, “RA”) is a chronic and debilitatinginflammatory arthritis. The diagnosis of RA is made by clinical criteriaand radiographs. A new class of medication, TNF blockers, are effective,but the drugs are expensive, have side effects and not all patientsrespond to treatment. In addition, relief of disease symptoms does notalways correlate with inhibition of joint destruction. For thesereasons, an alternative mechanism for the titration of therapy isneeded.

An observational study was conducted in which a cohort of patientsmeeting American College of Rheumatology (hereinafter “ARC”) criteriafor the diagnosis of RA was identified. Arnett et al. (1988) ArthritisRheum 31:315-24. Patients gave informed consent and a peripheral bloodmononuclear cell RNA sample was obtained by the methods as describedherein. When available, RNA samples were also obtained from surgicalspecimens of bone or synovium from effected joints, and synovial fluid.Also, T-cells were isolated from the peripheral blood for some patientsfor expression analysis. This was done using the protocol given inExample 7.

From each patient, the following clinical information was obtained ifavailable: Demographic information; information relating to the ACRcriteria for RA; presence or absence of additional diagnoses ofinflammatory and non-inflammatory conditions; data from laboratory test,including complete blood counts with differentials, CRP, ESR, ANA, SerumIL6, Soluble CD40 ligand, LDL, HDL, Anti-DNA antibodies, rheumatoidfactor, C3, C4, serum creatinine and any medication levels; data fromsurgical procedures such as gross operative findings and pathologicalevaluation of resected tissues and biopsies; information onpharmacological therapy and treatment changes; clinical diagnoses ofdisease “flare”; hospitalizations; quantitative joint exams; resultsfrom health assessment questionnaires (HAQs); other clinical measures ofpatient symptoms and disability; physical examination results andradiographic data assessing joint involvement, synovial thickening, boneloss and erosion and joint space narrowing and deformity. In some cases,data includes pathological evaluation of synovial memebranes and jointtissues from RA and control patients. Pathology scoring systems wereused to determine disease category, inflammation, type of inflammatoryinfiltrate, cellular and makeup of the synovial inflammation.

For some specimens of synovium, mononuclear cells or subsets ofmononuclear cells (such as T cells) can be isolated for expressionprofiling. The relative number of lyphocyte subsets for some specimenscan be determined by fluorescence activated cell sorting. Examples aredetermination of the CD4/CD8 T-cell ratio for a specimen. Thisinformation can be used as a variable to correlate to other outcomes oras an outcome for correlation analysis.

From these data, measures of improvement in RA are derived asexemplified by the ACR 20% and 50% response/improvement rates (Felson etal. 1996). Measures of disease activity over some period of time isderived from these data as are measures of disease progression. Serialradiography of effected joints is used for objective determination ofprogression (e.g., joint space narrowing, peri-articular osteoporosis,synovial thickening). Disease activity is determined from the clinicalscores, medical history, physical exam, lab studies, surgical andpathological findings.

The collected clinical data (disease criteria) is used to define patientor sample groups for correlation of expression data. Patient groups areidentified for comparison, for example, a patient group that possesses auseful or interesting clinical distinction, verses a patient group thatdoes not possess the distinction. Examples of useful and interestingpatient distinctions that can be made on the basis of collected clinicaldata are listed here:

Samples from patients during a clinically diagnosed RA flare versussamples from these same or different patients while they areasymptomatic.

Samples from patients who subsequently have high measures of diseaseactivity versus samples from those same or different patients who havelow subsequent disease activity.

Samples from patients who subsequently have high measures of diseaseprogression versus samples from those same or different patients whohave low subsequent disease progression.

Samples from patients who subsequently respond to a given medication ortreatment regimen versus samples from those same or different patientswho subsequently do not respond to a given medication or treatmentregimen (for example, TNF pathway blocking medications).

Samples from patients with a diagnosis of osteoarthritis versus patientswith rheumatoid arthritis.

Samples from patients with tissue biopsy results showing a high degreeof inflammation versus samples from patients with lesser degrees ofhistological evidence of inflammation on biopsy.

Expression profiles correlating with progression of RA are identified.Subsets of the candidate library (or a previously identified diagnosticnucleotide set) are identified, according to the above procedures, thathave predictive value for the progression of RA.

Diagnostic nucleotide set(s) are identified which predict respond to TNFblockade. Patients are profiled before and during treatment with thesemedications. Patients are followed for relief of symptoms, side effectsand progression of joint destruction, e.g., as measured by handradiographs. Expression profiles correlating with response to TNFblockade are identified. Subsets of the candidate library (or apreviously identified diagnostic nucleotide set) are identified,according to the above procedures that have predictive value forresponse to TNF blockade.

Example 10 Identification of Diagnostic Oligonucleotide andOligonucleotide Sets for Diagnosis of Systemic Lupus Erythematosis

SLE is a chronic, systemic inflammatory disease characterized bydysregulation of the immune system. Clinical manifestations affect everyorgan system and include skin rash, renal dysfunction, CNS disorders,arthralgias and hematologic abnormalities. SLE clinical manifestationstend to both recur intermittently (or “flare”) and progress over time,leading to permanent end-organ damage.

An observational study was conducted in which a cohort of patientsmeeting American College of Rheumatology (hereinafter “ACR”) criteriafor the diagnosis of SLE were identified. See Tan et al. (1982)Arthritis Rheum 25:1271-7. Patients gave informed consent and aperipheral blood mononuclear cell RNA sample or a peripheral T cellsample was obtained by the methods as described in example 7.

From each patient, the following clinical information was obtained ifavailable: Demographic information, ACR criteria for SLE, additionaldiagnoses of inflammatory and non-inflammatory conditions, data fromlaboratory testing including complete blood counts with differentials,CRP, ESR, ANA, Serum IL6, Soluble CD40 ligand, LDL, HDL, Anti-DNAantibodies, rheumatoid factor, C3, C4, serum creatinine (and othermeasures of renal dysfunction), medication levels, data from surgicalprocedures such as gross operative findings and pathological evaluationof resected tissues and biopsies (e.g., renal, CNS), information onpharmacological therapy and treatment changes, clinical diagnoses ofdisease “flare”, hospitalizations, quantitative joint exams, resultsfrom health assessment questionnaires (HAQs), SLEDAls (a clinical scorefor SLE activity that assess many clinical variables; Bombadier C,Gladman DD, Urowitz MB, Caron D, Chang CH and the Committee on PrognosisStudies in SLE: Derivation of the SLEDAI for Lupus Patients. ArthritisRheum 35:630-640, 1992), other clinical measures of patient symptoms anddisability, physical examination results and carotid ultrasonography.

The collected clinical data (disease criteria) is used to define patientor sample groups for correlation of expression data. Patient groups areidentified for comparison, for example, a patient group that possesses auseful or interesting clinical distinction, verses a patient group thatdoes not possess the distinction. Measures of disease activity in SLEare derived from the clinical data described above to divide patients(and patient samples) into groups with higher and lower disease activityover some period of time or at any one point in time. Such data areSLEDAI scores and other clinical scores, levels of inflammatory markersor complement, number of hospitalizations, medication use and changes,biopsy results and data measuring progression of end-organ damage orend-organ damage, including progressive renal failure, carotidatherosclerosis, and CNS dysfunction.

Expression profiles correlating with progression of SLE are identified,including expression profiles corresponding to end-organ damage andprogression of end-organ damage. Expression profiles are identifiedpredicting disease progression or disease “flare”, response to treatmentor likelihood of response to treatment, predict likelihood of “low” or“high” disease measures-(optionally described using the SLEDAI score),and presence or likelihood of developing premature carotidatherosclerosis. Subsets of the candidate library (or a previouslyidentified diagnostic nucleotide set) are identified, according to theabove procedures that have predictive value for the progression of SLE.

Further examples of useful and interesting patient distinctions that canbe made on the basis of collected clinical data are listed here. Samplescan be grouped and groups are compared to discover diagnostic gene sets:

-   -   1. Samples from patients during a clinically diagnosed SLE flare        versus samples from these same or different patients while they        are asymptomatic or while they have a documented infection.    -   2. Samples from patients who subsequently have high measures of        disease activity versus samples from those same or different        patients who have low subsequent disease activity.    -   3. Samples from patients who subsequently have high measures of        disease progression versus samples from those same or different        patients who have low subsequent disease progression.    -   4. Samples from patients who subsequently respond to a given        medication or treatment regimen versus samples from those same        or different patients who subsequently do not respond to a given        medication or treatment regimen.    -   5. Samples from patients with premature carotid atherosclerosis        on ultrasonography versus patients with SLE without premature        atherosclerosis.

Identification of a Diagnostic Oligonucleotide or Oligonucleotide Setfor Diagnosis of Lupus

Mononuclear RNA samples were collected from patients with SLE andpatients with Rheumatoid or Osteoarthritis (RA and OA) or controls usingthe protocol described in example 7. The patient diagnoses weredetermined using standard diagnostic algorithms such as those that areemployed by the American College of Rheumatology (see example See Tan etal. (1982) Arthritis Rheum 25:1271-7; Arnett et al. (1988) ArthritisRheum 31:315-24).

32 samples were included in the anaysis. 15 samples were derived frompatients with a clinical diagnosis of SLE and the remainder were derivedfrom patients with RA (9), OA (4) and subjects without known disease (4)who served as controls. Samples from patients with SLE or RA wereclassified as “Active” or “Controlled” (with respect to diseaseactivity) by the patient's physician based on objective and subjectivecriteria, such as patient history, physical exam and lab studies. Anattempt was made to match SLE patients and controls with respect toimportant variables such as medication use, sex, age and secondarydiagnoses.

After preparation of RNA (example 7), amplification, labeling,hybridization, scanning, feature extraction and data processing weredone as described in Example 14 using the oligonucleotide microarraysdescribed in Example 13. The resulting log ratio of expression of Cy3(patient sample)/Cy5 (R50 reference RNA) was used for analysis.

Initially, significance analysis for microarrays (SAM, Tusher 2001,Example 16) was used to discover that were differentially expressedbetween 7 of the Lupus samples and 17 control samples. 1 gene wasidentified that was expressed at a higher level in the lupus patientsthan in all controls. This gene had a 0.5% false detection rate usingSAM. This means that there is statistically, a 99.5% chance that thegene is truly differentially expressed between the Lupus and controlsamples. This gene was oligonucleotide and SEQ ID #4637. Theoligonucleotide: GCCTCTTGCTTGGCGTGATAACCCTGTCATCTTCCCAAAGCTCATTTATGdetects a specific human gene: sialyltransferase (SIAT4A),Unigene:Hs.301698 Locus: NM_(—)003033, GI: 4506950. Expression ratiosfor the gene are given for each sample in FIGS. 4A-B. The average foldchange in expression between SLE and controls was 1.48.

When a larger data set was used, 15 SLE samples were compared to 17controls. Using SAM, genes were identified as significantlydifferentially expressed between Lupus and controls. These genes andtheir FDRs are given in Table 10A. Supervised harvesting classification(X-Mine, Brisbane, Calif.) and CARTF (Salford Systems, San Diego Calif.)were also used on the same data to determine which set of genes bestdistinguish SLE from control samples (Example 16).

CART was used to build a decision tree for classification of samples aslupus or not lupus using the gene expression data from the arrays. Theanalysis identitifies sets of genes that can be used together toaccurately identify samples derived from lupus patients. The set ofgenes and the identified threshold expression levels for the decisiontree are referred to as “models”. Multiple models for diagnosis of Lupuswere derived by using different settings and parameters for the CARTalgorithm and using different sets of genes in the analysis. When usingCART, it may be desirable to limit the number of independent variables.In the case of the genes on the arrays, a subset of ˜8000 can beselected for analysis in CART based on significant differentialexpression discovered by using SAM or some other algorithm.

Model I was based on a data set consisting of thirty-two samples(fifteen SLE and seventeen non-SLE). These samples were used to derivethe model and are referred to a the “training set”. Model I used theexpression values for twenty-nine genes, which were found to be mostsignificant in differentiating SLE and non-SLE samples in the analysisusing SAM described above. SLE samples were designated as Class 1 andnon-SLE samples were designated as Class 2. For this analysis, thefollowing settings were used in the MODEL SETUP (CART, Salford Systems,San Diego, Calif.). In the Model settings, the tree type selected forthe analysis was classification. In the Categorical settings, thedefault values were used. In the Testing settings, V-foldcross-validation was selected with a value of 10. In the Select Casessettings, the default values were used. In the Best Tree settings, thedefault values were used. In the Combine settings, the default valueswere used. In the Method settings, Symmetric Gini was selected as thetype of classification tree and Linear combinations for splitting wasalso selected. The default values were used for the linear combinations.In the Advance Settings, the default values were used. In the Costssettings, the default values were used. In the Priors settings, Equalwas selected as the priors for Class. In the penalty settings, thedefault values were used.

From this analysis, CART built two models, a two-gene model and athree-gene model (FIGS. 4C-E). The sensitivity and specificity for theidentification of lupus in the training set samples of the two genesmodel were 100% and 94%, respectively. The sensitivity and specificityfor the 10-fold cross validation set of the two-gene model were 100% and88%, respectively, with a relative cost of 0.118. The sensitivity andspecificity for the training set of the three genes model were 100% and100%, respectively. The sensitivity and specificity for the 10-foldcross validation set of the three genes model were 93% and 94%,respectively, with a relative cost of 0.125.

Model II was based on a data set consisted of thirty-two samples,fifteen SLE and seventeen non-SLE (training set) and six thousandforty-four genes with expression values for at least 80% of the samples.The MODEL SETUP for the analysis of this data set was the same as forthe analysis above, except for the following correction. In the Methodsettings, Linear combination for splitting was unchecked after theanalysis yielded no classification tree. The change in the linearcombination setting resulted in the following.

The sensitivity and specificity for the training set of the one genemodel were 87% and 82%, respectively. The sensitivity and specificityfor the 10-fold cross validation set of the one gene model were 80% and59%, respectively, with a relative cost of 0.612. The sensitivity andspecificity for the training set of the three genes model were 100% and88%, respectively. The sensitivity and specificity for the 10-fold crossvalidation set of the three genes model were 67% and 65%, respectively,with a relative cost of 0.686. The sensitivity and specificity for thetraining set of the five genes model were 100% and 94%, respectively.The sensitivity and specificity for the 10-fold cross validation set ofthe five genes model were 67% and 59%, respectively, with a relativecost of 0.745. Results and models are summarized in FIGS. 4C and F.

Those genes that were found to be useful for classification are noted inTable 10A.

These genes can be used alone or in association with other genes orvariables to build a diagnostic gene set or a classification algorithm.These genes can be used in association with known gene markers for lupus(such as those identified in the prior art) to provide a diagnosticalgorithm.

Primers for real-time PCR validation were designed for each of the genesas described in Example 15 and are listed in Table 10B.

Surrogates for some of the most useful genes were identified and arelisted in Table 10C. Surrogates can be used in addition to or in placeof a diagnostic gene in a method of detecting lupus or in diagnosticgene set. For genes that were splitters in CART, surrogates wereidentified and reported by the software. In these cases, the bestavailable surrogates are listed. For other genes, hierarchicalclustering of the data was performed with default settings (x-miner,X-mine, Brisbane, Calif.) and members of gene expression clusters werenoted. A cluster was selected that included the gene of interest and themembers of that cluster were recorded in Table 10C.

Example 11 Probe Selection for a 24,000 Feature Array

This Example describes the compilation of almost 8,000 unique genes andESTs using sequences identified from the sources described below. Thesequences of these genes and ESTs were used to design probes, asdescribed in the following Example.

Tables 3A, 3B and 3C list the sequences identified in the subtractedleukocyte expression libraries. All sequences that were identified ascorresponding to a known RNA transcript were represented at least once,and all unidentified sequences were represented twice—once by thesequence on file and again by the complementary sequence—to ensure thatthe sense (or coding) strand of the gene sequence was included.

Table 3A. Table 3A contained all those sequences in the subtractedlibraries of example 1 that matched sequences in GenBank's nr,EST_Human, and UniGene databases with an acceptable level of confidence.All the entries in the table representing the sense strand of theirgenes were grouped together and all those representing the antisensestrand were grouped. A third group contained those entries whose strandcould not be determined. Two complementary probes were designed for eachmember of this third group.

Table 3B and 3C. Table 3B and 3C contained all those sequences in theleukocyte expression subtracted libraries of example 1 that did notmatch sequences in GenBank's nr, EST_Human, and UniGene databases withan acceptable level of confidence, but which had a high probability ofrepresenting real mRNA sequences. Sequences in Table 3B did not matchanything in the databases above but matched regions of the human genomedraft and were spatially clustered along it, suggesting that they wereexons, rather than genomic DNA included in the library by chance.Sequences in Table 3C also aligned well to regions of the human genomedraft, but the aligned regions were interrupted by genomic DNA, meaningthey were likely to be spliced transcripts of multiple exon genes.

Table 3B lists 510 clones and Table 3C lists 48 clones that originallyhad no similarity with any sequence in the public databases. Blastnsearches conducted after the initial filing have identified sequences inthe public database with high similarity (E values less than 1e-40) tothe sequences determined for these clones. Table 3B contained 272 clonesand Table 3C contained 25 clones that were found to have high similarityto sequences in dbEST. The sequences of the similar dbEST-clones wereused to design probes. Sequences from clones that contained no similarregions to any sequence in the database were used to design a pair ofcomplementary probes.

Probes were designed from database sequences that had the highestsimilarity to each of the sequenced clones in Tables 3A, 3B, and 3C.Based on BLASTn searches the most similar database sequence wasidentified by locus number and the locus number was submitted to GenBankusing batch Entrez (located at the websitencbi.nlm.nih.gov/entrez/batchentrez.cgi?db=Nucleotide) to obtain thesequence for that locus. The GenBank entry sequence was used because inmost cases it was more complete or was derived from multi-passsequencing and thus would likely have fewer errors than the single passcDNA library sequences. When only UniGene cluster IDs were available forgenes of interest, the respective scquences were extracted from theUniGene_unique database, build 137, downloaded from NCBI(ftp://ncbi.nlm.nih.gov/repository/UniGene/). This database contains onerepresentative sequence for each cluster in UniGene.

Summary of library clones used in array probe design Table Sense StrandAntisnese Strand Strand Undetermined 3A 3621 763 124 3B 142 130 238 3C19 6 23 Totals 3782 899 385

Literature Searches

Example 2 describes searches of literature databases. We also searchedfor research articles discussing genes expressed only in leukocytes orinvolved in inflammation and particular disease conditions, includinggenes that were specifically expressed or down-regulated in a diseasestate. Searches included, but were not limited to, the following termsand various combinations of theses terms: inflammation, atherosclerosis,rheumatoid arthritis, osteoarthritis, lupus, SLE, allograft, transplant,rejection, leukocyte, monocyte, lymphocyte, mononuclear, macrophage,neutrophil, eosinophil, basophil, platelet, congestive heart failure,expression, profiling, microarray, inflammatory bowel disease, asthma,RNA expression, gene expression, granulocyte.

A UniGene cluster ID or GenBank accession number was found for each genein the list. The strand of the corresponding sequence was determined, ifpossible, and the genes were divided into the three groups: sense(coding) strand, anti-sense strand, or strand unknown. The rest of theprobe design process was carried out as described above for thesequences from the leukocyte subtracted expression library.

Database Mining

Database mining was performed as described in Example 2. In addition,the Library Browser at the NCBI UniGene web site (located on the web atncbi.nlmn.nih.gov/UniGene/lbrowse.cgi?ORG=Hs&DISPLAY=ALL) was used toidentify genes that are specifically expressed in leukocyte cellpopulations. All expression libraries available at the time wereexamined and those derived from leukocytes were viewed individually.Each library viewed through the Library Browser at the UniGene web sitecontains a section titled “Shown below are UniGene clusters of specialinterest only” that lists genes that are either highly represented orfound only in that library. Only the genes in this section weredownloaded from each library. Alternatively, every sequence in eachlibrary is downloaded and then redundancy between libraries is reducedby discarding all UniGene cluster IDs that are represented more thanonce. A total of 439 libraries were downloaded, containing 35,819 genes,although many were found in more than one library. The most importantlibraries from the remaining set were separated and 3,914 genesremained. After eliminating all redundancy between these libraries andcomparing the remaining genes to those listed in Tables 3A, 3B and 3C,the set was reduced to 2,573 genes in 35 libraries as shown in Table 4.From these, all genes in first 30 libraries were used to design probes.A random subset of genes was used from Library Lib.376,“Activated_T_cells_XX”. From the last four libraries, a random subset ofsequences listed as “ESTs, found only in this library” was used.

Angiozenesis Markers

215 sequences derived from an angiogenic endothelial cell subtractedcDNA library obtained from Stanford University were used for probedesign. Briefly, using well known subtractive hybridization procedures,(as described in, e.g., U.S. Pat. Nos. 5,958,738; 5,589,339; 5,827,658;5,712,127; 5,643,761; 5,565,340) modified to normalize expression bysuppressing over-representation of abundant RNA species while increasingrepresentation of rare RNA species, a library was produced that isenriched for RNA species (messages) that are differentially expressedbetween test (stimulated) and control (resting) HUVEC populations. Thesubtraction/suppression protocol was performed as described by the kitmanufacturer (Clontech, PCR-select cDNA Subtraction Kit).

Pooled primary HUVECs (Clonetics) were cultured in 15% FCS, M199(GibcoBRL) with standard concentrations of Heparin, Penicillin,Streptomycin, Glutamine and Endothelial Cell Growth Supplement. Thecells were cultured on 1% gelatin coated 10 cm dishes. Confluent HUVECswere photographed under phase contrast microscopy. The cells formed amonolayer of flat cells without gaps. Passage 2-5 cells were used forall experiments. Confluent HUVECs were treated with trypsin/EDTA andseeded onto collagen gels. Collagen gels were made according to theprotocol of the Collagen manufacturer (Becton Dickinson Labware).Collagen gels were prepared with the following ingredients: Rat tailcollagen type I (Collaborative Biomedical) 1.5 mg/mL, mouse laminin(Collaborative Biomedical) 0.5 mg/mL, 10% 10X media 199 (Gibco BRL). 1NNaOH, 10 X PBS and sterile water were added in amounts recommended inthe protocol. Cell density was measured by microscopy. 1.2×10⁶ cellswere seeded onto gels in 6-well, 35 mm dishes, in 5% FCS M199 media. Thecells were incubated for 2 hrs at 37 C with 5% CO₂. The media was thenchanged to the same media with the addition of VEGF (Sigma) at 30 ng/mLmedia. Cells were cultured for 36 hrs. At 12, 24 and 36 hrs, the cellswere observed with phase contrast microscopy. At 36 hours, the cellswere observed elongating, adhering to each other and forming lumenstructures. At 12 and 24 hrs media was aspirated and refreshed. At 36hrs, the media was aspirated, the cells were rinsed with PBS and thentreated with Collagenase (Sigma) 2.5 mg/mL PBS for 5 min with activeagitation until the collagen gels were liquefied. The cells were thencentrifuged at 4C, 2000 g for 10 min. The supernatant was removed andthe cells were lysed with 1 mL Trizol Reagent (Gibco) per 5×10⁶ cells.Total RNA was prepared as specified in the Trizol instructions for use.mRNA was then isolated as described in the micro-fast track mRNAisolation protocol from Invitrogen. This RNA was used as the tester RNAfor the subtraction procedure.

Ten plates of resting, confluent, p4 HUVECs, were cultured with 15% FCSin the M199 media described above. The media was aspirated and the cellswere lysed with 1 mL Trizol and total RNA was prepared according to theTrizol protocol. mRNA was then isolated according to the micro-fasttrack mRNA isolation protocol from Invitrogen. This RNA served as thecontrol RNA for the subtraction procedure.

The entire subtraction cloning procedure was carried out as per the usermanual for the Clontech PCR Select Subtraction Kit. The cDNAs preparedfrom the test population of HUVECs were divided into “tester” pools,while cDNAs prepared from the control population of HUVECs weredesignated the “driver” pool. cDNA was synthesized from the tester andcontrol RNA samples described above. Resulting cDNAs were digested withthe restriction enzyme Rsal. Unique double-stranded adapters wereligated to the tester cDNA. An initial hybridization was performedconsisting of the tester pools of cDNA (with its corresponding adapter)and an excess of the driver cDNA. The initial hybridization results in apartial normalization of the cDNAs such that high and low abundancemessages become more equally represented following hybridization due toa failure of driver/tester hybrids to amplify.

A second hybridization involved pooling unhybridized sequences from thefirst hybridization together with the addition of supplemental drivercDNA. In this step, the expressed sequences enriched in the two testerpools following the initial hybridization can hybridize. Hybridsresulting from the hybridization between members of each of the twotester pools are then recovered by amplification in a polymerase chainreaction (PCR) using primers specific for the unique adapters. Again,sequences originating in a tester pool that form hybrids with componentsof the driver pool are not amplified. Hybrids resulting between membersof the same tester pool are eliminated by the formation of “panhandles”between their common 5′ and 3′ ends. The subtraction was done in bothdirections, producing two libraries, one with clones that areupregulated in tube-formation and one with clones that aredown-regulated in the process.

The resulting PCR products representing partial cDNAs of differentiallyexpressed genes were then cloned (i.e., ligated) into an appropriatevector according to the manufacturer's protocol (pGEM-Teasy fromPromega) and transformed into competent bacteria for selection andscreening. Colonies (2180) were picked and cultured in LB broth with 50ug/mL ampicillin at 37C overnight. Stocks of saturated LB+50 ug/mLampicillin and 15% glycerol in 96-well plates were stored at −80C.Plasmid was prepared from 1.4 mL saturated LB broth containing 50 ug/mLampicillin. This was done in a 96 well format using commerciallyavailable kits according to the manufacturer's recommendations (Qiagen96-turbo prep).

2 probes to represent 22 of these sequences required, therefore, a totalof 237 probes were derived from this library.

Viral Genes

Several viruses may play a role in a host of disease includinginflammatory disorders, atherosclerosis, and transplant rejection. Table12 lists the viral genes represented by oligonucleotide probes on themicroarray. Low-complexity regions in the sequences were masked usingRepeatMasker before using them to design probes.

Strand Selection

It was necessary to design sense oligonucleotide probes because thelabeling and hybridization protocol to be used with the microarrayresults in fluorescently-labeled antisense cRNA. All of the sequences weselected to design probes could be divided into three categories:

-   (1) Sequences known to represent the sense strand-   (2) Sequences known to represent the antisense strand-   (3) Sequences whose strand could not be easily determined from their    descriptions

It was not known whether the sequences from the leukocyte subtractedexpression library were from the sense or antisense strand. GenBanksequences are reported with sequence given 5′ to 3′, and the majority ofthe sequences we used to design probes came from accession numbers withdescriptions that made it clear whether they represented sense orantisense sequence. For example, all sequences containing “mRNA” intheir descriptions were understood to be the sequences of the sensemRNA, unless otherwise noted in the description, and all IMAGEConsortium clones are directionally cloned and so the direction (orsense) of the reported sequence can be determined from the annotation inthe GenBank record.

For accession numbers representing the sense strand, the sequence wasdownloaded and masked and a probe was designed directly from thesequence. These probes were selected as close to the 3′ end as possible.For accession numbers representing the antisense strand, the sequencewas downloaded and masked, and a probe was designed complementary tothis sequence. These probes were designed as close to the 5′ end aspossible (i.e., complementary to the 3′ end of the sense strand).

Minimizing Probe Redundancy.

Multiple copies of certain genes or segments of genes were included inthe sequences from each category described above, either by accident orby design. Reducing redundancy within each of the gene sets wasnecessary to maximize the number of unique genes and ESTs that could berepresented on the microarray.

Three methods were used to reduce redundancy of genes, depending on whatinformation was available. First, in gene sets with multiple occurrencesof one or more UniGene numbers, only one occurrence of each UniGenenumber was kept. Next, each gene set was searched by GenBank accessionnumbers and only one occurrence of each accession number was conserved.Finally, the gene name, description, or gene symbol were searched forredundant genes with no UniGene number or different accession numbers.In reducing the redundancy of the gene sets, every effort was made toconserve the most information about each gene.

We note, however, that the UniGene system for clustering submissions toGenBank is frequently updated and UniGene cluster IDs can change. Two ormore clusters may be combined under a new cluster ID or a cluster may besplit into several new clusters and the original cluster ID retired.Since the lists of genes in each of the gene sets discussed wereassembled at different times, the same sequence may appear in severaldifferent sets with a different UniGene ID in each.

Sequences from Table 3A were treated differently. In some cases, two ormore of the leukocyte subtracted expression library sequences aligned todifferent regions of the same GenBank entry, indicating that thesesequences were likely to be from different exons in the same genetranscript. In these cases, one representative library sequencecorresponding to each presumptive exon was individually listed in Table3A.

Compilation.

After redundancy within a gene set was sufficiently reduced, a table ofapproximately 8,000 unique genes and ESTs was compiled in the followingmanner. All of the entries in Table 3A were transferred to the newtable. The list of genes produced by literature and database searcheswas added, eliminating any genes already contained in Table 3A. Next,each of the remaining sets of genes was compared to the table and anygenes already contained in the table were deleted from the gene setsbefore appending them to the table.

Probes Subtracted Leukocyte Expression Library Table 3A 4,872 Table 3B796 Table 3C 85 Literature Search Results 494 Database Mining 1,607Viral genes a. CMV 14 b. EBV 6 c. HHV 6 14 d. Adenovirus 8 Angiogenesismarkers: 215, 22 of which needed two probes 237 Arabidopsis thalianagenes 10 Total sequences used to design probes 8,143

Example 12 Design of Oligonucleotide Probes

By way of example, this section describes the design of fouroligonucleotide probes using Array Designer Ver 1.1 (Premier BiosoftInternational, Palo Alto, Calif.). The major steps in the process aregiven first.

1) Obtain best possible sequence of mRNA from GenBank. If a full-lengthsequence reference sequence is not available, a partial sequence isused, with preference for the 3′ end over the 5′ end. When the sequenceis known to represent the antisense strand, the reverse complement ofthe sequence is used for probe design. For sequences represented in thesubtracted leukocyte expression library that have no significant matchin GenBank at the time of probe design, our sequence is used.

2) Mask low complexity regions and repetitive elements in the sequenceusing an algorithm such as RepeatMasker.

3) Use probe design software, such as Array Designer, version 1.1, toselect a sequence of 50 residues with specified physical and chemicalproperties. The 50 residues nearest the 3′ end constitute a searchframe. The residues it contains are tested for suitability. If theydon't meet the specified criteria, the search frame is moved one residuecloser to the 5′ end, and the 50 residues it now contains are tested.The process is repeated until a suitable 50-mer is found.

4) If no such 50-mer occurs in the sequence, the physical and chemicalcriteria are adjusted until a suitable 50-mer is found.

5) Compare the probe to dbEST, the UniGene cluster set, and theassembled human genome using the BLASTn search tool at NCBI to obtainthe pertinent identifying information and to verify that the probe doesnot have significant similarity to more than one known gene.

Clone 40H12

Clone 40H12 was sequenced and compared to the nr, dbEST, and UniGenedatabases at NCBI using the BLAST search tool. The sequence matchedaccession number NM_(—)002310, a ‘curated RefSeq project’ sequence, seePruitt et al. (2000) Trends Genet. 16:44-47, encoding leukemiainhibitory factor receptor (LIFR) mRNA with a reported E value of zero.An E value of zero indicates there is, for all practical purposes, nochance that the similarity was random based on the length of thesequence and the composition and size of the database. This sequence,cataloged by accession number NM_(—)002310, is much longer than thesequence of clone 40H 12 and has a poly-A tail. This indicated that thesequence cataloged by accession number NM_(—)002310 is the sense strandand a more complete representation of the mRNA than the sequence ofclone 40H 12, especially at the 3′ end. Accession number “NM_(—)002310”was included in a text file of accession numbers representing sensestrand mRNAs, and sequences for the sense strand mRNAs were obtained byuploading a text file containing desired accession numbers as an Entrezsearch query using the Batch Entrez web interface and saving the resultslocally as a FASTA file. The following sequence was obtained, and theregion of alignment of clone 40H12 is outlined:

The FASTA file, including the sequence of NM_(—)002310, was masked usingthe RepeatMasker web interface (Smit, AFA & Green, P RepeatMasker atgenome.washington.edu/RM/RepeatMasker.html, Smit and Green).Specifically, during masking, the following types of sequences werereplaced with “N's”: SINE/MIR & LINE/L2, LINE/L1, LTR/MaLR,LTR/Retroviral, Alu, and other low informational content sequences suchas simple repeats. Below is the sequence following masking:

The length of this sequence was determined using batch, automatedcomputational methods and the sequence, as sense strand, its length, andthe desired location of the probe sequence near the 3′ end of the mRNAwas submitted to Array Designer Ver 1.1 (Premier Biosoft International,Palo Alto, Calif.). Search quality was set at 100%, number of bestprobes set at 1, length range set at 50 base pairs, Target Tm set at 75C. degrees plus or minus 5 degrees, Hairpin max deltaG at 6.0-kcal/mol.,Self dimmer max deltaG at 6.0-kcal/mol, Run/repeat (dinucleotide) maxlength set at 5, and Probe site minimum overlap set at 1. When none ofthe 49 possible probes met the criteria, the probe site would be moved50 base pairs closer to the 5′ end of the sequence and resubmitted toArray Designer for analysis. When no possible probes met the criteria,the variation on melting temperature was raised to plus and minus 8degrees and the number of identical basepairs in a run increased to 6 sothat a probe sequence was produced.

In the sequence above, using the criteria noted above, Array DesignerVer 1.1 designed a probe corresponding to oligonucleotide number 2280 inTable 8 and is indicated by underlining in the sequence above. It has amelting temperature of 68.4 degrees Celsius and a max run of 6nucleotides and represents one of the cases where the criteria for probedesign in Array Designer Ver 1.1 were relaxed in order to obtain anoligonucleotide near the 3′ end of the mRNA (Low melting temperature wasallowed).

Clone 463D12

Clone 463D12 was sequenced and compared to the nr, dbEST, and UniGenedatabases at NCBI using the BLAST search tool. The sequence matchedaccession number A 184553, an EST sequence with the definition line“qd60a05.x1 Soares_testis_NHT Homo sapiens cDNA clone IMAGE:1733840 3′similar to gb:M29550 PROTEIN PHOSPHATASE 2B CATALYTIC SUBUNIT 1 (HUMAN);mRNA sequence.” The E value of the alignment was 1.00×10⁻¹¹⁸. TheGenBank sequence begins with a poly-T region, suggesting that it is theantisense strand, read 5′ to 3′. The beginning of this sequence iscomplementary to the 3′ end of the mRNA sense strand. The accessionnumber for this sequence was included in a text file of accessionnumbers representing antisense sequences. Sequences for antisense strandmRNAs were obtained by uploading a text file containing desiredaccession numbers as an Entrez search query using the Batch Entrez webinterface and saving the results locally as a FASTA file. The followingsequence was obtained, and the region of alignment of clone 463D12 isoutlined:

The FASTA file, including the sequence of AA184553, was then maskedusing the RepeatMasker web interface, as shown below. The region ofalignment of clone 463D12 is outlined.

The sequence was submitted to Array Designer as described above,however, the desired location of the probe was indicated at base pair 50and if no probe met the criteria, moved in the 3′ direction. Thecomplementary sequence from Array Designer was used, because theoriginal sequence was antisense. The oligonucleotide designed by ArrayDesigner corresponds to oligonucleotide number 4342 in Table 8 and iscomplementary to the underlined sequence above. The probe has a meltingtemperature of 72.7 degrees centigrade and a max run of 4 nucleotides.

Clone 72D4

Clone 72D4 was sequenced and compared to the nr, dbEST, and UniGenedatabases at NCBI using the BLAST search tool. No significant matcheswere found in any of these databases. When compared to the human genomedraft, significant alignments were found to three consecutive regions ofthe reference sequence NT_(—)008060, as depicted below, suggesting thatthe insert contains three spliced exons of an unidentified gene.

Residue Numbers on Matching Residue

clone 72D4 sequence numbers on NT_008060  1-198 478646-478843 197-489479876-480168 491-585 489271-489365

Because the reference sequence contains introns and may represent eitherthe coding or noncoding strand for this gene, BioCardia's own sequencefile was used to design the oligonucleotide. Two complementary probeswere designed to ensure that the sense strand was represented. Thesequence of the insert in clone 72D4 is shown below, with the threeputative exons outlined.

The sequence was submitted to RepeatMasker, but no repetitive sequenceswere found. The sequence shown above was used to design the two 50-merprobes using Array Designer as described above. The probes are shown inbold typeface in the sequence depicted below. The probe in the sequenceis oligonucleotide number 6415 (SEQ ID NO: 6415) in Table 8 and thecomplementary probe is oligonucleotide number 6805 (SEQ ID NO:6805).

CAGGTCACACAGCACATCAGTGGCTACATGTGAGCTCAGACCTGGGTCTGCTGCTGTCTGTCTTCCCAATATCCATGACCTTGACTGATGCAGGTGTCTAGGGATACGTCCATCCCCGTCCTGCTGGAGCCCAGAGCACGGAAGCCTGGCCCTCCGAGGAGACAGAAGGGAGTGTCGGACACCATGACGAGAGCTTGGCAGAATAAATAACTTCTTTAAACAATTTTACGGCATGAAGAAATCTGGACCAGTTTATTAAATGGGATTTCTGCCACAAACCTTGGAAGAATCACATCATCTTANNCCCAAGTGAAAACTGTGTTGCGTAACAAAGAACATGACTGCGCTCCACACATACATCATTGCCCGGCGAGGCGGGACACAAGTCAACGACGGAACACTTGAGACAGGCCTACAACTGTGCACGGGTCAGAAGCAAGTTTAAGCCATACTTGCTGCAGTGAGACTACATTTCTGTCTATAGAAGATACCTGACTTGATCTGTTTTTCAGCTCCAGTTCCCAGATGTGC--->                                        <----3′-GTCAAGGGTCTACACGTGTTGTGGTCCCCAAGTATCACCTTCCAATTTCTGGGAG--->CACAACACCAGGGGTTCATAGTGGAAGGTTAAAG-5′(SEQ ID NO:6805))CAGTGCTCTGGCCGGATCCTTGCCGCGCGGATAAAAACT---->(end of SEQ ID:8545)

Confirmation of Probe Sequence

Following probe design, each probe sequence was confirmed by comparingthe sequence against dbEST, the UniGene cluster set, and the assembledhuman genome using BLASTn at NCBI. Alignments, accession numbers, ginumbers, UniGene cluster numbers and names were examined and the mostcommon sequence used for the probe. The final probe set was compiledinto Table 8. In this table, the sequence ID is given which correspondsto the sequence listing. The origin of the sequence for inclusion on thearray is noted as coming from one of the cDNA libraries described inexample 1, mining from databases as described in examples 2 and 11 oridentification from the published literature. The unigene number,genebank accession and GI number are also given for each sequence whenknown. The name of the gene associated with the accession number isnoted. The strand is noted as −1 or 1, meaning that the probe wasdesigned from the complement of the sequence (−1) or directly from thesequence (1). Finally, the nucleotide sequence of each probe is alsogiven.

Example 13 Production of an Array of 8000 Spotted 50mer Oligonucleotides

We produced an array of 8000 spotted 50mer oligonucleotides. Examples 11and 12 exemplify the design and selection of probes for this array.

Sigma-Genosys (The Woodlands, Tex.) synthesized un-modified 50-meroligonucleotides using standard phosphoramidite chemistry, with astarting scale of synthesis of 0.05 μmole (see, e.g., R. Meyers, ed.(1995) Molecular Biology and Biotechnology: A Comprehensive DeskReference). Briefly, to begin synthesis, a 3′ hydroxyl nucleoside with adimethoxytrityl (DMT) group at the 5′ end was attached to a solidsupport. The DMT group was removed with trichloroacetic acid (TCA) inorder to free the 5′-hydroxyl for the coupling reaction. Next, tetrazoleand a phosphoramidite derivative of the next nucleotide were added. Thetetrazole protonates the nitrogen of the phosphoramidite, making itsusceptible to nucleophilic attack. The DMT group at the 5′-end of thehydroxyl group blocks further addition of nucleotides in excess. Next,the inter-nucleotide linkage was converted to a phosphotriester bond inan oxidation step using an oxidizing agent and water as the oxygendonor. Excess nucleotides were filtered out and the cycle for the nextnucleotide was started by the removal of the DMT protecting group.Following the synthesis, the oligo was cleaved from the solid support.The oligonucleotides were desalted, resuspended in water at aconcentration of 100 or 200 μM, and placed in 96-deep well format. Theoligonucleotides were re-arrayed into Whatman Uniplate 384-wellpolyproylene V bottom plates. The oligonucleotides were diluted to afinal concentration 30 μM in 1X Micro Spotting Solution Plus(Telechem/arrayit.com, Sunnyvale, Calif.) in a total volume of 15)μl. Intotal, 8,031 oligonucleotides were arrayed into twenty-one 384-wellplates.

Arrays were produced on Telechem/arrayit.com Super amine glasssubstrates (Telechem/arrayit.com), which were manufactured in 0.1 mmfiltered clean room with exact dimensions of 25×76×0.96 mm. The arrayswere printed using the Virtek Chipwriter with a Telechem 48 pin MicroSpotting Printhead. The Printhead was loaded with 48 Stealth SMP3BTeleChem Micro Spotting Pins, which were used to print oligonucleotidesonto the slide with the spot size being 110-115 microns in diameter.

Example 14 Amplification, Labeling, and Hybridization of Total RNA to anOligonucleotide Microarray

Amplification, Labeling, Hybridization and Scanning

Samples consisting of at least 2 μg of intact total RNA were furtherprocessed for array hybridization. Amplification and labeling of totalRNA samples was performed in three successive enzymatic reactions.First, a single-stranded DNA copy of the RNA was made (hereinafter,“ss-cDNA”). Second, the ss-cDNA was used as a template for thecomplementary DNA strand, producing double-stranded cDNA (hereinafter,“ds-cDNA, or cDNA”). Third, linear amplification was performed by invitro transcription from a bacterial T₇ promoter. During this step,fluorescent-conjugated nucleotides were incorporated into the amplifiedRNA (hereinafter, “aRNA”).

The first strand cDNA was produced using the Invitrogen kit (SuperscriptII). The first strand cDNA was produced in a reaction composed of 50 mMTris-HCl (pH 8.3), 75 mM KCl, and 3 mM MgCl₂ (1×First Strand Buffer,Invitrogen), 0.5 mM dGTP, 0.5 mM DATP, 0.5 mM dTTP, 0.5 mM dCTP, 10 mMDTT, 10 U reverse transcriptase (Superscript II, Invitrogen, #18064014),15 U RNase inhibitor (RNAGuard, Amersham Pharmacia, #27-0815-01), 5 μMT7T24 primer (5′-GGCCAGTGAATIGTAATACGACTCACTATAGGGAGGCCGGTTTTTTTTTTTTTTTTTTTTTTT-3′), (SEQ ID NO:8831) and 2 μg of selected sample totalRNA. Several purified, recombinant control mRNAs from the plantArabidopsis thaliana were added to the reaction mixture: 2-20 pg of thefollowing genes CAB, RCA, LTP4, NAC1, RCP1,XCP2, RBCL, LTP6, TIM, andPRKase (Stratagene, #252201, #252202, #252204, #252208, #252207,#252206, #252203, #252205, #252209, #252210 respectively). The controlRNAs allow the estimate of copy numbers for individual mRNAs in theclinical sample because corresponding sense oligonucleotide probes foreach of these plant genes are present on the microarray. The finalreaction volume of 20 μl was incubated at 42° C. for 60 min.

For synthesis of the second cDNA strand, DNA polymerase and RNase wereadded to the previous reaction, bringing the final volume to 150 μl. Theprevious contents were diluted and new substrates were added to a finalconcentration of 20 mM Tris-HCl (pH 7.0) (Fisher Scientific, Pittsburgh,Pa. #BP1756-100), 90 mMKCl (Teknova, Half Moon Bay, Calif., #0313-500),4.6 mM MgCl₂ (Tcknova, Half Moon Bay, Calif., #0304-500), 10 mM(NH₄)₂SO₄(Fisher Scientific #A702-500)(1×Second Strand buffer, Invitrogen), 0.266mM dGTP, 0.266 mM dATP, 0.266 mM dTTP, 0.266 mM dCTP, 40 U E. coli DNApolymerase (Invitrogen, #18010-025), and 2 U RNaseH (Invitrogen,#18021-014). The second strand synthesis took place at 16° C. for 120minutes.

Following second-strand synthesis, the ds-cDNA was purified from theenzymes, dNTPs, and buffers before proceeding to amplification, usingphenol-chloroform extraction followed by ethanol precipitation of thecDNA in the presence of glycogen.

Alternatively, a silica-gel column is used to purify the cDNA (e.g.Qiaquick PCR cleanup from Qiagen, #28104). The cDNA was collected bycentrifugation at >10,000×g for 30 minutes, the supernatant isaspirated, and 150 μl of 70% ethanol, 30% water was added to wash theDNA pellet. Following centrifugation, the supernatant was removed, andresidual ethanol was evaporated at room temperature.

Linear amplification of the cDNA was performed by in vitro transcriptionof the cDNA. The cDNA pellet from the step described above wasresuspended in 7.4 μl of water, and in vitro transcription reactionbuffer was added to a final volume of 20 μl containing 7.5 mM GTP, 7.5mM ATP, 7.5 mM TTP, 2.25 mM CTP, 1.025 mM Cy3-conjugated CTP (PerkinElmer; Boston, Mass., #NEL-580), 1x reaction buffer (Ambion, MegascriptKit, Austin, Tex. and #1334) and 1% T₇ polymerase enzyme mix (Ambion,Megascript Kit, Ausfin, Tex. and #1334). This reaction was incubated at37° C. overnight. Following in vitro transcription, the RNA was purifiedfrom the enzyme, buffers, and excess NTPs using the RNeasy kit fromQiagen (Valencia, Calif.; # 74106) as described in the vendor'sprotocol. A second elution step was performed and the two eluates werecombined for a final-volume of 60 μl. RNA is quantified using an Agilent2100 bioanalyzer with the RNA 6000 nano LabChip.

Reference RNA was prepared as described above, except Cy5-CTP wasincorporated instead of Cy3CTP. Reference RNA from five reactions, eachreaction started with 2 ug total RNA, was pooled together andquantitated as described above.

Hybridization to an Array

RNA was prepared for hybridization as follows: for an 18 mm×55 mm array,20 μg of amplified RNA (aRNA) was combined with 20 μg of reference aRNA.The combined sample and reference aRNA was concentrated by evaporatingthe water to 10 μl in a vacuum evaporator. The sample was fragmented byheating the sample at 95° C. for 30 minutes to fragment the RNA into50-200 bp pieces. Alternatively, the combined sample and reference aRNAwas concentrated by evaporating the water to 5 μl in a vacuumevaporator. Five μl of 20 mM zinc acetate was added to the aRNA and themix incubated at 60° C. for 10 minutes. Following fragmentation, 40 μlof hybridization buffer was added to achieve final concentrations of5×SSC and 0.20% SDS with 0.1 μg/μl of Cot-1 DNA (Invitrogen) as acompetitor DNA. The final hybridization mix was heated to 98° C., andthen reduced to 50° C. at 0.1° C. per second.

Alternatively, formamide is included in the hybridization mixture tolower the hybridization temperature.

The hybridization mixture was applied to a pre-heated 65° C. microarray,surface, covered with a glass coverslip (Corning, #2935-246), and placedon a pre-heated 65° C. hybridization chamber (Telechem, AHC-10). 15 ulof 5×SSC was placed in each of the reservoir in the hybridizationchamber and the chamber was scaled and placed in a water bath at 62° C.for overnight (16-20 hrs). Following incubation, the slides were washedin 2×SSC, 0.1% SDS for five minutes at 30° C., then in 2×SSC for fiveminutes at 30° C., then in 2×SSC for another five minutes at 30° C.,then in 0.2×SSC for two minutes at room temperature. The arrays werespun at 1000×g for 2 minutes to dry them. The dry microarrays are thenscanned by methods described above.

The microarrays were imaged on the Agilent (Palo Alto, Calif.) scannerG2565AA. The scan settings using the Agilent software were as follows:for the PMT Sensitivity (100% Red and 100% Green); Scan Resolution (10microns); red and green dye channels; used the default scan region forall slides in the carousel; using the largest scan region; scan date forInstrument ID; and barcode for Slide ID. The full image produced by theAgilent scanner was flipped, rotated, and split into two images (one foreach signal channel) using TIFFSplitter (Agilent, Palo Alto, Calif.).The two channels are the output at 532 nm (Cy3-labeled sample) and 633nm (Cy5-labeled R50). The individual images were loaded into GenePix 3.0(Axon Instruments, Union City, Calif.) for feature extraction, eachimage was assigned an excitation wavelength corresponding the fileopened; Red equals 633 nm and Green equals 532 mm. The setting file(gal) was opened and the grid was laid onto the image so that each spotin the grid overlaped with >50% of the feature. Then the GenePixsoftware was used to find the features without setting minimum thresholdvalue for a feature. For features with low signal intensity, GenePixreports “not found”. For all features, the diameter setting was adjustedto include only the feature if necessary.

The GenePix software determined the median pixel intensity for eachfeature (F_(i)) and the median pixel intensity of the local backgroundfor each feature (B_(i)) in both channels. The standard deviation(SDF_(i and) and SDB_(i)) for each is also determined. Features forwhich GenePix could not discriminate the feature from the backgroundwere “flagged” as described below.

Following feature extraction into a .gpr file, the header information ofthe .gpr file was changed to carry accurate information into thedatabase. An Excel macro was written to change the headers. The steps inthat macro were:

-   -   1. Open .gpr file.    -   2. Check the value in the first row, first column. If it is        “ATF”, then the header has likely already been reformatted. The        file is skipped and the user is alerted. Otherwise, proceed        through the following steps.    -   3. Store the following values in variables.        -   a. Name of .tif image file: parsed from row 11.        -   b. SlideD: parsed from name of .tif image file.        -   c. Version of the feature extraction software: parsed from            row 25        -   d. GenePix Array List file: parsed from row 6        -   e. GenePix Settings file: parsed from row 5    -   4. Delete rows 1-8, 10-12, 20, 22, and 25.    -   5. Arrange remaining values in rows 15-29.    -   6. Fill in rows 1-14 with the following:        -   Row 1: ScanID (date image file was last modified, formatted            as yyyy.mm.dd-hh.mm.ss)        -   Row 2: SlideID, from stored value        -   Row 3: Name of person who scanned the slide, from user input        -   Row 4: Image file name, from stored value        -   Row 5: Green PMT setting, from user input        -   Row 6: Red PMT setting, from user input        -   Row 7: ExtractID (date .gpr file was created, formatted as            yyyy.mm.dd-hh.mm.ss)        -   Row 8: Name of person who performed the feature extraction,            from user input        -   Row 9: Feature extraction software used, from stored value        -   Row 10: Results file name (same as the .gpr file name)        -   Row 11: GenePix Array List file, from stored value        -   Row 12: GenePix Settings file, from stored value        -   Row 13: StorageCD, currently left blank        -   Row 14: Extraction comments, from user input (anything about            the scanning or feature extraction of the image the user            feels might be relevant when selecting which hybridizations            to include in an analysis)            Pre-Processing with Excel Templates

Following analysis of the image and extraction of the data, the datafrom each hybridization was pre-processed to extract data that wasentered into the database and subsequently used for analysis. Thecomplete GPR file produced by the feature extraction in GenePix wasimported into an excel file pre-processing template. The same exceltemplate was used to process each GPR file. The template performs aseries of calculations on the data to differentiate poor features fromothers and to combine triplicate feature data into a single data pointfor each probe.

Each GPR file contained 31 rows of header information, followed by rowsof data for 24093 features. The last of these rows was retained with thedata. Rows 31 through the end of the file were imported into the exceltemplate. Each row contained 43 columns of data. The only columns usedin the pre-processing were: Oligo ID, F633 Median (median value from allthe pixels in the feature for the Cy5 dye), B633 Median (the medianvalue of all the pixels in the local background of the selected featurefor Cy5), B633 SD (the standard deviation of the values for the pixelsin the local background of the selected feature for Cy5), F532 Median(median value from all the pixels in the feature for the Cy3 dye), B532Median (the median value of all the pixels in the local background ofthe selected feature for Cy3), B532 SD (the standard deviation of thevalues for the pixels in the local background of the selected featurefor Cy3), and Flags. The GenePix Flags column contains the flags setduring feature extraction. “−75” indicates there were no featuresprinted on the array in that position, “−50” indicates that GenePixcould not differentiate the feature signal from the local background,and “−100” indicates that the user marked the feature as bad.

Once imported, the rows with −75 flags were deleted. Then the median ofB633 SD and B532 SD were calculated over all features with a flag valueof “0”. The minimum values of B633 Median and B532 Median wereidentified, considering only those values associated with a flag valueof “0”. For each feature, the signal to noise ratio (S/N) was calculatedfor both dyes by taking the fluorescence signal minus the localbackground (BGSS) and dividing it by the standard deviation of the localbackground: ${S\text{/}N} = \frac{F_{i} - B_{i}}{{SDB}_{i}}$

If the S/N was less than 3, then an adjusted background-subtractedsignal was calculated as the fluorescence minus the minimum localbackground on the slide. An adjusted SIN was then calculated as theadjusted background subtracted signal divided by the median noise overall features for that channel. If the adjusted S/N was greater thanthree and the original S/N were less than three, a flag of 25 was setfor the Cy5 channel, a flag of 23 was set for the Cy3 channel, and ifboth met these criteria, then a flag of 20 was set. If both the adjustedS/N and the original S/N were less than three, then a flag of 65 was setfor Cy5, 63 set for Cy3, and 60 set if both dye channels had an adjustedS/N less than three. All signal to noise calculations, adjustedbackground-subtracted signal, and adjusted S/N were calculated for eachdye channel. If the BGSS value was greater than or equal to 64000, aflag was set to indicate saturation; 55 for Cy5, 53 for Cy3, 50 forboth.

The BGSS used for further calculations was the original BGSS if theoriginal S/N was greater than or equal to three. If the original S/Nratio was less than three and the adjusted S/N ratio was greater than orequal to three, then the adjusted BGSS was used. If the adjusted S/Nratio was less than three, then the adjusted BGSS was used, but withknowledge of the flag status.

To facilitate comparison among arrays, the Cy3 and Cy5 data were scaledto have a median of 1. For each dye channel, the median value of allfeatures with flags=0,20,23, or 25 was calculated. The BGSS for each dyein each feature was then divided by this median value. The Cy3/Cy5 ratiowas calculated for each feature using the scaled$R_{n\quad} = \frac{{Cy3S}_{i}}{{Cy5S}_{i}}$

The flag setting for each feature was used to determine the expressionratio for each probe, a combination of three features. If all threefeatures had flag settings in the same category (categories=negatives, 0to 25, 50-55, and 60-65), then the average and CV of the three featureratios was calculated. If the CV of all three features was less than 15,the average was used. If the CV was greater than 15, then the CV of eachcombination of two of the features was calculated and the two featureswith the lowest CV were averaged. If none of the combinations of twofeatures had a CV less than 15, then the median ratio of the threefeatures was used as the probe feature.

If the three features do not have flags in the same category, then thefeatures with the best quality flags were used(0>25>23>20>55>53>50>65>63>60). Features with negative flags were neverused. When the best flags were two features in the samc category, theaverage was used. If a single feature had a better flag category thanthe other two then that feature was used.

Once the probe expression ratio was calculated from the three features,the log of the ratio was taken as described below and stored for use inanalyzing the data. Whichever features were used to calculate the probevalue, the worst of the flags from those features was carried forwardand stored as the flag value for that probe. 2 different data sets canbe used for analysis. Flagged data uses all values, including those withflags. Filtered data sets are created by removing flagged data from theset before analysis.

Example 15 Real-Time PCR Validation of Array Expression Results

In example 10, leukocyte gene expression was used to discover expressionmarkers and diagnostic gene sets for clinical outcomes. It is desirableto validate the gene expression results for each gene using a moresensitive and quantitative technology such as real-time PCR. Further, itis possible for the diagnostic nucleotide sets to be implemented as adiagnostic test as a real-time PCR panel. Alternatively, thequantitative information provided by real-time PCR validation can beused to design a diagnostic test using any alternative quantitative orsemi-quantitative gene expression technology.

To validate the results of the microarray experiments we used real-time,or kinetic, PCR. In this type of experiment the amplification product ismeasured during the PCR reaction. This enables the researcher to observethe amplification before any reagent becomes rate limiting foramplification. In kinetic PCR the measurement is of C_(T) (thresholdcycle) or C_(P) (crossing point). This measurement (C_(T)=C_(P)) is thepoint at which an amplification curve crosses a threshold fluorescencevalue. The threshold is set to a point within the area where all of thereactions were in their linear phase of amplification. When measuringC_(T), a lower C_(T) value is indicative of a higher amount of startingmaterial since an earlier cycle number means the threshold was crossedmore quickly.

Several fluorescence methodologies are available to measureamplification product in real-time PCR. Taqman (Applied BioSystems,Foster City, Calif.) uses fluorescence resonance energy transfer (FRET)to inhibit signal from a probe until the probe is degraded by thesequence specific binding and Taq 3′ exonuclease activity. MolecularBeacons (Stratagene, La Jolla, Calif.) also use FRET technology, wherebythe fluorescence is measured when a hairpin structure is relaxed by thespecific probe binding to the amplified DNA. The third commonly usedchemistry is Sybr Green, a DNA-binding dye (Molecular Probes, Eugene,Oreg.). The more amplified product that is produced, the higher thesignal. The Sybr Green method is sensitive to non-specific amplificationproducts, increasing the importance of primer design and selection.Other detection chemistries can also been used, such as ethedium bromideor other DNA-binding dyes and many modifications of the fluorescentdye/quencher dye Taqman chemistry, for example scorpions.

Initially, samples are chosen for validation, which have already beenused for microarray based expression analysis. They are also chosen torepresent important disease classes or disease criteria. For the firststeps of this example (primer design, primer endpoint testing, andprimer efficiency testing) we examined β-actin and β-GUS. These genesare considered “housekeeping” genes because they are required formaintenance in all cells. They are commonly used as a reference that isexpected to not change with experimental treatment. We chose these twoparticular genes as references because they varied the least inexpression across 5 mRNA samples examined by real-time PCR.

The inputs for real time PCR reaction are gene-specific primers, cDNAfrom specific patient samples, and the standard reagents. The cDNA wasproduced from mononuclear RNA (prepared as in example 7) by reversetranscription using OligodT primers (Invitrogen, 18418-012) and randomhexamers (Invitrogen, 48190-011) at a final concentration of 0.5 ng/lpand 3 ng/μl respectively. For the first strand reaction mix, 1.45 μg/μlof total RNA (R50, universal leukocyte reference RNA as described inExample 8) and 1 μl of the Oligo dT/Random Hexamer Mix, were added towater to a final volume of 11.5 s. The sample mix was then placed at 70°C. for 10 minutes. Following the 70° C. incubation, the samples werechilled on ice, spun down, and 88.5 μl of first strand buffer mixdispensed into the reaction tube. The final first strand buffer mixproduced final concentrations of 1X first strand buffer (Invitrogen,Y00146, Carlsbad, Calif.), 0.01 mM DTT (Invitrogen, Y00147), 0.1 mM dATP(NEB, N0440S, Beverly, Mass.), 0.1 mM dGTP (NEB, N0442S), 0.1 mM dATP(NEB, N0443S), 0.1 mM dCTP (NEB, N0441S), 2U of reverse transcriptase(Superscript II, Invitrogen, 18064-014), and 0.18U of RNase inhibitor(RNAGaurd Amersham Pharmacia, 27-0815-01, Piscataway, N.J.). Thereaction was incubated at 42° C. for 1 hour. After incubation the enzymewas heat inactivated at 70° C. for 15 minutes, 1 μl of RNAse H added tothe reaction tube, and incubated at 37° C. for 20 minutes.

Primer Design

Two methods were used to design primers. The first was to use thesoftware, Primer Express™ and recommendations for primer design that areprovided with the GeneAmp® 7700 Sequence Detection System supplied byApplied BioSystems (Foster City, Calif.). The second method used todesign primers was the PRIMER3 ver 0.9 program that is available fromthe Whitehead Research Institute, Cambridge, Mass. The program can alsobe accessed on the World Wide Web at:genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi. Primers andTaqman/hybridization probes were designed as described below using bothprograms.

The Primer Express literature explains that primers should be designedwith a melting temperature between 58 and 60 degrees C. while the Taqmanprobes should have a melting temperature of 68 to 70 under the saltconditions of the supplied reagents. The salt concentration is fixed inthe software. Primers should be between 15 and 30 basepairs long. Theprimers should produce and ampricon in size between 50 and 150 basepairs, have a C-G content between 20% and 80%, have no more than 4identical base pairs next to one another, and no more than 2 C's and G'sin the last 5 bases of the 3′ end. The probe cannot have a G on the 5′end and the strand with the fewest G's should be used for the probe.

Primer3 has a large number of parameters. The defaults were used for allexcept for melting temperature and the optimal size of the amplicon wasset at 100 bases. One of the most critical is salt concentration as itaffects the melting temperature of the probes and primers. In order toproduce primers and probes with melting temperatures equivalent toPrimer Express, a number of primers and probes designed by PrimerExpress were examined using PRIMER3. Using a salt concentration of 50 mMthese primers had an average melting temperature of 3.7 degrees higherthan predicted by Primer Express. In order to design primers and probeswith equivalent melting temperatures as Primer Express using PRIMER3, amelting temperature of 62.7 plus/minus 1.0 degree was used in PRIMER3for primers and 72.7 plus/minus 1.0 degrees for probes with a saltconcentration of 50 mM.

The C source code for Primer3 was downloaded and complied on a SunEnterprise 250 server using the GCC complier. The program was then usedfrom the command line using a input file that contained the sequence forwhich we wanted to design primers and probes along with the inputparameters as described by help files that accompany the software. Usingscripting it was possible to input a number of sequences andautomatically generate a number of possible probes and primers.

Primers for β-Actin (Beta Actin, Genbank Locus: NM_(—)0010) and β-GUS:glucuronidase, beta, (GUSB, Genbank Locus: NM_(—)000181), two referencegenes, were designed using both methods and are shown here as examples.

The first step was to mask out repetitive sequences found in the mRNAsequences using RepeatMasker program that can be accessed at the website located at repeatmasker.genome.washington.edu/cgi-bin/RepeatMasker(Smit, AFA & Green, P “RepeatMasker” at the web site located atftp.genome.washington.edu/RM/RepeatMasker.html).The last 500 basepairs on the last 3′ end of masked sequence was thensubmitted to PRIMER3 using the following exemplary input file:

PRIMER_SEQUENCE_ID=>ACTB Beta Actin PRIMER_EXPLAIN_FLAG=1PRIMER_MISPRIMING_LIBRARY=SEQUENCE=TTGGCTTGACTCAGGATTTAAAAACTGGAACGGTGAAGGTGACAGCAGTCGGTTGGACGAGCATCCCCCAAAGTTCACAATGTGGCCGAGGACTTTGATTGCACATTGTTGTTTTTTAATAGTCATTCCAAATATGAGATGCATTGTTACAGGAAGTCCCTTGCCATCCTAAAAGCACCCCACTTCTCTCTAAGGAGAATGGCCCAGTCCTCTCCCAAGTCCACACAGGGGAGGGATAGCATTGCTTTCGTGTAAATTATGTAATGCAAAATTTTTTTAATCTTCGCCTTAATCTTTTTTATTTTGTTTTATTTTGAATGATGAGCCTTCGTGCCCCCCCTTCCCCCTTTTTTCCCCCAACTTGAGATGTATGAAGGCTTTTGGTCTCCCTGGGAGTGGGTGGAGGCAGCCGGGCTTACCTGTACACTGACTTGAGACCAGTTGAATAAAAGTGCACACCTTA (SEQ ID NO: 8833)PRIMER_PRODUCT_OPT_SIZE=100 PRIMER_NUM_RETURN=100PRIMER_MAX_END_STABILITY=9.0 PRIMER_MAX_MISPRIMING=12.00PRIMER_PAIR_MAX_MISPRIMING=24.00 PRIMER_MIN_SIZE=18 PRIMER_OPT_SIZE=20PRIMER_MAX_SIZE=32 PRIMER_MIN_TM=61.7 PRIMER_OPT_TM=62.7PRIMER_MAX_TM=63.7 PRIMER_MAX_DIFF_TM=100.0 PRIMER_MIN_GC=20.0PRIMER_MAX_GC=80.0 PRIMER_SELF_ANY=8.00 PRIMER_SELF_END=3.00PRIMER_NUM_NS_ACCEPTED=0 PRIMER_MAX_POLY_X=4 PRIMER_OUTSIDE_PENALTY=0PRIMER_GC_CLAMP=0 PRIMER_SALT_CONC=50.0 PRIMER_DNA_CONC=50.0PRIMER_LIBERAL_BASE=1 PRIMER_MIN_QUALITY=0 PRIMER_MIN_END_QUALITY=0PRIMER_QUALITY_RANGE_MIN=0 PRIMER_QUALITY_RANGE_MAX=100PRIMER_WT_TM_LT=1.0 PRIMER_WT_TM_GT=1.0 PRIMER_WT_SIZE_LT=1.0PRIMER_WT_SIZE_GT=1.0 PRIMER_WT_GC_PERCENT_LT=0.0PRIMER_WT_GC_PERCENT_GT=0.0 PRIMER_WT_COMPL_ANY=0.0PRIMER_WT_COMPL_END=0.0 PRIMER_WT_NUM_NS=0.0 PRIMER_WT_REP_SIM=0.0PRIMER_WT_SEQ_QUAL=0.0 PRIMER_WT_END_QUAL=0.0 PRIMER_WT_POS_PENALTY=0.0PRIMER_WT_END_STABILITY=0.0 PRIMER_PAIR_WT_PRODUCT_SIZE_LT=0.05PRIMER_PAIR_WT_PRODUCT_SIZE_GT=0.05 PRIMER_PAIR_WT_PRODUCT_TM_LT=0.0PRIMER_PAIR_WT_PRODUCT_TM_GT=0.0 PRIMER_PAIR_WT_DIFF_TM=0.0PRIMER_PAIR_WT_COMPL_ANY=0.0 PRIMER_PAIR_WT_COMPL_END=0.0PRIMER_PAIR_WT_REP_SIM=0.0 PRIMER_PAIR_WT_PR_PENALTY=1.0PRIMER_PAIR_WT_IO_PENALTY=0.0 PRIMER_INTERNAL_OLIGO_MIN_SIZE=18PRIMER_INTERNAL_OLIGO_OPT_SIZE=20 PRIMER_INTERNAL_OLIGO_MAX_SIZE=35PRIMER_INTERNAL_OLIGO_MIN_TM=71.7 PRIMER_INTERNAL_OLIGO_OPT_TM=72.7PRIMER_INTERNAL_OLIGO_MAX_TM=73.7 PRIMER_INTERNAL_OLIGO_MIN_GC=20.0PRIMER_INTERNAL_OLIGO_MAX_GC=80.0 PRIMER_INTERNAL_OLIGO_SELF_ANY=12.00PRIMER_INTERNAL_OLIGO_SELF_END=12.00 PRIMER_INTERNAL_OLIGO_NUM_NS=0PRIMER_INTERNAL_OLIGO_MAX_POLY_X=5 PRIMER_INTERNAL_OLIGO_MISHYB_LIBRARY=PRIMER_INTERNAL_OLIGO_MAX_MISHYB=12.00PRIMER_INTERNAL_OLIGO_MIN_QUALITY=0 PRIMER_INTERNAL_OLIGO_SALT_CONC=50.0PRIMER_INTERNAL_OLIGO_DNA_CONC=50.0 PRIMER_IO_WT_TM_LT=1.0PRIMER_IO_WT_TM_GT=1.0 PRIMER_IO_WT_SIZE_LT=1.0 PRIMER_IO_WT_SIZE_GT=1.0PRIMER_IO_WT_GC_PERCENT_LT=0.0 PRIMER_IO_WT_GC_PERCENT_GT=0.0PRIMER_IO_WT_COMPL_ANY=0.0 PRIMER_IO_WT_NUM_NS=0.0PRIMER_IO_WT_REP_SIM=0.0 PRIMER_IO_WT_SEQ_QUAL=0.0PRIMER_TASK=pick_pcr_primers_and_hyb_probePRIMER_PRODUCT_SIZE_RANGE=50-150 PRIMER_FIRST_BASE_INDEX=1PRIMER_PICK_ANYWAY=1 = PRIMER_SEQUENCE_ID=>GUSB PRIMER_EXPLAIN_FLAG=1PRIMER_MISPRIMING_LIBRARY=SEQUENCE=GAAGAGTACCAGAAAAGTCTGCTAGAGCAGTACCATCTGGGTCTGGATCAAAAACGCAGAAAATATGTGGTTGGAGAGCTCATTTGGAATTTTGCCGATTTCATGACTGAACAGTCACCGACGAGAGTGCTGGGGAATAAAAAGGGGATCTTCACTCGGCAGAGACAACCAAAAAGTGCAGCGTTCCTTTTGCGAGAGAGATACTGGAAGATTGCCAATGAAACCAGGTATCCCCACTCAGTAGCCAAGTCACAATGTTTGGAAAACAGCCCGTTTACTTGAGCAAGACTGATACCACCTGCGTGTCCCTTCCTCCCCGAGTCAGGGCGACTTCCACAGCAGCAGAACAAGTGCCTCCTGGACTGTTCACGGCAGACCAGAACGTTTCTGGCCTGGGTTTTGTGGTCATCTATTCTAGCAGGGAACACTAAAGGTGGAAATAAAAGATTTTCTATTATGGAAATAAAGAGTTGGCATGAAAGTCGCTACTG (SEQ ID NO: 8834) PRIMER_PRODUCT_OPT_SIZE=100 PRIMER_NUM_RETURN=100PRIMER_MAX_END_STABILITY=9.0 PRIMER_MAX_MISPRIMING=12.00PRIMER_PAIR_MAX_MISPRIMING=24.00 PRIMER_MIN_SIZE=18 PRIMER_OPT_SIZE=20PRIMER_MAX_SIZE=32 PRIMER_MIN_TM=61.7 PRIMER_OPT_TM=62.7PRIMER_MAX_TM=63.7 PRIMER_MAX_DIFF_TM=100.0 PRIMER_MIN_GC=20.0PRIMER_MAX_GC=80.0 PRIMER_SELF_ANY=8.00 PRIMER_SELF_END=3.00PRIMER_NUM_NS_ACCEPTED=0 PRIMER_MAX_POLY_X=4 PRIMER_OUTSIDE_PENALTY=0PRIMER_GC_CLAMP=0 PRIMER_SALT_CONC=50.0 PRIMER_DNA_CONC=50.0PRIMER_LIBERAL_BASE=1 PRIMER_MIN_QUALITY=0 PRIMER_MIN_END_QUALITY=0PRIMER_QUALITY_RANGE_MIN=0 PRIMER_QUALITY_RANGE_MAX=100PRIMER_WT_TM_LT=1.0 PRIMER_WT_TM_GT=1.0 PRIMER_WT_SIZE_LT=1.0PRIMER_WT_SIZE_GT=1.0 PRIMER_WT_GC_PERCENT_LT=0.0PRIMER_WT_GC_PERCENT_GT=0.0 PRIMER_WT_COMPL_ANY=0.0PRIMER_WT_COMPL_END=0.0 PRIMER_WT_NUM_NS=0.0 PRIMER_WT_REP_SIM=0.0PRIMER_WT_SEQ_QUAL=0.0 PRIMER_WT_END_QUAL=0.0 PRIMER_WT_POS_PENALTY=0.0PRIMER_WT_END_STABILITY=0.0 PRIMER_PAIR_WT_PRODUCT_SIZE_LT=0.05PRIMER_PAIR_WT_PRODUCT_SIZE_GT=0.05 PRIMER_PAIR_WT_PRODUCT_TM_LT=0.0PRIMER_PAIR_WT_PRODUCT_TM_GT=0.0 PRIMER_PAIR_WT_DIFF_TM=0.0PRIMER_PAIR_WT_COMPL_ANY=0.0 PRIMER_PAIR_WT_COMPL_END=0.0PRIMER_PAIR_WT_REP_SIM=0.0 PRIMER_PAIR_WT_PR_PENALTY=1.0PRIMER_PAIR_WT_IO_PENALTY=0.0 PRIMER_INTERNAL_OLIGO_MIN_SIZE=18PRIMER_INTERNAL_OLIGO_OPT_SIZE=20 PRIMER_INTERNAL_OLIGO_MAX_SIZE=35PRIMER_INTERNAL_OLIGO_MIN_TM=71.7 PRIMER_INTERNAL_OLIGO_OPT_TM=72.7PRIMER_INTERNAL_OLIGO_MAX_TM=73.7 PRIMER_INTERNAL_OLIGO_MIN_GC=20.0PRIMER_INTERNAL_OLIGO_MAX_GC=80.0 PRIMER_INTERNAL_OLIGO_SELF_ANY=12.00PRIMER_INTERNAL_OLIGO_SELF_END=12.00 PRIMER_INTERNAL_OLIGO_NUM_NS=0PRIMER_INTERNAL_OLIGO_MAX_POLY_X=5 PRIMER_INTERNAL_OLIGO_MISHYB_LIBRARY=PRIMER_INTERNAL_OLIGO_MAX_MISHYB=12.00PRIMER_INTERNAL_OLIGO_MIN_QUALITY=0 PRIMER_INTERNAL_OLIGO_SALT_CONC=50.0PRIMER_INTERNAL_OLIGO_DNA_CONC=50.0 PRIMER_IO_WT_TM_LT=1.0PRIMER_IO_WT_TM_GT=1.0 PRIMER_IO_WT_SIZE_LT=1.0 PRIMER_IO_WT_SIZE_GT=1.0PRIMER_IO_WT_GC_PERCENT_LT=0.0 PRIMER_IO_WT_GC_PERCENT_GT=0.0PRIMER_IO_WT_COMPL_ANY=0.0 PRIMER_IO_WT_NUM_NS=0.0PRIMER_IO_WT_REP_SIM=0.0 PRIMER_IO_WT_SEQ_QUAL=0.0PRIMER_TASK=pick_pcr_primers_and_hyb_probePRIMER_PRODUCT_SIZE_RANGE=50-150 PRIMER_FIRST_BASE_INDEX=1PRIMER_PICK_ANYWAY=1 =

After running PRIMER3, 100 sets of primers and probes were generated forACTB and GUSB. From this set, nested primers were chosen based onwhether both left primers could be paired with both right primers and asingle Taqman probe could be used on an insert of the correct size. Withmore experience we have decided not use the mix and match approach toprimer selection and just use several of the top pairs of predictedprimers.

For ACTB this turned out to be:

Forward  75 CACAATGTGGCCGAGGACTT, (SEQ ID NO: 8835) Forward  80TGTGGCCGAGGACTTTGATT, (SEQ ID NO: 8836) Reverse 178TGGCTTTTAGGATGGCAAGG, (SEQ ID NO: 8837) and Reverse 168GGGGGCTTAGTTTGCTTCCT. (SEQ ID NO: 8838)

Upon testing, the F75 and R178 pair worked best.

For GUSB the following primers were chosen:

Forward  59 AAGTGCAGCGTTCCTTTTGC, (SEQ ID NO: 8839) Forward  65AGCGTTCCTTTTGCGAGAGA, (SEQ ID NO: 8840) Reverse 158 CGGGCTGTTTTCCAAACATT(SEQ ID NO: 8841) and Reverse 197 GAAGGGACACGCAGGTGGTA. (SEQ ID NO:8842)

No combination of these GUSB pairs worked well.

In addition to the primer pairs above, Primer Express predicted thefollowing primers for GUSB: Forward 178 TACCACCTGCGTGTCCCTTC (SEQ ID NO:8843) and Reverse 242 GAGGCACTTGTTCTGCTGCTG (SEQ ID NO: 8844). This pairof primers worked to amplify the GUSB mRNA.

The parameters used to predict these primers in Primer Express were:

-   Primer Tm: min 58, Max=60, opt 59, max difference=2 degrees-   Primer GC: min=20% Max=80% no 3′ G/C clamp-   Primer: Length: min=9 max=40 opt=20-   Amplicon: min T_(m)=0 max T_(m)=85    -   min=50 bp max=150 bp-   Probe: Tm 10 degrees>primers, do not begin with a G on 5′ end-   Other: max base pair repeat=3    -   max number of ambiguous residues=0    -   secondary structure: max consec bp=4, max total bp=8    -   Uniqueness: max consec match=9        -   max % match=75        -   max 3′ consecutive match=7

Using this approach, multiple primers were designed for genes that wereshown to have expression patterns that correlated with clinical data inexample 10. These primer pairs are shown in Table 10B and are added tothe sequence listing. Primers can be designed from any region of atarget gene using this approach.

Granzyme B is an important marker of CMV infection and transplantrejection. For Granzyme B the following sequence (NM_(—)004131) was usedas input for Primer3:

(SEQ ID No: 9086) GGGGACTCTGGAGGCCCTCTTGTGTGTAACAAGGTGGCCCAGGGCATTGTCTCCTATGGACGAAACAATGGCATGCCTCCACGAGCCTGCACCAAAGTCTCAAGCTTTGTACACTGGATAAAGAAAACCATGAAACGCTACTAACTACAGGAAGCAAACTAAGCCCCCGCTGTAATGAAACACCTTCTCTGGAGCCAAGTCCAGATTTACACTGGGAGAGGTGCCAGCAACTGAATAAATACCTCTCCCAGTGTAAATCTGGAGCCAAGTCCAGATTTACACTGGGAGAGGTGCCAGCAACTGAATAAATACCTCTTAGCTGAGTGG

For Granzyme B the following primers were chosen for testing:

Forward  81 ACGAGCCTGCACCAAAGTCT (SEQ ID No: 9087) Forward  63AAACAATGGCATGCCTCCAC (SEQ ID No: 9088) Reverse 178 TCATTACAGCGGGGGCTTAG(SEQ ID No: 9089) Reverse 168 GGGGGCTTAGTTTGCTTCCT (SEQ ID No: 9090)

Testing demonstrated that F81 and R178 worked well in amplifying aproduct.

Primer Endpoint Testing

Primers were first tested to examine whether they would produce thecorrect size product without non-specific amplification. The standardreal-time PCR protocol was used with out the Rox and Sybr green dyes.Each primer pair was tested on cDNA made from universal mononuclearleukocyte reference R NA that was produced from 50 individuals asdescribed in Example 8 (R50).

The PCR reaction consisted of 1X RealTime PCR Buffer (Ambion, Austin,Tex.), 3 mM MgC12 (Applied BioSystems, B02953), 0.2 mM dATP (NEB), 0.2mM dTTP (NEB), 0.2 mM dCTP (NEB), 0.2 mM dGTP (NEB), 1.25U AmpliTaq Gold(Applied BioSystems, Foster City, Calif.), 0.3 μM of each primer to beused (Sigma Genosys, The Woodlands, Tex.), 5 μl of the R50reverse-transcription reaction and water to a final volume of 19 μl.

Following 40 cycles of PCR, one microliter of the product was examinedby agarose gel electrophoresis and on an Agilent Bioanalyzer, DNA1000chip (Palo Alto, Calif.). Results for 2 genes are shown in FIG. 5. Fromthe primer design and the sequence of the target gene, one can calculatethe expected size of the amplified DNA product. Only primer pairs withamplification of the desired product and minimal amplification ofcontaminants were used for real-time PCR. Primers that produced multipleproducts of different sizes are likely not specific for the gene ofinterest and may amplify multiple genes or chromosomal loci.

Primer Op Tjm!Za Tion/Efficiency

Once primers passed the end-point PCR, the primers were tested todetermine the efficiency of the re action in a real-time PCR reaction.cDNA was synthesized from starting total RNA as described above. A setof 5 serial dilutions of the R50 reverse-transcribed cDNA (as describedabove) were made in water: 1:10, 1:20, 1:40, 1:80, and 1:160.

The Sybr Green real-time PCR reaction was performed using the Taqman PCRReagent kit (Applied BioSystcms, Foster City, Calif., N808-0228). Amaster mix was made that consisted of all reagents except the primes andtemplate. The final concentration of all ingredients in the reaction was1×Taqman Buffer A (Applied BioSystems), 2 mM MgCl2 (Applied BioSystems),200 μM dATP (Applied BioSystems), 200 μM dCTP (Applied BioSystems), 200μM dGTP (Applied BioSystems), 400 μM dUTP (Applied BioSystems),1:400,000 diluted Sybr Green dye (Molecular Probes), 1.25U AmpliTaq Gold(Applied BioSystems). The master mix for 92 reactions was made to afinal volume of 2112 μl. 1012 μl of PCR master mix was dispensed intotwo, light-tight tubes. Each β-Actin primer F75 and R178 (Genosys), wasadded to one tube of PCR master mix and Each β-GUS primer F178 and R242(Genosys), was added to the other tube of PCR master mix to a finalprimer concentration of 300 nM, and a final volume of 1035 μl perreaction tube. 45 μl of the β-Actin master mix was dispensed into 23wells, in a 96well plate (Applied BioSystems). 45 μl of the β-GUS mastermix was dispensed into 23 wells, in a 96well plate (Applied BioSystems).5 μl of the template dilution series was dispensed into triplicate wellsfor each primer. The reaction was run on an ABI 7700 Sequence Detector(Applied BioSystems).

The Sequence Detector v1.7 software was used to analyze the fluorescentsignal from each well. A threshold value was selected that allowed mostof the amplification curves to cross the threshold during the linearphase of amplification. The cycle number at which each amplificationcurve crossed the threshold (CT) was recorded and the file transferredto MS Excel for further analysis. The C_(T) values for triplicate wellswere averaged. The data were plotted as a function of the log₁₀ of thecalculated starting concentration of RNA. The starting RNA concentrationfor each cDNA dilution was determined based on the original amount ofRNA used in the RT reaction, the dilution of the RT reaction, and theamount used (5 μl) in the real-time PCR reaction. For each gene, alinear regression line was plotted through all of the dilutions seriespoints. The slope of the line was used to calculate the efficiency ofthe reaction for each primer set using the equation:$E = 10^{(\frac{- 1}{slope})}$

Using this equation (Pfaffl 2001), the efficiency for these β-actinprimers is 2.28 and the efficiency for these P-GUS primers is 2.14 (FIG.2). This efficiency was used when comparing the expression levels amongmultiple genes and multiple samples. This same method was used tocalculate reaction efficiency for primer pairs for each gene we studied.

Assay and Results

Once primers were designed and tested and efficiency analysis wascompleted, primers were used examine expression of a single gene amongmany clinical samples. The basic design was to examine expression ofboth the experimental gene and a reference gene in each sample and, atthe same time, in a control sample. The control sample we used was theuniversal mononuclear leukocyte reference RNA described in example 8(R50).

In this example, three patient samples from patients with known CMVinfection were compared to three patient samples from patients with nodiagnosis of CMV infection based on standard diagnostic algorithms foractive CMV infection (including viral PCR assays, serologies, cultureand other tests). cDNA was made from all six RNA samples and the R50control as described above. The cDNA was diluted 1:10 in water and 5 μlof this dilution was used in the 50 μl PCR reaction. Each 96-well plateconsisted of 32 reactions, each done in triplicate. There were 17templates and 3 primer sets. The three primer sets were β-GUS, β-Actin,and Granzyme B AS described above. Each of the three primer sets wasused to measure template levels in 8 templates: the six experimentalsamples, R50, and water (no-template control). The β-GUS primers werealso used to measure template levels a set of 8 templates identicalexcept for the absence of the reverse transcriptase enzyme in the cDNAsynthesis reaction (−RT). The real-time PCR reactions were performed asdescribed above in “primer optimization/efficiency”.

The β-GUS amplification with +RT and −RT cDNA synthesis reactiontemplates were compared to measure the amount of genomic DNAcontamination of the patient RNA sample (FIG. 6A). The only source ofamplifiable material in the −RT cDNA synthesis reaction is contaminatinggenomic DNA. Separation by at least four C_(T) between the −RT and +RTfor each sample was required to consider the sample useful for analysisof RNA levels. Since a C_(T) decrease of one is a two-fold increase intemplate, a difference of four C_(T) would indicate that genomic DNAcontamination level in the +RT samples was 6.25% of the total signal.Since we used these reactions to measure 30% or greater differences, a6% contamination would not change the result.

For samples with sufficiently low genomic DNA contamination the datawere used to identify differences in gene expression by measuring RNAlevels. C_(T) values from the triplicate wells for each reaction wereaveraged and the coefficient of variation (CV) determined. Samples withhigh CV (>2%) were examined and outlier reaction wells were discardedfrom further analysis. The average of the wells for each sample wastaken as the C_(T) value for each sample. For each gene, the ΔC_(T) wasthe R50 control C_(T) minus the sample C_(T). The equation below wasthen used to identify an expression ratio compared to a reference gene(β-Actin) and control sample (R50) for Granzyme B expression in eachexperimental sample (Pfaffl, M. W. 2001). E is the amplificationefficiency determined above.${ratio} = \frac{\left( E_{target} \right)^{\Delta\quad C_{T}{{target}{({{control} - {sample}})}}}}{\left( E_{ref} \right)^{\Delta\quad C_{T}{{ref}{({{control} - {sample}})}}}}$

The complete experiment was performed in duplicate and the average ofthe two ratios taken for each gene. When β-Actin was used as thereference gene, the data show that Granzyme B is expressed at 25-foldhigher levels in mononuclear cell RNA from patients with CMV than frompatients without CMV (FIG. 6B). In this graph, each circle represents apatient sample and the black bars are the average of the three samplesin each category.

Example 16 Correlation and Classification Analysis

After generation and processing of expression data sets from microarraysas described in Example 14, a log ratio value is used for mostsubsequent analysis. This is the logarithm of the expression ratio foreach gene between sample and universal reference. The processingalgorithm assigns a number of flags to data that are of low signal tonoise or are in some other way of uncertain quality. Correlationanalysis can proceed with all the data (including the flagged data) orcan be done on filtered data sets where the flagged data is removed fromthe set. Filtered data should have less variability and may result inmore significant results. Flagged data contains all informationavailable and may allow discovery of genes that are missed with thefiltered data set.

In addition to expression data, clinical data are included in theanalysis. Continuous variables, such as the ejection fraction of theheart measured by echocardiography or the white blood cell count can beused for correlation analysis. In some cases, it may be desirable totake the logarithm of the values before analysis. These variables can beincluded in an analysis along with gene expression values, in which casethey are treated as another “gene”. Sets of markers can be discoveredthat work to diagnose a patient condition and these can include bothgenes and clinical parameters. Categorical variables such as male orfemale can also be used as variables for correlation analysis. Forexample, the sex of a patient may be an important splitter for aclassification tree.

Clinical data are used as supervising vectors for the significance orclassification analysis. In this case, clinical data associated with thesamples are used to divide samples in to clinically meaningfuldiagnostic categories for correlation or classification analsysis. Forexample, pathologic specimens from kidney biopsies can be used to dividelupus patients into groups with and without kidney disease. A third ormore categories can also be included (for example “unknown” or “notreported”). After generation of expression data and definition of usingsupervising vectors, correlation, significance and classificationanalysis is used to determine which set of genes are most appropriatefor diagnosis and classification of patients and patient samples.

Significance Analysis for Microarrays (SAM)

Significance analysis for microarrays (SAM) (Tusher 2001) is a methodthrough which genes with a correlation between their expression valuesand the response vector are statistically discovered and assigned astatistical significance. The ratio of false significant to significantgenes is the False Discovery Rate (FDR). This means that for eachthreshold there are a set of genes which are called significant, and theFDR gives a confidence level for this claim. If a gene is calleddifferentially expressed between 2 classes by SAM, with a FDR of 5%,there is a 95% chance that the gene is actually differentially expressedbetween the classes. SAM takes into account the variability and largenumber of variables of microarrays. SAM will identify genes that aremost globally differentially expressed between the classes. Thus,important genes for identifying and classifying outlier samples orpatients may not be identified by SAM.

After generation of data from patient samples and definition ofcategories using clinical data as supervising vectors, SAM is used todetect genes that are likely to be differentially expressed between thegroupings. Those genes with the highest significance can be validated byreal-time PCR (Example 15) or can be used to build a classificationalgorithm as described here.

Classification

Supervised harvesting of expression trees (Hastie 2001) identifies genesor clusters that best distinguish one class from all the others on thedata set. The method is used to identify the genes/clusters that canbest separate one class versus all the others for datasets that includetwo or more classes from each other. This algorithm can be used toidentify genes that are used to create a diagnostic algorithm. Genesthat are identified can be used to build a classification tree withalgorithms such as CART.

CART is a decision tree classification algorithm (Breiman 1984). Fromgene expression and or other data, CART can develop a decision tree forthe classification of samples. Each node on the decision tree involves aquery about the expression level of one or more genes or variables.Samples that are above the threshold go down one branch of the decisiontree and samples that are not go down the other branch. Genes fromexpression data sets can be selected for classification building usingCART by significant differential expression in SAM analysis or othersignificance test), identification by supervised tree-harvestinganalysis, high fold change between sample groups, or known relevance toclassification of the target diseases. In addition, clinical data canalso be used as variables for CART that are of know importance to theclinical question or are found to be significant predictors bymultivariate analysis or some other technique. CART identifiessurrogates for each splitter (genes that are the next best substitutefor a useful gene in classification). Analysis is performed in CART byweighting misclassification costs to optimize desired performance of theassay. For example, it may be most important the sensitivity of a testfor a given diagnosis be near 100% while specificity is less important.

Once a set of genes and expression criteria for those genes have beenestablished for classification, cross validation is done. There are manyapproaches, including a 10 fold cross validation analysis in which 10%of the training samples are left out of the analysis and theclassification algorithm is built with the remaining 90%. The 10% arethen used as a test set for the algorithm. The process is repeated 10times with 10% of the samples being left out as a test set each time.Through this analysis, one can derive a cross validation error whichhelps estimate the robustness of the algorithm for use on prospective(test) samples. When a gene set is established for a diagnosis with alow cross validation error, this set of genes is tested using samplesthat were not included in the initial analysis (test samples). Thesesamples may be taken from archives generated during the clinical study.Alternatively, a new prospective clinical study can be initiated, wheresamples are obtained and the gene set is used to predict patientdiagnoses.

TABLE 1 Disease Classification Disease/Patient Group CardiovascularDisease Atherosclerosis Unstable angina Myocardial Infarction Restenosisafter angioplasty Congestive Heart Failure Myocarditis EndocarditisEndothelial Dysfunction Cardiomyopathy Cardiovascular drug use EndocrineDisease Diabetes Mellitus I and II Thyroiditis Addisson's DiseaseInfectious Disease Hepatitis A, B, C, D, E, G Malaria Tuberculosis HIVPneumocystis Carinii Giardia Toxoplasmosis Lyme Disease Rocky MountainSpotted Fever Cytomegalovirus Epstein Barr Virus Herpes Simplex VirusClostridium Dificile Colitis Meningitis (all organisms) Pneumonia (allorganisms) Urinary Tract Infection (all organisms) Infectious Diarrhea(all organisms) Anti-infectious drug use Anglogenesis Pathologicangiogenesis Physiologic angiogenesis Treatment induced angiogenesis Proor anti-angiogenic drug use Inflammatory/Rheumatic Rheumatoid ArthritisSystemic Lupus Erythematosis Sjogrens Disease CREST syndrome SclerodermaAnkylosing Spondylitis Crohn's Ulcerative Colitis Primary SclerosingCholangitis Appendicitis Diverticulitis Primary Biliary SclerosisWegener's Granulomatosis Polyarteritis nodosa Whipple's DiseasePsoriasis Microscopic Polyanngiitis Takayasu's Disease Kawasaki'sDisease Autoimmune hepatitis Asthma Churg-Strauss Disease Beurger'sDisease Raynaud's Disease Cholecystitis Sarcoidosis AsbestosisPneumoconioses Antinflammatory drug use Transplant Rejection Heart LungLiver Pancreas Bowel Bone Marrow Stem Cell Graft versus host diseaseTransplant vasculopathy Skin Cornea Immunosupressive drug use MalignantDisorders Leukemia Lymphoma Carcinoma Sarcoma Neurological DiseaseAlzheimer's Dementia Pick's Disease Multiple Sclerosis Guillain BarreSyndrome Peripheral Neuropathy

TABLE 2 Candidate genes, Database mining Unigene clusters are listed.Cluster numbers are defined as in Unigene build #133 uploaded on: FriApr 20 2001 CD50 Hs.99995 Homo sapiens cAMP responsive element Hs.79194binding protein 1 (CREB1) mRNA. CD70 = CD27L Hs.99899 Nucleolin (NCL)Hs.79110 MDC Hs.97203 MAPK14 Hs.79107 CD3z Hs.97087 CD100 Hs.79089 CD19Hs.96023 OX-2 Hs.79015 Hs.95388 PCNA Hs.78996 CD3d Hs.95327 Hs.78909Hs.9456 GRO-a Hs.789 interleukin 6 Hs.93913 CDw32A Hs.78864phospholipaseA2 Hs.93304 H. sapiens mRNA for herpesvirus associatedHs.78683 ubiquitin-specific protease (HAUSP). Human mRNA for KIAA0128gene, partial Hs.90998 CD41b = LIBS1 Hs.785 cds. CD48 Hs.901 ANXA1(LPC1) Hs.78225 heat shock 70 kD protein 1A Hs.8997 CD31 Hs.78146 TxA2receptor Hs.89887 Homo sapiens TERF1 (TRF1)-interacting Hs.7797 nuclearfactor 2 (TINF2), mRNA. fragile X mental retardation protein (FMR-Hs.89764 major histocompatibility complex, class I, B Hs.77961 1) CD20Hs.89751 LOX1 Hs.77729 ENA-78 Hs.89714 major histocompatibility complex,class II, Hs.77522 DM alpha IL-2 Hs.89679 CD64 Hs.77424 CD79b Hs.89575CD71 Hs.77356 CD2 Hs.89476 Hs.77054 SDF-1 = CXCR4 Hs.89414 HLA-DRAHs.76807 CD61 Hs.87149 CD105 Hs.76753 IFN-g Hs.856 Hs.76691 CD34Hs.85289 TNF-alpha Hs.76507 CD104 Hs.85266 LCP1 Hs.76506 CD8 Hs.85258TMSB4X Hs.75968 IGF-1 Hs.85112 PAI2 Hs.75716 CD103 Hs.851 MIP-1bHs.75703 IL-13 Hs.845 CD58 Hs.75626 RPA1 Hs.84318 CD36 Hs.75613 CD74Hs.84298 hnRNP A2/hnRNP B1 Hs.75598 CD132 Hs.84 CD124 Hs.75545 CD18Hs.83968 MIP-3a Hs.75498 Cathepsin K Hs.83942 beta-2-microglobulinHs.75415 CD80 Hs.838 FPR1 Hs.753 CD46 Hs.83532 Topo2B Hs.75248 NFKB1Hs.83428 interleukin enhancer binding factor 2, 45 kD Hs.75117 IL-18Hs.83077 chloride intracellular channel 1 Hs.74276 interleukin 14Hs.83004 EGR3 Hs.74088 L-selectin = CD62L Hs.82848 MIP-1a Hs.73817CD107b Hs.8262 CD62P = p-selectin Hs.73800 CD69 Hs.82401 CD21 Hs.73792CD95 Hs.82359 APE Hs.73722 CD53 Hs.82212 IL12Rb2 Hs.73165 Humanlymphocyte specific interferon Hs.82132 NFKB2 Hs.73090 regulatoryfactor/interferon regulatory factor 4 (LSIRF/IRF4) mRNA, complete cds.IL-16 Hs.82127 I-309 Hs.72918 DUT Hs.82113 immunoglobulin superfamily,member 4 Hs.70337 CDw121a Hs.82112 IL-3 Hs.694 PAI-1 Hs.82085 Hs.6895TGF-bR2 Hs.82028 NTH1 Hs.66196 CD117 Hs.81665 CD40L Hs.652 HLA-DPB1Hs.814 IL-11R Hs.64310 NFKBIA Hs.81328 Homo sapiens toll-like receptor 2(TLR2) Hs.63668 mRNA. CD6 Hs.81226 ferritin H chain Hs.62954 IL-1 RAHs.81134 IL8 Hs.624 UBE2B (RAD6B) Hs.811 Tissue Factor Hs.62192 LynHs.80887 F-box only protein 7 Hs.5912 STAT4 Hs.80642 CD5 Hs.58685 UBE2A(RAD6A) Hs.80612 guanine nucleotide binding protein (G Hs.5662 protein),beta polypeptide 2-like 1 Fractalkine Hs.80420 SCYA11 Hs.54460 IKcytokine, down-regulator of HLA II Hs.8024 IK1 Hs.54452 Hs.79933 CCR1Hs.516 CD79a Hs.79630 Homo sapiens TRAIL receptor 2 mRNA, Hs.51233complete cds. Hs.7942 CD11c Hs.51077 nuclear factor, interleukin 3regulated Hs.79334 CD66a Hs.50964 CD83 Hs.79197 JAK1 Hs.50651 DC-CK1Hs.16530 Homo sapiens programmed cell death 4 Hs.100407 (PDCD4), mRNA.CCR7 Hs.1652 SCYB13 (CXCL13) Hs.100431 TLR4 Hs.159239 SMAD7 Hs.100602EST Hs.158975 RAD51L1 (RAD51B) Hs.100669 EST Hs.158966 PPARG Hs.100724EST Hs.158965 transcription factor 3 (E2A immunoglobulin Hs.101047enhancer binding factors E12/E47) EST Hs.158943 major histocompatibilitycomplex, class I- Hs.101840 like sequence EST Hs.158894 immunoglobulinsuperfamily containing Hs.102171 leucine-rich repeat EST Hs.158877 CD166Hs.10247 EST Hs.157815 fibroblast tropomyosin TM30 (pl) Hs.102824 ESTHs.157813 interleukin 1 receptor-like 2 Hs.102865 ESTs Hs.157569 GTF2H4Hs.102910 immunoglobulin kappa constant Hs.156110 Hs.10326 INPP5DHs.155939 Human ITAC (IBICK) Hs.103982 C3AR1 Hs.155935 novel proteinwith MAM domain Hs.104311 PRKDC Hs.155637 ESTs, Weakly similar tointerleukin Hs.105125 enhancer binding factor 2 [H. sapiens] MHC classII HLA-DRw53-associated Hs.155122 Homo sapiens clone 24686 mRNAHs.105509 glycoprotein sequence. CD73 Hs.153952 Hs.105532 CD37 Hs.153053Homo sapiens granulysin (GNLY), Hs.105806 transcript variant 519, mRNA.IFNAR1 Hs.1513 CD77 Hs.105956 Homo sapiens solute carrier family 21Hs.14805 RD RNA-binding protein Hs.106061 (organic anion transporter),member 11 (SLC21A11), mRNA. EST Hs.146627 Hs.106673 SET translocation(myeloid leukemia- Hs.145279 Hs.10669 associated) EST Hs.144119 Homosapiens clone 24818 mRNA Hs.106823 sequence. ESTs Hs.143534 Hs.106826STAT3 Hs.142258 Hs.10712 CD96 Hs.142023 Hs.107149 CD23 Hs.1416hypothetical protein Hs.10729 EGR2 Hs.1395 Tachykinin Receptor 1 Hs.1080CDw84 Hs.137548 glycophorin A Hs.108694 CD55 Hs.1369 Histone H1xHs.109804 EST Hs.135339 CD66d Hs.11 GM-CSF Hs.1349 interleukin 17Hs.110040 EST Hs.133175 Hs.110131 CD1a Hs.1309 major histocompatibilitycomplex, class I, F Hs.110309 CD10 Hs.1298 REV1 Hs.110347 HVEM Hs.129708HCR Hs.110746 C9 Hs.1290 VWF Hs.110802 C6 Hs.1282 high affinityimmunoglobulin epsilon Hs.11090 receptor beta subunit C1R Hs.1279interleukin 22 receptor Hs.110915 IL-1b Hs.126256 Hs.110978 CD9 Hs.1244Homo sapiens ubiquitin specific protease 6 Hs.111065 (Tre-2 oncogene)(USP6), mRNA. Hs.12305 Hs.111128 Homo sapiens Vanin 2 (VNN2) mRNA.Hs.121102 MMP2 Hs.111301 Hsp10 Hs.1197 major histocompatibility complex,class II, Hs.11135 DN alpha CD59 Hs.119663 LTBR Hs.1116 CD51 Hs.118512ESTs, Weakly similar to A41285 Hs.111941 interleukin enhancer-bindingfactor ILE-1 [H. sapiens] CD49a Hs.116774 Homo sapiens STRIN protein(STRIN), Hs.112144 mRNA. CD72 Hs.116481 MSH5 Hs.112193 HLA-DMB Hs.1162TCRg Hs.112259 MCP-4 Hs.11383 Hs.11307 Hs.111554 CMKRL2 Hs.113207ferritin L chain Hs.111334 CCR8 Hs.113222 TGF-b Hs.1103 LILRA3 Hs.113277Homo sapiens ras homolog gene family, Hs.109918 Human CXCR-5 (BLR-1)Hs.113916 member H (ARHH), mRNA. lysosomal alpha-mannosidase (MANB)Hs.108969 RAD51C Hs.11393 Hs.108327 myosin, heavy polypeptide 8,skeletal Hs.113973 muscle, perinatal granzyme B Hs.1051 CD42a Hs.1144HCC-4 Hs.10458 TNFRSF11A Hs.114676 Hs.10362 Hs.114931 Hs.102630 MSH4Hs.115246 Hs.101382 Homo sapiens dendritic cell Hs.115515 immunoreceptor(DCIR), mRNA. C4BPA Hs.1012 REV3L (POLZ) Hs.115521 CD125 Hs.100001 JAK2Hs.115541 TERF2 Hs.100030 OPG ligand Hs.115770 LIG3 Hs.100299 PCDH12Hs.115897 Hs.157489 Hs.166235 EST Hs.157560 POLE1 Hs.166846 ESTHs.157808 regulatory factor X, 5 (influences HLA class Hs.166891 IIexpression) EST Hs.157811 PIG-F (phosphatidyl-inositol-glycan classHs.166982 F) Hs.158127 ESTs, Moderately similar to Hs.167154 ILF1_HUMANINTERLEUKIN ENHANCER-BINDING FACTOR 1 [H. sapiens] interleukin 18receptor accessory protein Hs.158315 HLA-DRB6 Hs.167385 CCR3 Hs.158324ret finger protein-like 3 Hs.167751 Human DNA sequence from clone CTA-Hs.158352 CD56 Hs.167988 390C10 on chromosome 22q11.21-12.1 Contains anImmunoglobulin-like gene and a pseudogene similar to Beta Crystallin,ESTs, STSs, GSSs and taga and tat repeat polymorphisms ESTs Hs.158576RBT1 Hs.169138 Hs.158874 APOE Hs.169401 EST Hs.158875 Hs.16944 ESTHs.158876 Hs.169470 EST Hs.158878 MMP12 Hs.1695 EST Hs.158956 CD161Hs.169824 EST Hs.158967 tenascin XB Hs.169886 EST Hs.158969 Hs.170027EST Hs.158971 Hs.170150 EST Hs.158988 C4A Hs.170250 CD120a = TNFR-1Hs.159 TP53BP1 Hs.170263 EST Hs.159000 ESTs Hs.170274 Hs.159013 ESTs,Weakly similar to ALU1_HUMAN Hs.170338 ALU SUBFAMILY J SEQUENCECONTAMINATION WARNING ENTRY□ [H. sapiens] EST Hs.159025 ESTs Hs.170578EST Hs.159059 EST Hs.170579 IL18R1 Hs.159301 ESTs Hs.170580 ftp-3Hs.159494 EST Hs.170581 CASP8 Hs.159651 ESTs Hs.170583 EST Hs.159655 ESTHs.170586 EST Hs.159660 EST Hs.170588 EST Hs.159678 EST Hs.170589kallikrein 12 (KLK12) Hs.159679 Hs.170772 EST Hs.159682 ESTs Hs.170786EST Hs.159683 EST Hs.170909 EST Hs.159693 EST Hs.170912 EST Hs.159706EST Hs.170933 EST Hs.159718 ESTs Hs.171004 SPO11 Hs.159737 EST Hs.171095EST Hs.159754 EST Hs.171098 EST Hs.160401 ESTs Hs.171101 EST Hs.160405EST Hs.171108 EST Hs.160408 ESTs Hs.171110 EST Hs.160410 ESTs Hs.171113EST Hs.160423 ESTs Hs.171117 RPA3 Hs.1608 EST Hs.171119 ESTs Hs.160946ESTs Hs.171120 EST Hs.160956 EST Hs.171122 ESTs Hs.160978 EST Hs.171123EST Hs.160980 EST Hs.171124 EST Hs.160981 EST Hs.171140 EST Hs.160982EST Hs.171216 EST Hs.160983 EST Hs.171260 Tachykinin Receptor 2Hs.161305 ESTs Hs.171264 RAD17 (RAD24) Hs.16184 RIP Hs.171545 Humanphosphatidylinositol 3-kinase Hs.162808 ESTs, Weakly similar toimmunoglobulin Hs.171697 catalytic subunit p110delta mRNA, superfamilymember [D. melanogaster] complete cds. Human alpha-1 Ig germlineC-region Hs.163271 CD22 Hs.171763 membrane-coding region, 3′ end GCP-2Hs.164021 Hs.171776 Hs.164284 sema domain, immunoglobulin domain (Ig),Hs.171921 short basic domain, secreted, (semaphorin) 3C EST Hs.164331interleukin 11 Hs.1721 Hs.164427 CD11b Hs.172631 Hs.165568 EST, Highlysimilar to APS [H. sapiens] Hs.172656 ER Hs.1657 ALK1 Hs.172670 EST,Highly similar to JM26 [H. sapiens] Hs.165701 Hs.172674 EST Hs.165702CD123 Hs.172689 EST Hs.165704 ESTs Hs.172822 EST Hs.165732 CollaIHs.172928 regulatory factor X, 3 (influences HLA class Hs.166019Hs.172998 II expression) LIG4 Hs.166091 Hs.173081 TNFSF18 Hs.248197myosin, heavy polypeptide 3, skeletal Hs.173084 muscle, embryonic ESTHs.248228 Hs.173201 H. sapiens rearranged gene for kappa Hs.248756Mediterranean fever (MEFV) Hs.173730 immunoglobulin subgroup V kappa IVcaspase 1, apoptosis-related cysteine Hs.2490 Hs.173749 protease(interleukin 1, beta, convertase) EST Hs.249031 interleukin 1 receptoraccessory protein Hs.173880 TNFRSF10A Hs.249190 EST, Weakly similar toRL13_HUMAN Hs.174231 60S RIBOSOMAL PROTEIN L13 [H. sapiens]immunoglobulin lambda variable 3-10 Hs.249208 EST Hs.174242 Homo sapiensmRNA for single-chain Hs.249245 EST Hs.174300 antibody, complete cds ESTHs.250473 EST Hs.174634 ESTs Hs.250591 EST Hs.174635 ESTs Hs.250605 ESTHs.174650 Hs.25063 EST Hs.174673 Human DNA sequence from clone RP1-Hs.250675 EST Hs.174716 149A16 on chromosome 22 Contains an IGLC(Immunoglobulin Lambda Chain C) pseudogene, the RFPL3 gene for Retfinger protein-like 3, the RFPL3S gene for Ret finger protein-like 3antisense, the gene for a novel Immunoglobulin Lambda Chain V familyprotein, the gene for a novel protein similar to mouse RGDS (RALGDS,RALGEF, Guanine Nucleotide Dissociation Stimulator A) and rabbitoncogene RSC, the gene for a novel protein (ortholog of worm F16A11.2and bacterial and archea-bacterial predicted proteins), the gene for anovel protein similar to BPI (Bacterial Permeability-Increasing Protein)and rabbit LBP (Liposaccharide-Binding Protein) and the 5′ part of anovel gene. Contains ESTs, STSs, GSSs and three putative CpG islands ACEHs.250711 EST Hs.174740 TREX2 Hs.251398 EST Hs.174778 Human DNA sequencefrom clone 1170K4 Hs.251417 EST Hs.174779 on chromosome 22q12.2-13.1.Contains three novel genes, one of which codes for a Trypsin familyprotein with class A LDL receptor domains, and the IL2RB gene forInterleukin 2 Receptor, Beta (IL-2 Receptor, CD122 antigen). Contains aputative CpG island, ESTs, and GSSs EST Hs.251539 EST, Weakly similar toRL13_HUMAN Hs.174780 60S RIBOSOMAL PROTEIN L13 [H. sapiens] ESTHs.251540 (KIAA0033) for ORF, partial cds. Hs.174905 C3 Hs.251972Hs.175270 EST Hs.252273 EST Hs.175281 EST Hs.252359 EST Hs.175300 ESTs,Moderately similar to Hs.252867 EST Hs.175336 T2DT_HUMAN TRANSCRIPTIONINITIATION FACTOR TFIID 105 KDA SUBUNIT [H. sapiens] EST, Moderatelysimilar to RS2_HUMAN Hs.253150 EST Hs.175388 40S RIBOSOMAL PROTEIN S2[H. sapiens] EST Hs.253151 Hs.175437 EST Hs.253154 EST, Weakly similarto salivary proline-rich Hs.175777 protein precursor [H. sapiens] ESTHs.253165 EST Hs.175803 EST Hs.253166 ESTs Hs.176337 EST Hs.253167 ESTHs.176374 EST Hs.253168 EST Hs.176380 EST Hs.253169 EST Hs.176404interleukin 1 receptor, type II Hs.25333 EST Hs.176406 Hs.25361 LCKHs.1765 EST Hs.253742 LIG1 Hs.1770 EST Hs.253743 EST Hs.177012 EST,Weakly similar to AF161429_1 Hs.253744 PERB11 family member in MHC classI Hs.17704 HSPC311 [H. sapiens] region EST Hs.253747 EST Hs.177146 ESTHs.253748 EST Hs.177209 EST Hs.253753 Hs.177376 EST, Moderately similarto Hs.254108 Hs.177461 ALU5_HUMAN ALU SUBFAMILY SC SEQUENCECONTAMINATION WARNING ENTRY□ [H. sapiens] ESTs Hs.254948 CD99 Hs.177543ESTs Hs.255011 PMS2 Hs.177548 EST Hs.255118 human calmodulin Hs.177656EST Hs.255119 Hs.177712 EST Hs.255123 Homo sapiens immunoglobulin lambdaHs.178665 gene locus DNA, clone:288A10 EST Hs.255129 Hs.178743 ESTHs.255134 EST Hs.179008 EST Hs.255135 EST Hs.179070 EST Hs.255139 ESTHs.179130 EST Hs.255140 EST Hs.179132 ESTs Hs.255142 Hs.179149 ESTHs.255150 EST Hs.179490 EST Hs.255152 EST Hs.179492 ESTs Hs.255153promyelocytic leukemia cell mRNA, clones Hs.179735 pHH58 and pHH81. ESTsHs.255157 Hs.179817 ESTs Hs.255171 major histocompatibility complex,class II, Hs.1802 DO beta EST Hs.255172 HLA-DRB1 Hs.180255 EST,Moderately similar to Hs.255174 TNFRSF12 Hs.180338 PGTA_HUMAN RABGERANYLGERANYLTRANSFERASE ALPHA SUBUNIT [H. sapiens] EST Hs.255177RAD23A (HR23A) Hs.180455 EST Hs.255178 MKK3 Hs.180533 EST Hs.255245 ESTHs.180637 EST Hs.255246 CD27 Hs.180841 EST Hs.255249 STAT6 Hs.181015 ESTHs.255251 TNFSF4 Hs.181097 EST Hs.255253 immunoglobulin lambda locusHs.181125 EST Hs.255254 Hs.181368 EST Hs.255255 CD3 Hs.181392 ESTsHs.255256 EST Hs.255745 EST Hs.255330 EST Hs.255746 EST, Weakly similarto putative G protein- Hs.255333 EST Hs.255747 coupled Receptor [H.sapiens] EST Hs.255336 EST Hs.255749 EST Hs.255337 EST Hs.255754 ESTHs.255339 ESTs, Moderately similar to KIAA1271 Hs.255759 protein [H.sapiens] EST Hs.255340 EST Hs.255762 EST Hs.255341 EST Hs.255763 ESTsHs.255343 EST Hs.255764 EST Hs.255347 EST Hs.255766 EST Hs.255349 ESTHs.255767 EST Hs.255350 EST Hs.255768 EST Hs.255354 EST Hs.255769 ESTsHs.255359 EST Hs.255770 ESTs Hs.255387 EST Hs.255772 EST Hs.255388 ESTHs.255777 EST Hs.255389 EST Hs.255778 ESTs Hs.255390 EST Hs.255779 ESTHs.255392 EST Hs.255782 EST Hs.255444 EST Hs.255783 EST Hs.255446 ESTHs.255784 EST Hs.255448 EST Hs.255785 ESTs Hs.255449 EST, Weakly similarto Con1 [H. sapiens] Hs.255788 EST Hs.255454 EST Hs.255791 EST Hs.255455EST Hs.255794 EST Hs.255457 EST Hs.255796 EST Hs.255459 EST Hs.255797EST Hs.255462 EST Hs.255799 EST Hs.255464 ESTs Hs.255877 EST Hs.255492EST Hs.255880 EST Hs.255494 EST Hs.255920 EST Hs.255495 EST Hs.255927EST Hs.255497 CD40 Hs.25648 EST Hs.255498 interleukin enhancer bindingfactor 3, 90 kD Hs.256583 EST Hs.255499 ESTs Hs.256810 EST Hs.255501 ESTHs.256956 EST Hs.255502 EST Hs.256957 EST Hs.255505 EST Hs.256959 ESTHs.255541 EST Hs.256961 EST Hs.255543 EST Hs.256970 ESTs Hs.255544 ESTHs.256971 EST Hs.255546 ESTs Hs.256979 EST Hs.255549 ESTs Hs.257572 ESTHs.255552 EST Hs.257579 EST Hs.255554 EST Hs.257581 EST Hs.255556 ESTHs.257582 EST Hs.255558 EST Hs.257630 EST Hs.255559 EST Hs.257632 ESTHs.255560 EST Hs.257633 EST Hs.255561 EST Hs.257636 EST Hs.255569 ESTHs.257640 EST Hs.255572 ESTs Hs.257641 EST Hs.255573 EST Hs.257644 ESTHs.255575 EST Hs.257645 EST Hs.255577 EST Hs.257646 EST Hs.255578 ESTHs.257647 EST Hs.255579 EST Hs.257667 EST Hs.255580 EST Hs.257668 ESTHs.255590 EST Hs.257677 EST Hs.255591 EST Hs.257679 EST Hs.255598 ESTHs.257680 TNFRSF17 Hs.2556 ESTs Hs.257682 EST Hs.255600 ESTs Hs.257684EST Hs.255601 EST Hs.257687 ESTs, Highly similar to KIAA1039 proteinHs.255603 EST Hs.257688 [H. sapiens] EST Hs.255614 EST Hs.257690 ESTHs.255615 EST Hs.257695 ESTs Hs.255617 EST Hs.257697 EST Hs.255618 ESTHs.257705 EST Hs.255621 EST Hs.257706 EST Hs.255622 EST Hs.257709 ESTsHs.255625 ESTs, Moderately similar to Hs.257711 ALU8_HUMAN ALU SUBFAMILYSX SEQUENCE CONTAMINATION WARNING ENTRY□ [H. sapiens] EST Hs.255626 ESTHs.257713 ESTs Hs.255627 EST Hs.257716 ESTs Hs.255630 EST Hs.257719 ESTHs.255632 EST Hs.257720 EST Hs.255633 EST Hs.257727 EST Hs.255634 ESTHs.257730 EST Hs.255635 EST Hs.257738 EST Hs.255637 EST Hs.257743 ESTsHs.255639 ESTs Hs.258513 EST Hs.255641 EST Hs.258820 EST Hs.255644 ESTHs.258864 EST Hs.255645 sema domain, immunoglobulin domain (Ig),Hs.25887 transmembrane domain (TM) and short cytoplasmic domain,(semaphorin) 4F EST Hs.255646 EST Hs.258898 EST Hs.255647 EST Hs.258933EST Hs.255648 interleukin 13 receptor, alpha 2 Hs.25954 EST Hs.255649Homo sapiens HSPC101 mRNA, partial cds Hs.259683 EST Hs.255650 ESTHs.263695 EST Hs.255653 ESTs Hs.263784 EST Hs.255657 TNFSF12 Hs.26401EST Hs.255661 EST Hs.264154 ESTs Hs.255664 EST Hs.264654 EST Hs.255665CDw116b Hs.265262 EST Hs.255666 MHC binding factor, beta Hs.2654 ESTHs.255668 EST Hs.265634 EST Hs.255671 EST Hs.266387 EST Hs.255672 ESTsHs.268027 EST Hs.255673 ATHS (LDLR?) Hs.268571 EST Hs.255674 ESTs,Highly similar to AAD18086 BAT2 Hs.270193 [H. sapiens] EST Hs.255675ESTs Hs.270198 EST Hs.255677 ESTs Hs.270294 EST Hs.255679 ESTs, Weaklysimilar to alternatively Hs.270542 spliced product using exon 13A [H.sapiens] EST Hs.255681 ESTs, Moderately similar to Hs.270561 ALU2_HUMANALU SUBFAMILY SB SEQUENCE CONTAMINATION WARNING ENTRY□ [H. sapiens] ESTHs.255682 ESTs, Weakly similar to pro alpha 1(I) Hs.270564 collagen [H.sapiens] EST Hs.255686 ESTs, Weakly similar to ALU1_HUMAN Hs.270578 ALUSUBFAMILY J SEQUENCE CONTAMINATION WARNING ENTRY□ [H. sapiens] ESTsHs.255687 ESTs, Moderately similar to brain-derived Hs.270588immunoglobulin superfamily molecule [M. musculus] EST Hs.255688 TALL1Hs.270737 ESTs Hs.255689 ESTs Hs.271206 EST Hs.255691 MYH Hs.271353 ESTHs.255692 POLI (RAD30B) Hs.271699 ESTs Hs.255693 ADPRTL3 Hs.271742 ESTHs.255695 ESTs, Moderately similar to Hs.272075 ALU8_HUMAN ALU SUBFAMILYSX SEQUENCE CONTAMINATION WARNING ENTRY□ [H. sapiens] EST, Highlysimilar to transmembrane Hs.255697 Human DNA sequence from clone RP5-Hs.272271 chloride conductor protein [H. sapiens] 1170K4 on chromosome22q12.2-13.1 Contains three novel genes, one of which codes for aTrypsin family protein with class A LDL receptor domains, and the IL2RBgene for Interleukin 2 Receptor, Beta (IL-2 Receptor, CD122 antigen), aputative CpG island, ESTs, and GSSs EST Hs.255698 interleukin 1 receptoraccessory protein-like 2 Hs.272354 EST Hs.255699 Homo sapiens partialIGVH3 V3-20 gene Hs.272355 for immunoglobulin heavy chain V region, case1, clone 2 EST Hs.255705 Homo sapiens partial IGVH3 gene for Hs.272356immunoglobulin heavy chain V region, case 1, clone 16 EST Hs.255706 Homosapiens partial IGVH3 gene for Hs.272357 immunoglobulin heavy chain Vregion, case 1, clone 19 EST Hs.255708 Homo sapiens partial IGVH3 genefor Hs.272358 immunoglobulin heavy chain V region, case 1, cell Mo IV 72EST Hs.255710 Homo sapiens partial IGVH1 gene for Hs.272359immunoglobulin heavy chain V region, case 1, cell Mo V 94 EST Hs.255713Homo sapiens partial IGVL2 gene for Hs.272360 immunoglobulin lambdalight chain V region, case 1, cell Mo V 94 EST Hs.255717 Homo sapienspartial IGVH3 gene for Hs.272361 immunoglobulin heavy chain V region,case 1, cell Mo VI 7 EST Hs.255718 Homo sapiens partial IGVL1 gene forHs.272362 immunoglobulin lambda light chain V region, case 1, cell Mo VI65 EST Hs.255721 Homo sapiens partial IGVH3 gene for Hs.272363immunoglobulin heavy chain V region, case 1, cell Mo VI 162 ESTsHs.255723 Homo sapiens partial IGVH3 DP29 gene Hs.272364 forimmunoglobulin heavy chain V region, case 1, cell Mo VII 116 ESTHs.255725 Homo sapiens partial IGVH4 gene for Hs.272365 immunoglobulinheavy chain V region, case 2, cell D 56 EST Hs.255726 Homo sapienspartial IGVH3 gene for Hs.272366 immunoglobulin heavy chain V region,case 2, cell E 172 EST Hs.255727 interleukin 20 Hs.272373 EST Hs.255736Human DNA sequence from clone RP1- Hs.272521 149A16 on chromosome 22Contains an IGLC (Immunoglobulin Lambda Chain C) pseudogene, the RFPL3gene for Ret finger protein-like 3, the RFPL3S gene for Ret fingerprotein-like 3 antisense, the gene for a novel Immunoglobulin LambdaChain V family protein, the gene for a novel protein similar to mouseRGDS (RALGDS, RALGEF, Guanine Nucleotide Dissociation Stimulator A) andrabbit oncogene RSC, the gene for a novel protein (ortholog of wormF16A11.2 and bacterial and archea-bacterial predicted proteins), thegene for a novel protein similar to BPI (BacterialPermeability-Increasing Protein) and rabbit LBP (Liposaccharide-BindingProtein) and the 5′ part of a novel gene. Contains ESTs, STSs, GSSs andthree putative CpG islands EST Hs.255740 TdT Hs.272537 EST Hs.255742 retfinger protein-like 3 antisense Hs.274285 EST Hs.255743 PRKR Hs.274382EST Hs.7569 H. sapiens immunoglobulin epsilon chain Hs.274600 SMAD4Hs.75862 EST, Weakly similar to HLA-DQ alpha Hs.275720 chain [H.sapiens] Homo sapiens splicing factor, Hs.76122 EST, Weakly similar toRL13_HUMAN Hs.276279 arginine/serine-rich 4 (SFRS4) mRNA. 60S RIBOSOMALPROTEIN L13 [H. sapiens] thymosin beta-10 Hs.76293 EST Hs.276341 CD63Hs.76294 EST Hs.276342 AIF1 Hs.76364 EST, Weakly similar to RL13_HUMANHs.276353 60S RIBOSOMAL PROTEIN L13 [H. sapiens] phospholipase A2, groupIIA (platelets, Hs.76422 EST Hs.276774 synovial fluid), CES1 Hs.76688EST Hs.276819 ubiquitin conjugating enzyme Hs.76932 EST Hs.276871 Homosapiens KIAA0963 protein Hs.7724 EST, Weakly similar to FBRL_HUMANHs.276872 (KIAA0963), mRNA. FIBRILLARIN [H. sapiens] Homo sapiensfragile histidine triad gene Hs.77252 EST Hs.276887 (FHIT) mRNA. PAF-AHHs.77318 EST Hs.276902 Mig Hs.77367 EST Hs.276917 DDB2 Hs.77602 ESTHs.276918 ATR Hs.77613 EST, Weakly similar to RL13_HUMAN Hs.276938 60SRIBOSOMAL PROTEIN L13 [H. sapiens] XPB (ERCC3) Hs.77929 EST Hs.277051PNKP Hs.78016 EST Hs.277052 C7 Hs.78065 EST, Moderately similar toRL13_HUMAN Hs.277236 60S RIBOSOMAL PROTEIN L13 [H. sapiens] Homo sapienssmall nuclear RNA activating Hs.78403 EST, Moderately similar to DEADBox Hs.277237 complex, polypeptide 2, 45 kD (SNAPC2) Protein 5 [H.sapiens] mRNA. Hs.78465 EST Hs.277238 sphingolipid activatorprotein/cerebroside Hs.78575 EST Hs.277286 sulfate activator proteinHomo sapiens aminolevulinate, delta-, Hs.78712 major histocompatibilitycomplex, class I, C Hs.277477 synthase 1 (ALAS1), nuclear gene encodingmitochondrial protein, mRNA. tyrosine kinase with immunoglobulin andHs.78824 EST, Weakly similar to AF150959 1 Hs.277591 epidermal growthfactor homology domains immunoglobulin G1 Fc fragment [H. sapiens] Hsp72Hs.78846 EST Hs.277714 UNG Hs.78853 EST Hs.277715 CX3CR1 Hs.78913 ESTHs.277716 MSH2 Hs.78934 EST Hs.277717 CRHR1 Hs.79117 EST Hs.277718 BCL2Hs.79241 EST, Weakly similar to BAT3_HUMAN Hs.277774 LARGE PROLINE-RICHPROTEIN BAT3 [H. sapiens] P-selectin Hs.79283 EST Hs.277975 UBE2VE(MMS2) Hs.79300 EST Hs.278060 retinoid X receptor, beta Hs.79372cytochrome P450, subfamily XXIA (steroid Hs.278430 21-hydroxylase,congenital adrenal hyperplasia), polypeptide 2 MPG Hs.79396 KIAA0015gene product Hs.278441 RPA2 Hs.79411 CD32B Hs.278443 heat shock 70 kDprotein-like 1 Hs.80288 KIR2DL1 Hs.278453 FANCG (XRCC9) Hs.8047 CD158aHs.278455 CD43 Hs.80738 CD24 Hs.278667 POLG Hs.80961 HLA class II regionexpressed gene KE4 Hs.278721 Human CB-4 transcript of unrearrangedHs.81220 IL-17C Hs.278911 immunoglobulin V(H)5 gene Human L2-9transcript of unrearranged Hs.81221 HSPC048 protein (HSPC048) Hs.278944immunoglobulin V(H)5 pseudogene immunoglobulin superfamily, member 3Hs.81234 HSPC054 protein (HSPC054) Hs.278946 UBL1 Hs.81424 HSPC073protein (HSPC073) Hs.278948 PF4 Hs.81564 ESTs Hs.279066palmitoyl-protein thioesterase 2 Hs.81737 ESTs Hs.279067 natural killercell receptor, immunoglobulin Hs.81743 ESTs Hs.279068 superfamily memberTNFRSF11B Hs.81791 ESTs Hs.279069 interleukin 6 signal transducer(gp130, Hs.82065 ESTs Hs.279070 oncostatin M receptor) CD138 Hs.82109ESTs Hs.279071 Human monocytic leukaemia zinc finger Hs.82210 ESTsHs.279072 protein (MOZ) mRNA, complete cds. sema domain, immunoglobulindomain (Ig), Hs.82222 ESTs, Weakly similar to KIAA0052 protein Hs.279073short basic domain, secreted, (semaphorin) [H. sapiens] 3B HPRT Hs.82314ESTs Hs.279074 Human RNA binding protein Etr-3 mRNA, Hs.82321 ESTsHs.279075 complete cds. MNAT1 Hs.82380 ESTs Hs.279076 SMAD2 Hs.82483ESTs Hs.279077 CD47 Hs.82685 EST Hs.279078 CETN2 Hs.82794 EST Hs.279079protein phosphatase 1, regulatory (inhibitor) Hs.82887 ESTs Hs.279080subunit 11 MMP1 Hs.83169 EST Hs.279081 D3-type cyclin (CCND3) Hs.83173ESTs Hs.279082 MMP3 Hs.83326 ESTs Hs.279083 TNFSF10 Hs.83429 ESTsHs.279084 CD33 Hs.83731 ESTs Hs.279085 CD102 Hs.83733 ESTs Hs.279086Hs.84153 ESTs, Weakly similar to AF201422_1 Hs.279087 splicingcoactivator subunit SRm300 [H. sapiens] interleukin 8 receptor, betaHs.846 ESTs Hs.279088 titin immunoglobulin domain protein Hs.84665 ESTsHs.279089 (myotilin) KU80 (XRCC5) Hs.84981 Hs.86437 Raf-1 Hs.85181Hs.86761 major histocompatibility complex, class I, J Hs.85242 CD118 =IFNAR-2 Hs.86958 (pseudogene) RELB Hs.858 Hs.87113 Hs.85923 PGHS-1Hs.88474 ERK1 Hs.861 Hs.8882 FADD Hs.86131 LT-b Hs.890 MHC class Ipolypeptide-related sequence A Hs.90598 EST Hs.92440 TNFreceptor-associated factor 6 Hs.90957 Hs.92460 Topo3A Hs.91175myosin-binding protein H Hs.927 PARG Hs.91390 IFN-b Hs.93177 HLA-DPA1Hs.914 C8A Hs.93210 SEEK1 Hs.91600 pre-B-cell leukemia transcriptionfactor 2 Hs.93728 POLD1 Hs.99890 Tachykinin Receptor 3 Hs.942 ALK4Hs.99954 Homo sapiens cDNA FLJ12242 fis, clone Hs.94810 MAMMA1001292 XPD(ERCC2) Hs.99987 CD29 Hs.287797 SCYA25 (CCL25) Hs.50404 LIF Hs.2250SCYA19 (CCL19) Hs.50002 Human IP-10 Hs.2248 TCIRG1 Hs.46465 IL-5 Hs.2247PAF-Receptor Hs.46 G-CSF Hs.2233 CD26 Hs.44926 TGF-bR Hs.220 Hs.44865G-CSFR Hs.2175 REL Hs.44313 CD15 Hs.2173 IL-17 Hs.41724 STAT1 Hs.21486CD49d Hs.40034 CD85 Hs.204040 CCR2 Hs.395 HCC-1 Hs.20144 Hs.3688 Fasligand Hs.2007 TNF-b Hs.36 CD28 Hs.1987 lactoferrin Hs.347 HLA-DQA1Hs.198253 MCP-1 Hs.340 Ku70 (G22P1) Hs.197345 CD150 Hs.32970 PGHS-2Hs.196384 IL-10Ra Hs.327 CDw128 Hs.194778 EGR1 Hs.326035 IL-10 Hs.193717SCYC1 (XCL1) Hs.3195 CD126 Hs.193400 HLA-DR Hs.318720 Hs.1880 Topo I(TOP1) Hs.317 CD98 Hs.184601 SCYA2 (MCP1) Hs.303649 Hs.184542 HuRNPDHs.303627 MHC class I region ORF Hs.1845 Human C mu gene for IgM heavychain Hs.302063 CDw116a Hs.182378 exons CH1-4, secretory P1 Hs.297681HLA-DRB5 Hs.181366 immunoglobulin lambda joining 3 Hs.289110 majorhistocompatibility complex, class I, A Hs.181244 majorhistocompatibility complex, class II, Hs.289095 elongation factor1-alpha (clone CEF4) Hs.181165 DQ alpha 2 HSPCA Hs.289088 CD119Hs.180866 interleukin 22 Hs.287369 Hs.180804 ribosomal protein L4 Hs.286Hs.180532 IgM Hs.285823 POLB Hs.180107 EST Hs.283267 CD1d Hs.1799 TREM1Hs.283022 CD87 Hs.179657 HLA-DRB3 Hs.279930 minichromosome maintenancedeficient (S. Hs.179565 cerevisiae) 3 LIFR Hs.2798 RAD23B (HR23B)Hs.178658 C4B Hs.278625 Hs.178391 EST Hs.276907 Hs.177781 CDw52Hs.276770 ADPRT Hs.177766 CD16b Hs.274467 IFNGR2 Hs.177559 heat shock 70kD protein 1B Hs.274402 CD16a Hs.176663 Th1 Hs.273385 CD4 Hs.17483MIP-5/HCC-2 Hs.272493 SCYC2 (XCL2) Hs.174228 TBX21 Hs.272409 CD115Hs.174142 Homo sapiens mRNA; cDNA Hs.272307 CD11a Hs.174103DKFZp434O2417 (from clone DKFZp434O2417); partial cds Human DNA sequencefrom clone RP1- Hs.272295 IL-10Rb Hs.173936 108C2 on chromosome6p12.1-21.1. Contains the MCM3 gene for minichromosome maintenancedeficient (S. cerevisiae) 3 (DNA replication licensing factor, DNApolymerase alpha holoenzyme- associated protein P1, RLF beta subunit), aCACT (carnitine/acylcarnitine translocase) pseudogene, part of the genefor a PUTATIVE novel protein similar to IL17 (interleukin 17 (cytotoxicT-lymphocyte- associated serine esterase 8)) (cytotoxic Tlymphocyte-associated antigen 8, CTLA8), ESTs, STSs, GSSs and a putativeCpG island CD49b Hs.271986 MSCF Hs.173894 MCP-2 Hs.271387 TDG Hs.173824CD49c Hs.265829 RAC1 Hs.173737 NBS1 Hs.25812 integrin cytoplasmicdomain-associated Hs.173274 protein 1 CD120b = TNFRSF1B Hs.256278 IL2RHs.1724 CDw75 Hs.2554 IL-1a Hs.1722 CD82 Hs.25409 Hs.171872 MCP-3Hs.251526 Hs.171118 xanthine oxidase Hs.250 EST Hs.171009 Human Igrearranged lambda-chain mRNA, Hs.247947 EST Hs.170934 subgroup VL3, V-Jregion, partial cds Eotaxin-2/MPIF-2 Hs.247838 EST Hs.170587 CTLA-4Hs.247824 IL-9R Hs.1702 immunoglobulin kappa variable 1-9 Hs.247792 CD45Hs.170121 CD68 Hs.246381 TGF-a Hs.170009 OSMR Hs.238648 CD44 Hs.169610CDw127 Hs.237868 Fyn Hs.169370 transcription factor 8 (repressesinterleukin Hs.232068 MPIF-1 Hs.169191 2 expression) CD8b Hs.2299 ICAM-1Hs.168383 EST Hs.229374 IL-15 Hs.168132 TRF4-1 Hs.225951 STAT5AHs.167503 CD3g Hs.2259 ESTs Hs.167208 C2 Hs.2253 ESTs Hs.165693Hs.116834 Hs.135750 Hs.117741 DINB1 (POLK) Hs.135756 Human MHC Class Iregion proline rich Hs.118354 Human DNA sequence from clone RP1-Hs.136141 protein mRNA, complete cds 238O23 on chromosome 6. Containspart of the gene for a novel protein similar to PIGR (polymericimmunoglobulin receptor), part of the gene for a novel protein similarto rat SAC (soluble adenylyl cyclase), ESTs, STSs and GSS ESTs, Weaklysimilar to FCE2 MOUSE Hs.118392 Hs.136254 LOW AFFINITY IMMUNOGLOBULINEPSILON FC RECEPTOR [M. musculus] MKK6 Hs.118825 Hs.13646 Hs.118895Hs.136537 H. sapiens mRNA for ITBA4 gene. Hs.119018 Histone H1 (F3)Hs.136857 Hs.119057 MGMT Hs.1384 TNFRSF10c Hs.119684 Hs.138563 Hs.12064IgG Hs.140 Hs.120907 Hs.140478 acid phosphatase 5, tartrate resistantHs.1211 Hs.14070 Hs.121297 Hs.141153 Human immunoglobulin (mAb59) lightHs.121508 Hs.143954 chain V region mRNA, partial sequence IL12Rb1Hs.121544 ESTs, Moderately similar to Hs.144814 I1BC_HUMAN INTERLEUKIN-1BETA CONVERTASE PRECURSOR [H. sapiens] Human MHC class II DO-alpha mRNA,Hs.123041 CHK2 (Rad53) Hs.146329 partial cds Histone H4 (H4F2) Hs.123053EST Hs.146591 TSHR Hs.123078 Hs.147040 Hs.123445 CD42b Hs.1472regulatory factor X, 1 (influences HLA class Hs.123638 Hs.149235 IIexpression) CD13 Hs.1239 AICD Hs.149342 IL-15R Hs.12503 Homo sapiensputative tumor suppressor Hs.149443 protein (101F6) mRNA, complete cds.RAD51L3 (RAD51D) Hs.125244 CD49e Hs.149609 CDw90 Hs.125359 heparansulfate proteoglycan (HSPG) core Hs.1501 protein LYPLA1 Hs.12540 CD107aHs.150101 ESTs, Weakly similar to AF201951 1 high Hs.126580 ESTs, Weaklysimilar to 157587 MHC HLA Hs.150175 affinity immunoglobulin epsilonreceptor SX-alpha [H. sapiens] beta subunit [H. sapiens] Hs.127128 ALK2Hs.150402 Hs.127444 WRN Hs.150477 C5 Hs.1281 EST Hs.150708 C8G Hs.1285XRCC4 Hs.150930 RAD54B Hs.128501 IFN-a Hs.1510 Hs.129020 MAPK Hs.151051Hs.129268 Hs.15200 Hs.129332 immunoglobulin mu binding protein 2 Hs.1521XRCC2 Hs.129727 4-1BBL Hs.1524 potassium voltage-gated channel, Shaw-Hs.129738 Hs.152818 related subfamily, member 3 (KCNC3) interleukin 17receptor Hs.129751 HUS1 Hs.152983 CD134 Hs.129780 SWAP70 Hs.153026TNFRSF10d Hs.129844 DOM-3 (C. elegans) homolog Z Hs.153299 POLLHs.129903 Hs.153551 GADD153 = growth arrest and DNA-damage Hs.129913Hs.15370 inducible gene/fus-chop fusion protein solute carrier family 5(neutral amino acid Hs.130101 SMAD6 Hs.153863 transporters, system A),member 4 Hs.130232 APEXL2 Hs.154149 Hs.13034 Hs.154198 CD30L Hs.1313Hs.154366 SCYA26 (CCL26) Hs.131342 BCL6 Hs.155024 CD30 Hs.1314 Hs.155150Hs.131885 Hs.155402 Hs.131887 RAIDD Hs.155566 Hs.13256 POLH Hs.155573ESTs Hs.132775 Hs.15589 Homo sapiens (clone 3.8-1) MHC class I Hs.132807Homo sapiens mRNA for KIAA0695 Hs.155976 mRNA fragment protein completecds. Hs.13288 SNM1 (P502) Hs.1560 Hs.132943 Topo2A Hs.156346 ESTHs.133261 ESTs, Highly similar to MHC class II Hs.156811 antigen [H.sapiens] Hs.133388 Histamine H1 receptor Hs.1570 EST Hs.133393 Hs.157118EST Hs.133930 Hs.157267 ESTs Hs.133947 EST Hs.157279 ESTs Hs.133949 ESTHs.157280 EST Hs.134017 EST Hs.157308 EST Hs.134018 EST Hs.157309 ESTHs.134590 EST Hs.157310 Hs.135135 EST Hs.157311 immunoglobulinsuperfamily, member 6 Hs.135194 ESTs Hs.157344 Hs.135570 ret fingerprotein-like 2 Hs.157427 Homo sapiens arrestin, beta 2 (ARRB2) Hs.18142Hs.214956 mRNA. myeloperoxidase Hs.1817 WASP Hs.2157 APO-1 Hs.182359CD88 Hs.2161 TRAP1 Hs.182366 Hs.21618 Hs.182594 ring finger protein 5Hs.216354 TNFRSF16 Hs.1827 class II cytokine receptor ZCYTOR7 Hs.21814Hs.182817 Hs.219149 regulatory factor X, 4 (influences HLA classHs.183009 cyclophilin-related protein Hs.219153 II expression) Homosapiens killer cell lectin-like receptor Hs.183125 Homo sapiens mannosyl(alpha-1,6-)- Hs.219479 F1 (KLRF1), mRNA. glycoprotein beta-1,2-N-acetylglucosaminyltransferase (MGAT2) mRNA. Hs.183171 perforin Hs.2200EST Hs.183386 Hs.220154 Hs.183656 ESTs, Weakly similar to FCE2 MOUSEHs.220649 LOW AFFINITY IMMUNOGLOBULIN EPSILON FC RECEPTOR [M. musculus]Hs.18368 Hs.220868 advanced glycosylation end product-specific Hs.184Hs.220960 receptor CDK7 Hs.184298 immunoglobulin superfamily, member 1Hs.22111 Hs.184376 Hs.221539 CCR4 Hs.184926 ESTs Hs.221694 EST, Weaklysimilar to A27307 proline- Hs.185463 Hs.222921 rich phosphoprotein [H.sapiens] EST Hs.185498 Hs.222942 EST, Weakly similar to B39066 proline-Hs.186243 EST Hs.223520 rich protein 15 - rat [R. norvegicus] EST,Weakly similar to salivary proline-rich Hs.186265 EST Hs.223935 protein[R. norvegicus] EST Hs.187200 EST, Moderately similar to SMO_HUMANHs.224178 SMOOTHENED HOMOLOG PRECURSOR [H. sapiens] Hs.188048 BlkHs.2243 EST Hs.188075 EST Hs.224344 EST Hs.188194 EST Hs.224408 ESTHs.188300 EST Hs.224409 Hs.190251 CPN1 Hs.2246 Hs.19056 MMP7 Hs.2256 ESTHs.190831 MMP10 Hs.2258 MAPK8 Hs.190913 CCR9 Hs.225946 EST Hs.190921toll-like receptor 6 (TLR6) Hs.227105 EST, Weakly similar to S39206Hs.190924 XPR1 Hs.227656 hypothetical protein 1 - rat□ [R. norvegicus]GTF2H2 Hs.191356 CD49f Hs.227730 Hs.191367 Hs.22790 Hs.191914 ESTHs.228337 ESTs, Weakly similar to immunoglobulin Hs.192078 EST, Highlysimilar to 1409218A elastase Hs.228525 superfamily member [D.melanogaster] [H. sapiens] XPA Hs.192803 EST Hs.228528 CD89 Hs.193122EST, Moderately similar to Hs.228874 R37A_HUMAN 60S RIBOSOMAL PROTEINL37A□ [H. sapiens] DFFRY Hs.193145 EST Hs.228891 CD35 Hs.193716 ESTHs.228926 REV7 (MAD2L2) Hs.19400 EST Hs.229071 Hs.194082 EST Hs.229405Hs.194110 EST Hs.229494 BRCA1 Hs.194143 EST, Weakly similar toALU1_HUMAN Hs.229560 ALU SUBFAMILY J SEQUENCE CONTAMINATION WARNINGENTRY□ [H. sapiens] ESTs, Moderately similar to MHC Class I Hs.194249EST, Moderately similar to AAD18086 Hs.229901 region proline richprotein [H. sapiens] BAT2 [H. sapiens] Hs.194534 EST Hs.229902 Topo3BHs.194685 EST, Highly similar to 1409218A elastase Hs.230053 [H.sapiens] Human DNA sequence from clone 1170K4 Hs.194750 RAD51 Hs.23044on chromosome 22q12.2-13.1. Contains three novel genes, one of whichcodes for a Trypsin family protein with class A LDL receptor domains,and the IL2RB gene for Interleukin 2 Receptor, Beta (IL-2 Receptor,CD122 antigen). Contains a putative CpG island, ESTs, and GSSs majorhistocompatibility complex, class II, Hs.194764 EST, Moderately similarto A54746 adhalin Hs.230485 DP alpha 2 (pseudogene) precursor - human□[H. sapiens] Human DNA sequence from clone RP11- Hs.194976 EST Hs.230691367J7 on chromosome 1. Contains (part of) two or more genes for novelImmunoglobulin domains containing proteins, a SON DNA binding protein(SON) pseudogene, a voltage-dependent anion channel 1 (VDAC1)(plasmalemmal porin) pseudogene, ESTs, STSs and GSSs Hs.195447 ESTHs.230775 PDGF-B Hs.1976 EST Hs.230805 CXCR3 Hs.198252 EST Hs.230848Hs.198694 EST Hs.230862 Hs.198738 EST Hs.230874 MAR/SAR DNA bindingprotein (SATB1) Hs.198822 EST Hs.230931 CHUK Hs.198998 EST Hs.231031hemochromatosis Hs.20019 EST Hs.231261 T-cell receptor active beta-chainHs.2003 EST Hs.231284 APO-1 Hs.2007, EST Hs.231285 RXRA Hs.20084 ESTHs.231292 EST Hs.200876 EST, Weakly similar to putative Hs.231512mitochondrial outer membrane protein import receptor [H. sapiens]Hs.201194 Homo sapiens mRNA for KIAA0529 Hs.23168 protein, partial cds.TCRd Hs.2014 EST Hs.235042 ESTs, Highly similar to TNF-alpha Hs.202407EST Hs.235826 converting enzyme [H. sapiens] Hs.202608 TREX1 (Dnase III)Hs.23595 Integrin b1 = CD29 Hs.202661 EST Hs.237126 thrombomodulinHs.2030 Hs.23860 Hs.203064 RAD9 Hs.240457 Hs.2031841-acylglycerol-3-phosphate O- Hs.240534 acyltransferase 1(lysophosphatidic acid acyltransferase, alpha) Hs.203584 EST Hs.240635EST Hs.204477 EST, Weakly similar to ALU8_HUMAN Hs.241136 ALU SUBFAMILYSX SEQUENCE CONTAMINATION WARNING ENTRY□ [H. sapiens] EST Hs.204480TNFSF15 Hs.241382 EST, Weakly similar to CA13_HUMAN Hs.204483interleukin 1 receptor accessory protein-like 1 Hs.241385 COLLAGEN ALPHA1(III) CHAIN PRECURSOR□ [H. sapiens] ESTs Hs.204588 RANTES Hs.241392EST, Weakly similar to salivary proline-rich Hs.204598 sema domain,immunoglobulin domain (Ig), Hs.2414 protein 1 [H. sapiens] short basicdomain, secreted, (semaphorin) 3A EST Hs.204610 POLQ Hs.241517 ESTsHs.204703 TNF-a Hs.241570 ESTs Hs.204751 Homo sapiens genes encodingRNCC Hs.241586 protein, DDAH protein, Ly6-C protein, Ly6- D protein andimmunoglobulin receptor EST Hs.204760 megakaryocyte-enhanced genetranscript 1 Hs.241587 protein EST Hs.204771 EST, Moderately similar to1409218A Hs.241981 elastase [H. sapiens] ESTs Hs.204873 EST Hs.241982ESTs Hs.204932 EST Hs.241983 EST Hs.204954 EST Hs.242605 EST Hs.205158ADPRT2 Hs.24284 ESTs Hs.205159 EST Hs.243284 ESTs Hs.205327 ESTHs.243286 CD39 Hs.205353 ESTs Hs.243288 ESTs Hs.205435 SCYB14 Hs.24395EST Hs.205438 EST Hs.244046 EST, Highly similar to elastic titinHs.205452 EST Hs.244048 [H. sapiens] EST Hs.205456 EST Hs.244049 MRE11AHs.20555 EST Hs.244050 HLA class II region expressed gene KE2 Hs.205736RFXAP Hs.24422 EST Hs.205788 Hs.24435 ESTs Hs.205789 STAT5B Hs.244613EST Hs.205803 EST Hs.244666 EST Hs.205815 EST Hs.245586 ESTs Hs.206160CDw108 Hs.24640 Hs.206654 ESTs Hs.246796 EST Hs.207060 dimethylargininedimethylaminohydrolase 2 Hs.247362 EST Hs.207062 Homo sapiens clonemcg53-54 Hs.247721 immunoglobulin lambda light chain variable region 4amRNA, partial cds EST Hs.207063 Homo sapiens ELK1 pseudogene (ELK2)Hs.247775 and immunoglobulin heavy chain gamma pseudogene (IGHGP) ESTHs.207473 immunoglobulin kappa variable 1/OR2-108 Hs.247804 ESTsHs.207474 butyrophilin-like 2 (MHC class II Hs.247808 associated) ESTsHs.207971 Homo sapiens genes encoding RNCC Hs.247879 protein, DDAHprotein, Ly6-C protein, Ly6- D protein and immunoglobulin receptor ESTHs.207993 Histamine H2 receptor Hs.247885 EST Hs.208153 Humananti-streptococcal/anti-myosin Hs.247898 immunoglobulin lambda lightchain variable region mRNA, partial cds EST, Weakly similar to S10889proline-rich Hs.208667 Homo sapiens isolate donor Z clone Z55K Hs.247907protein - human□ [H. sapiens] immunoglobulin kappa light chain variableregion mRNA, partial cds ESTs Hs.209142 Homo sapiens isolate donor Dclone D103L Hs.247908 immunoglobulin lambda light chain variable regionmRNA, partial cds EST Hs.209261 Homo sapiens isolate 459 immunoglobulinHs.247909 lambda light chain variable region (IGL) gene, partial cdsESTs Hs.209306 Homo sapiens isolate donor N clone N88K Hs.247910immunoglobulin kappa light chain variable region mRNA, partial cdsHs.209362 Homo sapiens isolate donor N clone N8K Hs.247911immunoglobulin kappa light chain variable region mRNA, partial cds EST,Weakly similar to FCEB MOUSE Hs.209540 Human Ig rearranged mu-chainV-region Hs.247923 HIGH AFFINITY IMMUNOGLOBULIN gene, subgroup VH-III,exon 1 and 2 EPSILON RECEPTOR BETA-SUBUNIT [M. musculus] EST Hs.209913Epsilon, IgE = membrane-bound IgE, Hs.247930 epsilon m/s isoform{alternative splicing} [human, mRNA Partial, 216 nt] EST Hs.209989 H.sapiens (T1.1) mRNA for IG lambda light Hs.247949 chain EST Hs.210049 H.sapiens mRNA for Ig light chain, variable Hs.247950 region (ID:CLL001VL)EST, Moderately similar to probable Hs.210276 Human interleukin 2 gene,clone pATtacIL- Hs.247956 sodium potassium ATPase gamma chain 2C/2TT,complete cds, clone pATtacIL- [H. sapiens] 2C/2TT EST, Weakly similar toN-WASP Hs.210306 pre-B lymphocyte gene 1 Hs.247979 [H. sapiens] ESTHs.210307 Human immunoglobulin heavy chain Hs.247987 variable region(V4-31) gene, partial cds EST Hs.210385 Human immunoglobulin heavy chainHs.247989 variable region (V4-30.2) gene, partial cds interleukin 21receptor Hs.210546 Human DNA sequence from phage LAW2 Hs.247991 from acontig from the tip of the short arm of chromosome 16, spanning 2Mb of16p13.3 Contains Interleukin 9 receptor pseudogene EST Hs.210727 Homosapiens HLA class III region Hs.247993 containing NOTCH4 gene, partialsequence, homeobox PBX2 (HPBX) gene, receptor for advanced glycosylationend products (RAGE) gene, complete cds, and 6 unidentified cds Hs.211266Homo sapiens immunoglobulin lambda Hs.248010 gene locus DNA, clone: 61D6SMAD3 Hs.211578 immunoglobulin lambda variable 9-49 Hs.248011 MHC classI polypeptide-related sequence B Hs.211580 immunoglobulin lambdavariable 4-3 Hs.248012 ESTs, Weakly similar to CA1B_MOUSE Hs.211744 H.sapiens mRNA for IgG lambda light Hs.248030 COLLAGEN ALPHA 1(XI) CHAINchain V-J-C region (clone Tgl11) PRECURSOR□ [M. musculus] sema domain,immunoglobulin domain (Ig), Hs.212414 Human immunoglobulin (mAb56) lightHs.248043 short basic domain, secreted, (semaphorin) chain V regionmRNA, partial sequence 3E TNFRSF18 Hs.212680 Homo sapienslymphocyte-predominant Hs.248077 Hodgkin's disease case #4immunoglobulin heavy chain gene, variable region, partial cds Homosapiens general transcription factor 2- Hs.212939 Homo sapienslymphocyte-predominant Hs.248078 I pseudogene 1 (GTF2IP1) mRNA.Hodgkin's disease case #7 immunoglobulin heavy chain gene, variableregion, partial cds RAD 18 Hs.21320 Homo sapiens clone ASMneg1-b3Hs.248083 immunoglobulin lambda chain VJ region, (IGL) mRNA, partial cdsHs.213226 OSM Hs.248156 ESTs Hs.279090 Hs.29128 ESTs Hs.279091 Homosapiens clone 24659 mRNA Hs.29206 sequence. ESTs Hs.279092 EST Hs.292235EST Hs.279093 EST Hs.292450 ESTs Hs.279094 EST, Moderately similar toEwing sarcoma Hs.292455 breakpoint region 1, isoform EWS [H. sapiens]ESTs Hs.279095 EST Hs.292461 ESTs, Weakly similar to AF279265_1Hs.279096 ESTs Hs.292501 putative anion transporter 1 [H. sapiens] ESTsHs.279097 EST Hs.292516 EST Hs.279098 EST Hs.292517 ESTs Hs.279099 ESTHs.292520 ESTs Hs.279100 EST, Moderately similar to RL13_HUMAN Hs.29254060S RIBOSOMAL PROTEIN L13 [H. sapiens] ESTs Hs.279101 EST Hs.292545 ESTsHs.279102 EST, Weakly similar to ORFII [H. sapiens] Hs.292704 ESTsHs.279103 EST Hs.292761 ESTs Hs.279104 ESTs Hs.292803 ESTs Hs.279105ESTs Hs.293183 ESTs Hs.279106 ESTs Hs.293280 EST Hs.279107 ESTsHs.293281 ESTs Hs.279108 ESTs, Moderately similar to 0501254A Hs.293441protein Tro alpha1 H,myeloma [H. sapiens] EST Hs.279109 MMP13 Hs.2936ESTs Hs.279110 major histocompatibility complex, class II, Hs.293934 DRbeta 4 ESTs Hs.279111 Human MHC class III serum complement Hs.294163factor B, mRNA ESTs Hs.279112 EST Hs.294315 EST Hs.279113 EST Hs.294316ESTs Hs.279114 EST, Highly similar to Y196_HUMAN Hs.295582 HYPOTHETICALPROTEIN KIAA0196□ [H. sapiens] ESTs Hs.279115 EST Hs.295583 ESTsHs.279116 EST, Highly similar to ZN07_HUMAN Hs.295584 ZINC FINGERPROTEIN 7 [H. sapiens] ESTs Hs.279117 EST Hs.295585 ESTs Hs.279118 ESTHs.295586 ESTs Hs.279119 EST, Moderately similar to angiotensinHs.295595 converting enzyme [H. sapiens] ESTs Hs.279120 EST Hs.295621ESTs Hs.279121 EST Hs.295622 ESTs Hs.279122 EST, Moderately similar toRL13_HUMAN Hs.295629 60S RIBOSOMAL PROTEIN L13 [H. sapiens] ESTsHs.279123 EST Hs.295724 ESTs Hs.279124 EST Hs.296064 ESTs Hs.279125 EST,Moderately similar to IDS_HUMAN Hs.296070 IDURONATE 2-SULFATASEPRECURSOR□ [H. sapiens] ESTs Hs.279126 EST Hs.296073 ESTs Hs.279127interleukin enhancer binding factor 1 Hs.296281 EST Hs.279128 similar torat integral membrane Hs.296429 glycoprotein POM121 ESTs, Weakly similarto aconitase Hs.279129 Human histocompatibility antigen mrna Hs.296476[H. sapiens] clone phla-1 ESTs Hs.279130 immunoglobulin lambda-likepolypeptide 3 Hs.296552 ESTs Hs.279131 RFXANK Hs.296776 ESTs Hs.279132Hs.29826 ESTs Hs.279133 Hs.29871 ESTs, Weakly similar to PYRG_HUMANHs.279134 MEKK1 Hs.298727 CTP SYNTHASE [H. sapiens] ESTs, Weakly similarto RIR1_HUMAN Hs.279135 Hs.30029 RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE M1CHAIN [H. sapiens] ESTs Hs.279136 CD3e Hs.3003 ESTs Hs.279137 ESTs,Weakly similar to CA13_HUMAN Hs.300697 COLLAGEN ALPHA 1(III) CHAINPRECURSOR [H. sapiens] ESTs Hs.279138 Homo sapiens clone BCSynL38Hs.300865 immunoglobulin lambda light chain variable region mRNA,partial cds ESTs Hs.279139 FCGR3A Hs.300983 ESTs Hs.279140 Homo sapiensDP47 gene for Hs.301365 immunoglobulin heavy chain, partial cds ESTsHs.279141 PMS2L9 Hs.301862 EST Hs.279142 CCR1 Hs.301921 ESTs Hs.279143FANCE Hs.302003 ESTs Hs.279144 interleukin 21 Hs.302014 ESTs Hs.279145interleukin 17E Hs.302036 ESTs Hs.279146 Hs.30446 EST Hs.279147 ESTHs.30709 ESTs Hs.279148 EST Hs.30731 ESTs Hs.279149 MHC class IItransactivator Hs.3076 ESTs Hs.279150 EST Hs.30766 ESTs, Weakly similarto PUR2_HUMAN Hs.279151 EST Hs.30793 TRIFUNCTIONAL PURINE BIOSYNTHETICPROTEIN ADENOSINE 3 [H. sapiens] ESTs Hs.279152 Hs.30818 ESTs Hs.279153CD97 Hs.3107 ESTs Hs.279154 RAR-beta2 Hs.31408 ESTs Hs.279155 RECQL4Hs.31442 ESTs Hs.279156 XPC Hs.320 ESTs Hs.279157 ERK2 Hs.324473 ESTsHs.279158 Hs.32456 ESTs Hs.279159 MSH6 Hs.3248 ESTs Hs.279160 ribosomalprotein L23-related Hs.3254 ESTs, Weakly similar to IDHA_HUMAN Hs.279161PI3CG Hs.32942 ISOCITRATE DEHYDROGENASE [H. sapiens] ESTs Hs.279162 CSA(CKN1) Hs.32967 ESTs Hs.279163 sema domain, immunoglobulin domain (Ig),Hs.32981 short basic domain, secreted, (semaphorin) 3F ESTs Hs.279164BRCA2 Hs.34012 ESTs Hs.279165 MEK1 Hs.3446 ESTs Hs.279166 STRL33 (CXCR6)Hs.34526 ESTs Hs.279167 MBD4 Hs.35947 ESTs Hs.279168 immunoglobulin(CD79A) binding protein 1 Hs.3631 EST Hs.279169 CD7 Hs.36972 ESTsHs.279170 IFNA1 Hs.37026 ESTs Hs.279171 PDGF-A Hs.37040 EST Hs.279172immunoglobulin kappa variable 1-13 Hs.37089 ESTs Hs.279174 DMC1 Hs.37181ESTs Hs.279175 Hs.37892 CD86 Hs.27954 Homo sapiens suppressor ofvariegation 3-9 Hs.37936 (Drosophila) homolog (SUV39H) mRNA, andtranslated products. CGI-81 protein Hs.279583 C8B Hs.38069 ESTsHs.279821 MTH1 (NUDT1) Hs.388 ESTs Hs.279823 Adrenomedullin Hs.394 ESTs,Weakly similar to IRE1_HUMAN Hs.279824 Hs.39441 IRON-RESPONSIVE ELEMENTBINDING PROTEIN 1 [H. sapiens] ESTs Hs.279825 CD66b Hs.41 ESTs Hs.279826RAD50 Hs.41587 MLH3 Hs.279843 CD94 Hs.41682 TNFRSF14 Hs.279899 HLJ1Hs.41693 RPA4 Hs.283018 ESM1 Hs.41716 EST Hs.283165 MSH3 Hs.42674 ESTHs.283166 cAMP responsive element binding protein- Hs.42853 like 1 ESTHs.283167 IKBKG Hs.43505 EST Hs.283168 Homo sapiens suppressor of whiteapricot Hs.43543 homolog 2 (SWAP2), mRNA. ESTs Hs.283169 LEU2 Hs.43628EST Hs.283245 Homo sapiens immunoglobulin lambda Hs.43834 gene locusDNA, clone:288A10 EST Hs.283247 SIRT2 Hs.44017 ESTs Hs.283248 Hs.44087EST Hs.283249 TREM2 Hs.44234 EST Hs.283250 serine/threonine kinase 19Hs.444 EST Hs.283251 Hs.44512 EST Hs.283252 Hs.44628 EST Hs.283253Hs.45063 EST Hs.283254 LTC4 synthase Hs.456 EST Hs.283255 FUT2 Hs.46328EST Hs.283256 CCR6 Hs.46468 EST Hs.283257 POLM Hs.46964 EST Hs.283258EXO1 (HEX1) Hs.47504 ESTs Hs.283259 FEN1 (Dnase IV) Hs.4756 ESTHs.283261 Hs.4863 EST Hs.283262 golgin-165 Hs.4953 EST Hs.283263Hs.50102 EST Hs.283264 ATP-binding cassette, sub-family B Hs.502(MDR/TAP), member 3 EST Hs.283266 Hs.5057 ESTs Hs.283268 corneodesmosinHs.507 EST Hs.283269 Histone H2 (H2AFP) Hs.51011 EST, Weakly similar toAF189011_1 Hs.283270 CCNH Hs.514 ribonuclease III [H. sapiens] ESTHs.283271 EST Hs.5146 EST Hs.283272 SMUG1 Hs.5212 EST Hs.283274 ABH(ALKB) Hs.54418 EST Hs.283275 CCR5 Hs.54443 EST Hs.283276 CD81 Hs.54457ESTs, Weakly similar to S32605 collagen Hs.283392 TNFSF13 Hs.54673 alpha3(VI) chain - mouse [M. musculus] ESTs Hs.283433 PRPS1 Hs.56 ESTsHs.283434 Hs.56156 ESTs Hs.283438 Hs.56265 ESTs Hs.283442 killer cellimmunoglobulin-like receptor, Hs.56328 three domains, long cytoplasmictail, 2 ESTs Hs.283443 EST Hs.5656 ESTs Hs.283456 Hs.56845 ESTsHs.283457 MLH1 Hs.57301 ESTs, Weakly similar to similar to collagenHs.283458 testis specific basic protein Hs.57692 [C. elegans] ESTsHs.283459 ESTs Hs.57841 ESTs Hs.283460 Human 6Ckine Hs.57907 ESTsHs.283462 EST Hs.5816 ESTs Hs.283463 Homo sapiens cell growth regulatorywith Hs.59106 ring finger domain (CGR19) mRNA. ESTs Hs.283496 ERCC1Hs.59544 ESTs Hs.283497 Hs.61558 ESTs Hs.283499 Homo sapiens GPItransamidase mRNA, Hs.62187 complete cds. ESTs Hs.283500 Hs.62699 ESTs,Weakly similar to ORF YDL014w Hs.283504 Hs.63913 [S. cerevisiae] ESTs,Weakly similar to S09646 collagen Hs.283505 Homo sapiens chlorideintracellular channel Hs.64746 alpha 2(VI) chain precursor, mediumsplice 3 (CLIC3), mRNA. form - human□ [H. sapiens] ESTs Hs.283608 FANCFHs.65328 CD42c Hs.283743 Hs.6544 tenascin XA Hs.283750 interleukin 1receptor-like 1 Hs.66 immunoglobulin kappa variable 1D-8 Hs.283770 CD38Hs.66052 protocadherin gamma subfamily A, 2 Hs.283801 Hs.6607 (PCDHGA2)Homo sapiens mRNA; cDNA Hs.283849 RAD54L Hs.66718 DKFZp762F0616 (fromclone DKFZp762F0616) Homo sapiens clone bsmneg3-t7 Hs.283876 SCYA17(CCL17) Hs.66742 immunoglobulin lambda light chain VJ region, (IGL)mRNA, partial cds Homo sapiens transgenic-JHD mouse #2357 Hs.283878IL-12 Hs.673 immunoglobulin heavy chain variable region (IgG VH251)mRNA, partial cds Homo sapiens clone N97 immunoglobulin Hs.283882 HumanIL-12 p40 Hs.674 heavy chain variable region mRNA, partial cds Homosapiens clone case06H1 Hs.283924 LILRB4 Hs.67846 immunoglobulin heavychain variable region gene, partial cds Homo sapiens HSPC077 mRNA,partial cds Hs.283929 interleukin 5 receptor, alpha Hs.68876 Homosapiens HSPC088 mRNA, partial cds Hs.283931 Hs.6891 Homo sapiens HSPC097mRNA, partial cds Hs.283933 Hs.69233 Homo sapiens HSPC102 mRNA, partialcds Hs.283934 FUT1 Hs.69747 Homo sapiens HSPC107 mRNA, partial cdsHs.283935 B-factor, properdin Hs.69771 CMKRL1 Hs.28408 Hs.70333 FANCAHs.284153 Hs.71618 Homo sapiens immunoglobulin mu chain Hs.284277 RAD1Hs.7179 antibody MO30 (IgM) mRNA, complete cds gamma-glutamyltransferase1 Hs.284380 interleukin 19 Hs.71979 putative human HLA class IIassociated Hs.285013 MEK2 Hs.72241 protein I interleukin 13 receptor,alpha 1 Hs.285115 IL-7 Hs.72927 CDw131 Hs.285401 STAT2 Hs.72988 Homosapiens VH2-D3.10-JH5b gene for Hs.287403 CD42d Hs.73734 immunoglobulinheavy chain variable region Homo sapiens cDNA: FLJ22546 fis, cloneHs.287697 MIF Hs.73798 HSI00290 Homo sapiens cDNA: FLJ23140 fis, cloneHs.287728 ECP Hs.73839 LNG09065 H. sapiens mRNA for HLA-C alpha chainHs.287811 CPN2 Hs.73858 (Cw*1701) Homo sapiens clone ASMneg1-b1Hs.287815 MMP8 Hs.73862 immunoglobulin lambda chain VJ region, (IGL)mRNA, partial cds Homo sapiens clone CPRF1-T2 Hs.287816 HLA-Ghistocompatibility antigen, class I, G Hs.73885 immunoglobulin lambdachain VJ region, (IGL) mRNA, partial cds EST Hs.287817 TNFRSF9 Hs.73895myelin protein zero-like 1 Hs.287832 IL-4 Hs.73917 immunoglobulinlambda-like polypeptide 1 Hs.288168 HLA-DQB1 Hs.73931 cathepsinBHs.288181 RAG1 Hs.73958 G18.2 protein Hs.288316 LAG-3 Hs.74011 ESTsHs.288403 Hs.7402 EST Hs.288431 CD163 Hs.74076 Homo sapiens partialIGVH2 gene for Hs.288553 immunoglobulin superfamily, member 2 Hs.74115immunoglobulin heavy chain V region, case 2, cell B 45 polymericimmunoglobulin receptor Hs.288579 CD158b Hs.74134 Human immunoglobulinheavy chain Hs.288711 Hs.7434 variable region (V4-4) gene, partial cdsHuman immunoglobulin heavy chain Hs.289036 TCRa Hs.74647 variable region(V4-4b) gene, partial cds Hs.28921 human immunodeficiency virus type IHs.75063 enhancer-binding protein 2 EST Hs.289577 MLN50 Hs.75080 ESTHs.289836 lysyl hydroxylase (PLOD) Hs.75093 EST Hs.289878 TAK1 Hs.7510GSN Hs.290070 Homo sapiens transcription factor 6-like 1 Hs.75133(mitochondrial transcription factor 1-like) (TCF6L1) mRNA. EST, Weaklysimilar to unnamed protein Hs.290133 UBE2N (UBC13, BTG1) HS.75355product [H. sapiens] EST Hs.290227 Hs.75450 ESTs Hs.290315 HSPA2Hs.75452 EST Hs.290339 CD151 Hs.75564 EST Hs.290340 RELA Hs.75569Hs.29055 CD122 Hs.75596 EST Hs.291125 CD14-UZ Hs.75627 EST Hs.291126nuclear factor erythroid 2 isoform f = basic Hs.75643 leucine zipperprotein {alternatively spliced CD91 = LRP Hs.89137 C1QB Hs.8986 XPF(ERCC4) Hs.89296 superkiller viralicidic activity 2 (S. Hs.89864cerevisiae homolog)-like Carbonic anhydrase IV Hs.89485 EST Hs.90165CETP Hs.89538 EST Hs.90171 RAD52 Hs.89571 GTF2H3 Hs.90304 GTF2H1Hs.89578 protein tyrosine kinase related sequence Hs.90314 Fc fragmentof IgE, high affinity I, receptor Hs.897 Hs.90463 for; alpha polypeptidetranscript ch138 Hs.94881 SGRF protein, Interleukin 23 p19 subunitHs.98309 Hs.9578 XRCC1 Hs.98493 IL-9 Hs.960 Homo sapiens mRNA forKIAA0543 Hs.98507 protein, partial cds. NFATC1 Hs.96149 Hs.9893 OGG1Hs.96398 DIR1 protein Hs.99134 Hs.96499 XRCC3 Hs.99742 NFKBIB Hs.9731Elastase(leukocyte) Hs.99863 XAB2 (HCNP) Hs.9822 JAK3 Hs.99877 CD40Hs.652

TABLE 3A Candidate nucleotide sequences identified using differentialcDNA hybridization analysis Offset Example on Acc Accession Number CloneStart End Number UniGene Signif Clones Genbank Description 56D1 15211685 D00022 Hs.25 1.00E−84 1 for F1 beta subunit, complete 586E3 12271448 NM_001686 Hs.25 1.00E−89 1 ATP synthase, H+ transporting,mitochondrial 459F4 1484 2522 NM_002832 Hs.35 0 3 protein tyrosinephosphatase, non-receptor t 41A11 885 1128 D12614 Hs.36 1.00E−125 1lymphotoxin (TNF-beta), complete 41G12 442 1149 D10202 Hs.46 0 1 forplatelet-activating factor receptor, 98E12 1928 2652 NM_002835 Hs.62 0 1protein tyrosine phosphatase, non-receptor t 170E1 473 1071 U13044 Hs.780 1 nuclear respiratory factor-2 subunit alpha mRNA, com 40C6 939 1357D11086 Hs.84 0 1 interleukin 2 receptor gamma chain 521F9 283 1176NM_000206 Hs.84 0 8 interleukin 2 receptor, gamma (severe combined 60A11989 1399 L08069 Hs.94 0 2 heat shock protein, E. coli DnaJ homologuecomplete cd 520B9 545 1438 NM_001539 Hs.94 0 3 heat shock protein,DNAJ-like 2 (HSJ2), mRNA/ 460H9 626 1104 NM_021127 Hs.96 0 1phorbol-12-myristate-13-acetate-induced p 127G12 651 1223 NM_004906Hs.119 0 2 Wilms' tumor 1-associating protein (KIAA0105 586A7 438 808NM_000971 Hs.153 0 3 ribosomal protein L7 (RPL7), mRNA/cds = (10,75699H12 2447 4044 NM_002600 Hs.188 0 2 phosphodiesterase 4B, cAMP-specific(dunce ( 464D4 2317 2910 NM_002344 Hs.210 0 1 leukocyte tyrosine kinase(LTK), mRNA/cds = (17 464B3 10 385 NM_002515 Hs.214 1.00E−164 1neuro-oncological ventral antigen 1 (NOVA1), 40A12 296 1153 L11695Hs.220 0 1 activin receptor-like kinase (ALK-5) mRNA, complete 129A24138 4413 NM_000379 Hs.250 1.00E−155 1 xanthene dehydrogenase (XDH),mRNA 36B10 80 1475 AF068836 Hs.270 0 3 cytohesin binding protein HEmRNA, complete cd 45C11 58 1759 NM_004288 Hs.270 0 2 pleckstrinhomology, Sec7 and coiled/coil dom 128C12 2555 3215 NM_000153 Hs.273 0 4galactosylceramidase (Krabbe disease) (GALC) 67H2 259 1418 D23660 Hs.2860 8 ribosomal protein, complete cds 151E6 624 1170 AF052124 Hs.313 0 1clone 23810 osteopontin mRNA, complete cds/c 45A7 4 262 NM_000582 Hs.3131.00E−136 1 secreted phosphoprotein 1 (osteopontin, bone 44C10 2288 2737J03250 Hs.317 0 1 topoisomerase I mRNA, complete cds/ cds = (211,2508)/99H9 2867 3246 NM_001558 Hs.327 0 2 interleukin 10 receptor, alpha(IL10RA), mRNA 41B4 2867 3315 U00672 Hs.327 0 6 interleukin-10 receptormRNA, complete 144E1 283 989 M26683 Hs.340 0 36 interferon gammatreatment inducible/cds = (14,1 41A12 1854 2590 X53961 Hs.347 0 1lactoferrin/cds = (294,2429)/gb = X53961/gi = 40F1 1377 1734 U95626Hs.395 0 1 ccr2b (ccr2), ccr2a (ccr2), ccr5 (ccr5) and cc 463H4 55 434NM_001459 Hs.428 0 1 fms-related tyrosine kinase 3 ligand (FLT3LG) 127E1552 1048 NM_005180 Hs.431 0 1 murine leukemia viral (bmi-1) oncogenehomolo 73G12 189 1963 NM_004024 Hs.460 0 17 activating transcriptionfactor 3 (ATF3), ATF 524A4 1361 2136 NM_004168 Hs.469 0 2 succinatedehydrogenase complex, subunit A, 41C7 1554 2097 D10925 Hs.516 0 1HM145/cds = (22,1089)/gb = D10925/gi = 219862 588A2 48 163 NM_001032Hs.539 1.00E−59 1 ribosomal protein S29 (RPS29), mRNA/cds = (30,2 177B41 1674 AF076465 Hs.550 2.00E−37 2 PhLOP2 mRNA, complete cds/cds =(5,358)/gb = AF 68G5 2 1454 M26383 Hs.624 0 17 monocyte-derivedneutrophil-activating protein (M 45F10 1 1454 NM_000584 Hs.624 0 11interleukin 8 (IL8), mRNA/cds = (74,373)/gb = N 59F11 59 1822 X68550Hs.652 0 14 TRAP mRNA for ligand of CD40/cds = (56,841)/gb = X6 471C93115 3776 NM_000492 Hs.663 0 1 cystic fibrosis transmembrane conductancere 68D1 228 866 M20137 Hs.694 0 3 interleukin 3 (IL-3) mRNA, completecds, clone pcD- SR 49H3 42 665 NM_000588 Hs.694 0 1 interleukin 3(colony-stimulating factor, mu 147H3 110 340 BF690338 Hs.695 1.00E−102 1602186730T1 cDNA, 3′ end/clone = IMAGE: 4299006 483E4 310 846 NM_000942Hs.699 0 1 peptidylprolyl isomerase B (cyclophilin B) ( 522B12 349 755NM_000788 Hs.709 0 2 deoxycytidine kinase (DCK), mRNA/cds = (159,94331E5 1293 1470 J03634 Hs.727 9.00E−75 1 erythroid differentiationprotein mRNA (EDF), comple 514D12 1164 1579 NM_004907 Hs.737 1.00E−169 3immediate early protein (ETR101), mRNA/cds = ( 73H7 1953 3017 AJ243425Hs.738 0 8 EGR1 gene for early growth response protein 1/ 592A8 10 454NM_003973 Hs.738 0 5 ribosomal protein L14 (RPL14), mRNA 519A1 116 1527NM_000801 Hs.752 1.00E−163 2 FK506-binding protein 1A (12 kD) (FKBP1A),mRN 109H11 1 1206 M60626 Hs.753 0 10 N-formylpeptide receptor (fMLP-R98)mRNA, complete 99C5 1 1175 NM_002029 Hs.753 0 25 formyl peptide receptor1 (FPR1), mRNA 103C1 2285 2890 NM_002890 Hs.758 0 1 RAS p21 proteinactivator (GTPase activating p 41H4 3142 3332 NM_000419 Hs.785 1.00E−841 integrin, alpha 2b (platelet glycoprotein IIb 171D2 198 748 X54489Hs.789 1.00E−132 2 melanoma growth stimulatory activity (MGSA) 458H72165 2818 NM_001656 Hs.792 0 1 ADP-ribosylation factor domain protein 1,64 62B3 833 1241 M60278 Hs.799 0 2 heparin-binding EGF-like growthfactor mRNA, complet 53G4 1299 2166 AK001364 Hs.808 0 6 FLJ10502 fis,clone NT2RP2000414, highly 597F3 1136 1797 NM_004966 Hs.808 0 2heterogeneous nuclear ribonucleoprotein F ( 143F7 575 985 M74525 Hs.8110 3 HHR6B (yeast RAD 6 homologue) mRNA, complete 518H8 580 974 NM_003337Hs.811 0 1 ubiquitin-conjugating enzyme E2B (RAD6 homol 45G8 277 833NM_002121 Hs.814 0 1 major histocompatibility complex, class II, 41H11719 1534 NM_005191 Hs.838 0 1 CD80 antigen (CD28 antigen ligand 1, B7-1antig 41G1 117 557 U31120 Hs.845 0 1 interleukin-13 (IL-13) precursorgene, complete cds 75E1 693 862 J05272 Hs.850 2.00E−58 4 IMPdehydrogenase type 1 mRNA complete 129B11 3361 3883 L25851 Hs.851 0 1integrin alpha E precursor, mRNA, complete cds 481E9 3361 3742 NM_002208Hs.851 1.00E−173 1 integrin, alpha E (antigen CD103, human mucosa 71G7 11193 NM_000619 Hs.856 0 111 interferon, gamma (IFNG), mRNA/cds =(108,608) 75H5 1 1193 X13274 Hs.856 0 314 interferon IFN-gamma/cds =(108,608)/gb = X13 525B12 672 894 NM_002341 Hs.890 1.00E−121 1lymphotoxin beta (TNF superfamily, member 3) 40E8 75 999 AL121985 Hs.9010 6 DNA sequence RP11-404F10 on chromosome 1q2 48H4 680 933 NM_001778Hs.901 1.00E−130 2 CD48 antigen (B-cell membrane protein) (CD48) 179G81652 2181 AL163285 Hs.926 0 1 chromosome 21 segment HS21C085 48G11 10492092 NM_002463 Hs.926 0 3 myxovirus (influenza) resistance 2, homolog o110B12 209 1734 M32011 Hs.949 0 8 neutrophil oxidase factor (p67-phox)mRNA, complete 99C9 207 1733 NM_000433 Hs.949 0 11 neutrophil cytosolicfactor 2 (65 kD, chronic g 125D2 958 1645 NM_004645 Hs.966 0 1 coilin(COIL), mRNA/cds = (22,1752)/gb = NM_004 458C1 1649 2285 NM_006025Hs.997 0 1 protease, serine, 22 (P11), mRNA/cds = (154,126 40H11 621 864L26953 Hs.1010 1.00E−135 1 chromosomal protein mRNA, complete cds/cds =(7 116D10 513 858 NM_002932 Hs.1010 0 1 regulator of mitotic spindleassembly 1 (RMSA 40G11 1565 2151 M31452 Hs.1012 0 1 proline-rich protein(PRP) mRNA, complete 192A6 321 908 NM_000284 Hs.1023 0 1 pyruvatedehydrogenase (lipoamide) alpha 1 ( 460H11 2158 2402 NM_004762 Hs.10502.00E−91 1 pleckstrin homology, Sec7 and coiled/coil dom 41F12 291 565M57888 Hs.1051 1.00E−112 1 (clone lambda B34) cytotoxicT-lymphocyte-associate 41A5 1311 1852 M55654 Hs.1100 0 1 TATA-bindingprotein mRNA, complete 461D7 999 1277 NM_002698 Hs.1101 1.00E−92 1 POUdomain, class 2, transcription factor 2 (P 597H9 1083 1224 NM_000660Hs.1103 3.00E−75 1 transforming growth factor, beta 1 (TGFB1), mR 40B51433 2010 X02812 Hs.1103 0 1 transforming growth factor-beta (TGF-beta)106A10 1977 2294 M73047 Hs.1117 1.00E−176 1 tripeptidyl peptidase IImRNA, complete cds/c 165E8 4273 4582 NM_003291 Hs.1117 1.00E−173 1tripeptidyl peptidase II (TPP2), mRNA/cds = (23 63G12 1114 2339 D49728Hs.1119 0 7 NAK1 mRNA for DNA binding protein, complete 45B10 1317 1857NM_002135 Hs.1119 0 1 nuclear receptor subfamily 4, group A, member 37H3568 783 M24069 Hs.1139 1.00E−119 1 DNA-binding protein A (dbpA) gene, 3′end 476F9 209 608 NM_000174 Hs.1144 0 1 glycoprotein IX (platelet)(GP9), mRNA/cds = ( 43A10 1105 1357 U15085 Hs.1162 3.00E−41 1 HLA-DMBmRNA, complete cds 139D6 1345 1680 L11329 Hs.1183 1.00E−102 1 proteintyrosine phosphatase (PAC-1) mRNA, co 134B12 1233 1675 NM_004418 Hs.11830 1 dual specificity phosphatase 2 (DUSP2), mRNA 58F1 17 341 NM_002157Hs.1197 0 1 heat shock 10 kD protein 1 (chaperonin 10) (HSP 158G5 20 341U07550 Hs.1197 1.00E−180 2 chaperonin 10 mRNA, complete cds 167C8 8131453 NM_000022 Hs.1217 0 4 adenosine deaminase (ADA), mRNA/cds =(95,1186 179H1 730 1452 X02994 Hs.1217 0 6 adenosine deaminase(adenosine aminohydrola 40E10 594 792 M38690 Hs.1244 1.00E−109 1 CD9antigen mRNA, complete cds 41C5 1280 1438 AK024951 Hs.1279 2.00E−80 1FLJ21298 fis, clone COL02040, highly sim 40E3 1002 1735 NM_000065Hs.1282 0 1 complement component 6 (C6) mRNA/cd 40A11 1638 1821 K02766Hs.1290 3.00E−98 1 complement component C9 mRNA, complete 40B12 46395215 NM_007289 Hs.1298 0 1 membrane metallo-endopeptidase (neutral end41G2 1576 1870 M28825 Hs.1309 1.00E−115 1 thymocyte antigen CD1a mRNA,complete cds 41F8 1171 1551 AX023365 Hs.1349 0 1 Sequence 36 from PatentWO0006605 40E1 673 1147 M30142 Hs.1369 0 1 decay-accelerating factormRNA, complete cds 118B12 1129 1719 NM_000574 Hs.1369 0 1 decayaccelerating factor for complement (CD5 75F8 830 2979 NM_000399 Hs.13950 48 early growth response 2 (Krox-20 (Drosophila) 41F11 973 1428 M15059Hs.1416 0 1 Fc-epsilon receptor (IgE receptor) mRNA, complete cd 110G121931 2071 AL031729 Hs.1422 2.00E−70 1 DNA seq RP1-159A19 on chromosome1p36 113D10 1718 2066 NM_005248 Hs.1422 6.00E−76 2 Gardner-Rasheedfeline sarcoma viral (v-fgr) 477C2 3292 3842 NM_000152 Hs.1437 0 1glucosidase, alpha; acid (Pompe disease, glyc 124D1 795 1127 NM_000167Hs.1466 0 1 glycerol kinase (GK), mRNA/cds = (66,1640)/gb 41B9 2231 2447J03171 Hs.1513 1.00E−108 1 interferon-alpha receptor (HuIFN-alpha-Rec)mRNA, 99F7 927 1889 NM_014882 Hs.1528 0 2 KIAA0053 gene product(KIAA0053), mRNA/cds = ( 469G9 1220 1507 NM_005082 Hs.1579 1.00E−117 1zinc finger protein 147 (estrogen-responsive 195B7 190 1801 BC002971Hs.1600 0 3 clone IMAGE: 3543711, mRNA, partial cds/cds = 195F10 36763856 NM_000110 Hs.1602 1.00E−85 1 dihydropyrimidine dehydrogenase(DPYD), mRN 129E7 648 1827 L08176 Hs.1652 0 2 Epstein-Barr virus inducedG-protein coupled recepto 478H5 1839 2050 NM_002056 Hs.1674 7.00E−79 1glutamine-fructose-6-phosphate transaminas 39H1 436 865 L35249 Hs.1697 01 vacuolar H+-ATPase Mr 56,000 subunit (HO57) mR 183H8 972 1183NM_001693 Hs.1697 1.00E−106 1 ATPase, H+ transporting, lysosomal(vacuolar 481A4 1594 1785 NM_001420 Hs.1701 2.00E−79 1 ELAV (embryoniclethal, abnormal vision, Dros 40B3 3846 4009 L39064 Hs.1702 4.00E−70 1interleukin 9 receptor precursor (IL9R) gene, 176G8 1033 1400 NM_006084Hs.1706 0 1 interferon-stimulated transcription factor 589C11 1 1347NM_005998 Hs.1708 0 2 chaperonin containing TCP1, subunit 3 (gamma) 70H51 494 X74801 Hs.1708 0 1 Cctg mRNA for chaperonin/cds = (0,1634)/gb =X7480 460C12 3310 3809 NM_012089 Hs.1710 0 1 ATP-binding cassette,sub-family B (MDR/TAP), 41D5 484 1862 M28983 Hs.1722 0 3 interleukin 1alpha (IL 1) mRNA, complete cds/ 119E8 493 904 NM_000575 Hs.17221.00E−151 2 interleukin 1, alpha (IL1A), mRNA/cds = (36,851 479E11 5 268NM_000417 Hs.1724 1.00E−145 1 interleukin 2 receptor, alpha (IL2RA),mRNA/ 62C8 85 1887 X01057 Hs.1724 0 2 interleukin-2 receptor/cds =(180,998)/gb = X 466A3 2166 2675 NM_000889 Hs.1741 0 1 integrin, beta 7(ITGB7), mRNA/cds = (151,2547) 107A4 4960 5610 L33075 Hs.1742 0 1 rasGTPase-activating-like protein (IQGAP1) 189A5 4318 7450 NM_003870Hs.1742 0 3 IQ motif containing GTPase activating protein 597D1 12301737 NM_005356 Hs.1765 1.00E−127 5 lymphocyte-specific protein tyrosinekinase 41C10 1057 1602 J04142 Hs.1799 0 1 (lambda-gt11ht-5) MHC class Iantigen-like gl 104H1 1854 2023 L06175 Hs.1845 4.00E−54 1 P5-1 mRNA,complete cds/cds = (304,735)/gb = L06 98F7 34 2041 NM_006674 Hs.18454.00E−63 5 MHC class I region ORF (P5-1),/cds = (304,735)/ 104F1 13901756 NM_002436 Hs.1861 0 2 membrane protein, palmitoylated 1 (55 kD)(MPP 171F7 1760 2192 M55284 Hs.1880 0 1 protein kinase C-L (PRKCL) mRNA,complete cds 134B2 123 1182 NM_002727 Hs.1908 0 10 proteoglycan 1,secretory granule (PRG1), mRN 61C11 126 902 X17042 Hs.1908 0 11hematopoetic proteoglycan core protein/cds 458G1 1 475 NM_001885 Hs.19400 1 crystallin, alpha B (CRYAB), mRNA 520E10 71 343 NM_001024 Hs.19481.00E−142 3 ribosomal protein S21 (RPS21), mRNA 459D6 2435 3055NM_001761 Hs.1973 0 1 cyclin F (CCNF), mRNA/cds = (43,2403) 41H3 1841620 NM_006139 Hs.1987 0 2 CD28 antigen (Tp44) (CD28), mRNA/cds =(222,884 71C5 721 1329 NM_000639 Hs.2007 0 2 tumor necrosis factor(ligand) superfamily, m 73C1 721 1603 X89102 Hs.2007 0 8 fasligand/cds =(157,1002) 135G3 940 1352 NM_002852 Hs.2050 6.00E−96 1 pentaxin-relatedgene, rapidly induced by IL 44A10 1562 1748 M58028 Hs.2055 7.00E−69 1ubiquitin-activating enzyme E1 (UBE1) mRNA, complete 155G5 973 2207AL133415 Hs.2064 0 7 DNA sequence from clone RP11-124N14 on chromosome10. 599H7 48 3022 AK025306 Hs.2083 0 12 cDNA: FLJ21653 fis, cloneCOL08586, 71H1 1598 2163 NM_004419 Hs.2128 0 5 dual specificityphosphatase 5 (DUSP5), mRNA 69H7 1595 2161 U15932 Hs.2128 0 11dual-specificity protein phosphatase mRNA, complete 458C4 1928 2356NM_005658 Hs.2134 0 1 TNF receptor-associated factor 1 (TRAF1), mRN192E11 6 414 NM_002704 Hs.2164 0 1 pro-platelet basic protein (includesplatele 40D12 1935 2645 M58597 Hs.2173 0 2 ELAM-1 ligandfucosyltransferase (ELFT) mRNA, comple 40E5 2834 3024 M59820 Hs.21751.00E−104 1 granulocyte colony-stimulating factor receptor (CSF 482D82521 2943 NM_000760 Hs.2175 0 2 colony stimulating factor 3 receptor(granuloc 60H6 918 1723 AF119850 Hs.2186 0 6 PRO1608 mRNA, completecds/cds = (1221,2174)/ 597F11 99 1267 NM_001404 Hs.2186 0 29 eukaryotictranslation elongation factor 1 g 595G4 6 570 L40410 Hs.2210 0 1 thyroidreceptor interactor (TRIP3) mRNA, 3′ 41H12 970 1353 X03656 Hs.2233 0 1granulocyte colony-stimulating factor (G-C 461A9 287 730 Z29067 Hs.22360 1 H. sapiens nek3 mRNA for protein kinase 493E11 212 608 NM_000879Hs.2247 1.00E−141 2 interleukin 5 (colony-stimulating factor, eo 150B5363 815 X04688 Hs.2247 0 1 T-cell replacing factor (interleukin-5)/cd461E12 255 342 NM_001565 Hs.2248 8.00E−34 1 small inducible cytokinesubfamily B (Cys-X-C 129A8 1790 1970 NM_002309 Hs.2250 2.00E−94 1leukemia inhibitory factor (cholinergic diff 40G10 2152 2560 X04481Hs.2253 0 1 complement component C2/cds = (36,2294)/gb = X 479A2 95 610NM_000073 Hs.2259 0 2 CD3G antigen, gamma polypeptide (TiT3 complex592G6 783 1163 NM_002950 Hs.2280 0 2 ribophorin I (RPN1), mRNA/cds =(137,1960)/gb 459G11 673 1316 NM_004931 Hs.2299 0 1 CD8 antigen, betapolypeptide 1 (p37) (CD8B1), 129B8 1159 1316 X13444 Hs.2299 1.00E−74 1CD8 beta-chain glycoprotein (CD8 beta. 1)/cd 467F12 2928 3239 NM_000346Hs.2316 3.00E−85 1 SRY (sex determining region Y)-box 9 (campomeli 44A61506 1629 U23028 Hs.2437 7.00E−62 1 eukaryotic initiation factor2B-epsilon mRNA, partia 127B8 1814 2405 NM_003816 Hs.2442 0 1 adisintegrin and metalloproteinase domain 9 36G6 1361 2019 D13645 Hs.24710 2 KIAA0020 gene, complete cds/cds = (418,1944) 458D6 396 961 NM_021966Hs.2484 0 1 T-cell leukemia/lymphoma 1A (TCL1A), mRNA/c 124G1 966 1473NM_005565 Hs.2488 0 1 lymphocyte cytosolic protein 2 (SH2 domain-con107A6 1962 2031 U20158 Hs.2488 2.00E−22 1 76 kDa tyrosine phosphoproteinSLP-76 mRNA, complete 592E12 2175 2458 NM_002741 Hs.2499 1.00E−158 1protein kinase C-like 1 (PRKCL1), mRNA/cds = (8 106A11 1455 2219 U34252Hs.2533 0 2 gamma-aminobutyraldehyde dehydrogenase mRNA, compl 40F8 22012694 NM_003032 Hs.2554 0 1 sialyltransferase 1 (beta-galactoside alpha-460G6 565 2052 NM_002094 Hs.2707 0 2 G1 to S phase transition 1 mRNA60G5 35 184 X92518 Hs.2726 7.00E−27 2 HMGI-C protein/cds = UNKNOWN461F10 1034 1520 NM_002145 Hs.2733 0 2 homeo box B2 (HOXB2), mRNA 69G2408 1369 AK026515 Hs.2795 0 4 FLJ22862 fis, clone KAT01966, highly sim71D8 13 541 NM_005566 Hs.2795 0 1 lactate dehydrogenase A (LDHA),mRNA/cds = (97 40H12 4119 4807 NM_002310 Hs.2798 0 1 leukemia inhibitoryfactor receptor (LIFR) mR 189C12 696 1287 NM_006196 Hs.2853 0 2poly(rC)-binding protein 1 (PCBP1), mRNA/cds 111E8 1298 1938 NM_003566Hs.2864 0 1 early endosome antigen 1, 162 kD (EEA1), mRNA/ 127F12 34 248NM_001033 Hs.2934 1.00E−109 1 ribonucleotide reductase M1 polypeptide(RRM 74G6 11 241 AK023088 Hs.2953 1.00E−128 38 FLJ13026 fis, cloneNT2RP3000968, modera 128D8 178 518 NM_000117 Hs.2985 1.00E−173 1 emerin(Emery-Dreifuss muscular dystrophy) ( 169G7 2406 3112 AL136593 Hs.3059 01 DKFZp761K102 (from clone DKFZp761K1 193A3 2405 3017 NM_016451 Hs.30590 5 coatomer protein complex, subunit beta (COPB) 53F12 486 1007 L11066Hs.3069 0 3 sequence/cds = UNKNOWN/gb = L11066/gi = 307322/u 71E8 16232131 NM_004134 Hs.3069 0 2 heat shock 70 kD protein 9B (mortalin-2)(HSPA9 458A5 2236 2874 NM_014877 Hs.3085 0 1 KIAA0054 gene product;Helicase (KIAA0054), m 69E8 1752 1916 D31884 Hs.3094 7.00E−68 1 KIAA0063gene, complete cds/cds = (279,887)/ 66B3 251 1590 D32053 Hs.3100 0 2 forLysyl tRNA Synthetase, complete cds/ 458E1 1645 1964 NM_001666 Hs.31091.00E−178 1 Rho GTPase activating protein 4 (ARHGAP4), mRN 331D8 28823585 U26710 Hs.3144 0 1 cbl-b mRNA, complete cds/cds = (322,3270)/ gb =U26710 73D9 1 613 AL031736 Hs.3195 0 18 DNA sequence clone 738P11 onchromosome 1q24.1-2 58B1 1 607 NM_002995 Hs.3195 0 17 small induciblecytokine subfamily C, member 98F11 145 588 NM_003172 Hs.3196 0 1 surfeit1 (SURF1), mRNA/cds = (14,916)/gb = NM_(—) 124E9 1258 2414 NM_007318Hs.3260 0 2 presenilin 1 (Alzheimer disease 3) (PSEN1), tr 64G7 10401569 NM_002155 Hs.3268 0 1 heat shock 70 kD protein 6 (HSP70B') (HSPA6),mR 36D4 1116 1917 X51757 Hs.3268 0 4 heat-shock protein HSP70B' gene/cds= (0,1931)/ gb = X5 39H11 1 507 BE895166 Hs.3297 1.00E−152 4 601436095F1cDNA, 5′ end/clone = IMAGE: 3921239 103G4 16 540 NM_002954 Hs.3297 0 4ribosomal protein S27a (RPS27A), mRNA/cds = (3 127H7 1391 1806 AB037752Hs.3355 0 1 mRNA for KIAA1331 protein, partial cds/cds = (0 107D3 19322517 AK027064 Hs.3382 0 1 FLJ23411 fis, clone HEP20452, highly sim 121B31270 3667 NM_005134 Hs.3382 0 4 protein phosphatase 4, regulatorysubunit 1 ( 58H1 104 573 NM_001122 Hs.3416 0 6 adiposedifferentiation-related protein (AD 75G1 104 1314 X97324 Hs.3416 0 16adipophilin/cds = (0,1313)/gb = X97324/ 182A4 147 334 NM_001867 Hs.34621.00E−102 1 cytochrome c oxidase subunit VIIc (COX7C), mRN 134D7 36 270NM_001025 Hs.3463 1.00E−127 3 ribosomal protein S23 (RPS23), mRNA/cds =(13,4 192B10 129 1135 AL357536 Hs.3576 0 3 mRNA full length insert cDNAclone EUROIMAGE 37 112G12 56 687 NM_003001 Hs.3577 0 1 succinatedehydrogenase complex, subunit C, 526H6 143 537 BF666961 Hs.3585 0 1602121608F1 cDNA, 5′ end/clone = IMAGE: 4278768 599F10 2098 2351NM_004834 Hs.3628 1.00E−118 2 mitogen-activated protein kinase kinasekina 594F1 239 1321 NM_001551 Hs.3631 0 4 immunoglobulin (CD79A) bindingprotein 1 (IG 463E7 911 1033 AL359940 Hs.3640 1.00E−63 1 mRNA; cDNADKFZp762P1915 (from clone DKFZp762P 182A9 657 1179 AL050268 Hs.3642 0 2mRNA; cDNA DKFZp564B163 (from clone DKFZp564B1 38B4 257 568 AB034205Hs.3688 1.00E−151 3 for cisplatin resistance-associated ove 185H6 769995 NM_006003 Hs.3712 2.00E−88 1 ubiquinol-cytochrome c reductase,Rieske iro 587A1 716 1609 NM_006007 Hs.3776 0 2 zinc finger protein 216(ZNF216), mRNA/cds = (2 473B5 46 531 NM_021633 Hs.3826 0 1 kelch-likeprotein C3IP1 (C3IP1), mRNA/cds = ( 194G5 2456 2984 AB002366 Hs.3852 0 1mRNA for KIAA0368 gene, partial cds/cds = (0,4327)/ gb 589B4 526 1337NM_000310 Hs.3873 0 3 palmitoyl-protein thioesterase 1 (ceroid-lip515A10 1618 2130 NM_002267 Hs.3886 0 1 karyopherin alpha 3 (importinalpha 4) (KPNA3) 186A8 1160 1632 NM_002807 Hs.3887 0 1 proteasome(prosome, macropain) 26S subunit, 102F7 4226 4531 AB023163 Hs.40141.00E−158 1 for KIAA0946 protein, partial cds/cds = (0 50B8 1 166AL117595 Hs.4055 3.00E−89 2 cDNA DKFZp564C2063 (from clone DKFZp564473A10 1064 1709 NM_006582 Hs.4069 0 1 glucocorticoid modulatory elementbinding pr 524A12 2863 3386 AL136105 Hs.4082 0 1 DNA sequence from cloneRP4-670F13 on chromosome 1q42 525E1 521 974 BC002435 Hs.4096 0 1 cloneIMAGE: 3346451, mRNA, partial cds/cds = t-complex 163G12 1130 1630X52882 Hs.4112 0 6 polypeptide 1 gene/cds = (21,1691)/ gb = X528 176A7515 892 BC000687 Hs.4147 0 1 translocating chain-associating membrane p185B5 3480 3707 AB023216 Hs.4278 1.00E−86 1 mRNA for KIAA0999 protein,partial cds/cds = (0 154E12 1731 2531 AF079566 Hs.4311 0 2ubiquitin-like protein activating enzyme (UB 331C9 1595 1966 AF067008Hs.4747 0 1 dyskerin (DKC1) mRNA, complete cds/cds = (60,16 182C8 16761966 NM_001363 Hs.4747 1.00E−148 2 dyskeratosis congenita 1, dyskerin(DKC1), mR 178C4 1623 2162 AL136610 Hs.4750 0 3 mRNA; cDNA DKFZp564K0822(from clone DKFZp564K 107F9 3857 4266 AB032976 Hs.4779 0 1 for KIAA1150protein, partial cds/cds = (0 191C11 1945 2618 AF240468 Hs.4788 0 3nicastrin mRNA, complete cds/cds = (142,2271) 143G11 869 2076 AK022974Hs.4859 0 2 FLJ12912 fis, clone NT2RP2004476, highly 127H11 977 1666NM_020307 Hs.4859 0 1 cyclin L ania-6a (LOC57018), mRNA/cds = (54,163479A11 215 544 AK001942 Hs.4863 1.00E−173 1 cDNA FLJ11080 fis, clonePLACE1005181/cds = UN 73C5 2314 2851 AF105366 Hs.4876 0 1 K-CIcotransporter KCC3a mRNA, alternatively 525F9 1059 1764 NM_006513Hs.4888 0 3 seryl-tRNA synthetase (SARS), mRNA/cds = (75,1 114D8 9311061 Z24724 Hs.4934 4.00E−52 1 H. sapiens polyA site DNA/cds = UNKNOWN/gb = Z24724/gi = 50503 587C10 1104 1343 NM_006787 Hs.4943 3.00E−94 1hepatocellular carcinoma associated protein; 174F12 1749 2291 NM_018107Hs.4997 0 3 hypothetical protein FLJ10482 (FLJ10482), mR 514C11 899 1489AK021776 Hs.5019 0 1 cDNA FLJ11714 fis, clone HEMBA1005219, weakly 126H925 397 BE379724 Hs.5027 1.00E−118 1 601159415T1 cDNA, 3′ end/clone =IMAGE: 3511107 599B5 801 970 NM_017840 Hs.5080 5.00E−73 1 hypotheticalprotein FLJ20484 (FLJ20484), mR 47E5 4 720 AL034553 Hs.5085 0 2 DNAsequence from clone 914P20 on chromosome 20q13.13 122C11 492 860NM_003859 Hs.5085 0 1 dolichyl-phosphate mannosyltransferase pol 116H61644 2902 NM_014868 Hs.5094 1.00E−102 2 ring finger protein 10 (RNF10),mRNA/cds = (698, 187G7 700 1268 NM_004710 Hs.5097 0 1 synaptogyrin 2(SYNGR2), mRNA/cds = (29,703)/ 174G3 240 500 NM_003746 Hs.5120 1.00E−1444 dynein, cytoplasmic, light polypeptide (PIN) 145B6 199 695 BE539096Hs.5122 1.00E−165 2 601061641F1 cDNA, 5′ end/clone = IMAGE: 3447850486C1 1 529 BG028906 Hs.5122 0 2 602293015F1 cDNA, 5′ end/clone = IMAGE:4387778 69F6 62 455 BF307213 Hs.5174 0 1 601891365F1 cDNA, 5′ end/clone= IMAGE: 4136752 583F4 82 477 NM_001021 Hs.5174 0 1 ribosomal proteinS17 (RPS17), mRNA/cds = (25,4 74C4 1955 2373 AK025367 Hs.5181 1.00E−1791 FLJ21714 fis, clone COL10256, highly sim 73E12 702 987 AL109840Hs.5184 1.00E−161 1 DNA sequence from clone RP4-543J19 on chromosome 20C 180G4 26 639 NM_002212 Hs.5215 0 2 integrin beta 4 binding protein(ITGB4BP), mRN 98F1 17 636 NM_014165 Hs.5232 0 5 HSPC125 protein(HSPC125), mRNA/cds = (79,606) 525A8 479 992 NM_006698 Hs.5300 0 1bladder cancer associated protein (BLCAP), mR 99C1 19 507 NM_003333Hs.5308 0 3 ubiquitin A-52 residue ribosomal protein fusi 172D11 7141805 NM_005721 Hs.5321 0 3 ARP3 (actin-related protein 3, yeast) homolog591F6 475 970 NM_015702 Hs.5324 0 1 hypothetical protein (CL25022),mRNA/cds = (1 68H8 724 1190 NM_014106 Hs.5327 0 2 PRO1914 protein(PRO1914), mRNA/cds = (1222,14 194D12 2128 2499 AB018305 Hs.5378 0 1mRNA for KIAA0762 protein, partial cds/cds = (0 501G11 823 1322NM_020122 Hs.5392 0 3 potassium channel modulatory factor (DKFZP434 74B4502 1257 AF008442 Hs.5409 0 7 RNA polymerase I subunit hRPA39 mRNA,complete 134H7 543 916 NM_004875 Hs.5409 0 1 RNA polymerase I subunit(RPA40), mRNA/cds = (2 168A3 1909 2379 AF090891 Hs.5437 0 1 clone HQ0105PRO0105 mRNA, complete cds/cds = ( 145C10 2375 2564 AF016270 Hs.54641.00E−104 2 thyroid hormone receptor coactivating protein 587H7 18572563 NM_006696 Hs.5464 0 4 thyroid hormone receptor coactivating protein183D10 1199 1347 NM_006495 Hs.5509 9.00E−40 1 ecotropic viralintegration site 2B (EVI2B), m 181D7 1385 1752 AK002173 Hs.5518 0 1 cDNAFLJ11311 fis, clone PLACE1010102/cds = UNK 173B1 1 642 NM_003315 Hs.55420 2 tetratricopeptide repeat domain 2 (TTC2), mRN 120F8 1782 2430AF157323 Hs.5548 0 2 p45SKP2-like protein mRNA, complete cds/cds =ribosomal 464H2 46 357 NM_000998 Hs.5566 1.00E−163 2 protein L37a(RPL37A), mRNA/cds = (1 75F5 1252 2194 AK027192 Hs.5615 0 9 FLJ23539fis, clone LNG08101, highly sim 56E8 27 205 AI570531 Hs.5637 2.00E−95 1tm77g04.x1 cDNA, 3′ end/clone = IMAGE: 2164182 524G2 2 926 NM_006098Hs.5662 0 9 guanine nucleotide binding protein (G protein 39F6 2311 2902AB014579 Hs.5734 0 1 for KIAA0679 protein, partial cds/cds = (0 587G22883 4606 NM_012215 Hs.5734 0 11 meningioma expressed antigen 5(hyaluronidase 469E5 5041 5393 NM_014864 Hs.5737 3.00E−75 2 KIAA0475gene product (KIAA0475), mRNA/cds = ( 120H3 1022 1553 NM_016230 Hs.57410 1 flavohemoprotein b5+b5R (LOC51167), mRNA/cd 63H8 1049 1507 AK025729Hs.5798 0 1 FLJ22076 fis, clone HEP12479, highly sim 590D9 1015 1470NM_015946 Hs.5798 0 1 pelota (Drosophila) homolog (PELO), mRNA/cds 102E3665 1027 AK000474 Hs.5811 0 1 FLJ20467 fis, clone KAT06638/cds = (360,77187E5 665 1028 NM_017835 Hs.5811 0 1 chromosome 21 open reading frame 59(C21ORF59), 39F9 1402 1728 AK025773 Hs.5822 0 3 FLJ22120 fis, cloneHEP18874/cds = UNKNOW 39E12 1064 1843 AF208844 Hs.5862 0 1 BM-002 mRNA,complete cds/cds = (39,296)/gb = A 173H9 906 1684 NM_016090 Hs.5887 0 2RNA binding motif protein 7 (LOC51120), mRNA/ 120E8 1702 2055 NM_012179Hs.5912 1.00E−146 1 F-box only protein 7 (FBXO7), mRNA/cds = (205,17195D1 1309 2656 AK025620 Hs.5985 0 8 cDNA: FLJ21967 fis, clone HEP05652,highly sim 116A6 1451 2073 AK024941 Hs.6019 0 1 cDNA: FLJ21288 fis,clone COL01927/cds = UNKNOW 113F9 1232 1598 NM_002896 Hs.6106 1.00E−1261 RNA binding motif protein 4 (RBM4), mRNA/cds = ( 520H1 563 1007NM_018285 Hs.6118 0 2 hypothetical protein FLJ10968 (FLJ10968), mR180H12 5224 5568 AF315591 Hs.6151 1.00E−135 1 Pumilio 2 (PUMH2) mRNA,complete cds/cds = (23,3 185A7 612 1558 NM_016001 Hs.6153 0 6 CGI-48protein (LOC51096), mRNA/cds = (107,167 595G2 3207 4752 Z97056 Hs.6179 010 DNA seq from clone RP3-434P1 on chromosome 22 592B11 234 4611AI745230 Hs.6187 1.00E−130 6 wg10e05.x1 cDNA, 3′ end/clone = IMAGE:2364704 590F2 994 1625 NM_004517 Hs.6196 0 3 integrin-linked kinase(ILK), mRNA/cds = (156, 188A3 1550 2929 M61906 Hs.6241 0 3 P13-kinaseassociated p85 mRNA sequence 103C12 502 1129 AF246238 Hs.6289 0 1 HT027mRNA, complete cds/cds = (260,784)/gb = A 100C2 804 1111 AK024539Hs.6289 1.00E−122 1 FLJ20886 fis, clone ADKA03257/cds = (359, 480A111149 1242 AB032977 Hs.6298 1.00E−46 1 mRNA for KIAA1151 protein, partialcds/cds = (0 473C8 3944 4149 NM_014859 Hs.6336 1.00E−106 1 KIAA0672 geneproduct (KIAA0672), mRNA/cds = ( 125A10 1293 1766 NM_006791 Hs.6353 0 1MORF-related gene 15 (MRG15), mRNA/cds = (131,1 182F5 143 2118 NM_018471Hs.6375 0 3 uncharacterized hypothalamus protein HT010 587E8 398 2287NM_016289 Hs.6406 0 7 MO25 protein (LOC51719), mRNA/cds = (53,1078)135C3 2519 3084 AF130110 Hs.6456 0 2 clone FLB6303 PRO1633 mRNA,complete cds/cds = DNA 178B5 1744 2425 AL117352 Hs.6523 0 2 seq fromclone RP5-876B10 on chromosome 1q42 522F10 2392 2591 NM_001183 Hs.65511.00E−110 2 ATPase, H+ transporting, lysosomal (vacuolar 595C4 1676 2197NM_021008 Hs.6574 0 4 suppressin (nuclear deformed epidermal autor 481F3745 904 AL117565 Hs.6607 9.00E−82 1 mRNA; cDNA DKFZp566F164 (from cloneDKFZp566F1 124A3 1046 1575 NM_017792 Hs.6631 0 1 hypothetical proteinFLJ20373 (FLJ20373), mR 177F11 1966 2281 AB046844 Hs.6639 1.00E−152 1for KIAA1624 protein, partial cds/cds = (0 521G7 4600 5210 NM_014856Hs.6684 0 2 KIAA0476 gene product (KIAA0476), mRNA/cds = ( 54C6 265 756AB037801 Hs.6685 0 1 for KIAA1380 protein, partial cds/cds = (0 75F7 953507 AB014560 Hs.6727 0 4 for KIAA0660 protein, complete cds/cds = (477H12 2 457 BF976590 Hs.6749 0 1 602244267F1 cDNA, 5′ end/clone =IMAGE: 4335353 60A1 1028 1307 AB026908 Hs.6790 1.00E−155 1 formicrovascular endothelial differenti 100G9 341 454 BE875609 Hs.68202.00E−58 1 601487048F1 cDNA, 5′ end/clone = IMAGE: 3889762 184F7 12591633 AF056717 Hs.6856 0 5 ash2l2 (ASH2L2) mRNA, complete cds/cds =(295,1 195E7 1250 1711 NM_004674 Hs.6856 0 3 ash2 (absent, small, orhomeotic, Drosophila, 135F11 328 600 NM_020188 Hs.6879 1.00E−151 1 DC13protein (DC13), mRNA/cds = (175,414)/gb = DKFZP434D156 172G2 1477 1782NM_015530 Hs.6880 1.00E−169 1 protein (DKFZP434D156), mRNA/c 483G5 37123947 AL031681 Hs.6891 3.00E−72 1 DNA sequence from clone 862K6 onchromosome 20q12-13.1 184B1 1 622 AF006086 Hs.6895 0 3 Arp2/3 proteincomplex subunit p21-Arc (ARC21 599C12 1 622 NM_005719 Hs.6895 0 24 actinrelated protein 2/3 complex, subunit 3 ( 43A1 2111 2312 AF037204 Hs.69009.00E−78 1 RING zinc finger protein (RZF) mRNA, complete c 105F6 6381209 AK026850 Hs.6906 0 1 FLJ23197 fis, clone REC00917/cds = UNKNOW178G10 5939 6469 AJ238403 Hs.6947 0 1 mRNA for huntingtin interactingprotein 1/cd 72A2 178 2992 AF001542 Hs.6975 0 9 AF001542/clone =alpha_est218/52C1/gb = FLJ12506 37F2 1757 2397 AK022568 Hs.7010 0 1 fis,clone NT2RM2001700, weakly 598D3 1153 1299 NM_004637 Hs.7016 8.00E−56 1RAB7, member RAS oncogene family (RAB7), mRNA 524C11 5542 5678 AB033034Hs.7041 3.00E−72 1 mRNA for KIAA1208 protein, partial cds/cds = (2109E10 452 1093 AF104921 Hs.7043 0 1 succinyl-CoA synthetase alphasubunit (SUCLA1 595F7 449 1150 NM_003849 Hs.7043 0 2 succinate-CoAligase, GDP-forming, alpha sub 104H2 644 992 NM_020194 Hs.7045 1.00E−1561 GL004 protein (GL004), mRNA/cds = (72,728)/gb 155C1 3322 3779 AK024478Hs.7049 0 2 FLJ00071 protein, partial cds/cds = (3 473B1 3029 3439AB051492 Hs.7076 1.00E−152 1 mRNA for KIAA1705 protein, partial cds/cds= (1 125E3 3612 3948 AL390127 Hs.7104 0 1 mRNA; cDNA DKFZp761P06121(from clone DKFZp761 499B11 1451 1852 NM_021188 Hs.7137 0 2 clones 23667and 23775 zinc finger protein (LOC 52B12 1850 2178 U90919 Hs.71371.00E−174 1 clones 23667 and 23775 zinc finger protein mRNA, compl486A11 855 1186 NM_003904 Hs.7165 1.00E−132 1 zinc finger protein 259(ZNF259), mRNA/cds = (2 460B6 2514 3182 NM_021931 Hs.7174 0 1hypothetical protein FLJ22759 (FLJ22759), mR 592H8 3999 4524 AB051544Hs.7187 0 2 mRNA for KIAA1757 protein, partial cds/cds = (3 180A10 102468 AL117502 Hs.7200 1.00E−141 3 mRNA; cDNA DKFZp434D0935 (from cloneDKFZp434 127A12 1503 2688 AL035661 Hs.7218 0 2 DNA sequence from cloneRP4-568C11 on chromosome 20p1 592G9 12 263 NM_015953 Hs.7236 1.00E−138 2CGI-25 protein (LOC51070), mRNA/cds = (44,949) 127E3 2624 4554 AB028980Hs.7243 0 3 mRNA for KIAA1057 protein, partial cds/cds = (0 135F2 50295175 AB033050 Hs.7252 3.00E−78 1 mRNA for KIAA1224 protein, partialcds/cds = (0 57G1 2299 2723 NM_014319 Hs.7256 0 1 integral inner nuclearmembrane protein (MAN1 122D11 2920 3123 AB014558 Hs.7278 5.00E−74 1 mRNAfor KIAA0658 protein, partial cds/cds = (0 471H6 1 449 AV702692 Hs.73120 1 AV702692 cDNA 5′ end/clone = ADBBQC12/clone_(—) 104G12 4314 4797AF084555 Hs.7351 0 2 okadaic acid-inducible and cAMP-regulated ph 590G7771 1259 NM_005662 Hs.7381 0 5 voltage-dependent anion channel 3(VDAC3), mR 159H2 355 1252 AL137423 Hs.7392 0 3 mRNA; cDNA DKFZp761E0323(from clone DKFZp761E 161F3 1708 2371 NM_024045 Hs.7392 0 1 hypotheticalprotein MGC3199 (MGC3199), mRNA 195E1 1107 1362 NM_022736 Hs.75031.00E−129 1 hypothetical protein FLJ14153 (FLJ14153), mR 137F5 59 666NM_018491 Hs.7535 0 2 COBW-like protein (LOC55871), mRNA/cds = (64,9597E1 2302 2893 AF126028 Hs.7540 0 2 unknown mRNA/cds = (0,1261)/gb =AF126028/gi = cDNA: 473B6 3006 3302 AK025615 Hs.7567 1.00E−158 1FLJ21962 fis, clone HEP05564/cds = UNKNOW 519H1 232 720 BG112505 Hs.75890 2 602282107F1 cDNA, 5′ end/clone = IMAGE: 4369729 73A9 106 3912 M20681Hs.7594 0 8 glucose transporter-like protein-III (GLUT3), compl 51D3 1063200 NM_006931 Hs.7594 0 2 solute carrier family 2 (facilitated glucoset 596E8 1512 1748 M94046 Hs.7647 1.00E−129 2 zinc finger protein (MAZ)mRNA/cds = UNKNOWN/ gb = M9404 472A8 1575 1983 NM_004576 Hs.7688 0 1protein phosphatase 2 (formerly 2A), regulator 191A10 386 889 NM_007278Hs.7719 0 3 GABA(A) receptor-associated protein (GABARAP 459C4 5636 5897AB002323 Hs.7720 2.00E−87 1 mRNA for KIAA0325 gene, partial cds/cds =(0,6265)/ gb 99A12 606 1253 NM_018453 Hs.7731 0 1 uncharacterized bonemarrow protein BM036 (BM 72G8 5806 6409 AB007938 Hs.7764 0 5 forKIAA0469 protein, complete cds/cds = ( 45G2 6168 6404 NM_014851 Hs.77641.00E−132 1 KIAA0469 gene product (KIAA0469), mRNA/cds = ( 172A4 371 588NM_007273 Hs.7771 1.00E−107 1 B-cell associated protein (REA), mRNA/cds= (9 177B8 2055 2431 AK023166 Hs.7797 0 1 FLJ13104 fis, cloneNT2RP3002343/cds = (28 99B6 865 1244 NM_012461 Hs.7797 0 1 TERF1(TRF1)-interacting nuclear factor 2 (T 160G8 727 860 U94855 Hs.78115.00E−66 1 translation initiation factor 3 47 kDa subunit 54G6 1 1007AK001319 Hs.7837 1.00E−148 3 FLJ10457 fis, clone NT2RP1001424/cds = UN594A7 1295 1793 NM_013446 Hs.7838 0 4 makorin, ring finger protein, 1(MKRN1), mRNA 188A12 1 2013 NM_017761 Hs.7862 0 3 hypothetical proteinFLJ20312 (FLJ20312), mR 594A2 3060 3588 AK023813 Hs.7871 0 2 cDNAFLJ13751 fis, clone PLACE3000339, weakly 124C12 472 1251 NM_001550Hs.7879 0 1 interferon-related developmental regulator 147A8 1381 1711Y10313 Hs.7879 1.00E−134 1 for PC4 protein (IFRD1 gene)/cds = (219,15874H3 4430 4978 AF302505 Hs.7886 0 2 pellino 1 (PELI1) mRNA, completecds/cds = (4038 71G3 473 1112 NM_016224 Hs.7905 0 2 SH3 and PXdomain-containing protein SH3PX1 (S 52C7 1637 2231 AB029551 Hs.7910 0 1YEAF1 mRNA for YY1 and E4TF1 associated factor 177H5 5411 6045 AB002321Hs.7911 0 1 KIAA0323 gene, partial cds/cds = (0,2175)/gb 114C8 1678 3078NM_017657 Hs.7942 1.00E−149 2 hypothetical protein FLJ20080 (FLJ20080),mR 169D8 1453 2158 AK001437 Hs.7943 0 1 FLJ10575 fis, cloneNT2RP2003295, highly 599G8 618 1204 NM_003796 Hs.7943 0 1 RPB5-mediatingprotein (RMP), mRNA/cds = (465, 127E11 107 796 NM_016099 Hs.7953 0 3HSPC041 protein (LOC51125), mRNA/cds = (141,45 98D6 4769 6506 NM_001111Hs.7957 0 20 adenosine deaminase, RNA-specific (ADAR), tr 37H10 24796594 X79448 Hs.7957 0 8 IFI-4 mRNA for type I protein/cds =(1165,3960)/g 178G4 4209 5132 AB028981 Hs.8021 0 4 mRNA for KIAA1058protein, partial cds/cds = (0 118E9 630 1688 NM_006083 Hs.8024 0 2 IKcytokine, down-regulator of HLA II (IK), mRN 171A8 1658 1973 AK002026Hs.8033 1.00E−151 1 FLJ11164 fis, clone PLACE1007226, weakly 103G5 15041977 NM_018346 Hs.8033 0 1 hypothetical protein FLJ11164 (FLJ11164), mR179G7 2860 3032 AK022497 Hs.8068 6.00E−46 1 FLJ12435 fis, cloneNT2RM1000059/cds = (88 594A11 2327 2658 NM_018210 Hs.8083 1.00E−167 1hypothetical protein FLJ10769 (FLJ10769), mR 103B5 1968 2448 AF267856Hs.8084 0 1 HT033 mRNA, complete cds/cds = (203,931)/gb = A 98E4 13671808 AF113008 Hs.8102 0 7 clone FLB0708 mRNA sequence/cds = UNKNOWN/ gb= erbb2-interacting 191H10 4581 5819 NM_018695 Hs.8117 0 3 protein ERBIN(LOC55914), 99F1 550 2672 AB014550 Hs.8118 0 4 mRNA for KIAA0650protein, partial cds/cds = (0 165H11 488 663 NM_024408 Hs.8121 3.00E−931 Notch (Drosophila) homolog 2 (NOTCH2), mRNA/ 515C7 2188 2514 AL050371Hs.8128 1.00E−114 1 mRNA; cDNA DKFZp566G2246 (from clone DKFZp566G166A12 234 1196 AF131856 Hs.8148 1.00E−155 2 clone 24856 mRNA sequence,complete cds/cds = ( 520H8 512 712 NM_016275 Hs.8148 1.00E−110 1selenoprotein T (LOC51714), mRNA/cds = (138,62 592D4 1 735 NM_014886Hs.8170 1.00E−152 3 hypothetical protein (YR-29), mRNA/cds = (82,8105F12 349 760 AK001665 Hs.8173 0 1 FLJ10803 fis, clone NT2RP4000833/cds= (1 75A7 737 1458 AF000652 Hs.8180 0 1 syntenin (sycl) mRNA, completecds/cds = (148,1 64H5 105 618 NM_005625 Hs.8180 0 3 syndecan bindingprotein (syntenin) (SDCBP), 61G9 3147 3660 AB018339 Hs.8182 0 2 forKIAA0796 protein, partial cds/cds = (0 39G2 255 1675 AF042284 Hs.8185 04 unknown mRNA/cds = (76,1428)/gb = AF042284/gi 192G5 1054 1580NM_021199 Hs.8185 0 8 CGI-44 protein; sulfide dehydrogenase like (y109D3 1463 2503 AF269150 Hs.8203 0 2 transmembrane protein TM9SF3(TM9SF3) mRNA, c 115H4 1251 3187 NM_020123 Hs.8203 0 12 endomembraneprotein emp70 precursor isolog ( 113F12 2349 3576 AL355476 Hs.82174.00E−35 2 DNA sequence from clone RP11-517O1 on chromosome X Co 125D5582 1050 NM_005006 Hs.8248 0 1 NADH dehydrogenase (ubiquinone) Fe-Sprotein 460D3 4851 5043 AF035947 Hs.8257 7.00E−76 1 cytokine-inducibleinhibitor of signalling t 111E7 729 3182 NM_013995 Hs.8262 0 2lysosomal-associated membrane protein 2 (LAM 590F10 3012 4133 AK022790Hs.8309 0 6 cDNA FLJ12728 fis, clone NT2RP2000040, highly 109B1 138 476AW973507 Hs.8360 1.00E−161 1 EST385607/gb = AW973507/gi = 8164686/ug =for 61A3 1137 1649 AB033017 Hs.8594 0 1 KIAA1191 protein, partialcds/cds = (0 523E12 905 2998 NM_007271 Hs.8724 0 4 serine threonineprotein kinase (NDR), mRNA/ 590G2 3618 3932 NM_018031 Hs.8737 1.00E−1663 WD repeat domain 6 (WDR6), mRNA/cds = (39,3404) 464C3 2299 2494NM_018255 Hs.8739 1.00E−107 1 hypothetical protein FLJ10879 (FLJ10879),mR 128H8 1580 1711 NM_018450 Hs.8740 2.00E−64 1 uncharacterized bonemarrow protein BM029 (BM 179D3 921 1457 AF083255 Hs.8765 0 1 RNAhelicase-related protein complete c 195H11 1247 1481 NM_007269 Hs.88131.00E−100 1 syntaxin binding protein 3 (STXBP3), mRNA/cds 460F1 68 308AA454036 Hs.8832 1.00E−105 1 zx48b04.r1 cDNA, 5′ end/clone = IMAGE:795439/ 110E10 3672 5371 AB032252 Hs.8858 0 3 BAZ1A mRNA for bromodomainadjacent to zinc fi 113D1 4814 5890 NM_013448 Hs.8858 0 2 bromodomainadjacent to zinc finger domain, 1A 120H7 373 633 NM_017748 Hs.89281.00E−143 1 hypothetical protein FLJ20291 (FLJ20291), mR 470F10 16702260 NM_003917 Hs.8991 0 2 adaptor-related protein complex 1, gamma 2 su72H11 1785 2418 M11717 Hs.8997 1.00E−147 23 heat shock protein (hsp 70)gene, complete cds/ cds = (2 49H4 1769 2243 NM_005345 Hs.8997 1.00E−14512 heat shock 70 kD protein 1A (HSPA1A), mRNA/cds = VAMP 519E7 270 729NM_003574 Hs.9006 0 1 (vesicle-associated membrane protein)-a 142E2 12651518 AK022215 Hs.9043 1.00E−107 1 FLJ12153 fis, clone MAMMA1000458/cds =UNK 108B9 1160 1823 AJ002030 Hs.9071 0 1 for putative progesteronebinding protein 47C7 452 795 AB011420 Hs.9075 0 1 for DRAK1, completecds/cds = (117,1361)/ 590A4 791 1377 NM_004760 Hs.9075 0 4serine/threonine kinase 17a (apoptosis-induc 168D11 1000 1641 NM_017426Hs.9082 0 1 nucleoporin p54 (NUP54), mRNA/cds = (25,1542) 63H9 799 1163Y17829 Hs.9192 0 1 for Homer-related protein Syn47/cds = (75, 167B111466 1863 NM_006251 Hs.9247 0 1 protein kinase, AMP-activated, alpha 1cataly 196D5 1021 1492 AK024327 Hs.9343 0 1 cDNA FLJ14265 fis, clonePLACE1002256/cds = UNK 192F3 245 790 NM_017983 Hs.9398 0 1 hypotheticalprotein FLJ10055 (FLJ10055), mR 121C3 3381 3567 AF217190 Hs.94143.00E−90 1 MLEL1 protein (MLEL1) mRNA, complete cds/cds = SWI/SNF 196B6959 1551 NM_003601 Hs.9456 0 1 related, matrix associated, actin dep331B5 2624 2950 AF027302 Hs.9573 1.00E−179 1 TNF-alpha stimulated ABCprotein (ABC50) mRNA 592E11 1 479 NM_002520 Hs.9614 1.00E−139 7nucleophosmin (nucleolar phosphoprotein B23 515D6 1739 2091 AB037796Hs.9663 1.00E−160 1 mRNA for KIAA1375 protein, partial cds/cds = (0124A5 1387 1762 NM_012068 Hs.9754 0 2 activating transcription factor 5(ATF5), mRN 122A7 1484 1928 AB028963 Hs. 9846 1.00E−154 1 mRNA forKIAA1040 protein, partial cds/cds = (0 591E2 1626 2194 AF123073 Hs. 98510 5 C/EBP-induced protein mRNA, complete cds/cds 111G2 4208 5361AB033076 Hs. 9873 0 2 mRNA for KIAA1250 protein, partial cds/cds = (0469D5 932 3551 AK022758 Hs. 9908 1.00E−178 6 cDNA FLJ12696 fis, cloneNT2RP1000513, highly 590D5 172 742 NM_001425 Hs. 9999 2.00E−94 2epithelial membrane protein 3 (EMP3), mRNA/c 112E7 1065 1753 NM_001814Hs. 10029 0 1 cathepsin C (CTSC), mRNA/cds = (33,1424)/gb = N 106C7 10661641 X87212 Hs. 10029 0 1 cathepsin C/cds = (33,1424)/gb = X87212/ 127B11003 1429 NM_014959 Hs. 10031 0 1 KIAA0955 protein (KIAA0955), mRNA/cds= (313,1 462E5 332 487 AW293461 Hs. 10041 3.00E−46 1UI-H-BI2-ahm-e-02-0-UI.s1 cDNA, 3′ end/clon 190E3 101 356 NM_016551 Hs.10071 6.00E−98 1 seven transmembrane protein TM7SF3 (TM7SF3), 61B6 25712764 AL163249 Hs. 10175 7.00E−94 1 chromosome 21 segment HS21C049/cds =(128,2599 110F6 5310 5808 D87432 Hs. 10315 0 1 KIAA0245 gene, completecds/cds = (261,1808) 196E10 5312 5753 NM_003983 Hs. 10315 0 1 solutecarrier family 7 (cationic amino acid t 49D8 315 2207 AK024597 Hs. 103620 3 cDNA: FLJ20944 fis, clone ADSE01780/cds = UNKNO 129C7 1000 1364AB018249 Hs. 10458 0 1 CC chemokine LEC, complete cds/cds = (1 62F111239 2034 AL031685 Hs. 10590 0 2 DNA sequence from clone RP5-963K23 onchromosome 20q1 460D5 86 815 AL357374 Hs. 10600 0 4 DNA sequence fromclone RP11-353C18 on chromosome 20 179C12 3765 4300 AK000005 Hs. 10647 02 FLJ00005 protein, partial cds/cds = (0 482D12 1753 2359 NM_004848 Hs.10649 0 1 basement membrane-induced gene (ICB-1), mRNA 184F4 2686 3194AL137721 Hs. 10702 0 1 mRNA; cDNA DKFZp761H221 (from clone DKFZp761H2186F10 2688 3084 NM_017601 Hs. 10702 1.00E−137 2 hypothetical proteinDKFZp761H221 (DKFZp761H 461E3 593 1110 NM_021821 Hs. 10724 0 1 MDS023protein (MDS023), mRNA/cds = (335,1018) 598D5 660 1191 NM_014306 Hs.10729 0 2 hypothetical protein (HSPC117), mRNA/cds = (75 125D9 104 397NM_002495 Hs. 10758 1.00E−165 1 NADH dehydrogenase (ubiquinone) Fe-Sprotein 36A7 172 1114 NM_006325 Hs. 10842 0 11 RAN, member RAS oncogenefamilyRAN, member RAS 54H1 240 1467 NM_012257 Hs. 10882 0 2 HMG-boxcontaining protein 1 (HBP1), mRNA/cds 596B8 1186 1895 AK025212 Hs. 108880 17 cDNA: FLJ21559 fis, clone COL06406/cds = UNKNOW 458G7 989 1492Z78330 Hs. 10927 0 1 HSZ78330 cDNA/clone = 2.49-(CEPH)/gb = Z78330 115D2308 638 BF793378 Hs. 10957 1.00E−102 1 602254823F1 cDNA, 5′ end/clone =IMAGE: 4347076 148H9 226 863 AF021819 Hs. 10958 0 1 RNA-binding proteinregulatory subunit mRNA, 173D5 356 816 NM_007262 Hs. 10958 0 1RNA-binding protein regulatory subunit (DJ-1 39B7 1553 2256 AF063605 Hs.11000 0 1 brain my047 protein mRNA, complete cds/cds = (8 592H5 15532257 NM_015344 Hs. 11000 0 3 MY047 protein (MY047), mRNA/cds =(84,479)/gb 112G3 2591 3180 AB046813 Hs. 11123 0 1 mRNA for KIAA1593protein, partial cds/cds = (4 592E8 251 725 NM_014041 Hs. 11125 0 2HSPC033 protein (HSPC033), mRNA/cds = (168,443 477A2 1610 1697 NM_003100Hs. 11183 8.00E−43 2 sorting nexin 2 (SNX2), mRNA/cds = (29,1588)/g 41G46498 6751 AB014522 Hs. 11238 1.00E−142 1 for KIAA0622 protein, partialcds/cds = (0 519A3 759 987 NM_018371 Hs. 11260 1.00E−127 1 hypotheticalprotein FLJ11264 (FLJ11264), mR 175B4 404 688 BE788546 Hs. 113554.00E−75 1 601476186F1 cDNA, 5′ end/clone = IMAGE: 3878948 114F11 245401 BF665055 Hs. 11356 4.00E−55 1 602119656F1 cDNA, 5′ end/clone =IMAGE: 4276860 40D2 96 824 U59808 Hs. 11383 0 1 monocyte chemotacticprotein-4 precursor (MCP-4) mR 109C3 767 2345 M74002 Hs. 11482 0 2arginine-rich nuclear protein mRNA, complete cds/cds 117G9 408 2345NM_004768 Hs. 11482 0 8 splicing factor, arginine/serine-rich 11 (SF458G6 2053 2164 AK022628 Hs. 11556 1.00E−54 1 cDNA FLJ12566 fis, cloneNT2RM4000852/cds = UNK 181E7 644 1004 AK021632 Hs. 11571 1.00E−167 1cDNA FLJ11570 fis, clone HEMBA1003309/cds = UNK 458B3 85 522 R12665 Hs.11594 1.00E−137 1 yf40a04.s1 cDNA, 3′ end/clone = IMAGE: 129294/ 146B6498 677 BE794595 Hs. 11607 5.00E−82 1 601590368F1 5′ end/clone = IMAGE:3944489 516F12 388 711 BG288429 Hs. 11637 1.00E−132 1 602388093F1 cDNA,5′ end/clone = IMAGE: 4517086 60B1 1291 1882 NM_005121 Hs. 11861 0 1thyroid hormone receptor-associated protein, 44C6 2613 2834 NM_000859Hs. 11899 9.00E−72 1 3-hydroxy-3-methylglutaryl-Coenzyme A reduc 39F10 1221 BF668230 Hs. 12035 1.00E−120 2 602122419F1 cDNA, 5′ end/clone =IMAGE: 4279300 596D8 234 849 U72514 Hs. 12045 0 2 C2f mRNA, complete cds481E7 1902 2190 AB028986 Hs. 12064 1.00E−151 1 mRNA for KIAA1063protein, partial cds/cds = (0 465D9 2529 2699 NM_004003 Hs. 120688.00E−91 1 carnitine acetyltransferase (CRAT), nuclear 116H8 283 738NM_003321 Hs. 12084 0 1 Tu translation elongation factor, mitochondri44A4 319 836 S75463 Hs. 12084 0 1 P43 = mitochondrial elongation factorhomolog [human, live 114F7 4254 4495 AL137753 Hs. 12144 1.00E−115 1mRNA; cDNA DKFZp434K1412 (from clone DKFZp434K 123F12 1 219 NM_021203Hs. 12152 1.00E−114 1 APMCF1 protein (APMCF1), mRNA/cds = (82,225)/519H7 166 753 AK025775 Hs. 12245 0 1 cDNA: FLJ22122 fis, cloneHEP19214/cds = UNKNOW 70E3 953 4720 AB014530 Hs. 12259 0 3 for KIAA0630protein, partial cds/cds = (0 107H1 680 1078 AK024756 Hs. 12293 0 1FLJ21103 fis, clone CAS04883/cds = (107,1 71E5 4750 5283 NM_003170 Hs.12303 0 1 suppressor of Ty (S. cerevisiae) 6 homolog (SUP 106F3 977 1490AL050272 Hs. 12305 0 1 cDNA DKFZp566B183 (from clone DKFZp566B1 481F41859 2403 NM_015509 Hs. 12305 0 1 DKFZP566B183 protein (DKFZP566B183),mRNA/c 114D3 1271 1520 AF038202 Hs. 12311 1.00E−118 1 clone 23570 mRNAsequence/cds = UNKNOWN/ gb = AF0 463B9 1006 1224 AK021670 Hs. 123151.00E−121 1 cDNA FLJ11608 fis, clone HEMBA1003976/cds = (56 167A8 71 723BG034192 Hs. 12396 0 2 602302446F1 cDNA, 5′ end/clone = IMAGE: 4403866460E9 3808 4166 D83776 Hs. 12413 1.00E−176 1 mRNA for KIAA0191 gene,partial cds/cds = (0,4552)/ gb 157E1 1887 3154 NM_020403 Hs. 12450 0 3cadherin superfamily protein VR4-11 (LOC57123 69F11 2715 3447 AK001676Hs. 12457 0 1 FLJ10814 fis, clone NT2RP4000984/cds = (92 118B8 5781 6374AB032973 Hs. 12461 0 1 mRNA for KIAA1147 protein, partial cds/cds = (0193G12 2069 2368 NM_005993 Hs. 12570 1.00E−169 1 tubulin-specificchaperone d (TBCD), mRNA/cd 459D11 2828 3122 NM_021151 Hs. 127431.00E−147 1 carnitine octanoyltransferase (COT), mRNA/c 196H4 1 5439AB046785 Hs. 12772 0 2 mRNA for KIAA1565 protein, partial cds/cds = (056G11 458 1088 AL080156 Hs. 12813 0 1 cDNA DKFZp434J214 (from cloneDKFZp434J2 476E6 1221 1638 NM_006590 Hs. 12820 0 1 SnRNP assemblydefective 1 homolog (SAD1), mRN 109E7 1 180 AF208855 Hs. 12830 3.00E−791 BM-013 mRNA, complete cds/cds = (67,459)/gb = A 458A2 1818 2276AK026747 Hs. 12969 0 1 cDNA: FLJ23094 fis, clone LNG07379, highly sim466D10 1469 1745 AK001822 Hs. 12999 9.00E−39 1 cDNA FLJ10960 fis, clonePLACE1000564/cds = UNK 187A11 1866 2555 NM_003330 Hs. 13046 0 2thioredoxin reductase 1 (TXNRD1), mRNA/cds = ( 60D9 1757 3508 X91247 Hs.13046 0 3 thioredoxin reductase/cds = (439,1932) 75D7 2071 2550 AF055581Hs. 13131 0 1 adaptor protein Lnk mRNA, complete cds/cds = (3 196C2 190845 AK026239 Hs. 13179 0 2 cDNA: FLJ22586 fis, clone HSI02774/cds =UNKNOW 480G6 11 380 AL570416 Hs. 13256 1.00E−161 1 AL570416 cDNA/clone =CS0DI020YK05-(3-prime) 196H3 2814 3382 AB020663 Hs. 13264 0 1 mRNA forKIAA0856 protein, partial cds/cds = (0 460H3 127 431 BF029796 Hs. 132681.00E−151 1 601556721F1 cDNA, 5′ end/clone = IMAGE: 3826637 170B2 14871635 AB011164 Hs. 13273 1.00E−69 1 for KIAA0592 protein, partial cds/cds= (0, 115E6 2153 2376 AK025707 Hs. 13277 1.00E−124 1 cDNA: FLJ22054 fis,clone HEP09634/cds = (144,9 110F10 119 648 BE537908 Hs. 13328 0 1601067373F1 cDNA, 5′ end/clone = IMAGE: 3453594 36C2 427 4137 AF054284Hs. 13453 0 5 spliceosomal protein SAP 155 mRNA, complete cd 594C3 54229 NM_012433 Hs. 13453 0 10 splicing factor 3b, subunit 1, 155 kD(SF3B1), m 110C6 4 1853 AF131753 Hs. 13472 0 5 clone 24859 mRNAsequence/cds = UNKNOWN/ gb = AF 173B6 1156 1672 NM_013236 Hs. 13493 0 1like mouse brain protein E46 (E46L), mRNA/cds = 462C4 794 1093 BC001909Hs. 13580 1.00E−115 1 clone IMAGE: 3537447, mRNA, partial cds/cds =597H11 412 936 NM_014174 Hs. 13645 0 1 HSPC144 protein (HSPC144),mRNA/cds = (446,112 107F8 429 821 AK025767 Hs. 13755 0 1 FLJ22114 fis,clone HEP18441/cds = UNKNOW 102D12 3153 4764 AF000993 Hs. 13980 0 2ubiquitous TPR motif, X isoform (UTX) mRNA, alt 515G12 1710 2120AK025425 Hs. 14040 0 2 cDNA: FLJ21772 fis, clone COLF7808/ cds = UNKNOW480H5 1945 2259 AK024228 Hs. 14070 1.00E−119 1 cDNA FLJ14166 fis, cloneNT2RP1000796/cds = (20 61D1 73 499 NM_014245 Hs. 14084 0 1 ring fingerprotein 7 (RNF7), mRNA/cds = (53,394 122E4 2162 2685 NM_014454 Hs. 141250 1 p53 regulated PA26 nuclear protein (PA26), mRN 123D9 22 722NM_001161 Hs. 14142 0 1 nudix (nucleoside diphosphate linked moiety460F11 1084 1322 NM_017827 Hs. 14220 4.00E−74 1 hypothetical proteinFLJ20450 (FLJ20450), mR 458D2 127 536 NM_018648 Hs. 14317 0 1 nucleolarprotein family A, member 3 (H/ACA sm 167G1 30 198 AK022939 Hs. 143473.00E−91 1 cDNA FLJ12877 fis, clone NT2RP2003825/cds = (3 117H10 9751721 NM_003022 Hs. 14368 0 1 SH3 domain binding glutamic acid-richprotein 591B12 1082 1801 NM_001614 Hs. 14376 0 9 actin, gamma 1 (ACTG1),mRNA/cds = (74,1201)/g 179H3 1160 1791 X04098 Hs. 14376 1.00E−178 5cytoskeletal gamma-actin/cds = (73,1200)/g 116D9 5818 6073 NM_012199 Hs.14520 5.00E−84 1 eukaryotic translation initiation factor 2C, 64D11 19012506 NM_003592 Hs. 14541 0 1 cullin 1 (CUL1), mRNA/cds = (124,2382)/gb =NM_0 516F4 750 1331 AK025166 Hs. 14555 0 1 cDNA: FLJ21513 fis, cloneCOL05778/cds = UNKNOW 459G5 1 260 AK025269 Hs. 14562 5.00E−88 1 cDNA:FLJ21616 fis, clone COL07477/cds = (119,1 521B7 7 1825 NM_005335 Hs.14601 0 8 hematopoietic cell-specific Lyn substrate 1 110D7 7 1295X16663 Hs. 14601 0 3 HS1 gene for heamatopoietic lineage cell specificpro 114D11 1460 1559 NM_003584 Hs. 14611 1.00E−45 1 dual specificityphosphatase 11 (RNA/RNP comp 589A3 1665 2197 NM_016293 Hs. 14770 0 2bridging integrator 2 (BIN2), mRNA/cds = (38,17 104C8 2113 2380 AB031050Hs. 14805 1.00E−135 2 for organic anion transporter OATP-D, com 481D102466 2694 NM_013272 Hs. 14805 1.00E−68 1 solute carrier family 21(organic anion transp 125B2 2704 3183 NM_001455 Hs. 14845 0 1 forkheadbox O3A (FOXO3A), mRNA/cds = (924,2945 500D7 2174 2379 AL050021 Hs.14846 1.00E−100 1 mRNA; cDNA DKFZp564D016 (from clone DKFZp564D0 123B51793 2195 NM_016598 Hs. 14896 0 1 DHHC1 protein (LOC51304), mRNA/cds =(214,1197 499E2 1266 1549 AB020644 Hs. 14945 1.00E−155 3 mRNA forKIAA0837 protein, partial cds/cds = (0 123H6 2980 3652 NM_007192 Hs.14963 0 3 chromatin-specific transcription elongation 61G10 264 528D13627 Hs. 15071 1.00E−144 1 KIAA0002 gene, complete cds/cds =(28,1674)/ 460D10 2162 4305 NM_014837 Hs. 15087 0 4 KIAA0250 geneproduct (KIAA0250), mRNA/cds = ( 176E12 9289 9739 NM_022473 Hs. 15220 01 zinc finger protein 106 (ZFP106), mRNA/cds = (3 487E11 1561 1989NM_006170 Hs. 15243 0 1 nucleolar protein 1 (120 kD) (NOL1), mRNA/cds =75E11 1628 2201 AF127139 Hs. 15259 0 20 Bcl-2-binding protein BIS (BIS)mRNA, complete 71H9 1656 2532 NM_004281 Hs. 15259 0 12 BCL2-associatedathanogene 3 (BAG3), mRNA/cd 484G9 465 1006 NM_005826 Hs. 15265 0 1heterogeneous nuclear ribonucleoprotein R ( 480H8 2013 2635 AB037828 Hs.15370 0 1 mRNA for KIAA1407 protein, partial cds/cds = (0 587G9 24362769 AK024088 Hs. 15423 1.00E−167 1 cDNA FLJ14026 fis, cloneHEMBA1003679, weakly 483D6 5239 5810 NM_004774 Hs. 15589 0 1 PPARbinding protein (PPARBP), mRNA/cds = (235, 514A7 673 942 NM_006833 Hs.15591 1.00E−151 1 COP9 subunit 6 (MOV34 homolog, 34 kD) (MOV34-34 125A2522 746 NM_024348 Hs. 15961 1.00E−112 1 dynactin 3 (p22) (DCTN3),transcript variant 591A5 295 704 NM_005005 Hs. 15977 0 3 NADHdehydrogenase (ubiquinone) 1 beta subcom 39H12 1641 1993 X74262 Hs.16003 1.00E−180 1 RbAp48 mRNA encoding retinoblastoma binding prot 113A91328 1891 NM_016334 Hs. 16085 0 1 putative G-protein coupled receptor(SH120), 45C2 765 1674 NM_006461 Hs. 16244 0 2 mitotic spindlecoiled-coil related protein ( 494H10 113 2576 NM_016312 Hs. 16420 0 3Npw38-binding protein NpwBP (LOC51729), mRNA 40D8 52 246 Y13710 Hs.16530 1.00E−107 1 for alternative activated macrophage spe 597E7 244 524AL523085 Hs. 16648 1.00E−147 1 AL523085 cDNA/clone =CS0DC001YF21-(5-prime) 458D11 232 319 AY007106 Hs. 16773 1.00E−42 1clone TCCCIA00427 mRNA sequence/ cds = UNKNOWN 70F2 824 991 AL021786 Hs.17109 2.00E−90 2 DNA sequence from PAC 696H22 on chromosome Xq21.1-21.2167C5 5768 5905 D86964 Hs. 17211 3.00E−62 1 mRNA for KIAA0209 gene,partial cds/cds = (0,5530)/ gb 460H2 3424 3624 AL162070 Hs. 173771.00E−103 1 mRNA; cDNA DKFZp762H186 (from clone DKFZp762H1 70G11 13841885 AK023680 Hs. 17448 0 2 FLJ13618 fis, clone PLACE1010925/cds = UNK129C11 2458 3044 U47924 Hs. 17483 0 2 chromosome 12p13 sequence/cds =(194,1570)/ gb = U4792 467H3 4713 4908 NM_014521 Hs. 17667 1.00E−61 1SH3-domain binding protein 4 (SH3BP4), mRNA/ 71A11 100 370 BG035218 Hs.17719 1.00E−142 1 602324727F1 cDNA, 5′ end/clone = IMAGE: 4412910 598C7513 902 NM_021622 Hs. 17757 1.00E−178 1 pleckstrin homologydomain-containing, fami 595A7 3296 5680 AB046774 Hs. 17767 0 5 mRNA forKIAA1554 protein, partial cds/cds = (0 58D12 5225 5857 AB007861 Hs.17803 0 1 KIAA0401 mRNA, partial cds/cds = (0,1036)/gb = 524G8 357 809NM_014350 Hs. 17839 0 1 TNF-induced protein (GG2-1), mRNA/cds = (197,7521B10 1008 1476 NM_002707 Hs. 17883 0 2 protein phosphatase 1G(formerly 2C), magnesiu 69B12 1014 1490 Y13936 Hs. 17883 0 1 for proteinphosphatase 2C gamma/cds = (24, 178E6 1903 4365 NM_014827 Hs. 17969 0 3KIAA0663 gene product (KIAA0663), mRNA/cds = ( 173H3 481 2362 AK001630Hs. 18063 0 4 cDNA FLJ10768 fis, clone NT2RP4000150/cds = UN 113A8 12851393 NM_005606 Hs. 18069 5.00E−48 1 protease, cysteine, 1 (legumain)(PRSC1), mRN 118H9 3709 3950 AB020677 Hs. 18166 1.00E−125 1 mRNA forKIAA0870 protein, partial cds/cds = (0 513H7 2204 2757 NM_005839 Hs.18192 1.00E−112 3 Ser/Arg-related nuclear matrix protein (plen 523G9 507768 AB044661 Hs. 18259 1.00E−147 1 XAB1 mRNA for XPA binding protein 1,complete c 105B9 695 1115 AJ010842 Hs. 18259 0 1 for putativeATP(GTP)-binding protein, p 589D12 335 715 NM_016565 Hs. 18552 0 2 E2IG2protein (LOC51287), mRNA/cds = (131,421) 170C8 414 737 AF072860 Hs.18571 0 2 protein activator of the interferon-induced p 189A12 414 736NM_003690 Hs. 18571 0 1 protein kinase, interferon-inducible double134B9 2751 3057 AB046808 Hs. 18587 1.00E−165 1 mRNA for KIAA1588protein, partial cds/cds = (2 519G5 1291 1581 NM_012332 Hs. 186251.00E−157 2 Mitochondrial Acyl-CoA Thioesterase (MT-ACT4 526H2 827 1205NM_004208 Hs. 18720 0 1 programmed cell death 8 (apoptosis-inducing f462F12 409 556 NM_017899 Hs. 18791 2.00E−78 1 hypothetical proteinFLJ20607 (FLJ20607), mR 138B2 388 995 AF003938 Hs. 18792 0 1thioredoxin-like protein complete cds 36G12 935 1272 AJ250014 Hs. 188270 2 for Familial Cylindromatosis cyld gene/ 194D3 924 2123 NM_018253 Hs.18851 0 2 hypothetical protein FLJ10875 (FLJ10875), mR 523E1 3653 4056NM_012290 Hs. 18895 0 1 tousled-like kinase 1 (TLK1), mRNA/cds = (212,2587G5 1 350 NM_016302 Hs. 18925 1.00E−166 1 protein × 0001 (LOC51185),mRNA/cds = (33,1043) 595C10 161 1281 AC006042 Hs. 18987 0 4 BAC cloneRP11-505D17 from 7p22-p21/cds = (0,12 125G10 54 752 NM_002492 Hs. 192360 3 NADH dehydrogenase (ubiquinone) 1 beta subcom 478G7 1 193 NM_021603Hs. 19520 9.00E−51 1 FXYD domain-containing ion transport regulat 595F113623 3736 AB051481 Hs. 19597 3.00E−49 1 mRNA for KIAA1694 protein,partial cds/cds = (0 177C6 284 671 AF161339 Hs. 19807 0 2 HSPC076 mRNA,partial cds/cds = (0,301)/gb = AF 37E12 3485 3919 AB018298 Hs. 19822 0 1for KIAA0755 protein, complete cds/cds = ( 64G8 962 1311 NM_001902 Hs.19904 0 1 cystathionase (cystathionine gamma-lyase) ( 499D5 2829 3183AB011169 Hs. 20141 0 1 mRNA for KIAA0597 protein, partial cds/cds = (0,40D11 62 684 NM_004166 Hs. 20144 0 1 small inducible cytokine subfamilyA (Cys-Cys 66C10 1240 2240 U76248 Hs. 20191 0 12 hSIAH2 mRNA, completecds/cds = (526,1500)/ gb = U76248 586B12 1686 4288 AB040922 Hs. 20237 02 mRNA for KIAA1489 protein, partial cds/cds = (1 173G8 2578 3197AL096776 Hs. 20252 0 1 DNA sequence from clone RP4-646B12 on chromosome1q42 98C6 3303 4699 AB051487 Hs. 20281 0 6 mRNA for KIAA1700 protein,partial cds/cds = (1 107H11 781 1380 AK022103 Hs. 20281 0 1 FLJ12041fis, clone HEMBB1001945/cds = UNK 121B8 778 1264 NM_001548 Hs. 20315 0 1interferon-induced protein with tetratricope 110C4 1050 1431 AF244137Hs. 20597 0 1 hepatocellular carcinoma-associated antigen 99H6 899 1412NM_014315 Hs. 20597 0 2 host cell factor homolog (LCP), mRNA/cds = (316,152B12 69 424 AK025446 Hs. 20760 0 1 FLJ21793 fis, clone HEP00466/cds =UNKNOW 459A8 1858 2143 AL021366 Hs. 20830 1.00E−155 1 DNA sequence fromcosmid ICK0721Q on chromosome 587A11 720 1080 AL137576 Hs. 21015 0 1mRNA; cDNA DKFZp564L0864 (from clone DKFZp564L 191E12 1688 2235 AK025019Hs. 21056 0 2 cDNA: FLJ21366 fis, clone COL03012, highly sim 52G3 2251652 NM_005880 Hs. 21189 0 6 HIRA interacting protein 4 (dnaJ-like)(HIRIP 181B7 3176 3316 AB018325 Hs. 21264 3.00E−72 1 mRNA for KIAA0782protein, partial cds/cds = (0 45E11 1378 1518 NM_003115 Hs. 212931.00E−72 1 UDP-N-acteylglucosamine pyrophosphorylase 109G1 2989 3487AB032948 Hs. 21356 0 1 for KIAA1122 protein, partial cds/cds = (0 116D45522 5741 NM_016936 Hs. 21479 1.00E−107 1 ubinuclein 1 (UBN1), mRNA/cds= (114,3518)/gb 37G10 294 3960 M97935 Hs. 21486 0 4 transcription factorISGF-3 mRNA, complete cd 599E8 329 3568 NM_007315 Hs. 21486 0 6 signaltransducer and activator of transcripti 592D10 2223 3204 NM_002709 Hs.21537 0 3 protein phosphatase 1, catalytic subunit, bet 68A7 1327 1612AB028958 Hs. 21542 1.00E−161 1 for KIAA1035 protein, partial cds/cds =(0 72B3 2519 2862 L03426 Hs. 21595 1.00E−179 1 XE7 mRNA, completealternate coding regions/ cds = (166 592E6 2520 2854 NM_005088 Hs. 215951.00E−161 1 DNA segment on chromosome X and (unique) 155 ex 589G6 190522 AL573787 Hs. 21732 1.00E−141 1 AL573787 cDNA/clone =CS0DI055YM17-(3-prime) 593H1 452 899 NM_005875 Hs. 21756 0 2 translationfactor sui1 homolog (GC20), mRNA 59B8 2893 3273 NM_012406 Hs. 21807 0 1PR domain containing 4 (PRDM4), mRNA/cds = (122, 196A9 12 543 AL562895Hs. 21812 0 1 AL562895 cDNA/clone = CS0DC021YO20-(3-prime) 67D8 62 631AW512498 Hs. 21879 1.00E−150 3 xx75e03.x1 cDNA, 3′ end/clone = IMAGE:2849500 477B6 1969 2520 D84454 Hs. 21899 0 1 mRNA for UDP-galactosetranslocator, complete cds/c 515D1 2232 2647 NM_007067 Hs. 21907 0 2histone acetyltransferase (HBOA), mRNA/cds = 100F8 1082 1508 AK022554Hs. 21938 0 1 FLJ12492 fis, clone NT2RM2001632, weakly 470E4 1135 1244NM_020239 Hs. 22065 4.00E−45 2 small protein effector 1 of Cdc42(SPEC1), mRNA 68G4 1391 2013 AK022057 Hs. 22265 0 2 FLJ11995 fis, cloneHEMBB1001443, highly 193H6 922 1328 NM_022494 Hs. 22353 1.00E−178 1hypothetical protein FLJ21952 (FLJ21952), mR 151D2 1492 1694 AL049951Hs.22370 4.00E−88 1 cDNA DKFZp564O0122 (from clone DKFZp564O 497E8 15814794 D83781 Hs.22559 0 3 mRNA for KIAA0197 gene, partial cds/cds =(0,3945)/gb 182D10 999 1830 AL117513 Hs.22583 0 5 mRNA; cDNADKFZp434K2235 (from clone DKFZp434K 75B5 1775 2380 AF006513 Hs.22670 0 1CHD1 mRNA, complete cds/cds = (163,5292)/gb = A 126H8 1776 2377NM_001270 Hs.22670 0 1 chromodomain helicase DNA binding protein 1 (73D5 1599 1696 AK025485 Hs.22678 2.00E−42 1 FLJ21832 fis, cloneHEP01571/cds = (32,15 481D11 128 562 BF968270 Hs.22790 1.00E−172 1602269653F1 cDNA, 5′ end/clone = lMAGE: 4357740 74E4 724 1195 NM_012124Hs.22857 0 1 chord domain-containing protein 1 (CHP1), mRN 459C6 8131472 NM_012244 Hs.22891 0 1 solute carrier family 7 (cationic amino acidt 462G7 2972 3144 AB037784 Hs.22941 2.00E−93 1 mRNA for KIAA1363protein, partial cds/cds = (0 70F12 37 846 AB020623 Hs.22960 0 3 DAM1mRNA, complete cds/cds = (48,725)/gb = AB0 585H10 91 748 NM_005872Hs.22960 0 1 breast carcinoma amplified sequence 2 (BCAS2) 142C8 13591597 AK024023 Hs.23170 1.00E−103 1 FLJ13961 fis, clone Y79AA1001236,highly 164F2 1220 1474 NM_012280 Hs.23170 1.00E−135 1 homolog of yeastSPB1 (JM23), mRNA/cds = (300,12 127F11 682 806 AL046016 Hs.232472.00E−58 1 DKFZp434P246_r1 cDNA, 5′ end/clone = DKFZp434P 98G7 760 1368NM_022496 Hs.23259 0 1 hypothetical protein FLJ13433 (FLJ13433), mR470C9 2 538 AL574514 Hs.23294 0 2 AL574514 cDNA/clone =CS0DI056YA07-(3-prime) 458F12 4293 4917 AB002365 Hs.23311 0 1 mRNA forKIAA0367 gene, partial cds/cds = (0,2150)/gb 57D8 460 566 BF439063Hs.23349 3.00E−54 1 nab70e03.x1 cDNA/clone = IMAGE/gb = BF439063/ 599G12352 983 NM_014814 Hs.23488 0 2 KIAA0107 gene product (KIAA0107),mRNA/cds = ( 112B3 2400 2715 NM_014887 Hs.23518 1.00E−172 1 hypotheticalprotein from BCRA2 region (CG005 167C10 1771 2107 NM_004380 Hs.235981.00E−175 1 CREB binding protein (Rubinstein-Taybi syndr 196G9 114 307BF970427 Hs.23703 1.00E−101 1 602272760F1 cDNA, 5′ end/clone = IMAGE:4360767 184B3 2488 2882 AK026983 Hs.23803 0 1 FLJ23330 fis, cloneHEP12654/cds = (69,13 480H4 4871 5467 AB023227 Hs.23860 0 1 mRNA forKIAA1010 protein, partial cds/cds = (0 479C12 4 190 NM_005556 Hs.238814.00E−91 1 keratin 7 (KRT7), mRNA/cds = (56,1465)/gb = NM_(—) 36E7 7421126 AL360135 Hs.23964 0 1 full length insert cDNA clone EUROIMAGE 12598B5 544 1271 NM_005870 Hs.23964 0 12 sin3-associated polypeptide, 18kD (SAP18), m 462D8 1205 1653 NM_004790 Hs.23965 0 1 solute carrierfamily 22 (organic anion transp 479A5 1817 2164 NM_002967 Hs.23978 0 1scaffold attachment factor B (SAFB), mRNA/cds 188E2 1762 2160 NM_014950Hs.24083 0 1 KIAA0997 protein (KIAA0997), mRNA/cds = (262,2 67D2 13041856 AK024240 Hs.24115 0 2 FLJ14178 fis, clone NT2RP2003339/cds = UNK177D8 4674 5185 AF251039 Hs.24125 0 1 putative zinc finger protein mRNA,complete cd 190E1 5222 5394 NM_016604 Hs.24125 8.00E−73 1 putative zincfinger protein (LOC51780), mRNA 192A5 1517 1985 NM_003387 Hs.241431.00E−135 2 Wiskott-Aldrich syndrome protein interacting 170A4 1666 3280X86019 Hs.24143 4.00E−23 1 PRPL-2 protein/cds = (204,1688)/gb = X860480B6 1517 1937 NM_012155 Hs.24178 1.00E−133 1 microtubule-associatedprotein like echinode 143H11 177 656 BE877357 Hs.24181 0 2 601485590F1cDNA, 5′ end/clone = IMAGE: 3887951 473D10 146 491 AW960486 Hs.24252 0 1EST372557 cDNA/gb = AW960486/gi = 8150170/ug = 98H1 23 562 NM_003945Hs.24322 0 1 ATPase, H+ transporting, lysosomal (vacuolar 169G2 391 638BE612847 Hs.24349 4.00E−75 2 601452239F1 5′ end/clone = IMAGE: 3856304479B12 1132 1599 AY007126 Hs.24435 0 1 clone CDABP0028 mRNA sequence/cds= UNKNOWN/g 480H9 4716 5012 NM_006048 Hs.24594 1.00E−145 1ubiquitination factor E4B (homologous to yeas 110B10 520 1171 AL163206Hs.24633 0 1 chromosome 21 segment HS21C006/cds = (82,1203) 99A3 5191000 NM_022136 Hs.24633 0 2 SAM domain, SH3 domain and nuclearlocalisation 109G7 2024 2350 AB037797 Hs.24684 1.00E−141 1 for KIAA1376protein, partial cds/cds = (1 61B7 485 1656 AK024029 Hs.24719 0 4FLJ13967 fis, clone Y79AA1001402, weakly 166C11 1216 1509 AF006516Hs.24752 1.00E−165 1 eps8 binding protein e3B1 mRNA, complete cds/464D12 166 764 NM_002882 Hs.24763 0 1 RAN binding protein 1 (RANBP1),mRNA/cds = (149 98C12 6523 8023 AB051512 Hs.25127 0 3 mRNA for KIAA1725protein, partial cds/cds = (0 63F7 2164 2802 AL133611 Hs.25362 0 1 cDNADKFZp434O1317 (from clone DKFZp434O 41D11 45 463 X53795 Hs.25409 0 1 R2mRNA for an inducible membrane protein/ cds = (156,95 62G6 1452 1827V01512 Hs.25647 0 3 cellular oncogene c-fos (complete sequence)/cds =(15 593D12 1135 2111 NM_015832 Hs.25674 0 8 methyl-CpG binding domainprotein 2 (MBD2), tr 172G9 2014 2371 NM_021211 Hs.25726 0 1transposon-derived Buster1 transposase-like 106D6 432 1878 AF058696Hs.25812 0 2 cell cycle regulatory protein p95 (NBS1) mRNA, 98A4 5333758 NM_002485 Hs.25812 0 2 Nijmegen breakage syndrome 1 (nibrin)(NBS1), 477H5 6320 6599 NM_004638 Hs.25911 1.00E−111 3 HLA-B associatedtranscript-2 (D6S51E), mRNA 71F11 2070 2931 NM_019555 Hs.25951 0 3 Rhoguanine nucleotide exchange factor (GEF) 164B9 2163 2502 AK023999Hs.26039 1.00E−159 1 cDNA FLJ13937 fis, clone Y79AA1000805/cds = UNK100A3 2043 2620 M34668 Hs.26045 0 1 protein tyrosine phosphatase(PTPase-alpha) mRNA/c 123A5 2046 2638 NM_002836 Hs.26045 0 1 proteintyrosine phosphatase, receptor type, 466E5 7817 8241 NM_014112 Hs.261020 2 trichorhinophalangeal syndrome I gene (TRPS1) 588A1 361 857 AF070582Hs.26118 0 1 clone 24766 mRNA sequence/cds = UNKNOWN/ gb = AF 526H12 1761809 NM_018384 Hs.26194 0 5 hypothetical protein FLJ11296 (FLJ11296), mR149G7 96 1123 AK027016 Hs.26198 0 3 FLJ23363 fis, clone HEP15507/cds =(206,1 122A4 1196 1332 AL050166 Hs.26295 3.00E−72 1 mRNA; cDNADKFZp586D1122 (from clone DKFZp586D 122D5 1936 2435 AB029006 Hs.26334 01 mRNA for KIAA1083 protein, complete cds/cds = ( 137G5 137 452 AK025778Hs.26367 1.00E−145 1 FLJ22125 fis, clone HEP19410/cds = (119,5 595D2 1372 NM_022488 Hs.26367 3.00E−89 3 PC3-96 protein (PC3-96), mRNA/cds =(119,586) 64D12 1024 1135 NM_017746 Hs.26369 2.00E−57 1 hypotheticalprotein FLJ20287 (FLJ20287), mR 39E4 2132 2750 AK000367 Hs.26434 0 1FLJ20360 fis, clone HEP16677/cds = (79,230 473C10 4318 4623 AF051782Hs.26584 1.00E−154 1 diaphanous 1 (HDIA1) mRNA, complete cds/cds = (590C4 1740 2198 AL050205 Hs.26613 0 1 mRNA; cDNA DKFZp586F1323 (fromclone DKFZp586F 523F3 454 792 AC002073 Hs.26670 1.00E−164 1 PAC cloneRP3-515N1 from 22q11.2-q22/cds = (0,791)/g 587E11 1226 1876 NM_004779Hs.26703 0 2 CCR4-NOT transcription complex, subunit 8 (C 110G4 191 685BE868389 Hs.26731 0 1 601444360F1 cDNA, 5′ end/clone = IMAGE: 3848487110E11 1001 3955 AL117448 Hs.26797 0 2 cDNA DKFZp586B14I7 (from cloneDKFZp586B 152A8 12 112 AI760224 Hs.26873 2.00E−48 1 wh62g06.x1 cDNA, 3′end/clone = IMAGE: 2385370 467G11 528 858 NM_016106 Hs.27023 1.00E−174 1vesicle transport-related protein (KIAA0917) 465E11 634 1065 AL136656Hs.27181 3.00E−83 1 mRNA; cDNA DKFZp564C1664 (from clone DKFZp564C 58E111 551 AJ238243 Hs.27182 0 1 mRNA for phospholipase A2 activating protein590H2 398 1016 NM_014412 Hs.27258 0 1 calcyclin binding protein(CACYBP), mRNA/cds 179E9 1039 1905 AK025586 Hs.27268 0 4 FLJ21933 fis,clone HEP04337/cds = UNKNOW 459D7 1293 1936 AL050061 Hs.27371 0 1 mRNA;cDNA DKFZp566J123 (from clone DKFZp566J1 54A11 709 1542 AK022811Hs.27475 0 1 FLJ12749 fis, clone NT2RP2001149/cds = UNK 111A5 42 686NM_022485 Hs.27556 0 1 hypothetical protein FLJ22405 (FLJ22405), mR123D4 879 1005 NM_016059 Hs.27693 3.00E−49 1 peptidylprolyl isomerase(cyclophilin)-like 518E11 1245 2235 AF332469 Hs.27721 0 5 putativeprotein WHSC1L1 (WHSG1L1) mRNA, comp 103B11 631 1343 NM_014805 Hs.280200 1 KIAA0766 gene product (KIAA0766), mRNA/cds = ( 479H3 4 100 AB007928Hs.28169 7.00E−37 1 mRNA for KIAA0459 protein, partial cds/cds = (0526B3 1901 1995 NM_007218 Hs.28285 4.00E−47 1 patched related proteintranslocated in renal 480E4 4088 4596 AB046766 Hs.28338 0 1 mRNA forKIAA1546 protein, partial cds/cds = (0 164D10 651 970 NM_002970 Hs.284911.00E−163 2 spermidine/spermine N1-acetyltransferase ( 69E10 729 1588AB007888 Hs.28578 0 2 KIAA0428 mRNA, complete cds/cds = (1414,2526) 49B1632 4266 NM_021038 Hs.28578 0 4 muscleblind (Drosophila)-like (MBNL),mRNA/ 173A10 2105 2391 AL034548 Hs.28608 1.00E−161 2 DNA sequence fromclone RP5-1103G7 on chromosome 20p1 156H8 467 585 AV691642 Hs.287398.00E−43 1 AV691642 5′ end/clone = GKCDJG11/clone_(—) 588D3 444 909NM_004800 Hs.28757 1.00E−123 1 transmembrane 9 superfamily member 2(TM9SF2) 493B12 500 930 NM_003512 Hs.28777 0 1 H2A histone family,member L (H2AFL), mRNA/cd 115C5 63 661 BF341640 Hs.28788 0 1 602016073F1cDNA, 5′ end/clone = IMAGE: 4151706 524C10 37 412 NM_007217 Hs.288661.00E−179 1 programmed cell death 10 (PDCD10), mRNA/cds = ( 39A8 13801873 AK000196 Hs.29052 0 1 FLJ20189 fis, clone COLF0657/cds = (122,84477H7 690 1047 NM_005859 Hs.29117 1.00E−163 1 purine-rich elementbinding protein A (PURA), 134C8 2462 2789 NM_002894 Hs.29287 1.00E−173 1retinoblastoma-binding protein 8 (RBBP8), mR 108A11 182 992 M31165Hs.29352 0 9 tumor necrosis factor-inducible (TSG-6) mRNA fragme 99E8179 992 NM_007115 Hs.29352 0 7 tumor necrosis factor, alpha-inducedprotein 169B3 2219 2683 AF039942 Hs.29417 0 1 HCF-binding transcriptionfactor Zhangfei (Z 526A7 2219 2670 NM_021212 Hs.29417 0 1 HCF-bindingtranscription factor Zhangfei (Z 184H12 2380 4852 AB033042 Hs.29679 0 2KIAA1216 protein, partial cds/cds = (0 125G9 1169 1814 AB037791 Hs.297160 1 mRNA for KIAA1370 protein, partial cds/cds = (4 68F3 1011 1892AK027197 Hs.29797 0 5 FLJ23544 fis, clone LNG08336/cds = (125,5 72H122103 2564 L27071 Hs.29877 0 2 tyrosine kinase (TXK) mRNA, complete cds/cds = (86,166 588D5 793 1321 NM_003328 Hs.29877 0 1 TXK tyrosine kinase(TXK), mRNA/cds = (86,1669) 127C3 1 1424 AK024961 Hs.29977 0 4 cDNA:FLJ21308 fis, clone COL02131/cds = (287,1 128H7 351 977 NM_014188Hs.30026 0 1 HSPC182 protein (HSPC182), mRNA/cds = (65,649) 521G4 5021260 NM_004593 Hs.30035 0 4 splicing factor, arginine/serine-rich (trans47A2 503 1265 U61267 Hs.30035 0 4 putative splice factortransformer2-beta mRN 37G9 1287 1763 M16967 Hs.30054 0 2 coagulationfactor V mRNA, complete cds/ cds = (90,6764 459E1 43 536 NM_015919Hs.30303 0 1 Kruppel-associated box protein (LOC51595), m 465F6 256 573NM_005710 Hs.30570 7.00E−75 1 polyglutamine binding protein 1 (PQBP1),mRNA 120H1 5305 5634 NM_012296 Hs.30687 1.00E−172 2 GRB2-associatedbinding protein 2 (GAB2), mRN 189G2 1 147 BG260954 Hs.30724 2.00E−68 1602372562F1 cDNA, 5′ end/clone = IMAGE: 4480647 482E6 3086 3254 AK023743Hs.30818 4.00E−91 1 cDNA FLJ13681 fis, clone PLACE2000014, weakly 179H520 1232 AK001972 Hs.30822 0 2 FLJ11110 fis, clone PLACE1005921, weakly598B6 1 1169 NM_018326 Hs.30822 0 19 hypothetical protein FLJ11110(FLJ11110), mR 126G10 1309 2463 AK000689 Hs.30882 0 18 cDNA FLJ20682fis, clone KAIA3543, highly simi 126G7 5221 5904 NM_019081 Hs.309091.00E−163 2 KIAA0430 gene product (KIAA0430), mRNA/cds = ( 483D1 14812098 NM_003098 Hs.31121 0 1 syntrophin, alpha 1(dystrophin-associated p464C9 1188 1755 NM_003273 Hs.31130 0 1 transmembrane 7 superfamilymember 2 (TM7SF2), 478A6 3024 3837 NM_012238 Hs.31176 1.00E−176 2sir2-like 1 (SIRT1), mRNA/cds = (53,2296)/gb = 122E5 1060 1294 NM_002893Hs.31314 1.00E−113 1 retinoblastoma-binding protein 7 (RBBP7), mR 117B12056 2489 AF153419 Hs.31323 0 1 IkappaBkinase complex-associated protein(I 462E10 337 569 AV752358 Hs.31409 1.00E−108 1 AV752358 cDNA, 5′end/clone = NPDBHG03/clone_(—) 126E7 1962 2748 AB014548 Hs.31921 0 2mRNA for KIAA0648 protein, partial cds/cds = (0 186G11 729 954 BC000152Hs.31989 1.00E−125 1 Similar to DKFZP586G1722 protein, clone MGC: 67H71705 2336 AJ400877 Hs.32017 0 2 ASCL3 gene, CEGP1 gene, C11orf14 gene,C11orf1 102B11 175 874 AK026455 Hs.32148 0 1 FLJ22802 fis, cloneKAIA2682, highly sim 458D4 46 449 H14103 Hs.32149 1.00E−167 1 ym62a02.r1cDNA, 5′ end/clone = IMAGE: 163466/ 99A2 3991 4532 AB007902 Hs.32168 0 1KIAA0442 mRNA, partial cds/cds = (0,3519)/gb = 458G5 27 540 N30152Hs.32250 0 1 yx81f03.s1 cDNA, 3′ end/clone = IMAGE: 268157/ 112D11 43995040 NM_005922 Hs.32353 0 1 mitogen-activated protein kinase kinase kina48C8 3278 3988 AB002377 Hs.32556 0 2 mRNA for KIAA0379 protein, partialcds/cds = (0, 515F9 761 989 NM_003193 Hs.32675 1.00E−116 1tubulin-specific chaperone e (TBCE), mRNA/c 158C12 342 809 NM_016063Hs.32826 0 1 CGI-130 protein (LOC51020),/cds = (63,575 585E6 128 512NM_005594 Hs.32916 0 3 nascent-polypeptide-associated complex alp 459B51271 1972 NM_017632 Hs.32922 0 1 hypothetical protein FLJ20036(FLJ20036), mR 469G12 2711 2978 NM_001566 Hs.32944 1.00E−136 1 inositolpolyphosphate-4-phosphatase, type 71B7 483 1787 NM_003037 Hs.32970 0 29signaling lymphocytic activation molecule (S 74G1 1 1780 U33017 Hs.329700 33 signaling lymphocytic activation molecule (SLAM) mR 473B11 29933361 NM_006784 Hs.33085 1 .00E−111 1 WD repeat domain 3 (WDR3), mRNA/cds= (47,2878) 56B5 23 578 AB019571 Hs.33190 0 1 expressed only inplacental villi, clone 469D12 187 394 AL359654 Hs.33756 1.00E−110 1 mRNAfull length insert cDNA clone EUROIMAGE 19 98H8 371 618 AI114652Hs.33757 3.00E−98 1 HA1247 cDNA/gb = AI114652/gi = 6359997/ug = Hs.594E7 2134 2320 NM_012123 Hs.33979 5.00E−93 1 CGI-02 protein (CGI-02),mRNA/cds = (268,2124) 110D1 1158 1349 NM_018579 Hs.34401 1.00E−105 1hypothetical protein PRO1278 (PRO1278), mRNA 596A6 1950 2144 NM_022766Hs.34516 1.00E−102 2 hypothetical protein FLJ23239 (FLJ23239), mR 37B10237 563 AI123826 Hs.34549 1.00E−145 1 ow61c10.x1 cDNA, 3′ end/clone =IMAGE: 1651314 458H4 3656 4415 AB040929 Hs.35089 0 1 mRNA for KIAA1496protein, partial cds/cds = (0 100D1 3563 3777 D25215 Hs.35804 1.00E−1051 KIAA0032 gene, complete cds/cds = (166,3318) 519A12 402 623 AW960004Hs.36475 3.00E−48 1 EST372075 cDNA/gb = AW960004/gi = 8149688/ug = 498H211143 11490 NM_000081 Hs.36508 0 1 Chediak-Higashi syndrome 1 (CHS1),mRNA/cds = ( 521D6 304 791 NM_002712 Hs.36587 0 2 protein phosphatase 1,regulatory subunit 7 ( 460E1 1200 1542 AF319476 Hs.36752 0 2 GKAP42(FKSG21) mRNA, complete cds/cds = (174,1 184G9 498 1191 AF082569Hs.36794 0 2 D-type cyclin-interacting protein 1 (DIP1) mR 462D3 4931517 NM_012142 Hs.36794 0 3 D-type cyclin-interacting protein 1 (DIP1),m 74E12 659 3054 D86956 Hs.36927 0 23 KIAA0201 gene, complete cds/cds =(347,2923) 58G5 1268 2888 NM_006644 Hs.36927 0 12 heat shock 105 kD(HSP105B), mRNA/cds = (313,275 52C10 1479 2588 AK022546 Hs.37747 0 2FLJ12484 fis, clone NT2RM1001102, weakly 479F9 2066 2322 AL136932Hs.37892 1.00E−119 1 mRNA; cDNA DKFZp586H1322 (from clone DKFZp586H483C2 2222 2723 NM_003173 Hs.37936 0 1 suppressor of variegation 3-9(Drosophila) ho 593G6 673 1213 NM_004510 Hs.38125 0 1 interferon-inducedprotein 75, 52 kD (IFI75), 101G12 118 436 N39230 Hs.38218 1.00E−173 1yy50c03.s1 cDNA, 3′ end/clone = IMAGE: 276964/ 107E5 238 525 AW188135Hs.38664 1.00E−158 1 xj92g04.x1 cDNA, 3′ end/clone = IMAGE: 2664726596F2 9 504 BF892532 Hs.38664 0 9 IL0-MT0152-061100-501-e04 cDNA/gb =BF892532 469D7 47 474 NM_014343 Hs.38738 0 1 claudin 15 (CLDN15),mRNA/cds = (254,940)/gb = 166H8 1 81 BF103848 Hs.39457 9.00E−34 1601647352F1 cDNA, 5′ end/clone = IMAGE: 3931452 465F3 157 296 NM_017859Hs.39850 2.00E−47 1 hypothetical protein FLJ20517 (FLJ20517), mR 195C122684 2944 NM_000885 Hs.4C034 1.00E−146 1 integrin, alpha 4 (antigenCD49D, alpha 4 subu 151F11 1393 1661 AL031427 Hs.40094 6.00E−81 1 DNAsequence from clone 167A19 on chromosome 1p32.1-33 134C12 4532 4802NM_004973 Hs.40154 1.00E−114 1 jumonji (mouse) homolog (JMJ), mRNA/cds =(244, 115C9 5279 5614 AB033085 Hs.40193 1.00E−157 1 mRNA for KIAA1259protein, partial cds/cds = (1 119A8 862 2087 NM_006152 Hs.40202 0 3lymphoid-restricted membrane protein (LRMP), 104D4 924 1398 U10485Hs.40202 0 2 lymphoid-restricted membrane protein (Jaw1) mRNA, c 155G3226 530 AF047472 Hs.40323 1.00E−114 1 spleen mitotic checkpoint BUB3(BUB3) mRNA, c 521C2 233 710 NM_004725 Hs.40323 0 1 BUB3 (buddinguninhibited by benzimidazoles 3 107B8 187 545 AI927454 Hs.40328 0 1wo90a02.x1 cDNA, 3′ end/clone = IMAGE: 2462570 458F10 1 436 BE782824Hs.40334 0 1 601472323F1 cDNA, 5′ end/clone = IMAGE: 3875501 463G6 16496 AI266255 Hs.40411 0 1 qx69f01.x1 cDNA, 3′ end/clone = IMAGE: 2006617162F1 2711 2895 D87468 Hs.40888 4.00E−96 1 KIAA0278 gene, partialcds/cds = (0,1383)/gb 463E1 70 272 AL137067 Hs.40919 1.00E−109 1 DNAsequence from clone RP11-13B9 on chromosome 9q22. 458E7 107 774 AK024474Hs.41045 0 1 mRNA for FLJ00067 protein, partial cds/cds = (1 185G12 10512315 AL050141 Hs.41569 1.00E−140 11 mRNA; cDNA DKFZp586O031 (from cloneDKFZp586O0 593F5 2106 2490 NM_006190 Hs.41694 0 1 origin recognitioncomplex, subunit 2 (yeast h 513H4 739 1249 NM_002190 Hs.41724 0 6interleukin 17 (cytotoxic T-lymphocyte-assoc 155F4 739 1247 U32659Hs.41724 0 1 IL-17 mRNA, complete cds/cds = (53,520)/gb = U32659/g108H12 892 1227 L40377 Hs.41726 1.00E−170 1 cytoplasmic antiproteinase 2(CAP2) mRNA, com 477E7 249 404 BG033294 Hs.41989 6.00E−75 1 602298548F1cDNA, 5′ end/clone = IMAGE: 4393186 143E2 5775 6018 A8033112 Hs.421791.00E−136 2 for KIAA1286 protein, partial cds/cds = (1 586B10 720 1225NM_001952 Hs.42287 0 1 E2F transcription factor 6 (E2F6), mRNA/cds = (583A10 346 883 NM_012097 Hs.42500 0 1 ADP-ribosylation factor-like 5(ARL5), mRNA 459A7 152 251 BC003525 Hs.42712 2.00E−50 1 Similar to Max,clone MGC: 10775, mRNA, comple 37B7 43 2687 AF006082 Hs.42915 1.00E−1302 actin-related protein Arp2 (ARP2) mRNA, compl 120E3 512 2426 NM_005722Hs.42915 0 3 ARP2 (actin-related protein 2, yeast) homolog 99D1 32983761 NM_014939 Hs.42959 0 1 KIAA1012 protein (KIAA1012), mRNA/cds =(57,43 473B2 3025 3425 AK023647 Hs.43047 1.00E−164 1 cDNA FLJ13585 fis,clone PLACE1009150/cds = UNK 460E6 2988 3184 AB033093 Hs.43141 1.00E−1051 mRNA for KIAA1267 protein, partial cds/cds = (9 471F7 232 575 AW993524Hs.43148 0 1 RC3-BN0034-120200-011-h06 cDNA/gb = AW993524 460B10 402 706BE781009 Hs.43273 1.00E−78 1 601469768F1 cDNA, 5′ end/clone = IMAGE:3872704 36F6 2815 3403 AK024439 Hs.43616 0 1 for FLJ00029 protein,partial cds/cds = (0 471G3 43 454 NM_006021 Hs.43628 1.00E−165 1 deletedin lymphocytic leukemia, 2 (DLEU2), mR 184H3 1819 2128 D14043 Hs.439101.00E−168 2 MGC-24, complete cds/cds = (79,648)/gb = D1404 195F4 5112370 NM_006016 Hs.43910 0 7 CD164 antigen, sialomucin (CD164), mRNA/cds= 188H9 1573 2277 NM_006346 Hs.43913 0 3 PIBF1 gene product (PIBE1),mRNA/cds = (0,2276) 177H6 1575 2272 Y09631 Hs.43913 0 2 PIBF1 protein,complete/cds = (0,2276)/ 481E6 2529 2873 AB032952 Hs.44087 1.00E−159 1mRNA for KIAA1126 protein, partial cds/cds = (0 112F5 1105 1701 AF197569Hs.44143 0 1 BAF180 (BAF180) mRNA, complete cds/cds = (96,48 146F5 26203147 AL117452 Hs.44155 0 1 DKFZp586G1517 (from clone DKFZp586G 514C5 166431 NM_018838 Hs.44163 1.00E−149 3 13 kDa differentiation-associatedprotein (L 71D9 1117 1800 AF263613 Hs.44198 0 2 membrane-associatedcalcium-independent ph 68E1 289 527 AA576946 Hs.44242 4.00E−83 1nm82b03.s1 cDNA, 3′ end/clone = IMAGE: 1074701 53H12 1925 2112 X75042Hs.44313 4.00E−84 1 rel proto-oncogene mRNA/cds = (177,2036)/gb = X75595D4 21 402 NM_017867 Hs.44344 0 1 hypothetical protein FLJ20534(FLJ20534), mR 165B10 250 658 BC000758 Hs.44468 0 1 clone MGC: 2698,mRNA, complete cds/cds = (168, 592E9 37 2422 NM_002687 Hs.44499 0 5pinin, desmosome associated protein (PNN), mR 69F10 14 1152 Y09703Hs.44499 0 3 MEMA protein/cds = (406,2166)/gb = Y09703 458H6 1 352NM_015697 Hs.44563 0 1 hypothetical protein (CL640), mRNA/cds = (0,39182C11 690 1324 AB046861 Hs.44566 0 4 mRNA for KIAA1641 protein, partialcds/cds = (6 115G3 318 731 BG288837 Hs.44577 0 1 602388170F1 cDNA, 5′end/clone = IMAGE: 4517129 70B11 1879 4363 U58334 Hs.44585 0 3 Bcl2, p53binding protein Bbp/53BP2 (BBP/53BP2) mRNA 165F10 265 496 AV726117Hs.44656 6.00E−66 1 AV726117 cDNA, 5′ end/clone = HTCAXB05/clone_(—)36F1 444 1176 AK001332 Hs.44672 0 1 FLJ10470 fis, clone NT2RP2000032,weakly 596H1 1073 2711 AF288571 Hs.44865 0 14 lymphoid enhancer factor-1(LEF1) mRNA, compl 41C4 2876 3407 X60708 Hs.44926 0 1 pcHDP7 mRNA forliver dipeptidyl peptidase IV/ cds = (75 588A7 7564 7849 AL031667Hs.45207 1.00E−158 1 DNA sequence from clone RP4-620E11 on chromosome20q1 183G6 3967 4942 AB020630 Hs.45719 0 5 mRNA for KIAA0823 protein,partial cds/cds = (0 465C9 700 1325 BC002796 Hs.46446 0 1 lymphoblasticleukemia derived sequence 1, 464B1 1519 1997 NM_006019 Hs.46465 0 1T-cell, immune regulator 1 (TCIRG1), mRNA/cds 466F10 455 518 AW974756Hs.46476 6.00E−26 1 EST386846 cDNA/gb = AW974756/gi = 8165944/ug = 110E7620 1153 AF223469 Hs.46847 0 1 AD022 protein (AD022) mRNA, completecds/cds = 112D5 618 1197 NM_016614 Hs.46847 0 4 TRAF and TNFreceptor-associated protein (AD0 172G6 4157 4527 NM_003954 Hs.47007 0 1mitogen-activated protein kinase kinase kina 177C8 4217 4469 Y10256Hs.47007 1.00E−96 1 serine/threonine protein kinase, NIK/c 458H9 18 457AW291458 Hs.47325 0 1 UI-H-BI2-agh-c-02-0-UI.s1 cDNA, 3′ end/clon 62B6562 697 BE872760 Hs.47334 7.00E−54 1 601450902F1 cDNA, 5′ end/clone =IMAGE: 3854544 178F12 169 2413 AF307339 Hs.47783 0 2 B aggressivelymphoma short isoform (BAL) mRNA 460G4 598 1081 NM_005985 Hs.48029 0 1snail 1 (drosophila homolog), zinc finger prot 70D12 1 2038 AK027070Hs.48320 0 13 FLJ23417 fis, clone HEP20868/cds = (59,12 41G5 6587 7128NM_014345 Hs.48433 0 1 endocrine regulator (HRIHFB2436), mRNA/cds =516H2 1 212 NM_017948 Hs.48712 2.00E−90 2 hypothetical protein FLJ20736(FLJ20736), mR 517G9 665 1649 NM_004462 Hs.48876 0 2farnesyl-diphosphate farnesyltransferase 1 146A2 88 440 X76770 Hs.490070 1 PAP/cds = UNKNOWN/gb = X76770/gi = 556782/ug 174H4 2612 3200AF189011 Hs.49163 0 1 ribonuclease III (RN3) mRNA, complete cds/cds121G3 463 829 NM_017917 Hs.49376 0 1 hypothetical protein FLJ20644(FLJ20644), mR 170B9 2260 2948 AK023825 Hs.49391 0 1 FLJ13763 fis, clonePLACE4000089/cds = (56 65E2 629 1798 AF062075 Hs.49587 0 4 leupaxinmRNA, complete cds/cds = (93,1253)/g 518B2 26 1798 NM_004811 Hs.49587 012 leupaxin (LPXN), mRNA/cds = (93,1253)/gb = NM_0 472E8 1182 1516AL390132 Hs.49822 0 1 mRNA; cDNA DKFZp547E107 (from clone DKFZp547E141B12 57 576 AB000887 Hs.50002 0 1 for EBI1-ligand chemokine, completecds 41D1 1 310 U86358 Hs.50404 1.00E−135 1 chemokine (TECK) mRNA,complete cds/cds = (0,452)/gb 107C9 2861 3541 M64174 Hs.50651 0 3protein-tyrosine kinase (JAK1) mRNA, complete cds/c 599H12 202 3541NM_002227 Hs.50651 0 11 Janus kinase 1 (a protein tyrosine kinase) (JAK105E3 621 1101 AF047442 Hs.50785 0 1 vesicle trafficking protein sec22bmRNA, comp 129B5 2489 2919 X16354 Hs.50964 0 2 transmembranecarcinoembryonic antigen BGPa 587H2 748 1673 NM_000521 Hs.51043 0 2hexosaminidase B (beta polypeptide) (HEXB), m 458H12 4043 4561 NM_000887Hs.51077 0 1 integrin, alpha X (antigen CD11C (p150), alpha 129C9 40554567 Y00093 Hs.51077 0 1 leukocyte adhesion glycoprotein p150,95 125D82502 3966 AF016266 Hs.51233 0 3 TRAIL receptor 2 mRNA, complete cds/cds= (117,1 179E1 17 343 M22538 Hs.51299 1.00E−179 1 nuclear-encodedmitochondrial NADH-ubiquinone redu 165D7 35 754 NM_021074 Hs.51299 0 4NADH dehydrogenase (ubiquinone) flavoprotein 107F10 2632 2993 Y11251Hs.51957 0 2 novel member of serine-arginine domain p 195B12 1344 1590NM_017903 Hs.52184 3.00E−96 1 hypothetical protein FLJ20618 (FLJ20618),mR 69D7 3046 3568 AB014569 Hs.52526 0 4 for KIAA0669 protein, completecds/cds = ( 55D1 2607 2847 NM_014779 Hs.52526 1.00E−130 1 KIAA0669 geneproduct (KIAA0669), mRNA/cds = ( 480B8 1943 2062 AL080213 Hs.527928.00E−44 1 mRNA; cDNA DKFZp586I1823 (from clone DKFZp586I 72G7 1236 1348NM_018607 Hs.52891 2.00E−55 1 hypothetical protein PRO1853 (PRO1853),mRNA 526D1 1 256 NM_004597 Hs.53125 1.00E−114 1 small nuclearribonucleoprotein D2 polypeptid 458E8 1182 1701 NM_002621 Hs.53155 0 1properdin P factor, complement (PFC), mRNA/cd 458G2 2171 2836 NM_001204Hs.53250 0 1 bone morphogenetic protein receptor, type II 458F7 30 650NM_002200 Hs.54434 0 1 interferon regulatory factor 5 (IRF5), mRNA/459F12 2023 3325 NM_006060 Hs.54452 0 2 zinc finger protein, subfamily1A, 1 (lkaros) ( 41A6 498 755 U46573 Hs.54460 1.00E−140 1 eotaxinprecursor mRNA, complete cds/cds = (53,346)/ 590A10 243 659 NM_004688Hs.54483 0 2 N-myc (and STAT) interactor (NMI), mRNA/cds = ( 461C11 8721415 NM_014291 Hs.54609 0 1 glycine C-acetyltransferase (2-amino-3-keto170H5 412 1630 AJ243721 Hs.54642 0 3 for dTDP-4-keto-6-deoxy-D-glucose4-re 521F5 270 1491 NM_013283 Hs.54642 0 8 methionineadenosyltransferase II, beta (MAT 189H5 737 1049 X76302 Hs.546491.00E−131 2 H. sapiens RY-1 mRNA for putative nucleic acid bindingprotei 599D10 2614 3035 AB029015 Hs.54886 0 5 mRNA for KIAA1092 protein,partial cds/cds = (0 458D5 1026 1676 AK027243 Hs.54890 0 1 cDNA:FLJ23590 fis, clone LNG14491/cds = (709,1 37A10 1633 2040 AK026024Hs.55024 0 1 FLJ22371 fis, clone HRC06680/cds = (77,12 121A8 799 1217NM_018053 Hs.55024 1.00E−160 1 hypothetical protein FLJ10307 (FLJ10307),mR 460B1 11195 11326 AF231023 Hs.55173 1.00E−45 1 protocadherin Flamingo1 (FMI1) mRNA, complete 57F1 1450 2070 NM_003447 Hs.55481 0 2 zincfinger protein 165 (ZNF165), mRNA/cds = (5 68D10 979 2070 U78722Hs.55481 0 4 zinc finger protein 165 (Zpf165) mRNA, complete 584G7 2681674 NM_003753 Hs.55682 0 4 eukaryotic translation initiation factor 3,161C8 63 394 NM_017897 Hs.55781 1.00E−177 1 hypothetical proteinFLJ20604 (FLJ20604), mR 588F6 1 387 NM_016497 Hs.55847 0 1 hypotheticalprotein (LOC51258), mRNA/cds = ( 597E10 334 2073 NM_004446 Hs.55921 0 5glutamyl-prolyl-tRNA synthetase (EPRS), mRN 138H10 3603 4112 X54326Hs.55921 0 1 glutaminyl-tRNA synthetase/cds = (58,43 121D5 3959 4192AB018348 Hs.55947 1.00E−130 1 mRNA for KIAA0805 protein, partial cds/cds= (0 473D12 1428 1866 AJ245539 Hs.55968 0 2 partial mRNA for GaINAc-T5(GALNT5 gene)/cds = 71E3 843 1724 NM_005542 Hs.56205 0 30 insulininduced gene 1 (INSIG1), mRNA/cds = (414 73F4 843 2495 U96876 Hs.56205 032 insulin induced protein 1 (INSIG1) gene, compl 75C8 180 2439 AJ277832Hs.56247 0 13 for inducible T-cell co-stimulator (ICOS 187A6 2073 2255AF195530 Hs.56542 2.00E−99 1 soluble aminopeptidase P (XPNPEP1) mRNA,comp 584H5 1496 1889 NM_001494 Hs.56845 1.00E−151 1 GDP dissociationinhibitor 2 (GDI2), mRNA/cds 460C5 2395 2860 AK022936 Hs.56847 0 1 cDNAFLJ12874 fis, clone NT2RP2003769/cds = UNK 460B5 164 741 BC003581Hs.56851 0 1 Similar to RIKEN cDNA 2900073H19 gene, clone 54G4 1359 1761AK027232 Hs.57209 0 2 FLJ23579 fis, clone LNG13017/cds = UNKNOW 192D81576 2872 AL136703 Hs.57209 0 3 mRNA; cDNA DKFZp566J091 (from cloneDKFZp566J0 66F9 618 1056 U41654 Hs.57304 0 1 adenovirus protein E3-14.7kinteracting protein 1 ( 183A1 2093 2334 NM_003751 Hs.57783 1.00E−132 1eukaryotic translation initiation factor 3, 117B3 6933 7225 NM_022898Hs.57987 1.00E−154 3 B-cell lymphoma/leukaemia 11B (BCL11B), mRNA 74C11273 359 BE739287 Hs.58066 7.00E−21 1 601556492F1 cDNA, 5′ end/clone =IMAGE: 3826247 174H2 5591 5977 AJ131693 Hs.58103 0 1 mRNA for AKAP450protein/cds = (222,11948)/gb 599H8 26 993 NM_003756 Hs.58189 0 3eukaryotic translation initiation factor 3, 168F12 295 593 U54559Hs.58189 1.00E−166 1 translation initiation factor elF3 p40 subuni 68B111 297 BE867841 Hs.58297 1.00E−146 1 601443614F1 cDNA, 5′ end/clone =IMAGE: 3847827 104A6 376 2578 AF001862 Hs.58435 0 3 FYN binding proteinmRNA, complete cds/cds = (67 192E3 230 648 NM_001465 Hs.58435 0 4FYN-binding protein (FYB-120/130) (FYB), mRN 73B4 1287 1763 AK022834Hs.58488 0 1 FLJ12772 fis, clone NT2RP2001634, highly 100G3 1568 1786NM_004850 Hs.58617 1.00E−108 1 Rho-associated, coiled-coil containingprot 116G9 1997 2464 NM_013352 Hs.58636 0 1 squamous cell carcinomaantigen recognized by 178C6 5 710 AV760147 Hs.58643 1.00E−111 5 AV760147cDNA, 5′ end/clone = MDSEPB12/clone_(—) 519B1 2203 2320 NM_014207Hs.58685 1.00E−56 1 CD5 antigen (p56-62) (CD5), mRNA/cds = (72,1559 40B61655 2283 X04391 Hs.58685 0 1 lymphocyte glycoprotein T1/Leu-1/cds =(72,1 466B9 262 534 AI684437 Hs.58774 1.00E−107 1 wa82a04.x1 cDNA, 3′end/clone = IMAGE: 2302638 480H7 86 234 NM_006568 Hs.59106 1.00E−54 1cell growth regulatory with ring finger domain 44A7 2229 2703 X17094Hs.59242 0 1 fur mRNA for furin/cds = (216,2600)/gb = X17094/ gi = 314106D12 21 380 M96982 Hs.59271 0 2 U2 snRNP auxiliary factor smallsubunit, compl 39C5 1821 2653 AB011098 Hs.59403 0 1 for KIAA0526protein, complete cds/cds = ( 185H7 1826 2352 NM_004863 Hs.59403 0 1serine palmitoyltransferase, long chain base 459C5 126 443 AA889552Hs.59459 1.00E−158 1 ak20d12.s1 cDNA, 3′ end/clone = IMAGE: 1406519108B8 2760 3079 AJ132592 Hs.59757 1.00E−138 1 for zinc finger protein,3115/cds = (107,27 194F7 2074 2461 NM_018227 Hs.59838 0 1 hypotheticalprotein FLJ10808 (FLJ10808), mR 465D4 2 132 AI440512 Hs.59844 7.00E−67 1tc83f09.x1 cDNA, 3′ end/clone = IMAGE: 2072777 161H10 1 381 AA004799Hs.60088 1.00E−169 1 zh96b05.s1 cDNA, 3′ end/clone IMAGE: 429105/ 465B6228 383 NM_018986 Hs.61053 1.00E−66 1 hypothetical protein (FLJ20356),mRNA/cds = ( 102G9 359 725 D11094 Hs.61153 0 1 MSS1, complete cds/cds =(66,1367)/gb = D11094 193C6 359 725 NM_002803 Hs.61153 1.00E−174 2proteasome (prosome, macropain) 26S subunit, 99E7 1768 2339 AL023653Hs.61469 0 10 DNA sequence from clone 753P9 on chromosome Xq25-26.1.462B9 5 411 BE779284 Hs.61472 1.00E−152 1 601464557F1 cDNA, 5′ end/clone= IMAGE: 3867566 594F11 220 569 NM_003905 Hs.61828 1.00E−159 2 amyloidbeta precursor protein-binding prote 102E7 1216 1921 AF046001 Hs.62112 03 zinc finger transcription factor (ZNF207) mRN 192B4 754 934 NM_003457Hs.62112 2.00E−98 2 zinc finger protein 207 (ZNF207), mRNA/cds = (2 41G91664 2096 J02931 Hs.62192 0 1 placental tissue factor (two forms) mRNA,complete cd 482E12 1857 2149 NM_001993 Hs.62192 5.00E−87 1 coagulationfactor III (thromboplastin, tiss 459C10 1548 1845 AB011114 Hs.622091.00E−166 1 mRNA for KIAA0542 protein, partial cds/cds = (39 114D6 22512712 NM_002053 Hs.62661 0 1 guanylate binding protein 1,interferon-induc 590C9 83 760 NM_002032 Hs.62954 0 43 ferritin, heavypolypeptide 1 (FTH1), mRNA/c 458C5 1798 2407 AB033118 Hs.63128 0 1 mRNAfor KIAA1292 protein, partial cds/cds = (0 109E5 4661 5114 AB002369Hs.63302 0 1 KIAA0371 gene, complete cds/cds = (247,3843) 589G9 250 5650NM_021090 Hs.63302 0 6 myotubularin related protein 3 (MTMR3), mRNA182E4 1751 2144 NM_002831 Hs.63489 0 1 protein tyrosine phosphatase,non-receptor t 589C8 1787 2222 AK023529 Hs.63525 0 2 cDNA FLJ13467 fis,clone PLACE1003519, highly 458D7 1595 1912 NM_022727 Hs.63609 1.00E−1801 Hpall tiny fragments locus 9C (HTF9C), mRNA/c 193A2 144 2588 NM_003264Hs.63668 0 5 toll-like receptor 2 (TLR2), mRNA/cds = (129,24 117C3 15042366 AF131762 Hs.64001 0 3 clone 25218 mRNA sequence/cds = UNKNOWN/ gb =AF 109F1 568 2157 AL031602 Hs.64239 0 3 DNA sequence from cloneRP5-1174N9 on chromosome 1p34 40D5 698 1192 U32324 Hs.64310 0 1interleukin-11 receptor alpha chain mRNA, complete c 522F4 12 504NM_006356 Hs.64593 0 1 ATP synthase, H+ transporting, mitochondrial462E9 215 891 NM_015423 Hs.64595 0 1 aminoadipate-semialdehydedehydrogenase-ph 164G10 37 889 NM_006851 Hs.64639 0 2 gliomapathogenesis-related protein (RTVP1), 155G10 1 601 U16307 Hs.64639 0 1glioma pathogenesis-related protein (GliPR) mRNA, c 110D11 341 712S60099 Hs.64797 0 1 APPH = amyloid precursor protein homolog [human,placenta, 513E8 3411 3986 AF148537 Hs.65450 0 7 reticulon 4a mRNA,complete cds/cds = (141,3719 460F4 1415 1749 NM_018174 Hs.660481.00E−163 1 hypothetical protein FLJ10669 (FLJ10669), mR 478H8 486 1037NM_001775 Hs.66052 0 1 CD38 antigen (p45) (CD38), mRNA/cds = (69,971)461A6 2977 3516 AB051540 Hs.66053 0 1 mRNA for KIAA1753 protein, partialcds/cds = (0 191E7 1 494 AL157438 Hs.66151 0 6 mRNA; cDNA DKFZp434A115(from clone DKFZp434A1 464B6 76 623 NM_002528 Hs.66196 0 1 nth (E. coliendonuclease III)-like 1 (NTHL1), 473C6 149 517 BE673759 Hs.66357 0 17d69d02.x1 cDNA, 3′ end/clone = IMAGE: 3278211 171G11 1001 1385 Z98884Hs.66708 0 1 DNA sequence from clone RP3-467L1 on chromosome 1p36. 169H315 1800 X82200 Hs.68054 0 4 Staf50/cds = (122,1450)/gb = X82200/gi =8992 167G9 747 1104 NM_005932 Hs.68583 1.00E−101 1 mitochondrialintermediate peptidase (MIPEP) 170H3 747 1104 U80034 Hs.68583 6.00E−99 1mitochondrial intermediate peptidase precurs 69F9 321 1348 U78027Hs.69089 0 5 Bruton's tyrosine kinase (BTK), alpha-D-galac 586D6 16 676NM_006360 Hs.69469 1.00E−173 2 dendritic cell protein (GA17), mRNA/cds =(51,1 591E3 74 189 NM_002385 Hs.69547 2.00E−59 1 myelin basic protein(MBP), mRNA/cds = (10,570) 597H2 482 2702 NM_007158 Hs.69855 0 8NRAS-related gene (D15155E), mRNA/cds = (420,2 515C5 3257 3421 NM_003169Hs.70186 8.00E−45 1 suppressor of Ty (S.cerevisiae) 5 homolog (SUP 461B944 425 H06786 Hs.70258 0 1 yl83g05.r1 cDNA, 5′ end/clone = IMAGE:44737/c 525H4 2834 2978 NM_014933 Hs.70266 4.00E−77 1 yeast Sec31phomolog (KIAA0905), mRNA/cds = (53 521C3 1 1165 NM_016628 Hs.703331.00E−176 2 hypothetical protein (LOC51322), mRNA/cds = ( 460E5 414 994AF138903 Hs.70337 0 1 immunoglobulin superfamily protein beta-like 190C71406 1788 D50926 Hs.70359 0 1 mRNA for KIAA0136 gene, partial cds/cds =(0,2854)/gb 497F10 653 1096 NM_014210 Hs.70499 0 3 ecotropic viralintegration site 2A (EVI2A), m 37C11 820 1523 AB002368 Hs.70500 0 4KIAA0370 gene, partial cds/cds = (0,2406)/gb 464B2 496 721 BG283002Hs.71243 3.00E−99 1 602406192F1 cDNA, 5′ end/clone = IMAGE: 4518214 69G41292 2708 AL161991 Hs.71252 0 4 cDNA DKFZp761C169 (from clone DKFZp761C1485E4 176 485 AA131524 Hs.71433 1.00E−151 1 zl31h02.s1 cDNA, 3′end/clone = IMAGE: 503571/ 161G2 1338 1877 NM_003129 Hs.71465 0 1squalene epoxidase (SQLE), mRNA/cds(214,193 188D6 328 597 NM_016630Hs.71475 1.00E−129 1 hypothetical protein (LOC51324), mRNA/cds = ( 483B512 384 NM_021128 Hs.71618 0 1 polymerase (RNA) II (DNA directed)polypeptide 161F6 675 1114 U79277 Hs.71848 0 1 clone 23548 mRNAsequence/cds = UNKNOWN/ gb = U79277/g 473F8 377 729 BE889075 Hs.719411.00E−146 1 601513514F1 cDNA, 5′ end/clone = IMAGE: 3915003 102A6 11291560 AK023183 Hs.72782 0 1 FLJ13121 fis, clone NT2RP3002687/cds = (3941E2 56 539 M57506 Hs.72918 0 1 secreted protein (I-309) gene, completecds/cds = (72, 476E12 1790 2311 S76638 Hs.73090 0 2 p50-NF-kappa Bhomolog [human, peripheral blood T cells, mR 41G7 3116 3469 U64198Hs.73165 1.00E−173 1 II-12 receptor beta2 mRNA, complete cds/ cds =(640,322 51C9 1721 2339 NM_005263 Hs.73172 0 4 growth factor independent1 (GFI1), mRNA/cds = 67H6 1723 2342 U67369 Hs.73172 0 1 growth factorindependence-1 (Gfi-1) mRNA, complete 179E7 211 610 M92444 Hs.73722 0 1apurinic/apyrimidinic endonuclease (HAP1) g 585G3 174 589 NM_001641Hs.73722 0 8 APEX nuclease (multifunctional DNA repair enz 138A11 13601717 M72709 Hs.73737 1.00E−151 1 alternative splicing factor mRNA,complete cds/cds = 49C8 1628 2276 AK001313 Hs.73742 0 4 cDNA FLJ10451fis, clone NT2RP1000959, highly 41D7 2760 3563 J03565 Hs.73792 0 1Epstein-Barr virus complement receptor type ll(cr2) 121F8 2470 2815AL136131 Hs.73793 1.00E−123 1 DNA sequence from clone RP1-261G23 onchromosome 6p12 482C7 2864 3199 NM_003005 Hs.73800 1.00E−165 3 selectinP (granule membrane protein 140 kD, an 153E12 160 778 D90144 Hs.73817 022 gene for LD78 alpha precursor, complete cds/c 489E12 161 776NM_002983 Hs.73817 0 6 small inducible cytokine A3 (homologous to mo177D7 112 388 BF673951 Hs.73818 1.00E−143 1 602137331F1 cDNA, 5′end/clone = IMAGE: 4274094 587E10 5 387 NM_006004 Hs.73818 1.00E−155 6ubiquinol-cytochrome c reductase hinge prote 142H11 119 436 AL110183Hs.73851 1.00E−148 1 cDNA DKFZp566A221 (from clone DKFZp566A2 190G11 1375 NM_001685 Hs.73851 0 6 ATP synthase, H+ transporting, mitochondrial119D10 675 1700 BC001267 Hs.73957 0 4 RAB5A, member RAS oncogene family,clone MGC: 135H12 1244 1772 NM_003016 Hs.73965 0 2 splicing factor,arginine/serine-rich 2 (SFR 160E6 1811 2196 X75755 Hs.73965 0 5 PR264gene/cds = (98,763)/gb = X75755/gi = 455418 175F9 791 1446 L29218Hs.73986 0 2 clk2 mRNA, complete cds/cds = (129,1628)/gb = L2 516D9 7821144 NM_003992 Hs.73987 0 1 CDC-like kinase 3 (CLK3), transcript variantp 469F3 1778 1956 NM_002286 Hs.74011 4.00E−78 1 lymphocyte-activationgene 3 (LAG3), mRNA/cd 481D6 1323 1805 Z22970 Hs.74076 1.00E−173 1 H.sapiens mRNA for M130 antigen cytoplasmic variant 2/cds = ( 193H9 8131569 NM_007360 Hs.74085 1.00E−127 3 DNA segment on chromosome 12(unique) 2489 expr 39D9 810 994 X54870 Hs.74085 1.00E−100 1 NKG2-Dgene/cds = (338,988)/gb = X54870/gi = 3 71F3 3014 3858 NM_004430Hs.74088 1.00E−114 4 early growth response 3 (EGR3), mRNA/cds = (357,74B12 3651 4214 S40832 Hs.74088 1.00E−114 7 EGR3 = EGR3 protein mRNA,105E11 2 142 AL050391 Hs.74122 6.00E−72 2 cDNA DKFZp586A181 (from cloneDKFZp586A1 174A12 141 1072 NM_001225 Hs.74122 0 9 caspase 4,apoptosis-related cysteine protea 599E9 351 1864 AF279903 Hs.74267 0 660S ribosomal protein L15 (EC45) mRNA, complet 74F7 126 1867 AF283772Hs.74267 0 8 clone TCBAP0781 mRNA sequence/cds = (40,654)/ 156G12 554831 AF034607 Hs.74276 1.00E−156 1 chloride channel ABP mRNA, completecds/cds = ( 118F4 1 148 BG112085 Hs.74313 7.00E−65 2 602283260F1 cDNA,5′ end/clone = IMAGE: 4370727 70G10 1 2177 M16660 Hs.74335 0 26 90-kDaheat-shock protein gene, cDNA, complete cds/c 64D1 330 2219 NM_007355Hs.74335 0 26 heat shock 90 kD protein 1, beta (HSPCB), mRNA/ 121E12 7001033 NM_006826 Hs.74405 0 1 tyrosine 3-monooxygenase/tryptophan 5-monoo177D3 480 1645 X57347 Hs.74405 0 2 HS1 protein/cds = (100,837)/gb =X57347/ 155A5 680 1176 U86602 Hs.74407 0 1 nucleolar protein p40 mRNA,complete cds/ cds = (142,10 181G10 1802 2302 NM_012381 Hs.74420 0 2origin recognition complex, subunit 3 (yeast h 66D8 927 1490 X86691Hs.74441 0 1 218 kD Mi-2 protein/cds = (89,5827)/gb = X 189D10 383 1102NM_001749 Hs.74451 0 7 calpain 4, small subunit (30 K) (CAPN4), mRNA/171A3 721 1092 X04106 Hs.74451 1.00E−174 1 calcium dependent protease(small subunit)/ 173F3 1069 1468 NM_004559 Hs.74497 0 1 nucleasesensitive element binding protein 1 176B7 1592 1990 NM_001178 Hs.74515 01 aryl hydrocarbon receptor nuclear translocato 481A11 2012 2210NM_000947 Hs.74519 2.00E−61 1 primase, polypeptide 2A (58 kD) (PRIM2A),mRNA 116G8 689 1417 NM_002537 Hs.74563 0 4 ornithine decarboxylaseantizyme 2 (OAZ2), mR 526F6 185 1088 NM_003145 Hs.74564 0 3 signalsequence receptor, beta (translocon-as 104D3 713 1127 X79353 Hs.74576 01 XAP-4 mRNA for GDP-dissociation inhibitor/cds = ( 518G1 2725 2993NM_001357 Hs.74578 1.00E−134 1 DEAD/H (Asp-Glu-Ala-Asp/His) boxpolypeptide 459H1 3093 3268 NM_014767 Hs.74583 3.00E−67 1 KIAA0275 geneproduct (KIAA0275), mRNA/cds = ( 69C5 2304 2781 M97287 Hs.74592 0 3MAR/SAR DNA binding protein (SATB1) mRNA 587F12 930 2777 NM_002971Hs.74592 0 6 special AT-rich sequence binding protein 1 (b 124H10 12401812 NM_002808 Hs.74619 0 2 proteasome (prosome, macropain) 26S subunit,57F10 700 2310 NM_000311 Hs.74621 0 60 prion protein (p27-30)(Creutzfeld-Jakob dis 74A10 870 2252 U29185 Hs.74621 0 34 prion protein(PrP) gene, complete cds/cds = (24 176H10 465 923 NM_000108 Hs.74635 0 1dihydrolipoamide dehydrogenase (E3 component 98F4 870 2566 NM_003217Hs.74637 0 7 testis enhanced gene transcript (TEGT), mRNA 179H8 1 1210X75861 Hs.74637 0 3 TEGT gene/cds = (40,753)/gb = X75861/gi = 456258/125C4 417 1425 NM_014280 Hs.74711 0 2 splicing factor similar to dnaJ(SPF31), mRNA 74C5 21 177 BE549137 Hs.74861 4.00E−65 1 601076443F1 cDNA,5′ end/clone = IMAGE: 3462154 497B12 124 384 NM_006713 Hs.748611.00E−123 2 activated RNA polymerase II transcription cof 191E10 497 859NM_022451 Hs.74899 0 1 hypothetical protein FLJ12820 (FLJ12820), mR114A3 1032 1446 AY007131 Hs.75061 0 1 clone CDABP0045 mRNA sequence117G3 279 799 NM_004622 Hs.75066 0 1 translin (TSN), mRNA/cds =(81,767)/gb = NM_004 483G2 3293 3639 NM_006148 Hs.75080 1.00E−180 1 LIMand SH3 protein 1 (LASP1),/cds = (75,860)/g 181E11 8314 8804 NM_000038Hs.75081 0 1 adenomatosis polyposis coli (APC), mRNA/cds = 597G6 3742361 NM_003406 Hs.75103 0 6 tyrosine 3-monooxygenase/tryptophan 5-monoo596F11 684 1088 NM_002097 Hs.75113 0 1 general transcription factor IIIA(GTF3A), mR 69C9 995 1564 AF113702 Hs.75117 0 4 clone FLC1353 PRO3063mRNA, complete cds/cds = 46E7 128 1519 NM_004515 Hs.75117 1.00E−164 2interleukin enhancer binding factor 2, 45 kD ( 481B10 66 515 NM_003201Hs.75133 0 1 transcription factor 6-like 1 (mitochondrial 469C5 368 969NM_006708 Hs.75207 0 1 glyoxalase I (GLO1), mRNA/cds = (87,641)/gb = N71B4 939 2049 NM_002539 Hs.75212 0 24 ornithine decarboxylase 1 (ODC1)mRNA/cds = (33 75E10 173 1991 X16277 Hs.75212 0 51 ornithinedecarboxylase ODC (EC 4.1.1.17)/c 166G9 2077 2632 L36870 Hs.75217 0 1MAP kinase kinase 4 (MKK4) mRNA, complete cds/ 167A12 2074 2619NM_003010 Hs.75217 0 1 mitogen-activated protein kinase kinase 4 (M105B12 3030 5207 D67029 Hs.75232 0 3 SEC14L mRNA, complete cds 125D14782 5209 NM_003003 Hs.75232 0 1 SEC14 (S. cerevisiae)-like 1 (SEC14L1),mRNA 184E4 2075 3174 D42040 Hs.75243 0 5 KIAA9001 gene, complete cds/cds= (1701,4106) 191E5 2071 3174 NM_005104 Hs.75243 0 2bromodomain-containing 2 (BRD2), mRNA/cds = (1 186C12 4159 4866NM_001068 Hs.75248 0 6 topoisomerase (DNA) II beta (180 kD) (TOP2B), m177C9 4473 4866 X68060 Hs.75248 0 1 topIIb mRNA for topoisomeraseIIb/cds = (0,4865) 39D8 743 1980 D31885 Hs.75249 0 6 KIAA0069 gene,partial cds/cds = (0,680)/gb = 127G2 1363 1769 NM_016166 Hs.75251 0 1DEAD/H (Asp-Glu-Ala-Asp/His) box binding pro 64E5 4 1214 NM_002922Hs.75256 0 6 regulator of G-protein signalling 1 (RGS1), mR 69G5 276 914S59049 Hs.75256 0 6 BL34 = B cell activation gene [human, mRNA, 1398 nt]101F6 315 758 AF054174 Hs.75258 0 1 histone macroH2A1.2 mRNA, completecds/cds = ( 596E10 320 1667 NM_004893 Hs.75258 0 5 H2A histone family,member Y (H2AFY), mRNA/cds 587G10 639 953 NM_001628 Hs.75313 1.00E−147 1aldo-keto reductase family 1, member B1 (aldo 128F7 181 933 X06956Hs.75318 0 4 HALPHA44 gene for alpha-tubulin, exons 1-3 74A1 321 3290D21262 Hs.75337 0 10 KIAA0035 gene, partial cds/cds = (0,2125)/gb 50D8 2667 BF303895 Hs.75344 0 4 601886515F2 cDNA, 5′ end/clone = IMAGE:4120514 179F7 379 720 L07633 Hs.75348 1.00E−179 4 (clone 1950.2)interferon-gamma IEF SSP 5111 m 191F3 158 872 NM_006263 Hs.75348 0 18proteasome (prosome, macropain) activator su 463G4 1849 2394 NM_001873Hs.75360 0 1 carboxypeptidase E (CPE), mRNA/cds = (290,1720 117D6 224671 AB023200 Hs.75361 0 1 mRNA for KIAA0983 protein, complete cds/cds =( 73E8 1 2339 D89077 Hs.75367 0 8 for Src-like adapter protein, completecd 49H5 1 2388 NM_006748 Hs.75367 0 4 Src-like-adapter (SLA), mRNA/cds =(41,871)/ 134A3 550 1126 NM_005917 Hs.75375 0 1 malate dehydrogenase 1,NAD (soluble) (MDH1), 462F2 73 361 NM_004172 Hs.75379 1.00E−158 1 solutecarrier family 1 (glial high affinity gl 477G6 769 2043 NM_004300Hs.75393 0 3 acid phosphatase 1, soluble (ACP1), transcript 62A10 10282528 X87949 Hs.75410 0 7 BiP protein/cds = (222,2183)/gb = X87949 125H4510 807 NM_006010 Hs.75412 1.00E−130 2 Arginine-rich protein (ARP),mRNA/cds = (132,8 70H1 29 2349 AK026463 Hs.75415 0 30 FLJ22810 fis,clone KAIA2933, highly sim 60D3 160 1666 D31767 Hs.75416 0 6 KIAA0058gene, complete cds/cds = (69,575)/g 98D5 103 1233 NM_014764 Hs.75416 010 DAZ associated protein 2 (DAZAP2), mRNA/cds = ( 55H1 1183 1390NM_016525 Hs.75425 2.00E−81 1 ubiquitin associated protein (UBAP),mRNA/cd 44B12 51 480 BF131654 Hs.75428 0 3 601820480F1 cDNA, 5′end/clone = IMAGE: 4052586 64E11 1 177 NM_000454 Hs.75428 7.00E−94 1superoxide dismutase 1, soluble (amyotrophic 65D3 387 969 L33842Hs.75432 0 4 (clone FFE-7) type II inosine monophosphate de 58F9 379 672NM_000884 Hs.75432 1.00E−149 1 IMP (inosine monophosphate) dehydrogenase2 73B1 87 291 BE790474 Hs.75458 5.00E−71 2 601476059F1 cDNA, 5′end/clone = IMAGE: 3878799 585G5 1 302 NM_000979 Hs.75458 1.00E−170 8ribosomal protein L18 (RPL18), mRNA/cds = (15,5 173A1 1893 2653NM_006763 Hs.75462 0 2 BTG family, member 2 (BTG2), mRNA/cds = (71,547)166A10 601 1147 AB00015 Hs.75470 0 1 mRNA expressed in osteoblast,complete cds/cd 180D10 601 1045 NM_006820 Hs.75470 0 1 hypotheticalprotein, expressed in osteoblast 122D9 3322 5191 AB023173 Hs.75478 0 2mRNA for KIAA0956 protein, partial cds/cds = (0 461E5 2484 2804 AL133074Hs.75497 1.00E−144 1 mRNA; cDNA DKFZp434M1317 (from clone DKFZp434M512D6 69 799 NM_004591 Hs.75498 0 12 small inducible cytokine subfamilyA (Cys-Cys 146B12 54 783 U64197 Hs.75498 0 4 chemokine exodus-1 mRNA,complete cds/cds = (4 596H5 685 1952 NM_001157 Hs.75510 0 5 annexin A11(ANXA11), mRNA/cds = (178,1695)/g 179D6 215 603 D23662 Hs.755121.00E−168 2 ubiquitin-like protein, complete cds 522G12 52 603 NM_006156Hs.75512 0 2 neural precursor cell expressed, developmenta 46B6 11081418 NM_000270 Hs.75514 1.00E−166 1 nucleoside phosphorylase (NP),mRNA/cds = (109 73H11 83 1418 X00737 Hs.75514 1.00E−104 3 purinenucleoside phosphorylase (PNP; EC 2. 154F7 1279 2056 L05425 Hs.75528 0 3nucleolar GTPase mRNA, complete cds/cds = (79,2 164C10 1268 1910NM_013285 Hs.75528 0 2 nucleolar GTPase (HUMAUANTIG), mRNA/cds = (79,106C8 76 322 Z25749 Hs.75538 1.00E−130 3 gene for ribosomal proteinS7/cds = (81,665)/gb = 98E5 474 1188 NM_003405 Hs.75544 0 1 tyrosine3-monooxygenase/tryptophan 5-monoo 459G10 2160 2717 NM_000418 Hs.75545 01 interleukin 4 receptor (IL4R), mRNA/cds = (175, 44B2 71 692 U03851Hs.75546 0 1 capping protein alpha mRNA, partial cds/ cds = (16,870)483F2 1207 1392 NM_004357 Hs.75564 1.00E−80 1 CD151 antigen (CD151),mRNA/cds = (84,845)/gb 596D6 1968 2392 NM_021975 Hs.75569 0 1 v-relavian reticuloendotheliosis viral onco 466G10 679 896 NM_014763 Hs.755741.00E−120 2 mitochondrial ribosomal protein L19 (MRPL19), 524B3 61946477 NM_001759 Hs.75586 1.00E−147 1 cyclin D2 (CCND2), mRNA/cds =(269,1138)/gb = N 481B4 3423 3804 NM_000878 Hs.75596 1.00E−160 2interleukin 2 receptor, beta (IL2RB), mRNA/cd 162B5 753 1694 M29064Hs.75598 0 6 hnRNP B1 protein mRNA/cds = (149,1210)/ gb = M29064/gi176F5 730 922 NM_002137 Hs.75598 1.00E−106 1 heterogeneous nuclearribonucleoprotein A2/ 106C2 1654 2589 D10522 Hs.75607 0 8 for 80K-Lprotein, complete cds/cds = (369, 98C5 1538 2589 NM_002356 Hs.75607 0 20myristoylated alanine-rich protein kinase C 192E5 1007 1416 NM_006819Hs.75612 0 1 stress-induced-phosphoprotein 1 (Hsp70/Hsp9 40E12 836 1765M98399 Hs.75613 0 2 antigen CD36 (clone 21) mRNA, complete cds/cds(254,1 107C6 1491 1595 AF113676 Hs.75621 3.00E−51 1 clone FLB2803PRO0684 mRNA, complete cds/cds = 117E9 149 1033 NM_001779 Hs.75626 0 2CD58 antigen, (lymphocyte function-associate 482H10 740 1367 NM_000591Hs.75627 0 1 CD14 antigen (CD14), mRNA/cds = (119,1246)/gb 482D4 13421659 NM_006163 Hs.75643 3.00E−82 1 nuclear factor (erythroid-derived 2),45 kD (N 73F8 2864 3657 L49169 Hs.75678 0 20 G0S3 mRNA, complete cds/cds= (593,1609)/ gb = L49169/ 58G3 3222 3657 NM_006732 Hs.75678 0 6 FBJmurine osteosarcoma viral oncogene homolo 53A7 30 836 J04130 Hs.75703 0138 activation (Act-2) mRNA, complete cds/cds = (108,386) 500E11 41 688NM_002984 Hs.75703 0 128 small inducible cytokine A4 (homologous to mo170E9 415 2376 M16985 Hs.75709 0 6 cation-dependent mannose6-phosphate-specific rece 591E8 1759 2401 NM_002355 Hs.75709 0 3mannose-6-phosphate receptor (cation depende 191A11 20 1900 NM_002575Hs.75716 0 13 serine (or cysteine) proteinase inhibitor, cl 184F5 181900 Y00630 Hs.75716 0 8 Arg-Serpin (plasminogen activator-inhibito593G8 238 747 NM_005022 Hs.75721 1.00E−110 2 profilin 1 (PFN1), mRNA/cds= (127,549)/gb = NM 178G9 504 2101 NM_002951 Hs.75722 0 2 ribophorin II(RPN2), mRNA/cds = (288,2183)/g 138F12 2341 2488 Y00282 Hs.757224.00E−60 1 ribophorin II/cds = (288,2183)/gb = Y00282/g 37F7 1328 1863AK023290 Hs.75748 0 3 FLJ13228 fis, clone OVARC1000085, highly 119C73736 4103 NM_003137 Hs.75761 1.00E−172 1 SFRS protein kinase 1 (SRPK1),mRNA/cds = (108,2 52E8 574 1106 M36820 Hs.75765 0 2 cytokine (GRO-beta)mRNA, complete cds/ cds = (74,397) 74C8 2055 3026 M10901 Hs.75772 0 4glucocorticoid receptor alpha mRNA, complete cds/cd 196C5 2600 4591NM_000176 Hs.75772 0 5 nuclear receptor subfamily 3, group C, member68E7 2194 2597 D87953 Hs.75789 0 1 RTP, complete cds/cds = (122,1306)/gb= D87953 116E3 289 621 NM_016470 Hs.75798 0 1 hypothetical protein(HSPC207), mRNA/cds = (0 107C10 650 1165 AK025732 Hs.75811 0 1 FLJ22079fis, clone HEP13180, highly sim 123C12 459 969 NM_004315 Hs.75811 0 1N-acylsphingosine amidohydrolase (acid cera 99E11 1007 2346 NM_014761Hs.75824 0 2 KIAA0174 gene product (KIAA0174), mRNA/cds = ( 128C11 377906 NM_006817 Hs.75841 0 2 endoplasmic reticulum lumenal protein (ERP28175F5 455 843 X94910 Hs.75841 1.00E−173 1 ERp28 protein/cds =(11,796)/gb = X9491 182F12 4263 4842 D86550 Hs.75842 0 1 mRNA forserine/threonine protein kinase, complete c 175E3 3255 3787 AL110132Hs.75875 0 1 mRNA; cDNA DKFZp564H192 (from clone DKFZp564H1 195G3 14352132 NM_003349 Hs.75875 0 2 ubiquitin-conjugating enzyme E2 variant 1 (U184B12 17 282 BF698920 Hs.75879 1.00E−138 8 602126495F1 cDNA, 5′end/clone = IMAGE: 4283350 67G6 1218 1605 AK000639 Hs.75884 1.00E−173 1FLJ20632 fis, clone KAT03756, highly simi 516A11 721 1109 NM_015416Hs.75884 0 2 DKFZP586A011 protein (DKFZP586A011), mRNA/c 44B1 1066 4914NM_004371 Hs.75887 0 4 coatomer protein complex, subunit alpha (COPA594D3 3971 4158 NM_003791 Hs.75890 1.00E−73 1 site-1 protease(subtilisin-like, sterol-reg 459H8 5291 5688 D87446 Hs.75912 1.00E−160 1mRNA for KIAA0257 gene, partial cds/cds = (0,5418)/gb 113F6 2281 2807NM_006842 Hs.75916 0 1 splicing factor 3b, subunit 2, 145 kD (SF382), m104F9 2334 2804 U41371 Hs.75916 0 1 spliceosome associated protein (SAP145) mRNA, compl 100F12 656 825 AK024890 Hs.75932 6.00E−83 1 FLJ21237fis, clone COL01114/cds = UNKNOW 39E1 40 526 BF217687 Hs.75968 1.00E−1242 601882510F1 cDNA, 5′ end/clone = IMAGE: 4094907 111G8 41 547 NM_021109Hs.75968 1.00E−166 19 thymosin, beta 4, X chromosome (TMSB4X), mRNA478A7 1335 1653 NM_006813 Hs.75969 1.00E−119 1 proline-rich protein withnuclear targeting s 70E9 652 1065 U03105 Hs.75969 0 1 B4-2 protein mRNA,complete cds/cds = (113,1096)/ gb = U 596B9 508 1461 NM_003133 Hs.759750 2 signal recognition particle 9 kD (SRP9), mRNA 513F12 1359 2169NM_005151 Hs.75981 0 3 ubiquitin specific protease 14 (tRNA-guanine 74B31361 2166 U30888 Hs.75981 0 2 tRNA-guanine transglycosylase mRNA,complete cds/c 67B6 81 1457 X17025 Hs.76038 0 4 homolog of yeast IPPisomerase/cds = (50,736)/ gb = X170 586F2 1471 2197 NM_004396 Hs.76053 013 DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 70B3 762 2211 X52104Hs.76053 0 12 p68 protein/cds = (175,2019)/gb = X52104/gi = 3 73B2 32494 BF214146 Hs.76064 0 1 601847762F1 cDNA, 5′ end/clone = IMAGE:4078622 523E6 10 441 NM_000990 Hs.76064 0 2 ribosomal protein L27a(RPL27A), mRNA/cds = (1 38F7 6 372 Z23090 Hs.76067 0 2 28 kDa heat shockprotein/cds = (491,1108) 59B6 916 1274 AF071596 Hs.76095 1.00E−174 1apoptosis inhibitor (IEX-1L) gene, complete c 493B3 540 1206 NM_003897Hs.76095 0 3 immediate early response 3 (IER3), mRNA/cds = ( 483D7 13992063 NM_005626 Hs.76122 0 1 splicing factor, arginine/serine-rich 4 (SFR591C12 13412 13873 NM_003922 Hs.76127 0 3 hect (homologous to the E6-AP(UBE3A) carboxyl 65H7 12209 12580 U50078 Hs.76127 0 1 guanine nucleotideexchange factor p532 mRNA, complet 160B6 79 535 X77584 Hs.761361.00E−140 1 ATL-derived factor/thiredoxin/cds = (80 596A9 1 124NM_001009 Hs.76194 3.00E−62 1 ribosomal protein S5 (RPS5), mRNA/cds =(37,651 51H5 2834 3174 AK025353 Hs.76230 1.00E−180 1 cDNA: FLJ21700 fis,clone COL09849, highly sim 115C8 1589 2005 NM_001748 Hs.76288 0 1calpain 2, (m/II) large subunit (CAPN2), mRNA 588C5 4 336 NM_004492Hs.76362 0 2 general transcription factor IIA, 2 (12 kD subu 111D9 7321077 NM_004930 Hs.76368 1.00E−161 2 capping protein (actin filament)muscle Z-lin 192A11 1589 1995 NM_002462 Hs.76391 0 3 myxovirus(influenza) resistance 1, homolog o 39F5 8481 8730 Y00285 Hs.764731.00E−111 1 insuline-like growth factor II receptor/cds 98C4 487 3719NM_002298 Hs.76506 0 38 lymphocyte cytosolic protein 1 (L-plastin) (L124H12 611 1747 NM_004862 Hs.76507 0 5 LPS-induced TNF-alpha factor(PIG7), mRNA/cd 37A6 920 1524 U77396 Hs.76507 1.00E−162 2 LPS-InducedTNF-Alpha Factor (LITAF) mRNA, co 71E9 759 3362 D00099 Hs.76549 0 4 mRNAfor Na,K-ATPase alpha-subunit, complete 73F5 951 1277 AK001361 Hs.765561.00E−168 1 FLJ10499 fis, clone NT2RP2000346, weakly 48H6 1097 1603NM_014330 Hs.76556 0 2 growth arrest and DNA-damage-inducible 34 (G160C8 74 181 BE730376 Hs.76572 2.00E−40 1 601563816F1 5′ end/clone =IMAGE: 3833690 589D11 86 455 NM_001697 Hs.76572 0 2 ATP synthase, H+transporting, mitochondrial 38B1 227 886 NM_014059 Hs.76640 0 9 RGC32protein (RGC32), mRNA/cds = (146,499)/g 174B12 3024 4628 D80005 Hs.766661.00E−136 4 mRNA for KIAA0183 gene, partial cds/cds = (0,3190)/gb 37A111788 3255 AF070673 Hs.76691 0 5 stannin mRNA, complete cds/cds =(175,441)/gb 58H11 1706 2088 AL136807 Hs.76698 0 2 mRNA; cDNADKFZp434L1621 (from clone DKFZp434L 477F9 6930 7298 AB002299 Hs.76730 02 mRNA for KIAA0301 gene, partial cds/cds = (0,6144)/gb 40G7 293 819NM_000118 Hs.76753 0 1 endoglin (Osler-Rendu-Weber syndrome 1) (EN 75C1110 1113 J00194 Hs.76807 0 5 human hla-dr antigen alpha-chain mrna & ivsfragments/cds = 99F4 10 969 NM_019111 Hs.76807 0 6 majorhistocompatibility complex, class II, 61G12 1870 2511 AL133096 Hs.768530 1 cDNA DKFZp434N1728 (from clone DKFZp434N 599C2 41 346 NM_002790Hs.76913 1.00E−124 1 proteasome (prosome, macropain) subunit, alp 155C2508 870 X61970 Hs.76913 0 1 for macropain subunit zeta/cds = (21,746)/g70C5 3398 3754 AF002020 Hs.76918 0 1 Niemann-Pick C disease protein(NPC1) mRNA, co 57A11 2173 2764 NM_000271 Hs.76918 0 1 Niemann-Pickdisease, type C1 (NPC1), mRNA/cd 158C9 314 1233 NM_001679 Hs.76941 0 3ATPase, Na+/K+ transporting, beta 3 polypeptid 520E1 4175 4502 NM_014757Hs.76986 1.00E−158 1 mastermind (Drosophila), homolog of (MAML1), 587D822 869 NM_001006 Hs.77039 0 5 ribosomal protein S3A (RPS3A), mRNA/cds =(36,8 481F2 440 1488 NM_001731 Hs.77054 0 3 B-cell translocation gene 1,anti-proliferati 53G11 340 1490 X61123 Hs.77054 0 3 BTG1 mRNA/cds =(308,823)/gb = X61123/gi = 29508/ ug = Hs 521A6 147 1325 D55716 Hs.771520 2 mRNA for P1cdc47, complete cds/cds = (116,2275)/ gb = D 37H9 21092530 X07109 Hs.77202 0 1 protein kinase C (PKC) type/cds = (136,2157)/167H5 3915 4508 NM_006437 Hs.77225 0 1 ADP-ribosyltransferase (NAD+;poly (ADP-ribo 139G5 2183 2389 U61145 Hs.77256 1.00E−111 1 enhancer ofzeste homolog 2 (EZH2) mRNA, complete cds 109H2 2502 2893 D38549Hs.77257 0 1 KIAA0068 gene, partial cds/cds = (0,3816)/gb 184B7 619 1111L25080 Hs.77273 0 1 GTP-binding protein (rhoA) mRNA, complete cds 587H1614 1371 NM_001664 Hs.77273 0 9 ras homolog gene family, member A(ARHA), mRNA 99G10 1387 2219 NM_002658 Hs.77274 0 1 plasminogenactivator, urokinase (PLAU), mRN 143C12 2403 2905 AL049332 Hs.77311 0 2cDNA DKFZp564L176 (from clone DKFZp564L1 519B11 5248 5555 NM_000430Hs.77318 1.00E−160 1 platelet-activating factor acetylhydrolase, 52F103249 3459 AF095901 Hs.77324 1.00E−114 2 eRF1 gene, complete cds/cds =(136,1449)/gb = A 494G1 3255 3453 NM_004730 Hs.77324 1.00E−109 2eukaryotic translation termination factor 1 517E4 305 973 NM_014754Hs.77329 0 2 phosphatidylserine synthase 1 (PTDSS1), mRNA 72F9 1934 4605AF187320 Hs.77356 0 10 transferrin receptor (TFRC) gene, complete cd46D6 241 4902 NM_003234 Hs.77356 0 2 transferrin receptor (p90, CD71)(TFRC), mRNA 113A12 1028 1290 NM_024033 Hs.77365 1.00E−145 1hypothetical protein MGC5242 (MGC5242), mRNA 173A7 1142 1649 AK026164Hs.77385 0 2 cDNA: FLJ22511 fis, clone HRC11837, highly sim 189E7 466798 NM_002004 Hs.77393 0 1 farnesyl diphosphate synthase (farnesyl pyro479B1 306 482 NM_000566 Hs.77424 8.00E−55 1 Fc fragment of IgG, highaffinity Ia, receptor 41E12 351 898 X14356 Hs.77424 0 1 high affinity Fcreceptor (FcRI)/cds = (36,116 122D3 562 855 NM_002664 Hs.77436 1.00E−1451 pleckstrin (PLEK), mRNA/cds = (60,1112)/gb = N 59C11 1 2745 X07743Hs.77436 0 5 pleckstrin (P47)/cds = (60,1112)/gb = X07743 590B1 51855274 NM_001379 Hs.77462 1.00E−44 1 DNA (cytosine-5-)-methyltransferase 1(DNMT1 522D1 572 956 NM_001929 Hs.77494 0 1 deoxyguanosine kinase(DGUOK), mRNA/cds = (11, 109E12 723 2474 D87684 Hs.77495 1.00E−163 5 forKIAA0242 protein, partial cds/cds = (0, 148E2 61 271 BE737246 Hs.774961.00E−81 1 601305556F1 5′ end/clone = IMAGE: 3640165 586D4 1887 2362NM_003363 Hs.77500 0 1 ubiquitin specific protease 4 (proto-oncogene57E8 29 2808 BC001854 Hs.77502 0 30 methionine adenosyltransferase II,alpha, c 70H9 87 1283 X68836 Hs.77502 0 14 S-adenosylmethioninesynthetase/cds = ( 69B2 778 3033 M20867 Hs.77508 0 2 glutamatedehydrogenase (GDH) mRNA, complete cds/cd 513F9 2694 2929 NM_005271Hs.77508 1.00E−105 1 glutamate dehydrogenase 1 (GLUD1), mRNA/cds = 75A3190 701 X62744 Hs.77522 0 1 RING6 mRNA for HLA class II alpha product/cds = (45,830 105E10 72 597 BE673364 Hs.77542 0 3 7d34a03.x1 cDNA, 3′end/clone = IMAGE: 3249100 124B2 85 683 BF508702 Hs.77542 0 8UI-H-BI4-aop-g-05-0-UI.s1 cDNA, 3′ end/clon 524C9 829 1233 AK021563Hs.77558 0 3 cDNA FLJ11501 fis, clone HEMBA1002100/cds = UNK 523B12 75808153 NM_004652 Hs.77578 0 2 ubiquitin specific protease 9, X chromosome(D 166F3 169 340 AL021546 Hs.77608 7.00E−63 1 DNA sequence from BAC 15E1on chromosome 12. Contains 195A11 164 451 NM_003769 Hs.77608 1.00E−162 1splicing factor, arginine/serine-rich 9 (SF 595E1 618 1461 AF056322Hs.77617 0 7 SP100-HMG nuclear autoantigen (SP100) mRNA, c 115A6 29543541 AL137938 Hs.77646 0 2 mRNA; cDNA DKFZp761M0223 (from cloneDKFZp761M 592H6 261 951 NM_014752 Hs.77665 0 3 KIAA0102 gene product(KIAA0102), mRNA/cds = ( 461F3 4657 4980 NM_014749 Hs.77724 1.00E−174 1KIAA0586 gene product (KIAA0586), mRNA/cds = ( 98C8 27 1961 NM_002543Hs.77729 0 4 oxidised low density lipoprotein (lectin-like 598A12 1011396 NM_006759 Hs.77837 0 4 UDP-glucose pyrophosphorylase 2 (UGP2), mRNA594H8 1 872 NM_006802 Hs.77897 1.00E−144 2 splicing factor 3a, subunit3, 60 kD (SF3A3), mR 171E4 1140 1394 X81789 Hs.77897 1.00E−110 1 forsplicing factor SF3a60/cds = (565,2070) 500F1 2185 2496 AK025736Hs.77910 1.00E−160 1 cDNA: FLJ22083 fis, clone HEP14459, highly sim525B10 1696 2060 NM_000122 Hs.77929 0 1 excision repaircross-complementing rodent r 53E1 877 1539 AK026595 Hs.77961 0 7FLJ22942 fis, clone KAT08170, highly sim 521C6 631 1089 NM_005514Hs.77961 1.00E−115 4 major histocompatibility complex, class I, B 588C3300 653 NM_004792 Hs.77965 0 1 Clk-associating RS-cyclophilin (CYP),mRNA 523C6 277 582 NM_001912 Hs.78056 1.00E−143 1 cathepsin L (CTSL),mRNA/cds = (288,1289)/gb = 140D10 292 1549 X12451 Hs.78056 0 3pro-cathepsin L (major excreted protein MEP) 463E5 129 552 NM_005969Hs.78103 0 1 nucleosome assembly protein 1-like 4 (NAP1L4) 166H3 540 895U77456 Hs.78103 0 1 nucleosome assembly protein 2 mRNA, complete cds/cd40B10 2433 2543 M28526 Hs.78146 5.00E−29 1 platelet endothelial celladhesion molecule (PECAM-1 114E5 1671 2029 NM_000442 Hs.78146 1.00E−1621 platelet/endothelial cell adhesion molecule 513D11 28 1399 NM_000700Hs.78225 0 5 annexin A1 (ANXA1), mRNA/cds = (74,1114)/gb = N 331B3 2191370 X05908 Hs.78225 0 3 lipocortin/cds = (74,1114)/gb = X05908/gi = 3456A12 1383 2379 X94232 Hs.78335 0 4 novel T-cell activation protein/cds= (14 465H1 386 904 NM_002812 Hs.78466 0 2 proteasome (prosome,macropain) 26S subunit, 108H7 2067 2486 L42572 Hs.78504 0 1 p87/89 gene,complete cds/cds = (92,2368)/gb = 187E9 729 1494 NM_006839 Hs.78504 0 2inner membrane protein, mitochondrial (mitofi 102F2 672 2947 L14561Hs.78546 0 2 plasma membrane calcium ATPase isoform 1 (ATP 591H12 421949 NM_004034 Hs.78637 0 3 annexin A7 (ANXA7), transcript variant 2,mRN 595H3 2775 3030 NM_003470 Hs.78683 3.00E−96 1 ubiquitin specificprotease 7 (herpes virus-as 62F5 2775 3838 Z72499 Hs.78683 0 2herpesvirus associated ubiquitin-speci 46G4 2632 3238 NM_003580 Hs.786870 1 neutral sphingomyelinase (N-SMase) activatio 513A11 342 1258NM_002635 Hs.78713 0 10 solute carrier family 25 (mitochondrial carri472A4 3018 3286 NM_024298 Hs.78768 1.00E−132 1 malignant cellexpression-enhanced gene/tumo 177A3 377 1186 AL049589 Hs.78771 0 3 DNAsequence from clone 570L12 on chromosome Xq13.1-2 71E6 303 1767NM_000291 Hs.78771 0 12 phosphoglycerate kinase 1 (PGK1), mRNA/cds = (181D8 2104 3677 NM_018834 Hs.78825 0 4 matrin 3 (MATR3), mRNA/cds =(254,2800)/gb = NM 126G6 2498 2959 AL162049 Hs.78829 0 1 mRNA; cDNADKFZp762E1712 (from clone DKFZp762E 41C3 1743 2340 M31932 Hs.78864 0 2IgG low affinity Fc fragment receptor (FcRIIa) mRNA, c 166D11 1696 2156M81601 Hs.78869 0 1 transcription elongation factor (SII) mRNA, complete517B3 565 1392 D42039 Hs.78871 0 3 mRNA for KIAA0081 gene, partialcds/cds = (0,702)/ gb = 180G11 59 517 NM_020548 Hs.78888 0 1 diazepambinding inhibitor (GABA receptor mod 99B7 2356 3329 U07802 Hs.78909 0 45Tis11d gene, complete cds/cds = (291,1739)/ gb = U07802 54C4 557 1101U13045 Hs.78915 0 1 nuclear respiratory factor-2 subunit beta 1 mRNA,com 44A5 634 1128 U29607 Hs.78935 0 2 methionine aminopeptidase mRNA,complete cds/ cds = (2 63A2 964 1050 X92106 Hs.78943 7.00E−31 1bleomycin hydrolase/cds = (78,1445)/gb 163G9 228 877 L13463 Hs.78944 0 3helix-loop-helix basic phosphoprotein (G0S8) mRNA, 119H6 472 877NM_002923 Hs.78944 0 1 regulator of G-protein signalling 2,24 kD (RG166E2 5629 5764 U51903 Hs.78993 2.00E−69 1 RasGAP-related protein(IQGAP2) mRNA, complete cds 40F9 66 603 M15796 Hs.78996 0 1 cyclinprotein gene, complete cds/cds = (118,903)/gb 593E5 156 854 NM_012245Hs.79008 0 5 SKI-INTERACTING PROTEIN (SNW1), mRNA/ cds = (2 485B7 276599 AF063591 Hs.79015 1.00E−136 1 brain my033 protein mRNA, completecds/cds = (5 61B4 125 732 X05323 Hs.79015 0 2 MRC OX-2 gene signalsequence/cds = (0,824)/ gb = X05323 71C8 330 1958 NM_005261 Hs.79022 024 GTP-binding protein overexpressed in skeletal 75G8 330 1957 U10550Hs.79022 0 63 Gem GTPase (gem) mRNA, complete cds/ cds = (213,1103)/584G1 4424 5153 AF226044 Hs.79025 0 2 HSNFRK (HSNFRK) mRNA, completecds/ cds = (641,2 117C5 358 933 NM_012413 Hs.79033 0 1glutaminyl-peptide cyclotransferase (glutam 72B2 910 2015 AJ250915Hs.79037 0 9 p10 gene for chaperonin 10 (Hsp10 protein) and 71G11 8801981 NM_002156 Hs.79037 0 5 heat shock 60 kD protein 1 (chaperonin)(HSPD1) 193H12 1859 2474 NM_003243 Hs.79059 0 5 transforming growthfactor, beta receptor III 460B4 846 1325 NM_001930 Hs.79064 0 1deoxyhypusine synthase (DHPS), transcript va 75C4 1166 2087 K02276Hs.79070 0 85 (Daudi) translocated t(8;14) c-myc oncogene mRNA, co 71G101274 2121 NM_002467 Hs.79070 0 12 v-myc avian myelocytomatosis viraloncogene h 183D8 385 741 NM_002710 Hs.79081 0 1 protein phosphatase 1,catalytic subunit, gam 170A12 741 1203 X74008 Hs.79081 0 1 proteinphosphatase 1 gamma/cds = (154,11 121D9 2920 3385 NM_006378 Hs.79089 0 1sema domain, immunoglobulin domain (Ig), tran 40C12 2933 4108 U60800Hs.79089 0 4 semaphorin (CD100) mRNA, complete cds/ cds = (87,2675)104E1 1708 1932 L35263 Hs.79107 1.00E−101 1 CSaids binding protein(CSBP1) mRNA, complete cds/cd 70B2 913 2497 AK000221 Hs.79110 0 9FLJ20214 fis, clone COLF2014, highly simi 123B12 1929 2644 D42043Hs.79123 0 3 mRNA for KIAA0084 gene, partial cds/cds = (0,1946)/gb 193G7802 1425 NM_004379 Hs.79194 0 2 cAMP responsive element binding protein1 (CR 75D5 158 2139 NM_004233 Hs.79197 0 16 CD83 antigen (activated Blymphocytes, immuno 74H2 98 1357 NM_001154 Hs.79274 0 2 annexin A5(ANXA5), mRNA/cds = (192,1154)/gb = 519G7 5358 5496 D86985 Hs.792762.00E−69 1 mRNA for KIAA0232 protein, partial cds/cds = (0, 462C2 14772031 NM_003006 Hs.79283 0 1 selectin P ligand (SELPLG), mRNA/cds =(59,1267 65C6 23 1609 M15353 Hs.79306 0 6 cap-binding protein mRNA,complete cds/cds = (1 64H8 326 1610 NM_001968 Hs.79306 0 3 eukaryotictranslation initiation factor 4E 52C3 1333 1904 X64318 Hs.79334 0 1E4BP4 gene/cds = (213,1601)/gb = X64318/gi = 30955 39F7 1179 1740AF109733 Hs.79335 0 1 SWI/SNF-related, matrix-associated, actin-d 194A71512 1803 NM_003076 Hs.79335 1.00E−118 1 SWI/SNF related, matrixassociated, actin dep 463E12 4326 4831 NM_015148 Hs.79337 0 1 KIAA0135protein (KIAA0135), mRNA/cds = (1803, 526B5 1420 1867 NM_002958 Hs.793500 2 RYK receptor-like tyrosine kinase (RYK), mRNA 460F3 1755 2242NM_006285 Hs.79358 0 2 testis-specific kinase 1 (TESK1), mRNA/cds = (98B11 2076 4834 X76061 Hs.79362 0 11 H. sapiens p130 mRNA for 130Kprotein/ cds = (69,3488)/gb = X76 45F3 2286 2666 NM_001423 Hs.79368 0 1epithelial membrane protein 1 (EMP1), mRNA/cd 50C10 2016 2666 Y07909Hs.79368 0 2 Progression Associated Protein/cds = (21 118E3 549 1078NM_012198 Hs.79381 0 1 grancalcin (GCL), mRNA/cds = (119,772)/gb =NM_(—) 181F4 657 1271 NM_002805 Hs.79387 0 2 proteasome (prosome,macropain) 26S subunit, 105H3 1114 1538 D83018 Hs.79389 0 1 fornel-related protein 2, complete cds/ 173B2 429 3009 NM_006159 Hs.79389 05 nel (chicken)-like 2 (NELL2), mRNA/cds = (96,25 177B3 662 991 AC004382Hs.79402 0 1 Chromosome 16 BAC clone CIT987SK-A-152E5/cds 590H3 663 1002NM_002694 Hs.79402 0 1 polymerase (RNA) II (DNA directed) polypeptide523B7 223 582 NM_002946 Hs.79411 0 1 replication protein A2 (32 kD)(RPA2), mRNA/c 182B10 472 1024 U02019 Hs.79625 1.00E−121 2 AU-richelement RNA-binding protein AUF1 mRNA, comple 479F3 100 301 NM_001783Hs.79630 2.00E−86 1 CD79A antigen (immunoglobulin-associated al 40H9 5821107 U05259 Hs.79630 0 1 MB-1 gene, complete cds/cds = (36,716)/gb =U05259/gi 116A2 1003 1368 NM_006224 Hs.79709 1.00E−176 1phosphotidylinositol transfer protein (PITPN 74G8 252 1297 D21853Hs.79768 0 5 KIAA0111 gene, complete cds/cds = (214,1449) 525G2 830 1297NM_014740 Hs.79768 0 2 KIAA0111 gene product (KIAA0111), mRNA/cds = (125G3 2757 3339 AF072928 Hs.79877 0 1 myotubularin related protein 6mRNA, partial c 184A2 532 1102 AF135162 Hs.79933 0 1 cyclin I (CYC1)mRNA, complete cds/cds = (199,13 514C6 329 1256 NM_006835 Hs.79933 0 6cyclin I (CCNI), mRNA/cds = (0,1133)/gb = NM_006 116G5 824 1058NM_006875 Hs.80205 1.00E−121 1 pim-2 oncogene (PIM2), mRNA/cds =(185,1189)/ 106C11 1700 1995 U77735 Hs.80205 1.00E−125 1 pim-2protooncogene homolog pim-2 h mRNA, complete cd 110E3 276 653 AL136139Hs.80261 0 1 DNA sequence from clone RP4-76112 on chromosome 6 Con 478D11067 2761 NM_006403 Hs.80261 2.00E−70 2 enhancer of filamentation 1(cas-like docking; 178C8 880 1226 AL050192 Hs.80285 0 1 mRNA; cDNADKFZp586C1723 (from clone DKFZp586C 494F11 477 5535 NM_014739 Hs.80338 08 KIAA0164 gene product (KIAA0164), mRNA/cds = ( 190A1 1165 1540NM_004156 Hs.80350 1.00E−166 2 protein phosphatase 2 (formerly 2A),catalytic 461A1 4639 4913 NM_004653 Hs.80358 1.00E−140 1 SMC (mouse)homolog, Y chromosome (SMCY), mRNA 158A8 2656 3229 L24498 Hs.80409 0 1gadd45 gene, complete cds/cds = (2327,2824)/ gb = L2449 41E6 2385 2992U84487 Hs.80420 0 2 CX3C chemokine precursor, mRNA, alternatively splice40H4 2830 3605 NM_000129 Hs.80424 0 1 coagulation factor XIII, A1polypeptide (F13A 464D3 214 835 NM_004899 Hs.80426 0 2 brain andreproductive organ-expressed (TNFR 75H8 1180 4930 U12767 Hs.80561 0 60mitogen induced nuclear orphan receptor (MINOR) mRNA 593E10 1 510NM_004552 Hs.80595 1.00E−158 5 NADH dehydrogenase (ubiquinone) Fe-Sprotein 113C5 1182 1583 NM_003336 Hs.80612 0 1 ubiquitin-conjugatingenzyme E2A (RAD6 homol 515B7 268 538 NM_001020 Hs.80617 2.00E−91 3ribosomal protein S16 (RPS16), mRNA/cds = (37,4 477F12 460 606 NM_018996Hs.80618 1.00E−47 1 hypothetical protein (FLJ20015), mRNA/cds = ( 41A81331 1788 L78440 Hs.80642 0 1 STAT4 mRNA, complete cds/cds =(81,2327)/gb = L 594C1 1594 2586 NM_003151 Hs.80642 0 4 signaltransducer and activator of transcripti 112C8 1802 1932 NM_002198Hs.80645 2.00E−35 1 interferon regulatory factor 1 (IRF1), mRNA/ 522H81130 1533 NM_003355 Hs.80658 1.00E−135 4 uncoupling protein 2(mitochondrial, proton c 123E4 259 757 NM_002129 Hs.80684 0 4high-mobility group (nonhistone chromosomal) 109H1 263 754 X62534Hs.80684 0 1 HMG-2 mRNA/cds = (214,843)/gb = X62534/gi = 32332 149G91020 1607 J05032 Hs.80758 0 2 aspartyl-tRNA synthetase alpha-2 subunitmRNA, compl 461F12 1702 2246 AL031600 Hs.80768 0 1 DNA sequence fromclone 390E6 on chromosome 16. Contai 102B2 1486 2008 M16038 Hs.80887 0 1lyn mRNA encoding a tyrosine kinase/cds = (297,1835)/ 125B11 1260 2013NM_002350 Hs.80887 0 5 v-yes-1 Yamaguchi sarcoma viral related oncog37C9 2901 5260 D79990 Hs.80905 0 8 KIAA0168 gene, complete cds/cds =(196,1176) 196D6 2949 5261 NM_014737 Hs.80905 0 9 Ras association(RalGDS/AF-6) domain family 2 584H1 4072 4296 NM_002693 Hs.809613.00E−91 1 polymerase (DNA directed), gamma (POLG), nucl 584F9 31 568AF174605 Hs.81001 0 5 F-box protein Fbx25 (FBX25) mRNA, partial cds102D11 1037 1632 J03459 Hs.81118 0 1 leukotriene A-4 hydrolase mRNA,complete cds/ cds = (68 193F8 1037 1643 NM_000895 Hs.81118 0 2leukotriene A4 hydrolase (LTA4H), mRNA/cds = ( 118H7 354 1148 U65590Hs.81134 0 5 IL-1 receptor antagonist IL-1Ra (IL-1RN) gene 41H1 25492936 X60992 Hs.81226 0 1 CD6 mRNA for T cell glycoprotein CD6/cds =(120,152 171B9 2070 2479 AF248648 Hs.81248 0 1 RNA-binding proteinBRUNOL2 (BRUNOL2) mRNA, c 590A6 291 512 NM_002961 Hs.81256 3.00E−66 1S100 calcium-binding protein A4 (calcium prot 73H2 389 1481 M69043Hs.81328 0 14 MAD-3 mRNA encoding IkB-like activity, complet 513G1 6371481 NM_020529 Hs.81328 0 13 nuclear factor of kappa light polypeptidegene 488F2 1065 1417 NM_004499 Hs.81361 1.00E−180 4 heterogeneousnuclear ribonucleoprotein A/B 151C8 1260 1423 U76713 Hs.81361 1.00E−61 1apobec-1 binding protein 1 mRNA, complete cds/ cds = (15 593B9 41 954NM_001688 Hs.81634 0 3 ATP synthase, H+ transporting, mitochondrial104H12 352 912 X60221 Hs.81634 0 1 H+-ATP synthase subunit b/cds =(32,802) 141G8 1132 1642 AK001883 Hs.81648 0 1 FLJ11021 fis, clonePLACE1003704, weakly 41A1 4214 4395 X06182 Hs.81665 5.00E−67 1 c-kitproto-oncogene mRNA/cds = (21,2951)/ gb = X06182 102F5 3037 3646 D38551Hs.81848 0 1 KIAA0078 gene, complete cds/cds = (184,2079) 111E11 13751752 NM_006265 Hs.81848 0 1 RAD21 (S. pombe) homolog (RAD21), mRNA/cds =(1 592F8 38 720 NM_014736 Hs.81892 0 1 KIAA0101 gene product (KIAA0101),mRNA/cds = ( 194F1 6886 7115 AF241785 Hs.81897 1.00E−117 1 NPD012(NPD012) mRNA, complete cds/cds = (552,2 525C6 1 615 NM_005563 Hs.819150 4 leukemia-associated phosphoprotein p18 (sta 101D12 3249 3508 D38555Hs.81964 1.00E−143 1 KIAA0079 gene, complete cds/cds = (114,3491) 176D112996 3168 NM_004922 Hs.81964 9.00E−94 2 SEC24 (S. cerevisiae) relatedgene family, mem 129B7 5068 5759 D50683 Hs.82028 0 4 for TGF-betallRalpha, complete cds/cds = 195H6 946 1208 NM_006023 Hs.82043 6.00E−74 1D123 gene product (D123), mRNA/cds = (280,1290) 481D9 2709 3085NM_002184 Hs.82065 1.00E−134 1 interleukin 6 signal transducer (gp130,oncos 129A5 1338 1802 M14083 Hs.82085 0 1 beta-migrating plasminogenactivator inhibitor I mR 57G9 500 1561 AF220656 Hs.82101 1.00E−145 3apoptosis-associated nuclear protein PHLDA1 40C11 3748 4497 M27492Hs.82112 0 1 interleukin 1 receptor mRNA, complete cds/ cds = (82,17481B6 3164 3609 NM_000877 Hs.82112 0 1 interleukin 1 receptor, type I(IL1R1), mRNA/ 40H6 161 557 AB049113 Hs.82113 0 1 DUT mRNA for dUTPpyrophosphatase, complete cd 592B7 184 568 NM_001948 Hs.82113 1.00E−1112 dUTP pyrophosphatase (DUT), mRNA/cds = (29,523 114F1 465 720 U70451Hs.82116 1.00E−135 1 myleoid differentiation primary response protein My71H5 194 3415 NM_006186 Hs.82120 0 36 nuclear receptor subfamily 4,group A, member 75C1 1264 3422 X75918 Hs.82120 0 84 NOT/cds =(317,2113)/gb = X75918/gi = 4158 40D1 1621 2080 M90391 Hs.82127 0 1putative IL-16 protein precursor, mRNA, comple 71C4 678 5065 NM_002460Hs.82132 0 88 interferon regulatory factor 4 (IRF4), mRNA/ 75G12 32195316 U52682 Hs.82132 0 27 lymphocyte specific interferon regulatoryfactor/in 193G6 1118 2682 NM_006874 Hs.82143 1.00E−178 3 E74-like factor2 (ets domain transcription fa 147F6 1484 1951 AK025643 Hs.82148 0 1FLJ21990 fis, clone HEP06386/cds = (22,49 155E4 853 1264 M64992 Hs.821590 1 prosomal protein P30-33K (pros-30) mRNA, complete cd 595F1 30 614NM_002786 Hs.82159 0 3 proteasome (prosome, macropain) subunit, alp 58A4473 1715 NM_005655 Hs.82173 0 3 TGFB inducible early growth response(TIEG), m 67E6 784 2109 S81439 Hs.82173 0 7 EGR alpha = early growthresponse gene alpha [human, prostate 593H2 132 722 NM_000985 Hs.82202 02 ribosomal protein L17 (RPL17), mRNA/cds = (138, 40H5 283 1442 M37033Hs.82212 0 12 CD53 glycoprotein mRNA, complete cds/ cds = (93,752)/592C4 1 1442 NM_000560 Hs.82212 0 11 CD53 antigen (CD53), mRNA/cds =(93,752)/gb = N 460D4 1519 1845 NM_002510 Hs.82226 1.00E−160 1glycoprotein (transmembrane) nmb (GPNMB), mR 61A8 507 736 AF045229Hs.82280 1.00E−116 1 regulator of G protein signaling 10 mRNA, compl45F7 418 651 NM_002925 Hs.82280 1.00E−119 1 regulator of G-proteinsignalling 10 (RGS10), 49C2 416 1323 NM_006417 Hs.82316 0 7interferon-induced, hepatitis C-associated 41C11 847 1716 X63717Hs.82359 0 2 APO-1 cell surface antigen/cds = (220,122 71H4 15 1627NM_001781 Hs.82401 0 21 CD69 antigen (p60, early T-cell activation ant75B10 9 1627 Z22576 Hs.82401 0 33 CD69 gene/cds = (81,680)/gb =Z22576/gi = 397938/ 117B7 1441 1515 NM_022059 Hs.82407 7.00E−28 1 CXCchemokine ligand 16 (CXCL16), mRNA/cds = (4 110D6 1219 1721 AF006088Hs.82425 0 1 Arp2/3 protein complex subunit p16-Arc (ARC16) 598F10 391497 NM_005717 Hs.82425 0 5 actin related protein 2/3 complex, subunit 5( 99A9 621 1214 D26018 Hs.82502 0 1 mRNA for KIAA0039 gene, partialcds/cds = (0,1475)/gb 183F6 222 2235 NM_001637 Hs.82542 0 2 acyloxyacylhydrolase (neutrophil) (AOAH), m 459G4 5196 5801 NM_003682 Hs.82548 0 1MAP-kinase activating death domain (MADD), mR 75A6 301 2231 D85429Hs.82646 0 44 heat shock protein 40, complete cds/c 64A5 300 2008NM_006145 Hs.82646 0 17 heat shock 40 kD protein 1 (HSPF1), mRNA/cds =(4 50E5 628 2399 AK025459 Hs.82689 0 2 FLJ21806 fis, clone HEP00829,highly sim 115C6 23 589 NM_005087 Hs.82712 0 1 fragile X mentalretardation, autosomal homol 105H10 1017 1429 M61199 Hs.82767 0 1cleavage signal 1 protein mRNA, complete cds/ cds = (97, 461A11 204 748NM_006296 Hs.82771 0 1 vaccinia related kinase 2 (VRK2), mRNA/cds = (139B4 1049 1203 M25393 Hs.82829 8.00E−83 1 protein tyrosine phosphatase(PTPase) mRNA, complete 590F5 123 436 NM_002828 Hs.82829 1.00E−178 1protein tyrosine phosphatase, non-receptor t 517F10 1038 2618 AK025583Hs.82845 0 9 cDNA: FLJ21930 fis, clone HEP04301, highly sim 40B7 9721933 M25280 Hs.82848 0 6 lymph node homing receptor mRNA, complete cds/cds = (11 515B1 1 2322 NM_000655 Hs.82848 0 12 selectin L (lymphocyteadhesion molecule 1) ( 587A10 190 685 NM_001344 Hs.82890 0 1 defenderagainst cell death 1 (DAD1), mRNA/cd 113G9 1 2812 AF208850 Hs.82911 0 7BM-008 mRNA, complete cds/cds = (341,844)/gb = 127H6 1828 2501 NM_003591Hs.82919 0 2 cullin 2 (CUL2), mRNA/cds = (146,2383)/gb = NM_0 477E3 9311777 NM_006416 Hs.82921 0 2 solute carrier family 35 (CMP-sialic acidtran 184D2 1355 1773 AL049795 Hs.83004 1.00E−164 1 DNA sequence fromclone RP4-622L5 on chromosome 1p34. 41F10 507 774 D49950 Hs.830771.00E−150 1 for interferon-gamma inducing factor(IGI 482E7 499 774NM_001562 Hs.83077 5.00E−97 1 interleukin 18 (interferon-gamma-inducingf 515C6 111 1162 L38935 Hs.83086 1.00E−107 2 GT212 mRNA/cds = UNKNOWN/gb= L38935/ gi = 100884 479D3 1775 2028 NM_001760 Hs.83173 1.00E−122 1cyclin D3 (CCND3), mRNA/cds = (165,1043)/gb = N 583H12 945 1655NM_012151 Hs.83363 0 9 coagulation factor VIII-associated (intronic 47B32140 3625 M58603 Hs.83428 0 13 nuclear factor kappa-B DNA bindingsubunit (NF- kappa- 58G1 2538 3625 NM_003998 Hs.83428 0 4 nuclear factorof kappa light polypeptide gene 477C6 1628 2131 Z49995 Hs.83465 0 1 H.sapiens mRNA (non-coding; clone h2A)/ cds = UNKNOWN/gb = Z4 587D10 15761900 AF064839 Hs.83530 0 2 map 3p21; 3.15 cR from WI-9324 region,complete 516B9 1662 3296 X59405 Hs.83532 0 4 H. sapiens, gene forMembrane cofactor protein/ cds = UNKNOWN 459A5 120 298 NM_017459Hs.83551 7.00E−42 1 microfibrillar-associated protein 2 (MFAP2), 591A12321 1116 NM_005731 Hs.83583 0 17 actin related protein 2/3 complex,subunit 2 ( 102C1 554 1127 AK025198 Hs.83623 0 1 FLJ21545 fis, cloneCOL06195/cds = UNKNOW 458C8 1022 1831 NM_001619 Hs.83636 0 1 adrenergic,beta, receptor kinase 1 (ADRBK1), 107G1 303 1008 L20688 Hs.83656 0 4GDP-dissociation inhibitor protein (Ly-GDI) mRNA, c 597F8 293 1180NM_001175 Hs.83656 0 55 Rho GDP dissociation inhibitor (GDI) beta (AR591G5 1 216 NM_003142 Hs.83715 1.00E−108 3 Sjogren syndrome antigen B(autoantigen La) ( 184H9 240 392 X69804 Hs.83715 4.00E−77 2 for La/SS-Bprotein/cds = UNKNOWN/gb = X69804 193C10 1 1605 BC000957 Hs.837241.00E−154 4 Similar to hypothetical protein MNCb-2146, c 40A2 1101 1294U90904 Hs.83724 1.00E−72 1 clone 23773 mRNA sequence/cds = UNKNOWN/ gb =U90904/g 57H2 191 422 NM_001827 Hs.83758 1.00E−126 1 CDC28 proteinkinase 2 (CKS2), mRNA/cds = (95,33 60E10 191 422 X54942 Hs.837581.00E−129 1 ckshs2 mRNA for Cks1 protein homologue/cds = (95,3 164F51896 2293 NM_016325 Hs.83761 0 1 zinc finger protein 274 (ZNF274),mRNA/cds = (4 463E6 555 1128 NM_000791 Hs.83765 0 1 dihydrofolatereductase (DHFR), mRNA/cds = (47 194F8 1806 2223 NM_002199 Hs.837951.00E−161 1 interferon regulatory factor 2 (IRF2), mRNA/ 520D11 180 1229NM_000365 Hs.83848 0 5 triosephosphate isomerase 1 (TPI1), mRNA/cds168B6 530 891 U47924 Hs.83848 0 1 chromosome 12p13 sequence/cds =(373,1122)/ gb = U4792 331E11 2591 3485 NM_000480 Hs.83918 0 8 adenosinemonophosphate deaminase (isoform E 458A11 125 409 NM_000396 Hs.839421.00E−108 1 cathepsin K (pycnodysostosis) (CTSK), mRNA/ 185H2 2501 2690NM_000195 Hs.83951 3.00E−85 1 Hermansky-Pudlak syndrome (HPS), mRNA/cds= (2 99D2 977 1191 NM_019006 Hs.83954 1.00E−97 1 protein associated withPRK1 (AWP1), mRNA/cds 167D5 2275 2755 NM_000211 Hs.83968 0 4 integrin,beta 2 (antigen CD18 (p95), lymphocyt 524B2 262 575 BF028896 Hs.839921.00E−155 1 601765270F1 cDNA, 5′ end/clone = lMAGE: 3997576 523B2 6881065 NM_015937 Hs.84038 0 1 CGI-06 protein (LOC51604), mRNA/cds =(6,1730) 102F1 951 1416 M63180 Hs.84131 0 1 threonyl-tRNA synthetasemRNA, complete cds/ cds = (13 589D5 863 1700 NM_006400 Hs.84153 0 3dynactin 2 (p50) (DCTN2), mRNA/cds = (136,1356) 108F6 448 704 U70439Hs.84264 1.00E−117 1 silver-stainable protein SSP29 mRNA, complete cds/146D6 1022 1253 K01144 Hs.84298 6.00E−95 2 major histocompatibilityclass II antigen gamma chain 188B10 823 1302 NM_004355 Hs.84298 0 1 CD74antigen (invariant polypeptide of major 175D2 1060 1479 M63488 Hs.843181.00E−158 1 replication protein A 70 kDa subunit mRNA complete cds 115F42305 2393 NM_002945 Hs.84318 2.00E−43 1 replication protein A1 (70 kD)(RPA1), mRNA/cd 595H4 5400 5649 NM_004239 Hs.85092 1.00E−131 1 thyroidhormone receptor interactor 11 (TRIP1 106F1 493 1371 NM_017491 Hs.851000 3 WD repeat domain 1 (WDR1), transcript variant 1 40C10 438 880 X57025Hs.85112 0 1 IGF-I mRNA for insulin-like growth factor I/cds = (166,44C5 2247 2430 AF017257 Hs.85146 5.00E−89 1 chromosome 21 derived BACcontaining erythrobl 45D4 1962 3324 X79067 Hs.85155 0 6 H. sapiens ERF-1mRNA 3′ end/cds = UNKNOWN/ gb = X79067/gi = 483 591B9 2378 2603NM_002880 Hs.85181 1.00E−109 1 v-raf-1 murine leukemia viral oncogenehomolo 39E2 67 2493 X76488 Hs.85226 0 3 lysosomal acid lipase/cds =(145,1344)/ 62H12 1249 1975 M12824 Hs.85258 0 3 T-cell differentiationantigen Leu-2/T8 mRNA, partia 40C8 4505 4856 X53587 Hs.85266 0 1integrin beta 4/cds = UNKNOWN/gb = X53587/gi = 40E11 1983 2633 S53911Hs.85289 0 1 CD34 = glycoprotein expressed in lymphohematopoietic proge135A2 121 695 BC001646 Hs.85301 0 2 clone MGC: 2392, mRNA, completecds/cds = (964, 459H4 33 244 AK027067 Hs.85567 2.00E−90 1 cDNA: FLJ23414fis, clone HEP20704/cds = (37,10 479A4 5556 5974 AB040974 Hs.857521.00E−171 1 mRNA for KIAA1541 protein, partial cds/cds = (9 146C3 16102062 AL049796 Hs.85769 0 1 DNA sequence from clone RP4-561L24 onchromosome 1p22 463H11 871 1153 NM_006546 Hs.86088 5.00E−83 1 IGF-IImRNA-binding protein 1 (IMP-1), mRNA/ 480A12 2 165 NM_004876 Hs.863717.00E−84 1 zinc finger protein 254 (ZNF254), mRNA/cds = (1 192F7 28543462 AF198614 Hs.86386 0 3 McI-1 (MCL-1) and McI-1 delta S/TM (MCL-1)gene 459G3 12 577 AL049340 Hs.86405 0 1 mRNA; cDNA DKFZp564P056 (fromclone DKFZp564P0 460E4 2361 2787 NM_000161 Hs.86724 0 2 GTPcyclohydrolase 1 (dopa-responsive dystoni 62F9 834 1282 M60724 Hs.868580 1 p70 ribosomal S6 kinase alpha-1 mRNA, complete cds/cd 187E7 84 766NM_001695 Hs.86905 0 1 ATPase, H+ transporting, lysosomal (vacuolar159D4 315 559 J03798 Hs.86948 1.00E−113 1 autoantigen small nuclearribonucleoprotein Sm-D mR 459F9 1557 1619 NM_006938 Hs.86948 2.00E−25 1small nuclear ribonucleoprotein D1 polypeptid 480G11 87 603 BG168139Hs.87113 0 1 602341526F1 cDNA, 5′ end/clone = IMAGE: 4449343 41D6 22082320 M35999 Hs.87149 4.00E−39 1 platelet glycoprotein lll a (GPllla)mRNA, complete c 462H11 387 648 NM_003806 Hs.87247 1.00E−133 1 harakiri,BCL2-interacting protein (contains 99D7 614 5517 NM_003246 Hs.87409 0 62thrombospondin 1 (THBS1), mRNA/cds = (111,3623 39B8 2130 5517 X14787Hs.87409 0 33 thrombospondin/cds = (111,3623)/gb = X14787 525A2 329 560NM_007047 Hs.87497 1.00E−129 2 butyrophilin, subfamily 3, member A2(BTN3A2) 583F2 3303 3622 D63876 Hs.87726 1.00E−155 1 mRNA for KIAA0154gene, partial cds/cds = (0,2080)/gb 184D7 2211 2556 M34181 Hs.877731.00E−165 1 testis-specific cAMP-dependent protein kinase catal 460A4499 1074 AL117637 Hs.87794 0 1 mRNA; cDNA DKFZp4341225 (from cloneDKFZp43412 459G2 258 452 AW967701 Hs.87912 8.00E−88 1 EST379776 cDNA/gb= AW967701/gi = 8157540/ug = 74H7 1660 2397 AK026960 Hs.88044 0 9FLJ23307 fis, clone HEP11549, highly sim 463D12 351 568 AI184553Hs.88130 1.00E−118 1 qd60a05.x1 cDNA, 3′ end/clone = IMAGE: 1733840595B1 309 986 NM_003454 Hs.88219 0 1 zinc finger protein 200 (ZNF200),mRNA/cds = (2 458D3 1018 1285 NM_000487 Hs.88251 6.00E−74 1arylsulfatase A (ARSA), mRNA/cds = (375,1898) 462F4 4272 4846 AJ271878Hs.88414 0 1 mRNA for putative transcription factor (BACH2 460B12 12672022 NM_006800 Hs.88764 0 3 male-specific lethal-3 (Drosophila)-like 1461A4 2039 2421 AL161659 Hs.88820 0 1 DNA sequence from cloneRP11-526K24 on chromosome 20 460F9 3413 3654 NM_000397 Hs.889741.00E−133 1 cytochrome b-245, beta polypeptide (chronic g 459G9 790 1160NM_006228 Hs.89040 1.00E−145 1 prepronociceptin (PNOC), mRNA/cds =(211,741) 70H12 1 661 AV716500 Hs.89104 0 274 AV716500 cDNA, 5′end/clone = DCBAKA08/clone_(—) 469H5 1620 2142 AB040961 Hs.89135 0 1mRNA for KIAA1528 protein, partial cds/cds = (4 175G6 2069 2501 D83243Hs.89385 0 1 NPAT mRNA, complete cds/cds = (66,4349)/ gb = D83243/g592B10 3703 3936 NM_002519 Hs.89385 1.00E−130 1 nuclear protein,ataxia-telangiectasia locu 120B7 337 630 NM_005176 Hs.89399 1.00E−114 1ATP synthase, H+ transporting, mitochondrial 39D2 370 1892 AF147204Hs.89414 0 68 chemokine receptor CXCR4-Lo (CXCR4) mRNA, alt 99H4 7 1625NM_003467 Hs.89414 0 137 chemokine (C-X-C motif), receptor 4 (fusin) (C106D2 2 266 U03644 Hs.89421 1.00E−143 1 recepin mRNA, complete cds/cds =(32,1387)/ gb = U03644 41F5 1203 1522 M16336 Hs.89476 1.00E−170 1 T-cellsurface antigen CD2 (T11) mRNA, complete cds, c 463A3 876 1025 NM_000698Hs.89499 1.00E−79 1 arachidonate 5-lipoxygenase (ALOX5), mRNA/c 47D121198 4887 AB028969 Hs.89519 0 2 for KIAA1046 protein, complete cds/cds =( 498G2 4420 5265 NM_014928 Hs.89519 0 2 KIAA1046 protein (KIAA1046),mRNA/cds = (577,1 589G3 598 689 NM_002796 Hs.89545 4.00E−45 2 proteasome(prosome, macropain) subunit, bet 331B1 699 788 S71381 Hs.89545 1.00E−411 prosome beta-subunit = multicatalytic proteinase complex 110A2 14031739 AK026432 Hs.89555 1.00E−177 1 FLJ22779 fis, clone KAIA1741/cds =(234,1 118E4 780 1672 NM_002110 Hs.89555 0 5 hemopoietic cell kinase(HCK), mRNA/cds = (168, 41B8 570 1166 M89957 Hs.89575 0 1 immunoglobulinsuperfamily member B cell receptor co 44A11 2567 2808 L20814 Hs.895821.00E−115 1 glutamate receptor 2 (HBGR2) mRNA, complete cds/ cds = (191G11 309 596 NM_006284 Hs.89657 1.00E−162 11 TATA box binding protein(TBP)-associated fac 72G5 1172 1575 AX023367 Hs.89679 0 38 Sequence 38from Patent WO0006605 71B12 40 559 NM_000586 Hs.89679 0 13 interleukin 2(IL2), mRNA/cds = (47,517)/gb = N 179G12 158 737 M36821 Hs.89690 0 1cytokine (GRO-gamma) mRNA, complete cds 193B5 680 1146 NM_002994Hs.89714 0 17 small inducible cytokine subfamily B (Cys-X-Cy 182G10 6811146 X78686 Hs.89714 0 7 ENA-78 mRNA/cds = (106,450)/gb = X78686/gi =47124 191C6 617 1597 NM_021950 Hs.89751 0 2 membrane-spanning 4-domains,subfamily A, m 40H3 1347 1597 X07203 Hs.89751 3.00E−71 1 CD20 receptor(S7)/cds = (90,983)/gb = X07203 458H2 3524 4331 NM_002024 Hs.89764 0 2fragile X mental retardation 1 (FMR1), mRNA/c 40F6 1665 2210 D38081Hs.89887 0 1 thromboxane A2 receptor, complete cds/cds = (9 473E1 578956 AL515381 Hs.89986 1.00E−172 1 AL515381 cDNA/clone =CLOBB017ZH06-(3-prime) 126A12 770 982 AL558028 Hs.90035 1.00E−102 1AL558028 cDNA/clone = CS0DJ002YF02-(5-prime) 183E12 2203 2814 NM_001316Hs.90073 0 1 chromosome segregation 1 (yeast homolog)-like 145H12 16021811 AK026766 Hs.90077 1.00E−113 2 FLJ23113 fis, clone LNG07875, highlysim 62C2 1472 2610 AB023420 Hs.90093 0 2 for heat shock protein apg-2,complete cds 46H6 3172 3411 D26488 Hs.90315 6.00E−86 1 mRNA for KIAA0007gene, partial cds/cds = (0,2062)/gb 116E2 1637 2016 AK025800 Hs.904211.00E−118 1 cDNA: FLJ22147 fis, clone HEP22163, highly sim 525H3 6 1231NM_004261 Hs.90606 0 2 15 kDa selenoprotein (SEP15), mRNA/cds = (4,492184D8 287 387 BE888304 Hs.90654 1.00E−46 2 601514033F1 cDNA, 5′end/clone = IMAGE: 3915177 99D4 1948 4309 D50918 Hs.90998 0 5 mRNA forKIAA0128 gene, partial cds/cds = (0,1276)/gb 72B9 571 1312 AK026954Hs.91065 0 1 FLJ23301 fis, clone HEP11120/cds = (2,188 586H8 189 478NM_000987 Hs.91379 2.00E−83 1 ribosomal protein L26 (RPL26), mRNA/cds =(6,44 160A12 1 132 X69392 Hs.91379 4.00E−69 5 ribosomal protein L26/cds= (6,443)/gb = 331H4 1632 2166 AK027210 Hs.91448 0 1 FLJ23557 fis, cloneLNG09686, highly sim 473E6 915 1390 NM_004556 Hs.91640 0 2 nuclearfactor of kappa light polypeptide gene 69E4 673 1328 A8007956 Hs.923811.00E−122 2 mRNA, chromosome 1 specific transcript KIAA04 182F10 117 781AF070523 Hs.92384 0 1 JWA protein mRNA, complete cds/cds = (115,681)585F10 77 1890 NM_006407 Hs.92384 0 13 vitamin A responsive;cytoskeleton related (J 469G3 2061 2293 AK025683 Hs.92414 1.00E−110 1cDNA: FLJ22030 fis, clone HEP08669/cds = UNKNOW 472H4 247 671 AW978555Hs.92448 0 1 EST390664 cDNA/gb = AW978555/gi = 8169822/ug = 193F11 20514721 NM_003103 Hs.92909 0 3 SON DNA binding protein (SON), mRNA/cds =(414,4 37E7 1287 1805 AK002059 Hs.92918 0 1 FLJ11197 fis, clonePLACE1007690/cds = (37 111D7 244 596 NM_016623 Hs.92918 1.00E−166 1hypothetical protein (BM-009), mRNA/cds = (385 41B10 1216 1530 U24577Hs.93304 1.00E−173 1 LDL-phospholipase A2 mRNA, complete cds/ cds =(216,15 48B4 76 723 NM_001417 Hs.93379 0 5 eukaryotic translationinitiation factor 4B 39F8 76 876 X55733 Hs.93379 0 1 initiation factor4B cDNA/cds = (0,1835)/gb = X557 471B10 660 886 NM_007020 Hs.935021.00E−125 1 U1-snRNP binding protein homolog (70 kD) (U1SN 467A3 11891284 X91348 Hs.93522 3.00E−36 1 H. sapiens predicted non coding cDNA(DGCR5)/ cds = UNKNOWN/ 461B5 652 874 NM_003367 Hs.93649 1.00E−104 1upstream transcription factor 2, c-fos intera 62B8 1386 1739 J05016Hs.93659 1.00E−170 1 (clone pA3) protein disulfide isomerase relatedprote 461E7 1931 2086 NM_004911 Hs.93659 1.00E−65 1 protein disulfideisomerase related protein ( 458G11 2423 3161 AB040959 Hs.93836 0 1 mRNAfor KIAA1526 protein, partial cds/cds = 104E3 516 981 AK000967 Hs.938720 1 FLJ10105 fis, clone HEMBA 1002542/cds = UN 41B6 87 846 X04430Hs.93913 0 2 IFN-beta 2a mRNA for interferon-beta-2/cds = (86,724) 179H71610 1682 AF009746 Hs.94395 9.00E−34 1 peroxisomal membrane protein 69(PMP69) mRNA, 470G3 74 493 NM_007221 Hs.94446 0 1 polyamine-modulatedfactor 1 (PMF1), mRNA/c 472A5 2325 2429 AK022267 Hs.94576 2.00E−48 1cDNA FLJ12205 fis, clone MAMMA1000931/ cds = UNK 459C9 5356 6120NM_006421 Hs.94631 0 3 brefeldin A-inhibited guanine nucleotide-exc465F8 3580 4049 NM_015125 Hs.94970 0 1 KIAA0306 protein (KIAA0306),mRNA/cds = (0,436 57B9 4145 4379 NM_005109 Hs.95220 1.00E−126 1oxidative-stress responsive 1 (OSR1), mRNA/c 160D6 30 480 X01451Hs.95327 0 2 gene for 20 K T3 glycoprotein (T3-delta-chain) of T-c 512G11 415 BF107010 Hs.95388 1.00E−175 2 601824367F1 cDNA, 5′ end/clone =IMAGE: 4043920 593E11 24 273 BG291649 Hs.95835 1.00E−79 10 602385778F1cDNA, 5′ end/clone = IMAGE: 4514827 41H2 1011 1306 M28170 Hs.960231.00E−114 1 cell surface protein CD19 (CD19) gene, complete cds/c 149G8213 435 BF222826 Hs.96487 1.00E−119 2 7q23f06.x1/clone = IMAGE/gb =BF222826/g 101G7 2266 3173 AL133227 Hs.96560 0 2 DNA sequence from cloneRP11-394O2 on chromosome 20 C 103E6 2840 3451 BC000143 Hs.96560 0 1Similar to hypothetical protein FLJ11656, cl 107G5 226 2349 BF673956Hs.96566 7.00E−24 1 602137338F1 cDNA, 5′ end/clone = IMAGE: 4274048461A12 3602 4135 AB014555 Hs.96731 0 2 mRNA for KIAA0655 protein,partial cds/cds = (0 595A8 82 1571 NM_000734 Hs.97087 1.00E−147 10 CD3Zantigen, zeta polypeptide (TiT3 complex) 479H8 883 1378 NM_014373Hs.97101 0 3 putative G protein-coupled receptor (GPCR150) 466D12 20015732 NM_012072 Hs.97199 0 2 complement component C1q receptor (C1QR),mRN 194B3 1835 2898 NM_002990 Hs.97203 0 2 small inducible cytokinesubfamily A (Cys-Cys) 109E9 2880 3536 AF083322 Hs.97437 0 1 centrioleassociated protein CEP110 mRNA, com 459H5 9 230 BF438062 Hs.978961.00E−116 1 7q66e08.x1 cDNA/clone = IMAGE/gb = BF438062/g 473A4 871 1327NM_007015 Hs.97932 0 1 chondromodulin I precursor (CHM-I), mRNA/cds466E9 1408 1808 AL442083 Hs.98026 1.00E−172 2 mRNA; cDNA DKFZp547D144(from clone DKFZp547D1 460E3 1290 1687 AF038564 Hs.98074 0 1 atrophin-1interacting protein 4 (AIP4) mRNA, 462E6 103 642 NM_016440 Hs.98289 0 1VRK3 for vaccinia related kinase 3 (LOC51231), 460B8 114 546 AA418743Hs.98306 1.00E−178 1 zv98f06.s1 cDNA, 3′ end/clone = IMAGE: 767843/124A8 1 157 NM_019044 Hs.98324 2.00E−69 1 hypothetical protein(FLJ10996), mRNA/cds = ( 71B10 79 520 AI761058 Hs.98531 1.00E−112 34wi69b03.x1 cDNA, 3′ end/clone = IMAGE: 2398541 49F1 36 435 AA913840Hs.98903 0 1 oI39d11.s1 cDNA, 3′ end/clone = IMAGE: 1525845 462F6 61 201AC006276 Hs.99093 2.00E−74 1 chromosome.19, cosmid R28379/cds =(0,633)/gb 473A2 47 475 BE326857 Hs.99237 0 1 hr65h06.x1 cDNA, 3′end/clone = IMAGE: 3133403 599D8 1468 1748 NM_005825 Hs.99491 1.00E−1321 RAS guanyl releasing protein 2 (calcium and DA 459F8 300 541 AW444899Hs.99665 1.00E−123 1 UI-H-BI3-ajz-d-07-0-UI.s1 cDNA, 3′ end/clon 163H9 8141 AL049319 Hs.99821 2.00E−58 1 cDNA DKFZp564C046 (from cloneDKFZp564C0 165H8 1176 1930 NM_015400 Hs.99843 0 2 DKFZP586N0721 protein(DKFZP586N0721), mRNA 188C9 543 998 NM_001436 Hs.99853 0 2 fibrillarin(FBL), mRNA/cds = (59,1024)/gb = N 37H2 759 2017 AC018755 Hs.99855 0 4chromosome 19, BAC BC330783 (CIT-HSPC_470E3), 127H3 758 2183 NM_001462Hs.99855 0 5 formyl peptide receptor-like 1 (FPRL1), mRNA 62F2 1 642BF315159 Hs.99858 0 6 601899519F1 cDNA, 5′ end/clone = IMAGE: 4128749599A7 26 838 NM_000972 Hs.99858 0 11 ribosomal protein L7a (RPL7A),mRNA/cds = (31,8 167B3 1994 2101 AB032251 Hs.99872 2.00E−37 1 BPTF mRNAfor bromodomain PHD finger transcript 41G8 461 751 L08096 Hs.998991.00E−161 1 CD27 ligand mRNA, complete cds/cds = (150,731)/ gb = L08479C10 327 738 NM_001252 Hs.99899 0 1 tumor necrosis factor (ligand)superfamily, m 36D8 1180 2315 AL162047 Hs.99908 0 7 cDNA DKFZp762E1112(from clone DKFZp762E 593E2 62 435 NM_000983 Hs.99914 1.00E−145 1ribosomal protein L22 (RPL22), mRNA/cds = (51,4 478C8 48 311 NM_000023Hs.99931 1.00E−112 1 sarcoglycan, alpha (50 kD dystrophin-associat 61A1827 1053 S62140 Hs.99969 1.00E−126 1 TLS = translocated in liposarcoma[human, mRNA, 1824 nt]/cd 40C7 971 1724 X69819 Hs.99995 0 1 ICAM-3mRNA/cds = (8,1651)/gb = X69819/gi = 32627 116F8 109 376 NM_002964Hs.100000 1.00E−123 5 S100 calcium-binding protein A8 (calgranulin 121F430 540 NM_001629 Hs.100194 1.00E−118 7 arachidonate5-lipoxygenase-activating pro 46G10 5175 5624 NM_003605 Hs.100293 0 2O-linked N-acetylglucosamine (GlcNAc) transf 49E4 1279 2585 NM_006773Hs.100555 0 4 DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 61E1 12791767 X98743 Hs.100555 0 2 RNA helicase (Myc-regulated dead box pro460A10 824 1321 NM_018099 Hs.100895 0 1 hypothetical protein FLJ10462(FLJ10462), mR 458F1 1 303 R18757 Hs.100896 1.00E−157 1 yg17e04.r1 cDNA,5′ end/clone = IMAGE: 32522/c 64B8 2062 2711 AB007859 Hs.100955 0 1 mRNAfor KIAA0399 protein, partial cds/cds = (0, 515H6 131 201 NM_001207Hs.101025 6.00E−33 1 basic transcription factor 3 (BTF3), mRNA/cd 472H1210 358 AW968686 Hs.101340 0 1 EST380762 cDNA/gb = AW968686/gi =8158527/ug = 99G6 2427 4860 AB002384 Hs.101359 0 9 mRNA for KIAA0386gene, complete cds/ cds = (177,3383) 62E12 193 573 AI936516 Hs.1013701.00E−100 6 wd28h07.x1 cDNA, 3′ end/clone = IMAGE: 2329501 493B9 3 638AL583391 Hs.101370 0 8 AL583391 cDNA/clone = CS0DL012YA12-(3-prime)117D4 2812 2966 NM_006291 Hs.101382 7.00E−79 1 tumor necrosis factor,alpha-induced protein 462A9 382 620 BC000764 Hs.101514 1.00E−133 1hypothetical protein FLJ10342, clone MGC: 27 193G3 3368 3659 AL139349Hs.102178 3.00E−88 1 DNA sequence from clone RP11-261P9 on chromosome20. 62H6 3035 4257 AF193339 Hs.102506 0 5 eukaryotic translationinitiation factor 2 a 46E2 3223 4023 NM_004836 Hs.102506 0 2 eukaryotictranslation initiation factor 2-a 460C4 151 635 AW978361 Hs.102630 0 2EST390470 cDNA/gb = AW978361/gi = 8169626/ug = 58E4 1 321 BF970875Hs.102647 1.00E−177 2 602271536F1 cDNA, 5′ end/clone = IMAGE: 4359609189G9 5473 6137 NM_018489 Hs.102652 0 2 hypothetical protein ASH1(ASH1), mRNA/cds = ( 111H5 3043 3331 AK000354 Hs.102669 1.00E−125 1 cDNAFLJ20347 fis, clone HEP13790/cds = (708,14 465B8 27 348 AI707589Hs.102793 1.00E−164 1 as30b05.x1 cDNA, 3′ end/clone = IMAGE: 2318673126G11 1069 1431 NM_016128 Hs.102950 0 2 coat protein gamma-cop(LOC51137), mRNA/cds = 165H5 326 564 BF698884 Hs.103180 4.00E−71 1602126455F1 cDNA, 5′ end/clone = IMAGE: 4283340 108H6 2135 2505 AB023187Hs.103329 1.00E−59 1 for KIAA0970 protein, complete cds/cds = ( 521C91440 1962 AL136885 Hs.103378 0 2 mRNA; cDNA DKFZp434P116 (from cloneDKFZp434P1 458C9 3876 4415 AF254411 Hs.103521 0 1 ser/arg-rich pre-mRNAsplicing factor SR-A1 ( 99F6 349 767 NM_018623 Hs.103657 0 5hypothetical protein PRO2219 (PRO2219), mRNA 162G11 1745 2161 AF117829Hs.103755 1.00E−151 1 8q21.3: RICK gene/cds = (224,1846)/gb = AF11782188G1 1757 2566 NM_004501 Hs.103804 0 2 heterogeneous nuclearribonucleoprotein U ( 470F7 56 302 NM_024056 Hs.103834 1.00E−137 1hypothetical protein MGC5576 (MGC5576), mRNA 460A11 225 288 BG033732Hs.103902 3.00E−29 1 602301101F1 cDNA, 5′ end/clone = IMAGE: 4402465522H7 2157 2397 NM_006342 Hs.104019 1.00E−132 1 transforming, acidiccoiled-coil containing 39E5 1007 2535 L12168 Hs.104125 0 10 adenylylcyclase-associated protein (CAP) mRN 98C11 1023 2558 NM_006367 Hs.1041250 29 adenylyl cyclase-associated protein (CAP), m 461B2 88 221 AW968823Hs.104157 1.00E−38 1 EST380899 cDNA/gb = AW968823/gi = 8158664/ug =110A4 4010 4306 AB023143 Hs.104305 1.00E−125 1 for KIAA0926 protein,complete cds/cds = ( 122H5 4634 5232 NM_014922 Hs.104305 0 2 KIAA0926protein (KIAA0926), mRNA/cds = (522,4 105C2 1817 2174 AB020669 Hs.1043150 1 for KIAA0862 protein, complete cds/cds = ( 37G4 1321 2886 AF016495Hs.104624 0 46 small solute channel 1 (SSC1) mRNA, complete cd 98D4 15782946 NM_020980 Hs.104624 0 71 aquaporin 9 (AQP9), mRNA/cds =(286,1173)/gb = 458E6 1007 1399 NM_015898 Hs.104640 0 1 HIV-1 inducer ofshort transcripts binding pro 462C11 1037 1532 NM_018492 Hs.104741 0 1PDZ-binding kinase; T-cell originated protein 118G4 1940 2513 BC002538Hs.104879 0 2 serine (or cysteine) proteinase inhibitor, c 496A7 1 618BG035120 Hs.104893 0 4 602324815F1 cDNA, 5′ end/clone = IMAGE: 4413099112G4 3421 3933 NM_003633 Hs.104925 0 2 ectodermal-neural cortex (withBTB-like doma 460E2 16 460 AI479075 Hs.104985 0 1 tm30h01.x1 cDNA, 3′end/clone = IMAGE: 2158129 461H4 1500 1781 NM_020979 Hs.105052 1.00E−1481 adaptor protein with pleckstrin homology and 469C7 231 380 NM_018331Hs.105216 1.00E−77 1 hypothetical protein FLJ11125 (FLJ11125), mR 461B684 489 AA489227 Hs.105230 0 1 aa57f07.s1 cDNA, 3′ end/clone = IMAGE:825061/ 462D5 1735 2129 NM_015393 Hs.105460 0 1 DKFZP564O0823 protein(DKFZP564O0823), mRNA 465H7 1 624 NM_017780 Hs.105461 0 1 hypotheticalprotein FLJ20357 (FLJ20357), mR 471F3 819 1126 AY007243 Hs.1054841.00E−160 1 regenerating gene type IV mRNA, complete cds/ 473C1 42 479AW970759 Hs.105621 0 1 EST382842 cDNA/gb = AW970759/gi = 8160604/ug =102A9 1 331 AK025947 Hs.105664 0 1 FLJ22294 fis, clone HRC04426/cds =(240,6 465G9 193 524 AI475680 Hs.105676 0 1 tc93d12.x1 cDNA, 3′end/clone = IMAGE: 2073719 469G2 1528 1625 AK022481 Hs.105779 8.00E−38 1cDNA FLJ12419 fis, clone MAMMA1003047, highly 482A9 289 839 NM_012483Hs.105806 0 3 granulysin (GNLY), transcript variant 519, m 595B11 9181300 NM_002343 Hs.105938 0 1 lactotransferrin (LTF), mRNA/cds =(294,2429) 69B3 3649 4226 Y13247 Hs.106019 0 1 fb19 mRNA/cds =(539,3361)/gb = Y13247/gi = 2117 459E8 106 563 NM_013322 Hs.106260 0 1sorting nexin 10 (SNX10), mRNA/cds = (128,733) 459E2 1939 2361 NM_003171Hs.106469 0 1 suppressor of var1 ( S. cerevisiae) 3-like 1 (S 98H12 6581040 BC002748 Hs.106650 0 2 Similar to hypothetical protein FLJ20533, cl594H5 1418 1501 NM_001568 Hs.106673 6.00E−36 1 eukaryotic translationinitiation factor 3, 194H12 751 1233 NM_021626 Hs.106747 0 1 serinecarboxypeptidase 1 precursor protein ( 138G6 2749 3214 AF189723Hs.106778 0 3 calcium transport ATPase ATP2C1 (ATP2C1A) mRN 56A5 1 1089AL355722 Hs.106875 0 2 EST from clone 35214, full insert/cds = UNKNOWN67H8 844 1102 X71490 Hs.106876 1.00E−103 1 vacuolar proton ATPase,subunit D/cds = (2 463G10 538 725 AF035306 Hs.106890 1.00E−102 1 clone23771 mRNA sequence/cds = UNKNOWN/ gb = AF 121H2 14 394 NM_016619Hs.107139 0 1 hypothetical protein (LOC51316), mRNA/cds = ( 185D12 118884 NM_001564 Hs.107153 0 3 inhibitor of growth family, member 1-like(ING 186D6 1140 1507 NM_017892 Hs.107213 0 1 hypothetical proteinFLJ20585 (FLJ20585), mR 462B10 192 541 AI707896 Hs.107369 1.00E−168 1as34a10.x1 cDNA, 3′ end/clone = IMAGE: 2319066 59A10 1694 2335 AJ270952Hs.107393 0 3 for putative membrane protein (GENX-3745 499G1 2987 4266AL035683 Hs.107526 1.00E−104 2 DNA sequence from clone RP5-1063B2 onchromosome 20q1 466F11 327 493 AI391443 Hs.107622 9.00E−90 1 tf96e06.x1cDNA, 3′ end/clone = IMAGE: 2107138 182F9 153 649 AF265439 Hs.107707 0 1DC37 mRNA, complete cds/cds = (5,856)/gb = AF26 481F9 1216 1609NM_016270 Hs.107740 0 2 Kruppel-like factor (LOC51713), mRNA/cds = (84184H4 189 576 AF081282 Hs.107979 0 1 small membrane protein 1 (SMP1)mRNA, complete 103E11 1006 2137 NM_014313 Hs.107979 0 4 small membraneprotein 1 (SMP1), mRNA/cds = (99, 596H7 1265 1771 NM_004078 Hs.108080 03 cysteine and glycine-rich protein 1 (CSRP1), m 46H8 777 914 AF070640Hs.108112 2.00E−47 1 clone 24781 mRNA sequence/cds = UNKNOWN/ gb = AF53B4 1552 1967 U32986 Hs.108327 0 2 xeroderma pigmentosum group EUV-damaged DNA binding 124A10 1089 1733 AK001428 Hs.108332 0 3 cDNAFLJ10566 fis, clone NT2RP2002959, highly 127F8 428 746 AL136941Hs.108338 0 1 mRNA; cDNA DKFZp586C1924 (from clone DKFZp586 191G10 518883 AL136640 Hs.108548 0 2 mRNA; cDNA DKFZp564F163 (from cloneDKFZp564F1 458G8 2374 5101 NM_016227 Hs.108636 0 2 membrane protein CH1(CH1), mRNA/cds = (124,434 58F11 735 798 NM_006963 Hs.108642 2.00E−28 1zinc finger protein 22 (KOX 15) (ZNF22), mRNA/ 118B5 2715 2797 AK022874Hs.108779 2.00E−38 1 cDNA FLJ12812 fis, clone NT2RP2002498/cds = (3,110H2 18 661 AF026292 Hs.108809 0 1 chaperonin containing t-complexpolypeptide 181G4 1008 1142 NM_006429 Hs.108809 2.00E−71 1 chaperonincontaining TCP1, subunit 7 (eta) (C 189F11 415 615 AK024569 Hs.1088542.00E−79 1 cDNA: FLJ20916 fis, clone ADSE00738, highly s 596F8 5958 6097AB011087 Hs.108945 8.00E−48 1 mRNA for KIAA0515 protein, partial cds/cds= (0, 157D8 399 830 NM_016145 Hs.108969 0 1 PTD008 protein (PTD008),/cds= (233,553) 175E7 712 1849 AL133111 Hs.109150 0 2 mRNA; cDNADKFZp434H068 (from clone DKFZp434H0 514E1 66 613 NM_012417 Hs.109219 0 4retinal degeneration B beta (RDGBB), mRNA/cd 106A4 1864 2220 AJ011895Hs.109281 1.00E−111 1 for HIV-1, Nef-associated factor 1 alpha 169E1 9381331 AK024297 Hs.109441 0 2 FLJ14235 fis, clone NT2RP4000167/cds = (82100B8 1 191 NM_012456 Hs.109571 3.00E−85 1 translocase of innermitochondrial membrane 1 115B7 983 1193 NM_007074 Hs.109606 1.00E−116 1coronin, actin-binding protein, 1A (CORO1A), 62H11 1 626 BF245892Hs.109641 1.00E−154 10 601864070F1 cDNA, 5′ end/clone = lMAGE: 4082465595B2 4976 5286 AB040884 Hs.109694 1.00E−142 1 mRNA for KIAA1451protein, partial cds/cds = (0 75H11 227 482 BF244603 Hs.109697 1.00E−1291 601862620F1 cDNA, 5′ end/clone = IMAGE: 4080412 118G3 219 392NM_024292 Hs.109701 2.00E−66 1 ubiquitin-like 5 (UBL5), mRNA/cds =(65,286)/ 105A5 3271 3532 AL117407 Hs.109727 1.00E−147 2 cDNADKFZp434D2050 (from clone DKFZp434D 481B7 1101 1201 NM_006026 Hs.1098049.00E−42 1 H1 histone family, member X (H1FX), mRNA/cds = ( 476H12 10181429 NM_004310 Hs.109918 0 3 ras homolog gene family, member H (ARHH),mRNA 144C8 1252 1429 Z35227 Hs.109918 7.00E−92 1 TTF for small Gprotein/cds = (579,1154)/gb = 141E10 630 1269 AK001779 Hs.110445 0 4FLJ10917 fis, clone OVARC1000321/cds = (18 494D8 4102 4476 NM_014918Hs.110488 0 1 KIAA0990 protein (KIAA0990), mRNA/cds = (494,2 47C3 22982431 D86974 Hs.110613 1.00E−60 1 KIAA0220 gene, partial cds/cds =(0,1661)/gb 194C10 1210 1704 AL157477 Hs.110702 0 1 mRNA; cDNADKFZp761E212 (from clone DKFZp761E2 192F1 3254 3686 NM_015726 Hs.1107071.00E−150 2 H326 (H326), mRNA/cds = (176,1969)/gb = NM_0157 595B8 11481414 NM_003472 Hs.110713 1.00E−147 1 DEK oncogene (DNA binding) (DEK),mRNA/cds = (3 459F3 3337 3915 NM_001046 Hs.110736 0 1 solute carrierfamily 12 (sodium/potassium/ch 195F5 1051 1482 AK025557 Hs.110771 0 2cDNA: FLJ21904 fis, clone HEP03585/cds = UNKNOW 53B10 163 742 NM_020150Hs.110796 0 1 SAR1 protein (SAR1), mRNA/cds = (100,696)/gb = 164B11 122932 NM_016039 Hs.110803 0 5 CGI-99 protein (LOC51637), mRNA/cds =(161,895 594H4 982 1454 AK026528 Hs.111222 6.00E−95 3 cDNA: FLJ22875fis, clone KAT02879/cds = (30,51 50A10 1688 2095 AF119897 Hs.111334 0 2PRO2760 mRNA, complete cds/cds = UNKNOWN/ gb = A 102H11 175 498 AI436587Hs.111377 1.00E−148 1 ti03d11.x1 cDNA, 3′ end/clone = IMAGE: 2129397109G11 1324 1388 AB016811 Hs.111554 2.00E−29 1 for ADP ribosylationfactor-like protein, 144E10 77 304 BF219474 Hs.111611 1.00E−122 2601884269F1 5′ end/clone = IMAGE: 4102769 583C9 4 272 NM_000988Hs.111611 1.00E−148 10 ribosomal protein L27 (RPL27), mRNA/cds = (17,4111F4 31 380 NM_014463 Hs.111632 0 1 Lsm3 protein (LSM3), mRNA/cds =(29,337)/gb = N 106E6 2646 2892 AL096723 Hs.111801 1.00E−135 1 cDNADKFZp564H2023 (from clone DKFZp564H 169A2 773 1015 D14696 Hs.1118941.00E−135 2 KIAA0108 gene, complete cds/cds = (146,847)/ 182D6 264 748NM_014713 Hs.111894 0 1 lysosomal-associated protein transmembrane460D11 205 452 AI557431 Hs.111973 4.00E−60 1 PT2.1_7_C05.r cDNA, 3′end/clone_end = 3′ /gb = 121A7 355 589 NM_020382 Hs.111988 1.00E−128 1PR/SET domain containing protein 07 (SET07), m 476C12 254 463 AA442585Hs.112071 1.00E−111 1 zv57f09.r1 cDNA, 5′ end/clone = IMAGE: 757769/172E7 469 736 AF228422 Hs.112242 1.00E−143 1 normal mucosa of esophagusspecific 1 (NMES1) 108E10 4800 4901 AF071076 Hs.112255 6.00E−48 1cell-line HeLa Nup98-Nup96 precursor, mRNA, c 47G12 1 301 BF237710Hs.112318 1.00E−165 5 601842210F1 cDNA, 5′ end/clone = IMAGE: 4079930599G7 38 455 NM_019059 Hs.112318 0 32 6.2 kd protein (LOC54543),mRNA/cds = (93,260) 469F9 226 546 NM_002638 Hs.112341 1.00E−107 1protease inhibitor 3, skin-derived (SKALP) (P 589G11 482 1336 AK026396Hs.112497 0 2 cDNA: FLJ22743 fis, clone HUV00901/ cds = UNKNOW 464F101686 1917 NM_002978 Hs.112842 1.00E−119 1 sodium channel,nonvoltage-gated 1, delta (SC 54B11 1 423 BF025727 Hs.113029 0 26601670406F1 cDNA, 5′ end/clone = IMAGE: 3953425 591C5 31 469 NM_001028Hs.113029 0 10 ribosomal protein S25 (RPS25), mRNA/cds = (71,4 585F41882 3918 AK027136 Hs.113205 1.00E−130 3 cDNA: FLJ23483 fis, cloneKAIA04052/cds = UNKNO 61B12 1168 2386 AF105253 Hs.113368 0 5neuroendocrine secretory protein 55 mRNA, com 163D9 3470 4109 Y08890Hs.113503 0 1 mRNA for Ran_GTP binding protein 5 466C4 276 946 AL359916Hs.113872 0 1 DNA sequence from clone RP11-550O8 on chromosome 20 C592C12 2506 2696 AF323540 Hs.114309 2.00E−80 1 apolipoprotein L-I mRNA,splice variant B, co 476A11 121 528 AA702108 Hs.114931 0 1 zi85e01.s1cDNA, 3′ end/clone = IMAGE: 447576/ 109F4 3123 3521 D30783 Hs.115263 0 1for epiregulin, complete cds/cds = (166,67 123D1 3123 3526 NM_001432Hs.115263 0 1 epiregulin (EREG), mRNA/cds = (166,675)/gb = N 465D7 1 175BG288391 Hs.115467 1.00E−94 1 602388053F1 cDNA, 5′ end/clone = IMAGE:4517076 74H9 346 602 AK027114 Hs.115659 1.00E−108 1 FLJ23461 fis, cloneHSI07757/cds = UNKNOW 585E4 384 1146 NM_024061 Hs.115659 0 3hypothetical protein MGC5521 (MGC5521), mRNA 462C1 945 1222 NM_024036Hs.115960 1.00E−152 1 hypothetical protein MGC3103 (MGC3103), mRNA 464E41276 1635 AK023633 Hs.116278 1.00E−138 1 cDNA FLJ13571 fis, clonePLACE1008405/cds = UNK 43B10 1601 1798 AF283777 Hs.116481 9.00E−47 1clone TCBAP0702 mRNA sequence/cds = UNKNOWN/g 465G1 374 654 NM_001782Hs.116481 5.00E−85 2 CD72 antigen (CD72), mRNA/cds = (108,1187)/gb 51G829 203 BF341330 Hs.116567 6.00E−26 1 602013274F1 cDNA, 5′ end/clone =IMAGE: 4149066 40D10 2694 3430 X68742 Hs.116774 0 1 integrin, alphasubunit/cds = UNKNOWN/g 107D1 1778 1943 U71383 Hs.117005 1.00E−84 1 OBbinding protein-2 (OB-BP2) mRNA, complete cds/ cds 459D4 2882 3522AK025364 Hs.117268 0 1 cDNA: FLJ21711 fis, clone COL10156/cds = UNKNOW473E8 2104 2233 AB029016 Hs.117333 2.00E−65 3 mRNA for KIAA1093 protein,partial cds/cds = (0 458E2 88 627 AI825645 Hs.117906 0 2 wb75b09.x1cDNA, 3′ end/clone = IMAGE: 2311481 163A7 1160 1420 X53793 Hs.1179501.00E−109 1 ADE2H1 mRNA showing homologies to SAICAR syntheta 123B8 18740 NM_002799 Hs.118065 0 1 proteasome (prosome, macropain) subunit, bet583G3 924 1199 AB011182 Hs.118087 1.00E−155 4 mRNA for KIAA0610 protein,partial cds/cds = (0, 127A1 263 557 NM_006441 Hs.118131 1.00E−141 15,10-methenyltetrahydrofolate synthetase ( 459A10 188 817 AL522477Hs.118142 0 1 AL522477 cDNA/clone = CS0DB008YK14-(3-prime) 584A10 84848875 NM_003316 Hs.118174 0 1 tetratricopeptide repeat domain 3 (TTC3),mRN 52D4 1287 1752 AK026486 Hs.118183 0 1 FLJ22833 fis, cloneKAIA4266/cds = (479,8 470B6 68 532 BF030930 Hs.118303 0 1 601558648F1cDNA, 5′ end/clone = IMAGE: 3828706 41B3 5041 5669 M14648 Hs.118512 0 1cell adhesion protein (vitronectin) receptor alpha s 125B8 999 1573NM_003733 Hs.118633 0 1 2′-5′oligoadenylate synthetase-like (OASL),459D3 3 427 AI052447 Hs.118659 0 1 oz07g04.x1 cDNA, 3′ end/clone =IMAGE: 1674678 112F11 191 387 NM_006923 Hs.118684 1.00E−103 1 stromalcell-derived factor 2 (SDF2), mRNA/c 129E4 1727 1891 AL050404 Hs.1186952.00E−86 1 DNA sequence from clone 955M13 on chromosome 20. Conta 126H21512 2209 NM_000358 Hs.118787 0 2 transforming growth factor,beta-induced, 68 598D9 817 1106 NM_001155 Hs.118796 1.00E−108 1 annexinA6 (ANXA6), transcript variant 1, mRN 331E6 89 475 BE311727 Hs.118857 01 601143334F1 cDNA, 5′ end/clone = IMAGE: 3507009 521C1 700 1180NM_006292 Hs.118910 0 2 tumor susceptibility gene 101 (TSG101), mRNA139E8 463 1198 AJ012506 Hs.118958 0 1 activated in tumor suppression,clone TSA 69H2 578 1117 U05040 Hs.118962 0 1 FUSE binding protein mRNA,complete cds/ cds = (26,1960 461F1 1241 1715 AK024119 Hs.118990 0 1 cDNAFLJ14057 fis, clone HEMBB1000337/cds = UNK 481E1 1682 1969 NM_017544Hs.119018 1.00E−129 1 transcription factor NRF (NRF), mRNA/cds = (653479B4 45 203 AL109806 Hs.119057 5.00E−43 1 DNA sequence from cloneRP5-1153D9 on chromosome 20 C 520F1 177 672 NM_012423 Hs.1191221.00E−148 8 ribosomal protein L13a (RPL13A), mRNA/cds = (1 477E4 46 1565AL109786 Hs.119155 0 3 mRNA full length insert cDNA clone EUROIMAGE 81166F10 304 814 M37583 Hs.119192 0 3 histone (H2A.Z) mRNA, completecds/cds = (106,492)/g 592E5 302 814 NM_002106 Hs.119192 0 7 H2A histonefamily, member Z (H2AFZ), mRNA/cd 54B1 47 1144 AJ400717 Hs.119252 0 9TPT1 gene for translationally controlled tumo 594H9 609 1013 NM_000520Hs.119403 0 1 hexosaminidase A (alpha polypeptide) (HEXA), 492D9 30 272NM_001004 Hs.119500 1.00E−135 2 ribosomal protein, large P2 (RPLP2),mRNA/cd 59H8 14 1890 NM_016091 Hs.119503 0 12 HSPC025 (HSPC025),mRNA/cds = (33,1727)/gb = N 525E8 12 446 NM_006432 Hs.119529 0 2epididymal secretory protein (19.5 kD) (HE1), 166G7 1323 2293 M88108Hs.119537 0 3 p62 mRNA, complete cds/cds = (106,1437)/ gb = M88108/g112D10 1054 1722 NM_006559 Hs.119537 0 1 GAP-associated tyrosinephosphoprotein p62 158E9 847 1273 AL022326 Hs.119598 0 1 DNA sequencefrom clone 333H23 on chromosome 22q12.1-1 161H7 738 1272 NM_000967Hs.119598 0 1 ribosomal protein L3 (RPL3), mRNA/cds = (6,1217 168F8 284778 M34671 Hs.119663 0 1 lymphocytic antigen CD59/MEM43 mRNA, completecds/c 585C9 285 783 NM_000611 Hs.119663 0 1 CD59 antigen p18-20 (antigenidentified by mo 143G12 753 1329 AK023975 Hs.119908 0 4 FLJ13913 fis,clone Y79AA1000231, highly 55D12 1107 1365 NM_015934 Hs.119908 1.00E−1191 nucleolar protein NOP5/NOP58 (NOP5/NOP58), m 467E7 37 419 AI492066Hs.119923 0 1 tg12b03.x1 cDNA, 3′ end/clone = IMAGE: 2108525 462C10 26693025 NM_012318 Hs.120165 0 1 leucine zipper-EF-hand containingtransmembr 473F11 396 1006 AK025068 Hs.120170 0 1 cDNA: FLJ21415 fis,clone COL04030/cds = (138,7 98E11 211 458 AW081455 Hs.120219 1.00E−114 2xc31c07.x1 cDNA, 3′ end/clone = IMAGE: 2585868 471C8 60 301 NM_014487Hs.120766 1.00E−120 1 nucleolar cysteine-rich protein (HSA6591), m 134C4284 529 AK000470 Hs.120769 9.00E−98 1 cDNA FLJ20463 fis, clone KAT06143/cds = UNKNOWN 469C10 1 441 AA677952 Hs.120891 0 1 zi14a06.s1 cDNA, 3′end/clone = IMAGE: 430738/ 60C9 1022 1615 AB011421 Hs.120996 0 1 forDRAK2, complete cds/cds = (261,1379)/ 461A7 738 1274 NM_014205 Hs.1210250 1 chromosome 11 open reading frame 5 (C11ORF5), m 104A4 557 1942D89974 Hs.121102 0 4 for glycosylphosphatidyl inositol-ancho 196C9 5571463 NM_004665 Hs.121102 0 9 vanin 2 (VNN2), mRNA/cds = (11,1573)/gb =NM_004 467F4 4 328 AW972196 Hs.121210 1.00E−162 1 EST384285 cDNA/gb =AW972196/gi = 8162042/ug = 587A12 224 367 AW975541 Hs.121572 1.00E−62 1EST387650 cDNA/gb = AW975541/gi = 8166755/ug = 36G5 13 604 AL008729Hs.121591 0 1 DNA sequence from PAC 257A7 on chromosome 6p24. Contai464C1 120 413 AA772692 Hs.121709 1.00E−120 1 ai35b09.s1 cDNA, 3′end/clone = 1358969/clone 36E2 411 821 AK025556 Hs.121849 0 1 FLJ21903fis, clone HEP03579/cds = (84,46 196A6 411 1113 NM_022818 Hs.121849 0 1Microtubule-associated proteins 1A and 1B, I 471G2 176 333 AW469546Hs.122116 2.00E−64 1 hd19e09.x1 cDNA, 3′ end/clone = IMAGE: 2909992462F5 218 611 BF677944 Hs.122406 1.00E−166 1 602084766F1 cDNA, 5′end/clone = IMAGE: 4248905 465A6 376 478 AV762642 Hs.122431 2.00E−28 1AV762642 cDNA, 5′ end/clone = MDSEMB08/clone_(—) 467G10 603 803 AL040371Hs.122487 9.00E−96 1 DKFZp434P0213_r1 cDNA, 5′ end/clone = DKFZp434465C12 66 260 AI804629 Hs.122848 3.00E−83 1 tc81g03.x1 cDNA, 3′end/clone = IMAGE: 2072596 98H6 442 591 AI081246 Hs.122983 5.00E−78 1oy67b06.x1 cDNA, 3′ end/clone = IMAGE: 1670867 52B4 123 236 BE676541Hs.123254 8.00E−46 1 7f31g03.x1 cDNA, 3′ end/clone = IMAGE: 3296308128C7 4875 5186 AB020631 Hs.123654 1.00E−131 1 mRNA for KIAA0824protein, partial cds/cds = (0 184B5 594 1187 AL109865 Hs.124186 0 1 DNAsequence from clone GS1-120K12 on chromosome 1q25 106A6 1135 1456AK026776 Hs.124292 9.00E−99 1 FLJ23123 fis, clone LNG08039/cds = UNKNOW525G12 314 503 BF996704 Hs.124344 1.00E−72 1 MR1-GN0173-071100-009-g10cDNA/gb = BF996704 466C3 120 496 AA831838 Hs.124391 1.00E−172 1oc85h06.s1 cDNA, 3′ end/clone = IMAGE: 1356539 48G4 1 568 AA203497Hs.124601 0 1 zx58g05.r1 cDNA, 5′ end/clone = IMAGE: 446744/ 517G2 577756 AA858297 Hs.124675 3.00E−61 1 ob13b08.s1 cDNA, 3′ end/clone = IMAGE:1323543 107H3 913 1220 AK023013 Hs.124762 1.00E−174 1 FLJ12951 fis,clone NT2RP2005457, highly 473A7 729 929 NM_019062 Hs.124835 4.00E−82 1hypothetical protein (FLJ20225), mRNA/cds = ( 108D12 3225 3531 AF023142Hs.125134 1.00E−142 2 pre-mRNA splicing SR protein rA4 mRNA, partial463E11 158 519 AI380443 Hs.125608 0 1 tg02f04.x1 cDNA, 3′ end/clone =IMAGE: 2107615 104F6 1581 2028 NM_019853 Hs.125682 0 1 proteinphosphatase 4 regulatory subunit 2 (P 462A5 5 282 AW975851 Hs.1258151.00E−149 1 EST387960 cDNA/gb = AW975851/gi = 8167072/ug = 462B1 534 702AI378032 Hs.125892 1.00E−69 1 te67g08.x1 cDNA, 3′ end/clone = IMAGE:2091806 121A6 3074 3494 AB028978 Hs.126084 1.00E−174 1 mRNA for KIAA1055protein, partial cds/cds = (0 171G12 94 1240 M15330 Hs.126256 0 7interleukin 1-beta (IL1B) mRNA, complete cds/ cds = (86 183D12 100 1275NM_000576 Hs.126256 0 9 interleukin 1, beta (IL1B), mRNA/cds = (86,895)458B2 6 415 AI393205 Hs.126265 0 1 tg14b07.x1 cDNA, 3′ end/clone =IMAGE: 2108725 102G6 885 1906 AJ271684 Hs.126355 1.00E−171 2 for myeloidDAP12-associating lectin (MD 463E4 847 1015 NM_013252 Hs.126355 2.00E−891 C-type (calcium dependent, carbohydrate-reco 167B2 2468 2721 AF195514Hs.126550 1.00E−142 1 VPS4-2 ATPase (VPS42) mRNA, complete cds/cds =473D8 19 397 BF445163 Hs.126594 0 1 nad21d12.x1 cDNA, 3′ end/clone =IMAGE: 3366191 143C9 333 551 BE250027 Hs.126701 1.00E−121 1 600943030F1cDNA, 5′ end/clone = IMAGE: 2959639 471E10 806 945 AK021519 Hs.1267072.00E−71 1 cDNA FLJ11457 fis, clone HEMBA1001522/cds = (1 462B4 159 572NM_017762 Hs.126721 0 1 hypothetical protein FLJ20313 (FLJ20313), mR41D8 1 2519 AK023275 Hs.126925 0 5 FLJ13213 fis, clone NT2RP4001126,weakly 463F5 2 563 NM_014464 Hs.127011 0 1 tubulointerstitial nephritisantigen (TIN-A 597C8 2662 2905 AB046765 Hs.127270 1.00E−136 1 mRNA forKIAA1545 protein, partial cds/cds = (0 458F11 15 212 BF508731 Hs.1273118.00E−81 1 UI-H-BI4-aoq-b-08-0-UI.s1 cDNA, 3′ end/clon 462B3 76 389AW978753 Hs.127327 1.00E−133 1 EST390862 cDNA/gb = AW978753/gi =8170027/ug = 463E2 176 787 AI028267 Hs.127514 0 1 ow01d06.x1 cDNA, 3′end/clone = IMAGE: 1645547 465G5 181 372 AA953396 Hs.127557 6.00E−78 1on63h10.s1 cDNA, 3′ end/clone = IMAGE: 1561411 125B8 999 1573 NM_003733Hs.118633 0 1 2′-5′oligoadenylate synthetase-like (OASL), 459D3 3 427AI052447 Hs.118659 0 1 oz07g04.x1 cDNA, 3′ end/clone = IMAGE: 1674678112F11 191 387 NM_006923 Hs.118684 1.00E−103 1 stromal cell-derivedfactor 2 (SDF2), mRNA/c 129E4 1727 1891 AL050404 Hs.118695 2.00E−86 1DNA sequence from clone 955M13 on chromosome 20. Conta 126H2 1512 2209NM_000358 Hs.118787 0 2 transforming growth factor, beta-induced, 68598D9 817 1106 NM_001155 Hs.118796 1.00E−108 1 annexin A6 (ANXA6),transcript variant 1, mRN 331E6 89 475 BE311727 Hs.118857 0 1601143334F1 cDNA, 5′ end/clone = IMAGE: 3507009 521C1 700 1180 NM_006292Hs.118910 0 2 tumor susceptibility gene 101 (TSG101), mRNA 139E8 4631198 AJ012506 Hs.118958 0 1 activated in tumor suppression, clone TSA69H2 578 1117 U05040 Hs.118962 0 1 FUSE binding protein mRNA, completecds/ cds = (26,1960 461F1 1241 1715 AK024119 Hs.118990 0 1 cDNA FLJ14057fis, clone HEMBB1000337/cds = UNK 481E1 1682 1969 NM_017544 Hs.1190181.00E−129 1 transcription factor NRF (NRF), mRNA/cds = (653 479B4 45 203AL109806 Hs.119057 5.00E−43 1 DNA sequence from clone RP5-1153D9 onchromosome 20 C 520F1 177 672 NM_012423 Hs.119122 1.00E−148 8 ribosomalprotein L13a (RPL13A), mRNA/cds = (1 477E4 46 1565 AL109786 Hs.119155 03 mRNA full length insert cDNA clone EUROIMAGE 81 166F10 304 814 M37583Hs.119192 0 3 histone (H2A.Z) mRNA, complete cds/cds = (106,492)/g 592E5302 814 NM_002106 Hs.119192 0 7 H2A histone family, member Z (H2AFZ),mRNA/cd 54B1 47 1144 AJ400717 Hs.119252 0 9 TPT1 gene fortranslationally controlled tumo 594H9 609 1013 NM_000520 Hs.119403 0 1hexosaminidase A (alpha polypeptide) (HEXA), 492D9 30 272 NM_001004Hs.119500 1.00E−135 2 ribosomal protein, large P2 (RPLP2), mRNA/cd 59H814 1890 NM_016091 Hs.119503 0 12 HSPC025 (HSPC025), mRNA/cds =(33,1727)/gb = N 525E8 12 446 NM_006432 Hs.119529 0 2 epididymalsecretory protein (19.5 kD) (HE1), 166G7 1323 2293 M88108 Hs.119537 0 3p62 mRNA, complete cds/cds = (106,1437)/ gb = M88108/g 112D10 1054 1722NM_006559 Hs.119537 0 1 GAP-associated tyrosine phosphoprotein p62 158E9847 1273 AL022326 Hs.119598 0 1 DNA sequence from clone 333H23 onchromosome 22q12.1-1 161H7 738 1272 NM_000967 Hs.119598 0 1 ribosomalprotein L3 (RPL3), mRNA/cds = (6,1217 168F8 284 778 M34671 Hs.119663 0 1lymphocytic antigen CD59/MEM43 mRNA, complete cds/c 585C9 285 783NM_000611 Hs.119663 0 1 CD59 antigen p18-20 (antigen identified by mo143G12 753 1329 AK023975 Hs.119908 0 4 FLJ13913 fis, clone Y79AA1000231,highly 55D12 1107 1365 NM_015934 Hs.119908 1.00E−119 1 nucleolar proteinNOP5/NOP58 (NOP5/NOP58), m 467E7 37 419 AI492066 Hs.119923 0 1tg12b03.x1 cDNA, 3′ end/clone = IMAGE: 2108525 462C10 2669 3025NM_012318 Hs.120165 0 1 leucine zipper-EF-hand containing transmembr473F11 396 1006 AK025068 Hs.120170 0 1 cDNA: FLJ21415 fis, cloneCOL04030/cds = (138,7 98E11 211 458 AW081455 Hs.120219 1.00E−114 2xc31c07.x1 cDNA, 3′ end/clone = IMAGE: 2585868 471C8 60 301 NM_014487Hs.120766 1.00E−120 1 nucleolar cysteine-rich protein (HSA6591), m 134C4284 529 AK000470 Hs.120769 9.00E−98 1 cDNA FLJ20463 fis, clone KAT06143/cds = UNKNOWN 469C10 1 441 AA677952 Hs.120891 0 1 zi14a06.s1 cDNA, 3′end/clone = IMAGE: 430738/ 60C9 1022 1615 AB011421 Hs.120996 0 1 forDRAK2, complete cds/cds = (261,1379)/ 461A7 738 1274 NM_014205 Hs.1210250 1 chromosome 11 open reading frame 5 (C11ORF5), m 104A4 557 1942D89974 Hs.121102 0 4 for glycosylphosphatidyl inositol-ancho 196C9 5571463 NM_004665 Hs.121102 0 9 vanin 2 (VNN2), mRNA/cds = (11,1573)/gb =NM_004 467F4 4 328 AW972196 Hs.121210 1.00E−162 1 EST384285 cDNA/gb =AW972196/gi = 8162042/ug = 587A12 224 367 AW975541 Hs.121572 1.00E−62 1EST387650 cDNA/gb = AW975541/gi = 8166755/ug = 36G5 13 604 AL008729Hs.121591 0 1 DNA sequence from PAC 257A7 on chromosome 6p24. Contai464C1 120 413 AA772692 Hs.121709 1.00E−120 1 ai35b09.s1 cDNA, 3′end/clone = 1358969/clone 36E2 411 821 AK025556 Hs.121849 0 1 FLJ21903fis, clone HEP03579/cds = (84,46 196A6 411 1113 NM_022818 Hs.121849 0 1Microtubule-associated proteins 1A and 1B, I 471G2 176 333 AW469546Hs.122116 2.00E−64 1 hd19e09.x1 cDNA, 3′ end/clone = IMAGE: 2909992462F5 218 611 BF677944 Hs.122406 1.00E−166 1 602084766F1 cDNA, 5′end/clone = IMAGE: 4248905 465A6 376 478 AV762642 Hs.122431 2.00E−28 1AV762642 cDNA, 5′ end/clone = MDSEMB08/clone_(—) 467G10 603 803 AL040371Hs.122487 9.00E−96 1 DKFZp434P0213_r1 cDNA, 5′ end/clone = DKFZp434465C12 66 260 AI804629 Hs.122848 3.00E−83 1 tc81g03.x1 cDNA, 3′end/clone = IMAGE: 2072596 98H6 442 591 AI081246 Hs.122983 5.00E−78 1oy67b06.x1 cDNA, 3′ end/clone = IMAGE: 1670867 52B4 123 236 BE676541Hs.123254 8.00E−46 1 7f31g03.x1 cDNA, 3′ end/clone = IMAGE: 3296308128C7 4875 5186 AB020631 Hs.123654 1.00E−131 1 mRNA for KIAA0824protein, partial cds/cds = (0 184B5 594 1187 AL109865 Hs.124186 0 1 DNAsequence from clone GS1-120K12 on chromosome 1q25 106A6 1135 1456AK026776 Hs.124292 9.00E−99 1 FLJ23123 fis, clone LNG08039/cds = UNKNOW525G12 314 503 BF996704 Hs.124344 1.00E−72 1 MR1-GN0173-071100-009-g10cDNA/gb = BF996704 466C3 120 496 AA831838 Hs.124391 1.00E−172 1oc85h06.s1 cDNA, 3′ end/clone = IMAGE: 1356539 48G4 1 568 AA203497Hs.124601 0 1 zx58g05.r1 cDNA, 5′ end/clone = IMAGE: 446744/ 517G2 577756 AA858297 Hs.124675 3.00E−61 1 ob13b08.s1 cDNA, 3′ end/clone = IMAGE:1323543 107H3 913 1220 AK023013 Hs.124762 1.00E−174 1 FLJ12951 fis,clone NT2RP2005457, highly 473A7 729 929 NM_019062 Hs.124835 4.00E−82 1hypothetical protein (FLJ20225), mRNA/cds = ( 108D12 3225 3531 AF023142Hs.125134 1.00E−142 2 pre-mRNA splicing SR protein rA4 mRNA, partial463E11 158 519 AI380443 Hs.125608 0 1 tg02f04.x1 cDNA, 3′ end/clone =IMAGE: 2107615 104F6 1581 2028 NM_019853 Hs.125682 0 1 proteinphosphatase 4 regulatory subunit 2 (P 462A5 5 282 AW975851 Hs.1258151.00E−149 1 EST387960 cDNA/gb = AW975851/gi = 8167072/ug = 462B1 534 702AI378032 Hs.125892 1.00E−69 1 te67g08.x1 cDNA, 3′ end/clone = IMAGE:2091806 121A6 3074 3494 AB028978 Hs.126084 1.00E−174 1 mRNA for KIAA1055protein, partial cds/cds = (0 171G12 94 1240 M15330 Hs.126256 0 7interleukin 1-beta (IL1B) mRNA, complete cds/ cds = (86 183D12 100 1275NM_000576 Hs.126256 0 9 interleukin 1, beta (IL1B), mRNA/cds = (86,895)458B2 6 415 AI393205 Hs.126265 0 1 tg14b07.x1 cDNA, 3′ end/clone =IMAGE: 2108725 102G6 885 1906 AJ271684 Hs.126355 1.00E−171 2 for myeloidDAP12-associating lectin (MD 463E4 847 1015 NM_013252 Hs.126355 2.00E−891 C-type (calcium dependent, carbohydrate-reco 167B2 2468 2721 AF195514Hs.126550 1.00E−142 1 VPS4-2 ATPase (VPS42) mRNA, complete cds/cds =473D8 19 397 BF445163 Hs.126594 0 1 nad21d12.x1 cDNA, 3′ end/clone =IMAGE: 3366191 143C9 333 551 BE250027 Hs.126701 1.00E−121 1 600943030F1cDNA, 5′ end/clone = IMAGE: 2959639 471E10 806 945 AK021519 Hs.1267072.00E−71 1 cDNA FLJ11457 fis, clone HEMBA1001522/cds = (1 462B4 159 572NM_017762 Hs.126721 0 1 hypothetical protein FLJ20313 (FLJ20313), mR41D8 1 2519 AK023275 Hs.126925 0 5 FLJ13213 fis, clone NT2RP4001126,weakly 463F5 2 563 NM_014464 Hs.127011 0 1 tubulointerstitial nephritisantigen (TIN-A 597C8 2662 2905 AB046765 Hs.127270 1.00E−136 1 mRNA forKIAA1545 protein, partial cds/cds = (0 458F11 15 212 BF508731 Hs.1273118.00E−81 1 UI-H-BI4-aoq-b-08-0-UI.s1 cDNA, 3′ end/clon 462B3 76 389AW978753 Hs.127327 1.00E−133 1 EST390862 cDNA/gb = AW978753/gi =8170027/ug = 463E2 176 787 AI028267 Hs.127514 0 1 ow01d06.x1 cDNA, 3′end/clone = IMAGE: 1645547 465G5 181 372 AA953396 Hs.127557 6.00E−78 1on63h10.s1 cDNA, 3′ end/clone = IMAGE: 1561411 463E10 11190 11634NM_016239 Hs.127561 0 1 unconventional myosin-15 (LOC51168), mRNA/c476A9 27 216 AW384918 Hs.127574 1.00E−101 1 PM1-HT0422-291299-002-d01cDNA/gb = AW384918 111B10 1825 2463 NM_014007 Hs.127649 0 1 KIAA0414protein (KIAA0414), mRNA/cds = (1132, 499A7 2134 5198 AF070674 Hs.1277990 8 inhibitor of apoptosis protein-1 (MIHC) mRNA, 331F5 4 460 BF342439Hs.127863 0 1 602013944F1 cDNA, 5′ end/clone = IMAGE: 4149562 176A12 7961351 NM_022900 Hs.128003 0 1 hypothetical protein FLJ21213 (FLJ21213),mR 462B5 1766 1949 NM_014406 Hs.128342 5.00E−82 1 potassium largeconductance calcium-activate 467D5 157 279 AI222805 Hs.128630 6.00E−62 1qp39c07.x1 cDNA, 3′ end/clone = IMAGE: 1925388 465G3 1 529 BE222032Hs.128675 0 1 hr61g11.x1 cDNA, 3′ end/clone = IMAGE: 3133028 467C7 11721726 AF118274 Hs.128740 0 1 DNb-5 mRNA, partial cds/cds = (0,1601)/gb =AF11 175G11 358 724 AL110151 Hs.128797 0 1 mRNA; cDNA DKFZp586D0824(from clone DKFZp586 472A12 402 782 BE745645 Hs.129135 1.00E−153 1601578727F1 cDNA, 5′ end/clone = IMAGE: 3927535 473C7 46 217 BE670584Hs.129192 3.00E−37 1 7e36h08.x1 cDNA, 3′ end/clone = IMAGE: 3284607463G11 7 397 AA746320 Hs.129572 0 1 ob08f01.s1 cDNA, 3′ end/clone =IMAGE: 1323097 63D8 18 1167 D13748 Hs.129673 0 4 eukaryotic initiationfactor 4AI/cds = (16,12 57F3 19 1279 NM_001416 Hs.129673 0 4 eukaryotictranslation initiation factor 4A, 144G5 1071 1192 AF064090 Hs.1297083.00E−62 3 ligand for herpesvirus entry mediator (HVEM-L) 118A9 26843198 AB046805 Hs.129750 0 1 mRNA for KIAA1585 protein, partial cds/cds =(2 50G5 1119 1440 AK024068 Hs.129872 1.00E−172 1 FLJ14006 fis, cloneY79AA1002399, highly 469D6 376 603 D43968 Hs.129914 1.00E−126 1 AML1mRNA for AML1b protein (alternatively spliced pr 590G11 823 1571NM_003563 Hs.129951 0 3 speckle-type POZ protein (SPOP), mRNA/cds = (15591C7 68 571 NM_005243 Hs.129953 0 1 Ewing sarcoma breakpoint region 1(EWSR1), tra 459F5 579 768 AI763262 Hs.130059 1.00E−35 1 wi66c04.x1cDNA, 3′ end/clone = IMAGE: 2398278 479A10 259 448 AI089359 Hs.1302321.00E−103 1 qb05h03.x1 cDNA, 3′ end/clone = IMAGE: 1695413 461G5 193 347AW898615 Hs.130729 2.00E−68 1 RC1-NN0073-090500-012-f02 cDNA/gb =AW898615 466B1 373 569 AI347054 Hs.130879 1.00E−76 1 qp60a04.x1 cDNA, 3′end/clone = IMAGE: 1927374 463G3 3212 5430 AJ404611 Hs.130881 0 2 mRNAfor B-cell lymphoma/leukaemia 11A extra 462C3 48 468 AI421806 Hs.1310670 1 tf44h11.x1 cDNA, 3′ end/clone = IMAGE: 2099109 596G10 39 491NM_006294 Hs.131255 0 3 ubiquinol-cytochrome c reductase binding pro469G10 189 361 AI024984 Hs.131580 1.00E−81 1 ov39d11.x1 cDNA, 3′end/clone = IMAGE: 1639701 458B7 169 659 AW978870 Hs.131828 0 1EST390979 cDNA/gb = AW978870/gi = 8170147/ug = 63D1 185 500 AF176706Hs.131859 1.00E−133 1 F-box protein FBX11 mRNA, partial cds/cds = (0,58C10 4188 4313 NM_014913 Hs.131915 2.00E−65 1 KIAA0863 protein(KIAA0863), mRNA/cds = (185,3 117H2 282 569 NM_003608 Hs.1319241.00E−143 1 G protein-coupled receptor 65 (GPR65), mRNA/ 462D11 441 683AW976422 Hs.132064 1.00E−118 1 EST388531 cDNA/gb = AW976422/gi =8167649/ug = 586F11 161 1094 NM_017830 Hs.132071 0 2 hypotheticalprotein FLJ20455 (FLJ20455), mR 466A8 118 224 AI042377 Hs.1321562.00E−44 1 ox62c03.x1 cDNA, 3′ end/clone = IMAGE: 1660900 472F6 979 1431AK022463 Hs.132221 0 1 cDNA FLJ12401 fis, clone MAMMA 1002796/cds = (3,462E4 19 567 AI031656 Hs.132237 0 1 ow48e06.x1 cDNA, 3′ end/clone =IMAGE: 1650082 462E2 4 539 AI829569 Hs.132238 0 1 wf28e02.x1 cDNA, 3′end/clone = IMAGE: 2356922 461H9 453 618 BG037042 Hs.132555 4.00E−57 1602288311F1 cDNA, 5′ end/clone = IMAGE: 4374122 467D10 4518 4689AK024449 Hs.132569 2.00E−55 1 mRNA for FLJ00041 protein, partial cds/cds= (0 463H7 162 438 AI346336 Hs.132594 1.00E−132 1 qp50b04.x1 cDNA, 3′end/clone = IMAGE: 1926415 592B8 2415 2957 NM_005337 Hs.132834 0 1hematopoietic protein 1 (HEM1), mRNA/cds = (158 70H2 6370 6718 AF047033Hs.132904 1.00E−175 1 sodium bicarbonate cotransporter 3 (SLC4A7) m50G10 1167 2041 AL121985 Hs.132906 0 4 DNA sequence from cloneRP11-404F10 on chromosome 1q2 123C10 1323 1570 NM_015071 Hs.1329421.00E−136 1 GTPase regulator associated with the focal adh 121B10 92 503AA504269 Hs.133032 0 1 aa61c09.s1 cDNA, 3′ end/clone = IMAGE: 825424/171A12 696 909 AL050035 Hs.133130 6.00E−83 1 mRNA; cDNA DKFZp566H0124(from clone DKFZp566 463B5 123 449 AI051673 Hs.133175 1.00E−176 1oy77g06.x1 cDNA, 3′ end/clone = IMAGE: 1671898 463B7 966 1103 AL044498Hs.133262 3.00E−46 1 DKFZp4341082_s1 cDNA, 3′ end/clone = DKFZp4341463B8 1 322 AV661783 Hs.133333 1.00E−176 1 AV661783 cDNA, 3′ end/clone =GLCGXE12/clone_(—) 463A10 431 694 AW966876 Hs.133543 1.00E−110 1EST378950 cDNA/gb = AW966876/gi = 8156712/ug = 464B10 63 547 BF965766Hs.133864 0 1 602276890F1 cDNA, 5′ end/clone = IMAGE: 4364495 460C6 454653 AW009671 Hs.134272 8.00E−70 1 ws85g09.x1 cDNA, 3′ end/clone = IMAGE:2504800 459C12 3337 3745 AJ278245 Hs.134342 1.00E−121 1 mRNA forLanC-like protein 2 (lancl2 gene)/cds 462G1 33 454 AI074016 Hs.134473 01 oy66g02.x1 cDNA, 3′ end/clone = IMAGE: 1670834 462G6 260 597 BE676210Hs.134648 1.00E−156 1 7f25c05.x1 cDNA, 3′ end/clone = IMAGE: 3295688466H12 505 662 AV706481 Hs.134829 3.00E−65 1 AV706481 cDNA, 5′ end/clone= ADBBYF02 148H11 16 474 BE786820 Hs.135056 0 1 601477630F1 5′ end/clone= IMAGE: 3880471 462E1 139 487 BF109873 Hs.135106 0 1 7170e11.x1 cDNA,3′ end/clone = IMAGE: 3526772 147E6 11 364 AV712376 Hs.135167 0 2AV712376 cDNA, 5′ end/clone = DCAAND12/clone_(—) 465B4 1993 2237AJ271326 Hs.135187 1.00E−92 1 mRNA for unc-93 related protein (UNC93gene)/ 463B4 185 352 AI051664 Hs.135339 4.00E−48 1 oy77f06.x1 cDNA, 3′end/clone = IMAGE: 1671875 478H4 2126 2458 AK024921 Hs.135570 1.00E−1701 cDNA: FLJ21268 fis, clone COL01718/cds = UNKNOW 148B6 119 444 AI004582Hs.135764 3.00E−82 8 ou04a11.x1 3′ end/clone = IMAGE: 1625276 598E9 19482184 NM_022117 Hs.136164 3.00E−93 1 cutaneous T-cell lymphoma-associatedtumor a 514C10 398 840 AL049597 Hs.136309 0 2 DNA sequence from cloneRP4-612B15 on chromosome 1p22 461C6 18 219 BF513274 Hs.136375 1.00E−1011 UI-H-BW1-amo-d-11-0-UI.s1 cDNA, 3′ end/clon 482E4 291 699 BF526066Hs.136537 1.00E−142 1 602071176F1 cDNA, 5′ end/clone = IMAGE: 4214059461G7 43 466 NM_013378 Hs.136713 0 1 pre-B lymphocyte gene 3 (VPREB3),mRNA/cds = (4 119B10 10 677 NM_013269 Hs.136748 0 2 lectin-like NK cellreceptor (LLT1), mRNA/cd 462A10 1233 1727 AK024426 Hs.137354 0 1 mRNAfor FLJ00015 protein, partial cds/cds = (3 41F2 2684 3000 AJ223324Hs.137548 1.00E−156 1 for MAX.3 cell surface antigen/cds = (44,10 74E816 2000 D10923 Hs.137555 0 15 HM74/cds = (60,1223)/gb = D10923/gi =219866/ 58D10 8 2000 NM_006018 Hs.137555 0 9 putative chemokinereceptor; GTP-binding pro 120E2 210 814 NM_002027 Hs.138381 0 1farnesyltransferase, CAAX box, alpha (FNTA), 168E12 1953 2522 D38524Hs.138593 0 1 5′-nucleotidase/cds = (83,1768)/gb = D38524 178F7 573 824NM_006413 Hs.139120 1.00E−115 1 ribonuclease P (30 kD) (RPP30), mRNA/cds= (27,8 473D1 1635 1767 AL049942 Hs.139240 6.00E−50 1 mRNA; cDNADKFZp564F1422 (from clone DKFZp564F 188A8 924 1038 NM_017523 Hs.1392621.00E−56 2 XIAP associated factor-1 (HSXIAPAF1), mRNA/c 168F7 933 1038X99699 Hs.139262 1.00E−53 1 for XIAP associated factor-1/cds = (0,953)/181B10 1556 2517 NM_005816 Hs.142023 0 3 T cell activation, increasedlate expression ( 514E7 2052 2339 NM_003150 Hs.142258 1.00E−114 1 signaltransducer and activator of transcripti 196C7 355 524 NM_016123Hs.142295 9.00E−92 1 putative protein kinase NY-REN-64 antigen (LO585B10 3261 3465 AK023129 Hs.142442 1.00E−100 1 cDNA FLJ13067 fis, cloneNT2RP3001712, highly 458F2 283 413 BE293343 Hs.142737 3.00E−68 1601143756F1 cDNA, 5′ end/clone = IMAGE: 3051493 134C6 289 572 BE886127Hs.142838 1.00E−160 1 601509912F1 cDNA, 5′ end/clone = IMAGE: 3911451110A11 345 584 AI126688 Hs.143049 1.00E−102 1 qb94a06.x1 cDNA, 3′end/clone = IMAGE: 1707730 472G7 127 452 AW976331 Hs.143254 0 1EST388440 cDNA/gb = AW976331/gi = 8167557/ug = 464G11 425 547 AI357640Hs.143314 1.00E−56 1 qy15b06.x1 cDNA, 3′ end/clone = IMAGE: 2012051463F11 257 640 BF446017 Hs.143389 0 1 7p18a11.x1 cDNA, 3′ end/clone =IMAGE: 3646004 463H2 107 443 AA825245 Hs.143410 1.00E−151 1 oe59g09.s1cDNA, 3′ end/clone = IMAGE: 1415968 48B7 1 3366 NM_005813 Hs.143460 0 2protein kinase C, nu (PRKCN), mRNA/cds = (555,32 463C9 290 405 AW173163Hs.143525 5.00E−41 1 xj84b08.x1 cDNA, 3′ end/clone = IMAGE: 2663895463C8 330 473 AI095189 Hs.143534 5.00E−57 2 oy83b06.s1 cDNA, 3′end/clone = IMAGE: 1672403 464G5 94 189 BG033028 Hs.143554 1.00E−38 1602300135F1 cDNA, 5′ end/clone = IMAGE: 4401776 463D7 120 563 NM_006777Hs.143604 0 1 Kaiso (ZNF-kaiso), mRNA/cds = (0,2018)/gb = NM 471A10 132586 AK026372 Hs.143631 0 1 cDNA: FLJ22719 fis, clone HSI14307/cds =UNKNOW 74G2 5129 5285 AF073310 Hs.143648 2.00E−79 2 insulin receptorsubstrate-2 (IRS2) mRNA, com 471G11 7 320 AI568622 Hs.143951 1.00E−154 2tn41e10.x1 cDNA, 3′ end/clone = IMAGE: 2170218 478H12 963 1532 NM_018270Hs.143954 0 1 hypothetical protein FLJ10914 (FLJ10914), mR 462G3 100 529AI074020 Hs.144114 0 1 oy66g06.x1 cDNA, 3′ end/clone = IMAGE: 1670842463C1 52 151 AI090305 Hs.144119 1.00E−42 1 oy81b01.s1 cDNA, 3′ end/clone= IMAGE: 1672201 472H8 157 485 BF509758 Hs.144265 1.00E−178 1UI-H-B14-apg-d-04-0-UI.s1 cDNA, 3′ end/clon 166E1 23 443 D63874Hs.144321 0 1 HMG-1, complete cds/cds = (76,723)/gb = D63874 145G8 1251606 NM_018548 Hs.144477 0 2 hypothetical protein PRO2975 (PRO2975),mRNA 191H8 46 624 BF036686 Hs.144559 0 1 601459771F1 cDNA, 5′ end/clone= IMAGE: 3863248 151B1 1983 2561 M93651 Hs.145279 0 2 set gene, completecds/cds = (3,836)/gb = M93651/ gi = 33 514B2 115 1583 NM_003011Hs.145279 0 4 SET translocation (myeloid leukemia-associat 596D4 89 734AA631938 Hs.145668 0 8 fmfc5 cDNA/clone = CR6-21/gb = AA631938/gi = 25492B3 512 2226 NM_004902 Hs.145696 0 2 splicing factor (CC1.3) (CC1.3),mRNA/cds = (14 192E4 1483 1837 AF246126 Hs.145956 0 1 zinc fingerprotein mRNA, complete cds/cds = (1 480B9 1094 1426 AL136874 Hs.1460371.00E−111 1 mRNA; cDNA DKFZp434C135 (from clone DKFZp434C1 49H1 17612182 NM_022894 Hs.146123 0 1 hypothetical protein FLJ12972 (FLJ12972),mR 129C6 517 603 BE220959 Hs.146215 6.00E−21 1 hu02b06.x1 cDNA, 3′end/clone = IMAGE: 3165395 583D9 249 646 NM_003641 Hs.146360 0 1interferon induced transmembrane protein 1 ( 589D9 125 1866 NM_002139Hs.146381 0 5 RNA binding motif protein, X chromosome (RBMX) 68H11 1221567 Z23064 Hs.146381 0 2 mRNA gene for hnRNP G protein/cds =(11,1186)/gb = 174A8 461 1008 NM_004757 Hs.146401 0 1 small induciblecytokine subfamily E, member 1 171A6 461 686 U10117 Hs.146401 1.00E−1001 endothelial-monocyte activating polypeptide II mRN 465C4 53 342AI141004 Hs.146627 3.00E−89 1 oy68f02.x1 cDNA, 3′ end/clone = IMAGE:1671003 190H7 1306 3107 AB033079 Hs.146668 0 3 mRNA for KIAA1253protein, partial cds/cds = (0 102E9 412 1022 AF054187 Hs.146763 0 3alpha NAC mRNA, complete cds/cds = (309,956)/g 179B1 364 843 D16481Hs.146812 0 1 mitochondrial 3-ketoacyl-CoA thiolas 126H12 1 358NM_000183 Hs.146812 0 1 hydroxyacyl-Coenzyme A dehydrogenase/3-keto476C9 20 249 AI187423 Hs.147040 1.00E−128 2 qf31d04.x1 cDNA, 3′end/clone = IMAGE: 1751623 70H11 47 1593 AF272148 Hs.147644 0 7 KRABzinc finger protein (RITA) mRNA, complete 51F1 635 1039 NM_018555Hs.147644 0 3 C2H2-like zinc finger protein (ZNF361), mRNA 72H1 948 5026AF000982 Hs.147916 0 7 dead box, X isoform (DBX) mRNA, alternative tra37F10 3128 3652 X63563 Hs.148027 0 1 RNA polymerase II 140 kDa/cds =(43,3567) 64C11 163 279 AA908367 Hs.148288 6.00E−29 1 og76c11.s1 cDNA,3′ end/clone = IMAGE: 1454228 463G2 52 473 AI335004 Hs.148558 0 1tb21e09.x1 cDNA, 3′ end/clone = IMAGE: 2055016 471F8 17 463 AI471866Hs.149095 0 1 ti67d04.x1 cDNA, 3′ end/clone = IMAGE: 2137063 169C12 4491711 L06132 Hs.149155 0 2 voltage-dependent anion channel isoform 1(VDAC) mRN 189G6 1353 1711 NM_003374 Hs.149155 0 5 voltage-dependentanion channel 1 (VDAC1), mR 481E3 501 669 NM_007022 Hs.149443 5.00E−84 1putative tumor suppressor (101F6), mRNA/cds = 472B3 93 182 BF029894Hs.149595 6.00E−44 1 601557056F1 cDNA, 5′ end/clone = IMAGE: 3827172173D1 3719 3877 AB037901 Hs.149918 3.00E−83 1 GASC-1 mRNA, completecds/cds = (150,3320)/gb 153G12 1429 1787 M31627 Hs.149923 0 2 X boxbinding protein-1 (XBP-1) mRNA, complete cds/cd 116B10 1435 1787NM_005080 Hs.149923 1.00E−180 1 X-box binding protein 1 (XBP1), mRNA/cds= (12,7 111G4 480 1891 L12052 Hs.150395 0 2 cAMP phosphodiesterase PDE7(PDE7A1) mRNA, co 461D6 1407 1904 NM_000790 Hs.150403 0 1 dopadecarboxylase (aromatic L-amino acid dec 73B3 896 1779 AL050005Hs.150580 0 23 cDNA DKFZp564A153 (from clone DKFZp564A1 465G12 1 549AJ272212 Hs.150601 0 1 mRNA for protein serine kinase (PSKH1 gene)/c140G12 2 195 BF028489 Hs.150675 1.00E−100 1 601763692F1 cDNA, 5′end/clone = IMAGE: 3995950 496E10 17 1686 BC000167 Hs.151001 0 5 cloneIMAGE: 2900671, mRNA, partial cds/cds = 597G7 623 1488 NM_005015Hs.151134 0 2 oxidase (cytochrome c) assembly 1-like (OXA1L 50C9 10511467 X80695 Hs.151134 0 1 OXA1Hs mRNA/cds = (6,1313)/gb = X80695/ gi =619490 125H7 3154 3957 NM_001421 Hs.151139 0 3 E74-like factor 4 (etsdomain transcription fa 111F2 306 638 BG286500 Hs.151239 1.00E−149 1602382992F1 cDNA, 5′ end/clone = IMAGE: 4500527 177A4 9686 10035AF075587 Hs.151411 0 1 protein associated with Myc mRNA, complete cds185C7 6934 13968 NM_015057 Hs.151411 0 3 KIAA0916 protein (KIAA0916),mRNA/cds = (146,1 115E7 3406 4005 NM_004124 Hs.151413 0 1 gliamaturation factor, beta (GMFB), mRNA/cds 182H7 234 833 AF099032Hs.151461 0 1 embryonic ectoderm development protein short 169C10 42474727 U38847 Hs.151518 0 1 TAR RNA loop binding protein (TRP-185) mRNA,complete 167D6 1013 1197 NM_002870 Hs.151536 6.00E−83 1 RAB13, memberRAS oncogene family (RAB13), mRN 588G11 1249 1898 AK023362 Hs.1516041.00E−157 9 cDNA FLJ13300 fis, clone OVARC1001342, highly 479G10 1 277NM_007210 Hs.151678 1.00E−103 1 UDP-N-acetyl-alpha-D-galactosamine:polype 178B7 2664 3033 NM_004247 Hs.151787 0 4 U5 snRNP-specificprotein, 116 kD (U5-116 KD), 59A6 382 860 D42054 Hs.151791 0 1 KIAA0092gene, complete cds/cds = (53,1477)/ 521B6 2017 2205 NM_014679 Hs.1517912.00E−93 1 KIAA0092 gene product (KIAA0092), mRNA/cds = ( 59C10 37 697AF070525 Hs.151903 0 5 clone 24706 mRNA sequence/cds = UNKNOWN/ gb = AF519A7 165 686 NM_005792 Hs.152720 0 1 M-phase phosphoprotein 6(MPHOSPH6), mRNA/c 481E11 3990 4280 NM_005154 Hs.152818 1.00E−135 1ubiquitin specific protease 8 (USP8), mRNA/cd 110F2 1210 1841 L25931Hs.152931 0 2 lamin B receptor (LBR) mRNA, complete cds/ cds = (75,192516F8 1217 1708 NM_002296 Hs.152931 0 1 lamin B receptor (LBR), mRNA/cds= (75,1922)/g 462B2 93 2385 AF244129 Hs.153042 0 2 cell-surface moleculeLy-9 mRNA, complete cds 41F4 617 905 X14046 Hs.153053 1.00E−162 1leukocyte antigen CD37/cds = (63,908)/gb = X14 462G8 2312 2843 AF311312Hs.153057 0 1 infertility-related sperm protein mRNA, comp 142H5 17 221M94856 Hs.153179 1.00E−92 1 fatty acid binding protein homologue(PA-FABP) mRNA, 486G9 3 431 NM_001444 Hs.153179 0 1 fatty acid bindingprotein 5 (psoriasis-associ 40A1 2158 2716 X79201 Hs.153221 0 1 SYT/cds= (3,1178)/gb = X79201/gi = 531105 101D9 1524 2060 AB014601 Hs.153293 01 for KIAA0701 protein, partial cds/cds = (0 460F10 1457 6107 AB032972Hs.153489 0 2 mRNA for KIAA1146 protein, partial cds/cds = (0 106A5 445547 AI761622 Hs.153523 2.00E−37 1 wg66f05.x1 cDNA, 3′ end/clone = IMAGE:2370081 482A6 49 369 AI859076 Hs.153551 1.00E−106 1 wl33b04.x1 cDNA, 3′end/clone = IMAGE: 2426671 589B2 1054 1556 AF261091 Hs.153612 0 1 ironinhibited ABC transporter 2 mRNA, complet 57A3 1586 1757 NM_004073Hs.153640 9.00E−87 1 cytokine-inducible kinase (CNK), mRNA/cds = (3466H3 2 257 NM_003866 Hs.153687 1.00E−133 1 inositolpolyphosphate-4-phosphatase, type 483B6 3337 3544 NM_002526 Hs.1539522.00E−72 1 5′ nucleotidase (CD73) (NT5), mRNA/cds = (49,17 41F1 27493371 X55740 Hs.153952 0 1 placental cDNA coding for 5′ nucleotidase (EC3.1.3.5) 44C3 1319 1574 X82206 Hs.153961 1.00E−130 1alpha-centractin/cds = (66,1196)/gb = X8 64F12 2578 2713 NM_022790Hs.154057 1.00E−26 1 matrix metalloproteinase 19 (MMP19), transcri 72E111886 2717 U38320 Hs.154057 0 15 clone rasi-3 matrix metalloproteinaseRASI-1 165H12 414 663 AW970676 Hs.154172 2.00E−22 1 EST382759 cDNA/gb =AW970676/gi = 8160521/ug = 37A4 1151 2746 M31210 Hs.154210 0 2endothelial differentiation protein (edg-1) gene mR 597F4 1125 2395NM_001400 Hs.154210 0 11 endothelial differentiation, sphingolipid G106F2 24 1657 U22897 Hs.154230 0 2 nuclear domain 10 protein (ndp52)mRNA, comple 466E2 116 373 AB023149 Hs.154296 1.00E−131 2 mRNA forKIAA0932 protein, partial cds/cds = (0 107F11 1386 1743 AL117566Hs.154320 0 1 cDNA DKFZp566J164 (from clone DKFZp566J1 166E12 4490 4894D86967 Hs.154332 0 1 KIAA0212 gene, complete cds/cds = (58,2031)/ 188D125148 5666 NM_014674 Hs.154332 0 2 KIAA0212 gene product (KIAA0212),mRNA/cds = ( 66A1 88 615 M82882 Hs.154365 0 1 cis-acting sequence/cds =UNKNOWN/gb = M82882/ gi = 180 37C1 4320 4776 AB028999 Hs.154525 0 1 forKIAA1076 protein, partial cds/cds = (0 98D2 2317 4907 NM_000104Hs.154654 0 6 cytochrome P450, subfamily I (dioxin-inducibl 37C4 44454907 U03688 Hs.154654 0 3 dioxin-inducible cytochrome P450 (CYP1B1)mRNA, comp 464A5 1418 2027 NM_006636 Hs.154672 0 3 methylenetetrahydrofolate dehydrogenase (N 36C5 615 1689 X16396 Hs.154672 0 7NAD-dependent methylene tetrahydrofolate d 67C8 1 397 U85773 Hs.154695 01 phosphomannomutase (PMM2) mRNA, complete cds/ cds = ( 525D3 2084 2533NM_002651 Hs.154846 0 1 phosphatidylinositol 4-kinase, catalytic, b109A7 1979 3148 D10040 Hs.154890 0 2 for long-chain acyl-CoA synthetase,compl 167F6 1817 3359 NM_021122 Hs.154890 0 8 fatty-acid-Coenzyme Aligase, long-chain 2 ( 182A1 344 793 NM_021825 Hs.154938 0 1hypothetical protein MDS025 (MDS025), mRNA/ 104E2 1254 1762 D87450Hs.154978 0 1 KIAA0261 gene, partial cds/cds = (0,3865)/gb 519G10 49125303 NM_003489 Hs.155017 0 1 nuclear receptor interacting protein 1(NRIP1 595C6 4067 4631 NM_006526 Hs.155040 0 2 zinc finger protein 217(ZNF217), mRNA/cds = (2 105D4 1768 2418 L42373 Hs.155079 0 1 phosphatase2A B56-alpha (PP2A) mRNA, complete 174B7 1768 2320 NM_006243 Hs.155079 01 protein phosphatase 2, regulatory subunit B ( 75G4 920 1775 X59066Hs.155101 0 2 mitochondrial ATP synthase (F1-ATPase) alpha 523G12 20 848NM_004681 Hs.155103 0 3 eukaryotic translation initiation factor 1A,74D7 292 1094 M16942 Hs.155122 0 3 MHC class II HLA-DRw53-associatedglycoprotein beta- 137D4 2500 2822 AL049761 Hs.155140 1.00E−176 1 DNAsequence from clone RP5-863C7 on chromosome 20p12 471B5 908 1168AK023379 Hs.155160 1.00E−141 1 cDNA FLJ13317 fis, clone OVARC1001577,highly 176C9 2104 2635 NM_003664 Hs.155172 0 1 adaptor-related proteincomplex 3, beta 1 sub 99F5 212 671 NM_005642 Hs.155188 0 1 TATA boxbinding protein (TBP)-associated fac 166E9 1215 1637 U18062 Hs.155188 01 TFIID subunit TAFII55 (TAFII55) mRNA, complete cds/c 163A11 60 3052AL162086 Hs.155191 0 8 cDNA DKFZp762H157 (from clone DKFZp762H1 71E4 44558 NM_003379 Hs.155191 1.00E−175 4 villin 2 (ezrin) (VIL2), mRNA/cds =(117,1877) 145D8 2135 2669 L47345 Hs.155202 0 1 elongin A mRNA, completecds/cds = (32,2350)/g 477H9 357 2812 NM_014670 Hs.155291 0 2 KIAA0005gene product (KIAA0005), mRNA/cds = ( 58D8 38 336 NM_000518 Hs.1553761.00E−100 1 hemoglobin, beta (HBB), mRNA/cds = (50,493)/g 48F11 576 2131NM_006164 Hs.155396 0 2 nuclear factor (erythroid-derived 2)-like 265G11 426 1179 S74017 Hs.155396 0 1 Nrf2 = NF-E2-like basic leucinezipper transcriptional act 480G12 852 1246 NM_001352 Hs.155402 0 1 Dsite of albumin promoter (albumin D-box) bind 182B12 245 592 NM_006899Hs.155410 0 1 isocitrate dehydrogenase 3 (NAD+) beta (IDH3B 599C9 31883487 NM_021643 Hs.155418 1.00E−163 1 GS3955 protein (GS3955), mRNA/cds =(1225,2256 68H2 563 1749 AF037448 Hs.155489 0 2 RRM RNA binding proteinGry-rbp (GRY-RBP) mRNA 173F6 1243 1811 AF208043 Hs.155530 0 2 IFI16b(IFI16b) mRNA, complete cds/cds = (264,2 170B3 1061 1342 D50063Hs.155543 1.00E−139 1 proteasome subunit p40_/Mov34 protein, comp 590E9494 1323 NM_002811 Hs.155543 0 2 proteasome (prosome, macropain) 26Ssubunit, 522D11 1463 1710 AB029003 Hs.155546 1.00E−138 2 mRNA forKIAA1080 protein, partial cds/cds = (0 587A8 3514 3923 NM_001746Hs.155560 0 1 calnexin (CANX), mRNA/cds = (89,1867)/gb = NM_0 39A6 8301474 D63878 Hs.155595 0 1 KIAA0158 gene, complete cds/cds = (258,1343)167F5 745 2735 NM_004404 Hs.155595 0 3 neural precursor cell expressed,developmenta 106E10 1922 2340 U15173 Hs.155596 1.00E−179 2BCL2/adenovirus E1B 19 kD-interacting protein 524A8 1639 2229 NM_014666Hs.155623 0 1 KIAA0171 gene product (KIAA0171), mRNA/cds = ( 166D6 1217712974 U47077 Hs.155637 0 3 DNA-dependent protein kinase catalytic subuni488A10 1961 2426 NM_002827 Hs.155894 0 3 protein tyrosine phosphatase,non-receptor t 65D6 696 1107 S68271 Hs.155924 0 3 cyclic AMP-responsiveelement modulator (CRE 113E8 682 1435 NM_004054 Hs.155935 0 1 complementcomponent 3a receptor 1 (C3AR1), mR 105F10 119 1591 U62027 Hs.155935 0 3anaphylatoxin C3a receptor (HNFAG09) mRNA, complete 111C1 4122 4779NM_005541 Hs.155939 0 5 inositol polyphosphate-5-phosphatase, 145 kD40A9 1727 2300 D76444 Hs.155968 0 1 hkf-1 mRNA, complete cds/cds =(922,2979)/gb = 124F1 1464 2121 NM_005667 Hs.155968 0 1 zinc fingerprotein homologous to Zfp103 in mo 481E12 2237 2691 NM_003588 Hs.1559760 1 cullin 4B (CUL4B), mRNA/cds = (78,2231)/gb = NM 109H3 36 440NM_020414 Hs.155986 0 1 DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide193B10 1103 1892 AK024974 Hs.156110 1.00E−180 5 cDNA: FLJ21321 fis,clone COL02335, highly sim 463H6 26 149 AI337347 Hs.156339 5.00E−57 1tb98e10.x1 cDNA, 3′ end/clone = IMAGE: 2062410 107H5 34 253 AI146787Hs.156601 7.00E−93 1 qb83f02.x1 cDNA, 3′ end/clone = IMAGE: 1706715517E8 209 822 NM_015646 Hs.156764 0 3 RAP1B, member of RAS oncogenefamily (RAP1B), 478H11 456 768 NM_005819 Hs.157144 1.00E−172 1 syntaxin6 (STX6), mRNA/cds = (0,767)/gb = NM_0 463G12 44 283 AI351144 Hs1572133.00E−95 1 qt23f10.x1 cDNA, 3′ end/clone = IMAGE: 1948459 520A2 23592565 BC001913 Hs.157236 1.00E−95 2 Similar to membrane protein ofcholinergic sy 473A8 2944 3570 AK026394 Hs.157240 0 1 cDNA: FLJ22741fis, clone HUV00774/ cds = UNKNOW 464D5 433 601 AW207701 Hs.1573158.00E−37 1 UI-H-BI2-age-e-03-0-UI.s1 cDNA, 3′ end/clon 464B8 288 633BF184881 Hs.157396 2.00E−99 1 601843756F1 cDNA, 5′ end/clone = IMAGE:4064508 463A6 225 554 AW976630 Hs.157447 1.00E−169 1 EST388739 cDNA/gb =AW976630/gi = 8167861/ug = 464G10 423 661 AI356405 Hs.157556 1.00E−103 1qz26g04.x1 cDNA, 3′ end/clone = IMAGE: 2028054 464H3 396 642 AI568755Hs.157564 1.00E−123 1 th15f03.x1 cDNA, 3′ end/clone = IMAGE: 2118365466C1 110 384 AI760026 Hs.157569 1.00E−135 1 wh83c05.x1 cDNA, 3′end/clone = IMAGE: 2387336 465A2 11 178 AI823541 Hs.157710 1.00E−79 1wh55c11.x1 cDNA, 3′ end/clone = IMAGE: 2384660 464A8 2000 2248 AK023779Hs.157777 1.00E−134 1 cDNA FLJ13717 fis, clone PLACE2000425/cds = UNK464G1 122 447 AI361761 Hs.157813 1.00E−163 2 qz19a07.x1 cDNA, 3′end/clone = IMAGE: 2021940 464G7 293 395 AI361849 Hs.157815 4.00E−30 1qz19h11.x1 cDNA, 3′ end/clone = IMAGE: 2022021 145B8 238 598 BF303931Hs.157850 1.00E−179 3 601886564F2 cDNA, 5′ end/clone = IMAGE: 4120574115D1 111 712 NM_000661 Hs.157850 1.00E−159 2 ribosomal protein L9(RPL9), mRNA/cds = (29,607 102F8 4161 4818 AB023198 Hs.158135 0 1 forKIAA0981 protein, partial cds/cds = (0 597H12 1253 2625 NM_000593Hs.158164 0 5 ATP-binding cassette, sub-family B (MDR/TAP), 465A3 172342 T78173 Hs.158193 5.00E−64 1 yd79c05.r1 cDNA, 5′ end/clone = IMAGE:114440/ 465H8 740 1171 NM_006354 Hs.158196 1.00E−149 1 transcriptionaladaptor 3 (ADA3, yeast homolo 59H12 1646 6883 NM_002313 Hs.158203 0 4actin-binding LIM protein (ABLIM), transcript 464A2 32 549 NM_004571Hs.158225 0 1 PBX/knotted 1 hoemobox 1 (PKNOX1), mRNA/cds = ( 124F126603 6907 AB007915 Hs.158286 1.00E−172 1 mRNA for KIAA0446 protein,partial cds/cds = (3 519F5 80 268 AI199223 Hs.158289 1.00E−86 1qi47c06.x1 cDNA, 3′ end/clone = IMAGE: 1859626 463F8 33 286 BF433857Hs.158501 1.00E−123 1 7q71b07.x1 cDNA/clone = IMAGE/gb = BF433857/g137A8 204 452 AI370965 Hs.158653 5.00E−32 1 ta29b11.x1 cDNA, 3′end/clone = IMAGE: 2045469 466A11 1 565 BE676408 Hs.158714 0 17f29b11.x1 cDNA, 3′ end/clone = IMAGE: 3296061 73C2 5 396 AW362008Hs.158794 0 1 PM2-CT0265-211099-002-d04/gb = AW362008 465C6 242 433AI378113 Hs.158877 2.00E−95 1 tc80c12.x1 cDNA, 3′ end/clone = IMAGE:2072470 465C2 29 153 AI378457 Hs.158894 4.00E−60 2 tc79d10.x1 cDNA, 3′end/clone = IMAGE: 2072371 465C10 47 442 AI379953 Hs.158943 0 1tc81a07.x1 cDNA, 3′ end/clone = IMAGE: 2072532 477B9 151 396 AI380220Hs.158965 1.00E−109 2 tf94a04.x1 cDNA, 3′ end/clone = IMAGE: 2106894477B10 1 414 AI380236 Hs.158966 0 2 tf94b10.x1 cDNA, 3′ end/clone =IMAGE: 2106907 466F8 128 233 AI380388 Hs.158975 4.00E−30 1 tf96a03.x1cDNA, 3′ end/clone = IMAGE: 2107084 467E12 109 350 AI799909 Hs.1589891.00E−82 1 wc46c08.x1 cDNA, 3′ end/clone = IMAGE: 2321678 469G6 169 470AI631850 Hs.158992 1.00E−119 1 wa36h07.x1 cDNA, 3′ end/clone = IMAGE:2300221 467H4 17 292 BF508694 Hs.158999 1.00E−117 1UI-H-BI4-aop-f-09-0-UI.s1 cDNA, 3′ end/clon 469B2 179 388 AI568751Hs.159014 4.00E−94 1 th15d09.x1 cDNA, 3′ end/clone = IMAGE: 2118353464E8 742 945 AL538276 Hs.159065 1.00E−110 1 AL538276 cDNA/clone =CS0DF027YC09-(5-prime) 469D9 1 413 AI431873 Hs.159103 0 1 ti26b11.x1cDNA, 3′ end/clone = IMAGE: 2131581 122C7 1916 2375 NM_003266 Hs.1592390 1 toll-like receptor 4 (TLR4), mRNA/cds = (284,26 462H4 79 239BF307871 Hs.159336 7.00E−66 1 601890687F1 cDNA, 5′ end/clone = IMAGE:4132028 179C1 428 734 AJ225093 Hs.159386 3.00E−88 1 single-chainantibody, complete cds 473D11 267 339 AI380255 Hs.159424 5.00E−34 1tf94d08.x1 cDNA, 3′ end/clone = IMAGE: 2106927 107B2 1 617 BE783628Hs.159441 1.00E−160 2 601471696F1 cDNA, 5′ end/clone = IMAGE: 3874823590E12 52 654 BG290141 Hs.159441 0 6 602385221F1 cDNA, 5′ end/clone =IMAGE: 4514380 70E1 2095 2333 AK027194 Hs.159483 1.00E−119 1 FLJ23541fis, clone LNG08276, highly sim 58A5 10448 12675 AF193556 Hs.159492 0 10sacsin (SACS) gene, complete cds/cds = (76,1156 482E11 2064 2559NM_000061 Hs.159494 0 1 Bruton agammaglobulinemia tyrosine kinase (B147A11 755 2415 AF001622 Hs.159523 0 7 class-I MHC-restricted T cellassociated mole 486H6 1164 1382 NM_019604 Hs.159523 1.00E−117 2 class-IMHC-restricted T cell associated mole 465A5 2693 3039 NM_000033Hs.159546 1.00E−148 1 ATP-binding cassette, sub-family D (ALD), mem 60C41102 1962 AK024833 Hs.159557 1.00E−147 4 FLJ21180 fis, clone CAS11176,highly sim 465B11 457 1126 NM_016952 Hs.159565 0 1 surface glycoprotein,Ig superfamily member ( 477A12 89 581 AI797788 Hs.159577 0 5 wh78b11.x1cDNA, 3′ end/clone = IMAGE: 2386845 595H8 19 912 NM_004632 Hs.159627 0 2death associated protein 3 (DAP3), mRNA/cds = ( 74D2 7 2119 AF153609Hs.159640 0 9 serine/threonine protein kinase sgk mRNA, com 71B2 8 533NM_005627 Hs.159640 0 1 serum/glucocorticoid regulated kinase (SGK)467G8 310 488 AW006352 Hs.159643 2.00E−92 1 wt04d12.x1 cDNA, 3′end/clone = IMAGE: 2506487 467B8 11 363 AI392893 Hs.159655 1.00E−173 1tg05d07.x1 cDNA, 3′ end/clone = IMAGE: 2107885 471F11 16 303 AI827950Hs.159659 1.00E−162 1 wk31a11.x1 cDNA, 3′ end/clone = IMAGE: 2413916467C11 18 501 BF508053 Hs.159673 0 1 UI-H-B14-apx-b-11-0-UI.s1 cDNA, 3′end/clon 477F4 3 405 AI394671 Hs.159678 0 2 tg24a07.x1 cDNA, 3′end/clone = IMAGE: 2109684 472F5 194 366 NM_018490 Hs.160271 1.00E−93 1G protein-coupled receptor 48 (GPR48), mRNA/ 468B11 72 481 AI393041Hs.160273 0 1 tg25b10.x1 cDNA, 3′ end/clone = IMAGE: 2109787 477D3 5 484AI393906 Hs.160401 0 2 tg05f08.x1 cDNA, 3′ end/clone = IMAGE: 2107911477D12 11 389 AI393962 Hs.160405 1.00E−178 1 tg11d08.x1 cDNA, 3′end/clone = IMAGE: 2108463 477D5 15 262 AI393992 Hs.160408 1.00E−138 1tg06c05.x1 cDNA, 3′ end/clone = IMAGE: 2107976 65A9 4106 5547 AF137030Hs.160417 0 5 transmembrane protein 2 (TMEM2) mRNA, complete 513A2 41095547 NM_013390 Hs.160417 0 5 transmembrane protein 2 (TMEM2), mRNA/cds =(14 463F12 688 1425 AF218032 Hs.160422 0 1 clone PP902 unknown mRNA/cds= (693,1706)/gb = 165C1 2625 2987 X85116 Hs.160483 0 1 H. sapiens epb72gene exon 1/cds = (61,927)/ gb = X85116/gi = 1 469G4 145 550 AI634652Hs.160795 0 1 wa07e10.x1 CDNA, 3′ end/clone = IMAGE: 2297418 472C7 343565 AI760020 Hs.160951 1.00E−105 1 wh83b05.x1 cDNA, 3′ end/clone =IMAGE: 2387313 466F12 485 662 BF207290 Hs.160954 2.00E−62 1 601870777F1cDNA, 5′ end/clone = IMAGE: 4100850 477C10 5 290 BF437585 Hs.1609801.00E−149 1 7p74d12.x1 cDNA, 3′ end/clone = IMAGE: 3651526 61E8 44356593 U83115 Hs.161002 0 3 non-lens beta gamma-crystallin like protein(AIM1) m 458E5 1 462 R84314 Hs.161043 1.00E−159 1 yq23a02.r1 cDNA, 5′end/clone = IMAGE: 274443/ 466E12 117 447 BF001821 Hs.161075 0 17g93g02.x1 cDNA, 3′ end/clone = IMAGE: 3314066 102H4 7 219 AW963155Hs.161786 1.00E−111 1 EST375228/gb = AW963155/gi = 8152991/ug = 118B62050 2260 NM_022570 Hs.161786 2.00E−75 1 C-type (calcium dependent,carbohydrate-reco 593C4 3863 4092 U86453 Hs.162808 9.00E−92 1phosphatidylinositol 3-kinase catalytic subunit p1 467B7 129 455AI023714 Hs.163442 1.00E−164 1 ow91h05.x1 cDNA, 3′ end/clone = IMAGE:1654233 107G8 592 1016 AK023670 Hs.163495 0 1 FLJ13608 fis, clonePLACE1010628/cds = UNK 74F3 229 449 AA627122 Hs.163787 4.00E−77 1nq70g02.s1 cDNA, 3′ end/clone = IMAGE: 1157714 68B3 1094 1771 AK023494Hs.164005 0 5 FLJ13432 fis, clone PLACE1002537/cds = UNK 469H10 420 850NM_002993 Hs.164021 0 1 small inducible cytokine subfamily B (Cys-X-C464E9 86 424 AA811244 Hs.164168 1.00E−166 1 ob58h11.s1 cDNA, 3′end/clone = IMAGE: 1335621 467E11 788 1330 NM_007063 Hs.164170 0 1vascular Rab-GAP/TBC-containing (VRP), mRNA 597C5 59 1251 AY007135Hs.164280 1.00E−126 3 clone CDABP0051 mRNA sequence/cds = (89,985)/464H11 2 202 BF689700 Hs.164675 9.00E−65 1 602186609F1 cDNA, 5′end/clone = IMAGE: 4298402 459D5 6 496 AI248204 Hs.165051 0 1 qh64h11.x1cDNA, 3′ end/clone = IMAGE: 1849509 120F12 23 502 NM_001017 Hs.1655901.00E−159 5 ribosomal protein S13 (RPS13), mRNA/cds = (32,4 469C11 301613 AW364833 Hs.165681 1.00E−136 1 QV3-DT0043-211299-044-d03 cDNA/gb =AW364833 465D3 289 481 AI766638 Hs.165693 2.00E−62 1 wi02a10.x1 cDNA, 3′end/clone = IMAGE: 2389050 465D6 107 238 AW850041 Hs.165695 3.00E−61 1IL3-CT0216-170300-097-C07 cDNA/gb = AW850041 466C7 166 421 AI538546Hs.165696 1.00E−122 1 td08b07.x1 cDNA, 3′ end/clone = IMAGE: 2075029469C4 351 691 AI436561 Hs.165703 1.00E−148 1 ti03b03.x1 cDNA, 3′end/clone = IMAGE: 2129357 62A12 32 256 AV727063 Hs.165980 1.00E−120 4AV727063 cDNA, 5′ end/clone = HTCCED11/clone_(—) 107C2 2427 2613AJ250865 Hs.165986 1.00E−82 1 for TESS 2 protein (TESS/cds = (128,1393)/461D5 1762 1935 NM_004031 Hs.166120 8.00E−81 1 interferon regulatoryfactor 7 (IRF7), transc 147D11 38 1283 AL022097 Hs.166203 0 5 DNAsequence from PAC 256G22 on chromosome 6p24 595H12 1321 1597 NM_002636Hs.166204 1.00E−135 2 PHD finger protein 1 (PHF1), mRNA/cds = (56,142958H7 41 2036 AL136711 Hs.166254 0 2 mRNA; cDNA DKFZp566I133 (from cloneDKFZp566I1 98D12 5559 6110 NM_014646 Hs.166318 0 1 lipin 2 (LPIN2),mRNA/cds = (239,2929)/gb = NM_0 468G1 146 509 AW873324 Hs.1663381.00E−168 2 hl92a07.x1 cDNA, 3′ end/clone = IMAGE: 3009396 477D7 29003748 L14922 Hs.166563 0 1 DNA-binding protein (PO-GA) mRNA, complete cd177E7 3265 3595 L23320 Hs.166563 0 1 replication factor C large subunitmRNA, complete cds 584H2 206 1613 NM_006925 Hs.166975 1.00E−112 5splicing factor, arginine/serine-rich 5 (SFR 481F5 647 917 NM_002643Hs.166982 1.00E−128 1 phosphatidylinositol glycan, class F (PIGF), 598E4112 538 NM_002788 Hs.167106 1.00E−174 1 proteasome (prosome, macropain)subunit, alp 466D8 46 470 AI805131 Hs.167206 0 1 td11f04.x1 cDNA, 3′end/clone = IMAGE:2075359 464C8 342 469 BE674762 Hs.167208 4.00E−50 17e98d05.x1 cDNA, 3′ end/clone = IMAGE: 3293193 468A6 1177 1417 NM_003658Hs.167218 4.00E−85 1 BarH-like homeobox 2 (BARX2), mRNA/cds = (96,9374H10 1 1271 AF107405 Hs.167460 0 12 pre-mRNA splicing factor (SFRS3)mRNA, comple 60E9 3154 3926 U43185 Hs.167503 1.00E−143 2 signaltransducer and activator of transcription Sta 517G3 1129 2787 NM_006994Hs.167741 0 3 butyrophilin, subfamily 3, member A3 (BTN3A3), 175H2 22612467 U90548 Hs.167741 2.00E−86 1 butyrophilin (BTF3) mRNA, complete cds/cds = (171,192 588H5 1324 1735 NM_002901 Hs.167791 0 1 reticulocalbin 1,EF-hand calcium binding dom 331D7 53 625 AF116909 Hs.167827 4.00E−22 1clone HH419 unknown mRNA/cds = (189,593)/gb = A 39C11 938 1672 AF026402Hs.168103 0 1 U5 snRNP 100 kD protein mRNA, cds/cds = (39,2501 583C8 9061669 NM_004818 Hs.168103 0 5 prp28, U5 snRNP 100 kd protein (U5-100K),mRNA 43B1 1156 1224 AF031167 Hs.168132 1.00E−22 1 interleukin 15precursor (IL-15) mRNA, complet 479A7 424 801 NM_000585 Hs.1681321.00E−149 1 interleukin 15 (IL15), mRNA/cds = (316,804)/g 67D6 1783 2336AK024030 Hs.168232 0 1 FLJ13968 fis, clone Y79AA1001493, weakly 122H31646 2894 NM_023079 Hs.168232 0 2 hypothetical protein FLJ13855(FLJ13855), mR 459H3 9 504 AI392830 Hs.168287 0 1 tg10b09.x1 cDNA, 3′end/clone = IMAGE: 2108345 463G5 103 851 NM_003002 Hs.168289 0 1succinate dehydrogenase complex, subunit D, 144G9 5588 5937 AL049935Hs.168350 0 2 DKFZp564O1116 (from clone DKFZp564O 459A9 2293 2727NM_000201 Hs.168383 0 2 intercellular adhesion molecule 1 (CD54), hum123G3 2194 2675 AB046801 Hs.168640 0 2 mRNA for KIAA1581 protein,partial cds/cds = (0 112H10 505 864 AF007155 Hs.168694 1.00E−175 2 clone23763 unknown mRNA, partial cds/cds = (0, 60H7 223 897 AF083420Hs.168913 0 1 brain-specific STE20-like protein kinase 3 ( 105C12 16982052 AK026671 Hs.169078 1.00E−176 1 FLJ23018 fis, clone LNG00903/cds =(27,14 181B9 1148 1610 NM_003937 Hs.169139 0 1 kynureninase(L-kynurenine hydrolase) (KYNU) 462B7 13 478 AA977148 Hs.169168 0 1oq24g08.s1 cDNA, 3′ end/clone = IMAGE: 1587326 41H5 197 624 U58913Hs.169191 0 1 chemokine (hmrp-2a) mRNA, complete cds/ cds = (71,484)69G6 11 552 BF214508 Hs.169248 1.00E−160 4 601845758F1 cDNA, 5′end/clone = IMAGE: 4076510 460B2 904 2904 NM_003202 Hs.169294 1.00E−1612 transcription factor 7 (T-cell specific, HMG- 464G12 543 994 D26121Hs.169303 0 1 mRNA for ZFM1 protein alternatively spliced product, 464B5163 762 NM_013259 Hs.169330 0 1 neuronal protein (NP25), mRNA/cds =(49,897)/ 593G4 787 1353 Z97989 Hs.169370 0 2 DNA sequence from PAC66H14 on chromosome 6q21-22. Con 165F12 1177 1751 AK001725 Hs.169407 0 1cDNA FLJ10863 fis, clone NT2RP4001575, highly 483B12 10871 11349NM_004010 Hs.169470 0 1 dystrophin (muscular dystrophy, Duchenne and518B3 22 1257 NM_002046 Hs.169476 0 5 glyceraldehyde-3-phosphatedehydrogenase ( 67E7 1289 1597 U34995 Hs.169476 3.00E−88 1 normalkeratinocyte substraction library mRNA, clon 47E9 2148 2452 NM_005461Hs.169487 1.00E−172 1 Kreisler (mouse) maf-related leucine zipper h 69C3846 3195 U41387 Hs.169531 0 24 Gu protein mRNA, partial cds/cds =(0,2405)/ gb = U41387 468G7 73 450 AI523598 Hs.169541 1.00E−178 1th08g11.x1 cDNA, 3′ end/clone = IMAGE: 2117732 72E12 490 3074 AJ251595Hs.169610 0 29 for transmembrane glycoprotein (CD44 gen 471F2 97 533AW172306 Hs.169738 0 1 xj37a08.x1 cDNA, 3′ end/clone = IMAGE: 2659382589D4 96 488 NM_000994 Hs.169793 1.00E−163 2 ribosomal protein L32(RPL32), mRNA/cds = (34,4 105B6 1590 2215 AK027212 Hs.169854 0 1FLJ23559 fis, clone LNG09844/cds = UNKNOW 462A8 1043 1529 NM_000305Hs.169857 0 1 paraoxonase 2 (PON2), mRNA/cds = (32,1096)/gb 175D11 390929 AF061736 Hs.169895 1.00E−132 2 ubiquitin-conjugating enzyme RIG-BmRNA, com 149A2 2442 2942 U75686 Hs.169900 0 1 polyadenylate bindingprotein mRNA, complete 524B9 2484 2709 NM_007049 Hs.169963 1.00E−125 2butyrophilin, subfamily 2, member A1 (BTN2A1), 169G8 1192 1684 U90543Hs.169963 0 1 butyrophilin (BTF1) mRNA, complete cds/ cds = (210,179129E9 686 1227 X70340 Hs.170009 0 1 transforming growth factor alpha/cds= (3 589C1 1893 3451 NM_004350 Hs.170019 0 5 runt-related transcriptionfactor 3 (RUNX3), 331E1 5084 5496 NM_001621 Hs.170087 0 1 arylhydrocarbon receptor (AHR) mRNA/cds = (643 595H7 659 4185 NM_002838Hs.170121 0 34 protein tyrosine phosphatase, receptor type, 184G8 10833762 Y00062 Hs.170121 0 10 T200 leukocyte common antigen (CD45, LC-A)/c109D4 4529 4876 AF032885 Hs.170133 0 1 forkhead protein (FKHR) mRNA,complete cds/cd 98A12 4529 4882 NM_002015 Hs.170133 1.00E−160 1 forkheadbox O1A (rhabdomyosarcoma) (FOXO1A), 99E3 2098 2334 NM_004761 Hs.1701601.00E−125 1 RAB2, member RAS oncogene family-like (RAB2L), 498F10 34724909 AL161952 Hs.170171 0 28 mRNA; cDNA DKFZp434M0813 (from cloneDKFZp434M 465G7 390 462 AI475666 Hs.170288 2.00E−31 1 tc93c08.x1 cDNA,3′ end/clone = IMAGE: 2073710 467E6 68 482 AK025743 Hs.170296 0 1 cDNA:FLJ22090 fis, clone HEP16084/cds = UNKNOW 459H9 4659 5168 NM_014636Hs.170307 0 1 Ral guanine nucleotide exchange factor RalGPS 38D9 618 992089678 Hs.170311 0 25 for A + U-rich element RNA binding factor, 589F111033 2022 NM_005463 Hs.170311 0 13 heterogeneous nuclearribonucleoprotein D-I 469B9 127 573 AI436418 Hs.170326 0 1 ti01h02.x1cDNA, 3′ end/clone = IMAGE: 2129235 183E4 2725 3777 NM_002444 Hs.1703280 7 moesin (MSN), mRNA/cds = (100,1833)/gb = NM_002 170G2 1693 3305Z98946 Hs.170328 0 4 DNA sequence from clone 376D21 on chromosomeXq11.1-12 464F6 162 534 AI492865 Hs.170331 1.00E−163 1 th78a05.x1 cDNA,3′ end/clone = IMAGE: 2124752 472F8 412 554 AI373163 Hs.170333 1.00E−751 qz13a07.x1 cDNA, 3′ end/clone = IMAGE: 2021364 473C3 376 610 AW291507Hs.170381 1.00E−123 1 UI-H-BI2-aga-g-11-0-UI.s1 cDNA, 3′ end/clon 465E5421 547 BE676049 Hs.170584 3.00E−54 1 7f21a03.x1 cDNA, 3′ end/clone =IMAGE: 3295276 477A3 25 202 AI475884 Hs.170587 4.00E−92 2 tc95c12.x1cDNA, 3′ end/clone = IMAGE: 2073910 477A4 34 489 AI475905 Hs.170588 0 1tc95f06.x1 cDNA, 3′ end/clone = IMAGE: 2073923 469F2 238 490 AI478556Hs.170777 2.00E−84 1 tm53e03.x1 cDNA, 3′ end/clone = IMAGE: 2161852472C5 357 474 AI479022 Hs.170784 1.00E−53 1 tm30a05.x1 cDNA, 3′end/clone = IMAGE: 2158064 477D6 23 407 AI492034 Hs.170909 0 2tg06f12.x1 cDNA, 3′ end/clone = lMAGE: 2108015 471D4 187 416 AI492181Hs.170913 1.00E−106 1 tg07e06.x1 cDNA, 3′ end/clone = IMAGE: 2108098464F8 14 142 AI492651 Hs.170934 7.00E−53 1 qz18b10.x1 cDNA, 3′ end/clone= IMAGE: 2021851 466D3 173 461 AI540204 Hs.170935 1.00E−131 1 td10h12.x1cDNA, 3′ end/clone = IMAGE: 2075303 478F10 314 461 AI761144 Hs.1710044.00E−45 1 wh97h01.x1 cDNA, 3′ end/clone = IMAGE: 2388721 476E2 187 253AI494612 Hs.171009 2.00E−30 2 qz17a03.x1 cDNA, 3′ end/clone = IMAGE:2021740 107G12 2413 2929 AK024436 Hs.171118 0 1 for FLJ00026 protein,partial cds/cds = (0 478H3 1237 1509 AL161725 Hs.171118 1.00E−107 1 DNAsequence from clone RP11-165F24 on chromosome 9. 477H10 252 489 BE674709Hs.171120 3.00E−87 1 7e94f05.x1 cDNA, 3′ end/clone = IMAGE: 3292833477H11 18 521 AI524202 Hs.171122 0 1 th10d11.x1 cDNA, 3′ end/clone =IMAGE: 2117877 466C10 24 216 BE816212 Hs.171261 8.00E−81 1MR1-BN0212-280600-001-c06 cDNA/gb = BE816212 470A4 22 562 AI628893Hs.171262 0 1 ty95h02.x1 cDNA, 3′ end/clone = IMAGE: 2286867 477C4 216464 AI540161 Hs.171264 1.00E−112 2 td10c10.x1 cDNA, 3′ end/clone =IMAGE: 2075250 519E12 1 321 NM_016468 Hs.171566 1.00E−167 2 hypotheticalprotein (LOC51241), mRNA/cds = ( 44C11 5363 5829 AF012872 Hs.171625 0 1phosphatidylinositol 4-kinase 230 (pi4K230) 517D4 19 559 NM_003197Hs.171626 0 3 transcription elongation factor B (SIII), pol 48E9 15631809 NM_004417 Hs.171695 1.00E−138 2 dual specificity phosphatase 1(DUSP1), mRNA 520H5 941 3667 NM_002719 Hs.171734 0 2 protein phosphatase2, regulatory subunit B ( 106G2 1 308 BF243010 Hs.171774 1.00E−167 2601877795F1 cDNA, 5′ end/clone = IMAGE: 4106303 524A7 14 359 NM_015933Hs.171774 0 14 hypothetical protein (HSPC016), mRNA/cds = (3 117A11 311614 BF966361 Hs.171802 1.00E−143 2 602286929F1 cDNA, 5′ end/clone =IMAGE: 4375783 38H11 885 2087 M55543 Hs.171862 0 6 guanylate bindingprotein isoform II (GBP-2) mRNA, co 512F8 232 1971 NM_004120 Hs.171862 012 guanylate binding protein 2, interferon-induc 111B9 3748 4161NM_004941 Hs.171872 0 1 DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide192H11 5738 5903 NM_000937 Hs.171880 2.00E−68 1 polymerase (RNA) II (DNAdirected) polypeptide 176F11 1322 4789 AL109935 Hs.171917 0 3 DNAsequence from clone RP5-1022P6 on chromosome 20 C 596G12 2472 3152NM_001110 Hs.172028 0 5 a disintegrin and metalloproteinase domain 10170A5 2438 2767 AK023154 Hs.172035 0 1 FLJ13092 fis, cloneNT2RP3002147/cds = (34 469D11 71 535 AI474074 Hs.172070 0 1 ti68h11.x1cDNA, 3′ end/clone = IMAGE: 2137221 100G4 5574 5662 U02882 Hs.1720813.00E−24 1 rolipram-sensitive 3′,5′-cyclic AMP phosphodiester 524A11 12517 AL110202 Hs.172089 0 20 mRNA; cDNA DKFZp586I2022 (from cloneDKFZp586 49A2 929 2845 NM_002568 Hs.172182 0 30 poly(A)-binding protein,cytoplasmic 1 (PABP 54C5 929 2484 Y00345 Hs.172182 0 9 polyA bindingprotein/cds = (502,2403)/gb = Y0 586B1 1042 1504 NM_002408 Hs.172195 0 1mannosyl (alpha-1,6-)-glycoprotein beta-1,2 169H6 5576 5958 D25538Hs.172199 0 1 KIAA0037 gene, complete cds/cds = (265,3507) 115G7 45314976 NM_001114 Hs.172199 0 1 adenylate cyclase 7 (ADCY7), mRNA/cds =(265,35 120F2 1 2496 NM_007363 Hs.172207 0 11 non-POU-domain-containing,octamer-binding 74A3 860 1364 Y11289 Hs.172207 0 1 p54nrb gene, exon 3(and joined/cds = (136,1551) 60B7 695 1160 NM_000202 Hs.172458 0 1iduronate 2-sulfatase (Hunter syndrome) (IDS 479D10 4059 4347 NM_000632Hs.172631 1.00E−125 1 integrin, alpha M (complement component recep167B10 1 389 NM_003761 Hs.172684 0 4 vesicle-associated membrane protein8 (endob 189E11 1773 2038 NM_001345 Hs.172690 1.00E−149 2 diacylglycerolkinase, alpha (80 kD) (DGKA), m 177C2 983 1489 X62535 Hs.172690 0 1diacylglycerol kinase/cds = (103,2310) 458B12 535 1002 NM_012326Hs.172740 0 1 microtubule-associated protein, RP/EB family 53A11 69 430W26908 Hs.172762 1.00E−180 1 16b3/gb = W26908/gi = 1306136/ug = Hs.17276151H2 2016 2572 M80359 Hs.172766 0 1 protein p78 mRNA, complete cds/cds= (171,2312)/ gb = M8 100G10 3983 4302 AB037808 Hs.172789 1.00E−149 1for KIAA1387 protein, partial cds/cds = (0 515D9 354 548 NM_004182Hs.172791 3.00E−65 1 ubiquitously-expressed transcript (UXT), mR 193D92282 2757 AL109669 Hs.172803 0 3 mRNA full length insert cDNA cloneEUROIMAGE 31 460H10 12 490 NM_016466 Hs.172918 0 1 hypothetical protein(LOC51239), mRNA/cds = ( 483D3 3473 3941 AB011102 Hs.173081 0 1 mRNA forKIAA0530 protein, partial cds/cds = (0, 195B9 380 854 NM_005729Hs.173125 0 2 peptidylprolyl isomerase F (cyclophilin F) ( 173H6 60086412 NM_006283 Hs.173159 0 1 transforming, acidic coiled-coil containing113E6 142 240 AI554733 Hs.173182 3.00E−49 1 tn27f08.x1 cDNA, 3′end/clone = IMAGE: 2168871 56G8 140 630 AK002009 Hs.173203 0 2 FLJ11147fis, clone PLACE1006678, weakly 69E6 1 463 BF131656 Hs.173205 1.00E−1478 601820483F1 cDNA, 5′ end/clone = IMAGE: 4052348 44A2 6 196 X06347Hs.173255 1.00E−94 1 U1 small nuclear RNP-specific A protein/cds = clone149G1 79 498 AY007165 Hs.173274 1.00E−117 2 CDABP0163 mRNA sequence/cds= UNKNOWN/g 464F3 53 500 AW005376 Hs.173280 0 1 ws94a12.x1 cDNA, 3′end/clone = IMAGE: 2505598 587H5 3299 4083 NM_014633 Hs.173288 0 2KIAA0155 gene product (KIAA0155), mRNA/cds = ( 499B9 1032 1923 NM_012081Hs.173334 0 2 ELL-RELATED RNA POLYMERASE II, ELONGATION FAC 54F11 3681923 U88629 Hs.173334 0 2 RNA polymerase II elongation factor ELL2,complete cd 459A4 2170 2775 AK001362 Hs.173374 0 1 cDNA FLJ10500 fis,clone NT2RP2000369/cds = UNK 124B1 2566 3019 AB046825 Hs.173422 0 1 mRNAfor KIAA1605 protein, partial cds/cds = (3 126H6 1080 1626 NM_006363Hs.173497 0 1 Sec23 (S. cerevisiae) homolog B (SEC23B), mRNA 596D5 12331365 NM_004550 Hs.173611 8.00E−63 5 NADH dehydrogenase (ubiquinone) Fe-Sprotein 108C5 1709 1864 AK022681 Hs.173685 2.00E−83 1 FLJ12619 fis,clone NT2RM4001682/cds = (39 583D12 3 1960 AK025703 Hs.173705 0 4 cDNA:FLJ22050 fis, clone HEP09454/cds = UNKNOW 70B6 579 1140 AL049610Hs.173714 0 2 DNA sequence from clone 1055C14 on chromosome Xq22.1- 46D7590 1150 NM_012286 Hs.173714 0 1 MORF-related gene X (KIAA0026),mRNA/cds = (305 467G5 17 283 AA534537 Hs.173720 1.00E−104 1 nf80h10.s1cDNA, 3′ end/clone = IMAGE: 926275/ 168H5 1 1066 D25274 Hs.173737 0 5mRNA, clone: PO2ST9/cds = UNKNOWN/gb = D25274/ 471B8 5347 5922 NM_014832Hs.173802 0 1 KIAA0603 gene product (KIAA0603), mRNA/cds = ( 177F4 10531622 U51166 Hs.173824 0 1 G/T mismatch-specific thymine DNA glycosylasemRNA, 471C3 396 719 AF277292 Hs.173840 1.00E−176 1 C4orf1 mRNA/cds =(0,281)/gb = AF277292/gi = 96 477F7 2053 2694 U80735 Hs.173854 0 3CAGF28 mRNA, partial cds/cds = (0,2235)/gb = U80 41F3 3595 3890 M37435Hs.173894 1.00E−143 1 macrophage-specific colony-stimulating factor (CSF460C8 1542 1939 NM_014225 Hs.173902 0 1 protein phosphatase 2 (formerly2A), regulator 458A9 292 414 AI763121 Hs.173904 4.00E−57 1 wi06d12.x1cDNA, 3′ end/clone = IMAGE: 2389463 170B10 1230 3510 AL137681 Hs.1739121.00E−176 5 cDNA DKFZp434M0326 (from clone DKFZp434M 126E10 1061 1795Z17227 Hs.173936 1.00E−111 2 mRNA for transmebrane receptor protein/cds= (4 72H7 1210 1907 U08316 Hs.173965 0 2 insulin-stimulated proteinkinase 1 (ISPK-1) mRNA, c 123G7 554 858 NM_005777 Hs.173993 1.00E−168 1RNA binding motif protein 6 (RBM6), mRNA/cds = ( 469C8 261 528 BE674902Hs.174010 1.00E−113 1 7e97a04.x1 cDNA, 3′ end/clone = IMAGE: 3293070117G6 2450 2657 NM_003089 Hs.174051 1.00E−112 1 small nuclearribonucleoprotein 70 kD polypept 103A5 4907 5011 NM_002209 Hs.1741031.00E−48 1 integrin, alpha L (antigen CD11A (p180), lymph 159F4 333 925AF261087 Hs.174131 0 7 DNA-binding protein TAXREB107 mRNA, complete588F9 333 926 NM_000970 Hs.174131 0 8 ribosomal protein L6 (RPL6),mRNA/cds = (26,892 187A2 2993 3464 NM_001096 Hs.174140 0 2 ATP citratelyase (ACLY), mRNA/cds = (84,3401) 41C6 3652 3992 X03663 Hs.174142 0 1c-fms proto-oncogene/cds = (300,3218)/gb = X0 465G10 199 489 BE674951Hs.174144 1.00E−152 1 7e97g10.x1 cDNA, 3′ end/clone = IMAGE: 3293154468H10 28 159 AI524263 Hs.174193 6.00E−62 1 th11g07.x1 cDNA, 3′end/clone = IMAGE: 2118012 99C7 402 733 NM_006435 Hs.174195 1.00E−179 2interferon induced transmembrane protein 2 ( 467E4 162 516 BF062628Hs.174215 1.00E−157 1 7h62h05.x1 cDNA, 3′ end/clone = IMAGE: 332060174E5 2 485 D63789 Hs.174228 0 15 DNA for SCM-1beta precursor, completecds/cd 470F11 108 305 AI590337 Hs.174258 1.00E−104 1 tn49c03.x1 cDNA, 3′end/clone = IMAGE: 2171716 463D2 1 194 AV734916 Hs.175971 1.00E−94 1AV734916 cDNA, 5′ end/clone = cdAAHE11/clone_(—) 477E5 75 222 AI380955Hs.176374 2.00E−33 1 tg18b08.x1 cDNA, 3′ end/clone = IMAGE: 2109111473A9 1 296 AI708327 Hs.176430 1.00E−162 1 at04c02.x1 cDNA, 3′ end/clone= IMAGE: 2354114 468C3 24 235 AW081098 Hs.176498 6.00E−91 1 xc29a12.x1cDNA, 3′ end/clone = IMAGE: 2585662 479D11 595 1810 J04162 Hs.176663 014 leukocyte IgG receptor (Fc-gamma-R) mRNA, complete c 108G2 388 579AI638800 Hs.176920 6.00E−78 4 tt32e01.x1 cDNA, 3′ end/clone = IMAGE:2242488 467A10 98 170 AI865603 Hs.177045 6.00E−27 1 wk47g03.x1 cDNA, 3′end/clone = IMAGE: 2418580 117A6 1179 1403 AF116606 Hs.177415 1.00E−1122 PRO0890 mRNA, complete cds/cds = (1020,1265)/ 73F2 236 919 NM_016406Hs.177507 0 4 hypothetical protein (HSPC155), mRNA/cds = (2 516D8 24 340NM_006886 Hs.177530 1.00E−179 1 ATP synthase, H+ transporting,mitochondrial 479F4 163 676 NM_002414 Hs.177543 0 1 antigen identifiedby monoclonal antibodies 1 126A9 906 2105 NM_005534 Hs.177559 0 35interferon gamma receptor 2 (interferon gamma 41H6 905 1826 U05875Hs.177559 0 10 clone pSK1 interferon gamma receptor accessory factor37G1 1690 2420 U62961 Hs.177584 0 1 succinyl CoA: 3-oxoacid CoAtransferase precursor (O 597H7 1764 2520 AF218002 Hs.177596 0 7 clonePP2464 unknown mRNA/cds = (675,2339)/gb 520B8 1036 1202 NM_006888Hs.177656 4.00E−90 3 calmodulin 1 (phosphorylase kinase, delta) (C 151G72439 3048 J03473 Hs.177766 0 1 poly(ADP-ribose) synthetase mRNA,complete cds/ cds = clone 116C6 318 834 BC001980 Hs.177781 1.00E−144 4MGC: 5618, mRNA, complete cds/cds = (156, 179C11 211 737 X07834Hs.177781 0 3 manganese superoxide dismutase (EC 1.15.1.1) 98A9 213 648M73547 Hs.178112 0 4 polyposis locus (DP1 gene) mRNA, complete cds/ cds= (82 459E10 149 789 AK023719 Hs.178357 0 1 cDNA FLJ13657 fis, clonePLACE1011563/cds = (8 120H6 137 404 NM_021029 Hs.178391 1.00E−136 1ribosomal protein L44 (RPL44), mRNA/cds = (37,3 589E9 371 596 NM_000973Hs.178551 1.00E−125 1 ribosomal protein L8 (RPL8), mRNA/cds = (43,816142F5 1848 2210 D21090 Hs.178658 1.00E−179 1 XP-C repair complementingprotein (p58/HHR23 120H11 402 532 AV716627 Hs.178703 9.00E−69 1 AV716627cDNA, 5′ end/clone = DCBBCH05/clone_(—) 98G11 3287 6017 NM_004859Hs.178710 0 5 clathrin, heavy polypeptide (Hc) (CLTC), mRNA 177H1 142421 BF130300 Hs.178732 1.00E−139 1 601818357F1 cDNA, 5′ end/clone =IMAGE: 4041902 472A10 421 562 AI681868 Hs.178784 4.00E−63 1 tx50a12.x1cDNA, 3′ end/clone = IMAGE: 2272990 467G6 194 292 AW138461 Hs.1790031.00E−49 1 UI-H-BI1-adg-e-06-0-UI.s1 cDNA, 3′ end/clon 465C11 3312 3606NM_016562 Hs.179152 1.00E−166 1 toll-like receptor 7 (LOC51284),mRNA/cds = (13 469F7 268 405 AI568459 Hs.179419 3.00E−45 1 tn39e07.x1cDNA, 3′ end/clone = IMAGE: 2170020 99F11 750 2687 NM_006472 Hs.179526 073 upregulated by 1,25-dihydroxyvitamin D-3 (VD 39G9 526 2687 S73591Hs.179526 0 17 brain-expressed HHCPA78 homolog VDUP1 (Gene) 102A1 22352659 AL034343 Hs.179565 0 1 DNA sequence from clone RP1-108C2 onchromosome 6p12. 492B2 1074 2126 NM_002717 Hs.179574 1.00E−131 3 proteinphosphatase 2 (formerly 2A), regulator 143F2 242 457 NM_005771 Hs.1796081.00E−117 1 retinol dehydrogenase homolog (RDHL]) mRNA/ 111G7 626 898NM_002659 Hs.179657 1.00E−153 1 plasminogen activator, urokinasereceptor (P 585D2 61 3189 AL162068 Hs.179662 0 6 mRNA; cDNA DKFZp762G106(from clone DKFZp762G1 125G4 1159 1627 NM_000389 Hs.179665 1.00E−130 2cyclin-dependent kinase inhibitor 1A (p21, Ci 331A1 51 377 AK026642Hs.179666 1.00E−161 2 FLJ22989 fis, clone KAT11824, highly sim 516H12 19362 NM_000997 Hs.179779 1.00E−180 3 ribosomal protein L37 (RPL37),mRNA/cds = (28,3 170A11 1390 2087 L20298 Hs.179881 0 1 transcriptionfactor (CBFB) mRNA, 3′ end/cds = ( 195H8 1732 2110 NM_001755 Hs.1798811.00E−173 1 core-binding factor, beta subunit (CBFB), tra 127G6 24062924 AK022499 Hs.179882 0 2 cDNA FLJ12437 fis, clone NT2RM1000118,weakly 461E6 610 1148 NM_014153 Hs.179898 0 1 HSPC055 protein (HSPC055),mRNA/cds = (1400,19 516B3 4 584 NM_000975 Hs.179943 1.00E−136 2ribosomal protein L11 (RPL11), mRNA/cds = (0,53 62F8 24 537 X79234Hs.179943 1.00E−175 1 ribosomal protein L11/cds = (0,536)/gb = tumor471B11 1990 2496 NM_005802 Hs.179982 0 1 protein p53-binding protein(TP53BPL), 194B4 693 956 NM_004159 Hs.180062 1.00E−112 1 proteasome(prosome, macropain) subunit, bet 49D4 1002 1259 NM_002690 Hs.1801071.00E−125 1 polymerase (DNA directed), beta (POLB), mRNA 184A11 26 515AK024823 Hs.180139 0 2 FLJ21170 fis, clone CAS10946, highly sim 593A8 43535 NM_006937 Hs.180139 0 13 SMT3 (suppressor of mif two 3, yeast)homolog 2 61D10 102 722 AF161415 Hs.180145 0 1 HSPC297 mRNA, partialcds/cds = (0,438)/gb = AF 178A4 131 628 NM_017924 Hs.180201 0 2hypothetical protein FLJ20671 (FLJ20671), mR 463H9 54 171 NM_005507Hs.180370 1.00E−60 1 cofilin 1 (non-muscle) (CFL1), mRNA/cds = (51,5162B9 2139 2386 AB013382 Hs.180383 1.00E−124 1 for DUSP6, completecds/cds = (351,1496)/ 190B7 1743 2386 NM_001946 Hs.180383 1.00E−124 2dual specificity phosphatase 6 (DUSP6), trans 589B11 21 1566 NM_006597Hs.180414 0 11 heat shock 70 kD protein 8 (HSPA8), mRNA/cds = (8 73G2 211567 Y00371 Hs.180414 0 16 hsc70 gene for 71 kd heat shock protein/ cds= (83,2023) 62G1 985 1559 X89602 Hs.180433 0 1 rTS beta protein/cds =(17,1267)/gb = X896 98F9 1479 3653 L38951 Hs.180446 0 9 importin betasubunit mRNA, complete cds/cds = ( 590F12 283 614 NM_001026 Hs.180450 01 ribosomal protein S24 (RPS24), mRNA/cds = (142, 597F2 2670 3046AF187554 Hs.180532 0 47 sperm antigen-36 mRNA, complete cds/cds = (234,482E2 85 366 AL571386 Hs.180546 1.00E−106 1 AL571386 cDNA/clone =CS0DI009YL09-(3-prime) 109C2 324 682 BE540238 Hs.180549 1.00E−143 1601059809F1 cDNA, 5′ end/clone = IMAGE: 3446283 68G8 1447 3594 AF123094Hs.180566 0 3 API2-MLT fusion protein (API2-MLT) mRNA, comp 180B9 18512142 NM_002087 Hs.180577 1.00E−160 2 granulin (GRN), mRNA/cds =(62,1843)/gb = NM_00 51E4 880 2466 NM_005066 Hs.180610 0 6 splicingfactor proline/glutamine rich (poly 50G4 880 1280 X70944 Hs.180610 0 1PTB-associated splicing factor/cds = (85 127C8 317 3175 AK023143Hs.180638 0 5 cDNA FLJ13081 fis, clone NT2RP3002033/cds = (17 125E2 2871692 AL117621 Hs.180777 0 2 mRNA; cDNA DKFZp564M0264 (from cloneDKFZp564 521F11 1969 2431 AF126964 Hs.180799 0 1 C3HC4-type zinc fingerprotein (LZK1) mRNA, co 479C11 1186 2245 AK000271 Hs.180804 1.00E−155 2cDNA FLJ20264 fis, clone COLF7912/ cds = UNKNOWN 479C2 732 911 NM_001242Hs.180841 3.00E−62 1 tumor necrosis factor receptor superfamily, m 596D267 942 NM_000977 Hs.180842 0 11 ribosomal protein L13 (RPL13), mRNA/cds= (51,6 41E9 884 1779 AL050337 Hs.180866 0 2 DNA sequence from clone503F13 on chromosome 6q24.1-25 196C10 679 1338 NM_000416 Hs.180866 0 2interferon gamma receptor 1 (IFNGR1), mRNA/cd 99A10 1 1655 AF218029Hs.180877 0 11 clone PP781 unknown mRNA/cds = (113,523)/gb = A 65H9 11320 Z48950 Hs.180877 0 6 hH3.3B gene for histone H3.3/cds = (10,420)/gb= Z 160G1 2065 2538 AF045555 Hs.180900 0 2 wbscr1 (WBSCR1) and wbscr5(WBSCR5) genes, com 596B1 5 860 NM_001008 Hs.180911 0 5 ribosomalprotein S4, Y-linked (RPS4Y), mRNA 192F11 1857 2521 AK000299 Hs.180952 01 cDNA FLJ20292 fis, clone HEP05374/cds = (21,140 75D10 94 1656 AY007118Hs.181013 0 8 clone CDABP0006 mRNA sequence/cds = (20,784)/ 46H2 1051661 NM_002629 Hs.181013 0 5 phosphoglycerate mutase 1 (brain) (PGAM1),mR 107G10 4869 5527 AK024391 Hs.181043 0 1 FLJ14329 fis, clonePLACE4000259, highly 179A1 22 908 AK001934 Hs.181112 0 2 FLJ11072 fis,clone PLACE1004982/cds = (2 118D5 610 1130 NM_014166 Hs.181112 0 1HSPC126 protein (HSPC126), mRNA/cds = (25,837) 483D9 659 915 X57809Hs.181125 1.00E−123 1 rearranged immunoglobulin lambda light chainmRNA/c 596B10 499 1198 NM_005517 Hs.181163 0 2 high-mobility group(nonhistone chromosomal) 74A12 34 1674 AK026650 Hs.181165 0 192 FLJ22997fis, clone KAT11962, highly sim 99H8 1079 2742 BC001412 Hs.181165 0 260eukaryotic translation elongation factor 1 70F10 144 840 AB015798Hs.181195 0 1 HSJ2 mRNA for DnaJ homolog, complete cds/cds = MRJ 64E1072 856 BC002446 Hs.181195 0 2 gene for a member of protein family, clone597F6 1119 1767 NM_001675 Hs.181243 0 3 activating transcription factor4 (tax-respon 109D8 825 1233 D32129 Hs.181244 0 1 HLA class-I (HLA-A26)heavy chain, complete c 593H10 465 1222 NM_016057 Hs.181271 0 3 CGI-120protein (LOC51644), mRNA/cds = (37,570 127H10 4782 5154 AB020335Hs.181300 0 1 Pancreas-specific TSA305 mRNA, complete cds 150F7 509 1238M11353 Hs.181307 1.00E−175 5 H3.3 histone class C mRNA, complete cds/cds = (374,784) 127F7 895 1057 NM_002107 Hs.181307 3.00E−85 2 H3histone, family 3A (H3F3A), mRNA/cds = (374,7 39H10 6 416 BF676042Hs.181357 0 7 602084011F1 cDNA, 5′ end/clone = IMAGE: 4248195 99G12 193842 NM_002295 Hs.181357 0 28 laminin receptor 1 (67 kD, ribosomalprotein SA 66A12 312 1084 M20430 Hs.181366 0 4 MHC class II HLA-DR-beta(DR2-DQw1/DR4 DQw3) mRNA, co 71H11 748 1096 NM_002125 Hs.1813661.00E−176 1 major histocompatibility complex, class II, 56E4 272 521AI827911 Hs.181400 1.00E−126 1 wf34e11.x1 cDNA, 3′ end/clone = IMAGE:2357516 170F6 5255 5724 D63486 Hs.181418 0 1 KIAA0152 gene, completecds/cds = (128,1006) 464A11 5981 6322 NM_014730 Hs.181418 1.00E−159 1KIAA0152 gene product (KIAA0152), mRNA/cds = ( 514F6 1 232 AW955745Hs.181426 1.00E−117 1 EST367815 cDNA/gb = AW955745/gi = 8145428/ug =TRAF4 177E2 690 947 U81002 Hs.181466 1.00E−130 2 associated factor 1mRNA, partial cds/c 99B5 260 1660 NM_001549 Hs.181874 0 6interferon-induced protein with tetratricope 595H9 104 645 M90356Hs.181967 0 1 BTF3 protein homologue gene, complete cds/ cds = (0,64467E2 1057 1782 AK026664 Hs.182225 4.00E−85 3 FLJ23011 fis, cloneLNG00572/cds = (288,7 190A3 319 1615 NM_014052 Hs.182238 0 7 GW128protein (GW128), mRNA/cds = (698,889)/g 140B10 1770 2034 U46751Hs.182248 2.00E−92 1 phosphotyrosine independent ligand p62 for the LckS 158H11 371 597 D50420 Hs.182255 1.00E−126 1 OTK27, complete cds/cds =(94,480)/gb 584A12 95 1397 NM_005008 Hs.182255 0 3 non-histonechromosome protein 2 (S. cerevisia 40G2 735 908 Y00503 Hs.1822657.00E−41 1 keratin 19/cds = (32,1234)/gb = Y00503/gi = 340 596E7 1 886NM_001743 Hs.182278 0 3 calmodulin 2 (phosphorylase kinase, delta) (C129E10 36 350 L29348 Hs.182378 1.00E−174 2 granulocyte-macrophagecolony-stimulating 487G1 184 934 NM_002952 Hs.182426 0 3 ribosomalprotein S2 (RPS2), mRNA/cds = (240,90 517G6 126 1497 NM_005742 Hs.1824290 4 protein disulfide isomerase-related protein 60E12 10 1329 M16342Hs.182447 0 4 nuclear ribonucleoprotein particle (hnRNP) C protein 98E910 1184 NM_004500 Hs.182447 0 8 heterogeneous nuclear ribonucleoproteinC ( 496A4 87 1835 NM_014394 Hs.182470 0 2 PTD10 protein (PTD010),mRNA/cds = (129,1088) 110F11 947 1571 AF061738 Hs.182579 0 2 leucineaminopeptidase mRNA, complete cds/cd 124E1 1330 1889 NM_005739 Hs.1825910 2 RAS guanyl releasing protein 1 (calcium and DA 143B2 32 565 Z47087Hs.182643 0 1 RNA polymerase II elongation factor-like 103D2 161 538NM_001015 Hs.182740 8.00E−97 5 ribosomal protein S11 (RPS11), mRNA/cds =(15,4 331C2 1310 1585 D64015 Hs.182741 1.00E−136 1 for T-cluster bindingprotein, complete c 59E9 27 269 BF245224 Hs.182825 1.00E−105 1601863885F1 cDNA, 5′ end/clone = IMAGE: 4082396 525E3 12 261 NM_007209Hs.182825 1.00E−135 2 ribosomal protein L35 (RPL35), mRNA/cds = (27,370C9 189 625 BE963551 Hs.182928 1.00E−129 1 601657346R1 cDNA, 3′end/clone = IMAGE: 3866266 177B9 14 561 BF242969 Hs.182937 0 2601877739F1 cDNA, 5′ end/clone = IMAGE: 4106289 519H3 34 526 NM_021130Hs.182937 0 1 peptidylprolyl isomerase A (cyclophilin A) ( 159A5 31633579 AK026491 Hs.182979 1.00E−141 2 FLJ22838 fis, clone KAIA4494, highlysim 106G11 2956 3527 AF204231 Hs.182982 1.00E−138 2 88-kDa Golgi protein(GM88) mRNA, complete cds 169A3 2117 2495 M33336 Hs.183037 1.00E−105 3cAMP-dependent protein kinase type I-alpha subunit ( 124H9 2767 2955NM_002734 Hs.183037 7.00E−91 1 protein kinase, cAMP-dependent,regulatory, 107B3 2877 3182 U17989 Hs.183105 1.00E−170 1 nuclearautoantigen GS2NA mRNA, complete cds/ 476A6 538 893 NM_016523 Hs.1831250 1 killer cell lectin-like receptor F1 (KLRF1), m 75A1 629 1222AK001433 Hs.183297 0 1 FLJ10571 fis, clone NT2RP2003121, weakly 597E1197 1656 AF248966 Hs.183434 0 5 HT028 mRNA, complete cds/cds =(107,1159)/gb = cDNA 124A2 2015 2756 AK024275 Hs.183506 0 1 FLJ14213fis, clone NT2RP3003572/cds = (11 74F2 2082 2418 U53347 Hs.1835561.00E−177 2 neutral amino acid transporter B mRNA, complete cds/ 482C51211 1688 NM_018399 Hs.183656 0 1 VNN3 protein (HSA238982), mRNA/cds =(45,1550) 594H12 1718 3458 NM_001418 Hs.183684 0 4 eukaryotictranslation initiation factor 4 g 61H11 1457 2024 U73824 Hs.183684 0 2p97 mRNA, complete cds/cds = (306,3029)/ gb = U73824/g 75H7 342 2258M26880 Hs.183704 0 7 ubiquitin mRNA, complete cds/cds = (135,2192)/ gb =M26 599E7 2306 3111 D44640 Hs.183706 0 6 HUMSUPY040 cDNA/clone =035-00-1/gb = D44640/ 518H4 1554 1973 NM_002078 Hs.183773 0 1 golgiautoantigen, golgin subfamily a, 4 (GOL 520C3 98 255 NM_018955 Hs.1838423.00E−64 1 ubiquitin B (UBB), mRNA/cds = (94,783)/gb = NM_(—) 102C111730 1808 M15182 Hs.183868 8.00E−33 2 beta-glucuronidase mRNA, completecds/ cds = (26,1981 523D3 1730 2183 NM_000181 Hs.183868 0 2glucuronidase, beta (GUSB), mRNA/cds = (26,198 187A12 122 828 NM_003589Hs.183874 0 1 cullin 4A (CUL4A), mRNA/cds = (160,2139)/gb = N 156F4 228907 AF119665 Hs.184011 0 4 inorganic pyrophosphatase complete cds 525B8225 791 NM_021129 Hs.184011 0 2 pyrophosphatase (inorganic) (PP),nuclear ge 589B1 3 394 NM_000993 Hs.184014 0 10 ribosomal protein L31(RPL31), mRNA/cds = (7,38 99D6 3909 4308 NM_004985 Hs.184050 1.00E−145 1v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene 166B3 12 345 BE964596Hs.184052 1.00E−90 1 601658521R1 cDNA, 3′ end/clone = IMAGE: 3885796591G6 1348 1958 NM_022152 Hs.184052 0 3 PP1201 protein (PP1201),mRNA/cds = (66,1001) 114E11 1780 1942 AK025645 Hs.184062 4.00E−59 1cDNA: FLJ21992 fis, clone HEP06554/cds = (60,84 597E4 8 407 NM_000982Hs.184108 1.00E−114 6 ribosomal protein L21 (gene or pseudogene) (RP162C5 295 1062 L41887 Hs.184167 0 3 splicing factor,arginine/serine-rich 7 (SFR 109F6 151 749 AF054182 Hs.184211 0 1mitochondrial processing peptidase beta-subu 462C6 4590 5087 NM_015001Hs.184245 0 1 KIAA0929 protein Msx2 interacting nuclear tar 517D1 15101936 NM_004252 Hs.184276 1.00E−162 7 solute carrier family 9(sodium/hydrogen exch 55E3 174 427 NM_018370 Hs.184465 1.00E−107 1hypothetical protein FLJ11259 (FLJ11259), mR 50F9 2484 3108 AB023182Hs.184523 0 1 for KIAA0965 protein, partial cds/cds = (0 100A4 297 1941AK025730 Hs.184542 1.00E−149 3 FLJ22077 fis, clone HEP12728, highly sim113D4 950 1623 NM_016061 Hs.184542 0 1 CGI-127 protein (LOC51646),mRNA/cds = (125,49 145D11 41 339 BE730026 Hs.184582 1.00E−111 1601562642F1 cDNA, 5′ end/clone = IMAGE: 3832258 595F4 69 548 NM_000986Hs.184582 0 1 ribosomal protein L24 (RPL24), mRNA/cds = (39,5 108H10 250701 U00946 Hs.184592 0 1 clone A9A2BRB5 (CAC)n/(GTG)n repeat-containingmRN 43B5 4399 4488 AF104032 Hs.184601 3.00E−24 1 L-type amino acidtransporter subunit LAT1 mRN 104F12 298 1713 NM_014999 Hs.184627 0 2KIAA0118 protein (KIAA0118), mRNA/cds = (255,9 122E8 513 995 AF035307Hs.184697 0 2 clone 23785 mRNA sequence/cds = UNKN0WN/ gb = AF 40H2 662605 M37197 Hs.184760 1.00E−177 4 CCAAT-box-binding factor (CBF) mRNA,complete cds/c 514E4 29 519 NM_000984 Hs.184776 0 3 ribosomal proteinL23a (RPL23A), mRNA/cds = (2 589A7 736 983 AK025533 Hs.184793 1.00E−1381 cDNA: FLJ21880 fis, clone HEP02743/cds = UNKNOW 142G5 1918 2157AL049782 Hs.184938 8.00E−83 3 Novel human gene mapping to chomosome 13/cds = UNKNOWN/gb = A 462G9 178 398 AI085568 Hs.185062 1.00E−76 1oy68b05.x1 cDNA, 3′ end/clone = IMAGE: 1670961 470C12 81 333 T98171Hs.185675 1.00E−105 1 ye56c12.s1 cDNA, 3′ end/clone = IMAGE: 121750/463F2 3175 3359 NM_014686 Hs.186840 1.00E−72 1 KIAA0355 gene product(KIAA0355), mRNA/cds = ( 461E4 907 1118 NM_018519 Hs.186874 4.00E−91 1hypothetical protein PRO2266 (PRO2266), mRNA 155A1 53 379 AI619574Hs.187362 1.00E−109 1 ty50c09.x1 cDNA, 3′ end/clone = IMAGE: 2282512461C9 2948 3458 NM_014504 Hs.187660 0 1 putative Rab5 GDP/GTP exchangefactor homologu 470F2 5 331 BE646499 Hs.187872 1.00E−156 1 7e87h02.x1cDNA, 3′ end/clone = IMAGE: 3292179 68D12 590 740 AW963239 Hs.1879084.00E−66 1 EST375312/gb = AW963239/gi = 8153075/ug = 75H12 2012 2585AL110269 Hs.187991 0 1 cDNA DKFZp564A122 (from clone DKFZp564A1 167G41474 1958 NM_015626 Hs.187991 0 1 DKFZPS64A122 protein (DKFZP564A122),mRNA/c 137G3 54 197 AI625368 Hs.188365 2.00E−34 46 ts37c10.x1 cDNA, 3′end/clone = IMAGE: 2230770 464C12 183 404 AA432364 Hs.188777 7.00E−94 1zw76a09.s1 cDNA, 3′ end/clone = IMAGE: 782104/ 467E9 29 183 AA576947Hs.188886 1.00E−63 1 nm82b04.s1 cDNA, 3′ end/clone = IMAGE: 1074703467B4 349 459 AI392805 Hs.189031 2.00E−49 1 tg04h03.x1 cDNA, 3′end/clone = IMAGE: 2107829 461E2 242 473 BE674964 Hs.190065 1.00E−109 17f11b09.x1 cDNA, 3′ end/clone = IMAGE: 3294329 466F4 58 295 BG326781Hs.190219 1.00E−132 1 602425659F1 cDNA, 5′ end/clone = IMAGE: 4563471465H4 111 558 AA582958 Hs.190229 0 1 nn80d08.s1 cDNA, 3′ end/clone =IMAGE: 1090191 470F9 26 529 AI763206 Hs.190453 0 1 wh95e09.x1 cDNA, 3′end/clone = IMAGE: 2388520 66H12 1 3459 D00099 Hs.190703 0 5 for Na,K-ATPase alpha-subunit, complete 472E1 338 540 AW294083 Hs.1909042.00E−46 1 UI-H-BI2-ahg-b-05-0-UI.s1 cDNA, 3′ end/clon 522G10 433 970NM_003757 Hs.192023 0 2 eukaryotic translation initiation factor 3, 54GB29 410 AW838827 Hs.192123 0 1 CM1-LT0059-280100-108-e02/gb = AW838827465G4 261 515 BF224348 Hs.192463 1.00E−104 1 7q86c05.x1 cDNA/clone =IMAGE/gb = BF224348/g 468F9 392 487 AI524039 Hs.192524 2.00E−36 1tg99h02.x1 cDNA, 3′ end/clone = IMAGE: 2116947 466C6 111 392 AW972048Hs.192534 1.00E−153 1 EST384032 cDNA/gb = AW972048/gi = 8161789/ug =184F12 1 677 AF090927 Hs.192705 0 1 clone HQ0457 PRO0457 mRNA, completecds/cds = ( 464C11 1 65 BE298181 Hs.192755 3.00E−23 1 601118566F1 cDNA,5′ end/clone = IMAGE: 3028193 465H3 108 706 BG036938 Hs.192965 0 1602287708F1 cDNA, 5′ end/clone = IMAGE: 4375153 169F9 4138 4890 D87454Hs.192966 0 1 KIAA0265 gene, partial cds/cds = (0,1205)/gb 118H10 11041858 AK024263 Hs.193063 1.00E−132 2 cDNA FLJ14201 fis, cloneNT2RP3002955/cds = UNK 472F3 28 405 BF062295 Hs.193237 0 1 7k76b11.x1cDNA, 3′ end/clone = IMAGE: 3481293 40A5 1933 2611 X12830 Hs.193400 0 1interleukin-6 (IL-6) receptor/cds = (437,184 63B5 327 582 AW959162Hs.193669 1.00E−103 1 EST371232/gb = AW959162/gi = 8148846/ug = 52G10803 1173 M57627 Hs.193717 0 1 interleukin 10 (IL10) mRNA, complete cds/cds = (30,566 469F5 2088 2438 AL110204 Hs.193784 1.00E−179 1 mRNA; cDNADKFZp586K1922 (from clone DKFZp586K 598H7 1428 1715 NM_014828 Hs.1940351.00E−119 1 KIAA0737 gene product (KIAA0737), mRNA/cds = ( 462B6 103 546BE618004 Hs.194362 1.00E−165 1 601462354F1 cDNA, 5′ end/clone = IMAGE:3865861 472F12 1177 1667 AB036737 Hs.194369 0 2 mRNA for RERE, completecds/cds = (636,5336)/g 182E10 11785 13486 U82828 Hs.194382 0 5 ataxiatelangiectasia (ATM) gene, complete cd 458F4 258 408 NM_022739 Hs.1944772.00E−62 1 E3 ubiquitin ligase SMURF2 (SMURF2), mRNA/cd 583D2 1425 1732NM_014232 Hs.194534 1.00E−136 1 vesicle-associated membrane protein 2(synapt 38H8 1198 1620 U89387 Hs.194638 0 1 RNA polymerase II subunithsRPB4 gene, complete cds/ 122H10 5292 5481 NM_023005 Hs.194688 4.00E−801 bromodomain adjacent to zinc finger domain, 1B 186G9 1 1908 AL136945Hs.194718 0 2 mRNA; cDNA DKFZp586O012 (from clone DKFZp586O0 113F3 18522375 NM_000634 Hs.194778 0 1 interleukin 8 receptor, alpha (IL8RA),mRNA/ 106A3 35 404 U11870 Hs.194778 0 1 interleukin-8 receptor type A(IL8RBA) gene, promote 473B8 1001 1314 AF319438 Hs.194976 1.00E−172 1SH2 domain-containing phosphatase anchor pro 57F9 442 1934 Y14039Hs.195175 0 27 mRNA for CASH alpha protein/cds = (481,1923)/g 49E5 23142512 NM_018666 Hs.195292 2.00E−37 1 putative tumor antigen (SAGE),mRNA/cds = (167, 473B10 406 532 BE671815 Hs.195374 1.00E−54 1 7a47c12.x1cDNA, 3′ end/clone = IMAGE: 3221878 595B5 59 311 AI653766 Hs.1953786.00E−46 1 ty01b06.x1 cDNA, 3′ end/clone = IMAGE: 2277779 60G4 42 1554D13642 Hs.195614 0 2 KIAA0017 gene, complete cds/cds = (136,1335) 473B9739 927 AF241534 Hs.196015 2.00E−73 1 hydatidiform mole associated andimprinted (H 99C10 1075 1424 NM_000294 Hs.196177 1.00E−115 1phosphorylase kinase, gamma 2 (testis) (PHKG2 45H9 956 1405 AF283645Hs.196270 0 1 folate transporter/carrier mRNA, complete cd 54F9 25672954 U04636 Hs.196384 0 1 cyclooxygenase-2 (hCox-2) gene, complete cds/cds = (1 38F12 401 606 AI984074 Hs.196398 1.00E−104 1 wz56c02.x1 cDNA,3′ end/clone = IMAGE: 2562050 157G1 403 551 AJ006835 Hs.196769 7.00E−772 RNA transcript from U17 small nucleolar RNA ho 163F4 1 402 AI650871Hs.197028 0 1 wa95f03.x1 cDNA, 3′end/clone = IMAGE: 2303933 160B3 408476 AI832038 Hs.197091 5.00E−27 1 wj99e02.x1 3′end/clone = IMAGE:2410970 105E8 1299 3674 AB020657 Hs.197298 0 6 for KIAA0850 protein,complete cds/cds = ( 178G12 2097 3593 AF205218 Hs.197298 0 8 NS1-bindingprotein-like protein mRNA, compl 585F1 284 1711 NM_001469 Hs.197345 0 4thyroid autoantigen 70 kD (Ku antigen) (G22P1) 39C10 545 1984 Z83840Hs.197345 0 2 DNA sequence from clone CTA-216E10 on chromosome 22 C58E12 2162 3013 NM_001530 Hs.197540 0 2 hypoxia-inducible factor 1,alpha subunit (ba 125G11 3673 4059 D29805 Hs.198248 0 1 mRNA forbeta-1,4-galactosyltransferase, complete 41H10 6 821 M33906 Hs.1982531.00E−156 2 MHC class II HLA-DQA1 mRNA, complete cds/ cds = (43,810)186A11 551 1031 NM_004544 Hs.198271 0 2 NADH dehydrogenase (ubiquinone)1 alpha subco 126D8 993 1381 NM_021105 Hs.198282 0 1 phospholipidscramblase 1 (PLSCR1), mRNA/cds 174C12 4824 5257 NM_003070 Hs.198296 0 1SWI/SNF related, matrix associated, actin dep 109C6 128 833 X04327Hs.198365 0 1 erythrocyte 2,3-bisphosphoglycerate mutase mRNA EC 64B124383 5289 NM_000189 Hs.198427 0 2 hexokinase 2 (HK2), mRNA/cds =(1490,4243)/gd 70B4 3267 5289 Z46376 Hs.198427 0 4 HK2 mRNA forhexokinase II/cds = (1490,4243)/gb = Z 478H6 186 475 AI978581 Hs.1986941.00E−129 1 wq72d08.x1 cDNA, 3′ end/clone = IMAGE: 2476815 587G1 7671143 NM_006837 Hs.198767 1.00E−170 1 COP9 (constitutivephotomorphogenic, Arabido 465F12 373 554 BE621611 Hs.198802 2.00E−77 1601493754T1 cDNA, 3′ end/clone = IMAGE: 3895836 123B3 310 3608 AB011108Hs.198891 0 3 mRNA for KIAA0536 protein, partial cds/cds = (0, 157H33457 5268 D50929 Hs.198899 0 2 KIAA0139 gene, complete cds/cds =(128,4276) 477H1 35 592 NM_002229 Hs.198951 0 1 jun B proto-oncogene(JUNB), mRNA/cds = (253,12 53C5 979 1296 X51345 Hs.198951 1.00E−160 1jun-B mRNA for JUN-B protein/cds = (253,1296)/ gb = X513 54H8 350 501AW450874 Hs.199014 5.00E−81 1 UI-H-BI3-all-a-11-0-UI.s1 cDNA, 3′end/clon 520E12 3506 3878 L04731 Hs.199160 0 1 translocation T(4:11) ofALL-1 gene to chromoso 57F4 5941 6266 NM_006267 Hs.199179 1.00E−158 1RAN binding protein 2 (RANBP2), mRNA/cds = (127, 50B10 5 3645 D86984Hs.199243 0 2 KIAA0231 gene, partial cds/cds = (0,1430)/gb 68E12 17572052 L25124 Hs.199248 1.00E−156 2 prostaglandin E2 receptor mRNA,complete cds/ 484H3 1879 1958 NM_000958 Hs.199248 3.00E−33 1prostaglandin E receptor 4 (subtype EP4) (PTGE 466G6 368 3287 NM_013233Hs.199263 0 2 Ste-20 related kinase (SPAK), mRNA/cds = (173,1 464B9 6331068 AF015041 Hs.199291 0 1 NUMB-R protein (NUMB-R) mRNA, complete cds/c522F9 2 116 AI669591 Hs.200442 5.00E−59 1 tw34b09.x1 cDNA, 3′ end/clone= IMAGE: 2261561 60F11 4945 5114 AB040942 Hs.201500 7.00E−92 1 forKIAA1509 protein, partial cds/cds = (0 72D12 819 1293 AF104398 Hs.2016730 1 comichon mRNA, complete cds/cds = (56,490)/g 105G5 1629 2130AF091263 Hs.201675 0 1 RNA binding motif protein 5 (RBM5) mRNA, comple116G3 1637 2854 NM_005778 Hs.201675 0 2 RNA binding motif protein 5(RBM5), mRNA/cds = ( 40A10 254 431 AI693179 Hs.201789 5.00E−85 1wd68d12.x1 cDNA, 3′ end/clone = IMAGE: 2336759 473D4 421 547 BE551203Hs.201792 3.00E−49 1 7b55h12.x1 cDNA, 3′ end/clone = IMAGE: 3232199472D8 313 623 AW390251 Hs.202402 1.00E−123 1 CM4-ST0182-051099-021-b06cDNA/gb = AW390251 66H5 176 482 AI271437 Hs.203041 1.00E−173 1qi19c05.x1 cDNA, 3′ end/clone = IMAGE: 1856936 594C2 35 368 AW131782Hs.203606 1.00E−147 2 xf34e08.x1 cDNA, 3′ end/clone = IMAGE: 2619974138B12 101 420 AW194379 Hs.203755 1.00E−93 3 xm08h07.x1 3′ end/clone =IMAGE: 2683645 473D3 1 234 AI538474 Hs.203784 1.00E−117 1 td06h08.x1cDNA, 3′ end/clone = IMAGE: 2074911 471A5 113 442 AI393908 Hs.2038291.00E−153 1 tg05f10.x1 cDNA, 3′ end/clone = IMAGE: 2107915 40A4 16212037 AF004230 Hs.204040 0 1 monocyte/macrophage Ig-related receptor MIR463H1 7 319 AW977671 Hs.204214 1.00E−161 1 EST389900 cDNA/gb =AW977671/gi = 8169049/ug = 478E7 25 434 AI762023 Hs.204610 0 2wh89f04.x1 cDNA, 3′ end/clone = IMAGE: 2387935 55E11 324 469 AI741246Hs.204656 100E−58 12 wg26g09.x1 cDNA, 3′ end/clone = IMAGE: 2366272478G10 345 476 AI760901 Hs.204703 9.00E−34 1 wi09h06.x1 cDNA, 3′end/clone = IMAGE: 2389787 470E11 374 507 AI762741 Hs.204707 2.00E−49 1wh93h02.x1 cDNA, 3′ end/clone = IMAGE: 2388339 478F5 179 437 AI086035Hs.204873 1.00E−110 1 oy70h04.x1 cDNA, 3′ end/clone = IMAGE: 1671223464G4 33 320 AI749444 Hs.204929 5.00E−50 1 at24c03.x1 cDNA, 3′ end/clone= IMAGE: 2356036 472D2 88 198 AI760018 Hs.205071 4.00E−54 1 wh83b02.x1cDNA, 3′ end/clone = IMAGE: 2387307 470D9 5 422 AW976641 Hs.205079 0 1EST388750 cDNA/gb = AW976641/gi = 8167872/ug = 470D4 122 500 AA885473Hs.205175 0 1 am10c12.s1 cDNA, 3′ end/clone = IMAGE: 1466422 473C5 285525 BF679831 Hs.205319 2.00E−96 1 602154415F1 cDNA, 5′ end/clone =IMAGE: 4295595 470E7 295 521 AI762557 Hs.205327 9.00E−95 2 wh92f07.x1cDNA, 3′ end/clone = IMAGE: 2388229 478F11 11 447 AI761141 Hs.205452 0 3wh97g08.x1 cDNA, 3′ end/clone = IMAGE: 2388734 459A12 111 323 N72600Hs.205555 9.00E−96 1 za46f08.s1 cDNA, 3′ end/clone = IMAGE: 295623/470F4 214 481 AW977820 Hs.205675 1.00E−131 1 EST389824 cDNA/gb =AW977820/gi = 8168971/ug = 102G3 1 249 BF680988 Hs.205696 2.00E−78 1602156272F1 cDNA, 5′ end/clone = IMAGE: 4297216 472B2 312 700 BF794256Hs.206761 0 1 602255454F1 cDNA, 5′ end/clone = IMAGE: 4338949 470C1 11131643 AK024118 Hs.206868 0 1 cDNA FLJ14056 fis, clone HEMBB1000335/cds =UNK 469H7 1076 1215 U15177 Hs.206984 3.00E−69 1 cosmid CRI-JC2015 atD10S289 in 10sp13/ cds = (0,1214) 61F9 5 181 AW340421 Hs.207995 4.00E−941 hc96h02.x1 cDNA, 3′ end/clone = IMAGE: 2907891 473C2 239 551 BF439675Hs.208854 1.00E−151 1 nab69e11.x1 cDNA/clone = IMAGE/gb = BF439675/62G11 159 292 BE781611 Hs.208985 1.00E−60 1 601467463F1 cDNA, 5′end/clone = IMAGE: 3870902 472E2 258 554 AI343473 Hs.209203 1.00E−135 1tb97a08.x1 cDNA, 3′ end/clone = IMAGE: 2062262 471C10 148 498 AI768880Hs.209511 0 1 wh71e04.x1 cDNA, 3′ end/clone = IMAGE: 2386206 470G9 416561 AI798144 Hs.209609 4.00E−63 1 wh81g12.x1 cDNA, 3′ end/clone = IMAGE:2387206 478C10 120 447 AI809310 Hs.210385 1.00E−158 2 wh75h08.x1 cDNA,3′ end/clone = IMAGE: 2386623 476B7 64 341 AI075288 Hs.210727 1.00E−1512 oy69h10.x1 cDNA, 3′ end/clone = IMAGE: 1671139 477G4 915 1541 AB040919Hs.210958 0 1 mRNA for KIAA1486 protein, partial cds/cds = (1 468C2 215498 AI832182 Hs.210995 1.00E−145 1 td13h11.x1 cDNA, 3′ end/clone =IMAGE: 2075589 472D11 1 300 AI860120 Hs.211024 1.00E−126 1 wh39e01.x1cDNA, 3′ end/clone = IMAGE: 2383128 470D3 30 317 AW362304 Hs.2111941.00E−137 1 CM3-CT0275-031199-031-a08 cDNA/gb = AW362304 179F6 105 551AI823649 Hs.211535 0 1 wi85g03.x1 3′ end/clone = IMAGE: 2400148 477G122439 4050 NM_020993 Hs.211563 0 4 B-cell CLL/lymphoma 7A (BCL7A),mRNA/cds = (953 39A11 5178 5792 L10717 Hs.211576 0 2 T cell-specifictyrosine kinase mRNA, complete 187B9 5365 5790 NM_005546 Hs.211576 0 1IL2-inducible T-cell kinase (ITK), mRNA/cds = 152C2 3965 4297 Z22551Hs.211577 1.00E−174 1 kinectin gene/cds = (69,4139)/gb = Z22551/gi = 296120A2 2556 2917 NM_005955 Hs.211581 0 1 metal-regulatory transcriptionfactor 1 (MTF 147A2 2915 4407 M59465 Hs.211600 0 6 tumor necrosis factoralpha inducible protein A20 mRN 583B12 2404 3981 NM_006290 Hs.211600 011 tumor necrosis factor, alpha-induced protein 589F3 1905 2274 AF090693Hs.211610 0 1 apoptosis-related RNA binding protein (NAPOR- 470G11 277462 AI862623 Hs.211744 5.00E−99 1 wh99h10.x1 cDNA, 3′ end/clone = IMAGE:2388931 473F2 195 423 BE675092 Hs.211828 2.00E−95 1 7f02d07.x1 cDNA, 3′end/clone = IMAGE: 3293485 517D2 1059 1366 BC000747 Hs.211973 1.00E−1622 Similar to homolog of Yeast RRP4 (ribosomal RN 109D9 391 533 AI922921Hs.212553 2.00E−68 1 wn81c05.x1 cDNA, 3′ end/clone = IMAGE: 2452232494H12 172 549 AI912585 Hs.213385 0 3 we11d07.x1 cDNA, 3′ end/clone =IMAGE: 2340781 596G11 4740 5687 AB007916 Hs.214646 0 8 mRNA for KIAA0447protein, partial cds/cds = (2 104C12 843 1787 AL031282 Hs.215595 0 2 DNAsequence from clone 283E3 on chromosome 1p36.21-36 124F8 1391 2913NM_002074 Hs.215595 0 4 guanine nucleotide binding protein (G protein)157E8 1264 1627 AK001548 Hs.215766 0 4 FLJ10686 fis, clone NT2RP3000252,highly 519G3 1729 2094 NM_012341 Hs.215766 0 1 GTP-binding protein(NGB), mRNA/cds = (23,1924 473E7 2278 2472 AB022663 Hs.215857 3.00E−52 1HFB30 mRNA, complete cds/cds = (236,1660)/gb = 104F7 4 1324 D00017Hs.217493 0 3 for lipocortin II, complete cds/cds = (49,1 58G2 11 1324NM_004039 Hs.217493 0 7 annexin A2 (ANXA2), mRNA/cds = (49,1068)/gb = N467D4 27 443 AI392814 Hs.221014 1.00E−180 1 tg10a02.x1 cDNA, 3′end/clone = IMAGE: 2108330 463B1 69 457 AV686223 Hs.221642 0 1 AV686223cDNA, 5′ end/clone = GKCGXH11/clone_(—) 464D10 295 552 BF058398Hs.221695 1.00E−115 1 7k30d01.x1 cDNA, 3′ end/clone = IMAGE: 3476785466C12 1 427 AI540165 Hs.222186 0 1 td10d05.x1 cDNA, 3′ end/clone =IMAGE: 2075241 125H10 2596 2917 AB046830 Hs.222746 0 1 mRNA for KIAA1610protein, partial cds/cds = (0 473C4 1 193 BF435098 Hs.222833 9.00E−72 17p05g01.x1 cDNA, 3′ end/clone = IMAGE: 3645097 37B4 18 371 AW389509Hs.223747 1.00E−147 1 CM3-ST0163-051099-019-b11/gb = AW389509 470H7 106357 AI766706 Hs.223935 1.00E−116 1 wi02g11.x1 cDNA, 3′ end/clone =IMAGE: 2389124 472D12 1 370 AL133721 Hs.224680 0 1 DKFZp761H09121_r1cDNA, 5′ end/clone = DKFZp76 124E4 53 208 AI874107 Hs.224760 7.00E−50 3wm49b01.x1 cDNA, 3′ end/clone = IMAGE: 2439241 477G3 146 412 AI400714Hs.225567 1.00E−141 1 tg93g12.x1 cDNA, 3′ end/clone = IMAGE: 2116390112F12 2313 2799 AL163279 Hs.225674 0 1 chromosome 21 segmentHS21C079/cds = (0,6888) 118D12 6187 6775 NM_015384 Hs.225767 0 1 IDN3protein (IDN3), mRNA/cds = (706,7182)/gb 109B7 2208 3315 AF119417Hs.225939 0 2 nonfunctional GM3 synthase mRNA, alternativel 125A8 28773381 NM_006999 Hs.225951 0 1 topoisomerase-related function protein 4-1129C8 5510 5893 AF012108 Hs.225977 0 1 Amplified in Breast Cancer (AIB1)mRNA, comple 39G12 4498 4859 NM_014977 Hs.227133 1.00E−93 2 KIAA0670protein/acinus (KIAA0670), mRNA/cd 153D10 1 286 AF000145 Hs.2274001.00E−139 2 germinal center kinase related protein kinase 464B12 9011425 AL050131 Hs.227429 0 1 mRNA; cDNA DKFZp586I111 (from cloneDKFZp586I1 459D9 3828 4314 NM_004841 Hs.227806 0 1 ras GTPase activatingprotein-like (NGAP), mR 135E9 135 773 NM_004049 Hs.227817 0 1BCL2-related protein A1 (BCL2A1), mRNA/cds = ( 59F10 123 808 Y09397Hs.227817 0 12 GRS protein/cds = (102,629)/gb = Y09397/ 516H4 1901 2462NM_014287 Hs.227823 0 1 pM5 protein (PM5), mRNA/cds = (0,3668)/gb = NM_0107C12 2776 3390 Y15906 Hs.227913 0 1 for XAGL protein/cds =(132,1646)/gb = Y159 152C7 171 1390 AF052155 Hs.227949 0 2 clone 24761mRNA sequence/cds = UNKNOWN/ gb = AF 522G8 108 293 AI917348 Hs.2284862.00E−70 1 ts83d10.x1 cDNA, 3′ end/clone = IMAGE: 2237875 66C7 304 445AI094726 Hs.228795 1.00E−26 1 qa08f05.x1 cDNA, 3′ end/clone = IMAGE:1686177 585D1 51 294 AI199388 Hs.228817 5.00E−73 1 qs75e05.x1 cDNA, 3′end/clone = IMAGE: 1943936 468E9 113 324 AI523873 Hs.228926 7.00E−77 2tg97c12.x1 cDNA, 3′ end/clone = IMAGE: 2116726 466F1 44 139 AI380491Hs.229374 3.00E−39 2 tf95b10.x1 cDNA, 3′ end/clone = IMAGE: 2107003182F1 40 465 AI354231 Hs.229385 1.00E−138 4 qv12c04.x1 cDNA, 3′end/clone = IMAGE: 1981350 465C1 237 318 AW812896 Hs.229868 3.00E−38 1RC3-ST0186-250200-018-a11 cDNA/gb = AW812896 178H7 42 353 AI581732Hs.229918 1.00E−68 5 ar74f03.x1 cDNA, 3′ end/clone = IMAGE: 2128349 72H648 534 AI818777 Hs.229990 1.00E−85 3 wl11f10.x1 cDNA, 3′ end/clone =IMAGE: 2424619 181E9 52 279 AI827451 Hs.229993 1.00E−66 1 wl17d11.x1cDNA, 3′ end/clone = IMAGE: 2425173 38H1 225 311 AI579979 Hs.2304301.00E−25 1 tq45a01.x1 cDNA, 3′ end/clone = IMAGE: 2211720 489G11 66 369AI818596 Hs.230492 1.00E−112 5 wk74d04.x1 cDNA, 3′ end/clone = IMAGE:2421127 118D6 40 161 AI025427 Hs.230752 6.00E−37 1 ow27g06.s1 cDNA, 3′end/clone = IMAGE: 1648090 462H6 305 437 AI087055 Hs.230805 3.00E−67 1oy70c09.x1 cDNA, 3′ end/clone = IMAGE: 1671184 107C11 93 240 AI796419Hs.230939 1.00E−40 1 wj17f02.x1 cDNA, 3′ end/clone = IMAGE: 2403099591A1 65 316 AA767883 Hs.231154 7.00E−59 4 oa30h07.s1 cDNA, 3′ end/clone= IMAGE: 1306525 471B3 177 519 BE407125 Hs.231510 1.00E−166 1601301818F1 cDNA, 5′ end/clone = IMAGE: 3636412 64G11 609 950 AL542592Hs.231816 1.00E−166 1 AL542592 cDNA/clone = CS0DE012YA05-(5-prime) 108G11 210 AW006867 Hs.231987 1.00E−109 1 ws15d07.x1 cDNA, 3′ end/clone =IMAGE: 2497261 115F3 44 185 AW016002 Hs.232000 7.00E−75 2UI-H-BI0p-abh-h-06-0-UI.s1 cDNA, 3′ end/clo 138A6 4771 5194 D15050Hs.232068 0 1 transcription factor AREB6, complete cds/cd 472A6 311 497BF195579 Hs.232257 1.00E−78 1 7n85c03.x1 cDNA, 3′ end/clone = IMAGE:3571205 111A7 285 463 AW026667 Hs.233261 1.00E−41 1 wv15d09.x1 cDNA, 3′end/clone = IMAGE: 2529617 67G8 292 560 BE719483 Hs.233383 4.00E−94 3MR1-HT0858-020800-001-c06/gb = BE719483 123B11 180 351 AW006045Hs.233560 5.00E−82 1 wz81b09.x1 cDNA, 3′ end/clone = IMAGE: 2565209472E3 1 319 AW027530 Hs.233564 1.00E−180 1 wv74c06.x1 cDNA, 3′end/clone−IMAGE: 2535274 36F11 943 1896 Z85996 Hs.233750 0 6 DNAsequence from PAC 431A14 on chromosome 6p21. Conta 184G6 49 491 BF694761Hs.233936 0 9 602080851F2 cDNA, 5′ end/clone = IMAGE: 4245133 599C7 12540 NM_006471 Hs.233936 0 55 myosin, light polypeptide, regulatory,non-s 156B4 405 774 AF054185 Hs.233952 1.00E−164 1 proteasome subunitHSPC complete cds/c 595G5 85 315 NM_002792 Hs.233952 1.00E−126 1proteasome (prosome, macropain) subunit, alp 67F5 108 556 AK000654Hs.234149 0 1 FLJ20647 fis, clone KAT02147/cds = (90,836 591B6 1 555NM_017918 Hs.234149 0 6 hypothetical protein FLJ20647 (FLJ20647), mR111B7 1887 2217 AK023204 Hs.234265 1.00E−120 1 cDNA FLJ13142 fis, cloneNT2RP3003212, modera 72F6 314 2581 AL035071 Hs.234279 0 2 DNA sequencefrom clone 1085F17 on chromosome 20q11.1 514H4 2105 2523 NM_012325Hs.234279 0 1 microtubule-associated protein, RP/EB family 599A10 1 1163NM_002300 Hs.234489 0 30 lactate dehydrogenase B (LDHB), mRNA/cds = (84163A8 470 1153 X13794 Hs.234489 0 4 lactate dehydrogenase B gene exon 1and (EC 1.1.1. 125E5 31 465 NM_000978 Hs.234518 1.00E−117 2 ribosomalprotein L23 (RPL23), mRNA/cds = (25,4 471B1 1499 2033 L05148 Hs.234569 01 protein tyrosine kinase related mRNA sequence/ cds = UN 466D7 10501402 NM_013451 Hs.234680 0 1 fer-1 (C.elegans)-like 3 (myoferlin)(FER1L3) 108B11 407 742 X14008 Hs.234734 0 1 lysozyme gene (EC3.2.1.17)/cds = (82,474)/ gb = X14008 476A12 3 440 AI076222 Hs.235042 02 oy65b09.x1 cDNA, 3′ end/clone = IMAGE: 1670681 464H7 994 2425 AL157426Hs.235390 1.00E−22 1 mRNA; cDNA DKFZp761B101 (from clone DKFZp761B1472F2 2203 2431 AK024137 Hs.235498 7.00E−97 1 cDNA FLJ14075 fis, cloneHEMBB1001905, weakly 63C7 1159 1751 AK000260 Hs.235712 0 1 FLJ20253 fis,clone COLF6895/cds = UNKNOWN 73C8 39 485 AI379474 Hs.235823 0 1tc57g08.x1 cDNA, 3′ end/clone = IMAGE: 2068766 590H8 182 449 AA020845Hs.235883 1.00E−145 3 ze64a07.r1 cDNA, 5′ end/clone = IMAGE: 363732/182H3 468 2009 NM_001535 Hs.235887 1.00E−119 5 HMT1 (hnRNPmethyltransferase, S. cerevisiae) 119B12 253 596 NM_003075 Hs.236030 0 1SWI/SNF related, matrix associated, actin dep 461C5 654 1112 AK026410Hs.236449 0 1 cDNA: FLJ22757 fis, clone KAIA0803/cds = (92,24 182G3 5142817 AK023223 Hs.236494 0 2 FLJ13161 fis, clone NT2RP3003589, highly469G7 857 1336 AK026359 Hs.236744 0 1 cDNA: FLJ22706 fis, cloneHSI13163/cds = UNKNOW 592A9 1522 1888 NM_020135 Hs.236828 0 1 putativehelicase RUVBL (LOC56897), mRNA/cds 177A1 1260 1704 AK001514 Hs.2368441.00E−170 1 FLJ10652 fis, clone NT2RP2005886/cds = (50 594G2 916 1537NM_018169 Hs.236844 0 2 hypothetical protein FLJ10652 (FLJ10652), mR98D10 1881 1964 NM_006947 Hs.237825 9.00E−36 1 signal recognitionparticle 72 kD (SRP72), mRN 72C7 36 1214 M29696 Hs.237868 0 2interleukin-7 receptor (IL-7) mRNA, complete cds/cd 591B10 577 1658NM_002185 Hs.237868 0 9 interleukin 7 receptor (IL7R), mRNA/cds = (22,1109G2 16 405 AF116682 Hs.238205 0 1 PRO2013 mRNA, complete cds/cds =(135,380)/gb 41E1 2163 2733 U60805 Hs.238648 0 1 oncostatin-M specificreceptor beta subunit (OSMRB) 599C11 508 1734 AK026110 Hs.238707 0 5cDNA: FLJ22457 fis, clone HRC09925/cds = (56,14 143E8 2 595 AV700542Hs.238730 1.00E−177 6 AV700542 cDNA, 3′ end/clone = GKCAFD05/clone_(—)596C11 77 658 AW955090 Hs.238954 0 5 EST367160 cDNA/gb = AW955090/gi =8144773/ug = 169C7 1371 1634 AY004255 Hs.238990 1.00E−148 1 cdkinhibitor p27KIP1 mRNA, complete cds/cds = 173C1 1599 1859 BC001971Hs.238990 1.00E−146 1 Similar to cyclin-dependent kinase inhibitor 458B51539 1809 AL136828 Hs.238996 1.00E−131 1 mRNA; cDNA DKFZp434K0427 (fromclone DKFZp434K 591H9 6104 6559 AL157902 Hs.239114 0 1 DNA sequence fromclone RP4-675C20 on chromosome 1p13 512G4 231 2376 NM_005746 Hs.239138 061 pre-B-cell colony-enhancing factor (PBEF), m 53D11 935 2053 U02020Hs.239138 0 15 pre-B cell enhancing factor (PBEF) mRNA, complete cds38B7 2187 2263 AK025021 Hs.239189 1.00E−36 1 FLJ21368 fis, cloneCOL03056, highly sim 458E10 90 622 NM_016533 Hs.239208 0 1 ninjurin 2(NINJ2), mRNA/cds = (56,484)/gb = NM 184G10 1608 2056 AK026535 Hs.2393070 1 FLJ22882 fis, clone KAT03587, highly sim 194D9 1544 1683 NM_003680Hs.239307 4.00E−57 1 tyrosyl-tRNA synthetase (YARS), mRNA/cds = (0,110C7 450 1216 AF246221 Hs.239625 0 4 transmembrane protein BRI mRNA,complete cds 599G9 446 1205 NM_021999 Hs.239625 0 13 integral membraneprotein 2B (ITM2B), mRNA/cd 515E4 1404 1671 NM_014515 Hs.2397201.00E−132 1 CCR4-NOT transcription complex, subunit 2 (C 115H10 11242079 BC000105 Hs.239760 0 2 Similar to CG14740 gene product, clone MGC:25 466E3 605 923 NM_005301 Hs.239891 1.00E−164 2 G protein-coupledreceptor 35 (GPR35), mRNA/ 52B5 993 1243 AJ223075 Hs.239894 1.00E−106 1for TRIP protein/cds = (178,2532)/gb = AJ22 171E10 88 399 AW002624Hs.240077 1.00E−145 1 wu60d10.x1 cDNA, 3′ end/clone = IMAGE: 990854/75C5 325 1604 AK027191 Hs.240443 0 8 FLJ23538 fis, clone LNG08010,highly sim 597D3 1134 1792 BC001255 Hs.240770 0 1 nuclear cap bindingprotein subunit 2, 20 kD, 98A11 596 6834 NM_005385 Hs.241493 0 10natural killer-tumor recognition sequence (N 98C10 1580 2204 AK027187Hs.241507 0 40 cDNA: FLJ23534 fis, clone LNG06974, highly sim 463E8 324846 AF047002 Hs.241520 0 1 transcriptional coactivator ALY mRNA, partia514G6 802 1238 NM_012392 Hs.241531 0 3 peflin (PEF), mRNA/cds =(12,866)/gb = NM_01239 177G4 1375 1887 AF099149 Hs.241558 0 1 TRIAD1type I mRNA, complete cds/cds = (144,1625 110E4 1320 1937 AK021704Hs.241567 0 1 FLJ11642 fis, clone HEMBA 1004356, highly 513B12 700 1447NM_016839 Hs.241567 0 3 RNA binding motif, single stranded interacting500G10 910 1249 NM_000594 Hs.241570 0 1 tumor necrosis factor (TNFsuperfamily, membe 514B6 735 1032 NM_018630 Hs.241576 1.00E−155 1hypothetical protein PRO2577 (PRO2577), mRNA 590H9 61 251 NM_016200Hs.241578 1.00E−104 1 U6 snRNA-associated Sm-like protein LSm8 (LOC 50A6200 311 AK026704 Hs.242868 3.00E−57 3 FLJ23051 fis, clone LNG02642/cds =UNKNOW 104C10 199 353 AA424812 Hs.243029 2.00E−74 1 zw04b02.s1 cDNA, 3′end/clone = IMAGE: 768267/ 72G4 182 415 AW081232 Hs.243321 1.00E−99 4xc22e08.x1 cDNA, 3′ end/clone = IMAGE: 2585030 521D12 32 287 AW102836Hs.243457 6.00E−96 1 xd38h12.x1 cDNA, 3′ end/clone = IMAGE: 2596103102F3 79 157 W45562 Hs.243720 4.00E−26 1 zc26e07.s1 cDNA, 3′ end/clone =IMAGE: 323460/ 56D6 193 454 M97856 Hs.243886 1.00E−122 1 histone-bindingprotein mRNA, complete cds/c 595D8 25 495 NM_002482 Hs.243886 0 1nuclear autoantigenic sperm protein (histone- 46G5 2137 2661 AK000745Hs.243901 0 1 cDNA FLJ20738 fis, clone HEP08257/ cds = UNKNOWN 477D4 141250 AI394001 Hs.244666 4.00E−51 1 tg06d04.x1 cDNA, 3′ end/clone = IMAGE:2107975 139B7 50 235 AW078847 Hs.244816 4.00E−32 2 xb18g07.x1 cDNA, 3′end/clone = IMAGE: 2576700 472C4 74 464 AW139918 Hs.245138 0 1UI-H-BI1-aee-d-05-0-UI.s1 cDNA, 3′ end/clon 459F7 45 229 AW080951Hs.245616 7.00E−58 1 xc28c10.x1 cDNA, 3′ end/clone = IMAGE: 2585586100A6 41 1795 L22009 Hs.245710 1.00E−143 3 hnRNP H mRNA, completecds/cds = (72,1421)/ gb = L22009 592G8 41 1798 NM_005520 Hs.245710 0 6heterogeneous nuclear ribonucleoprotein H1 71G4 382 583 AL136607Hs.245798 1.00E−104 1 mRNA; cDNA DKFZp564I0422 (from clone DKFZp564118B9 4495 5528 AK024391 Hs.246112 0 4 cDNA FLJ14329 fis, clonePLACE4000259, highly 471E5 148 464 AI568725 Hs.246299 1.00E−177 1th15a01.x1 cDNA, 3′ end/clone = IMAGE: 2118312 464D11 26 526 N28843Hs.246358 0 1 yx59d10.r1 cDNA, 5′ end/clone = IMAGE: 266035/ 40H7 5501108 S57235 Hs.246381 0 1 CD68 = 110 kda transmembrane glycoprotein[human, promonocy 471E12 152 507 AW117189 Hs.246494 1.00E−149 1xd83f08.x1 cDNA, 3′ end/clone = IMAGE: 2604231 479C1 47 345 AV739961Hs.246796 1.00E−140 1 AV739961 cDNA, 5′ end/clone = CBFBRA10/clone_(—)472C9 43 400 BF796642 Hs.246818 0 1 602259846F1 cDNA, 5′ end/clone =IMAGE: 4343171 47F11 2 227 AB015856 Hs.247433 1.00E−123 1 for ATF6,complete cds/cds = (68,2080)/gb 179H9 12 379 AL031313 Hs.2477831.00E−111 1 DNA sequence from clone 581F12 on chromosome Xq21. Co 167A95 352 Z00013 Hs.247792 1.00E−163 5 H. sapiens germilne gene for theleader peptide and variable 72B8 402 672 L15006 Hs.247824 1.00E−139 2 Igsuperfamily CTLA-4 mRNA, complete cds/cds = 488H10 135 672 NM_005214Hs.247824 1.00E−146 5 cytotoxic T-lymphocyte-associated protein 4 188G81 255 NM_002991 Hs.247838 1.00E−135 1 small inducible cytokine subfamilyA (Cys-Cys 153D11 401 720 AL049545 Hs.247877 1.00E−133 2 DNA sequencefrom clone 263J7 on chromosome 6q14.3-15 44D2 42 448 AL035604 Hs.2478941.00E−133 1 DNA sequence from clone 38C16 on chromosome 6q22.33-2 180B710 271 L21961 Hs.247947 4.00E−72 1 Ig rearranged lambda-chain mRNA,subgroup VL3, V- J re 110B11 311 803 U08626 Hs.247984 0 1 glutaminesynthetase pseudogene/cds = (0,899)/gb = U 74G5 361 965 X14798 Hs.2481090 1 DNA for c-ets-1 proto-oncogene/cds = (278,1603)/gb = 60H10 214 527AW150084 Hs.248657 1.00E−99 3 xg36f03.x1 cDNA, 3′ end/clone = IMAGE:2629661 64E2 329 536 BF512500 Hs.248689 1.00E−112 1UI-H-BI3-alw-h-10-0-UI.s1 cDNA, 3′ end/clon 470C6 278 470 AI832183Hs.249031 1.00E−103 1 wh80g09.x1 cDNA, 3′ end/clone = IMAGE: 2387104146A9 1145 1422 S63912 Hs.249247 1.00E−113 1 D10S102 = FBRNP [human,fetal brain, mRNA, 3043 nt]/cds = (30, 519E8 37 628 NM_002136 Hs.2494950 1 heterogeneous nuclear ribonucleoprotein A1 458C7 2232 2520 NM_000964Hs.250505 1.00E−163 1 retinoic acid receptor, alpha (RARA), mRNA/cd476A8 1060 1601 AF308285 Hs.250528 0 1 serologically defined breastcancer antigen N 123D7 436 2077 AL157499 Hs.250535 1.00E−153 3 mRNA;cDNA DKFZp434N2412 (from clone DKFZp434 477A10 285 370 AW291304Hs.250600 2.00E−34 1 UI-H-BI2-agg-b-11-0-UI.s1 cDNA, 3′ end/clon 172G12726 1598 AF182420 Hs.250619 0 6 MDS019 (MDS019) mRNA, complete cds/cds =(231,1 167E11 11633 13714 NM_016252 Hs.250646 1.00E−180 2 baculoviralIAP repeat-containing 6 (BIRC6), 591E4 198 714 NM_002823 Hs.2506554.00E−99 3 prothymosin, alpha (gene sequence 28) (PTMA), 40D9 2289 3010M95585 Hs.250692 0 1 hepatic leukemia factor (HLF) mRNA, complete cds/cds 110D9 2336 3259 NM_003144 Hs.250773 0 3 signal sequence receptor,alpha (translocon-a 166A3 1 302 AF103458 Hs.250806 6.00E−93 2 isolatedonor N clone N168K immunoglobulin kap 110C12 629 1228 M35416 Hs.2508110 1 GTP-binding protein (RALB) mRNA, complete cds/ cds = (1 458D12 11361714 AY007158 Hs.250820 0 1 clone CDABP0113 mRNA sequence/cds =UNKNOWN/g 177C5 658 823 J02621 Hs.251064 3.00E−32 1 non-histonechromosomal protein HMG-14 mRNA, complet 126A2 658 1009 NM_004965Hs.251064 0 3 high-mobility group (nonhistone chromosomal) 523G1 1 337AE000660 Hs.251465 1.00E−178 2 T-cell receptor alpha delta locus frombases 5 40G1 4 781 X72308 Hs.251526 0 3 for monocyte chemotacticprotein-3 (MCP- 188G7 1 1030 NM_002789 Hs.251531 0 3 proteasome(prosome, macropain) subunit, alp 61E12 578 2275 NM_006537 Hs.251636 0 2ubiquitin specific protease 3 (USP3), mRNA/cd 38B10 995 1211 AK026594Hs.251653 1.00E−107 1 FLJ22941 fis, clone KAT08078, highly sim 70C3 20222405 X52142 Hs.251871 0 1 CTP synthetase (EC 6.3.4.2)/cds = (75,1850)/177E9 49 406 S80990 Hs.252136 1.00E−125 2 ficolin [human, uterus, mRNA,1736 nt]/ cds = (532,1512)/gb 50F8 1841 2048 AK026712 Hs.2522591.00E−114 15 FLJ23059 fis, clone LNG03912/cds = (41,16 585E12 16 194AI383340 Hs.252300 1.00E−63 1 tc76g05.x1 cDNA, 3′ end/clone = IMAGE:2070584 181E12 22 99 BE963374 Hs.252338 4.00E−30 1 601657137R1 cDNA, 3′end/clone = IMAGE: 3866193 477H4 290 451 AI524022 Hs.252359 8.00E−87 1tg99f02.x1 cDNA, 3′ end/clone = IMAGE: 2116923 188G11 95 700 NM_007104Hs.252574 0 2 ribosomal protein L10a (RPL10A), mRNA/cds = (1 471H9 1 285AV706014 Hs.252580 1.00E−145 1 AV706014 cDNA, 5′ end/clone =ADBAOB12/clone_(—) 134F9 1358 1464 AL359626 Hs.252588 5.00E−50 1 mRNA;cDNA DKFZp564F172 (from clone DKFZp564F1 597B10 13 279 NM_000981Hs.252723 1.00E−149 28 ribosomal protein L19 (RPL19), mRNA/cds = (28,6120D7 962 1674 NM_006054 Hs.252831 0 5 reticulon 3 (RTN3), mRNA/cds =(124,834)/gb = N 593B10 102 467 AW191929 Hs.252989 7.00E−93 1 x177c10.x1cDNA, 3′ end/clone = IMAGE: 2680722 482C11 32 122 AW195119 Hs.2531513.00E−33 1 xn66b07.x1 cDNA, 3′ end/clone = IMAGE: 2699413 472C6 34 279AW204029 Hs.253384 1.00E−137 1 UI-H-BI1-aen-d-02-0-UI.s1 cDNA, 3′end/clon 472D4 27 440 AW205624 Hs.253502 0 1 UI-H-BI1-afr-e-01-0-UI.s1cDNA, 3′ end/clon 472D1 120 362 BF750565 Hs.253550 1.00E−133 1RC1-BN0410-261000-014-f11 cDNA/gb = BF750565 480F11 367 558 AW237483Hs.253820 1.00E−105 1 xm72e01.x1 cDNA, 3′ end/clone = IMAGE: 2689752472B5 35 363 AI432340 Hs.254006 1.00E−169 1 tg54e06.x1 cDNA, 3′end/clone = IMAGE: 2112610 75E5 1 904 M14328 Hs.254105 0 5 alpha enolasemRNA, complete cds/cds = (94,1398)/ gb = 592A12 1 1100 NM_001428Hs.254105 0 5 enolase 1, (alpha) (EN01), mRNA/cds = (94,1398) 472D10 183414 AI364936 Hs.255100 1.00E−126 1 qz23c12.x1 cDNA, 3′ end/clone =IMAGE: 2027734 479H9 43 184 AW292772 Hs.255119 2.00E−70 1UI-H-BW0-aij-d-03-0-UI.s1 cDNA, 3′ end/clon 480A2 18 523 AW293267Hs.255178 0 1 UI-H-BW0-aii-e-10-0-UI.s1 cDNA, 3′ end/clon 480B7 16 298AW293895 Hs.255249 1.00E−116 1 UI-H-BW0-ain-f-10-0-UI.s1 cDNA, 3′end/clon 479H11 23 202 AW293955 Hs.255255 3.00E−79 1UI-H-BW0-aik-d-05-0-UI.s1 cDNA, 3′ end/clon 480A4 415 598 AW294681Hs.255336 5.00E−66 1 UI-H-BW0-ail-g-10-0-UI.s1 cDNA, 3′ end/clon 480A7223 427 AW294695 Hs.255339 1.00E−103 1 UI-H-BW0-aim-a-02-0-UI.s1 cDNA,3′ end/clon 480A8 26 338 BF514247 Hs.255340 1.00E−167 IUI-H-BW1-ani-h-09-0-UI.s1 cDNA, 3′ end/clon 480C12 239 483 AW295088Hs.255389 1.00E−124 1 UI-H-BW0-ait-d-09-0-UI.s1 cDNA, 3′ end/clon 480F91 423 BF531016 Hs.255390 0 1 602072345F1 cDNA, 5′ end/clone = IMAGE:4215251 480B3 68 377 AW295610 Hs.255446 1.00E−161 1UI-H-BW0-aip-c-03-0-UI.s1 cDNA, 3′ end/clon 460H5 44 427 AA455707Hs.255452 1.00E−161 1 aa22d09.r1 cDNA, 5′ end/clone = IMAGE: 814001/480B12 132 212 AW295664 Hs.255454 7.00E−39 1 UI-H-BW0-aip-g-12-0-UI.s1cDNA, 3′ end/clon 472E7 163 489 AI439645 Hs.255490 1.00E−166 1tc91e08.x1 cDNA, 3′ end/clone = IMAGE: 2073542 480D12 84 258 AW296005Hs.255492 8.00E−90 1 UI-H-BW0-aiu-b-01-0-UI.s1 cDNA, 3′ end/clon 480F434 464 AW296063 Hs.255501 0 1 UI-H-BW0-aiu-g-08-0-UI.s1 cDNA, 3′end/clon 480D5 18 404 AW296490 Hs.255554 0 2 UI-H-BW0-aiq-f-08-0-UI.s1cDNA, 3′ end/clon 480E1 95 379 AW296532 Hs.255559 1.00E−101 1UI-H-BW0-aiv-b-07-0-UI.s1 cDNA, 3′ end/clon 480E5 17 326 AW296545Hs.255560 1.00E−128 1 UI-H-BW0-aiv-c-11-0-UI.s1 cDNA, 3′ end/clon 480F220 330 AW296730 Hs.255573 1.00E−160 1 UI-H-BW0-aix-f-12-0-UI.s1 cDNA, 3′end/clon 480G7 38 479 AW296797 Hs.255579 0 1 UI-H-BW0-ajb-e-07-0-UI.s1cDNA, 3′ end/clon 480C9 19 274 AW297339 Hs.255637 1.00E−117 1UI-H-BW0-air-c-03-0-UI.s1 cDNA, 3′ end/clon 480C4 70 191 AW297400Hs.255647 1.00E−49 1 UI-H-BW0-ais-a-05-0-UI.s1 cDNA, 3′ end/clon 480G517 242 AW297522 Hs.255661 2.00E−87 1 UI-H-BW0-aja-e-02-0-UI.s1 cDNA, 3′end/clon 480F10 230 560 AW294654 Hs.255687 0 1 UI-H-BW0-ail-d-10-0-UI.s1cDNA, 3′ end/clon 480G9 47 582 AW297813 Hs.255695 0 1UI-H-BW0-aiy-g-09-0-UI.s1 cDNA, 3′ end/clon 480G10 31 453 AW297827Hs.255697 0 1 UI-H-BW0-aiy-h-11-0-UI.s1 cDNA, 3′ end/clon 482G6 16 242AW339651 Hs.255927 3.00E−78 1 he15g04.x1 cDNA, 3′ end/clone = IMAGE:2919126 469B11 4 221 AW341086 Hs.256031 1.00E−99 1 xz92h04.x1 cDNA, 3′end/clone = IMAGE: 2871703 140E7 2870 3589 M32315 Hs.256278 1.00E−84 2tumor necrosis factor receptor mRNA, complete cds/cd 189H12 2839 3294NM_001066 Hs.256278 0 2 tumor necrosis factor receptor superfamily, m99H11 83 589 NM_005620 Hs.256290 0 4 S100 calcium-binding protein A11(calgizzarin 58C7 1778 2264 AJ271747 Hs.256583 0 1 partial mRNA fordouble stranded RNA binding nu 482F4 373 628 AV719442 Hs.2569591.00E−124 1 AV719442 cDNA, 5′ end/clone = GLCBNA01/clone_(—) 482F5 8 377AW440866 Hs.256961 1.00E−179 1 he05f02.x1 cDNA, 3′ end/clone = IMAGE:2918139 482F8 191 315 AW440974 Hs.256971 2.00E−62 1 he06e12.x1 cDNA, 3′end/clone = IMAGE: 2918254 479E7 136 567 AW444482 Hs.256979 0 2UI-H-BI3-akb-e-05-0-UI.s1 cDNA, 3′ end/clon 471H5 3 432 AI438957Hs.257066 0 1 tc89b05.x1 cDNA, 3′ end/clone = IMAGE: 2073297 472G3 233617 AW450350 Hs.257283 0 1 UI-H-B13-akn-c-01-0-UI.s1 cDNA, 3′ end/clon472G11 112 338 AI809475 Hs.257466 1.00E−101 1 wh76d06.x1 cDNA, 3′end/clone = IMAGE: 2386667 479F7 22 421 AW452467 Hs.257572 0 1UI-H-BI3-als-e-09-0-UI.s1 cDNA, 3′ end/clon 479G9 95 304 AW452513Hs.257579 1.00E−81 1 UI-H-BW1-ame-b-03-0-UI.s1 cDNA, 3′ end/clon 479F1116 329 AW453021 Hs.257640 1.00E−163 1 UI-H-BW1-ama-c-02-0-UI.s1 cDNA, 3′end/clon 479G4 45 441 AW453044 Hs.257646 0 1 UI-H-BW1-ama-e-01-0-UI.s1cDNA, 3′ end/clon 482F9 11 256 AW467193 Hs.257667 1.00E−108 1 he07a04.x1cDNA, 3′ end/clone = IMAGE: 2918286 482G2 9 271 AW467400 Hs.2576801.00E−112 1 he10f11.x1 cDNA, 3′ end/clone = IMAGE: 2918637 482G8 108 428AW467437 Hs.257682 1.00E−177 1 he17d05.x1 cDNA, 3′ end/clone = IMAGE:2919273 482G12 1 417 AW467501 Hs.257687 0 1 he19e06.x1 cDNA, 3′end/clone = IMAGE: 2919490 482H4 39 143 AW467746 Hs.257695 3.00E−51 1he23d05.x1 cDNA, 3′ end/clone = IMAGE: 2919849 482H6 1 116 AW467863Hs.257705 2.00E−59 1 he27c04.x1 cDNA, 3′ end/clone = IMAGE: 2920230482H7 1 321 AW467864 Hs.257706 1.00E−156 1 he27c05.x1 cDNA, 3′ end/clone= IMAGE: 2920232 482H9 1 112 AW467992 Hs.257709 1.00E−47 1 he30b01.x1cDNA, 3′ end/clone = IMAGE: 2920489 483A2 20 429 AW468207 Hs.257716 0 1he34a12.x1 cDNA, 3′ end/clone = IMAGE: 2920894 483A9 11 373 AW468431Hs.257727 0 1 he37h11.x1 cDNA, 3′ end/clone = IMAGE: 2921253 483B2 2 241AW468621 Hs.257743 1.00E−119 1 he42e03.x1 cDNA, 3′ end/clone = IMAGE:2921692 75B1 157 246 BE531180 Hs.258494 5.00E−44 1 601278313F1 cDNA, 5′end/clone = IMAGE: 3610443 585F6 2200 4106 AL136549 Hs.258503 0 8 mRNA;cDNA DKFZp761I12121 (from clone DKFZP761 169E2 5186 5415 U20489Hs.258609 1.00E−119 2 glomerular epithelial protein 1 (GLEPP1) comple127A5 2142 2477 AB037790 Hs.258730 1.00E−177 1 mRNA for KIAA1369protein, partial cds/cds = (0 171B12 4202 4314 Y10129 Hs.258742 4.00E−452 mybpc3 gene/cds = (33,3857)/gb = Y10129/gi = 20583 75B7 531 682 L14542Hs.258850 3.00E−81 1 lectin-like type II integral membrane protein(NKG2-E 471G5 344 473 AI144328 Hs.259084 3.00E−61 1 oy84g04.x1 cDNA, 3′end/clone = IMAGE: 1672566 479B7 73 307 AF161364 Hs.259683 1.00E−123 1HSPC101 mRNA, partial cds/cds = (0,556)/gb = AF 146B11 1942 2174AL136842 Hs.260024 8.00E−92 1 DKFZp434A0530 (from clone DKFZp434A 584A11085 1470 AL022398 Hs.261373 1.00E−166 1 DNA sequence from PAC 434O14 onchromosome 1q32 148B1 119 817 X60656 Hs.261802 0 2 elongation factor1-beta/cds = (95,772) 60G3 203 3170 NM_001634 Hs.262476 0 15S-adenosylmethionine decarboxylase 1 (AMD1) 462E7 292 374 AW300868Hs.262789 8.00E−40 1 xk07d09.x1 eDNA, 3′ end/clone = IMAGE: 266603356F11 33 234 BF243724 Hs.263414 4.00E−82 1 601877832F1 cDNA, 5′end/clone = IMAGE: 4106359 119C5 2414 2664 NM_002108 Hs.263435 1.00E−1371 histidine ammonia-lyase (HAL), mRNA/cds(297 105A4 3225 3775 AK025774Hs.264190 0 3 FLJ22121 fis, clone HEP18876, highly sim 469H1 369 576AI380111 Hs.264298 1.00E−103 1 tf98a11.x1 cDNA, 3′ end/clone = IMAGE:2107292 181A3 2434 2768 NM_002535 Hs.264981 1.00E−148 22′-5′oligoadenylate synthetase 2 (OAS2), tra 41B7 3209 3885 M59911Hs.265829 0 1 integrin alpha-3 chain mRNA, complete cds/ cds = (73,3275F9 264 452 AW150944 Hs.265838 2.00E−96 1 xg42e09.x1 cDNA, 3′ end/clone= IMAGE: 2630248 99C3 2684 3155 AK000680 Hs.266175 0 2 cDNA FLJ20673fis, clone KAIA4464/cds = (104,14 598E12 2417 2894 AK026669 Hs.266940 02 cDNA: FLJ23016 fis, clone LNG00874/cds = UNKNOW 468B6 863 1515NM_016569 Hs.267182 0 1 TBX3-iso protein (TBX3-iso), mRNA/cds = (116,1115E11 1234 1713 AF271994 Hs.267288 0 1 dopamine responsive proteinDRG-1 mRNA, compl 114A4 31 382 NM_024095 Hs.267400 1.00E−179 1hypothetical protein MGC5540 (MGC5540), mRNA 166C7 1315 1919 AK001749Hs.267604 0 2 FLJ10887 fis, clone NT2RP4002018, weakly 56A8 564 3624AB033054 Hs.267690 0 3 for KIAA1228 protein, partial cds/cds = (0 70B10229 2138 AK001471 Hs.268012 0 3 FLJ10609 fis, clone NT2RP2005276, highly178D10 1831 2796 NM_012255 Hs.268555 0 2 5′-3′exoribonuclease 2 (XRN2),mRNA/cds = (68, 168B9 451 881 AF068235 Hs.268763 0 1barrier-to-autointegration factor mRNA, com 465F2 91 433 AA613224Hs.270264 0 1 no19d06.s1 cDNA, 3′ end/clone = IMAGE: 1101131 469E2 302422 BE857296 Hs.270293 1.00E−57 1 7g27b01.x1 cDNA, 3′ end/clone = IMAGE:3307657 465D10 284 405 AI270476 Hs.270341 4.00E−51 1 qu88e12.x1 cDNA, 3′end/clone = IMAGE: 1979182 473F10 831 1096 AK021517 Hs.270557 1.00E−1401 cDNA FLJ11455 fis, clone HEMBA1001497/cds = UNK 193A10 458 563AI818951 Hs.270614 5.00E−31 1 wj89e12.x1 cDNA, 3′ end/clone = IMAGE:2410030 458E11 44 264 W03955 Hs.270717 1.00E−118 1 za62d04.r1 cDNA,5′end/clone = IMAGE: 297127/ 163C12 280 954 M30704 Hs.270833 1.00E−168 2amphiregulin (AR) mRNA, complete cds, clones lambda-A 196F4 208 567NM_001657 Hs.270833 1.00E−158 1 amphiregulin (schwannoma-derived growthfac 464G2 378 529 AW172850 Hs.270999 4.00E−77 1 xj04f02.x1 cDNA, 3′end/clone = IMAGE: 2656251 464F5 131 476 AW572930 Hs.271264 0 1hf17f07.x1 cDNA, 3′ end/clone = IMAGE: 2932165 41G6 458 880 Y16645Hs.271387 0 1 for monocyte chemotactic protein-2/cds = 464F2 139 220AW975086 Hs.271420 2.00E−34 1 EST387192 cDNA/gb = AW975086/gi =8166291/ug = 178E10 961 1452 AK021715 Hs.271541 0 1 cDNA FLJ11653 fis,clone HEMBA1004538/cds = UNK 129E1 73 441 NM_016049 Hs.271614 1.00E−1361 CGI-112 protein (LOC51016), mRNA/cds = (158,78 40C9 4195 4949 X17033Hs.271986 0 1 integrin alpha-2 subunit/cds = (48,3593)/gb 108E1 917 1331NM_006811 Hs.272168 0 2 tumor differentially expressed 1 (TDE1), mRNA155H10 232 715 AL021395 Hs.272279 1.00E−164 1 DNA sequence from cloneRP1-269M15 on chromosome 20q1 159D3 38 238 AL034343 Hs.272295 1.00E−1064 DNA sequence from clone RP1-108C2 on chromosome 6p12. 477C3 744 1166AL133015 Hs.272307 0 2 mRNA; cDNA DKFZp434O2417 (from clone DKFZp434O173D12 228 594 AL121934 Hs.272340 1.00E−140 5 DNA sequence from cloneRP11-209A2 on chromosome 6. C 472D9 27 418 NM_016135 Hs.272398 0 1transcription factor ets (TEL2), mRNA/cds = (7 465F9 1885 2345 NM_013351Hs.272409 0 1 T-box 21 (TBX21), mRNA/cds = (211,1818)/gb = NM 41E11 1277 NM_004167 Hs.272493 1.00E−113 1 small inducible cytokine subfamily A(Cys-Cys 462E11 8 526 NM_001503 Hs.272529 0 1glycosylphosphatidylinositol specific phos 104C6 210 327 AE000659Hs.272550 5.00E−61 1 T-cell receptor alpha delta locus from bases 2596A3 411 1208 NM_013392 Hs.272736 0 5 nuclear receptor binding protein(NRBP), mRNA 75C2 1892 2188 AK000316 Hs.272793 1.00E−165 1 FLJ20309 fis,clone HEP07296/cds = (41,127 58C6 1 956 NM_006009 Hs.272897 0 2 Tubulin,alpha, brain-specific (TUBA3), mRNA 190H8 3246 3771 AK024471 Hs.2732301.00E−165 2 mRNA for FLJ00064 protein, partial cds/cds = (0 590E11 15121860 NM_014230 Hs.273307 1.00E−168 4 signal recognition particle 68 kD(SRP68), mRN 588H2 696 1454 NM_000516 Hs.273385 0 3 guanine nucleotidebinding protein (G protein) 165E9 3186 3695 NM_014871 Hs.273397 0 1KIAA0710 gene product (KIAA0710), mRNA/cds = ( 462A6 394 496 AA527312Hs.273775 2.00E−42 1 ng36a08.s1 cDNA, 3′ end/clone = IMAGE: 936854/587F1 1763 1978 AL050353 Hs.274170 1.00E−112 1 mRNA; cDNA DKFZp564C0482(from clone DKFZp564C 177E5 1448 1876 AK000765 Hs.274248 0 1 FLJ20758fis, clone HEP01508/cds = (464,13 59E7 1 301 AF151049 Hs.2743441.00E−159 3 HSPC215 mRNA, complete cds/cds = (92,451)/gb = 174A6 9311352 NM_004301 Hs.274350 0 1 BAF53 (BAF53A), mRNA/cds = (136,1425)/gb =NM_0 99E2 718 1391 NM_018477 Hs.274369 0 4 uncharacterized hypothalamusprotein HARP11 117F6 3046 3478 AB037844 Hs.274396 0 2 mRNA for KIAA1423protein, partial cds/cds = (0 52F3 1724 2342 NM_005346 Hs.274402 1.00E−149 48 heat shock 70 kD protein 1 (HSPA1B), mRNA/cds = ( 516B1 7191026 NM_018975 Hs.274428 1.00E−161 2 TRF2-interacting telomeric RAP1protein (RAP 104A1 1943 2396 AK002127 Hs.274439 0 1 FLJ11265 fis, clonePLACE1009158/cds = (30 137D6 1697 1817 NM_001403 Hs.274466 8.00E−49 1eukaryotic translation elongation factor 1 a 108D11 321 646 X16863Hs.274467 1.00E−160 1 Fc-gamma RIII-1 cDNA for Fc-gamma receptor III-1(CD 107F1 567 895 AF283771 Hs.274472 1.00E−168 1 clone TCBAP0774 mRNAsequence/cds = UNKNOWN/g 517B9 4 480 NM_002128 Hs.274472 0 3high-mobility group (nonhistone chromosomal) 514C8 254 539 M12888Hs.274474 1.00E−144 2 T-cell receptor germline beta-chain gene C-regionC- 460G5 602 775 M12679 Hs.274485 3.00E−94 1 Cw1 antigen mRNA, completecds/cds = (0,617)/ gb = M1267 463G7 163 744 D90145 Hs.274535 0 4 LD78beta gene/cds = (86,367)/gb = D90145/ gi = 219907/ 472E10 277 391AI393960 Hs.274851 6.00E−59 1 tg11d04.x1 cDNA, 3′ end/clone = IMAGE:2108455 115A11 156 446 NM_014624 Hs.275243 1.00E−157 8 S100calcium-binding protein A6 (calcyclin) ( 102C6 23 448 AA610514 Hs.2756111.00E−161 1 np93h02.s1/clone = IMAGE: 1133907/gb = AA6 160E3 24 304AA757952 Hs.275773 1.00E−74 3 zg49e07.s1 3′ end/clone = IMAGE: 396708/500B8 26 536 NM_022551 Hs.275865 0 3 ribosomal protein S18 (RPS18),mRNA/cds = (46,5 522D9 184 593 NM_001959 Hs.275959 0 1 eukaryotictranslation elongation factor 1 b 151H4 1 196 AA984890 Hs.2760635.00E−58 1 am62e06.s1 cDNA, 3′ end/clone = IMAGE: 1576642 476B10 362 615BF510670 Hs.276341 1.00E−116 1 UI-H-BI4-aof-b-08-0-UI.s1 cDNA, 3′end/clon 144F10 73 279 Al318342 Hs.276662 8.00E−57 1 ta73c09.x1 3′end/clone = IMAGE: 2049712 593G1 17 88 BE747210 Hs.276718 2.00E−26 1601580926F1 cDNA, 5′ end/clone = IMAGE: 3929430 473E3 205 488 AI380791Hs.276766 1.00E−144 1 tg04b12.x1 cDNA, 3′ end/clone = IMAGE: 2107775598A2 72 427 NM_001803 Hs.276770 0 19 CDW52 antigen (CAMPATH-1 antigen)(CDW52), mR 170H2 83 432 X62466 Hs.276770 0 1 CAMPATH-1 (CDw52)antigen/cds = (33,218) 464F7 2 454 AI492640 Hs.276903 0 2 qz18a06.x1cDNA, 3′ end/clone = IMAGE: 2021842 464E5 102 191 AI493726 Hs.2769073.00E−44 2 qz12f08.x1 cDNA, 3′ end/clone = IMAGE: 2021319 50B5 42 308AI581383 Hs.276988 5.00E−77 1 to71c02.x1 cDNA, 3′ end/clone = IMAGE:2183714 468C6 40 279 AI740667 Hs.277201 1.00E−64 1 wg07b07.x1 cDNA, 3′end/clone = IMAGE: 2364373 111D12 1 562 AI749435 Hs.277224 1.00E−118 9at24b04.x1 cDNA, 3′ end/clone = IMAGE: 2356015 459B4 176 367 AI811065Hs.277293 2.00E−38 1 tr03f05.x1 cDNA, 3′ end/clone = IMAGE: 2217249477H3 6227 6584 NM_013449 Hs.277401 1.00E−132 1 bromodomain adjacent tozinc finger domain, 2A 54A8 34 301 AW050975 Hs.277672 3.00E−48 1wz25f04.x1 cDNA, 3′ end/clone = IMAGE: 2559103 459E4 1532 2061 NM_006389Hs.277704 0 1 oxygen regulated protein (150 kD) (ORP150), mR 109B6 32813721 U65785 Hs.277704 0 1 150 kDa oxygen-regulated protein ORP150 mRNA,complet 524H7 2979 3350 NM_005899 Hs.277721 0 1 membrane component,chromosome 17, surface ma 472F10 425 556 AW082714 Hs.277738 5.00E−69 1xb61f07.x1 cDNA, 3′ end/clone = IMAGE: 2580805 176D1 113 269 AW262728Hs.277994 6.00E−32 1 xq94a12.x1 cDNA, 3′ end/clone = IMAGE: 2758270464H4 2138 3563 NM_016733 Hs.278027 0 9 LIM domain kinase 2 (LIMK2),transcript varian 145C9 533 1446 D13316 Hs.278238 0 3 transcriptionfactor, E4TF1-47, complete cds 161C3 339 560 NM_002041 Hs.2782381.00E−123 1 GA-binding protein transcription factor, bet 74C9 345 1048AK026632 Hs.278242 0 3 FLJ22979 fis, clone KAT11379, highly sim 59E2 255782 L24804 Hs.278270 0 2 (p23) mRNA, complete cds/cds = (232,714)/ gb =L24804/ 521H10 8 461 AI720536 Hs.278302 1.00E−114 4 as83c02.x1 cDNA, 3′end/clone = IMAGE: 2335298 118C6 830 1104 NM_001995 Hs.278333 1.00E−1481 fatty-acid-Coenzyme A ligase, long-chain 1 ( 104E9 248 417 AF151054Hs.278429 2.00E−78 1 HSPC220 mRNA, complete cds/cds = (288,818)/gb594F10 379 1760 NM_016520 Hs.278429 0 4 hepatocellularcarcinoma-associated antigen 126D11 7374 7716 NM_006289 Hs.278559 0 1talin (TLN), mRNA/cds = (126,7751)/gb = NM_0062 589E6 3078 5778NM_003105 Hs.278571 0 3 sortilin-related receptor, L(DLR class) A re102C10 669 1180 D14041 Hs.278573 0 1 for H-2K binding factor-2, completecds/ 526H8 167 4709 NM_015874 Hs.278573 0 5 H-2K binding factor-2(LOC51580), mRNA/cds = ( 120A12 732 1305 AB029031 Hs.278586 0 1 mRNA forKIAA1108 protein, partial cds/cds = (0 126F4 3138 3515 AF035737Hs.278589 0 2 general transcription factor 2-I (GTF2I) mRNA 40A7 31793864 U24578 Hs.278625 0 1 RP1 and complement C4B precursor (C4B) genes,partial 50C4 4401 4581 AB002334 Hs.278671 2.00E−60 1 KIAA0336 gene,complete cds/cds = (253,5004) 106E12 104 1222 D50525 Hs.278693 0 11TI-227H/cds = UNKNOWN/gb = D50525/gi = 1167502 467E10 168 542 BE973840Hs.278704 1.00E−145 1 601680647F1 cDNA, 5′ end/clone = IMAGE: 395115475F2 1121 1772 J04755 Hs.278718 0 37 ferritin H processed pseudogene,complete cds/ cds = UN 170E12 204 843 AL121735 Hs.278736 0 2 Isoform ofhuman GTP-binding protein G25K/ cds = (104,679)/ 103F4 589 926 NM_019597Hs.278857 0 1 heterogeneous nuclear ribonucleoprotein H2 37F8 3 519UO1923 Hs.278857 0 1 BTK region clone ftp-3 mRNA/cds = UNKNOWN/ gb =U01923/ 66B11 2195 2512 AB029027 Hs.279039 1.00E−172 1 for KIAA1104protein, complete cds/cds = ( 171G3 219 815 AK027258 Hs.279040 0 2FLJ23605 fis, clone LNG15982, highly sim 172E12 18 95 NM_014065Hs.279040 4.00E−27 2 HT001 protein (HT001), mRNA/cds = (241,1203)/596A12 1 225 BE220869 Hs.279231 2.00E−78 1 hu01g02.x1 cDNA, 3′ end/clone= IMAGE: 3165362 61H2 20 220 BE279328 Hs.279429 2.00E−32 3 601157666F1cDNA, 5′ end/clone = IMAGE: 3504328 458E12 1835 2473 NM_014160 Hs.2794740 1 HSPC070 protein (HSPC070), mRNA/cds(331,158 110F3 983 1614 NM_016160Hs.279518 0 1 amyloid precursor protein homolog HSD-2 (LOC5 37E5 39 732AK001403 Hs.279521 0 1 FLJ10541 fis, clone NT2RP2001381/cds = (3 66D6 6463 BE502919 Hs.279522 0 1 hz81b08.x1 cDNA, 3′ end/clone = IMAGE:3214359 123A11 411 903 NM_013237 Hs.279529 0 2 px19-like protein (PX19),mRNA/cds = (176,835) 185A10 809 1324 NM_002817 Hs.279554 0 1 proteasome(prosome, macropain) 26S subunit, 472H9 88 543 AL582047 Hs.279555 0 1AL582047 cDNA/clone = CS0DL003YD01-(3-prime) 41A2 1 326 AK000575Hs.279581 1.00E−162 1 FLJ20568 fis, clone REC00775/cds = (6,422) 135F4648 935 NM_016283 Hs.279586 1.00E−110 1 adrenal gland protein AD-004(LOC51578), mRNA 69D9 841 935 D16217 Hs.279607 9.00E−40 1 calpastatin,complete cds/cds = (162,2288)/ 116B6 938 1562 NM_001750 Hs.279607 0 1calpastatin (CAST), mRNA/cds = (66,1358)/gb = 473F4 6847 7401 NM_007329Hs.279611 0 1 deleted in malignant brain tumors 1 (DMBT1), tr 123C7 24882684 NM_021644 Hs.279681 1.00E−105 1 heterogeneous nuclearribonucleoprotein H3 586E2 357 633 NM_014169 Hs.279761 3.00E−97 1HSPC134 protein (HSPC134), mRNA/cds = (45,716) 464D6 383 524 NM_016154Hs.279771 1.00E−33 1 ras-related GTP-binding protein 4b (RAB4B), m 99G91375 1835 NM_013388 Hs.279784 0 1 prolactin regulatory element binding(PREB), 590F4 1045 1540 NM_003883 Hs.279789 0 2 histone deacetylase 3(HDAC3), mRNA/cds = (55,1 163E1 59 564 NM_015932 Hs.279813 0 3hypothetical protein (HSPC014), mRNA/cds = (8 525G5 3914 4160 NM_014819Hs.279849 1.00E−138 1 KIAA0438 gene product (KIAA0438), mRNA/cds = (598A10 9 821 NM_003295 Hs.279860 0 19 tumor protein,translationally-controlled 1 526C8 734 1166 NM_016007 Hs.279867 0 1CGI-59 protein (LOC51625), mRNA/cds = (2,1153) 183G12 758 1093 NM_017774Hs.279893 0 1 hypothetical protein FLJ20342 (FLJ20342), mR 36B3 247 611AK025623 Hs.279901 0 1 FLJ21970 fis, clone HEP05733, highly sim 592G3479 1052 NM_016146 Hs.279901 0 4 PTD009 protein (PTD009), mRNA/cds =(257,916) 38F5 811 1256 AF151875 Hs.279918 0 4 CGI-117 protein mRNA,complete cds/cds = (456,9 161E3 542 862 NM_016391 Hs.279918 1.00E−151 1hypothetical protein (HSPC111), mRNA/cds = (6 584F11 10 212 NM_014248Hs.279919 1.00E−112 2 ring-box 1 (RBX1), mRNA/cds = (6,332)/gb = NM_0588H7 400 1155 NM_003404 Hs.279920 0 12 tyrosine3-monooxygenase/tryptophan 5-monoo 169C8 400 1155 X57346 Hs.2799201.00E−131 2 HS1 protein/cds = (372,1112)/gb = X57346 147A1 209 1978AK025927 Hs.279921 0 8 FLJ22274 fis, clone HRC03616, highly sim 591H1148 1810 NM_016127 Hs.279921 1.00E−176 33 HSPC035 protein (LOC51669),mRNA/cds = (16,103 69D1 727 1776 NM_014366 Hs.279923 0 3 putativenucleotide binding protein, estradio 52C6 303 1151 V00522 Hs.279930 0 2encoding major histocompatibility complex gene 158C11 2483 2785 D84224Hs.279946 1.00E−166 2 methionyl tRNA synthetase, complete c 194E7 15251767 NM_004990 Hs.279946 1.00E−125 1 methionine- tRNA synthetase (MARS),mRNA/cds 62E5 215 701 U93243 Hs.279948 0 1 Ubc6p homolog mRNA, completecds/cds = (27,983) 145G3 1 1882 AK024090 Hs.281434 1.00E−147 5 FLJ14028fis, clone HEMBA1003838/cds = UN 473A6 1 310 BE552131 Hs.2820911.00E−158 1 hw29b05.x1 cDNA, 3′ end/clone = IMAGE: 3184305 52C12 1 455R67739 Hs.282401 0 1 yi28c06.r1 cDNA, 5′ end/clone = IMAGE: 140554/112A3 5072 5274 NM_006165 Hs.282441 3.00E−83 1 nuclear factor related tokappa B binding prote 61H3 443 577 AV648638 Hs.282867 2.00E−68 4AV648638 cDNA, 3′ end/clone = GLCBLE12/clone_(—) 37D3 38 766 AF287008Hs.283022 0 5 triggering receptor expressed on monocytes 1 125C5 32 748NM_018643 Hs.283022 0 13 triggering receptor expressed on myeloid cell41B1 597 1084 NM_018636 Hs.283106 0 2 hypothetical protein PRO2987(PRO2987), mRNA 111E9 1111 1405 AB037802 Hs.283109 1.00E−152 1 mRNA forKIAA1381 protein, partial cds/cds = (0 169D7 5 175 BE672733 Hs.2832162.00E−37 1 7b75g07.x1 3′ end/clone = IMAGE: 3234108 74G11 47 384BE676472 Hs.283267 1.00E−151 1 7f30c05.x1 cDNA, 3′ end/clone = IMAGE:3296168 191A5 256 890 NM_018507 Hs.283330 0 3 hypothetical proteinPRO1843 (PRO1843), mRNA 465B7 114 638 AW979262 Hs.283410 0 2 EST391372cDNA/gb = AW979262/gi = 8170550/ug = 143E1 1970 2258 NM_020217 Hs.2836111.00E−110 1 hypothetical protein DKFZp547I014 (DKFZp547I 54E9 385 739AF116620 Hs.283630 0 3 PRO1068 mRNA, complete cds/cds = UNKNOWN/ gb = A462D10 63 279 NM_007220 Hs.283646 1.00E−119 1 carbonic anhydrase VB,mitochondrial (CA5B), 518B11 359 690 NM_016056 Hs.283670 1.00E−167 2CGI-119 protein (LOC51643), mRNA/cds = (0,776) 36H5 1 226 BE778549Hs.283674 8.00E−85 1 601466063F1 cDNA, 5′ end/clone = IMAGE: 3869391126H10 907 1431 NM_017801 Hs.283685 0 1 hypothetical protein FLJ20396(FLJ20396), mR 69B1 2288 3232 AF103803 Hs.283690 0 6 clone H41 unknownmRNA/cds = (323,1099)/gb = AF 98B1 162 489 NM_018476 Hs.283719 1.00E−1101 uncharacterized hypothalamus protein HBEX2 39C3 997 3088 NM_020151Hs.283722 0 2 GTT1 protein (GTT1), mRNA/cds = (553,1440)/gb 592E4 132219 NM_020357 Hs.283728 0 2 PEST-containing nuclear protein (pcnp),mRNA 142F11 138 371 AF173296 Hs.283740 1.00E−130 1 e(y)2 homolog mRNA,complete cds/cds = (216,521 592F3 480 858 NM_013234 Hs.283781 0 2 musclespecific gene (M9), mRNA/cds = (171,827) 159E5 3 281 AL121916 Hs.2838381.00E−113 6 DNA sequence from clone RP1-189G13 on chromosome 20. 142H10517 892 AL121585 Hs.283864 9.00E−70 2 DNA sequence from clone RP11-504H3on chromosome 20 C 166D3 1 227 X72475 Hs.283972 6.00E−70 1 forrearranged lg kappa light chain variable 134E8 980 1302 NM_014110Hs.284136 0 47 PRO2047 protein (PRO2047), mRNA/cds = (798,968 596C5 30705 NM_006134 Hs.284142 0 2 chromosome 21 open reading frame 4(C21ORF4), m 74A4 1944 2157 AL359585 Hs.284158 1.00E−110 3 cDNADKFZp762B195 (from clone DKFZp762B1 159A4 159 1414 AF165521 Hs.284162 04 ribosomal protein L30 isolog (L30) mRNA, compl 597F9 836 1000NM_016304 Hs.284162 1.00E−88 1 60S ribosomal protein L30 isolog(LOC51187), m 462D2 655 1306 NM_016301 Hs.284164 0 1 protein × 0004(LOC51184), mRNA/cds = (31,885) 458C6 720 910 AP001753 Hs.2841891.00E−102 1 genomic DNA, chromosome 21q, section 97/105/ 165D5 1482 2302AB040120 Hs.284205 0 2 mRNA for BCG induced integral membrane protein180C12 309 602 BF381953 Hs.284235 1.00E−148 2 601816251F1 cDNA, 5′end/clone = IMAGE: 4050061 67D9 27 2026 AK024969 Hs.284249 0 10 FLJ21316fis, clone COL02253, highly sim 39D1 307 2899 U90552 Hs.284283 0 5butyrophilin (BTF5) mRNA, complete cds/ cds = (359,190 147C8 391 556AF161451 Hs.284295 2.00E−58 1 HSPC333 mRNA, partial cds/cds = (0,443)/gb= AF 192C12 333 484 AV700210 Hs.284605 5.00E−57 1 AV700210 cDNA, 3′end/clone = GKBALC03/clone_(—) 49G11 380 523 AV700636 Hs.284674 4.00E−331 AV700636 cDNA, 3′ end/clone = GKBAGH12/clone_(—) 115C11 375 1001AK023291 Hs.285017 0 1 cDNA FLJ13229 fis, clone OVARC1000106/cds = (15458H8 1544 2233 AK023459 Hs.285107 0 1 cDNA FLJ13397 fis, clonePLACE1001351/cds = (22 70F4 11 605 AV700298 Hs.285173 0 4 AV700298 cDNA,3′ end/clone = GKCBVGO5/clone_(—) 66C6 684 1415 NM_001300 Hs.285313 0 5core promoter element binding protein (COPEB), 169F2 4 460 BF684382Hs.285555 0 2 602141836F1 5′ end/clone = IMAGE: 4302776 171F12 646 839X58529 Hs.285823 6.00E−99 2 rearranged immunoglobulin mRNA for mu heavychain enh 142F10 1438 1728 AK025788 Hs.285833 1.00E−152 1 FLJ22135 fis,clone HEP20858/cds = UNKNOW 171H2 1 2500 AL050376 Hs.285853 5.00E−21 1mRNA; cDNA DKFZp586J101 (from clone DKFZp586J1 40C5 786 1163 AK026603Hs.286124 0 2 FLJ22950 fis, clone KAT09618, highly sim 458D9 55 684NM_016041 Hs.286131 0 1 CGI-101 protein (LOC51009), mRNA/cds = (6,635)458D1 1 310 AK025886 Hs.286194 1.00E−151 1 cDNA: FLJ22233 fis, cloneHRC02016/cds = (35,12 515C10 817 1136 AK021791 Hs.286212 1.00E−138 1cDNA FLJ11729 fis, clone HEMBA1005394, modera 71C7 285 2441 AK026933Hs.286236 0 7 cDNA: FLJ23280 fis, clone HEP07194/cds = (468,1 184B9 372612 BE965319 Hs.286754 3.00E−66 2 601659229R1 cDNA, 3′ end/clone =IMAGE: 3895783 586C12 18 381 NM_000996 Hs.287361 0 3 ribosomal proteinL35a (RPL35A), mRNA/cds = (6 36C6 152 685 AJ277247 Hs.287369 0 37 forinterleukin 21 (IL-21 gene)/cds = (71, 513H8 17 690 NM_020525 Hs.2873690 510 interleukin 22 (IL22), mRNA/cds = (71,610)/gb 586G2 3978 4107NM_021621 Hs.287387 3.00E−68 1 caspase recruitment domain protein 7(CARD7), 99D12 2330 2851 NM_015906 Hs.287414 0 1 transcriptionalintermediary factor 1 gamma ( 182A2 284 576 AK024331 Hs.287631 1.00E−1561 cDNA FLJ14269 fis, clone PLACE1003864/cds = UN 465A11 2226 2321AK024372 Hs.287634 1.00E−42 1 cDNA FLJ14310 fis, clone PLACE3000271/cds= (40 190A11 679 1126 AK026769 Hs.287725 0 1 cDNA: FLJ23116 fis, cloneLNG07945, highly sim 75E2 479 837 AL390738 Hs.287788 1.00E−146 3 DNAsequence from clone RP11-438F9 on chromosome 13 C 59B7 488 1071 AK022537Hs.287863 0 1 FLJ12475 fis, clone NT2RM1000962/cds = (16 460E8 1611 1979AK024092 Hs.287864 0 1 cDNA FLJ14030 fis, clone HEMBA1004086/cds = UNK465F11 5714 6271 NM_006312 Hs.287994 0 1 nuclear receptor co-repressor 2(NCOR2), mRNA 150E12 2041 2720 AK026834 Hs.287995 0 3 FLJ23181 fis,clone LNG11094/cds = UNKNOW 52D9 703 1482 AB016247 Hs.288031 0 1 forsterol-C5-desaturase, complete cds 37F4 1091 1655 AK025375 Hs.2880611.00E−141 20 FLJ21722 fis, clone COLF0522, highly sim 188G5 1081 1753NM_001101 Hs.288061 0 69 actin, beta (ACTB), mRNA/cds = (73,1200)/gb = N171C12 2103 2426 AB046857 Hs.288140 1.00E−158 1 KIAA1637 protein,partial cds/cds = (0 104E8 1354 1790 AK023078 Hs.288141 0 1 FLJ13016fis, clone NT2RP3000624, modera 181A4 1890 2507 AK022030 Hs.288178 0 2cDNA FLJ11968 fis, clone HEMBB1001133/cds = UNK 129A1 3522 3748 J04144Hs.288204 1.00E−125 1 angiotensin I-converting enzyme mRNA, completecds/ 598D12 1464 1947 AK025643 Hs.288224 0 3 cDNA: FLJ21990 fis, cloneHEP06386/cds = (22,49 52E6 920 1388 AK023402 Hs.288416 0 2 FLJ13340 fis,clone OVARC1001942, weakly 165E3 303 640 NM_020666 Hs.288417 0 1 proteinserine threonine kinase Clk4 (CLK4), 53D3 1 153 AK022280 Hs.2884356.00E−76 1 FLJ12218 fis, clone MAMMA1001075, modera 586C2 223 448BF110312 Hs.288443 1.00E−63 3 7n36d08.x1 cDNA, 3′ end/clone = IMAGE:3566654 521F12 1922 2248 AK026923 Hs.288455 0 1 cDNA: FLJ23270 fis,clone COL10309, highly sim 120A11 825 1855 AK026078 Hs.288555 0 2 cDNA:FLJ22425 fis, clone HRC08686/ cds = UNKNOW 129D11 1723 1984 AK023470Hs.288673 1.00E−143 2 FLJ13408 fis, clone PLACE1001672, weakly 109B121686 2086 AK025215 Hs.288708 1.00E−121 8 FLJ21562 fis, cloneCOL06420/cds = (238,2 178F11 387 558 NM_005402 Hs.288757 3.00E−93 1v-ral simian leukemia viral oncogene homolog 58F8 1262 1604 AK022735Hs.288836 0 1 cDNA FLJ12673 fis, clone NT2RM4002344/cds = (2, 163E11 3601687 AK024094 Hs.288856 1.00E−25 2 FLJ14032 fis, clone HEMBA1004353,highly 105B4 741 1243 AK025092 Hs.288872 0 1 FLJ21439 fis, cloneCOL04352/cds = (206,1 106D10 1598 2291 AB014515 Hs.288891 0 3 forKIAA0615 protein, complete cds/cds = ( 460F8 154 2487 NM_021818Hs.288906 1.00E−150 2 WW Domain-Containing Gene (WW45), mRNA/cds = (48A6 560 1258 NM_017644 Hs.288922 0 1 hypothetical protein FLJ20059(FLJ20059), mR 168B10 1271 1747 AK023320 Hs.288929 0 1 FLJ13258 fis,clone OVARC1000862, modera 114E2 2395 2849 AK023256 Hs.288932 0 1 cDNAFLJ13194 fis, clone NT2RP3004378, weakly 586F9 368 730 AK026363Hs.288936 1.00E−162 4 cDNA: FLJ22710 fis, clone HSI13340/cds = UNKNOW180B4 831 959 NM_000344 Hs.288986 1.00E−32 1 survival of motor neuron 1,telomeric (SMN1), 149A12 10 1958 AK025467 Hs.289008 0 5 FLJ21814 fis,clone HEP01068/cds = UNKNOW 117B5 5160 5611 NM_012231 Hs.2890241.00E−141 1 PR domain containing 2, with ZNF domain (PRDM2) 469A5 31323365 AK024456 Hs.289034 1.00E−106 1 mRNA for FLJ00048 protein, partialcds/cds = (2 461F6 396 473 AK024197 Hs.289037 7.00E−37 1 cDNA FLJ14135fis, clone MAMMA1002728/cds = UN 176G11 1049 1811 AK024669 Hs.289069 0 4cDNA: FLJ21016 fis, clone CAE05735/cds = (90,11 473A5 1343 1937NM_013326 Hs.289080 0 1 colon cancer-associated protein Mic1 (MIC1),591G2 14 2259 NM_005348 Hs.289088 0 14 heat shock 90 kD protein 1, alpha(HSPCA), mRNA 70D3 21 2912 X15183 Hs.289088 0 17 90-kDa heat-shockprotein/cds = (60,2258)/g 37E8 780 1509 AK026033 Hs.289092 0 5 FLJ22380fis, clone HRC07453, highly sim 74B10 408 791 X00453 Hs.289095 1.00E−1532 gene fragment for DX alpha-chain signal peptide, 518B5 870 1128NM_005313 Hs.289101 1.00E−119 1 glucose regulated protein, 58 kD(GRP58), mRNA 472A3 116 304 X83300 Hs.289103 4.00E−84 1 H. sapiens SMA4mRNA/cds = (66,488)/gb = X83300/ gi = 603028/ 112G6 1703 2550 NM_001166Hs.289107 0 5 baculoviral IAP repeat-containing 2 (BIRC2), 37F11 19962580 U37547 Hs.289107 0 2 IAP homolog B (MIHB) mRNA, complete cds/ cds =(1159,301 169A12 371 588 X57812 Hs.289110 2.00E−84 1 rearrangedimmunoglobulin lambda light chain/c 472D6 2102 2424 AF294900 Hs.2891181.00E−121 1 beta, beta-carotene 15, 15′-dioxygenase (BCD 151D1 2214 2294AK025846 Hs.289721 1.00E−38 2 FLJ22193 fis, clone HRC01108/cds = UNKNOW40A8 160 346 AI761924 Hs.289834 2.00E−94 1 wg68h03.x1 cDNA, 3′ end/clone= IMAGE: 2370293 468D5 42 105 AA719103 Hs.290535 5.00E−29 1 zh33d10.s1cDNA, 3′ end/clone = IMAGE: 413875/ 515B6 7 249 AA837754 Hs.2911292.00E−61 1 oe10d02.s1 cDNA/clone = IMAGE: 1385475/gb = AA 594C9 16 319NM_005745 Hs.291904 1.00E−150 1 accessory proteins BAP31/BAP29(DXS1357E), m 476C10 180 311 AI184710 Hs.292276 8.00E−62 1 qd64a01.x1cDNA, 3′ end/clone = IMAGE: 1734216 466G5 65 431 AA461604 Hs.292451 0 1zx51d08.r1 cDNA, 5′ end/clone = IMAGE: 795759/ 331F12 142 314 BF310166Hs.292457 3.00E−85 1 601894826F1 cDNA, 5′ end/clone = IMAGE: 4124119590D6 1 406 BG339050 Hs.292457 0 2 602436875F1 cDNA, 5′ end/clone =IMAGE: 4554643 150G5 160 431 AI440234 Hs.292490 6.00E−66 1 ti99h12.x1cDNA, 3′ end/clone = IMAGE: 2140199 594F8 319 447 AA761571 Hs.2925191.00E−57 1 nz23d06.s1 cDNA, 3′ end/clone = lMAGE: 1288619 122E2 91 307AI582954 Hs.292553 4.00E−47 1 tr98e07.x1 cDNA, 3′ end/clone = IMAGE:2227140 41E5 363 463 D59502 Hs.292590 3.00E−48 1 HUM041H11A cDNA, 3′end/clone = GEN-041H11/cl 99B8 215 378 AI672433 Hs.292615 6.00E−62 4wa03b05.x1 cDNA, 3′ end/clone = IMAGE: 2296977 72C6 198 484 AA719537Hs.292877 1.00E−112 3 zh40g12.s1 cDNA, 3′ end/clone = IMAGE: 414598/157H5 49 447 AI962127 Hs.292901 1.00E−126 1 wx77f07.x1 3′ end/clone =IMAGE: 2549701 115C2 2052 2613 NM_006310 Hs.293007 0 1 aminopeptidasepuromycin sensitive (NPEPPS), 463F3 14 445 AW629485 Hs.293352 0 2hi59b07.x1 cDNA, 3′ end/clone = IMAGE: 2976565 193H8 94 333 AI263141Hs.293444 7.00E−58 1 qw90c01.x1 cDNA, 3′ end/clone = IMAGE: 1998336170G9 46 713 AI452611 Hs.293473 9.00E−21 1 tj27g07.x1 cDNA, 3′ end/clone= lMAGE: 2142780 100F9 554 666 BE905040 Hs.293515 2.00E−43 1 601496859F1cDNA, 5′ end/clone = IMAGE: 3898767 588G9 153 507 BF794089 Hs.2936581.00E−143 1 602255649F1 cDNA, 5′ end/clone = IMAGE: 4338732 142G8 2 231AV701332 Hs.293689 1.00E−79 1 AV701332 cDNA, 5′ end/clone =ADAABD03/clone_(—) 137A4 1 557 BF029654 Hs.293777 0 1 601765621F1 cDNA,5′ end/clone = IMAGE: 3997900 478C6 442 622 BE748123 Hs.293842 3.00E−631 601571679F1 cDNA, 5′ end/clone = lMAGE: 3838675 100E7 198 488 BE748663Hs.293842 1.00E−145 1 601571679T1 cDNA, 3′ end/clone = lMAGE: 3838675110B4 246 469 NM_016398 Hs.293905 1.00E−122 1 hypothetical protein(HSPC131), mRNA/cds = (1 466D2 198 543 AW972477 Hs.294083 1.00E−180 1EST384568 cDNA/gb = AW972477/gi = 8162323/ug = 100C10 1 398 AW963235Hs.294092 0 2 EST375308/gb = AW963235/gi = 8153071/ug = 118F10 418 552BF245076 Hs.294110 1.00E−48 1 601863910F1 cDNA, 5′ end/clone = IMAGE:4082235 596H2 1150 2308 BC002450 Hs.294135 0 20 ribosomal protein L4,clone MGC: 776, mRNA, co 596B4 139 414 BE621121 Hs.294309 7.00E−73 3601493943F1 cDNA, 5′ end/clone = IMAGE: 3896051 114D4 600 738 BE961923Hs.294348 8.00E−33 1 601655335R1 cDNA, 3′ end/clone = IMAGE: 384576866D11 185 625 BE963811 Hs.294578 1.00E−127 6 601657462R1 cDNA, 3′end/clone = IMAGE: 3875846 53E11 433 701 BE964149 Hs.294612 5.00E−81 1601657833R1 cDNA, 3′ end/clone = IMAGE: 3875984 179A11 442 776 BF313856Hs.294754 9.00E−79 1 601902261F1 5′ end/clone = IMAGE: 4134998 102B9 146347 H71236 Hs.295055 7.00E−90 2 ys12f10.s1 cDNA, 3′ end/clone = IMAGE:214603/ 110F4 136 358 H80108 Hs.295107 1.00E−118 1 yu09f02.s1 cDNA, 3′end/clone = IMAGE: 233307/ 593F2 78 381 AF212224 Hs.295231 1.00E−172 3CLK4 mRNA, complete cds/cds = (153,1514)/gb = A 50G9 355 415 AI052431Hs.295451 1.00E−26 2 oz07e08.x1 cDNA, 3′ end/clone = IMAGE: 1674662102E4 99 413 AI560651 Hs.295682 1.00E−146 8 tq60f01.x1 cDNA, 3′end/clone = IMAGE: 2213209 486F7 263 489 BF572855 Hs.295806 1.00E−100 1602079424F2 cDNA, 5′ end/clone = lMAGE: 4254172 39C1 2054 2315 AL050141Hs.295833 1.00E−144 6 cDNA DKFZp586O031 (from clone DKFZp586O0 192D3 48551 AW081320 Hs.295945 1.00E−158 4 xc30f12.x1 cDNA, 3′ end/clone =IMAGE: 2585807 102B7 753 850 AL117536 Hs.295969 5.00E−39 1 cDNADKFZp434G012 (from clone DKFZp434G0 168D1 73 1193 AL360190 Hs.2959781.00E−134 3 mRNA full length insert cDNA clone EUROIMAGE 74 47D6 103 331AW150085 Hs.295997 3.00E−79 8 xg36f04.x1 cDNA, 3′ end/clone = lMAGE:2629663 151H9 197 507 AW264291 Hs.296057 1.00E−113 1 xq97g08.x1 cDNA, 3′end/clone = IMAGE: 2758622 56A1 1034 1220 AJ012504 Hs.296151 3.00E−74 1activated in tumor suppression, clone TSA 525D12 42 545 AI922889Hs.296159 1.00E−148 42 wn64g11.x1 cDNA, 3′ end/clone = IMAGE: 245027672C12 280 545 AW166001 Hs.296159 1.00E−84 10 xf43e11.x1 cDNA, 3′end/clone = IMAGE: 2620844 99B1 21 286 BE259480 Hs.296183 4.00E−81 3601106571F1 cDNA, 5′ end/clone = IMAGE: 3342929 143F5 18 178 BE962588Hs.296183 1.00E−55 1 601655929R1 cDNA, 3′ end/clone = IMAGE: 3855823110A10 2115 2237 AL096752 Hs.296243 1.00E−61 1 cDNA DKFZp434A012 (fromclone DKFZp434A0 170G1 16 304 BE964134 Hs.296246 4.00E−96 1 601657818R1CDNA, 3′ end/clone = IMAGE: 3876028 597G5 168 1564 NM_014456 Hs.296251 018 programmed cell death 4 (PDCD4), mRNA/cds = (84 184A12 686 1564U96628 Hs.296251 0 2 nuclear antigen H731-like protein mRNA, compl479H10 247 540 NM_002072 Hs.296261 1.00E−117 1 guanine nucleotidebinding protein (G protein 179H11 48 250 BF315059 Hs.296266 3.00E−56 1601899090F1 5′ end/clone = IMAGE: 4128334 182E9 1576 2251 AK023460Hs.296275 0 2 FLJ13398 fis, clone PLACE1001377, highly 459B11 305 545BF340402 Hs.296317 1.00E−79 1 602036746F1 cDNA, 5′ end/clone = IMAGE:4184602 459B12 349 721 AK001838 Hs.296323 0 1 cDNA FLJ10976 fis, clonePLACE1001399/cds = UN 179F8 1 756 BF342246 Hs.296333 0 2 602013019F1 5′end/clone = IMAGE: 4148741 171D1 12 330 AV693913 Hs.296339 1.00E−100 1AV693913 cDNA, 5′ end/clone = GKCDVG04/clone_(—) 39B9 1 297 AB046771Hs.296350 1.00E−167 1 for KIAA1551 protein, partial cds/cds = (0 36H12547 1089 M96995 Hs.296381 0 2 epidermal growth factor receptor-bindingpro 459F1 867 1020 NM_014499 Hs.296433 4.00E−76 1 putative purinergicreceptor (P2Y10), mRNA/c 584A11 615 1287 NM_006392 Hs.296585 0 4nucleolar protein (KKE/D repeat) (NOP56), mRN 593F7 209 752 NM_005678Hs.296948 0 2 SNRPN upstream reading frame (SNURF), transcr 174F7 493681 BE253125 Hs.297095 2.00E−60 5 601116648F1 cDNA, 5′ end/clone =IMAGE: 3357178 123H9 132 413 BE965554 Hs.297190 9.00E−88 1 601659486R1cDNA, 3′ end/clone = IMAGE: 3896204 123D6 1105 1595 AF113676 Hs.297681 01 clone FLB2803 PRO0684 mRNA, complete cds/cds = 71C6 1076 1630NM_003380 Hs.297753 0 2 vimentin (VIM), mRNA/cds = (122,1522)/gb = NM_0586G5 1179 1452 NM_001908 Hs.297939 1.00E−142 1 cathepsin B (CTSB),mRNA/cds = (177,1196)/gb = 521E7 1 220 NM_001022 Hs.298262 1.00E−119 4ribosomal protein S19 (RPS19), mRNA/cds = (22,4 466H7 9 339 AW614181Hs.298654 1.00E−153 1 hg77d03.x1 cDNA, 3′ end/clone = IMAGE.2951621464A4 675 1232 BC001077 Hs.299214 0 1 clone IMAGE: 2822295, mRNA,partial cds/cds = 466F3 49 337 AA132448 Hs.299416 1.00E−141 1 zo20a03.s1cDNA, 3′ end/clone = IMAGE: 587404/ 589B10 123 339 AW073707 Hs.2995811.00E−55 30 xb01h03.x1 cDNA, 3′ end/clone = IMAGE: 2575061 521H4 3 371NM_001000 Hs.300141 1.00E−125 4 ribosomal protein L39 (RPL39), mRNA/cds= (37,1 599F12 36 328 AW243795 Hs.300220 2.00E−67 1 xo56f02.x1 cDNA, 3′end/clone = IMAGE: 2707995 479A6 173 356 AW262077 Hs.300229 3.00E−64 1xq61e07.x1 cDNA, 3′ end/clone = IMAGE: 2755140 111C8 806 1350 NM_018579Hs.300496 1.00E−147 6 mitochondrial solute carrier (LOC51312), mRN 459D81 679 NM_014478 Hs.300684 0 1 calcitonin gene-related peptide-receptorco 522C5 98 1360 NM_001154 Hs.300711 0 10 annexin A5 (ANXA5), mRNA/cds =(192,1154)/gb = 596B7 407 750 NM_003130 Hs.300741 2.00E−83 1 sorcin(SRI), mRNA/cds = (12,608)/gb = NM_00313 191A3 210 440 AA788623Hs.301104 4.00E−34 9 ah29f09.s1 cDNA, 3′ end/clone = 1240265/clone 123E115 267 BE963194 Hs.301110 1.00E−60 11 601656811R1 cDNA, 3′ end/clone =IMAGE: 3865731 116F11 346 650 NM_014029 Hs.301175 2.00E−71 2 HSPC022protein (HSPC022), mRNA/cds = (18,623) 58D4 489 611 AW863111 Hs.3011838.00E−50 1 MR3-SN0009-010400-101-f02 cDNA/gb = AW863111 122D8 3644 4034AB037808 Hs.301434 0 1 mRNA for KIAA1387 protein, partial cds/cds = (0520F11 276 553 BE886472 Hs.301486 1.00E−111 1 601509688F1 cDNA, 5′end/clone = IMAGE: 3911301 512E5 71 687 NM_001011 Hs.301547 0 8ribosomal protein S7 (RPS7), mRNA/cds = (81,665 463F9 168 689 AV702152Hs.301570 0 1 AV702152 cDNA, 5′ end/clone = ADBBFH05/clone_(—) 117A122239 2395 NM_007167 Hs.301637 5.00E−78 1 zinc finger protein 258(ZNF258), mRNA/cds = (9 190A6 12942 13156 AF155238 Hs.301698 1.00E−114 1BAC 180i23 chromosome 8 map 8q24.3 beta-galacto 594F12 1409 1841NM_005442 Hs.301704 0 1 eomesodermin (Xenopus laevis) homolog (EOMES)116G12 5477 5571 AB033081 Hs.301721 6.00E−47 1 mRNA for KIAA1255protein, partial cds/cds = (0 123C4 23 579 BE260041 Hs.301809 1.00E−1294 601150579F1 cDNA, 5′ end/clone = IMAGE: 3503419 192E12 1458 1854NM_007145 Hs.301819 0 1 zinc finger protein 146 (ZNF146), mRNA/cds = (8590G8 1100 1307 AF132197 Hs.301824 3.00E−57 1 PRO1331 mRNA, completecds/cds = (422,616)/gb 482E5 1764 2139 NM_001295 Hs.301921 0 1 chemokine(C-C motif) receptor 1 (CCR1), mRNA 583C5 4283 4684 NM_014415 Hs.3019560 1 zinc finger protein (ZNF-U69274), mRNA/cds = ( 173G11 645 839 X58529Hs.302063 1.00E−104 4 rearranged immunoglobulin mRNA for mu heavy chainenh 597D11 30 369 AL137162 Hs.302114 1.00E−150 5 DNA sequence from cloneRP5-843L14 on chromosome 20. 191G9 182 353 AC004079 Hs.302183 9.00E−60 1PAC clone RP1-167F23 from 7p15/cds = (0,569)/g 473D2 102 333 BF477640Hs.302447 1.00E−126 1 7r01c05.x1 cDNA/clone = IMAGE/gb = BF477640/g479A9 18 267 BE964028 Hs.302585 7.00E−79 1 601657601R1 cDNA, 3′end/clone = IMAGE: 3875617 180A5 894 1325 NM_018295 Hs.302981 0 2hypothetical protein FLJ11000 (FLJ11000), mR 593H6 950 1151 X00437Hs.303157 1.00E−104 1 mRNA for T-cell specific protein/cds = (37,975)/gb= XC 51G12 274 533 BG054649 Hs.303214 1.00E−138 4 7o45b01.x1 cDNA, 3′end/clone = IMAGE: 3576912 189B10 785 1024 NM_002138 Hs.303627 1.00E−1332 heterogeneous nuclear ribonucleoprotein D ( 99B11 1 529 NM_002982Hs.303649 0 51 small inducible cytokine A2 (monocyte chemota 461E1 397496 AI472078 Hs.303662 2.00E−28 1 tj85h03.x1 cDNA, 3′ end/clone = IMAGE:2148341 103A1 359 687 AF130085 Hs.304177 1.00E−151 1 clone FLB8503PRO2286 mRNA, complete cds/cds 180B11 52 240 AI824522 Hs.304477 4.00E−571 tx71d03.x1 cDNA, 3′ end/clone = lMAGE: 2275013 519A10 1 104 AI880542Hs.304620 3.00E−26 1 at80h05.x1 cDNA, 3′ end/clone = IMAGE: 2378361479F6 331 582 AA873734 Hs.304886 1.00E−131 1 oh55h07.s1 cDNA, 3′end/clone = IMAGE: 1470589 176G3 61 324 AI904802 Hs.304919 2.00E−74 1IL-BT067-190199-037 cDNA/gb = AI904802/gi = 6 471G6 169 397 AW592876Hs.304925 1.00E−122 1 hg04d05.x1 cDNA, 3′ end/clone = IMAGE: 2944617119D11 3 348 AL049282 Hs.306030 1.00E−179 1 mRNA; cDNA DKFZp564M113(from clone DKFZp564M1 112F7 2398 3008 U80743 Hs.306094 0 1 CAGH32 mRNA,partial cds/cds = (0,1671)/gb = U80 460C1 243 533 NM_001353 Hs.3060985.00E−71 1 aldo-keto reductase family 1, member C1 (dihy 126A4 469 543L08048 Hs.306192 2.00E−28 1 non-histone chromosomal protein (HMG-1)retropseudo 119F3 2113 2237 AL096752 Hs.306327 3.00E−60 1 mRNA; cDNADKFZp434A012 (from clone DKFZp434A0 467F8 1860 2406 AL390039 Hs.307106 01 DNA sequence from clone RP13-383K5 on chromosome Xq22 192B12 1 454X72475 Hs.307183 0 6 H. sapiens mRNA for rearranged Ig kappa light chainvariable 116H11 60 402 AF067519 Hs.307357 1.00E−160 1 PITSLRE proteinkinase beta SV1 isoform (CDC2L 472D3 150 478 AW975895 Hs.307486 1.00E−124 1 EST388004 cDNA/gb = AW975895/gi = 8167117/ug = 458B4 87 354AW206977 Hs.307542 1.00E−143 1 UI-H-BI1-afs-h-11-0-UI.s1 cDNA, 3′end/clon 463A11 181 397 AI057025 Hs.307879 1.00E−69 1 oy75a12.x1 cDNA,3′ end/clone = IMAGE: 1671646 479C6 138 403 BE264564 Hs.308154 1.00E−1441 601192330F1 cDNA, 5′ end/clone = IMAGE: 3536383 468G10 118 446AI361642 Hs.309028 0 1 qy86d04.x1 cDNA, 3′ end/clone = IMAGE: 2018887461G12 64 466 AI379735 Hs.309117 7.00E−25 1 tc41c11.x1 cDNA, 3′end/clone = IMAGE: 2067188 466H8 15 487 AI380278 Hs.309120 0 1tf99f08.x1 cDNA, 3′ end/clone = IMAGE: 2107431 477C8 28 187 AI380449Hs.309122 7.00E−84 1 tg02f12.x1 cDNA, 3′ end/clone = IMAGE: 2107631477C9 47 537 AI380687 Hs.309127 0 1 tg03e04.x1 cDNA, 3′ end/clone =IMAGE: 2107710 465F4 68 631 AI440337 Hs.309279 0 1 tc88b03.x1 cDNA, 3′end/clone = IMAGE: 2073197 465G6 313 404 AI475653 Hs.309347 9.00E−31 1tc93b04.x1 cDNA, 3′ end/clone = IMAGE: 2073679 465E7 1 340 AI475827Hs.309349 1.00E−171 2 tc87a05.x1 cDNA, 3′ end/clone = IMAGE: 2073104517G11 62 516 AI707809 Hs.309433 1.00E−115 2 as28g09.x1 cDNA, 3′end/clone = IMAGE: 2318560 468D11 290 497 AI523766 Hs.309484 1.00E−103 1tg94f07.x1 cDNA, 3′ end/clone = IMAGE: 2116453 186F5 77 418 AI569898Hs.309629 1.00E−81 1 tr57c12.x1 cDNA, 3′ end/clone = IMAGE: 2222422116A12 8 158 AI735206 Hs.310333 2.00E−43 1 at07f03.x1 cDNA, 3′ end/clone= IMAGE: 2354429 126G12 35 170 AI866194 Hs.310948 1.00E−54 1 wl27a03.x1cDNA, 3′ end/clone = IMAGE: 2426092 172G8 86 227 AI926251 Hs.3111373.00E−44 1 wo41h05.x1 cDNA, 3′ end/clone = IMAGE: 2457945 477D8 1 115AI968387 Hs.311448 4.00E−42 2 wu02e08.x1 cDNA, 3′ end/clone = IMAGE:2515814 462F10 13 220 AW043857 Hs.311783 1.00E−107 1 wy81g04.x1 cDNA, 3′end/clone = IMAGE: 2554998 185A9 46 423 AW130007 Hs.312182 1.00E−130 2xf26f10.x1 cDNA, 3′ end/clone = IMAGE: 2619211 515F6 34 181 AW148618Hs.312412 3.00E−58 2 xe99f02.x1 cDNA, 3′ end/clone = IMAGE: 2616699583E12 5945 6393 AL133572 Hs.312840 0 1 mRNA; cDNA DKFZp434I0535 (fromclone DKFZp434I 471D5 306 411 AW298430 Hs.313413 1.00E−46 1UI-H-BW0-ajI-c-09-0-UI.s1 cDNA, 3′ end/clon 482F7 1 449 AW440965Hs.313578 0 1 he06d07.x1 cDNA, 3′ end/clone = IMAGE: 2918221 473B3 179463 BG150461 Hs.313610 1.00E−135 1 7k01d08.x1 cDNA, 3′ end/clone =IMAGE: 3443006 479E9 138 434 AW450835 Hs.313715 1.00E−127 1UI-H-BI3-alf-f-06-0-UI.s1 cDNA, 3′ end/clon 71B9 344 577 AI733018Hs.313929 1.00E−115 1 oh60h01.x5 cDNA, 3′ end/clone = IMAGE: 1471441479B6 217 443 AW629176 Hs.314085 2.00E−70 1 hi52a04.x1 cDNA, 3′end/clone = IMAGE: 2975886 191F11 55 123 BE255377 Hs.314898 1.00E−26 1601115405F1 cDNA, 5′ end/clone = IMAGE: 3355872 522F11 14 204 BE962883Hs.314941 9.00E−83 3 601656423R1 cDNA, 3′ end/clone = IMAGE: 3856325195F12 120 363 BE351010 Hs.315050 2.00E−77 1 ht22g04.x1 cDNA, 3′end/clone = IMAGE: 3147510 173A5 429 824 BE410105 Hs.315263 1.00E−133 1601302278F1 cDNA, 5′ end/clone = IMAGE: 3637002 481B2 1063 1283NM_006255 Hs.315366 3.00E−72 1 protein kinase C, eta (PRKCH), mRNA/cds =(166,2 459G1 1428 1700 NM_006850 Hs.315463 1.00E−124 1 suppression oftumorigenicity 16 (melanoma di 113H4 22 359 BE901218 Hs.315633 1.00E−1272 601676034F1 cDNA, 5′ end/clone = IMAGE: 3958617 583B7 510 754 BE963666Hs.316047 2.00E−55 2 601656685R1 cDNA, 3′ end/clone = IMAGE: 3865820466E10 488 644 AV729160 Hs.316771 1.00E−54 1 AV729160 cDNA, 5′ end/clone= HTCCAB04/clone_(—) 597A6 50 249 AV710763 Hs.316785 4.00E−31 2 AV710763cDNA, 5′ end/clone = CuAAJH09/clone_(—) 123C3 41 529 BF183507 Hs.3182151.00E−158 1 601809991R1 cDNA, 3′ end/clone = IMAGE: 4040470 193E12 152274 NM_006074 Hs.318501 0 7 stimulated trans-acting factor (50 kDa)(STAF 165D8 727 1344 BC002867 Hs.318693 0 1 clone IMAGE: 3940519, mRNA,partial cds/cds = 49F8 520 1094 M16942 Hs.318720 0 1 MHC class IIHLA-DRw53-associated glycoprotein beta- 172E10 310 944 NM_016018Hs.318725 0 1 CGI-72 protein (LOC51105), mRNA/cds = (69,1400 585B1 51296 BF696330 Hs.318782 6.00E−90 4 602125273F1 cDNA, 5′ end/clone =IMAGE: 4281906 45E12 208 737 NM_000636 Hs.318885 0 7 superoxidedismutase 2, mitochondrial (SOD2) 460G2 409 663 BG106948 Hs.3188935.00E−96 1 602291361F1 cDNA, 5′ end/clone = IMAGE: 4386159 480C1 155 325BF889206 Hs.319926 4.00E−74 1 RC6-TN0073-041200-013-H02 cDNA/gb =BF889206 178F1 1 387 BG112503 Hs.320972 1.00E−133 3 602282105F1 cDNA, 5′end/clone = IMAGE: 4369633 176G4 1092 1339 AL110236 Hs.321022 1.00E−1361 mRNA; cDNA DKFZp566P1124 (from clone DKFZp566P 461H6 1701 2239NM_024101 Hs.321130 0 1 hypothetical protein MGC2771 (MGC2771), mRNA513F2 605 1614 AK001111 Hs.321245 0 2 cDNA FLJ10249 fis, cloneHEMBB1000725, highly 525B4 9 251 BE871962 Hs.321262 6.00E−98 15601448005F1 cDNA, 5′ end/clone = IMAGE: 3852001 467A4 1974 2223 AK026270Hs.321454 6.00E−87 1 cDNA: FLJ22617 fis, clone HSI05379, highly sim589F10 39 276 BF970928 Hs.321477 5.00E−77 1 602270204F1 cDNA, 5′end/clone = IMAGE: 4358425 125A7 1102 1584 BC000627 Hs.321677 0 1 Signaltransducer and activator of transcript 597H3 2786 2920 AL136542Hs.322456 4.00E−46 2 mRNA; cDNA DKFZp761D0211 (from clone DKFZp761D465E2 40 107 BE747224 Hs.322643 7.00E−22 1 601580941F1 cDNA, 5′end/clone = IMAGE: 3929386 515A12 1 698 AL050376 Hs.322645 0 2 mRNA;cDNA DKFZp586J101 (from clone DKFZp586J1 589H11 26 265 BG283132Hs.322653 4.00E−79 6 602406784F1 cDNA, 5′ end/clone = IMAGE: 4518957586E5 1939 2162 AK025200 Hs.322680 1.00E−120 3 cDNA: FLJ21547 fis, cloneCOL06206/cds = UNKNOW 595A2 1 306 BG311130 Hs.322804 2.00E−70 2ia55a08.y1 cDNA, 5′ end/clone_end = 5′/gb = BG3 459H11 742 951 BC002746Hs.322824 1.00E−111 1 Similar to dodecenoyl-Coenzyme A delta isome 64C3655 887 NM_020368 Hs.322901 1.00E−112 1 disrupter of silencing 10(SAS10), mRNA/cds = ( 591B8 3626 4574 D80006 Hs.322903 0 3 mRNA forKIAA0184 gene, partial cds/cds = (0,2591)/gb 458C3 5106 5198 NM_003035Hs.323032 3.00E−43 1 TAL1 (SCL) interrupting locus (SIL), mRNA/cds 526B72132 2750 NM_024334 Hs.323193 0 2 hypothetical protein MGC3222(MGC3222), mRNA 167F4 467 731 NM_014953 Hs.323346 1.00E−136 2 KIAA1008protein (KIAA1008), mRNA/cds = (93,28 194B8 1913 3596 AB051480 Hs.3234630 9 mRNA for KIAA1693 protein, partial cds/cds = (0 478H9 75 564BF700502 Hs.323662 0 1 602128860F1 cDNA, 5′ end/clone = IMAGE: 4285502119B1 1598 2284 NM_014664 Hs.323712 0 2 KIAA0615 gene product(KIAA0615), mRNA/cds = ( 167H2 1410 3683 AB046771 Hs.323822 0 4 mRNA forKIAA1551 protein, partial cds/cds = (0 595C12 1 528 NM_021998 Hs.3239500 6 zinc finger protein 6 (CMPX1) (ZNF6), mRNA/cd 462F1 1 356 AK026836Hs.324060 1.00E−176 1 cDNA: FLJ23183 fis, clone LNG11477/cds = (226,7122D10 217 424 AK026091 Hs.324187 2.00E−83 1 cDNA: FLJ22438 fis, cloneHRC09232, highly sim 525B2 1028 3282 AL136739 Hs.324275 0 2 mRNA; cDNADKFZp434D2111 (from clone DKFZp434D 459B6 3 482 BF668584 Hs.324342 0 1602123634F1 cDNA, 5′ end/clone = IMAGE: 4280408 583D10 232 466 NM_021104Hs.324406 1.00E−130 2 ribosomal protein L41 (RPL41), mRNA/cds = (83,1118F8 2262 2819 NM_016824 Hs.324470 0 1 adducin 3 (gamma) (ADD3),transcript variant 1 461A5 46 391 AW968541 Hs.324481 1.00E−111 1EST380617 cDNA/gb = AW968541/gi = 8158382/ug = 467F11 927 1189 NM_000817Hs.324784 1.00E−147 1 glutamate decarboxylase 1 (brain, 67 kD) (GAD1103E12 1686 1771 AK024863 Hs.325093 9.00E−42 1 cDNA: FLJ21210 fis, cloneCOL00479/cds = UNKNOW 521E11 4276 4689 AB028990 Hs.325530 0 1 mRNA forKIAA1067 protein, partial cds/cds = (0 480A9 112 333 AA760848 Hs.3258741.00E−108 1 nz14f06.s1 cDNA, 3′ end/clone = IMAGE: 1287779 71G8 26192868 NM_001964 Hs.326035 1.00E−116 1 early growth response 1 (EGR1),mRNA/cds = (270, 593D6 742 3372 NM_004735 Hs.326159 0 4 leucine richrepeat (in FLII) interacting prot 463G9 42 608 AW975482 Hs.326165 0 1EST387591 cDNA/gb = AW975482/gi = 8166696/ug = 526B12 2380 2639 U83857Hs.326247 1.00E−143 2 Aac11 (aac11) mRNA, complete cds/cds = (77,1663)/gb = 36A1 63 338 AA010282 NA 1.00E−116 1 zi08h07.r1Soares_fetal_liver_spleen_1NFLS_S1 cDNA 459D10 67 164 AA044450 NA3.00E−47 1 zk55a02.r1 Soares_pregnant_uterus_NbHPU cDNA clone 469E6 1216 AA069335 NA 1.00E−104 1 zf74e10.r1 Soares_pineal_gland_N3HPG cDNAclone 463B2 4 205 AA077131 NA 4.00E−88 1 Brain cDNA Library cDNA clone7B08E10 68H9 17 383 AA101212 NA 0 1 endothelial cell 937223 cDNA cloneIMAGE: 549605 3′ 458F3 120 498 AA115345 NA 0 1 zl09f11.r1Soares_pregnant_uterus_NbHPU cDNA clone 459E6 36 532 AA122297 NA 0 1zk97a11.r1 Soares_pregnant_uterus_NbHPU cDNA clone 462C5 1 122 AA136584NA 2.00E−59 1 fetal retina 937202 cDNA clone IMAGE: 565899 3′ 594A1 60412 AA149078 NA 0 1 zl45e09.r1 Soares_pregnant_uterus_NbHPU cDNA clone515A9 329 449 AA182528 NA 2.00E−46 1 NT2 neuronal precursor 937230 cDNAclone 75H4 7 371 AA187234 NA 1.00E−119 1 endothelial cell 937223 cDNAclone IMAGE: 624540 3′ 73F10 1 544 AA210786 NA 0 1 cDNA clone IMAGE:682976 5′ 525D8 1 119 AA214691 NA 6.00E−60 1 Express cDNA library cDNA5′ 37H4 250 401 AA243144 NA 3.00E−48 1 cDNA clone IMAGE: 685113 5′463B10 145 408 AA250809 NA 1.00E−123 1 cDNA clone IMAGE: 684374 5′464E10 1 303 AA251184 NA 1.00E−119 1 cDNA clone IMAGE: 684046 5′ 477H8 1123 AA252909 NA 4.00E−58 3 cDNA clone IMAGE: 669292 5′ 465C3 1 279AA258979 NA 1.00E−129 1 cDNA clone IMAGE: 687151 5′ 588G6 275 529AA280051 NA 2.00E−94 1 cDNA clone IMAGE: 705062 5′ 465E9 74 429 AA282774NA 0 1 cDNA clone IMAGE: 713136 5′ 459E7 49 466 AA283061 NA 0 1 cDNAclone IMAGE: 713078 5′ 164B4 41 329 AA284232 NA 1.00E−148 2 zc39c01.T7Soares_senescent_fibroblasts_NbHSF cDNA 461G8 289 532 AA290921 NA1.00E−123 1 cDNA clone IMAGE: 700335 5′ 470G7 29 441 AA290993 NA 0 1cDNA clone IMAGE: 700425 5′ 500A12 1 519 AA307854 NA 1.00E−174 1 (HCC)cell line cDNA 5′ end similar to 471F4 9 326 AA309188 NA 1.00E−153 1cDNA 194B6 134 467 AA312681 NA 1.00E−163 1 cDNA 5′ end 69F3 5 321AA314369 NA 1.00E−176 1 (HCC) cell line II cDNA 5′ end similar 67G10 1171 AA319163 NA 3.00E−64 2 cDNA 5′ end 99A5 1 287 AA322158 NA 1.00E−1361 cDNA 5′ end similar to similar to tropomyosin 171B1 13 310 AA332553 NA1.00E−135 1 cDNA 5′ end 485D11 46 210 AA360634 NA 2.00E−75 1 cDNA 5′ end462G2 1 183 AA377352 NA 4.00E−89 2 cDNA 5′ end 523A8 1 407 AA397592 NA 01 cDNA clone IMAGE: 728546 5′ 171G10 1 409 AA401648 NA 0 2 cDNA cloneIMAGE: 726936 5′ 100F5 42 172 AA402069 NA 4.00E−60 1 cDNA clone IMAGE:727161 5′ 459H7 48 375 AA412436 NA 1.00E−163 1 cDNA clone IMAGE: 7314465′ 102A8 25 120 AA418765 NA 1.00E−46 1 cDNA clone IMAGE: 767795 5′ 73A31 424 AA426506 NA 0 1 cDNA clone IMAGE: 768117 5′ 72E10 1 442 AA427653NA 0 11 tumor NbHOT cDNA clone IMAGE: 770045 5′ 72A1 1 261 AA429783 NA1.00E−142 1 zw57b01.r1 Soares_total_fetus_Nb2HF8_9w cDNA clone 460D12126 388 AA431959 NA 1.00E−93 1 cDNA clone IMAGE: 782188 3′ 450B11 1 437AA454987 NA 0 1 cDNA clone IMAGE: 811916 5′ 518A8 1 329 AA457757 NA1.00E−177 1 fetal retina 937202 cDNA clone IMAGE: 838756 5′ 460F7 47 490AA460876 NA 0 1 zx69d04.r1 Soares_total_fetus_Nb2HF8_9w cDNA clone118H12 1 304 AA476568 NA 1.00E−163 1 zx02f11.r1Soares_total_fetus_Nb2HF8_9w cDNA clone 40F11 1 533 AA479163 NA 0 1 cDNAclone IMAGE: 754246 5′ similar to gb: X15606 470F3 76 356 AA482019 NA1.00E−142 1 cDNA clone IMAGE: 746046 3′ 466C2 1 354 AA490796 NA1.00E−148 1 cDNA clone IMAGE: 82101 5′ 464A9 228 364 AA496483 NA7.00E−71 1 tumor NbHOT cDNA clone IMAGE: 755690 5′ similar to 123D11 99297 AA501725 NA 1.00E−103 1 cDNA clone IMAGE: 929806 similar to containsAlu 119G10 128 374 AA501934 NA 1.00E−134 1 cDNA clone IMAGE: 956346166A11 19 140 AA516406 NA 1.00E−48 1 cDNA clone IMAGE: 923858 3′ 36G1 5480 AA524720 NA 0 1 cDNA clone IMAGE: 937468 3′ 109H9 37 286 AA573427 NA1.00E−130 2 cDNA clone IMAGE: 1028913 3′ 477B2 8 273 AA579400 NA1.00E−143 1 cDNA clone IMAGE: 915561 similar to contains Alu 178C10 1354 AA588755 NA 1.00E−177 1 cDNA clone IMAGE: 1084243 3′ 486G7 35 99AA613460 NA 6.00E−28 1 cDNA clone IMAGE: 1144571 similar to contains472E9 27 389 AA628833 NA 1 .00E−119 1 af37g04.s1Soares_total_fetus_Nb2HF8_9w cDNA clone 100C3 122 505 AA639796 NA 0 1cDNA clone IMAGE: 1159029 3′ 518A7 39 226 AA665359 NA 4.00E−83 1 cDNAclone IMAGE: 1205697 similar to 473D9 377 446 AA683244 NA 1.00E−30 1schizo brain S11 cDNA clone IMAGE: 971252 3′ 523D7 80 502 AA701667 NA1.00E−158 1 zi43g09.s1 Soares_fetal_liver_spleen_1NFLS_S1 cDNA 472B1 37130 AA744774 NA 1.00E−35 1 cDNA clone IMAGE: 1283731 3′ 98C9 10 254AA748714 NA 1.00E−111 1 cDNA clone IMAGE: 1270595 3′ 196D7 3 442AA806222 NA 0 1 cDNA clone IMAGE: 1409989 3′ 118A8 10 381 AA806766 NA 01 cDNA clone IMAGE: 1338727 3′ 98B3 56 159 AA826572 NA 7.00E−47 1 cDNAclone IMAGE: 1416447 3′ 154D9 38 405 AA846378 NA 1.00E−164 1 cDNA cloneIMAGE: 1394232 3′ 459C2 1 491 AA909983 NA 0 2 Soares_NFL_T_GBC_S1 cDNAclone IMAGE: 1523142 3′ 486A7 1 176 AA916990 NA 1.00E−72 1Soares_NFL_T_GBC_S1 cDNA clone IMAGE: 1527333 3′ 460D2 78 537 AA923567NA 0 1 cDNA clone IMAGE: 1536231 3′ 105F4 86 390 AA974839 NA 4.00E−94 1cDNA clone IMAGE: 1567639 3′ 461H7 295 383 AA974991 NA 2.00E−30 1Soares_NFL_T_GBC_S1 cDNA clone IMAGE: 1560953 3′ 162B1 398 470 AA976045NA 9.00E−28 1 cDNA clone IMAGE: 1558392 3′ 53D8 1 422 AA984245 NA1.00E−162 1 schizo brain S11 cDNA clone IMAGE: 1629672 3′ 524A5 35684037 AB020681 NA 0 1 mRNA for KIAA0874 protein, partial cds Length =4440 174H3 81 271 AB021288 NA 1.00E−101 1 mRNA for beta 2-microglobulin,complete cds Length = 925 115A2 1920 2309 AB034747 NA 0 4 SIMPLE mRNAfor small integral membrane protein of lysosome/late endos 39G7 15781920 AB040875 NA 1 .00E−135 3 hxCT mRNA for cystine/glutamate exchanger,complete cds Length = 2000 149H2 430 713 AB044971 NA 1.00E−158 1 mRNAfor nucleolar phosphoprotein Nopp34, complete cds Length = 1005 458F6780 1235 AB045118 NA 0 1 FRAT2 mRNA, complete cds Length = 2164 459D122694 3564 AB045278 NA 0 2 beta3GnT5 mRNA for beta1,3-N-acetylglucosaminyltransferase 5, complete 103H7 1294 1933 AB049881 NA1.00E−139 1 similar to Macaca fascicularis brain cDNA, clone: QnpA 18828Length = 2517 102E11 1142 1772 AB050511 NA 0 1 similar to Macacafascicularis brain cDNA, clone: QnpA- 18828 Length = 2518 460C3 798 930AB050514 NA 9.00E−54 1 similar to Macaca fascicularis brain cDNA, clone:QnpA- 18828 Length = 2519 480A10 4649 5183 AB058677 NA 0 1 mRNA forMEGF11 protein (KIAA1781), complete cds Length = 5702 142G10 2251 2430AB060884 NA 6.00E−44 1 similar to Macaca fascicularis brain cDNA clone:QtrA- 13024, full insert sequence 494G5 1585 1998 AF005213 NA 0 1ankyrin 1 (ANK1) mRNA, complete cds Length = 2651 154C6 520 826 AF005775NA 1.00E−150 3 caspase-like apoptosis regulatory protein 2 (clarp) mRNA,alternativel 186B6 772 1248 AF039575 NA 0 1 heterogeneous nuclearribonucleoprotein D0B mRNA partial cds 471A4 395 611 AF061944 NA6.00E−84 1 kinase deficient protein KDP mRNA, partial cds Length = 265337G5 277 525 AF067529 NA 1.00E−129 1 PITSLRE protein kinase beta SV18isoform (CDC2L2) mRNA, partial cds 479D1 1270 1570 AF070635 NA 1.00E−1441 clone 24818 mRNA sequence Length = 1643 491E2 38 226 AF086214 NA9.00E−74 1 full length insert cDNA clone ZD64D04 Length = 691 517C2 230465 AF086431 NA 1.00E−113 1 full length insert cDNA clone ZD79H10 Length= 530 593C6 1 359 AF113210 NA 0 5 MSTP030 mRNA, complete cds Length =1024 191A8 135 1169 AF113213 NA 0 3 MSTP033 mRNA, complete cds Length =1281 144E9 799 943 AF116679 NA 9.00E−29 1 PRO2003 mRNA, complete cdsLength = 1222 106E3 583 1187 AF116702 NA 0 2 PRO2446 mRNA, complete cdsLength = 1356 72F8 878 1205 AF130094 NA 1.00E−175 1 clone FLC0165 mRNAsequence Length = 1548 458G9 730 1463 AF157116 NA 0 1 clone 274512, mRNAsequence Length = 2172 139F11 18 229 AF161430 NA 1.00E−115 1 HSPC312mRNA, partial cds Length = 360 149H10 406 621 AF161455 NA 3.00E−95 2HSPC337 mRNA, partial cds Length = 1033 68A9 19 243 AF173954 NA 2.00E−271 Cloning vector pGEM-URA3, complete sequence Length = 4350 165B7 65 418AF202092 NA 0 1 PC3-96 mRNA, complete cds Length = 1068 52H1 361 594AF212226 NA 1.00E−34 1 RPL24 mRNA, complete cds Length = 1474 162H8 52404 AF212233 NA 1.00E−179 1 microsomal signal peptidase subunit mRNA,complete cds Length = 794 54E10 680 1316 AF212241 NA 0 3 CDA02 mRNA,complete cds Length = 2179 117D8 2052 2482 AF248648 NA 0 3 RNA-bindingprotein BRUNOL2 mRNA, complete cds Length = 2615 75E3 326 662 AF249845NA 0 2 isolate Siddi 10 hypervariable region 1, mitochondrial sequence459G12 791 1267 AF260237 NA 0 1 hairy/enhancer of split 6 (HES6) mRNA,complete cds Length = 1286 177F6 1968 2423 AF267856 NA 0 1 HT033 mRNA,complete cds Length = 2972 115G8 996 1399 AF267863 NA 0 1 DC43 mRNA,complete cds Length = 2493 501H3 426 1152 AF279437 NA 0 107 interleukin22 (IL22) mRNA, complete cds Length = 1167 174B4 900 1332 AF283771 NA 02 clone TCBAP0774 mRNA sequence Length = 1814 126C7 454 843 AF332864 NA1.00E−116 2 similar to Mus Ras association domain family 3 protein(Rassf3) mRNA 105A9 232 624 AF333025 NA 1.00E−140 1 prokineticin 2precursor (PROK2) mRNA, complete cds Length = 1406 186F1 4543 5058AF347010 NA 0 3 mitochondrion, complete genome Length = 16570 590B124684 5053 AF347013 NA 0 1 mitochondrion, complete genome Length = 16566517H7 4669 5058 AF347015 NA 0 1 mitochondrion, complete genome Length =16571 596E9 220 295 AI027844 NA 3.00E−34 1 cDNA clone IMAGE: 1671612 3′599B3 608 609 AI039890 NA 1.00E−45 1 ox97d11.x1Soares_senescent_fibroblasts_NbHSF cDNA 189H9 22 524 AI041828 NA 0 1oy34b08.x1 Soares_parathyroid_tumor_NbHPA cDNA clone 471F6 63 526AI084224 NA 0 1 cDNA clone IMAGE: 1671418 3′ 142E9 6 372 AI091533 NA1.00E−179 1 oo23d05.x1 Soares_NSF_F8_9W_OT_PA_P_S1 cDNA clone 72D2 65529 AI131018 NA 0 6 qb82e07.x1 Soares_fetal_heart_NbHH19W cDNA clone468F6 9 428 AI223400 NA 0 1 cDNA clone IMAGE: 1838447 3′ similar to TR:O15383 185H1 94 199 AI267714 NA 5.00E−50 1 SB pool 1 cDNA clone IMAGE:2038526 166A9 1 480 AI275205 NA 0 1 cDNA clone IMAGE: 1990616 3′ 499F2 4395 AI281442 NA 0 2 cDNA clone IMAGE: 1967452 3′ 517H5 155 457 AI298509NA 1.00E−158 1 cDNA clone IMAGE: 1896546 3′ 144F7 24 364 AI299573 NA 0 1cDNA clone IMAGE: 1900105 3′ 519E9 52 408 AI352690 NA 1.00E−180 1 cDNAclone IMAGE: 1946884 3′ 466F9 172 440 AI361839 NA 1.00E−109 1 cDNA cloneIMAGE: 2022012 3′ 144C9 118 373 AI362793 NA 7.00E−63 1 cDNA clone IMAGE:2018948 3′ similar to gb: M60854 464B11 19 455 AI363001 NA 0 1 cDNAclone IMAGE: 2018452 3′ similar to contains 127B6 40 257 AI370412 NA6.00E−96 1 cDNA clone IMAGE: 1987587 3′ 166C4 58 271 AI371227 NA1.00E−62 1 cDNA clone IMAGE: 1987633 3′ similar to 467G7 1 450 AI380016NA 0 1 cDNA clone IMAGE: 2109169 3′ similar to 466C5 316 497 AI380390 NA8.00E−44 1 cDNA clone IMAGE: 2107088 3′ 466B5 200 477 AI381586 NA1.00E−126 1 cDNA clone IMAGE: 2074796 3′ 458G10 347 444 AI384128 NA2.00E−40 1 cDNA clone IMAGE: 2088819 3′ similar to contains 467A8 415522 AI391500 NA 1.00E−41 1 cDNA clone IMAGE: 2107686 3′ 477D1 14 269AI392705 NA 1.00E−137 2 cDNA clone IMAGE: 2109581 3′ 467B11 1 293AI393970 NA 1.00E−122 1 cDNA clone IMAGE: 2107950 3′ 522D3 250 526AI419082 NA 1.00E−127 1 cDNA clone IMAGE: 2103029 3′ 149A11 25 313AI440491 NA 1.00E−132 1 cDNA clone IMAGE: 2073277 3′ 471C1 77 215AI458739 NA 1.00E−50 1 cDNA clone IMAGE: 2149471 3′ similar to gb:S85655 116E10 162 503 AI469584 NA 1.00E−171 1 cDNA clone IMAGE: 21565223′ 472C8 1 369 AI498316 NA 0 1 cDNA clone IMAGE: 2160886 3′ similar toTR: Q62717 468E8 2 451 AI523854 NA 3.00E−92 1 cDNA clone IMAGE: 21166833′ 477B5 23 295 AI524624 NA 2.00E−86 1 cDNA clone IMAGE: 2075323 3′193H3 368 489 AI525644 NA 4.00E−34 1 cDNA 5′ 66F1 277 436 AI571519 NA7.00E−84 2 cDNA clone IMAGE: 2225079 3′ similar to gb: J03909 171A11 225429 AI581199 NA 1.00E−101 3 cDNA clone IMAGE: 2154787 3′ similar to116F2 337 429 AI597917 NA 4.00E−42 1 cDNA clone IMAGE: 2258495 3′similar to contains 461G10 9 398 AI627495 NA 1.00E−179 1 cDNA cloneIMAGE: 2285386 3′ 594D11 206 434 AI628930 NA 1.00E−110 1 cDNA cloneIMAGE: 2281541 3′ similar to 489H9 1 507 AI633798 NA 0 4 cDNA cloneIMAGE: 2242115 3′ 171G7 212 431 AI634972 NA 1.00E−103 1 cDNA cloneIMAGE: 2284157 3′ 165C12 270 581 AI651212 NA 1.00E−175 1 cDNA cloneIMAGE: 2304186 3′ 64B3 1 529 AI678099 NA 0 1 Soares_NFL_T_GBC_S1 cDNAclone IMAGE: 2330166 3′ 134H3 186 289 AI684022 NA 1.00E−34 1 cDNA cloneIMAGE: 2267411 3′ 110B8 169 496 AI688560 NA 1.00E−132 1Soares_NFL_T_GBC_S1 cDNA clone IMAGE: 2330535 3′ 459F2 160 542 AI697756NA 0 1 cDNA clone IMAGE: 2341330 3′ 481F11 21 340 AI700738 NA 1.00E−1671 cDNA clone IMAGE: 2343628 3′ 488C5 37 533 AI701165 NA 0 4 cDNA cloneIMAGE: 2340734 3′ 104D9 116 241 AI709236 NA 4.00E−60 1 HPLRB6 cDNA cloneIMAGE: 2353865 3′ similar to 112E1 18 576 AI742850 NA 0 1 wg47a05.x1Soares_NSF_F8_9W_OT_PA_P_S1 cDNA clone 113H12 5 140 AI748827 NA 1.00E−631 HPLRB6 cDNA clone IMAGE: 2356401 3′ 458B8 150 474 AI760353 NA 0 1 cDNAclone IMAGE: 2387703 3′ 461H11 334 578 AI762870 NA 1.00E−111 1 cDNAclone IMAGE: 2397996 3′ 458D10 1 465 AI765153 NA 0 1 cDNA clone IMAGE:2393531 3′ 38B5 2 295 AI766963 NA 1.00E−140 1 cDNA clone IMAGE: 24006933′ 471A2 320 394 AI796317 NA 2.00E−31 1 cDNA clone IMAGE: 2384100 3′74D10 15 377 AI802547 NA 1.00E−124 2 cDNA clone IMAGE: 2186739 3′similarto TR: O15510 482C9 117 409 AI803065 NA 1.00E−164 1 tj47a07.x1Soares_NSF_F8_9W_OT_PA_P_S1 cDNA clone 480C5 177 517 AI807278 NA 0 1Soares_NFL_T_GBC_S1 cDNA clone IMAGE: 2357909 3′ 175B12 228 513 AI817153NA 1.00E−132 1 cDNA clone IMAGE: 2413005 3′ 66E10 14 268 AI858771 NA1.00E−119 1 cDNA clone IMAGE: 2429769 3′ 470H6 65 500 AI880607 NA 0 1HPLRB6 cDNA clone IMAGE: 2355013 3′ 181D12 7 512 AI884548 NA 0 1 cDNAclone IMAGE: 2437818 3′similar to gb: L06797 468H6 52 528 AI884671 NA 01 cDNA clone IMAGE: 2431488 3′ 597C9 284 383 AI904071 NA 1.00E−48 1 cDNA467C2 206 351 AI917642 NA 2.00E−59 1 cDNA clone IMAGE: 2392330 3′ 459D125 575 AI948513 NA 0 1 cDNA clone IMAGE: 2470532 3′ 166E11 152 280AI954499 NA 4.00E−54 1 cDNA clone IMAGE: 2550263 3′ 493D7 2032 2171AJ001235 NA 4.00E−29 1 similar to Papio hamadryas ERV-9 like LTRinsertion Length = 2240 116B1 1169 1744 AJ009771 NA 0 1 mRNA forputative RING finger protein, partial Length = 3038 137B9 296 407AJ271637 NA 4.00E−32 1 similar to Elaeis guineensis microsatellite DNA,clone mEgCIR0219 483E6 4250 4492 AJ278191 NA 1.00E−95 1 similar to Musmusculus mRNA for putative mc7 protein (mc7 gene) 144A8 988 1152AK001163 NA 1.00E−75 1 cDNA FLJ10301 fis, clone NT2RM2000032 Length =1298 525C11 49 496 AK001451 NA 0 1 cDNA FLJ10589 fis, clone NT2RP2004389177D9 707 980 AK004265 NA 7.00E−76 1 similar to Mus 18 days embryo cDNA,RIKEN full- length enriched library, 111E10 777 1121 AK004400 NA1.00E−112 1 similar to Mus 18 days embryo cDNA, RIKEN full- lengthenriched library, 458G4 650 1259 AK008020 NA 8.00E−86 1 similar to Musadult male small intestine cDNA, RIKEN full-length enrich 47G7 31 328AK009988 NA 1.00E−111 1 similar to Mus adult male tongue cDNA, RIKENfull- length enriched librar 69G7 1801 1987 AK012426 NA 5.00E−68 3similar to Mus 11 days embryo cDNA, RIKEN full- length enriched library,62C10 1092 1267 AK013164 NA 6.00E−46 2 similar to Mus 10, 11 days embryocDNA, RIKEN full- length enriched libra 46D9 3243 3564 AK014408 NA1.00E−104 1 similar to Mus 12 days embryo embryonic body below diaphragmregion 1078C11 2069 2326 AK016683 NA 9.00E−83 1 similar to Mus adultmale testis cDNA, RIKEN full- length enriched librar 102C12 698 1339AK018758 NA 0 1 similar to Mus adult male liver cDNA, RIKEN full- lengthenriched library 585B3 1278 1873 AK021925 NA 0 1 cDNA FLJ11863 fis,clone HEMBA1006926 Length = 2029 46F3 1377 2006 AK022057 NA 0 1 cDNAFLJ11995 fis, clone HEMBB1001443, highly similar to Rattus norveg 73E7344 1112 AK023512 NA 0 9 cDNA FLJ13450 fis, clone PLACE1003027, highlysimilar to Homo sapiens 465B12 681 1338 AK024202 NA 0 1 cDNA FLJ14140fis, clone MAMMA1002858, highly similar to Rat cMG1 142D12 254 358AK024740 NA 9.00E−27 1 cDNA: FLJ21087 fis, clone CAS03323 Length = 826472F7 1330 1623 AK024764 NA 1.00E−164 1 cDNA: FLJ21111 fis, cloneCAS05384, highly similar to AF144700 Homo sa 521A3 26 195 AK024976 NA2.00E−90 1 cDNA: FLJ21323 fis, clone COL02374 Length = 1348 465D1 20912255 AK025769 NA 1.00E−74 1 cDNA: FLJ22116 fis, clone HEP18520 Length =2271 595E9 16 546 AK026264 NA 0 1 cDNA: FLJ22611 fis, clone HSI04961Length = 1426 103E1 1353 1866 AK026334 NA 1.00E−126 1 cDNA: FLJ22681fis, clone HSI10693 Length = 1903 524F3 1635 1742 AK026443 NA 9.00E−51 2cDNA: FLJ22790 fis, clone KAIA2176, highly similar to HUMPMCA 196H10 9381286 AK026819 NA 6.00E−82 1 cDNA: FLJ23166 fis, clone LNG09880 Length =1941 172F7 349 738 AK027258 NA 0 1 cDNA: FLJ23605 fis, clone LNG15982,highly similar to AF113539 Homo sa 187B10 1583 2142 AK027260 NA1.00E−129 1 cDNA: FLJ23607 fis, clone LNG16050 Length = 2560 190F11 76636 AL042081 NA 0 1 (synonym: htes3) cDNA clone DKFZp434P171 3′ 525A9 1653 AL042370 NA 0 1 (synonym: htes3) cDNA clone DKFZp434A1821 5′ 464G859 686 AL042376 NA 0 1 (synonym: htes3) cDNA clone DKFZp434A2421 5′172B12 380 624 AL047171 NA 1.00E−131 1 (synonym: hute1) cDNA cloneDKFZp586F2018 5′ 193F3 915 1309 AL049305 NA 1.00E−133 1 mRNA; cDNADKFZp564A186 (from clone DKFZp564A186) Length = 1669 111H8 102 660AL049356 NA 1.00E−146 1 mRNA; cDNA DKFZp566E233 (from cloneDKFZp566E233) Length = 808 526E6 118 551 AL049932 NA 1.00E−147 2 mRNA;cDNA DKFZp564H2416 (from clone DKFZp564H2416) Length = 1865 37C8 707 996AL050218 NA 1.00E−156 1 mRNA; cDNA DKFZp586I0923 (from cloneDKFZp58610923) Length = 1282 72A9 1235 1391 AL110164 NA 2.00E−70 1 mRNA;cDNA DKFZp586I0324 (from clone DKFZp586I0324) Length = 1705 107C8 10421398 AL117644 NA 0 2 mRNA; cDNA DKFZp434M095 (from clone DKFZp434M095)Length = 1455 62E7 1 475 AL120453 NA 1.00E−117 1 (synonym: hamy2) cDNAclone DKFZp761I208 5′ 492A7 77 390 AL121406 NA 1.00E−101 1 (synonym:hmel2) cDNA clone DKFZp762G117 5′ 598B1 443 812 AL133879 NA 1.00E−172 1(synonym: hamy2) cDNA clone DKFZp761J0114 5′ 458C10 47 351 AL133913 NA5.00E−76 1 (synonym: hamy2) cDNA clone DKFZp761M2014 5′ 98E7 922 2284AL136558 NA 0 6 mRNA; cDNA DKFZp761B1514 (from clone DKFZp761B1514)Length = 3453 157F6 3511 3847 AL136797 NA 0 1 mRNA; cDNA DKFZp434N031(from clone DKFZp434N031); complete cds 68B4 1009 1595 AL136932 NA 0 1mRNA; cDNA DKFZp586H1322 (from clone DKFZp586H1322); complete cds 458B6278 955 AL137601 NA 0 1 mRNA; cDNA DKFZp434E0811 (from cloneDKFZp434E0811); partial cds 172C9 1866 2423 AL137608 NA 0 1 mRNA; cDNADKFZp434J1111 (from clone DKFZp434J1111); partial cds 72G1 194 474AL138429 NA 1.00E−151 1 (synonym: htes3) cDNA clone DKFZp434E0629 3′463H12 12 356 AL513780 NA 1.00E−124 1 cDNA clone CL0BA003ZF07 5 prime181B6 43 638 AL520535 NA 0 1 cDNA clone CS0DB006YD20 3 prime 69B6 352858 AL520892 NA 0 1 cDNA clone CS0DB002YG16 5 prime 182A5 119 617AL521097 NA 0 1 cDNA clone CS0DB001YA13 3 prime 458E9 3 865 AL528020 NA0 2 cDNA clone CS0DC028YO09 3 prime 485C11 1 431 AL532303 NA 0 1 cDNAclone CS0DM014YJ04 5 prime 196G3 78 698 AL532406 NA 0 1 cDNA cloneCS0DM014YL03 5 prime 105H4 154 486 AL533737 NA 1.00E−156 1 cDNA cloneCS0DF002YH09 5 prime 594G1 337 756 AL534564 NA 0 1 cDNA cloneCS0DF004YI09 5 prime 524A9 403 906 AL540260 NA 0 1 cDNA cloneCS0DF032YF03 3 prime 118H5 433 532 AL540399 NA 4.00E−39 1 cDNA cloneCS0DE001YM08 5 prime 124C2 270 815 AL543900 NA 0 1 cDNA cloneCS0DI005YK13 3 prime 471D3 216 403 AL550229 NA 9.00E−49 1 cDNA cloneCS0DI039YD11 5 prime 191F2 324 844 AL554506 NA 0 1 cDNA cloneCS0DI083YJ17 5 prime 166F6 64 576 AL556016 NA 0 1 cDNA cloneCS0DK010YH04 5 prime 467G9 61 401 AL556919 NA 1.00E−138 1 cDNA cloneCS0DK012YI02 5 prime 37D7 149 685 AL559029 NA 0 1 cDNA cloneCS0DJ010YJ11 5 prime 590B3 76 287 AL559422 NA 1.00E−111 2 cDNA cloneCS0DJ013YN07 5 prime 181H2 168 780 AL559555 NA 0 1 cDNA cloneCS0DJ013YP21 5 prime 589E3 28 447 AL561074 NA 0 1 cDNA cloneCS0DL001YN01 5 prime 487F9 326 739 AL561892 NA 1.00E−149 1 cDNA cloneCS0DB006YL04 3 prime 68F10 12 658 AL562895 NA 0 1 cDNA cloneCS0DC021YO20 3 prime 157D7 2 108 AL565736 NA 1.00E−28 1 cDNA cloneCS0DF007YC06 3 prime 177B1 231 505 AL567986 NA 1.00E−128 1 cDNA cloneCS0DF036YI04 3 prime 512E3 627 815 AL575666 NA 1.00E−94 1 cDNA cloneCS0DI069YD02 3 prime 112E10 193 623 AL575755 NA 0 1 cDNA cloneCS0DI070YG17 3 prime 70H7 197 757 AL576149 NA 0 1 cDNA cloneCS0DI072YK21 3 prime 37F1 275 411 AL577970 NA 1.00E−43 1 cDNA cloneCS0DK008YK22 3 prime 65D4 278 828 AL578975 NA 0 1 cDNA cloneCS0DK012YN01 3 prime 182G2 70 684 AL579745 NA 0 1 cDNA cloneCS0DJ003YG20 5 prime 194F9 450 669 AL582354 NA 3.00E−94 1 cDNA cloneCS0DL006YH05 3 prime 184F2 27 501 AL583322 NA 2.00E−37 1 cDNA cloneCS0DL012YI10 5 prime 40A3 432 638 AL583391 NA 4.00E−83 1 cDNA cloneCS0DL012YA12 3 prime 53G7 6 462 AU117298 NA 0 1 sapiens cDNA cloneHEMBA1001091 5′ 37G7 218 706 AU118159 NA 0 1 sapiens cDNA cloneHEMBA1002998 5′ 180F9 174 698 AU120731 NA 0 1 sapiens cDNA cloneHEMBB1001298 5′ 191F1 298 608 AU135154 NA 1.00E−137 1 sapiens cDNA clonePLACE1001348 5′ 466G7 11 125 AU158636 NA 1.00E−53 1 sapiens cDNA clonePLACE4000063 3′ 67F9 1 453 AV648670 NA 0 2 cDNA clone GLCBLH08 3′ 155D697 337 AV650434 NA 1.00E−104 1 cDNA clone GLCCEG06 3′ 596H6 1 397AV651615 NA 0 1 cDNA clone GLCCRF09 3′ 99D5 41 232 AV653169 NA 6.00E−781 cDNA clone GLCDIB01 3′ 331C10 33 365 AV654188 NA 1.00E−103 6 cDNAclone GLCDTC01 3′ 121A12 70 188 AV659358 NA 3.00E−47 1 cDNA cloneGLCFWC05 3′ 460G9 69 476 AV687530 NA 0 1 cDNA clone GKCATH08 5′ 470F5 1174 AV689330 NA 2.00E−50 1 cDNA clone GKCDJE03 5′ 109E8 71 471 AV705900NA 0 1 cDNA clone ADBBFE11 5′ 166C9 121 226 AV709955 NA 2.00E−26 1 cDNAclone ADCABF08 5′ 117F1 69 582 AV710415 NA 0 1 cDNA clone CuAAND10 5′523C9 41 536 AV716565 NA 0 6 cDNA clone DCBCAF01 5′ 103D7 1 164 AV716644NA 3.00E−77 2 cDNA clone DCBAUG10 5′ 195F11 232 459 AV716791 NA1.00E−113 2 cDNA clone DCBAZC04 5′ 63C4 208 421 AV719659 NA 1.00E−101 1cDNA clone GLCGRA09 5′ 496C4 156 563 AV719938 NA 0 1 cDNA clone GLCFUC085′ 479A1 120 469 AV720984 NA 1.00E−162 1 cDNA clone HTBBIC02 5′ 499D6 70406 AV721008 NA 1.00E−112 4 cDNA clone HTBBHG03 5′ 461C8 182 676AV723437 NA 0 1 cDNA clone HTBBUE10 5′ 585G1 173 552 AV724531 NA 0 1cDNA clone HTBARD04 5′ 113B8 1 149 AV724559 NA 3.00E−40 1 cDNA cloneHTBCFB08 5′ 111H4 497 498 AV724665 NA 0 1 cDNA clone HTBAYG03 5′ 458F5 1534 AV730135 NA 0 1 cDNA clone HTFAHA06 5′ 589F6 21 226 AV735258 NA6.00E−70 1 cDNA clone cdAAIF03 5′ 172C8 209 426 AV738173 NA 9.00E−98 1cDNA clone CBMAHC04 5′ 464G3 43 498 AV743635 NA 0 1 cDNA clone CBLBAC035′ 72D4 43 384 AV745692 NA 1.00E−178 2 cDNA clone NPAACB06 5′ 592G12 175571 AV749844 NA 1.00E−176 1 cDNA clone NPCBVG08 5′ 169F6 110 250AV755117 NA 3.00E−28 1 cDNA cloneTPAABA12 5′ 99H3 200 513 AV755367 NA1.00E−131 2 cDNA clone BMFAIB02 5′ 595G9 399 549 AV756188 NA 2.00E−31 1cDNA clone BMFABD08 5′ 595A12 8 572 AW002985 NA 0 2 cDNA clone IMAGE:2475831 3′ 586B7 184 330 AW004905 NA 8.00E−50 1 cDNA clone IMAGE:2565317 3′ similar to 591D6 15 436 AW021037 NA 0 1 Cochlea cDNA cloneIMAGE: 2483601 5′ 188F1 135 476 AW021551 NA 0 1 Cochlea cDNA cloneIMAGE: 2484414 5′ 467E8 73 474 AW027160 NA 1.00E−162 1Soares_thymus_NHFTh cDNA clone IMAGE: 2512983 3′ similar to 472G2 11 110AW064187 NA 9.00E−38 1 CD4 intrathymic T-cell cDNA library cDNA 3′ 598F343 453 AW071894 NA 0 1 cDNA clone IMAGE: 2501169 3′ 181C7 10 96 AW131768NA 8.00E−41 1 cDNA clone IMAGE: 2619947 3′ 181D1 69 216 AW134512 NA2.00E−77 1 UI-H-BI1-abv-e-05-0-UI.s1 NCI_CGAP_Sub3 cDNA clone IMAGE:2713065 3′ 472B10 339 458 AW136717 NA 4.00E−54 1UI-H-BI1-adm-a-03-0-UI.s1 NCI_CGAP_Sub3 cDNA clone IMAGE: 2717092 3′166B9 240 408 AW137104 NA 6.00E−88 1 UI-H-BI1-acp-e-02-0-UI.s1NCI_CGAP_Sub3 cDNA clone IMAGE: 2714979 3′ 188C1 323 461 AW137149 NA2.00E−72 1 UI-H-BI1-acq-a-05-0-UI.s1 NCI_CGAP_Sub3 cDNA clone IMAGE:2715152 3′ 65B2 106 298 AW148765 NA 7.00E−75 1 cDNA clone IMAGE: 26169153′ 524C3 234 429 AW151854 NA 1.00E−76 2 cDNA clone IMAGE: 2623546 3′similar to 479A8 6 327 AW161820 NA 1.00E−151 1 brain 00004 cDNA cloneIMAGE: 2781653 3′ 585E10 7 391 AW166442 NA 0 1 Soares_NHCe_cervix cDNAclone IMAGE: 269740 3′ 482C6 9 329 AW188398 NA 1.00E−133 1 cDNA cloneIMAGE: 2665252 3′ 522G11 39 516 AW248322 NA 0 1 cDNA clone IMAGE:2820662 5′ 473D5 283 416 AW274156 NA 4.00E−69 1 Soares_NFL_T_GBC_S1 cDNAclone IMAGE: 2814367 3′ 71C12 20 530 AW293159 NA 0 2UI-H-BW0-aii-b-08-0-UI.s1 NCI_CGAP_Sub6 cDNA clone IMAGE: 2729414 3′472H11 205 501 AW293424 NA 1.00E−151 1 UI-H-BI2-ahm-a-12-0-UI.s1NCI_CGAP_Sub4 cDNA clone IMAGE: 2727094 3′ 465H11 17 124 AW293426 NA1.00E−48 1 UI-H-BI2-ahm-b-02-0-UI.s1 NCI_CGAP_Sub4 cDNA clone IMAGE:2727122 3′ 461H8 19 452 AW295965 NA 0 1 UI-H-BI2-ahh-f-07-0-UI.s1NCI_CGAP_Sub4 cDNA clone IMAGE: 2726917 3′ 464B7 250 551 AW300500 NA3.00E−95 1 cDNA clone IMAGE: 2774602 3′ 465C7 1 322 AW338115 NA 0 1 cDNAclone IMAGE: 2833029 3′ 466H5 10 523 AW341449 NA 0 1 Soares_NFL_T_GBC_S1cDNA clone IMAGE: 2909026 3′ similar to 461D9 12 325 AW379049 NA1.00E−134 1 HT0230 cDNA 186E8 51 277 AW380881 NA 1.00E−103 1 HT0283 cDNA180D4 260 348 AW384988 NA 2.00E−30 1 HT0427 cDNA 472C1 13 404 AW390233NA 1.00E−122 1 ST0181 cDNA 462G12 236 321 AW402007 NA 3.00E−40 1UI-HF-BK0-aao-g-02-0-UI.r1 NIH_MGC_36 cDNA clone IMAGE: 3054530 5′ 177H218 338 AW405863 NA 9.00E−52 1 UI-HF-BL0-acf-e-06-0-UI.r1 NIH_MGC_37 cDNAclone IMAGE: 3059026 5′ 140G10 6 308 AW440517 NA 1.00E−152 1 cDNA cloneIMAGE: 2890615 3′ 482A10 1 231 AW440869 NA 1.00E−114 1 cDNA clone IMAGE:2918151 3′ similar to contains 40B2 18 353 AW444632 NA 4.00E−45 1UI-H-BI3-ajw-b-11-0-UI.s1 NCI_CGAP_Sub5 cDNA clone IMAGE: 2733260 3′61C2 21 392 AW444812 NA 0 1 UI-H-BI3-ajy-d-11-0-UI.s1 NCI_CGAP_Sub5 cDNAclone IMAGE: 2733380 3′ 461H10 151 248 AW449610 NA 8.00E−48 1UI-H-BI3-aku-g-11-0-UI.s1 NCI_CGAP_Sub5 cDNA clone IMAGE: 2735804 3′479E10 9 425 AW451293 NA 0 1 UI-H-BI3-alh-f-06-0-UI.s1 NCI_CGAP_Sub5cDNA clone IMAGE: 2736899 3′ 489G6 16 303 AW452023 NA 1.00E−125 1UI-H-BI3-alm-f-06-0-UI.s1 NCI_CGAP_Sub5 cDNA clone IMAGE: 2737306 3′463H8 99 289 AW452096 NA 1.00E−103 1 UI-H-BI3-alo-d-02-0-UI.s1NCI_CGAP_Sub5 cDNA clone IMAGE: 3068186 3′ 459B8 71 535 AW499658 NA 0 1UI-HF-BR0p-ajj-c-07-0-UI.r1 NIH_MGC_52 cDNA clone IMAGE: 3074677 5′ 37A2128 395 AW499828 NA 1.00E9−110 I UI-HF-BN0-ake-c-06-0-UI.rl NIH_MGC_50cDNA clone IMAGE: 3076619 5′ 112E5 88 557 AW499829 NA 0 1UI-HF-BN0-ake-c-07-0-UI.r1 NIH_MGC_50 cDNA clone IMAGE: 3076621 5′ 523F5435 517 AW500534 NA 4.00E−36 1 UI-HF-BN0-akj-d-04-0-UI.r1 NIH_MGC_50cDNA clone IMAGE: 3077406 5′ 476E10 152 450 AW501528 NA 1.00E−129 1UI-HF-BP0p-ajf-c-02-0-UI.r1 NIH_MGC_51 cDNA clone IMAGE: 3073923 5′67D10 36 413 AW504212 NA 0 1 UI-HF-BN0-alp-a-11-0-UI.r1 NIH_MGC_50 cDNAclone IMAGE: 3080348 5′ 100E10 29 364 AW504293 NA 1.00E−159 1UI-HF-BN0-alg-b-10-0-UI.r1 NIH_MGC_50 cDNA clone IMAGE: 3079267 5′484D12 35 353 AW510795 NA 1.00E−167 1 Soares_NFL_T_GBC_S1 cDNA cloneIMAGE: 2911933 3′ similar to 480B2 109 446 AW572538 NA 1.00E−162 1 cDNAclone IMAGE: 2832030 3′ 465D2 272 464 AW573211 NA 2.00E−49 1Soares_NFL_T_GBC_S1 cDNA clone IMAGE: 2933767 3′ similar to 47G6 125 126AW614193 NA 1.00E−51 1 cDNA clone IMAGE: 2951662 3′ 499D7 1 341 AW630825NA 0 2 cDNA clone IMAGE: 2969854 5′ 62H5 10 423 AW651682 NA 0 2 cDNAclone IMAGE: 2901099 5′ 104A7 3 461 AW778854 NA 0 1 cDNA clone IMAGE:3037337 3′ 484H1 9 453 AW780057 NA 0 1 cDNA clone IMAGE: 3036046 3′491E8 18 348 AW792856 NA 1.00E−164 2 UM0001 cDNA 65D11 64 648 AW810442NA 0 3 ST0125 cDNA 596F6 49 623 AW813133 NA 0 1 ST0189 cDNA 518H1 131386 AW819894 NA 1.00E−133 1 ST0294 cDNA 115A7 1 315 AW836389 NA1.00E−169 3 LT0030 cDNA 486D9 32 237 AW837717 NA 1.00E−65 1 LT0042 cDNA477B12 84 253 AW837808 NA 4.00E−67 1 LT0042 cDNA 121A11 253 444 AW842489NA 1.00E−98 1 CN0032 cDNA 472E6 132 447 AW846856 NA 1.00E−149 1 CT0195cDNA 164F9 1 462 AW856490 NA 0 1 CT0290 cDNA 103C4 23 366 AW859565 NA 01 CT0355 cDNA 129D3 81 295 AW866426 NA 1.00E−108 1 SN0024 cDNA 501F9 88421 AW873028 NA 1.00E−170 3 cDNA clone IMAGE: 3120038 3′ 98G4 1 294AW873326 NA 1.00E−107 1 cDNA clone IMAGE: 3009400 3′ 72D5 55 648AW886511 NA 0 1 OT0083 cDNA 460A5 101 294 AW891344 NA 1.00E−102 1 NT0079cDNA 459E9 196 260 AW945538 NA 8.00E−28 1 EN0024 cDNA 479H5 17 224AW948395 NA 1.00E−102 1 FN0040 cDNA 165E7 2 599 AW949461 NA 0 1 MAGAcDNA 123G9 104 715 AW954112 NA 0 2 MAGC cDNA 183F3 84 503 AW954476 NA1.00E−159 1 MAGC cDNA 196C6 8 189 AW954580 NA 5.00E−98 1 MAGC cDNA515H10 1 512 AW955265 NA 0 1 MAGC cDNA 41E8 16 671 AW957139 NA 1.00E−1452 MAGD cDNA 66A7 335 503 AW958538 NA 4.00E−85 1 MAGE cDNA 465G8 169 615AW960484 NA 0 1 MAGF cDNA 519E6 44 290 AW960593 NA 1.00E−134 1 MAGF cDNA594F4 306 571 AW963171 NA 1.00E−112 1 MAGH cDNA 155B2 30 673 AW964218 NA0 3 MAGH cDNA 173B5 1 553 AW965078 NA 0 1 MAGI cDNA 176A6 7 312 AW965490NA 1.00E−136 1 MAGI cDNA 498H9 1 456 AW965987 NA 0 2 MAGI cDNA 517D11105 484 AW966098 NA 0 2 MAGI cDNA 166H7 63 559 AW967388 NA 0 1 MAGJ cDNA462C8 69 212 AW967948 NA 2.00E−72 1 MAGJ cDNA 189C5 8 566 AW968561 NA 01 MAGJ cDNA 459C3 129 587 AW969359 NA 0 2 MAGK cDNA 174C1 155 527AW969546 NA 1.00E−170 1 MAGK cDNA 191F6 158 543 AW973953 NA 1.00E−152 2MAGM cDNA 461G9 311 437 AW974749 NA 7.00E−47 1 MAGN cDNA 104D1 182 594AW993791 NA 0 1 BN0034 cDNA 188F5 734 1292 AY007110 NA 0 4 cloneTCCCTA00084 mRNA sequence Length = 1656 48D7 692 1169 AY029066 NA1.00E−76 4 Humanin (HN1) mRNA, complete cds Length = 1567 55B8 1802 2045BC000141 NA 3.00E−96 1 Similar to myelocytomatosis oncogene, clone MGC:5183, mRNA 37A8 34 301 BC000374 NA 1.00E−101 1 ribosomal protein L18,clone MGC: 8373, mRNA, complete cds 178E5 20 551 BC000408 NA 5.00E−53 1acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase596G2 27 263 BC000449 NA 3.00E−43 2 Similar to ubiquitin C, clone MGC:8448, mRNA, complete cds 179A3 693 1002 BC000514 NA 1.00E−160 3ribosomal protein L13a, clone MGC: 8547, mRNA, complete cds 158F10 169522 BC000523 NA 1.00E−157 1 Similar to ribosomal protein S24, clone MGC:8595, mRNA, complete cds 515G5 34 270 BC000530 NA 7.00E−38 1 ribosomalprotein L19, clone MGC: 8653, mRNA, complete cds 39B6 286 1073 BC000590NA 0 9 actin related protein 2/3 complex, subunit 2 (34 kD), clone MGC:1416, 169A4 929 1314 BC000672 NA 0 1 guanine nucleotide binding protein(G protein), beta polypeptide 2-lik 166H4 1350 1745 BC000771 NA1.00E−169 8 Similar to tropomyosin 4, clone MGC: 3261, mRNA, completecds 331F9 482 949 BC000967 NA 0 1 clone IMAGE: 3449287, mRNA, partialcds Length = 2156 526C6 633 829 BC001169 NA 1.00E−100 1 Similar toesterase 10, clone MGC: 1873, mRNA, complete cds 135G12 1598 1766BC001303 NA 6.00E−42 1 Similar to splicing factor, arginine/serine-rich2 (SC- 35), clone MGC: 491C6 613 714 BC001385 NA 3.00E−34 1 Similar toleucine rich repeat (in FLII) interacting protein 1, clone 108D10 234641 BC001399 NA 2.00E−79 1 ferritin, heavy polypeptide 1, clone MGC:1749, mRNA, complete cds 196H5 1387 1899 BC001412 NA 6.00E−55 4eukaryotic translation elongation factor 1 alpha 1, clone MGC: 1332, mR460F5 973 1350 BC001413 NA 0 1 clone IMAGE: 3140866, mRNA Length = 1634520C5 348 472 BC001632 NA 5.00E−34 1 Similar to NADH dehydrogenase(ubiquinone) flavoprotein 2 (24 kD), clon 520D10 1729 2205 BC001637 NA 02 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit524A1 564 922 BC001660 NA 1.00E−94 2 ribonuclease 6 precursor, cloneMGC: 1360, mRNA, complete cds 121E7 275 381 BC001697 NA 2.00E−26 1Similar to ribosomal protein S15a, clone MGC: 2466, mRNA, complete cds109D1 2441 2835 BC001798 NA 1.00E−123 1 clone MGC: 3157, mRNA, completecds Length = 3041 180D9 741 921 BC001819 NA 5.00E−85 2 ribonuclease 6precursor, clone MGC: 3554, mRNA, complete cds 72H5 1264 2808 BC001854NA 0 8 methionine adenosyltransferase II, alpha, clone MGC: 4537, mRNA,comple 167H8 1099 1436 BC002409 NA 1.00E−49 1 actin, beta, clone MGC:8647, mRNA, complete cds Length = 1858 53H1 2398 2513 BC002538 NA3.00E−41 1 serine (or cysteine) proteinase inhibitor, clade B(ovalbumin), member 125B3 246 585 BC002711 NA 1.00E−40 1 cell divisioncycle 42 (GTP-binding protein, 25 kD), clone MGC: 3497, mR 331H8 201 557BC002837 NA 0 1 clone MGC: 4175, mRNA, complete cds Length = 1092 150C41699 2040 BC002845 NA 8.00E−29 1 eukaryotic translation elongationfactor 1 alpha 1, clone MGC: 3711, mR 70D7 345 850 BC002900 NA 0 1Similar to proteasome (prosome, macropain) subunit, alpha type, 2, clo476B5 1431 1761 BC002929 NA 1.00E−141 1 clone IMAGE: 3954899, mRNA,partial cds Length = 2467 38D7 200 688 BC002971 NA 0 2 clone IMAGE:3543711, mRNA, partial cds Length = 1934 74A11 652 1724 BC003063 NA 0 5Similar to likely ortholog of yeast ARV1, clone IMAGE: 3506392, mRNA105H12 1148 1370 BC003090 NA 1.00E−105 1 COP9 homolog, clone MGC: 1297,mRNA, complete cds Length = 1637 50F4 8 301 BC003137 NA 1.00E−115 1ribosomal protein S3, clone MGC: 3657, mRNA, complete cds 175G9 93 216BC003352 NA 1.00E−33 1 tumor protein, translationally-controlled 1,clone MGC: 5308, mRNA, com 587E9 72 554 BC003358 NA 4.00E−60 2 ribosomalprotein L10, clone MGC: 5189, mRNA, complete cds 71F8 491 911 BC003406NA 0 1 cytidine monophosphate-N-acetylneuraminic acid hydroxylase(CMP-N-acet 512E11 308 372 BC003563 NA 2.00E−27 1 guanine nucleotidebinding protein (G protein), gamma 5, clone MGC: 196 118B11 76 343BC003577 NA 1.00E−111 1 clone IMAGE: 3544292, mRNA, partial cds Length =826 107E3 9 634 BC003697 NA 0 1 clone MGC: 5564, mRNA, complete cdsLength = 2145 128D4 1408 1550 BC004186 NA 1.00E−34 1 guanine nucleotidebinding protein, beta 1, clone MGC: 2819, mRNA, comp 58H6 554 859BC004245 NA 1.00E−171 2 ferritin, light polypeptide, clone MGC: 10465,mRNA, complete cds 481D8 134 460 BC004258 NA 6.00E−73 1 hypotheticalprotein PRO1741, clone MGC: 10753, mRNA, complete cds 520F6 160 1400BC004317 NA 0 3 clone MGC: 10924, mRNA, complete cds Length = 1837 489G7511 787 BC004458 NA 2.00E−60 1 enolase 1, (alpha), clone MGC: 4315,mRNA, complete cds 115B8 1162 1640 BC004521 NA 0 2 ATP synthase, H+transporting, mitochondrial F1 complex, alpha subunit 118A2 1126 1369BC004805 NA 4.00E−38 1 similar to Mus musculus, clone IMAGE: 3584831,mRNA Length = 1910 73D2 1174 1751 BC004872 NA 0 1 clone MGC: 11034,mRNA, complete cds Length = 2471 522E3 681 993 BC004900 NA 1.00E−175 10ribosomal protein L13a, clone IMAGE: 3545758, mRNA, partial cds 55G12 1232 BC004928 NA 3.00E−68 1 clone MGC: 10493, mRNA, complete cds Length =2567 520C2 3 139 BC004994 NA 1.00E−31 1 myosin regulatory light chain,clone MGC: 4405, mRNA, complete cds 460H4 1577 1923 BC005101 NA 0 1clone IMAGE: 3618561, mRNA Length = 2113 154F12 122 283 BC005128 NA2.00E−46 1 ribosomal protein L7a, clone MGC: 10607, mRNA, complete cds592C8 647 925 BC005187 NA 2.00E−32 1 Similar to hypothetical protein,clone MGC: 12182, mRNA, complete cds 591D1 726 837 BC005361 NA 5.00E−311 proteasome (prosome, macropain) subunit, alpha type, 4, clone MGC:1246 458A7 1307 1568 BC005816 NA 4.00E−98 1 Similar to deltex(Drosophila) homolog 1, clone IMAGE: 3688330, mRNA, p 122C6 263 378BC005928 NA 1.00E−29 1 S100 calcium-binding protein A8 (calgranulin A),clone MGC: 14536, mRNA 47H11 273 854 BC006008 NA 0 1 clone IMAGE:4285740, mRNA Length = 1040 598E1 850 1226 BC006176 NA 0 2 clone IMAGE:4054156, mRNA, partial cds Length = 1423 175A1 570 887 BC006282 NA1.00E−161 1 Similar to RIKEN cDNA 1110020N13 gene, clone MGC: 10540150H12 543 1098 BC006464 NA 0 1 calmodulin 2 (phosphorylase kinase,delta), clone MGC: 2168 583E5 980 1246 BC006849 NA 1.00E−127 1 Similarto RIKEN cDNA 2410044K02 gene, clone MGC: 5469 41H7 619 1308 BC007004 NA0 2 Similar to oxysterol-binding protein-related protein 1, clone IMAGE:40 56C12 13 187 BC007063 NA 6.00E−27 1 peroxiredoxin 1, clone MGC:12514, mRNA, complete cds Length = 973 183C11 2986 3328 BC007203 NA1.00E−169 1 hypothetical protein MGC10823, clone MGC: 12957, mRNA,complete cds 109H10 1343 1627 BC007277 NA 1.00E−156 1 Similar to RIKENcDNA 0610039P13 gene, clone MGC: 15619, mRNA 588E11 423 1324 BC007299 NA0 3 Similar to ATP synthase, H+ transporting, mitochondrial F1 complex,al 164F12 72 336 BE002854 NA 1.00E−147 1 BN0090 cDNA 106A12 22 608BE005703 NA 0 1 BN0120 cDNA 472E11 168 297 BE044364 NA 1.00E−66 1Soares_NFL_T_GBC_S1 cDNA clone IMAGE: 3040218 3′ 458H11 2 510 BE049439NA 0 1 cDNA clone IMAGE: 2834924 3′ 46F7 18 527 BE061115 NA 0 1 BT0041cDNA 105A8 1 166 BE085539 NA 3.00E−74 1 BT0669 cDNA 467F5 27 247BE086076 NA 1.00E−115 1 BT0672 cDNA 469B6 5 188 BE091932 NA 6.00E−87 1BT0733 cDNA 66D7 18 568 BE160822 NA 0 1 HT0422 cDNA 593F8 110 451BE163106 NA 1.00E−165 1 HT0457 cDNA 468B10 1 461 BE168334 NA 0 1 HT0514cDNA 192E1 1 602 BE176373 NA 0 1 HT0585 cDNA 109A9 100 377 BE177661 NA1.00E−129 1 HT0598 cDNA 468B9 27 145 BE178880 NA 3.00E−31 1 HT0609 cDNA526E11 6 222 BE217848 NA 1.00E−118 3 cDNA clone IMAGE: 3174941 3′ 115H2226 227 BE218938 NA 2.00E−97 1 cDNA clone IMAGE: 3176478 3′ 126B3 1 509BE222301 NA 1.00E−151 1 cDNA clone IMAGE: 3166180 3′ 195F2 123 470BE222392 NA 4.00E−91 1 cDNA clone IMAGE: 3166335 3′ 170F7 1 375 BE242649NA 0 1 acute myelogenous leukemia cell (FAB M1) Baylor- HGSC 459F10 35432 BE247056 NA 5.00E−84 1 cell acute lymphoblastic leukemia Baylor-HGSCproject = TCBA 491G11 269 516 BE253336 NA 1.00E−116 1 cDNA clone IMAGE:3357826 5′ 471H10 140 202 BE254064 NA 2.00E−26 1 cDNA clone IMAGE:3354554 5′ 521H9 22 605 BE292793 NA 0 2 cDNA clone IMAGE: 2987838 5′472A9 33 436 BE297329 NA 0 1 cDNA clone IMAGE: 3532809 5′ 99E10 59 423BE328818 NA 0 1 cDNA clone IMAGE: 3181355 3′ 192C3 4 335 BE348809 NA 0 1cDNA clone IMAGE: 3152438 3′ 140G6 206 405 BE348955 NA 3.00E−85 1 cDNAclone IMAGE: 3144625 3′ 483D12 1 534 BE349148 NA 1.00E−160 1 cDNA cloneIMAGE: 3150275 3′ 491H12 1 526 BE379820 NA 0 1 cDNA clone IMAGE: 35109605′ 481D5 212 333 BE464239 NA 3.00E−45 1 cDNA clone IMAGE: 3194693 3′469H8 31 179 BE466500 NA 2.00E−71 1 cDNA clone IMAGE: 3195395 3′ 56D1172 353 BE467470 NA 1.00E−113 1 cDNA clone IMAGE: 3212950 3′ 471D10 1 249BE502246 NA 1.00E−119 2 cDNA clone IMAGE: 3197344 3′ 471C2 255 486BE502992 NA 1.00E−128 1 cDNA clone IMAGE: 3214462 3′ 56A2 291 669BE538333 NA 1.00E−164 1 cDNA clone IMAGE: 3454710 5′ 191F12 488 587BE547584 NA 9.00E−28 1 cDNA clone IMAGE: 3461312 5′ 525F3 5 236 BE550944NA 1.00E−125 1 cDNA clone IMAGE: 3233200 3′ 473B7 46 228 BE551867 NA4.00E−86 1 cDNA clone IMAGE: 3195555 3′ 467C6 48 404 BE569141 NA1.00E−162 1 cDNA clone IMAGE: 3681180 5′ 110D3 193 473 BE613237 NA1.00E−157 2 cDNA clone IMAGE: 3856357 3′ 140F9 20 344 BE614297 NA1.00E−84 1 cDNA clone IMAGE: 3906037 3′ 473B12 63 216 BE645630 NA3.00E−51 1 cDNA clone IMAGE: 3288143 3′ similar to contains 460C2 156594 BE646470 NA 0 1 cDNA clone IMAGE: 3292133 3′ 172E5 329 491 BE670804NA 7.00E−72 8 cDNA clone IMAGE: 3285031 3′ similar to gb: J04130 469D450 553 BE674685 NA 0 1 cDNA clone IMAGE: 3292800 3′ similar to TR:O60688 171F2 10 280 BE676054 NA 1.00E−96 1 cDNA clone IMAGE: 3295273 3′102E12 102 357 BE737348 NA 2.00E−93 1 cDNA clone IMAGE: 3640772 5′121C11 198 488 BE748663 NA 1.00E−150 1 cDNA clone IMAGE: 3838675 3′126D1 208 449 BE763412 NA 1.00E−122 1 NT0036 cDNA 172H5 52 581 BE768647NA 0 1 FT0010 cDNA 176F12 178 646 BE792125 NA 0 1 cDNA clone IMAGE:3936215 5′ 71A6 16 437 BE825187 NA 0 1 CN0028 cDNA 115F11 14 132BE858152 NA 4.00E−60 1 cDNA clone IMAGE: 3306735 3′ 61A11 1 448 BE872245NA 0 1 cDNA clone IMAGE: 3850435 5′ 171B8 155 377 BE875145 NA 8.00E−88 1cDNA clone IMAGE: 3891244 5′ 108A6 370 539 BE876375 NA 7.00E−72 2 cDNAclone IMAGE: 3889033 5′ 166B1 1 472 BE877115 NA 1.00E−153 1 cDNA cloneIMAGE: 3887598 5′ 63D11 208 496 BE878973 NA 1.00E−141 1 cDNA cloneIMAGE: 3895002 5′ 525C3 208 400 BE879482 NA 7.00E−88 1 cDNA clone IMAGE:3894277 5′ 526F7 335 603 BE881113 NA 1.00E−126 1 cDNA clone IMAGE:3894306 5′ 152G12 122 659 BE881351 NA 0 2 cDNA clone IMAGE: 3892808 5′589H4 118 510 BE882335 NA 0 2 cDNA clone IMAGE: 3907044 5′ 51B12 199 631BE884898 NA 3.00E−56 1 cDNA clone IMAGE: 3908551 5′ 114C1 286 530BE887646 NA 1.00E−121 1 cDNA clone IMAGE: 3913468 5′ 120H2 282 706BE888744 NA 0 1 cDNA clone IMAGE: 3915133 5′ 107D11 172 497 BE891242 NA0 1 cDNA clone IMAGE: 3917201 5′ 513G4 263 662 BE891269 NA 0 1 cDNAclone IMAGE: 3917064 5′ 166B8 7 453 BE891928 NA 0 1 cDNA clone IMAGE:3920185 5′ 185G9 23 390 BE894437 NA 1.00E−145 1 cDNA clone IMAGE:3918224 5′ 189A8 211 485 BE896691 NA 1.00E−82 1 cDNA clone IMAGE:3925062 5′ 598A7 78 301 BE897669 NA 1.00E−83 1 cDNA clone IMAGE: 39233465′ 191D9 189 575 BE899595 NA 0 3 cDNA clone IMAGE: 3952215 5′ 331F2 109287 BF001438 NA 3.00E−96 2 cDNA clone IMAGE: 3313517 3′ 192C9 57 419BF033741 NA 0 1 cDNA clone IMAGE: 3857635 5′ 117H4 73 454 BF056055 NA 01 cDNA clone IMAGE: 3443950 3′ similar to contains 104B10 6 412 BF058599NA 1.00E−177 1 cDNA clone IMAGE: 3477311 3′ 331A12 13 164 BF059133 NA1.00E−72 1 cDNA clone IMAGE: 3480249 3′ 40H1 81 507 BF060725 NA 0 17j59h07.x1 Soares_NSF_F8_9W_OT_PA_P_S1 cDNA clone 464F1 1 510 BF061421NA 0 1 7j52c11.x1 Soares_NSF_F8_9W_OT_PA_P_S1 cDNA clone 71E11 1 441BF105172 NA 0 1 cDNA clone IMAGE: 4042560 5′ 129D7 92 561 BF116224 NA 02 cDNA clone IMAGE: 3570793 3′ 145E10 83 624 BF131060 NA 0 1 cDNA doneIMAGE: 4051731 5′ 113B6 105 410 BF194880 NA 1.00E−157 1 cDNA cloneIMAGE: 3643600 3′ 157E9 102 308 BF197153 NA 1.00E−108 2 cDNA cloneIMAGE: 3561933 3′ 127H8 1 173 BF197762 NA 3.00E−92 1 cDNA clone IMAGE:3653139 3′ 462D1 29 177 BF221780 NA 7.00E−78 1 cDNA clone IMAGE: 35786033′ 472B8 7 229 BF306204 NA 9.00E−70 1 cDNA clone IMAGE: 4138980 5′ 62A3187 612 BF309911 NA 1.00E−162 1 cDNA clone IMAGE: 4138171 5′ 476G4 316487 BF330908 NA 5.00E−66 1 BT0333 cDNA 524D1 86 258 BF339088 NA 8.00E−881 cDNA clone IMAGE: 4182956 5′ 58G4 13 606 BF341359 NA 0 2 cDNA cloneIMAGE: 4149195 5′ 480E7 68 288 BF357523 NA 4.00E−97 1 HT0945 cDNA 116C98 170 BF364413 NA 2.00E−81 1 NN1068 cDNA 168F4 11 595 BF369763 NA 0 1GN0120 cDNA 495F1 1 318 BF373638 NA 1.00E−108 2 FT0176 cDNA 98E1 81 499BF377518 NA 0 2 TN0115 cDNA 169C5 17 500 BF380732 NA 0 1 UT0073 cDNA464E11 12 272 BF432643 NA 1.00E−129 1 cDNA clone IMAGE: 3406531 3′ 183G2119 548 BF433058 NA 1.00E−112 1 cDNA clone IMAGE: 3565500 3′ 473F9 21411 BF433353 NA 0 1 cDNA clone IMAGE: 3703678 3′ 117C9 179 462 BF433657NA 2.00E−99 1 cDNA clone IMAGE: 3702965 3′ similar to contains 514A3 170245 BF435621 NA 2.00E−34 2 Lupski_sciatic_nerve cDNA clone IMAGE:3394901 3′ similar to 459G8 78 417 BF445405 NA 1.00E−179 1 cDNA cloneIMAGE: 3699337 3′ 483D10 12 474 BF447885 NA 0 1 cDNA clone IMAGE:3706147 3′ 519H12 319 394 BF449068 NA 3.00E−27 1 cDNA clone IMAGE:3579069 3′ 584H11 78 487 BF475501 NA 7.00E−50 1 Lupski_sciatic_nervecDNA clone IMAGE: 3396242 3′ 471G8 214 400 BF478238 NA 9.00E−61 1 cDNAclone IMAGE: 3700476 3′ similar to contains 109F10 20 329 BF507849 NA1.00E−172 1 UI-H-BI4-apv-h-02-0-UI.s1 NCI_CGAP_Sub8 cDNA clone IMAGE:3088755 3′ 173E10 147 231 BE510393 NA 1.00E−39 1UI-H-BI4-aon-h-07-0-UI.s1 NCI_CGAP_Sub8 cDNA clone IMAGE: 3085669 3′464D1 32 460 BF513602 NA 1.00E−106 1 UI-H-BW1-amt-a-11-0-UI.s1NCI_CGAP_Sub7 cDNA clone IMAGE: 3070773 3′ 118D9 106 248 BF514341 NA4.00E−46 1 UI-H-BW1-and-h-10-0-UI.s1 NCI_CGAP_Sub7 cDNA clone IMAGE:3082218 3′ 462E3 29 197 BF515538 NA 1.00E−87 1 UI-H-BW1-anq-b-09-0-UI.s1NCI_CGAP_Sub7 cDNA clone IMAGE: 3083081 3′ 459C7 70 661 BF525720 NA 0 1cDNA clone IMAGE: 4212877 5′ 462F8 151 684 BF526421 NA 0 1 cDNA cloneIMAGE: 4213536 5′ 174H6 1 367 BF530382 NA 0 1 cDNA clone IMAGE: 42143275′ 477C5 183 689 BF569545 NA 0 1 cDNA clone IMAGE: 4310435 5′ 46C3 2 626BF571362 NA 0 1 cDNA clone IMAGE: 4252059 5′ 465B1 350 508 BF591040 NA3.00E−39 1 cDNA clone IMAGE: 3319177 3′ 477G7 6 127 BF592138 NA 2.00E−571 cDNA clone IMAGE: 3573334 3′ 180B2 53 264 BF593930 NA 1.00E−114 1nab48e03.x1 Soares_NSF_F8_9W_OT_PA_P_S1 cDNA clone 185F12 139 578BF663116 NA 0 1 cDNA clone IMAGE: 4308392 5′ 471F9 77 590 BF667621 NA 01 cDNA clone IMAGE: 4278888 5′ 41D10 16 664 BF668050 NA 0 2 cDNA cloneIMAGE: 4279827 5′ 491G6 87 275 BF670567 NA 1.00E−97 1 cDNA clone IMAGE:4290961 5′ 112B4 17 303 BF671020 NA 1.00E−120 1 cDNA clone IMAGE:4292143 5′ 194H6 6 196 BF678298 NA 1.00E−100 1 cDNA clone IMAGE: 42489165′ 514H9 96 179 BF691178 NA 2.00E−32 1 cDNA clone IMAGE: 4332544 5′ 99H1146 327 BF691895 NA 2.00E−69 1 cDNA clone IMAGE: 4333460 5′ 465E12 29681 BF725383 NA 0 1 cDNA (Un-normalized, unamplified): BX cDNA clone69B10 17 96 BF726114 NA 3.00E−37 1 cDNA (Un-normalized, unamplified): BYcDNA clone 151H10 18 366 BF732404 NA 0 1 cDNA clone IMAGE: 3434918 3′124D2 36 378 BF736784 NA 1.00E−179 1 KT0018 cDNA 463H5 30 152 BF740663NA 3.00E−56 1 HB0031 cDNA 469D2 164 398 BF744387 NA 6.00E−74 1 BT0636cDNA 72E1 17 128 BF749089 NA 1.00E−44 3 BN0386 cDNA 98C3 9 515 BF758480NA 0 1 CT0539 cDNA 46E11 26 162 BF773126 NA 5.00E−57 1 IT0048 cDNA 124C832 257 BF773393 NA 1.00E−115 1 IT0039 cDNA 166G8 312 549 BF797348 NA1.00E−108 1 cDNA clone IMAGE: 4340490 5′ 146D8 222 288 BF805164 NA5.00E−29 1 CI0173 cDNA 49G4 99 460 BF813798 NA 0 5 CI0084 cDNA 469F8 31455 BF816700 NA 4.00E−88 1 CI0128 cDNA 98C1 37 375 BF818594 NA 1.00E−1631 CI0184 cDNA 62C9 166 359 BF821451 NA 3.00E−28 1 RT0038 cDNA 51F8 28367 BF827734 NA 1.00E−175 1 HN0025 cDNA 56F7 15 429 BF845167 NA 9.00E−841 HT1035 cDNA 476D11 1 303 BF869167 NA 1.00E−165 2 ET0119 cDNA 476H4 12262 BF875575 NA 1.00E−131 2 ET0100 cDNA 68D6 242 452 BF877979 NA3.00E−98 1 ET0109 cDNA 37C10 1 381 BF897042 NA 0 3 MT0179 cDNA 465B3 63193 BF898285 NA 5.00E−60 1 MT0229 cDNA 331C7 274 485 BF899464 NA3.00E−83 1 MT0211 cDNA 72D8 50 334 BF904425 NA 1.00E−152 1 MT0245 cDNA159F6 333 417 BF906114 NA 2.00E−35 1 MT0267 cDNA 108H5 6 409 BF926187 NA0 1 NT0193 cDNA 71F9 192 286 BF928644 NA 1.00E−43 1 NT0216 cDNA 481D4 27334 BF938959 NA 1.00E−102 1 cDNA clone IMAGE: 3706689 3′ 189B11 69 183BF939014 NA 4.00E−29 1 cDNA clone IMAGE: 3706658 3′ 115G2 85 399BF940103 NA 1.00E−177 1 cDNA clone IMAGE: 3439383 3′ 463B3 304 449BF940291 NA 8.00E−62 1 cDNA clone IMAGE: 3577096 3′ 122G1 8 339 BF950968NA 1.00E−170 1 NN1186 cDNA 470B4 251 320 BF962743 NA 2.00E−28 1 NN0045cDNA 516D5 39 208 BF962934 NA 5.00E−69 1 NN0045 cDNA 593G10 242 597BF965068 NA 1.00E−177 2 cDNA clone IMAGE: 4356776 5′ 101A1 6 356BF965438 NA 1.00E−132 1 cDNA clone IMAGE: 4356453 5′ 477F3 25 653BF965960 NA 0 1 cDNA clone IMAGE: 4365102 5′ 588E4 67 562 BF966028 NA1.00E−134 1 cDNA clone IMAGE: 4364887 5′ 467F10 11 282 BF966049 NA1.00E−122 1 cDNA clone IMAGE: 4364941 5′ 59E12 81 355 BF966269 NA1.00E−144 1 cDNA clone IMAGE: 4375212 5′ 480E11 416 755 BF968628 NA8.00E−41 1 cDNA clone IMAGE: 4359351 5′ 37H8 200 500 BF968963 NA1.00E−148 1 cDNA clone IMAGE: 4358390 5′ 98H5 396 397 BF969990 NA1.00E−133 1 cDNA clone IMAGE: 4360614 5′ 597C3 15 571 BF971075 NA 0 1cDNA clone IMAGE: 4358911 5′ 101F1 188 305 BF971984 NA 6.00E−42 1 cDNAclone IMAGE: 4329095 5′ 464H5 246 602 BF980139 NA 0 1 cDNA clone IMAGE:4373963 3′ 63B6 130 597 BF981080 NA 0 1 cDNA clone IMAGE: 4401411 5′167A3 223 418 BF981263 NA 1.00E−101 1 cDNA clone IMAGE: 4400757 5′512C12 1 494 BF981634 NA 0 1 cDNA clone IMAGE: 4397101 5′ 187H7 26 433BF997765 NA 1.00E−180 2 GN0127 cDNA 458E4 54 242 BG006820 NA 3.00E−62 1GN0227 cDNA 106A7 1 604 BG024761 NA 0 1 cDNA clone IMAGE: 4363858 5′459H6 1 524 BG026279 NA 0 1 cDNA clone IMAGE: 4386607 5′ 460B9 264 512BG028577 NA 1.00E−105 1 cDNA clone IMAGE: 4387518 5′ 49E9 100 537BG033909 NA 0 1 cDNA clone IMAGE: 4402729 5′ 54C10 1 582 BG033953 NA 0 2cDNA clone IMAGE: 4402647 5′ 182B3 1 489 BG034799 NA 0 1 cDNA cloneIMAGE: 4413514 5′ 166F8 13 586 BG036101 NA 0 1 cDNA clone IMAGE: 44141355′ 104A12 56 240 BG054966 NA 1.00E−100 1 cDNA clone IMAGE: 3441756 3′171H10 4 269 BG056668 NA 3.00E−85 1 cDNA clone IMAGE: 4169714 3′ 146G1113 522 BG057282 NA 0 5 cDNA clone IMAGE: 4140477 3′ similar to contains472A11 69 358 BG057892 NA 1.00E−145 1 7f76e08.x1Lupski_dorsal_root_ganglion cDNA clone 513B4 2 418 BG058599 NA 0 1 cDNAclone IMAGE: 4141266 3′ 134B4 201 519 BG058739 NA 1.00E−75 4 cDNA cloneIMAGE: 4140551 3′ 163E7 83 327 BG110599 NA 1.00E−126 1 cDNA clone IMAGE:4368492 5′ 118A7 180 577 BG110835 NA 0 1 cDNA clone IMAGE: 4366502 5′37F12 38 649 BG111212 NA 0 5 cDNA clone IMAGE: 4369233 5′ 464A10 57 673BG111773 NA 0 1 cDNA clone IMAGE: 4372861 5′ 464A7 56 411 BG118529 NA1.00E−167 1 cDNA clone IMAGE: 4443519 5′ 458D8 186 715 BG121288 NA 0 1cDNA clone IMAGE: 4450407 5′ 166H12 25 339 BG149747 NA 1.00E−177 1 cDNAclone IMAGE: 3367325 3′ 51H4 4 224 BG149986 NA 1.00E−121 1 cDNA cloneIMAGE: 3406766 3′ 75G3 70 280 BG150273 NA 1.00E−115 4 cDNA clone IMAGE:3442930 3′ 500F10 18 677 BG163237 NA 0 3 cDNA clone IMAGE: 4446802 5′519E4 39 575 BG164898 NA 0 3 cDNA clone IMAGE: 4453661 5′ 119E5 21 276BG165998 NA 1.00E−120 1 cDNA clone IMAGE: 4456017 5′ 519B8 29 214BG166279 NA 5.00E−86 1 cDNA clone IMAGE: 4455496 5′ 103B8 377 499BG170647 NA 1.00E−45 1 cDNA clone IMAGE: 4426826 5′ 470F8 184 307BG180098 NA 4.00E−63 1 cDNA clone IMAGE: 4430875 5′ 585C4 4 98 BG230563NA 5.00E−46 1 cDNA clone IMAGE: 4143330 3′ similar to contains 48G7 2298 BG231557 NA 1.00E−119 1 cDNA clone IMAGE: 4142471 3′ 73C4 188 430BG231805 NA 1.00E−130 1 cDNA clone IMAGE: 4142814 3′ 148H4 2 525BG231961 NA 1.00E−133 12 cDNA clone IMAGE: 4143104 3′ 484B5 364 533BG235942 NA 5.00E−81 1 cDNA clone IMAGE: 4141389 3′ 137B5 97 523BG236015 NA 6.00E−87 1 cDNA clone IMAGE: 4141365 3′ 489B11 12 294BG236084 NA 4.00E−75 2 cDNA clone IMAGE: 4141856 3′ similar to 45H2 1492 BG249224 NA 1.00E−139 1 cDNA clone IMAGE: 4470038 5′ 172F1 1 562BG254117 NA 0 1 cDNA clone IMAGE: 4475233 5′ 588F3 66 202 BG254292 NA9.00E−43 1 cDNA clone IMAGE: 4477042 5′ 583B5 8 183 BG272304 NA 7.00E−451 cDNA clone IMAGE: 4257371 73A4 119 311 BG282346 NA 3.00E−42 1 cDNAclone IMAGE: 4545131 5′ 586A2 99 511 BG283706 NA 1.00E−160 1 cDNA cloneIMAGE: 4519866 5′ 152F12 1 676 BG286649 NA 0 5 cDNA clone IMAGE: 44992245′ 479A12 228 601 BG286817 NA 1.00E−142 1 cDNA clone IMAGE: 4500259 5′99B4 1 449 BG288308 NA 0 2 cDNA clone IMAGE: 4512706 5′ 584G2 54 468BG288554 NA 0 1 cDNA clone IMAGE: 4517068 5′ 464E2 244 549 BG289048 NA1.00E−159 2 cDNA clone IMAGE: 4512868 5′ 113H1 149 436 BG289347 NA1.00E−161 1 cDNA clone IMAGE: 4516241 5′ 39G6 1 503 BG290577 NA 0 1 cDNAclone IMAGE: 4517986 5′ 48D8 38 440 BG291970 NA 0 1 cDNA clone IMAGE:4517457 5′ 60E7 1 398 BG319445 NA 0 4 Keratinocyte SubtractionLibrary-Downregulated Transcripts Homo 168C2 3 221 BG319498 NA 1.00E−1112 Keratinocyte Subtraction Library-Downregulated Transcripts Homo 461B121 393 BG387694 NA 0 2 cDNA clone IMAGE: 4521084 5′ 174G11 3 542 BG391695NA 0 1 cDNA clone IMAGE: 4537243 5′ 597A4 164 612 BG396292 NA 0 2 cDNAclone IMAGE: 4581548 5′ 190B10 469 667 BG397564 NA 3.00E−62 2 cDNA cloneIMAGE: 4564968 5′ 593C3 35 461 BG403635 NA 0 1 cDNA clone IMAGE: 45263645′ 57H10 121 495 BG413494 NA 0 1 7j54e06.x1 Soares_NSF_F8_9W_OT_PA_P_S1cDNA clone 155G11 119 347 BG424974 NA 3.00E−52 1 cDNA clone IMAGE:4591378 5′ 45G3 17 332 BG427404 NA 1.00E−159 1 cDNA clone IMAGE: 46125185′ 185C9 16 185 BG432194 NA 3.00E−62 1 cDNA clone IMAGE: 4610035 5′331D4 60 386 BG434865 NA 1.00E−179 1 cDNA clone IMAGE: 4605025 5′ 464H1297 295 BG438232 NA 1.00E−105 1 cDNA clone IMAGE: 4622433 5′ 521F2 280534 BG468330 NA 1.00E−111 1 cDNA clone IMAGE: 4644153 5′ 56F6 167 582BG473228 NA 0 2 cDNA clone IMAGE: 4646938 5′ 61G3 8 185 BG473813 NA2.00E−95 1 cDNA clone IMAGE: 4647416 5′ 119E9 7 377 BG482798 NA1.00E−178 3 cDNA clone IMAGE: 4616253 5′ 125F8 47 318 BG489375 NA1.00E−149 1 cDNA clone IMAGE: 4636634 5′ 73H3 55 154 BG493253 NA5.00E−49 1 cDNA clone IMAGE: 4672787 5′ 111H9 79 754 BG497765 NA 0 1cDNA clone IMAGE: 4665582 5′ 171A10 74 476 BG501063 NA 0 1 cDNA cloneIMAGE: 4668643 5′ 471G1 65 197 BG501895 NA 1.00E−63 1 cDNA clone IMAGE:4654344 5′ 111E1 16 181 BG503693 NA 4.00E−85 2 cDNA clone IMAGE: 46573815′ 121B6 77 553 BG505271 NA 0 2 cDNA clone IMAGE: 4664028 5′ 599F2 379484 BG505379 NA 3.00E−45 1 cDNA clone IMAGE: 4657121 5′ 105C1 208 646BG505961 NA 0 1 cDNA clone IMAGE: 4072795 5′ 521E10 23 440 BG506168 NA 04 cDNA clone IMAGE: 4072226 5′ 119A5 188 596 BG506472 NA 1.00E−103 1cDNA clone IMAGE: 4070820 5′ 479D7 34 308 BG527060 NA 1.00E−121 1 cDNAclone IMAGE: 4685209 5′ 71H3 27 542 BG527658 NA 0 1 cDNA clone IMAGE:4685854 5′ 186A7 2 336 BG531486 NA 5.00E−96 1 cDNA clone IMAGE: 46994095′ 187H11 186 662 BG532345 NA 0 1 cDNA clone IMAGE: 4699954 5′ 64G4 166650 BG532470 NA 0 1 cDNA clone IMAGE: 4699923 5′ 486E6 224 561 BG533994NA 1.00E−168 5 cDNA clone IMAGE: 4663102 5′ 116F9 188 392 BG536394 NA7.00E−67 1 cDNA clone IMAGE: 4689645 5′ 75C7 1 452 BG536641 NA 0 2 cDNAclone IMAGE: 4691078 5′ 175D10 3 114 BG537502 NA 2.00E−49 1 cDNA cloneIMAGE: 4690780 5′ 599E1 356 659 BG538731 NA 1.00E−111 1 cDNA cloneIMAGE: 4691392 5′ 191H9 80 631 BG541679 NA 0 1 cDNA clone IMAGE: 46958055′ 466A4 1 408 BG542394 NA 0 1 cDNA clone IMAGE: 4696046 5′ 67G12 29 698BG547561 NA 0 3 cDNA clone IMAGE: 4703738 5′ 467B6 60 234 BG547627 NA3.00E−93 2 cDNA clone IMAGE: 4703608 5′ 488F8 2041 2132 D10495 NA9.00E−31 1 mRNA for protein kinase C delta-type, complete cds Length =2163 525B6 21 222 D17042 NA 1.00E−100 2 HepG2 partial cDNA, clonehmd3f07m5 Length = 222 471E4 2287 2877 D17391 NA 0 2 mRNA for alpha4(IV) collagen, C-terminal Length = 3558 134D8 561 694 D28589 NA2.00E−59 1 mRNA (KIAA00167), partial sequence Length = 792 112D1 16142159 D30036 NA 0 1 mRNA for phosphatidylinositol transfer protein (PI-TPalpha), complete 98H4 1 357 F11941 NA 1.00E−180 1 brain cDNA cDNAclone c-33f05 585G7 15 264 F13765 NA 1.00E−136 1 (1992) cDNA cloneFII112 3′ 47D11 1 296 F35665 NA 1.00E−146 1 cDNA clone sH5-000005-0/E06465F5 34 225 H03298 NA 1.00E−70 1 cDNA clone IMAGE: 151865 5′ 481A6 43362 H51796 NA 1.00E−123 1 spleen 1NFLS cDNA clone IMAGE: 194250 5′ 100E3116 205 H56344 NA 1.00E−37 1 spleen 1NFLS cDNA clone IMAGE: 203711 5′similar to 464F9 10 398 H57221 NA 5.00E−45 2 spleen 1NFLS cDNA cloneIMAGE: 204710 5′ 66C3 10 77 H78395 NA 8.00E−28 1 liver spleen 1NFLS cDNAclone IMAGE: 233597 3′ 105D11 63 365 H81660 NA 1.00E−154 1 2NbHM cDNAclone IMAGE: 249138 5′ 60G10 1 189 H86841 NA 1.00E−100 1 cDNA cloneIMAGE: 220310 5′ similar to SP: S44265 470D6 1 314 H92914 NA 1.00E−146 1Soares_pineal_gland_N3HPG cDNA clone IMAGE: 231988 3′ 483E5 839 944K02885 NA 1.00E−26 1 T-cell receptor active beta-chain V-D-J-beta-1.2-C-beta-1 (TCRB) mRNA, 516F5 1753 2047 L11284 NA 1.00E−131 1 Homo sapiensERK activator kinase (MEK1) mRNA Length = 2222 525E11 105 738 L40557 NA1.00E−112 1 perforin (PRF1) mRNA, 3′ end Length = 818 74F1 661 826M11124 NA 5.00E−41 1 MHC HLA DQ alpha-chain mRNA from DRw9 cell lineLength = 835 121E3 1323 1870 M12824 NA 0 4 T-cell differentiationantigen Leu-2/T8 mRNA, partial cds Length = 197 66H2 713 1190 M17783 NA0 1 glia-derived nexin (GDN) mRNA, 5′ end Length = 1191 41A9 698 883M32577 NA 4.00E−28 1 MHC HLA-DQ beta mRNA, complete cds Length = 1104478D10 436 605 M55674 NA 4.00E−33 1 (clone M212) phosphoglycerate mutase2 (muscle specific isozyme) (PGAM 469B8 5 377 N20190 NA 0 1 2NbHM cDNAclone IMAGE: 264340 3′ 109E4 21 449 N23307 NA 0 2 2NbHM cDNA cloneIMAGE: 267836 3′ 171D9 80 381 N25486 NA 1.00E−147 1 2NbHM cDNA cloneIMAGE: 264068 5′ 73H12 1 398 N27575 NA 1.00E−144 2 2NbHM cDNA cloneIMAGE: 264499 5′ 490A11 25 475 N31700 NA 0 1 2NbHM cDNA clone IMAGE:267025 5′ 599D6 185 483 N34261 NA 1.00E−150 1 2NbHM cDNA clone IMAGE:267967 5′ 188F3 112 357 N36787 NA 1.00E−107 1 2NbHM cDNA clone IMAGE:273145 3′ 465B10 7 558 N49836 NA 0 1 yz08a11.s1Soares_multiple_sclerosis_2NbHMSP cDNA 40D4 199 575 N58136 NA 1.00E−1531 spleen 1NFLS cDNA clone IMAGE: 247587 3′ 183E2 227 366 N80578 NA2.00E−53 1 Soares_fetal_lung_NbHL19W cDNA clone IMAGE: 300873 3′ similarto 139G6 9 269 N94511 NA 1.00E−125 1 zb80g04.s1Soares_senescent_fibroblasts_NbHSF cDNA 126B8 1 256 N99577 NA 1.00E−1372 spleen 1NFLS cDNA clone IMAGE: 295067 5′ 118A10 893 5056 NC_001807 NA0 7 mitochondrion, complete genome Length = 16568 41B2 1 471 NM_000873NA 0 1 intercellular adhesion molecule 2 (ICAM2), mRNA Length = 103562A8 1877 1958 NM_000958 NA 1.00E−37 4 prostaglandin E receptor 4(subtype EP4) (PTGER4), mRNA 179H10 53 265 NM_000983 NA 1.00E−44 1ribosomal protein L22 (RPL22), mRNA Length = 602 331D3 71 343 NM_001024NA 1.00E−144 5 ribosomal protein S21 (RPS21), mRNA Length = 343 41G103162 3565 NM_001243 NA 3.00E−47 1 tumor necrosis factor receptorsuperfamily, member 8 (TNFRSF8), mRNA 591E9 1027 1483 NM_002211 NA 0 2integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29497C6 4946 5064 NM_002460 NA 9.00E−36 2 interferon regulatory factor 4(IRF4), mRNA Length = 5065 597D8 1232 1461 NM_005356 NA 2.00E−48 1lymphocyte-specific protein tyrosine kinase (LCK), mRNA Length = 2032166G2 50 319 NM_005745 NA 2.00E−90 1 accessory proteins BAP31/BAP29(DXS1357E), mRNA Length = 1314 468D2 3245 3480 NM_011086 NA 8.00E−63 1similar to Mus phosphoinositide kinase, fyve- containing (Pikfyve), mRNA599A4 1335 1630 NM_014644 NA 2.00E−69 1 KIAA0477 gene product(KIAA0477), mRNA Length = 5676 69C2 818 1361 NM_014905 NA 0 3glutaminase (GLS), mRNA Length = 4606 495C6 622 838 NM_015435 NA1.00E−104 1 double ring-finger protein, Dorfin (DORFIN), mRNA Length =1640 463D11 480 632 NM_015995 NA 1.00E−77 1 Kruppel-like factor 13(KLF13), mRNA Length = 1079 49C10 817 964 NM_019604 NA 3.00E−28 1class-I MHC-restricted T cell associated molecule (CRTAM), mRNA 188E4390 643 NM_019997 NA 6.00E−79 1 similar to Mus musculus cDNA sequenceAB041581 (AB041581) 103H2 1421 1662 NM_021432 NA 3.00E−66 1 similar toMus RIKEN cDNA 1110020M21 gene (1110020M21Rik) 465G11 1685 1761NM_021777 NA 1.00E−34 1 a disintegrin and metalloproteinase domain 28(ADAM28), transcirpt var 166D8 1265 1951 NM_022152 NA 0 1 PP1201 protein(PP1201), mRNA Length = 2309 459G6 1 123 NM_024567 NA 2.00E−36 1hypothetical protein (FLJ21616), mRNA Length = 1858 461G2 667 1182NM_025977 NA 1.00E−28 1 similar to Mus RIKEN cDNA 2510048L02 gene(2510048L02Rik) 62A5 759 1200 NM_030780 NA 0 1 folatetransporter/carrier (LOC81034), mRNA Length = 2534 52C11 1277 1954NM_030788 NA 0 1 DC-specific transmembrane protein (LOC81501), mRNALength = 1974 108A7 910 3014 NM_031419 NA 0 4 molecule possessingankyrin repeats induced by lipopolysaccharide 74E11 47 464 NM_031435 NA0 1 hypothetical protein DKFZp56410422 (DKFZP56410422), mRNA 56B3 15181962 NM_031453 NA 1.00E−176 1 hypothetical protein MGC11034 (MGC11034),mRNA Length = 3301 46F2 118 663 NM_031480 NA 1.00E−105 1 hypotheticalprotein AD034 (AD034), mRNA Length = 2495 192B3 51 290 R11456 NA1.00E−105 1 spleen 1NFLS cDNA clone IMAGE: 129880 5′ similar to 458B9 43359 R64054 NA 1.00E−159 1 cDNA clone IMAGE: 139969 5′ 169F11 1 429R85137 NA 0 1 brain N2b4HB55Y cDNA clone IMAGE: 180492 5′ 465B5 16 392R88126 NA 1.00E−164 1 cDNA clone IMAGE: 186850 5′ 477F8 1 525 T77017 NA0 1 1NIB cDNA clone IMAGE: 23326 5′ 39G11 162 455 T80378 NA 1.00E−145 11NIB cDNA clone IMAGE: 24693 5′ 107D7 1 371 T80654 NA 0 1 spleen 1NFLScDNA clone IMAGE: 108950 5′ 465A1 6 314 T85880 NA 1.00E−114 1 spleen1NFLS cDNA clone IMAGE: 112441 5′ 48D12 2300 2533 U08015 NA 1.00E−128 1NF-ATc mRNA, complete cds Length = 2743 121F1 13 380 U46388 NA 1.00E−1501 cell line Patu 8988t cDNA clone xs425 127B12 3 330 U52054 NA 0 4 S6H-8 mRNA expressed in chromosome 6- suppressed melanoma cells 487C2 40544187 U52682 NA 2.00E−28 1 lymphocyte specific interferon regulatoryfactor/interferon regulatory 110B3 1404 2081 U53530 NA 0 1 cytoplasmicdynein 1 heavy chain mRNA, partial cds Length = 2694 466C8 34 175 U75805NA 3.00E−47 1 cDNA clone f46 148G12 1513 1639 U87954 NA 1.00E−27 1 erbB3binding protein EBP1 mRNA, complete cds Length = 1648 70A4 564 1381U94359 NA 0 2 glycogenin-2 like mRNA sequence Length = 4066 158E4 843945 U97075 NA 1.00E−33 1 FLICE-like inhibitory protein short form mRNA,complete cds 459A1 227 446 W00466 NA 1.00E−60 1 2NbHM cDNA clone IMAGE:291193 5′ 459A2 60 350 W00491 NA 1.00E−126 1 2NbHM cDNA clone IMAGE:291255 5′ similar to 459B1 76 551 W02600 NA 0 1 spleen 1NFLS cDNA cloneIMAGE: 296099 5′ 166C10 10 415 W16552 NA 0 1 Soares_fetal_lung_NbHL19WcDNA clone IMAGE: 301703 5′ 471C6 3 383 W19201 NA 1.00E−149 1Soares_fetal_lung _NbHL19W cDNA clone IMAGE: 303118 5′ similar to 520A875 382 W19487 NA 1.00E−154 1 zb36f09.r1 Soares_parathyroid_tumor_NbHPAcDNA clone 459B7 57 158 W25068 NA 9.00E−50 1 Soares_fetal_lung _NbHL19WcDNA clone IMAGE: 308696 5′ 188D3 39 283 W26193 NA 2.00E−91 1 randomlyprimed sublibrary cDNA 75B12 8 386 W27656 NA 1.00E−166 1 randomly primedsublibrary cDNA 163F8 74 330 W47229 NA 1.00E−117 1 zc39c01.r1Soares_senescent_fibroblasts_NbHSF cDNA 478E6 2 322 W56487 NA 3.00E−51 1zc59c07.r1 Soares_parathyroid _tumor_NbHPA cDNA clone 73H4 76 297 W72392NA 1.00E−121 1 Soares_fetal_heart_NbHH19W cDNA clone IMAGE: 345661 3′66D5 1 457 W74397 NA 0 3 Soares_fetal_heart_NbHH19W cDNA clone IMAGE:345236 5′ 496D4 85 450 W79598 NA 0 1 Soares_fetal_heart_NbHH1 9W cDNAclone IMAGE: 347020 5′ 165D1 108 287 W80882 NA 4.00E−94 1Soares_fetal_heart_NbHH19W cDNA clone IMAGE: 347240 5′ 463G1 5 406W86427 NA 0 1 zh61c11.s1 Soares_fetal_liver spleen_1NFLS_S1 cDNA 469G111276 1621 X06180 NA 0 1 mRNA for CD7 antigen (gp40) Length = 1656 113E11126 885 X65318 NA 0 1 Cloning vector pGEMEX-2 Length = 3995 482E1 9211168 X79536 NA 1.00E−102 1 mRNA for hnRNPcore protein A1 Length = 1198123G8 408 848 XM_002068 NA 8.00E−73 1 glutamate-ammonia ligase(glutamine synthase) (GLUL), mRNA 185E1 508 734 XM_002158 NA 1.00E−27 1proteasome (prosome, macropain) subunit, alpha type, 5 (PSMA5), mRNA71A9 1131 1252 XM_002269 NA 4.00E−29 1 ARP3 (actin-related protein 3,yeast) homolog (ACTR3), mRNA 49G7 1 257 XM_003189 NA 1.00E−142 3 similarto eukaryotic translation initiation factor 4A, isoform 2 (H. 128B5 783980 XM_003304 NA 6.00E−41 1 toll-like receptor 2 (TLR2), mRNA Length =2600 185G10 853 1057 XM_003507 NA 2.00E−26 1 small inducible cytokinesubfamily B (Cys-X-CyS), member 5 (epithelial 41C9 588 1221 XM_003593 NA0 1 CD38 antigen (p45) (CD38), mRNA Length = 1227 156C4 127 270XM_004020 NA 6.00E−71 1 ribosomal protein S23 (RPS23), mRNA Length = 48866E2 1344 1577 XM_004500 NA 1.00E−46 1 CD83 antigen (activated Blymphocytes, immunoglobulin superfamily) (CD 61C6 474 987 XM_004611 NA2.00E−80 1 Ras homolog enriched in brain 2 (RHEB2), mRNA Length = 987184A7 971 1361 XM_004720 NA 0 1 hypothetical protein FLJ11000(FLJ11000), mRNA Length = 1680 128E6 580 741 XM_004839 NA 5.00E−38 1pre-B-cell colony-enhancing factor (PBEF), mRNA Length = 2377 55A11 10961305 XM_005162 NA 1.00E−60 1 GTP-binding protein overexpressed inskeletal muscle (GEM), mRNA 519C4 1307 1441 XM_005543 NA 1.00E−69 1aquaporin 3 (AQP3), mRNA Length = 1441 129F1 1854 2367 XM_005693 NA 0 1inositol polyphosphate-5-phosphatase, 40 kD (INPP5A), mRNA 522C10 700916 XM_005698 NA 7.00E−53 1 programmed cell death 4 (PDCD4), mRNA Length= 1622 180G6 1884 2290 XM_005799 NA 1.00E−166 1 integrin, beta 1(fibronectin receptor, beta polypeptide, antigen CD29 55F4 2573 2748XM_005883 NA 4.00E−73 1 early growth response 2 (Krox-20 (Drosophila)homolog) (EGR2), mRNA 492H7 976 1176 XM_005980 NA 4.00E−33 1proteoglycan 1, secretory granule (PRG1), mRNA Length = 1176 476B4 15411918 XM_006741 NA 0 1 hypothetical protein FLJ10701 (FLJ10701), mRNALength = 2299 493H5 145 379 XM_006881 NA 2.00E−56 1 interleukin 22(IL22), mRNA Length = 676 499B4 11117 11410 XM_007156 NA 3.00E−34 1spastic ataxia of Charlevoix-Saguenay (sacsin) (SACS), mRNA 183D7 42704376 XM_007189 NA 5.00E−37 1 forkhead box O1A (rhabdomyosarcoma)(FOXO1A), mRNA Length = 5037 115B6 4151 4408 XM_007606 NA 2.00E−50 2thrombospondin 1 (THBS1), mRNA Length = 5719 587B4 31 264 XM_007650 NA1.00E−114 3 beta-2-microglobulin (B2M), mRNA Length = 918 598H5 206 300XM_008062 NA 1.00E−31 1 ribosomal protein S15a (RPS15A), mRNA Length =435 73E4 3252 3505 XM_008082 NA 1.00E−119 1 adaptor-related proteincomplex 1, gamma 1 subunit (AP1G1), mRNA 64F7 186 334 XM_008449 NA1.00E−47 1 small inducible cytokine A4 (homologous to mouse Mip-1b)(SCYA4) 585E1 904 1020 XM_009533 NA 1.00E−26 1 CGI-06 protein(LOC51604), mRNA Length = 2146 75B8 710 1406 XM_009574 NA 0 1 nucleolarprotein (KKE/D repeat) (NOP56), mRNA Length = 1910 467A5 210 620XM_009641 NA 0 1 v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogenehomolog (SRC), 44A3 480 854 XM_009917 NA 0 1 splicing factor 3a, subunit1, 120 kD (SF3A1), mRNA Length = 2614 114D12 2269 2491 XM_009929 NA7.00E−56 1 LIM domain kinase 2 (LIMK2), mRNA Length = 3699 52F6 1 230XM_010593 NA 2.00E−36 1 signaling lymphocytic activation molecule(SLAM), mRNA Length = 1791 185E5 1576 1695 XM_010897 NA 3.00E−32 1neural precursor cell expressed, developmentally down-regulated 5 (NED106C3 1359 1824 XM_011080 NA 0 1 T cell activation, increased lateexpression (TACTILE), mRNA 56H11 40 617 XM_011082 NA 0 1 interleukin 21(IL21), mRNA Length = 617 53B2 2711 2839 XM_011714 NA 3.00E−29 1 neutralsphingomyelinase (N-SMase) activation associated factor (NSMAF 47A3 8961231 XM_011865 NA 1.00E−55 1 isopentenyl-diphosphate delta isomerase(IDI1), mRNA Length = 1835 159E9 17 178 XM_011914 NA 1.00E−73 1ribosomal protein S24 (RPS24), mRNA Length = 515 39E6 339 535 XM_012059NA 1.00E−44 1 hypothetical protein MDS025 (MDS025), mRNA Length = 1225142F6 623 745 XM_012328 NA 2.00E−40 1 granzyme B (granzyme 2, cytotoxicT-lymphocyte- associated serine ester 118D4 329 765 XM_012649 NA1.00E−114 1 small inducible cytokine A7 (monocyte chemotactic protein 3)(SCYA7), 168H9 2502 2616 XM_015180 NA 2.00E−33 1 apolipoprotein L, 6(APOL6), mRNA Length = 2915 58D2 1582 1742 XM_015921 NA 2.00E−30 1putative chemokine receptor; GTP-binding protein (HM74), mRNA 466H9 86440 XM_016138 NA 2.00E−45 1 hypothetical protein FLJ12439 (FLJ12439),mRNA Length = 1614 184G1 2651 3584 XM_016481 NA 0 3 hypothetical protein(DJ328E19.C1.1), mRNA Length = 3603 107G9 8199 8786 XM_016721 NA 0 1zinc finger protein 106 (ZFP106), mRNA Length = 10462 39F11 2719 3671XM_016972 NA 0 2 similar to hypothetical protein (H. sapiens)(LOC82646), mRNA 159A7 19 561 XM_018498 NA 1.00E−167 3 ribosomal proteinL5 (RPL5), mRNA Length = 984 459H2 2956 3450 Y16414 NA 0 1 mRNA forexportin (tRNA) Length = 3497

TABLE 3B Identified Genomic Regions that code for novel human mRNA'sExample Genome Number Clone Start End Accession Probability ClonesGenbank Description 172H5 12457 13616 AC000015 0 2 chromosome 4 cloneB271E1 map 4q25, complete sequence L 464A9 21144 21280 AC000068 2.00E−701 Chromosome 22q11.2 Cosmid Clone 102g9 In DGCR Region, c 472B10 2034020745 AC000087 2.00E−67 1 Chromosome 22q11.2 Cosmid Clone 83c5 In DGCRRegion, co 103C4 93389 93611 AC000119 0 5 BAC clone RG104I04 from7q21-7q22, 119111 119521 AC000119 complete sequence [H 119522 119890AC000119 119989 121059 AC000119 514A3 201218 201293 AC000353 5.00E−34 2Chromosome 11q13 BAC Clone 18h3, complete sequence Leng 524A9 2431524820 AC002073 0 3 PAC clone RP3-515N1 from 22q11.2-q22, 24879 25274AC002073 complete sequence 458D10 28080 28625 AC002297 0 1 Genomicsequence from 9q34, complete sequence [Homo sap 476D3 106080 106289AC002302 1.00E−86 1 Chromosome 16 BAC clone CIT987-SKA- 345G4-completegeno 471D10 34638 34885 AC002306 1.00E−118 2 DNA from chromosome19-cosmid R33799, genomic sequence, 596F6 75526 76327 AC002467 0 1 BACclone CTA-364P16 from 7q31, complete sequence [Homo 473F3 74912 75540AC002549 0 2 Xp22 BAC GS-377014 (Genome Systems BAC library) complet111E12 24581 24992 AC003086 0 1 BAC clone CTB-104F4 from 7q21-q22,complete sequence Le 471E9 39706 40014 AC003103 1.00E−151 1 chromosome17, clone HCIT268N12, complete sequence Leng 526B9 39477 39615 AC0036953.00E−29 1 chromosome 17, clone hRPC.859_O_20, complete sequence L 331A347793 48492 AC003976 1.00E−164 5 chromosome 17, clone hCIT.91_J_4,complete sequence Len 105C1 115642 116079 AC004067 0 1 chromosome 4clone B366O24 map 4q25, complete sequence 469H8 35828 35976 AC0040805.00E−71 1 PAC clone RP1-170O19 from 7p15-p21, complete sequence L 55F9114263 114415 AC004169 3.00E−46 1 chromosome 4 clone C0236G06 map 4p16,complete sequence 487F9 35319 35718 AC004187 0 1 clone UWGC: y17c131from 6p21, complete sequence Length 459H7 13409 13739 AC004190 1.00E−1661 from UWGC: y18c282 from 6p21, complete sequence Length = 464D1 2853029042 AC004221 1.00E−106 1 DNA from chromosome 19, cosmid R29144(LLNLR-252D12) an 468A7 53111 53416 AC004386 5.00E−80 2 Homo SapiensChromosome X clone bWXD691, complete seque 188F1 859 1200 AC004520 0 1BAC clone CTB-119C2 from 7p15, complete sequence Length 523F5 3826938756 AC004644 3.00E−38 1 chromosome 16, cosmid clone 367E12 (LANL),complete seq 142E4 113118 114014 AC004686 0 14 chromosome 17, clonehRPC.1073_F_15, 117050 117275 AC004686 complete sequence 135F10 3946939637 AC004762 3.00E−75 1 chromosome 20, P1 clone 28 (LBNL H134),complete sequen 472C8 120427 120603 AC004838 6.00E−92 1 PAC cloneRP4-589D8 from 7q31.1-q31.3, complete sequenc 464F11 64853 65242AC004849 5.00E−59 2 PAC clone RP4-659J6 from 7q33-q35, complete sequenceLe 460D2 54796 55320 AC004854 0 1 PAC clone RP4-673M15 from 7p13-p11.2,complete sequence 513B4 94866 95147 AC004858 2.00E−57 1 PAC cloneRP4-687K1 from 14, complete sequence Length = 463C7 53959 54083 AC0049061.00E−44 1 PAC clone RP5-852O24 from 7p22, complete sequence Lengt 584D356155 56311 AC004913 5.00E−36 1 clone DJ0876A24, complete sequenceLength = 98870 171B1 23796 24098 AC004918 1.00E−145 1 PAC cloneRP5-894A10 from 7q32-q32, complete sequence L 463B10 33758 34061AC004923 1.00E−135 1 PAC clone RP5-901A4, complete sequence Length =94851 101A1 50075 50425 AC004997 1.00E−129 1 PAC clone RP1-130H16 from22q12.1-qter, complete sequen 465G8 28181 28635 AC005014 0 1 BAC cloneGS1-166A23 from 7p21, complete sequence Lengt 470C3 93162 93469 AC0050681.00E−160 1 BAC clone CTB-137N13 from 7, complete sequence Length =119E5 28806 29061 AC005156 1.00E−119 1 PAC clone RP5-1099C19 from7q21-q22, complete sequence 98C3 24385 25049 AC005192 0 1 BAC cloneCTB-163K11 from 7q31, complete sequence Lengt 140G6 37679 37878 AC0052806.00E−85 1 PAC clone RP1-240K6 from 14, complete sequence Length =476A10 12753 12826 AC005306 8.00E−33 1 chromosome 19, cosmid R27216(LLNLR- 232D4) and 3′ overl 331A12 34177 34328 AC005391 2.00E−72 1chromosome 19, cosmid R29942, complete sequence Length 111H11 8515686081 AC005488 0 2 clone NH0313P13, complete sequence Length = 185737472H11 22517 22813 AC005531 1.00E−150 1 PAC clone RP4-701O16 from7q33-q36, complete sequence L 139G6 96577 97117 AC005540 0 3 cloneRP11-533I8, complete sequence 116180 116836 AC005540 Length = 133761472F4 70951 71038 AC005593 3.00E−41 1 chromosome 5, P1 clone 1369f10(LBNL H28), complete seq 469D4 27949 28457 AC005667 0 1 chromosome 17,clone hRPK.329_E_11, complete sequence L 463A7 127455 127799 AC0057401.00E−154 1 chromosome 5p, BAC clone 50g21 (LBNL H154), complete se126B8 27782 28073 AC005837 1.00E−160 2 chromosome 17, clonehRPK.318_A_15, complete sequence L 479D2 202167 202536 AC005859 2.00E−461 Xp22-83 BAC GSHB-324M7 (Genome Systems BAC Library) com 39G6 6258263099 AC005920 0 1 chromosome 17, clone hRPK.700_H_6, complete sequenceLe 63E1 39129 39250 AC006006 3.00E−59 1 PAC clone RP4-813F11 from7q32-q34, complete sequence L 461B11 140287 140770 AC006010 1.00E−154 2clone DJ0935K16 119G10 81312 81740 AC006033 0 1 BAC clone RP11-121A8from 7p14-p13, complete sequence L 64A2 109063 109613 AC006050 0 2chromosome 17, clone hRPK.268_F_2, complete sequence Le 459B7 1363014294 AC006077 0 1 chromosome 5, P1 clone 254f11 (LBNL H62), completesequ 37H4 58820 59068 AC006111 1.00E−67 1 chromosome 16 cloneRP11-461A8, complete sequence Lengt 512E3 39935 40123 AC006139 3.00E−941 clone UWGC: y55c068 from 6p21, complete sequence Length 171H10 3370433969 AC006165 8.00E−78 1 clone UWGC: y54c125 from 6p21, completesequence Length 72A1 106659 106958 AC006207 1.00E−149 1 12p13.3 BACRPCI3-488H23 (Roswell Park Cancer Institute 195H12 38763 38930 AC0063232.00E−61 1 clone RP5-1151M5, complete sequence Length = 86267 113B636330 36635 AC006344 1.00E−157 1 PAC clone RP4-726N20 from 7q32-q34,complete sequence L 588G6 174012 174265 AC006449 2.00E−93 1 chromosome17, clone hCIT.58_E_17, complete sequence Le 463B2 65534 66031 AC0064830 1 BAC clone CTB-161C1 from 7, complete sequence Length = 115F11 7197672094 AC006511 8.00E−60 1 12p13.1 (17.1-21.3 cM) BAC RPCI11-69M1(Roswell Park Ca 187H11 34068 34544 AC006536 0 1 chromosome 14 cloneBAC257P13 map 14q31, complete seque 477E6 106567 106656 AC0070096.00E−30 1 BAC clone RP11-560C1 from 7p22-p21, complete sequence L 53E10123408 123785 AC007040 0 1 BAC clone RP11-298H3 from 2, completesequence Length = 462C8 164080 164223 AC007068 4.00E−72 2 12p BACRPCI11-75L1 (Roswell Park 174303 174379 AC007068 Cancer Institute BAC478C7 27207 27305 AC007097 4.00E−43 1 BAC clone RP11-332E22 from7q35-q36, complete sequence 181A8 4600 4798 AC007201 5.00E−59 2chromosome 19, cosmid R34383, complete sequence Length 159F6 111852112188 AC007263 1.00E−151 1 chromosome 14 clone RP11-79J20 containinggene for chec 163F10 94927 95303 AC007283 1.00E−126 2 BAC cloneRP11-536I18 from 2, complete sequence Length 124G4 192082 192785AC007318 0 3 clone RP11-420C9, complete sequence Length = 204230 331A5117939 118047 AC007383 3.00E−51 1 BAC clone RP11-310K15 from 2, completesequence Length 463C5 101528 101815 AC007444 9.00E−41 1 clone RP11-340F1from 7p14-15, complete sequence Length 485D5 94681 95267 AC0074581.00E−152 8 12q15 BAC RPCI11-444B24 (Roswell Park 95517 95826 AC007458Cancer Institute 95858 96487 AC007458 96742 96838 AC007458 187608 187732AC007458 181B6 95554 96149 AC007488 0 2 3q27 BAC RPCI11-246B7 (RoswellPark Cancer Institute BA 102E12 12533 12977 AC007540 4.00E−93 1 12q24.1BAC RPCI11-128P10 (Roswell Park Cancer Institut 471C6 9877 10401AC007561 1.00E−160 1 clone RP11-394E1, complete sequence Length = 106093471C1 27629 27769 AC007676 1.00E−27 1 clone RP11-9B17, complete sequenceLength = 152138 40D4 120766 121349 AC007882 0 1 BAC clone RP11-499D5from 7p11.2-q11.2, complete sequen 166C10 90374 90790 AC007899 0 1 BACclone RP11-531C11 from 2, complete sequence Length 492A7 11200 11376AC007911 7.00E−57 1 chromosome 18, clone RP11-520K18, complete sequenceLen 459B3 65768 66232 AC008009 0 2 3q26.2-27 BAC RPCI11-436A20 (RoswellPark Cancer Instit 463F10 127622 127783 AC008083 3.00E−85 1 12 BACRP11-493L12 (Roswell Park Cancer Institute BAC L 585C4 176255 176348AC008124 6.00E−38 1 Chromosome 12q13-62.7-72 BAC RPCI11- 352M15 (RoswellPar 468E6 134033 134685 AC008279 0 2 BAC clone RP11-427F22 from 2,complete sequence Length 112E9 37565 37926 AC008408 0 4 chromosome 5clone CTC-278H1, complete 37996 38360 AC008408 sequence Length 145C5131866 132484 AC008592 1.00E−141 8 chromosome 5 clone CTC-576H9,complete 134190 134862 AC008592 sequence Length 458D8 82521 83080AC008623 0 1 chromosome 19 clone CTB-14D10, complete sequence Length584G2 44371 44929 AC008723 0 2 chromosome 5 clone CTB-95B16, completesequence Length 144F7 73662 74295 AC008750 2.00E−54 2 chromosome 19clone CTD-2616J11, complete sequence Leng 149G2 99171 99875 AC0087601.00E−121 6 chromosome 19 clone CTD-3128G10, complete sequence Leng194H6 52930 53250 AC008795 5.00E−89 2 chromosome 5 clone CTD-2052F19,57088 57263 AC008795 complete sequence Lengt 117H9 101321 102169AC008860 0 11 chromosome 5 clone CTD-2185A1, complete 102715 102980AC008860 sequence Length 103113 103402 AC008860 155D6 34277 34517AC008982 1.00E−103 1 chromosome 19 clone LLNLF-172E10, complete sequenceLen 458E4 33802 34039 AC008985 8.00E−77 1 chromosome 19 cloneLLNLF-198H7, complete sequence Leng 176A6 170428 170746 AC0090731.00E−138 1 chromosome 16 clone RP11-31O11, complete sequence Lengt146D8 11633 11699 AC009086 1.00E−28 1 chromosome 16 clone RP11-368N21,complete sequence Leng 458B8 176406 176888 AC009120 0 1 chromosome 16clone RP11-484E3, complete sequence Lengt 73C4 136885 137479 AC009299 01 BAC clone RP11-26B22 from 2, complete sequence Length = 54F4 202039202564 AC009312 0 1 clone RP11-425F6, complete sequence Length = 204834480E2 143559 143986 AC009313 0 1 BAC clone RP11-440P12 from 2, completesequence Length 519E9 13492 13848 AC009404 1.00E−178 1 BAC cloneRP11-28H22 from 2, complete sequence Length = 129D12 81260 81769AC009466 1.00E−151 1 chromosome 11, clone RP11-87N22, complete sequenceLeng 37E10 124522 125457 AC009477 0 3 BAC clone RP11-209H16 from 2,complete sequence Length 129A12 6750 7331 AC009506 0 1 clone RP11-542H1,complete sequence Length = 191764 515H10 5494 5990 AC009812 3.00E−69 4chromosome 3, clone RP11-48B3, complete 74019 74540 AC009812 sequenceLength 165D1 53879 54343 AC009951 0 1 clone RP11-107E5, completesequence Length = 159791 53D8 30308 30860 AC010132 1.00E−159 1 BAC cloneRP11-111K18 from 7p11.2-p2, complete sequence 487F11 16839 17267AC010480 1.00E−130 3 chromosome 5 clone CTD-2315M5, complete sequenceLength 461G10 8988 9327 AC010677 1.00E−163 1 BAC clone CTD-2304L4 from7, complete sequence Length = 115H2 19073 19679 AC010789 4.00E−97 2chromosome 10, clone RP11-190J1, 126247 126428 AC010789 completesequence Leng 168A9 78976 79540 AC010877 0 2 BAC clone RP11-218F6 fromY, complete sequence Length = 468G6 98034 98744 AC010878 1.00E−107 3clone RP11-230E20, complete sequence Length = 154115 477B12 167367167895 AC010913 0 1 BAC clone RP11-44N22 from 2, complete sequenceLength = 192E1 10683 11328 AC011245 0 1 clone RP11-498O5, completesequence Length = 56793 467C2 4521 4890 AC011462 1.00E−178 1 chromosome19 clone CTC-435M10, complete sequence Lengt 189F3 12090 12208 AC0114958.00E−60 1 chromosome 19 clone CTB-33G10, complete sequence Length 144C938166 38421 AC011500 1.00E−62 1 chromosome 19 clone CTB-60E11, completesequence Length 162E8 41387 41499 AC012005 8.00E−30 1 clone RP11-533E23,complete sequence Length = 189557 158G6 70285 70462 AC012170 3.00E−95 1chromosome 15 clone RP11-562A8 map 15q21.1, complete se 189B11 1912719241 AC013436 8.00E−29 3 BAC clone RP11-105B9 from 7, complete 2319623655 AC013436 sequence Length = 98C9 178883 179326 AC015651 1.00E−107 1chromosome 17, clone RP11-55A13, complete sequence Leng 69F8 57839 58168AC015819 0 1 chromosome 18, clone RP11-405M12, complete sequence Len47F9 3198 3826 AC016395 0 1 chromosome 10 clone RP11-153K11, completesequence Leng 480E3 39766 40155 AC016623 2.00E−35 1 chromosome 5 cloneCTD-2345N17, complete sequence Lengt 196G12 59552 60523 AC016637 0 2chromosome 5 clone RP11-34J15, complete sequence Length 518A8 6101161433 AC016751 0 1 BAC clone RP11-504O20 from 2, complete sequenceLength 36C11 54765 54868 AC017002 2.00E−30 2 clone RP11-68E19, completesequence Length = 205662 489H9 108513 109049 AC017003 0 2 cloneRP11-78C11, complete sequence Length = 118385 479H6 142657 142930AC017020 8.00E−45 1 BAC clone RP11-185K15 from Y, complete sequenceLength 483D10 99413 99875 AC017101 0 1 clone RP11-556A11, completesequence Length = 195635 112B4 87464 88155 AC018511 1.00E−129 2chromosome 10 clone RP11-77G23, 117653 117940 AC018511 complete sequenceLengt 171F2 157933 158203 AC018673 2.00E−96 1 clone RP11-145A4, completesequence Length = 187099 166H12 116351 116665 AC018682 1.00E−177 1 cloneRP11-417F21, complete sequence Length = 181405 123F8 140561 141314AC018904 0 3 chromosome 15 clone RP11-50C13 map 15q21.3, complete se116C9 191414 191866 AC019206 0 1 BAC clone RP11-401N16 from 2, completesequence Length 472E9 148765 149172 AC020550 1.00E−140 1 BAC cloneRP11-198M19 from 2, complete sequence Length 129D1 66284 67154 AC0205950 3 BAC clone RP11-358M9 from 2, complete sequence Length = 465H10 8247683166 AC020629 0 2 12q BAC RP11-76E16 (Roswell Park Cancer Institute BACL 182E2 83346 83465 AC020716 1.00E−33 2 clone RP11-449G13, completesequence 84373 84451 AC020716 Length = 171805 37G8 35257 35957 AC0207500 1 chromosome 3 clone RP11-105H19 map 3p, complete sequenc 125F8 4385444125 AC022007 1.00E−149 1 chromosome 3 clone RP11-481H17 map 3p,complete sequenc 523A8 2991 3475 AC022149 0 1 chromosome 19 cloneCTD-3093B17, complete sequence Leng 459E7 90726 91104 AC022173 0 1chromosome 7 clone RP11-29B3, complete sequence Length 469F8 53281 53724AC022336 6.00E−92 1 3 BAC RP11-71H17 (Roswell Park Cancer Institute BACLib 463H5 75118 75256 AC022382 5.00E−72 1 chromosome 3 clone RP11-266J6map 3p, complete sequence 466G7 20276 20522 AC023058 2.00E−53 2 3 BACCTB-187G23 (CalTech BAC Library 21327 21875 AC023058 B) complete seque470B8 127894 128301 AC024568 1.00E−169 1 chromosome 5 clone CTD-2179L22,complete sequence Lengt 473E11 21558 21818 AC024939 1.00E−117 1 12 BACRP11-485K18 (Roswell Park Cancer institute BAC L 470E1 150190 150573AC025165 1.00E−171 1 12 BAC RP11-571M6 (Roswell Park Cancer InstituteBAC Li 480B5 107499 107766 AC025253 9.00E−66 1 12 BAC RP11-499A10(Roswell Park Cancer Institute BAC L 583B5 27783 27958 AC025257 1.00E−441 12 BAC RP11-56G10 (Roswell Park Cancer Institute BAC Li 37H8 8611886418 AC026425 1.00E−148 1 chromosome 5 clone CTD-2183D23, completesequence Lengt 166A9 119110 119797 AC026794 0 1 chromosome 5 cloneCTD-2276B5, complete sequence Length 103D4 105697 105794 AC0342405.00E−40 2 chromosome 5 clone CTD-2335C11, complete sequence Lengt 117H449581 49962 AC053513 0 1 clone RP11-359J14, complete sequence Length =155958 459B8 64143 64709 AC066580 0 1 chromosome 3 clone RP11-109J15 map3p, complete sequenc 174D1 41807 42055 AC067945 2.00E−69 2 cloneRP11-629B4, complete sequence 115078 115365 AC067945 Length = 162471178F5 105048 105223 AC068492 7.00E−37 1 BAC clone RP11-809C23 from 2,complete sequence Length 66E6 2116 2578 AC068499 1.00E−135 2 chromosome19, cosmid R26574 (LLNL- R_225F10), complete 178C12 15618 15959 AC0687890 1 12 BAC RP11-1049A21 (Roswell Park Cancer Institute BAC 145F12 110468110647 AC069298 3.00E−89 4 chromosome 3 clone RP11-56K23, complete110779 111202 AC069298 sequence Length 141211 141790 AC069298 519F3159763 160355 AC069304 0 1 BAC clone RP11-632K21 from 7, completesequence Length 464B11 52608 53051 AC073347 0 1 BAC clone RP11-775L16from 7, complete sequence Length 469E12 85540 85930 AC073917 0 2 12q BACRP11-415D21 (Roswell Park Cancer Institute BAC 118C12 141407 141495AC083868 6.00E−70 3 chromosome 7 clone RP11-148L5, complete 142293142607 AC083868 sequence Length 168G5 6632 7097 AC087065 0 2 chromosome22q11 clone cos6, complete sequence Length = 479G12 127024 127342AC090942 1.00E−119 1 chromosome 3 clone RP11-220D14 map 3p, completesequenc 122G1 41957 42383 AC091118 0 1 chromosome 16 clone CTC-510K1,complete sequence Length 479D7 153992 154141 AF001549 6.00E−29 1Chromosome 16 BAC clone CIT987SK-A- 270G1, complete sequ 461H7 2197722331 AF015262 2.00E−69 1 chromosome 21 clone Pac 255P7 map 21q- AML,complete seq 463E9 27006 27615 AF015725 0 1 chromosome 21 clone cosmidclone D68F9 map 21q22.2, com 480D9 15848 16252 AF027207 1.00E−123 1chromosome 21 clone cosmid D13C2 map 21q22.2, complete 465E9 296143296800 AF131216 0 1 chromosome 8 map 8p23-p22 clones CTB- 164D9,CTB-169o5, 469D2 23811 24045 AF161800 2.00E−78 1 chromosome 8q21.2 BAC189m5, complete sequence Length = 37G7 200214 200755 AJ003147 0 2complete genomic sequence between 201078 201309 AJ003147 D16S3070 andD16S3275 459A1 36969 37402 AL008730 8.00E−82 2 DNA sequence from PAC487J7 on chromosome 6q21-22.1. Co 480C8 37929 38457 AL008733 0 1 DNAsequence from clone RP1-163G9 on chromosome 1p36.2- 462D9 36712 37037AL021878 0 2 DNA sequence from clone RP1-257I20 on 40603 40772 AL021878chromosome 22q13. 182H1 30506 30760 AL022238 3.00E−96 2 DNA sequencefrom clone RP5-1042K10 on chromosome 22q13 166F6 75035 75547 AL022240 01 DNA sequence from clone 328E19 on chromosome 1q12-21.2 165C12 179455179766 AL022329 1.00E−175 1 DNA sequence from clone CTA-407F11 onchromosome 22q12 465A12 26329 26834 AL022331 0 1 DNA sequence from cloneCTA-440B3 on chromosome 22q12.1 524D1 70719 70891 AL022394 2.00E−87 1DNA sequence from clone RP3-511B24 on chromosome 20q11. 53E3 129077129538 AL022396 0 1 DNA sequence from PAC 380E11 on chromosome6p22.3-p24. 126D1 69809 70220 AL031178 0 1 DNA sequence from cloneRP3-341E18 on chromosome 6p11.2 466A9 103757 104346 AL031277 0 1 DNAsequence from clone 1177E19 on chromosome 1p36.12-3 472E11 41594 41778AL031595 9.00E−97 1 DNA sequence from clone RP4-671O14 on chromosome22q13. 462E8 72042 72629 AL031672 0 1 DNA sequence from clone RP4-691N24on chromosome 20p11. 478C2 29633 29708 AL031708 9.00E−28 1 DNA sequencefrom clone LA16-315G5 on chromosome 16, co 53B1 30963 31311 AL0317291.00E−163 1 DNA sequence from clone RP1-159A19 on chromosome 1p36.1178B2 38674 38800 AL033383 3.00E−27 1 DNA sequence from cloneRP5-1013A10 on chromosome 6p24. 104A7 40604 41062 AL033397 0 1 DNAsequence from clone 27K12 on chromosome 6p11.2-12.3 190F11 77693 78285AL033519 0 1 DNA sequence from clone RP3-340B19 on chromosome 6p21.2121A11 15252 15679 AL034344 9.00E−52 1 DNA sequence from cloneRP1-118B18 on chromosome 6p24.1 173B5 102500 102752 AL034384 7.00E−58 1chromosome Xq28, cosmid clones 7H3, 14D7, C1230, 11E7, 121A12 3456634684 AL034397 6.00E−47 1 DNA sequence from clone 159A1 on chromosomeXq12-13.3. 104B10 73639 74045 AL034418 1.00E−176 1 DNA sequence fromclone RP5-1049G16 on chromosome 20q12 471F1 37083 37364 AL0345531.00E−150 1 DNA sequence from clone RP5-914P20 on chromosome 20q13.463H8 97563 97753 AL035405 1.00E−102 1 DNA sequence from clone 21O18 onchromosome 1p35.1-36.2 472E6 20949 21271 AL035413 1.00E−155 1 DNAsequence from clone RP4-657E11 on chromosome 1p35.1 121F1 65029 65503AL035455 0 1 DNA sequence from clone RP5-1018E9 on chromosome 20q13.465B1 37269 37445 AL035530 2.00E−47 1 DNA sequence from clone RP1-111C20on chromosome 6q25.3 482C9 64837 65129 AL035662 1.00E−163 1 DNA sequencefrom clone RP4-599F21 on chromosome 20q12- 166B9 39808 39976 AL0497151.00E−87 1 DNA sequence from clone RP4-646P11 on chromosome 1, com 591D665470 65892 AL049795 0 1 DNA sequence from clone RP4-622L5 on chromosome1p34.2- 72G1 82160 82440 AL049829 1.00E−148 1 chromosome 14 DNA sequence*** IN PROGRESS *** BAC R-12 112H3 2111 2535 AL050330 0 2 DNA sequencefrom clone RP1-3E1 on chromosome 6p21.23-2 479G5 18853 19244 AL0967121.00E−125 1 DNA sequence from clone RP4-744I24 on chromosome 6p12.1464C10 80145 80583 AL096773 4.00E−85 1 DNA sequence from clone 1000E10on chromosome 1p12-13.3 123D11 34999 35510 AL096808 1.00E−166 1 genomicregion containing hypervariable minisatellites 129F10 1148 2507 AL1096160 95 chromosome 21 Cosmid LLNLc116L1110, complete sequence L 469B8 1315513527 AL109755 0 1 DNA sequence from clone RP3-340H11 on chromosome6q24.1 105F4 57995 58306 AL109758 5.00E−98 1 chromosome 14 DNA sequence*** IN PROGRESS *** BAC R-87 465H5 136248 136356 AL109847 7.00E−29 1chromosome 14 DNA sequence BAC R- 603H7 of library RPCI- 60G8 8470684959 AL109914 1.00E−135 1 DNA sequence from clone RP11-27F12 onchromosome 6p22.3 102A8 169378 169473 AL109918 2.00E−34 1 DNA sequencefrom clone RP1-152L7 on chromosome 6p11.2- 471D6 63862 64021 AL1171864.00E−80 1 chromosome 14 DNA sequence *** IN PROGRESS *** BAC R-29176E10 145991 146554 AL117258 3.00E−63 1 chromosome 14 DNA sequence BACR- 244E17 of library RPCI 480E7 2975 3356 AL117352 1.00E−153 1 DNAsequence from clone RP5-876B10 on chromosome 1q42.1 110D3 48631 48886AL121573 3.00E−65 2 DNA sequence from clone RP1-306F2 on chromosome6p12.1- 40B2 106788 107123 AL121657 2.00E−42 1 BAC sequence from theSPG4 candidate region at 2p21-2p2 52B9 56473 56690 AL121899 1.00E−104 2DNA sequence from clone RP11-128M1 on chromosome 20. Co 485A6 5475 7084AL121985 1.00E−138 7 DNA sequence from clone RP11-404F10 on 15867 16574AL121985 chromosome 1q23. 17098 17504 AL121985 24037 24292 AL121985 40E454176 54528 AL121998 1.00E−179 1 DNA sequence from clone RP5-1103B4 onchromosome 1 Cont 118H12 21398 21744 AL132838 0 1 chromosome 14 DNAsequence BAC R- 85G20 of library RPCI- 599F11 153822 154345 AL133153 0 1chromosome 14 DNA sequence BAC R- 895M11 of library RPCI 478G8 115784116115 AL133243 1.00E−120 1 BAC sequence from the SPG4 candidate regionat 2p21-2p2 107H8 119760 120729 AL133330 0 22 DNA sequence from cloneRP1-68D18 on 121182 121863 AL133330 chromosome 11p12-1 122773 122940AL133330 143751 144379 AL133330 146057 147016 AL133330 159262 159639AL133330 471E7 127891 128013 AL133340 6.00E−46 1 DNA sequence from cloneRP11-204H22 on chromosome 20. C 118H5 3922 4021 AL133392 1.00E−38 2 DNAsequence from clone CITF22-45C1 on 4557 5184 AL133392 chromosome 22 Co40A3 96202 96785 AL133412 0 3 DNA sequence from clone RP11-131A5 on97177 97568 AL133412 chromosome 9q22.1 482A5 28668 29037 AL1334153.00E−34 4 DNA sequence from clone RP11-124N14 on 51083 51210 chromosome10. C 54G9 54866 55153 AL135783 1.00E−154 1 DNA sequence from cloneRP3-527F8 on chromosome Xq25-27 515C12 72222 72601 AL135818 1.00E−146 2chromosome 14 DNA sequence BAC C- 2547L24 of library Cal 109A9 5317153447 AL136320 1.00E−137 1 DNA sequence from clone RP3-323N1 onchromosome 10. Con 476H10 127150 127680 AL137017 0 1 DNA sequence fromclone RP11-120J1 on chromosome 9 Cont 192C3 122511 122837 AL1371001.00E−117 1 chromosome 14 DNA sequence BAC R- 108M12 of library RPCl55G3 38923 39058 AL137142 7.00E−44 2 DNA sequence from clone RP11-173P16on 42456 42686 AL137142 chromosome 13q12 466G2 24290 24402 AL1371449.00E−42 1 DNA sequence from clone RP11-210E23 on chromosome 13q31 140F927354 27715 AL137798 8.00E−82 1 DNA sequence from clone RP5-1182A14 onchromosome 1 Con 37A2 134590 134750 AL137800 3.00E−69 1 DNA sequencefrom clone RP1 -127C7 on chromosome 1q25.1- 493C2 734 1052 AL1387141.00E−157 1 DNA sequence from clone RP11-121J7 on chromosome 13q32.468B9 1911 2509 AL138717 9.00E−70 1 DNA sequence from clone RP11-11D8 onchromosome 6 Conta 194F9 46595 46814 AL138755 6.00E−94 1 DNA sequencefrom clone RP11-48M17 on chromosome 9p24.1 483D12 80220 80755 AL1387761.00E−157 1 DNA sequence from clone RP11-20H6 on chromosome 1q25.1-464G9 14032 14659 AL139020 0 1 chromosome 14 DNA sequence BAC R- 164H13of library RPCI 59G1 34476 34936 AL139274 0 1 DNA sequence from cloneRP11-393I2 on chromosome 6, com 129D3 65447 65661 AL139289 1.00E−107 2DNA sequence from clone RP1-92O14 on 66950 67158 AL139289 chromosome1p33-34 464C2 55616 56289 AL139328 0 1 DNA sequence from clone RP11-84N7on chromosome 13. Con 57H10 155342 155810 AL139330 0 2 DNA sequence fromclone RP11-266C7 on chromosome 6q25.2 470G6 44695 44978 AL1393991.00E−130 1 DNA sequence from clone RP11-574A21 on chromosome Xq2l.476F5 42969 43159 AL139801 5.00E−98 1 DNA sequence from clone RP11-247M1on chromosome 13, co 107G11 139776 140378 AL157402 0 2 DNA sequence fromclone RP11-553K8 on chromosome 1q31.2 172B12 136072 136492 AL1577681.00E−155 1 DNA sequence from clone RP11-481A22 on chromosome 13 Co149A11 438 663 AL157776 1.00E−123 1 DNA sequence from clone RP11-68J15on chromosome 6, com 165E7 66361 67034 AL157789 0 1 chromosome 14 DNAsequence BAC R- 880O3 of library RPCI- 192B3 51907 52253 AL1579381.00E−176 1 DNA sequence from clone RP11-544A12 on chromosome 9q34.50A11 5753 5886 AL158136 1.00E−59 1 DNA sequence from clone RP1-44N23 onchromosome 6 Conta 472F9 84638 85232 AL158159 0 1 DNA sequence fromclone RP11-498N2 on chromosome 9, com 462G12 132520 132708 AL1601552.00E−95 1 DNA sequence from clone RP11-461N23 on chromosome 13, c 117H61976 2518 AL160233 0 1 chromosome 14 DNA sequence BAC C- 2373J19 oflibrary Cal 460B9 207 739 AL160408 1.00E−104 2 DNA sequence from cloneRP4-781K5 on 2023 2537 AL160408 chromosome 1q42.1- 467F10 8461 8829AL161627 1.00E−122 1 DNA sequence from clone RP11-287A8 on chromosome 9,com 469A10 81966 82313 AL161781 1.00E−175 1 DNA sequence from cloneRP11-297B17 on chromosome 9, co 598H2 222231 222679 AL162151 0 1chromosome 14 DNA sequence *** IN PROGRESS*** BAC C-31 466C5 147064147687 AL162578 0 1 DNA sequence from clone RP11-2J18 on chromosome 6,comp 467C9 216403 216544 AL163303 3.00E−38 1 chromosome 21 segmentHS21C103 Length = 340000 462H9 63385 63502 AL163853 6.00E−59 1chromosome 14 DNA sequence BAC R- 248B10 of library RPCI 464A10 6342163807 AL353744 2.00E−55 1 clone RP13-100-A9 on chromosome X 99E10 67897153 AL353804 0 1 DNA sequence from clone RP13-216E22 on chromosomeXq13. 477D10 49708 50171 AL354716 4.00E−96 1 DNA sequence from cloneRP11-86F4 on chromosome 6, comp 518F10 3379 3602 AL354891 2.00E−94 1 DNAsequence from clone RP11-44I7 on chromosome 13, com 464D8 122494 122702AL354977 1.00E−87 2 DNA sequence from clone RP11-509J21 on chromosome 9,co 459H6 109525 109864 AL355520 1.00E−179 1 DNA sequence from cloneRP4-595C2 on chromosome 1q24.1- 196C6 21603 21783 AL355615 7.00E−96 2DNA sequence from clone RP11-33E24 on chromosome 6, com 110B8 1190712312 AL355797 1.00E−145 1 DNA sequence from clone RP1-9E2 on chromosome6, comple 180B2 142517 142726 AL355871 1.00E−72 1 DNA sequence fromclone RP11-47K11 on chromosome 1, com 464H5 50106 50463 AL356276 0 2 DNAsequence from clone RP11-367J7 on chromosome 1. Con 105H4 32156 32236AL356379 2.00E−27 2 DNA sequence from clone RP1-63P18 on 32440 32804AL356379 chromosome 1. Cont 113H1 22550 22837 AL356481 1.00E−160 1 DNAsequence from clone RP11-216B9 on chromosome 9, com 170F7 46442 46855AL357374 0 1 DNA sequence from clone RP11-353C18 on chromosome 20 Co522D3 113148 113424 AL360182 1.00E−127 1 DNA sequence from cloneRP11-549L6 on chromosome 10, co 36E9 38157 38346 AL390196 4.00E−47 9clone RP11-60E24 on chromosome 6 587E3 15704 16062 AL442128 1.00E−173 2DNA sequence from clone RP11-365P13 on chromosome 13, c 468E8 5277953344 AL445201 1.00E−123 1 DNA sequence from clone RP11-358L16 onchromosome 10, c 39G11 106047 106169 AL445687 2.00E−26 1 cloneRP11-567B20 on chromosome 1 101F1 1538 1656 AL449244 5.00E−44 2 Novelhuman gene mapping to chomosome 1676 2096 AL449244 22 Length = 2315466D1 56761 56929 AL450344 5.00E−85 1 DNA sequence from cloneRP11-136K14 on chromosome 6 Con 142E9 116227 116568 AL590763 0 8chromosome X sequence from 6 PACs 1 116669 117358 AL590763 BAC and 1cosmid, r 154792 155165 AL590763 459E9 26826 26890 AP000471 2.00E−27 1genomic DNA, chromosome 21q22.3, clone:B2308H15 Length 472C1 95646 96035AP000501 1.00E−101 1 genomic DNA, chromosome 8p11.2, clone:91h23 to 9-41Len 464A7 7930 8285 AP000526 1.00E−178 1 genomic DNA, chromosome22q11.2, Cat Eye Syndrome regio 165E11 643 1244 AP000554 1.00E−147 2genomic DNA, chromosome 22q11.2, BCRL2 region, clone:KB 72D8 27091 27486AP000555 0 1 genomic DNA, chromosome 22q11.2, BCRL2 region, clone:KB470B4 15634 15703 AP001429 5.00E−28 1 genomic DNA, chromosome 21q22.2,clone:T1212, LB7T-ERG 59E12 59103 59520 AP001574 1.00E−144 2 genomicDNA, chromosome 8q23, clone: 60671 61189 AP001574 KB1991G8 Length =138G5 313261 313931 AP001693 1.00E−31 27 genomic DNA, chromosome 21q,section 315877 315967 AP001693 37/105 Length = 34 319062 319564 AP001693319957 320293 AP001693 320563 321212 AP001693 328757 329184 AP001693158G11 107888 108375 AP001721 0 1 genomic DNA, chromosome 21q, section65/105 Length = 34 462F9 330129 330645 AP001728 1.00E−133 1 genomic DNA,chromosome 21q, section 72/105 Length = 34 479A12 74529 74902 AP0029071.00E−141 1 genomic DNA, chromosome 8q23, clone: KB431C1 Length = 9470B2 123506 123689 AP003117 4.00E−72 2 genomic DNA, chromosome 8q23,clone: KB1958F4 Length = 46D1 79174 79657 AP003471 1.00E−164 2 genomicDNA, chromosome 8q23, clone: 83490 84099 AP003471 KB1552D7 Length =496C4 745790 746197 NT_004406 0 1 chromosome 1 working draft sequencesegment 468E10 2015 2118 NT_004452 2.00E−32 2 chromosome 1 working draftsequence segment 479H12 394087 394676 NT_004480 0 1 chromosome 1 workingdraft sequence segment 472G2 268543 268642 NT_004525 3.00E−42 1chromosome 1 working draft sequence segment 477D9 231154 231469NT_004531 1.00E−177 1 chromosome 1 working draft sequence segment 460F7786014 786511 NT_004623 0 1 chromosome 1 working draft sequence segment171F11 1E+06 1036701 NT_004658 1.00E−26 1 chromosome 1 working draftsequence segment 184H1 2E+06 1770512 NT_004698 0 4 chromosome 1 workingdraft sequence 2E+06 1822054 NT_004698 segment 2E+06 1832854 NT_004698514H9 289858 289941 NT_004705 1.00E−29 1 chromosome 1 working draftsequence segment 463G1 175158 175615 NT_004725 0 1 chromosome 1 workingdraft sequence segment 466C9 543567 544240 NT_004753 0 1 chromosome 1working draft sequence segment 496D7 2E+06 1515549 NT_004754 0 1chromosome 1 working draft sequence segment 583G8 733247 733667NT_004771 1.00E−128 1 chromosome 1 working draft sequence segment 124D2107397 107739 NT_004916 1.00E−178 1 chromosome 1 working draft sequencesegment 479A8 285973 286345 NT_005130 1.00E−165 1 chromosome 2 workingdraft sequence segment 165F7 1E+06 1435537 NT_005151 1.00E−125 1chromosome 2 working draft sequence segment 465F7 773772 774502NT_005166 0 2 chromosome 2 working draft sequence segment 73A3 8091981448 NT_005182 0 2 chromosome 2 working draft sequence 81502 81742NT_005182 segment 124G7 2E+06 1859389 NT_005204 1.00E−180 1 chromosome 2working draft sequence segment 479G6 552674 553005 NT_005229 1.00E−141 5chromosome 2 working draft sequence 1E+06 1122605 NT_005229 segment194C2 481052 481444 NT_005230 1.00E−101 1 chromosome 2 working draftsequence segment 159F11 795978 796616 NT_005275 0 1 chromosome 2 workingdraft sequence segment 472B1 1013 1410 NT_005311 0 1 chromosome 2working draft sequence segment 470G7 375182 375594 NT_005399 0 1chromosome 2 working draft sequence segment 100C3 803712 804094NT_005420 0 2 chromosome 2 working draft sequence 970577 971108NT_005420 segment 98H4 2E+06 1829143 NT_005423 0 1 chromosome 2 workingdraft sequence segment 105A10 1E+06 1144092 NT_005435 1.00E−167 2chromosome 2 working draft sequence segment 465C3 13444 13890 NT_0054710 1 chromosome 2 working draft sequence segment 112E5 3169 3793NT_005485 0 1 chromosome 2 working draft sequence segment 111H6 146878146999 NT_005499 2.00E−55 1 chromosome 3 working draft sequence segment467G7 198880 199329 NT_005505 0 1 chromosome 3 working draft sequencesegment 182F12 140059 140193 NT_005516 1.00E−144 3 chromosome 3 workingdraft sequence 140754 141039 NT_005516 segment 112B5 137689 138300NT_005529 0 4 chromosome 3 working draft sequence segment 64B3 5521355793 NT_005535 0 1 chromosome 3 working draft sequence segment 465E12866776 867258 NT_005769 0 2 chromosome 3 working draft sequence 1E+061021292 NT_005769 segment 470D5 1E+06 1395364 NT_005795 1.00E−147 3chromosome 3 working draft sequence 2E+06 1749621 NT_005795 segment479G2 294179 294607 NT_005910 0 1 chromosome 3 working draft sequencesegment 112E1 392884 393490 NT_005973 0 1 chromosome 3 working draftsequence segment 466H5 339511 340153 NT_005985 0 2 chromosome 3 workingdraft sequence segment 189A8 22414 22869 NT_005991 1.00E−110 1chromosome 3 working draft sequence segment 45H8 1E+06 1012040 NT_0060981.00E−113 1 chromosome 4 working draft sequence segment 104D1 282259282753 NT_006102 0 2 chromosome 4 working draft sequence segment 459G8367701 368248 NT_006111 0 1 chromosome 4 working draft sequence segment480E11 486179 486804 NT_006114 0 1 chromosome 4 working draft sequencesegment 115G2 4E+06 3514655 NT_006204 1.00E−177 1 chromosome 4 workingdraft sequence segment 479G3 71744 72258 NT_006258 0 1 chromosome 4working draft sequence segment 461H11 378023 378482 NT_006397 0 1chromosome 4 working draft sequence segment 462F11 80360 81081 NT_0064100 1 chromosome 4 working draft sequence segment 463A5 2E+06 1609976NT_006489 1.00E−138 1 chromosome 5 working draft sequence segment 464C5190095 190533 NT_006611 0 2 chromosome 5 working draft sequence segment109H9 89260 89769 NT_006946 0 3 chromosome 5 working draft sequencesegment 137B5 2E+06 1613357 NT_006951 1.00E−86 4 chromosome 5 workingdraft sequence segment 73H4 992358 992685 NT_007288 0 1 chromosome 6working draft sequence segment 174H6 431672 432054 NT_007308 0 1chromosome 6 working draft sequence segment 124C8 282413 283138NT_007951 0 1 chromosome 7 working draft sequence segment 174G11 829762830370 NT_007972 0 1 chromosome 8 working draft sequence segment 471H11613132 613314 NT_007978 9.00E−96 1 chromosome 8 working draft sequencesegment 471G8 189279 189630 NT_008012 1.00E−147 1 chromosome 8 workingdraft sequence segment 67C5 287017 287563 NT_008037 0 2 chromosome 8working draft sequence segment 479H4 90555 90944 NT_008047 1.00E−174 1chromosome 8 working draft sequence segment 100D7 64180 64371 NT_0080501.00E−134 6 chromosome 8 working draft sequence 331150 331412 NT_008050segment 45B9 479878 480193 NT_008060 1.00E−165 12 chromosome 8 workingdraft sequence 489788 490607 NT_008060 segment 169F11 291836 292284NT_008081 0 1 chromosome 8 working draft sequence segment 468H11 106661106897 NT_008128 1.00E−121 2 chromosome 8 working draft sequence 110374110691 NT_008128 segment 470H6 520107 520754 NT_008139 0 1 chromosome 8working draft sequence segment 471F9 392744 393279 NT_008157 0 1chromosome 8 working draft sequence segment 469G8 433686 434156NT_008338 0 1 chromosome 9 working draft sequence segment 193E6 1E+061228306 NT_008445 6.00E−56 1 chromosome 9 working draft sequence segment480D2 90407 90990 NT_008484 0 1 chromosome 9 working draft sequencesegment 58G4 1E+06 1055972 NT_008513 1.00E−139 1 chromosome 9 workingdraft sequence segment 490F10 669853 669980 NT_008653 5.00E−39 2chromosome 10 working draft sequence 743459 744217 NT_008653 segment463B3 1E+06 1369815 NT_008682 0 1 chromosome 10 working draft sequencesegment 116E10 1E+06 1462064 NT_008769 0 5 chromosome 10 working draftsequence 2E+06 2026887 NT_008769 segment 2E+06 2027460 NT_008769 2E+062028265 NT_008769 190A9 806672 807345 NT_008774 0 4 chromosome 10working draft sequence segment 473B7 75339 75524 NT_008783 4.00E−72 2chromosome 10 working draft sequence 75869 76181 NT_008783 segment490A11 484304 484753 NT_008921 0 1 chromosome 10 working draft sequencesegment 585E10 328767 329151 NT_008978 0 1 chromosome 11 working draftsequence segment 458B9 955258 955846 NT_009073 0 1 chromosome 11 workingdraft sequence segment 471F4 288811 289312 NT_009107 0 1 chromosome 11working draft sequence segment 478H7 1E+06 1255050 NT_009184 1.00E−92 1chromosome 11 working draft sequence segment 109F10 1E+06 1136705NT_009314 1.00E−171 1 chromosome 11 working draft sequence segment 117F1401530 402043 NT_009334 0 2 chromosome 11 working draft sequence 2E+061600694 NT_009334 segment 467B6 3E+06 3011938 NT_009338 5.00E−93 2chromosome 11 working draft sequence segment 158H6 351515 351940NT_009438 0 2 chromosome 12 working draft sequence segment 471C2 977560977791 NT_009452 1.00E−127 1 chromosome 12 working draft sequencesegment 182G2 21455 21913 NT_009458 0 3 chromosome 12 working draftsequence 167133 167630 NT_009458 segment 462B12 518389 518876 NT_0094640 1 chromosome 12 working draft sequence segment 458A3 2E+06 1890445NT_009471 0 1 chromosome 12 working draft sequence segment 470D7 954010050 NT_009540 0 1 chromosome 12 working draft sequence segment 525F3163261 163590 NT_009616 1.00E−125 1 chromosome 12 working draft sequencesegment 186E8 2E+06 1502030 NT_009714 0 1 chromosome 12 working draftsequence segment 465G2 2E+06 1787964 NT_009759 1.00E−130 2 chromosome 12working draft sequence segment 476C1 321714 322118 NT_009763 1.00E−170 1chromosome 12 working draft sequence segment 476G8 2E+06 1609230NT_009770 6.00E−26 1 chromosome 12 working draft sequence segment 588E41E+06 1136791 NT_010036 1.00E−134 1 chromosome 14 working draft sequencesegment 479H5 2E+06 2151529 NT_010062 0 1 chromosome 14 working draftsequence segment 178C10 6E+06 6026576 NT_010113 0 1 chromosome 14working draft sequence segment 192C9 5E+06 5344032 NT_010194 0 1chromosome 15 working draft sequence segment 119F12 3E+06 2680702NT_010204 1.00E−128 1 chromosome 15 working draft sequence segment 67G10112609 112890 NT_010222 1.00E−132 2 chromosome 15 working draft sequencesegment 98C1 6684 7232 NT_010237 0 1 chromosome 15 working draftsequence segment 458G10 478693 479052 NT_010253 1.00E−120 1 chromosome15 working draft sequence segment 459D1 2E+06 2123962 NT_010289 0 1chromosome 15 working draft sequence segment 110G1 303146 303706NT_010308 0 1 chromosome 15 working draft sequence segment 73A4 758542758734 NT_010310 6.00E−42 1 chromosome 15 working draft sequence segment470F5 495497 496038 NT_010360 0 1 chromosome 15 working draft sequencesegment 469B6 1E+06 1095404 NT_010419 1.00E−123 1 chromosome 16 workingdraft sequence segment 479E10 468259 468674 NT_010432 0 1 chromosome 16working draft sequence segment 100F5 177425 177795 NT_010505 1.00E−169 1chromosome 16 working draft sequence segment 462C5 22345 22727 NT_0105230 1 chromosome 16 working draft sequence segment 71H3 125549 125838NT_010530 5.00E−77 1 chromosome 16 working draft sequence segment 161E81E+06 1067677 NT_010641 1.00E−123 1 chromosome 17 working draft sequencesegment 464D9 120516 121079 NT_010657 0 1 chromosome 17 working draftsequence segment 114G3 385825 386329 NT_010672 1.00E−152 3 chromosome 17working draft sequence 387069 387398 NT_010672 segment 424808 425286NT_010672 459E6 262663 263161 NT_010757 0 1 chromosome 17 working draftsequence segment 134H3 583781 583868 NT_010799 7.00E−32 1 chromosome 17working draft sequence segment 467E5 1E+06 1376833 NT_010808 0 1chromosome 17 working draft sequence segment 462A11 436300 437040NT_010816 0 2 chromosome 17 working draft sequence segment 460C2 168998169554 NT_010833 0 1 chromosome 17 working draft sequence segment 467A8480458 480865 NT_010986 0 1 chromosome 18 working draft sequence segment480F8 137902 138430 NT_011029 0 1 chromosome 18 working draft sequencesegment 470F8 472324 472740 NT_011141 0 1 chromosome 19 working draftsequence segment 100E3 445588 445677 NT_011145 2.00E−37 2 chromosome 19working draft sequence 445757 446041 NT_011145 segment 104A12 169627169811 NT_011240 2.00E−99 1 chromosome 19 working draft sequence segment69B10 358921 359000 NT_011245 6.00E−37 1 chromosome 19 working draftsequence segment 465C7 243467 243788 NT_011269 0 1 chromosome 19 workingdraft sequence segment 464E7 1E+06 1182829 NT_011597 1.00E−107 1chromosome X working draft sequence segment 61A11 67055 67582 NT_0117240 1 chromosome X working draft sequence segment 140G10 761394 761693NT_015805 1.00E−138 3 chromosome 2 working draft sequence 761753 762151NT_015805 segment 486C4 503899 504524 NT_016354 0 2 chromosome 4 workingdraft sequence segment 480G4 260275 260648 NT_016355 0 1 chromosome 4working draft sequence segment 461G8 276786 277233 NT_016593 0 1chromosome 4 working draft sequence segment 118D9 413201 413343NT_016968 7.00E−46 1 chromosome 6 working draft sequence segment 68C92E+06 2193260 NT_017568 1.00E−169 1 chromosome 9 working draft sequencesegment 470E5 526603 527148 NT_017582 1.00E−131 2 chromosome 9 workingdraft sequence segment 127H8 248872 249411 NT_019390 0 1 chromosome 5working draft sequence segment 47G6 204946 205445 NT_019447 0 1chromosome 7 working draft sequence segment 467E8 210239 210638NT_021889 1.00E−170 1 chromosome 1 working draft sequence segment 480C6210001 210545 NT_021897 0 1 chromosome 1 working draft sequence segment69H11 94439 94993 NT_021903 1.00E−104 1 chromosome 1 working draftsequence segment 107D7 466791 467280 NT_021918 0 1 chromosome 1 workingdraft sequence segment 471E11 418049 418124 NT_021967 8.00E−32 1chromosome 1 working draft sequence segment 468F11 370984 371480NT_022103 0 1 chromosome 1 working draft sequence segment 464H12 1E+061024449 NT_022171 1.00E−155 1 chromosome 2 working draft sequencesegment 462B11 242113 242753 NT_022174 0 1 chromosome 2 working draftsequence segment 196D7 65778 66218 NT_022315 0 5 chromosome 2 workingdraft sequence 66514 66886 NT_022315 segment 100E10 148157 148338NT_022358 4.00E−95 1 chromosome 2 working draft sequence segment 142F9193054 193433 NT_022457 0 6 chromosome 3 working draft sequence 240726241196 NT_022457 segment 286545 287198 NT_022457 595A12 40034 40650NT_022488 0 2 chromosome 3 working draft sequence segment 75A2 2479225256 NT_022555 1.00E−133 1 chromosome 3 working draft sequence segment468G12 276616 277068 NT_022751 0 1 chromosome 4 working draft sequencesegment 471F6 403620 404200 NT_022765 6.00E−89 1 chromosome 4 workingdraft sequence segment 463H12 197991 198185 NT_022795 2.00E−88 1chromosome 4 working draft sequence segment 473E4 408745 409322NT_022840 1.00E−123 2 chromosome 4 working draft sequence segment 461C8544633 545127 NT_022844 0 1 chromosome 4 working draft sequence segment470G10 148269 148781 NT_022855 0 1 chromosome 4 working draft sequencesegment 480F3 471820 472173 NT_023178 1.00E−138 1 chromosome 5 workingdraft sequence segment 176G2 98388 98683 NT_023529 1.00E−153 1chromosome 7 working draft sequence segment 71F2 62180 62604 NT_023654 01 chromosome 8 working draft sequence segment 459F2 324390 324869NT_023660 0 1 chromosome 8 working draft sequence segment 124F9 275971276413 NT_023666 0 1 chromosome 8 working draft sequence segment 111H9388593 389283 NT_023676 0 1 chromosome 8 working draft sequence segment460D12 527418 527528 NT_023703 3.00E−43 1 chromosome 8 working draftsequence segment 129D7 104058 104672 NT_023833 1.00E−170 1 chromosome 8working draft sequence segment 183G2 183398 183840 NT_023923 1.00E−112 1chromosome 9 working draft sequence segment 478G6 41677 41996 NT_0239451.00E−137 1 chromosome 9 working draft sequence segment 163E7 1E+061455953 NT_023959 1.00E−126 1 chromosome 9 working draft sequencesegment 472G12 21182 21574 NT_024016 0 1 chromosome 9 working draftsequence segment 466B7 471195 471690 NT_024040 1.00E−138 1 chromosome 10working draft sequence segment 459D2 315088 315482 NT_024091 0 1chromosome 10 working draft sequence segment 468B10 791272 792086NT_024101 0 2 chromosome 10 working draft sequence segment 175D1 270651271264 NT_024115 0 2 chromosome 10 working draft sequence segment 472D716139 16549 NT_024223 0 1 chromosome 11 working draft sequence segment476G3 71426 71803 NT_024498 1.00E−144 1 chromosome 13 working draftsequence segment 138B6 2E+06 1638986 NT_024680 0 2 chromosome 15 workingdraft sequence segment 466A4 308514 309137 NT_024767 0 1 chromosome 16working draft sequence segment 583D6 551386 551654 NT_024781 1.00E−133 1chromosome 16 working draft sequence segment 468F10 91355 92043NT_024815 1.00E−132 2 chromosome 16 working draft sequence segment 461D9406470 406916 NT_024897 0 2 chromosome 17 working draft sequence 440400440720 NT_024897 segment 520A8 168514 168868 NT_024997 0 1 chromosome 18working draft sequence segment 128F5 113027 113221 NT_025378 6.00E−82 1chromosome X working draft sequence segment 467B11 519341 519633NT_025635 1.00E−113 1 chromosome 1 working draft sequence segment 464E118932 9161 NT_025657 1.00E−126 1 chromosome 2 working draft sequencesegment 188C1 1E+06 1221531 NT_025823 4.00E−72 1 chromosome 10 workingdraft sequence segment 468B2 156035 156630 NT_025900 1.00E−150 2chromosome 16 working draft sequence segment 470F3 427484 428029NT_026379 0 2 chromosome 10 working draft sequence segment 36G1 483362484059 NT_026443 0 1 chromosome 15 working draft sequence segment 466B519929 20420 NT_026455 1 .00E−123 1 chromosome 16 working draft sequencesegment 105A8 3431 3518 U12202 6.00E−34 1 ribosomal protein S24 (rps24)gene, complete cds Length 175D10 18139 18285 U18671 8.00E−45 2 Stat2gene, complete cds Length = 18648 BAC956, complete sequence Length =116F9 68889 69093 U85199 6.00E−69 1 105232 598F3 22246 22656 U91318 0 1chromosome 16 BAC clone CIT987SK-A- 962B4, complete sequ 471G1 1 109Z56926 9.00E−54 1 CpG island DNA genomic Mse1 fragment, clone 153c6,forw 516D5 1 143 Z62429 4.00E−53 1 CpG island DNA genomic Mse1 fragment,clone 69a1, forwa 107D11 81 292 Z63603 1.00E−104 1 CpG island DNAgenomic Mse1 fragment, clone 87h3, forwa 481D4 12379 12686 Z693041.00E−101 1 DNA sequence from cosmid V311G7, between markers DXS366461G6 23967 24497 Z69715 1.00E−173 2 DNA sequence from cloneLL22NC03-74G7 on chromosome 22 465F5 15468 15659 Z77852 3.00E−70 1 DNAsequence from cosmid LUCA2 on chromosome 3p21.3 con 459B2 26193 26772Z82248 0 2 DNA sequence from clone LL22NC03-44A4 on chromosome 22 478E549480 49615 Z83847 6.00E−50 1 DNA sequence from clone RP3-496C20 onchromosome 22 Con 469E6 4705 5229 Z83851 0 1 DNA sequence from clone989H11 on chromosome 22q13.1-13 517H5 128852 129155 Z85986 1.00E−156 1DNA sequence from clone 108K11 on chromosome 6p21 Conta 114C1 1599516486 Z93016 1.00E−121 3 DNA sequence from clone RP1-211D12 on 7794078185 Z93016 chromosome 20q12- 118A8 117801 118272 Z97989 0 2 DNAsequence from PAC 66H14 on 132708 132773 Z97989 chromosome 6q21-22. Cont

TABLE 3C Table of novel human nucleotide sequences compared to assembledhuman sequences, depicting putative exon-intron structure Exon ExonClone Genome Clone Genome Clone Accession Start Stop Start Stop StartStop Start Stop 47D11 NT_008060 90 407 480193 479876 406 586 478843478662 53G7 NT_008060 4 204 478642 478842 204 459 479917 480171 62C9NT_015169 29 224 220269 220464 321 384 220540 220603 62G9 NT_006328 1145 566357 566213 144 219 565724 565649 65B1 NT_006098 243 454 24181342418345 303 462 2421648 2421807 65D10 NT_025892 218 401 369301 369483404 541 370290 370427 65D11 NT_025892 98 241 367311 367453 240 425369301 369486 65D12 NT_025892 98 219 367333 367453 218 399 369301 36948372D4 NT_008060 1 198 478646 478843 197 489 479876 480168 73A7 NT_0080601 197 478646 478842 197 538 479917 480259 75B12 NT_010265 1 171 309301309471 169 267 315278 315376 NT_010265 587 658 319041 319112 100B5NT_006098 16 142 556012 556138 143 336 560579 560772 105B11 NT_022315 2226 66662 66886 429 491 89124 89186 170F9 NT_010194 4 324 64050686405386 323 465 6407864 6408006 144F5 NT_011595 1 280 125097 124818 345491 120524 120378 166H7 NT_009729 59 130 537939 537668 127 281 537177537023 NT_009729 579 672 491513 491419 171A10 NT_009151 2 244 65562276556469 245 396 6556693 6558846 98E1 NT_006098 12 138 556012 556138 139328 560579 560768 134B4 NT_011512 3 251 12517461 12517709 252 33812519881 12519967 172E5 NT_009935 5 449 1427508 1427952 448 551 14344571434560 176F12 NT_011520 48 309 6163505 6163766 308 409 6163866 616396751B9 NT_021980 75 578 120596 121099 3 79 120203 120279 51B12 NT_007140 185 309298 309214 79 609 300215 299684 191F6 NT_010194 7 330 64050636405386 329 473 6407864 6408008 459F10 NT_008982 1 121 92783 92903 116314 93005 93202 461H12 NT_023539 19 94 332693 332768 92 166 334220334294 463C3 NT_010478 1 186 1307774 1307960 183 314 1308993 1309124465B3 NT_010222 41 227 700806 700992 227 414 701556 701743 513G4NT_005130 1 134 384702 384569 133 204 383722 383651 515E10 NT_023563 1169 9743 9575 169 309 8111 7971 466B10 NT_006292 1 331 936306 935977 244745 935875 935374 466F9 NT_024872 17 186 64694 64525 184 295 61751 61640121B6 NT_023169 2 98 183171 183075 258 455 164976 164779 462D1 NT_023923139 298 191231 191072 297 528 190168 189937 64G9 NT_025892 68 210 367311367453 209 394 369301 369486 467C6 NT_010101 1 73 1265999 1266071 218330 1295695 1295807 NT_010101 546 687 1334907 1335047 467G9 NT_011157 69142 917117 917044 142 253 916090 915979 476G4 NT_007592 58 121 23823802382443 120 362 2382598 2382840 477E1 NT_008680 1 116 1185208 1185323116 472 1186107 1186462 477A11 NT_006292 1 325 936300 935977 238 851935875 935262 480A3 NT_010478 1 99 2220394 2220492 181 525 22215462221890 518H1 NT_005337 1 73 2383056 2383128 125 229 2386650 2386754519A9 NT_016632 64 193 172305 172434 191 279 176990 177078 521F2NT_023563 3 107 7651 7756 110 254 7968 8111 597A4 NT_023563 1 109 76477755 109 256 7964 8111 491G11 NT_010265 1 127 284740 284866 123 242288529 288648 494B11 NT_007343 25 246 3168142 3167921 244 334 31624773162387 479A1 NT_015169 1 109 293941 293833 112 217 289082 288977 47D11NT_008060 53G7 NT_008060 62C9 NT_015169 449 518 220668 220737 517 774220958 221215 62G9 NT_006328 217 315 563987 563889 315 418 563775 56367265B1 NT_006098 65D10 NT_025892 65D11 NT_025892 423 562 370288 370427 561690 376519 376648 65D12 NT_025892 402 541 370290 370427 72D4 NT_008060491 585 489271 489365 73A7 NT_008060 75B12 NT_010265 264 441 316976317153 440 588 317239 317387 NT_010265 100B5 NT_006098 331 416 561268561353 105B11 NT_022315 170F9 NT_010194 144F5 NT_011595 279 347 123833123765 490 559 118816 118747 166H7 NT_009729 282 362 529971 529891 363581 495632 495414 NT_009729 171A10 NT_009151 98E1 NT_006098 330 506561271 561447 134B4 NT_011512 336 448 12523936 12524048 172E5 NT_009935176F12 NT_011520 51B9 NT_021980 51B12 NT_007140 191F6 NT_010194 459F10NT_008982 461H12 NT_023539 164 298 334438 334572 300 470 335340 335510463C3 NT_010478 315 429 1309210 1309324 427 559 1309492 1309625 465B3NT_010222 513G4 NT_005130 202 281 378695 378616 287 346 299615 299556515E10 NT_023563 466B10 NT_006292 466F9 NT_024872 294 626 59515 59185121B6 NT_023169 460 576 163071 162955 462D1 NT_023923 64G9 NT_025892 392531 370288 370427 467C6 NT_010101 330 468 1315073 1315211 467 5471315798 1315878 NT_010101 467G9 NT_011157 476G4 NT_007592 477E1NT_008680 477A11 NT_006292 480A3 NT_010478 518H1 NT_005337 227 3662393104 2393243 519A9 NT_016632 521F2 NT_023563 597A4 NT_023563 258 4529575 9771 491G11 NT_010265 494B11 NT_007343 479A1 NT_015169 218 338285931 285811

TABLE 4 The Library Browser at the NCBI UniGene web site was used toidentify genes that are specifically expressed in leukocyte cellpopulations. Sequences before Library Library Name Category reductionSequences on array* Lib. 2228 Human_leukocyte_MATCHMAKER_cDNA_Libraryother/unclassified 4  3 Lib. 238 RA-MO-III (activated monocytes from RApatient) Blood 2  1 Lib. 242Human_peripheral_blood_(Whole)_(Steve_Elledge) Blood 4  2 Lib. 2439Subtracted_cDNA_libraries_from_human_Jurkat_cells other/unclassified 4 1 Lib. 323 Activated_T-cells_I other/unclassified 19  3 Lib. 327Monocytes,_stimulated_II Blood 92 35 Lib. 387 Macrophage_Iother/unclassified 84 24 Lib. 409 Activated_T-cells_IVother/unclassified 37 10 Lib. 410 Activated_T-cells_VIIIother/unclassified 27 10 Lib. 411 Activated_T-cells_V other/unclassified41  9 Lib. 412 Activated_T-cells_XII other/unclassified 29 12 Lib. 413Activated_T-cells_XI other/unclassified 13  6 Lib. 414Activated_T-cells_II other/unclassified 69 30 Lib. 429 Macrophage_IIother/unclassified 56 24 Lib. 4480Homo_sapiens_rheumatoid_arthritis_fibroblast-like_synovialother/unclassified 7  6 Lib. 476 Macrophage,_subtracted_(total_cDNA)other/unclassified 11  1 Lib. 490 Activated_T-cells_IIIother/unclassified 9  5 Lib. 491 Activated_T-cells_VIIother/unclassified 27  8 Lib. 492 Activated_T-cells_IXother/unclassified 16  5 Lib. 493 Activated_T-cells_VIother/unclassified 31 15 Lib. 494 Activated_T-cells_X other/unclassified18  5 Lib. 498 RA-MO-I (activated peripheral blood monocytes from RApatient) Blood 2  1 Lib. 5009 Homo_Sapiens_cDNA_Library_from_Periph-other/unclassified 3  3 eral_White_Blood_Cell Lib. 6338human_activated_B_lymphocyte Tonsils 9  8 Lib. 6342 Human_lymphocytesother/unclassified 2  2 Lib. 646 Human_leukocyte_(M. L. Markelov)other/unclassified 1  1 Lib. 689Subtracted_cDNA_library_of_activated_B_lymphocyte Tonsil 1  1 Lib. 773PMA-induced_HL60_cell_subtraction_library (leukemia) other/unclassified6  3 Lib. 1367 cDNA_Library_from_rIL-2_activated_lymphocytesother/unclassified 3  2 Lib. 5018 Homo_sapiens_CD4+_T-cell_clone_HA1.7other/unclassified 6  3 Lib. 376 Activated_T-cells_XX other/unclassified999 119  Lib. 669 NCI_CGAP_CLL1 (Lymphocyte) Blood 353  81† Lib. 1395NCI_CGAP_Sub6 (germinal center b-cells) B cells germinal 389 100† Lib.2217 NCI_CGAP_Sub7 (germinal center b-cells) B cells germinal 605 200†Lib. 289 NCI_CGAP_GCB1 (germinal center b-cells) Tonsil 935 200† Total3914 939  *Redundancy of UniGene numbers between the libraries waseliminated. †A subset of genes flagged as “Found only in this library”were taken.

TABLE 5 Nucleotide sequence databases used for analysis Threshold ofSignificance Database Version Description Location of file Used nrRelease GenBank + EMBL + DDBJ + P ftp:/ncbi.nlm.nih.gov/ Expect value123.0 DB sequences (but no EST, blast/nt.Z (e) < 10⁻²⁵ STS, GSS, or HTGSsequences). No longer “non- redundant”. dbEST Apr. 10, 2001Non-redundant Database of ftp:/ncbi.nlm.nih.gov/ Expect value GenBank +EMBL + DDBJ blast/est_human.Z (e) < 10⁻²⁵ EST Division UniGene_uniqueBuild 132 One sequence selected from ftp:/ncbi.nlm.nih.gov/ Expect valueeach UniGene cluster (the pub/shuler/unigene/ (e) < 10⁻²⁵ one with thelongest region of Hs.seq.uniq.Z high-quality sequence data). HumanGenome Build 22 Sequence data of all contigs ftp:/ncbi.nlm.nih.gov/Expect value used to assemble the human genomes/H_sapiens/ (e) < 10⁻²⁵genome CHR_#/hs_chr#.fa.gz

TABLE 6 Algorithms used for exon and polypeptide prediction AlgorithmDescription Web address Genscan Predicts the locations and exon-introngenes.mit.edu/GENSCAN.html structures of genes in genomic sequences.Genomescan Incorporates protein homology genes.mit.edu/genomescan.htmlinformation when predicting genes. GrailEXP Predicts exons, genes,promoters, Grail.lsd.ornl.gov/grailexp/ polyAs, CpG islands, ESTsimilarities, and repetitive elements within a DNA sequence. G-KnownPredicts genes and features of a DNA cse.ucsc.edu/research/compbio/pgf/sequence at user-specified levels of complexity. Can incorporate extrainformation supplied by user including gene predictions from other genefinding programs, EST hits, similarities to known proteins, syntenybetween corresponding genomic regions in related organisms, methylationof the bases, regulatory binding sites, and topology information. FGENESUses linear and hidden Markov models genomic.sanger.ac.uk/gf/gf.shtmlfor exon prediction

TABLE 7 Databases and algorithms used for Protein Analysis AlgorithmDescription Web address BLASTP, version 2.0 Identification of unknownprotein or .ncbi.nlm.nih.gov/BLAST/ subunit based on similarity to knownproteins or subunits. BLASTX Algorithm for translating a nucleotide.ncbi.nlm.nih.gov/BLAST/ query sequence and aligning the translation tosequences in protein databases TBLASTN Algorithm for aligning anunidentified ncbi.nlm.nih.gov/BLAST/ peptide sequence to predictedtranslations of nucleotide sequences SWISS-PROT, Protein sequencedatabase expasy.ch/cgi-bin/ release 39.0 sprot-search-de ProteinInternational Protein sequence database nbrf.georgetown.edu/ Resource(PIR) pirwww/ GenPept Amino acid translations fromncbi.nlm.nih.gov/genbank/ GenBank/EMBL/DDBJ records that aregenpept.fsa.gz annotated with one or more CDS features TrEMBL Containsthe translations of all coding ebi.ac.uk/swissprot/ sequences present inthe EMBL Nucleotide Sequence Database, which are not yet integrated intoSWISS-PROT Prosite, release 16.39 Database of protein families andexpasy.ch/prosite/ domains. Consists of biologically significant sites,patterns and profiles. Pfam, version 6.2 Collection of multiple sequence.sanger.ac.uk/Software/ alignments and hidden Markov models Pfam/covering many common protein domains ProDom, version 2001.1 Domainarrangements of proteins and protein.toulouse.inra.fr/ protein familiesprodom.html TMpred Prediction of transmembrane regions toch.embnet.org/software/ aid in subcellular localization andTMPRED_form.html function predictions

TABLE 8 SEQ ID Origin Unigene Locus GI Nominal Description Strand ProbeSequence 1 cDNA Hs.100001 NM_005074 4827009 solute carrier family 17(sodium 1 AGAGCACTTGCAGAGCCTGGGACAA T-cells phosphate), member 1(SLC17A1). CCTCCTTATTGAAGGGAAGAGGGAC 2 cDNA Hs.104157 AW968823 8158664EST380899 cDNA/gb = 1 TGGTCTCAAAGATTTACATGGCAACA T-cells AW968823direction unknown TTCGAAAGTCCCCAGAGAAGTCCT 3 cDNA Hs.104157 AW9688238158664 Complement of EST380899 cDNA −1 AGGACTTCTCTGGGGACTTTCGAATGT-cells /gb = AW968823 direction TTGCCATGTAAATCTTTGAGACCA unknown 4literature Hs.1051 NM_004131 7262379 granzyme B (granzyme 2, 1AGGTGCCAGCAACTGAATAAATACCT cytotoxic T-lymphocyte-associatedCTCCCAGTGTAAATCTGGAGCCAA serine esterase 1) (GZMB). 5 cDNA Hs.105230AA489227 2218829 aa57f07.s1 cDNA, 3′ end 1 GGGTGTCTTTAAATAGCACTAGCCAAT-cells /clone = IMAGE:825061 strand ATCACATATCTCCAACACTCCTTA unknown 6cDNA Hs.105230 AA489227 2218829 Complement, aa57f07.s1 cDNA, 3′ −1TAAGGAGTGTTGGAGATATGTGATTT T-cells end/clone = IMAGE:825061 strandGGCTAGTGCTATTTAAAGACACCC unknown 7 cDNA Hs.107979 NM_014313 7657594small membrane protein 1 (SMP1), 1 CCCACAGTGCAATTCAGAATATGCTC T-cellsmRNA/cds = (99, AGGGAATGCCAGCCACCTTGTAAA 8 cDNA Hs.10888 AK02521210437679 cDNA: FLJ21559 fis, clone 1 GCCAAGACAATAAGCTAGGCTACTGG T-cellsCOL05406/cds = UNKNOW GTCCAGCTACTACTTTGGTGGGAT 9 cDNA Hs.10888 AK02521210437679 complement cDNA: FLJ21559 fis, −1 ATCCCACCAAAGTAGTAGCTGGACCCT-cells clone COL06406/cds = UNKNOW AGTAGCCTAGCTTATTGTCTTGGC 10 cDNAHs.1100 M55654 339491 TATA-binding protein mRNA, 1AATTTATAACTCCTAGGGGTTATTTCT T-cells complete cds/cds = (241, 12GTGCCAGACACATTCCACCTCTC 11 cDNA Hs.11000 NM_015344 7662509 MY47_BRAINMY047 PROTEIN 1 ACTAATTGCATTGGCAGCATTGTGTC T-cellsTTTGACCTTGTATACTAGCTTGAC 12 cDNA Hs.1101 NM_002698 4505958 POU domain,class 2, transcription 1 AAACCAAAAATAATCACAACAGAAAC T-cells factor 2 (PCAGCTGCCCCAAAGGAACCAGAGG 13 cDNA Hs.11238 AB014522 3327057 KIAA0622protein; Drosophila 1 TCCCACCAGGACTTTGCTAACAATAA T-cells “multipleasters” (Mast)-like TGTTTGGAAATAAAGAAGTGCTCT homolog 1 14 cDNA Hs.116481NM_001782 4502682 CD72, B cell differentiation 1TGACACTCATGCCAACAAGAACCTGT T-cells antigen GCCCCTCCTTCCTAACCTGAGGCC 15cDNA Hs.295726 M14648 340306 cell adhesion protein (vitronectin) 1ACAAATTTTACCCTAACAGTTTTACCA T-cells receptor alpha s Platelets,CCTAGCAACAGTCATTTCTGAAA megakaryocytes 16 cDNA Hs.119155 AL1097865725475 mRNA full length insert cDNA 1 TTTATTGGTACTTCCTAAAGATAGAGAT-cells clone EUROIMAGE 81 CTAAAGTCATGGTAGTATTGGCC 17 cDNA Hs.119155AL109786 5725475 Complement of mRNA full length −1GGCCAATACTACCATGACTTTAGTCT T-cells insert cDNA clone EUROIMAGECTATCTTTAGGAAGTACCAATAAA 82 18 cDNA Hs.119537 NM_006559 5730026GAP-associated tyrosine 1 CCTCCCATTTTGTTCTCGGAAGATTA T-cellsphosphoprotein p62 (Sam88) AATGCTACATGTGTAAGTCTGCCT 19 cDNA Hs.121025NM_014205 7656935 chromosome 11 open reading 1 CCGTGCCCGGAAACAGGCCGTGGCTT-cells frame 5 (C11ORF5), m AGAGAAGAGCGAGATCATCTTTACC 20 literatureHs.126256 NM_000576 10835144 interleukin 1-beta (IL1B) mRNA, 1GGTCTAATTTATTCAAAGGGGGCAAG monocytes, macrophagesAAGTAGCAGTGTCTGTAAAAGAGC 21 cDNA Hs.126925 AK023275 10435137 FLJ13213fis, clone 1 AGATGGGTGAATCAGTTGGGTTTTGT T-cells NT2RP4001126, weaklyAAATACTTGTATGTGGGGAAGACA 22 cDNA Hs.1279 AK024951 10437374 FLJ21298 fis,clone COL02040, 1 TCTCTAGTTGTCACTTTCCTCTTCCAC T-cells highly simTTTGATACCATTGGGTCATTGAA 23 cDNA Hs.129780 NM_003327 4507578 OX40homolog, ACT35 Antigen, 1 TCAAAAGAAAGCCTTCTGGATGCTGT T-cells TNFreceptor superfamily, TAAGATGTACCCTTCAGGTGAACC member 4 24 cDNA Hs.1309M28825 180035 thymocyte antigen CD1a mRNA 1 CCCCCTTTCCTTCTAATTTTTCAGCTCT-cells CTTCAATGCAAAGTACATGTATT 25 cDNA Hs.1349 NM_000758 4503076 colonystimulating factor 2 1 CCTCCAACCCCGGAAACTTCCTGTGC T-cells(granulocyte-macrophage) (CSF2). AACCCAGACTATCACCTTTGAAAG 26 cDNAHs.136375 BF513274 11598453 ESTs, Weakly similar to S65824 1GGAAGGTAGTCTTCATTTGCAATCAG T-cells reverse transcriptase homologGAAAACGAACGTAAAGGCACAGGT (3′ EST read) 27 cDNA Hs.138375 BF51327411598453 Complement of ESTs, Weakly −1 ACCTGTGCCTTTACGTTCGTTTTCCTT-cells similar to S65824 reverse GATTGCAAATGAAGACTACCTTCC transcriptasehomolog (3′ EST read) 28 cDNA Hs.137548 NM_003874 4502686 CD84 antigen(leukocyte antigen) 1 TGTTTTCCTCACTACATTGTACATGTG T-cells (CD84)GGAATTACAGATAAACGGAAGCC 29 cDNA Hs.1418 M15059 182447 Fc-epsilonreceptor (IgE receptor) 1 CAGAGCAAGACCCTGAAGACCCCCA T-cells mRNA,complete cd ACCACGGCCTAAAAGCCTCTTTGTG 30 cDNA Hs.142023 NM_0058165032140 TACT_T-CELL SURFACE 1 GCTTCATATGTATGGCTGTTGCTTTG T-cells PROTEINCTTCATGTGTATGGCTATTTGTAT 31 cDNA Hs.1481 NM_002112 4504364 histidinedecarboxylase 1 CAGATGGGTTCAGCAGTCTGGTCAGT T-cells (EC 4.1.1.22) (HDC).GAGAAAGGGCCGAGGGTAGACAGG 32 cDNA Hs.150403 NM_000790 4503260 dopadecarboxylase (aromatic 1 TCCAGGGCAATCAATGTTCACGCAAC T-cells L-aminoacid decarboxylase) TTGAAATTATATCTGTGGTCTTCA 33 cDNA Hs.1513 NM_00062910835182 interferon (alpha, beta and omega) 1 TCATCCCGAGAACATTGGCTTCCACAT-cells receptor 1 (IFNAR1). TCACAGTATCTACCCTTACATGGT 34 literatureHs.153053 NM_001774 4502662 leukocyte antigen CD37 1CGCTCTCGATATTCCTGTGCAGAAAC CTGGACCACGTCTACAACCGGCTC 35 cDNA Hs.153952X55740 23896 placental cDNA coding for 1 CCTGCTCAGCTCTGCATAAGTAATTCT-cells 5′nucleotidase (EC 3.1.3.5) AAGAAATGGGAGGCTTCACCTTAA 36 cDNAHs.155595 NM_004404 4758157 Neural precursor cell expressed, 1GGAGGACCCACACTGCTACACTTCTG T-cells developmentally down-regulated 5ATCCCCTTTGGTTTTACTACCCAA 37 cDNA Hs.1570 Z34897 510295 H1 histaminereceptor 1 GAAGAACAGCAGATGGCGGTGATCA T-cells GCAGAGAGATTGAACTTTGAGGAGG38 cDNA Hs.159557 AK024833 10437239 FLJ21180 fis, clone CAS11176, 1GGAATTTCCTATCTTGCAGCATCCTG T-cells highly sim TAAATAAACATTCAAGTCCACCCT39 cDNA Hs.160417 NM_013390 7019554 transmembrane protein 2 1CCTCAAAGTGCTACCGATAAACCTTT T-cells (TMEM2), mRNA/cds = (14CTAATTGTAAGTGCCCTTACTAAG 40 cDNA Hs.16488 BC007911 14043948 calreticulin1 AGTGGGTCCCAGATTGGCTCACACT T-cells GAGAATGTAAGAACTACAAACAAAA 41 cDNAHs.166120 NM_004031 4809287 interferon regulatory factor 7 1CTGTCCAGCGCCAACAGCCTCTATGA T-cells (IRF7), transcCGACATCGAGTGCTTCCTTATGGA 42 cDNA Hs.166975 NM_006925 5902077 splicingfactor, arginine/serine-rich 1 AAATTCTGGTAAGTATGTGCTTTTCTG T-cells 5(SFR TGGGGGTGGGATTTGGAAGGGGG 43 literature Hs.167988 S71824 632775 N-CAM= 145 kda neural cell 1 ATGGGTGAAGAGAACCGAGCAAAGA adhesion moleculeTCAAAATAAAAAGTGACACAGCAGC 44 cDNA Hs.168103 AF026402 2655201 U5 snRNP100 kD protein mRNA, 1 GCTGTGTCCATCTTTGTCACTGAGTG T-cells cds/cds = (39,2501 AAATCTCTGTTTTCTATTCTCTGA 45 cDNA Hs.168132 U14407 540098interleukin 15 (IL15) mRNA 1 ATGTGCTGTCAAAACAAGTTTTTCTGT T-cellsCAAGAAGATGATCAGACCTTGGA 46 literature Hs.168383 NM_000201 4557877intercellular adhesion molecule 1 1 CAGTGATCAGGGTCCTGCAAGCAGT (CD54),rhinovirus receptor GGGGAAGGGGGCCAAGGTATTGGAG (ICAM1). 47 cDNA Hs.169191U58913 4204907 chemokine (hmrp-2a) mRNA, 1 TGGACACACGGATCAAGACCAGGAAT-cells complete cds/cds = (71, 484) GAATTGAACTTGTCAAGGTGAAGGG 48literature Hs.169610 AJ251595 6491738 transmembrane glycoprotein 1AACAGACCCCCTCTAGAAATTTTTCA (CD44 gene). GATGCTTCTGGGAGACACCAAAGG 49 cDNAHs.170311 D89678 3218539 50 for A + U-rich element RNA 1GTCAGTAGGTGCGGTGTCTAGGGTA T-cells binding factor.GTGAATCCTGTAAGTTCAAATTTAT 50 cDNA Hs.170311 D89678 3218539 60 for A +U-rich element RNA 1 AGTTGTGTGGTCAGTAGGTGCGGTG T-cells binding factor.TCTAGGGTAGTGAATCCTGTAAGTTC AAATTTATG 51 cDNA Hs.170311 D89678 3218539 70for A + U-rich element RNA 1 TTTAAGTTGTGTGGTCAGTAGGTGCG T-cells bindingfactor. GTGTCTAGGGTAGTGAATCCTGTAAG TTCAAATTTATGATTAGG 52 cDNA Hs.171763X59350 36090 mRNA for B cell membrane 1 GTTTGAGATGGACACACTGGTGTGGAT-cells protein CD22 TTAACCTGCCAGGGAGACAGAGCT 53 cDNA Hs.171917 AB0378557243265 mRNA for KIAA1434 protein, 1 TTGTGACTCTGAATCCCATGTTCTCA T-cellspartial cds AACTACGCTGCCTTCCGAAGTCTG 54 cDNA Hs.172089 AL110202 5817121cDNA DKFZp586I2022 (from 1 TTTAAGTACTAAGTCATCATTTGCCTT T-cells cloneDKFZp586I GAAAGTTTCCTCTGCATTGGGTT 55 cDNA Hs.172089 AL110202 5817121Complement of cDNA −1 AACCCAATGCAGAGGAAACTTTCAAG T-cells DKFZp586I2022(from clone GCAAATGATGACTTAGTACTTAAA DKFZp586I 56 literature Hs.1722M28983 186279 50 interleukin 1 alpha (IL 1) 1TACCTGGGCATTCTTGTTTCATTCAAT mRNA, macrophages TCCACCTGCAATCAAGTCCTACA 57literature Hs.1722 M28983 186279 60 interleukin 1 alpha (IL 1) 1CCATTAAACTTACCTGGGCATTCTTG mRNA, macrophages TTTCATTCAATTCCACCTGCAATCAAGTCCTACA 58 literature Hs.1722 M28983 186279 70 interleukin 1 alpha(IL 1) 1 CACCTGCAATCAAGTCCTACAAGCTA mRNA, macrophagesAAATTAGATGAACTCAACTTTGACAA CCATGAGACCACTGTTAT 59 literature Hs.1724X01057 33812 50 mRNA for interleukin-2 1 AATGCGTACGTTTCCTGAGAAGTGTCreceptor TAAAAACACCAAAAAGGGATCCGT 60 literature Hs.1724 X01057 33812 60mRNA for interleukin-2 1 ACGTTTCCTGAGAAGTGTCTAAAAAC receptorACCAAAAAGGGATCCGTACATTCAAT GTTTATGC 61 literature Hs.1724 X01057 3381270 mRNA for interleukin-2 1 CAAATCAATGCGTACGTTTCCTGAGA receptorAGTGTCTAAAAACACCAAAAAGGGAT CCGTACATTCAATGTTTA 62 cDNA Hs.172631 J04145189068 neutrophil adherence receptor 1 CTCCGGGAGAGGGGACGGTCAATCC T-cellsalpha-M subunit mRNA TGTGGGTGAAGACAGAGGGAAACAC 63 cDNA Hs.305870NM_003781 14043025 vesicle-associated membrane 1GGCTGGGAAACTGTTGGTGGCCAGT T-cells protein 8 (endobGGGTAATAAAGACCTTTCAGTATCC 64 cDNA Hs.172791 NM_004182 4759297ubiquitously-expressed transcript 1 TGCTAGAGGGGCTTAGAGAACTACAA T-cells(UXT), mR GGCCTGCAGAATTTCCCAGAGAAG 65 literature Hs.173894 NM_0007574503074 macrophage-specific colony- 1 CTGACTCAGGATGACAGACAGGTGGstimulating factor (CSF-1) AACTGCCAGTGTAGAGGGAATTCTA 66 cDNA Hs.174103NM_002209 4504756 integrin, alpha L (CD11A (p180), 1GTAAAGGCTATACTTGTCTTGTTCAC T-cells lymphocyte function-associatedCTTGGGATGACGCCGCATGATATG antigen 1; alpha polypeptide) 67 cDNA Hs.174142X03663 29899 c-fms proto-oncogene Monocytes 1 CAAGCAGGAAGCACAAACTCCCCCAT-cells AGCTGACTCATCCTAACTAACAGTC 68 cDNA Hs.169610 AA156937 1728552zl19c02.s1 1 TCTTCAACAGACCCCCTCTAGAAATT T-cellsSoares_pregnant_uterus_NbHPU TTTCAGATGCTTCTGGGAGACACC 69 cDNA Hs.17483NM_000616 10835168 CD4 antigen (p55) (CD4). 1 GTCCTCCACGCCATTTCCTTTTCCTTT-cells CAAGCCTAGCCCTTCTCTCATTAT 70 cDNA Hs.177559 U05875 463549 clonepSK1 interferon gamma 1 GGCCCTTCATGTACATCCATGGTGTG T-cells receptoraccessory factor CTGGCTTAAAATGTAATTAATCTT 71 cDNA Hs.179526 S73591688296 brain-expressed HHCPA78 1 AAGATGCCCAACCCTGTGATCAGAAC T-cellshomolog VDUP1 (Gene) CTCCAAATACTGCCATGAGAAACT 72 cDNA Hs.1799 J04142619799 (lambda-gt11ht-5) MHC class I 1 CAGGAGTTTGTGTGTCTTTTATAAAAAT-cells antigen-like gl GTTTGCCCTGGATGTCATATTGG 73 cDNA Hs.180804AK000271 7020240 cDNA FLJ20264 fis, clone 1 CCCTGAGTGACAGTCACGACAGAACT-cells COLF7912/cds = UNKNOWN AAAACCACAAGACCAGACCACATTT 74 cDNAHs.180866 NM_000416 4557879 interferon gamma receptor 1 1CCTTTACATCCAGATAGGTTACCAGT T-cells (IFNGR1). AACGGAACATATCCAGTACTCCTG 75cDNA Hs.181165 AK026650 10439548 FLJ22997 fis, clone KAT11962, 1TGCATCGTAAAACCTTCAGAAGGAAA T-cells highly sim GGAGAATGTTTTGTGGACCACTTT76 cDNA Hs.181357 NM_002295 9845501 laminin receptor 1 (67 kD, 1GGCCACTGAATGGGTAGGAGCAACC T-cells ribosomal protein SAACTGACTGGTCTTAAGCTGTTCTTG 77 cDNA Hs.187660 NM_014504 7657495 Majorhistocompatibility complex, 1 TGTAGGGTAAATGTGACTGGAATACA T-cells classI, E (HLA-E) CCTTTGGAACGGAATTCTTTATCA 78 cDNA Hs.182740 NM_00101514277698 ribosomal protein S11 (RPS11), 1 AGGCTGGACATCGGCCCGCTCCCCAT-cells mRNA/cds = (15, 4 CAATGAAATAAAGTTATTTTCTCAT 79 cDNA Hs.187660NM_014504 7657495 putative Rab5 GDP/GTP exchange 1TGTAGGGTAAATGTGACTGGAATACA T-cells factor homologuCCTTTGGAACGGAATTCTTTATCA 80 cDNA Hs.197345 NM_001469 4503840 thyroidautoantigen 70 kD 1 GTTGCCATGGTGATGGTGTAGCCCTC T-cells (Ku antigen)(G22P1). CCACTTTGCTGTTCCTTACTTTAC 81 cDNA Hs.198253 M33906 184194 MHCclass II HLA-DQA1 mRNA, 1 CCACCCACCCCTCAATTAAGGCAACA T-cells completecds/cds = (43, 810) ATGAAGTTAATGGATACCCTCTGC 82 cDNA Hs.197345 NM_0014694503840 thyroid autoantigen 70 kD 1 GTTGCCATGGTGATGGTGTAGCCCTC T-cells(Ku antigen) (G22P1). CCACTTTGCTGTTCCTTACTTTAC 83 cDNA Hs.198253 M33906184194 MHC class II HLA-DQA1 mRNA, 1 CCACCCACCCCTCAATTAAGGCAACA T-cellscomplete cds/cds = (43, 810) ATGAAGTTAATGGATACCCTCTGC 84 cDNA Hs.1987NM_006139 5453610 CD28 antigen (Tp44) (CD28) 1GCTCACCTATTTGGGTTAAGCATGCC T-cells AATTTAAAGAGACCAAGTGTATGT 85 cDNAHs.336769 NM_002074 11321584 guanine nucleotide binding protein 1TCCACCTTTTGTATTTAATTTTAAAGT T-cells (G protein) CAGTGTACTGCAAGGAAGCTGGA86 cDNA Hs.211576 L10717 307507 T cell-specific tyrosine kinase 1CCCTATCCCGCAAAATGGGCTTCCTG T-cells mRNA, completeCCTGGGTTTTTCTCTTCTCACATT 87 cDNA Hs.336769 NM_002074 11321584 guaninenucleotide binding protein 1 TCCACCTTTTGTATTTAATTTTAAAGT T-cells (Gprotein) CAGTGTACTGCAAGGAAGCTGGA 88 cDNA Hs.2188 AF119850 7770136PRO1608 mRNA, complete cds 1 AGATCTTCAAGTGAACATCTCTTGCC T-cells /cds =(1221, 2174)/ ATCACCTAGCTGCCTGCACCTGCC 89 cDNA Hs.21907 NM_0070675901961 histone acetyltransferase (HBOA), 1 GCTAATTTTAAGCATGTTCAGTGGCAT-cells mRNA/cds = GCTCCCCTCCAGTTTCAGTGTCAC 90 cDNA Hs.2200 NM_0050414826941 Perforin 1 (pore forming protein; 1 CCTGTGATCAGGCTCCCAAGTCTGGTT-cells PRF1) TCCCATGAGGTGAGATGCAACCTG 91 cDNA Hs.2233 NM_000759 4503078granulocyte colony-stimulating 1 ACATGGTTTGACTCCCGAACATCACC T-cellsfactor 3 (CFS3) GACGTGTCTCCTGTTTTTCTGGGT 92 cDNA Hs.2236 Z29067 479172NEK3_SERINE/THREONINE- 1 TCAGAGCTGAAGAAGCGAGCTGGAT T-cells PROTEINKINASE NEK3 GGCAAGGCCTGTGCGACAGATAATG 93 cDNA Hs.233938 NM_0064715453739 myosin, light polypeptide, 1 TCAGCCATTTTGGGCATATGTATCTTT T-cellsregulatory, non-s ATAATCAGACTGGAAACGGGACT 94 cDNA Hs.236449 NM_02489813376352 cDNA: FLJ22757 fis, clone 1 ATCCTGGCAACCTTACAATTCCTCTC T-cellsKAIA0803/cds = (92, 24 GGCATTTGTCACTTCCATCTCAGC 95 cDNA Hs.238848NM_003999 4557039 oncostatin-M specific receptor beta 1AGCTTACTACAGTGAAAGAATGGGAT T-cells subunit (OSMRB)TGGCAAGTAACTTCTGACTTACTG 96 cDNA Hs.238707 NM_024901 13378358 cDNA:FLJ22457 fis, clone 1 ATTATAACATCTTCAACACAGAACACA T-cells HRC09925/cds =(56, 14 CTTTGTGGTCGAAAGGCTCAGCC 97 cDNA Hs.239138 NM_005746 5031976pre-B-cell colony-enhancing factor 1 TGTCAGAGATTGCCTGTGGCTCTAAT T-cells(PBEF), m ATGCACCTCAAGATTTTAAGGAGA 98 cDNA Hs.239189 NM_014905 7662327glutaminase (GLS). 1 TGTCTGGCAGGGACTGAATGACCTG T-cellsATGTCAGATTTAGATTCTTCCTGGG 99 cDNA Hs.241392 NM_002985 4506848 smallinducible cytokine A5 1 GGGAGGAACACTGCACTCTTAAGCTT T-cells (RANTES)(SCYA5). CCGCCGTCTCAACCCCTCACAGGA 100 cDNA Hs.241587 NM_016838 8400721RNA binding motif, single 1 ATGAAGAAGGGTGTGAAGGCTGAAC T-cells strandedinteracting AATCATGGATTTTTCTGATCAATTG 101 cDNA Hs.241570 NM_00059410835154 Tumor necrosis factor (TNF 1 GCCTCTGCTCCCCAGGGAGTTGTGT T-cellssuperfamily, member 2 CTGTAATCGGCCTACTATTCAGTGG 102 cDNA Hs.247885NM_022304 13435404 Histamine receptor H2 (HRH2) 1GGATGCTACTGATGGGAATGATTAAG T-cells GGAGCTGCTGTTTAGGTGGTGCTG 103 cDNAHs.248156 NM_020530 10092620 oncostatin M (OSM). 1TCAGGAACAACATCTACTGCATGGCC T-cells CAGCTGCTGGACAACTCAGACACG 104 cDNAHs.298469 NM_000789 4503272 dipeptidyl carboxypeptidase 1 1CTTACATCAGGTACTTTGTCAGCTTC T-cells (angiotensin I converting enzyme)ATCATCCAGTTCCAGTTCCACGAG (ACE) 105 cDNA Hs.336780 NM_006088 5174734tubulin, beta, 2 (TUBB2), mRNA 1 CATCCAGGAGCTGTTCAAGCGCATCT T-cellsCCGAGCAGTTCACGGCCATGTTCC 106 cDNA Hs.252723 NM_000981 4506608 ribosomalprotein L19 (RPL19), 1 ACCTCCCACTTTGTCTGTACATACTG T-cells mRNA/cds =(28, 6 GCCTCTGTGATTACATAGATCAGC 107 cDNA NA X53795 35832 R2 mRNA for aninducible 1 GTCTTTGAGAATATGATGTCAGACAT T-cells membrane protein/cds =(156, 95 TTTCGGATGGGCTGTTTAGATGTT 108 literature Hs.25648 NM_0012504507580 Tumor necrosis factor receptor 1 GGTCACCCAGGAGGATGGCAAAGAGsuperfamily, member 5 AGTCGCATCTCAGTGCAGGAGAGAC 109 cDNA Hs.258503AF160973 5816319 P53 inducible protein 1 AGACCCTTATCTGGAGGAGGAAGAGT-cells AAGCAGGAGAGAGAAAGCCACAGCC 110 cDNA Hs.265829 NM_002204 4504748integrin, alpha 3 (antigen 1 GGCTGTGTCCTAAGGCCCATTTGAGA T-cells CD49C,alpha 3 subunit of AGCTGAGGCTAGTTCCAAAAACCT VLA-3 receptor) (ITGA3). 111cDNA Hs.271387 Y18645 2916795 for monocyte chemotactic 1GTGCTCCTGTAAGTCAAATGTGTGCT T-cells protein-2/cds =TTGTACTGCTGTTGTTGAAATTGA 112 cDNA Hs.272493 NM_004167 14602450 smallinducible cytokine subfamily 1 CAGAGACATAAAGAGAAGATGC T-cells A (Cys—CysCAAGGCCCCCTCCTCCACCCACC GCTAA 113 cDNA Hs.176683 NM_000570 10835138 Fcfragment of IgG, low affinity 1 ATGGGAGTAATAAGAGCAGTGGCAG T-cells IIIb,receptor for (CD16) CAGCATCTCTGAACATTTCTCTGGA (FCGR38). 114 literatureHs.278443 NM_004001 4557021 Fc fragment of IgG, low affinity 1CCACTAATCCTGATGAGGCTGACAAA IIb, receptor for (CD32)GTTGGGGCTGAGAACACAATCACC (FCGR2B). 115 cDNA Hs.62954 J04755 182512ferritin H processed pseudogene, 1 TGTTGGGGTTTCCTTTACCTTTTCTAT T-cellscomplete cds/cds = UN AAGTTGTACCAAAACATCCACTT 116 cDNA Hs.279581AK000575 7020763 FLJ20588 fis, clone REC00775 1CAGAGTAGGCATCTGGGCACCAAGA T-cells /cds = (6, 422)CCTTCCCTCAACAGAGGACACTGAG 117 cDNA Hs.279930 V00522 32122 encoding majorhistocompatibility 1 CTTTGCCTAAACCCTATGGCCTCCTG T-cells complex geneTGCATCTGTACTCACCCTGTACCA 118 cDNA Hs.181357 NM_002295 9845501 Lamininreceptor 1 (67 kD, 1 GGCCACTGAATGGGTAGGAGCAACC T-cells ribosomal proteinSA) ACTGACTGGTCTTAAGCTGTTCTTG 119 cDNA Hs.283722 NM_020151 9910251 GTT1protein (GTT1), mRNA 1 TGATTCTGCACTTGGGGTCTGTCTGT T-cells /cds = (553,1440)/gb ACAGTTACTCATGTCATTGTAATG 120 cDNA Hs.78961 NM_014110 13899255PRO2047 protein (PRO2047), 1 TGTGTAATAGGCCTTTTCATGCTTTAT T-cellsmRNA/cds = (798, 988 GTGTAGCTTTTTACCTGTAACCT 121 cDNA Hs.334853NM_006013 5174430 cDNA DKFZp762B195 (from 1 AAGTTATCATGTCCATCCGCACCAAGT-cells clone DKFZp762B195) CTGCAGAACAAGGAGCATGTGATT 122 cDNA Hs.334853NM_006013 5174430 Complement cDNA −1 AAGTTATCATGTCCATCCGCACCAAG T-cellsDKFZp762B195 (from clone CTGCAGAACAAGGAGCATGTGATT DKFZp762B195) 123 cDNAHs.284283 U90552 2082705 butyrophilin (BTF5) mRNA, 1TGGTGGATGTTAAACCAATATTCCTTT T-cells complete cds/cds = (359, 190CAACTGCTGCCTGCTAGGGAAAA 124 cDNA Hs.286212 AK021791 10433048 cDNAFLJ11729 fis, clone 1 TGAACTTGCTGAATGTAAGGCAGGCT T-cells HEMBA1005394,modera ACTATGCGTTATAATCTAATCACA 125 cDNA Hs.287369 NM_020525 10092624 50interleukin 22 (IL22), mRNA 1 ATTTGACCAGAGCAAAGCTGAAAAAT T-cells /cds =(71, 610)/gb GAATAACTAACCCCCTTTCCCTGC 126 cDNA Hs.287369 NM_02052510092624 60 interleukin 22 (IL22), mRNA 1 GCAATTGGAGAACTGGATTTGCTGTTT-cells /cds = (71, 610)/gb TATGTCTCTGAGAAATGCCTGCATTT GACCAGAG 127 cDNAHs.287369 NM_020525 10092624 70 interleukin 22 (IL22), mRNA 1TTTGACCAGAGCAAAGCTGAAAAATG T-cells /cds = (71, 610)/gbAATAACTAACCCCCTTTCCCTGCTAG AAATAACAATTAGATGCC 128 cDNA Hs.288061NM_001101 5016088 actin, beta (ACTB). 1 CCCTTTTTGTCCCCCAACTTGAGATGT-cells TATGAAGGCTTTTGGTCTCCCTGG 129 cDNA Hs.315054 NM_032921 14249707hypothetical protein MGC15875 1 ATTAGACCAGACCAGTGTATTTCTAA T-cells(MGC15875). AGAAAATCCTGACATGCACACCCA 130 cDNA Hs.289088 NM_00534813129149 heat shock 90 kD protein 1, 1 GACCCTACTGCTGATGATACCAGTGCT-cells alpha (HSPCA). TGCTGTAACTGAAGAAATGCCACC 131 cDNA Hs.29052AK000196 7020122 FLJ20189 fis, clone COLF0657 1ACAGGCAAAGTGACAGGGGAAAAGG T-cells /cds = (122, 84AATTAGTCTAAGAGTAAGGGGATGA 132 cDNA Hs.291129 AA837754 2912953 oe10d02.s1cDNA 1 CTTTCCTCTTGCTGCTGGGGCCTAGG T-cells /clone = IMAGE:TCTTCTTGCTGCTGCTTCCTTTTC 1385475/gb = AA 133 cDNA Hs.292590 O59502960608 HUM041H11A cDNA, 3′ end 1 AGAGTTTTTGTTGGTAGACTGGAGCT T-cells/clone = GEN-041H11/cl GGGATGTTGAATCAACCTCAGGCA 134 cDNA Hs.292590D59502 960608 Complement HUM041H11A −1 TGCCTGAGGTTGATTCAACATCCCAGT-cells cDNA, 3′ end/clone = CTCCAGTCTACCAACAAAAACTCT GEN-041H11/cl 135cDNA Hs.99858 X61923 36646 Ribosomal protein L7a Gene with 1CTGACGATCAGCTTGGAACAGCCAAA T-cells exons/intronsCAGAATTAACGCAACTAATAACCT 136 cDNA Hs.323483 AL050141 4884352 cDNADKFZp586O031 (from 1 TCCTTTTATGCATTGGAGGAAAAACA T-cells clone DKFZp586O0TGTTGGCTTTTCTCTTGACGTGGG 137 cDNA Hs.323463 AL050141 4884352 ComplementcDNA −1 CCCACGTCAAGAGAAAAGCCAACATG T-cells DKFZp586O031 (from cloneTTTTTCCTCCAATGCATAAAAGGA DKFZp586O1 138 cDNA Hs.323822 AB046771 10047166for KIAA1551 protein, partial 1 CTCAGGAAACCCGACAGAAGAAA T-cells cds/cds= (0 CATGTAACACAGAACTCACGTCC ACTA 139 cDNA NA AF347015 13273284Mitochondial DNA, chyochrome B 1 ACTCGAGACGTAAATTATGGCTGAAT T-cells geneCATCCGCTACCTTCACGCCAATGG 140 cDNA Hs.30035 U61267 1418285 putativesplice factor 1 TGCTGTTTTCATTCTGCATTTGTGTAG T-cells transformer2-betamRN TTTGGTGCTTTGTTCCAAGTTAA 141 cDNA Hs.30909 NM_019081 11464998KIAA0430 gene product 1 AAAAATGACAAAAGTTATCACCAAAA T-cells (KIAA0430),mRNA/cds = ( CCCCCTTTCCCATCTTGCACTGTT 142 cDNA Hs.3195 NM_002995 4506852sapiens small inducible cytokine 1 AGCTTTTAATGCTCCAAATGCTGACC T-cellssubfamily C, member 1 CATGCAATATTTCCTCATGTGATC (lymphotactin) (SCYC1).143 cDNA Hs.322645 AL050376 4914609 mRNA; cDNA DKFZp586J101 1AAAAGAAATGCAGGTTTATTATCCAG T-cells (from clone DKFZp586J1CACTGAGAGAGTTAACAAGGACTG 144 cDNA Hs.324481 AL050376 4914609 ComplementmRNA; cDNA −1 AGAGAGACTTCTCATTGGCTGTGAAG T-cells DKFZp586J101 (fromclone GTAGAGCTTTTGGGGAAATTCCTG DKFZp586J2 145 cDNA Hs.324481 AW9685418158382 Complement EST380617 cDNA −1 CAGGAATTTCCCCAAAAGCTCTACCT T-cells/gb = AW968541 unknown TCACAGCCAATGAGAAGTCTCTCT coding strand 146 cDNAHs.324481 AW968541 8158382 EST380617 cDNA/gb = 1AGAGAGACTTCTCATTGGCTGTGAAG T-cells AW968541 unknown coding strandGTAGAGCTTTTGGGGAAATTCCTG 147 cDNA Hs.327 NM_001558 4504632interleukin-10 receptor mRNA, 1 CATCTCAGCCCTGCCTTTCTCTGGAG T-cellscomplete IL10RA CATTCTGAAAACAGATATTCTGGC 148 cDNA Hs.32970 NM_0030374506968 signaling lymphocytic activation 1 TCATGATAACCTGCAGACCTGATCAAT-cells molecule (S GCCTCTGTGCCTCAGTTTCTCTCT 149 literature Hs.334687NM_000569 12056966 Fc fragment of IgG, low affinity 1ATGGGGGTAATAAGAGCAGTAGCAG IIIa, receptor for (CD18)CAGCATCTCTGAACATTTCTCTGGA (FCGR3A) 150 cDNA Hs.303649 M26683 184641interferon gamma treatment 1 GAAATTGCTTTTCCTCTTGAACCACA T-cellsinducible mRNA Monocytes GTTCTACCCCTGGGATGTTTTGAG 151 cDNA Hs.105938X53961 34415 lactoferrin/cds = (294, 2429) 1 AATTCCTCAGGAAGTAAAACCGAAGAT-cells Neutrophils AGATGGCCCAGCTCCCCAAGAAAG 152 cDNA Hs.38 D12614219911 lymphotoxin (TNF-beta), complete 1 AACATCCAAGGAGAAACAGAGACAGT-cells cds T-cells, B-cells GCCCAAGAGATGAAGAGTGAGAGGG 153 cDNAHs.278870 AB034205 6899845 Acid-inducible phosphoprotein 1TCGTGTGAATCAGACTAAGTGGGATT T-cells TCATTTTTACAACTCTGCTCTACT 154 cDNAHs.3886 NM_002267 4504898 karyopherin alpha 3 (importin 1GCATATACAAGTTGGAAGACTAAAGA T-cells alpha 4) (KPNA3)GGTGCAATGTGATCTGAGCCTCCA 155 cDNA Hs.394 NM_001124 4501944adrenomedullin (ADM). 1 TGAGTGTGTTTGTGTGCATGAAAGAG T-cellsAAAGACTGATTACCTCCTGTGTGG 156 literature Hs.40034 NM_000885 6006032integrin, alpha 4 (antigen 1 AGCTGTTCCCAAATTTTCTAACGAGT CD49D, alpha 4subunit of VLA-4 GGACCATTATCACTTTAAAGCCCT receptor) (ITGA4) 157 cDNAHs.41724 NM_002190 4504650 interleukin 17 (cytotoxic 1ATCAACAGACCAACATTTTTCTCTTCC T-cells T-lymphocyte-associated serineTCAAGCAACACTCCTAGGGCCTG esterase 8) 158 cDNA Hs.44163 NM_018838 1009265613 kDa differentiation-associated 1 TATGACTGATGATCCTCCAACAACAA T-cellsprotein (L AACCACTTACTGCTCGTAAATTCA 159 cDNA Hs.44926 X60708 35335pcHDP7 mRNA for liver 1 AAAATACTGATGTTCCTAGTGAAAGA T-cells dipeptidylpeptidase IV/cds = (75 GGCAGCTTGAAACTGAGATGTGAA 160 literature Hs.46D10202 219975 for platelet-activating factor 1GGAAGACTTTAAACCACCTAGTTCTC receptor. CCACTGGGGCATCGGTCTAAAGCT 161 cDNAHs.48433 NM_014345 7657183 endocrine regulator 1CCCTGTTCCACAAACCCATATGTATC T-cells (HRIHFB2436), mRNA/cds =CTTTCCTCAACCTCCTCCTTTCCC 162 cDNA Hs.50002 AB000887 2189952 forEBI1-ligand chemokine, 1 GTGTGTGAGTGTGAGTGTGAGCGAG T-cells complete cdsAGGGTGAGTGTGGTCAGAGTAAAGC 163 cDNA Hs.50404 U86358 2388626 chemokine(TECK) mRNA, 1 TCTGGTCATTCAAGGATCCCCTCCCA T-cells complete cds/cds = (0,452)/gb AGGCTATGCTTTTCTATAACTTTT 164 cDNA Hs.50984 NM_001712 4502404carcinoembryonic antigen-related 1 GGCAGCTCAGGACCACTCCAATGAC T-cellscell adhesion molecule 1 CCACCTAACAAGATGAATGAAGTTA (CEACAM1) 165 cDNAHs.301921 NM_001295 4502630 chemokine (C—C motif) 1TGTTCTTCATCTAAGCCTTCTGGTTTT T-cells receptor 1 (CCR1).ATGGGTCAGAGTTCCGACTGCCA 166 cDNA Hs.54457 NM_004358 4757943 CD81 antigen(target of 1 GCCTTCATGCACCTGTCCTTTCTAAC T-cells antiproliferativeantibody 1) ACGTCGCCTTCAACTGTAATCACA 167 cDNA Hs.54460 U46573 1280140eotaxin precursor mRNA, complete 1 CCCTCTCCTCTCTTCCTCCCTGGAAT T-cellscds/cds = (53, 346)/ CTTGTAAAGGTCCTGGCAAAGATG 168 cDNA Hs.54609NM_014291 7857117 glycine C-acetyltransferase 1CTGGGCTGGGACGTGACCTGTGCTG T-cells (2-amino-3-ketoAGGGCTGTGAGAATGTGAAACAACA 169 cDNA Hs.55921 NM_004446 4758293glutamyl-prolyl-tRNA synthetase 1 GGGATGAACGAAAGCCCCCTCTTCAA T-cells(EPRS), mRN CTCCTCTCACTTTTTAAAGCATTG 170 cDNA Hs.57987 NM_02289812597634 B-cell lymphoma/leukaemia 11B 1 ACAATGTTGAGTTCAGCATGTGTCTGT-cells (BCL11B), mRNA CCATTTCATTTGTACGCTTGTTCA 171 cDNA Hs.59403NM_004863 4758667 serine palmitoyltransferase, long 1TTTCAGTCCCAGAACCTACAGATACC T-cells chain base subunit 2 (SPTLC2)CTGCTACTTGCTTCACGTGGATGC 172 cDNA Hs.5985 NM_020240 9910377 non-kinaseCdc42 effector protein 1 AATTCAGTTAGCTCCATTCAGAACCA T-cells SPEC2(LOC56990). AATGCAGTCCAAGGGAGGTTATGG 173 cDNA Hs.6179 BG929114 14323837Does not hit the NM_numbers two 1 CCCATCTTACAGAAGTTGAGGCCAAG T-cellssplice variants. Direction unknown GGAGAATGGTAGGCACAGAAGAAA 174 cDNAHs.62192 J02931 339501 placental tissue factor 1TGTGTTAAGTGCAGGAGACATTGGTA T-cells (two forms) mRNA, complete cdTTCTGGGCACCTTCCTAATATGCT 175 cDNA Hs.62192 NM_001993 10518499coagulation factor III 1 TGTGTTAAGTGCAGGAGACATTGGTA T-cells(thromboplastin, tissue factor) TTCTGGGCAGCTTCCTAATATGCT (F3), mRNA. 176literature Hs.624 NM_000584 10834977 interleukin 8 (IL8). 1AGCTGTGTTGGTAGTGCTGTGTTGAA TTACGGAATAATGAGTTAGAACTA 177 literatureHs.62954 NM_002032 4503794 50 ferritin, heavy polypeptide 1 1TGTTGGGGTTTCCTTTACCTTTTCTAT (FTH1), mRNA/c AAGTTGTACCAAAACATCCACTT 178literature Hs.62954 NM_002032 4503794 60 ferritin, heavy polypeptide 1 1TGCATGTTGGGGTTTCCTTTACCTTTT (FTH1), mRNA/c CTATAAGTTGTACCAAAACATCCACTTAAGTTC 179 literature Hs.62954 NM_002032 4503794 70 ferritin, heavypolypeptide 1 1 TGTTGGGGTTTCCTTTACCTTTTCTAT (FTH1), mRNA/cAAGTTGTACCAAAACATCCACTTAAG TTCTTTGATTTGTACCA 180 literature Hs.652NM_000074 4557432 tumor necrosis factor (ligand) 1TCTACCTGCAGTCTCCATTGTTTCCA superfamily, member 5, TNFSF5GAGTGAACTTGTAATTATCTTGTT 181 cDNA Hs.66053 AB051540 12698050 mRNA forKIAA1753 protein, 1 GTGTGCGTGTGTGTGTGCCTGTCCA T-cells partial cds/cds =(0 GTGTATATTGTGTCTTAGCTTCCAT 182 cDNA Hs.66151 AL157438 7018513 mRNA;cDNA DKFZp434A115 1 CTGAAGGGAAGAGAGCCTTGAATAG T-cells (from cloneDKFZp434A1 ACTGAAGCGAAGACGGTTCTGCAAG 183 cDNA Hs.6975 NM_014088 7662589PRO1073 protein (PRO1073). 1 TTCTCTGCATCTAGGCCATCATACTG T-cellsCCAGGCTGGTTATGACTCAGAAGA 184 cDNA Hs.70188 NM_003169 4507312 suppressorof Ty (S. cerevisiae) 1 CTTCCTGTACCTCCTCCCCACAGCTT T-cells 5 homolog(SUP GCTTTTGTTGTACCGTCTTTCAAT 185 cDNA Hs.70258 N21089 1126259IMAGE:265324 Foreskin 3′ 1 AACCTGCACAAGCATGTAATAAAAGA T-cells read 2.0kb GCACACTTAAAAACATTCTGACCA 186 cDNA Hs.70258 N21089 1126259 ComplementIMAGE:265324 −1 TGGTCAGAATGTTTTTAAGTGTGCTC T-cells Foreskin 3′ read 2.0kD TTTTATTACATGCTTGTGCAGGTT 187 cDNA Hs.70258 AA743863 2783214IMAGE:1308639 5′ read, 1 CCTTCTGAAGGTGTATAGATACAGCT T-cells perfect hit.TGTCTTGAAATGTCTTTCTCCACA 188 cDNA Hs.70258 AA743863 2783214 ComplementIMAGE:1308639 5′ −1 TGTGGAGAAAGACATTTCAAGACAAG T-cells read, perfecthit. CTGTATCTATACACCTTCAGAAGG 189 cDNA Hs.72918 NM_002981 4506832 smallinducible cytokine A1 1 TGCTAGGTCACAGAGGATCTGCTTGG T-cells (I-309,homologous to mouse TCTTGATAAGCTATGTTGTTGCAC Tca-3) (SCYA1) 190 cDNAHs.73165 U64198 1685027 II-12 receptor beta2 mRNA, 1CTAGAGGACCATTCATGCAATGACTA T-cells complete cds/cds = (640, 322TTTCTAAAGCACCTGCTACACAGC 191 cDNA Hs.737 NM_004907 4758313 immediateearly protein (ETR101), 1 GGGAGTTTCTGAGGGTCTGCTTTGTT T-cells mRNA/cds =( TACCTTTCGTGCGGTGGATTCTTT 192 cDNA Hs.73742 NM_001002 4506666 ribosomalprotein, large, P0 1 TCGGAGGAGTCGGACGAGGATATGG T-cells (RPLP0).GATTTGGTCTCTTTGACTAATCACC 193 cDNA Hs.73792 J03565 181919 Epstein-Barrvirus complement 1 TTCCTTCCTCGGTGGTGTTAATCATTT T-cells receptor type II(cr2) CGTTTTTACCCTTTACCTTCGGA 194 cDNA Hs.73798 NM_002415 4505184macrophage migration inhibitory 1 GTCTACATCAACTATTACGACATGAA T-cellsfactor (MIF) CGCGGCCAATGTGGGCTGGAACAA 195 cDNA Hs.738 NM_003973 4506800ribosomal protein L14 (RPL14), 1 CAGAAGGGTCAAAAAGCTCCAGCCC T-cellsmRNA/cds = (17, 6 AGAAAGCACCTGCTCCAAAGGCATC 196 cDNA Hs.73800 NM_0030056031196 selectin P (granule membrane 1 GACCTTCCTGCCACCAGTCACTGTCCT-cells protein 140 kD, antigen CD62) CTCAAATGACCCAAAGACCAATAT (SELP)197 cDNA Hs.73817 D90144 219905 LD78 alpha precursor, complete 1GAGATGGGGAGGGCTACCACAGAGT T-cells cds/c TATCCACTTTACAACGGAGACACAG 198cDNA Hs.73818 NM_006004 5174744 ubiquinol-cytochrome c reductase 1ATGGGTTTGGCTTGAGGCTGGTAGCT T-cells hinge prote TCTATGTAATTCGCAATGATTCCA199 cDNA Hs.73839 NM_002935 4508550 ribonuclease, RNase A family, 1CATCCCTCCATGTACTCTGGGTATCA T-cells 3 (eosinophil cationic protein)GCAACTGTCCTCATCAGTCTCCAT (RNASE3) 200 cDNA Hs.73917 M13982 186334interleukin 4 (IL-4) mRNA 1 ACCTTACAGGAGATCATCAAAACTTT T-cellsGAACAGCCTCACAGAGCAGAAGAC 201 cDNA Hs.74011 NM_002286 11693297lymphocyte-activation gene 3 1 GAGAAGACAGTGGCGACCAAGACGA T-cells (LAG3).TTTTCTGCCTTAGAGCAAGGGATTC 202 cDNA Hs.74085 X54870 35082 NKG2-D gene/cds= (338, 988) 1 CAGGGGATCAGTGAAGGAAGAGAAG T-cells /gb = X54870/gi = 3GCCAGCAGATCAGTGAGAGTGCAAC 203 cDNA Hs.74335 NM_007355 6880306 heat shock90 kD protein 1, 1 CCCATTCCCTCTCTACTCTTGACAGC T-cells beta (HSPCB),mRNA/ AGGATTGGATGTTGTGTATTGTGG 204 cDNA Hs.74821 NM_000311 4508112 prionprotein (p27-30) 1 ACTTAATATGTGGGAAACCCTTTTGC T-cells (Creutzfeld-Jakobdis GTGGTCCTTAGGCTTACAATGTGC 205 cDNA Hs.75249 D31885 505097ADP-ribosylation factor-like 6 1 AAAATACAAGGGCTGTTGGTGAGAGC T-cellsinteracting protein AGACTTGAGGTGATGATAGTTGGC 206 cDNA Hs.75348 NM_0082635453989 proteasome (prosome, macropain) 1 CCAGATTTTCCCCAAACTTGCTTCTGT-cells activator subunit 1 (PA28 alpha) TTGAGATTTTTCCCTCACCTTGCC(PSME1). 207 cDNA Hs.75545 X52425 33833 interleukin 4 receptor 1ACCTTGGGTTGAGTAATGCTCGTCTG T-cells TGTGTTTTAGTTTCATCACCTGTT 208 cDNAHs.75596 NM_000878 4504664 interleukin 2 receptor, beta 1AAACTCCCCTTTCTTGAGGTTGTCTG T-cells (IL2RB). AGTCTTGGGTCTATGCCTTGAAAA 209literature Hs.75813 M24795 178670 CD36 antigen mRNA 1CTCAGTGTTGGTGTGGTGATGTTTGT TGCTTTTATGATTTCATATTGTGC 210 cDNA Hs.75678NM_006732 5803018 FBJ murine osteosarcoma viral 1CTGTATCTTTGACAATTCTGGGTGCG T-cells oncogene homoloAGTGTGAGAGTGTGAGCAGGGCTT 211 cDNA Hs.75703 J04130 178017 50 activation(Act-2) mRNA, 1 GATAAGTGTCCTATGGGGATGGTCCA T-cells complete cds/cds =(108, 386) CTGTCACTGTTTCTCTGCTGTTGC 212 cDNA Hs.75703 J04130 178017 60activation (Act-2) mRNA, 1 TTTAGCCAAAGGATAAGTGTCCTATG T-cells completecds/cds = (108, 386) GGGATGGTCCACTGTCACTGTTTCTC TGCTGTTG 213 cDNAHs.75703 J04130 178017 70 activation (Act-2) mRNA, 1ATTTATATTAGTTTAGCCAAAGGATAA T-cells complete cds/cds = (108, 386)GTGTCCTATGGGGATGGTCCACTGTC ACTGTTTCTCTGCTGTT 214 cDNA Hs.75968 NM_02110911056060 thymosin, beta 4, X chromosome 1 GAAGGAAGAAGTGGGGTGGAAGAAGT-cells (TMSB4X), mRNA TGGGGTGGGACGACAGTGAAATCTA 215 cDNA Hs.76506NM_002298 7382490 lymphocyte cytosolic protein 1 1CCATCAATGAGGTATCTTCTTTAGTG T-cells (L-plastin) (LGTGGTATGTAATGGAACTTAGCCA 216 cDNA Hs.76640 NM_014059 7682650 RGC32protein (RGC32), mRNA 1 AAAGACGTGCACTCAACCTTCTACCA T-cells /cds = (148,499)/g GGCCACTCTCAGGCTCACCTTAAA 217 cDNA Hs.76753 NM_000118 4557554endoglin (Oster-Rendu-Weber 1 CCAAGCTGCTTGTCCTGGGCCTGCC T-cellssyndrome 1) (ENG). CCTGTGTATTCACCACCAATAAATC 218 cDNA Hs.77039 NM_0010064508722 ribosomal protein S3A (RPS3A), 1 CACTGGGGACGAGACAGGTGCTAAAT-cells mRNA/cds = (36, 8 GTTGAACGAGCTGATGGATATGAAC 219 literatureHs.77318 L13385 349823 Miller-Dieker lissencephaly protein 1CGTTGCTGAAGTGGTAATTGAGGAAA (LIS1) ACAGTTCCCCAGATTGTTAAGAGT 220 cDNAHs.77424 X14358 31331 high affinity Fc receptor 1CTCCCCGTGAGCACTGCGTACAAACA T-cells (FcRI)/cds = (36, 118TCCAAAAGTTCAACAACACCAGAA 221 cDNA Hs.77502 BC001854 12804818 ,methionine adenosyltransferase 1 AGTGCCTTTCAGGATCTATTTTTGGA T-cells II,alpha, c GGTTTATTACGTATGTCTGGTTCT 222 cDNA Hs.77729 NM_002543 4505500oxidised low density lipoprotein 1 AGAACAAACTAAGCCAGGTATGCAAA T-cells(lectin-like TATCGCTGAATAGAAACAGATGGA 223 cDNA Hs.77729 AB010710 2828355lectin-like oxidized LDL receptor 1 AGAACAAACTAAGCCAGGTATGCAAA T-cellsTATCGCTGAATAGAAACAGATGGA 224 cDNA Hs.78148 M28526 189775 plateletendothelial cell adhesion 1 GCAATTCCTCAGGCTAAGCTGCCGGT T-cells molecule(PECAM-1) TCTTAAATCCATCCTGCTAAGTTA 225 cDNA Hs.78225 NM_000700 4502100annexin A1 (ANXA1), 1 TCCTGGTGGCTCTTTGTGGAGGAAAC T-cells mRNA/cds = (74,1114)/gb = N TAAACATTCCCTTGATGGTCTCAA 226 literature Hs.785 NM_0004196006009 integrin, alpha 2b (platelet 1 CTTTGGGTTGGAGCTGTTCCATTGGGglycoprotein IIb TCCTCTTGGTGTCGTTTCCCTCCC 227 cDNA Hs.78713 NM_0026354505774 solute carrier family 25 1 AGAAAAAGCTTGGGTTAACTCAGTAG T-cells(mitochondrial carri TTAGATCAAAGCAAATGTGGACTG 228 cDNA Hs.78864 M31932182473 IgG low affinity Fc fragment 1 ACAGATGTAGCAACATGAGAAACGCT T-cellsreceptor (FcRIIa) mRNA, c TATGTTACAGGTTACATGAGAGCA 229 cDNA Hs.789X54489 34825 melanoma growth stimulatory 1 TGTTTAATGGTAGTTTTACAGTGTTTCT-cells activity (MGSA) TGGCTTAGAACAAAGGGGCTTAA 230 literature Hs.78996BC000491 12653440 proliferating cell nuclear antigen 1TGCCAGCATATACTGAAGTCTTTTCT GTCACCAAATTTGTACCTCTAAGT 231 cDNA Hs.79008NM_012245 6912675 SKI-INTERACTING PROTEIN 1 GCTGCATATGAGTAAAGTTACCCCAAT-cells (SNW1), mRNA/cds = (2 CCACAGTGAGGAGGAAGATGTTCA 232 cDNA Hs.79022U10550 762886 Gem GTPase (gem) mRNA, 1 AAACCTCCAGTACTTTGGTTGACCCTT-cells complete cds/cds = (213, 1103)/ TGTATGTCACAGCTCTGCTCTATT 233cDNA Hs.79110 NM_005381 4885510 nucleolin (NCL). 1ACCTGATCAATGACAGAGCCTTCTGA T-cells GGACATTCCAAGACAGTATACAGT 234 cDNAHs.79197 NM_004233 4757945 CD83 antigen (activated B 1GCCCTTCCCTTCTTGGTTTCCAAAGG T-cells lymphocytes, immunoCATTTATTGCTGAGTTATATGTTC 235 cDNA Hs.79630 S75217 241773 mb-1 =IgM-alpha 1 CTGATTGTAGCAGCCTCGTTAGTGTC T-cells ACCCCCTCCTCCCTGATCTGTCAG236 cDNA Hs.80358 NM_004653 4759149 SMC (mouse) homolog, Y 1ACCAAAAAGAATAGGGAAAAA T-cells chromosome (SMCY), mRNACAAGAATTTCATGACTCTACCTGT GGTCT 237 cDNA Hs.80420 U84487 1888522 CX3Cchemokine precursor, 1 GACTTTTCCAACCCTCATCACCAACG T-cells mRNA,alternatively splice TCTGTGCCATTTTGTATTTTACTA 238 cDNA Hs.80617NM_001020 14591912 ribosomal protein S16 (RPS16), 1GCTCGCTACCAGAAATCCTACCGATA T-cells mRNA/cds = (37, 4AGCCCATCGTGACTCAAAACTCAC 239 cDNA Hs.80642 L78440 1479978 STAT4 mRNA,complete cds 1 ACCTGAGTCCCACAACAATTGAAACT T-cells /cds = (81, 2327)/gb =L GCAATGAAGTCTCCTTATTCTGCT 240 cDNA Hs.81226 X60992 29817 CD8 mRNA for Tcell 1 AATTGATGAGGATGCTCCTGGGAGG T-cells glycoprotein CD8/cds = (120,152 GATGCGTGACTATGTGGTGTTGCAC 241 cDNA Hs.8128 NM_014338 13489111phosphatidylserine decarboxylase 1 TGAAATATGGGAAAGTTGCTGCTATT T-cells(PISD). GATTCAGGGTCTGTCTTGGAGGCA 242 cDNA Hs.81584 NM_002619 4505732platelet factor 4 (PF4), 1 CAACTGATAGCCACGCTGAAGAATGG T-cells mRNA.AAGGAAAATTTGCTTGGACCTGCA 243 cDNA Hs.81665 X06182 34084 c-kitproto-oncogene mRNA 1 TGTGTAAATACATAAGCGGCGTAAGT T-cells /cds = (21,2951)/gb = X06182 TTAAAGGATGTTGGTGTTCCACGT 244 cDNA Hs.82132 NM_0024604505286 50 interferon regulatory factor 4 1 AACCCTCCTCCAATGGAAATTCCCGTT-cells (IRF4), mRNA/ GTTGCTTCAAACTGAGACAGATGG 245 cDNA Hs.82132NM_002460 4505286 60 interferon regulatory factor 4 1CCTCCAATGGAAATTCCCGTGTTGCT T-cells (IRF4), mRNA/TCAAACTGAGACAGATGGGACTTAAC AGGCAATG 246 cDNA Hs.82132 NM_002460 450528670 interferon regulatory factor 4 1 CCAACCCTCCTCCAATGGAAATTCCC T-cells(IRF4), mRNA/ GTGTTGCTTCAAACTGAGACAGATGG GACTTAACAGGCAATGGG 247literature Hs.82359 X63717 28741 APO-1 cell surface antigen 1AATCATCATCTGGATTTAGGAATTGC /cds = (220, 122 TCTTGTCATACCCCCAAGTTTCTA 248literature Hs.82401 NM_001781 4502680 CD69 antigen (p60, early T-cell) 1GCAAGACATAGAATAGTGTTGGAAAA Activated B & T cells.TGTGCAATATGTGATGTGGCAAAT 249 cDNA Hs.279841 NM_006296 5454163 vacciniarelated kinase 2 1 TCTCCATCTTGGTATAAATACACTTCC T-cells (VRK2), mRNA/cds= (1 ACAGTCAGCACGGGGATCACAGA 250 cDNA Hs.82829 M25393 190740 proteintyrosine phosphatase 1 TCTCCTTACTGGGATAGTCAGGTAAA T-cells (PTPase) mRNA,complete CAGTTGGTCAAGACTTTGTAAAGA 251 literature Hs.82848 NM_0006555713320 selectin L (lymphocyte adhesion 1 ACCCATGATGAGCTCCTCTTCCTGGCmolecule 1) ( TTCTTACTGAAAGGTTACCCTGTA 252 cDNA Hs.83077 D49950 1405318for interferon-gamma inducing 1 TGACATCATATTCTTTCAGAGAAGTG T-cellsactivated macrophages TCCCAGGACATGATAATAAGATGC 253 cDNA Hs.83086 L389351008845 GT212 mRNA/cds = UNKNOWN 1 ATCAGAAACCGAAGATTAACTACACA T-cells/gb = L38935/gi = 100884 GCTCCAGAAGACTCAGACCTCAAA 254 cDNA Hs.83583NM_005731 5031598 actin related protein 2/3 complex, 1CAGGTTCTTAAGGGATTCTCCGTTTT T-cells subunit 2 ( GGTTCCATTTTGTACACGTTTGGA255 cDNA Hs.83731 NM_001772 4502654 CD33 antigen (gp67) (CD33), 1CTAGAAGATCCACATCCTCTACAGGT T-cells mRNA. CGGGGACCAAAGGCTGATTCTTGG 256cDNA Hs.838 NM_005191 4885122 CD80 antigen (CD28 antigen 1CTTCTTTTGCCATGTTTCCATTCTGCC T-cells ligand 1, B7-1 antigATCTTGAATTGTCTTGTCAGCCA 257 literature Hs.83968 NM_000211 4557885integrin, beta 2 (antigen CD18 1 CATGGAGACTTGAGGAGGGCTTGAG (p95),macrophage antigen 1 GTTGGTGAGGTTAGGTGCGTGTTTC (mac-1) 258 literatureHs.84 D11086 303611 interleukin 2 receptor gamma chain 1CCCATGTAAGCACCCCTTCATTTGGC ATTCCCCACTTGAGAATTACCCTT 259 cDNA Hs.845U31120 1045451 interleukin-13 (IL-13) precursor 1CTTGGGCCAGACTGTCAGGGTTCAA T-cells gene, activated T cellsGGAGGGCATCAGGAGCAGACGGAGA 260 cDNA Hs.85258 M12824 339426 T-celldifferentiation antigen 1 CCTCCGCTCAACTAGCAGATACAGG T-cells Leu-2/T8mRNA GATGAGGCAGACCTGACTCTCTTAA 261 cDNA Hs.85266 X51841 33910 mRNA forintegrin beta(4)subunit 1 CAGCGGAACCCTTAGCACCCACATG T-cellsGACCAACAGTTCTTCCAAACTTGAC 262 literature Hs.856 NM_000619 10835170interferon, gamma (IFNG), mRNA 1 ATGCCTGGTGCTTCCAAATATTGTTG T-cells, NKcells ACAACTGTGACTGTACCCAAATGG 263 cDNA Hs.87149 M35999 183532 plateletglycoprotein IIIa 1 CCTCTCTCCAAACCCGTTTTCCAACA T-cells (GPIIIa) mRNA,complete c TTTGTTAATAGTTACGTCTCTCCT 264 cDNA Hs.87409 X14787 37464thrombospondin/cds = (111, 3823) 1 TCATTTGTTGTGTGACTGAGTAAAGA T-cells/gb = X14787 ATTTTTGGATCAAGCGGAAAGAGT 265 cDNA Hs.88474 M59979 189886prostaglandin endoperoxide 1 TGAGGATGTAGAGAGAACAGGTGGG T-cells synthaseCTGTATTCACGCCATTGGTTGGAAG 266 cDNA Hs.88820 NM_018849 7705402 HDCMC28Pprotein 1 GAAATTAAATGGGTTCCAGGTCTTAA T-cells (HDCMC28P).AGAAAGTGCAGAAGAGATGGTCAA 267 cDNA NA AQ338195 4143104 cDNA cloneIMAGE:4143104 1 AACCACTATCATCTACGGCACAAACT T-cells blood 3′ readTGCAAAAGCTGTCCACACCATTTT 268 literature Hs.89137 X13916 34338LDL-receptor related protein 1 CCCGTTTTGGGGACGTGAACGTTTTAATAATTTTTGCTGAATTCTTTACA 269 cDNA Hs.89414 AF147204 6002763 chemokinereceptor CXCR4-Lo 1 TCAGTTTTCAGGAGTGGGTTGATTTC T-cells (CXCR4) mRNA, altAGCACCTACAGTGTACAGTCTTGT 270 cDNA Hs.89476 M16338 180093 T-cell surfaceantigen CD2 1 AGCCTATCTGCTTAAGAGACTCTGGA T-cells (T11) mRNA, completecds, c GTTTCTTATGTGCCCTGGTGGACA 271 cDNA Hs.89575 M89957 179311immunoglobulin superfamily 1 GAGTAGAAGGACAACAGGGCAGCAA T-cells member Bcell receptor co CTTGGAGGGAGTTCTCTGGGGATGG 272 literature Hs.89879NM_000586 10835148 50 interleukin 2 (IL2). 1 GTTCTGGAACTAAAGGGATCTGAAACAACATTCATGTGTGAATATGCAGA 273 literature Hs.89879 NM_000586 10835148 60interleukin 2 (IL2). 1 TGGAACTAAAGGGATCTGAAACAACATTCATGTGTGAATATGCAGATGAGAC AGCAACCA 274 literature Hs.89879 NM_00058810835148 70 interleukin 2 (IL2). 1 CAGGGACTTAATCAGCAATATCAACGTAATAGTTCTGGAACTAAAGGGATCT GAAACAACATTCATGTGT 275 cDNA Hs.89751NM_021950 11386188 CD20 antigen 1 ACCCATTCCATTTATCTTTCTACAGG T-cellsGCTGACATTGTGGCACATTCTTAG 276 cDNA Hs.89887 D38081 533325 thromboxane A2receptor 1 TGAACCTCCAACAGGGAAGGCTCTGT T-cells CCAGAAAGGATTGAATGTGAAACG277 cDNA Hs.93304 U24577 1314245 LDL-phospholipase A2 mRNA, 1TGAAGGAGATGATGAGAATCTTATTC T-cells complete cds/cds = (216, 15CAGGGACCAACATTAACACAACCA 278 cDNA Hs.93649 NM_003367 4507846 upstreamtranscription factor 2, 1 CTCTCTGGAGGTACTGAGACAGGGT T-cells c-fos interaGCTGATGGGAAGGAGGGGAGCCTTT 279 literature Hs.93913 X04430 32673 IFN-beta2a mRNA for interferon- 1 CTCTTCGGCAAATGTAGCATGGGCAC beta-2, T-cells,macrophages CTCAGATTGTTGTTGTTAATGGGC 280 cDNA Hs.960 NM_000590 10834979interleukin 9 (IL9). 1 TTCCAGAAAGAAAAGATGAGAGGGAT T-cellsGAGAGGCAAGATATGAAGATGAAA 281 cDNA Hs.96023 M28170 882622 cell surfaceprotein CD19 (CD19) 1 GGCCAGCCTGGACCCAATCATGAGG T-cells gene, Most Bcells AAGATGCAGACTCTTATGAGAACAT 282 cDNA Hs.96487 BF222826 11130003ESTs, Highly similar to SO8228 1 AATGTTTGCCCAGAATAAAGAAAATA T-cellsribosomal protein S2, cytosolic AGCTTTGCACACACTCTCAATTCT 283 cDNAHs.9663 NM_013374 7019486 programmed cell death 6- 1GGGAAAGAAATACCAACCCTGCAATA T-cells interacting protein (PDCD6IP).AGTGTACTAAACTCTACGCTCTGG 284 cDNA Hs.96731 AB014555 3327123 mRNA forKIAA1375 protein, 1 CACCAGCGCCTTGGCTTTGTGTTAGC T-cells partial cds/cds =(0 ATTTCCTCCTGAAGTGTTCTGTTG 285 literature Hs.99863 NM_001972 4503548elastase 2, neutrophil (ELA2). 1 ACATCGTGATTCTCCAGCTCAACGGGTCGGCCACCATCAACGCCAACGTG 286 cDNA Hs.99899 NM_001252 4507604 tumornecrosis factor (ligand) 1 AGCTACGTATCCATCGTGATGGCATC T-cellssuperfamily, member 7 (TNFSF7) TACATGGTACACATCCAGGTGACG 287 literatureHs.169476 NM_002048 7669491 50 Glyceraldehyde-3-phosphate 1CCACACTGAATCTCCCCTCCTCACAG dehydrogenase TTGCCATGTAGACCCCTTGAAGAG 288literature Hs.169476 NM_002048 7689491 60 Glyceraldehyde-3-phosphate 1CAGTCCCCCACCACACTGAATCTCCC dehydrogenase CTCCTCACAGTTGCCATGTAGACCCCTTGAAGAG 289 literature Hs.169476 NM_002048 7669491 70Glyceraldehyde-3-phosphate 1 CCATGTAGACCCCTTGAAGAGGGGA dehydrogenaseGGGGCCTAGGGAGCCGCACCTTGTC ATGTACCATCAATAAAGTAC 290 literature Hs.169478NM_002048 7669491 50 Complement Glyceraldehyde-3- −1CTCTTCAAGGGGTCTACATGGCAACT phosphate dehydrogenaseGTGAGGAGGGGAGATTCAGTGTGG 291 literature Hs.169476 NM_002048 7669491 60Complement Glyceraldehyde-3- −1 CTCTTCAAGGGGTCTACATGGCAACT phosphatedehydrogenase GTGAGGAGGGGAGATTCAGTGTGGT GGGGGACTG 292 literatureHs.169476 NM_002048 7669491 70 Complement Glyceraldehyde-3- −1GTACTTTATTGATGGTACATGACAAG phosphate dehydrogenaseGTGCGGCTCCCTAGGCCCCTCCCCT CTTCAAGGGGTCTACATGG 293 literature Hs.182937NM_021130 10883926 50 peptidylprolyl isomerase A 1TTTCCTTGTTCCCTCCCATGCCTAGC (cyclophilin A), cloneTGGATTGCAGAGTTAAGTTTATGA 294 literature Hs.182937 NM_021130 10883926 60peptidylprolyl isomerase A 1 TTTCCTTGTTCCCTCCCATGCCTAGC (cyclophilin A),clone TGGATTGCAGAGTTAAGTTTATGATT ATGAAATA 295 literature Hs.182937NM_021130 10883926 70 peptidylprolyl isomerase A 1GTTCCATGTTTTCCTTGTTCCCTCCC (cyclophilin A), cloneATGCCTAGCTGGATTGCAGAGTTAAG TTTATGATTATGAAATAA 296 literature Hs.182937NM_021130 10863926 50 complement peptidylprolyl −1TCATAAACTTAACTCTGCAATCCAGC isomerase A (cyclophilin A), cloneTAGGCATGGGAGGGAACAAGGAAA 297 literature Hs.182937 NM_021130 10883926 60complement peptidylprolyl −1 TATTTCATAATCATAAACTTAACTCTG isomerase A(cyclophilin A), clone CAATCCAGCTAGGCATGGGAGGGAA CAAGGAAA 298 literatureHs.182937 NM_021130 10883926 70 complement peptidylprolyl −1TTATTTCATAATCATAAACTTAACTCT isomerase A (cyclophilin A), cloneGCAATCCAGCTAGGCATGGGAGGGA ACAAGGAAAACATGGAAC 299 literature Hs.288883NM_005877 5032088 mRNA for splicing factor (SF3A1) 1GTCATCCACCTGGCCCTCAAGGAGA (120 kD) GAGGCGGGAGGAAGAAGTAGACAAG 300literature Hs.12084 NM_003321 4507732 Tu translation elongation factor,1 TGACTGAGGAGGAGAAGAATATCAAA mitochondrial (TUFM)TGGGGTTGAGTGTGCAGATCTCTG 301 literature Hs.75887 NM_004371 6996002coatomer protein complex, subunit 1 TGGTTTTCCAAAATGCACACTGCGGG alpha(COPA) TTATTGATTTGTTCTTTACAACTA 302 literature Hs.182278 NM_0017434502548 calmodulin 2 (phosphorylase 1 ACTGTCAGCATGTTGTTGTTGAAGTG kinase,delta) (CALM2). TGGAGTTGTAACTCTGCGTGGACT 303 literature Hs.2795NM_005568 5031856 mRNA for lactate dehydrogenase- 1TGAGTCACATCCTGGGATCCAGTGTA A (LDH-A, EC 1.1.1.27)TAAATCCAATATCATGTCTTGTGC 304 literature Hs.1708 NM_005998 5174726chaperonin containing TCP1, 1 GTTCTGCTACTGCGAATTGATGACAT subunit 3(gamma) (CCT3). CGTTTCAGGCCACAAAAAGAAAGG 305 literature Hs.75428NM_000454 4507148 superoxide dismutase (SOD-1) 1ACATTCCCTTGGATGTAGTCTGAGGC mRNA, complete cds. CCCTTAACTCATCTGTTATCCTGC306 literature Hs.2271 NM_001955 4503460 Arabidopsis endothelin-1 (EDN1)1 ACTGGCTTCCATCAGTGGTAACTGCT TTGGTCTCTTCTTTCATCTGGGGA 307 literature NAX56062 16208 Arabidopsis CAB photosystem 1 1 CCATTGGAGAACTTGGCAACTCACTTchlorophyll a/b-binding protein GGCGGATCCATGGCACAACAACAT (500 bp) 308literature NA X14212 16470 Arabidopsis RCA RUBISCO 1TTTTCTCCTTTGTGTAATTGTGGATTG activase (513) GATCTTGTCCTCTTTTGTTCCCT 309literature NA U91968 1928871 Arabidopsis RBCL ribulose-1,5- 1TATTCTTTCGTGTCAGGGCTTGAACC biophosphate carboxylase/AAGTATCCCCGCTTCTTCTACCCC oxygenase large subunit 310 literature NAAF159801 8571922 Arabidopsis lipid transfer protein 4 1CATCAAGTGAAGTGGGGAATAACGAC (527) ATCATTTGCCTGAAGAGTATGGTT 311 literatureNA AF159803 8571926 Arabidopsis lipid transfer protein 6 1AATGAGGGCATTGGTTTGCTAGTTGC (477) TAATTGATCAGTGATGTATTGTCA 312 literatureNA AF191028 6708182 Arabidopsis papain-type cysteine 1TGGAATCAACAAGATGGCTTCTTTCC endopepetidase (507) CCACCAAAACTAAGTGATCATCAG313 literature NA AF168390 6137137 Arabidopsis root cap 1 (533) 1TGGACCGTAATGAATGAATGTACACG CCATAAACGCCCTTTGTTCAAGCA 314 literature NAAF198054 6649235 Arabidopsis NAC1 (457) 1 CCTCACTCTTGTACCCACGGTAGATTCATGTAAAATACCACTTATGACGC 315 literature NA AF247559 7839390 Arabidopsistriosphosphate 1 GGTTAGCGACCTTGTTGTTGTTGTTG isomerase (498)TGTTCTTACATCTTCTTCTTGAAC 316 literature NA X58149 16440 ArabidopsisPRKase gene for 1 GGCGAAAAGGACGGTCTTGCTTGTTT ribulose-5-phosphate kinase(497) GTAATTTGTGTGGAGATAAAAAGA 317 literature Hs.288061 NM_0011015016088 actin, beta (ACTB). 1 CCCTTTTTGTCCCCCAACTTGAGATGTATGAAGGCTTTTGGTCTCCCTGG 318 literature Hs.77356 XM_002788 4507456 50Transferrin receptor 1 TGAAATATCAGACTAGTGACAAGCTCCTGGTCTTGAGATGTCTTCTCGTT 319 literature Hs.77356 XM_002788 4507456 60Transferrin receptor 1 GGTTGAGTTACTTCCTATCAAGCCAGTACCGTGCTAACAGGCTCAATATTCC TGAATGAA 320 literature Hs.77356 XM_0027884507456 70 Transferrin receptor 1 GTTGAGTTACTTCCTATCAAGCCAGTACCGTGCTAACAGGCTCAATATTCCT GAATGAAATATCAGACTA 321 literature Hs.77356XM_002788 4507456 50 Complement Transferrin −1 AACGAGAAGACATCTCAAGACreceptor CAGGAGCTTGTCACTAGTCTGA TATTTCA 322 literature Hs.77356XM_002788 4507456 60 Complement Transferrin −1TTCATTCAGGAATATTGAGCCTGTTA receptor GCACGGTACTGGCTTGATAGGAAGTA ACTCAACC323 literature Hs.77356 XM_002788 4507456 70 Complement Transferrin −1TAGTCTGATATTTCATTCAGGAATATT receptor GAGCCTGTTAGCACGGTACTGGCTTGATAGGAAGTAACTCAAC 324 Table 3A NA 36E9 1 TTTCAAGACAGAAAGTGACGCAGAGAACCTCCCCGGCCCAGTCTCG ACGC 325 Table 3A NA 38E9 −1GCGTCGAGACTGGGCCGGGGAGGTT CTCTGCGTCACTTTCTGTCTTGAAA 326 Table 3A NA47D11 1 CCTAGACACCTGCATCAGTCAAGGTC ATGGATATTGGGAAGACAGACAGC 327 Table 3ANA 47D11 −1 GCTGTCTGTCTTCCCAATATCCATGA CCTTGACTGATGCAGGTGTCTAGG 328Table 3A NA 53G7 1 AAATAAGAAGAGGAAAGAGAGAGGC CTGCCCTAACCCACTGTTGTGCTGA329 Table 3A NA 53G7 −1 TCAGCACAACAGTGGGTTAGGGCAGGCCTCTCTCTTTCCTCTTCTTATTT 330 Table 3A NA 82C9 1CTCATGCCTGCAGTGCTGCTCATGTT GCCCCCTTGGAATTACTTGTTCAA 331 Table 3A NA 82C9−1 TTGAACAAGTAATTCCAAGGGGGCAA CATGAGCAGCACTGCAGGCATGAG 332 Table 3A NA82G9 1 CCAATTTCTATAATTATTGAACAGCTT TTCGTGGGGCCAGCACAAAGTCT 333 Table 3ANA 82G9 −1 AGACTTTGTGCTGGCCCCACGAAAAG CTGTTCAATAATTATAGAAATTGG 334 Table3A NA 65B1 1 TGGCTACAAATAGAGTAGAGAACAGA CTCCAGTCCTCAAAGACTTTCAGT 335Table 3A NA 65B1 −1 ACTGAAAGTCTTTGAGGACTGGAGTC TGTTCTCTACTCTATTTGTAGCCA336 Table 3A NA 65D10 1 AGTTAAGATGGAAGAATATAGAGACCTTCTGAAGAGCACTGTAGCTTGGA 337 Table 3A NA 65D10 −1TCCAAGCTACAGTGCTCTTCAGAAGG TCTCTATATTCTTCCATCTTAACT 338 Table 3A NA100D7 1 CACTCCTATGGCATGTGGAAGCAGGT CTGAGCAGTGTGCATAGAAGAAAA 339 Table 3ANA 100D7 −1 TTTTCTTCTATGCACACTGCTCAGAC CTGCTTCCACATGCCATAGGAGTG 340Table 3A NA 107H8 1 GCTCTCCGTTGACAATGGCCAAAGAA TAGAAGCTCTAGACCTTCCTTATT341 Table 3A NA 107H8 −1 AATAAGGAAGGTCTAGAGCTTCTATTCTTTGGCCATTGTCAACGGAGAGC 342 Table 3A NA 129F10 1GGCAAAACGCACCTGGCACAACAGA ACGAATAATACAGAAGCTGGATGAC 343 Table 3A NA129F10 −1 GTCATCCAGCTTCTGTATTATTCGTTC TGTTGTGCCAGGTGCGTTTTGCC 344 Table3A NA 137B5 1 TAGCCATTTCTTCCTGATTGTGCCTA GTATATCCCAGACAGTTTGTTTCT 345Table 3A NA 137B5 −1 AGAAACAAACTGTCTGGGATATACTA GGCACAATCAGGAAGAAATGGCTA346 Table 3A NA 139G6 1 GGTTGGAATGGTGATCGGGATGCAGTGAGATACTCTTGTGAGAGGGCAAA 347 Table 3A NA 139G6 −1TTTGCCCTCTCACAAGAGTATCTCAC TGCATCCCGATCACCATTCCAACC 348 Table 3A NA142E4 1 GCCATGAGATTCAACAGTCAACATCA GTCTGATAAGCTACCCGACAAAGT 349 Table 3ANA 142E4 −1 ACTTTGTCGGGTAGCTTATCAGACTG ATGTTGACTGTTGAATCTCATGGC 350Table 3A NA 142E9 1 AAGAGGACAAGTTTGAGAGGCAACA CTTAAACACTAGGGCTACTGTGGCA351 Table 3A NA 142E9 −1 TGCCACAGTAGCCCTAGTGTTTAAGTGTTGCCTCTCAAACTTGTCCTCTT 352 Table 3A NA 142F9 1ATTTGCTTTAAATTGAGTTTCCTTGCC ATTGCACACTCCTATCTTTCTGA 353 Table 3A NA142F9 −1 TCAGAAAGATAGGAGTGTGCAATGGC AAGGAAACTCAATTTAAAGCAAAT 354 Table3A NA 331A3 1 AAAAGTCACTACCAGGCTGGCAGGG AATGGGGCAATCTATTCATACTGAT 355Table 3A NA 331A3 −1 ATCAGTATGAATAGATTGCCCCATTC CCTGCCAGCCTGGTAGTGACTTTT356 Table 3A NA 138G5 1 ATATTGATTTGGATACGGTGAATAAGCTGGACAAGATGTTGAGGAGAGGG 357 Table 3A NA 138G5 −1CCCTCTCCTCAACATCTTGTCCAGCT TATTCACCGTATCCAAATCAATAT 358 Table 3A NA145C5 1 AATGTGCAAGGTGAAATGCTTTTGGA TAAACGTAAGCCTATTTTCTGACG 359 Table 3ANA 145C5 −1 CGTCAGAAAATAGGCTTACGTTTATC CAAAAGCATTTCACCTTGCACATT 360Table 3A NA 184H1 1 TTCATCTCTAAGGCACACTTGCTACC CCTCTTTGCTGACCCCAGATTGTG361 Table 3A NA 184H1 −1 CACAATCTGGGGTCAGCAAAGAGGGGTAGCAAGTGTGCCTTAGAGATGAA 362 Table 3A NA 45B9 1TTCTGGCAAGCTCTTGTCATGGTGTT CGACACTTCCTTCTGTCTTCTTGG 363 Table 3A NA 45B9−1 CCAAGAAGACAGAAGGAAGTGTCGA ACACCATGACAAGAGCTTGCCAGAA 364 Table 3A NA112B5 1 GGTCAATGTAGCCAATTATTTGTTTCA ACAGTTGCAGAACAGATATTTCA 365 Table 3ANA 112B5 −1 TGAAATATCTGTTCTGCAACTGTTGA AACAAATAATTGGCTACATTGACC 366Table 3A NA 117H9 1 TGAAAAGACAGCTAATTTGGTCCAAC AAACATGACTGGGTCTAGGGCACC367 Table 3A NA 117H9 −1 GGTGCCCTAGACCCAGTCATGTTTGTTGGACCAAATTAGCTGTCTTTTCA 368 Table 3A NA 515H10 1TGGATCATTGCCCAAAGTTGCACGCA CTGACTCCTTACCTGTGAGGAATG 369 Table 3A NA515H10 −1 CATTCCTCACAGGTAAGGAGTCAGTG CGTGCAACTTTGGGCAATGATCCA 370 Table3A NA 103C4 1 TTAAAACATTAAAAGATTGACTCCACT TTGTGCCAAGCTCTGCGGGTAGG 371Table 3A NA 103C4 −1 CCTACCCGCAGAGCTTGGCACAAAG TGGAGTCAATCTTTTAATGTTTTAA372 Table 3A NA 116E10 1 TGAATTTGGAGTCCCTGGCACATAAATCTACCTTCAAATCAGAGGTCCTT 373 Table 3A NA 116E10 −1AAGGACCTCTGATTTGAAGGTAGATT TATGTGCCAGGGACTCCAAATTCA 374 Table 3A NA196D7 1 TGGGTCAGAGACGAAAAGGGCTATTA TTAGGTCAAACATTACAGAAATCA 375 Table 3ANA 196D7 −1 TGATTTCTGTAATGTTTGACCTAATAA TAGCCCTTTTCGTCTCTGACCCA 376Table 3A NA 524A9 1 CTGATTTAACAGGTGGTTCTGCGGGC GTCCAGGTCAACATCTTTTTGTCC377 Table 3A NA 524A9 −1 GGACAAAAAGATGTTGACCTGGACGCCCGCAGAACCACCTGTTAAATCAG 378 Table 3A NA 485A6 1GTCACTTTAGCGAGCGGGAAAACAAT GGCGGAAAGGGAAAACCTGGAAAG 379 Table 3A NA485A6 −1 CTTTCCAGGTTTTCCCTTTCCGCCAT TGTTTTCCCGCTCGCTAAAGTGAC 380 Table3A NA 485D5 1 TAATTAATAGAGCTCACTTAAGATTGC CCATCAAGAAACAGGAGGGTGGT 381Table 3A NA 485D5 −1 ACCACCCTCCTGTTTCTTGATGGGCA ATCTTAAGTGAGCTCTATTAATTA382 Table 3A NA 479G6 1 AGTCCTGCTGAATCATTGGTTTATAGAAGACTATCTGGAGGGCCTGATAG 383 Table 3A NA 479G6 −1CTATCAGGCCCTCCAGATAGTCTTCT ATAAACCAATGATTCAGCAGGACT 384 Table 3A NA482A5 1 ATGTGATTCCATGATAATCAAATAGT GAATACATTATAAAGTCAGCAACT 385 dbmining Hs.195219 W83776 1371377 hypothetical protein FLJ14486 1ATATATGGGGGCTGGGCCTCGGGAC (FLJ14486), mRNA/cds =TCTCGCTCTAATAAAGGACTGTAGG (80, 1615) 386 Table 3A Hs.183454 AK02778914042727 cDNA FLJ14883 fis, clone 1 TTTTGACCCAGATGATGGTTCCTTTAPLACE1003596, moderately CAGAACAATAAAATGGCTGAACAT similar toOLIGOSACCHARYL TRANSFERASE STT3 SUBUNIT/cds = (2, 862) 387 db miningHs.69171 NM_006256 5453973 protein kinase C-like 2 1TGAGCACTGGAAACAGTTTCATGGAG (PRKCL2), mRNA/cds = (9, 2963)TTTAAGTTGAGTGAACATCGGCCA 388 Table 3A Hs.131828 R67468 840106 EST390979cDNA 1 ATGCATTTAGTTTTTGGCACCGTAGT TTAAGGGTGGGATTGCCAGTTTTT 389 Table 3AHs.181297 AA010282 1471308 tc35a11.x1 cDNA, 3′ end 1GGTTGTGTCTCTGGTTTCCCCTTTTC /clone = IMAGE:2066588/CCCGTGGTTTTAATTTTTAAGAAC clone_end = 3′ 390 Table 3A Hs.235883 AA0208451484616 602628774F1 cDNA, 5′ end 1 GGAGGACACCCCTGTGTGTTGCTGC /clone =IMAGE:4753483/ TGCCTTCCGTGCTGTCTACTGTATC clone_end = 5′ 391 Table 3AHs.330145 AA044450 1522307 RST29149 cDNA 1 GCATCAGAGAGAATATGGAAGGACATCGACCCTAACTTCATCCAGTGAGG 392 Table 3A Hs.189468 AA069335 1576904tm30a06.x1 cDNA, 3′ end 1 ACCATAGCAGACAGGGTCAGATGGA /clone =IMAGE:2158066/ ATATTAGCGGTTTAGGTGAAGAACC clone_end = 3′ 393 Table 3AHs.205675 AA111921 1664016 EST389824 cDNA 1 AGACAGAAGACAAGGCCAAATGGGTGTCTCTGGAATGATAGACTTAGAAA 394 Table 3A Hs.13859 AA115345 1670525 mRNA;cDNA DKFZp586F2423 1 ATCCACATTCTTACCTTTGGTAGTCA (from cloneDKFZp586F2423) GGTTTGGCTACTTTGCAGCTCGCC /cds = UNKNOWN 395 Table 3AHs.11861 AA122297 1678553 thyroid hormone receptor- 1ATAGCAGTGGATTACCAACACCTTGA associated protein, 240 kDaCTTCTTGTACAGTGCTAACATCTT subunit (TRAP240), mRNA/cds = (77, 6601) 396Table 3A Hs.183454 AA149078 1719368 cDNA FLJ14883 fis, clone 1TAGTAAAAGTGAAAGAGAAAGGGTTT PLACE1003596, moderatelyTTCCTGCCACAGGATATAACTTTT similar to OLIGOSACCHARYL TRANSFERASE STT3SUBUNIT/cds = (2, 862) 397 Table 3A Hs.124601 AA203497 1799265zx58g05.r1 cDNA, 5′ end 1 AAAGCGGTCGTTTCCCCACAAGGTGT /clone =IMAGE:446744/ CCAACTTTGCGGTACTCACACTTA clone_end = 5′ 398 Table 3AHs.73798 AA210788 1809440 macrophage migration inhibitory 1CTAGGCCCGCCCACCCCAACCTTCT factor (glycosylation-inhibitingGGTGGGGAGAAATAAACGGTTTAGA factor) (MIF), mRNA/cds = (97, 444) 399 Table3A NA AA214691 1814479 Express cDNA library cDNA 5′ 1TGCACTAAACAGTTGCCCCAAAAGAC ATATCTTGTTTTAAGGCCCAGACC 400 Table 3A NAAA243144 1874139 cDNA clone IMAGE:685113 5′ 1 TTGGATGAAGCTGAAAAGACACTAAGACCTTCTGTGCCTCAGATCCCTGA 401 Table 3A Hs.135187 AA250809 1885832zs06a08.r1 cDNA, 5′ end 1 GTGTGGCCTAAGGAACACCTCTTGTGGGGAGTAAGAGCCAGCCCTTCTCC 402 Table 3A Hs.100651 AA251184 1886149 golgiSNAP receptor complex 1 AAGGATGAAGGACTGATGGAGGGCA member 2 (GOSR2),mRNA/cds = GAGGAACTGGAGGCAGCAGGCACAA (0, 638) 403 Table 3A NA AA2529091885512 cDNA clone IMAGE:669292 5′ 1 AGATGTCTGTATAAACAACCTTTGGGTAGCAGGTGGTCAGTTAGGCAGGA 404 Table 3A Hs.194480 AA258979 1894268EST389427 cDNA 1 TGCTTGTCTTTTAAACACCTTCACAGA TATCATTTGCACCTTGCCAAAGG 405Table 3A Hs.5241 AA280051 1921589 fatty acid binding protein 1, liver 1GGGTAGGCAGCTTGCACCCAGTTCT (FABP1), mRNA/cds = (42, 425)CCTTTATCTCAACTTATTTTCCTGG 406 Table 3A NA AA282774 1925825 cDNA cloneIMAGE:713136 5′ 1 CCGGTGTCCCTGAGTGAGGGCAAAG TTGTAATAACACTTGTTCTCTCCTT407 Table 3A Hs.89072 AA283061 1926050 hypothetical protein MGC4618 1ACGGCGTTCTGAAATTTAGCACACTG (MGC4618), mRNA/cds =GGAAGTCCACATGGTTCATCTGAA (107, 1621) 408 Table 3A Hs.291448 AA2909211938772 EST388168 cDNA 1 AATGAGATCACAGATGGTGACACTGAGCGGAAGGATGCAGTACCTCGGAG 409 Table 3A Hs.211866 AA290993 1938989wh99f02.x1 cDNA, 3′ end 1 TCCTTGCAAAACATTTGGCTAGTGGT /clone =IMAGE:2388891/ GTTCAGAGAAATACCAAAACGTGT clone_end = 3′ 410 Table 3AHs.323950 AA307854 1960203 zinc finger protein 6 (CMPX1) 1GGCAAAGGGGAAGGATGATGCCATG (ZNF6), mRNA/cds = TAGATCCTGTTTGACATTTTTATGG(1285, 3381) 411 Table 3A Hs.100293 AA312681 1965030 O-linkedN-acetylglucosamine 1 ACTGTTAACCAAATTTTGAGCAAGGA (GlcNAc) transferase(UDP-N- GTCTCAAAGGTAATTCTGAACCAG acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) (OGT), mRNA/cds = (2039, 4801) 412 Table3A Hs.217493 AA314369 1966698 annexin A2 (ANXA2), mRNA 1ACTAGCAGATTGAATCGATATTCATTA /cds = (49, 1068) AGTTAGGAATGGTTGGTGGTCCT413 Table 3A Hs.85844 AA322158 1974484 neurotrophic tyrosine kinase, 1AATTGTGCTTTGTATCAGTCAGTGCT receptor, type 1 (NTRK1),GGAGAAATCTTGAATAGCTTATGT mRNA/cds = (0, 2390) 414 Table 3A Hs.260238AA332553 1984806 hypothetical protein FLJ10842 1AGGAAACCAAGCCCTCACAGGAAAG (FLJ10842), mRNA/cds =AAAGCCTGAATCAAGAAAACAAAGT (39, 1307) 415 Table 3A Hs.323463 AA3606342012954 mRNA for KIAA1693 protein, 1 ACTGAGCAGGACAACTGACCTGTCTC partialcds/cds = (0, 2707) CTTCACATAGTCCATATCACCACA 416 Table 3A NA AA3773522029681 EST89924 Small intestine II cDNA 1 GCGTAAAACGCCAGGGCCATCTTCTT 5′end ACTTAAGCCACATCCTGAACCAGG 417 Table 3A Hs.27973 AA397592 2050712KIAA0874 protein (KIAA0874), 1 AGCGACAAGAAGGAATCTGGTGAATT mRNA/cds = (0,6188) TTAGTCATCCCAGCTTTTTAGTCT 418 Table 3A Hs.343557 AA401648 2056830601500320F1 cDNA, 5′ end 1 GCTGGGGCTGAGAGAGGGTCTGGGT /clone =IMAGE:3902237/ TATCTCCTTCTGATCTTCAAAACAA clone_end = 5′ 419 Table 3AHs.186674 AA402069 2056860 qf56f06.x1 cDNA, 3′ end 1TCATGGACACAAACTTTGGAGTATAA /clone = IMAGE:1754051/GCGACATCCCTTAAGCAACAGGCT clone_end = 3′ 420 Table 3A Hs.301985 AA4124362071006 602435787F1 cDNA, 5′ end 1 ATTCAAGTCAGGGCCTCTCTGCCCTT /clone =IMAGE:4553884/ TTCCCTCCAGAAACAAAACCAAGA clone_end = 5′ 421 Table 3AHs.9691 AA418765 2080566 cDNA: FLJ23249 fis, clone 1TGTTTGTACCACTAGCATTCTTATGTC COL04196/cds = UNKNOWNTGTACTTGAACGTGTAGTTAGCA 422 Table 3A Hs.24143 AA426506 2106769Wiskott-Aldrich syndrome protein 1 AATATAGCTCCACTAAAGGACCATAGinteracting protein (WASPIP), GGAAGAGCCAGCCTTGCCTTTTCT mRNA/cds = (108,1619) 423 Table 3A Hs.303214 AA427653 2111519 7o45b01.x1 cDNA, 3′ end 1GACAGTCCATTAAGTTGATTTCCAGT /clone = IMAGE:3576912/GGTGAAGGGTCAGACACGCCTCCC clone_end = 3′ 424 Table 3A Hs.89519 AA4297832112974 KIAA1046 protein (KIAA1046), 1 CCTGGGTTGCCTTGTAATGAAAAGGGmRNA/cds = (577, 1782) AGATCGAGCCATTGTACCACCTTA 425 Table 3A Hs.112071AA442585 2154463 zv57f09.r1 cDNA, 5′ end 1 GTTCACTGTTTAACAGCCAGAAGCCA/clone = IMAGE:757769/ GAGCCTGCGTACTAGAAGTGGATG clone_end = 5′ 426 Table3A Hs.8832 AA454036 2167705 zx48b04.r1 cDNA, 5′ end 1TTGTCAAGTGGATCTGCCCCAAAGTT /clone = IMAGE:795439/TGCTTTGAGGAAACGGGCCTCCCT clone_end = 5′ 427 Table 3A Hs.286148 AA4549872177763 stromal antigen 1 (STAG1), 1 CTTGTATGGAAAACAGATGCTGACAG mRNA/cds= (400, 4176) AATTGTAGACTACCATGCCACACA 428 Table 3A Hs.255452 AA4557072178483 aa22d09.r1 cDNA, 5′ end 1 AAATCTAAGACACCCAAACCCCTCTT /clone =IMAGE:814001/ TGTCCCTAAGTAGCCCTAGCCTGG clone_end = 5′ 429 Table 3A NAAA457757 2180477 fetal retina 937202 cDNA clone 1AGCTGTTTAATTGAATTGGAATCGTT IMAGE:838756 5′ CCACTTGGAACCCAAGTTTGGAAA 430Table 3A Hs.82772 AA460876 2185996 collagen, type XI, alpha 1 1TTTTTCTACGTTATCTCATCTCCTTGT (COL11A1), mRNA/cds =TTTCAGTGTGCTTCAATAATGCA (161, 5581) 431 Table 3A Hs.292451 AA4616042185468 zx51d08.r1 cDNA, 5′ end 1 CTCCCATCTGCACACCTGGATCAAGG /clone =IMAGE:795759/ TAGCCTCTCTGCACAAGGGCAGGT clone_end = 5′ 432 Table 3AHs.13809 AA476568 2204779 mRNA for KIAA1525 protein, 1TGTTTTTGCTTCCTCAGAAACTTTTTA partial cds/cds = (0, 2922)TTGCATCTGCCATCCTTCATTGG 433 Table 3A Hs.83733 AA479163 10433041 cDNAFLJ11724 fis, clone 1 ACAGCCAACTGGAAAGATATAAAAGT HEMBA1005331/cds =TTGGGTCTGTCTCCTCTCCTTCAG UNKNOWN 434 Table 3A Hs.190154 AA490796 2219969td07e03.x1 cDNA, 3′ end 1 ACTCCTGCTTTAGAGAGAAGCCACCA /clone =IMAGE:2074972/ TGAAAAGTCCTCATCATCAGGGGA clone_end = 3′ 435 Table 3AHs.119960 AA496483 2229804 mRNA; cDNA DKFZp727G051 1TCCGTACTGTATGTGATATAGTGCCA (from clone DKFZp727G051);TTTTCAGTAACTGCTGTACACACA partial cds/cds = (0, 1423) 436 Table 3AHs.75470 AB000115 2564034 hypothetical protein, expressed in 1ACTTGCCATTACTTTTCCTTCCCACTC osteoblast (GS3686), mRNATCTCCAACATCACATTCACTTTA /cds = (241, 1482) 437 Table 3A Hs.50002AB000887 2189952 small inducible cytokine 1 GTGAGTGTGAGCGAGAGGGTGAGTGsubfamily A (Cys—Cys), TGGTCAGAGTAAAGCTGCTCCACCC member 19 (SCYA19),mRNA/cds = (138, 434) 438 Table 3A Hs.76730 AB002299 2224542 mRNA forKIAA0301 gene, partial 1 TAATATGCTGGCTTTGCAGCAGAATG cds/cds = (0, 6144)AAAAGGATGAGTTGGTGTAGCCTT 439 Table 3A Hs.7911 AB002321 2224586 mRNA forKIAA0323 gene, partial 1 TTCCTTCCCTGGAGGAACTCTTTGGT cds/cds = (0, 2175)TGCAGGGCTAAACTTAGAGGCTGC 440 Table 3A Hs.7720 AB002323 2224590 mRNA forKIAA0325 gene, partial 1 TCTGACGGTTGGGAGTGGTGGAAATT cds/cds = (0, 6285)GGAAGGATACCAGGAGGTATTTGG 441 Table 3A Hs.278671 AB002334 2224612KIAA0338 gene product 1 TGATTACAAAAGGCGTATTCTTTCAT (KIAA0338), mRNA/cds= GGTTTCTGCAATGAGAGGAAGTGT (253, 5004) 442 Table 3A Hs.23311 AB0023652224674 mRNA for KIAA0367 gene, partial 1 TCATGCATTGGATTGCTCAGAATAAAcds/cds = (0, 2150) GTGTCTGTTAGACTTCGTTTTGGT 443 Table 3A Hs.3852AB002368 2224876 mRNA for KIAA0368 gene, partial 1TGACGTTAACACCAGGAATCTCCATG cds/cds = (0, 4327) TTTATTATTTTTCGTGGAAACTCC444 Table 3A Hs.70500 AB002368 2224680 mRNA for KIAA0370 gene, partial 1TTGCAAAGACTCACGTTTTTGTTGTTT cds/cds = (0, 2406) TCTCATCATTCCATTGTGATACT445 Table 3A Hs.63302 AB002369 2224682 myotubularin related protein 3 1AGCTGTACATATAACCCTTTTCTCCTA (MTMR3), mRNA/cds = AAGAGGAGTCAGTCAGTGCTCCT(247, 3843) 446 Table 3A Hs.32556 AB002377 6634024 mRNA for KIAA0379protein, 1 AGTTCAGGAGATCTCTAAGTGTAGCT partial cds/cds = (0, 3180)GTAAATTTTGGGGTTAATTTGGCT 447 Table 3A Hs.101359 AB002384 2224712 mRNAfor KIAA0386 gene, 1 TGTTTGGTTGAGGGGTGCTTTTAGTT complete cds/cds = (177,3383) GTGTGGCATTTGTATTCATTGATC 448 Table 3A Hs.100955 AB007859 6834028mRNA for KIAA0399 protein, 1 TCAGCCTGAGTGAGTTCAGCCTGTAA partial cds/cds= (0, 2961) AAAGGATGTTAAGCTGTGGGTAAA 449 Table 3A Hs.118047 AB0078612662082 602971981F1 cDNA, 5′ end 1 AGGGGAAAAGAGGGGAGAAAAACAG /clone =IMAGE:5111324/ GAGTGATGTCATTTCTTTTTCATGT clone_end = 5′ 450 Table 3AHs.28578 AB007888 2887430 muscleblind (Drosophila)-like 1ACTTTCTGCTTGTAGTTGCTTAAAATT (MBNL), mRNA/cds = ATGTATTTTGTCTTGGGCTGCAA(1414, 2526) 451 Table 3A Hs.32168 AB007902 2662164 KIAA0442 mRNA,partial cds 1 AAGCAACTGAATCTTCAGCATGTTCT /cds = (0, 3519)CATCGGCGGAGCCTTCTTGTGTAA 452 Table 3A Hs.158286 AB007915 6634034 mRNAfor KIAA0446 protein, 1 TGATTGGAGCACTGAGGAACAAGGG partial cds/cds =(3480, 4586) AATGAAAAGGCAGACTCTCTGAACG 453 Table 3A Hs.214646 AB0079166683704 mRNA for KIAA0447 protein, 1 TTGTCCAAACGAAGCAGCCGTGGTA partialcds/cds = (233, 1633) GTAGCTGTCTATGATTCTTGCTCAG 454 Table 3A Hs.28169AB007928 3413879 mRNA for KIAA0459 protein, 1 TGGTGCAATAGAAGCTGCAAAGATGTpartial cds/cds = (0, 461) GCCACTTTATCTATGAAATGGAGT 455 Table 3A Hs.7764AB007938 3413899 KIAA0469 gene product 1 GGCTTCCATGTCCAGAATCCTGCTTA(KIAA0469), mRNA/cds = AGGTTTTAGGGTACCTTCAGTACT (184, 1803) 456 Table 3AHs.92381 AB007956 3413930 mRNA, chromosome 1 specific 1TTTTGGCCAGCTTTTCTAGATAAGGT transcript KIAA0487/cds =TGTATTGCTACTGCAACTAACAAA UNKNOWN 457 Table 3A Hs.306193 AB011087 9558752hypothetical protein (LQFBS-1), 1 CACACATCCTGGTACCCTTGGTCTTC mRNA/cds =(0, 743) AAAGGCCATTTCCAGCAGACCCTC 458 Table 3A Hs.59403 AB011098 3043575serine palmitoyltransferase, long 1 AAACATGTCTTTTTCTCGCCTCAACTT chainbase subunit 2 (SPTLC2), TATCCACATGAAATGTGTGCCCA mRNA/cds = (188, 1876)459 Table 3A Hs.173081 AB011102 3043583 mRNA for KIAA0530 protein, 1TAAGCATAAAACCTGACACGTTAAAA partial cds/cds = (0, 4692)TCCCTGCCCTTTGGTGAGCCCACT 460 Table 3A Hs.198891 AB011108 3043595 mRNAfor KIAA0536 protein, 1 AACTTGCATTTTAGCAGTGCATGTTT partial cds/cds = (0,3087) CTAATTGACTTACTGGGAAACTGA 461 Table 3A Hs.62209 AB011114 6635200mRNA for KIAA0542 protein, 1 AGGCCTCAGGCCACCTCCAGGAACA partial cds/cds =(390, 4028) GAACACAGTTTTAAGTTTGATTTTT 462 Table 3A Hs.13273 AB0111643043707 mRNA for KIAA0592 protein, 1 TGAGTCTTAGCAATATGGGAGCAGGT partialcds/cds = (0, 4061) TTTCACTGAATTCTGAGGGTGCCT 463 Table 3A Hs.20141AB011169 3043717 mRNA for KIAA0597 protein, 1 GTTGTCCTGGCACACAAGGAGGCGApartial cds/cds = (0, 2915) GGCTATGCGTTCGAGGCCAACCTAG 464 Table 3AHs.118087 AB011182 3043743 DNA sequence from clone RP11- 1TGGGAACACATAGAACTGATGGAGG 251J8 on chromosome 13 ContainsCTTTTCCTAAGGCCAAGGATAATGT ESTs, STSs, GSSs and a CpG island. Containstwo novel genes with two isoforms each and the KIAA0610 gene with twoisoforms/cds = (61, 2061) 465 Table 3A Hs.9075 AB011420 3834353serine/threonine kinase 17a 1 GGATTGAACAGTTCAGTTGTATCTAT(apoptosis-inducing) (STK17A), GCCCCACAGTGACCAGTAAAGTCC mRNA/cds = (117,1361) 466 Table 3A Hs.120996 AB011421 3834355 serine/threonine kinase17b 1 CGATGACTCATTACCCAATCCCCATG (apoptosis-inducing) (STK17B),AACTTGTTTCAGATTTGCTCTGTT mRNA/cds = (261, 1379) 467 Table 3A Hs.180383AB013382 3869139 dual specificity phosphatase 6 1GTCGCAAAGGGGATAATCTGGGAAA (DUSP6), transcript variant 1,GACACCAAATCATGGGCTCACTTTA mRNA/cds = (351, 1496) 468 Table 3A Hs.323712AB014515 3327043 KIAA0615 gene product 1 ACTCAAGCTCACACCTGTACCTGATG(KIAA0615), mRNA/cds = GGAATGAACATAATGTGAAGAAAC (237, 2927) 469 Table 3AHs.11238 AB014522 3327057 mRNA for KIAA0622 protein, 1CACCAAAATAGTTATGTTGGCACTGT partial cds/cds = (0, 3869)GTTCACACGCATGGTCCCCACACC 470 Table 3A Hs.12259 AB014530 3327073 mRNA forKIAA0630 protein, 1 GTGCGCTTTCTTTTACAACAAGCCTC partial cds/cds = (0,1473) TAGAAACAGATAGTTTCTGAGAAT 471 Table 3A Hs.31921 AB014548 3327109mRNA for KIAA0648 protein, 1 GTGTGTATAATGTAAAGTAGTTTTGC partial cds/cds= (0, 2557) ATATTCTTGTGCTGCACATGGGCT 472 Table 3A Hs.8118 AB0145503327113 mRNA for KIAA0650 protein, 1 AGGAATCCTTTTCTACATTTGAGCAA partialcds/cds = (0, 2548) ATACTGAGGTTCATGTTGTACCAA 473 Table 3A Hs.96731AB014555 3327123 mRNA for KIAA0655 protein, 1 CGCCTTGGCTTTGTGTTAGCATTTCCpartial cds/cds = (0, 3253) TCCTGAAGTGTTCTGTTGGCAATA 474 Table 3AHs.65450 AB014558 3327129 reticulon 4a mRNA, complete cds 1AGAGATTTTCTATTGCTGGGAAGGTG /cds = (141, 3719) TGTTTCTCCCACAATTTGTTTGTG475 Table 3A Hs.6727 AB014560 3327133 mRNA for KIAA0660 protein, 1TGCAACCAAATTGGCTTTACCATCTT complete cds/cds = (120, 1568)GGCTTTAGTAGGTATAGAAGACAA 476 Table 3A Hs.52526 AB014569 3327151 KIAA0669gene product 1 TGTCAAATAAAAGAGAACGAACAGGT (KIAA0669), mRNA/cds =AGTTTGGTGGAGCTGAGCTAGTGT (1016, 3358) 477 Table 3A Hs.5734 AB0145793327171 meningioma expressed antigen 5 1 TCCTGTAGAAAACGAACTGTAAAAGA(hyaluronidase) (MGEA5), mRNA CCATGCAAGAGGCAAAATAAAACT /cds = (395,3145) 478 Table 3A Hs.153293 AB014601 3327215 mRNA for KIAA0701 protein,1 ACAGTAGCTTTGTAGTGGGTTTTCTG partial cds/cds = (0, 1892)TGCTGTGCTTTTTAATTTCATGTA 479 Table 3A Hs.192705 AB015798 11087388PRO0457 protein (PRO0457), 1 GATTCCTGTCATGAAGGAAAGCAAGA mRNA/cds = (985,1431) CAGCTCACAGACCAGCGGCATCTG 480 Table 3A Hs.247433 AB015856 3953530activating transcription factor 6 1 TTTTCTGTACCTTTCTAAACCTCTCTT (ATF6),mRNA/cds = (42, 2054) CCCTCTGTGATGGTTTTGTGTTT 481 Table 3A Hs.288031AB016247 3721881 sterol-C5-desaturase (fungal 1AAATCTTATTCCTCCTCTTCTCCCCTC ERG3, delta-5-desaturase)-likeACTTTTCCCTACTTCCTCTGCAA (SC5DL), mRNA/cds = (48, 947) 482 Table 3AHs.179729 AB016811 4514825 collagen, type X, alpha 1 (Schmid 1TGGAATCAGACATCTTCCAGATGGTT metaphyseal chondrodysplasia)TGGACCCTGTCCATGTGTAGGTCA (COL10A1), mRNA/cds = (0, 2042) 483 Table 3AHs.10458 AB018249 4033626 gene for CC chemokine LEC, 1AATTTAGCACCTCAGGAATAACTTATT complete cds GGTTTAGGTCAGTTCTTGGCGGG 484Table 3A Hs.19822 AB018298 3882230 SEC24 (S. cerevisiae) related gene 1AACCATGTAACTCCATTGAACATTTTT family, member D (SEC24D),CAACTTAAGGTCTGCATAGCAGA mRNA/cds = (200, 3298) 485 Table 3A Hs.5378AB018305 3882244 mRNA for KIAA0762 protein, 1 AAACCAGGTTAATGGCTAAGAATGGGpartial cds/cds = (0, 1874) TAACATGACTCTTGTTGGATTGTT 486 Table 3AHs.21264 AB018325 3882284 mRNA for KIAA0762 protein, 1CTCTTGGCTGAGCTTCTACAGGGCTG partial cds/cds = (0, 3540)AGAGCTGCGCTTTGGGGACTTCAG 487 Table 3A Hs.8182 AB018339 3882312 mRNA forKIAA0796 protein, 1 TTTCCTTTGGGGCATGATGTTTTAAC partial cds/cds = (0,3243) CTTTGCTTTAGAAGCACAAGCTGT 488 Table 3A Hs.55947 AB018348 3882330mRNA for KIAA0805 protein, 1 ATAGAATGAGCTTGGTTAAGCACCTC partial cds/cds= (0, 3985) TCCTTTGCCCTTCACCCTGACTCC 489 Table 3A Hs.181300 AB0203356518494 Pancreas-specific TSA305 mRNA, 1 TTGAGTAGAACTCTGATTTTCCCTAGcomplete cds/cds = (45, 2429) AGGCCAAATTCTTTTTATCTGGGT 490 Table 3AHs.22960 AB020623 3985929 breast carcinoma amplified 1TTCTAAACACATTCTTGATCACCAAAC sequence 2 (BCAS2), mRNA/AACTTCAGAAAGACAGTGACTGT cds = (48, 725) 491 Table 3A Hs.45719 AB0206304240131 CAAX box protein TIMAP 1 TGGAGTTGCTTCCAGCTGCCAAGGC mRNA,complete cds/cds = CTGTGACAGAATTCGCTGTTAAGAG (52, 1755) 492 Table 3AHs.123654 AB020631 4240136 mRNA for KIAA0824 protein, 1AATGATGCAAAGTTTTATTCTTGAACT partial cds/cds = (0, 4936)TGGACACTGATGCCATCAAACAA 493 Table 3A Hs.334700 AB020640 14133218 mRNAfor KIAA0833 protein, 1 GGCCAGTAAATTCCATGTTTTTGGCT partial cds/cds = (0,5017) ATATCTCATCCAAACTGAGCAGTT 494 Table 3A Hs.14945 AB020644 4240162mRNA for KIAA0837 protein, 1 TTCCCATTGTCCTCCTACTCAACTAAA partial cds/cds= (0, 2237) ATTCATAGTTGGCTTTAAGCCCA 495 Table 3A Hs.197298 AB0206574240188 NS1-binding protein-like protein 1 GCATGTCCTAATGCTTGCTGCTGATTmRNA, complete cds/cds = TAAACACATTAAAGGTACTTTGCA (555, 2483) 496 Table3A Hs.13264 AB020683 4240200 mRNA for KIAA0856 protein, 1ACAATGGCATAAAAGTAACTTTCTCT partial cds/cds = (0, 3212)GAAGATGTGATGTTCAGGCTGTGA 497 Table 3A Hs.104315 AB020669 4240212suppressor of clear, C. elegans, 1 AATGGAAGGCAGGTGAAGATATAAAA homolog of(SHOC2), mRNA CCCTAGAATGCTTAAATGTGCTGT /cds = (277, 2025) 498 Table 3AHs.18166 AB020877 6635136 mRNA for KIAA0870 protein, 1TTAATGCCAGTCCTCATGTAACCTCA partial cds/cds = (0, 3061)GGTATCTTCAGCTTGTGGAGAATA 499 Table 3A Hs.27973 AB020681 4240236 KIAA0874protein (KIAA0874), 1 TGGAGTATATGCCTGAAAAGGTTTTG mRNA/cds = (0, 6188)GATTCAGAAAGAAAAAGGATGGTT 500 Table 3A Hs.75415 AB021288 4038732 cDNA:FLJ22810 fis, clone 1 AAAGTAAGGCATGGTTGTGGTTAATC KAIA2933, highlysimilar to TGGTTTATTTTTGTTCCACAAGTT AB021288 mRNA for beta 2-microglobulin/cds = UNKNOWN 501 Table 3A Hs.215857 AB022683 5019617HFB30 mRNA, complete cds 1 GGTGTGTGTGTCCAGAGTGAGCAAG /cds = (238, 1660)GATTATGTTTTTGGATTGTCAAAGA 502 Table 3A Hs.104305 AB023143 4589483 deatheffector filament-forming 1 AACCATTTGCCTCTGGCTGTGTCACA Ced-4-likeapoptosis protein GGGTGAGCCCCAAAATTGGGGTTC (DEFCAP), transcript variantB, mRNA/cds = (522, 4811) 503 Table 3A Hs.154296 AB023149 4589507 mRNAfor KIAA0932 protein, 1 GAAAGTGGAGAGGACCTAACATATGT partial cds/cds = (0,2782) CTCTACCTAGAAAGGATGGTTTCA 504 Table 3A Hs.4014 AB023163 4589535mRNA for KIAA0946 protein, 1 ACCAACTATAAACCCAGTTCTAAAGT partial cds/cds= (0, 2005) TGTGTATGATGGTGAACCTTTGGG 505 Table 3A Hs.75478 AB0231734589555 mRNA for KIAA0956 protein, 1 GGACCTGAGACACTGTGGCTGTCTAA partialcds/cds = (0, 2020) TGTAATCCTTTAAAAATTCTCTGC 506 Table 3A Hs.184523AB023182 4589573 mRNA for KIAA0965 protein, 1TTTGGTGTTCAGTTACTGAGTTTCAAA partial cds/cds = (0, 1392)AATGTTTTGGTGGCATGAGGACA 507 Table 3A Hs.103329 AB023187 14133226KIAA0970 protein (KIAA0970), 1 CCTGTTTAAGAAAGTGAAATGTTATG mRNA/cds =(334, 2687) GTCTCCCCTCTTCCAATGAGCTTA 508 Table 3A Hs.158135 AB0231984589605 mRNA for KIAA0981 protein, 1 ACGGACCAGGCCATTCATTATTCCTC partialcds/cds = (0, 1737) AAGTGTTAATATACTGACTTATGC 509 Table 3A Hs.75381AB023200 4589609 mRNA for KIAA0983 protein, 1ACAGTTTTGTCAAAAAGTGTATCTTGA complete cds/cds = (55, 2106)CCCCACCATCAGTACTCCATTCT 510 Table 3A Hs.343557 AB023216 14133228601500320F1 cDNA, 5′ end 1 TTTGGTTCATCCGTGTGCTGTTCTTTT /clone =IMAGE:3902237/ GGGTTCTGAGAGGGTTTTGCCAT clone_end = 5′ 511 Table 3AHs.23860 AB023227 4589669 mRNA for KIAA1010 protein, 1GGCAGTAATGCAAGAGTCCTTTTGTG partial cds/cds = (0, 3949)AAGAGTGTTTCTATGTAGAGATGT 512 Table 3A Hs.90093 AB023420 4579908 mRNA forheat shock protein 1 AAATGCAGAGCAGAATGGACCAGTG apg-2, complete cds/cds =GATGGACAAGGAGACAACCCAGGCC (278, 2800) 513 Table 3A Hs.6790 AB0269085931603 microvascular endothelial 1 AGTGTTCCTGCTGCCAGTTCTTTCCTdifferentiation gene 1 (MDG1), CTTTAGGCGTGGTTGAGAAAAAGC mRNA/cds = (202,873) 514 Table 3A Hs.21542 AB028958 5689406 KIAA1035 protein (KIAA1035),1 CAGTCTCTGCCACTTGTGCTAGTTTT mRNA/cds = (88, 3648)TGTGTGGTGTTTAGAAACATGGGC 515 Table 3A Hs.9846 AB028963 5689416 mRNA forKIAA1040 protein, 1 TTCCACTTAGGTTTGGCATTTTGGCA partial cds/cds = (0,1636) GATAAGCTAATCTTGTATAAAGCA 516 Table 3A Hs.89519 AB028969 5889428KIAA1046 protein (KIAA1046), 1 GTAAATGCCCTACATGGTGTGATGCT mRNA/cds =(577, 1782) GCATTATATATAAAACTGTGTGCA 517 Table 3A Hs.126084 AB0289785689446 mRNA for KIAA1055 protein, 1 AGCTCCTGTGCTGACCTTCAAGTTAC partialcds/cds = (0, 2607) GTTTTGGAACTGTAATACTAAAGG 518 Table 3A Hs.7243AB028980 5689450 mRNA for KIAA1057 protein, 1 ACACTAGGGAAGAACCTTAATTCTAApartial cds/cds = (0, 2934) ATTTGGTTCATGTGTGGCAAAGTT 519 Table 3AHs.8021 AB028981 5689452 mRNA for KIAA1058 protein, 1TAACTGGAATCACTGCCCTGCTGTAA partial cds/cds = (0, 4604)TTAAACATTCTGTACCACATCTGT 520 Table 3A Hs.76118 AB028986 5689462ubiquitin carboxyl-terminal 1 CCCCCAGTGCTTTGTAGTCTCTCCTA esterase L1(ubiquitin thiolesterase) TGTCATAATAAAGCTACATTTTCT (UCHL1), mRNA/cds =(31, 669) 521 Table 3A Hs.325530 AB028990 5689470 mRNA for KIAA1067protein, 1 GACAGACTTGGACACAAAACCGATCC partial cds/cds = (0, 2072)ATAGAAGGGCTTCCCAAACCTTGT 522 Table 3A Hs.154525 AB028999 5689488 mRNAfor KIAA1076 protein, 1 CCATATGTAACTTGTTTTGAAGAGAA partial cds/cds = (0,2415) GTGTTTCCGTTGTGTGTCTTGATG 523 Table 3A Hs.155546 AB029003 5689496mRNA for KIAA1080 protein, 1 GTATCATCTGCCAAGACCAGGGCCT partial cds/cds =(0, 1554) GCTTCACCACAGCCACAATAAAGTC 524 Table 3A Hs.26334 AB0290085689502 mRNA for KIAA1083 protein, 1 AATGAACCATTTACAGTTCGGTTTTG completecds/cds = (221, 1975) GACTCTGAGTCAAAGGATTTTCCT 525 Table 3A Hs.54886AB029015 5689520 mRNA for KIAA1092 protein, 1 GCCGAGTCAGCACATGGGTAGAGATpartial cds/cds = (0, 3484) GATGTAAAAGCAGCCAATCTGGAAA 526 Table 3AHs.117333 AB029016 14133234 mRNA for KIAA1093 protein, 1ACCTTCTGGGAGGAGGGTCGGATTC partial cds/cds = (179, 5382)AATCTGAACTTAGAACTTTCAACTC 527 Table 3A Hs.279039 AB029027 5689544KIAA1104 protein (KIAA1104), 1 GCACCATGTAGAATTTTCACTTTGTA mRNA/cds =(494, 2281) CTGGCAGGCTCGTTTTACCTCATT 528 Table 3A Hs.278586 AB0290315689552 mRNA for KIAA1108 protein, 1 TCTCCAGTCCTGATTACTGTACACAG partialcds/cds = (0, 2291) TAGCTTTAGATGGCGTGGACGTGA 529 Table 3A Hs.7910AB029551 6714542 YEAF1 mRNA for YY1 and 1 TTCCTGTTACTGGCATGTGCACGACTE4TF1 associated factor 1, ATGTTATTAGAAGCCACTTTATCA complete cds/cds =(198, 878) 530 Table 3A Hs.14805 AB031050 7664246 solute carrier family21 1 GCCAGCTTGGAGGATGGACATTTCTG (organic anion transporter),GATACACATACACATACAAAACAG member 11 (SLC21A11), mRNA/cds = (193, 2325)531 db mining Hs.91600 AB031479 6539431 SEEK1 protein (SEEK1), 1TCAGCTCCTTGATCTAAGCCTCCCAG mRNA/cds = (274, 732)AGAGACCCCTAGAATGTTTCCCTC 532 db mining Hs.146824 AB031480 6539433 SPR1protein (SPR1), 1 CCGGCGGCAGGAACTATCAGTAGAC mRNA/cds = (315, 725)AGCTGCTGCTTCCATGAAACGGAAA 533 Table 3A Hs.99872 AB032251 6683491 BPTFmRNA for bromodomain 1 TGTTGCCTTGAATATAACAGTACAATT PHD fingertranscription factor, TGTCAATTACTCTGCACCAGGCT complete cds/cds = (471,8816) 534 Table 3A Hs.8858 AB032252 6683493 bromodomain adjacent to zinc1 AAAAGTAACACCCTCCCTTTTTCCTG finger domain, 1A (BAZ1A),ACAGTTCTTTCAGCTTTACAGAAC mRNA/cds = (115, 5139) 535 Table 3A Hs.288430AB032948 6329727 601655928R1 cDNA, 3′ end 1 AATGAAATGTAGTTGGGTTCTTCCTG/clone = IMAGE:3855679/ TAATGCGCTATTATGTCTTGGGCT clone_end = 3′ 536Table 3A Hs.44087 AB032952 6329754 mRNA for KIAA1126 protein, 1AACCTCCTTGTGTCTGTTTCTCTGTTC partial cds/cds = (0, 1857)CTCTGTGGCTGACTCAATAAACT 537 Table 3A Hs.153489 AB032972 6330026 mRNA forKIAA1146 protein, 1 GTGGGAGGGTGAGATGTGAAGATGT partial cds/cds = (0, 815)GGGATGAACCTGGAATGAACGAATT 538 Table 3A Hs.12461 AB032973 6330032 mRNAfor KIAA1147 protein, 1 GGCCTAAAGAAAGCTGGGGTTAATCC partial cds/cds = (0,589) TGAAGCTAAAAGTAAATGTTTCTT 539 Table 3A Hs.343199 AB032976 6330050EST374106 cDNA 1 TCCCATCCTTTCCATCAAGACCTTCA TTAGCTTATGATATTTGCTGCCGA 540Table 3A Hs.6298 AB032977 6382017 mRNA for KIAA1151 protein, 1GGAGGTCTCTTCCAGATTGCTCTTCT partial cds/cds = (0, 689)GCCGAATTATTTGTATCTATTCCG 541 Table 3A Hs.290398 BF341403 11287894602013389F1 cDNA, 5′ end 1 GCACACCTCGTCAGAGGACCATAAC /clone =IMAGE:4149209/ CGTGTGGGGACAATAACCGCAGGGG clone_end = 5′ 542 Table 3AHs.7041 AB033034 6382021 mRNA for KIAA1208 protein, 1ACAATGGATTTGTGAAGAGCAGATTC partial cds/cds = (24, 2015)CATGAGTAACTCTGACAGGTATTT 543 Table 3A Hs.29679 AB033042 6330568 cofactorrequired for Sp1 1 TGAGAGACATTGTTAATTTTGGGGGA transcriptionalactivation, ATTGGCATTGCGAAAGACTTGAAA subunit 3 (130 kD) (CRSP3),mRNA/cds = (119, 4225) 544 Table 3A Hs.7252 AB033050 6330623 mRNA forKIAA1224 protein, 1 TGCTAGACATTTCTATACTCTGTTGTA partial cds/cds = (0,1908) ACACTGAGGTATCTCATTTGCCC 545 Table 3A Hs.267690 AB033054 6330689mRNA for KIAA1228 protein, 1 GTGGGGGATGGGGGTTAAAAAGTAG partial cds/cds =(0, 2176) AGAACCTCCTTTCTGTTCAACTAAT 546 Table 3A Hs.9873 AB03307614133246 mRNA for KIAA1250 protein, 1 CAGGTGAGTAGTTGCCGCGTAATATC partialcds/cds = (139, 5472) ATTGGAGTACATTCTTTATACTGT 547 Table 3A Hs.146888AB033079 6382025 mRNA for KIAA1253 protein, 1 CCCCAACCTTATTCTGTGTGTAGACApartial cds/cds = (0, 1416) TTGTATTCCACAATTTTGAATGGC 548 Table 3AHs.301721 AB033081 6330899 mRNA for KIAA1255 protein, 1CGAATGGCTTAAACTAATTTGCTATG partial cds/cds = (0, 2866)ATCCTCTAACACCGAAATTTCCCA 549 Table 3A Hs.40193 AB033085 6330932 mRNA forKIAA1259 protein 1 AGAGGGAATCAGAAAAATGCCAAGC CTTTTCTCTTTGAATGTGCTATTTT550 Table 3A Hs.43141 AB033093 6331205 mRNA for KIAA1267 protein, 1CACCCTTCTCTGTTAACCTTGTGCCT partial cds/cds = (94, 3411)GTCTCCTGTATGATCACATCACCA 551 Table 3A Hs.42179 AB033112 6331388 mRNA forKIAA1288 protein, 1 TGTGTCTCTGTCGCGTCTGCTGTGAA partial cds/cds = (197,3841) GCACATGATGCTCTATTTATTGTA 552 Table 3A Hs.63126 AB033118 6331442mRNA for KIAA1292 protein, 1 TGAGAGTAAGCACATGACAGCGTCTG partial cds/cds= (0, 1788) CTTGCGTTGTGTCTGTTTTATGTT 553 Table 3A Hs.278870 AB0342056899845 acid-inducible phosphoprotein 1 TCGTGTGAATCAGACTAAGTGGGATT(OA48-18), mRNA/cds = TCATTTTTACAACTCTGCTCTACT (275, 445) 554 Table 3AHs.76507 AB034747 12862475 LPS-induced TNF-alpha factor 1TGCAACGAATATGGATACCACATAGT (PIG7), mRNA/cds = ACTTTGGTGTTACCTGCTTTTGAA(233, 919) 555 db mining Hs.184 AB036432 6691625 advanced glycosylationend 1 AGAACTGAATCAGTCGGAGGAACCT product-specific receptor (AGER),GAGGCAGGCGAGAGTAGTACTGGAG mRNA/cds = (0, 1214) 556 Table 3A Hs.194369AB036737 8096339 mRNA for RERE, complete cds 1TTGCCATGAGATAACACAGTGTAAAC /cds = (638, 5336) AGTAGACACCCAGAAATCGTGACT557 Table 3A Hs.125037 AB037752 7243042 hypothetical protein FLJ20548 1GCTGTTAGGCTAAGAGGGTGCAGGG (FLJ20548), mRNA/cds =CTAGACACGAAGCTTAAACTATTCA (167, 1432) 558 Table 3A Hs.22941 AB0377847243106 mRNA for KIAA1383 protein, 1 CCAGTGTGGAGGTAGCAAAGCATCTA partialcds/cds = (0, 1293) TCTATTCTGAATCATGTTTGGAAA 559 Table 3A Hs.258730AB037790 7243118 mRNA for KIAA1369 protein, 1 GCCAGTATGCCACAGAATGTCCTAAApartial cds/cds = (0, 1963) CCCTTGCTGCCTCTTATCAAAACC 560 Table 3AHs.29716 AB037791 7243120 mRNA for KIAA1370 protein, 1TTTGTACTGTTGAAACCACTTCATTG partial cds/cds = (49, 3372)GACATGTTGCAATAGCAAAACCCC 561 Table 3A Hs.9663 AB037796 7243130 mRNA forKIAA1375 protein, 1 AGGGGGAACATTGTAAAGAAAC partial cds/cds = (0, 1640)AAAAAGGTCCAGATGAATGTATGC TAGA 562 Table 3A Hs.24684 AB037797 7243132mRNA for KIAA1376 protein, 1 GGTGCTGAATATGTCCTTGTAGGCTC partial cds/cds= (143, 1456) TGTTTTAAGAAAACAATATGTGGG 563 Table 3A Hs.6685 AB0378017243140 mRNA for KIAA1380 protein, 1 ACATTGGCTTGCTTTTGTTAAAGTGC partialcds/cds = (0, 3798) AAGTGTTACATATGGCTTTGTACA 564 Table 3A Hs.334878NM_032837 14249549 hypothetical protein FLJ14775 1TTGGTAGTGTCAGCGGGCACCTTTTA (FLJ14775), mRNA/cds =CACCTTCTAGTAGCTCAAGCTAGT (171, 533) 565 Table 3A Hs.301434 AB0378087243154 mRNA for KIAA1387 protein, 1 TCCTGGAATCGTTTAATCTAAAGCAG partialcds/cds = (0, 2852) TTTCCCCTGTTTTGGAGATTTTGT 566 Table 3A Hs.301434AB037808 7243154 mRNA for KIAA1387 protein, 1 TCCTGGAATCGTTTAATCTAAAGCAGpartial cds/cds = (0, 2852) TTTCCCCTGTTTTGGAGATTTTGT 567 Table 3AHs.15370 AB037828 7243194 mRNA for KIAA1407 protein, 1TGAGAAAGTCCTGTGCAGTCCTGAGA partial cds/cds = (0, 2235)TGATTACTCTTATTTGGTGTGCTG 568 Table 3A Hs.274396 AB037844 7243226 mRNAfor KIAA1423 protein, 1 TCGTCTTTTGCGAATGGCTTAATTCT partial cds/cds = (0,1851) GACACTACCTTTCTGGGAAATGTT 569 Table 3A Hs.149918 AB037901 10567183GASC-1 mRNA, complete cds 1 TTTGATTGTGTCTGATGGGAACTGAG /cds = (150,3320) TTGTTGGCCTTTGTGAAATGAAAT 570 Table 3A Hs.284205 AB040120 12657580up-regulated by BCG-CWS 1 TTGACAAAGCCCAACAATGATCTCAG (LOC64116),mRNA/cds = GAATTACATTTTCCAACAGACCAA (477, 1859) 571 Table 3A Hs.6682AB040875 13516845 solute carrier family 7, (cationic 1ACCTGTCACGCTTCTAGTTGCTTCAA amino acid transporter, y+ system)CCATTTTATAACCATTTTTGTACA member 11 (SLC7A11), mRNA/ cds = (235, 1740)572 Table 3A Hs.109694 AB040884 7959160 mRNA for KIAA1451 protein, 1TCCTTAAGGTGCACAGTAAATGTACA partial cds/cds = (0, 1467)GATAGTTATAGGCCACTGTTTTGT 573 Table 3A Hs.210958 AB040919 7959232 mRNAfor KIAA1486 protein, 1 AGCTCATATGAACACTGCTCTGAACT partial cds/cds =(11, 2044) CCTCTGACTTAGCATTCAACTTAA 574 Table 3A Hs.20237 AB0409227959238 mRNA for KIAA1489 protein, 1 CATGACAAACATTACTAGCATGTTCA partialcds/cds = (1619, 3154) ACTGCACCATGTTCTGGCACTGTA 575 Table 3A Hs.35089AB040929 7959252 mRNA for KIAA1496 protein, 1ACCTCTTTCCTACCAATTTCACATTTT partial cds/cds = (0, 2763)GCAGAAACTTGTTCACATTTCCA 576 Table 3A Hs.201500 AB040942 7959278 mRNA forKIAA1509 protein, 1 GGGTTGTGTATTAAATAGCCATTCAT partial cds/cds = (0,3982) TCTGGAACTCAAGGACAGGACTGT 577 Table 3A Hs.93836 AB040959 7959318mRNA for KIAA1526 protein, 1 GCCTTGCAGGTGACCAGCAGTGTCA partial cds/cds =(0, 2892) TTGTATTTATATACAGAGCTTATGA 578 Table 3A Hs.89135 AB0409617959322 mRNA for KIAA1528 protein, 1 CTGGACGGGCGTGGGTTCTGGGTCA partialcds/cds = (4, 2226) GCTTCTTTTACCTCAATTTTGTTTG 579 Table 3A Hs.85752AB040974 7959348 mRNA for KIAA1541 protein, 1 AAAGTCTGAGGTGTGGAACAGTTATTpartial cds/cds = (908, 2341) TAAGCATTAGTCAACCCTGGTCCT 580 Table 3AHs.18259 AB044661 11094140 XPA binding protein 1; putative 1TGGGCAAGACATGATTAATGAATCAG ATP(GTP)-binding proteinAATCCTGTTTCATTGGTGACTTGG (NTPBP), mRNA/cds = (24, 1148) 581 Table 3AHs.142838 AB044971 13699901 nucleolar protein interacting with 1CCTGTGTAAAAGAAGAAATACAAGAG the FHA domain of pKi-67ACTCAAACACCTACACATTCACGG (NIFK), mRNA/cds = (54, 935) 582 Table 3AHs.140720 AB045118 13365650 FRAT2 mRNA, complete cds 1TGGCTTGTTCATCCTCCAGATGTAGC /cds = (129, 830) TATTGATGTACACTTCGCAACGGA583 Table 3A Hs.136414 AB045278 13588433 UDP-GlcNAc:betaGal beta-1,3-N-1 AACTATCAGCTTGGATGGTCACTTGA acetylglucosaminyltransferase 5ATAGAAGATGGTTATACACAGTGT (B3GNT5), mRNA/cds = (129, 1265) 584 Table 3AHs.127270 AB046765 10047154 mRNA for KIAA1545 protein, 1CCACGGTGGACCCTGTTTGTTTTAAA partial cds/cds = (0, 2445)TATTCTGTTCCCATGTCAATCAGT 585 Table 3A Hs.65641 AB048766 10047156hypothetical protein FLJ20073 1 TTGTGTAGGAAACTTTTGCAGTTTGA (FLJ20073),mRNA/cds = CACTAAGATAACTTCTGTGTGCAT (16, 1908) 586 Table 3A Hs.323822AB046771 10047168 mRNA for KIAA1551 protein, 1ACTCAAATCAGTTAGCTTCAAACAAA partial cds/cds = (0, 3750)AACGAAAGTTAGACCAAGGGAACG 587 Table 3A Hs.323822 AB048771 10047166 mRNAfor KIAA1551 protein, 1 ACTCAAATCAGTTAGCTTCAAACAAA partial cds/cds = (0,3750) AACGAAAGTTAGACCAAGGGAACG 588 Table 3A Hs.17767 AB046774 10047172mRNA for KIAA1554 protein, 1 TTGTGTGCTGTGCTTCAAAGCCTTAA partial cds/cds= (0, 3983) CTGTCAAATCTTGCATTATCTTGT 589 Table 3A Hs.44054 AB04678510047194 ninein (GSK3B interacting protein) 1 ACATTATCATGGCATGACTTAAGGGA(NIN), mRNA/cds = (202, 6345) ACATTGGTTTGTGAAGGAAAAACA 590 Table 3AHs.168640 AB046801 10047236 mRNA for KIAA1581 protein, 1TGTGTGACTTTCATGCTTCTGGGGTT partial cds/cds = (0, 1839)GGAGCTTAAAGATCCAAACTGAGA 591 Table 3A Hs.129750 AB046805 10047244 mRNAfor KIAA1585 protein, 1 TGCTGGTATTCTCACTGCCACATTTTT partial cds/cds =(27, 1814) GGAAACCTGTATTACACCTTAAA 592 Table 3A Hs.18587 AB04680810047250 Homo sapiens, clone MGC:15071 1 TTGAGTGTCTGCAGCAGCCCTGGACTIMAGE:4110510, mRNA, TCCAGACTTCTATCACATGAGAAA complete cds/cds = (977,2212) 593 Table 3A Hs.11123 AB046813 10047260 mRNA for KIAA1593 protein,1 TGGTGCTGATGCTTAGTTGTCTCATG partial cds/cds = (477, 3338)CCATTAAATTGTAAAAGTGAGTTG 594 Table 3A Hs.343582 AB046825 10047284RC6-HT0592-270300-011-D11 1 GGAGGTCAGTTGATTTCCCCAGGTAC cDNAATTCATGGTGTGACAGACACATGG 595 Table 3A Hs.222748 AB046830 10047294 mRNAfor KIAA1610 protein, 1 AGATCCTTTCAGTCCCTAGACCTCCA partial cds/cds = (0,1458) TTCACTCTGTTTCTCTTCTGCTGG 596 Table 3A Hs.6639 AB046844 10047324mRNA for KIAA1624 protein, 1 GATCCGATCATGGTGATGTACGGGG partial cds/cds =(0, 1800) TGAATTCTCTTGCCGTGTTGCAAAT 597 Table 3A Hs.288140 AB04685710047350 mRNA for KIAA1637 protein, 1 ATGGTTTCAAAATTCAAGGTCCCCAA partialcds/cds = (0, 1441) ATGGCAGCATTTTATGTTCTGACC 598 Table 3A Hs.44566AB046861 10047358 KIAA1841 protein (KIAA1641), 1CAAGTATGTATGCAACTTTGCACACC mRNA/cds = (40, 453) AACAACTGTTAATCTGTAGCTAGT599 Table 3A Hs.82113 AB049113 10257384 dUTP pyrophosphatase (DUT), 1TGGTGATTCTCCAGGCCATTTAATAC mRNA/cds = (29, 523) CCTGCAATGTAATTGTCCCTCTGT600 Table 3A Hs.323463 AB051480 12697930 mRNA for KIAA1693 protein, 1TTCTGCCTCAATGTTTACTGTGCCTTT partial cds/cds = (0, 2707)GTTTTTGCTAGTTTGTGTTGTTG 601 Table 3A Hs.19597 AB051481 12697932 mRNA forKIAA1694 protein, 1 ACTACTGTCACGTAGCTGTGTACAAA partial cds/cds = (0,2274) GAGATGTGAAATACTTTCAGGCAA 602 Table 3A Hs.20281 AB051487 12697944mRNA for KIAA1700 protein, 1 TGTTGAACGGTTAAACTGTGCATTTC partial cds/cds= (108, 2180) TCATTTTGATGTGTCATGTATGTT 603 Table 3A Hs.7076 AB05149212697954 mRNA for KIAA1705 protein, 1 AATGGTCAAGGTTCAGCATATTCTAT partialcds/cds = (1713, 3209) ATGAAGATCACAAGGTGGTATCGT 604 Table 3A Hs.25127AB051512 12697994 mRNA for KIAA1725 protein, 1TGTGAACTTGTGCGCAAATGTGCAGA partial cds/cds = (0, 3129)TTCAATGTTCTTGTTACAGATTGA 605 Table 3A Hs.66053 AB051540 12698050 mRNAfor KIAA1753 protein, 1 CCCCTTGGGCTCAGCACGAAAGGGC partial cds/cds = (0,2457) TTTCAATGAATTAAGTGAAAACTTT 606 Table 3A Hs.7187 AB051544 12698058mRNA for KIAA1757 protein, 1 AATGAGTTGTGTTGAAGCCTCCGTCT partial cds/cds= (347, 4576) CCCATCCTTGCCTGTAGCCCGTAG 607 Table 3A Hs.248367 AB05867714017778 MEGF11 protein (MEGF11), 1 AGCCTAAACATGTATACTGTGCATTTT mRNA/cds= (159, 3068) ATGGGTGACTTTGAAAGATCTGT 608 Table 3A Hs.227400 AF0001453095031 mitogen-activated protein kinase 1 ACCAGGTTTTAGCAAAATGCACACTTkinase kinase kinase 3 (MAP4K3), TTGGCTCTTTTTGGTATATGTTCT mRNA/cds =(360, 3014) 609 Table 3A Hs.8180 AF000852 2795862 syndecan bindingprotein 1 CCTGACTCCTCCTTGCAAACAAAATG (syntanin) (SDCBP), mRNA/ATAGTTGACACTTTATCCTGATTT cds = (148, 1044) 610 Table 3A Hs.147916AF000982 2580549 DEAD/H (Asp—Glu—Ala— 1 TTGTATTGGCATAATCAGTGACTTGTAsp/His) box polypeptide 3 ACATTCAGCAATAGCATTTGAGCA (DDX3), transcriptvariant 2, mRNA/cds = (856, 2844) 611 Table 3A Hs.13980 AF000993 2580571ubiquitously transcribed 1 TTGTTAAGTTGCAATTACTGCAATGA tetratricopeptiderepeat gene, X CAGACCAATAAACAATTGCTGCCA chromosome (UTX), mRNA /cds =(26, 4231) 612 Table 3A Hs.159523 AF001622 3930162 class-IMHC-restricted T cell 1 ACAGCAAACTTTGGCATTTATGTGGA associated molecule(CRTAM), GCATTTCTCATTGTTGGAATCTGA mRNA/cds = (0, 1181) 613 Table 3AHs.58435 AF001862 2232149 FYN-binding protein 1TGGTCATTCTGCTGTGTTCATTAGGT (FYB-120/130) (FYB), GCCAATGTGAAGTCTGGATTTTAAmRNA/cds = (30, 2381) 614 Table 3A Hs.78918 AF002020 2276462Niemann-Pick disease, type C1 1 GGCATGAAATGAGGGACAAAGAAAG (NPC1),mRNA/cds = (123, 3959) CATCTCGTAGGTGTGTCTACTGGGT 615 Table 3A Hs.18792AF003938 2897941 thioredoxin-like, 32 kD (TXNL), 1AATCTTGACACATGCAATTGTAAATAA mRNA/cds = (205, 1074)AAGTCACCACTTTTGCCAAGCTT 616 Table 3A Hs.337778 AF004230 2343108hypothetical protein FLJ11068 1 TGATGCCTTCATCTGTTCAGTCATCT (FLJ11068),mRNA/cds = CCAAAAACAGTAAAAATAACCACT (163, 1188) 617 Table 3A Hs.183805AF005213 2843115 ankyrin 1, erythrocytic (ANK1), 1GGCCAAGCTGAATGCCATGAATATCA transcript variant 3, mRNAGTGAGACGCGTTATAAGGAATCCT /cds = (84, 5726) 618 Table 3A Hs.42915AF006082 2282029 ARP2 (actin-related protein 2, 1CCTGCCAGTGTCAGAAAATCCTATTT yeast) homolog (ACTR2), mRNAATGAATCCTGTCGGTATTCCTTGG /cds = (74, 1258) 619 Table 3A Hs.6895 AF0060862282037 actin related protein 2/3 complex, 1 TCAAGAATTTGGGTGGGAGAAAAGAAsubunit 3 (21 kD) (ARPC3), AGTGGGTTATCAAGGGTGATTTGA mRNA/cds = (25, 581)620 Table 3A Hs.82425 AF006088 2282041 actin related protein 2/3complex, 1 CAAACTGGTGCAGAAATTCTATAAAC subunit 5 (18 kD) (ARPC5),TCTTTGCTGTTTTTGATACCTGCT mRNA/cds = (24, 479) 621 Table 3A Hs.22670AF006513 2645428 chromodomain helicase DNA 1 GCTACTTGTTTACATTGTACACTGCGbinding protein 1 (CHD1), ACCACCTTGCCGCTTTTCATCACA mRNA/cds = (163,5292) 622 Table 3A Hs.24752 AF006516 2245670 spectrin SH3 domain binding1 ACTGGATGCTACAGACTTATAACAGC protein 1 (SSH3BP1),ATAGTGAATGGTAAGACTAGTGCA mRNA/cds = (81, 1607) 623 Table 3A Hs.321149AF007155 2852635 cDNA FLJ10257 fis, clone 1 CCTCCCCTATGCCTCAGCCCCATCTCHEMBB1000887/cds = TGCTCCTGTTTGAATTTTGTTATT UNKNOWN 624 Table 3A Hs.5409AF008442 2266928 RNA polymerase I subunit 1 CCAGTGTGACTAGGGATCCTGAGTTT(RPA40), mRNA/cds = (22, 1050) TCTGGGACAATTCCAGCTTTAATC 625 Table 3AHs.225977 AF012108 2331249 nuclear receptor coactivator 3 1TGACCCTTCTTTAAGTTATGTGTGTG (NCOA3), mRNA/cds = GGGAGAAATAGAATGGTGCTCTTA(183, 4421) 626 Table 3A Hs.334874 AF012872 2326226 phosphatidylinositol4-kinase 230 1 GTGTGAGTCCTCTGTTTGCACTGGAC (pl4K230) mRNA, complete cdsATATTCCCTACCTGTCTTATTTCA /cds = (0, 6134) 627 Table 3A Hs.199291AF015041 4102706 NUMB-R protein (NUMB-R) 1 AGGGGAAGGGGTGCCTGGCGGGTACmRNA, complete cds/cds = TTTTCTATCTTTTATTTCCAGATTT (209, 2038) 628 Table3A Hs.51233 AF016266 2529582 TRAIL receptor 2 mRNA, 1TCATGCTTCTGCCCTGTCAAAGGTCC complete cds/cds = (117, 1439)CTATTTGAAATGTGTTATAATACA 629 Table 3A Hs.76807 AF016270 2655005 majorhistocompatibility complex, 1 AGCTAGCAGATCGTAGCTAGTTTGTA class II, DRalpha (HLA-DRA), TTGTCTTGTCAATTGTACAGACTT mRNA/cds = (26, 790) 630 Table3A Hs.104624 AF016495 6560598 aquaporin 9 (AQP9), mRNA 1AGCCCAGAATTCCCAAAGGCATTAGG /cds = (286, 1173) TTTCCCAACTGCTTTGTGCTGATA631 Table 3A Hs.10958 AF021819 2460317 RNA-binding protein regulatory 1GTGTCTATACATTTCTAAGCCTTGTTT subunit (DJ-1), mRNA/cds =GCAGAATAAACAGGGCATTTAGC (20, 589) 632 Table 3A Hs.125134 AF0231424102966 pre-mRNA splicing SR protein rA4 1 TAGAGGTGTACAGATGCTATATTATAmRNA, partial cds/cds = (0, 3473) TCCGCTCCCGGTGTACTGCAGCCC 633 Table 3AHs.108809 AF028292 2559009 chaperonin containing TCP1, 1TTTTACAAGGAAGGGGTAGTAATTGG subunit 7 (eta) (CCT7),CCCACTCTCTTCTTACTGGAGGCT mRNA/cds = (68, 1699) 634 Table 3A Hs.168103AF026402 2655201 prp28, U5 snRNP 100 kd protein 1ACACGGTGAACTGGCTGTGTCCATCT (U5-100K), mRNA/cds =TTGTCACTGAGTGAAATCTCTGTT (39, 2501) 635 Table 3A Hs.9573 AF0273022522533 ATP-binding cassette, sub-family F 1 TGAGGACTTGGGGCAGGAAAGGAAT(GCN20), member 1 (ABCF1), GCTGCTGAACTTGAATTTCCCTTTA mRNA/cds = (94,2517) 636 Table 3A Hs.168132 AF031167 2739159 interleukin 15 (IL15),mRNA 1 TCAGACCTTGGATCAGATGAACTCTT /cds = (316, 804)AGAAATGAAGGCAGAAAAATGTCA 637 Table 3A Hs.170133 AF032885 2895491forkhead box O1A 1 CCACGTTCTTGTTCCGATACTCTGAG (rhabdomyosarcoma)(FOXO1A), AAGTGCCTGATGTTGATGTACTTA mRNA/cds = (385, 2352) 638 Table 3AHs.74276 AF034607 4426566 chloride intracellular channel 1 1GCCTGGGTCAGATTTTTATTGTGGGG (CLIC1), mRNA/cds = (236, 961)TGGGATGAGTAGGACAACATATTT 639 Table 3A Hs.106890 AF035306 2681087 clone23771 mRNA sequence 1 GGGTGCCCACCTGCATGTGAAGGGG /cds = UNKNOWNAGGCAGTTCTCAATTTATTTCAATA 640 Table 3A Hs.184897 AF035307 2661068 clone23785 mRNA sequence 1 CAGTCACTGGGTCTATATTAAACAGC /cds = UNKNOWNAACCAGAGCAACAAATGGCAAACA 641 Table 3A Hs.278589 AF035737 2827179 generaltranscription factor II, i 1 TGACATGGTAGCAGAAATAGGCCCTT (GTF2i),transcript variant 1, TTATGTGTTGCTTCTATTTTACCT mRNA/cds = (370, 3366)642 Table 3A Hs.8257 AF035947 9695283 cytokine-inducible inhibitor of 1AGCAAAGAACAGTTTGGTGGTCTTTT signalling type 1b mRNA,CTCTTCCACTGATTTTTCTGTAAT complete cds/cds = (3131, 3925) 643 Table 3AHs.8900 AF037204 2906012 ring finger protein 13 (RNF13), 1AGCCCTGCTAAACTATGTACAGAGGA mRNA/cds = (151, 1296)AACTGTTCAAGTATTGGATTTGAA 644 Table 3A Hs.155489 AF037448 3037012NS1-associated protein 1 (NSAP1), 1 TGTCAACGATGTTTCCAGTAGTGTTT mRNA/cds= (204, 1892) AGATTTGGTGTCTTCAAAGGTAGT 645 Table 3A Hs.12311 AF0382022795923 clone 23570 mRNA sequence 1 GGCTTTTTGCCCATCAAGAATAAAAA /cds =UNKNOWN GAAATAAAACCAAAGGGTTACCGG 646 Table 3A Hs.76807 AF038564 2708328major histocompatibility complex, 1 TGCCTGTTGCACATCTTGTAAAATTG class II,DR alpha (HLA-DRA), GACAATGGCTCTTTAGAGAGTTAT mRNA/cds = (26, 790) 647Table 3A Hs.303627 AF039575 2773157 heterogeneous nuclear 1TGCGGCTAGTTCAGAGAGATTTTTAG ribonucleoprotein D (AU-richAGCTGTGGTGGACTTCATAGATGA element RNA-binding protein 1, 37 kD) (HNRPD),transcript variant 1, mRNA/cds = (285, 1352) 648 Table 3A Hs.29417AF039942 4730928 HCF-binding transcription factor 1AATGGAAGGATTAGTATGGCCTATTT Zhangfei (ZF), mRNA/cds =TTAAAGCTGCTTTGTTAGGTTCCT (457, 1275) 649 Table 3A Hs.8185 AF0422845256829 CGI-44 protein; sulfide 1 CCATGTGGGCTACTCATGATGGGCTTdehydrogenase like (yeast) GATTCTTTGGGAATAATAAAATGA (CGI-44), mRNA/cds =(76, 1428) 650 db mining Hs.298727 AF042838 2815887 MEK kinase 1 (MEKK1)mRNA, 1 AACGAGGCCAGTGGGGAACCCTTAC partial cds/cds = (0, 4487)CTAAGTATGTGATTGACAAATCATG 651 Table 3A Hs.82280 AF045229 2908029regulator of G-protein signalling 10 1 CCTCTCAGGACGTGCCGGGTTTATCA(RGS10), mRNA/cds = (43, 546) TTGCTTTGTTATTTGTAAGGACTG 652 Table 3AHs.62112 AF046001 2895869 zinc finger protein 207 (ZNF207), 1CCACTGCCTGAAAGGTTTGTACAGAT mRNA/cds = (202, 1838)GCATGCCACAGTAGATGTCCACAT 653 Table 3A Hs.241520 AF047002 2896145transcriptional coactivator ALY 1 TTTTGGGATAAATTTTACTGGTTGCTG mRNA,partial cds/cds = (0, 701) TTGTGGAGAAGGTGGCGTTTCCA 654 Table 3AHs.132904 AF047033 5051627 sodium bicarbonate cotransporter 3 1TGAAGTATAAGCCTCTACTGGGTCTA (SLC4A7) mRNA, complete cdsTATTGTGAATCATCCTGCCTTTCA /cds = (71, 3715) 655 Table 3A Hs.50785AF047442 3335139 SEC22, vesicle trafficking protein 1CTCGTCTATTGGCCCCTGTAGAAAGT (S. cerevisiae)-like 1 (SEC22L1),TAACCTTTGTTGTTTTCCTTTTAT mRNA/cds = (119, 766) 656 Table 3A Hs.40323AF047472 2921872 BUB3 (budding uninhibited by 1TCCCCTTCTGTCCCCTAGTAAGCCCA benzimidazoles 3, yeast) homologGTTGCTGTATCTGAACAGTTTGAG (BUB3), mRNA/cds = (70, 1056) 657 Table 3AHs.26584 AF051782 2947237 diaphanous 1 (HDIA1) mRNA, 1AAACCTATTTCCCTTGCCTCATAGGC complete cds/cds = (0, 3746)TTCTGGGATGTCATCACCTCCAGT 658 Table 3A Hs.313 AF052124 3360431 secretedphosphoprotein 1 1 GAATTTGGTGGTGTCAATTGCTTATTT (osteopontin, bonesialoprotein I, GTTTTCCCACGGTTGTCCAGCAA early T-lymphocyte activation 1)(SPP1), mRNA/cds = (67, 989) 659 Table 3A Hs.227949 AF052155 3360468SEC13 (S. cerevisiae)-like 1 1 CTATTTTGGGTCATTTTTATGTACCTT (SEC13L1),mRNA/cds = TGGGTTCAGGCATTATTTGGGGG (60, 1028) 660 literature Hs.115770AF053712 3057145 tumor necrosis factor (ligand) 1TAATTGTTGAACAGGTGTTTTTCCACA superfamily, member 11AGTGCCGCAAATTGTACCTTTTT (TNFSF11), transcript variant 1, mRNA/cds =(156, 1109) 661 Table 3A Hs.178710 AF054174 3341991 clathrin, heavypolypeptide (Hc) 1 CCCCCTCAGAAGAATCATGAATTTGC (CLTC), mRNA/cds = (172,5199) AACAGACCTAATTTTTGGTTACTT 662 Table 3A Hs.233952 AF054185 4092057proteasome (prosome; macropain) 1 GGCCTTTCCATTCCATTTATTCACACT subunit,alpha type, 7 (PSMA7), GAGTGTCCTACAATAAACTTCCG mRNA/cds = (24, 770) 663Table 3A Hs.158164 AF054187 4092059 transporter 1, ATP-binding 1TGGTGTCTCAAAGGAGTAACTGCAGC cassette, sub-family B (MDR/TAP)TTGGTTTGAAATTTGTACTGTTTC (TAP1), mRNA/cds = (30, 2456) 664 Table 3AHs.334826 AF054284 4033734 splicing factor 3b, subunit 1, 1TGCCAGTAGTGACCAAGAACACAGTG 155 kD (SF3B1), mRNA/cds =ATTATATACACTATACTGGAGGGA (0, 3914) 665 Table 3A Hs.13131 AF0555813845720 lymphocyte adaptor protein (LNK), 1 AGGACACATCTGACATCCTGTGTTTGmRNA/cds = (357, 2084) GTTAAAATATACAGCACATTGTGA 666 Table 3A Hs.278501AF056322 3252910 SPG-100 (SP100) gene, partial cds; 1TGGGGGTTGTAAATTGGCATGGAAAT and high mobility group 1-likeTTAAAGCAGGTTCTTGTTAGTGCA protein L3 (HMG1L3) retropseudogenesequence/cds = (0, 617) 667 Table 3A Hs.6856 AF056717 3046994 ash2(absent, small, or homeotic, 1 TGTGAAAGAAACTTGCTTGCAGCTTT Drosophila,homolog)-like AACAAAATGAGAAACTTCCCAAAT (ASH2L), mRNA/cds = (4, 1890) 668Table 3A Hs.169895 AF061738 4335938 ubiquitin-conjugating enzyme 1GTATATATCCTCCAGCATTCAGTCCA E2L 6 (UBE2L6), mRNA/cds =GGGGGAGCCACGGAAACCATGTTC (47, 508) 669 Table 3A Hs.182579 AF0617384335940 leucine aminopeptidase 1 TGTGATGCTAGGAACATGAGCAAACT (LOC51058),mRNA/cds = GAAAATTACTATGCACTTGTCAGA (188, 1745) 670 Table 3A Hs.184592AF061944 6933863 protein kinase, lysine deficient 1 1AACCCAGTATATCTGTGTTATCTGAT (PRKWNK1), mRNA/cds =GGGACGGTTGACAGTGGTCAGGGA (0, 7148) 671 Table 3A Hs.79015 AF06359112002013 antigen identified by monoclonal 1 ATCCAGTGGCCTAGGAATTAAAGTGTantibody MRC OX-2 (MOX2), TGTTGTTTTTGCTGTTAAATTGGA mRNA/cds = (57, 866)672 Table 3A Hs.11000 AF083805 4071360 MY047 protein (MY047), mRNA 1GCATTGGCAGCATTGTGTCTTTGACC /cds = (84, 479) TTGTATACTAGCTTGACATAGTGC 673Table 3A Hs.129708 AF064090 3283355 tumor necrosis factor (ligand) 1TTTCATGGTGTGAAGGAAGGAGCGT superfamily, member 14GGTGCATTGGACATGGGTCTGACAC (TNFSF14), mRNA/cds = (48, 770) 674 Table 3AHs.83530 AF064839 4206051 map 3p21; 3.15 cR from WI-9324 1AGACTGCACAACCAAGAAGTTACTCA repeat region, complete sequenceAAGCTCTGTGGGAGCCCCTGCCTG /cds = UNKNOWN 675 Table 3A Hs.4747 AF0670083873220 dyskeratosis congenita 1, dyskerin 1 CAGTGCTCACCTAAATCCATCTGACT(DKC1), mRNA/cds = (92, 1836) ACTTGTTCCTGTGCCCTCTTGTTT 676 Table 3AHs.307357 AF067519 3850317 PITSLRE protein kinase beta SV1 1GTGACGACGACCTGAAGGAGACGGG isoform (CDC2L2) mRNA,CTTCCACCTTACCACCACGAACCAG complete cds/cds = (79, 2412) 677 Table 3AHs.307357 AF067529 3850337 PITSLRE protein kinase beta SV1 1AACAGGATAAAGCTCGCCGGGAATG isoform (CDC2L2) mRNA,GGAAAGACAGAAGAGAAGGGAAATG complete cds/cds = (79, 2412) 678 Table 3AHs.268763 AF068235 4321975 Breakpoint cluster region protein, 1CCTCACCCCCACCCTCACTTTCAATC uterine leiomyoma, 1; barrier toCGTTTGATACCATTTGGCTCCTTT autointegration factor (BCRP1), mRNA/cds =(507, 776) 679 Table 3A Hs.341182 AF068836 3192908 602417258F1 cDNA, 5′end 1 ATGGAAAGATGTGGTCTGAGATGGGT /clone = IMAGE:4538829/GCTGCAAAGATCATAATAAAGTCA clone_end = 5′ 680 Table 3A Hs.92384 AF0705233764088 vitamin A responsive; cytoskeleton 1 CCATGACTTCACAGACATGGTCTAGArelated (JWA), mRNA/cds = ATCTGTACCCTTACCCACATATGA (89, 655) 681 Table3A Hs.151903 AF070525 3387880 clone 24706 mRNA sequence 1CTGTGAATGTTTGCAGTCTCCTACCG /cds = UNKNOWN TCTCAACTACAGCTGCAGTTGCTA 682Table 3A Hs.26118 AF070582 3387954 hypothetical protein MGC13033 1CAGCCTGAATTGCCTCTGGGAAGAG (MGC13033), mRNA/cds =GGGTGGGAATGACTTTTCAATGTAC (200, 304) 683 Table 3A Hs.106823 AF0706353283905 mRNA for KIAA1823 protein, 1 AATGGCCTAGAATTTGTGGTAGTTGC partialcds/cds = (52, 1185) CAAAGAGGTTCTCCTAGGTGGTCT 684 Table 3A Hs.108112AF070640 3283913 Homo sapiens, histone fold protein 1CAGTGAAAAGTTTGTGAGTGAAGAAT CHRAC17; DNA polymeraseGCTGAGAAGATTGTAATGCTTTGT epsilon p17 subunit, clone MGC:2725IMAGE:2822216, mRNA, complete cds/cds = (80, 523) 685 Table 3A Hs.76691AF070673 3978241 stannin mRNA, complete cds 1 TTGTCTCAAAGCTACCAAGTTTGTGC/cds = (175, 441) AATAAGTGGAAGGGATGTCATCCT 686 Table 3A Hs.223615AF070874 3978243 RC2-BN0074-150400-018-c08 1 ACATCGAAGGTGTGCATATATGTTGAcDNA ATGACATTTTAGGGACATGGTGTT 687 Table 3A Hs.112255 AF071076 4545098nucleoporin 98 kD (NUP98), 1 GGCTATCTCAGGCAATATGGCCAGCA mRNA/cds = (124,5262) CCTGGGTCTTTATGCATGAAGATA 688 Table 3A Hs.76095 AF071596 3851531immediate early response 3 1 GCTGTCACGGAGCGACTGTCGAGAT (IER3), mRNA/cds= (11, 481) CGCCTAGTATGTTCTGTGAACACAA 689 Table 3A Hs.18571 AF0728603290197 protein kinase, interferon-inducible 1AGCTGCTGACTTGACTGTCATCCTGT double stranded RNA dependentTCTTGTTAGCCATTGTGAATAAGA activator (PRKRA), mRNA /cds = (96, 1037) 690Table 3A Hs.79877 AF072928 3916215 myotubularin related protein 6 1CTCACAGGTGGACTGAGAAATCAGTT mRNA, partial cds/cds = (0, 1398)ACATCTTAAGTGACCTACAGGGTA 691 Table 3A Hs.143648 AF073310 4511968 insulinreceptor substrate-2 (IRS2) 1 GTGCATTGTATTTAGTCTGTATTGATC mRNA, completecds/cds = ATGGATGCCCTCCTTAATAGCCA (518, 4532) 692 Table 3A Hs.151411AF075587 3319325 KIAA0916 protein (KIAA0916), 1CCTGTACAATTGCATCACGGGTGGG mRNA/cds = (146, 14071)GATAAAAAGAGGAATATTCTGGTTT 693 Table 3A Hs.550 AF076485 5430704 phosducin(PDC), transcript variant 1 AAACAGAGCTGTCTTCAGCAACATTA PhLOP2, mRNA/cds= (5, 358) TTAGTAGACAAAGAGGATGTGGAT 694 Table 3A Hs.4311 AF0795664574148 SUMO-1 activating enzyme 1 ACTCAAGTTTTCAGTTTGTACCGCCT subunit 2(UBA2), mRNA/cds = GGTATGTCTGTGTAAGAAGCCAAT (25, 1947) 695 db miningHs.159376 AF080577 3551871 RAG2 mRNA, partial cds/cds = 1TGACTCCTGCCAAGAAATCCTTTCTT (0, 324) AGAAGGTTGTTTGATTAGTTTTGC 696 Table3A Hs.107979 AF081282 4336324 small membrane protein 1 1TTGTATTATCTGCTTTGCTGATGTAGA (SMP1), mRNA/cds = (99, 572)CAAGAGTTAACTGAGTAGCATGC 697 Table 3A Hs.36794 AF082589 4206702 cyclinD-type binding-protein 1 1 AAAGATTGTTGGTTAGGCCAGATTGA (CCNDBP1),mRNA/cds = CACCTATTTATAAACCATATGCGT (87, 1172) 698 Table 3A Hs.8765AF083255 3435311 RNA helicase-related protein 1TGGTAACTGTTCCAGGATTGCTCCAG (RNAHP), mRNA/cds = GTTTGAGATGGTATTGCTAAATTT(17, 2148) 699 Table 3A Hs.168913 AF083420 5326765 serine/threoninekinase 24 1 TGCACCTTGTAGTGGATTCTGCATAT (Ste20, yeast homolog) (STK24),CATCTTTCCCACCTAAAAATGTCT mRNA/cds = (78, 1373) 700 Table 3A Hs.327546AF084555 5813858 hypothetical protein MGC10786 1CACTAGCACTTGTGATGCAATAGAAC (MGC10786), mRNA/cds =ACTTCGCCTGTACTGAAAGGGCCA (38, 169) 701 Table 3A Hs.211610 AF0906934249665 apoptosis-related RNA binding 1 ACGCAGGCTTTCCTATTTCTACAACTprotein (NAPOR-3) mRNA, GATTGTACTTATGCATTTTGTACC complete cds/cds = (67,1593) 702 Table 3A Hs.5437 AF090891 6690159 Tax1 (T-cell leukemia virustype I) 1 CAGGAGCTACTTTGAGTTTGGTGTTA binding protein 1 (TAX1BP1),CTAGGATCAGGGTCAGTCTTTGGC mRNA/cds = (83, 2326) 703 Table 3A Hs.192705AF090927 6890220 PRO0457 protein (PRO0457), 1 TAGAGAGAGGCCCGTGGCCTGAGGTmRNA/cds = (985, 1431) AGTGCAGAGGAGGATAGTAGAGCAG 704 Table 3A Hs.201675AF091263 4140646 RNA binding motif protein 5 1TTTTGGAAGATTTTCAGTCTAGTTGC (RBM5), mRNA/cds = (148, 2595)CAAATCTGGCTCCTTTACAAAAGA 705 Table 3A Hs.241558 AF099149 3930775 ariadne(Drosophila) homolog 2 1 AAGTTAATTGAGGCAATGTCATCTGC (ARIH2), mRNA/cds =TCAAAGTTGAGTGGTTTATTCACA (144, 1825) 706 Table 3A Hs.306357 AF1034584378245 isolate donor N clone N168K 1 TTGCAGTGTATTACTGTCAGCAGTATimmunoglobulin kappa light chain GGTAGCTCACCGTGGACGTTCGGC variableregion mRNA, partial cds /cds = (0, 303) 707 Table 3A Hs.184601 AF1040324426639 L-type amino acid transporter 1 TATTCTGTGTTAATGGCTAACCTGTTAsubunit LAT1 mRNA, complete CACTGGGCTGGGTTGGGTAGGGT cds/cds = (66, 1589)708 Table 3A Hs.294603 AF104398 4063708 601657573R1 cDNA, 3′ end 1AAACTGAATGAGAGAAAATTGTATAA /clone = IMAGE:3875611/CCATCCTGCTGTTCCTTTAGTGCA clone_end = 3′ 709 Table 3A Hs.7043 AF1049219409793 succinate-CoA ligase, GDP- 1 TGACACTGGTCTTGCAGTACAACTGG forming,alpha subunit (SUCLG1), AAGCCAAAACAAGGTGGAAGATGT mRNA/cds = (31, 1032)710 Table 3A Hs.4876 AF105366 5106522 solute carrier family 12 1GGTCAAGTATATTTGGACCTATTATC (potassium/chloride transporters),CTCGGCAAGCCAAGATGCAAACAT member 6 (SLC12A6), mRNA/cds = (51, 3350) 711Table 3A Hs.167460 AF107405 5531903 pre-mRNA splicing factor (SFRS3) 1AGTTCACAATATGGTTCAAATGTAAC mRNA, complete cds/cds =AGTGCAGAATTGAATATGGAGGCA (95, 589) 712 Table 3A Hs.79335 AF1097334566529 SWI/SNF related, matrix 1 TTGCATCTTTCCAGGAGAGCCTCACA associated,actin dependent TTCTTCTTCCAGGTTGTATCACCC regulator of chromatin,subfamily d, member 1 (SMARCD1), mRNA/cds = (265, 1572) 713 Table 3AHs.274472 AF113008 6642739 high-mobility group (nonhistone 1GTGAGTCAGGAGCAGGAGCGTGCGG chromosomal) protein 1 (HMG1),ACCAAAAATCCTCAGCCCTTACGAC mRNA/cds = (52, 699) 714 Table 3A Hs.180946U66589 1575566 ribosomal protein L5 pseudogene 1TCACCTTATGCAATGTGAATTATCACT mRNA, complete cds/cds =ACAGAACTCCATCTTACTCCAGA UNKNOWN 715 Table 3A Hs.109441 AF113213 11640573cDNA FLJ14235 fis, clone 1 TTTGATGTAATATAACCTAACGTTGTG NT2RP4000167/cds= (82, 2172) CTGGTACCTGTTTTACCATGTGT 716 Table 3A Hs.297681 AF1136766855600 clone FLB2803 PRO0684 mRNA, 1 CTCCATCCCTGGCCCCCTCCCTGGATcomplete cds/cds = (1108, 2364) GACATTAAAGAAGGGTTGAGCTGG 717 Table 3AHs.297681 AF113676 6855600 clone FLB2803 PRO0684 mRNA, 1CTCCATCCCTGGCCCCCTCCCTGGAT complete cds/cds = (1108, 2364)GACATTAAAGAAGGGTTGAGCTGG 718 Table 3A Hs.75117 AF113702 6855838interleukin enhancer binding 1 GGCTTAGCTGCCAGTCTCCCATTTGT factor 2, 45kD (ILF2), GACCTATGCCATCCATCTATAATG mRNA/cds = (39, 1259) 719 Table 3AHs.177415 AF116606 7959715 PRO0890 mRNA, complete cds 1GGCCCCAATGCCAACTCTTAAGTCTT /cds = (1020, 1265) TTGTAATTCTGGCTTTCTCTAATA720 Table 3A Hs.321158 AF116620 8924006 hypothetical protein PRO1068 1TGTCAGGTTTGGGTCTTGGGTTCAAG (PRO1068), mRNA/cds =TGTATATATTCCTGTAAGTTTCTT (1442, 1750) 721 Table 3A Hs.288036 AF1166797959856 tRNA isopentenylpyrophosphate 1 TGCATCGTAAAACCTTCAGAAGGAAAtransferase (IPT), mRNA GGAGAATGTTTTGTGGACCACTTT /cds = (60, 1040) 722Table 3A Hs.238205 AF116682 7959882 PRO2013 mRNA, complete cds 1TTGACATTCTGCGAAAGCAACAAGCA /cds = (135, 380) AACTGAAGACCAACTCCTATGAGA723 Table 3A Hs.83583 NM_005731 5031598 actin related protein 2/3complex, 1 CGCCTCTTCAGGTTCTTAAGGGATTC subunit 2 (34 kD) (ARPC2),TCCGTTTTGGTTCCATTTTGTACA mRNA/cds = (84, 986) 724 Table 3A Hs.128740AF118274 4680228 DNb-5 mRNA, partial cds 1 CCTTGTTGGACAGGGGGACAGGCTG/cds = (0, 1601) CCTACTGGAATGTAAATATGTGATA 725 Table 3A Hs.225939AF119417 7670074 sialyltransferase 9 (CMP- 1 TTTCTGAATGCCTACCTGGCGGTGTANeuAc:lactosylceramide alpha-2,3- TACCAGGCAGTGTCCCAGTTTAAAsialyltransferase; GM3 synthase) (SIAT9), mRNA/cds = (277, 1365) 726Table 3A Hs.184011 AF119665 6563255 pyrophosphatase (inorganic) (PP), 1TGTGCAAGGGGAGCACATATTGGAT nuclear gene encodingGTATATGTTACCATATGTTAGGAAA mitochondrial protein, mRNA/cds = (77, 946)727 Table 3A Hs.2186 AF119850 7770136 Homo sapiens, eukaryotic 1TCAAGTGAACATCTCTTGCCATCACC translation elongation factor 1TAGCTGCCTGCACCTGCCCTTCAG gamma, clone MGC:4501 IMAGE:2964623, mRNA,complete cds/cds = (2278, 3231) 728 Table 3A Hs.111334 AF119897 7770230PRO2760 mRNA, complete cds 1 CCGAGGAGAAGCGCGAGGGCTACGA /cds = UNKNOWNGCGTCTCCTGAAGATGCAAAACCAG 729 Table 3A Hs.9851 AF123073 12698331C/EBP-induced protein 1 GCAGCTGTTTGAAGTTTGTATATTTTC (LOC81558), mRNA/cds= CGTACTGCAGAGCTTACACAAAA (30, 1391) 730 Table 3A Hs.180566 AF1230945669089 mucosa associated lymphoid tissue 1 GCCTGTGAAATAGTACTGCACTTACAlymphoma translocation gene 1 TAAAGTGAGACATTGTGAAAAGGC (MALT1), mRNA/cds= (164, 2638) 731 Table 3A Hs.7540 AF126026 7158285 unknown mRNA/cds =(0, 1261) 1 GCTCTGATTGTACAAGAATTACCTGT GCTAGTCAAGTTGTTGTTTTTCCT 732Table 3A Hs.15259 AF127139 6724085 BCL2-associated athanogene 3 1CTGTCTTTTGTAGCTCTGGACTGGAG (BAG3), mRNA/cds = GGGTAGATGGGGAGTCAATTACCC(306, 2033) 733 Table 3A Hs.304177 AF130085 11493474 clone FLB8503PRO2286 mRNA, 1 GGTACAACCTTCAACTATTTCTTCCAT complete cds/cds = UNKNOWNGCGGACCCCCTCCTGCCAAAAGA 734 Table 3A Hs.279789 AF130094 11493492 histonedeacetylase 3 (HDAC3), 1 GCAATTCTCCCTGCGTCATGGATTTC mRNA/cds = (55,1341) AAGGTCTTTTAATCACCTTCGGTT 735 Table 3A Hs.6456 AF130110 11493523clone FLB6303 PRO1633 mRNA, 1 CCTTCGCTTTAACATAGGTCTAATTTA completecds/cds = (2546, 3097) TTTGCCGTGCCATTTTCCATACA 736 Table 3A Hs.333555AF131753 4406571 cytoplasmic protein mRNA, 1 TGGTTGGAAGTGGGTGGGGTTATGAcomplete cds/cds = (236, 3181) AATTGTAGATGTTTTTAGAAAAACT 737 Table 3AHs.64001 AF131762 4406584 clone 25218 mRNA sequence 1ACCTTCCTCCAGGAAAAGCCATTCAA /cds = UNKNOWN GCCTGATTATTTTTCTAAGTAACT 738Table 3A Hs.8148 AF131856 4406702 selenoprotein T (LOC51714), 1CTGTATAGCTTTCCCCACCTCCCACA mRNA/cds = (138, 629)AAATCACCCAGTTAATGTGTGTGT 739 Table 3A Hs.301824 AF132197 11493539hypothetical protein PRO1331 1 GGGGTACCTGTGTTGAGTTGATAAAC (PRO1331),mRNA/cds = ATTTCCATCTTCATTAAAACTGCT (422, 616) 740 Table 3A Hs.79933AF135162 7259481 cyclin I (CCNI), mRNA/cds = 1TGTCCACCTTTGCAGCCTGTTTCTGT (0, 1133) CATGTAGTTTCAACAAGTGCTACC 741 Table3A Hs.160417 AF137030 6649056 transmembrane protein 2 1ATGCTACCTCAAAGTGCTACCGATAA (TMEM2), mRNA/cds = ACCTTTCTAATTGTAAGTGCCCTT(148, 4299) 742 Table 3A Hs.70337 AF138903 7767238 nectin-like protein 2(NECL2) 1 AGCACCCATTCCGACCATAGTATAAT mRNA, complete cds/cds =CATATCAAAGGGTGAGAATCATTT (3, 1331) 743 Table 3A Hs.65450 AF14853710039550 reticulon 4a mRNA, complete cds 1 TGTGGTTTAAGCTGTACTGAACTAAA/cds = (141, 3719) TCTGTGGAATGCATTGTGAACTGT 744 Table 3A Hs.334468AF151049 7106819 hypothetical protein (LOC51245), 1ATTACGAAGATGAACCAGTAAACGAG mRNA/cds = (0, 359) GACATGGAGTGACTATCGGGGCGG745 Table 3A Hs.278429 AF151054 7106829 hepatocellular carcinoma- 1TCCTCCAGCTGACAGAAAAATCCAGG associated antigen 59 (LOC51759),ATGAGATCAGAAGGATACTGGTGT mRNA/cds = (27, 896) 746 db mining Hs.274509AF151103 5758136 T-cell receptor aberrantly 1 TTTACACGCCCTGAAGCAGTCTTCTTrearranged gamma-chain mRNA TGCTAGTTGAATTATGTGGTGTGT from cell lineHPB-MLT/cds = UNKNOWN 747 Table 3A Hs.279918 AF151875 4929702hypothetical protein (HSPC111), 1 GTTCACGGAAAAGCCAGAACCTGCT mRNA/cds =(62, 598) GTTTTCAGGGTGGGTGATGTAAATA 748 Table 3A Hs.31323 AF15341913133509 IkappaBkinase complex-associated 1 AGTGCTCTTGCTTTGGATAACTGTAAprotein (IKBKAP) mRNA, AGGGACCCATGCTGATAGACTGGA complete cds/cds = (310,4308) 749 Table 3A Hs.296323 AF153609 5231142 serum/glucocorticoidregulated 1 TGCCCCAGTTGTCAGTCAGAGCCGTT kinase (SGK), mRNA/cds =GGTGTTTTTCATTGTTTAAAATGT (42, 1337) 750 Table 3A Hs.22350 AF1571168571911 cDNA: FLJ23595 fis, clone 1 AAACCAATGGACAAACTTCTTGCTTCLNG15262/cds = UNKNOWN AAGGAACAAACTCTTAGGTTGGCA 751 Table 3A Hs.5548AF157323 7688696 p45SKP2-like protein mRNA, 1 AAACATCATGAGAGTGGAGGCCTGCcomplete cds/cds = (37, 2061) CACCCAGAAAGGCACATACTAGTGC 752 Table 3AHs.19807 AF161339 6841091 rho-gtpase activating protein 1AGTGGATTAACCCCTGCTTCTCTTCT ARHGAP9 (ARHGAP9), TGTTCCCTGTTATCATTCCTCCCCmRNA/cds = (406, 2658) 753 Table 3A Hs.259683 AF161384 6841141 HSPC101mRNA, partial cds 1 GTCTGCTTATTCGTGTCTCTTACTAG /cds = (0, 556)GTTCAATTTCTTGGAGGCCGTGAT 754 Table 3A Hs.180145 AF161415 6841243 HSPC297mRNA, partial cds 1 TGGCCTGACTGACATGCAGTTCCATA /cds = (0, 438)AATGCAGATGTTTGTCTCATTACC 755 Table 3A Hs.339814 AF161430 6841273nt85d12.s1 cDNA 1 GCCAGACTTGAAAGAGGGCTCCAGA /clone = IMAGE:1205303AAAAGTAGATGCGTATCTGTACAAA 756 Table 3A Hs.284295 AF161451 6841315HSPC333 mRNA, partial cds 1 CGTCTTAATGTTCACCGTCCACAGCT /cds = (0, 443)TTGGAATAAACCATCCTGGGAAGT 757 Table 3A Hs.284295 AF161455 6841323 HSPC333mRNA, partial cds 1 TTAATGTTCACCGTCCACAGCTTTGG /cds = (0, 443)AATAAACCATCCTGGGAAGTTGCT 758 Table 3A Hs.284162 AF165521 9294748 60Sribosomal protein L30 isolog 1 TCTAGCCCAGCATTGATCTAGAAGCA (LOC51187),mRNA/cds = GAGGAATCCCAGCGCCTTTTAAAA (143, 634) 759 Table 3A Hs.283740AF173296 9622516 DC6 protein (DC6), mRNA 1 TTGCTCAGCATGCCAGCCTTTAAGAT/cds = (161, 466) TGAATTAGATTGTGTTGTTGTGGT 760 Table 3A NA AF1739546002958 Cloning vector pGEM-URA3 1 AAAAGGTATAGAAATGCTGGTTGGAATGCTTATTTGAAAAAGACTGGCCA 761 Table 3A Hs.81001 AF174605 6164752 F-boxprotein Fbx25 (FBX25) 1 CTGCTTCACGCCTGTGTCTCCGCAGC mRNA, partial cds/cds= (0, 818) ACTTCATCGACCTCTTCAAGTTTT 762 Table 3A Hs.288836 AF1767066573265 hypothetical protein FLJ12673 1 AGAGCAGCTTGTGTATGTAAACGCTT(FLJ12673), mRNA/cds = CAGTGAACTTGCTAATGATCCAAT (2, 1687) 763 Table 3AHs.250619 AF182420 10197639 phorbolin-like protein MDS019 1TCAAACCTACTAATCCAGCGACAATT (MDS019), mRNA/cds = TGAATCGGTTTTGTAGGTAGAGGA(231, 1385) 764 Table 3A Hs.279789 AF187554 6653225 histone deacetylase3 (HDAC3), 1 TCAACCTCCGTCATGTTTTAGAAACC mRNA/cds = (55, 1341)TTTTATCTTTTCCTTCCTCATGCT 765 Table 3A Hs.49163 AF189011 8886721ribonuclease III (RN3) mRNA, 1 TTTCCATCTGTGTCCCAGATTGTGAC completecds/cds = (245, 4369) CCTAGACTTTCAATTGACAAGTAA 766 Table 3A Hs.106778AF189723 6826913 calcium transport ATPase ATP2C1 1CATGTCGTTAGATGGAACATGGAAGC (ATP2C1A) mRNA, complete cdsCATTGTCTAATCAACTCTATCATT /cds = (202, 2913) 767 Table 3A Hs.102506AF193339 7341090 eukaryotic translation initiation 1ATGTAATCCTGTAGGTTGGTACTTCC factor 2-alpha kinase 3CCCAAACTGATTATAGGTAACAGT (EIF2AK3), mRNA/cds = (72, 3419) 768 Table 3AHs.179573 AF193556 6907041 collagen, type I, alpha 2 1TGAATGATCAGAACTGACATTTAATTC (COL1A2), mRNA/cds = ATGTTTGTCTCGCCATGCTTCTT(139, 4239) 769 Table 3A Hs.126550 AF195514 11225484 VPS4-2 ATPase(VPS42) mRNA, 1 TTTGCACATTTTACATATGCTATGTGG complete cds/cds = (201,1535) TTGCCTTTGGGTTTTCTGTACAG 770 Table 3A Hs.56542 AF195530 9739016Homo sapiens, X-prolyl 1 TGGTCATGTTCCAGGTGCTAGTACAT aminopeptidase(aminopeptidase P) CATTCATGATCACCTTAATGCTCA 1, soluble, clone MGC:15561IMAGE:3139868, mRNA, complete cds/cds = (140, 2011) 771 Table 3AHs.44143 AF197569 11385353 BAF180 (BAF180) mRNA, 1AGCATAAAGAGTTGTGGATCAGTAGC complete cds/cds = (96, 4844)CATTTTAGTTACTGGGGGTGGGGG 772 Table 3A Hs.160999 AF198614 7582270AV648418 cDNA, 3′ end 1 TCAACACTTTGCTTTATTTGACACAAC /clone = GLCBJC04/CAGACTTTCTCAGTTCCTGTTCT clone_end = 3′ 773 Table 3A Hs.26367 AF20209211493699 PC3-96 protein (PC3-96), mRNA 1 ATGAAGAAAATCATTGAGACTGTTGC /cds= (119, 586) AGAAGGAGGGGGAGAACTTGGAGT 774 Table 3A Hs.182982 AF2042316808610 88-kDa Golgi protein (GM88) 1 ACTGAAAGACTTTTGCTTAAAGTGGC mRNA,complete cds/cds = ATTATTGACTGCTGATGTGATGCT (342, 2237) 775 Table 3AHs.197298 AF205218 12003206 NS1-binding protein-like protein 1TTGGTTGGTAACTCTGTAATTCCTAA mRNA, complete cds/cds =CTATCACTGGTTTGGTTCTGGACT (555, 2483) 776 Table 3A Hs.155530 AF2080436644296 IFI16b (IFI16b) mRNA, complete 1 CCACCATATATACTAGCTGTTAATCCTcds/cds = (264, 2312) ATGGAATGGGGTATTGGGAGTGC 777 literature Hs.185708AF208502 6630993 early B-cell transcription factor 1AGAGGAATCTGAAAGTGCAGGGTGTT (EBF) mRNA, partial cds/cds =GGTTAAAGTTGTACCTCCCAAGTA (0, 1761) 778 Table 3A Hs.5862 AF208844 7582275hypothetical protein (BM-002), 1 TTTTTCTCCATCCTGTTTCTAGCACAA mRNA/cds =(39, 296) AAATTTGCCTGCTGTGTTACAAA 779 Table 3A Hs.82911 AF208850 7582287BM-008 mRNA, complete cds 1 CAGATTGATTTGAAAGGTGTGCAGCC /cds = (341, 844)TGATTTAAAACCAAACCCTGAACC 780 Table 3A Hs.12830 AF208855 7582297hypothetical protein (LOC51320), 1 GCAACTAATAAGCCAAGGAATCGACA mRNA/cds =(67, 459) TATATTAGGTGCGTGTACTGTTTC 781 Table 3A Hs.295231 AF2122249437514 CLK4 mRNA, complete cds 1 TGTCCAGTGATAAATGTGATTGATCT /cds =(153, 1514) TGCCTTTTGTACATGGAGGTCACC 782 Table 3A Hs.284162 AF21222613445483 60S ribosomal protein L30 isolog 1 TCTAGCCCAGCATTGATCTAGAAGCA(LOC51187), mRNA/cds = GAGGAATCCCAGCGCCTTTTAAAA (143, 634) 783 Table 3AHs.68644 AF212233 13182746 microsomal signal peptidase 1AGGGAACAGTGTGGAGATGTTTTTGT subunit mRNA, complete cds/CTTGTCCAAATAAAAGATTCACCA cds = (57, 635) 784 Table 3A Hs.332404 AF21224113182760 CDA02 protein (CDA02), mRNA 1 ACCCATTGGTATACACAGAATATTCC /cds =(2, 1831) TGTGCCCACACTTAATGTCAATCT 785 Table 3A Hs.9414 AF21719011526792 MLEL1 protein (MLEL1) mRNA, 1 TTGATGATACCACCAGTAAAAATAGGcomplete cds/cds = (73, 3099) ATGTTTACCCCAAAACAAGTGTCA 786 Table 3AHs.288850 AF220656 7107358 cDNA: FLJ22528 fis, clone 1TTTCAACCGAAAGGGCAGATCCAATA HRC12825/cds = UNKNOWNGAAGACCCGCTCCTTAAATAAACA 787 Table 3A Hs.46847 AF223469 7578788 TRAF andTNF receptor- 1 ACAGAGGCAAAGTTAAGCTTGATGAT associated protein (AD022),GGTTAAAATCGGTTTGATAGCACC mRNA/cds = (16, 1104) 788 Table 3A Hs.79025AF226044 9295326 HSNFRK (HSNFRK) mRNA, 1 TGGTTGATTTCCCTCATTGTGTAAACcomplete cds/cds = (641, 2938) ATTGACAGGTATGTGACAAATGGG 789 Table 3AHs.112242 AF228422 12656020 normal mucosa of esophagus 1CACAAACTAGATTCTGGACACCAGTG specific 1 (NMES1), mRNA/TGCGGAAATGCTTCTGCTACATTT cds = (189, 440) 790 Table 3A Hs.55173 AF2310237407145 cadherin, EGFLAG seven-pass G- 1 GGCCCTCTTTCCTGTCTGTGTAAATT typereceptor 3, flamingo GTTCCGTGAAGCCGCGCTCTGTTT (Drosophila) homolog(CELSR3), mRNA/cds = (281, 10219) 791 Table 3A Hs.4788 AF240468 9992877nicastrin mRNA, complete cds 1 CACTGTCCTTTCTCCAGGCCCTCAGA /cds = (142,2271) TGGCACATTAGGGTGGGCGTGCTG 792 Table 3A Hs.196015 AF241534 9502099hydatidiform mole associated and 1 AGGAGCTATGATTAGACTTCTGTTAG imprinted(HYMAI) mRNA, ACTTCCTCACTCTATCACCCACAT complete sequence/cds = UNKNOWN793 Table 3A Hs.81897 AF241785 12005486 NPD012 (NPD012) mRNA, 1ACCCACTTTCTCCTTGGTAAAGCGTT complete cds/cds = (552, 2252)TACTTAACAAAATAATACCCGAGA 794 Table 3A Hs.153042 AF244129 10197716cell-surface molecule Ly-9 mRNA, 1 GTCACACATGACACAAGATGTACATA completecds/cds = (30, 1994) ATATCATGCTCACGCCTGGAGTGT 795 Table 3A Hs.20597AF244137 7670839 host cell factor homolog (LCP), 1ATGTGCATGTGAATGGCCTAGAGAAC mRNA/cds = (316, 1536)CTATTTTTGTGTCTAAAGTTTACA 796 Table 3A Hs.145956 AF246126 8571416 zincfinger protein mRNA, 1 AGATCCTGTCCTCCTTTAGCCTCACT complete cds/cds =(1073, 3133) AATCAAGTTGGGTCCTATCTTCCC 797 Table 3A Hs.239625 AF2462217658294 integral membrane protein 2B 1 AGTTGTTAGTTGCCCTGCTACCTAGT(ITM2B), mRNA/cds = (170, 970) TTGTTAGTGCATTTGAGCACACAT 798 Table 3AHs.6289 AF246238 12005510 hypothetical protein FLJ20886 1AATCCTTTAACTCTGCGGATAGCATT (FLJ20886), mRNA/cds = (0, 524)TGGTAGGTAGTGATTAACTGTGAA 799 Table 3A Hs.81248 AF248648 9246972 CUGtriplet repeat, RNA-binding 1 GGAGGAGGAGCTTATTTCTTGGTGTA protein 1(CUGBP1), mRNA CTTGAATCAGAAGGTCCCTGCAAG /cds = (137, 1585) 800 Table 3AHs.81248 AF248648 9248972 CUG triplet repeat, RNA-binding 1GGAGGAGGAGCTTATTTCTTGGTGTA protein 1 (CUGBP1), mRNACTTGAATCAGAAGGTCCCTGCAAG /cds = (137, 1585) 801 Table 3A Hs.183434AF248966 12005668 ATPase, H+ transporting, 1 AAGTGGAAGTGGGTGAATTCTACTTTlysosomal (vacuolar proton pump) TTATGTTGGAGTGGACCAATGTCT membranesector associated protein M8-9 (APT6M8-9), mRNA/cds = (102, 1154) 802Table 3A Hs.24125 AF251039 7547030 putative zinc finger protein 1TGGGATTCATTGGCCCATAGGTACAT (LOC51780), mRNA/cds =TGGAAAATGTATATCTCTCCAGCT (744, 4997) 803 Table 3A Hs.103521 AF2544119438032 ser/arg-rich pre-mRNA splicing 1 GGGACCCCCAGGAGGCTGAGGATGGfactor SR-A1 (SR-A1) gene GAGACAGAGACCAGACTGTGACTTG 804 Table 3AHs.42949 AF260237 14009497 hypothetical protein HES6 (HES6), 1TGTTTGTAGCACACTTGAGTTTGTGT mRNA/cds = (0, 674) ATTCCATTGACATCAAATGTGACA805 Table 3A Hs.174131 AF261087 9802305 ribosomal protein L6 (RPL6), 1CGATCTGTGTTTGCTCTGACGAATGG mRNA/cds = (26, 892) AATTTATCCTCACAAATTGGTGTT806 Table 3A Hs.153612 AF261091 10179833 iron inhibited ABC transporter2 1 CCAGGAGCGTGGTTTTCTGATTGTGA mRNA, complete cds/cds =TCTGAGGTTCTGCCCCAACTGCAC (111, 1982) 807 Table 3A Hs.44198 AF2636138453173 membrane-associated calcium- 1 ACATTACCTAATATTCTCACTAGCTATindependent phospholipase A2 GTTCTCCAATCCACACTGCCTTT gamma mRNA,complete cds/ cds = (225, 2573) 808 Table 3A Hs.107707 AF265439 12005981mitochondrial ribosomal protein 1 AGACAGCCCTGCCAAAGCCATACCAA S15(MRPS15), mRNA/cds = AGACACTCAAAGACAGCCAATAAA (0, 851) 809 Table 3AHs.8084 AF287856 12006038 HT033 mRNA, complete cds 1AGAGATAGCACAGATGGACCAAAGG /cds = (203, 931) TTATGCACAGGTGGGAGTCTTTTGT810 Table 3A Hs.8084 AF267856 12006038 HT033 mRNA, complete cds 1AGAGATAGCACAGATGGACCAAAGG /cds = (203, 931) TTATGCACAGGTGGGAGTCTTTTGT811 Table 3A Hs.77690 AF267863 12006052 RAB5B, member RAS oncogene 1GCCTTTCTTCCTCTCCCAACATAACA family (RAB5B), mRNA/cds =ATCGTGGTAACAGAATGCGACTGC (20, 687) 812 Table 3A Hs.8203 AF269150 9755050endomembrane protein emp70 1 ACCGTGTAAAGTGGGGATGGGGTAA precursor isolog(LOC58889), AAGTGGTTAACGTACTGTTGGATCA mRNA/cds = (19, 1779) 813 Table 3AHs.267288 AF271994 8515856 dopamine responsive protein 1GCCCAGTGCTTAAAAACGCCTTCTTG DRG-1 mRNA, complete cds/CATGAGGGGATTGAACTATACAAT cds = (15, 938) 814 Table 3A Hs.147644 AF2721488575774 zinc finger protein 331: zinc finger 1 GCGGGAAGGCATGTAACCACCTAAAprotein 463 (ZNF361), mRNA CCATCTCCGAGAACATCAGAGGATC /cds = (376, 1767)815 Table 3A Hs.339912 AF277292 9664852 qh07h06.x1 cDNA, 3′ end 1TGTCAGGCTGGCTTGGTTAGGTTTTA /clone = IMAGE:1844027/CTGGGGCAGAGGATAGGGAATCTC clone_end = 3′ 816 Table 3A Hs.287389 AF27943710719561 interleukin 22 (IL22), mRNA 1 GGTGGATTCCAAATGAACCCCTGCGT /cds =(71, 610) TAGTTACAAAGGAAACCAATGCCA 817 Table 3A Hs.196270 AF28364511545416 folate transporter/carrier 1 ATTTATCGTAAACATCCACGAGTGCT(LOC81034), mRNA/cds = GTTGCACTACCATCTATTTGTTGT (128, 1075) 818 Table 3AHs.324278 L08048.1 184250 mRNA: cDNA DKFZp566M063 1TGGGGGTTGTAAATTGGCATGGAAAT (from clone DKFZp566M063)TTAAAGCAGGTTCTTGTTGGTGCA /cds = UNKNOWN 819 Table 3A Hs.116481 AF28377710281735 CD72 antigen (CD72), mRNA 1 GATAGGGGCGGCCCGGAGCCAGCCA /cds =(108, 1187) GGCAGTTTTATTGAAATCTTTTTAA 820 Table 3A Hs.283022 AF2870089624485 triggering receptor expressed on 1 CATTTGTACCCTAGGCCCACGAACCCmyeloid cells 1 (TREM1), ACGAGAATGTCCTCTGACTTCCAG mRNA/cds = (47, 751)821 Table 3A Hs.44865 AF288571 9858157 lymphoid enhancer factor-1 (LEF1)1 AGTGGGATTTTATGCCAGTTGTTAAA mRNA, complete cds/cds =ATGAGCATTGATGTACCCATTTTT (654, 1853) 822 Table 3A Hs.212172 AF29490010242315 beta-carotene 15,15′-dioxygenase 1 CTTTCCTTTGCTCCCTCCCATGTTTCT(BCDO), mRNA/cds = (218, 1861) GGTGGACTAAATTGTGTATCTGG 823 Table 3AHs.7886 AF302505 10242358 pellino (Drosophila) homolog 1 1AGTTTTCTAGATTGTCACATGCTTTGT (PELI1), mRNA/cds = GACTAATGCAAGAAAGCAAGTCC(4038, 5294) 824 Table 3A Hs.47783 AF307339 12751140 B aggressivelymphoma gene 1 GAAACACTTTCAGGACCTTCCTTCCT (BAL), mRNA/cds =CTTGCAGTTGTTCTTTAATCTCCT (228, 2792) 825 Table 3A Hs.250528 AF30828512060821 Homo sapiens, clone IMAGE: 1 CTCGAGGGGCCAATTACAGGAGCAC 4098694,mRNA, partial cds/ AGGAAGGTTCTGATTACACACCTCT cds = (0, 2501) 826 Table3A Hs.153057 AF311312 10863767 infertility-related sperm protein 1TTGAGTTAAGTTGCATTTCTTTGGGC mRNA, complete cds/cds =TATGAAGGAGTCCTCTTAAGTTTG (198, 2978) 827 Table 3A Hs.6151 AF31559111139703 pumilio (Drosophila) homolog 2 1 AGGGATTGTTTCTGGACCAGTTTGTC(PUM2), mRNA/cds = TAAGTCCTGGCTCTTATTGGTTCA (23, 3217) 828 Table 3AHs.194976 AF319438 12667351 SH2 domain-containing 1TGAACTGCTGCTACATCCAGACACTG phosphatase anchor protein 1TGCAAATAAATTATTTCTGCTACC (SPAP1), mRNA/cds = (303, 1070) 829 Table 3AHs.36752 AF319476 11762083 protein kinase anchoring protein 1ACTATGCAGTTTTTCTTGAAGGAACT GKAP42 (GKAP42), mRNAAAAAGCAACTAGCTCCCTAATGGT /cds = (174, 1274) 830 Table 3A Hs.114309AF323540 12408012 apolipoprotein L-I mRNA, splice 1GTCTTTCCAGCATCCACTCTCCCTTG variant B, complete cdsTCCTCCTGGGGGCATATCTCAGTC /cds = (273, 1517) 831 Table 3A Hs.27721AF332469 12642816 Wolf-Hirschhom syndrome 1 GCAGTAGGTAGGCTCACTTCTCTTTCcandidate 1-like 1 (WHSC1L1), CCTTCAAAATGCTTTTCATAGGCT transcriptvariant long, mRNA/cds = (518, 4831) 832 Table 3A Hs.203181 AF33302513936737 Bv8 protein (BV8) mRNA, 1 TCTGCTGTTGGGCTGGTGTGTGGAC partialcds/cds = (0, 358) AGAAGGAATGGAAAGCCAAATTAAT 833 Table 3A NA AI9048026495189 1q12-21.2 Contains a cyclophilin- 1 CCACTTGGAATAGGAATATCACCCCTlike gene, a novel gene, ATCTTGGAAGACCAGGTGGAGGCT ESTs, GSSs and STS 834Table 3A Hs.5122 AJ001235 12418001 602293015F1 cDNA, 5′ end 1GCCCTATGGCGTTGTTAAACACGAGC /clone = IMAGE:4387778/GTATGCTAGTAAGTATCATTCATA clone_end = 5′ 835 Table 3A Hs.9071 AJ0020302570006 progesterone receptor membrane 1 GTGGGTGCATGGGGCTGTGGAGTGGcomponent 2 (PGRMC2), GTGTCAGTATGGATGTGTCTGAATG mRNA/cds = (6, 677) 836Table 3A Hs.196769 AJ006835 3236105 RNA transcript from U17 small 1CATTCGTCTGTATGCCCAGTCCCATC nucleolar RNA host gene, variantCGTGTCCTGCTGTAACTACATAGA U17HG-AB/cds = UNKNOWN 837 Table 3A Hs.181461AJ009771 3846273 ariadne (Drosophila) homolog, 1TGTCTGCTTCTTCCATTTTCTCGTCTC ubiquitin-conjugating enzyme E2-TCTCCCCTCTTCCCCCATTATCC binding protein, 1 (ARIH1), mRNA/cds = (314,1987) 838 Table 3A Hs.18259 AJ010842 3846129 XPA binding protein 1:putative 1 TGGGCAAGACATGATTAATGAATCAG ATP(GTP)-binding proteinAATCCTGTTTCATTGGTGACTTGG (NTPBP), mRNA/cds = (24, 1148) 839 Table 3AHs.109281 AJ011895 3758818 Nef-associated factor 1 (NAF1), 1CCAGATTAGGGTGGCTGTCCATCCCT mRNA/cds = (110, 2017)GGATAGCTATTTGCACGAATCATG 840 Table 3A Hs.306328 AJ012504 5441364 mRNAactivated in tumor 1 CGGAGCTCTGGCTCTGCTGTAGGAA suppression, clone TSAP13GCCCGGTACGTCCTTCATGACAGCA extended/cds = UNKNOWN 841 Table 3A Hs.118958AJ012506 5441365 syntaxin 11 (STX11), mRNA 1 GCACTGAATATCGAACAAGCACTCAA/cds = (183, 1046) ATTGAAGTATCAGTCATGTTTTGT 842 Table 3A Hs.58103AJ131693 4584422 mRNA for AKAP450 protein 1 AGCTCGAGGTGTCCTGCACTTTTCTT/cds = (222, 11948) ATAAGGCTACTGAAGTTACATGTT 843 Table 3A Hs.59757AJ132592 6822171 zinc finger protein 281 (ZNF281), 1TGCCATTGGAATGTTTCTACACGATC mRNA/cds = (23, 2710)CTATTAAGAATAATGTGATGCCCT 844 Table 3A Hs.326159 AJ223075 3355596 leucinerich repeat (in FLII) 1 GGATAACAAGTAAATGTCTGAAAGCA interacting protein 1(LRRFIP1), TGAGGGGCTTTATTTGCCTTTACC mRNA/cds = (178, 2532) 845 Table 3AHs.137548 AJ223324 3392916 CD84 antigen (leukocyte antigen) 1TGTTTTCCTCACTACATTGTACATGTG (CD84), mRNA/cds = (44, 1030)GGAATTACAGATAAACGGAAGCC 846 Table 3A Hs.333140 AJ225093 3090427 mRNA forsingle-chain antibody, 1 AAAACTCATCTCAGAAGAGGATCTGA complete cds(scFv2)/cds = ATGGGGCCGCACATCACCATCATC (0, 806) 847 Table 3A Hs.27182AJ238243 4826530 mRNA for phospholipase A2 1 AAACCCCTTTAAATGAGGGCCAGTATactivating protein/cds = TATCTCTGCTTTCAGAAGTAGACA (28, 2244) 848 Table3A Hs.6947 AJ238403 12697195 mRNA for huntingtin interacting 1GACCTGACTCCACTCTTAAACCTGGG protein 1 TCTTCTCCTTGGCGGTGCTGTCAG 849 Table3A Hs.54842 AJ243721 6006497 methionine adenosyltransferase II, 1CTTTTATAGCAGTTTATGGGGAGCAC beta (MAT2B), mRNA/cds =TTGAAAGAGCGTGTGTACATGTAT (0, 1004) 850 Table 3A Hs.55968 AJ2455396688168 partial mRNA for GalNAc-T5 1 AGATCCTGAAAGTAGCTGCCTGTGAC (GALNT5gene)/cds = (0, 2006) CCAGTGAAGCCATATCAAAAGTGG 851 Table 3A Hs.18827AJ250014 8250235 cylindromatosis (turban tumor 1TACTGCTAAGTGCTTGGTTGGGGTGG syndrome) (CYLD), mRNATGAGATGATGATTAGATCAGGGGT /cds = (391, 3261) 852 Table 3A Hs.250905AJ250865 6688221 hypothetical protein (LOC51234), 1TTGTACCCAGAGACTATGATTTATATT mRNA/cds = (0, 551) GATTGCACTTGCCTGCCATGATT853 Table 3A Hs.169610 AJ251595 6491738 mRNA for transmembrane 1TTTCAGATGCTTCTGGGAGACACCAA glycoprotein (CD44 gene)AGGGTGAAGCTATTTATCTGTAGT /cds = (178, 2406) 854 Table 3A Hs.107393AJ270952 7687995 chromosome 3 open reading 1 TTGTGGTAATATGATGTGCCTTTCCTTframe 4 (C3orf4), mRNA/ GCCTAAATCCCTTCCTGGTGTGT cds = (880, 1641) 855Table 3A Hs.135187 AJ271326 12043566 unc93 (C. elegans) homolog B 1CACAAGGTGCGCGGTTACCGCTACTT (UNC938), mRNA/cds = GGAGGAGGACAACTCGGACGAGAG(41, 1834) 856 Table 3A Hs.126355 AJ271684 6900101 C-type (calciumdependent, 1 TAGACTCACGAACAAATCCACCTGAG carbohydrate-recognition domain)ATCAGCAGAGCCACCCTAGATCAG lectin, superfamily member 5 (CLECSF5),mRNA/cds = (197, 763) 857 Table 3A Hs.334647 AJ271747 9714271hypothetical protein FLJ20011 1 CCTCAGAGGCTTACTCTAACCCATCC (FLJ20011),mRNA/cds = CAGAATAAATGGAGACTTCATGTG (380, 856) 858 Table 3A Hs.88414AJ271878 12666977 BTB and CNC homology 1, basic 1AGGCTGTTGATGCTTATTCTCTGTAA leucine zipper transcription factor 2CTAAGAATTTTACCTTTTGGGGGA (BACH2), mRNA/cds = (708, 3233) 859 Table 3AHs.150601 AJ272212 7981276 mRNA for protein serine kinase 1GTAAACGTATCCTCTGTATTCAGTAA (PSKH1 gene)/cds = ACAGGCTGCCTCTCCAGGGAGGGC(130, 1404) 860 Table 3A Hs.287389 AJ277247 9968293 interleukin 22(IL22), mRNA 1 AACTAACCCCCTTTCCCTGCTAGAAA /cds = (71, 610)TAACAATTAGATGCCCCAAAGCGA 861 Table 3A Hs.56247 AJ277832 9968295 mRNA forinducible T-cell co- 1 GCCTCGACACATCCTCATCCCCAGCA stimulator (ICOSgene)/cds = TGGGACACCTCAAGATGAATAATA (67, 668) 862 Table 3A Hs.14512AJ278191 8745180 DIPB protein (HSA249128), 1 GCACAGTGACATTCCCTCCTTAGGAAmRNA/cds = (177, 1211) TCTTCCCCTTCCACCCTTTACA 863 Table 3A Hs.134342AJ278245 12227251 mRNA for LanC-like protein 2 1TTTGAGGTTCTTTGGTTTTGTTAGTAA (lancl2 gene)/cds = (186, 1538)AAGCCAGTTCTGTGGTGATGACC 864 Table 3A Hs.279860 AJ400717 7573518 tumorprotein, translationally- 1 CATCTGAAGTGTGGAGCCTTACCCAT controlled 1(TPT1), mRNA/cds = TTCATCACCTACAACGGAAGTAGT (94, 612) 865 Table 3AHs.130881 AJ404611 11558481 B-cell CLL/lymphoma 11A (zinc 1TTTTGGCAGTTGTCTGCATTAACCTG finger protein) (BCL11A),TTCATACACCCATTTTGTCCCTTT mRNA/cds = (228, 2735) 866 Table 3A Hs.10647AK000005 7209310 mRNA for FLJ00005 protein, 1TGGTGTTTATGTACTACTCTATAGAAC partial cds/cds = (0, 337)TCTTGGCTTGCACTTCTACAGCT 867 Table 3A Hs.29052 AK000196 7020122hypothetical protein FLJ20189 1 ACAGGCAAAGTGACAGGGGAAAAGG (FLJ20189),mRNA/cds = AATTAGTCTAAGAGTAAGGGGATGA (122, 841) 868 Table 3A Hs.79110AK000221 7020163 nucleolin (NCL), mRNA 1 TGGTCTCCTTGGAAATCCGTCTAGTT /cds= (111, 2234) AACATTTCAAGGGCAATACCGTGT 869 Table 3A Hs.20157 NM_02519713376787 hypothetical protein FLJ13680 1 GTCTACCAGGCGAAAACCACAGATTCsimilar to CDK5 activator- TCCTTCTAGTTAGTATAGCGGACT binding protein C53(FLJ13660), mRNA/cds = (993, 2252) 870 Table 3A Hs.180804 AK0002717020240 cDNA FLJ20264 fis, clone 1 ACTTCTCTTGATGTAGAAAGAGATGACOLF7912/cds = UNKNOWN CGTTGTTACCCTGAGTGACAGTCA 871 Table 3A Hs.180952AK000299 7020288 cDNA FLJ20292 fis, clone 1 TGAGCTAAGTGTCATGCATATTTGTGHEP05374/cds = (21, 1403) AAGAAACACCCTTGTTTGGTCCCT 872 Table 3AHs.272793 AK000316 7020318 hypothetical protein FLJ20309 1CTGAGCAAGGCAGATGACCTAATCAC (FLJ20309), mRNA/cds =CTCACGACAGCAATACAGCAGTGA (41, 1279) 873 Table 3A Hs.102669 AK0003547020383 cDNA FLJ20347 fis, clone 1 TTTGTACTATTGCTAGACCCTCTTCTGHEP13790/cds = (708, 1481) TAATGGGTAATGCGTTTGATTGT 874 Table 3A Hs.26434AK000367 7020405 hypothetical protein FLJ20360 1TGCTATGCTAATGTCTAGAAAGGCAT (FLJ20360), mRNA/cds =ACGATGCTACTATTATGCTCTGTT (79, 2304) 875 Table 3A Hs.120769 AK0004707020580 cDNA FLJ20483 fis, clone 1 ACTGCTCTTTCTCAGGCCCAAGGTAAKAT08143/cds = UNKNOWN AAAGGTTTTTGGTCTCATGTTGAC 876 Table 3A Hs.5811AK000474 7020586 chromosome 21 open reading 1 TCACCAGCTGATGACACTTCCAAAGAframe 59 (C21ORF59), GATTAGCTCACCTTTCTCCTAGGC mRNA/cds = (360, 776) 877Table 3A Hs.279581 AK000575 7020763 hypothetical protein FLJ20568 1CAGAGTAGGCATCTGGGCACCAAGA (FLJ20568), mRNA/cds = (6, 422)CCTTCCCTCAACAGAGGACACTGAG 878 Table 3A Hs.75884 AK000639 7020863DKFZP586A011 protein 1 TGCATGAAGCACTGTTTTTAAACCCA (DKFZP586A011), mRNAAGTAAAGACTGCTTGAAACCTGTT /cds = (330, 632) 879 Table 3A Hs.234149AK000654 7020886 hypothetical protein FLJ20647 1TGATTTTGCAACTTAGGATGTTTTTGA (FLJ20647), mRNA/cds =GTCCCATGGTTCATTTTGATTGT (90, 836) 880 Table 3A Hs.266175 AK0006807020924 cDNA FLJ20673 fis, clone 1 TTTGAGCGATCTCTCACATGATGGGGKAIA4464/cds = (104, 1402) TTCTTTAGTACATGGTAACAGCCA 881 Table 3AHs.30882 AK000689 7020935 cDNA FLJ20682 fis, clone 1CCCGGCCTGGGACTCAGCATTTCTG KAIA3543, highly similar toATATGCCTTAAGAATTCATTCTGTT AF131826 clone 24945 mRNA sequence/cds =UNKNOWN 882 Table 3A Hs.243901 AK000745 7021025 cDNA FLJ20738 fis, clone1 AGTTTTGCTGAAGACTGGCCTTATTA HEP08257/cds = UNKNOWNATGGACAGCTTTCCTAACAAGAGA 883 Table 3A Hs.274248 AK000765 7021058hypothetical protein FLJ20758 1 GGGTCAATAGTTTCCCAATTTCAGGA (FLJ20758),mRNA/cds = TATTTCGATGTCAGAAATAACGCA (464, 1306) 884 Table 3A Hs.93872AK000987 7021958 mRNA for KIAA1682 protein, 1 TGAGAGCTGAAATGAGACCATTTACTpartial cds/cds = (19, 2346) TTGTTTAAAATGCTGTACTGTGCA 885 Table 3AHs.321245 AK001111 7022169 cDNA FLJ10249 fis; clone 1TTGAGCTAAGACCTTAGGAAATTCAC HEMBB1000725, highly similar toTTTCTGCATGATAAAATGACCCAA Rattus norvegicus GTPase Rab8b mRNA/cds =UNKNOWN 886 Table 3A Hs.117950 AK001163 7022244 multifunctionalpolypeptide similar 1 TGTCATTGTACACTTTATTTCCCTCAC to SAICAR synthetaseand AIR ACTGTGTTATGCTCTGATGTGCT carboxylase (ADE2H1), mRNA/cds = (24,1301) 887 Table 3A Hs.194676 AK001313 7022490 tumor necrosis factorreceptor 1 GGTCTCTTTGACTAATCACCAAAAAG superfamily, member 6b, decoyCAACCAACTTAGCCAGTTTTATTT (TNFRSF6B), transcript variant 2, mRNA/cds =(827, 4486) 888 Table 3A Hs.7837 AK001319 7022500 phosphoproteinregulated by 1 AGGTTCTTCCTGTACATACGTGTATA mitogenic pathways (C8FW),TATGTGAACAGTGAGATGGCCGTT mRNA/cds = (273, 1391) 889 Table 3A Hs.44672AK001332 7022524 hypothetical protein FLJ10470 1ACTTGGATGCTGCCGCTACTGAATGT (FLJ10470), mRNA/cds =TTACAAATTGCTTGCCTGCTAAAG (6, 2054) 890 Table 3A Hs.76556 AK0013817022572 protein phosphatase 1, regulatory 1 GGGAGGCGTGGCTGAGACCAACTGG(inhibitor) subunit 15A TTTGCCTATAATTTATTAACTATTT (PPP1R15A), mRNA/cds =(240, 2264) 891 Table 3A Hs.173374 AK001382 7022574 cDNA FLJ10500 fis,clone 1 TCTCCCAGAATGTACTTATCTTACCTC NT2RP2000369/cds =GGCATGTACTGTAGTCACTCAGT UNKNOWN 892 Table 3A Hs.808 AK001364 7022577heterogeneous nuclear 1 TGTGCACTGTTGTAAACCATTCAGAA ribonucleoprotein F(HNRPF), TTTTCCTGCTAGGCCCTTGATGCT mRNA/cds = (323, 1570) 893 Table 3AHs.279521 AK001403 7022638 hypothetical protein FLJ20530 1CATCGGCCAGACAGAGTTGAATGCAA (FLJ20530), mRNA/cds =GCAATCCAGAAGAAGTGTTACAGC (10, 1683) 894 Table 3A Hs.108332 AK0014287022679 cDNA FLJ10566 fis, clone 1 TGCTCTAGCCATCAGGTTCTTTCAAANT2RP2002959, highly similar to TGCATCTTTACACTCTTGCACAAAUBIQUITIN-CONJUGATING ENZYME E2-17 KD 2 (EC 6.3.2.19)/cds = UNKNOWN 895Table 3A Hs.183297 AK001433 7022686 enhancer of polycomb 1 (EPC1) 1TGAGCATGAAATGGGATCCTGCATCA mRNA, complete cds/cds =CTTGTTTTAACTATTTATTTTGCC (151, 2442) 896 Table 3A Hs.7943 AK0014377022693 RPB5-mediating protein (RMP), 1 TTTGCGGCTAGTTGGCTATTCAAGAAmRNA/cds = (465, 1991) ACCTCGCCCCTCTGAATGTCATAC 897 Table 3A Hs.343211AK001451 7022717 602321909F1 cDNA, 5′ end 1 GTTTACGTGGAAGAAACGCTAAGGGT/clone = IMAGE:4425098/ TTGCTCCCAGGAAAGGAGAGGAAG clone_end = 5′ 898Table 3A Hs.268012 AK001471 7022749 fatty-acid-Coenzyme A ligase, 1TGCTCAAATCAGGACTTAAATCATAG long-chain 3 (FACL3), mRNAGCACCACATTTTTCATGTCAGACT /cds = (142, 2304) 899 Table 3A Hs.238844AK001514 7022816 hypothetical protein FLJ10652 1TGAAATTCTACCCATCTTGAGGGAGG (FLJ10652), mRNA/cds =ACCGTTCCTCAGTTAAGGACTTGT (50, 1141) 900 Table 3A Hs.215766 AK0015487022888 GTP-binding protein (NGB), 1 ATGAGTGTGTCGGAATCCCGTGCTTA mRNA/cds= (23, 1924) AAATACGCTCTTAAATTATTTTCT 901 Table 3A Hs.18063 AK0016307023001 cDNA FLJ10768 fis, clone 1 AAATCAGAACTGAGGTAGCTTAGAGANT2RP4000150/cds = TGTAGCGATGTAAGTGTCGATGTT UNKNOWN 902 Table 3AHs.14347 AK001685 7023061 cDNA FLJ12877 fis, clone 1AGGCTTTAGCAAAGATGGATATATTG NT2RP2003825/cds = GTGACTGAGACAGAAGAACTGGCA(313, 738) 903 Table 3A Hs.12457 AK001676 7023081 hypothetical proteinFLJ10814 1 AGTGGGCCTAACTCATGTGAGCTTGA (FLJ10814), mRNA/cds =TAACTGATGAACTCATTGGGAGCA (92, 3562) 904 Table 3A Hs.169407 AK0017257023165 SAC2 (suppressor of actin 1 AACACTAACCTCTCCCCTCCTGGCTC mutations2, yeast, homolog)-like AAGAATTACTCCGAAGTCAGTCTG (SACM2L), mRNA/cds =(0, 2165) 905 Table 3A Hs.267604 AK001749 7023206 hypothetical proteinFLJ10450 1 TCTGTCAGGAAATGTAACTTTGGTTTT (FLJ10450), mRNA/cds =ATTTTTGGCTTATTCCAAGGGGT (68, 1622) 906 Table 3A Hs.110445 AK0017797023263 CGI-97 protein (LOC51119), 1 AAATTGTGCCGGACTTACCTTTCATT mRNA/cds= (170, 922) GAACATGCTGCCATAACTTAGATT 907 Table 3A Hs.12999 AK0018227023330 cDNA FLJ10960 fis, clone 1 TGGCAGGGAGCTGGGACCTGGAGAGPLACE1000564/cds = ACAACTCCTGTAAATAAAACACTTT UNKNOWN 908 Table 3AHs.296323 AK001838 7023355 serum/glucocorticoid regulated 1AGGGAGATAATGGAGTCCACTTTAAT kinase (SGK), mRNA/cds =TTGGAATTCTGTGTGAGCTATGAT (42, 1337) 909 Table 3A Hs.81648 AK0018837023426 hypothetical protein FLJ11021 1 AGATCAGTGATACTGGTGTTAGTGTTsimilar to splicing factor, GTAATCAGGTTAAACCCACTTCCAarginine/serine-rich 4 (FLJ11021), mRNA/cds = (446, 1054) 910 Table 3AHs.181112 AK001934 7023506 HSPC126 protein (HSPC126), 1CCATTTGACAGTAAAGGCTCTTGGCT mRNA/cds = (25, 837) TCTGTTGGAGGCATGGGAAATTGT911 Table 3A Hs.4863 AK001942 7023519 cDNA FLJ11080 fis, clone 1TTTAACAGCCTGTCCTCCCGGCATCA PLACE1005181/cds = GGAGTCATTGAACAATCATGGATTUNKNOWN 912 Table 3A Hs.30822 AK001972 7023569 hypothetical proteinFLJ11110 1 AATACTTATTGTTTGGCAGGTCATCC (FLJ11110), mRNA/cds =ACACACTTCTGCCCCCACTGCATT (44, 1033) 913 Table 3A Hs.173203 AK0020097023629 beta-1,3-N- 1 TTATCAGATGGGATACTGGGGACTATacetylglucosaminyltransferase AAACAATGGAAATAAAGCCACTGT (BETA3GNT),mRNA/cds = (235, 1428) 914 Table 3A Hs.8033 AK002026 7023858hypothetical protein FLJ11164 1 CCCTGTGCCTTTCCTTTGAGAGTGAA (FLJ11164),mRNA/cds = GGTGGGTGGAGTTGACCAGAGAAA (56, 1384) 915 Table 3A Hs.92918AK002059 7023711 hypothetical protein (BM-009), 1TGTGTGCGTAGAATATTACGTATGCA mRNA/cds = (385, 1047)TGTTCATGTCTAAAGAATGGCTGT 916 Table 3A Hs.155313 AK002127 7023814 DNAsequence from clone 1 TCTACATGTGACTGGCTTTCTTGCCC RP5-885L7 on chromosomeTCGTCTCTTGAATGTTTAGACTCT 20q13.2-13.33 Contains ESTs, STSs, GSSs andeight CpG islands. Contains the 3′ end of the NTSR1 gene for highaffinity neurotensin receptor 1, a putative novel gene, a novel genesimilar to a fly gene, the gene for opioid growth factor receptor (7-60protein), the COL9A3 gene for collagen IX alpha 3, a putative novel genesimilar to a fly gene, the TCFL5 gene for basic helix-loop-helixtranscription factor-like 5, an ARF4 (ADP-ribosylation factor 4)pseudogene, a novel gene and the 3′ end of the gene for a novel proteinsimilar to mouse death inducer obliterator 1 (DIO-1) (containsKIAA0333)/cds = (0, 3129) 917 Table 3A Hs.5518 AK002173 7023889 cDNAFLJ11311 fis, clone 1 TGGTACCCAAACTCACCATTTGGTCC PLACE1010102/cds =TCTTTAATCTTTGAGGGTTTCAAT UNKNOWN 918 Table 3A Hs.270557 AK02151710432713 cDNA FLJ11455 fis, clone 1 TTCCATTTATTCATGTACATTGGCCAGHEMBA1001497/cds = TTCCTGGTCCTTGTCTGACTTCT UNKNOWN 919 Table 3AHs.126707 AK021519 10432715 hypothetical protein FLJ11457 1AACCATCTGGAGTCAGTACAGATCAT (FLJ11457), mRNA/cds =CAATCCTTCCACATATACAAGTTC (103, 867) 920 Table 3A Hs.77558 AK02156310432767 cDNA FLJ11501 fis, clone 1 GGCCACCTGCTGACTATTTGTGGTTTHEMBA1002100/cds = AAAATAAAAGGTTTACTTGTCTGC UNKNOWN 921 Table 3AHs.11571 AK021632 10432852 cDNA FLJ11570 fis, clone 1TCTTTGTAAAGCACGATGATACAAAT HEMBA1003309/cds = CTGGTGCCAGTGTTATATTTTGCAUNKNOWN 922 Table 3A Hs.12315 AK021670 10432901 hypothetical proteinFLJ11608 1 CATGGATATCATGTATCCTTCCTGGT (FLJ11608), mRNA/cds =GCTCACACACCTGTCACCTTGTAA (561, 1184) 923 Table 3A Hs.241567 AK02170410432943 RNA binding motif, single 1 ATAAGGTGCATAAAACCCTTAAATTC strandedinteracting protein 1 ATCTAGTAGCTGTTCCCCCGAACA (RBMS1), transcriptvariant MSSP-2, mRNA/cds = (265, 1434) 924 Table 3A Hs.271541 AK02171510432954 cDNA FLJ11653 fis, clone 1 TGGACCGGAGTCTGCTGAGTTTATAAHEMBA1004538/cds = GGTTCCAAAAATATGGTAAAATCT UNKNOWN 925 Table 3A Hs.5019AK021776 10433029 cDNA FLJ11714 fis, clone 1 ACTCGACCTTGGTAAACGGAAATGTTHEMBA1005219, weakly similar GGGGGTGAAGAGAAACAATCACTA to NUCLEAR PROTEINSNF7 /cds = UNKNOWN 926 Table 3A Hs.288212 AK021791 10433048hypothetical protein FLJ11729 1 TTCAAGGTTCTGCGAAATTAATTGGG (FLJ11729),mRNA/cds = CAGGTTAATTGTGTACCTGAAACT (311, 1150) 927 Table 3A Hs.9096AK021925 10433223 hypothetical protein FLJ20473 1TCCCCAGGATGGGGCCTCATACAAC (FLJ20473), mRNA/cds =CCTTCATCTGCACTCAACATTTAAT (57, 1472) 928 Table 3A Hs.288178 AK02203010433346 cDNA FLJ11968 fis, clone 1 TTTTAGACATGGAGTGCAGGTGGACAHEMBB1001133/cds = CTGTGTGAACTGTTTTTGGTCAGT UNKNOWN 929 Table 3AHs.22265 AK022057 10433376 pyruvate dehydrogenase 1CAAGAAACTTGGTCTGCAGTCTGGAA phosphatase (PDP), mRNA/GCTTGTCTGCTCTATAGAAATGAA cds = (131, 1855) 930 Table 3A Hs.22265AK022057 10433376 pyruvate dehydrogenase 1 CAAGAAACTTGGTCTGCAGTCTGGAAphosphatase (PDP), mRNA/ GCTTGTCTGCTCTATAGAAATGAA cds = (131, 1855) 931Table 3A Hs.20281 AK022103 10433424 mRNA for KIAA1700 protein, 1TGTTGAACGGTTAAACTGTGCATTTC partial cds/cds = (108, 2180)TCATTTTGATGTGTCATGTATGTT 932 Table 3A Hs.9043 AK022215 10433563 cDNAFLJ12153 fis, clone 1 CCCCTTCAACTGAGGGTCATTTTACC MAMMA1000458/cds =AGAGTCAATAAAGGCCAACCCTTC UNKNOWN 933 Table 3A Hs.94576 AK022267 10433826cDNA FLJ12205 fis, clone 1 ATTCTGAGGGTGACTGAGGCTACAG MAMMA1000931/cds =CTGCTATCACATGCCGAACTTTCTT UNKNOWN 934 Table 3A Hs.318725 AK02228010433640 CGI-72 protein (LOC51105), 1 TGGTATCAGGAGTTGGGATTTCTCAGmRNA/cds = (69, 1400) CACTGCTAATGAAGATCCCCTCTT 935 Table 3A Hs.132221AK022463 10433867 hypothetical protein FLJ12401 1CGCAGAGAGGAGAAAAGGAGACAGC (FLJ12401), mRNA/cds =AAGACGCCAATAAAGAAACACAACT (3, 1526) 936 Table 3A Hs.105779 AK02248110433892 cDNA FLJ12419 fis, clone 1 CCCGCACGGGCAGCTGAAGGCCGCTMAMMA1003047, highly similar GTTTTCTAATATTTGTATTCTAATT to proteininhibitor of activated STAT protein PIASy mRNA/cds = UNKNOWN 937 Table3A Hs.8068 AK022497 10433916 hematopoietic PBX-interacting 1CCCCTGGGAGATGTAGCAAATTGAGT protein (HPIP), mRNA/GTGGGTTTTGGAGTCTGAGCCTCA cds = (80, 2275) 938 Table 3A Hs.179882AK022499 10433920 hypothetical protein FLJ12443 1GCAGAGGGAGGGTTGCCATGAAGGA (FLJ12443), mRNA/cds =ACTTGGGATTTTCAATGGAATAAAT (187, 900) 939 Table 3A Hs.287863 AK02253710433983 hypothetical protein FLJ12475 1 CCTTTCACGTCTGGACGAATTACCAA(FLJ12475), mRNA/cds = ATGCCATGAATTGCCACTGTGTGT (16, 1065) 940 Table 3AHs.332541 AK022546 10433997 Homo sapiens, Similar to RIKEN 1AGGAAGATGGCGCTGTTATCAGCGG cDNA 2700083B06 gene, cloneGGAAATGTACTATTTAAGATCAGCT MGC:4669 IMAGE:3531883, mRNA, complete cds/cds= (67, 1050) 941 Table 3A Hs.21938 AK022554 10434010 hypotheticalprotein FLJ12492 1 ATCCAAGTCTGAAACTCTGCGCTCTA (FLJ12492), mRNA/cds =GTACTGCTGTTAAGATACACAACT (172, 1848) 942 Table 3A Hs.7010 AK02256810434032 Homo sapiens, clone MGC:14452 1 TGGATAGCCATTTCTGCTCAACCACAIMAGE:4304209, mRNA, CATTCTCTAAGAAACAGCTTGAAA complete cds/cds = (88,1953) 943 Table 3A Hs.11556 AK022628 10434128 cDNA FLJ12568 fis, clone 1TGTTGTATGTGGATGGGGAAGTTTTG NT2RM4000852/cds = TTTCTCCTCTTAGCATTTGTTTCTUNKNOWN 944 Table 3A Hs.173885 AK022681 10434216 hypothetical proteinFLJ12619 1 TCTGAATGATCCTACTCCTTTGGAGT (FLJ12619), mRNA/cds =AAAACTAGTGCTTACCAGTTTCCA (391, 1080) 945 Table 3A Hs.288836 AK02273510434309 hypothetical protein FLJ12673 1 TCCTTTTGTAGCCACTTTGAGTCTGC(FLJ12673), mRNA/cds = AGTTGTCAGTAAGCCTTTTTAAAG (2, 1687) 946 Table 3AHs.9908 AK022758 10434350 cDNA FLJ12696 fis, clone 1GGGGGAAATTACCAGTAGAATGCCTT NT2RP1000513, highly similar toGGTCTGAATATTTGATAGAACCAA NifU-like protein (hNifU) mRNA/cds = UNKNOWN947 Table 3A Hs.77573 AK022790 10434395 uridine phosphorylase (UP), 1CTGGTACTTTACAGTTTTGCACCAAC mRNA/cds = (352, 1284)TCTGCCAAGCCACTGGATCTTACA 948 Table 3A Hs.27475 AK022611 10434426 cDNAFLJ12749 fis, clone 1 ATCCAGTCACTCATCAAGTGTAATCT NT2RP2001149/cds =GTCTCCTAAATATCTCTGGAACCT UNKNOWN 949 Table 3A Hs.58488 AK022834 10434461catenin (cadherin-associated 1 AGCTTTTGGGGTCAGATCTCTGGAAC protein),alpha-like 1 (CTNNAL1), ATCATGTGATGAAGCTGACATTTT mRNA/cds = (43, 2247)950 Table 3A Hs.108779 AK022874 10434520 cDNA FLJ12812 fis, clone 1AGCAGTTAGGCTTGACTTTGAGGAGA NT2RP2002498/cds = (3, 2360)GGCTGTGATGTTTATGATCCCTGA 951 Table 3A Hs.56847 AK022936 10434613 cDNAFLJ12874 fis, clone 1 GCTGTCCACAGAAAACGCCCTTAAGT NT2RP2003769/cds =AGCCCTACCTTACTCCTTAGAGCT UNKNOWN 952 Table 3A Hs.14347 AK022939 10434618cDNA FLJ12877 fis, clone 1 CATGGGTATTAATAGTCTTTGCTGCT NT2RP2003825/cds =(313, 738) GGTAATACTGAAAGAACCTGCTTT 953 Table 3A Hs.4859 AK02297410434675 cyclin L ania-6a (LOC57018), 1 AGGATTTGATTTCTTGAAACCCTCTAmRNA/cds = (54, 1634) GGTCTCTAGAACACTGAGGACAGT 954 Table 3A Hs.193313AK023013 10434731 Homo sapiens, NADH 1 GGACTCAGGAGCTAATACTGTCTACAdehydrogenase (ubiquinone) 1, GTGGAGCTTGGTGCAATTAGAAGC subcomplexunknown, 2 (14.5 kD, B14.5b), clone MGC:1432 IMAGE:2990088, mRNA,complete cds/cds = (150, 509) 955 Table 3A Hs.288141 AK023078 10434831hypothetical protein MGC3156 1 ACCAGGAGGACAGAGTTTGCTTTCAT (MGC3156),mRNA/cds = ATTTTCCCTGTAAGTAAGAGGGCT (156, 2501) 956 Table 3A Hs.17279AK023088 10434845 tyrosylprotein sulfotransferase 1 1CCATGAAGAAGCAAGACGAAAACACA (TPST1), mRNA/cds = (81, 1193)CAGGAGGGAAAATCCTGGGATTCT 957 Table 3A Hs.142442 AK023129 10434909 cDNAFLJ13067 fis, clone 1 TTGGAATTTGTGTTGCATGTAAGGCA NT2RP3001712, highlysimilar ATCTTTCCTGTTGTAAATCTTCCT to HP1-BP74 protein mRNA/ cds = UNKNOWN958 Table 3A Hs.180838 AK023143 10434930 hypothetical protein FLJ13081 1AGGAAACTGAGTAGACTCCTGTGTAA (FLJ13081), mRNA/cds =CCCTGTTTGGAACTTTGCCTTCTT (170, 2098) 959 Table 3A Hs.172035 AK02315410434948 cDNA FLJ13092 fis, clone 1 TTTACAAGGCAGAATGGGGTGTAACANT2RP3002147/cds = (34, 606) GTTGAATTAAACTAGCAATCACGT 960 Table 3AHs.7797 AK023166 10434966 TERF1 (TRF1)-interacting nuclear 1TAGTAGGAATGAAGTGGAAGTCCAG factor 2 (TINF2), mRNAGCTTGGATTGCCTAACTACACTGCT /cds = (262, 1326) 961 Table 3A Hs.72782AK023183 10434995 hypothetical protein FLJ11171 1AGTGTTTAGTCTCATGTTGGGAACAC (FLJ11171), mRNA/cds =ATGAATGTGATGAACATAGTGAAT (134, 2446) 962 Table 3A Hs.234265 AK02320410435025 cDNA FLJ13142 fis, clone 1 ACCCTTTGAGAGTTCCACAAGTGGTANT2RP3003212, moderately GTAGAGTGGTTTAACGTCTTTCCT similar to Rattusnorvegicus lamina associated polypeptide 1C (LAP1C) mRNA/cds = (55,1443) 963 Table 3A Hs.236494 AK023223 10435057 RAB10, member RASoncogene 1 TTGCCCCTTTTCTGTAAGTCTCTTGG family (RAB10), mRNA/GATCCTGTGTAGAAGCTGTTCTCA cds = (90, 692) 964 Table 3A Hs.288932 AK02325610435106 hypothetical protein FLJ13194 1 ACTCATCAATTGAAAAGTCCTCCAAA(FLJ13194), mRNA/cds = AAGAGAACTATTGGGAAACCATGG (300, 809) 965 Table 3AHs.126925 AK023275 10435137 hypothetical protein FLJ13213 1AGATGGGTGAATCAGTTGGGTTTTGT (FLJ13213), mRNA/cds =AAATACTTGTATGTGGGGAAGACA (233, 1669) 966 Table 3A Hs.75748 AK02329010435162 cDNA FLJ13228 fis, clone 1 TCAGACCTGGTTGATTTTGTACTTTGOVARC1000085, highly similar to GAACTGTACCTTGGATGGTTTTGT mRNA forproteasome subunit HC5/cds = UNKNOWN 967 Table 3A Hs.285017 AK02329110435163 hypothetical protein FLJ21799 1 GTATCTCATGGCCTCTTGATGTGGAA(FLJ21799), mRNA/cds = AGAAGTTGACAGAGGGTTGCAGGG (159, 923) 968 Table 3AHs.288929 AK023320 10435204 hypothetical protein FLJ13258 1AGTTCAGTGAGAAGAAACCAGA similar to fused toes (FLJ13258),ACACTTGTTCCTAGTGTTGTGTTG mRNA/cds = (163, 1041) TTTT 969 Table 3AHs.227400 AK023362 10435266 mitogen-activated protein kinase 1GCAGATGGCTATGTGCTAGAGGGCA kinase kinase kinase 3 (MAP4K3),AAGAGTTGGAGTTCTATCTTAGGAA mRNA/cds = (360, 3014) 970 Table 3A Hs.155180AK023379 10435291 Homo sapiens, Similar to splicing 1TTGGTGTCAATGATCTGGTGACAATA factor, arginine/serine-rich 2GGATTACATTGGAGCCAATTGAAT (SC-35), clone MGC:2622 IMAGE:3501687, mRNA,complete cds/cds = (30, 878) 971 Table 3A Hs.125034 AK023402 10435324mRNA for putative 1 AACTAGAAGATGTACTTCGACAGCAT N-acetyltransferase/cds =CCATTTTACTTCAAGGCAGCAAGA (208, 2808) 972 Table 3A Hs.285107 AK02345910435401 hypothetical protein FLJ13397 1 ATACACTTTTCCAAATTTGTCCCAACA(FLJ13397), mRNA/cds = GCCCTGTAAGCCAGCTTTCTTCT (221, 1558) 973 Table 3AHs.172028 AK023460 10435403 a disintegrin and metalloproteinase 1GCATTTTCTTCACTTGCAGGCAAACT domain 10 (ADAM10), mRNATGGCTCTCAATAAACTTTTACCAC /cds = (469, 2715) 974 Table 3A Hs.315054AK023470 10435414 hypothetical protein MGC15875 1ATTAGACCAGACCAGTGTATTTCTAA (MGC15875), mRNA/cds =AGAAAATCCTGACATGCACACCCA (651, 1178) 975 Table 3A Hs.164005 AK02349410435442 cDNA FLJ13432 fis, clone 1 AGCCAAATGTGTCATACATCAAATCTPLACE1002537/cds = TCAGCAGCTTTTGCATAATCCAGG UNKNOWN 976 Table 3AHs.129872 AK023512 10435467 sperm associated antigen 9 1TCCTCAAAGGGGAAAACTATGAAGGG (SPAG9), mRNA/cds = GAAGAAGACAAACCTAAGATACCA(110, 2410) 977 Table 3A Hs.63525 AK023529 10435489 cDNA FLJ13467 fis,clone 1 AGATGGACTGGAGCTTTTTCTTTGTG PLACE1003519, highly similarAATAGAAACTGGATGCCACAGTGA to hnRNP-E2 mRNA/cds = UNKNOWN 978 Table 3AHs.116278 AK023633 10435617 cDNA FLJ13571 fis, clone 1AGTTGTCAGAAGACTCCTGGGTGTAC PLACE1008405/cds = AGAGCAAATCAAGCTGCATCAGTAUNKNOWN 979 Table 3A Hs.43047 AK023647 10435832 cDNA FLJ13585 fis, clone1 AGTGGCTTCATAGCTACTGACAAATG PLACE1009150/cds = TCTGAACTATTGTCGTGCCCTTCAUNKNOWN 980 Table 3A Hs.163495 AK023670 10435662 cDNA FLJ13608 fis,clone 1 GCCTGTACAAACATTCAAGTTAGTTG PLACE1010628/cds =GCAGTCTATAAATGTGAGTTGGGT UNKNOWN 981 Table 3A Hs.17448 AK023680 10435678cDNA FLJ13618 fis, clone 1 AAGGAAGGTAAAGTTAGGGGACTAG PLACE1010925/cds =AAGACTCTAAATTGGCTTCTACAGA UNKNOWN 982 Table 3A Hs.178357 AK02371910435734 hypothetical protein FLJ13657 1 AGAACTAATTGCCCATGTTTAATTATA(FLJ13657), mRNA/cds = GCAGACACGCCATTCTAACAGGT (87, 1172) 983 Table 3AHs.30818 AK023743 10435768 cDNA FLJ13681 fis, clone 1AACTTGGTATTGTTGTAGTTTATGTAG PLACE2000014, weakly similar toTAAGTGACTTGGCACCCATCAGA HYPOTHETICAL HELICASE C28H8.3 IN CHROMOSOME III/cds = UNKNOWN 984 Table 3A Hs.157777 AK023779 10435815 cDNA FLJ13717fis, clone 1 AGTTTAACTTTTCCTCACCCCTGTATA PLACE2000425/cds =GAAAATGCCTTGCCTCTCAAGAG UNKNOWN 985 Table 3A Hs.7871 AK023813 10435861cDNA FLJ13751 fis, clone 1 GTCTTGGGCTGGATGGGTTATAGAG PLACE3000339,weakly similar to CTGAGCGGCTGTGATGGTTCTGTTT GLUCOAMYLASE S1/S2 PRECURSOR(EC 3.2.1.3)/ cds = (436, 2805) 986 Table 3A Hs.49391 AK023825 10435876cDNA FLJ13763 fis, clone 1 GACACATCTAGAATGTTTTTCTTTCAC PLACE4000089/cds= CGTACCTCCAAAAGAGGCAATTT (58, 547) 987 Table 3A Hs.119908 AK02397510436193 nucleolar protein NOP5/NOP58 1 ACCAGGGATGCTCTCTAACGTAATCA(NOP5/NOP58), mRNA/cds = AGGGAAGGTTCAGTAAGACAAAGT (0, 1589) 988 Table 3AHs.26039 AK023999 10436234 cDNA FLJ13937 fis, clone 1ACACAGTTCAGTTTTTGAGGGAACTA Y79AA1000805/cds = GTTTTGTCATAATACTACACCCCTUNKNOWN 989 Table 3A Hs.23170 AK024023 10436276 homolog of yeast SPB1(JM23), 1 TGCAGTGGGAATTCTTGAGTGAGGTC mRNA/cds = (300, 1289)TTACCTCTTCTTTAAACCTCTTCA 990 Table 3A Hs.24719 AK024029 10436287 cDNAFLJ13987 fis, clone 1 AAGGCAGAATAGAATGCTGAGATTGG Y79AA1001402, weaklysimilar to TTAAGTTTGCAATGACCATCTTGA paraneoplastic cancer-testis-brainantigen (MA4) mRNA/cds = (684, 1397) 991 Table 3A Hs.168232 AK02403010438289 hypothetical protein FLJ13855 1 TGCCCTAATCTTGAGTTGAGGAAATA(FLJ13855), mRNA/cds = TATGCACAGGAGTCAAAGAGATGT (314, 1054) 992 Table 3AHs.129872 AK024068 10436350 sperm associated antigen 9 1GCTAGATTGTGAAGTACATGGGATTT (SPAG9), mRNA/cds = CATGAGCCAGAGGAGGCATTTGGA(110, 2410) 993 Table 3A Hs.333300 AK024088 10438379 hypotheticalprotein FLJ14026 1 GCCTCAAAGAAAACCCAGAGTGCCCT (FLJ14026), mRNA/cds =GTTCTAAAACGTAGTTCTGAATCC (57, 1826) 994 Table 3A Hs.281434 AK02409010436383 cDNA FLJ14028 fis, clone 1 AATCCCAGGGCTTGGTTAAGTGCTGTHEMBA1003838/cds = GTGATAACTTGTTTGGATGAGACT UNKNOWN 995 Table 3AHs.287864 AK024092 10436385 cDNA FLJ14030 fis, clone 1AGGTTTCTTACCCAACACAAATGGAC HEMBA1004086/cds = AGTGGATTTGACTTTCTAAAGACTUNKNOWN 996 Table 3A Hs.288856 AK024094 10436388 prefoldin 5 (PFDN5),mRNA 1 CCTGGTGATGGGAAGGGTCTTGTGTT /cds = (423, 926)TTAATGCCAATAAATGTGCCAGCT 997 Table 3A Hs.206868 AK024118 10436421 cDNAFLJ14056 fis, clone 1 AAAATATTGAGCCAGGCCCTGGGGA HEMBB1000335/cds =AGTGGGAAGTGAGAGCCAGAGCGGC UNKNOWN 998 Table 3A Hs.118990 AK02411910436422 cDNA FLJ14057 fis, clone 1 AGCACACAAGGAATCCCAGAAAATGTHEMBB1000337/cds = TGGCTGAAGGAATAAATGGATGGA UNKNOWN 999 Table 3AHs.235498 AK024137 10436443 hypothetical protein FLJ14075 1CACTGCCTACCGCCATTCATGATTAA (FLJ14075), mRNA/cds =ACCATCCAGAAATACCATCCCTGT (111, 2027) 1000 Table 3A Hs.289037 AK02419710436518 cDNA FLJ14135 fis, clone 1 AAATGAGATGGCCTCTGCGGACACATMAMMA1002728/cds = GAAAGGGTACTTCAGCTTACCAAA UNKNOWN 1001 Table 3AHs.289088 AK024202 10436523 heat shock 90 kD protein 1, alpha 1TGGACTAGGAGAGACTTGATTTTGGT (HSPCA), mRNA/cds = (60, 2258)GCTAAAGTTCCCCAGTTCATATGT 1002 Table 3A Hs.14070 AK024228 10436554hypothetical protein FLJ14166 1 CTCACAGCCAGCACGACCCCCAGAA (FLJ14166),mRNA/cds = AGAGGCGTCCCACAATAAACACGTC (203, 568) 1003 Table 3A Hs.24115AK024240 10436567 cDNA FLJ14178 fis, clone 1 ACAGAACATTGAGATGTGCCTAGTTCNT2RP2003339/cds = CGTATTTACAGTTTGGTCTGGCTG UNKNOWN 1004 Table 3AHs.193063 AK024263 10436597 cDNA FLJ14201 fis, clone 1TGAATTTCAGATGGGTGATTTAAGTG NT2RP3002955/cds = AGTCACAAGTCACAAAACTTTGCTUNKNOWN 1005 Table 3A Hs.183506 AK024275 10436615 hypothetical proteinFLJ14213 1 TGTACTTAAGTGCTGATGACTGTTAG (FLJ14213), mRNA/cds =CCAGTTTACAACTTTTTACCATCG (119, 841) 1006 Table 3A Hs.109441 AK02429710436644 cDNA FLJ14235 fis, clone 1 TTCTGAACATTTTAGTCAAGCTACAACNT2RP4000167/cds = AGGTTTGGAAAACCTCTGTGGGG (82, 2172) 1007 Table 3AHs.9343 AK024327 10436684 cDNA FLJ14265 fis, clone 1TGTCAAGGGCATTAAAAGCCTCCTGA PLACE1002256/cds = AGCATAATCTTATCAAAGGGATACUNKNOWN 1008 Table 3A Hs.287631 AK024331 10436690 cDNA FLJ14269 fis,clone 1 TCAGTCCATCTCAAGACCTGTGCCTG PLACE1003864/cds =TCAGATTTCACAATTATGGAGATT UNKNOWN 1009 Table 3A Hs.287634 AK02437210436742 hypothetical protein FLJ14310 1 GGTAGGAGTGAAATCTCTCTCTCAAA(FLJ14310), mRNA/cds = CTCTAGGAAAGCCCGAGTCATACT (406, 768) 1010 Table 3AHs.246112 AK024391 10436767 cDNA FLJ14329 fis, clone 1ACAGCAGGTGTCATGGGTCAAGCATA PLACE4000259, highly similarAATCATATATAGCATTTTCAGGCA to gene for U5 snRNP-specific 200 kDprotein/cds = (188, 5623) 1011 Table 3A Hs.246112 AK024391 10436767 cDNAFLJ14329 fis, clone 1 ACAGCAGGTGTCATGGGTCAAGCATA PLACE4000259, highlysimilar AATCATATATAGCATTTTCAGGCA to gene for U5 snRNP-specific 200 kDprotein/cds = (188, 5623) 1012 Table 3A Hs.137354 AK024426 10440360 mRNAfor FLJ00015 protein, 1 TGTGGGTCCCTATGAGTGTAGAGCC partial cds/cds =(373, 1296) CATATCCCCATAGAGTCTACCTAGA 1013 Table 3A Hs.171118 AK02443610440380 DNA sequence from clone RP11- 1 TGTTTTCATTTCAGAACATTGTGCTGT165F24 on chromosome 9. CTGTCAGCATATGTATATCAGCT Contains the 3′ end ofthe gene for a novel protein (similar to Drosophila CG6630 and CG11376,KIAA1058, rat TRG), an RPL12 (60S ribosomal protein L12) pseudogene,ESTs, STSs, GSSs and a CpG island/cds = (0, 4617) 1014 Table 3A Hs.43816AK024439 14020950 mRNA for FLJ00029 protein, 1TGGCTACTGCAAAACCAGTTTTGACA partial cds/cds = (0, 723)GGTCAGATTTTCATATGTATAGGT 1015 Table 3A Hs.132569 AK024449 10440411 mRNAfor FLJ00041 protein, 1 AGAGGTTCTGAAAGGTCTGTGTCTTG partial cds/cds = (0,994) TCAAAACAAGTAAACGGTGGAACT 1016 Table 3A Hs.289034 AK024456 10440425mRNA for FLJ00048 protein, 1 ATGCGTCCTGGTTTTCAATCGCTGCT partial cds/cds= (2940, 3380) GAACAAACCTATCAAAAATGTAGC 1017 Table 3A Hs.273230 AK02447110440455 mRNA for FLJ00064 protein, 1 AGTATGATCCCTCAAAACCTCACTAA partialcds/cds = (0, 830) CTGGAAGGATGATTTTGTCTCAGT 1018 Table 3A Hs.41045AK024474 10440461 mRNA for FLJ00067 protein, 1 GAGGGTTCCTCACTGAGGTTGAGAGpartial cds/cds = (1209, 2933) GTGTGTTGGATAGGACTGATCCCAC 1019 Table 3AHs.7049 AK024478 10440469 mRNA for FLJ00071 protein, 1AAGTGTGGTTCCTGAAGGCTGTCTTT partial cds/cds = (3020, 3772)GTAACTTTTTGTAGTTCTTTGTGT 1020 Table 3A Hs.6289 AK024539 10436843hypothetical protein FLJ20886 1 AATCCTTTAACTCTGCGGATAGCATT (FLJ20886),mRNA/cds = (0, 524) TGGTAGGTAGTGATTAACTGTGAA 1021 Table 3A Hs.108854AK024569 10436879 cDNA: FLJ20916 fis, clone 1 CTGGAAAGGGGGCTAAGATCAGGGCADSE00738, highly similar to CTTCATTCTGGATCAGGCGAAATTT AF161512 HSPC163mRNA /cds = UNKNOWN 1022 Table 3A Hs.10382 AK024597 10436910 cDNA:FLJ20944 fis, clone 1 GTTCCTCTTCGGGAAGCTTTTGATAA ADSE01780/cds = UNKNOWNGGAATTCTCAGACCGATAGGGTGT 1023 Table 3A Hs.289089 AK024689 10437005hypothetical protein FLJ21016 1 AGTTTTGTACTTTTCACATAGCTTGTT (FLJ21016),mRNA/cds = GCCCCGTAAAAGGGTTAACAGCA (90, 1193) 1024 Table 3A Hs.10600AK024740 10437104 DNA sequence from clone RP11- 1TTGGATCTGGTTCTGAGGAGGACACA 353C18 on chromosome 20CCTGGCATCGGATGACCTTTATAA Contains ESTs, STSs, GSSs and CpG islands.Contains the NIFS gene for cysteine desulfurase, two genes for novelproteins and the gene for the splicing factor CC1.3 with a secondisoform (CC1.4)/cds = (68, 839) 1025 Table 3A Hs.12293 AK024756 10437124hypothetical protein FLJ21103 1 TAGACATGCTTGTGTCCACACAGCAC (FLJ21103),mRNA/cds = ACCAATGTGATACTTCCACTGACC (88, 1143) 1026 Table 3A Hs.23410AK024764 10437139 translocase of inner mitochondrial 1ATGGGATGCGGTGGGTTGCCCAATA membrane 13 (yeast) homolog BAACGGCTGTGGAGTGGAAATTCCTC (TIMM13B), mRNA/cds = (46, 333) 1027 Table 3AHs.180139 AK024823 10437226 SMT3 (suppressor of mif two 3, 1TTTGTACGTAGCTGTTACATGTAGGG yeast) homolog 2 (SMT3H2),CAATCTGTCTTTAAGTAGGGATAA mRNA/cds = (90, 377) 1028 Table 3A Hs.159557AK024833 10437239 karyopherin alpha 2 (RAG 1 GGAATTTCCTATCTTGCAGCATCCTGcohort 1, importin alpha 1) TAAATAAACATTCAAGTCCACCCT (KPNA2), mRNA/cds =(132, 1721) 1029 Table 3A Hs.325093 AK024863 10437271 cDNA: FLJ21210fis, clone 1 GAGATGAGTTTTGTTATTTTGGGGTT COL00479/cds = UNKNOWNTTCAAGCATTGGAACCAAAGGCCA 1030 Table 3A Hs.306720 AK024890 10437303 cDNA:FLJ21237 fis, clone 1 TCACTTAGACCCCTGTAACAGGTTAA COL01114/cds = UNKNOWNATCTTCATGGTGTTCTGTTTCCTA 1031 Table 3A Hs.135570 AK024921 10437337 cDNA:FLJ21268 fis, clone 1 GCTCTCCAGACTGTTACAGTGCATGA COL01718/cds = UNKNOWNGTGATAATAAAAATGAGTCAGTCA 1032 Table 3A Hs.6019 AK024941 10437362 cDNA:FLJ21288 fis, clone 1 GGAGGTAAACATTGGAGATGTTTGTG COL01927/cds = UNKNOWNAAAATATTACTCTTGCTGTGAGGT 1033 Table 3A Hs.1279 AK024951 10437374 cDNA:FLJ21298 fis, clone 1 GGCCCCTTTCTTTCTTCTGAGGATTG COL02040, highlysimilar to CAGAGGATATAGTTATCAATCTCT HSC1R mRNA for complement componentC1r/cds = UNKNOWN 1034 Table 3A Hs.29977 AK024961 10437386 hypotheticalprotein FLJ21308 1 TCAACAGCACTTAAACTGAAGTTTGG (FLJ21308), mRNA/cds =GTTGCTCATACAATAAACAGATTG (287, 1792) 1035 Table 3A Hs.166254 AK02496910437398 hypothetical protein 1 GGGCCATTTTATGATGCATTGCACAC DKFZp566I133(DKFZP566I133), CCTCTGGGGAAATTGATCTTTAAA mRNA/cds = (133, 1353) 1036Table 3A Hs.156110 AK024974 10437403 cDNA: FLJ21321 fis, clone 1TTTTCCACAGGGGACCTACCCCTATT COL02335, highly similar toGCGGTCCTCCAGCTCATCTTTCAC HSA010422 mRNA for immunoglobulin kappa lightchain/cds = UNKNOWN 1037 Table 3A Hs.323376 AK024978 10437405 coatedvesicle membrane protein 1 GGGTGAGAACACTTGCAACAGTTTAT (RNP24), mRNA/cds= (27, 632) TAATGAGGTGACTTTCACCTTAGG 1038 Table 3A Hs.21056 AK02501910437453 cDNA: FLJ21386 fis, clone 1 AATGTACCATCAATAAAATTGGCTGCCOL03012, highly similar to TTGGGCAGTTTTAGTTACCACCTT AB002445 mRNA fromchromosome 5q21-22 /cds = UNKNOWN 1039 Table 3A Hs.337266 AK02502110437455 RC-BT163-140599-023 cDNA 1 TTTTCAGAGGCTTCCTAATTAATCTTGCCCTCCTCCATTTCAGTCCATTT 1040 Table 3A Hs.120170 AK025068 10437507hypothetical protein FLJ21415 1 AGCTCCAACCTTACGATGGAGAATTA (FLJ21415),mRNA/cds = AACTTGCTTGTATTTCCACTTTGT (138, 755) 1041 Table 3A Hs.288872AK025092 10437538 mRNA for KIAA1840 protein, 1AGCTTCCTCTTCCTCAGGACAGCTTC partial cds/cds = (71, 4384)TACTTTAGATGATCCAATAATGAT 1042 Table 3A Hs.14555 AK025168 10437628 cDNA:FLJ21513 fis, clone 1 CACTGACTTCTATTCCATGAGCTTTTT COL05778/cds = UNKNOWNCAAGGCGCTTATTTTATGGCAGC 1043 Table 3A Hs.83623 AK025198 10437682 nuclearreceptor subfamily 1, 1 TGTTTCGTAAATTAAATAGGTCTGGC group I, member 3(NR1I3), CCAGAAGACCCACTCAATTGCCTT mRNA/cds = (272, 1318) 1044 Table 3AHs.322680 AK025200 10437664 cDNA: FLJ21547 fis, clone 1GGAAGACCCAAGGAAATCCGGAATTT COL06206/cds = UNKNOWNCGCACCAGAGGACCCACCACGTCC 1045 Table 3A Hs.10888 AK025212 10437679hypothetical protein FLJ21709 1 TCTTGTTACTTCCAAGGAGAACCAAG (FLJ21709),mRNA/cds = AATGGCTCTGTCACACTCGAAGCC (55, 2316) 1046 Table 3A Hs.288708AK025215 10437682 hypothetical protein FLJ21562 1TCTTTCTCTAAAGCTTGTTTGATGAAA (FLJ21562), mRNA/cds =CTGGTTGGTCCTTTCAGTGAACA (238, 2145) 1047 Table 3A Hs.337581 AK02526910437749 hypothetical protein FLJ21616 1 GCTGTGTGACTTAGTAGATAAAATAC(FLJ21616), mRNA/cds = TGCCTTCTGCCTTTGGGACCATGA (119, 1093) 1048 Table3A Hs.2083 AK025306 10437795 cDNA: FLJ21853 fis, clone 1TCTGTAATTGGACAGCTCTCTCGAAG COL08586, highly similar toAGATCTTACAGACTGTATCAGTCT HUMKINCDC protein kinase mRNA/cds = UNKNOWN1049 Table 3A Hs.76230 AK025353 10437852 cDNA: FLJ21700 fis, clone 1GGTCGTGGACGTGGTCAGCCACCTC COL09849, highly similar toAGTAAAATTGGAGAGGATTCTTTTG HSU14972 ribosomal protein S10 mRNA/cds =UNKNOWN 1050 Table 3A Hs.117268 AK025384 10437866 cDNA: FLJ21711 fis,clone 1 AAAGTGAAACCAAGAGTACAA COL10156/cds = UNKNOWNGAGACAGGTGAAATTAAAGAGCC CCTTGA 1051 Table 3A Hs.5181 AK025387 10437869proliferation-associated 2G4, 1 GTCCAGGATGCAGAGCTAAAGGCCC 38 kD (PA2G4),mRNA/cds = TCCTCCAGAGTTCTACAAGTCGAAA (97, 1281) 1052 Table 3A Hs.288061AK025375 10437878 actin, beta (ACTB), mRNA 1 CCAACTTGAGATGTATGAAGGCTTTT/cds = (73, 1200) GGTCTCCCTGGGAGTGGGTGGAGG 1053 Table 3A Hs.14040AK025425 10437933 cDNA: FLJ21772 fis, clone 1TTCCTCATCCCATTTACAGTTTTTCTA COLF7808/cds = UNKNOWNACTCCAGGGTAGTGTTTAGTGTT 1054 Table 3A Hs.85963 AK025446 10437961 cDNA:FLJ21793 fis, clone 1 CATGCCAAAGACTCAACTGCTTTCAA HEP00468/cds = UNKNOWNAGATAATGTGGGTGCTAGATGCAG 1055 Table 3A Hs.82689 AK025459 10437979 tumorrejection antigen (gp96) 1 1 TCCCCTTCTCCCCTGCACTGTAAAAT (TRA1), mRNA/cds= (105, 2516) GTGGGATTATGGGTCACAGGAAAA 1056 Table 3A Hs.289008 AK02546710437988 cDNA: FLJ21814 fis, clone 1 ACCATGCATAGAGTCAATCAAATCCTHEP01068/cds = UNKNOWN TGTGATGTTTTGTATGGACTTTGA 1057 Table 3A Hs.22678AK025485 10438014 chromosome 10 open reading 1TGTGCTGCCTCAAGACTGCTGGAGTC frame 2 (C10orf2), mRNA/cds =AGGACATTTTATAGAGCCTTTTCC (32, 1552) 1058 Table 3A Hs.184793 AK02553310438078 Homo sapiens, clone IMAGE: 1 GTGCAGTCTCTTAGCAGACTTCAGGC3865907, mRNA, partial cds/ CCAAACTGTATTCTTCACTCAGGC cds = (0, 1534)1059 Table 3A Hs.121849 AK025556 10438108 microtubule-associatedproteins 1 GTTAGTGAAAGCTGTTTACTGTAACG 1A/1B light chain 3GGGAAAACCAGATTCTTTGCATCT (MAP1A/1BLC3), mRNA/cds = (84, 461) 1060 Table3A Hs.110771 AK025557 10438108 cDNA: FLJ21904 fis, clone 1GCTTCTGTAAATGCCATCCCAATGTG HEP03585/cds = UNKNOWNGTTTGGTTTTGTTGAACAGAAACC 1061 Table 3A Hs.82845 AK025583 10438142 cDNA:FLJ21930 fis, clone 1 TTGCCTCGATAAGTTTCCAAGTCACT HEP04301, highlysimilar to GAAATCTGCTGAAGGTTTTACTGT HSU90918 clone 23815 mRNAsequence/cds = UNKNOWN 1062 Table 3A Hs.27268 AK025586 10438146 cDNA:FLJ21933 fis, clone 1 ACTTCTGAACTGAGGAATTTGCTGTT HEP04337/cds = UNKNOWNGACAGCCAAAGTATAGTGTACAAG 1063 Table 3A Hs.7567 AK025615 10438186 cDNA:FLJ21962 fis, clone 1 AGAGCCATCTGGTGTGAAGAACTCTA HEP05564/cds = UNKNOWNTATTTGTATGTTGAGAGGGCATGG 1064 Table 3A Hs.5985 AK025620 10438193 cDNA:FLJ21967 fis, clone 1 AGAACAAGTTTGCCTTGATTTTGTTTA HEP05652, highlysimilar to AAATGACTTCTGCTAAGCACCCA AF131831 clone 25188 mRNAsequence/cds = UNKNOWN 1065 Table 3A Hs.279901 AK025623 10438197 PTD009protein (PTD009), 1 CCTGCCAAAGCAAGAAGAAGGCTTG mRNA/cds = (257, 918)GTCCCCAGAAACAAACAGTAGTCAT 1066 Table 3A Hs.339696 AK025643 10438224ribosomal protein S12 (RPS12), 1 GGAGTCTCAGGCCAAGGATGTCATT mRNA/cds =(80, 478) GAAGAGTATTTCAAATGCAAGAAAT 1067 Table 3A Hs.339696 AK02564310438224 ribosomal protein S12 (RPS12), 1 GGAGTCTCAGGCCAAGGATGTCATTmRNA/cds = (80, 478) GAAGAGTATTTCAAATGCAAGAAAT 1068 Table 3A Hs.334489AK025645 10438227 hypothetical protein FLJ21992 1TTTCATCTGAATCCAGAGGTGCATCA (FLJ21992), mRNA/cds =AATTAAATGACAGCTCCACTTGGC (60, 845) 1069 Table 3A Hs.92414 AK02568310438280 cDNA: FLJ22030 fis, clone 1 TTGACACGTTCCACTTCCTTTGCAATTHEP08669/cds = UNKNOWN ATTGTATTTAGTTGTGCACTAGT 1070 Table 3A Hs.173705AK025703 10438305 cDNA: FLJ22050 fis, clone 1 CCAAATCAACTGTGTGAACTGTTTCTHEP09454/cds = UNKNOWN GCACTGCTTGCTAATGGTTTCATC 1071 Table 3A Hs.13277AK025707 10438310 hypothetical protein FLJ22054 1ATTGAGACGGGAAAAACTCGCTGTAA (FLJ22054), mRNA/cds =AATAATGCCAACCTAGATAATGCT (144, 956) 1072 Table 3A Hs.5798 AK02572910438338 pelota (Drosophila) homolog 1 TGTTCTTGCATTGCATTTAATGATCCC(PELO), mRNA/cds = (259, 1416) TTTTCTCCCCACCTCCACACACT 1073 Table 3AHs.184542 AK025730 10438339 CGI-127 protein (LOC51648), 1TGCAGATTCCTAGTAGCATGCCTTAC mRNA/cds = (125, 490)CTACAGCACTATGTGCATTTGCTG 1074 Table 3A Hs.75811 AK025732 10438341N-acylsphingosine amidohydrolase 1 GCAAGACCGTTTGTCCACTTCATTTT (acidceramidase) (ASAH), GTATAATCACAGTTGTGTTCCTGA mRNA/cds = (17, 1204) 1075Table 3A Hs.77910 AK025738 10438345 cDNA: FLJ22083 fis, clone 1AATTTAACTTTTGGGTGCCAGGAAAT HEP14459, highly similar toGGGTTTTCTCAAAGTCCATTGCCG HUM3H3M 3-hydroxy-3 methylglutaryl coenzyme Asynthase mRNA/cds = UNKNOWN 1076 Table 3A Hs.170298 AK025743 10438355cDNA: FLJ22090 fis, clone 1 TCGTGGAAGGGAGAGCCATCAGCAG HEP16084/cds =UNKNOWN AAAGAGACCCTGAGATCTTCGCCTG 1077 Table 3A NA AK025767 10438384FLJ22114 fis, clone HEP18441 1 AAACACACCAGGGAGACACCATAAAACAGACCAAGACTAACTTAA AAACA 1078 Table 3A Hs.34497 AK025769 10438386hypothetical protein FLJ22116 1 AACCACAATCAAACATATAAATAAGC (FLJ22116),mRNA/cds = CTGGAAAACCAACTACAACCAGCA (270, 3545) 1079 Table 3A Hs.5822AK025773 10438391 cDNA: FLJ22120 fis, clone 1 TTTCCTGATTATTTGATGCTAGCTGGHEP18874/cds = UNKNOWN AATTCAAGAAATGGCATTGACCTT 1080 Table 3A Hs.264190AK025774 10438392 cDNA: FLJ22121 fis, clone 1 TCACCCCAAGTAGCATGACTGATCTGHEP18876, highly similar to CAATTTAAAATTCCTGTGATCTGT AF191298 vacuolarsorting protein 35 (VPS35) mRNA/ cds = UNKNOWN 1081 Table 3A Hs.12245AK025775 10438393 cDNA: FLJ22122 fis, clone 1 TGAGAAGTGCGGAATAGGTTGCTTCTHEP19214/cds = UNKNOWN ACCACCTGTTCTTAATGTAACAGT 1082 Table 3A Hs.26367AK025778 10438396 PC3-96 protein (PC3-96), 1 TCGAATGAGTGGTCAGGTAGTCTTAAmRNA/cds = (119, 586) AGAGCCTCATGTTAAATAGACACA 1083 Table 3A Hs.285833AK025788 10438408 cDNA: FLJ22135 fis, clone 1 TGAAGTGCAAATAAAAGCACTGCTACHEP20858/cds = UNKNOWN TATAAGACATTCTGGAATGGTTGT 1084 Table 3A Hs.90421AK025800 10438421 cDNA: FLJ22147 fis, clone 1 GCAGTCCCCAGATCCAGAACATGGGHEP22163, highly similar to AAGTTAGGGAAAATGTGTGATTTTG AF113020 cloneFLB9138 mRNA sequence/cds = UNKNOWN 1085 Table 3A Hs.289721 AK02584610438485 cDNA: FLJ22193 fis, clone 1 AGGTATGACAGGAACTGTCTTCATGTHRC01108/cds = UNKNOWN CCTTACCCAAGCAAGTCATCCATG 1086 Table 3A Hs.286194AK025886 10438538 hypothetical protein FLJ22233 1AATTTTGAATTTCTCCTTGCCACGTTA (FLJ22233), mRNA/cds =ATAAAGCCAAAAGCAGCGGGTGC (35, 1204) 1087 Table 3A Hs.279921 AK02592710438592 HSPC035 protein (LOC51669), 1 TGACTCTGTGCTGGCAAAAATGCTTGmRNA/cds = (16, 1035) AAACCTCTATATTTCTTTCGTTCA 1088 Table 3A Hs.105684AK025947 10438619 hypothetical protein FLJ22294 1GCTCTCCCACAGAAACCTTTGTCCTT (FLJ22294), mRNA/cds =GCAACTTTATCCTTTGTCCCGATT (240, 602) 1089 Table 3A Hs.55024 AK02602410438731 hypothetical protein FLJ10307 1 TTGCCTTAGCCAGTGTACCTCCTACC(FLJ10307), mRNA/cds = TCAGTCTATGTGAGAGGAAGAGAA (28, 462) 1090 Table 3AHs.289092 AK026033 10438744 Homo sapiens, coactosin-like 1ACTGTATTGGGATTGTAAAGAACATC protein, clone MGC:19733TCTGCACTCAGACAGTTTACAGAA IMAGE:3604770, mRNA, complete cds/cds = (158,586) 1091 Table 3A Hs.288555 AK026078 10438812 cDNA: FLJ22425 fis, clone1 GTGTGTGTGCATGTGTGTGTTAGCAG HRC08686 AGGTATTTTACTCAGAAAATAGGT 1092Table 3A Hs.333500 AK026091 10438829 cDNA: FLJ22438 fis, clone 1GCCAGTCAAAAAGTAAAATGAA HRC09232, highly similar toGAGAGGCACGCCAACCACTCCAA AF093250 P38IP (P38IP) AATTT mRNA/cds = UNKNOWN1093 Table 3A Hs.238707 AK026110 10438854 hypothetical protein FLJ224571 CACTTTGTGGTCGAAAGGCTCAGCCT (FLJ22457), mRNA/cds =CTCTACATGAAGTCTGTGGACATG (56, 1462) 1094 Table 3A Hs.77385 AK02616410438926 cDNA: FLJ22511 fis, clone 1 AGGCTTTCTTGTCTCAGCAACTTTCCHRC11837, highly similar to CATCTTGTCTCTCTTGGATGATGT HUMMYLCB non-musclemyosin alkali light chain mRNA/cds = UNKNOWN 1095 Table 3A Hs.13179AK026239 10439028 cDNA: FLJ22586 fis, clone 1TTTTTCTTTTTGAAGCATGGAAAACAA HSI02774/cds = UNKNOWNATCTTTTATGCCACTCCAGCCAT 1096 Table 3A Hs.27774 AK026264 10439083602386841F1 cDNA, 5′ end 1 CCATGATATAAGGAAGGGCCGTGCC /clone =IMAGE:4515730/ TCATGGAAAAGCAACAGGTGGCCTC clone_end = 5′ 1097 Table 3AHs.297666 AK026270 10439073 cDNA: FLJ22617 fis, clone 1TAAAGGCGAGCACCGTCAGGAGCGC HSI05379, highly similar toAGAGATCGGCCCTACTAGATGCAGA HSEWS EWS mRNA/cds = UNKNOWN 1098 Table 3AHs.31137 AK026334 10439167 protein tyrosine phosphatase, 1TGAGCCTGACACCTGTGTTTCAGCAT receptor type, E (PTPRE),TTGGAGACATCCCCATGTTATTCT mRNA/cds = (51, 2153) 1099 Table 3A Hs.236744AK026359 10439200 cDNA: FLJ22706 fis, clone 1 CTGAGCCACATCCAAGCCTGGTTTGCHSI13163/cds = UNKNOWN TGCACTCTATTGCCAAAGACTGAC 1100 Table 3A Hs.288936AK026363 10439205 mitochondrial ribosomal protein L9 1ACTTGCCTCATTCTCATCATCCAAACT (MRPL9), mRNA/cds = (14, 817)GAACATTTGTATCCCAAGCAGAA 1101 Table 3A Hs.143631 AK028372 10439218 cDNA:FLJ22719 fis, clone 1 GTATGAAGAAGGAAGCCCAGCAGAG HSI14307/cds = UNKNOWNCAGGAGGCAGCAGCAACAATGAGAG 1102 Table 3A Hs.157240 AK026394 10439245hypothetical protein MGC4737 1 CTGTGTGTGTCCATGTCTGCAAGCAG (MGC4737),mRNA/cds = TTCTTCAATAAATGGCCTGCCTCC (2350, 2985) 1103 Table 3A Hs.112497AK026396 10439247 cDNA: FLJ22743 fis, clone 1 TCAAAGCAGAGCACAGAGTTATTTGGHUV00901/cds = UNKNOWN TGTTTGCTGAAGACAGCCTTTGTG 1104 Table 3A Hs.236449AK026410 10439266 hypothetical protein FLJ22757 1ACTTCCATCTCAGCTAATGCACCCAC (FLJ22757), mRNA/cds =CAGCTCAAACACACCAATAAAGCT (92, 2473) 1105 Table 3A Hs.89555 AK02643210439295 hemopoietic cell kinase (HCK), 1 TGCAATCCACAATCTGACATTCTCAGmRNA/cds = (168, 1685) GAAGCCCCCAAGTTGATATTTCTA 1106 Table 3A Hs.343522AK026443 10439309 ATPase, Ca++ transporting, 1CAGAAACCAATACTGCTGTGCACTGA plasma membrane 4 (ATP2B4),GAATAAAAACTCATGCCCCCTTGT mRNA/cds = (397, 4014) 1107 Table 3A Hs.32148AK026455 10439325 AD-015 protein (LOC558929), 1CACCAGTGAGGATTACTGATGTGGAC mRNA/cds = (30, 644) AGTTGATGGGGTTTGTTTCTGTAT1108 Table 3A Hs.75415 AK026463 10439333 cDNA: FLJ22810 fis, clone 1AAAGTAAGGCATGGTTGTGGTTAATC KAIA2933, highly similar toTGGTTTATTTTTGTTCCACAAGTT AB021288 mRNA for beta 2-microglobulin/cds =UNKNOWN 1109 Table 3A Hs.118183 AK026488 10439358 hypothetical proteinFLJ22833 1 TAAGGGGTAGACAAGATACCGAATAA (FLJ22833), mRNA/cds =TCTCCACAAGTTTATTTGTGGTCT (479, 883) 1110 Table 3A Hs.182979 AK02649110439364 cDNA: FLJ22838 fis, clone 1 ACATCAACAGTGGTGCTGTGGAATGCKAIA4494, highly similar to CCAGCCAGTTAAGCACAAAGGAAA HUML12A ribosomalprotein L12 mRNA/cds = UNKNOWN 1111 Table 3A Hs.2795 AK026515 10439391lactate dehydrogenase A (LDHA), 1 ACAAACAATGCAACCAACTATCCAAG mRNA/cds =(97, 1095) TGTTATACCAACTAAAACCCCCAA 1112 Table 3A Hs.334807 AK02652810439405 Homo sapiens, ribosomal protein 1 TTCACCTACAAAATTTCACCTGCAAAL30, clone MGC:2797, mRNA, CCTTAAACCTGCAAAATTTTCCTT complete cds/cds =(29, 376) 1113 Table 3A Hs.239307 AK026535 10439414 tyrosyl-tRNAsynthetase (YARS), 1 GGGTACTTCTCCATAAGGCATCTCAG mRNA/cds = (0, 1586)TCAAATCCCCATCACTGTCATAAA 1114 Table 3A Hs.251653 AK026594 10439481tubulin, beta, 2 (TUBB2), 1 CTTGCTGTTTTCCCTGTCCACATCCA mRNA/cds = (0,1337) TGCTGTACAGACACCACCATTGAA 1115 Table 3A Hs.277477 AK026595 10439482major histocompatibility complex, 1 AAGTCAATTCCTGGAATTTGAAAGAG class I,C (HLA-C), CAAATAAAGACCTGAGAACCTTCC mRNA/cds = (0, 1100) 1116 Table 3AHs.334729 AK026603 10439492 cDNA FLJ20161 fis, clone 1AAGCTACTGTGTGTGTGAATGAACAC COL09252, highly similar toTCTTGCTTTATTCCAGAATGCTGT L33930 CD24 signal transducer mRNA/cds =UNKNOWN 1117 Table 3A Hs.334842 AK026632 10439528 tubulin, alpha,ubiquitous 1 TGTCATGCTCCCAGAATTTCAGCTTC (K-ALPHA-1), mRNA/cds =AGCTTAACTGACAGATGTTAAAGC (67, 1422) 1118 Table 3A Hs.179668 AK02664210439539 uncharactorized hypothalamus 1 AGGTGGTACTCAAGCCATGCTGCCTCprotein HSMNP1 (HSMNP1), CTTACATCCTTTTTGGAACAGAGC mRNA/cds = (231, 1016)1119 Table 3A Hs.288036 AK026850 10439548 tRNA isopentenylpyrophosphate1 TGCATCGTAAAACCTTCAGAAGGAAA transferase (IPT), mRNAGGAGAATGTTTTGTGGACCACTTT /cds = (60, 1040) 1120 Table 3A Hs.301404AK026664 10439564 RNA binding motif protein 3 1TGTGGTTAGGAAGCAATTTCCCAATG (RBM3), mRNA/cds = (276, 749)TACCTATAAGAAATGTGCATCAAG 1121 Table 3A Hs.266940 AK026669 10439570 cDNA:FLJ23016 fis, clone 1 GCCTGCGTTGCCACTTGTCTTAACTC LNG00874/cds = UNKNOWNTGAATATTTCATTTCAAAGGTGCT 1122 Table 3A Hs.288468 IU00944 405046 cloneA9A2BRB6 (CAC)n/(GTG)n 1 AGCTAATATTGCTGCAATGGCTGGCA repeat-containingmRNA GGAAACAGGTGATCAAGAGTGTCA /cds = UNKNOWN 1123 Table 3A Hs.242868AK026704 10439618 cDNA: FLJ23051 fis, clone 1 TCGACCCCAGAGGTGAATGTATTGTTLNG02642/cds = UNKNOWN ATTATTGTTTTGTTGTTGTTGTGA 1124 Table 3A Hs.334861AK026712 10439629 hypothetical protein FLJ23059 1TCCTTGGCAGCTGTATTCTGGAGTCT (FLJ23059), mRNA/cds =GGATGTTGCTCTCTAAAGACCTTT (41, 1881) 1125 Table 3A Hs.12969 AK02674710439670 cDNA: FLJ23094 fis, clone 1 TTTGCCATGTCCAGTACAGAATAATTTLNG07379, highly similar to GTACTTAGTATTTGCAGCAGGGT HST000007 mRNA fulllength insert cDNA clone EUROIMAGE 293605/cds = UNKNOWN 1126 Table 3AHs.90077 AK026766 10439693 TGFB-induced factor (TALE 1TAGAGAACCTATAGCATCTTCTCATT family homeobox) (TGIF),CCCATGTGGAACAGGATGCCCACA mRNA/cds = (311, 1129) 1127 Table 3A Hs.287725AK026769 10439697 cDNA: FLJ23116 fis, clone 1 AACTCATGTGCAGGTTTGATAAACACLNG07945, highly similar to CAGAACAGAAGACAGTGATGCTGT HSU79240serine/threonine kinase mRNA/cds = UNKNOWN 1128 Table 3A Hs.124292AK026776 10439707 cDNA: FLJ23123 fis, clone 1 TGGCCCTGACAGTATTCATTATTTCALNG08039/cds = UNKNOWN GATAATTCCCTGTGATAGGACAAC 1129 Table 3A Hs.20242AK026819 10439764 hypothetical protein FLJ12788 1ACCTGGAGAGAGAAGGTATTGAAACA (FLJ12788), mRNA/cds = (9, 866)TCTCCTTTATGTGTGACTTTCCCA 1130 Table 3A Hs.287995 AK026834 10439781 cDNA:FLJ23181 fis, clone 1 AGAAATACCCACTAACAAAGAACAAG LNG11094/cds = UNKNOWNCATTAGTTTTGGCTGTCATCAACT 1131 Table 3A Hs.324060 AK026836 10439784hypothetical protein FLJ23183 1 ATGGGCAAATTCTTAGGTAAGACAAA (FLJ23183),mRNA/cds = AACACAGCCCCAAGGGCAGGTAGT (226, 732) 1132 Table 3A Hs.6906AK028850 10439805 cDNA: FLJ23197 fis, clone 1 GCTGATGCCACTACCCGATTTGTTTAREC00917/cds = UNKNOWN TTTGCAATTTGAGCCATTTAAAGA 1133 Table 3A Hs.288455AK026923 10439895 cDNA: FLJ23270 fis, clone 1 CCTGTTCCCTTCAGCCAACCCGTTTCCOL10309, highly similar to TGCAGTAAAATTAAGCCTGTCAAA HSU33271 normalkeratinocyte mRNA/cds = UNKNOWN 1134 Table 3A Hs.286238 AK02693310439907 mRNA for KIAA1856 protein, 1 TGGCTTAAACCAGTGTTCAGTCTGGT partialcds/cds = (0, 3404) GCCAAACTTCGAATGGAATACAAA 1135 Table 3A Hs.91065AK026954 10439935 cDNA: FLJ23301 fis, clone 1 TGTGAGTTGTGACCATGTAACATGAGHEP11120/cds = (2, 1888) AGGTTTTGCTAGGGCCTATTATTT 1136 Table 3A Hs.88044AK026960 10439945 cDNA: FLJ23307 fis, clone 1 AGCTGAGTAATTCTAATCTCTTCTGTHEP11549, highly similar to GTTTTCCTTGCCTTAACCACAAAT AF041037 novelantagonist of FGF signaling (sprouty-1) mRNA/cds = UNKNOWN 1137 Table 3AHs.298442 AK026983 10439978 adaptor-related protein complex 3, 1AATTTGCTAGAATCCAGTAAATCATTT mu 1 subunit (AP3M1),TGGTAGCTCTGGCTGTGCTATCA mRNA/cds = (69, 1325) 1138 Table 3A Hs.301732AK027018 10440025 hypothetical protein MGC5306 1TGGCTCGAAGTTTCTCTAGTGTTTTC (MGC5306), mRNA/cds =TGTGGAAGGAATAAAAATTTGAGT (206, 1042) 1139 Table 3A Hs.3382 AK02706410440089 protein phosphatase 4, regulatory 1 ACTCTTGGGAGTGCTGCAGTCTTTAAsubunit 1 (PPP4R1), mRNA TCATGCTGTTTAAACTGTTGTGGC /cds = (93, 2894) 1140Table 3A Hs.85567 AK027067 10440093 suppressor of variegation 3-9 1TTTACATGATTGGACCCTCAGATTCT (Drosophila) homolog 2:GTTAACCAAAATTGCAGAATGGGG hypothetic (SUV39H2), mRNA/cds = (37, 1089)1141 Table 3A Hs.48320 AK027070 10440098 mRNA for ring-IBR-ring domain 1TGAAATCAAAGCACGGTGCAGAACTT containing protein Dorfin,GTACCAAGTACAAAAGGTCCATGT complete cds/cds = (317, 2833) 1142 Table 3AHs.115659 AK027114 10440156 hypothetical protein MGC5521 1CCTTACTCTGTCCTTGATGGAGGGGA (MGC5521), mRNA/cds =GAAGGGAGGGCAAAGAAGTTAAAT (163, 708) 1143 Table 3A Hs.113205 AK02713610440188 cDNA: FLJ23483 fis, clone 1 CACCGCCATGCAACTCCATGCCTATTKAIA04052/cds = UNKNOWN TACTGGAAACCTGTTATGCCAAAC 1144 Table 3A Hs.289071AK027187 10440255 cDNA: FLJ22245 fis, clone 1 CAAGAGAATGAAGGAGGCTAAGGAGHRC02612/cds = UNKNOWN AAGCGCCAGGAACAAATTGCGAAGA 1145 Table 3A Hs.240443AK027191 10440260 cDNA: FLJ23538 fis, clone 1 AGTCTCGGGTATGCTGTTGTGAAATTLNG08010, highly similar to GAAACTGTAAAAGTAGATGGTTGA BETA2 MEN1 regionclone epsilon/beta mRNA/cds = UNKNOWN 1146 Table 3A Hs.323502 AK02719210440261 nuclear RNA export factor 1 1 ACTAAACTACCCGAAGGACTTAGGTG(NXF1), mRNA/cds = (0, 1679) CTTTGTGTACTTAACCCCAGGACC 1147 Table 3AHs.159483 AK027194 10440263 chromosome 1 open reading 1GCCACCACTGTCTGTTTGAGACTCCT frame 7 (C1orf7), TCATGAGCAAAGATTGATGTATGGmRNA/cds = (46, 1590) 1148 Table 3A Hs.334853 AK027197 10440266hypothetical protein FLJ23544 1 ATGAATTTGAAGACATGGTGGCTGAA (FLJ23544),mRNA/cds = AAGCGGCTCATCCCAGATGGTTGT (125, 517) 1149 Table 3A Hs.91448AK027210 10440285 MKP-1 like protein tyrosine 1AGCTTCAGTCTCTACTGGATTAGCCC phosphatase (MKP-L), TACTCTTTCCTTTCCCCTCCATTAmRNA/cds = (233, 829) 1150 Table 3A Hs.169854 AK027212 10440288hypothetical protein SP192 1 AGATGTGGTTATCACAAGTCTCGAGG (SP192),mRNA/cds = (179, 1603) GGGAAACTACTGCATAAAATAACT 1151 Table 3A Hs.57209AK027232 10440314 hypothetical protein 1 TCAGTAAAAATGCCTGTTGTGAGATGDKFZp566J091 (DKFZP566J091), AACCTCCTGTAACTTCTATCTGTT mRNA/cds = (212,529) 1152 Table 3A Hs.54890 AK027243 10440328 cDNA FLJ14739 fis, clone 1AGTTAACTGCGGAGCCAAGAGTTGG NT2RP3002402/cds = ACTATAATTAAATTACCTTCCTTGT(156, 2048) 1153 Table 3A Hs.279040 AK027258 10440392 HT001 protein(HT001), 1 CCGGTTTGGGTTGTTAATGGTTGAAA mRNA/cds = (241, 1203)ACTTAGAGGAACATAGTGAGGCCT 1154 Table 3A Hs.279040 AK027258 10440392 HT001protein (HT001), 1 CCGGTTTGGGTTGTTAATGGTTGAAA mRNA/cds = (241, 1203)ACTTAGAGGAACATAGTGAGGCCT 1155 Table 3A Hs.152925 AK027260 10440394 mRNAfor KIAA1268 protein, 1 CCAGTGATTTGATTAACTCAGGGCAA partial cds/cds = (0,3071) GGCTGAATATCAGAGTGTATCGCA 1156 Table 3A Hs.183454 AK027789 14042727cDNA FLJ14883 fis, clone 1 TTTTGACCCAGATGATGGTTCCTTTA PLACE1003596,moderately CAGAACAATAAAATGGCTGAACAT similar to OLIGOSACCHARYLTRANSFERASE STT3 SUBUNIT/cds = (2, 882) 1157 Table 3A Hs.122487 AL0403715409324 602365288F1 cDNA, 5′ end 1 ACTGGACATCGCCCTACGCAACCTCC /clone =IMAGE:4473836/ TCGCCATGACTGATAAGTTCCTTT clone_end = 5′ 1158 Table 3AHs.79709 AL042370 5421708 phosphotidylinositol transfer 1ACTGCTGGTAGCATTTATCTGACTTG protein (PITPN), mRNA/cds =GAAAGTTGGAGAAGAGGCATTCCT (216, 1028) 1159 Table 3A Hs.252721 AL0423765421714 602022214F1 cDNA, 5′ end 1 CTTCCGAAGAGAAGAGGCTGGGGCT /clone =IMAGE:4157715/ GTAACTGGAAAGGGGAAGCGCACAG clone_end = 5′ 1160 Table 3AHs.182278 AL048016 5434110 Homo sapiens, calmodulin 2 1CCTGACCTTGAGCTCTAGTCTCCCCT (phosphorylase kinase, delta),TTAAATCTTACCTTGGCAGTAACA clone MGC:1447 IMAGE: 3504793, mRNA, completecds/cds = (93, 542) 1161 Table 3A NA AL047171 5936355 (synonym: hute1)cDNA clone 1 TTGGTCCCACAGTTTTTATGTGTCCT DKFZp588F2018 5′ACTTGAAATTATGTTTGCTCCCGT 1162 Table 3A Hs.168757 AL049282 4500041 Homosapiens, clone MGC:5584, 1 TGGAGGATTTTTGTTAAGTCAAGTGT mRNA, completecds/cds = CAATCGAAGTTAAAAAGCAAGGGT (227, 304) 1163 Table 3A Hs.104918AL049305 4500074 hypothetical protein FLJ21940 1ATGGCTCTTTTCCTATTAGAGCAACTT (FLJ21940), mRNA/cds =GTGTTTCCCTGATAATGTGTACA (92, 2107) 1164 Table 3A Hs.99821 AL0493194500092 hypothetical protein FLJ14547 1 GTCGTGACTGACTTGGTGTGTTGCTA(FLJ14547), mRNA/cds = TTGTGTTTCTATATACTCCGTCCA (25, 711) 1165 Table 3AHs.77311 AL049332 4500108 mRNA; cDNA DKFZp564L176 1TTTAGTCCAGTGGTTTCCACAGCTGG (from clone DKFZp564L176)CTAAGCCAGGAGTCACTTGGAGGC /cds = UNKNOWN 1166 Table 3A Hs.86405 AL0493404500124 mRNA; cDNA DKFZp564P056 1 TGGAAGACAGTAAAGAACAGCCCTCT (from cloneDKFZp564P056) GTAGTCAGTAAAGTTTCACCTTCT /cds = UNKNOWN 1167 Table 3AHs.42915 AL049358 4500146 ARP2 (actin-related protein 2, 1TGGGTGGAGTATTATGTTTAACTGGA yeast) homolog (ACTR2),GTTGTCAAGTATGAGTCCCTCAGG mRNA/cds = (74, 1258) 1168 Table 3A Hs.184938AL049782 4902604 Novel gene mapping to 1 AAAGTAGTAAATCGGGCTGTCTTAATchomosome 13/cds = UNKNOWN AGTGCGCCTGTTACTAATGGAATT 1169 Table 3AHs.326248 AK025724 10438333 cDNA: FLJ22071 fis, clone 1ATGTCAAGCTTTGGGTCTCTGGAGTA HEP11691/cds = UNKNOWNTAACTTTTTGTAACATTAGCCATT 1170 Table 3A Hs.139240 AL049942 4884185 mRNA;cDNA DKFZp564F1422 1 ATCTAGGACACCTCCATCAAACCTCC (from cloneDKFZp564F1422)/ TCTTGCACTTTCCCTCTGGCTTCC cds = (0, 1491) 1171 Table 3AHs.22370 AL049951 4884198 mRNA; cDNA DKFZp564O0122 1TGTGATGGGAACAGTGTCTTAGGGA (from clone DKFZp564O0122)/GATGCAGCTTGGACTTGAGGTAAAT cds = UNKNOWN 1172 Table 3A Hs.150580 AL0500054884260 mRNA; cDNA DKFZp564A153 1 AGAATGGGAGGCCAACCTTCTATCAG (from cloneDKFZp564A153)/ AGTTAAACTTTTGACAAGGGAACA cds = UNKNOWN 1173 Table 3AHs.14846 AL050021 4884264 mRNA; cDNA DKFZp564D016 1AAAAATGTGAAACTGCCCTGCCTCCC (from clone DKFZp564D016)/CTTTTTGCTGACAACACTGTGTAC cds = UNKNOWN 1174 Table 3A Hs.133130 AL0500354884276 mRNA; cDNA DKFZp566H0124 1 GGCCCCATTACAAAACTCCTTAGGAA (fromclone DKFZp566H0124)/ CCTCGCCCTCTCTCTGCTGTAAGG cds = UNKNOWN 1175 Table3A Hs.27371 AL050061 4884292 mRNA; cDNA DKFZp566J123 1GCTGCTGTCTAGATTTATGTGTGCTC (from clone DKFZp566J123)/TGACAAGAAATGTTTTGTGTAACA cds = UNKNOWN 1176 Table 3A Hs.227429 AL0501314884338 mRNA; cDNA DKFZp586I111 1 CCAGGCTGCGGTGAGAATGCCAAGA (from cloneDKFZp586I111); AGGCACTACCTCCCACCCACATCAC partial cds/cds = (0, 617) 1177Table 3A Hs.323463 AL050141 4884352 mRNA for KIAA1693 protein, 1CCAGTTGTCTTGAACAGCCTGACTCC partial cds/cds = (0, 2707)TGCCAGCCCTATGGAAGTTCCTTT 1178 Table 3A Hs.323463 AL050141 4884352 mRNAfor KIAA1693 protein, 1 CCAGTTGTCTTGAACAGCCTGACTCC partial cds/cds = (0,2707) TGCCAGCCCTATGGAAGTTCCTTT 1179 Table 3A Hs.26295 AL050166 4884381mRNA; cDNA DKFZp586D1122 1 TCTTTAAGAAGACCACCACATAGAAT (from cloneDKFZp586D1122)/ ACCCCTTCCTATCAGCTCGCTCTG cds = UNKNOWN 1180 Table 3AHs.80285 AL050192 4884408 mRNA; cDNA DKFZp586C1723 1TTTGACTTTCAGGATGTCATACTACTT (from clone DKFZp586C1723)/CTGTACCTAGCATTTTCAGTCCT cds = UNKNOWN 1181 Table 3A Hs.26613 AL0502054884444 mRNA; cDNA DKFZp586F1323 1 TGCTTAGATTTGTTCCTGTTGTCAAAA (fromclone DKFZp586F1323)/ CTGTTACCCCCAAAATTGGTGTG cds = UNKNOWN 1182 Table3A Hs.15020 AL050218 4884459 DNA sequence from clone 51J12 1AACAAGGTACATGCATTATGTGTCAC on chromosome 6q26-27.ATTACTGGGCAAACTGTTCAAGTA Contains the 3′ part of the alternativelyspliced gene for the orthologs of mouse QKI-7 and QKI-7B (KH Domain RNABinding proteins) and zebrafish ZKQ-1 (Quaking protein homolog).Contains ESTs, STSs and GSSs/cds = (0, 692) 1183 Table 3A Hs.3842AL050268 4886442 RAB1, member RAS oncogene 1 AGCACAAGCAGTGTCTGTCACTTTCCfamily (RAB1), mRNA/cds = ATGCATAAAGTTTAGTGAGATGTT (50, 667) 1184 Table3A Hs.12305 AL050272 4886498 DKFZP566B183 protein 1AGTGACTAAATACTGGGAACCTATTT (DKFZP566B183), mRNA TCTCAATCTTCCTCCATGTTGTGT/cds = (351, 749) 1185 Table 3A Hs.274170 AL050353 4914574 mRNA; cDNADKFZp564C0482 1 CTTCAGGACTGTATGAGCCGAGCAGT (from clone DKFZp564C0482)TACAAGACACAAAGAAGTTAAAAA /cds = UNKNOWN 1186 Table 3A Hs.8128 AL0503714914606 phosphatidylserine decarboxylase 1 AGGGCCAGATTTCATGTTGACCCTGG(PISD), mRNA/cds = (223, 1350) GGATGCTGTGAATTTCTCCTGCAG 1187 Table 3AHs.322645 AL050376 4914609 mRNA; cDNA DKFZp586J101 1AAATGCAGGTTTATTATCCAGCACTG (from clone DKFZp586J101)AGAGAGTTAACAAGGACTGGAAAA /cds = UNKNOWN 1188 Table 3A Hs.322645 AL0503764914609 mRNA; cDNA DKFZp586J101 1 AAATGCAGGTTTATTATCCAGCACTG (from cloneDKFZp586J101) AGAGAGTTAACAAGGACTGGAAAA /cds = UNKNOWN 1189 Table 3AHs.321247 AL050391 4914591 mRNA; cDNA DKFZp586A181 1CCCTCCTTAATCAACTTCAAGGAGCA (from clone DKFZp586A181);CCTTCATTAGTACAGCTTGCATAT partial cds/cds = (0, 314) 1190 Table 3AHs.12813 AL080156 5282614 mRNA; cDNA DKFZp434J214 1AAACCAGTGACTCCTAATCTTTTTCAA (from clone DKFZp434J214);GTTAAGACACCTTACCATTGCTT partial cds/cds = (0, 1081) 1191 Table 3AHs.52792 AL080213 5262703 mRNA; cDNA DKFZp586I1823 1AAGGGAACACAAAACTGTGGTCCTGA (from clone DKFZp586I1823)CAATACTAATTCTACCCGTTTTCA /cds = UNKNOWN 1192 Table 3A Hs.111801 AL0967235419856 mRNA; cDNA DKFZp564H2023 1 TTTTTGTACGATCAGCCTTACTGCTAA (fromclone DKFZp564H2023) TAAAAGCACTTCCACAGGGAAAA /cds = UNKNOWN 1193 Table3A Hs.306327 AL098752 5419888 mRNA; cDNA DKFZp434A012 1AAATTCTACAAAGGAGAGGTTGGGCG (from clone DKFZp434A012)TTACAAAGGCATTGTGAATCTAAT /cds = UNKNOWN 1194 Table 3A Hs.308327 AL0967525419888 mRNA; cDNA DKFZp434A012 1 AAATTCTACAAAGGAGAGGTTGGGCG (from cloneDKFZp434A012) TTACAAAGGCATTGTGAATCTAAT /cds = UNKNOWN 1195 Table 3AHs.172803 AL109669 5689801 mRNA full length insert cDNA 1TTCACCGAGGACATGAAACTCCACCT clone EUROIMAGE 31839/TGCGGGGATAAAGAGAGAAAAACA cds = UNKNOWN 1196 Table 3A Hs.119155 AL1097885725475 mRNA full length insert cDNA 1 TGTGCTCTTCAGTAGAGGATTTTCTG cloneEUROIMAGE 814975/ TGATCCTACAATGAAGGGAAAGCT cds = UNKNOWN 1197 Table 3AHs.75875 AL110132 5817027 ubiquitin-conjugating enzyme E2 1TTTGTGTAAAACCACCTTTTGAAGCA variant 1 (UBE2V1), transcriptGCAACTATCAAGTCTGAAAAGCAA variant 2, mRNA/cds = (69, 734) 1198 Table 3AHs.128797 AL110151 5817052 mRNA; cDNA DKFZp586D0824 1AGTGGGTGAATCACAGTAATTTCCCT (from clone DKFZp586D0824);GTAAAATGTGGTACCTGAAGTCAT partial cds/cds = (0, 1080) 1199 Table 3AHs.193700 AL110164 5817089 cDNA: FLJ22008 fis, clone 1TAGGCTCATAGCCTTGTATTTCGTTTT HEP06934/cds = UNKNOWNAGATTGTAAGCTCAATGGCAGGG 1200 Table 3A Hs.73851 AL110183 5817095 ATPsynthase, H+ transporting, 1 GCTCAAGCAAATGTTTGGTAATGCAG mitochondrial F0complex, ACATGAATACATTTCCCACCTTCA subunit F6 (ATP5J), mRNA/cds = (1,327) 1201 Table 3A Hs.172089 AL110202 5817121 mRNA; cDNA DKFZp586I2022 1AAGTCATCATTTGCCTTGAAAGTTTC (from clone DKFZp586I2022)/CTCTGCATTGGGTTTGAAGTAGTT cds = UNKNOWN 1202 Table 3A Hs.193784 AL1102045817123 mRNA; cDNA DKFZp586K1922 1 GAGCAGGGGTGGGAGTGGCTGTAAC (from cloneDKFZp586K1922)/ TTCACAATCCTAATACAGTAAATGT cds = UNKNOWN 1203 Table 3AHs.321022 AL110236 5817178 mRNA; cDNA DKFZp566P1124 1TTCTTAAGGAGTCTTAACTCGGTACT (from clone DKFZp566P1124)/TGGGTTAACGCCAGAAATTACTTT cds = UNKNOWN 1204 Table 3A Hs.187991 AL1102695817043 DKFZP564A122 protein 1 TTGGTGAGTTGCCAAAGAAGCAATAC(DKFZP564A122), mRNA AGCATATCTGCTTTTGCCTTCTGT /cds = (2570, 2908) 1205Table 3A Hs.109727 AL117407 5911992 mRNA; cDNA DKFZp434D2050 1AGGCCTTGTTTTTCAGCTTCATCTGC (from clone DKFZp434D2050);AGTTCTATGTGAAGATTGATAAAT partial cds/cds = (110, 1720) 1206 Table 3AHs.26797 AL117448 5911896 mRNA; cDNA DKFZp586B1417 1TGCAACTTAGAAACCAGCTACAGTAT (from clone DKFZp586B1417);GGCCCACTTAATAAAACACCTGAA partial cds/cds = (0, 3878) 1207 Table 3AHs.7200 AL117502 5912009 hypothetical protein MGC16714 1AGTTTATTGTTAGCCAGGTTGCTTGA (MGC16714), mRNA/cds =AAGGTTGAGAGTGGAGTGGTTTGG (394, 990) 1208 Table 3A Hs.22583 AL1175135912025 mRNA; cDNA DKFZp434K2235 1 GCATAACTGCTCTAGCTTCTTGTTTA (fromclone DKFZp434K2235); CCATAGTACTGTGGCTTCAGATTT partial cds/cds = (0,1086) 1209 Table 3A Hs.303154 AL117536 5912065 popaye protein 3 (POP3),1 TGTATCTTTTCCTGTTAAACACACAGA mRNA/cds = (147, 1022)CCCCTCCCCAATCTGGACATTGA 1210 Table 3A Hs.6607 AL117565 5912115 URAX1mRNA, complete cds 1 GCCTTGCCAGCCTGTGTGCTTGTGG /cds = (191, 1960)GAACACCTTGTACCTGAGCTTACAG 1211 Table 3A Hs.154320 AL117568 5912116ubiquitin-activating enzyme E1C 1 GCATGAATGGGCAATATTTTCATCTG (homologousto yeast UBA3) TTTACTTGTAGTGCCATAGAGGCC (UBE1C), mRNA/cds = (0, 1328)1212 Table 3A Hs.4055 AL117595 5912159 mRNA; cDNA DKFZp564C2063 1GGCCTTCTATGTGCTTAGCCATAACA (from clone DKFZp564C2063)ATTCCATTAAGCAAGAAGGTAAGC /cds = UNKNOWN 1213 Table 3A Hs.180777 AL1176215912202 mRNA; cDNA DKFZp564M0264 1 AATTGAACAATAACCATTGGTGACTG (fromclone DKFZp564M0264) GAGCAGGTAATTATAGCCTGCAGA /cds = UNKNOWN 1214 Table3A Hs.87794 AL117637 5912225 mRNA; cDNA DKFZp434I225 1AGGGGTCCCAAGAGCCTGTCCTCTTT (from clone DKFZp434I225);TGTTCAAAATACATCTTGAAACGT partial cds/cds = (0, 1281) 1215 Table 3AHs.79709 AL117644 5912234 phosphotidylinositol transfer 1CCTGCTGGGACTCCCTGACTTACTTT protein (PITPN), mRNA/cds =GGTTGGTTCCTAGTGCTACTTGTT (216, 1028) 1216 Table 3A NA AL120453 5928352(synonym: hamy2) cDNA clone 1 GGAAAGCTCGTCAGTTTAGTAGGCTC DKFZp761I208 5′CGAAATAGAATAGCAGTTGTCACT 1217 Table 3A Hs.6986 AL121406 5927407 glucosetransporter pseudogene 1 AGAAGGTAACTTTATAGAAGTAACAC /cds = UNKNOWNCAATATCCTAGTCTGCTTGCCCCG 1218 Table 3A Hs.274481 AL121735 6012990cellular growth-regulating protein 1 GCTGCTCCCTGGTTCCACTCTGGAGA(LOC51038), mRNA/cds = GTAATCTGGGACATCTTAGTGTTT (612, 785) 1219 Table 3AHs.272307 AL133015 6453493 mRNA; cDNA DKFZp434O2417 1CTCTCCTCTTCCCACCTCTGTATCCC (from clone DKFZp434O2417);ACACAGGCATCTGGTGATGTTCTC partial cds/cds = (0, 724) 1220 Table 3AHs.75497 AL133074 6453517 p53DINP1 mRNA for p53DINP1b, 1ACACCTGTTCTTTGTAATTGGGTTGT complete cds/cds = (39, 533)GGTGCATTTTGCACTACCTGGAGT 1221 Table 3A Hs.76853 AL133098 6453550 mRNA;cDNA DKFZp434N1728 1 AGCCTAGGTGAAAATCTATTTATAAAT (from cloneDKFZp434N1728) GGACCACAACTCTGGGGTGTCGT /cds = UNKNOWN 1222 Table 3AHs.109150 AL133111 6453598 mRNA; cDNA DKFZp434H068 1CATGAAGCTCTCAAGTCCTGCATCCT (from clone DKFZp434H068)GAGGATCCAGATGGATGACAAGGA /cds = UNKNOWN 1223 Table 3A Hs.199009 AL1335728599150 PCCX2 mRNA for protein 1 GGTGGTGTTTCCTAGACCTTCCCTGA containingCXXC domain 2, TGCGATTTTACCTTTGTTGAATTT partial cds/cds = (0, 2483) 1224Table 3A Hs.25382 AL133811 6599222 mRNA; cDNA DKFZp434O1317 1ACGATGCTGTTTGCTCTGGAATGTTC (from clone DKFZp434O1317)ATCTTTTAGACAGGTTTTGGCTCA /cds = UNKNOWN 1225 Table 3A Hs.224680 AL1337216601909 DKFZp761H09121_r1 cDNA, 1 TCCGAGGGATGAGATTAAGGCAGAG 5′ end/clone= DKFZp761H09121 GCAAAAGTTTCACACAAAGTTTCTG /clone_end = 5′ 1226 Table 3AHs.306155 AL133879 6602066 chorionic somatomammotropin 1GCCACAACTCCCATAGATGCCAATGT hormone 1 (placental lactogen)TTTGATAGCCTCAGTTTCTCAACG (CSH1), transcript variant 2, mRNA/cds = (116,886) 1227 Table 3A Hs.322456 AL138542 12044472 hypothetical protein 1TGACCCACCCACCAAGGAAGAAAGC DKFZp761D0211 AGAATAAACATTTTTGCACTGCCTG(DKFZP761D0211), mRNA/ cds = (164, 1822) 1228 Table 3A Hs.258503AL138549 6807648 mRNA; cDNA DKFZp761I12121 1 CATGCTCTCCCATGACATCTCCATGC(from clone DKFZp761I12121); TGGTTTCTCCATAGCATAAATGAA complete cds/cds =(138, 3899) 1229 Table 3A Hs.177537 AL136558 13276622 hypotheticalprotein 1 GGTGCCGTGCATCACCAAATGAAAGT DKFZp761B1514TTGTATTTAACGAGGAGGTGCTTT (DKFZp761B1514), mRNA/ cds = (72, 1028) 1230Table 3A Hs.245798 AL136607 12052739 hypothetical protein 1AAATCCTCTCTGCTGTTCACATTATCC DKFZp564I0422 TTTGTTTAACGTATGAACCAGGT(DKFZP564I0422), mRNA/ cds = (510, 1196) 1231 Table 3A Hs.4750 AL13661012052745 hypothetical protein 1 GTGTAGAATTCCCGGAGCGTCCGTG DKFZp564K0822GTTCAGAGTAAACTTGAAGCAGATC (DKFZP564K0822), mRNA/ cds = (9, 527) 1232Table 3A Hs.108548 AL136640 12052805 mRNA; cDNA DKFZp564F163 1TGGGTAGGTTAAGCTGCCATACGTGT (from clone DKFZp564F163);TCAGTGTGAATAGTGTTTAAGTTG complete cds/cds = (149, 532) 1233 Table 3AHs.27181 AL136656 12052835 nuclear receptor binding factor-2 1TGATGCAAGAGTGGACGTAATGCTAG (NRBF-2), mRNA/cds = TTGGCAGTATTTTATTGTAAGAAA(179, 1042) 1234 Table 3A Hs.57209 AL136703 12052925 hypotheticalprotein 1 TCAGTAAAAATGCCTGTTGTGAGATG DKFZp566J091 (DKFZP566J091),AACCTCCTGTAACTTCTATCTGTT mRNA/cds = (212, 529) 1235 Table 3A Hs.168254AL136711 12052941 hypothetical protein 1 GGGCCATTTTATGATGCATTGCACACDKFZp566I133 (DKFZP566I133), CCTCTGGGGAAATTGATCTTTAAA mRNA/cds = (133,1353) 1236 Table 3A Hs.324275 AL136739 12052996 WW domain-containingprotein 1 1 AAAATGCTGCTGGCTTTTCTGAAGAC (WWP1), mRNA/cds = (10, 2778)AGGTGCTTGAACTTGTCAGTTTGT 1237 Table 3A Hs.273294 AL136797 12053106 mRNA;cDNA DKFZp434N031 1 CCGCCCAAAAGTCTGTTCTGATGGCA (from cloneDKFZp434N031); CTGAGTTTTCATTGTTCTGGATGT complete cds/cds = (18, 3608)1238 Table 3A Hs.76698 AL136807 12053124 mRNA; cDNA DKFZp434L1621 1TGGTTGTGCTAAATTCATAGCAGGTG (from clone DKFZp434L1621);CCTTATTCTTTGCTTTTAGTCAAA complete cds/cds = (315, 515) 1239 Table 3AHs.238996 AL136828 12053164 hypothetical protein 1TTTGCCAGGGTAATCTTCAGTTGGCC DKFZp434K0427 CTGATTCAATTAAATGGCCTTAAT(DKFZP434K0427), mRNA/cds = (341, 1813) 1240 Table 3A Hs.146037 AL13687412053252 hypothetical protein 1 ACACTCCTTAAGTTCCAAATGTTTTCC DKFZp434C135GCTAATAGTCTGTCCTAAAGCCT (DKFZP434C135), mRNA/cds = (118, 1208) 1241Table 3A Hs.103378 AL136885 12053268 hypothetical protein MGC11034 1AGGACTCTTGAACATCTGAGCAGTTT (MGC11034), mRNA/cds =TGTGCTTTGAGCCACTTTTTGACA (245, 840) 1242 Table 3A Hs.37892 AL13693212053358 KIAA0922 protein (KIAA0922), 1 CGCCTATATGAACCTGGACATATGGAmRNA/cds = (122, 3841) CTACCACAGCGAATAGGAATGCAA 1243 Table 3A Hs.37892AL136932 12053358 KIAA0922 protein (KIAA0922), 1CGCCTATATGAACCTGGACATATGGA mRNA/cds = (122, 3841)CTACCACAGCGAATAGGAATGCAA 1244 Table 3A Hs.108338 AL136941 12053376hypothetical protein 1 TTTCCTATTTTGCTCCAGACTATGTTT DKFZp586C1924TCAGCATACCTTGGGTCTGAACA (DKFZp586C1924), mRNA/cds = (105, 692) 1245Table 3A Hs.194718 AL136945 12053384 mRNA; cDNA DKFZp586O012 1TTGTGCTTTCTGTATTTAAAACTTTGG (from clone DKFZp586O012)CTGTACTAAGCAAATGCAAGGTT /cds = UNKNOWN 1246 Table 3A Hs.7392 AL1374236807979 nucleolar protein GU2 (GU2), 1 GGTCATCATAGTTGAGGTATGTGTCTmRNA/cds = (107, 2320) GCTATTTGCAAAGAAGTTGGTCGT 1247 Table 3A Hs.21015AL137576 6808287 mRNA; cDNA DKFZp564L0864 1 TTCAGGACCCTAGAGGAGAGCTTTAT(from clone DKFZp564L0864); ACAATTACCGATGTGAATTTCTCT partial cds/cds =(0, 568) 1248 Table 3A Hs.122752 AL137601 6808346 TATA box bindingprotein (TBP)- 1 TGTTTTGCTTAATGTGGACAATTTACA associated factor, RNApolymerase CACCCAACACATACTGTTTCCAA II, B, 150 kD (TAF2B), mRNA/cds =(57, 3656) 1249 Table 3A Hs.145612 AL137608 6808357 RNA helicase(RIG-I), 1 GAGATCAACGGGATGAGGTGTTACA mRNA/cds = (157, 2934)GCTGCCTCCCTCTTCATGCAATCTG 1250 Table 3A Hs.173912 AL137681 6807931eukaryotic translation initiation 1 AGGTAGGGTTTAATCCCCAGTAAAAT factor4A, isoform 2 TGCCATATTGCACATGTCTTAATG (EIF4A2), mRNA/cds = (15, 1238)1251 Table 3A Hs.306195 AL137721 6808159 over-expressed breast tumor 1AGGGGGTGATTTTTGCTCTTGTCCTG protein (OBTP), mRNA/cds =AGAAATAACAGTGCTGTTTTAAAA (0, 224) 1252 Table 3A Hs.12144 AL1377536808455 mRNA; cDNA DKFZp434K1412 1 ACTTGAGTGGGGTTTTCCTTTTCCCC (fromclone DKFZp434K1412) CAATTCTAAGAGAATATAATGTGT /cds = UNKNOWN 1253 Table3A Hs.77646 AL137938 6851002 mRNA; cDNA DKFZp761M0223 1GCGTCTGTTGTTAGCAAAGAATAGAT (from clone DKFZp761M0223)TCACACAGTCTAAGGTTTCCTTCC /cds = UNKNOWN 1254 Table 3A Hs.235390 AL1574267018455 mRNA; cDNA DKFZp761B101 1 CCCTCTTAGCCTATCCATCTTAAGCC (from cloneDKFZp761B101) CCAAGCTGAGTGTGGTTCTGGTAA /cds = UNKNOWN 1255 Table 3AHs.66151 AL157438 7018513 mRNA; cDNA DKFZp434A115 1TAAGGAGAATTAGACTCCCAAGTAGA (from clone DKFZp434A115)CACCAGAGTCACTGTTTGGTTGGT /cds = UNKNOWN 1256 Table 3A Hs.110702 AL1574777018497 mRNA; cDNA DKFZp761E212 1 ACGTGTTTTTGGGATATGTTTCCAAT (from cloneDKFZp761E212) CTTTAAATGACCTTGCCCTGTCCA /cds = UNKNOWN 1257 Table 3AHs.250535 AL157499 7018548 mRNA; cDNA DKFZp434N2412 1AACCATTTGTTAACTGTACTGAAGGT (from clone DKFZp434N2412)GTGTCCTCAAGAAGAAAGTGTTCA /cds = UNKNOWN 1258 Table 3A Hs.170171 AL1619527328002 mRNA; cDNA DKFZp434M0813 1 AAACAAACTGTGTAACTGCCCAAAGC (fromclone DKFZp434M0813); AGCACTTATAAATCAGCCTAACAT partial cds/cds = (430,768) 1259 Table 3A Hs.71252 AL161991 7328122 mRNA; cDNA DKFZp761C169 1AAACTGATCACACTGACTGGATCTGT (from clone DKFZp761C169);CCACGACATGGAAAATAAACTGGA partial cds/cds = (996, 2474) 1260 Table 3AHs.99908 AL162047 7328089 nuclear receptor coactivator 4 1TTGCATTGATGAATTTTGTATCTGCTT (NCOA4), mRNA/cds = CCATTAAAAGCATAACAGCCACA(140, 1984) 1261 Table 3A Hs.78829 AL162049 7328093 mRNA; cDNADKFZp762E1712 1 ATCTCTCCTTCAGTCTGCTCTGTTTAA (from clone DKFZp762E1712);TTCTGCTGTCTGCTCTTCTCTAA partial cds/cds = (0, 2477) 1262 Table 3AHs.302649 AL162068 7328143 HSP22-like protein interacting 1TTGAAGTTTTAAGGGACGTCAGTGTT protein (LOC64165), mRNA/cds =TATGCCATTTTTCCAGTTCCAAAA (0, 155) 1263 Table 3A Hs.17377 AL1620707328146 mRNA; cDNA DKFZp762H186 1 GGTCGGCTCTTATAGAGTGGCCATAG (from cloneDKFZp762H186); TGTTCTGTCAAAACACTTGCTTCC complete cds/cds = (0, 1489)1264 Table 3A Hs.155191 AL162086 7328174 villin 2 (ezrin) (VIL2), 1TTCTCCTTCACAGCTAAGATGCCATG mRNA/cds = (117, 1877)TGCAGGTGGATTCCATGCCGCAGA 1265 Table 3A Hs.3576 AL357536 8249879 Homosapiens, Similar to RIKEN 1 CATGATTCCAAGGATCAGCCTGGATG cDNA 5730494N06gene, clone CCTAGAGGACTAGATCACCTTAGT MGC:13348 IMAGE:4132400, mRNA,complete cds/cds = (132, 494) 1266 Table 3A Hs.29797 AL359585 8855645mRNA; cDNA DKFZp762B195 1 AGTGAAGATCTGGCTGAACCAGTTCC (from cloneDKFZp762B195) ACAAGGTTACTGTATACATAGCCT /cds = UNKNOWN 1267 Table 3AHs.252588 AL359626 8655704 mRNA; cDNA DKFZp564F172 1AGGCCATCATTCTATACCTCATTTAA (from clone DKFZp564F172)GCCATTGTTATCAAGGGTTTACCC /cds = UNKNOWN 1268 Table 3A Hs.33758 AL3596548670873 mRNA full length insert cDNA 1 AGAGTACATGGAAAGTTAGGTGTTCA cloneEUROIMAGE 196784 AATTCACATCTAATTTCCCTGGGA /cds = UNKNOWN 1269 Table 3AHs.3840 AL359940 8977897 mRNA; cDNA DKFZp762P1915 1GTTTTCAGTTTTCCCCTTTACAGTCTT (from clone DKFZp762P1915)CTCCCCTCACCTCCAGGACCCTC /cds = UNKNOWN 1270 Table 3A Hs.318501 AL3601908919391 stimulated trans-acting factor 1 ATCCTTCAGAATGTGTTGGTTTACCA (50kDa) (STAF50), GTGACACCCCATATTCATCACAAA mRNA/cds = (122, 1450) 1271Table 3A Hs.7104 AL390127 9368821 mRNA; cDNA DKFZp761P06121 1GTCTGGCCTTGGCTTGCTCGGATAAA (from clone DKFZp761P06121)ACTTTGTATGTATTTTGTATGGCA /cds = UNKNOWN 1272 Table 3A Hs.49822 AL3901329368828 mRNA; cDNA DKF2p547E107 1 TGCTGAGCATGGGGAATGTGGCTGC (from cloneDKFZp547E107) TGCAGAGACGTTATGAAACACTTCT /cds = UNKNOWN 1273 Table 3AHs.98026 AL442083 10241762 mRNA for KIAA1784 protein, 1TCTCCATCCTTGTGAATGTCCTCGTC partial cds/cds = (0, 3505)TGTTTCAAATACAGTGCAGTCAGT 1274 Table 3A Hs.77868 AL513780 12777274 ORF(LOC51035), mRNA 1 TGGTTCTTCTGATGAGCAAGGGAACA /cds = (135, 1031)ACACTGAGAATGAGGAGGAAGGAGT 1275 Table 3A Hs.181309 AL520892 12784385proteasome (prosome, macropain) 1 TGAAGTTAAGGATTACTTGGCTGCCA subunit,alpha type, 2 (PSMA2), TAGCATAACAATGAAGTGACTGAA mRNA/cds = (0, 704) 1276Table 3A Hs.16648 AL523085 12786578 AL523085 cDNA/clone = 1GGCTTTCTTGTTTTGGTGTCTTGGAG CS0DC001YF21-(5-prime)TGCTGGGTAAGGTTCAGTGGATAT 1277 Table 3A Hs.37617 AL532303 12795796602144947F1 cDNA, 5′ end 1 CTATCTACACCATCATGCGCTGGTTC /clone =IMAGE:4308683/ CGGAGACACAAGGTGCGGGCTCAC clone_end = 5′ 1278 Table 3AHs.83583 AL532406 12795899 actin related protein 2/3 complex, 1GAAGCGGCTGGCAACTGAAGGCTGG subunit 2 (34 kD) (ARPC2),AACACTTGCTACTGGATAATCGTAG mRNA/cds = (84, 986) 1279 Table 3A Hs.30120AL533737 12797230 602272333F1 cDNA, 5′ end 1 AAGCAAGAGATTGTAAACCGGGTACA/clone = IMAGE:4360233/ GAATCCAAGAGATGAGAGAGGACC clone_end = 5′ 1280Table 3A Hs.179999 AL534564 12798057 Homo sapiens, clone IMAGE: 1AGACGAATGCTTGTCAGTTGTAGCTT 3457003, mRNA/cds = TCCAGGATTCTGCTCCAATGAGGAUNKNOWN 1281 Table 3A Hs.159065 AL538276 12801769 AL538276 cDNA/clone =1 CAAACTGATTGCGGGGCAGGGACTT CS0DF027YC09-(5-prime)GAGTATGGGGAGAGGCTGCAAAAGA 1282 Table 3A Hs.285401 AL540399 12870508colony stimulating factor 2 1 GAACATCAGGAGAGGAGTCCAGAGC receptor, beta,low-affinity CCACGTCTACTGCGGAAAAGTCAGG (granulocyte-macrophage)(CSF2RB), mRNA/cds = (28, 2721) 1283 Table 3A Hs.181400 AL54259212874788 602650370T1 cDNA, 3′ end 1 AGTTGGAGAGTTACTCGAACCTCAGG /clone =IMAGE:4761353/ TGACAGTTGTAAGGCAGACATAGT clone_end = 3′ 1284 Table 3AHs.271599 AL550229 12886998 cDNA FLJ12347 fis, clone 1CTCCTCCAGGCCTCTCGGATGCCTCT MAMMA1002298/cds = GTTGGGACAGCTAAGTTCCTCTTCUNKNOWN 1285 Table 3A NA NC_001807 13959823 Mitochondrial Sequence 1TCCTCCATATATCCAAACAACAAAGC ATAATATTTCGCCCACTAAGCCAA 1286 Table 3AHs.218329 AL556016 12898299 mRNA for KIAA1245 protein, 1TGCTGTTGCAAAAGAAGAAGACATCT partial cds/cds = (701, 3379)CTGCCTGAGTTTTAATTTTGTCCA 1287 Table 3A Hs.250465 AL556919 12900027 mRNA;cDNA DKFZp434E2023 1 TTTCTGCTGGAGTCCCCTGTGTCCTC (from cloneDKFZp434E2023) AGCCATCCCAAGAAGGGTTTGCTG /cds = UNKNOWN 1288 Table 3AHs.90035 AL558028 12902157 AL558028 cDNA/clone = 1CTGGTTGGATCTGCATCTCACGCCCA CS0DJ002YF02-(5-prime)CTGCACACCGTTCCTCTCCATCTG 1289 Table 3A Hs.301756 AL559029 12904124 Homosapiens, clone MGC:17544 1 ACCTCGACTCCCTGGTGCTCTTTGCA IMAGE:3482146,mRNA, GAGTTGGGCAGTGAAATTACCTTT complete cds/cds = (256, 894) 1290 Table3A Hs.119274 AL559422 12904908 RAS p21 protein activator (GTPase 1ATACACAGCACGACGTATCCTTGTAC activating protein) 3CGACTTCTCCCGGTTCTTGTTTGA (Ins(1,3,4,5)P4-binding protein) (GAP1IP4BP),mRNA/cds = (46, 2550) 1291 Table 3A Hs.218329 AL559555 12905153 mRNA forKIAA1245 protein, 1 GTACTTAGGAAGACACAGCTAGATGG partial cds/cds = (701,3379) ACAACAGCATTGGGAGGCTTAGCC 1292 Table 3A Hs.33026 AL561074 12908145mRNA for FLJ00037 protein, 1 CATCTCTGGTTGTGTCTGTGCCGACT partial cds/cds= (3484, 3921) CGGTGTTGAATCAAATCAGGTGTG 1293 Table 3A Hs.335883 BE2623089135208 601462961T1 cDNA, 3′ end 1 CAACAATAGGAGGTGGAATGCTGCAA /clone =IMAGE:3866222/ GGGGCTGCAAATGAGGGCAATGCA clone_end = 3′ 1294 Table 3A NANC_001807 13959823 mitochondrial COX3 1 ATATTTCACTTTACATCCAAACATCACTTTGGCTTCGAAGCCGCCGCCTG 1295 Table 3A Hs.287797 AU117298 10932256 mRNAfor FLJ00043 protein, 1 TGGCAAATTCTGCGAGTGTGATAATT partial cds/cds = (0,4248) TCAACTGTGATAGATCCAATGGCT 1296 Table 3A Hs.1600 AU118159 10933184Homo sapiens, clone IMAGE: 1 TCTCACATGTCCATTTGAACCACCCA 3543711, mRNA,partial cds/cds = AACCAAAAACAAAGCATAAGCTGG (0, 1620) 1297 Table 3AHs.181165 AU120731 10935966 eukaryotic translation elongation 1TCCAGGATGTCTACAAAATTGGTGGT factor 1 alpha 1 (EEF1A1),ATTGGTACTGTTCCTGTTGGCCGA mRNA/cds = (53, 1441) 1298 Table 3A Hs.172028AU135154 10995693 a disintegrin and metalloproteinase 1TGGACATAGCAGCACATACTACTTCA domain 10 (ADAM10), mRNAGAGTTCATGATGTAGATGTCTGGT /cds = (469, 2715) 1299 Table 3A NA AV68622310288088 AV886223 cDNA, 5′ end 1 AACAGAAGACGAGGACACAGAGCGA /clone =GKCGXH11/clone_(—) GAATAAGCACAACTCAGACAACACA 1300 Table 3A Hs.343475AV687530 10289393 601558208T1 cDNA, 3′ end 1 TGACCACTTATGCACTTTCTGAATTTG/clone = IMAGE:3826392/ CTTTCCATGCTCAGAGTTCTGCT clone_end = 3′ 1301Table 3A NA AV689330 10291193 cDNA clone GKCDJE03 5′ 1CTTTGACCCCACCTTGTGGAAACCCA GCTGTCTACTGGCAGACATTGGTG 1302 Table 3AHs.28739 AV691642 10293505 602593745F1 cDNA, 5′ end 1AAACACCAGTTTGCAGGAAGAA /clone = IMAGE:4721002/ AGGAAGAGAATGGAAATTGCTTCTclone_end = 5′ GGAA 1303 Table 3A NA AV693913 13959823 mitochondrion,complete genome 1 CCCTACCATGAGCCCTACAAACAACT AACCTGCCACTAATAGTTATGTCA1304 Table 3A Hs.324602 AW969923 8159767 EST382001 cDNA 1AGTCGTATTAGAGCCTTGGCGTAATC ATGGTCATAGCTGTTTCCTGTGTG 1305 Table 3AHs.301570 AV702152 10718482 602585120F1 cDNA, 5′ end 1TTGCTGCCTGATCTGACATACATGAT /clone = IMAGE:4712861/CCATCGGGTTTTGTTACAAGGAAC clone_end = 5′ 1306 Table 3A Hs.7312 AV70269210719022 AV702692 cDNA, 5′ end 1 CATGTTCATAGGTAATCTTTGTACTCT /clone =ADBBQC12/ GTGTGCAGCAGTATTTGGTTTGC clone_end = 5′ 1307 Table 3A NAAV705900 10723195 Partial Cloning Vector 1 AATTCGCCCTATAGTGAGTCGATTACCAATCACTGCCCGCGTTTACAACG 1308 Table 3A Hs.167130 AV706014 10723303hypothetical protein (PRED22), 1 ACAGGTAACTGAAGATCAAAGTAAAG mRNA/cds =(245, 1021) CAACAGAGGAATGTACATCTACCT 1309 Table 3A Hs.134829 AV70648110723761 AV706481 cDNA, 5′ end 1 AACAGTTGGGCACCCTGAATGGCAAA /clone =ADBBYF02/ TGGCAAATTTGGAGCGCTAATAAT clone_end = 5′ 1310 Table 3A NANC_001807 13959823 mitochondrion, complete genome 1GCCAATCACTTTATTGACTCCTAGCC GCAGACCTCCTCATTCTAACCTGA 1311 Table 3AHs.90960 AV710415 10729044 602563938F1 cDNA, 5′ end 1ATGTGGGAGGGGCATGGCAGCTATG /clone = IMAGE:4688769/AAGGACCTCCTACCTCTGGTTTCTG clone_end = 5′ 1312 Table 3A Hs.316785AV710763 10730069 AV710763 cDNA, 5′ end 1 CATGGGACGGGGAGAAAAAGCAAAC/clone = CuAAJH09/ CCTGGCACTTGGGAATACTTATACC clone_end = 5′ 1313 Table3A Hs.135167 AV712376 10731682 AV712376 cDNA, 5′ end 1TTGTGCCCTTGACTGGGTATTTCTTG /clone = DCAAND12/ AAGCCCTTGGATCTACCTTTGGTCclone_end = 5′ 1314 Table 3A Hs.89104 AV716500 10798017 602590917F1cDNA, 5′ end 1 ACATAATACGGTTGTGCGAGCAGAGA /clone = IMAGE:4717348/ATCTACCTTTCCACTTCTAAGCCT clone_end = 5′ 1315 Table 3A Hs.237868 AV71656510813717 interleukin 7 receptor (IL7R), 1 CCAGCCTTTGCCTCTTCCTTCAATGTmRNA/cds = (22, 1401) GGTTTCCATGGGAATTTGCTTCAG 1316 Table 3A Hs.178703AV716627 10813779 AV716627 cDNA, 5′ end 1 AAAACCTCGAGTCATGGTGAATGAGT/clone = DCBBCH05/ GTCTCGGAGTTGCTCGTGTGTGTA clone_end = 5′ 1317 Table 3AHs.17481 AV716644 10813796 mRNA; cDNA DKFZp434G2415 1GTGAGCACGGACATGCGGCATCATC (from clone DKFZp434G2415)GAGTGAGACTGGTGTTCCAAGATTC /cds = UNKNOWN 1318 Table 3A Hs.256959AV719442 10816594 AV719442 cDNA, 5′ end 1 CACCACAGTCTCAGTGCAGGGCTGG/clone = GLCBNA01/ GAAGTGAAAGACGATTCACCAGACC clone_end = 5′ 1319 Table3A NA AV719659 10816811 cDNA clone GLCGRA09 5′ 1TTTGTGGGTGGGTGATTAGTCGTTGC TGATGAGATATTTTGAGGGTGGGG 1320 Table 3AHs.127160 AV719938 10817090 AV659177 cDNA, 3′ end 1ACCTTGTAAGTGCCTAAGAAATGAGA /clone = GLCFUC08/ CTACAAGCTCCATTTCAGCAGGACclone_end = 3′ 1321 Table 3A Hs.21536 AV720984 10818136 yl69a03.s1 cDNA,3′ end 1 GCCGAGATCTGCTCAGACTACATGG /clone = IMAGE:27414/CTTCCACTATAGGGTTCTACAGTGT clone_end = 3′ 1322 Table 3A Hs.119908AV721008 10818160 nucleolar protein NOP5/NOP58 1AAATCAGAATTCATTTAGCTCACCAC (NOP5/NOP58), mRNA/cds =ATCTCTTGAATGTGATTGACCTAC (0, 1589) 1323 Table 3A Hs.247474 AV72343710826838 hypothetical protein FLJ21032 1 AGGTGTTTAACAGTGTTATTTTGCCA(FLJ21032), mRNA/cds = CTGGTAATGTGTAAACTGTGAGTG (235, 1005) 1324 Table3A Hs.76728 AV724531 10829010 602570065F1 cDNA, 5′ end 1TGGAGTTTCCAGGAGAAAAATAATCA /clone = IMAGE:4694321/CCTTTGAAGGTTTTTAGAGCATGT clone_end = 5′ 1325 Table 3A Hs.280261 BE3828699328234 601297762F1 cDNA, 5′ end 1 GGTAACAACATCCGTCTGAAAGGGTC /clone =IMAGE:3627806/ GGACCTCGTCCAAAGGAGATAGGC clone_end = 5′ 1326 Table 3AHs.21351 AV724665 10829278 qd15g09.x1 cDNA, 3′ end 1ACATTTTGATTTCTTCTCTCTGTGGG /clone = IMAGE:1723840/GTGGCAAGTTGAGGGAGCATTCTT clone_end = 3′ 1327 Table 3A Hs.44656 AV72611710832185 AV726117 cDNA, 5′ end 1 CGTAAACCAATGTGGTACACTAGTTG /clone =HTCAXB05/ GCCCGAACTTGGTATAAACCGCCT clone_end = 5′ 1328 Table 3AHs.245798 AV727063 10836484 hypothetical protein 1TCTTTAAGTCTGTCAAACCAGAACTC DKFZp584I0422 TTTGAAGCACTTTGAACAATGCCC(DKFZP584I0422), mRNA/cds = (510, 1196) 1329 Table 3A Hs.316771 AV72916010838581 AV729160 cDNA, 5′ end 1 AGCTGGCGTAATAGCGAAGAGGCCC /clone =HTCCAB04/ GCACCGATCGCCTTTCCAACAAGTG clone_end = 5′ 1330 Table 3AHs.22003 AV730135 10839556 solute carrier family 6 1AGATGCATTTTAAATGTCTATAAATGG (neurotransmitter transporter,TGTCATAACTAGAGCACGGGCGT GABA), member 1 (SLC6A1), mRNA/cds = (234, 2033)1331 Table 3A Hs.175971 AV734916 10852461 AV734916 cDNA, 5′ end 1ATTAAAACGCTTGGAAGAAAATCCCC /clone = cdAAHE11/ TTTTGGCAGGTGGGGGAAAAAGCAclone_end = 5′ 1332 Table 3A NA AV735258 10852803 mitochondrion,complete genome 1 ATTCAACCAATAGCCCTTGCCGTACC GCCTACCCGTAACATTACTGGAGG1333 Table 3A NA NC_001807 10855754 Mitochondrial Sequence 1CGCCTATAGCACTCGAATAATTCTTC TCACCCTAACAGGTCAACCTCGCT 1334 Table 3AHs.246798 AV739961 10857542 AV739961 cDNA, 5′ end 1GTTGTGCATGATTCCCCACGTGTCTC /clone = CBFBRA10/ TGTTTATCCAGATAAGAAAAGATAclone_end = 5′ 1335 Table 3A Hs.122431 AV743635 10861216 AV713062 cDNA,5′ end 1 TCTTTTAGGATTTGTCTTTTAGAATCT /clone = DCAADD12/CCAGTCCTCACAGGAAAACCCCC clone_end = 5′ 1336 Table 3A Hs.42915 AV74569210865139 ARP2 (actin-related protein 2, 1 TGGGTGGAGTATTATGTTTAACTGGAyeast) homolog (ACTR2), GTTGTCAAGTATGAGTCCCTCAGG mRNA/cds = (74, 1258)1337 Table 3A Hs.26670 AV749844 10907692 PAC clone RP3-515N1 from 1ACCTCATTCTGACACCTGCATATAGT 22q11.2-q22/cds = (0, 791)GTGGGAAATTGCTCTGCATTTGAC 1338 Table 3A Hs.31409 AV752358 10910206602685862F1 cDNA, 5′ end 1 GTTCTGGAGGACAGGAAGGGTGACC /clone =IMAGE:4818566/ CACAGAGGATTATACCACCGGGGTG clone_end = 5′ 1339 Table 3AHs.335863 AV755117 10912965 601462961T1 cDNA, 3′ end 1GCCGCAGACCTCCTCATTCTAACCTG /clone = IMAGE:3866222/AATCGAAGGACAACCAGTAAGCTA clone_end = 3′ 1340 Table 3A Hs.339696 AV75536710913215 ribosomal protein S12 (RPS12), 1 TGAGTCGTATTACAATTCACTGGCCGmRNA/cds = (80, 478) TCGTTTTACAACGTCGTGACTGGG 1341 Table 3A Hs.181165AV756188 10914036 eukaryotic translation elongation 1TAAGATTATCAACCTTGGGGTCGTTT factor 1 alpha 1 (EEF1A1),TGTTGTTCGCGGATTGAGCACGGA mRNA/cds = (53, 1441) 1342 Table 3A Hs.58643AV760147 10917995 602438603F1 cDNA, 5′ end 1 CTGGGCTGAAGCCTATTCCTATGGG/clone = IMAGE:4564968/ GCTCTGGAATGTTTGTGACTGAATG clone_end = 5′ 1343Table 3A Hs.93194 AV762642 10920490 apolipoprotein A-I (APOA1), 1TTGTCCATTTGGAACAGAGTCACTAT mRNA/cds = (38, 841) AAAGAACGGGCTCAACTGGGCACC1344 Table 3A Hs.301553 AW021037 5874567 karyopherin alpha 6 1GCAGACATAGGCGAAGAAAACATGG (importin alpha 7) CATTGAGTGTGCTGAGTCCAGACAA(KPNA6), mRNA/cds = (55, 1665) 1345 Table 3A Hs.232400 AW021551 5875081heterogeneous nuclear 1 CTTTTCCCACCCCCTCCCCCTCCATG ribonucleoproteinA2/B1 TGAAGATTTGGGTGCTTAACATAT (HNRPA2B1), transcript variant B1,mRNA/cds = (169, 1230) 1346 Table 3A Hs.95835 AW248322 6591315 RST8356cDNA 1 GGCACTGCCTCCTTACCTGTGAGGAA TGCAAAATAAAGCATGGATTAAGT 1347 Table 3AHs.340753 AW362008 6866658 tw50h12.x1 cDNA, 3′ end 1AAACCACACCAGGAACTCCTTGCATG /clone = IMAGE:2263175/GCAAAAGCTGAACAGTACAAATCC clone_end = 3′ 1348 Table 3A Hs.127574 BG43638613342892 602509044F1 cDNA, 5′ end 1 ACACAGTCATCCCCATGCAGAAACCT /clone =IMAGE:4619579/ CAGAAAACACCAATGTATTACACA clone_end = 5′ 1349 Table 3AHs.8024 AW390233 6894892 IK cytokine, down-regulator of 1GTCTGAACGAGACTCAATTCCTCTCC HLA II (IK), mRNA/ GAGGCTCCCCAAACAAATTGTAGCcds = (111, 1784) 1350 Table 3A NA AW402007 6920693UI-HF-BKD-aao-g-02-0-UI.r1 1 GTGCAGTCCATCAGATCCAAGCCTGT NIH_MGC_38 cDNAclone CTCTTGAGGAACAACCGCGCAGAC IMAGE:3054530 5′ 1351 Table 3A Hs.181125AW405863 6924920 Homo sapiens, clone MGC:12849 1GACCCAGGCTATGGATGAGGCTGAC IMAGE:4308973, mRNA, completeTATTACTGTCAGGCGTGGGACAGCA cds/cds = (24, 725) 1352 Table 3A NA AW4996587111531 UI-HF-BR0p-ajj-c-07-0-UI.r1 1 TGGTGGCAAATCTGATTTTTGGAAACNIH_MGC_52 cDNA clone GAGTATTGGAGGACTATAAAACAA IMAGE:3074677 5′ 1353Table 3A NA AW499828 7111870 UI-HF-BN0-ake-c-06-0-UI.r1 1ACATTTCTTGTTGGCACTACAGCAAC NIH_MGC_50 cDNA cloneCACATACAGTACAGACAACCTCCA IMAGE:3076819 5′ 1354 Table 3A Hs.181461AW499829 7111872 ariadne (Drosophila) homolog, 1TGGGATAAAGGTGTGTCGGTTTAGCA ubiquitin-conjugating enzyme E2-CCTCTGGAAGACCTATCTAGAGCT binding protein, I (ARIH1), mRNA/cds = (314,1987) 1355 Table 3A Hs.145668 AW500534 7113240 fmfc5 cDNA/clone = CR6-211 CCTGGCACATGTTGTCTGGAGTCTGG CACACTGGTTATCAATAGCACATT 1356 Table 3AHs.304900 AW501528 7115141 602288147F1 cDNA, 5′ end 1GCATGTTCTCACCGTGAAGGAGAGT /clone = IMAGE:4373963/GATGCAGGGAGATACTACTGTGCAG clone_end = 5′ 1357 Table 3A Hs.37892 AW5042127141879 KIAA0922 protein (KIAA0922), 1 AAAGTGGGTGGAAGACTTCCTGGTGmRNA/cds = (122, 3841) CAGGAGGCTCACTCCGATTTAAGGT 1358 Table 3A Hs.120996AW504293 7141960 serine/threonine kinase 17b 1CTGTGGTCTGTTATATGAGAGAGATC (apoptosis-inducing) (STK17B),CTTTAACTAGAGCAAAGAGGGAGT mRNA/cds = (261, 1379) 1359 Table 3A Hs.182937AW630825 7377615 peptidylprolyl isomerase A 1GCTTGCTGTTCCTTAGAATTTTGCCTT (cyclophilin A) (PPIA),GTAAGTTCTAGCTCAAGTTGGGG mRNA/cds = (44, 541) 1360 Table 3A Hs.102647AW651682 7412932 602271538F1 cDNA, 5′ end 1 TTTCTCAGAGCTGGAGGTTGCTGGG/clone = IMAGE:4359609/ CACCTAAATGATGTTTCATGATAGC clone_end = 5′ 1361Table 3A NA AW792856 7844778 UM0001 cDNA 1 CTTTTTGTAAGTTACAACATTCCACTGGATCCTTATATTGCCTGTAGTGG 1362 Table 3A NA AW810442 7903438 ST0125 cDNA 1CTCATCTATGTCTTCTAAAGCTTTTCT GCATTCTTCCACCTGGGATTCAA 1363 Table 3A NAAW812896 7905890 RC3-ST0186-250200-018-a11 1 CTGTCTTTGGAAGGAGACACAAGAACcDNA/gb = AW812896 CTGATAACATTGGTTGTCTTCGGG 1364 Table 3A Hs.44577AW813133 7906127 602388170F1 cDNA, 5′ end 1 AAACAAGAACCCACTTAAACACAGCA/clone = IMAGE:4517129/ TCAAACTCTACCATGAAATGAAGA clone_end = 5′ 1365Table 3A Hs.23128 AW819894 7912888 Homo sapiens, Similar to RIKEN 1TTCTTCCTGGTCATATTCCTCTTTTGA cDNA 4931428D14 gene, cloneTTTTCTAAGAACTTCCCTCAGGA MGC:15407 IMAGE:4309613, mRNA, complete cds/cds= (123, 1151) 1366 Table 3A Hs.165895 AW850041 7945558IL3-CT0216-170300-097-C07 1 ACACAAGATACTGCCACTTTCTCTAC cDNAACAAAGACCCACCCAAACACCAGC 1367 Table 3A Hs.301756 AW866426 8000478 Homosapiens, clone MGC:17544 1 CTTTCTCAGGAAGTGGCTCTGCCAGG IMAGE:3482146,mRNA, CAGGACTATGTGGGAAAGGGTTTT complete cds/cds = (256, 894) 1368 Table3A Hs.130729 AW898615 8082820 RC1-NN0073-090500-012-t02 1ATTACATGCTAACTCAAACTTACAAAA cDNA TCAAGCTCTCTGTGATCCTGGTT 1369 Table 3AHs.166975 AW949461 8139088 splicing factor, arginine/serine- 1GATTAAAGGCTTCCATCGATTGGGTA rich 5 (SFRS5), mRNA/cds =GTGTCCTTCAAGTGGGTGGCGAAG (218, 541) 1370 Table 3A Hs.172028 AW9541128143795 a disintegrin and metalloproteinase 1 TGTATTAACAGGCTTATTGCTATGCAdomain 10 (ADAM10), GGGAAATAGAAGGGGCATTACAAA mRNA/cds = (469, 2715) 1371Table 3A Hs.76728 AW954476 8144159 802570085F1 cDNA, 5′ end 1TGGTGGATGGATGGAAACACATACCT /clone = IMAGE:4694321/CCTAATTAACCTGTTGGTGGAAAC clone_end = 5′ 1372 Table 3A Hs.292457 AW9545808144263 Homo sapiens, clone MGC:16382 1 GCCTTGGAGTGTGACATTTCTGCGAGIMAGE:3927795, mRNA, AATGCTTAAATACCGATTTCCCGC complete cds/cds = (498,635) 1373 Table 3A Hs.95835 AW955265 8144948 RST8356 cDNA 1AGGGAGTCGTTTTACCAATTCACTGG CCCGTGTTTTACAAACGTCTGACT 1374 Table 3AHs.205353 AW957139 8146822 ectonucleoside triphosphate 1TGGAGAGCTTGGGACAAGGTCAGAA diphosphohydrolase 1 (ENTPD1),TGAAAACATACCAGTCAATCCTGCT mRNA/cds = (67, 1599) 1375 Table 3A Hs.289088AW958538 8148222 heat shock 90 kD protein 1, alpha 1ACCTGTGCTCTTTGGATACCTAATGC (HSPCA), mRNA/cds = (60, 2258)GACATTTAAGTTGTATTTGACAGT 1376 Table 3A Hs.14453 AW960484 8150168interferon consensus sequence 1 AGGCTGGGCACAAAGGAGAAAGGAG bindingprotein 1 (ICSBP1), GACATGGAAAATCCGACAATTCGAA mRNA/cds = (47, 1327) 1377Table 3A Hs.198427 AW960593 8150277 hexokinase 2 (HK2), 1ATCTCAAATCCTTGAGCACTCAGTCT mRNA/cds = (1490, 4243)AGTGAAGATGTTGTCATTATGTACA 1378 Table 3A Hs.237868 AW963171 8153007interleukin 7 receptor (IL7R), 1 GGGTCATAGGTTCATGGGTTTGTTGA mRNA/cds =(22, 1401) GAATTGTGGCTCCTGGTTTCTGGT 1379 Table 3A Hs.56205 AW9642188154054 insulin induced gene 1 (INSIG1), 1 GCCTTCTTTCTGCTGACTGGGGGCTTmRNA/cds = (414, 1247) TCATTTAAAAGGAGTCTTTTTAAT 1380 Table 3A Hs.30212AW985078 8154914 thyroid receptor interacting 1TGTAAACAGTGGCAGGAGCGTGGAC protein 15 (TRIP15), TTAAAACAAGGCTTGCTTATTTGGTmRNA/cds = (15, 1346) 1381 Table 3A Hs.124764 AW965490 8155326602388504F1 cDNA, 5′ end 1 GCCCTTTGGGTTAAGCCTTTACATTC /clone =IMAGE:4515481/ ATGAAGACCCCTCCAGGGTAGAAT clone_end = 5′ 1382 Table 3AHs.132739 AW965967 8155823 EST378080 cDNA/ 1 AAAAGGAAAACGAAAAAGGAAAAGGTGGCCAATGTGGAAAAAGTTT CAAT 1383 Table 3A Hs.293418 AW966098 8155934EST385296 cDNA 1 ACTCTCAGGAGCCATGAAAGCTGCAC AGTTACTTTATATACCACGAGGCA1384 Table 3A Hs.25130 AW967388 8157225 cDNA FLJ14923 fis, clone 1TTATGTCACCAGAATGTTTGCCAACA PLACE1008244, weakly similar toCCCCGAAAAGGAACCAGAGGACTT VEGETATIBLE INCOMPATIBILITY PROTEIN HET-E-1/cds= UNKNOWN 1385 Table 3A Hs.343615 AW968581 8158402 602621493F1 cDNA, 5′end 1 AGGTTATTTGAGCACAGTGAAAGCAG /clone = IMAGE:4755166/AGTACTATGGTTGTCCAACACAGG clone_end = 5′ 1386 Table 3A Hs.82712 AW9693598159203 fragile X mental retardation, 1 GGCCTGCCATCCGAGGGACTGTGTTautosomal homolog 1 (FXR1), GTAGATTGTGATCAAGGTTGATTGG mRNA/cds = (12,1877) 1387 Table 3A Hs.199160 AW969548 8159390 translocation T(4:11) ofALL-1 1 ACAGGTAGTTGAATAATTGTTTCAAG gene to chromosome 4/AGCTCAACAGATGACAAGCTTCTT cds = UNKNOWN 1388 Table 3A Hs.293744 AW9739538165038 602279577F1 cDNA, 5′ end 1 AATACACTTTGTGCCAAGGGAAGAAC /clone =IMAGE:4387322/ ACTGCATGCCCTGGGTCTTCAGTC clone_end = 5′ 1389 Table 3AHs.43148 AW993524 8253690 602554063F1 cDNA, 5′ end 1GGGAACTGGAGGTGAGAAGCATTAT /clone = IMAGE:4663887/AATAGCCTCTCTGCCTTTATCTACA clone_end = 5′ 1390 Table 3A Hs.238990AY004255 9652559 Homo sapiens, Similar to cyclin- 1ACAAGCCAAAGTGGCATGTTTTGTGC dependent kinase inhibitor 1BATTTGTAAATGCTGTGTTGGGTAG (p27, Kip1), clone MGC:5304 IMAGE:3458141,mRNA, complete cds/cds = (377, 973) 1391 Table 3A Hs.16773 AY0071069955998 clone TCCCIA00427 mRNA 1 AACAGACTGTCGTAGAAAACTGTCTT sequence/cds= UNKNOWN TGCTTCCAAATCAGCAGAGGACCA 1392 Table 3A Hs.285013 AY0071109956004 putative HLA class II associated 1 GCCCCTCAGAAGAGCCAAACTTTGAGprotein I (PHAP1), TTTTATGTCTGTTTGTCATTGATA mRNA/cds = (148, 897) 1393Table 3A Hs.24435 AY007126 9956024 clone CDABP0028 mRNA 1CCTTGTGTCCAACGGGAATAGGAAGA sequence/cds = UNKNOWNATTAGTTACTGACTTCACCTGAGA 1394 Table 3A Hs.330838 BE910568 10407295601501121F1 cDNA, 5′ end 1 CCCACAATTGGACTGATAGGGGGAG /clone =IMAGE:3903053/ AAAATCCAAAGAGACGGAGCAACTG clone_end = 5′ 1395 Table 3AHs.250820 AY007158 9956071 hypothetical protein FLJ14827 1AACGGCAACTGGGAGATTTGTGAGT (FLJ14827), mRNA/cds =GAACACTGTTTCATCTTAATATGCT (468, 1277) 1396 Table 3A Hs.173274 AY0071659956080 integrin cytoplasmic domain- 1 ACATCTGAGAAACCCTGAATCCTGCAassociated protein 1 (ICAP-1A), ATCAAGTAGAAGTCAACTTCATCT transcriptvariant 1, mRNA/cds = (168, 770) 1397 Table 3A Hs.105484 AY00724312621025 regenerating gene type IV 1 GCCATAGGAAGGTTTACCAGTAGAAT(REG-IV), mRNA/cds = CCTTGCTAGGTTGATGTGGGCCAT (181, 657) 1398 Table 3AHs.5298 AY029066 14017398 CGI-45 protein (LOC51094), 1TCATCTCAACTTAGTATTATACCCACA mRNA/cds = (182, 1294)CCCACCCAAGAACAGGGTTTGTT 1399 Table 3A Hs.79070 BC000141 12652778 v-mycavian myelocytomatosis 1 GACTGAAAGATTTAGCCATAATGTAA viral oncogenehomolog (MYC), ACTGCCTCAAATTGGACTTTGGGC mRNA/cds = (558, 1877) 1400Table 3A Hs.334602 BC000167 13096801 cDNA FLJ14539 fis, clone 1GGCACTGTCTGTGTCCTTCCTTGAAC NT2RM2001345, weakly similarTGTCTACCCTGTTGCTTTTCACAA to VEGETATIBLE INCOMPATIBILITY PROTEIN HET-E-1/cds = (7, 1434) 1401 Table 3A Hs.75458 BC000374 12653212 ribosomalprotein L18 (RPL18), 1 GGCCAGCCGAGGCTACAAAAACTAA mRNA/cds = (15, 581)CCCTGGATCCTACTCTCTTATTAAA 1402 Table 3A Hs.278544 BC000408 12853278acetyl-Coenzyme A 1 ACTAGGTTGCAATATGTGAAATCAGA acetyltransferase 2(acetoacetyl GGACCAAAGTACAGATGGAAACCA Coenzyme A thiolase) (ACAT2),mRNA/cds = (37, 1230) 1403 Table 3A Hs.183704 BC000449 12653358ubiquitin mRNA, complete cds 1 CCCTGTCTGACTACAACATCCAGAAA /cds = (135,2192) GAGTCCACTCTGCACTTGGTCCTG 1404 Table 3A Hs.151242 BC000514 12653484serine (or cysteine) proteinase 1 GGCATCGCCCATGCTCCTCACCTGTA inhibitor,clade G (C1 inhibitor), TTTTGTAATCAGAAATAAATTGCT member 1 (SERPING1),mRNA/cds = (60, 1562) 1405 Table 3A Hs.180450 BC000523 12653502ribosomal protein S24 (RPS24), 1 AAAGCAACGAAAGGAACGCAAGAAC transcriptvariant 1, AGAATGAAGAAAGTCAGGGGGACTG mRNA/cds = (37, 429) 1406 Table 3AHs.272822 BC000530 12653516 RuvB (E. coli homolog)-like 1 1TCCCACTTTGTCTGTACATACTGGCC (RUVBL1), mRNA/cds = TCTGTGATTACATAGATCAGCCAT(76, 1446) 1407 Table 3A Hs.83583 BC000590 12653824 actin relatedprotein 2/3 complex, 1 GAAGCGGCTGGCAACTGAAGGCTGG subunit 2 (34 kD)(ARPC2), AACACTTGCTACTGGATAATCGTAG mRNA/cds = (84, 986) 1408 literatureHs.153026 BC000616 12653666 mRNA for KIAA0640 protein, 1CAGTCACGTCAGTTATGTAGATACTG partial cds/cds = (0, 1812)CATGGCAGGAGAGCTTTACGCTAA 1409 Table 3A Hs.321677 BC000627 12653884signal transducer and activator of 1 GCCACCCCTCACACAGCCAAACCCCtranscription 3 (acute-phase AGATCATCTGAAACTACTAACTTTG response factor)(STAT3), mRNA/cds = (220, 2532) 1410 Table 3A Hs.5662 BC000672 12653772guanine nucleotide binding protein 1 GCAGGTGACCATTGGCACACGCTAG (Gprotein), beta polypeptide 2- AAGTTTATGGCAGAGCTTTACAAAT like 1 (GNB2L1),mRNA/cds = (95, 1048) 1411 Table 3A Hs.4147 BC000687 12853796 Homosapiens, translocating chain- 1 TGCCATGCTGCTAGGAAATTGTCCTT associatingmembrane protein, TTTCTTTCTAGCTGTTAACCTACT clone MGC:784 IMAGE:3347823,mRNA, complete cds/cds = (91, 1215) 1412 Table 3A Hs.44468 BC00075812653928 Homo sapiens, clone MGC:2698 1 AACTTATTCCAGTGTTGATCGCAAGCIMAGE:2820737, mRNA, TGTTGATGCACAGGCGTCTTGTGG complete cds/cds = (168,266) 1413 Table 3A Hs.101514 BC000764 12653940 hypothetical proteinFLJ10342 1 TGAAAAGGATTAAAGCTGGTATTCTA (FLJ10342), mRNA/cds =GAACATGCCCTTCACTGGTTGTGT (533, 1144) 1414 Table 3A Hs.85844 BC00077112653954 neurotrophic tyrosine kinase, 1 GGTAAGGTTTCTAGGAGGTCTGTTAGreceptor, type 1 (NTRK1), GTGTACATCCTGCAGCTTATTGGC mRNA/cds = (0, 2390)1415 Table 3A Hs.195870 BC000987 13111833 chronic myelogenous leukemia 1TGATTCTGTAAAGCTGTGGAATGAAG tumor antigen 66 mRNA,CTGCAGATTTAGAGAACATTGGCT complete cds, alternatively spliced/cds = (232,1983) 1416 Table 3A Hs.299214 BC001077 12654494 Homo sapiens, clone 1CGATTTTACACGGCTGGGTAGAATTT IMAGE:2822295, mRNA, GTAGAAAAGATCCACAGGGCAAGCpartial cds/cds = (0, 661) 1417 Table 3A Hs.82193 BC001169 12654662 cDNAFLJ11763 fis, clone 1 GCTACTACTTCATTGCAACCTTTATTA HEMBA1005679/cds =CTGACCACATCAGACATCATGCT UNKNOWN 1418 Table 3A Hs.240770 BC00125512654824 Homo sapiens, nuclear cap binding 1 GGGCTGAAGTACCTAAGTGTGAATGTprotein subunit 2, 20 kD, clone CTCTCCCGTTAAACTGAGTGTAGA MGC:4991IMAGE:3458927, mRNA, complete cds/cds = (26, 496) 1419 Table 3A Hs.73957BC001267 12654846 Homo sapiens, RAB5A, member 1AGGAAAACGGTTCACCAGTGTTTAGT RAS oncogene family, cloneTTTATATTGAGGTGCTCAGGTTGG MGC:5048 IMAGE:3483669, mRNA, complete cds/cds= (165, 812) 1420 Table 3A Hs.73965 BC001303 12654914 splicing factor,arginine/serine- 1 CCGGGCCTTGCATATAAATAACGGAG rich 2 (SFRS2), mRNA/cds =CATACAGTGAGCACATCTAGCTGA (155, 820) 1421 Table 3A Hs.62954 BC00139912655094 ferritin, heavy polypeptide 1 1 ATAATGAAAGCTAAGCCTCGGGCTAA(FTH1), mRNA/cds = (91, 663) TTTCCCCATAGCCGTGGGGTGACT 1422 Table 3AHs.288038 BC001412 12655120 tRNA isopentenylpyrophosphate 1TGCATCGTAAAACCTTCAGAAGGAAA transferase (IPT), GGAGAATGTTTTGTGGACCACTTTmRNA/cds = (60, 1040) 1423 Table 3A Hs.3459 BC001413 13937593 cDNA:FLJ22003 fis, clone 1 TGCTCTGTTCTGGTTTCTGTTTTCAAA HEP06764/cds = UNKNOWNTCAAATGCCTGTTTGGGAGGAGA 1424 Table 3A Hs.51299 BC001632 12804450 NADHdehydrogenase 1 CAAAATCCCAAAACCAGGGCCAAGG (ubiquinone) flavoprotein 2AGTGGACGCTTCTCTTGTGAGCCAG (24 kD) (NDUFV2), mRNA/ cds = (18, 767) 1425Table 3A Hs.155101 BC001637 12804460 mRNA for KIAA1578 protein, 1ACAAATTTCTTGGCTGGATTTGAAGC partial cds/cds = (0, 3608)TTAAACTCCTGTGGATTCACATCA 1426 Table 3A Hs.318069 BC001646 12804476 cDNAFLJ20350 fis, clone 1 TCCACGGTTGTGCCTTATTGTTCCAT HEP13972, highlysimilar to TAAAATTGTATCTTCGATCCATCA Z184_ZINC FINGER PROTEIN 184/cds =UNKNOWN 1427 Table 3A Hs.8297 BC001660 12804498 cDNA FLJ10907 fis, clone1 GGTCTGAGAGTCTGTGAAGATGGCC OVARC1000060/cds = (319, 696)CAGTCTTCTATCCCCCACCTAAAAA 1428 Table 3A Hs.17279 BC001697 12804560tyrosylprotein sulfotransferase 1 1 ACACACAGGAGGGAAAATCCTGGGA (TPST1),mRNA/cds = (81, 1193) TTCTTTTTCTAGGGATGTAATACAT 1429 Table 3A Hs.284291BC001798 12804732 sorting nexin 6 (SNX6), 1 CTGTTTGAACTGTTGAGTTTCCGTTGmRNA/cds = (497, 1369) CTGGCTGAGTGCGTTTTGTCCTTC 1430 Table 3A Hs.8297BC001819 12804758 cDNA FLJ10907 fis, clone 1 GGTCTGAGAGTCTGTGAAGATGGCCOVARC1000060/cds = (319, 696) CAGTCTTCTATCCCCCACCTAAAAA 1431 Table 3AHs.77502 BC001854 12804818 Homo sapiens, methionine 1GGTACAGAGAAGCCAGCTTGTTTACA adenosyltransferase II, alpha,TGCTTATTCCATGACTGCTTGCCC clone MGC:4537 IMAGE:3010820, mRNA, completecds/cds = (116, 1303) 1432 Table 3A Hs.77502 BC001854 12804818 Homosapiens, methionine 1 GGTACAGAGAAGCCAGCTTGTTTACA adenosyltransferase II,alpha, TGCTTATTCCATGACTGCTTGCCC clone MGC:4537 IMAGE:3010820, mRNA,complete cds/cds = (116, 1303) 1433 Table 3A Hs.13580 BC001909 12804912Homo sapiens, clone 1 GGGAGAATGAATGTGCAACGTGGCT IMAGE:3537447, mRNA,GAAATCTATTTTGTGTAATAAAAGG partial cds/cds = (0, 790) 1434 Table 3AHs.157236 BC001913 12804920 Homo sapiens, clone 1CCCCACCACCCCATTACCACAGCTGC MGC:3015 IMAGE:3162543,CTTTGTGTGTTTGTGTCAATAAAA mRNA, complete cds/cds = (332, 1234) 1435 Table3A Hs.318885 BC001980 12805046 superoxide dismutase 2, 1CCAGCAAGATAATGTCCTGTCTTCTA mitochondrial (SOD2),AGATGTGCATCAAGCCTGGTACAT mRNA/cds = (4, 672) 1436 Table 3A Hs.288061BC002409 12803202 actin, beta (ACTB), 1 CCAACTTGAGATGTATGAAGGCTTTTmRNA/cds = (73, 1200) GGTCTCCCTGGGAGTGGGTGGAGG 1437 Table 3A Hs.284214BC002435 12803242 putative zinc finger protein 1GCTACTAGAGAGCAAGGGGCTTTCTT (LOC55818), mRNA/cds =ACCACCAGTGCTGAGGAGAAAAGT (299, 3937) 1438 Table 3A Hs.334822 1280327012803270 Homo sapiens, Similar to 1 ACCAAGAAACCAGCCCCTGAAA ribosomalprotein L4, AGAAGCCTGCAGAGAAGAAACCTA clone MGC:2966 CTAC IMAGE:3139805,mRNA, complete cds/cds = (1616, 2617) 1439 Table 3A Hs.104879 BC00253812803428 Homo sapiens, serine 1 TTTCCTCATCTATGAATTGTCATTCAC (orcysteine) proteinase ACACCTACTTTTCTGCTTCGTTT inhibitor, clade B(ovalbumin), member 9, clone MGC:2131 IMAGE:3140427, mRNA, completecds/cds = (92, 1222) 1440 Table 3A Hs.104879 BC002538 12803428 Homosapiens, serine 1 TTTCCTCATCTATGAATTGTCATTCAC (or cysteine) proteinaseACACCTACTTTTCTGCTTCGTTT inhibitor, clade B (ovalbumin), member 9, cloneMGC:2131 IMAGE:3140427, mRNA, complete cds/cds = (92, 1222) 1441 Table3A Hs.146409 BC002711 12803746 cell division cycle 42 1AATAATGACAAATGCCCTGCACCTAC (GTP-binding protein, 25 kD)CCACATGCACTCGTGTGAGACAAG (CDC42), mRNA/cds = (69, 644) 1442 Table 3AHs.322824 BC002746 12803812 Homo sapiens, Similar to 1GTGCCCCTGTGGGTCCCAGGGAGGT dodecenoyl-Coenzyme A deltaCTTAAACAAGGTATTTTTCAACTTA isomerase (3.2 trans enoyl- Coenzyme Aisomerase), clone MGC:3903 IMAGE:3830566, mRNA, complete cds/cds = (15,872) 1443 Table 3A Hs.46448 BC002796 12803898 lymphoblastic leukemiaderived 1 CAGTGAAGACGTCAGGGGCAAGGTC sequence 1 (LYL1),TCGGGGGTCCGGAAGGGTGATCATC mRNA/cds = (0, 803) 1444 Table 3A Hs.322404BC002837 12803976 hypothetical protein MGC4175 1TGCAAGGGAGACATATCCTAGATCAC (MGC4175), mRNA/cds =TTTGCTTTTTCTTTAAGGAGCTGA (221, 577) 1445 Table 3A Hs.288036 BC00284512803990 tRNA isopentenylpyrophosphate 1 TGCATCGTAAAACCTTCAGAAGGAAAtransferase (IPT), GGAGAATGTTTTGTGGACCACTTT mRNA/cds = (60, 1040) 1446Table 3A Hs.318693 BC002887 12804028 Homo sapiens, clone 1TTGGGGGAGGTTAGGGACTTATCCT IMAGE:3940519, mRNA, GTGCTTGTAAATAAATAAGGTCATGpartial cds/cds = (0, 902) 1447 Table 3A Hs.181309 BC002900 12804094proteasome (prosome, macropain) 1 ACTTGGCTGCCATAGCATAACAATGA subunit,alpha type, 2 (PSMA2), AGTGACTGAAAAATCCAGAATTTC mRNA/cds = (0, 704) 1448Table 3A Hs.96757 12804148 12804148 suppressor of Ty (S. cerevisiae) 3 1AAAATATTAAACACAAACTACCACCTA homolog (SUPT3H), CCTCCCTCACCAAAGCCCATAAAmRNA/cds = (71, 1024) 1449 Table 3A Hs.1600 BC002971 12804224 Homosapiens, clone 1 AGCTGTTTGGTAACCATAGTTTCACT IMAGE:3543711, mRNA, partialTGTTCAAAGCTGTGTAATCGTGGG cds/cds = (0, 1620) 1450 Table 3A Hs.1600BC002971 12804224 Homo sapiens, clone 1 AGCTGTTTGGTAACCATAGTTTCACTIMAGE:3543711, mRNA, partial TGTTCAAAGCTGTGTAATCGTGGG cds/cds = (0,1620) 1451 Table 3A Hs.75193 BC003090 13111846 COP9 homolog (COP9), 1TGTCGCCTTTTAGAAGGAGAAACTTA mRNA/cds = (49, 678) AGTGTGGAATGCATTATATGGGCA1452 Table 3A Hs.334861 BC003137 13111932 hypothetical protein FLJ230591 TCCTTGGCAGCTGTATTCTGGAGTCT (FLJ23059), mRNA/cds =GGATGTTGCTCTCTAAAGACCTTT (41, 1681) 1453 Table 3A Hs.326456 BC00335213097158 hypothetical protein FLJ20030 1 TTTGGAGTGGAGGCATTGTTTTTAAG(FLJ20030), mRNA/cds = AAAAACATGTCATGTAGGTTGTCT (1, 1239) 1454 Table 3AHs.77091 NM_006730 5803006 deoxyribonuclease I-like 1 1TGGCTGGGACGCTAGAAGGGTCATG (DNASE1L1), mRNA/cds =TGTTAACTATAATCACATTTATGGT (794, 1702) 1455 Table 3A Hs.24697 BC00340613097305 cDNA FLJ20709 fis, clone 1 ATTCTGGTTAACCGCTCACATGCATA KAIA1124,highly similar to ACAATAATGCTAGAAATTCAGGAA D86324 mRNA for CMP-N-acetylneuraminic acid/cds = UNKNOWN 1456 Table 3A Hs.42712 BC00352513097617 Homo sapiens, Similar to 1 TGCTGATTTCTAGTGTATACTCTGTA Max,clone MGC:10775 GTCTCAGTTCGTGTTTGATTCCAT IMAGE:3807261, mRNA, completecds/cds = (115, 570) 1457 Table 3A Hs.5322 BC003583 13097716 guaninenucleotide binding 1 AAATGAATCTTTCAAAGGTTTC protein (G protein), gamma 5CCAAACCACTCCTTATGATCCAG (GNG5), mRNA/cds = TGATA (333, 539) 1458 Table3A Hs.334861 BC003577 13097758 hypothetical protein FLJ23059 1TCCTTGGCAGCTGTATTCTGGAGTCT (FLJ23059), mRNA/cds =GGATGTTGCTCTCTAAAGACCTTT (41, 1681) 1459 Table 3A Hs.56851 BC00358113097767 hypothetical protein MGC2668 1 TGCGTGTGCCTCAGTTTCCTCCTCCA(MGC2668), mRNA/cds = CAACTGAATATTTATAGTGGCTGA (20, 325) 1460 Table 3AHs.188757 BC003897 13277575 Homo sapiens, clone MGC:5564, 1GGGATGTGGAGGATTTTTGTTAAGTG mRNA, complete cds/cds =TCAATCGAAGTTAAAAAGCAAGGG (227, 304) 1461 Table 3A Hs.215595 BC00418613278842 guanine nucleotide binding protein 1 AGCTCTCTGCACCCTTACCCCTTTCC(G protein), beta polypeptide 1 ACCTTTTGTATTTAATTTTAAAGT (GNB1),mRNA/cds = (280, 1302) 1462 Table 3A Hs.111334 BC004245 13279004 PRO2760mRNA, complete cds 1 CCCTCCAGCCAATAGGCAGCTTTCTT /cds = UNKNOWNAACTATCCTAACAAGCCTTGGACC 1463 Table 3A Hs.70333 BC004258 13279043 mRNAfor KIAA1844 protein, 1 CGTGGTTGTGGGAGGGGAAAGAGGA partial cds/cds = (0,1105) AACAGAGCTAGTCAGATGTGAATTG 1464 Table 3A Hs.9788 BC004317 13279217hypothetical protein MGC10924 1 ACAATGTGTTAGCAGAAACCAGTGGG similar toNedd4 WW-binding TTATAATGTAGAATGATGTGCTTT protein 5 (MGC10924), mRNA/cds= (104, 769) 1465 Table 3A Hs.254105 BC004458 13325288 enolase 1,(alpha) (ENO1), 1 GCTAGATCCCCGGTGGTTTTGTGCTC mRNA/cds = (94, 1398)AAAATAAAAAGCCTCAGTGACCCA 1466 Table 3A Hs.155101 BC004521 13325447 mRNAfor KIAA1578 protein, 1 ACAAATTTCTTGGCTGGATTTGAAGC partial cds/cds = (0,3608) TTAAACTCCTGTGGATTCACATCA 1467 Table 3A Hs.17132 BC004805 13937690602326876F1 cDNA, 5′ end 1 GCTGTGGTTGGTTGCATTACATGACA /clone =IMAGE:4427970/ CAGAAAACTGTCCTCTACCTCACG clone_end = 5′ 1468 Table 3AHs.103378 BC004872 13438100 hypothetical protein MGC11034 1GCCCTGGTAGGCTCCTTTAGAAGGA (MGC11034), mRNA/cds =CCATTTCTGTTCCTAGAGCTTAACT (245, 840) 1469 Table 3A Hs.151242 BC00490013438172 serine (or cysteine) proteinase 1 GGCATCGCCCATGCTCCTCACCTGTAinhibitor, clade G (C1 inhibitor), TTTTGTAATCAGAAATAAATTGCT member 1(SERPING1), mRNA/cds = (60, 1582) 1470 Table 3A Hs.74335 BC00492813436256 heat shock 90 kD protein 1, 1 TTTCCCTCTCCTGTCCTTGTGTTGAA beta(HSPCB), GGCAGTAAACTAAGGGTGTCAAGC mRNA/cds = (0, 2174) 1471 Table 3AHs.336916 BC004994 13436445 death-associated protein 6 1AGACTGGAAATGGGGATGAGGGTGT (DAXX), mRNA/cds = AAATTGTATTGAAAAAGATCGCGAA(147, 2369) 1472 Table 3A Hs.60377 BC005101 13937700 mRNA for KIAA1298protein, 1 CCATGAGTTGTTTGGTTTTCCAGAAG partial cds/cds = (55, 2271)CTGCCAGTGGGTTCCCGTGAATTG 1473 Table 3A Hs.99858 BC005128 13477308ribosomal protein L7a (RPL7A), 1 GATACGATGAGATCCGCCGTCACTG mRNA/cds =(31, 831) GGGTGGCAATGTCCTGGGTCCTAAG 1474 Table 3A Hs.177507 BC00518713528770 hypothetical protein (HSPC155), 1 AGTCTTTCTGGTTTCTGGAGATAACCmRNA/cds = (240, 743) CATCAATAAAGCTGCTTCCTCTGG 1475 Table 3A Hs.251531BC005361 13529190 proteasome (prosome, macropain) 1CGATGATGGTTACCCTTCATGGACGT subunit, alpha type, 4 (PSMA4),CTTAATCTTCCACACACATCCCCT mRNA/cds = (59, 844) 1476 Table 3A Hs.100000BC005928 13543538 S100 calcium-binding protein A8 1GGCCCCTGGACATGTACCTGCAGAA (calgranulin A) (S100A8),TAATAAAGTCATCAATACCTAAAAA mRNA/cds = (55, 339) 1477 Table 3A Hs.334573BC006008 13937718 clone IMAGE:4285740, 1 GCAAACCTGCAGATTCCCAAGATGTTmRNA/cds = UNKNOWN CACGAGCTTGTGCTTTCTAAAGAA 1478 Table 3A Hs.101150BC006176 13544094 clone IMAGE:4054158. 1 TCCCCATTGTGCCGCCTTTATCAATTGCCTGTTTTGTTTTGTTTGTTTTT 1479 Table 3A Hs.108824 BC006282 13623362hypothetical protein MGC10540 1 CTTTAGCTGCTGTTGCCTCCCTTCTC (MGC10540),mRNA/cds = AGGCTGGTGCTGGATCCTTCCTAG (49, 579) 1480 Table 3A Hs.239884BC008464 13623874 H2B histone family, member L 1CTGCTTATGGCACAATTTGCCTCAAA (H2BFL), mRNA/cds = (0, 380)ATCCATTCCAAGTTGTATATTTGT 1481 Table 3A Hs.19574 BC006849 13905123hypothetical protein MGC5469 1 CTGCTTCTGGGTGCATGGTAGACTTT (MGC5469),mRNA/cds = GTGGCATTTGATACAACTTGGACA (69, 1124) 1482 Table 3A Hs.252716BC007004 13937807 oxysterol-binding protein-related 1CTTATAGTATTTATCCACCCAAACCC protein 1 (FLJ10217),CAGACTGAGATACTGCTCCCAGGG mRNA/cds = (174, 3026) 1483 Table 3A Hs.180909BC007063 13937906 peroxiredoxin 1 (PRDX1), 1 GAGAGACCAGCCTTTCTTCCTTTGGTmRNA/cds = (60, 659) AGGAATGGCCTGAGTTGGCGTTGT 1484 Table 3A Hs.238730BC007203 13938171 hypothetical protein MGC10823 1CAGAGGTGGGAGTAACTGCTGGTAG (MGC10823), mRNA/cds =TGCCTTCTTTGGTTGTGTTGCTCAG (63, 1235) 1485 Table 3A Hs.334837 BC00727713938298 hypothetical protein MGC15619 1 CTGTGTGCCCCAGCTGCATCAGCCA(MGC15619), mRNA/cds = GCTTCTAGGTGGCTCCATTGTTTTC (744, 1454) 1486 Table3A Hs.298262 BE250027 9120132 ribosomal protein S19 (RPS19), 1AGAGCAGAATAGCAATATAAGAGCAC mRNA/cds = (69, 506) AGACGAACATAGACACGACAGCGA1487 Table 3A Hs.297095 BE253125 9123276 601116648F1 cDNA, 5′ end 1CTATTAGGACCCAGTGATTATGCTAC /clone = IMAGE:3357178/CTTGGCACGGTTAGGGTACTGCGG clone_end = 5′ 1488 Table 3A NA BE2533389123402 cDNA clone IMAGE:3357826 5′ 1 AAAGAAGCATGCACACTTATCACAAACAACTCTCTCAGGTGGCCAGTCTG 1489 Table 3A Hs.75313 BE254064 9124489aldo-keto reductase family 1, 1 TGCTGCCTATATGAAGTCTTTGAGAA member B1(aldose reductase) AGCCCCTCTTGGAGTCTGTGCCTT (AKR1B1), mRNA/cds = (45,995) 1490 Table 3A Hs.314898 BE255377 9125816 601115405F1 cDNA, 5′ end 1GATATACGAGGACAAAACCCATCTAC /clone = IMAGE:3355872/CAGGCAGCTAACAAACCGCCGCCA clone_end = 5′ 1491 Table 3A Hs.296183 BE2594809129918 601106571F1 cDNA, 5′ end 1 GCCACTTTATTAGTAATGGTCGATAG /clone =IMAGE:3342929/ TCCGAATCGATGGCTAGGGTGACT clone_end = 5′ 1492 Table 3AHs.301809 BE260041 9131017 601150579F1 cDNA, 5′ end 1TAATCTGGCGGGTTATACCCCCGTGT /clone = IMAGE:3503419/TCTCCGGATTATATTTCGGGACAC clone_end = 5′ 1493 Table 3A Hs.308154 BE2645849138121 601192330F1 cDNA, 5′ end 1 GCTGGATTTGTGGGTATGGGGGCGG /clone =IMAGE:3536383/ TTTTTGGGCGAAGGTTGGTTGTTAC clone_end = 5′ 1494 Table 3AHs.279429 BE279328 9154319 601157666F1 cDNA, 5′ end 1CCACATCATCGGGGGCGAAATAGAA /clone = IMAGE:3504328/GCCCAGAGAGAGGCTAGGTGTAGGA clone_end = 5′ 1495 Table 3A Hs.95835 BE2927939175433 RST8356 cDNA 1 AGGGAGACTCTCAGCCTTCAGCTTCCTAAATTCTGTGTCTGTGACTTTCG 1496 Table 3A Hs.142737 BE293343 9176482601143758F1 cDNA, 5′ end 1 TTGTCAAGCTGCTGCTGTCTTCAAGA /clone =IMAGE:3051493/ TCTACCTGGTCAGAATCTCCTGCT clone_end = 5′ 1497 Table 3AHs.337988 BE297329 9180903 Homo sapiens, clone MGC:17431 1GGCCAGTCTCTATGTGTCTTAATCCC IMAGE:2984883, mRNA, TTGTCCTTCATTAAAAGCAAAACTcomplete cds/cds = (1338, 1494) 1498 Table 3A Hs.192755 BE298181 9181768601118566F1 cDNA, 5′ end 1 TCTCTCACATTCTGTCTTTCCCCTCCT /clone =IMAGE:3028193/ CCTTCACCTTCCCTCCGTCCCTC clone_end = 5′ 1499 Table 3AHs.336628 BE311727 9148186 ribosomal protein L36a (RPL36A), 1ACACGAGACTATAGAGAATGCAGCAC mRNA/cds = (30, 350) ACAGATGAGAGCAGAGCAAATAGA1500 Table 3A Hs.129872 BE379820 9325198 sperm associated antigen 9 1GCATCCAGATGGTGGTTTACTCTGCA (SPAG9), mRNA/cds = ACAGTCTAATGTTCTTCACTTCCA(110, 2410) 1501 Table 3A Hs.231510 BE407125 9343575 601301818F1 cDNA,5′ end 1 GGGGTTTTCACCCTACCTAAAGATGC /clone = IMAGE:3636412/TTTAATTGCTGTTTTCCAAATTGT clone_end = 5′ 1502 Table 3A Hs.315263 BE4101059346555 601302278F1 cDNA, 5′ end 1 ATGCCTAACAAGCAACATGATCCTAT /clone =IMAGE:3837002/ AAATCCACCCCAAGCCAATCTGGT clone_end = 5′ 1503 Table 3AHs.258494 BE531180 9759916 Homo sapiens, Similar to 1CCACCATCTGGTACGTTTTTACTTCC hypothetical protein FLJ22376,TCACCCGCGTGTACTCCGATTACC clone MGC:16044 IMAGE:3610443, mRNA, completecds/cds = (478, 1776) 1504 Table 3A Hs.13328 BE537908 9766464602268829F1 cDNA, 5′ end 1 GAGTATATTCCCCCAGTTATTTGCTC /clone =IMAGE:4356968/ TTCCCCACACAGGGTGGTAGTACC clone_end = 5′ 1505 Table 3AHs.125819 BE538333 9766978 putative dimethyladenosine 1CAAAGGAAGGGGCGTGAAGGGGTGA transferase (HSA9761),GAAAAATATGGGACCCAAATTGTGG mRNA/cds = (78, 1019) 1506 Table 3A Hs.5122BE539096 9767741 602293015F1 cDNA, 5′ end 1 TTTCCTTACAGGCGGTAACACCGGTC/clone = IMAGE:4387778/ CACACAGTTCTTGCCAAAACAAAG clone_end = 5′ 1507Table 3A Hs.180549 BE540238 9768883 601059809F1 cDNA, 5′ end 1AATTTTCTCTCACCTCATCACTCGGG /clone = IMAGE:3448283/ACCTCCCCAGTGATAATAACCCGG clone_end = 5′ 1508 Table 3A Hs.155101 BE5475849776229 mRNA for KIAA1578 protein, 1 GCGGGTGTAAGGGGATATCTTGATAA partialcds/cds = (0, 3608) ACTGGAGCCCAGGAAGATTACAAA 1509 Table 3A Hs.74861BE549137 9777782 activated RNA polymerase II 1ACGCCGACAATCAAGAAAATGTGAGT transcription cofactor 4 (PC4),TATAACGGACAAGGTTGTATTATG mRNA/cds = (0, 383) 1510 Table 3A NA BE5691419812861 cDNA clone IMAGE:3681180 5′ 1 GATATTGGTAGTAAAGGGGTTACCTGTGAACTTCCAAAATTCCTTGGGGC 1511 Table 3A NA BE612847 9894444 601452239F15′ end 1 TAAAGATGTCCGGGTACACTTCGCCA /clone = IMAGE:3856304AGGGTTAGCGTCTTTGGGCATTTC 1512 Table 3A Hs.194362 BE618004 9888942 DNAsequence from clone RP11- 1 TCCTAATTTCTTCTGTGAACCTTCTCA 248N6 onchromosome 13 AATCCCCCAGCATGCGTGTAGTG Contains ESTs, STSs and GSSs.Contains two olfactory receptor pseudogenes, an NPM1 (nucleophosmin,nucleolar phosphoprotein B23, numatrin) pseudogene and a BCR (breakpointcluster region) pseudogene/cds = (0, 887) 1513 Table 3A Hs.294309BE821121 9892059 601493943F1 cDNA, 5′ end 1 CTGCATGATGTCATCAACCTGCTGTA/clone = IMAGE:3896051/ GTGCGGAAACGACCACAACACACA clone_end = 5′ 1514Table 3A Hs.184582 BE730026 10144018 ribosomal protein L24 (RPL24), 1AAAGACGAACGAGACACGAAAGCAA mRNA/cds = (39, 512) CGAACGAACACAGAGCACGCCGCAC1515 Table 3A Hs.76572 BE730376 10144368 ATP synthase, H+ transporting,1 TTTCAACACGCATCCCTTATGGGCGA mitochondrial F1 complex,ACTGTCCTCAAACAACAACAAGTG O subunit (oligomycin sensitivity conferringprotein) (ATP5O), mRNA/cds = (38, 677) 1516 Table 3A Hs.77496 BE73724810151226 small nuclear ribonucleoprotein 1 TAGGACGAGAAACGAAGAAGGACAGpolypeptide G (SNRPG), AGCGAGAACAAGTAAGCAGGGACAC mRNA/cds = (83, 313)1517 Table 3A Hs.271272 BE737348 10151340 DKFZp434K1715_r1 cDNA, 1GGTGGAGAATCAAAACGACCCCGCA 5′ end/clone = AATAAACATGGCGATTTGGCTTGGGDKFZp434K1715/ clone_end = 5′ 1518 Table 3A Hs.58066 BE739287 10153279602389077F1 cDNA, 5′ end 1 TGGCCTTTTAAATAACTGGGCTTCTC /clone =IMAGE:4517875/ ACAACCATAGTGAACAGAAACAGC clone_end = 5′ 1519 Table 3AHs.127951 BE745645 10159837 hypothetical protein FLJ14503 1ATTGTGACATGGTGATGCCTCATTGC (FLJ14503), mRNA/cds =TGATATGGTCCTGTGGTTATGTGC (19, 2217) 1520 Table 3A Hs.276718 BE74721010161202 601473284T1 cDNA, 3′ end 1 GGAAGAGATAACACCACAAC /clone =IMAGE:3876165/ GAAAGAGCAGGCAAGAGAGACCAA clone_end = 3′ AGCACA 1521 Table3A Hs.285647 BE747224 10161216 cDNA FLJ14704 fis, clone 1GGTAAAAGGCGTTACTCTCCGCCCTC NT2RP3000526/cds = TTCAAGGAACGGCCAAGAGTATAAUNKNOWN 1522 Table 3A Hs.293842 BE748123 10162115 601571679F1 cDNA, 5′end 1 ACCCAAGGGTCTCGCCAGTGGGGTT /clone = IMAGE:3838875/AAGTCACAATATTACTACACAAGGG clone_end = 5′ 1523 Table 3A Hs.283874BE778549 10199747 hypothetical protein MGC2495 1ACAGTACACAATCACCTGCAAGGGAC (MGC2495), mRNA/cds =ATAGCACACAAACCGCTAAAGAGG (0, 416) 1524 Table 3A Hs.61472 BE77928410200482 601464557F1 cDNA, 5′ end/ 1 TCTCACAGCGAGAGGAGGAGACGGG clone =IMAGE:3867566/clone_end = ATGACCGAGAGGTAGACGATTATAC 5′ 1525 Table 3AHs.43273 BE781009 10202207 602642428F1 cDNA, 5′ end/ 1CGCTGGTGTTGTCCCCAAGTGATTTA clone = IMAGE:4773534/clone_end =TTCTACTGGAGTGCCTGGTGTCTT 5′ 1526 Table 3A Hs.102558 BE781611 10202895601467463F1 cDNA, 5′ end/ 1 TTCCGGCTTTTAACAAACACACACCA clone =IMAGE:3870902/clone_end = CACTAACACAACAACACAAACAAA 5′ 1527 Table 3AHs.40334 BE782824 10204022 602557448F1 cDNA, 5′ end/ 1AAGACTTGCCTCTTTAAAATTGCTTTG clone = IMAGE:4686562/clone_end =TTTTCTGCAGTACTATCTGTGGT 5′ 1528 Table 3A Hs.79914 BE783628 10204826lumican (LUM), mRNA/cds = (84, 1 GAACTCGTCCACTCTTCTCGGGCCAC 1100)TATTCTGGTTCAGGGAATCTTGGG 1529 Table 3A Hs.135056 BE786820 10208018 DNAsequence from clone RP5-850E9 1 AGCAATAAACCGAAGCAGCTAGACAG on chromosome20. Contains part of CGAAGAAGTACAGCAAAGAGACGA the gene for a novel C2H2type zinc finger protein similar to Drosophila Scratch (Scrt), Slug andXenopus Snail, a novel gene similar to Drosophila CG6762, STSs, GSSs andfive CpG islands/cds = (0, 397) 1530 Table 3A Hs.11355 BE788546 10209744thymopoietin (TMPO), mRNA/ 1 CGCCCATACTAGAGAAGTTTGCCCTC cds = (204,2288) TATTGTCTCTCACACCACAATGAG 1531 Table 3A Hs.75458 BE790474 10211672ribosomal protein L18 (RPL18), 1 CACAGACATCCACGGACACAAAAGG mRNA/cds =(15, 581) CGGGGACCACCACCACAATGAACAC 1532 Table 3A Hs.20225 BE79212510213323 tuftelin-interacting protein (TIP39), 1GCGTCGATTGATATCAGACAGCATCG mRNA/cds = (263, 2776)TCTCTGCGAGCACAAAGATCTGTT 1533 Table 3A Hs.11607 BE794595 10215793602429913F1 cDNA, 5′ end/ 1 GGAACAGGGTTAATGGCCAGGCCCT clone =IMAGE:4547787/clone_end = TTGCCGCCCCTTTTAAAGGGAATCC 5′ 1534 Table 3AHs.58297 BE867841 10316617 CLLL8 protein (CLLD8), mRNA/ 1ACAGAGTAACATGGGATATGGGTATG cds = (825, 2984) AGTGGGATGTGCTGAGAAGGAACT1535 Table 3A Hs.179703 BE868349 10317165 tripartite motif protein 13(TRIM14), 1 GGGGGCAAAGAAAGTACATTGGGTG mRNA/cds = (10, 1230)AAAATTTAAAAAGGTATGGAGCATT 1536 Table 3A NA BE871962 10320738 601448005F1cDNA, 5′ end/ 1 CAAACGAACAGCGAAGACAA clone = IMAGE:3852001CAACTCACGATGCTGCACAACGCGA CCAAC 1537 Table 3A Hs.31314 BE872245 10321021retinoblastoma-binding protein 7 1 ACATTTTATAAGGCATTTGTGTTAGCC (RBBP7),mRNA/cds = (287, 1584) ACTCAGTCATCTTTGGGTGCTGC 1538 Table 3A Hs.47334BE872760 10321536 hypothetical protein FLJ14495 1GTCACAGCAACGTGTCGCTCCCCAG (FLJ14495), mRNA/cds = (83, 1141)ATCATTTATTAGCGTCGATTGTTGT 1539 Table 3A Hs.8820 BE875609 10324385602418418F1 cDNA, 5′ end/ 1 ATTCCAAACGGGATCTGCTGAGACCT clone =IMAGE:4525397/clone_end = CACAGAGGTGGGCCGCGATTATAA 5′ 1540 Table 3AHs.158164 BE876375 10325061 transporter 1, ATP-binding cassette, 1CCTAGGGTGAAACACGTGACAGAAG sub-family B (MDR/TAP) (TAP1),AATAAAGACTATTGAATAGTCCTCT mRNA/cds = (30, 2456) 1541 Table 3A Hs.237868BE877115 10325891 interleukin 7 receptor (IL7R), mRNA/ 1CCAGCCTTTGCCTCTTCCTTCAATGT cds = (22, 1401) GGTTTCCATGGGAATTTGCTTCAG1542 Table 3A Hs.24181 BE877357 10326133 601485590F1 cDNA, 5′ end/ 1CCCCTTGTTTACTCTGTCTGTATGTAT clone = IMAGE:3887951/clone_end =GTCAAAAGCGTGGCAAAACCTCT 5′ 1543 Table 3A Hs.237868 BE878973 10327749interleukin 7 receptor (IL7R), mRNA/ 1 CATGATCTCAGAGGAAACTGTCGCTG cds =(22, 1401) ACCCTGGACATGGGTACGTTTGAC 1544 Table 3A NA BE879482 13959823mitochondrion, complete genome 1 CCTCTACCTGCACGACAATACATAATGACCCACCAATCACATGCCTATCA 1545 Table 3A NA BE881113 10329889 cDNA cloneIMAGE:3894308 5′ 1 ATTTGGAAGCGCCACCCTAGCAAATA TACAAACCATTAAACCTTCCCTCT1546 Table 3A Hs.323950 BE881351 10330127 zinc finger protein 6 (CMPX1)(ZNF6), 1 TTTACCAATGATTTTCAGGTGACCTG mRNA/cds = (1265, 3361)GGCTAAGTCATTTAAACTGGGTCT 1547 Table 3A Hs.111554 BE882335 10331111ADP-ribosylation factor-like 7 (ARL7), 1 AGTTTACATCGACAGCATATCCACmRNA/cds = (14, 592) TGATTTCTAAATGGGCTGGTCCCA 1548 Table 3A NA BE88489810333674 cDNA clone IMAGE:3908551 5′ 1 ATCTGGAGTGGGACCCTTCAAACCATGTCTGTGCTTATGCGGGAAACAAT 1549 Table 3A Hs.142838 BE886127 10340315nucleolar protein interacting with the 1 GCGGAGAGAAGAAGAGGTAGATATG FHAdomain of pKi-67 (NIFK), AGAACAGTGTGTGGTATATGATAGT mRNA/cds = (54, 935)1550 Table 3A Hs.301488 BE886472 10340792 601509888F1 cDNA, 5′ end/ 1GAAATCCCACCGGCAAGTTAAGGTCA clone = IMAGE:3911301/clone_end =CGGAGCAAGTGAATAAACGCGGAG 5′ 1551 Table 3A Hs.250824 BE887646 10343176cDNA: FLJ23435 fis, clone HRC12631/ 1 GTGATCAAACAAATTCACAGCACAGA cds =UNKNOWN CACCGCGCAACAACGCAACTTCTC 1552 Table 3A Hs.320836 BE88830410344472 60154033F1 cDNA, 5′ end/ 1 GGTATTTGTGTTGTTGAGTATTGTGT clone =IMAGE:3915177/clone_end = CTGGGTGTGGGTATTTGATTCTTT 5′ 1553 Table 3AHs.169274 BE888744 10345354 AL528777 cDNA/ 1 GGGTTCGTCCAGGGCTGCGCTAAATclone = CS0DD001YG24-(3-prime) TATTCTCAATGATTTGTCTCTTTGC 1554 Table 3AHs.71941 BE889075 10346019 hypothetical protein MGC15677 1CAATGACGCAGTCGGACCCTCGGAT (MGC15677), mRNA/cds = (298, 807)CCAAGTCCTGCTTTGGGTGTGGACC 1555 Table 3A Hs.188757 BE891242 10350376 Homosapiens, clone MGC:5564, 1 GGGTTATAATAGATGGACGGGTCTTT mRNA, completecds/cds = (227, 304) CACGGTGGTGACAGCACCCTTTCC 1556 Table 3A Hs.171802BE891269 10350433 RST31551 cDNA 1 TCCGCTGCAATTTGAGTTTAGCTTTACAGATTGTGCCGGGTGTTTAACCT 1557 Table 3A Hs.4055 BE891928 10351744 mRNA,cDNA DKFZp564C2063 (from 1 CTCCTTCCCAAAGACTTGAGTGGAAC cloneDKFZp564C2063)/ TTCCCTTTCATGTGCGTATCGGTC cds = UNKNOWN 1558 Table 3AHs.3297 BE895166 10358288 ribosomal protein S27a (RPS27A), 1AAATTAGTCGCCTTCGTCGAGAGTGC mRNA/cds = (38, 508) CCTTCTGATGAATGTGGTGCTGGG1559 Table 3A NA BE896691 10361375 cDNA clone IMAGE:3925062 5′ 1GACAGTACTCCTAAGACCCCTGTGTG TGTCCCGATGAGATCATGACTGGG 1560 Table 3A NANC_001807 13959823 COX2 gene of mitochondria 1CATGCCCATCGTCCTAGAATTAATTC CCCTAAAAATCTTTGAAATAGGGC 1561 Table 3A NABE899595 10367264 cDNA clone IMAGE:3952215 5′ 1GGCGTATCATCAACTGGTGAGCCCG AAGGGATATTATTTCTAAGGCCTCT 1562 Table 3AHs.285122 BE901218 10390179 Homo sapiens, hypothetical protein 1CCAGAATCGTAAGGGGGCTGACGGA FLJ21839, clone MGC:2851GGATGAGAGGGGGCACCCAGAGATC IMAGE:2967512, mRNA, complete cds/cds = (444,2618) 1563 Table 3A Hs.293515 BE905040 10397924 602286727T1 cDNA, 3′end/ 1 CGGTGTTTTCTGATCGGTTTTTGTTTT clone = IMAGE:4375662/clone_end =CTGCTTACATATGATGTACTTGT 3′ 1564 Table 3A Hs.278704 BE973840 10567176RST30930 cDNA 1 ACAGAATGCAGCGGTGCAACACCGG CAAGGTTCCACACGCCACAAAGAAA 1565Table 3A Hs.217493 D00017 219909 annexin A2 (ANXA2), mRNA/ 1TGGAAGTGAAGTCTATGATGTGAAAC cds = (49, 1068) ACTTTGCCTCCTGTGTACTGTGTC1566 Table 3A Hs.25 D00022 219653 Homo sapiens, Similar to ATP 1CCAAAAAGCTTCATTTTTCTATATAGG synthase, H+ transporting,CTGCACAAGAGCCTTGATTGAAG mitochondrial F1 complex, beta polypeptide,clone MGC:19754 IMAGE:3629237, mRNA, complete cds/cds = (12, 1601) 1567Table 3A Hs.76549 D00099 219941 mRNA for Na, K-ATPase alpha- 1TCACAAGACAGTCATCAGAACCAGTA subunit, complete cds/cds = (318, 3389)AATATCCGTCTGCCAGTTCGATCA 1568 Table 3A Hs.76549 D00099 219941 mRNA forNa, K-ATPase alpha- 1 TCACAAGACAGTCATCAGAACCAGTA subunit, completecds/cds = (318, 3389) AATATCCGTCTGCCAGTTCGATCA 1569 Table 3A Hs.154890D10040 219899 fatty-acid-Coenzyme A ligase, long- 1GCTGTCATTTGTACATTTAAAGCAGC chain 2 (FACL2), mRNA/TGTTTTGGGGTCTGTGAGAGTACA cds = (13, 2109) 1570 Table 3A Hs.46 D10202219975 platelet-activating factor receptor 1 TATCCTGAGTCCCTTAATCTTATGGG(PTAFR), mRNA/cds = (25, 1053) GCCGGAAGGAATGTCAGGGCCAGG 1571 Table 3AHs.155342 D10495 520586 protein kinase C, delta (PRKCD), 1CTCTGCCTTCGGAGGGAAATTGTAAA mRNA/cds = (58, 2088)TCCTGTGTTTCATTACTTGAATGT 1572 Table 3A Hs.330716 D10522 219893 cDNAFLJ14368 fis, clone 1 AAACTCCTGCTTAAGGTGTTCTAATTT HEMBA 1001122/cds =UNKNOWN TCTGTGAGCACACTAAAAGCGAA 1573 Table 3A Hs.137555 D10923 219866putative chemokine receptor, GTP- 1 GGGTGCACGTTCCTCCTGGTTCCTTC bindingprotein (HM74), mRNA/ GCTTGTGTTTCTGTACTTACCAAA cds = (60, 1223) 1574Table 3A Hs.301921 D10925 219882 chemokine (C—C motif) receptor 1 1GGGGTTGGGAGGAAGTGTCTACTAG (CCR1), mRNA/cds = (52, 1129)GAGGGTGGGTGAGATCTGTGTTGAT 1575 Table 3A Hs.238893 D11086 303611od15g01.s1 cDNA/ 1 ATCTACCCTCCGATTGTTCCTGAACC clone = IMAGE:1368048GATGAGAAATAAAGTTTCTGTTGA 1576 Table 3A Hs.61153 D11094 219930 proteasome(prosome, macropain) 1 AAGTCTTATGCCAAATTCAGTGCTAC 26S subunit, ATPase, 2(PSMC2), TCCTCGTTACATGACATACAACTG mRNA/cds = (66, 1387) 1577 Table 3AHs.38 D12614 219911 lymphotoxin alpha (TNF superfamily, 1CACACGGAGGCATCTGCACCCTCGA member 1) (LTA), mRNA/TGAAGCCCAATAAACCTCTTTTCTC cds = (140, 757) 1578 Table 3A Hs.333114D13316 286022 AV713318 cDNA, 5′ end/ 1 ACAACGTCGTGACTGGGAAAACCCT clone =DCAAAC09/clone_end = 5′ GGCGTTACCCAACTTAATCGCCTTG 1579 Table 3A Hs.15071D13627 286010 chaperonin containing TCP1, subunit 8 1CCAAGCCTCCAAGTGGGAAGAAAGA (theta) (CCT8), mRNA/cds = (28,CTGGGATGATGACCAAAATGATTGA 1674) 1580 Table 3A Hs.195614 D13842 285998splicing factor 3b, subunit 3, 130 kD 1 CAACTACTTGTGGCATGCATTGGCAC(SF3B3), mRNA/cds = (156, 3809) TCGGAATAAAGCGCACTATTGTCA 1581 Table 3AHs.2471 D13645 286008 KIAA0020 gene product (KIAA0020), 1GAAGGGGTAGGGTCCACCATACTGG mRNA/cds = (418, 1944)TAATTGGGGTACTCTGTATATGTGT 1582 Table 3A Hs.278573 D14041 2326266 H-2Kbinding factor-2 (LOC51580), 1 GCTCAGTTCCATATTTCATCCGTGAA mRNA/cds =(238, 1500) AAACTTGCAATACGAGCAGTTTCA 1583 Table 3A Hs.43910 D14043219924 CD164 antigen, sialomucin (CD164), 1 AATTGTCATTTACCTGGGTATGAATTCmRNA/cds = (79, 648) CCTGACACACATTCATGTCAACA 1584 Table 3A Hs.111894D14696 285962 lysosomal-associated protein 1 GTGACTTGACTGTGGAAGATGATGGTtransmembrane 4 alpha (LAPTM4A), TGCATGTTTCTAGTTTGTATATGT mRNA/cds =(148, 849) 1585 Table 3A Hs.232068 D15050 457560 transcription factor 8(represses 1 CAGTGCTGTAATACAGACGGCAATGC interleukin 2 expression)(TCF8), AATAGCCTATTTAAAGAACTACGT cds = (66, 1358) 1586 Table 3AHs.279607 D16217 303598 calpastatin (CAST), mRNA/ 1AGCTGGTGGATGGTGACTTTTGAAGA cds = (66, 1358) ACAAAAGGCTTTGGCAACAGAAAA1587 Table 3A Hs.146812 D16481 473711 hydroxyacyl-Coenzyme A 1TCTGTTGTCACTAAAGACTAAATGAG dehydrogenase/3-ketoacyl-CoenzymeGGTTTGCAGTTGGGAAAGAGGTCA A thiolase/enoyl-Coenzyme A hydratase(trifunctional protein), beta subunit (HADHB), mRNA/ cds = (46, 1470)1588 Table 3A Hs.50651 D17042 598768 Janus kinase 1 (a protein tyrosine1 GCGGAGTTGACCAAAATAATATCTGA kinase) (JAK1), mRNA/cds = (75,GGATGATTGCTTTTCCCTGCTGCC 3503) 1589 Table 3A Hs.180828 D17391 440365collagen, type IV, alpha 4 (COL4A4), 1 CATCTTGAACTTGGCCTGAGAACATTmRNA/cds = (208, 5280) TTCTGGGAAGAGGTAAGGGTGACA 1590 Table 3A Hs.176658D21090 498147 RAD23 (S. cerevisiae) homolog B 1TCTGTGGAATCTCCTTCATTGGCATT (RAD23B), mRNA/cds = (313, 1542)GTTATTTAATCATAAACGGGGCAG 1591 Table 3A Hs.75337 D21262 434764 mRNA forKIAA0035 gene, partial cds/ 1 TGTACTGTTCATGCTGACACAGATAT cds = (0, 2125)TTCAGTCTGCATGGTAAAAGTTCT 1592 Table 3A Hs.79768 D21853 434770 KIAA0111gene product (KIAA0111), 1 TAATGGGGTTTATATGGACTTTCTTCT mRNA/cds = (214,1449) CATAAATGGCCTGCCGTCTCCCT 1593 Table 3A Hs.334822 D23660 432358 Homosapiens, Similar to ribosomal 1 ACCAAGAAACCAGCCCCTGAAAA protein L4,clone MGC:2966 GAAGCCTGCAGAGAAGAAACCTA IMAGE:3139805, mRNA, completeCTAC cds/cds = (1816, 2617) 1594 Table 3A Hs.75512 D23662 432362 neuralprecursor cell expressed, 1 AGTCCTGTGTGCTTCCCTCTCTTATG developmentallydown-regulated 8 ACTGTGTCCCTGGTTGTCAATAAA (NEDD8), mRNA/cds = (99, 344)1595 Table 3A Hs.35804 D25215 517114 hect domain and RLD 3 (HERC3), 1ACCCACCACCTCTTGCACTCTCGCTT mRNA/cds = (166, 3318)TTGGAGCAAGTTGCATTAACTATT 1596 Table 3A Hs.173737 D25274 464185ras-related C3 botulinum toxin 1 TGACAGTTGCAGAATTGTGGAGTGTT substrate 1(rho family, small GTP TTTACATTGATCTTTTGCTAATGC binding protein Rac1)(RAC1), transcript variant Rac1b, mRNA/ cds = (0, 635) 1597 Table 3AHs.172199 D25538 436217 adenylate cyclase 7 (ADCY7), mRNA/ 1ATGACAGACACACGTATCTAACAAAC cds = (265, 3507) AAACAAACAGTGACCTTCTCCATG1598 Table 3A Hs.82502 D26018 436221 mRNA for KIAA0039 gene, partialcds/ 1 GCAAGGGATAATACAAATCCTATGAT cds = (0, 1475)CTCTATGCCCAATATGCTGCCTCA 1599 Table 3A Hs.169303 D26121 785998 mRNA forZFM1 protein alternatively 1 AGTACTTTTCACAGCGTGGCCTTTCA spliced product,complete cds/ CCATAATTTTATATTTCTCCCCCT cds = (382, 624) 1600 Table 3AHs.90315 D26488 452522 mRNA for KIAA0007 gene, partical 1TCTTAAGAGCCAGAGCCATATAAGCA cds/cds = (0, 2062) TCTTGGGAAAGCAAGTTTGAACCA1601 Table 3A Hs.17719 D28589 460714 EBP50-PDZ interactor of 64 kD 1AAGCCGGTCATGAGATTATATGTGGT (EPI64), mRNA/cds = (24, 1550)AAAGTTAATTGACTAACAACCCCA 1602 Table 3A Hs.196246 D29605 474986UDP-Gat.betaGlcNAc beta 1,4- 1 AGGGGGCTGTGTCTGATCTTGGTGTTgalactosyltransferase, polypeptide 1 CAAAACAGAACTGTATTTTTGCCT (B4GALT1),mRNA/cds = (72, 1268) 1603 Table 3A Hs.79709 D30036 1060902phosphotidylinositol transfer protein 1 GTTCATAGCTTCCTGCAACTTGACAG(PITPN), mRNA/cds = (216, 1028) AGCCTGAGTTTGCCTCTTAGTGGG 1604 Table 3AHs.115263 D30783 2381480 epiregulin (EREG), mRNA/ 1CATATGGGAGAAGGGGGAGTAATGA cds = (166, 675) CTTGTACAAACAGTATTTCTGGTGT1605 Table 3A Hs.75416 D31767 505091 DAZ associated protein 2 (DAZAP2),1 ACATGTGATGTTTGACTGTACCATTG mRNA/cds = (69, 575)ACTGTTATGGAAGTTCAGCGTTGT 1606 Table 3A Hs.3094 D31884 505095 KIAA0063gene product (KIAA0063), 1 TCTTGCTTTTATTCCTTTTTGTTGTTG mRNA/cds = (279,867) GCCTTGTGCTGCGTTTGTTTACA 1607 Table 3A Hs.75249 D31885 505097 mRNAfor KIAA0069 gene, partial cds/ 1 AGTGTTGTTTTCTCCTCTTTAATATTG cds = (0,680) CTGTGAACAGTGGTGCCCATTGT 1608 Table 3A Hs.3100 D32053 2366751lysyl-tRNA synthetase (KARS), 1 AATTCTTGTGTGCTGCTTTCCATTTGA mRNA/cds =(40, 1833) CACCGCAGTTCTGTTCAGCCATC 1609 Table 3A Hs.181244 D32129 699597major histocompatibility complex, class 1 GAGGTGTCTCCATCTCTGCCTCAACT I,A (HLA-A), mRNA/cds = (0, 1097) TCATGGTGCACTGAGCTGTAACTT 1610 Table 3AHs.89887 D38081 533325 thromboxane A2 receptor (TBXA2R), 1TGAACCTCCAACAGGGAAGGCTCTGT mRNA/cds = (991, 2022)CCAGAAAGGATTGAATGTGAAACG 1611 Table 3A Hs.138593 D38524 6330705′-nucleotidase (purine), cytosolic type 1 TATTTTCTTCCATTCTTGTCATTGGTC B(NT5B), mRNA/cds = (83, 1768) AATAGGGGAGGGTAGATTAGCTG 1612 Table 3AHs.77257 D38549 559702 Homo sapiens. Similar to selective 1TCCCCTGCTTCCACTAAATCCAGTTG hybridizing clone, clone MGC:13167TGACAAAATCTAACGTGACATCAG IMAGE:3163591, mRNA, complete cds/cds = (52,3813) 1613 Table 3A Hs.81848 D38551 1531549 RAD21 (S. pombe) homolog(RAD21), 1 ACCTGGTCAACTTAGCTTTTAAGCAG mRNA/cds = (184, 2079)ACGATGCTGTAAAAACTAACGGCT 1614 Table 3A Hs.81964 D38555 559716 SEC24 (S.cerevisiae) related gene 1 ACCTGGGATGCCCCTGCTCTGGACC family, member C(SEC24C), mRNA/ TCTCATTTCTCTTCATTGGTTTATT cds = (114, 3491) 1615 Table3A Hs.78871 D42039 577290 mRNA for KIAA0081 gene, partial cds/ 1ATCTATCCTTGCCAGCCTTGGGCATC cds = (0, 702) ACATTTACCAGTTTAATAGATTGT 1616Table 3A Hs.75243 D42040 577292 bromodomain-containing 2 (BRD2), 1GCCCTGATCTGGAGTTACCTGAGGC mRNA/cds = (1701, 4106)CATAGCTGCCCTATTCACTTCTAAG 1617 Table 3A Hs.79123 D42043 577298 mRNA forKIAA0084 gene, partial cds/ 1 CTTGACCAAACCCACAGCCTGTCTCT cds = (0, 1946)TCTCTTGTTTAGTTACTTACGGCA 1618 literature Hs.1560 D42045 577302 mRNA forKIAA0086 gene, complete 1 CCTTAGAAGAGGAAGCAAAGGCAGA cds/cds = (918,4040) TTCAGGGACCAAAAGGATTAATGAT 1619 Table 3A Hs.151791 D42054 577310KIAA0092 gene product (KIAA0092), 1 ATGTGTCAACCACCATTTCAGCTATT mRNA/cds= (53, 1477) AAAAACTCCTGTTATCTCCTTGTT 1620 Table 3A Hs.129914 D43968966996 AML1 mRNA for AML1b protein 1 AGCCACCAGAGCCTTCCTCTCTTTGT(alternatively spliced product), ACCACAGTTTCTTCTGTAAATCCA completecds/cds = (1576, 2939) 1621 Table 3A Hs.163706 D44640 1572115 HUMSUPY040cDNA/clone = 1 ACATGAAATATAGTTGCATATATGGA 035-00-1CACCGACTTGGGAGGACAGGTCCT 1622 Table 3A Hs.1119 D49728 1813881 nuclearreceptor subfamily 4, group A, 1 CTTTCCAGCCTCCTGCTGGGCTCTCT member 1(NR4A1), mRNA/ CTTCCTACCCTCCTTCCACATGTA cds = (110, 1906) 1623 Table 3AHs.83077 D49950 1405316 Interleukin 1B (interferon-gamma- 1AGATAGCCAGCCTAGAGGTATGGCT inducing factor) (IL18), mRNA/GTAACTATCTCTGTGAAGTGTGAGA cds = (177, 758) 1624 Table 3A Hs.155543D50063 971269 proteasome (prosome, macropain) 1TGGCATCCTCAGGGGTTGTGATCCA 26S subunit, non-ATPase, 7 (Mov34GCTCCATATATTGTTTACCTTCAAA homolog) (PSMD7), mRNA/ cds = (83, 1057) 1625Table 3A Hs.182255 D50420 2618577 non-histone chromosome protein 2 (S. 1CATGAGGAGAGTGCTAGTTCATGTGT cerevisiae)-like 1 (NHP2L1), mRNA/TCTCCATTCTTGTGAGCATCCTAA cds = (94, 480) 1626 Table 3A Hs.699 D505251167502 peptidylprolyl isomerase B (cyclophilin 1CAGCAAATCCATCTGAACTGTGGAGG B) (PPIB), mRNA/cds = 21, 671)AGAAGCTCTCTTTACTGAGGGTGC 1627 Table 3A Hs.82028 D50683 1827474 mRNA forTGF-betaIIR alpha, 1 TCAGCATAAACTGGAATGTAGTGTCA complete cds/cds =(1572, 3275) GAGGATACTGTGGCTTGTTTTGTT, 1628 Table 3A Hs.90998 D509181469178 mRNA for KIAA0128 gene, partial cds/ 1TGGTGAAACAAAACCAGTCATTAGAA cds = (0, 1276) ATGGTCTGTGCTTTTATTTTCCCA 1629Table 3A Hs.70359 D50926 1469194 genomic DNA, chromosome 21q22.2, 1ACTATGCTTTATTGGTCCCATGTTTTG PCR fragment from BACTGCAATTTTAAAGAGATGGCTTT clone:KB739C11, CBR1-HLCS region/ cds = (0,2854) 1630 Table 3A Hs.198899 D50929 1469200 eukaryotic translationinitiation factor 3, 1 AAAGATGAACTATTTGGTCTCATTGA subunit 10 (theta,150/170 kD) AGCCAACACAGAACTTGCTGCTGT (EIF3S10), mRNA/cds = (113, 4261)1631 Table 3A Hs.77152 D55716 1255616 minichromosome maintenance 1GGAGCCCCTCTTTCTCCCATGCTGCA deficient (S. cerevisiae) 7 (MCM7),CTTACTCCTTTTGCTAATAAAAGT mRNA/cds = (544, 2175) 1632 Table 3A Hs.181418D63486 1469885 KIAA0152 gene product (KIAA0152), 1CCTTCCATGTCCCACCCCACTCCCAC mRNA/cds = (128, 1006)CAAAAAGTACAAAATCAGGATGTT 1633 Table 3A Hs.3195 D63789 1754608 smallinducible cytokine subfamily C, 1 TGATGGTAACCATAATGGAAGAGATT member 1(lymphotactin) (SCYC1), CTGGCTAGTGTCTATCAGAGGTGA mRNA/cds = (20, 364)1634 Table 3A Hs.274472 D63874 968887 high-mobility group (nonhistone 1GTCCTGGTGGTATCTTCAATAGCCAC chromosomal) protein 1 (HMG1),TAACCCTGCCTGGTACAGTATGGG mRNA/cds = (52, 699) 1635 Table 3A Hs.87726D63876 961443 ADP-ribosylation factor-binding protein 1CCCAGCTCTGCTGCCCTTGTTTTGCT GGA3 (GGA3), mRNA/cds = (8, 2080)GCATGTTAAATAAAACCATTTTCA 1636 Table 3A Hs.155595 D63878 961447 neuralprecursor cell expressed, 1 CCCACACTGCTACACTTCTGATCCCC developmentallydown-regulated 5 TTTGGTTTTACTACCCAAATCTAA (NEDD5), mRNA/cds = (258,1343) 1637 Table 3A Hs.182741 D64015 2281005 TIA1 cytotoxicgranule-associated 1 CTGTAATACCTCCTCCTAACCAAGCC RNA-binding protein-like1 (TIAL1), GGATATGGTATGGCAAGTTACCAA transcript variant 2, mRNA/ cds =(157, 954) 1638 Table 3A Hs.75232 D67029 1669538 SEC14 (S.cerevisiae)-like 1 1 CCCTTGTAAGGGAATTCTGGGGCAG (SEC14L1), mRNA/cds =(303, 2450) CTATGGTTTGAGTATGCAGTTTGCA 1639 Table 3A Hs.155968 D764441945614 zinc finger protein homologous to 1 ACCATCTCTGTCCAGCACCTCTTGGTZfp103 in mouse (ZFP103), mRNA/ TAAATAATGTATGCTGTGAGACAT cds = (922,2979) 1640 Table 3A Hs.80905 D79990 1136395 Ras association(RalGDS/AF-6) 1 ACAGGGCCTCAGCAAGGGAGCCATA domain family 2 (RASSF2),mRNA/ CATTTTTGTAACATTTTGATATGTT cds = (196, 1176) 1641 Table 3A Hs.76666D80005 1136425 mRNA for KIAA0183 gene, partial cds/ 1TTGACTGTCGATGGATTGTGGTGTGG cds = (0, 3190) TGTATCTGAAGGCTATTGAATGCA 1642Table 3A Hs.322903 D80006 1136427 mRNA for KIAA0184 gene, partial cds/ 1TTCTGTTCCAAACAAGTATTCTGTAGA cds = (0, 2591) TCCAAATGGATTACCAGTGTGCT 1643Table 3A Hs.79389 D83018 1827484 nel (chicken)-like 2 (NELL2), mRNA/ 1ATCTTCAGAATCAGTTAGGTTCCTCA cds = (96, 2546) CTGCAAGAAATAAAATGTCAGGCA1644 Table 3A Hs.89385 D83243 1304113 nuclear protein,ataxia-telangiectasia 1 TGAACCTTACTGCAAAAACTTGTGAT locus (NPAT),mRNA/cds = (34, 4317) GTAAGAAATTTGTATGGTGTGGCA 1645 Table 3A Hs.12413D83776 1228034 mRNA for KIAA0191 gene, particl cds/ 1GCTGTCTCAAGGGTATCCGTACCTCA cds = (0, 4552) ATGTCAGTTACATTCAGCAGAAAA 1646Table 3A Hs.22559 D83781 1228044 mRNA for KIAA0197 gene, partial cds/ 1TTGGTCAGATTTAGAAGCATTCATGC cds = (0, 3945) TCACAAGTTTTGGGAAAGTGAAAA 1647Table 3A Hs.343517 D84224 7804467 methionine-tRNA synthetase (MARS), 1CCCTAAAGGCAAGAAGAAAAAGTAAA mRNA/cds = (23, 2725)AGACCTTGGCTCATAGAAAGTCAC 1648 Table 3A Hs.21899 D84454 1526437 proteintranslocase, JM26 protein, 1 GTGTGTGCATGGAAGATGCCTGGGC UDP-galactosetranslocator, pim-2 TGTCTTTGCTATATGTAAATAGAGC protononcogene homologpim-2h, and shal-type potassium channel genes, complete cds; JM12protein and transcription factor IGHM enhancer 3 genes, partial cds; andunknown gene/ cds = (323, 1504) 1649 Table 3A Hs.300391 D85429 1816451Ul-H-Bl4-aoq-d-01-0-Ul.s1 cDNA, 3′ 1 GCCTTGGCTTTATTTGCAGGCTACTAend/clone = IMAGE:3085848/ AAGCTGCTTTTACTTTGTAACTTT clone_end = 3′ 1650Table 3A Hs.75842 D86550 1772437 mRNA for serine/threonine protein 1ACAGTTTGGTTACAGGACTTCTGTGC kinase, complete cds/cds = (1473, 3737)ATTGTAAACATAAACAGCATGGAA 1651 Table 3A Hs.36927 D86956 1503985 heatshock 105 kD (HSP105B), mRNA/ 1 TGTGAAAGTGTGGAATGGAAGAAATG cds = (313,2757) TCGATCCTGTTGTAACTGATTGTG 1652 Table 3A Hs.17211 D86964 1504001mRNA for KIAA0209 gene, partial cds/ 1 ACAACCAACCAGTTTCTTTTCTAGCC cds =(0, 5530) AATCATCTCTGAAGAGTTGCTGTT 1653 Table 3A Hs.154332 D869671504007 KIAA0212 gene product (KIAA0212), 1 GAACTCCCTGATTCTATACCCTCTTCmRNA/cds = (58, 2031) CTTCTTTCTGCAAGGCAGAGGAAT 1654 Table 3A Hs.110613D86974 1504021 Pl-3-kinase-related kinase SMG-1 1CACCCTCAGCTCCACCCTCAGCAGAT (SMG1), mRNA/cds = (132, 9227)GATAATATCAAGACACCTGCCGAG 1655 Table 3A Hs.199243 D86984 1504041 mRNA forKIAA0231 gene, partial cds/ 1 TTGGCCCTCAGGTTTACTGTGTAAAT cds = (0, 1430)CTGCATTTTTGGTGGTAAATCCCT 1656 Table 3A Hs.79276 D86985 6634002 mRNA forKIAA0232 protein, partial 1 GCATTTCCATAGCACTGAAGTACCAG cds/cds = (0,3836) TTTCCATTCCTGGGCTGAGATTGT 1657 Table 3A Hs.10315 D87432 1565758solute carrier family 8 (cationic amino 1 CTCCTTTTAAFCGTGTTATTGACA acidtransporter, y+ system), member 6 AACCTCCCCAAAAGAATATGCAA (SLC7A6),mRNA/cds = (261, 1808) TTGT 1658 Table 3A Hs.75912 D87446 1665780 mRNAfor KIAA0257 gene, partial cds/ 1 AACATTCAGTTGAGACCATATGCATT cds = (0,5418) TTCTGTGCTGTTTGTACTTGAGGT 1659 Table 3A Hs.154978 D87450 1665788mRNA for KIAA0261 gene, partial cds/ 1 TTAACCCTCAGAGAACTCTGCATTTT cds =(0, 3865) AGGGTACTTGAGGCTGACTTAACT 1660 Table 3A Hs.192968 D874541665796 mRNA for KIAA0265 gene, partial cds/ 1AGCGACCTCTTCTCTAGTCCGGTGTT cds = (0, 1205) ACGAACAGAAGTTCTGAGTTGTGC 1661Table 3A Hs.40888 D87468 1944419 mRNA for KIAA0278 gene, partial cds/ 1TAAATGTCGGTCCAGGCCCTGTGCAC cds = (0, 1383) CTTACCCCAGAGACAGACTCTTTT 1662Table 3A Hs.77495 D87684 1663703 mRNA for KIAA0242 protein, partial 1ATAAGGCTGTAAAATGAGAATTCTGC cds/cds = (0, 1590) CCCCTCACCTCTTACCCCAGTACT1663 Table 3A Hs.75789 D87953 1596166 N-myc downstream regulated 1AAAAGTCGGGGATCGGGGCAAGAGA (NDRG1), mRNA/cds = (110, 1294)GGCTGAGTACGGATGGGAAACTATT 1664 Table 3A Hs.75367 D89077 1694681Src-like-adapter (SLA), mRNA/ 1 GAGCACCCAGAGGGATTTTTCAGTG cds = (41,871) GGAAGCATTACACTTTGCTAAATCA 1665 Table 3A Hs.170311 D89678 3218539heterogeneous nuclear 1 TGATTAGGTGACGAGTTGACATTGAG ribonucleoproteinD-like (HNRPDL), ATTGTCCTTTTCCCCTGATCAAAA transcript variant 1, mRNA/cds = (580, 1842) 1666 Table 3A Hs.121102 D89974 5541649 vanin 2 (VNN2),mRNA/ 1 TGTATGTATGGGAGTGAGGAGTTTCA cds = (11, 1573)GGGCCATTGCAAACATAGCTGTGC 1667 Table 3A Hs.73817 D90144 219905 gene forLD78 alpha precursor, 1 ACAGAGTTATCCACTTTACAACGGAG complete cdsACACAGTTCTGGAACATTGAAACT 1668 Table 3A Hs.218387 H03298 866231tc88c11.x1 cDNA, 3′ end/ 1 ATACGGGACAATAAAATCTGCCTTTT clone =IMAGE:2073236/clone_end = GCTCTGGAGGGAGATACTACCTCT 3′ 1669 Table 3AHs.70258 H06786 870318 yl83g05.r1 cDNA, 5′ end/ 1GGGCAAACAACTTTAGGAATACTAGT clone = IMAGE:44737/clone_end = 5′TACTCACTTAACATGGAGGGCGGG 1670 Table 3A Hs.32149 H14103 878951 ym62a02.r1cDNA, 5′ end/ 1 AAAGGCCGCGCAGATTGTTTAATTCT clone =IMAGE:163466/clone_end = 5′ GGAAAGTCAATCCCCGGATTTAGC 1671 Table 3AHs.94881 H51796 991637 602387588F1 cDNA, 5′ end 1GGGACTCCATGGGAATATTTGCCCAG clone = IMAGE:4516388/clone_end =TAATGGTAAGGAAATCTTTCGGGT 5′ 1672 Table 3A Hs.178703 H56344 1004988AV716627 cDNA, 5′ end/ 1 CCAGAAAGGTGATGAATGAATAGGAC clone =DCBBCH05/clone_end = 5′ TGAGAGTCACAGTGAATGTGGCAT 1673 Table 3A Hs.270192H57221 1010053 ESTs 1 TCCCAAGGTTGTTAGTGACTGATAAGCTTCCAAACTACAGTACAGTTTTT 1674 Table 3A Hs.237146 H88841 1068420 mRNA forzinc finger protein RINZF 1 GTTTTCTTGTAGTTGCGGGTCCCTCG (RINZF gene)/cds= (598, 3141) CGAAAGTTCATTCATGGCCCCACT 1675 Table 3A Hs.76807 J00194188231 major histocompatibility complex, 1 CATGGGGCTCTCTTGTGTACTTATTGclass II, DR alpha (HLA-DRA), TTTAAGGTTTCCTCAAACTGTGAT mRNA/cds = (26,790) 1676 Table 3A Hs.251064 J02621 184229 high-mobility group(nonhistone 1 ACAAATTGAAATGTCTGTACTGATCC chromosomal) protein 14(HMG14), TCAACCAATAAAATCTCAGCCGAA mRNA/cds = (150, 452) 1677 Table 3AHs.62192 J02931 339501 coagulation factor III (thromboplastin, 1TGCAGGAGACATTGGTATTCTGGGCA tissue factor) (F3), mRNA/GCTTCCTAATATGCTTTACAATCT cds = (123, 1010) 1678 Table 3A Hs.1513 J03171184645 interferon (alpha, beta and omega) 1 TCATCCCGAGAACATTGGCTTCCACAreceptor 1 (IFNAR1), mRNA/ TCACAGTATCTACCCTTACATGGT cds = (78, 1751)1679 Table 3A Hs.317 J03250 339805 topoisomerase (DNA) 1 (TOP1), 1GGCATTGTTAGTTTAGTGTGTGTGCA mRNA/cds = (247, 2544)GAGTCCATTTCCCACATCTTTCCT 1680 Table 3A Hs.81118 J03459 187172leukotriene A4 hydrolase (LTA4H), 1 GACTGCAATGCTGGTGGGGAAAGAC mRNA/cds =(68, 1903) TTAAAAGTGGATTAAAGACCTGCGT 1681 Table 3A Hs.177766 J03473337423 ADP-ribosyltransferase (NAD+; poly 1 GCTTTCCTTCTCCAGGAATACTGAAC(ADP-ribose) polymerase) (ADPRT), ATGGGAGCTCTTGAAATATGTAGT mRNA/cds =(159, 3203) 1682 Table 3A Hs.73792 J03565 181919 complement component(3d/Epstein 1 TGGGAATCAAGATTTAATCCTAGAGA Barr virus) receptor 2 (CR2),mRNA/ TTTGGTGTACAATTCAGGCTTTGG cds = (69, 3170) 1683 Table 3A Hs.727J03634 181946 inhibin. beta A (activin A, activin AB 1GCAGTAGTGTGGACTAGAACAACCCA alpha polypeptide) (INHBA), mRNA/AATAGCATCTAGAAAGCCATGAGT cds = (85, 1365) 1684 Table 3A Hs.86948 J03798338264 small nuclear ribonucleoprotein D1 1 TGTGTAATGTACCTGTCAGTGCCTCCpolypeptide (16 kD) (SNRPD1), TTTATTAAGGGGTTCTTTGAGAAT mRNA/cds = (150,509) 1685 Table 3A Hs.75703 J04130 178017 small inducible cytokine A4 1CCACTGTCACTGTTTCTCTGCTGTTG (homologous to mouse Mip-1b)CAAATACATGGATAACACATTTGA (SCYA4), mRNA/cds = (108, 386) 1686 Table 3AHs.1799 J04142 619799 CD1D antigen, d polypeptide (CD1D), 1AGTTTGCCCTGGATGTCATATTGGCA mRNA/cds = (164, 1171)GTTGGAGGACACAGTTTCTATTGT 1687 Table 3A Hs.298469 J04144 178285dipeptidyl carboxypeptidase 1 1 CCAAGTTCCACATTCCTTCTAGCGTG (angiotensin1 converting enzyme) CCTTACATCAGGTACTTTGTCAGC (ACE), mRNA/cds = (22,3942) 1688 Table 3A Hs.176663 J04162 183036 leukocyte IgG receptor(Fc-gamma-R) 1 AGCTGTCTCCTGTTTTGTAAGCTTTC mRNA, complete cds/cds = (17,718) AGTGCAACATTTCTTGGTTCCAAT 1689 Table 3A Hs.82954 J04755 182512ferritin, heavy polypeptide 1 (FTH1), 1 TGCATGTTGGGGTTTCCTTTACCTTTTmRNA/cds = (91, 663) CTATAAGTTGTACCAAAACATCC 1690 Table 3A Hs.288156J05016 181507 cDNA: FLJ21819 fis, clone HEP01185/ 1GGGTTTGTGCTATACACTGGGATGTC cds = UNKNOWN TAATTGCAGCAATAAAGCCTTTCT 1691Table 3A Hs.80758 J05032 179101 aspartyl-tRNA synthetase (DARS), 1GCCACACTTATTCTTTTCAGTAACCT mRNA/cds = (93, 1595)GCTAGTGCACAGGCTGTACTTTAG 1692 Table 3A Hs.850 J05272 186393 IMP (inosinemonophosphate) 1 CAGTCGAAGGCTTTAACTTTGCACAC dehydrogenase 1 (IMPDH1),mRNA/ TTGGGATCACAGTTGCGTCATTGT cds = (600, 2144) 1693 Table 3A Hs.84298K01144 188469 CD74 antigen (invariant polypeptide of 1TTCCCTTTCCCCAGCATCACTCCCCA major histocompatibility complex, classAGGAAGAGCCAATGTTTTCCACCC II antigen-associated) (CD74), mRNA/ cds = (7,705) 1694 Table 3A Hs.79070 K02276 188927 v-myc avian myelocytomatosisviral 1 AGCCATAATGTAAACTGCCTCAAATT oncogene homolog (MYC), mRNA/GGACTTTGGGCATAAAAGAACTTT cds = (558, 1877) 1695 Table 3A Hs.1290 K02766179725 complement component 9 (C9), 1 TTGCTTTTACTAGTCTTAGCTCTACGAmRNA/cds = (4, 1683) TTTAAATCCATGTGTCCAAGGGG 1696 Table 3A Hs.303157K02885 338928 mRNA for T-cell specific protein/ 1CACACCTGCACACTCACGGCTGAAAT cds = (37, 975) CTCCCTAACCCAGGGGGACCTTAG 1697Table 3A Hs.21595 L03428 340386 DNA segment on chromosome X and 1AGCTGTAACGTTCGCGTTAGGAAAGA Y (unique) 155 expressed sequenceTGGTGTTTATTCCAGTTTGCATTT (DXYS155E), mRNA/cds = (168, 1323) 1698 Table3A Hs.199160 L04731 339921 translocation T(4:11) of ALL-1 gene to 1AGGGGTTCCACTAGTGTCTGCTTTCC chromosome 4/cds = UNKNOWNTTTATTATTGCACTGTGTGAGGTT 1699 Table 3A Hs.234569 L05148 340038 proteintyrosine kinase related mRNA/ 1 CATCCTCAGGTGGTCAGGCGTAGAT sequence/cds =UNKNOWN CACCAGAATAAACCCAGCTTCCCTC 1700 Table 3A Hs.75528 L05425 179284nucleolar GTPase (HUMAUANTIG), 1 ACACACAACGTGAAAAATAGGAA mRNA/cds = (79,2274) CAGGAACAAAAAGAAGACCAATG ACTC 1701 Table 3A Hs.284192 L06132 340198clone HQ0072/cds = UNKNOWN 1 TTTAGAGTCTTCCATTTTGTTGGAATTAGATCCTCCCCTTCAAATGCTGT 1702 Table 3A Hs.1845 L06175 189448 MHC class Iregion ORF (P5-1), 1 CTAATTTCAGTGCTTGTGCTTGGTTG mRNA/cds = (304, 735)TTCAGGGCCATTTCAGGTTTGGGT 1703 Table 3A Hs.75348 L07833 186512 proteasome(prosome, macropain) 1 CCAGATTTTCCCCAAACTTGCTTCTG activator subunit 1(PA28 alpha) TTGAGATTTTTCCCTCACCTTGCC (PSME1), mRNA/cds = (92, 841) 1704Table 3A Hs.324278 L08048 184250 mRNA; cDNA DKFZp566M063 (from 1TGGGGGTTGTAAATTGGCATGGAAAT clone DKFZp566M063)/ TTAAAGCAGGTTCTTGTTGGTGCAcds = UNKNOWN 1705 Table 3A Hs.94 L08069 306713 heat shock protein,DNAJ-like 2 1 AGGTGGTGTTCAGTGTCAGACCTCTT (HSJ2), mRNA/cds = (82, 1275)AATGGCCAGTGAATAACACTCACT 1706 Table 3A Hs.99899 L08096 307127 tumornecrosis factor (ligand) 1 GGGGGTAGTTTGTGGCAGGACAAGA superfamily, member7 (TNFSF7), GAAGGCATTGAGCTTTTTCTTTCAT mRNA/cds = (137, 718) 1707 Table3A Hs.1652 L08176 183484 chemokine (C—C motif) receptor 7 1TCGTTAAGAGAGCAACATTTTACCCA (CCR7), mRNA/cds = (66, 1202)CACACAGATAAAGTTTTCCCTTGA 1708 Table 3A Hs.211576 L10717 307507IL2-inducible T-cell kinase (ITK), 1 CCCTATCCCGCAAAATGGGCTTCCTG mRNA/cds= (2021, 3883) CCTGGGTTTTTCTCTTCTCACATT 1709 Table 3A Hs.3069 L11066307322 heat shock 70 kD protein 9B (mortalin- 1AAACAAGGTAGGAATGAGGCTAGAC 2) (HSPA9B), mRNA/cds = (29, 2068)CTTTAACTTCCCTAAGGCATACTTT 1710 Table 3A Hs.3446 L11284 307183mitogen-activated protein kinase 1 TTCCCCATATCCAAGTACCAATGCTG kinase 1(MAP2K1), mRNA/ TTGTAAACAACGTGTATAGTGCCT cds = (72, 1253) 1711 Table 3AHs.1183 L11329 559539 dual specificity phosphatase 2 1TGAGCCTTTCACACCTGTGCTGGCGC (DUSP2), mRNA/cds = (85, 1029)TGGAAAATTATTTGTGCTCAGCTG 1712 Table 3A Hs.220 L11695 431034 transforminggrowth factor, beta 1 TGGGATTGTACTATACCAGTAAGTGC receptor I (activin Areceptor type II- CACTTCTGTGTCTTTCTAATGGAA like kinase, 53 kD) (TGFBR1),mRNA/ cds = (76, 1587) 1713 Table 3A Hs.150395 L12052 179892 cAMPphosphodiesterase PDE7 1 TTTTTCCTCACAGGAGCGGAAGAACT (PDE7A1) mRNA,complete cds/ AGGGGGAGCAGGAGCTGCAATGCG cds = (50, 1498) 1714 Table 3AHs.104125 L12168 178083 adenylyl cyclase-associated protein 1TCTACCCATTTCCTGAGGCCTGTGGA (CAP), mRNA/cds = (62, 1489)AATAAACCTTTATGTACTTAAAGT 1715 Table 3A Hs.78944 L13463 292054 regulatorof G-protein signalling 2, 1 GTGTCCGTTATGAGTGCCAAAAATCT 24 kD (RGS2),mRNA/cds = (32, 667) GTCTTGAAGGCAGCTACACTTTGA 1716 Table 3A Hs.258850L14542 292360 killer cell lectin-like receptor subfamily 1CTGTGCAATGCTACATGTACGTGGAC C, member 3 (KLRC3), transcriptTTATATCAGACCAGTGTGGATCTT variant NKG2-E, mRNA/cds = (45, 767) 1717 Table3A Hs.161125 L21961 405227 Homo sapiens, clone MGC:12849 1AGTCCCCTGTCCTGGTCATCTATCAA IMAGE:4308973, mRNA, completeGATAACAAGCGGCCCTCAGGGATC cds/cds = (24, 725) 1718 Table 3A Hs.247824NM_005214 291928 cytotoxic T-lymphocyte-associated 1GGGTCTATGTGAAAATGCCCCCAACA protein 4 (CTLA4), mRNA/cds = (0,GAGCCAGAATGTGAAAAGCAATTT 671) 1719 Table 3A Hs.179881 L20298 388306core-binding factor, beta subunit 1 CTTGCCTTAAGCTACCAGATTGCTTT (CBFB),transcript variant 2, mRNA/ TGCCACCATTGGCCATACTGTGTG cds = (11, 559)1720 Table 3A Hs.83658 L20688 404044 Rho GDP dissociation inhibitor(GDI) 1 CCCCTGCCAGAGGGAGTTCTTCTTTT beta (ARHGDIB), mRNA/GTGAGAGACACTGTAAACGACACA cds = (152, 757) 1721 Table 3A Hs.89582 L20814493133 glutamate receptor, ionotropic, AMPA 1 TGCAGCCACTATTGTTAGTCTCTTGA2 (GRIA2), mRNA/cds = (160, 2811) TTCATAATGACTTAAGCACACTTG 1722 Table 3AHs.161125 L22009 347313 Homo sapiens, clone MGC:12849 1TGACTATTACTGTCAGGCGTGGGACA IMAGE:4308973, mRNA, completeCCAACACTGCGGTATTCGGCGGAG cds/cds = (24, 725) 1723 Table 3A Hs.245710L23332 408689 heterogeneous nuclear 1 TTTGAGACGCAATACCAATACTTAGGribonucleoprotein H1 (H) (HNRPH1), ATTTTGGTCTTGGTGTTTGTATGA mRNA/cds =(72, 1421) 1724 Table 3A Hs.79117 L23320 410217 mRNA for corticotrophinreleasing 1 TCCTTCCAGGGCTTCTTTGTGTCTGT factor receptor/cds = (226, 1473)GTTCTACTGTTTCCTCAATAGTGA 1725 Table 3A Hs.79117 L24498 403127 mRNA forcorticotrophin releasing 1 CCATGTCCATCCCCACCTCCCCAACC factorreceptor/cds = (226, 1473) CGTGTCAGCTTTCACAGCATCAAG 1726 db miningHs.80409 NM_021998 11527399 gadd45 gene, complete cds/ 1TGCCCTCAAGTAAAAGAAAAGCCGAA cds = (2327, 2824) AGGGTTAATCATATTTGAAAACCA1727 Table 3A Hs.326801 l25124 435049 DNA sequence from PAC 75N13 on 1ATGCTACTTGGGAGAAAACTCTCACT chromosome Xq21.1. Contains ZNF6AACTGTCTCACCGGGTTTCAAAGC like gene, ESTs, STSs and CpG islands/cds =(587, 2882) 1728 Table 3A Hs.199248 L25080 407696 prostaglandin Ereceptor 4 (subtype 1 GGACTTTGCGAATATCAGAGACCTCA EP4) (PTGER4), mRNA/GACTCTTCACAGGGTCAGGACTCA cds = (388, 1854) 1729 Table 3A Hs.199248L25851 4406707 prostaglandin E receptor 4 (subtype 1AGCTCCCTGCAAGTCACATTTCCCAG EP4) (PTGER4), mRNA/ TGAAACACTGAACTTATCAGAAAAcds = (388, 1854) 1730 Table 3A Hs.241545 L25931 438638 Homo sapiens.Similar to hypothetical 1 TTCCTTCAGGATGATCTAGAGCAGCA protein, cloneMGC:1824 TGGAGCTGTTGGTAGAATATTAGT IMAGE:3509518, mRNA, complete cds/cds= (533, 1504) 1731 Table 3A Hs.152931 L29218 632967 lamin B receptor(LBR), mRNA/ 1 GGGGAGGAAGGAAGGACATTAAATT cds = (75, 1922)CTTTCCCTGGTAATGAAAAGAGCCC 1732 Table 3A Hs.73986 L26953 537529 CDC-likekinase 2 (CLK2), transcript 1 GCCTTGTACATAATACTATTCCATCCA variantphclk2, mRNA/cds = (129, CACAGTTTCCACCCTCACCTGCC 1628) 1733 Table 3AHs.29877 L27071 951045 TXK tyrosine kinase (TXK), mRNA/ 1AGCAAGATAGCCAAATGTGACATCAA cds = (86, 1669) GCTCCATTGTTTCGGAAATCCAGG1734 Table 3A Hs.73986 L42572 1160962 CDC-like kinase 2 (CLK2),transcript 1 GCCGAGTGAGGTAACCAGGTGGCAT variant phclk2, mRNA/cds = (129,CTACCCCATGTTTTATAAGGAATTT 1628) 1735 Table 3A Hs.78504 L29348 460282inner membrane protein, mitochondrial 1 TTCTTTCCATTTGCTATCATGTCAGTG(mitofilin) (IMMT), mRNA/ AACGCCAGGAGTGCTTTCTTTGC cds = (92, 2368) 1736Table 3A Hs.1742 L33075 536843 IQ motif containing GTPase activating 1TGAATTTACTTCCTCCCAAGAGTTTG protein 1 (IQGAP1), mRNA/GACTGCCCGTCAGATTGTTTCTGC cds = (467, 5440) 1737 Table 3A Hs.137232L33842 602457 yq19a04.r1 cDNA, 5′ end/ 1 ACCCTCATTTCCAGGGGGAGCCTCA clone= IMAGE:274063/clone_end = 5′ GGCCCCGAGATAAATGTGCTCCATG 1738 Table 3AHs.1697 L35249 522192 ATPase, H+ transporting, lysosomal 1TTCTCTGAGGGCTGGGGGTTGGGGG (vacuolar proton pump), betaAGTCAGCATGATTATATTTTAATGT polypeptide,56/58 kD, isoform 2 (ATP6B2),mRNA/cds = (25, 1560) 1739 Table 3A Hs.79107 L35263 603916mitogen-activated protein kinase 14 1 ACTTGGCTGTAATCAGTTATGCCGTA(MAPK14), mRNA/cds = (362, 1444) TAGGATGTCAGACAATACCACTGG 1740 Table 3AHs.75217 L36870 685175 mitogen-activated protein kinase 1TGGAGCTCAGTAACATAACTGCTTCT kinase 4 (MAP2K4), mRNA/TGGAGCTTTGGAATATTTTATCCT cds = (9, 1208) 1741 Table 3A Hs.83086 L389351008845 GT212 mRNA/cds = UNKNOWN 1 AAATTTCACAAGCAATACTTTGGACCACTGGGGTTCAGGCCCCAAGAAAT 1742 Table 3A Hs.180446 L38951 893287 importinbeta subunit mRNA, complete 1 ACACACAAAACAGCAAACTTCAGGTA cds/cds = (337,2967) ACTATTTTGGATTGCAAACAGGAT 1743 Table 3A Hs.41726 L40377 1160926serine (or cysteine) proteinase 1 TCTTGCCTTAATTAACATTCCCTGTGA inhibitor,clade B (ovalbumin), member CCTAGTTGGTGCAGTGGCTTGAA 8 (SERPINB8),mRNA/cds = (83, 1207) 1744 Table 3A Hs.155079 L42373 1000887 proteinphosphatase 2, regulatory 1 ACTTGCAGTTGTGTGGAAAACTGTTT subunit B (B56),alpha isoform TGTAATGAAAGATCTTCATTGGGG (PPP2R5A), mRNA/cds = (571, 2031)1745 Table 3A Hs.78504 L78440 1479978 inner membrane protein,mitochondrial 1 TGTGATCTCTACTACTGTTGATTTTGC (mitofilin) (IMMT), mRNA/CCTCGGAGCAAACTGAATAAAGC cds = (92, 2368) 1746 Table 3A Hs.80642 L47345992562 signal transducer and activator of 1 TAGGAAATGTTTGACATCTGAAGCTCtranscription 4 (STAT4), mRNA/ TCTTCACACTCCCGTGGCACTCCT cds = (81, 2327)1747 Table 3A Hs.75678 L49169 1082037 FBJ murine osteosarcoma viral 1CGTCCCCTCTCCCCTTGGTTCTGCAC oncogene homolog B TGTTGCCAATAAAAAGCTCTTAAA1748 Table 3A Hs.80642 M11353 184092 signal transducer and activator of1 GGGAGTGTTGTGACTGAAATGCTTGA transcription 4 (STAT4), mRNA/AACCAAAGCTTCAGATAAACTTGC cds = (81, 2327) 1749 Table 3A Hs.181307 M10901183032 H3 histone, family 3A (H3F3A), 1 AGGGGACAGAAATCAGGTATTGGCAmRNA/cds = (374, 784) GTTTTTCCATTTTCATTTGTGTGTG 1750 Table 3A Hs.198253M11124 188109 major histocompatibility complex, class 1AGCCGCCCAGCTACCTAATTCCTCAG II, DQ alpha 1 (HLA-DQA1), mRNA/TAACATCGATCTAAAATCTCCATG cds = (43, 810) 1751 Table 3A Hs.181307 M12679187911 H3 histone, family 3A (H3F3A), 1 ACATGCAAGTACATGTTTTTAATGTTGmRNA/cds = (374, 784) TCTGTCTTCTGTGCTGTTCCTGT 1752 Table 3A Hs.277477M11717 184416 major histocompatibility complex, class 1CCTGTGTGGGACTGAGATGCAGGAT I, C (HLA-C), mRNA/cds = (0, 1100)TTCTTCACACCTCTCCTTTGTGACT 1753 Table 3A Hs.277477 M12824 339426 majorhistocompatibility complex, class 1 GGCATCTGAATGTGTCTGCGTTCCTG I, C(HLA-C), mRNA/cds = (0, 1100) TTAGCATAATGTGAGGAGGTGGAG 1754 Table 3AHs.85258 M14328 182113 CD8 antigen, alpha polypeptide (p32) 1CTGAGAGCCCAAACTGCTGTCCCAAA (CD8A), mRNA/cds = (65, 772)CATGCACTTCCTTGCTTAAGGTAT 1755 Table 3A Hs.254105 M12824 339426 enolase1, (alpha) (ENO1), mRNA/ 1 AAGCTCCCTGGAGCCCTGTTGGCAG cds = (94, 1398)CTCTAGCTTTTGCAGTCGTGTAATG 1756 Table 3A Hs.122007 M12888 338836qn52b08.x1 cDNA, 3′ end/ 1 AGCCCTCTTTCTCTCCACCCAATGCT clone =IMAGE:1901847/clone_end = GCTTTCTCCTGTTCATCCTGATGG 3′ 1757 Table 3AHs.82085 M14083 189566 serine (or cysteine) proteinase 1TCCACAGGGGTGGTGTCAAATGCTAT inhibitor, clade E (nexin, plasminogenTGAAATTGTGTTGAATTGTATGCT activator inhibitor type 1), member 1(SERPINE1), mRNA/cds = (75, 1283) 1758 Table 3A Hs.254105 M15182 183232enolase 1, (alpha) (ENO1), mRNA/ 1 GCTAGATCCCCGGTGGTTTTGTGCTC cds = (94,1398) AAAATAAAAAGCCTCAGTGACCCA 1759 Table 3A Hs.183868 M14648 340306glucuronidase, beta (GUSB), mRNA/ 1 GACTTCCACAGCAGCAGAACAAGTG cds = (26,1981) CCTCCTGGACTGTTCACGGCAGACC 1760 Table 3A Hs.1416 M15059 182447 Fcfragment of IgE, low affinity II, 1 TATCCCCAGCTCAGGTGGTGAGTCCT receptorfor (CD23A) (FCER2), CCTGTCCAGCCTGCATCAATAAAA mRNA/cds = (213, 1178)1761 Table 3A Hs.183868 M15330 186283 glucuronidase, beta (GUSB), mRNA/1 CTGGGTTTTGTGGTCATCTATTCTAG cds = (26, 1981) CAGGGAACACTAAAGGTGGAAATA1762 Table 3A Hs.126256 M15353 306486 interleukin 1, beta (IL1B), mRNA/1 AGCTATGGAATCAATTCAATTTGGAC cds = (86, 895) TGGTGTGCTCTCTTTAAATCAAGT1763 Table 3A Hs.79306 M16342 184266 eukaryotic translation initiationfactor 1 TGGCTCAAGTAGAAAAGCAGTCCCAT 4E (EIF4E), mRNA/cds = (18, 671)TCATATTAAGACAGTGTACAAAAC 1764 Table 3A Hs.182447 M15796 181271heterogeneous nuclear 1 AGCTCTTGAAAGCAGCTTTGAGTTAG ribonucleoprotein C(C1/C2) (HNRPC), AAGTATGTGTGTTACACCCTCACA transcript variant 1, mRNA/cds = (191, 1102) 1765 Table 3A Hs.80887 M16038 187268 v-yes-1 Yamaguchisarcoma viral 1 AACCGGATATATACATAGCATGACAT related oncogene homolog(LYN), TTCTTTGTGCTTTGGCTTACTTGT mRNA/cds = (297, 1835) 1766 Table 3AHs.89476 M16336 180093 CD2 antigen (p50), sheep red blood 1AGCCTATCTGCTTAAGAGACTCTGGA cell receptor (CD2), mRNA/GTTTCTTATGTGCCCTGGTGGACA cds = (6, 1061) 1767 Table 3A Hs.182447 M16342188352 heterogeneous nuclear 1 AAAGTTGATACTGTGGGATTTTTGTGribonucleoprotein C (C1/C2) (HNRPC), AACAGCCTGATGTTTGGGACCTTT transcriptvariant 1, mRNA/ cds = (191, 1102) 1768 Table 3A Hs.318720 M16660 184420Homo sapiens, clone MGC:12387 1 CTTCCTTAGCTCCTGTTCTTGGCCTGIMAGE:3933019, mRNA, complete AAGCCTCACAGCTTTGATGGCAGT cds/cds = (63,863) 1769 Table 3A Hs.318720 M16942 188352 Homo sapiens, clone MGC:123871 TTTGTGCTTCCCTTTACCTAAACTGTC IMAGE:3933019, mRNA, completeCTGCCTCCCATGCATCTGTACCC cds/cds = (63, 863) 1770 Table 3A Hs.318720M16942 188437 Homo sapiens, clone MGC:12387 1TTTGTGCTTCCCTTTACCTAAACTGTC IMAGE:3933019, mRNA, completeCTGCCTCCCATGCATCTGTACCC cds/cds = (63, 863) 1771 Table 3A Hs.308026M16967 182411 major histocompatibility complex, class 1CTTGTGGCTTCCTCAGCTCCTGCCCT II, DR beta 5 (HLA-DRB5), mRNA/TGGCCTGAAGTCCCAGCATTGATG cds = (29, 829) 1772 Table 3A Hs.75709 M16985187282 mannose-6-phosphate receptor (cation 1 ATTTGTTTGCATCCCTCCCCCACACCdependent) (M6PR), mRNA/ CTGGTGTTTTAAAATGAAGAAAAA cds = (170, 1003) 1773Table 3A Hs.21858 M17783 183063 trinucleotide repeat containing 3 1CATCCGACATAATCCTACAGGTGCTG (TNRC3), mRNA/cds = (517, 1356)TGTTATTCATGGGGCAGATAAACA 1774 Table 3A Hs.694 M20137 186328 interleukin3 (colony-stimulating factor, 1 AGTGGGGTGGGGAGCATGTTCATTT multiple)(IL3), mRNA/cds = (9, 467) GTACCTCGAGTTTTAAACTGGTTCC 1775 Table 3AHs.308026 M20430 187182 major histocompatibility complex, class 1CCTAAACCGTATGGCCTCCCGTGCAT II, DR beta 5 (HLA-DRB5), mRNA/CTGTATTCACCCTGTATGACAAAC cds = (29, 829) 1776 Table 3A Hs.62848 M20661183684 selectin L (lymphocyte adhesion 1 TTTCATCTCAGGCCTCCCTCAACCCCmolecule 1) (SELL), mRNA/ ACCACTTCTTTTATAACTAGTCCT cds = (88, 1206) 1777Table 3A Hs.237519 M20867 183059 yz35c09.s1 cDNA, 3′ end/ 1GCATGGCTTAACCTGGTGATAAAAGC clone = IMAGE:285040/clone_end = 3′AGTTATTAAAAGTCTACGTTTTCC 1778 Table 3A Hs.241392 M21121 339420 smallinducible cytokine A5 (RANTES) 1 AGCTTCCGCCGTCTCAACCCCTCACA (SCYA5),mRNA/cds = (26, 301) GGAGCTTACTGGCAAACATGAAAA 1779 literature Hs.76422M22430 190888 phospholipase A2, group IIA (platelets, 1TCTCCTCCACCTCAACTCCGTGCTTA synovial fluid) (PLA2G2A), nuclearACCAAAGAAGCTGTACTCCGGGGG gene encoding mitochondrial protein, mRNA/cds =(135, 569) 1780 db mining Hs.51299 M22538 986883 NADH dehydrogenase(ubiquinone) 1 ACCCAAGGGACCTGGATTTGGTGTAC flavoprotein 2 (24 kD)(NDUFV2), AAGCAGGCCTTTAATTTATATTGA mRNA/cds = (18, 767) 1781 Table 3AHs.82848 M25280 188555 selectin L (lymphocyte adhesion 1AGCTCCTCTTCCTGGCTTCTTACTGA molecule I) (SELL), mRNA/AAGGTTACCCTGTAACATGCAATT cds = (88, 1206) 1782 Table 3A Hs.73798 M25393190740 macrophage migration inhibitory factor 1GTCTACATCAACTATTACGACATGAA (glycosylation-inhibiting factor) (MIF),CGCGGCCAATGTGGGCTGGAACAA mRNA/cds = (97, 444) 1783 Table 3A Hs.73798M25639 188627 macrophage migration inhibitory factor 1CCACCCCAACCTTCTGGTGGGGAGA (glycosylation-inhibiting factor) (MIF),AATAAACGGTTTAGAGACAGCTCTG mRNA/cds = (97, 444) 1784 db mining Hs.624M26383 184641 interleukin 8 (IL8), mRNA/ 1 GCCAAGGGCCAAGAGAATATCCGAA cds= (74, 373) CTTTAATTTCAGGAATTGAATGGGT 1785 Table 3A Hs.303649 M26683186289 small inducible cytokine A2 (monocyte 1GAAATTGCTTTTCCTCTTGAACCACA chemotactic protein 1, homologous toGTTCTACCCCTGGGATGTTTTGAG mouse Sig-je) (SCYA2), mRNA/ cds = (53, 352)1786 Table 3A Hs.82112 M26880 340067 interleukin 1 receptor, type I(IL1R1), 1 CCGGTTGTTAAAACTGGTTTAGCACA mRNA/cds = (82, 1791)ATTTATATTTTCCCTCTCTTGCCT 1787 Table 3A Hs.82112 M27492 180035interleukin 1 receptor, I (IL1R1), 1 ATTAAAGCACCAAATTCATGTACAGC mRNA/cds= (82, 1791) ATGCATCACGGATCAATAGACTGT 1788 Table 3A Hs.1309 M28170862622 thymocyte antigen CD1a mRNA, 1 TAGCCGTACTTTGCTAACTGTGCTCCcomplete cds/cds = (533, 1516) TCACTTCCTCTTCTTCATTGCAGT 1789 Table 3AHs.78146 M28526 189775 platelet/endothelial cell adhesion 1AGGCTAAGCTGCCGGTTCTTAAATCC molecule (CD31 antigen) (PECAM1),ATCCTGCTAAGTTAATGTTGGGTA mRNA/cds = (141, 2357) 1790 Table 3A Hs.1309M28825 186279 thymocyte antigen CD1a mRNA, 1 AATATATGCATCCCTGGTGAAGGATCcomplete cds/cds = (533, 1516) TTGCCTGCATGAAACATGTTCTCA 1791 Table 3AHs.1722 M28983 186365 interleukin 1, alpha (IL1A), mRNA/ 1ACCTGGGCATTCTTGTTTCATTCAATT cds = (36, 581) CCACCTGCAATCAAGTCCTACAA 1792Table 3A Hs.237868 M29064 337452 interleukin 7 receptor (IL7R), mRNA/ 1CTCCCTCACAGCACAGAGAAGACAAA cds = (22, 1401) ATTAGCAAAACCCCACTACACAGT1793 Table 3A Hs.237868 M29696 180259 interleukin 7 receptor (IL7R),mRNA/ 1 GTTCAGTGGCACTCAACATGAGTCAA cds = (22, 1401)GAGCATCCTGCTTCTACCATGTGG 1794 Table 3A Hs.89538 M30142 181464cholesteryl ester transfer protein, 1 CTTGAGCTAGAAGTCTCCAAGGAGGT plasma(CETP), mRNA/ CGGGATGGGGCTTGTAGCAGAAGG cds = (130, 1611) 1795 Table 3AHs.89538 M30185 179039 cholesteryl ester transfer protein, 1CTCCCAACTCCTCCCTATCCTAAAGG plasma (CETP), mRNA/ CCCACTGGCATTAAAGTGCTGTATcds = (130, 1611) 1796 db mining Hs.270833 M30704 339994 amphiregulin(schwannoma-derived 1 TCGGTCCTCTTTCCAGTGGATCATAA growth factor) (AREG),mRNA/ GACAATGGACCCTTTTTGTTATGA cds = (209, 967) 1797 Table 3A Hs.29352M31165 184485 tumor necrosis factor, alpha-induced 1AACACACAGTGTTTATGTTGGAATCT protein 6 (TNFAIP6), mRNA/TTTGGAACTCCTTTGATCTCACTG cds = (68, 901) 1798 Table 3A Hs.149923 M31210181948 X-box binding protein 1 (XBP1), 1 GGGGCTCTTTCCCTCATGTATACTTCmRNA/cds = (48, 833) AAGTAAGATCAAGAATCTTTTGTG 1799 Table 3A Hs.1012M31452 190501 complement component 4-binding 1TCATCCTCTGTGTGGCTCATGTTTTT protein, alpha (C4BPA), mRNA/GCTTTTCAACACACAAAGCACAAA cds = (138, 1931) 1800 Table 3A Hs.101047M31523 339477 transcription factor (E2A) mRNA, 1TGGATGATTGGGACTTTAAAACGACC complete cds/cds = (30, 1994)CTCTTTCAGGTGGATTCAGAGACC 1801 db mining Hs.149923 M31827 182473 X-boxbinding protein 1 (XBP1), 1 TGTAGCTTCTGAAAGGTGCTTTCTCC mRNA/cds = (48,833) ATTTATTTAAAAACTACCCATGCA 1802 Table 3A Hs.78864 M31932 188194 Fcfragment of IgG, low affinity IIa, 1 TGTAGCAACATGAGAAACGCTTATGT receptorfor (CD32) (FCGR2A), TACAGGTTACATGAGAGCAATCAT mRNA/cds = (11, 958) 1803Table 3A Hs.73931 M32011 189267 major histocompatibility complex, class1 CTGATGGCTGTGACCCTGCTTCCTGC II, DQ beta 1 (HLA-DQB1), mRNA/ACTGACCCAGAGCCTCTGCCTGTG cds = (57, 842) 1804 Table 3A Hs.256278 M32315189185 tumor necrosis factor receptor 1 TGTGTGTTGATCCCAAGACAATGAAAsuperfamily, member 1B (TNFRSF1B), GTTTGCACTGTATGCTGGACGGCA mRNA/cds =(89, 1474) 1805 Table 3A Hs.73931 M32577 183628 major histocompatibilitycomplex, class 1 CTCTCCTCAGACTGCTCAAGAGAAGC II, DQ beta 1 (HLA-DQB1),mRNA/ ACATGAAAACCATTACCTGACTTT cds = (57, 842) 1806 Table 3A Hs.75765M33336 1526989 GRO2 oncogene (GRO2), mRNA/ 1 GCCAGTAAGATCAATGTGACGGCAGcds = (74, 397) GGAAATGTATGTGTGTCTATTTTGT 1807 Table 3A Hs.198253 M33906184194 major histocompatibility complex, class 1GCAACAATGAAGTTAATGGATACCCT II, DQ alpha 1 (HLA-DQA1), mRNA/CTGCCTTTGGCTCAGAAATGTTAT cds = (43, 810) 1808 Table 3A Hs.87773 M34181189982 protein kinase, cAMP-dependent, 1 TGTCTTTCGGTTATCAAGTGTTTCTGcatalytic, beta (PRKACB), mRNA/ CATGGTAATGTCATGTAAATGCTG cds = (47,1102) 1809 Table 3A Hs.26045 M34888 190738 protein tyrosine phosphatase,receptor 1 TATCATGGGGAGTAATAGGACCAGAG type, A (PTPRA), mRNA/CGGTATCTCTGGCACCACACTAGC cds = (695, 3103) 1810 Table 3A Hs.119663M34671 180152 CD59 antigen p18-20 (antigen 1 TGATCTTGGCTGTATTTAATGGCATAidentified by monoclonal antibodies GGCTGACTTTTGCAGATGGAGGAA 16.3A5,EJ16, EJ30, EL32 and G344) (CD59), mRNA/cds = (29, 415) 1811 Table 3AHs.250811 M35416 190851 v-ral simian leukemia viral oncogene 1AGTACTGAGAAAAATCCCTTCAGCTC homolog B (ras related: GTP bindingTAAGAACACTGAAAAATCCACCGA protein) (RALB), mRNA/cds = (170, 790) 1812Table 3A Hs.87149 M35999 183532 integrin, beta 3 (platelet glycoprotein1 ACTTTGCACACATTTGCATCCACATAT IIIa, antigen CD61) (ITGB3), mRNA/TAGGGAAGGAATAAGTAGCTGCA cds = (16, 2382) 1813 Table 3A Hs.75765 M36820183628 GRO2 oncogene (GRO2), mRNA/ 1 ATGCAGTGTTTCCCTCTGTGTTAGAG cds =(74, 397) CAGAGAGGTTTCGATATTTATTGA 1814 Table 3A Hs.89690 M38821 183632GRO3 oncogene (GRO3), mRNA/ 1 TGCTGAAGTTTCCCTTAGACATTTTAT cds = (77,397) GTCTTGCTTGTAGGGCATAATGC 1815 Table 3A Hs.82212 M37033 184059 CD53antigen (CD53), mRNA/ 1 CACTGGACCATTGTCACAACCCTCTG cds = (93, 752)TTTCTCTTTGACTAAGTGCCCTGG 1816 Table 3A Hs.119192 M37583 179968 H2Ahistone family, member Z 1 AAGTGTTACTGTGGCTTCAAAGAAGC (H2AFZ), mRNA/cds= (106, 492) TATTGATTCTGAAGTAGTGGGTTT 1817 Table 3A Hs.173894 NM_0007574503074 macrophage-specific colony- 1 GCTGCTTATATATTTAATAATAAAAGAstimulating factor (CSF-1) mRNA, AGTGCACAAGCTGCCGTTGACGT completecds/cds = (105, 1769) 1818 Table 3A Hs.119192 M37583 189988 H2A histonefamily, member Z 1 AACAAACATTTGGTTTTGTTCAGACCT (H2AFZ), mRNA/cds = (106,492) TATTTCCACTCTGGTGGATAAGT 1819 Table 3A Hs.315366 M55284 189988protein kinase C, eta (PRKCH), mRNA/ 1 GAGAGAGGGCACGAGAACCCAAAGG cds =(166, 2214) AATAGAGATTCTCCAGGAATTTCCT 1820 Table 3A Hs.315366 M55284189988 protein kinase C, eta (PRKCH), mRNA/ 1 TTCCCAGCATCAGCCTTAGAACAAGAcds = (166, 2214) ACCTTACCTTCAAGGAGCAAGTGA 1821 Table 3A Hs.171862M55543 829176 guanylate binding protein 2, interferon- 1CTGTCCAGCTCCCTCTCCCCAAGAAA inducible (GBP2), mRNA/CAACATGAATGAGCAACTTCAGAG cds = (156, 1931) 1822 Table 3A Hs.2055 M58028340071 ubiquitin-activating enzyme E1 (A1S9T 1 CTGTAACGACGAGAGCGGCGAGGATand BN75 temperature sensitivity GTCGAGGTTCCCTATGTCCGATACAcomplementing) (UBE1), mRNA/ cds = (32, 3208) 1823 Table 3A NA M55674189870 one single clone, artifact? 1 ACCTAGTCATCAGGACACTGAGCCAGGGCTGCAACCACTCCATGAGTTTG 1824 Table 3A Hs.72918 M57506 184505 smallinducible cytokine A1 (1-309, 1 CCCCAACCCTCTGGGCTCTTGGATTT homologous tomouse Tca-3) (SCYA1), CAGAGTGAAAACTTGATGGCATTG mRNA/cds = (72, 362) 1825Table 3A Hs.193717 M57627 186270 interleukin 10 (IL10), mRNA/ 1TCAATTCCTCTGGGAATGTTACATTG cds = (30, 566) TTTGTCTGTCTTCATAGCAGATTT 1826Table 3A Hs.1051 M57888 183154 granzyme B (granzyme 2, cytotoxic T- 1ACCAGTTTCTTTCCCTTCTAGATCAC lymphocyte-associated serine esteraseCCTGTTCTGAAGCCAGCCTCTCTC 1) (GZMB), mRNA/cds = (33, 776) 1827 Table 3AHs.2055 M58028 189177 ubiquitin-activating enzyme E1 (A1S9T 1CTACCTGAACCCCTCTTGCCACTGCC and BN75 temperature sensitivityTTCTACCTTGTTTGAAACCTGAAT complementing) (UBE1), mRNA/ cds = (32, 3208)1828 Table 3A Hs.83426 M58597 182070 nuclear factor of kappa light 1AACTCGAGACCTTTTCAACTTGGCTT polypeptide gene enhancer in B-cells 1CCTTTCTTGGTTCATAAATGAATT (p105) (NFKB1), mRNA/ cds = (397, 3303) 1829Table 3A Hs.83428 M58603 186496 nuclear factor of kappa light 1AGCTGCTGCTGGATCACAGCTGCTTT polypeptide gene enhancer in B-cells 1CTGTTGTCATTGCTGTTGTCCCTC (p105) (NFKB1), mRNA/ cds = (397, 3303) 1830Table 3A Hs.265829 M59465 177865 integrin, alpha 3 (antigen CD49C, 1GGCTGTGTCCTAAGGCCCATTTGAGA alpha 3 subunit of VLA-3 receptor)AGCTGAGGCTAGTTCCAAAAACCT (ITGA3), transcript, variant a, mRNA/ cds =(73, 3228) 1831 Table 3A Hs.2175 M59820 183048 colony stimulating factor3 receptor 1 ATCCAGCCCCACCCAATGGCCTTTTG (granulocyte) (CSF3R), mRNA/TGCTTGTTTCCTATAACTTCAGTA cds = (169, 2679) 1832 Table 3A Hs.265829M60278 183866 integrin, alpha 3 (antigen CD49C, 1CCTTCTTTGTATATAGGCTTCTCACC alpha 3 subunit of VLA-3 receptor)GCGACCAATAAACAGCTCCCAGTT (ITGA3), transcript variant a, mRNA/ cds = (73,3228) 1833 Table 3A Hs.799 M60724 189507 diphtheria toxin receptor(heparin- 1 AAAACGATGAAGGTATGCTGTCATGG binding epidermal growthfactor-like TCCTTTCTGGAAGTTTCTGGTGCC growth factor) (DTR), mRNA/ cds =(261, 887) 1834 Table 3A Hs.86658 M60826 182882 ribosomal protein S6kinase, 70 kD, 1 AATGCGAAATTATTGGTTGGTGTGAA polypeptide 1 (RPS6KB1),mRNA/ GAAAGCCAGACAACTTCTGTTTCT cds = (27, 1604) 1835 Table 3A Hs.88858M61906 189424 ribosomal protein S6 kinase, 70 kD, 1CTGTGGCTCGTTTGAGGGATTGGGG polypeptide 1 (RPS6KB1), mRNA/TGGACCTGGGGTTTATTTTCAGTAA cds = (27, 1604) 1836 Table 3A Hs.6241 M61199181122 P13-kinase associated p85 mRNA 1 GCTTCCCCACCCCAGTTTTTGTTGCTsequence/cds = UNKNOWN TGAAAATATTGTTGTCCCGGATTT 1837 Table 3A Hs.6241M61906 190734 P13-kinase associated p85 mRNA 1TGGACTGTTTTGTTGGGCAGTGCCTG sequence/cds = UNKNOWNATAAGCTTCAAAGCTGCTTTATTC 1838 Table 3A Hs.50651 M63180 339679 Januskinase 1 (a protein tyrosine 1 CCTGCCGTGCCCACCTAACTGTCCA kinase) (JAK1),mRNA/cds = (75, GATGAGGTTTATCAGCTTATGAGAA 3503) 1839 Table 3A Hs.84318M63488 337488 replication protein A1 (70 kD) (RPA1), 1CGAGCTGAGAAGCGGTCATGAGCAC mRNA/cds = (69, 1919)CTGGGGATTTTAGTAAGTGTGTCTT 1840 Table 3A Hs.50651 M64174 190446 Januskinase 1 (a protein tyrosine 1 ACCATCCAATCGGACAAGCTTTCAGA kinase)(JAK1), mRNA/cds = (75, ACCTTATTGAAGGATTTGAAGCAC 3503) 1841 Table 3AHs.82159 M64992 178996 proteasome (prosome, macropain) 1TGCTGATGAACCTGCAGAAAAGGCTG subunit, alpha type, 1 (PSMA1),ATGAACCAATGGAACATTAAGTGA mRNA/cds = (105, 896) 1842 Table 3A Hs.11482M69043 167290 splicing factor, arginine/serine-rich 11 1TCTTATGCACACGGTGATTTCATGTT (SFRS11), mRNA/cds = (83, 1537)ATATATGCAAAGTAGGCAACTGTT 1843 Table 3A Hs.155160 M72709 179073 Homosapiens. Similar to splicing 1 AACATAGGAGTGGATTCCTGCCCCAA factor,arginine/serine-rich 2 (SC-35), CCAAACCGCATTCGTGTGGATTTT clone, MGC:2622IMAGE:3501687, mRNA, complete cds/cds = (30, 878) 1844 Table 3A Hs.1117M73047 339879 tripeptidyl peptidase II (TPP2), mRNA/ 1AATAAATTTGCAAAACCAAGATCACA cds = (23, 3772) GTACACCATATGCACTCTGGTACC1845 Table 3A Hs.178112 M73547 190161 polyposis locus (DP1 gene) mRNA, 1AAATGACCTCATGTTGTGGTTTAAAC complete cds/cds = (82, 639)AGCAACTGCACCCACTAGCACAGC 1846 Table 3A Hs.11482 M74002 184045 splicingfactor, arginine/serine-rich 11 1 TGTGCAGTAGAAACAAAAGTAGGCTA (SFRS11),mRNA/cds = (83, 1537) CAGTCTGTGCCATGTTGATGTACA 1847 Table 3A Hs.811M74525 189511 ubiquitin-conjugating enzyme E2B 1CTGTTTATTCTGGGAAATGTTTTAATG (RAD6 homolog) (UBE2B), mRNA/CCAGGGCCTGCTGAGTTGCTTCT cds = (421, 879) 1848 Table 3A Hs.172766 M80359182353 MAP/microtubule affinity-regulating 1 CCTTAAGACCAGTTCATAGTTAATACkinase 3 (MARK3), mRNA/ AGGTTTACAGTTCATGCCTGTGGT cds = (171, 2312) 1849Table 3A Hs.153179 M81601 339442 fatty acid binding protein 5(psoriasis- 1 TCATCACTTTGGACAGGAGTTAATTA associated) (FABP5), mRNA/AGAGAATGACCAAGCTCAGTTCAA cds = (48, 455) 1850 Table 3A Hs.119537 M88108189499 GAP-associated tyrosine 1 AGTCTGCCTAAATAGGTAGCTTAAACphosphoprotein p62 (Sam68) (SAM68), TTATGTCAAAATGTCTGCAGCAGT mRNA/cds =(106, 1437) 1851 Table 3A Hs.89575 M89957 179311 CD79B antigen(immunoglobulin- 1 CTGGCCTCCAGTGCCTTCCCCCGTG associated beta) (CD79B),transcript GAATAAACGGTGTGTCCTGAGAAAC variant 1, mRNA/cds = (94, 783)1852 Table 3A Hs.181967 M90356 179575 BTF3 protein homologue gene, 1AGCTAATTAAGCTGCAGAACGTGGGA complete cds AATAAAGTTCGAAACAAAGGTTAA 1853Table 3A Hs.82127 M90391 4153827 putative IL-16 protein precursor, 1GGACAGGTGTGCCGACAGAAGGAAC mRNA, complete cds/cds = (303, 2198)CAGCGTGTATATGAGGGTATCAAAT 1854 Table 3A Hs.73722 M92444 183779apurinic/apyrimidinic endonuclease 1 CCCTTCGTGGGGCTACACATTCTCTT (HAP1)gene, complete cds CCTCATATTTTCATGCACACAAGT 1855 Table 3A Hs.145279M93651 338038 SET translocation (myeloid leukemia- 1TTCTGCACAGGTCTCTGTTTAGTAAA associated) (SET), mRNA/cds = (3,TACATCACTGTATACCGATCAGGA 836) 1856 Table 3A Hs.7647 M94046 187393MYC-associated zinc finger protein 1 CACCCTCCACCCCTTCCTTTTGCGCG(purine-binding transcription factor) GACCCCATTACAATAAATTTTAAA (MAZ),mRNA/cds = (91, 1584) 1857 Table 3A Hs.153179 M95585 184223 fatty acidbinding protein 5 (psoriasis- 1 CATGCAGCTATTTCAAAGTGTGTTGG associated)(FABP5), mRNA/ ATTAATTAGGATCATCCCTTTGGT cds = (48, 455) 1858 Table 3AHs.250692 M95585 337810 hepatic leukemia factor (HLF) mRNA, 1TGGAGAATTGTGGAAGGATTGTAACA complete cds/cds = (322, 1209)TGGACCATCCAAATTTATGGCCGT 1859 Table 3A Hs.74592 M98982 338262 specialAT-rich sequence binding 1 TTCACGGGATGCACCAAAGTGTGTAC protein 1 (bindsto nuclear CCCGTAAGCATGAAACCAGTGTTT matrix/scaffold-associating DNA's)(SATB1), mRNA/cds = (214, 2505) 1860 Table 3A Hs.296381 M96995 181975growth factor receptor-bound protein 2 1 TCTGTCCATCAGTGCATGACGTTTAA(GRB2), mRNA/cds = (78, 731) GGCCACGTATAGTCCTAGCTGACG 1861 Table 3AHs.74592 M97856 184432 special AT-rich sequence binding 1TCCTATAATTATTTCTGTAGCACTCCA protein 1 (binds to nuclearCACTGATCTTTGGAAACTTGCCC matrix/scaffold-associating DNA's) (SATB1),mRNA/cds = (214, 2505) 1862 Table 3A Hs.243886 M97935 2281070 nuclearautoantigenic sperm protein 1 GGGACACTGGAGGCTGGAGCTACAG(histone-binding) (NASP), mRNA/ TTGAAAGCACTGCATGTTAAGAGGG cds = (85,2446) 1863 Table 3A Hs.21486 M98399 180112 signal transducer andactivator of 1 TGCTACCACAACTATATTATCATGCAA transcription 1, 91 kD(STAT1), ATGCTGTATTCTTCTTTGGTGGA mRNA/cds = (196, 2448) 1864 Table 3AHs.75613 N27575 1142056 CD36 antigen (collagen type I 1GCAACTTACGCTTGGCATCTTCAGAA receptor, thrombospondin receptor)TGCTTTTCTAGCATTAAGAGATGT (CD36), mRNA/cds = (132, 1550) 1865 Table 3AHs.198427 N25486 1139799 hexokinase 2 (HK2), mRNA/ 1TTTACAAGAATTGTCCATGTGCTTCC cds = (1490, 4243) CTAGGCTGAGCTGGCATTGGTCTG1866 Table 3A Hs.198427 N99577 1271009 hexokinase 2 (HK2), mRNA/ 1AAAACTTCCCACCCTACTTTTCCAAG CDS = (1490, 4243) AGTGCCAGTTGGATTCTGAATCTG1867 Table 3A Hs.73965 N28843 1147079 splicing factor,arginine/serine-rich 2 1 TAGACCAATTCTCTGATCTCGAGTTG (SFRS2), mRNA/cds =(155, 820) TTTTTGTTTGGATACAGCCCTTTT 1868 Table 3A Hs.5122 N31700 1152099602293015F1 cDNA, 5′ end/ 1 AACATTCTACATAGCACAGGAGCTTA clone =IMAGE:4387778/clone_end = AGAGTGGCATTATCTTCTCGCCTT 5′ 1869 Table 3AHs.66151 N3426 1155403 mRNA; cDNA DKFZp434A115 (from 1AGATACGCAGACATTGTGGCATCTGG clone DKFZp434A115)/ GTAGAAGAATACTGTATTGTGTGTcds = UNKNOWN 1870 Table 3A Hs.73965 Z22642 296907 splicing factor,arginine/serine-rich 2 1 TTTGACCAGAAGCCCTTAGTAAGTAC (SFRS2), mRNA/cds =(155, 820) GTGCCTGAAACTGAAACCATGTGC 1871 Table 3A Hs.166563 L14922307337 DNA-binding protein (PO-GA) mRNA, 1 ACACCTGGCTTGGAGTCAGATTTAGTcomplete cds/cds = (393, 3836) TAACAATAATGAGCCTGGAGCAGT 1872 literatureHs.75772 M10901 183032 nuclear receptor subfamily 3, group C, 1TCTAATAGCGGGTTACTTTCACATAC member 1 (NR3C1), mRNA/AGCCCTCCCCCAGCAGTTGAATGA cds = (132, 2465) 1873 literature Hs.74561NM_000014 6226959 alpha-2-macroglobulin (A2M), mRNA/ 1CTGAAAAGTGCTTTGCTGGAGTCCTG cds = (43, 4467) TTCTCTGAGCTCCACAGAAGACAC1874 db mining Hs.172670 NM_000020 4557242 activin A receptor typeII-like 1 1 AAGCCTAAAGTGATTCAATAGCCCAG (ACVRL1), mRNA/cds = (282, 1793)GAGCACCTGATTCCTTTCTGCCTG 1875 Table 3A Hs.1217 NM_000022 4557248adenosine diaminase (ADA), mRNA/ 1 TGGGCATGGTTGAATCTGAAACCCTC cds = (95,1186) CTTCTGTGGCAACTTGTACTGAAA 1876 Table 3A Hs.99931 NM_000023 4506910sarcoglycan, alpha (50 kD dystrophin- 1 GGGGTGGGGTGGGGTGAGAGTGTGTassociated glycoprotein) (SGCA), GGAGTAAGGACATTCAGAATAAATA mRNA/cds =(11, 1174) 1877 literature Hs.207776 NM_000027 4557272aspartylglucosaminidase (AGA), 1 AGAAGTTGTGCGCGTGCTTTCTCAGC mRNA/cds =(170, 1210) AGCATTTTTCCTTCAAAATCATCT 1878 Table 3A Hs.159548 NM_0000337262392 ATP-binding cassette, sub-family D 1 CTTGCCAGCCAGGAGTGCGGACACC(ALD), member 1 (ABCD1), mRNA/ ATGTTCCCAGCTCAGTGCCAAAGAG cds = (386,2623) 1879 Table 3A Hs.75081 NM_000038 4557318 adenomatosis polyposiscoli (APC), 1 ATTTGGGGAGAGAAAACCTTTTTAAG mRNA/cds = (38, 8569)CATGGTGGGGCACTCAGATAGGAG 1880 literature Hs.36820 NM_000057 4557364Bloom syndrome (BLM), mRNA/ 1 ACCCTCTTTCTTGTTTGTCAGCATCT cds = (74,4327) GACCATCTGTGACTATAAAGCTGT 1881 literature Hs.34012 NM_0000594502450 breast cancer 2, early onset (BRCA2), 1TGGTCATCCAAACTCAAACTTGAGAA mRNA/cds = (228, 10484)AATATCTTGCTTTCAAATTGACAC 1882 Table 3A Hs.159494 NM_000061 4557376Bruton agammaglobulinemia tyrosine 1 ACCGAATTTGGCAAGAATGAAATGGT kinase(BTK), mRNA/cds = (163, GTCATAAAGATGGGAGGGGAGGGT 2142) 1883 Table 3AHs.1282 NM_000085 4559405 complement component 6 (C6), 1AGCCTGTGACATTAAGCATTCTCACA mRNA/cds = (155, 2959)ATTAGAAATAAGAATAAAACCCAT 1884 Table 3A Hs.2259 NM_000073 4557428 CD3Gantigen, gamma polypeptide 1 AAAAATAAAAACAAATACTGT (TiT3 complex)(CD3G), mRNA/ GTTTCAGAAGCGCCACCTATTGGG cds = (37, 585) GAAAA 1885 Table3A Hs.36508 NM_000081 4502838 Chediak-Higashi syndrome 1 (CHS1), 1TTATCACAAGCTCTGTTACCTTTATAT mRNA/cds = (189, 11594)ACGCTGCCTCTTCAATTTGGAAA 1886 literature Hs.32967 NM_000082 4557466Cockayne syndrome 1 (classical) 1 GCAGAAAATATCCTGGCAGGGAATCT (CKN1),mRNA/cds = (36, 1226) GGCTTAAACATGAAATGCTGTAAT 1887 Table 3A Hs.154654NM_000104 13325059 cytochrome P450, subfamily 1 (dioxin- 1TGTGTGCATAATAGCTACAGTGCATA inducible), polypeptide 1 (glaucoma 3,GTTGTAGACAAAGTACATTCTGGG primary infantile) (CYP1B1), mRNA/ cds = (372,2003) 1888 literature Hs.77602 NM_000107 4557514 damage-specific DNAbinding protein 1 TCTCAGTGGGTGGTAGCAGAGGGAT 2 (48 kD) (DDB2), mRNA/CAAGCAGTTATTTGATTTGTGCTCT cds = (175, 1458) 1889 Table 3A Hs.74635NM_000108 5016092 dihydrolipoamide dehydrogenase (E3 1GTCTATTTACGGAACTCAAATACGTG component of pyruvate dehydrogenaseGGCATTCAAATGTATTACAGTGGG complex, 2-oxo-glutarate complex, branchedchain keto acid dehydrogenase complex) (DLD), mRNA/cds = (82, 1611) 1890Table 3A Hs.1602 NM_000110 455874 dihydropyrimidine dehydrogenase 1TGCACTTTTAGAAATGCATATTTGCCA (DPYD), mRNA/cds = (101, 3178)CAAAACCTGTATTACTGAATAAT 1891 Table 3A Hs.2985 NM_000117 4557552 emerin(Emery-Dreifuss muscular 1 GGGAGGGGATTAACCAAAGGCCACC dystrophy) (EMD),mRNA/ CTGACTTTGTTTTTGTGGACACACA cds = (58, 822) 1892 Table 3A Hs.76753NM_000118 4557554 endoglin (Osier-Rendu-Weber 1GCCTGCCCCTGTGTATTCACCACCAA syndrome 1) (ENG), mRNA/TAAATCAGACCATGAAACCTGAAA cds = (350, 2227) 1893 Table 3A Hs.77929NM_000122 4557562 excision repair cross-complementing 1AGGTGTATTTATGTTACCGTTCTGAAT rodent repair deficiency,AAACAGAATGGACCATTGAACCA complementation group 3 (xeroderma pigmentosumgroup B complementing) (ERCC3), mRNA/cds = (95, 2443) 1894 literatureHs.48576 NM_000123 4503600 excision repair cross-complementing 1TGTAATGAATTTGTCGCAAAGACGTA rodent repair deficiency,ATAAAATTAACTGGTGGCACGGTC complementation group 5 (xeroderma pigmentosum,complementation group G (Cockayne syndrome)) (ERCC5), mRNA/cds = (197,3757) 1895 literature Hs.99924 NM_000124 4557564 excision repaircross-complementing 1 TGTCAATGGAAGTTGGCTGCACTTGA rodent repairdeficiency, TGTTTGTTTGCATGATGTCTACCT complementation group 6 (ERCC6),mRNA/cds = (79, 3757) 1896 db mining Hs.1657 NM_000125 4503602 estrogenreceptor 1 (ESR1), mRNA/ 1 TCGAGCACCTGTAAACAATTTTCTCA cds = (360, 2147)ACCTATTTGATGTTCAAATAAAGA 1897 Table 3A Hs.80424 NM_000129 9961355coagulation factor XIII, A1 polypeptide 1 AACTTTACTAAGTAATCTCACAGCATT(F13A1), mRNA/cds = (101, 2299) TGCCAAGTCTCCCAATATCCAAT 1898 literatureHs.284153 NM_000135 4503654 Fanconi anemia, complementation 1TAAGATCTTTAAACTGCTTTATACACT group A (FANCA), mRNA/GTCACGTGGCTTCATCAGCTGTG cds = (31, 4398) 1899 literature Hs.37953NM_000136 4557588 Fanconi anemia, complementation 1AAAACCACTACCCTCAGAGAGAGCCA group C (FANCC), mRNA/AAAATACAGAAGAGGCGGAGAGCG cds = (255, 1928) 1900 Table 3A Hs.1437NM_000152 11496988 glucosidase, alpha; acid (Pompe 1CGAGCAAGCCTGGGAACTCAGGAAA disease, glycogen storage disease typeATTCACAGGACTTGGGAGATTCTAA II) (GAA), mRNA/cds = (441, 3299) 1901 Table3A Hs.273 NM_000153 4557612 galatosylceramidase (Krabbe 1GGCTTAGCTACAGTGAAGTTTTGCAT disease) (GALC), mRNA/TGCTTTTGAAGACAAGAAAAGTGC cds = (263, 2272) 1902 Table 3A Hs.66724NM_000161 4503948 GTP cyclohydrolase 1 (dopa- 1ACTTCAAAATTACCTTTTCATATCCAT responsive dystonia) (GCH1), mRNA/GATCTTGAGTCCATTTGGGGGAT cds = (148, 900) 1903 Table 3A Hs.1466 NM_0001674504006 glycerol kinase (GK), mRNA/ 1 CAAACACTTTTGGGCCAGGATTTGAG cds =(66, 1640) TCTCTGCATGACATATACTTGATT 1904 Table 3A Hs.1144 NM_0001744504076 glycoprotein IX (platelet) (GP9), 1 CAGACTCCACCAAGCCTGGTCAGCCmRNA/cds = (222, 755) CAAACCACCAGAAGCCCAGAATAAA 1905 Table 3A Hs.75772NM_000176 4504132 nuclear receptor subfamily 3, group C, 1AGTGCAGAATCTCATAGGTTGCCAAT member 1 (NR3C1), mRNA/AATACACTAATTCCTTTCTATCCT cds = (132, 2465) 1906 literature Hs.3248NM_000179 4504190 mutS (E. coli) homolog 6 (MSH6), 1AGACTGACTACATTGGAAGCTTTGAG mRNA/cds = (87, 4169)TTGACTTCTGACCAAAGGTGGTAA 1907 Table 3A Hs.183868 NM_000181 4504222glucuronidase, beta (GUSB), mRNA/ 1 CTGGGTTTTGTGGTCATCTATTCTAG cds =(26, 1981) CAGGGAACACTAAAGGTGGAAATA 1908 literature Hs.75860 NM_0001824504324 hydroxyacyl-Coenzyme A 1 GTGGTGAGGGCAGTTCTGCACCCAGdehydrogenase/3-ketoacyl-Coenzyme CCAAACACATAACAATAAAAACCAA Athiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alphasubunit (HADHA), mRNA/ cds = (27, 2318) 1909 Table 3A Hs.146812NM_000183 4504326 hydroxyacyl-Coenzyme A 1 TCTGTGTCCTAAAGATGTGTTCTCTATdehydrogenase/3-ketoacyl-Coenzyme AAAATACAAACCAACGTGCCTAA Athiolase/enoyl-Coenzyme A hydratase (trifunctional protein), betasubunit (HADHB), mRNA/ cds = (46, 1470) 1910 Table 3A Hs.198427NM_000189 4504392 hexokinase 2 (HK2), mRNA/ 1 CTAGTCATAGAAATACCTCATTCGCCcds = (1490, 4243) TGTGGGAAGAGAAGGGAAGCCTCT 1911 Table 3A Hs.83951NM_000195 4504484 Hermansky-Pudlak syndrome (HPS), 1AGCAGCGGCTGGATGTGATATGTCTA mRNA/cds = (206, 2308)GTTTAACCAGTCCCCTTGATCTTT 1912 Table 3A Hs.168383 NM_000201 4557877intercellular adhesion molecule 1 1 TATTGGAGGACTCCCTCCCAGCTTTG (CD54),rhinovirus receptor (ICAM1). GAAGGGTCATCCGCGTGTGTGTGT mRNA/cds = (57,1655) 1913 Table 3A Hs.172458 NM_000202 5360215 iduronate 2-sulfatase(Hunter 1 ATACAAAGCAAACAAACTCAAGTTAT syndrome) (IDS), transcript variant1, GTCATACCTTTGGATACGAAGACC mRNA/cds = (331, 1983) 1914 Table 3AHs.238893 NM_000206 4557881 od15g01.s1 cDNA/ 1ATCTACCCTCCGATTGTTCCTGAACC clone = IMAGE:1388048GATGAGAAATAAAGTTTCTGTTGA 1915 Table 3A Hs.83968 NM_000211 4557885integrin, beta 2 (antigen CD18 (p95), 1 CATGGAGACTTGAGGAGGGCTTGAGlymphocyte function-associated antigen GTTGGTGAGGTTAGGTGCGTGTTTC 1;macrophage antigen 1 (mac-1) beta subunit) (ITGB2), mRNA/ cds = (72,2381) 1916 literature Hs.99877 NM_000215 4557680 Janus kinase 3 (aprotein tyrosine 1 GCCCAAAGAAGCAAGGAACCAAATTT kinase, leukocyte) (JAK3),mRNA/ AAGACTCTCGCATCTTCCCAACCC cds = (95, 3489) 1917 literature Hs.1770NM_000234 4557718 ligase I, DNA, ATP-dependent (LIG1), 1CCGGAGTCTGGGATTCATCCCGTCAT mRNA/cds = (120, 2879)TTCTTTCAATAAATAATTATTGGA 1918 db mining Hs.3076 NM_000246 4557748 MHCclass II transactivator 1 GCAATGGCAGCCTTGGCAAACGCTA (MHC2TA), mRNA/cds =(138, 3530) AATGAAAATCGTGACAACACTTGTG 1919 literature Hs.57301 NM_0002494557756 mutL (E. coli) homolog 1 (colon 1 AGTGTTGGTAGCACTTAAGACTTATAcancer, nonpolyposis type 2) (MLH1), CTTGCCTTCTGATAGTATTCCTTT mRNA/cds =(21, 2291) 1920 literature Hs.78934 NM_000251 4557760 mutS (E. coli)homolog 2 (colon 1 AACTGAGGACTGTTTGCAATTGACAT cancer, nonpolyposistype 1) (MSH2), AGGCAATAATAAGTGATGTGCTGA mRNA/cds = (66, 2672) 1921Table 3A Hs.75514 NM_000270 4557800 nucleoside phosphorylase (NP), 1GGGCTCAGTTCTGCCTTATCTAAATC mRNA/cds = (109, 978)ACCAGAGACCAAACAAGGACTAAT 1922 Table 3A Hs.76918 NM_000271 4557802Niemann-Pick disease, type C1 1 GGCATGAAATGAGGGACAAAGAAAG (NPC1),mRNA/cds = (123, 3959) CATCTCGTAGGTGTGTCTACTGGGT 1923 Table 3A Hs.1023NM_000284 4505684 pyruvate dehydrogenase (lipoamide) 1TCTTGGAAACTTCCATTAAGTGTGTA alpha 1 (PDHA1), mRNA/GATTGAGCAGGTAGTAATTGCATG cds = (105, 1277) 1924 Table 3A Hs.78771NM_000291 4505762 phosphoglycerate kinase 1 (PGK1), 1ACTACTCAGCATGGAAACAAGATGAA mRNA/cds = (79, 1332)ATTCCATTTGTAGGTAGTGAGACA 1925 Table 3A Hs.196177 NM_000294 4505784phosphorylase kinase, gamma 2 1 CACTAATGATCCTGCTACCCTCTTGA (testis)(PHKG2), mRNA/ AGACCAGCCCGGTACCTCTCTCCC cds = (93, 1313) 1926 Table 3AHs.169857 NM_000305 4505952 paraoxonase 2 (PON2), mRNA/ 1GTGACCTCACTTCTGGCACTGTGACT cds = (32, 1096) ACTATGGCTGTTTAGAACTACTGA1927 Table 3A Hs.3873 NM_000310 4506030 palmitoyl-protein thioesterase 1(ceroid- 1 AAGCCTTATTCTTCAACTAAAAGATGA lipofuscinosis, neuronal 1,infantile) GGATTAAGAGCAAGAAGTTGGGG (PPT1), mRNA/cds = (13, 933) 1928Table 3A Hs.74621 NM_000311 4506112 prion protein (p27-30) (Creutzfeld-1 GCACTGAATCGTTTCATGTAAGAATC Jakob disease, Gerstmann-Strausler-CAAAGTGGACACCATTAACAGGTC Scheinker syndrome, fatal familial insomnia)(PRNP), mRNA/ cds = (49, 810) 1929 Table 3A Hs.288986 NM_000344 13259515survival of motor neuron 1, telomeric 1 GGTGCTCACATTCCTTAAATTAAGGA(SMN1), transcript variant d, mRNA/ GAAATGCTGGCATAGAGCAGCACT cds = (163,1047) 1930 Table 3A Hs.2316 NM_000346 4557852 SRY (sex determiningregion Y)-box 9 1 CTTTTGTTCTCTCCGTGAAACTTACCT (campomelic dysplasia,autosomal sex- TTCCCTTTTTCTTTCTCTTTTTT reversal) (SOX9) 1931 Table 3AHs.118787 NM_000358 4507466 transforming growth factor, beta- 1TGGTATGTAGAGCTTAGATTTCCCTA induced, 68 kD (TGFBI), mRNA/TTGTGACAGAGCCATGGTGTGTTT cds = (47, 2098) 1932 literature Hs.2030NM_000361 4507482 Thrombomodulin 1 TGGAGATAATCTAGAACACAGGCAAAATCCTTGCTTATGACATCACTTGT 1933 Table 3A Hs.83848 NM_000365 4507644triosephosphate isomerase 1 (TPI1), 1 GTGCCTCTGTGCTGTGTATGTGAACCmRNA/cds = (34, 783) ACCCATGTGAGGGAATAAACCTAG 1934 db mining Hs.123078NM_000369 4507700 thyroid stimulating hormone receptor 1TGCAAACGGTTTTGTAAGTTAACACT (TSHR), mRNA/cds = (100, 2394)ACACTACTCACAATGGTAGGGGAA 1935 literature Hs.75593 NM_000375 4557872uroporphyrinogen III synthase 1 CCTGTGCCCAGCAGGAAGGAAGTCA (congenitalerythropoietic porphyria) AATAAACCACACTGACTACCTGTGC (UROS), mRNA/cds =(198, 993) 1936 db mining Hs.2157 NM_000377 4507908 Wiskott-Aldrichsyndrome (eczema- 1 CCCAACAATCCCAAGGCCCTTTTTAT thrombocytopenia) (WAS),mRNA/ ACAAAAATTCTCAGTTCTCTTCAC cds = (34, 1542) 1937 Table 3A Hs.250NM_000379 9257259 xanthene dehydrogenase (XDH), 1TGTCTGTTTTAATCATGTATCTGGAAT mRNA/cds = (81, 4082)AGGGTCGGGAAGGGTTTGTGCTA 1938 literature Hs.192803 NM_000380 4507936xeroderma pigmentosum, 1 CACGATGGTGGAAACAGTGGGGAAC complementation groupA (XPA), TACTGCTGGAAAAAGCCCTAATAGC mRNA/cds = (26, 847) 1939 Table 3AHs.179665 NM_000389 11386202 cyclin-dependent kinase inhibitor 1A 1CCCTGGAGGCACTGAAGTGCTTAGT (p21, Cip1) (CDKN1A), mRNA/GTACTTGGAGTATTGGGGTCTGACC cds = (75, 569) 1940 Table 3A Hs.83942NM_000396 4503150 cathepsin K (pyenodysostosis) 1 ACAAGTTTACATGATAAAAA(CTSK), mRNA/cds = (129, 1118) GAAATGTGATTTGTCTTCCCTTCTT TGCAC 1941Table 3A Hs.88974 NM_000397 6996020 cytochrome b-245, beta polypeptide 1TTGTATGTGAATAATTCTAGCGGGGG (chronic granulomatous disease)ACCTGGGAGATAATTCTACGGGGA (CYBB), mRNA/cds = (14, 1726) 1942 Table 3AHs.1395 NM_000399 9845523 early growth response 2 (Krox-20 1ATCTATTCTAACGCAAAACCACTAACT (Drosophila) homolog) (EGR2),GAAGTTCAGATATAATGGATGGT mRNA/cds = (337, 1768) 1943 Table 3A Hs.180866NM_000416 4557879 interferon gamma receptor 1 1GTAACGGAACATATCCAGTACTCCTG (IFNGR1), mRNA/cds = (43, 1512)GTTCCTAGGTGAGCAGGTGATGCC 1944 Table 3A Hs.1724 NM_000417 4557666interleukin 2 receptor, alpha (IL2RA), 1 ACTAATTTGATGTTTACAGGTGGACAmRNA/cds = (159, 977) CACAAGGTGCAAATCAATGCGTAC 1945 Table 3A Hs.75545NM_000418 4557668 interleukin 4 receptor (IL4R), mRNA/ 1TGTGTGTTTTACTTTCATCACCTGTTA cds = (175, 2652) TCTGTGTTTGCTGAGGAGAGTGG1946 Table 3A Hs.785 NM_000419 6006009 integrin, alpha 2b (plateletglycoprotein 1 TTGGAGCTGTTCCATTGGGTCCTCTT IIb of IIb/IIIa complex,antigen CD41B) GGTGTCGTTTCCCTCCCAACAGAG (ITGA2B), mRNA/cds = (32, 3151)1947 Table 3A Hs.77318 NM_000430 5031206 platelet-activating factor 1ATTTGTTGCTCTCAGACTGTGTAAAA acetylhydrolase, isoform Ib, alphaCAAAATTTATTCATGTTTTCTGCA subunit (45 kD) (PAFAH1B1), mRNA/ cds = (555,1787) 1948 Table 3A Hs.949 NM_000433 6557786 neutrophil cytosolic factor2 (65 kD, 1 CTGAACCATTACTGTAATTGGCTCTT chronic granulomalous disease.AAGGCTTGAAGTAACCTTATAGGT autosomal 2) (NCF2), mRNA/ cds = (67, 1647)1949 Table 3A Hs.78146 NM_000442 4505706 platelet/endothelial celladhesion 1 GCTAAGCTGCCGGTTCTTAAATCCAT molecule (CD31 antigen) (PECAM1),CCTGCTAAGTTAATGTTGGGTAGA mRNA/cds = (141, 2357) 1950 db mining Hs.166891NM_000449 4557842 regulatory factor X, 5 (influences HLA 1TGTAACCAATAAATCTGTAGTGACCT class II expression) (RFX5), mRNA/TACCTGTATTCCCTGTGCTATCCT cds = (161, 2011) 1951 Table 3A Hs.75428NM_000454 4507148 superoxide dismutase 1, soluble 1ACATTCCCTTGGATGTAGTCTGAGGC (amyotrophic lateral sclerosis 1 (adult))CCCTTAACTCATCTGTTATCCTGC (SOD1), mRNA/cds = (0, 464) 1952 Table 3AHs.83918 NM_000480 4502078 adenosine monophosphate deaminase 1ATTTCTCCCTTATCTACTGTGATGACT (isoform E) (AMPD3), mRNA/TCAGAAGATACAATGGTCCCAGG cds = (344, 2674) 1953 Table 3A Hs.88251NM_000487 7262293 arylsulfatase A (ARSA), mRNA/ 1TGTCTGGAGGGGGTTTGTGCCTGATA cds = (375, 1898) ACGTAATAACACCAGTGGAGACTT1954 Table 3A Hs.663 NM_000492 6995995 cystic fibrosis transmembrane 1ACACTGCCTTCTCAACTCCAAACTGA conductance regulator. ATP-bindingCTCTTAAGAAGACTGCATTATATT cassette (sub-family C, member 7) (CFTR),mRNA/cds = (132, 4574) 1955 Table 3A Hs.273385 NM_000516 8659565 guaninenucleotide binding protein (G 1 AGATGTTCCAAATTTAGAAAGCTTAA protein),alpha stimulating activity GGCGGCCTACAGAAAAAGGAAAAA polypeptide 1(GNAS1), mRNA/ cds = (68, 1252) 1956 Table 3A Hs.155376 NM_00051813788565 hemoglobin, beta (HBB), mRNA/ 1 AAGTCCAACTACTAAACTGGGGGATA cds= (50, 493) TTATGAAGGGCCTTGAGCATCTGG 1957 Table 3A Hs.119403 NM_00052013128865 hexosaminidase A (alpha polypeptide) 1ATCCACCTCCCTCCCCTAGAGCTATT (HEXA), mRNA/cds = (26, 1815)CTCCTTTGGGTTTCTTGCTGCTGC 1958 Table 3A Hs.51043 NM_000521 13128866hexosaminidase B (beta polypeptide) 1 AAAAGGCCACAGCAATCTGTACTACA (HEXB),mRNA/cds = (75, 1745) ATCAACTTTATTTTGAAATCATGT 1959 literature Hs.111749NM_000534 11496979 postmeiotic segregation increased (S. 1GATTAGTTACCATTGAAATTGGTTCT cerevisiae) 1 (PMS1), mRNA/GTCATAAAACAGCATGAGTCTGGT cds = (80, 2878) 1960 literature Hs.177548NM_000535 11125773 postmeiotic segregation increased (S. 1AAAAATACACATCACACCCATTTAAAA cerevisiae) 2 (PMS2), mRNA/GTGATCTTGAGAACCTTTTCAAA cds = (24, 2612) 1961 db mining Hs.301461NM_000538 4506500 601845227F1 cDNA, 5′ end/ 1 ACAGCAACAGCTATTAAATCAGCAAGclone = IMAGE:4070407/clone_end = TTTTGGAGCAAAGACAACAGCAGT 5′ 1962literature Hs.150477 NM_000553 5739523 Werner syndrome (WRN), mRNA/ 1TGACCAGGGCAGTGAAAATGAAACC cds = (231, 4529) GCATTTTGGGTGCCATTAAATAGGG1963 Table 3A Hs.82212 NM_000560 10834971 CD53 antigen (CD53), mRNA/ 1CAATTTCTTTATTAGAGGGCCTTATTG cds = (93, 752) ATGTGTTCTAAGTCTTTCCAGAA 1964Table 3A Hs.77424 NM_000566 10835132 Fc fragment of IgG, high affinityIa, 1 AGAGCTGAAATGTCAGGAACAAAAAG receptor for (CD64) (FCGR1A),AAGAACAGCTGCAGGAAGGGGTGC mRNA/cds = (0, 1124) 1965 literature Hs.334687NM_000569 12056966 Fc fragment of IgG, high affinity IIIa, 1GGTAATAAGAGCAGTAGCAGCAGCAT receptor for (CD16) (FCGR3A),CTCTGAACATTTCTCTGGATTTGC mRNA/cds = (33, 797) 1966 Table 3A Hs.1369NM_000574 10835142 decay accelerating factor for 1 AGAGTTTGGAAAAAGCCTGTGcomplement (CD55, Cromer blood AAAGGTGTCTTCTTTGACTTAATG group system)(DAF), mRNA/ TCTTT cds = (65, 1210) 1967 Table 3A Hs.1722 NM_00057513238493 interleukin 1, alpha (IL1A), mRNA/ 1 GTATGGTAGATTCAAATGAACCACTGcds = (36, 851) AAAAGGCATTTAGTTTCTTGTCCC 1968 Table 3A Hs.126256NM_000576 10835144 interleukin 1, beta (1L1B), mRNA/ 1AGCTATGGAATCAATTCAATTTGGAC cds = (86, 895) TGGTGTGCTCTCTTTAAATCAAGT 1969literature Hs.54443 NM_000579 4502638 chemokine (C—C motif) receptor 5 1GCTCTTAAGTTGTGGAGAGTGCAACA (CCR5), mRNA/cds = (357, 1415)GTAGCATAGGACCCTACCCTCTGG 1970 Table 3A Hs.313 NM_000582 4759165 secretedphosphoprotein 1 1 GAATTTGGTGGTGTCAATTGCTTATTT (osteopontin, bonesialoprotein I, early GTTTTCCCACGGTTGTCCAGCAA T-lymphocyte activation 1)(SPP1), mRNA/cds = (87, 989) 1971 Table 3A Hs.624 NM_000584 10834977interleukin 8 (IL8), mRNA/ 1 AAAACAGCCAAAACTCCACAGTCAAT cds = (74, 373)ATTAGTAATTTCTTGCTGGTTGAA 1972 Table 3A Hs.168132 NM_000585 10835152interleukin 15 (IL15), mRNA/ 1 TAGCATTTGTTTAAGGGTGATAGTCA cds = (316,804) AATTATGTATTGGTGGGGCTGGGT 1973 Table 3A Hs.89679 NM_000586 10835148interleukin 2 (IL2), mRNA/ 1 GCAGATGAGACAGCAACCATTGTAGA cds = (47, 517)ATTTCTGAACAGATGGATTACCTT 1974 Table 3A Hs.694 NM_000588 4504666interleukin 3 (colony-stimulating factor, 1 TCTAATTTCTGAAATGTGCAGCTCCCmultiple) (IL3), mRNA/cds = (9, 467) ATTTGGCCTTGTGCCGGTTGTGTTC 1975literature Hs.73917 NM_000589 4504668 interleukin 4 (IL4), mRNA/ 1ACCAGAGTACGTTGGAAAACTTCTTG cds = (65, 526) GAAAGGCTAAAGACGATCATGAGA 1976Table 3A Hs.75627 NM_000591 4557416 CD14 antigen (CD14), mRNA/ 1TGAGGACTTTTCGACCAATTCAACCC cds = (119, 1246) TTTGCCCCACCTTTATTAAAATCT1977 Table 3A Hs.158164 NM_000593 9665247 transporter 1, ATP-bindingcassette, 1 GCTGGCCCATAAACACCCTGTAGGTT sub-family B (MDR/TAP) (TAP1),CTTGATATTTATAATAAAATTGGT mRNA/cds = (30, 2456) 1978 Table 3A Hs.241570NM_000594 10835154 tumor necrosis factor (TNF 1CCCAGGGAGTTGTGTCTGTAATCGG superfamily, member 2) (TNF), mRNA/CCTACTATTCAGTGGCGAGAAATAA cds = (65, 786) 1979 Table 3A Hs.119663NM_000611 10835164 CD59 antigen p18-20 (antigen 1TGATCTTGGCTGTATTTAATGGCATA identified by monoclonal antibodiesGGCTGACTTTTGCAGATGGAGGAA 16.3A5, EJ16, EJ30, EL32 and G344) (CD59),mRNA/cds = (29, 415) 1980 Table 3A Hs.856 NM_000619 10835170 interferon,gamma (IFNG), mRNA/ 1 TTGTTGACAACTGTGACTGTACCCAA cds = (108, 608)ATGGAAAGTAACTCATTTGTTAAA 1981 Table 3A Hs.172631 NM_000632 6006013integrin, alpha M (complement 1 GTCAAGATTGTGTTTTGAGGTTTCCT componentreceptor 3, alpha: also TCAGACAGATTCCAGGCGATGTGC known as CD11b (p170),macrophage antigen alpha polypeptide) (ITGAM), mRNA/cds = (75, 3533)1982 Table 3A Hs.194778 NM_000634 4504680 interleukin 8 receptor, alpha(IL8RA), 1 TCACCAGTCCCTCCCCAAATGCTTTC mRNA/cds = (100, 1152)CATGAGTTGCAGTTTTTTCCTAGT 1983 Table 3A Hs.318885 NM_000636 10835186superoxide dismutase 2, mitochondrial 1 TACTTTGGGGACTTGTAGGGATGCCT(SOD2), mRNA/cds = (4, 672) TTCTAGTCCTATTCTATTGCAGTT 1984 Table 3AHs.2007 NM_000639 4557328 tumor necrosis factor (ligand) 1CCATCGGTGAAACTAACAGATAAGCA superfamily, member 6 (TNFSF6),AGAGAGATGTTTTGGGGACTCATT mRNA/cds = (157, 1002) 1985 Table 3A Hs.82846NM_000655 5713320 selectin L (lymphocyte adhesion 1AGCTCCTCTTCCTGGCTTCTTACTGA molecule 1) (SELL), mRNA/AAGGTTACCCTGTAACATGCAATT cds = (88, 1206) 1986 Table 3A Hs.1103NM_000660 10863872 transforming growth factor, beta 1 1CACCAGGAACCTGCTTTAGTGGGGG (TGFB1), mRNA/cds = (841, 2016)ATAGTGAAGAAGACAATAAAAGATA 1987 Table 3A Hs.157850 NM_000661 4506664 Homosapiens, clone MGC:15545 1 GGCTACAGAAAGAAGATGCCAGATG IMAGE:3050745,mRNA, complete ACATTAAGACCTACTTGTGATATT cds/cds = (1045, 1623) 1988Table 3A Hs.89499 NM_000698 4502056 arachidonate 5-lipoxygenase (ALOX5),1 GCATTTCCACACCAAGCAGCAACAGC mRNA/cds = (44, 2068)AAATCACGACCACTGATAGATGTC 1989 Table 3A Hs.78225 NM_000700 4502100annexin A1 (ANXA1), mRNA/ 1 TCCCCAAACCATAAAACCCTATACAA cds = (74, 1114)GTTGTTCTAGTAACAATACATGAG 1990 db mining Hs.89485 NM_000717 9951925carbonic anhydrase IV (CA4), mRNA/ 1 GCTTCCGGTCCTTAGCCTTCCCAGGT cds =(46, 984) GGGACTTTAGGCATGATTAAAATA 1991 Table 3A Hs.97087 NM_0007344557430 CD3Z antigen, zeta polypeptide (TiT3 1TGCTATTGCCTTCCTATTTTGCATAAT complex) (CD3Z), mRNA/AAATGCTTCAGTGAAAATGCAGC cds = (178, 669) 1992 db mining Hs.28408NM_000752 4505032 leukotriene b4 receptor (chemokine 1GGAAGAAGAGGGAGAGATGGAGCAA receptor-like 1) (LTB4R), mRNA/AGTGAGGGCCGAGTGAGAGCGTGCT cds = (1717, 2775) 1993 Table 3A Hs.2175NM_000760 4503080 colony stimulating factor 3 receptor 1ATCCAGCCCCACCCAATGGCCTTTTG (granulocyte) (CSF3R), mRNA/TGCTTGTTTCCTATAACTTCAGTA cds = (169, 2679) 1994 literature Hs.82568NM_000784 13904863 cytochrome P450, subfamily XXVIIA 1CTCAGCTAAAAGGCCACCCCTTTATC (steroid 27-hydroxylase,GCATTGCTGTCCTTGGGTAGAATA cerebrotendinous xanthomalosis), polypeptide 1(CYP27A1), mitochondrial protein encoded by nuclear gene, mRNA/cds =(201, 1796) 1995 Table 3A Hs.709 NM_000788 4503268 deoxycytidine kinase(DCK), mRNA/ 1 ACCTTATGAACTACAGTGGAGCTACA cds = (159, 941)CTCATTGAAATGTAATTTCAGTTC 1996 Table 3A Hs.150403 NM_000790 4503280 dopadecarboxylase (aromatic L-amino 1 TCCAGGGCAATCAATGTTCACGCAAC aciddecarboxylase) (DDC), mRNA/ TTGAAATTATATCTGTGGTCTTCA cds = (69, 1511)1997 Table 3A Hs.83765 NM_000791 7262376 dihydrofolate reductase (DHFR),GCCAGATTTGGGGCATTTGGAAAGAA mRNA/cds = (479, 1042)GTTCATTGAAGATAAAGCAAAAGT 1998 Table 3A Hs.179661 NM_000801 4503724 Homosapiens, tubulin, beta 5, clone 1 CTGCACCCTTCCCCCAGCACCATTTA MGC:4029IMAGE:3617988, mRNA, TGAGTCTCAAGTTTTATTATTGCA complete cds/cds = (1705,3039) 1999 Table 3A Hs.324784 NM_000817 4503872 glutamate decarboxylase1 (brain, 1 TTTTGAAGAAGGGAAATTCACACTGT 67 kD) (GAD1), transcript variantGCGTTTTGAGTATGCAAGAAGAAT GAD67, mRNA/cds = (550, 2334) 2000 Table 3AHs.11899 NM_000859 4557642 3-hydroxy-3-methylglutaryl-Coenzyme 1TGTTGTGACTTTTTAGCCAGTGACTTT A reductase (HMGCR), mRNA/TTCTGAGCTTTTCATGGAAGTGG cds = (50, 2716) 2001 literature Hs.1570NM_000861 13435403 histamine receptor H1 (HRH1), mRNA/ 1ACTTCACACAGACAAGTGGCTAAGTG cds = (178, 1641) TCCATTATTTACCTTGAACAATCA2002 Table 3A Hs.83733 NM_000873 10433041 cDNA FLJ11724 fis, clone 1ACAGCCAACTGGAAAGATATAAAAGT HEMBA 1005331/cds = UNKNOWNTTGGGTCTGTCTCCTCTCCTTCAG 2003 Table 3A Hs.82112 NM_000877 4504658interleukin 1 receptor, type I (IL1R1), 1 ATTAAAGCACCAAATTCATGTACAGCmRNA/cds = (82, 1791) ATGCATCACGGATCAATAGACTGT 2004 Table 3A Hs.75596NM_000878 4504664 interleukin 2 receptor, beta (IL2RB), 1ATGGAAATTGTATTTGCCTTCTCCACT mRNA/cds = (131, 1786)TTGGGAGGCTCCCACTTCTTGGG 2005 Table 3A Hs.2247 NM_000879 4504670interleukin 5 (colony-stimulating factor, 1 TCAGAGGGAAAGTAAATATTTCAGGCeosinophil) (IL5), mRNA/cds = (44, ATACTGACACTTTGCCAGAAAGCA 448) 2006 dbmining Hs.72927 NM_000880 4504676 interleukin 7 (IL7), mRNA/ 1GTGTAACACAGTGCCTTCAATAAATG cds = (384, 917) GTATAGCAAATGTTTTGACATGAA2007 literature Hs.673 NM_000882 4504638 interleukin 12A (natural killercell 1 TGGGACTATTACATCCACATGATACC stimulatory factor 1, cytotoxicTCTGATCAAGTATTTTTGACATTT lymphocyte maturation factor 1, p35) (IL12A),mRNA/cds = (169, 828) 2008 Table 3A Hs.75432 NM_000884 4504688 IMP(inosine monophosphate) 1 CATTCGTATGAGAAGCGGCTTTTCTG dehydrogenase 2(IMPDH2), mRNA/ AAAAGGGATCCAGCACACCTCCTC cds = (47, 1591) 2009 Table 3AHs.40034 NM_000885 6006032 integrin, alpha 4 (antigen CD49D, 1CTTCAGACTGAACATGTACACCT alpha 4 subunit of VLA-4 receptor)GGTTTGAGCTTAGTGAAATGACTT (ITGA4), mRNA/cds = (1151, 4267) CCGG 2010Table 3A Hs.51077 NM_000887 6006014 integrin, alpha X (antigen CD11C 1TTTAAATGTTTGTGTTAATACACATTA (p150), alpha polypeptide) (ITGAX),AAACATCGCACAAAAACGATGCA mRNA/cds = (56, 3549) 2011 Table 3A Hs.1741NM_00889 4504776 integrin, beta 7 (ITGB7), mRNA/ 1GCAACCTTGCATCCATCTGGGCTACC cds = (151, 2547) CCACCCAAGTATACAATAAAGTCT2012 Table 3A Hs.81118 NM_000895 4505028 leukotriene A4 hydrolase(LTA4H), 1 TGCTGGTGGGGAAAGACTTAAAAGTG mRNA/cds = (68, 1903)GATTAAAGACCTGCGTATTGATGA 2013 literature Hs.456 NM_000897 4505040leukotriene C4 synthase (LTC4S), 1 AGGGGCGCTCGCCTTCCGCATCCTAG mRNA/cds =(96, 548) TCTCTATCATTAAAGTTCTAGTGAC 2014 Table 3A Hs.171880 NM_00093714589948 polymerase (RNA) II (DNA directed) 1 AGCTGATCCTCGGGAAGAACAAAGCTpolypeptide A (220 kD) (POLR2A), AAAGCTGCCTTTTGTCTGTTATTT mRNA/cds =(386, 6298) 2015 Table 3A Hs.183842 NM_000942 4758949 ubiquitin B (UBB),mRNA/ 1 CACAGGCCCATGGACTCACTTTTGTA cds = (94, 783)ACAAACTCCTACCAACACTGACCA 2016 Table 3A Hs.74519 NM_000947 4506052primase, polypeptide 2A (58 kD) 1 AGGAGGAGTTTCTATTAAAATCTGTC (PRIM2A),mRNA/cds = (87, 1616) ACTTGAGTGATGTCATTTAAGTCC 2017 Table 3A Hs.199248NM_000958 4506258 prostaglandin E receptor 4 (subtype 1CCTGTGCAATAGACACATACATGTCA EP4) (PTGER4), mRNA/ CATTTAGCTGTGCTCAGAAGGGCTcds = (388, 1854) 2018 Table 3A Hs.199248 NM_000958 4506258prostaglandin E receptor 4 (subtype 1 CCTGTGCAATAGACACATACATGTCA EP4)(PTGER4), mRNA/ CATTTAGCTGTGCTCAGAAGGGCT cds = (388, 1854) 2019 Table 3AHs.250505 NM_000964 4506418 retinoic acid receptor, alpha (RARA), 1TGCACCTGTTACTGTTGGGCTTTCCA mRNA/cds = (102, 1490)CTGAGATCTACTGGATAAAGAATA 2020 Table 3A Hs.119598 NM_000967 4506648ribosomal protein L3 (RPL3), mRNA/ 1 AAGAAGGAGCTTAATGCCAGGAACA cds = (6,1217) GATTTTGCAGTTGGTGGGGTCTCAA 2021 Table 3A Hs.174131 NM_0009704506656 ribosomal protein L6 (RPL6), mRNA/ 1 AGGGCTACCTGCGATCTGTGTTTGCTcds = (26, 892) CTGACGAATGGAATTTATCCTCAC 2022 Table 3A Hs.153 NM_0009714506658 ribosomal protein L7 (RPL7), mRNA/ 1 CCATGATTATTTTTCTAAGCTGGTTGcds = (10, 756) GTTAATAAACAGTACCTGCTCTCA 2023 Table 3A Hs.99858NM_000972 4506660 ribosomal protein L7a (RPL7A), 1AAAGGCTAAAGAACTTGCCACTAAAC mRNA/cds = (31, 831) TGGGTTAAATGTACACTGTTGAGT2024 Table 3A Hs.178551 NM_000973 4506662 ribosomal protein L8 (RPL8),mRNA/ 1 GGAACCAAGACTGTGCAGGAGAAAG cds = (43, 816)AGAACTAGTGCTGAGGGCCTCAATA 2025 Table 3A Hs.179943 NM_000975 4508594ribosomal protein L11 (RPL11), 1 TGGTTCCAGCAGAAGTATGATGGGAT mRNA/cds =(0, 536) CATCCTTCCTGGCAAATAAATTCC 2026 Table 3A Hs.180842 NM_0009774506598 ribosomal protein L13 (RPL13), 1 TTGGTTGTTTGGTTAGTGACTGATGTmRNA/cds = (51, 686) AAAACGGTTTTCTTGTGGGGAGGT 2027 Table 3A Hs.234518NM_000978 14591907 ribosomoal protein L23 (RPL23) 1ATGCTGGCAGCATTGCATGATTCTCC AGTATATTTGTAAAAAATAAAAAA 2028 Table 3AHs.75458 NM_000979 4506606 ribosomal protein L18 (RPL18), 1CGGGCCAGCCGAGGCTACAAAAACT mRNA/cds = (15, 581) AACCCTGGATCCTACTCTCTTATTA2029 Table 3A Hs.272822 NM_000981 4506608 RuvB (E. coli homolog)-like 11 ACCTCCCACTTTGTCTGTACATACTG (RUVBL1), mRNA/cds = (76, 1446)GCCTCTGTGATTACATAGATCAGC 2030 Table 3A Hs.184108 NM_000982 4506610ribosomal protein L21 (gene or 1 TTCAACTAAAGCGCCACCTGCTCCAC pseudogene)(RPL21), mRNA/ CCAGAGAAGCACACTTTGTGAGAA cds = (33, 515) 2031 Table 3AHs.326249 NM_000983 4506612 ribosomal protein L22 (RPL22), 1TTGGAAATCATAGTCAAAGGGCTTCC mRNA/cds = (51, 437) TTGGTTCGCCACTCATTTATTTGT2032 Table 3A Hs.326249 NM_000983 4506612 ribosomal protein L22 (RPL22),1 TTGGAAATCATAGTCAAAGGGCTTCC mRNA/cds = (51, 437)TTGGTTCGCCACTCATTTATTTGT 2033 Table 3A Hs.184776 NM_000984 4506614ribosomal protein L23a (RPL23A), 1 CCTGATGGAGAGAAGAAGGCATATGT mRNA/cds =(23, 493) TCGACTGGCTCCTGATTACGATGC 2034 Table 3A Hs.82202 NM_00098514591906 ribosomal protein L17 (RPL17), 1 CAGAAGAAACTGAAGAAACAA mRNA/cds= (286, 840) AAACTTATGGCACGGGAGTAAATT CAGCA 2035 Table 3A Hs.184582NM_000986 4506618 ribosomal protein L24 (RPL24), 1GTTTCAGCTCCCCGAGTTGGTGGAAA mRNA/cds = (39, 512) ACGCTAAACTGGCAGATTAGATTT2036 Table 3A Hs.192760 NM_000987 4506620 kinesin family member 5A(KIF5A), 1 CTCCTGTTGGGTAAGGGTGTTGAGTG mRNA/cds = (148, 3246)TGACTTGTGCTGAAAACCTGGTTC 2037 Table 3A Hs.111611 NM_000988 4506622ribosomal protein L27 (RPL27), 1 GAACAAGTGGTTCTTCCAGAAACTGC mRNA/cds =(17, 427) GGTTTTAGATGCTTTGTTTTGATC 2038 Table 3A Hs.76064 NM_00099014141189 ribosomal protein L27a (RPL27A), 1 GGCTTGAAGCCACATGGAGGGAGTTmRNA/cds = (22, 468) TCATTAAATGCTAACTACTTTTAAA 2039 Table 3A Hs.184014NM_000993 4506632 ribosomal protein L31 (RPL31), 1ATCTACAGACAGTCAATGTGGATGAG mRNA/cds = (7, 384) AACTAATCGCTGATCAAATAACGT2040 Table 3A Hs.169793 NM_000994 4506634 ribosomal protein L32 (RPL32),1 GCGCAGTGAAGAAAATGAGTAGGCA mRNA/cds = (34, 441)GCTCATGTGCACGTTTTCTGTTTAA 2041 Table 3A Hs.289093 NM_000996 4506638 cDNAFLJ11509 fis, clone 1 CAATCTTCCTGCTAAGGCCATTGGAC HEMBA1002166/cds =UNKNOWN ACAGAATCCGAGTGATGCTGTACC 2042 Table 3A Hs.179779 NM_0009974506640 ribosomal protein L37 (RPL37), 1 GGCAGCTGTTGCAGCATCCAGTTCATmRNA/cds = (28, 321) CTTAAGAATGTCAACGATTAGTCA 2043 Table 3A Hs.5566NM_000998 4506642 ribosomal protein L37a (RPL37A), 1AGACGCTCCTCTACCTCTTTGGA mRNA/cds = (17, 295) GACATCACTGGCCTATAATAAATGGGTT 2044 Table 3A Hs.300141 NM_001000 4506648 cDNA FLJ14163 fis, clone1 TCTGTTATGAACACGTTGGTTGGCTG NT2RP1000409/cds = UNKNOWNGATTCAGTAATAAATATGTAAGGC 2045 Table 3A Hs.119500 NM_001004 4506670ribosomal protein, large P2 (RPLP2), 1 TGAGAAGAAGGAGGAGTCTGAAGAGmRNA/cds = (74, 421) TCAGATGATGACATGGGATTTGGCC 2046 Table 3A Hs.155101NM_001006 4506722 mRNA for KIAA1578 protein, partial 1GCTAAAGTTGAACGAGCTGATGGATA cds/cds = (0, 3608) TGAACCACCAGTCCAAGAATCTGT2047 Table 3A Hs.180911 NM_001008 4506726 ribosomal protein S4, Y-linked1 GCTGGCCACCAAACAGAGCAGTGGC (RPS4Y), mRNA/cds = (12, 603)TAAATTGCAGTAGCAGCATATCTTT 2048 Table 3A Hs.76194 NM_001009 13904869ribosomal protein S5 (RPS5), mRNA/ 1 GCCAAGTCCAACCGCTGATTTTCCCA cds =(53, 667) GCTGCTGCCCAATAAACCTGTCTG 2049 Table 3A Hs.301547 NM_0010114506740 ribosomal protein S7 (RPS7), mRNA/ 1 TGGTGTCTATAAGAAGCTCACGGGCAcds = (81, 665) AGGATGTTAATTTTGAATTCCCAG 2050 Table 3A Hs.182740NM_001015 14277698 ribosomal protein S11 (RPS11), 1AGGCTGGACATCGGCCCGCTCCCCA mRNA/cds = (33, 509) CAATGAAATAAAGTTATTTTCTCAT2051 Table 3A Hs.165590 NM_001017 14591910 ribosomal protein S13(RPS13), 1 CATCTACAGCCTCTGCCCTGGTCGCA mRNA/cds = (32, 487)TAAATTTGTCTGTGTACTCAAGCA 2052 Table 3A Hs.80617 NM_001020 14591912ribosomal protein S16 (RPS16), 1 CTACCAGAAATCCTACCGATAAGCCC mRNA/cds =(52, 492) ATCGTGACTCAAAACTCACTTGTA 2053 Table 3A Hs.5174 NM_00102114591913 ribosomal protein S17 (RPS17), 1 CTCGGGGACCTGTTTGAATTTTTTCTmRNA/cds = (25, 432) GTAGTGCTGTATTATTTTCAATAA 2054 Table 3A Hs.298262NM_001022 14591914 ribosomal protein S19 (RPS19), 1GCTGCCAACAAGAAGCATTAGAACAA mRNA/cds = (69, 506) ACCATGCTGGGTTAATAAATTGCC2055 Table 3A Hs.182979 NM_001024 14670385 cDNA: FLJ22838 fis, cloneKAIA4494, 1 GATGGCATCGTCTCAAAGAACTTTTG highly similar to HUML12Aribosomal ACTGGAGAGAATCACAGATGTGGA protein L12 mRNA/cds = UNKNOWN 2056Table 3A Hs.182979 NM_001024 14670385 cDNA: FLJ22838 fis, clone4 1GATGGCATCGTCTCAAAGAACTTTTG KAIA4494, highly similar toACTGGAGAGAATCACAGATGTGGA HUML12A ribosomal protein L12 mRNA/cds =UNKNOWN 2057 Table 3A Hs.215664 NM_001025 14790142 DNA for insulin-likegrowth factor II 1 CCAATGTTTCTCTTTTGGCCCTATACA (IGF-2); exon 7 andadditional ORF AAGGCAAGAAGGAAAGACCAAGA cds = (0, 233) 2058 Table 3AHs.180450 NM_001026 14916502 ribosomal protein S24 (RPS24), 1CTGGCAAAAAGCCGAAGGAGTAAAG transcript variant 1, mRNA/GTGCTGCAATGATGTTAGCTGTGGC cds = (37, 429) 2059 Table 3A Hs.113029NM_001028 1451918 ribosomal protein S25 (RPS25), 1TGGTGAAGATGCATGAATAGGTCCAA mRNA/cds = (63, 440) CCAGCTGTACATTTGGAAAAATAA2060 Table 3A Hs.539 NM_001032 13904868 ribosomal protein S29 (RPS29), 1GCCAGTGTTTCCGTCAGTACGCGAA mRNA/cds = (30, 200) GGATATCGGTTTCATTAAGTTGGAC2061 Table 3A Hs.2934 NM_001033 4506748 ribonucleotide reductase M1 1GAGTGATAACTCATGAGAAGTACTGA polypeptide (RRM1), mRNA/TAGGACCTTTATCTGGATATGGTC cds = (187, 2565) 2062 Table 3A Hs.172129NM_001046 4506974 cDNA: RLJ21409 fis, clone COL03924 1GGTGATTCTTCTCTGTTGAACTGAAG cds = UNKNOWN TTTGTGAGAGTAGTTTTCCTTTGC 2063Table 3A Hs.256278 NM_001066 4507576 tumor necrosis factor receptor 1TGTGTGTTGATCCCAAGACAATGAAA superfamily, member 1B (TNFRSF1B),GTTTGCACTGTATGCTGGACGGCA mRNA/cds = (89, 1474) 2064 literature Hs.156346NM_001067 4507632 topoisomerase (DNA) II alpha (170 kD) 1GGGGAAGGTGTTTTTAGTACAAGACA (TOP2A), mRNA/cds = (36, 4631)TCAAAGTGAAGTAAAGCCCAAGTG 2065 Table 3A Hs.75248 NM_001068 11225253topoisomerase (DNA) II beta (180 kD) 1 AGGAAAACATCCAAAACAACAAG (TOP2B),mRNA/cds = (0, 4865) CAAGAAACCGAAGAAGACATCTT TTGA 2066 Table 3AHs.174140 NM_001096 4501864 ATP citrate lyase (ACLY), mRNA/ 1AGCTGCCACCTCAGTCTCTTCTCTGT cds = (84, 3401) ATTATCATAGTCTGGTTTAAATAA2067 Table 3A Hs.288061 NM_001101 5016088 actin, beta (ACTB), mRNA/ 1GGAGGCAGCCAGGGCTTACCTGTAC cds = (73, 1200) ACTGACTTGAGACCAGTTGAATAAA2068 db mining Hs.150402 NM_001105 10862690 activin A receptor, type I(ACVR1), 1 AGCAAAGATTTCAGTAGAATTTTAGT mRNA/cds = (340, 1869)CCTGAACGCTACGGGGAAAATGCA 2069 Table 3A Hs.172028 NM_001110 4557250 adisintegrin and metalloproteinase 1 TGGTGGTATTCAGTGGTCCAGGATTC domain 10(ADAM10), mRNA/ TGTAATGCTTTACACAGGCAGTTT cds = (469, 2715) 2070 Table 3AHs.7957 NM_001111 7669471 adenosine deaminase, RNA-specific 1TGCTTTTATGTGTCCCTTGATAACAGT (ADAR), transcript variant ADAR-a,GACTTAACAATATACATTCCTCA mRNA/cds = (187, 3867) 2071 Table 3A Hs.172199NM_001114 4557254 adenylate cyclase 7 (ADCY7), mRNA/ 1TTGTTTCAAAATGCTGTTTCATTTTTA cds = (265, 3507) TAAAGTACCAGTGTTTAGCTGCT2072 Table 3A Hs.3416 NM_001122 4557260 adipose differentiation-relatedprotein 1 AGAGATGGACAAGAGCAGCCAGGAG (ADFP), mRNA/cds = (0, 1313)ACCCAGCGATCTGAGCATAAAACTC 2073 literature Hs.394 NM_001124 4501944adrenomedulin (ADM), mRNA/ 1 TGAAAGAGAAAGACTGATTACCTCCT cds = (156, 713)GTGTGGAAGAAGGAAACACCGAGT 2074 literature Hs.278398 NM_001151 4502096 DNAsequence from clone RP1- 1 GGAATACCTCCAGAAGAGATGCT 202D23 on chromosome6q14.1-15 TCATTGAGTGTTCATTAAACCACA Contains part of the gene for N- CATGacetylglucosamine-phosphate mutase. part of a gene for a novel protein,ESTs, STSs and GSSs/cds = (0, 5916) 2075 Table 3A Hs.300711 NM_0011544809273 annexin A5 (ANXA5), mRNA/ 1 ACCATGATACTTTAATTAGAAGCTTAG cds =(192, 1154) CCTTGAAATTGTGAACTCTTGGA 2076 Table 3A Hs.300711 NM_0011544809273 annexin A5 (ANXA5), mRNA/ 1 ACCATGATACTTTAATTAGAAGCTTAG cds =(192, 1154) CCTTGAAATTGTGAACTCTTGGA 2077 Table 3A Hs.118796 NM_0011554809274 annexin A6 (ANXA6), transcript variant 1GCCTCTGCCCTGGTTTGGCTATGTCA 1, mRNA/cds = (170, 2191)GATCCAATAAACATCCTGAACCTC 2078 Table 3A Hs.75510 NM_001157 4557316annexin A11 (ANXA11), mRNA/ 1 TGCCTTTTCTACCCCATCCCTCACAG cds = (178,1695) CCTCTTGCTGCTAAAATAGATGTT 2079 Table 3A Hs.14142 NM_001161 4502124nudix (nucleoside diphosphate linked 1 GGCCAGGCCCAAGTAAGTGTACCTT moietyX)-type motif 2 (NUDT2), GTACTTTATAAATAAACCTCAAGCA mRNA/cds = (174, 617)2080 Table 3A Hs.289107 NM_001166 10880127 baculoviral IAP repeatcontaining 2 1 GCCGAATTGTCTTTGGTGCTTTTCAC (BIRC2), mRNA/cds = (1159,3015) TTGTGTTTTAAAATAAGGATTTTT 2081 Table 3A Hs.83656 NM_001175 10835001Rho GDP dissociation inhibitor (GDI) 1 CCCCTGCCAGAGGGAGTTCTTCTTTT beta(ARHGDIB), mRNA/ GTGAGAGACACTGTAAACGACACA cds = (152, 757) 2082 Table 3AHs.74515 NM_001178 4502232 aryl hydrocarbon receptor nuclear 1AGAAGTCCCCCATGTGGATATTTCTT translocator-like (ARNTL), mRNA/ 1ATACTAATTGTATCATAAAGCCGT cds = (145, 1896) 2083 Table 3A Hs.6551NM_001183 4557340 ATPase, H+ transporting, lysosomal 1GGGCAGGAGCATGGGGTGCTTGGTT (vacuolar proton pump), subunit 1GTTTCCTTCCTAATAAAATAAACGC (ATP6S1), mRNA/cds = (1353, 2198) 2084literature Hs.77613 NM_001184 4502324 ataxia telangiectasia and Rad3related 1 ATGCATTTGGTATGAATCTGTGGTTG (ATR), mRNA/cds = (79, 8013)TATCTGTTCAATTCTAAAGTACAA 2085 literature Hs.2556 NM_001192 4507572 tumornecrosis factor receptor 1 TTCTCTAGGTTACTGTTGGGAGCTTA superfamily,member 17 (TNFRSF17), ATGGTAGAAACTTCCTTGGTTTCA mRNA/cds = (218, 772)2086 literature Hs.158303 NM_001198 4557362 PR domain containing 1, withZNF 1 CCTCCCAGCAACCCACTACCTCTGGT domain (PRDM1), mRNA/ACCTGTAAAGGTCAAACAAGAAAC cds = (223, 2592) 2087 db mining Hs.87223NM_001203 4502430 bone morphogenetic protein receptor, 1CCGTGTCTGTTTGTAGGCGGAGAAAC type IB (BMPR1B), mRNA/CGTTGGGTAACTTGTTCAAGATAT cds = (273, 1781) 2088 Table 3A Hs.53250NM_001204 4755129 bone morphogenetic protein receptor, 1TGAGGGTGAGGGCAGGCTGAGGCAA type II (serine/threonine kinase)CGAGTGGGAGGTTCAAACAAGAGTG (BMPR2), mRNA/cds = (408, 3524) 2089 Table 3AHs.101025 NM_001207 4502464 basic transcription factor 3 (BTF3), 1CCCAAACAATCTGTGGATGGAAAAGC mRNA/cds = (0, 476) ACCACTTGCTACTGGAGAGGATGA2090 Table 3A Hs.321247 NM_001225 4502576 mRNA: cDNA DKFZp586A181 (from1 AATCAACTTCAAGGAGCACCTTCATT clone DKFZp586A181): partial cds/AGTACAGCTTGCATATTTAACATT cds = (0, 314) 2091 db mining Hs.19949NM_001228 4502582 mRNA for MACH-alpha-1 protein 1AGGCGATGATATTCTCACCATCCTGA cds = (291, 1730) CTGAAGTGAACTATGAAGTAAGCA2092 literature Hs.514 NM_001239 4502622 cyclin H (CCNH), mRNA/ 1TGACGACCTGGTAGAATCTCTCTAAC cds = (60, 1031) CATTTGAAGTTGATTTCTCAATGC2093 Table 3A Hs.180841 NM_001242 4507586 tumor necrosis factor receptor1 GCTGCGAAAGACCCACATGCTACAA superfamily, member 7 (TNFRSF7),GACGGGCAAAATAAAGTGACAGATG mRNA/cds = (100, 882) 2094 Table 3A Hs.1314NM_001243 4507588 tumor necrosis factor receptor 1CGCCCATGATGGGAGGGATTGACAT superfamily, member 8 (TNFRSF8),GTTTCAACAAAATAATGCACTTCCT mRNA/cds = (222, 2009) 2095 literature Hs.1313NM_001244 4507606 tumor necrosis factor (ligand) 1TCTTTCAGATAGCAGGCAGGGAAGCA superfamily, member 8 (TNFSF8),ATGTAGTGTGGTGGGCAGAGCCCC mRNA/cds = (114, 818) 2096 db mining Hs.25648NM_001250 4507580 tumor necrosis factor receptor 1CAGGAGGATGGCAAAGAGAGTCGCA superfamily, member 5 (TNFSF5),TCTCAGTGCAGGAGAGACAGTGAGG mRNA/cds = (47, 880) 2097 Table 3A Hs.99899NM_001252 4507604 tumor necrosis factor (ligand) 1GGGGGTAGTGGTGGCAGGACAAGAG superfamily, member 7 (TNFSF7),AAGGCATTGAGCTTTTTCTTTCATT mRNA/cds = (137, 718) 2098 db mining Hs.76688NM_001266 7262373 carboxylesterase 1 1 GCCATGAAGGAGCAAGTTTTGTATTT(monocyte.macrophage serine GTGACCTCAGCTTTGGGAATAAAG esterase 1) (CES1),mRNA/ cds = (67, 1767) 2099 Table 3A Hs.22670 NM_001270 4557446chromodomain helicase DNA binding 1 GCTACTTGTTTACATTGTACACTGCG protein 1(CHD1), mRNA/ ACCACCTTGCCGCTTTTCATCACA cds = (163, 5292) 2100 literatureHs.20295 NM_001274 4502802 CHK1 (checkpoint, S. pombe) homolog 1ACCAAGTTTCAGGGGACATGAGTTTT (CHEK1), mRNA/cds = (34, 1464)CCAGCTTTTATACACACGTATCTC 2101 db mining Hs.306440 NM_001278 4502642mRNA; cDNA DKFZp566L084 (from 1 GGCAAATGAGGAACAGGGCAATAGT cloneDKFZp566L084)/ ATGATGAATCTTGATTGGAGTTGGT cds = UNKNOWN 2102 Table 3AHs.301921 NM_001295 4502630 chemokine (C—C motif) receptor 1 1TGTTCTTCATCTAAGCCTTCTGGTTTT (CCR1), mRNA/cds = (62, 1129)ATGGGTCAGAGTTCCGACTGCCA 2103 Table 3A Hs.285313 NM_001300 9961348 corepromoter element binding protein 1 TATACCATGAGATGAGATGACCACCA (COPEB)ATCATTTCCTTGGGGGGAGGGGGT 2104 Table 3A Hs.90073 NM_001316 4503072chromosome segregation 1 (yeast 1 CCTAGGAAATCACAGGCTTCTGAGCAhomolog)-like (CSE1L), mRNA/ CAGCTGCATTAAAACAAAGGAAGT cds = (123, 3038)2105 Table 3A Hs.82890 NM_001344 4503252 defender against cell death 1(DAD1), 1 AAATGTAACCTTTTGCTTTCCAAATTA mRNA/cds = (66, 407)AAGAACTCCATGCCACTCCTCAA 2106 Table 3A Hs.172690 NM_001345 11415023diacylglycerol kinase, alpha (80 kD) 1 ACACACATACACACACCCCAAAACAC(DGKA), mRNA/cds = (103, 2310) ATACATTGAAAGTGCCTCATCTGA 2107 Table 3AHs.301305 NM_001352 4503262 Homo sapiens, clone MGC:13202 1GACCCTATCCTCCCACCGCCTCCGTT IMAGE:3877838, mRNA, completeAACACGATCCTGAATAAATCTTGA cds/cds = (366, 2330) 2108 Table 3A Hs.306098NM_001353 5453542 aldo-keto reductase family 1, member 1ACAGCAAAGCCCATTGGCCAGAAAG C1 (dihydrodiol dehydrogenase 1: 20-GAAAGACAATAATTTTGTTTTTTCA alpha (3-alpha)-hydroxysteroid dehydrogenase)(AKR1C1), mRNA/ cds = (6, 977) 2109 Table 3A Hs.74578 NM_001357 13514819DEAD/H (Asp-Glu-Ala-Asp/His) box 1 AAGGAGTAAAGATTTGCCTTTAAATApolypeptide 9 (RNA helicase A, nuclear ACTTGGTATTTTCCTGGCTTTCGT DNAhelicase II; leukophysin) (DDX9), transcript variant 1, mRNA/ cds = (80,3919) 2110 Table 3A Hs.4747 NM_001383 4503336 dyskeratosis congenita 1,dyskerin 1 GGCCTCGTTTACTTTTAAAAAATGAAA (DKC1), mRNA/cds = (92, 1636)TTGTTCATTGCTGGGAGAAGAAT 2111 Table 3A Hs.77462 NM_001379 4503350 DNA(cytosine-5-)methyltransferase 1 1 TCAACTAATGATTTAGTGATCAAATTG (DNMT1),mRNA/cds = (237, 5087) TGCAGTACTTTGTGCATTCTGGA 2112 Table 3A Hs.154210NM_001400 13027635 endothelial differentiation, sphingolipid 1TAGGTTTCTGACTTTTGTGGATCATTT G-protein-coupled receptor, 1 (EDG1),TGCACATAGCTTTATCAACTTTT mRNA/cds = (243, 1391) 2113 Table 3A Hs.274488NM_001403 4503472 eukaryotic translation elongation factor 1AAATCAGTACTTTTTAATGGAAACAAC 1 alpha 1-like 14 (EEF1A1L14),TTGACCCCCAAATTTGTCACAGA mRNA/cds = (620, 1816) 2114 Table 3A Hs.2186NM_001404 4503480 Homo sapiens, eukaryotic translation 1AGATCTTCAAGTGAACATCTCTTGCC elongation factor 1 gamma, cloneATCACCTAGCTGCCTGCACCTGCC MGC:4501 IMAGE:2964823, mRNA, complete cds/cds= (2278, 3231) 2115 Table 3A Hs.129673 NM_001416 4503528 eukaryotictranslation initiation factor 1 CAGGAGGGGGGAGGGAAGGGAGCC 4A, isoform 1(EIF4A1), mRNA/ AAGGGATGGACATCTTGTCATTTTTT cds = (16, 1236) 2116 Table3A Hs.93379 NM_001417 4503532 eukaryotic translation initiation factor 1GCAAGTATGCTGCTCTCTCTGTTGAT 4B (EIF4B), mRNA/cds = (0, 1835)GGTGAAGATGAAAATGAGGGAGAA 2117 Table 3A Hs.183684 NM_001418 4503538eukaryotic translation initiation factor 4 1 TTGTGGGTGTGAAACAAATGGTGAGAgamma, 2 (EIF4G2), mRNA/ ATTTGAATTGGTCCCTCCTATTAT cds = (306, 3029) 2118Table 3A Hs.229533 NM_001420 5231299 ol06d12.s1 cDNA, 3′ end/ 1AAAGGGAAAAAGACCTCGTGGA clone = IMAGE:1522679/clone_end =GAATTTTTACTGGGGATTCTTGAA 3′ CTTG 2119 Table 3A Hs.151139 NM_0014214503554 E74-like factor 4 (els domain 1 AAATGTATTTACTATGCGTGTTTCCAGtranscription factor) (ELF4), mRNA/ CAGTTGGCATTAAAGTGCCTTTT cds = (382,2373) 2120 Table 3A Hs.79368 NM_001423 4503558 epithelial membraneprotein 1 (EMP1), 1 ATTTGCATTACTCTGGTGGATTGTTCT mRNA/cds = (218, 691)AGTACTGTATTGGGCTTCTTCGT 2121 Table 3A Hs.9999 NM_001425 4503562epithelial membrane protein 3 (EMP3), 1 GAGGAGGTCTCTTCTATGCCACCGGmRNA/cds = (241, 732) CCTCTGCCAGCTTTGCACCAGCGTG 2122 Table 3A Hs.254105NM_001428 4503570 enolase 1, (alpha) (ENO1), mRNA/ 1GCTAGATCCCCGGTGGTTTTGTGCTC cds = (94, 1398) AAAATAAAAAGCCTCAGTGACCCA2123 Table 3A Hs.115263 NM_001432 4557566 epiregulin (EREG), mRNA/ 1TTTGAAGAGCCATTTTGGTAAACGGT cds = (166, 675) TTTTATTAAAGATGCTATGGAACA2124 Table 3A Hs.99853 NM_001436 12056464 fibrillarin (FBL), mRNA/cds =(59, 1 GTCAGGATTGCGAGAGATGTGTGTTG 1024) ATACTGTTGCACGTGTGTTTTTCT 2125Table 3A Hs.153179 NM_001444 4557580 fatty acid binding protein 5(psoriasis- 1 CATGCAGCTATTTCAAAGTGTGTTGG associated) (FABP5), mRNA/ATTAATTAGGATCATCCCTTTGGT cds = (48, 455) 2126 Table 3A Hs.14845NM_001455 4503738 forkhead box O3A (FOXO3A), mRNA/ 1TAATGGCCCCTTACCCTGGGTGAAGC cds = (924, 2945) ACTTACCCTTGGAACAGAACTCTA2127 Table 3A Hs.428 NM_001459 4503750 fms-related tyrosine kinase 3ligand 1 AAGGCCTCATCCTGGGGAGGATACG (FLT3LG), mRNA/cds = (92, 799)TAGGCACACAGAGGGGAGTCACCAG 2128 Table 3A Hs.99855 NM_001462 4503780formyl peptide receptor-like 1 (FPRL1), 1 TGGGGTAAGTGGAGTTGGGAAATACmRNA/cds = (772, 1827) AAGAAGAGAAAGACCAGTGGGGATT 2129 Table 3A Hs.58435NM_001465 4503820 FYN-binding protein (FYB-120/130) 1ACCTAGCGGACAATGATGGAGAGAT (FYB), mRNA/cds = (30, 2381)CTATGATGATATTGCTGATGGCTGC 2130 Table 3A Hs.197345 NM_001469 4503840thyroid autoantigen 70 kD (Ku antigen) 1 GTGATGGTGTAGCCCTCCCACTTTGC(G22P1), mRNA/cds = (17, 1846) TGTTCCTTACTTTACTGCCTGAAT 2131 Table 3AHs.56845 NM_001494 6598322 GDP dissociation inhibitor 2 (GDI2), 1GCCTCTACTTCTGTCTCAAAATGGCT mRNA/cds = (152, 1489)CCAAATGATTTCTGTACTGCAAAA 2132 Table 3A Hs.272529 NM_001503 4504088glycosylphosphatidylinositol specific 1 TCTCCTTCCACAGTTTATTTCCTCGCTphospholipase D1 (GPLD1), mRNA/ TCCTTTGCATCTAAACCTTTCTT cds = (32, 2557)2133 literature Hs.191356 NM_001515 6681761 general transcription factorIIH, 1 ACACTGTTGCCCTGGCTGTATTCATA polypeptide 2 (44 kD subunit)AGATTCCAGCTCCTTCAGGTGTTT (GTF2H2), mRNA/cds = (0, 1187) 2134 literatureHs.90304 NM_001516 4504198 general transcription factor IIH, 1GTCAATATTCTGCAATTTCAGCCCCA polypeptide 3 (34 kD subunit)TTTGTACTACGTGCGAGACAGCCT (GTF2H3), mRNA/cds = (0, 911) 2135 literatureHs.102910 NM_001517 4504200 general transcription factor IIH, 1GGCGGGACTGGGCGGGGCGGGGCA polypeptide 4 (52 kD subunit)TCAGAACTCAGGTGTTTTTTATTTAC (GTF2H4), mRNA/cds = (127, 1515) 2136 Table3A Hs.187540 NM_001530 4504384 hypoxia-inducible factor 1, alpha 1TTCCTTTTGCTCTTTGTGGTTGGATCT subunit (basic helix-loop-helixAACACTAACTGTATTGTTTTGTT transcription factor) (HIF1A), mRNA/ cds = (264,2744) 2137 Table 3A Hs.235887 NM_001535 4504494 HMT1 (hnRNPmethyltransferase, S. 1 ACGTCTTCCAAATAAATTATGTGTTG cerevisiae)-like 1(HRMT1L1), GTGCCATCGCACATGCTCAATAAA mRNA/cds = 165, 1466) 2138 Table 3AHs.94 NM_001539 4504510 heat shock protein, DNAJ-like 2 1AGGTGGTGTTCAGTGTCACACCTCTT (HSJ2), mRNA/cds = (82, 1275)AATGGCCAGTGAATAACACTCACT 2139 Table 3A Hs.20315 NM_001548 4504584interferon-induced protein with 1 CTGAGACTGGCTGCTGACTTTGAGAAtetratricopeptide repeats 1 (IFIT1), CTCTGTGAGACAAGGTCCTTAGGC mRNA/cds =(64, 1500) 2140 Table 3A Hs.181874 NM_001549 4504588 interferon-inducedprotein with 1 GCAGGGAAGCTTTGCATGTTGCTCTA tetratricopeptide repeats 4(IFIT4), AGGTACATTTTTAAAGAGTTGTTT mRNA/cds = (61, 1533) 2141 Table 3AHs.7879 NM_001550 4504606 interferon-related developmental 1CGAACCAAAGCTAGAAGCAAATGTCG regulator 1 (IFRD1), mRNA/AGATAAGAGAGCAGATGTTGGAGA cds = (219, 1580) 2142 Table 3A Hs.239189NM_001551 4557882 glutaminase (GLS), mRNA/ 1 GGAAGGAAAAGAGTGCTGAGAAATGcds = (19, 2028) GCTCTGTATAATCTATGGCTATCCG 2143 db mining Hs.846NM_001557 4504682 interleukin 8 receptor, beta (IL8RB), 1ACCAAGGCTAGAACCACCTGCCTATA mRNA/cds = (408, 1490)TTTTTTGTTAAATGATTTCATTCA 2144 Table 3A Hs.327 NM_001558 4504632interleukin 10 receptor, alpha 1 CCTCTGCCAAAGTACTCTTAGGTGCC (IL10RA),mRNA/cds = (61, 1797) AGTCTGGTAACTGAACTCCCTCTG 2145 literature Hs.73895NM_001561 5730094 tumor necrosis factor receptor 1AAAATAATGCACCACTTTTAACAGAA superfamily, member 9 (TNFRSF9),CAGACAGATGAGGACAGAGCTGGT mRNA/cds = (139, 906) 2146 Table 3A Hs.83077NM_001562 4504652 interleukin 18 (interferon-gamma- 1GAATTGGGGGATAGATCTATAATGTT inducing factor) (IL18), mRNA/CACTGTTCAAAACGAAGACTAGCT cds = (177, 758) 2147 Table 3A Hs.107153NM_001564 4504694 inhibitor of growth family, member 1- 1CCGTTTGCTTTCAGAAAATGTTTTAG like (ING1L), mRNA/cds = (91, 933)GGTAAATGCATAAGACTATGCAAT 2148 Table 3A Hs.2248 NM_001565 4504700 smallinducible cytokine subfamily B 1 CCCAAATTCTTTCAGTGGCTACCTAC (Cys-X-Cys),member 10 (SCYBI0), ATACAATTCCAAACACATACAGGA mRNA/cds = (66, 362) 2149Table 3A Hs.32944 NM_001566 4504704 inositolpolyphosphate-4-phosphatase, 1 AAATTAATAAGTCACAAGAAAAA type I, 107 kD(INPP4A), transcript CAAAAGTGCCAGAAGATGTCCAG variant b. mRNA/cds = (294,3158) CCAC 2150 Table 3A Hs.106673 NM_001568 4503520 eukaryotictranslation initiation factor 3, 1 AGAGGCTCCTAACTGGGCAACTCAA subunit 6(48 kD) (EIF3S6), mRNA/ GATTCTGGCTTCTACTGAAGAACCA cds = (22, 1359) 2151Table 3A Hs.14376 NM_001614 11038618 actin, gamma 1 (ACTG1), mRNA/ 1GGTTTTCTACTGTTATGTGAGAACATT cds = (74, 1201) AGGCCCCAGCAACACGTCATTGT2152 Table 3A Hs.83636 NM_001619 6138971 adrenergic, beta, receptorkinase 1 1 CAGCTTCTGCCACTTCCCAGGTAAGC (ADRBK1), mRNA/cds = (85, 2154)AGGAGGAGGTGCCAACAGTGTTAG 2153 Table 3A Hs.170087 NM_001621 5016091 arylhydrocarbon receptor (AHR), 1 ACCATTTTTGTTACTCCTCTTCCA mRNA/cds = (643,3189) CATGTTACTGGATAAATTGTTTA GTGG 2154 Table 3A Hs.75313 NM_0016284502048 aldo-keto reductase family 1, member 1GTGCCACTAACGGTTGAGTTTTGACT B1 (aldose reductase) (AKR1B1),GCTTGGAACTGGAATCCTTTCAGC mRNA/cds = (45, 995) 2155 Table 3A Hs.100194NM_001629 4502058 arachidonate 5-lipoxygenase-activating 1TCTCCACCACCATCTCCCCTCTACTT protein (ALOX5AP), mRNA/CTCATTTCCTAACTCTCTGCTGAA cds = (30, 515) 2156 Table 3A Hs.262476NM_001634 5209326 S-adenosylmethionine decarboxylase 1GGTGTTGGACTTAAATCAGTTGAAAT 1 (AMD1), mRNA/cds = (320, 1324)GTATTTCTGTACCACAATTTACGC 2157 Table 3A Hs.82542 NM_001637 4502114acyloxyacyl hydrolase (neutrophil) 1 CCCTTCCGCTGTTCCTGAAATAACCT (AOAH),mRNA/cds = (274, 2001) TTCATAAAGTGCTTTGGGTGCCAT 2158 Table 3A Hs.73722NM_001641 4502136 APEX nuclease (multifunctional DNA 1TTCTCATGTATAAAACTAGGAATCCTC repair enzyme) (APEX), mRNA/CAACCAGGCTCCTGTGATAGAGT cds = (205, 1161) 2159 literature Hs.288850NM_001650 4755123 aquaporin 4 (AQP4), transcript variant 1AGACACGTCTATCAGCTTATTCCTTC a. mRNA/cds = (39, 1010)TCTACTGGAATATTGGTATAGTCA 2160 Table 3A Hs.792 NM_001656 4502196ADP-ribosylation factor domain protein 1 TGTCTGGTAACAAGATGTGACTTTTT 1,64 kD (ARFD1), mRNA/ GGTAGCACTGTTGTGGTTCATTCT cds = (22, 1746) 2161Table 3A Hs.270833 NM_001657 4502198 amphiregulin (schwannoma-derived 1TCCTCTTTCCAGTGGATCATAAGACA growth factor) (AREG), mRNA/ATGGACCCTTTTTGTTATGATGGT cds = (209, 967) 2162 literature Hs.74571NM_001658 6995997 ADP-ribosylation factor 1 (ARF1), 1ACTGTTTTGTATACTTGTTTTCAGTTT mRNA/cds = (75, 620) TCATTTCGACAAACAAGCACTGT2163 literature Hs.183153 NM_001661 4502206 ADP-ribosylation factor4-like 1 ACATAGTTTTTATTTTTGTGTCTGTGA (ARF4L), mRNA/cds = (158, 761)AAGTGCCAAGAACCCCTCCCCAC 2164 Table 3A Hs.77273 NM_001664 10835048 rashomolog gene family, member A 1 TCACCTGGACTTAAGCGTCTGGCTCT (ARHA),mRNA/cds = (151, 732) AATTCACAGTGCTCTTTCTCCTCA 2165 Table 3A Hs.3109NM_001666 11386132 Rho GTPase activating protein 4 1AGATGCCTGGCAGGGCTGGGTGGCG (ARHGAP4), mRNA/cds = (42, 2882)ATTCATAAAGACCTCGTGTTGATTC 2166 Table 3A Hs.181243 NM_001675 4502264activating transcription factor 4 (tax- 1 GGATAGTCAGGAGCGTCAATGTGCTTresponsive enhancer element B67) GTACATAGAGTGCTGTAGCTGTGT (ATF4),mRNA/cds = (881, 1936) 2167 Table 3A Hs.76941 NM_001679 4502280 ATPase,Na+/K+ transporting, beta 3 1 TTGTGAAATATCTTGTTACTGCTTTTA polypeptide(ATP1B3), mRNA/ TTTAGCAGACTGTGGACTGTAAT cds = (0, 839) 2168 Table 3AHs.73851 NM_001685 4502292 ATP synthase, H+ transporting, 1CTGGAGGACCTGTTGATGCTAGTTCA mitochondrial F0 complex, subunit F6GAGTATCACCAAGAGCTGGAGAGG (ATP5J), mRNA/cds = (1, 327) 2169 Table 3AHs.8110 NM_001686 4502294 L-3-hydroxyacyl-Coenzyme A 1GCTGCACAAGAGCCTTGATTGAAGAT dehydrogenase, short chainATATTCTTTCTGAACAGTATTTAA (HADHSC), mRNA/cds = (87, 1031) 2170 Table 3AHs.81634 NM_001688 4502298 ATP synthase, H+ transporting, 1TTGCCTTTATAAAAACTTGCTGCCTG mitochondrial F0 complex, subunit b,ACTAAAGATTAACAGGTTATAGTT isoform 1 (ATP5F1), mRNA/ cds = (32, 802) 2171Table 3A Hs.1697 NM_001693 4502310 ATPase, H+ transporting, lysosomal 1TGGTTCTGCTTTTTGACCTCTCTCTAC (vacuolar proton pump), betaCTTTTCAGGGTAATCTTTGTGGC polypeptide, 56/58 kD, isoform 2 (ATP6B2),mRNA/cds = (25, 1560) 2172 Table 3A Hs.86905 NM_001695 4502314 ATPase,H+ transporting, lysosomal 1 CCTGTCCTTGTGTTTGTGTGTGCTAA (vacuolar protonpump) 42 kD CAGAAATAAGTTGCAGTATGGTCG (ATP6C), mRNA/cds = (166, 1314)2173 Table 3A Hs.76572 NM_001697 4502302 ATP synthase, H+ transporting,1 AAAAGTGTTGGTTTTCTGCCATCAGT mitochondrial F1 complex, O subunitGAAAATTCTTAAACTTGGAGCAAC (oligomycin sensitivity conferring protein)(ATP5O), mRNA/ cds = (36, 677) 2174 db mining Hs.155024 NM_0017064502382 B-cell CLL/lymphoma 6 (zinc finger 1 AGGGTTTGGCTGTGTCTAAACTGCATprotein 51) (BCL6), mRNA/ TACCGCGTTGTAAAAAATAGCTGT cds = (327, 2447)2175 literature Hs.2243 NM_001715 4502412 B lymphoid tyrosine kinase(BLK), 1 CCTAGGCTGCGCTCCAGCACTGCGG mRNA/cds = (222, 1739)GGCTTTTCTGCAATAAAGTCACGAG 2176 literature Hs.113916 NM_001716 14589867Burkitt lymphoma receptor 1, GTP- 1 GGCAGCACAGAGACCCCCGGAACAA bindingprotein (BLR1), transcript GCCTAAAAATTGTTTCAAAATAAAA variant 2, mRNA/cds= (268, 1271) 2177 Table 3A Hs.77054 NM_001731 4502472 B-celltranslocation gene 1, anti- 1 AAGTCTTTTCCACAAACCACCATCTAT proliferative(BTG1), mRNA/ TTTGTGAACTTTGTTTAGTCATCT cds = (308, 823) 2178 db miningHs.263812 NM_001736 4502508 nuclear distribution gene C 1TGGCAAGTTGGAAAATATGTAACTGG (A. nidulans) homolog (NUDC),AATCTCAAAAGTTCTTTGGGACAA mRNA/cds = (90, 1085) 2179 Table 3A Hs.182278NM_001743 4502548 Homo sapiens, calmodulin 2 1TCTGCTTATGGCACAATTTGCCTCAA (phosphorylase kinase, delta), cloneATCCATTCCAAGTTGTATATTTGT MGC:1447 IMAGE:3504793, mRNA, complete cds/cds= (93, 542) 2180 Table 3A Hs.155560 NM_001746 10716562 calnexin (CANX),mRNA/ 1 CCATTGTTGTCAAATGCCCAGTGTCC cds = (89, 1867)ATCAGATGTGTTCCTCCATTTTCT 2181 Table 3A Hs.76288 NM_001748 12408845calpain 2, (m/II) large subunit 1 GCTGCCTCTGTAAATTCATGTATTCA (CAPN2),mRNA/cds = (14, 2244) AAGGAAAAGACACCTTGCCTATAA 2182 Table 3A Hs.279607NM_001750 5729759 calpastatin (CAST), mRNA/ 1 TCAAGTCAGCAACAGAGCAAAATAAAcds = (66, 1358) GGTTAGATAAGTCCTTGTGTAGCA 2183 Table 3A Hs.179881NM_001755 13124872 core-binding factor, beta subunit 1CTTGCCTTAAGCTACCAGATTGCTTT (CBFB), transcript variant 2, mRNA/TGCCACCATTGGCCATACTGTGTG cds = (11, 559) 2184 Table 3A Hs.75586NM_001759 4502616 cyclin D2 (CCND2), mRNA/ 1 TGGTTTTGAATGCAATTAGGTTATGCcds = (269, 1138) TATTTGGACAATAAACTCACCTTG 2185 Table 3A Hs.83173NM_001760 4502618 cyclin D3 (CCND3), mRNA/ 1 TGCAAGGTTTAGGCTGGTGGCCCAGcds = (165, 1043) GACCATCATCCTACTGTAATAAAGA 2186 Table 3A Hs.1973NM_001761 4502620 cyclin F (CCNF), mRNA/ 1 GTGTGGTCGGGGTGAGAACCCAAGC cds= (43, 2403) GTTGGAACTGTAGACCCGTCCTGTC 2187 literature Hs.343474NM_001762 4502642 601885667F1 cDNA, 5′ end/ 1 AGCAGCAGTGACATAAAATTCCATGTclone = IMAGE:4104184/clone_end = TAGATAAGCATATGTTACTTACCT 5′ 2188 Table3A Hs.66052 NM_001775 4502664 CD38 antigen (p45) (CD38), mRNA/ 1CTCCACAATAAGGTCAATGCCAGAGA cds = (69, 971) CGGAAGCCTTTTTCCCCAAAGTCT 2189literature Hs.205353 NM_001776 4502666 ectonucleoside triphosphate 1TGGAGGTATTCAATATCCTTTGCCTC diphosphohydrolase 1 (ENTPD1),AAGGACTTCGGCAGATACTGTCTC mRNA/cds = (67, 1599) 2190 Table 3A Hs.901NM_001778 4502674 CD48 antigen (B-cell membrane 1GGTGCCCACCATTCTTGGCCTGTTAC protein) (CD48), mRNA/cds = (36,TTACCTGAGATGAGCTCTTTTAAC 767) 2191 Table 3A Hs.287995 NM_001779 4502676cDNA: FLJ23181 fis, clone LNG11094 1 TTAAGAAGAAATACCCACTAACAAAG cds =UNKNOWN AACAAGCATTAGTTTTGGCTGTCA 2192 Table 3A Hs.82401 NM_0017814502680 CD69 antigen (p60, early T-cell 1 GCAAGACATAGAATAGTGTTGGAAAAactivation antigen) (CD69), mRNA/ TGTGCAATATGTGATGTGGCAAAT cds = (81,680) 2193 Table 3A Hs.116481 NM_001782 4502682 CD72 antigen (CD72),mRNA/ 1 GGGCGGCCCGGAGCCAGCCAGGCA cds = (108, 1187)GTTTTATTGAAATCTTTTTAAATAAT 2194 Table 3A Hs.79830 NM_001783 4502684CD79A antigen (immunoglobulin- 1 CTGATTGTAGCAGCCTCGTTAGTGTC associatedalpha) (CD79A), transcript ACCCCCTCCTCCCTGATCTGTCAG variant 1, mRNA/cds= (36, 716) 2195 literature Hs.184298 NM_001799 4502742 cyclin-dependentkinase 7 (homolog of 1 AGAGAACACTGGACAACATTTTACTA Xenopus MO15cdk-activating kinase) CTGAGGGAAATAGCCAAAAAGGCA (CDK7), mRNA/cds = (34,1074) 2196 Table 3A Hs.276770 NM_001803 4502760 CDW52 antigen (CAMPATH-11 CATGGGGGCAACAGCCAAAATAGGG antigen) (CDW52), mRNA/GGGTAATGATGTAGGGGCCAAGCAG cds = (24, 209) 2197 Table 3A Hs.10029NM_001814 4503140 cathepsin C (CTSC), mRNA/ 1 TTCTGGAAGATGGTCAGCTATGAAGTcds = (33, 1424) AATAGAGTTTGCTTAATCATTTGT 2198 literature Hs.41NM_001816 4502794 carcinoembryonic antigen-related cell 1GGGTGGCTCTGATATAGTAGCTCTGG adhesion molecule 8 (CEACAM8),TGTAGTTTCTGCATTTCAAGAAGA mRNA/cds = (32, 1081) 2199 Table 3A Hs.83758NM_001827 4502858 CDC28 protein kinase 2 (CKS2), 1TTCCAGTCAGTTTTTCTCTTAAGTGCC mRNA/cds = (95, 334) TGTTTGAGTTTACTGAAACAGTT2200 literature Hs.158324 NM_001837 4502636 chemokine (C—C motif)receptor 3 1 AAGGACCAAGGAGATGAAGCAAACA (CCR3), mRNA/cds = (31, 1098)CATTAAGCCTTCCACACTCACCTCT 2201 Table 3A Hs.3462 NM_001867 4502992cytochrome c oxidase subunit VIIc 1 AGGTGCAGCCTCTGGAAGTGGATCA (COX7C),mRNA/cds = (18, 209) AACTAGAACTCATATGCCATACTAG 2202 Table 3A Hs.75360NM_001873 4503008 carboxypeptidase E (CPE), mRNA/ 1ACTTAAAAGTTTAGGGTTTTCTCTTGG cds = (290, 1720) TTGTAGAGTGGCCCAGAATTGCA2203 Table 3A Hs.1940 NM_001885 4503056 crystallin, alpha B (CRYAB),mRNA/ 1 GTCTTGTGACTAGTGCTGAAGCTTAT cds = (25, 552)TAATGCTAAGGGCAGGCCCAAATT 2204 Table 3A Hs.19904 NM_001902 4503124cystathionase (cystathionine gamma- 1 CCAGAGCTGCTATTAGAAGCTGCTTC lyase)(CTH), mRNA/cds = (33, 1250) CTGTGAAGATCAATCTTCCTGAGT 2205 literatureHs.178452 NM_001903 4503126 catenin (cadherin-associated protein), 1TCCTCTTTCTCCCAGCTTCAAATGCA alpha 1 (102 kD) (CTNNA1), mRNA/CAATTCATCATTGGGCTCACTTCT cds = (4, 2727) 2206 Table 3A Hs.297939NM_001908 4503138 cathepsin B (CTSB), mRNA/ 1 CAGCTTCACCCTGTCAAGTTAACAAGcds = (177, 1196) GAATGCCTGTGCCAATAAAAGGTT 2207 Table 3A Hs.78056NM_001912 4503154 cathepsin L (CTSL), mRNA/ 1 CTCGAATCATTGAAGATCCGAGTGTGcds = (288, 1289) ATTTGAATTCTGTGATATTTTCAC 2208 literature Hs.289271NM_001916 4503184 cytochrome c-1 (CYC1), mRNA/ 1CTTCATCTGGAAGAAGAGGCAAGGG cds = (8, 985) GGCAGGAGACCAGGCTCTAGCTCTG 2209Table 3A Hs.77494 NM_001929 4503318 deoxyguanosine kinase (DGUOK), 1AGACTTTGCCATTGTTGCCATTGTTTT mRNA/cds = (11, 793) CTTTTGTACCTGAAGCATTTTGA2210 db mining Hs.334626 NM_032332 14150113 hypothetical protein MGC42381 AAAAGTAGGGGAGGGGCTGGGTCTG (MGC4238), mRNA/cds = (30, 977)CAAATTAATAAATAGAAGAGGGGGT 2211 Table 3A Hs.180383 NM_001946 4503418 dualspecificity phosphatase 6 1 GTCGCAAAGGGGATAATCTGGGAAA (DUSP6),transcript variant 1, mRNA/ GACACCAAATCATGGGCTCACTTTA cds = (351, 1496)2212 Table 3A Hs.82113 NM_001948 4503422 dUTP pyrophosphatase (DUT),mRNA/ 1 TCAGTAAACAAATTCTTTCACAAGGTA cds = (29, 523)CAAAATCTTGCATAAGCTGAACT 2213 Table 3A Hs.42287 NM_001952 12669917 E2Ftranscription factor 6 (E2F6), 1 GTTTTACTTAGGACAAGTTGTACCTT mRNA/cds =(0, 845) GCCCTCTCTCCAGCTCTGCTCCCA 2214 literature Hs.2271 NM_0019554503460 endothelin 1 (EDN1), mRNA/ 1 ACTGGCTTCCATCAGTGGTAACTGCT cds =(336, 974) TTGGTCTCTTCTTTCATCTGGGGA 2215 Table 3A Hs.275959 NM_0019594503476 eukaryotic translation elongation factor 1TGGATGTGGCTGCTTTCAACAAGATC 1 beta 2 (EEF1B2), mRNA/TAAAATCCATCCTGGATCATGGCA cds = (235, 912) 2216 Table 3A Hs.326035NM_001964 4503492 early growth response 1 (EGR1), 1TGTGGTGTATATCCTTCCAAAAAATTA mRNA/cds = (270, 1901)AAACGAAAATAAAGTAGCTGCGA 2217 Table 3A Hs.79306 NM_001968 4503534eukaryotic translation initiation factor 1 GTCTTCCATGTGAACAGCATAAGTTT 4E(EIF4E), mRNA/cds = (18, 671) GGAGCACTAGTTTGATTATTATGT 2218 literatureHs.99863 NM_001972 4503548 elastase 2, neutrophil (ELA2), mRNA/ 1GCCCACACCCACACTCTCCAGCATCT cds = (38, 841) GGCACAATAAACATTCTCTGTTTT 2219db mining Hs.211956 NM_012099 6912245 CD3-epsilon-associated protein; 1AGCTGTTTCCTGGGTAAATCTAGAGT antisense to ERCC-1 (ASE-1), mRNA/GGGGTTTTGGTTCTTTATTTTCCC cds = (488, 2020) 2220 Table 3A Hs.62192NM_001993 10518499 coagulation factor III (thromboplastin, 1GCAGGAGACATTGGTATTCTGGGCA tissue factor) (F3), mRNA/GCTTCCTAATATGCTTTACAATCTG cds = (123, 1010) 2221 Table 3A Hs.278333NM_001995 4503650 fatty-acid-Coenzyme A ligase, long- 1TGGTTTTCATATCAAAAGATCATGTTG chain 1 (FACL1), nuclear geneGGATTAACTTGCCTTTTTCCCCA encoding mitochondrial protein, mRNA/ cds = (73,2172) 2222 Table 3A Hs.77393 NM_002004 4503684 famesyl diphosphatesynthase 1 ATCTACAAGCGGAGAAAGTGACCTAG (famesyl pyrophosphate synthetase,AGATTGCAAGGGCGGGGAGAGGAG dimethylallyltranstransferase,geranyltranstransferase) (FDPS), mRNA/cds = (114, 1373) 2223 Table 3AHs.170133 NM_002015 9257221 forkhead box O1A 1TGTTTAAATGGCTTGGTGTCTTTCTTT (rhabdomyosarcoma) (FOXO1A),TCTAATTATGCAGAATAAGCTCT mRNA/cds = (385, 2352) 2224 Table 3A Hs.89764NM_002024 4503764 fragile X mental retardation 1 (FMR1), 1AAAACTGTACTTTGATTCACATGTTTT mRNA/cds = (219, 2117)CAAATGGAGTTGGAGTTCATTCA 2225 Table 3A Hs.138381 NM_002027 4503770famesyltransferase, CAAX box, alpha 1 TCCATCAGAGCTGGTCTGCACACTCA (FNTA),mRNA/cds = (6, 1145) CATTATCTTGCTATCACTGTAACC 2226 Table 3A Hs.753NM_002029 4503778 formyl peptide receptor 1 (FPR1), 1GACACTTTCGAGCTCCCAGCTCCAGC mRNA/cds = (81, 1113)TTCGTCTCACCTTGAGTTAGGCTG 2227 Table 3A Hs.82954 NM_002032 4503794ferritin, heavy polypeptide 1 (FTH1), 1 TGTTGGGGTTTCCTTTACCTTTTCTATmRNA/cds = (91, 663) AAGTTGTACCAAAACATCCACTT 2228 Table 3A Hs.278238NM_002041 8051596 GA-binding protein transcription factor, 1AGGAGTCTTTTACCCGGTGTGCTTTG beta subunit 2 (47 kD) (GABPB2),CCGCAGTCATCCAAAATAAATTCA transcript variant gamma, mRNA/ cds = (169,1251) 2229 Table 3A Hs.169476 NM_002046 7669491 Homo sapiens,glyceraldehyde-3- 1 TAGGGAGCCGCACCTTGTCATGTACC phosphate dehydrogenase,clone ATCAATAAAGTACCCTGTGCTCAA MGC:10926 IMAGE:3628129, mRNA/ completecds/cds = (2306, 3313) 2230 db mining Hs.334695 NM_002050 4503926GATA-binding protein 2 (GATA2), 1 GCTGTATATAAACGTGTCCCGAGCTT mRNA/cds =(193, 1617) AGATTCTGTATGCGGTGACGGCGG 2231 Table 3A Hs.62661 NM_0020534503938 guanylate binding protein 1, interferon- 1TGTCTTATGTGTCAAAAGTCCTAGGA inducible, 67 kD (GBP1), mRNA/AAGTGGTTGATGTTTTCTTATAGCA cds = (68, 1846) 2232 Table 3A Hs.1674NM_002056 4503980 glutamine-fructose-6-phosphate 1GCTGAATGACATATTTTATCTTGTTCT transaminase 1 (GFPT1), mRNA/TTAAAATCACAACACAGAGCTGC cds = (122, 2167) 2233 Table 3A Hs.296261NM_002072 4504044 guanine nucleotide binding protein (G 1TGTCTCTCTCTCTTTTTCTTTTCTATG protein), q polypeptide (GNAQ),GAGCAAAACAAAGCTGATTTCCC mRNA/cds = (220, 1299) 2234 Table 3A Hs.215595NM_002074 11321584 guanine nucleotide binding protein (G 1CAGTGTACTGCAAGGAAGCTGGATG protein), beta polypeptide 1 (GNB1),CAAGATAGATACTATATTAAACTGT mRNA/cds = (280, 1302) 2235 Table 3A Hs.183773NM_002078 6715599 golgi autoantigen, golgin subfamily a. 4 1TGTATTGTATGCAAATCTGTGATTGTT (GOLGA4), mRNA/cds = (285, 6977)GGCAGTGTCATCTCTGAGAAACA 2236 Table 3A Hs.180577 NM_002087 4504150granulin (GRN), mRNA/cds = (62, 1 GGGGTGTTTGTGTGTGTGCGCGTGT 1843)GCGTTTCAATAAAGTTTGTACACTT 2237 Table 3A Hs.2707 NM_002094 4504166 G1 toS phase transition 1 (GSPT1), 1 TTTAGTATTTTTCCCCCAGGCCAGAT mRNA/cds =(648, 2147) CATTCGTGAGTGTGCGAGTGTGTG 2238 Table 3A Hs.75113 NM_0020974753158 general transcription factor IIIA 1 TGCTTTGTTTAAAGGACTGCAGACCA(GTF3A), mRNA/cds = (19, 1290) AGGAGTCGAGCTTTCTCTCAGAGC 2239 Table 3AHs.119192 NM_002106 4504254 H2A histone family, member Z 1ACCTTATTTCCACTCTGGTGGATAAG (H2AFZ), mRNA/cds = (106, 492)TTCAATAAAGGTCATATCCCAAAC 2240 Table 3A Hs.181307 NM_002107 4504278 H3histone, family 3A (H3F3A), 1 AATGTTGTCTGTCTTCTGTGCTGTTC mRNA/cds =(374, 784) CTGTAAGTTTGCTATTAAAATACA 2241 Table 3A Hs.263435 NM_0021084809282 histidine ammonia-lyase (HAL), 1 ACCTTCCTCATTTCACAGATAAGGAAmRNA/cds = (297, 2270) TCTTTGGGGATTAACCAACCTCCT 2242 literature Hs.77798NM_002109 6996013 histidyl-tRNA synthetase (HARS), 1AGATACCTCCCCACCACCAATTGCCA mRNA/cds = (455, 1984)AAGGTCCAATAAAATGCCTCAACC 2243 Table 3A Hs.89555 NM_002110 4504356hemopoietic cell kinase (HCK), mRNA/ 1 GCAATCCACAATCTGACATTCTCAGG cds =(168, 1685) AAGCCCCCAAGTTGATATTTCTAT 2244 db mining Hs.277477 NM_00211711321588 major histocompatibility complex, class 1TCTCAGGCTGCGTGCAGCAACAGTG I, C (HLA-C), mRNA/cds = (0, 1100)CCCAGGGCTCTGATGAGTCTCTCAT 2245 Table 3A Hs.814 NM_002121 4504404 majorhistocompatibility complex, class 1 GCCTCCAACCATGTTCCCTTCTTCTT II, DPbeta 1 (HLA-DPB1), mRNA/ 1 AGCACCACAAATAATCAAAACCCA cds = (19, 795) 2246Table 3A Hs.308026 NM_002125 4504412 major histocompatibility complex,class 1 CTCATCTTCAACTTTTGTGCTCCCCTT II, DR beta 5 (HLA-DRB5), mRNA/TGCCTAAACCCTATGGCCTCCTG cds = (29, 829) 2247 Table 3A Hs.324278NM_002128 4504424 mRNA; cDNA DKFZp566M063 (from 1TGGGGGTTGTAAATTGGCATGGAAAT clone DKFZp566M063)/ TTAAAGCAGGTTCTTGTTGGTGCAcds = UNKNOWN 2248 Table 3A Hs.80684 NM_002129 14141173 high-mobilitygroup (nonhistone 1 TGTGTGTATGGTAGCACAGCAAACTT chromosomal) protein 2(HMG2), GTAGGAATTAGTATCAATAGTAAA mRNA/cds = (190, 819) 2249 Table 3AHs.1119 NM_002135 4504440 nuclear receptor subfamily 4, group A, 1CCTGCCTGGCTCTCTCTTCCTACCCT member 1 (NR4A1), mRNA/CCTTCCACATGTACATAAACTGTC cds = (110, 1906) 2250 Table 3A Hs.249495NM_002136 4504444 heterogeneous nuclear 1 AGATGGGAATGAAGCTTGTGTATCCAribonucleoprotein A1 (HNRPA1), TTATCATGTGTAATCAATAAACGA transcriptvariant 2, mRNA/ cds = (104, 1222) 2251 Table 3A Hs.232400 NM_00213714043073 heterogeneous nuclear 1 TTAAGATTTTTCTCAAAGTTTTGAAAAribonucleoprotein A2/B1 (HNRPA2B1), GCTATTAGCCAGGATCATGGTGT transcriptvariant B1, mRNA/ cds = (169, 1230) 2252 Table 3A Hs.303827 NM_00213814110413 heterogenous nuclear 1 TGCGGCTAGTTCAGAGAGATTTTTAGribonucleoprotein D (AU-rich element AGCTGTGGTGGACTTCATAGATGARNA-binding protein 1, 37 kD) (HNRPD), transcript variant 1, mRNA/ cds =(285, 1352) 2253 Table 3A Hs.146381 NM_002139 4504450 RNA binding motifprotein, X 1 CCATTTTGCCTTTCTGACATTTCCTTG chromosome (RBMX), mRNA/GGAATCTGCAAGAACCTCCCCTT cds = (11, 1186) 2254 Table 3A Hs.2733 NM_0021454504464 homeo box B2 (HOXB2), mRNA/ 1 TTCCGTTTGGTAGACTCCTTCCAATG cds =(78, 1148) AAATCTCAGGAATAATTAAACTCT 2255 Table 3A Hs.3268 NM_0021554504514 heat shock 70 kD protein 6 (HSP70B*) 1 GGCAGAGAAGGAGGAGTATGAGCAT(HSPA6), mRNA/cds = (0, 1931) CAGAAGAGGGAGCTGGAGCAAATCT 2256 Table 3AHs.79037 NM_002156 4504520 Homo sapiens, heat shock 60 kD 1AGCAGCCTTTCTGTGGAGAGTGAGAA protein 1 (chaperonin), cloneTAATTGTGTACAAAGTAGAGAAGT MGC:19755 IMAGE:3630225, mRNA/ complete cds/cds= (1705, 3396) 2257 Table 3A Hs.1197 NM_002157 4504522 heat shock 10 kDprotein 1 (chaperonin 1 AATGATAACTAATGACATCCAGTGTC 10) (HSPE1), mRNA/cds= (41, 349) TCCAAAATTGTTTCCTTGTACTGA 2258 db mining Hs.93177 NM_0021764504602 interferon, beta 1, fibroblast (IFNB1), 1TCCCTCTGGGACTGGACAATTGCTTC mRNA/cds = (0, 563) AAGCATTCTTCAACCAGCAGATGC2259 Table 3A Hs.82065 NM_002184 4504674 interleukin 6 signal transducer(gp130, 1 CGGCTACATGCCTCAGTGAAGGACTA oncostatin M receptor) (IL6ST),GTAGTTCCTGCTACAACTTCAGCA mRNA/cds = (255, 3011) 2260 Table 3A Hs.237888NM_002185 4504678 interleukin 7 receptor (IL7R), mRNA/ 1CATGAGTCAAGAGCATCCTGCTTCTA cds = (22, 1401) CCATGTGGATTTGGTCACAAGGTT2261 db mining Hs.1702 NM_002186 4504684 interleukin 9 receptorprecursor (IL9R) 1 GTCAGAGGTCCTGTCTGGATGGAGG gene, complete cds/cds =(214, 1779) CTGGAGGCTCCCCCCTCAACCCCTC 2262 db mining Hs.674 NM_0021874504640 interleukin 12B (natural killer cell 1CCTGATACACAATTATGACCAGAAAA stimulatory factor 2, cytotoxicTATGGCTCCATGAAGGTGCTACTT lymphocyte maturation factor 2, p40) (IL12B),mRNA/cds = (13, 999) 2263 Table 3A Hs.41724 NM_002190 4504650interleukin 17 (cytotoxic T-lymphocyte- 1 ATTCAATTCCAGAGTAGTTTCAAGTTTassociated serine esterase 8) (IL17), CACATCGTAACCATTTTCGCCCG mRNA/cds =(53, 520) 2264 Table 3A Hs.80645 NM_002198 4504720 interferon regulatoryfactor 1 (IRF1), 1 TGGAAATGTCATCTAACCATTAAGTC mRNA/cds = (197, 1174)ATGTGTGAACACATAAGGACGTGT 2265 Table 3A Hs.83795 NM_002199 4755144interferon regulatory factor 2 (IRF2), 1 AATTCCCAGATTTGAAGACAAAAATAmRNA/cds = (177, 1226) CTCTAATTCTAACCAGAGCAAGCT 2266 Table 3A Hs.334450NM_002200 4504726 interferon regulatory factor 5 (IRF5), 1TGGCAGCTACCCCCTTCTTGAGAGTC transcript variant 1, mRNA/CAAGAACCTGGAGCAGAAATAATT cds = (102, 1616) 2267 Table 3A Hs.241545NM_002208 6007850 Homo sapiens, Similar to hypothetical 1TTCCTTCAGGATGATCTAGAGCAGCA protein, clone MGC:1824TGGAGCTGTTGGTAGAATATTAGT IMAGE:3509518, mRNA, complete cds/cds = (533,1504) 2268 Table 3A Hs.174103 NM_002209 4504756 integrin, alpha L(antigen CD11A 1 TGCCAAGCACAGTGCCTGCATGTATT (p180), lymphocytefunction-associated TATCCAATAAATGTGAAATTCTGT antigen 1: alphapolypeptide) (ITGAL), mRNA/cds = (88, 3600) 2269 Table 3A Hs.287797NM_002211 4504766 mRNA for FLJ00043 protein, partial 1ACCACTGTATGTTTACTTCTCACCATT cds/cds = (0, 4248) TGAGTTGCCCATCTTGTTTCACA2270 Table 3A Hs.5215 NM_002212 4504770 integrin beta 4 binding protein1 GGCTGAGGGTTCTGCTGTCCTGTGC (ITGB4BP), mRNA/cds = (70, 807)CACCCCATTAAAGTGCAGTTCCTCC 2271 Table 3A Hs.50651 NM_002227 4504802 Januskinase 1 (a protein tyrosine 1 ACCATCCAATCGGACAAGCTTTCAGA kinase)(JAK1), mRNA/cds = (75, ACCTTATTGAAGGATTTGAAGCAC 3503) 2272 Table 3AHs.198951 NM_002229 4504808 jun B proto-oncogene (JUNB) 1AGTCTCTAAAGAGTTTATTTTAAGACG TGTTTGTGTTTGTGTGTGTTTGT 2273 Table 3AHs.3886 NM_002267 4504898 karyopherin alpha 3 (importin alpha 4) 1TGGAAGACTAAAGAGGTGCAATGTGA (KPNA3), mRNA/cds = (91, 1656)TCTGAGCCTCCATCATTGTCCTCC 2274 Table 3A Hs.74011 NM_002286 11693297lymphocyte-activation gene 3 (LAG3), 1 GCAGCCAGCAGATCTCAGCAGCCCAmRNA/cds = (349, 1938) GTCCAAATAAACGTCCTGTCTAGCA 2275 Table 3A Hs.334822NM_002295 9845501 Homo sapiens. Similar to ribosomal 1GGTAGGAGCAACCACTGACTGGTCTT protein L4, clone MGC:2966AAGCTGTTCTTGCATAGGCTCTTA IMAGE:3139805, mRNA, complete cds/cds = (1616,2617) 2276 Table 3A Hs.152931 NM_002298 4504960 lamin B receptor (LBR),mRNA/ 1 TCAGCTACACTTTGTTTTTAAGTTTGT cds = (75, 1922)TTTTGACATGTTTATTTGGCAAA 2277 Table 3A Hs.76506 NM_002298 7382490lymphocyte cytosolic protein 1 (L- 1 TCCCCCCTCCGCCTCCCAGGAAGAA plastin)(LCP1), mRNA/ AGAATGTTACTGCCTTAATAAAAAA cds = (173, 2056) 2278 Table 3AHs.234489 NM_002300 4557031 Homo sapiens, lactate dehydrogenase 1GTGAATTTGGGCTCACAGAATCAAAG B, clone MGC:3600 IMAGE:3028947,CCTATGCTTGGTAGCTCTTGAACA mRNA, complete cds/cds = (1745, 2749) 2279Table 3A Hs.2250 NM_002309 6006018 leukemia inhibitory factor(cholinergic 1 TCCTTCCTTTCCACTGAAAAGCACAT differentiation factor) (LIF),mRNA/ GGCCTTGGGTGACAAATTCCTCTT cds = (64, 672) 2280 Table 3A Hs.2798NM_002310 6042197 leukemia inhibitory factor receptor 1AGAAATGTTCAGTAATGAAAAAATATA (LIFR), mRNA/cds = (153, 3446)TCCAATCAGAGCCATCCCGAAAA 2281 literature Hs.166091 NM_002312 4504996ligase IV, DNA, ATP-dependent 1 TTTTAACTTTTAAGGTTGAAAAGA (LIG4),mRNA/cds = (474, 3008) CAATAGCCCAAATCCAAGAAAGA AAA 2282 Table 3AHs.158203 NM_002313 6006043 actin binding LIM protein 1 (ABLIM), 1GCACTCCTTTGTCATATACTCTGCAT transcript variant ABLIM-1, mRNA/CACTGTCATACTCACAACTTCGTG cds = (99, 2435) 2283 Table 3A Hs.890 NM_0023414505034 lymphotoxin beta (TNF superfamily, 1 TGGCAGTGGGAAAAATGTAGGAGACmember 3) (LTB), transcript variant 1, TGTTTGGAAATTGATTTTGAACCTGmRNA/cds = (8, 742) 2284 literature Hs.1116 NM_002342 4505038lymphotoxin beta receptor (TNFR 1 CATGCAAATAAAAAGAATGGGACCTAsuperfamily, member 3) (LTBR), AACTCGTGCCGCTCGTGCCGAATT mRNA/cds = (168,1475) 2285 Table 3A Hs.105938 NM_002343 4505042 lactotransferrin (LTF),mRNA/ 1 GGATTGCCCATCCATCTGCTTACAAT cds = (294, 2429)TCCCTGCTGTCGTCTTAGCAAGAA 2286 Table 3A Hs.210 NM_002344 4505044leukocyte tyrosine kinase (LTK), 1 GAGCACTGGATTGCTTTCCCATTATG mRNA/cds =(170, 2581) AGCGTCCTTCATCTGGGCAGACCC 2287 Table 3A Hs.80887 NM_0023504505054 v-yes-1 Yamaguchi sarcoma viral 1 AACCGGATATATACATAGCATGACATrelated oncogene homolog (LYN), TTCTTTGTGCTTTGGCTTACTTGT mRNA/cds =(297, 1835) 2288 Table 3A Hs.75709 NM_002355 10947032mannose-6-phosphate receptor (cation 1 ATTTGTTTGCATCCCTCCCCCACACCdependent) (M6PR), mRNA/ CTGGTGTTTTAAAATGAAGAAAAA cds = (170, 1003) 2289Table 3A Hs.330716 NM_002356 11125771 cDNA FLJ14368 fis, clone 1AAACTCCTGCTTAAGGTGTTCTAATTT HEMBA1001122/cds = UNKNOWNTCTGTGAGCACACTAAAAGCGAA 2290 Table 3A Hs.69547 NM_002385 4505122 myelinbasic protein (MBP), mRNA/ 1 GACATGCGGGCTGGGCAGCTGTTAG cds = (10, 570)AGTCCAACGTGGGGCAGCACAGAGA 2291 Table 3A Hs.172195 NM_002408 6031183mannosyl (alpha-1,6-)-glycoprotein 1 ACCAAAATTCAGTGAAGGCATTCTACbeta-1,2-N- AAGTTTTGAGTTAGCATTACATTT acetylglucosaminyltransferase(MGAT2), mRNA/cds = (489, 1832) 2292 literature Hs.1384 NM_0024124505176 O-6-methylguanine-DNA 1 TAACACTGCATCGGATGCGGGGCGTmethyltransferase (MGMT), mRNA/ 1 GGAGGCACCGCTGTATTAAAGGAAG cds = (40,663) 2293 Table 3A Hs.177543 NM_002414 4505182 antigen identified bymonoclonal 1 TCCATCGAGCACGTCTGAAACCCCTG antibodies I2E7, F21 and O13(MIC2), GTAGCCCCGACTTCTTTTTAATTA mRNA/cds = (123, 680) 2294 db miningHs.83169 NM_002421 13027798 matrix metalloproteinase 1 (interstitial 1CAGTCACTGGTGTCACCCTGGATAG collagenase) (MMP1), mRNA/GCAAGGGATAACTCTTCTAACACAA cds = (71, 1480) 2295 db mining Hs.83326NM_002422 13027803 matrix metalloproteinase 3 1GGGAAGCACTCGTGTGCAACAGACA (stromelysin 1, progelatinase) (MMP3),AGTGACTGTATCTGTGTAGACTATT mRNA/cds = (63, 1496) 2296 db mining Hs.2256NM_002423 13027804 matrix metalloproteinase 7 (matrilysin, 1TCTATGAGCTTTGTCAGTGCGCGTAG uterine) (MMP7), mRNA/cds = (47,ATGTCAATAAATGTTACATACACA 850) 2297 db mining Hs.73862 NM_002424 4505220matrix metalloproteinase 8 (neutrophil 1 ATATGGTGCTGTTTTCTACCCTTGGAcollagenase) (MMP8), mRNA/ AAGAAATGTAGATGATATGTTTCG cds = (71, 1474)2298 db mining Hs.2258 NM_002425 4505204 matrix metalloproteinase 10 1TTGCTAGGCGAGATAGGGGGAAGAC (stromelysin 2) (MMP10), mRNA/AGATATGGGTGTTTTTAATAAATCT cds = (22, 1452) 2299 db mining Hs.1695NM_002426 4505206 matrix metalloproteinase 12 1AAGTTGCTTCCTAACATCCTTGGACT (macrophage elastase) (MMP12),GAGAAATTATACTTACTTCTGGCA mRNA/cds = (12, 1424) 2300 db mining Hs.2936NM_002427 13027796 matrix metalloproteinase 13 1CTCAGGCAAAGAAAATGAAATGCATA (collagenase 3) (MMP13), mRNA/TTTGCAAAGTGTATTAGGAAGTGT cds = (28, 1443) 2301 literature Hs.82380NM_002431 4505224 menage a trois 1 (CAK assembly 1TGGAAGAGAGGAATAAATAATTCACC factor) (MNAT1), mRNA/cds = (34,TATATGTGTTTGAGGTTGTGACAG 963) 2302 literature Hs.79396 NM_002434 4505232N-methylpurine-DNA glycosylase 1 GCCTGAGCAAAGGGCCTGCCCAGAC (MPG),mRNA/cds = (146, 1042) AAGATTTTTTAATTGTTTAAAAACC 2303 Table 3A Hs.1861NM_002436 6006024 membrane protein, palmitoylated 1 1AAATGACACATCTGTGCAATAGAATG (55 kD) (MPP1), mRNA/ATGTCTGCTCTAGGGAAACCTTCA cds = (115, 1515) 2304 literature Hs.42674NM_002439 4505248 mutS (E. coli) homolog 3 (MHS3), 1ATATTTTTATTTGTTTCAGTTCAGATA mRNA/cds = (16, 3402)ATTGGCAACTGGGTGAATCTGGC 2305 literature Hs.115246 NM_002440 4505250 mutS(E. coli) homolog 4 (MSH4), 1 TTCCCAGGACCGAACAAGTTCCAGAA mRNA/cds = (41,2851) AAGACTGAAGAATAATCACAATTC 2306 literature Hs.112193 NM_0024414505252 mRNA for G7 protein (G7 gene 1 TTCCTTATCTCCCTCAGACGCAGAGTlocated in the class III region of the TTTTAGTTTCTCTAGAAATTTTGT majorhistocompatibility complex/ cds = (56, 2611) 2307 Table 3A Hs.288742NM_002444 4505256 cDNA: FLJ22712 fis, clone HSI13435/ 1TTTTGGAGGGGTTTATGCTCAATCCA cds = UNKNOWN TGTTCTATTTCAGTGCCAATAAAA 2308literature Hs.388 NM_002452 4505274 nudix (nucleoside diphosphate linked1 CATTGAGTGGGCGCAGAGCCGGGTTT moiety X)-type motif 1 (NUDT1),CATCTGGAATTAACTGGATGGAAGG mRNA/cds = (26, 496) 2309 Table 3A Hs.82132NM_002460 4505286 interferon regulatory factor 4 (IRF4), 1TGGAAATTCCCGTGTTGCTTCAAACT mRNA/cds = (105, 1460)GAGACAGATGGGACTTAACAGGCA 2310 Table 3A Hs.82132 NM_002460 4505286interferon regulatory factor 4 (IRF4) 1 TGGAAATTCCCGTGTTGCTTCAAACTmRNA/cds = (105, 1460) GAGACAGATGGGACTTAACAGGCA 2311 Table 3A Hs.76391NM_002462 4505290 myxovirus (influenza) resistance 1, 1CGTCCTGCGGAGCCCTGTCTCCTCT homolog of murine (interferon-inducibleCTCTGTAATAAACTCATTTCTAGCC protein p78) (MX1), mRNA/ cds = (345, 2333)2312 Table 3A Hs.926 NM_002463 11342663 myxovirus (influenza) resistance2, 1 TTTCCCTGATTATGATGAGCTTCCATT homolog of murine (MX2), mRNA/GTTCTGTTAAGTCTTGAAGAGGA cds = (104, 2251) 2313 Table 3A Hs.79070NM_002467 12962934 v-myc avian myelocytomatosis viral 1CAAATGCAACCTCACAACCTTGGCTG oncogene homolog (MYC), mRNA/AGTCTTGAGACTGAAAGATTTAGC cds = (558, 1877) 2314 Table 3A Hs.243886NM_002482 4505332 nuclear autoantigenic sperm protein 1GGGACACTGGAGGCTGGAGCTACAG (histone-binding) (NASP), mRNA/TTGAAAGCACTGCATGTTAAGAGGG cds = (85, 2448) 2315 Table 3A Hs.25812NM_002485 6996019 Nijmegen breakage syndrome 1 1TCTGTCATGCCCACAATCCCTTTCTA (nibrin) (NBS1), mRNA/cds = (52,AGGAAGACTGCCCTACTATAGCAG 2316) 2316 Table 3A Hs.19236 NM_002492 4505382NADH dehydrogenase (ubiquinone) 1 1 GGAGAAATAGGAATTTGTGAACCCCT betasubcomplex, 5 (16 kD, SGDH) AAAATTGTAGCAACTTTGAAAGGT (NDUFB5), mRNA/cds= (6, 575) 2317 Table 3A Hs.10758 NM_002495 4505368 NADH dehydrogenase(ubiquinone) Fe 1 ACAAGAGTATCCACAAAATAGGTTGG S protein 4 (18 kD)(NADH-coenzyme CACTGACTATATCTCTGCTTGACT Q reductase) (NDUFS4), mRNA/ cds= (8, 535) 2318 literature Hs.1827 NM_002507 4505392 nerve growth factorreceptor (TNFR 1 GCCCTCCTGAAACTTACACACAAAAC superfamily, member 16)(NGFR), GTTAAGTGATGAACATTAAATAGC mRNA/cds = (113, 1396) 2319 Table 3AHs.82226 NM_002510 4505404 glycoprotein (transmembrane) nmb 1AAACCATCTACTATATGTTAGACATGA (GPNMB), mRNA/cds = (91, 1773)CATTCTTTTTCTCTCCTTCCTGA 2320 Table 3A Hs.214 NM_002515 4505424neuro-oncoligcal ventral antigen 1 1 GTGTATCTCGTGGAATCAGTGGTTAG (NOVA1),transcript variant 1, mRNA/ CATTGCCGCTATTATATTTACTCA cds = (60, 1592)2321 Table 3A Hs.89385 NM_002519 4505430 nuclear protein,ataxia-telangiectasia 1 TTGTGATGTTAAGAAATTTGTATGGT locus (NPAT),mRNA/cds = (34, 4317) GTGGCAGTGGTCTATTCCTAAGGA 2322 Table 3A Hs.9614NM_002520 10835082 nucleophosmin (nucleolar 1 CGGATGACTGACCAAGAGGCTATTCAphosphoprotein B23, numatrin) AGATCTCTGGCAGTGGAGGAAGTC (NPM1), mRNA/cds= (0, 884) 2323 Table 3A Hs.153952 NM_002526 4505466 5′ nucleotidase(CD73) (NT5), mRNA/ 1 CCTAAATCTGTGTGTGTATTGTGAAG cds = (49, 1773)TGGTATAAGAAATGACTTTGAACC 2324 Table 3A Hs.66198 NM_002528 6224977 nth(E. coli endonuclease III)-like 1 1 CAGGCTGAGGTGGACCAAGAAGGCA (NTHL1),mRNA/cds = (0,938) ACCAAGTCCCCAGAGGAGACCCGCG 2325 Table 3A Hs.264981NM_002535 4505484 Z-5′-oligoadenylate synthetase 2 (69- 1GAATGTAGGGAAGAGGTGCCAAGCC 71 kD) (OAS2), transcript variant 2,AACCGTGGGGTTAGCTCTAATTATT mRNA/cds = (19, 2082) 2326 Table 3A Hs.74563NM_002537 9845508 ornithine decarboxylase antizyme 2 1ACGGGGATGTCAGGGAGGCAAGTGT (OAZ2), mRNA/cds = UNKNOWNGTTGTGTTACTGTGTCAATAAACTG 2327 Table 3A Hs.75212 NM_002539 4505488ornithine decarboxylase 1 (ODC1) 1 GGCAGAATGGGCCAAAAGCTTAGTG mRNA/cds =(334, 1719) TTGTGACCTGTTTTTAAAATAAAGT 2328 literature Hs.96398 NM_0025427949101 8-oxoguanine DNA glycosylase 1 CAAGATGGGGTGGGGGATATTGAGG (OGG1),nuclear gene encoding GAGACAGCGCTAAGGATGGTTTTAT mitochondrial protein,transcript variant 1b, mRNA/cds = (1266, 2240) 2329 Table 3A Hs.77729NM_002543 4505500 oxidised low density lipoprotein (lectin- 1TAGGCTTCTATTTCCTTTCCACCCACT like) receptor 1 (OLR1), mRNA/CTTCACAGGCTATTCTACTTTAA cds = (61, 882) 2330 literature Hs.81791NM_002548 4507566 tumor necrosis factor receptor 1GGTAACCAGGTCCAATCAGTAAAAAT superfamily, member 11bAAGCTGCTTATAACTGGAAATGGC (osteoprotegerin) (TNFRSF11B), mRNA/cds = (94,1299) 2331 Table 3A Hs.172182 NM_002568 4505574 poly(A)-binding protein,cytoplasmic 1 1 TCTGTTTTAAGTAACAGAATTGATAAC (PABPC1), mRNA/cds = (502,2403) TGAGCAAGGAAACGTAATTTGGA 2332 Table 3A Hs.75718 NM_002575 4505594serine (or cysteine) proteinase 1 TGCCTTTAATTGTTCTCATAATGAAGA inhibitor,clade B (ovalbumin) member ATAAGTAGGTACCCTCCATGCCC 2 (SERPINB2),mRNA/cds = (72, 1319) 2333 Table 3A Hs.188 NM_002600 4505662phosphodiesterase 4B, cAMP-specific 1 TGCCATTAAGCAGGAATGTCATGTTC (dunce(Drosophila)-homolog CAGTTCATTACAAAAGAAAACAAT phosphodiesterase E4)(PDE4B), mRNA/cds = (765, 2459) 2334 literature Hs.37040 NM_0026074505678 platelet-derived growth factor alpha 1ACCTGTTTTGTATACCTGAGAGCCTG polypeptide (PDGFA), mRNA/CTATGTTCTTCTTTTGTTGATCCA cds = (403, 993) 2335 literature Hs.1976NM_002608 4505680 platelet-derived growth factor beta 1CTGCTTCCTTCAGTTTGTAAAGTCGG polypeptide (simian sarcoma viral (v-TGATTATATTTTTGGGGGCTTTCC sis) oncogene homolog) (PDGFB), mRNA/cds =(1022, 1747) 2336 literature Hs.81564 NM_002619 4505732 platelet factor4 (PF4), mRNA/ 1 AGCATACTTCTTTTTTCCAGTTTCAAT cds = (7, 312)CTAACTGTGAAAGAAACTTCTGA 2337 Table 3A Hs.53155 NM_002621 4505738properdin P factor, complement (PFC), 1 GAACTCTAACACTTCTCTCCTCCACTmRNA/cds = (242, 1651) CTGAGCCCCCTGACCTTCCAAACC 2338 literature Hs.99910NM_002627 11321600 phosphofructokinase, platelet (PFKP), 1CCAGTGCGTGCTGTCTGTGGAGTGT mRNA/cds = (33, 2387)GTCTCATGCTTTCAGATGTGCATAT 2339 Table 3A Hs.181013 NM_002629 4505752phosphoglycerate mutase 1 (brain) 1 CCCTGCCACATGGGTCCAGTGTTCAT (PGAM1),mRNA/cds = (31, 795) CTGAGCATAACTGTACTAAATCCT 2340 Table 3A Hs.78713NM_002635 4505774 solute carrier family 25 (mitochondrial 1TGCTTAAGGCAAGAGTTTCAGATTTA carrier; phosphate carrier), member 3CTGTTGAAATAAACCCAACTGTTC (SLC25A3), nuclear gene encoding mitochondrialprotein, transcript variant 1b, mRNA/cds = (48, 1133) 2341 Table 3AHs.166204 NM_002638 13435395 PHD finger protein 1 (PHF1), transcript 1CCTGACCCCTCCCATCCTTCCCATTT variant 2, mRNA/cds = (215, 1916)CCTTTGATGTTATTTTGTTACAGC 2342 Table 3A Hs.112341 NM_002638 4505786protease inhibitor 3, skin-derived 1 TAAGTCCCTGCTGCCCTTCCCCTTCC (SKALP)(PI3), mRNA/cds = (119, CACACTGTCCATTCTTCCTCCCAT 472) 2343 Table 3AHs.250697 NM_002643 4505796 ras-like protein (TC10), mRNA/ 1TGATGTGATTGTAGCTTTTTAAACTAT cds = (0, 641) GAAACCCCTGAGAGATTGTACCT 2344db mining Hs.32942 NM_002649 4505802 phosphoinositide-3-kinase,catalytic, 1 CCCAAAGGTTCCTAAGCCTGGCTGCA gamma polypeptide (PIK3CG),mRNA/ AAGAAGAATCAACAGGGACACTTT cds = (323, 3628) 2345 Table 3A Hs.154846NM_002651 4505808 phosphatidylinositol 4-kinase, catalytic, 1TAGAAGTTTGCTTTTTCCCTGCCTGT beta polypeptide (PIK4CB), mRNA/CTTGGTCACTACCACCTCTTCCCT cds = (69, 2555) 2346 Table 3A Hs.77274NM_002658 4505862 plasminogen activator, urokinase 1TGACCAGCACTGTCTCAGTTTCACTT (PLAU), mRNA/cds = (76, 1371)TCACATAGATGTCCCTTTCTTGGC 2347 Table 3A Hs.179657 NM_002659 4505864plasminogen activator, urokinase 1 CTGCCCATCTCAGCCTCACCATCACC receptor(PLAUR), mRNA/ CTGCTAATGACTGCCAGACTGTGG cds = (426, 1433) 2348 Table 3AHs.77438 NM_002664 4505878 pleckstrin (PLEK), mRNA/ 1TTCCTGAAGCTGTTCCCACTCCCAGA cds = (60, 1112) TGGTTTTATCAATAGCCTAGAGGT2349 Table 3A Hs.44499 NM_002687 4505922 pinin, desmosome associatedprotein 1 GGATTACCTTTCCTTGTAAAGAGGAT (PNN), mRNA/cds = (30, 2261)GCTGCCTTAAGAATTGCATGTTGT 2350 Table 3A Hs.180107 NM_002690 4505930polymerase (DNA directed), beta 1 GGGTCTTTGGTGTTTTTAAATGATTGT (POLB),mRNA/cds = (113, 1120) TTCTTCTTCATGCTTTTGCTTGC 2351 literature Hs.99890NM_002691 4505932 polymerase (DNA directed), delta 1, 1CATGGGGCGGGGGCGGGACCAGGG catalytic subunit (125 kD) (POLD1),AGAATTAATAAAGTTCTGGACTTTTG mRNA/cds = (53, 3378) 2352 Table 3A Hs.334828AB058697 14017804 mRNA for KIAA1794 protein, partial 1ATTTAAAGCACAGTTTGTTTTTTCT cds/cds = (1592, 4000) GTCACCTATAGAGTGCAAGAATGCAC 2353 Table 3A Hs.79402 NM_002694 14702172 polymerase (RNA) II (DNAdirected) 1 CAGCACTGTCTCCAGATAGGAACATG polypeptide C (33 kD) (POLR2C),CACAAAGCAGTTAATTAGGCAGCC transcript variant gamma, mRNA/ cds = (57, 684)2354 Table 3A Hs.1101 NM_002698 4505958 POU domain, class 2,transcription 1 CTCCCCTCCCATTCCTCTGGTCCCTG factor 2 (POU2F2), mRNA/CCTTGGTCCCTTGCCTGGGAAGAG cds = (54, 1445) 2355 Table 3A Hs.2164NM_002704 4505980 pro-platelet basic protein (includes 1AAGGTTGGTTAAAAGATGGCAGAAAG platelet basic protein, beta-AAGATGAAAATAAATAAGCCTGGT thromboglobulin, connective tissue- activatingpeptide III, neutrophil- activating peptide-2) (PPBP), mRNA/ cds = (68,452) 2356 Table 3A Hs.17883 NM_002707 4505998 protein phosphatase 1G(formerly 2C), 1 CTCATCACCGGTTCTGTGCCTGTGCT magnesium-dependent, gammaCTGTTGTGTTGGAGGGAAGGACTG isoform (PPM1G), mRNA/ cds = (24, 1664) 2357Table 3A Hs.77876 NM_002709 4506004 Homo sapiens, Similar to RIKEN 1TTTGCTTGGCAACACGACTTGAAATA cDNA 2410153K17 gene, cloneAATAAAACTTTGTTTCTTAGGAGA MGC:19595 IMAGE:3840843, mRNA, complete cds/cds= (469, 1899) 2358 Table 3A Hs.79081 NM_002710 4506006 proteinphosphatase 1, catalytic 1 AAAAGAAATCTGTTTCAACAGATGAC subunit, gammaisoform (PPP1CC), CGTGTACAATACCGTGTGGTGAAA mRNA/cds = (154, 1125) 2359Table 3A Hs.36587 NM_002712 4506012 protein phosphatase 1, regulatory 1GACGCCACACACCATTTTCAGATGCC subunit 7 (PPP1R7), mRNA/GTTGCAATTAAATCTTGCCACACT cds = (15, 1097) 2360 Table 3A Hs.179574NM_002717 4506018 protein phosphatase 2 (formerly 2A), 1ATGTTTTAGTAACAGTTGGCTGTAAT regulatory subunit B (PR 52), alphaCACTCCTCGCCGTGTCTGGCACTG isoform (PPP2R2A), mRNA/ cds = (105, 1448) 2361Table 3A Hs.171734 NM_002719 4506022 protein phosphatase 2, regulatory 1AGTTCTGCGTTTGGCATCTTCACTCT subunit B (B56), gamma isoformTTCCAAAATGTATCTGTACATCAG (PPP2R5C), mRNA/cds = (88, 1632) 2362 Table 3AHs.1908 NM_002727 4506044 proteoglycan 1, secretory granule 1TGTGTTTGCAGAGCTAGTGGATGTGT (PRG1), mRNA/cds = (24, 500)TTGTCTACAAGTATGATTGCTGTT 2363 Table 3A Hs.183037 NM_002734 4506062protein kinase, cAMP-dependent, 1 AAATCTGGGGAAGAGGTTTTATTTAC regulatory,type I, alpha (tissue specific ATTTTAGGGTGGGTAAGAAAGCCA extinguisher I)(PRKAR1A), mRNA/ cds = (87, 1232) 2364 Table 3A Hs.2499 NM_0027414506072 protein kinase C-like 1 (PRKCL1), 1 CAGAGCGGAGGCTGGGATCTAGCGAmRNA/cds = (84, 2912) GAGAGATGCAGAAGATGTGAAGAAA 2365 literatureHs.324473 NM_002745 4506088 40 kDa protein kinase related to rat 1CGTTTGGAGGGGCGGTTTCTGGTAG ERK2/cds = (134, 1180)TTGTGGCTTTTATGCTTTCAAAGAA 2366 literature Hs.267445 NM_002750 4506094mRNA; cDNA DKFZp434B231 (from 1 GGGGTGGGAGGGATGGGGAGTCGG cloneDKFZp434B231)/ TTAGTCATTGATAGAACTACTTTGAA cds = UNKNOWN 2367 literatureHs.274382 NM_002759 4506102 protein kinase, interferon-inducible 1TGCAGAAACAGAAAGGTTTTCTTCTT double stranded RNA dependentTTTGCTTCAAAAACATTCTTACAT (PRKR), mRNA/cds = (435, 2090) 2368 db miningHs.56 NM_002764 4506126 phosphoribosyl pyrophosphate 1AGATTAACTGCTGGACCTCCTACCTG synthetase 1 (PRPS1), mRNA/CATTATCTCATTCTGGCTTCCTTG cds = (66, 1022) 2369 Table 3A Hs.82159NM_002786 4506178 proteasome (prosome, macropain) 1CTTTGTGGTTTTAAAGACAACTGTGA subunit, alpha type. 1 (PSMA1),AATAAAATTGTTTCACCGCCTGGT mRNA/cds = (105, 896) 2370 Table 3A Hs.167106NM_002788 4506182 proteasome (prosome, macropain) 1GAACTCAGCTGGGTTGGTGAATTAAC subunit, alpha type, 3 (PSMA3),TAATGGAAGACATGAAATTGTTCC mRNA/cds = (5, 772) 2371 Table 3A Hs.251531NM_002789 4506184 proteasome (prosome, macropain) 1ACGATGATGGTTACCCTTCATGGACG subunit, alpha type, 4 (PSMA4),TCTTAATCTTCCACACACATCCCC mRNA/cds = (59, 844) 2372 Table 3A Hs.76913NM_002790 4506186 proteasome (prosome, macropain) 1TTCAGTTCTAATAATGTCCTTAAATTT subunit, alpha type, 5 (PSMA5),TATTTCCAGCTCCTGTTCCTTGG mRNA/cds = (21, 746) 2373 Table 3A Hs.233952NM_002792 4506188 proteasome (prosome, macropain) 1GCCTTTCCATTCCATTTATTCACACTG subunit, alpha type, 7 (PSMA7),AGTGTCCTACAATAAACTTCCGT mRNA/cds = (24, 770) 2374 Table 3A Hs.89545NM_002796 4506198 proteasome (prosome, macropain) 1TGCATTATCCAGAACTGAAGTTGCCC subunit, beta type, 4 (PSMB4), mRNA/TACTTTTAACTTTGAACTTGGCTA cds = (23, 817) 2375 Table 3A Hs.118065NM_002799 4506202 proteasome (prosome, macropain) 1GCCCAGTAAGACACTCATGTGGCTAG subunit, beta type, 7 (PSMB7), mRNA/TGTTTGCCGAATGAAACTCAACTC cds = (14, 847) 2376 Table 3A Hs.61153NM_002803 4506208 proteasome (prosome, macropain) 1TAAGTCTTATGCCAAATTCAGTGCTA 28S subunit, ATPase, 2 (PSMC2),CTCCTCGTTACATGACATACAACT mRNA/cds = (66, 1367) 2377 Table 3A Hs.79387NM_002805 4506212 proteasome (prosome, macropain) 1AAGTGAGTGGACAGCCTTTGTGTGTA 26S subunit, ATPase, 5 (PSMC5),TCTCTCCAATAAAGCTCTGTGGGC mRNA/cds = (0, 1220) 2378 Table 3A Hs.341867NM_002807 4506224 z172b08.r1 cDNA, 5′ end/ 1 TCTCCAAGTCTTTGGTTGAAGAGAAGclone = IMAGE:727663/clone_end = ATATATGACTGTTGAGTGTGCTCT 5′ 2379 Table3A Hs.74619 NM_002808 4506226 proteasome (prosome, macropain) 1GGGGAATTGTCGCCTCCTGCTCTTTT 26S subunit, non-ATPase, 2 (PSMD2),GTTACTGAGTGAGATAAGGTTGTT mRNA/cds = (112, 2673) 2380 Table 3A Hs.155543NM_002811 4506230 proteasome (prosome, macropain) 1TGGCATCCTCAGGGGTTGTGATCCA 26S subunit, non-ATPase, 7 (Mov34GCTCCATATATTGTTTACCTTCAAA homolog) (PSMD7), mRNA/ cds = (83, 1057) 2381Table 3A Hs.78468 NM_002812 4506232 proteasome (prosome, macropain) 1CGGGCACTGGGTGGGGCAGGGCAC 26S subunit, non-ATPase, 8 (PSMD8),GAGTTATTTAAAACAGTTACACTGCA mRNA/cds = (70, 843) 2382 Table 3A Hs.306328NM_002817 4506222 mRNA activated in tumor suppression, 1CGGACATCTTTTCCGTTGCGGTTTGA clone TSAP13 extended/GAATGTTCCTATAATAAACCCCTC cds = UNKNOWN 2383 Table 3A Hs.250855 NM_0028234506276 prothymosin, alpha (gene sequence 1 TTTGGCCTGTTTTGATGTATGTGTGA28) (PTMA), mRNA/cds = (155, 487) AACAATGTTGTCCAACAATAAACA 2384 Table 3AHs.155894 NM_002827 4506288 protein tyrosine phosphatase, non- 1AGCGAGCTGCTCTGCTATGTCCTTAA receptor type 1 (PTPN1), mRNA/GCCAATATTTACTCATCAGGTCAT cds = (72, 1379) 2385 Table 3A Hs.82829NM_002828 4506290 protein tyrosine phosphatase, non- 1TGTAGTTGGGGTAGATTATGATTTAG receptor type 2 (PTPN2), mRNA/GAAGCAAAAGTAAGAAGCAGCATT cds = (60, 1307) 2386 Table 3A Hs.63489NM_002831 4506296 protein tyrosine phosphatase, non- 1GCGATGGACAGACTCACAACCTGAA receptor type 6 (PTPN6), mRNA/CCTAGGAGTGCCCCATTGCTTTTGTA cds = (144, 1931) 2387 Table 3A Hs.35NM_002832 4506298 protein tyrosine phosphatase, non- 1GCTCAGGAGGGTACAAGCTCCAGAA receptor type 7 (PTPN7), mRNA/CAGTAACCAAGTGGGAAAATAAAGA cds = (155, 1174) 2388 Table 3A Hs.62NM_002835 4506286 protein tyrosine phosphatase, non- 1CTGGATTCATGCAGCCAGCTTTGCAG receptor type 12 (PTPN12), mRNA/GTTATCAGAGATCAAAGATTGTAA cds = (19, 2361) 2389 Table 3A Hs.26045NM_002836 4506302 protein tyrosine phosphatase, receptor 1TATCATGGGGAGTAATAGGACCAGAG type, A (PTPRA), mRNA/CGGTATCTCTGGCACCACACTAGC cds = (695, 3103) 2390 Table 3A Hs.170121NM_002838 4506308 protein tyrosine phosphatase, receptor 1CTGTGGAAAAATATTTAAGATAGTTTT type, C (PTPRC), mRNA/GCCAGAACAGTTTGTACAGACGT cds = (86, 4000) 2391 Table 3A Hs.2050 NM_0028524506332 pentaxin-related gene, rapidly induced 1ACTCTCAAATAATTAAAAAGGACTGTA by IL-1 beta (PTX3), mRNA/TTGTTGAACAGAGGGACAATTGT cds = (67, 1212) 2392 literature Hs.7179NM_002853 4506384 RAD1 (S. pombe) homolog (RAD1), 1AACTCATGGGAATAATTGTGAGTCAG mRNA/cds = (437, 1285)CGTAACATTTCAAGAGTCTAAAGG 2393 Table 3A Hs.151536 NM_002870 4506362RAB13, member RAS oncogene 1 TGCTCCTGTTCTGTCACTTGTCATGG family (RAB13),mRNA/cds = (139, TCTTTCTTGGTATTAAAGGCCACC 750) 2394 literature Hs.16184NM_002873 4506382 RAD17 (S. pombe) homolog (RAD17), 1GGGGTTGTAAATATCAACTATTCAAC mRNA/cds = (642, 2654)AGTTTAGGATGCAATTACGAGTGT 2395 literature Hs.23044 NM_002875 4506388 Homosapiens, Similar to RIKEN 1 AATCTTATGTTTCCAAGAGAACTAAA cDNA 2610036L13gene, clone GCTGGAGAGACCTGACCCTTCTCT MGC:16386 IMAGE:3938081, mRNA,complete cds/cds = (82, 840) 2396 literature Hs.11393 NM_002876 4506390RAD51 (S. cerevisiae) homolog C 1 TGCACCAGGTGTTGGAAAAACACAAT (RAD51C),mRNA/cds = (16, 423) TATGGTAAAATAAAGTGTTCTCCT 2397 literature Hs.100669NM_002877 10835028 RAD51 (S. cerevisiae)-like 1 1AATGGGCACACAGGGAACAGGAAAT (RAD51L1), mRNA/cds = (70, 1122)GGGAATGAGAGCAAGGGTTGGGTTG 2398 literature Hs.125244 NM_002878 4506392RAD51 (S. cerevisiae)-like 3 1 TCTTCTTCATCTCTGTTTTGCTCTTAA (RAD51L3),mRNA/cds = (124, 993) AAATATAAAAAGGCAATTCCCCG 2399 literature Hs.89571NM_002679 4506394 RAD52 (S. cerevisiae) homolog 1AGATGTAACCCACCTTGACCATAAAT (RAD52), mRNA/cds = (31, 1290)TGGCTTTTCATAGTGCTCAGATGT 2400 Table 3A Hs.279474 NM_002880 8850222HSPC070 protein (HSPC070), mRNA/ 1 CTAGGCTCTGGGCACATTTCCTGTTC cds =(331, 1581) TTGAATTCTGCTCCTGAAGAGGGT 2401 Table 3A Hs.24763 NM_0028826382077 RAN binding protein 1 (RANBP1) 1 TACCCTGCCCCTCTTTTTCGGTTTGTTTTTATTCTTTCATTTTTACAAGG 2402 Table 3A Hs.758 NM_002890 4506430 RAS p21protein activator (GTPase 1 GCTGCCTAACTTATCCATCTTTGAAC activatingprotein) 1 (RASA1), TTCTGACTACTTGTTGTATCTGCT transcript variant 1, mRNA/cds = (118, 3261) 2403 Table 3A Hs.29287 NM_002894 4506440retinoblastoma-binding protein 8 1 CCTTTAAAACAATAAGGCGCTTTCATT (RBBP8),mRNA/cds = (298, 2991) TTGCACTCTAACTTAAGAGTTTT 2404 Table 3A Hs.6108NM_002896 4506444 RNA binding motif protein 4 (RBM4), 1TCCTGCCTCCTGCGGCTGTTGGATTT mRNA/cds = (55, 1155)GGGAATGACCTTGGTGAGAGTCTC 2405 Table 3A Hs.167791 NM_002901 4506454reticulocalbin 1, EF-hand calcium 1 ATACTCTGAGCTGTGGACTGAACTGG bindingdomain (RCN1), mRNA/ CAGACACAACCTGTACAGATTGAA cds = (52, 1047) 2406literature Hs.115521 NM_002912 4506482 REV3 (yeast homolog)-like,catalytic 1 AAGGAATTATGTGGTCAGTGCATTGT subunit of DNA polymerase zetaTTTTTAAACTGGAAATCATTTTGT (REV3L), mRNA/cds = (822, 9980) 2407 Table 3AHs.75256 NM_002922 4506514 regulator of G-protein signalling 1 1TGCTCTTAAAACCAGGGAGTCAGATA (RGS1), mRNA/cds = (14, 604)TATTTGTAAGGTTAAATCATTGGT 2408 Table 3A Hs.78944 NM_002923 4506516regulator of G-protein signalling 2, 1 GCCAAAAATCTGTCTTGAAGGCAGCT 24 kD(RGS2), mRNA/cds = (32, 667) ACACTTTGAAGTGGTCTTTGAATA 2409 Table 3AHs.82280 NM_002925 11184225 regulator of G-protein signalling 10 1CCTCTCAGGACGTGCCGGGTTTATCA (RGS10), mRNA/cds = (43, 548)TTGCTTTGTTATTTGTAAGGACTG 2410 Table 3A Hs.1010 NM_002932 4506544regulator of mitotic spindle assembly 1 1 TGACTATCTGTAATGGATCAATTTTG(RMSA1), mRNA/cds = (774, 2030) GATATGACTTTGGGTGGGGGTAAA 2411 Table 3AHs.64318 NM_002945 4506582 replication protein A1 (70 kD) (RPA1), 1CGAGCTGAGAAGCGGTCATGAGCAC mRNA/cds = (69, 1919)CTGGGGATTTTAGTAAGTGTGTCTT 2412 Table 3A Hs.79411 NM_002946 4506584replication protein A2 (32 kD) (RPA2), 1 GGTAGTGCCTCCAGGGGCAGAGGAAmRNA/cds = (77, 889) AAGAAGAAGTGTTACTGCATTTTGT 2413 literature Hs.1608NM_002947 4506588 replication protein A3 (14 kD) (RPA3), 1ATGGTCAGATTAGATGCAAGAATAAA mRNA/cds = (30, 395) GCAGTTGTCCGAGTCTAAGTTTCT2414 Table 3A Hs.2280 NM_002950 4506674 ribophorin I (RPN1), mRNA/ 1TGGTATTCTGTTCTGAAGTCTAGGAT cds = (137, 1960) ATTTTTCAGCCTATAAAGCCCCCT2415 Table 3A Hs.169476 NM_002951 4506676 Homo sapiens,glyceraldehyde-3- 1 ACTTACCCAGATGTTGCTTTTGAAAA phosphate dehydrogenase,clone GTTGAAATGTGTAATTGTTTTGGA MGC:10926 IMAGE:3628129, mRNA, completecds/cds = (2306, 3313) 2416 Table 3A Hs.182426 NM_002952 4506718ribosomal protein S2 (RPS2), mRNA/ 1 AGCGGACTCAGGCTCCAGCTGTGGC cds =(11, 892) TACAACATAGGGTTTTTATACAAGA 2417 Table 3A Hs.3297 NM_0029544506712 ribosomal protein S27a (RPS27A), 1 TTATTGTGGCAAATGTTGTCTGACTTAmRNA/cds = (38, 508) CTGTTTCAACAAACCAGAAGACA 2418 db mining Hs.20084NM_002957 10862707 retinoid X receptor, alpha (RXRA), 1TGGACAGTAGCATTAGAATTGTGGAA mRNA/cds = (75, 1463)AAGGAACACGCAAAGGGAGAAGTG 2419 Table 3A Hs.79350 NM_002958 11863158 RYKreceptor-like tyrosine kinase 1 CTGGTAAATTTTGTGCTTATCTTCAAG (RYK),mRNA/cds = (103, 1917) GCTGGCTTAAGTATAAAATTGTT 2420 Table 3A Hs.81256NM_002961 9845514 S100 calcium-binding protein A4 1CCCTGGCTCCTTCAGACACGTGCTTG (calcium protein, calvasculin,ATGCTGAGCAAGTTCAATAAAGAT metastasin, murine placental homolog) (S100A4),transcript variant 1, mRNA/ cds = (69, 374) 2421 Table 3A Hs.100000NM_002964 9845519 S100 calcium-binding protein A8 1GTTAACTTCCAGGAGTTCCTCATTCT (calgranulin A) (S100A8), mRNA/GGTGATAAAGATGGGCTGGCAGCC cds = (55, 339) 2422 Table 3A Hs.23978NM_002967 4506778 scaffold attachment factor B (SAFB), 1CCTGTCTCGTGGCAACAAGGCTATGT mRNA/cds = (53, 2800)TCTGTTAGGAGTTACCTTAAACTG 2423 Table 3A Hs.28491 NM_002970 4506788spermidine/spermine N1- 1 AGTCAGATCTTTCTCCTTGAATATCTT acetyltransferase(SAT), mRNA/ TCGATAAACAACAAGGTGGTGTG cds = (165, 680) 2424 Table 3AHs.74592 NM_002971 4506790 special AT-rich sequence binding 1TCCTATAATTATTTCTGTAGCACTCCA protein 1 (binds to nuclearCACTGATCTTTGGAAACTTGCCC matrix/scaffold-assocating DNA's) (SATB1),mRNA/cds = (214, 2505) 2425 Table 3A Hs.112842 NM_002978 4506818 sodiumchannel, nonvoltage-gated 1, 1 CCACGGGTGATGCTTCCAGGGGTTC delta (SCNN1D),mRNA/cds = (0, TGGCGGGAGTCTCAGCCGAAGAGAG 1916) 2426 Table 3A Hs.303649NM_002982 4506840 small inducible cytokine A2 (monocyte 1GAAATTGCTTTTCCTCTTGAACCACA chemotactic protein 1, homologous toGTTCTACCCCTGGGATGTTTTGAG mouse Sig-je) (SCYA2), mRNA/ cds = (53, 352)2427 Table 3A Hs.73817 NM_002983 4506842 small inducible cytokine A3 1ACCAGACTGACAAATGTGTATCGGAT (homologous to mouse Mip-1a)GCTTTTGTTCAGGGCTGTGATCGG (SCYA3), mRNA/cds = (83, 361) 2428 Table 3AHs.75703 NM_002984 4506844 small inducible cytokine A4 1CCACTGTCACTGTTTCTCTGCTGTTG (homologous to mouse Mip-1b)CAAATACATGGATAACACATTTGA (SCYA4), mRNA/cds = (108, 386) 2429 db miningHs.66742 NM_002987 4506828 small inducible cytokine subfamily A 1CGAAGAAGAGCCACAGTGAGGGAGA (Cys—Cys), member 17 (SCYA17),TCCCATCCCCTTGTCTGAACTGGAG mRNA/cds = (52, 338) 2430 cytokine Hs.57907NM_002989 4506834 small inducible cytokine subfamily A 1GACCTGATACGGCTCCCCAGTACAC arrays (Cys—Cys), member 21 (SCYA21),CCCACCTCTTCCTTGTAAATATGAT mRNA/cds = (58, 462) 2431 Table 3A Hs.97203NM_002990 4506836 small inducible cytokine subfamily A 1CTCAAGCGTCCTGGGATCTCCTTCTC (Cys—Cys), member 22 (SCYA22),CCTCCTGTCCTGTCCTTGCCCCTC mRNA/cds = (19, 300) 2432 Table 3A Hs.247838NM_002991 4506838 small inducible cytokine subfamily A 1CCTCAAGGGAGGAGTGATCTTCACCA (Cys—Cys), member 24 (SCYA24),CCAAGAAGGGCCAGCAGTTCTGTG mRNA/cds = (0, 359) 2433 Table 3A Hs.164021NM_002993 4506850 small inducible cytokine subfamily B 1TCCTGTGTGTCATGTTGGTTTTTGGT (Cys-X-Cys), member 6 (granulocyteACTTGTATTGTCATTTGGAGAAAC chemolactic protein 2) (SCYB6), mRNA/cds = (63,407) 2434 Table 3A Hs.89714 NM_002994 4506848 small inducible cytokinesubfamily B 1 TCCTGTGATGGAAATACAACTGGTAT (Cys-X-Cys), member 5(epithelial- CTTCACTTTTTTAGGAATTGGGAA derived neutrophil-activatingpeptide 78) (SCYB5), mRNA/cds = (106, 450) 2435 Table 3A Hs.3195NM_002995 4506852 small inducible cytokine subfamily C, 1AATTTGCAGTAAACTTTTAATTAAATG member 1 (lymphotactin) (SCYC1),CTCATCTGGTAACTCAACACCCC mRNA/cds = (20, 364) 2436 Table 3A Hs.3577NM_003001 9257243 succinate dehydrogenase complex, 1GCTGCTTTTGAGGAGAAAATATATAG subunit C, integral membrane protein,CTTTGGACACGAGGAAGATCTAGA 15 kD (SDHC), nuclear gene encodingmitochondrial protein, mRNA/ cds = (26, 535) 2437 Table 3A Hs.168289NM_003002 4506864 succinate dehydrogenase complex, 1AAACGCTTGGAGTGCTTCTGAATATA subunit D, integral membrane proteinCAGAAGTTCCATTTAAGGGCAAGT (SDHD), nuclear gene encoding mitochondrialprotein, mRNA/ cds = (11, 490) 2438 Table 3A Hs.75232 NM_003003 4506866SEC14 (S. cerevisiae)-like 1 1 TGCATCGTGTTTCTACCTTTAGTACCT (SEC14L1),mRNA/cds = (303, 2450) TGCCACTCTTTTAAAACGCTGCT 2439 Table 3A Hs.73800NM_003005 6031196 selectin P (granule membrane protein 1GACCTTCCTGCCACCAGTCACTGTCC 140 kD, antigen CD62 (SELP), mRNA/CTCAAATGACCCAAAGACCAATAT cds = (95, 2587) 2440 Table 3A Hs.79283NM_003006 6031197 selectin P ligand (SELPLG), mRNA/ 1AGACCTTTCTTTGGGACTGTGTGGAC cds = (59, 1267) CAAGGAGCTTCCATCTAGTGACAA2441 Table 3A Hs.75217 NM_003010 4506888 mitogen-activated proteinkinase 1 GCTCAGTAACATAACTGCTTCTTGGA kinase 4 (MAP2K4), mRNA/GCTTTGGAATATTTTATCCTGTAT cds = (9, 1208) 2442 Table 3A Hs.145279NM_003011 4506890 SET translocation (myeloid leukemia- 1TTCTGCACAGGTCTCTGTTTAGTAAA associated) (SET), mRNA/cds = (3,TACATCACTGTATACCGATCAGGA 836) 2443 Table 3A Hs.73965 NM_003016 4506898splicing factor, arginine/serine-rich 2 1 CGGGCCTTGCATATAAATAACGGAGC(SFRS2), mRNA/cds = (155, 820) ATACAGTGAGCACATCTAGCTGAT 2444 Table 3AHs.14388 NM_003022 4506924 SH3 domain binding glutamic acid-rich 1AGAGATGCCTTTGTTTGATGAGATTC protein like (SH3BGRL), mRNA/AAACTTGATGCTATGCTTTAAAAT cds = (78, 422) 2445 Table 3A Hs.2554 NM_0030324506948 sialyltransferase 1 (beta-galactoside 1AGTCCCATTCTTCCTTTTCAATACCTA alpha-2,6-sialytransferase) (SIAT1),CCCCCAAATCTTCTCCTAACCCT mRNA/cds = (310, 1530) 2446 Table 3A Hs.323032NM_003035 4506956 TAL 1 (SCL) interrupting locus (SIL), 1TGTCACACTGGCTATCAAAGAATAAG mRNA/cds = (380, 4243)AAAATTATTGAGTATGAGTGTGTT 2447 Table 3A Hs.32970 NM_003037 4506968signaling lymphocytic activation 1 GCAAAACCCAGAAGCTAAAAAGT molecule(SLAM), mRNA/ CAATAAACAGAAAGAATGATTTT cds = (133, 1140) GAGA 2448 Table3A Hs.198296 NM_003070 4507068 SWI/SNF related, matrix associated, 1TTGTGACCAAATGGGCCTCAAAGATT actin dependent regulator of chromatin,CAGATTGAAACAAACAAAAAGCTT subfamily a, member 2 (SMARCA2), mRNA/cds =(297, 5015) 2449 Table 3A Hs.236030 NM_003075 4507080 SWI/SNF relatedmatrix associated, 1 AAGGTTCTATTAACCACTTCTAAGGG actin dependentregulator or chromatin, TACACCTCCCTCCAAACTACTGCA subfamily c, member 2(SMARCC2), mRNA/cds = (22, 3663) 2450 Table 3A Hs.79335 NM_0030764507082 SWI/SNF related, matrix associated, 1 GTTGTATCACCCCCGAGTTAGCATATactin dependent regulator of chromatin, CCCAGGCTCGCAGACTCAACACAGsubfamily d, member 1 (SMARCD1), mRNA/cds = (285, 1572) 2451 Table 3AHs.174051 NM_003089 4507118 small nuclear ribonucleoprotein 70 kD 1CCACTTGAGTTTGTCCTCCAAGGGTA polypeptide (RNP antigen) (SNRP70),GGTGTCTCATTTGTTCTGGCCCCT mRNA/cds = (680, 2524) 2452 Table 3A Hs.31121NM_003098 4507136 syntrophin, alpha 1 (dystrophin- 1TCCTGTCTCTCTCCTCCTTACTCTTG associated protein A1, 59 kD, acidicGATAAATAAACAGCCTGTGAGCAC component) (SNTA1), mRNA/ cds = (37, 1554) 2453Table 3A Hs.11183 NM_003100 4507140 sorting nexin 2 (SNX2), mRNA/ 1CCTGACCCTCTTTGAATTAAGTGGAC cds = (29, 1588) TGTGGCATGACATTCTGCAATACT2454 Table 3A Hs.92909 NM_003103 4507152 NREBP mRNA, complete cds/ 1TCTAAACTTTATTTTCAAAAGCTTAAG cds = (49, 7209) GCCCAAATACAAACTTCTCTGGA2455 Table 3A Hs.278571 NM_003105 6325473 sortilin-related receptor, L(DLR class) 1 CATGGTGATAGCCTGAAAGAGCTTTC A repeats-containing (SORL1),mRNA/ CTCACTAGAAACCAAATGGTGTAA cds = (197, 6841) 2456 Table 3A Hs.21293NM_003115 4507758 UDP-N-acetylglucosamine 1 GGAGAAGGATTAGAAAGTTATGTGGCpyrophosphorylase 1 (UAP1), mRNA/ AGATAAAGAATTCCATGCACCTCT cds = (0,1517) 2457 Table 3A Hs.71465 NM_003129 6806899 squalene epoxidase(SQLE), mRNA/ 1 ACAGTTTTTCTTTTGAATTTAGTATTT cds = (214, 1938)GAGATGAGTTGTTGGGACATGCA 2458 Table 3A Hs.300741 NM_003130 4507206 sorcin(SRI), mRNA/cds = (12, 608) 1 GATCTAGTCTGTTACACCATTTAGAACTTTCCTCAGCCATTATCAGTCAT 2459 Table 3A Hs.75975 NM_003133 4507216 signalrecognition particle 9 kD (SRP9), 1 AGCATGGTAAGTTCCCTTAGCTATAT mRNA/cds= (106, 366) GAATTTTGGCATGTTTCAGAGAGA 2460 Table 3A Hs.75761 NM_0031374507218 SFRS protein kinase 1 (SRPK1), 1 ACATTTTTATTCTTTCTACTGAGGGCAmRNA/cds = (108, 2075) TTGTCTGTTTTCTTTGTAAATGC 2461 Table 3A Hs.83715NM_003142 10835066 Sjogren syndrome antigen B 1AAAAGGAAAACCGAATTAGGTCCACT (autoantigen La) (SSB), mRNA/TCAATGTCCACCTGTGAGAAAGGA cds = (72, 1298) 2462 Table 3A Hs.250773NM_003144 6552340 signal sequence receptor, alpha 1CCTATCCCCGGATGTGTGAGAATAAT (translocon-associated protein alpha)GTGTTCATAAAGCATGGATCTCGT (SSR1), mRNA/cds = (111, 971) 2463 Table 3AHs.74564 NM_003145 6552341 signal sequence receptor, beta 1CCAGTGTCTATTCTGGGTTAGAGAAG (translocon-associated protein beta)TGCTTACTAAGGGGTTTTCTAATA (SSR2), mRNA/cds = (50, 601) 2464 Table 3AHs.321677 NM_003150 4507252 signal transducer and activator of 1GGGTGATCTGCTTTTATCTAAATGCA transcription 3 (acute-phase responseAATAAGGATGTGTTCTCTGAGACC factor) (STAT3), mRNA/ cds = (220, 2532) 2465Table 3A Hs.80642 NM_003151 4507254 signal transducer and activator of 1GGGAGTGTTGTGACTGAAATGCTTGA transcription 4 (STAT4), mRNA/AACCAAAGCTTCAGATAAACTTGC cds = (81, 2327) 2466 literature Hs.251664NM_003153 4507258 DNA for insulin-like growth factor II 1GAGCCAATCCACTCCTTCCTTTCTAT (IGF-2); exon 7 and additional ORF/CATTCCCCTGCCCACCTCCTTCCA cds = (0, 233) 2467 Table 3A Hs.70186 NM_0031694507312 suppressor of Ty (S. cerevisiae) 5 1 CTTCCTGTACCTCCTCCCCACAGCTThomolog (SUPT5H), mRNA/ GCTTTTGTTGTACCGTCTTTCAAT cds = (48, 3311) 2468Table 3A Hs.12303 NM_003170 11321572 suppressor of Ty (S. cerevisiae) 61 GCTGCTGCCACCGCTTCCTGCCTGT homolog (SUPT6H), mRNA/CATTTGAATAAACAGTGTTTCTATT cds = (1164, 5975) 2469 Table 3A Hs.106469NM_003171 4507314 suppressor of var1 (S. cerevisiae) 3- 1TGGGACTCATCCAAAAGGGACGAGA like 1 (SUPV3L1), mRNA/AGAAAGAAGAAGGAACCTGATTCGG cds = (0, 2360) 2470 Table 3A Hs.3196NM_003172 4507318 surfeit 1 (SURF1), mRNA/ 1 TCAAGACTGCCTTTATGCTGGATCATcds = (14, 916) GTGCTACTGGTATAAAGTTCTGGC 2471 Table 3A Hs.37938NM_003173 4507320 suppressor of variegation 3-9 1GTACACCCCTCAACCCTATGCAGCCT (Drosophila) homolog 1 (SUV39H1),GGAGTGGGCATCAATAAAATGAAC mRNA/cds = (45, 1283) 2472 literature Hs.74101NM_003177 4507328 spleen tyrosine kinase (SYK), mRNA/ 1CCATGAGACTGATCCCTGGCCACTGA cds = (148, 1986) AAAGCTTTCCTGACAATAAAAATG2473 Table 3A Hs.32675 NM_003193 6006029 tubulin-specific chaperone e(TBCE), 1 TTGGGAAGTGACCATTTCTAGGCTTA mRNA/cds = (80, 1663)TACATAATAGCAATAATAAAGGCT 2474 Table 3A Hs.171626 NM_003197 6006030transcription elongation factor B (SIII), 1 ATGTGGTAAAACCCAGAAAGCATCCApolypeptide 1-like (TCEB1L), mRNA/ TCATGAATGCAAGATACTTTCAAT cds = (101,592) 2475 Table 3A Hs.75133 NM_003201 4507400 transcription factor6-like 1 1 TTCACATTGTATTCAGAGTTGATGGTT (mitochrondrial transcriptionfactor 1- GTACATATAAGTGATTGCTGGTT like) (TCF6L1), mRNA/cds = (132, 872)2476 Table 3A Hs.169294 NM_003202 4507402 transcription factor 7 (T-cellspecific, 1 GCCACTGGTTTCTCAGAATCCAAAGA HMG-box) (TCF7), mRNA/TCACATATTCTAGTGTAACACTGC cds = (79, 885) 2477 Table 3A Hs.74637NM_003217 4507432 testis enhanced gene transcript 1CTGTGCTTTTTGCTTGGGATAATGGA (TEGT), mRNA/cds = (40, 753)GTTTTTCTTTAGAAACAGTGCCAA 2478 Table 3A Hs.77356 NM_003234 4507456transferrin receptor (p90, CD71) 1 TATCAGACTAGTGACAAGCTCCTGGT (TFRC),mRNA/cds = (263, 2545) CTTGAGATGTCTTCTCGTTAAGGA 2479 Table 3A Hs.79059NM_003243 4507470 transforming growth factor, beta 1AGGGCTTGAGGTGAATTTCATTAAAT receptor III (betaglycan, 300 kD)GGAATAATATGATGCCACTTTGCA (TGFBR3), mRNA/cds = (348, 2897) 2480 Table 3AHs.87409 NM_003246 4507484 thrombospondin 1 (THBS1), mRNA/ 1TTGACCTCCCATTTTTACTATTTGCCA cds = (111, 3623) ATACCTTTTTCTAGGAATGTGCT2481 Table 3A Hs.63668 NM_003264 4507528 toll-like receptor 2 (TLR2),mRNA/ 1 AGCGGGAAGGATTTTGGGTAAATCTG cds = (129, 2483)AGAGCTGCGATAAAGTCCTAGGTT 2482 Table 3A Hs.159239 NM_003266 4507532toll-like receptor 4 (TLR4), mRNA/ 1 TGATGTTTGATGGACCTATGAATCTA cds =(284, 2683) TTTAGGGAGACACAGATGGCTGGG 2483 Table 3A Hs.31130 NM_0032734507546 transmembrane 7 superfamily member 1 AGCCCTGAGGATGAACAACCTCAGA 2(TM7SF2), mRNA/cds = (254, 2023) GAAGAGGTGGTTTAGAGCAAGGAAA 2484 Table 3AHs.1117 NM_003291 4507656 tripeptidyl peptidase II (TPP2), mRNA/ 1AATAAATTTGCAAAACCAAGATCACA cds = (23, 3772) GTACACCATATGCACTCTGGTACC2485 Table 3A Hs.326456 NM_003295 4507668 hypothetical protein FLJ200301 TTTGGAGTGGAGGCATTGTTTTTAAG (FLJ20030), mRNA/cds = (1, 1239)AAAAACATGTCATGTAGGTTGTCT 2486 Table 3A Hs.5542 NM_003315 4507712tetratricopeptide repeat domain 2 1 GCGGGGGTGGACAGGGAGGCAGCTT (TTC2),mRNA/cds = (26, 1480) GTGAATTTTTGTTTTACTGTTTAAC 2487 Table 3A Hs.178551NM_003316 10835036 ribosomal protein L8 (RPL8), mRNA/ 1AACTTCAGATACTTGTGAACATGCCT cds = (43, 816) TATATTTGTCCAACAACTGTCAGA 2488Table 3A Hs.274401 NM_003321 4507732 mRNA; cDNA DKFZp434P086 (from 1GAAGGGTTGGCCTGCCTGGCTGGGG clone DKFZp434P086); partial cds/AGGTCAGTAAACTTTGAATAGTAAG cds = (798, 1574) 2489 literature Hs.129780NM_003327 4507578 tumor necrosis factor receptor 1AAGATGTACCCTTCAGGTGAACCTGG superfamily, member 4 (TNFRSF4),TATCAGACCCACAGTACTTGCTGT mRNA/cds = (5, 838) 2490 Table 3A Hs.29877NM_003328 4507742 TXK tyrosine kinase (TXK), mRNA/ 1AGCAAGATAGCCAAATGTGACATCAA cds = (86, 1669) GCTCCATTGTTTCGGAAATCCAGG2491 Table 3A Hs.13046 NM_003330 4507746 thioredoxin reductase 1(TXNRD1), 1 AGTGGAATGTTCTATCCCCACAAGAA mRNA/cds = (439, 1932)GGATTATATCTTATAGACTTGTCT 2492 Table 3A Hs.5308 NM_003333 4507760ubiquitin A-52 residue ribosomal 1 CCCGTGGCCCTGGAGCCTCAATAAA proteinfusion product 1 (UBA52), GTGTCCCTTTCATTGACTGGAGCAG mRNA/cds = (37, 423)2493 Table 3A Hs.80612 NM_003338 4507768 ubiquitin-conjugating enzymeE2A 1 TTATGCATTTATCACTTCCAAATCTAA (RAD6 homolog) (UBE2A), mRNA/CTTTGCACAAGTAACCCATGTAA cds = (120, 578) 2494 Table 3A Hs.811 NM_0033374507770 ubiquitin-conjugating enzyme E2B 1 TCCGCACTATATAATTCGCACACATT(RAD6 homolog) (UBE28), mRNA/ AATTAGGGTTTATGTACCATACAA cds = (421, 879)2495 literature Hs.75355 NM_003348 4507792 ubiquitin-conjugating enzymeE2N 1 GCTTGTGACCATTTTGTATGGCTTGT (homologous to yeast UBC13)CTGGAAACTTCTGTAAATCTTATG (UBE2N), mRNA/cds = (63, 521) 2496 Table 3AHs.283667 NM_003349 12025659 arginyl aminopeptidase 1TGCTGATTTATGCAAAGGGCTGGCAT (aminopeptidase B) (RNPEP), mRNA/TCTGATGCTTTTCAGGTTTAATCC cds = (9, 1982) 2497 literature Hs.79300NM_003350 12025664 ubiquitin-conjugating enzyme E2 1TGCATTCTGGCAGTTCTTTTAGGATT variant 2 (UBE2V2), mRNA/ATAGGTTGCAAATTATCCAAATAT cds = (21, 458) 2498 Table 3A Hs.80658NM_003355 13259540 uncoupling protein 2 (mitochondrial, 1CCGACAGCCCAGCCTAGCCCACTTG proton carrier) (UCP2), nuclear geneTCATCCATAAAGCAAGCTCAACCTT encoding mitochondrial protein, mRNA/ cds =(380, 1309) 2499 literature Hs.78853 NM_003362 6224978 uracil-DNAglycosylase (UNG), 1 TTTGCTGTTAGTCGGGTTAGAGTTGG mRNA/cds = (106, 1020)CTCTACGCGAGGTTTGTTAATAAA 2500 Table 3A Hs.77500 NM_003363 4507852ubiquitin specific protease 4 (proto- 1 CAGACTGCTAGTGTTCTGTCTAAAAAoncogene) (USP4), mRNA/ CCAGACAAGGAAATACCCTTCTTT cds = (3, 2894) 2501literature Hs.173554 NM_003366 4507842 ubiquinol-cytochrome c reductasecore 1 TTTTCCAGTGAGGTAAAATAAGGCAT protein II (UQCRC2), mRNA/AAATGCAGGTAATTATTCCCAGCT cds = (53, 1414) 2502 Table 3A Hs.93649NM_003367 4507846 upstream transcription factor 2, c-fos 1CCGGCACTTCTAGTGGTCTCACCTGG interacting (USF2), mRNA/AGGCAAGAGGGAGGGTACAGAGCC cds = (0, 1040) 2503 Table 3A Hs.284192NM_003374 4507878 clone HQ0072/cds = UNKNOWN 1TTTAGAGTCTTCCATTTTGTTGGAATT AGATCCTCCCCTTCAAATGCTGT 2504 Table 3AHs.155191 NM_003379 9257254 villin 2 (ezrin) (VIL2), mRNA/ 1TTCTCCTTCACAGCTAAGATGCCATG cds = (117, 1877) TGCAGGTGGATTCCATGCCGCAGA2505 Table 3A Hs.297753 NM_003380 4507894 vimentin (VIM), mRNA/ 1TTTCCAGCAAGTATCCAACCAACTTG cds = (122, 1522) GTTCTGCTTTCAATAAATCTTTGGA2506 Table 3A Hs.24143 NM_003387 8400739 Wiskott-Aldrich syndromeprotein 1 ATGACTTGCATCCCAGCTTTCCACCA interacting protein (WASPIP), mRNA/ACCAAATTCAAACATTCACTGCTT cds = (108, 1619) 2507 literature Hs.150930NM_003401 12408643 X-ray repair complementing defective 1TGTATGAGACTTTTTGTTGCAAAGGA repair in Chinese hamster cells 4CACATTTATCATATTCATTCACAC (XRCC4), transcript variant 3, mRNA/ cds =(175, 1179) 2508 Table 3A Hs.279920 NM_003404 4507948 tyrosine3-monooxygenase/tryptophan 1 TGATCTGTCCAGTGTCACTCTGTACC 5-monooxygenaseactivation protein, CTCAACATATATCCCTTGTGCGAT beta polypeptide (YWHAB),mRNA/ cds = (372, 1112) 2509 Table 3A Hs.75544 NM_003405 4507950tyrosine 3-monooxygenase/tryptophan 1 AATTCACCCCTCCCACCTCTTTCTTC5-monooxygenase activation protein, AATTAATGGAAAAGCGTTAAGGGA etapolypeptide (YWHAH), mRNA/ cds = (200, 940) 2510 Table 3A Hs.75103NM_003406 4507952 tyrosine 3-monooxygenase/tryptophan 1CTCAGTACTTTGCAGAAAACACCAAA 5-monooxygenase activation protein,CAAAAATGCCATTTTAAAAAAGGT zeta polypeptide (YWHAZ), mRNA/ cds = (84, 621)2511 Table 3A Hs.55481 NM_003447 4508000 ainc finger protein 165(ZNF165), 1 AGCCTTCAGTCAGAGCTCAAACCTTA mRNA/cds = (587, 2024)GTCAACACCAGAGAATTCACATGA 2512 Table 3A Hs.88219 NM_003454 4508012 zincfinger protein 200 (ZNF200), 1 AACCCTCTAAGAATACCTGTTTAAGT mRNA/cds =(239, 1423) CTTGAGTGTTGAAAGGAATTGTTT 2513 Table 3A Hs.62112 NM_0034574508018 zinc finger protein 207 (ZNF207), 1 CCACTGCCTGAAAGGTTTGTACAGATmRNA/cds = (202, 1638) GCATGCCACAGTAGATGTCCACAT 2514 Table 3A Hs.89414NM_003467 4503174 chemokine (C-X-C motif), receptor 4 1TCAGGAGTGGGTTGATTTCAGCACCT (fusin) (CXCR4), mRNA/ACAGTGTACAGTCTTGTATTAAGT cds = (88, 1146) 2515 Table 3A Hs.78683NM_003470 4507856 ubiquitin specific protease 7 (herpes 1CCTTCAGTTATACTTTCAATGACCTTT virus-associated) (USP7), mRNA/TGTGCATCTGTTAAGGCAAAACA cds = (199, 3507) 2516 Table 3A Hs.110713NM_003472 4503248 DEK oncogene (DNA binding) (DEK), 1AAGTGAACAAAATAAGCAACTAAATG mRNA/cds = (33, 1160)AGACCTAATAATTGGCCTTCGATT 2517 Table 3A Hs.155017 NM_003489 4505454nuclear receptor interacting protein 1 1 CACAACCAAATTTGATGCGATCTGCT(NRIP1), mRNA/cds = (287, 3763) CAGTAATATAATTTGCCATTTTTA 2518 Table 3AHs.28777 NM_003512 4504244 H2A histone family, member L 1ACATTGTAATAGAAACAGATTTCCCA (H2AFL), mRNA/cds = (97, 489)AATTCCAGCCTGGCATGAGGTAAT 2519 literature Hs.2178 NM_003528 4504276 H2Bhistone family, member Q 1 CAGACTGAATAGATCTTAACTGTCTC (H2BFQ), mRNA/cds= (42, 422) CTACATGTGTGTTTTCAAATGTGT 2520 Table 3A Hs.278571 NM_0035634507182 sortilin-related receptor, L (DLR class) 1GATATCCCAGCGGTGGTACTTCGGA A repeats-containing (SQRL1), mRNA/GACACCTGTCTGCATCTGACTGAGC cds = (197, 6841) 2521 Table 3A Hs.2864NM_003566 4503488 early endosome antigen 1, 162 kD 1ACACTTTCCTCTGCCTTTTTCTCTTAT (EEA1), mRNA/cds = (136, 4368)ATGTGGGTTCATGGTTCAGTTCG 2522 Table 3A Hs.9006 NM_003574 4507866 VAMP(vesicle-associated membrane 1 AGATAATGTCACCAGTCCTCTTCCTTprotein)-associated protein A (33 kD) CACTTCTTGTTGTAATTGCAGCCA (VAPA),mRNA/cds = (0, 728) 2523 literature Hs.66718 NM_003579 4506396 RAD54 (S.cerevisiae)-like (RAD54L), 1 CCGGCACACAGGGACTAGGTCTAGT mRNA/cds = (100,2343) GAGAACATCAGGAGCAGCGAGGGAT 2524 Table 3A Hs.78687 NM_003580 4505484neutral sphingomyelinase (N-SMase) 1 CATCGGGTTTTGGGTGTGTGTTTTCAactivation associated factor (NSMAF), TAGCGTGGTTACTTTCTATAATGC mRNA/cds= (12, 2765) 2525 Table 3A Hs.14611 NM_003584 4503414 dual specificityphosphatase 11 1 ATGTATTTCTTTCTGACTAGACTTGTG (RNA/RNP complex1-interacting) ATATGCGTGTGTTTATGTACAGA (DUSP11), mRNA/cds = (124, 1116)2526 Table 3A Hs.155976 NM_003588 13270466 cullin 4B (CUL4B), mRNA/ 1GTTCTGTATCAGTTGAATTTTTGTGCT cds = (78, 2231) CTTTTCCCTGTGTACGTGGTGGT2527 Table 3A Hs.183874 NM_003589 11140810 cullin 4A (CUL4A), mRNA/ 1CATTTATGAGTTCCATGATATGTGGT cds = (160, 2139) CTAAGAAAGACCAAACAGATTTCT2528 Table 3A Hs.82919 NM_003591 4503162 cullin 2 (CUL2), mRNA/ 1AAATCGGTTGGGTACCATGCTTTTTC cds = (146, 2383) TCCCCTTCACGTTTGCAGTTGATG2529 Table 3A Hs.14541 NM_003592 4503160 cullin 1 (CUL1), mRNA/ 1GTTCATGTTGGAAAGAATGAAAACAA cds = (124, 2382) CTTCAAGTTCATAGGCAGCCAGCC2530 Table 3A Hs.9456 NM_003601 4507074 SWI/SNF related, matrixassociated, 1 TGTCATTTAAAGACATCAGGTTCATCT actin dependent regulator ofchromatin, GTTTACTGAGCTAGAAACATAGT subfamily a, member 5 (SMARCA5),mRNA/cds = (202, 3360) 2531 Table 3A Hs.100293 NM_003605 6006036O-linked N-acetylglucosamine 1 ATCTGGTGCCAAATGAAGATTTTTAG (GlcNAc)transferase (UDP-N- GAGTGATTACTAATTATCAAGGGCacetylglucosamine:polypeptide-N- acetylglucosaminyl transferase) (OGT),mRNA/cds = (2039, 4801) 2532 Table 3A Hs.131924 NM_003608 4507420 Gprotein-coupled receptor 65 1 TTCTGCACTGGGAGGTGTAATACATC (GPR65),mRNA/cds = (0, 1013) ACAAAGACAAAGAAAACGCATACT 2533 Table 3A Hs.104925NM_003633 4505460 ectodermal-neural cortex (with BTB- 1AGTTGAAGGAAAATGTTCATGTTCAT like domain) (ENC1), mRNA/ATGTACTTGTTTGCTATGACTACA cds = (399, 2166) 2534 db mining Hs.323879NM_003639 4504630 cDNA FLJ20588 fis, clone KAT09466, 1CACTGGGGAAGTCAAGAATGGGGCC highly similar to AF091453 NEMOTGGGGCTCTCAGGGAGAACTGCTTC protein/cds = UNKNOWN 2535 Table 3A Hs.146360NM_003641 4504580 interferon induced transmembrane 1CCCTAGATACAGCAGTTTATACCCAC protein 1 (9-27) (IFITM1), mRNA/ACACCTGTCTACAGTGTCATTCAA cds = (110, 487) 2536 Table 3A Hs.167218NM_003658 6633797 BarH-like homeobox 2 (BARX2), 1GAAAGTGCTTAGCTCTCTCCCTCCTG mRNA/cds = (96, 935) ACCTCTGGGCAGCCAGTCATCAAA2537 Table 3A Hs.155172 NM_003664 4501974 adaptor-related proteincomplex 3, 1 ATCATGTATGCAATACTTTCCCCCTTT beta 1 subunit (AP3B1), mRNA/TTGCTTTGCTAACCAAAGAGCAT cds = (53, 3334) 2538 Table 3A Hs.239307NM_003680 4507946 tyrosyl-tRNA synthetase (YARS), 1CTGCTGTCTCTTCAGTCTGCTCCATC mRNA/cds = (0, 1586) CATCACCCATTTACCCATCTCTCA2539 Table 3A Hs.82548 NM_003882 4505070 MAP-kinase activating deathdomain 1 TATAGAAAATGTACAGTTGTGTGAAT (MADD), mRNA/cds = (325, 5091)GTGAAATAAATGTCCTCAACTCCC 2540 literature Hs.47504 NM_003688 4504368exonuclease 1 (EXO1), mRNA/ 1 GGCCGTGTTCAAAGAGCAATATTCCA cds = (218,2629) GTAAATGCAGACTGCTGCAAAGCT 2541 Table 3A Hs.18571 NM_003690 4505580protein kinase, interferon-inducible 1 AGCTGCTGACTTGACTGTCATCCTGT doublestranded RNA dependent TCTTGTTAGCCATTGTGAATAAGA activator (PRKRA), mRNA/cds = (96, 1037) 2542 db mining Hs.296776 NM_003721 4506498 regulatoryfactor X-associated ankyrin- 1 GAACTGACTTCAAAGGCAGCTTCTGG containingprotein (RFXANK), mRNA/ ACAGGTGGTGGGAGGGACCCTTC cds = (417, 1199) 2543Table 3A Hs.118633 NM_003733 11321576 2′-5′oligoadenylatesynthetase-like 1 GGAGAGGCTCTGTTTCCAGCCAGTTA (OASL), mRNA/cds = (6,1550) GTTTTCTCTGGGAGACTTCTCTGT 2544 Table 3A Hs.5120 NM_003748 4505812dynein, cytoplasmic, light polypeptide 1 TTTCTATTCCATACTTCTGCCCACGTT(PIN), mRNA/cds = (93, 362) GTTTTCTCTCAAAATCCATTCCT 2545 Table 3AHs.57783 NM_003751 4503528 eukaryotic translation initiation factor 3, 1CCTGTACACAGCCGAGCAGCATTTCC subunit 9 (eta, 116 kD) (EIF3S9),GTTGAAGGACTTGCATCCCCATTG mRNA/cds = (53, 2674) 2546 Table 3A Hs.57973NM_003753 4503522 caspase recruitment domain protein 1TTGATGCTTAGTGGAATGTGTGTCTA 10 mRNA, complete cds/ACTTGCTCTCTGACATTTAGCAGA cds = (40, 3138) 2547 Table 3A Hs.58189NM_003756 4503514 eukaryotic translation initiation factor 3, 1AAGAAGTTAACATGAACTCTTGAAGT subunit 3 (gamma, 40 kD) (EIF3S3),CACACCAGGGCAACTCTTGGAAGA mRNA/cds = (5, 1063) 2548 Table 3A Hs.192023NM_003757 4503512 eukaryotic translation initiation factor 3, 1GGTGGATCTCCAACCAGGCCAGAGA subunit 2 (beta, 36 kD) (EIF3S2),AGATTCTCACAGAAGGTTTTGAACT mRNA/cds = (17, 994) 2549 Table 3A Hs.172684NM_003761 14043025 vesicle-associated membrane protein 1GGCTGGGAAACTGTTGGTGGCCAGT 8 (endobrevin) (VAMP8), mRNA/GGGTAATAAAGACCTTTCAGTATCC cds = (53, 355) 2550 Table 3A Hs.77608NM_003769 4506902 splicing factor, arginine/serine-rich 9 1GGTTCGCTCTACTATGGAGATCAACA (SFRS9), mRNA/cds = (52, 717)GTTACTGTGACTGAGTCGGCCCAT 2551 db mining Hs.89862 NM_003789 13378136TNFRSF1A-associated via death 1 GCTCACACTCAGCGTGGGACCCCGA domain(TRADD), mRNA/ ATGTTAAGCAATGATAATAAAGTAT cds = (66, 1004) 2552 db miningHs.251216 NM_003790 4507568 hypothetical protein DKFZp434A196 1CTGCTCGFCCCCTATCGCTCCAGCCAA (DKFZP434A196), mRNA/GGCGAAGAAGCACGAACGAATGTC cds = (168, 2732) 2553 Table 3A Hs.75890NM_003791 4506774 membrane-bound transcription factor 1ACCTGCCACCATGTTTTGTAATTTGA protease, site 1 (MBTPS1), mRNA/GGTCTTGATTTCACCATTGTCGGT cds = (496, 3654) 2554 Table 3A Hs.7943NM_003796 4506542 RPB5-mediating protein (RMP), 1AACGAAAGGAAGTTCTGTTGGAAGCA mRNA/cds = (465, 1991)TCTGAAGAAACTGGAAAGAGGGTT 2555 db mining Hs.155566 NM_003805 4503030CASP2 and RIPK1 domain containing 1 ACATTTACCTGAATGTTGTCTGAGGA adaptorwith death domain (CRADD), CTGAACTGTGGACTTTACTATTCA mRNA/cds = (37, 636)2556 Table 3A Hs.87247 NM_003806 4504492 harakiri, BCL2-interactingprotein 1 AAATCCAGCTGCAGAAACAGACACCC (contains only BH3 domain) (HRK),CAATGCTATTTACATACAGCTCTA mRNA/cds = (120, 395) 2557 literature Hs.54673NM_003808 4507598 tumor necrosis factor (ligand) 1CCCCGTTCCTCAGTTTTCCCTTTTCAT superfamily, member 13 (TNFSF13),TCCCACCCCCTAGACTTTGATTT mRNA/cds = (281, 1033) 2558 literature Hs.26401NM_003809 4507596 tumor necrosis factor (ligand) 1TTCAGGCACTAAGAGGGGCTGGACC superfamily, member 12 (TNFSF12),TGGCGGCAGGAAGCCAAAGAGACTG mRNA/cds = (17, 768) 2559 literature Hs.83429NM_003810 4507592 tumor necrosis factor (ligand) 1CGCAACAATCCATCTCTCAAGTAGTG superfamily, member 10 (TNFSF10),TATCACAGTAGTAGCCTCCAGGTT mRNA/cds = (87, 932) 2560 literature Hs.1524NM_003811 4507608 tumor necrosis factor (ligand) 1CCCAGGCTAGGGGGCTATAGAAACA superfamily, member 9 (TNFSF9),TCTAGAAATAGACTGAAAGAAAATC mRNA/cds = (3, 767) 2561 Table 3A Hs.2442NM_003816 4501914 a disintegrin and metalloproteinase 1ACCTACAAAAAAGTTACTGTGGTATC domain 9 (meltrin gamma) (ADAM9),TATGAGTTATCATCTTAGCTGTGT mRNA/cds = (78, 2537) 2562 literature Hs.279899NM_003820 4507570 tumor necrosis factor receptor 1TGGTGTTTAGTGGATACCACATCGGA superfamily, member 14 (herpesvirusAGTGATTTTCTAAATTGGATTTGA entry mediator) (TNFRSF14), mRNA/ cds = (293,1144) 2563 db mining Hs.86131 NM_003824 4505228 Fas (TNFRSF6)-associatedvia death 1 TCACTATCTTTCTGATAACAGAATTGC domain (FADD), mRNA/cds = (129,CAAGGCAGCGGGATCTCGTATCT 755) 2564 literature Hs.114676 NM_003839 4507564tumor necrosis factor receptor 1 GAAAAGATGGAGAAAATGAACAG superfamily,member 11a, activator of GACATGGGGCTCCTGGAAAGAAA NFKB (TNFRSF11A), mRNA/GGGC cds = (38, 1888) 2565 literature Hs.129844 NM_003840 4507562 tumornecrosis factor receptor 1 GTGGTTTTAGGATGTCATTCTTTGCA superfamily,member 10d, decoy with GTTCTTCATCATGAGACAAGTCTT truncated death domain(TNFRSF10D), mRNA/cds = (82, 1242) 2566 literature Hs.119664 NM_00384110835042 tumor necrosis factor receptor 1 AAGGGTGAGGATGAGAAGTGGTCACsuperfamily, member 10c, decoy GGGATTTATTCAGCCTTGGTCAGAG without anintracellular domain (TNFRSF10C), mRNA/cds = (29, 928) 2567 literatureHs.249190 NM_003844 4507558 tumor necrosis factor receptor 1GAGAAGATTCAGGACCTCTTGGTGGA superfamily, member 10aCTCTGGAAAGTTCATCTACTTAGA (TNFRSF10A), mRNA/cds = (0, 1406) 2568 Table 3AHs.7043 NM_003849 11321580 succinate-CoA ligase, GDP-forming, 1AGTACAACTGGAAGCCAAAACA alpha subunit (SUCLG1), mRNA/AGGTGGAAGATGTCCTGAATTAAG cds = (31, 1032) ACGT 2569 Table 3A Hs.5085NM_003859 4503362 dolichyl-phosphate 1 GTTGCTGGCCTAATGAGCAATGTTCTmannosyltransferase polypeptide 1, CAATTTTCGTTTTCATTTTGCTGT catalyticsubunit (DPM1), mRNA/ cds = (0, 782) 2570 Table 3A Hs.153687 NM_0038664504706 inositol polyphosphate-4-phosphatase, 1ACAGACCTCCAGAGGGGACTTATGG type II, 105 kD (INPP4B), mRNA/AAAAGCTGACACCTAAGTTTACCAA cds = (121, 2895) 2571 Table 3A Hs.1742NM_003870 4506786 IQ motif containing GTPase activating 1TGAATTTACTTCCTCCCAAGAGTTTG protein 1 (IQGAP1), mRNA/GACTGCCCGTCAGATTGTTTCTGC cds = (467, 5440) 2572 Table 3A Hs.279789NM_003883 13128861 histone deacetylase 3 (HDAC3), 1TGGCTTTATGTCCATTTTACCACTGTT mRNA/cds = (55, 1341)TTTATCCAATAAACTAAGTCGGT 2573 Table 3A Hs.76095 NM_003897 4503326immediate early response 3 (IER3), 1 GCTGTCACGGAGCGACTGTCGAGAT mRNA/cds= (11, 481) CGCCTAGTATGTTCTGTGAACACAA 2574 Table 3A Hs.7165 NM_0039044508020 zinc finger protein 259 (ZNF259), 1 CCTTTAAGGTTGGAACTTTGAAGTTGmRNA/cds = (28, 1407) GAGAAGGTGGAATAAAGTTACACC 2575 Table 3A Hs.61828NM_003905 4502168 amyloid beta precursor protein-binding 1TGCCTTCGGGTTGTGCTTTAGTCTGT protein 1, 59 kD (APPBP1), mRNA/AAAATTCTAAAGGAGAGCTGCTAA cds = (73, 1677) 2576 Table 3A Hs.8991NM_003917 4503842 adaptor-related protein complex 1, 1GCAAAAACCTGGGACCAGCCCCCTT gamma 2 subunit (AP1G2), mRNA/CTCCCACAAATAAAGCCCAATAAAG cds = (45, 2402) 2577 Table 3A Hs.58589NM_003918 5453673 glycogenin 2 (GYG2), mRNA/ 1 GTCATCGGCTTTCAGAGGGAGACCAcds = (283, 1788) CGGGAATGTTCAGGGAAACAATGTC 2578 Table 3A Hs.306359NM_003922 4557025 clone 25038 mRNA sequence/ 1TGAATTGCCTGTTCAGGGTTCCTTAT cds = UNKNOWN GCAGAGAAATAAAGCAGATTCAGG 2579literature Hs.35947 NM_003925 4505120 methyl-CpG binding domain protein4 1 ACCAACCACCTTTCCAGCCATAGAGA (MBD4), mRNA/cds = (176, 1918)TTTTAATTAGCCCAACTAGAAGCC 2580 literature Hs.194685 NM_003935 4507634topoisomerase (DNA) III beta 1 CTACTTTGTATGATGACCCTGTCCTC (TOP3B),mRNA/cds = (113, 2701) CCTCACCCAGGCTGCAGTGCCATG 2581 Table 3A Hs.169139NM_003937 4504936 kynureninase (L-kynurenine hydrolase) 1AAAGAGGAGTGGTTTGTGACAAGCG (KYNU), mRNA/cds = (106, 1503)GAATCCAAATGGCATTCGAGTGGCT 2582 Table 3A Hs.24322 NM_003945 4502318ATPase, H+ transporting, lysosomal 1 GAAGAGCCATCTCAACAGAATCGCAC(vacuolar proton pump) 9 kD (ATP6H), CAAACTATACTTTCAGGATGAATT mRNA/cds =(62, 307) 2583 Table 3A Hs.47007 NM_003954 4505396 mitogen-activatedprotein kinase 1 TCTGGGTTGTAGAGAACTCTTTGTAA kinase kinase 14 (MAP3K14),mRNA/ GCAATAAAGTTTGGGGTGATGACA cds = (232, 3075) 2584 literatureHs.24439 NM_003958 4504868 ring finger protein (C3HC4 type) 8 1CTGCTGTCCACTTTCCTTCAGGCTCT (RNF8), mRNA/cds = (112, 1569)GTGAATACTTCAACCTGCTGTGAT 2585 Table 3A Hs.108371 NM_003973 4506600 E2Ftranscription factor 4, p107/p130- 1 GCACCTGCTCCAAAGGCATCTGGCA binding(E2F4), mRNA/cds = (62, AGAAAGCATAAGTGGCAATCATAAA 1303) 2586 Table 3AHs.10315 NM_003983 4507052 solute carrier family 7 (cationic amino 1CTCCTTTTAACGTGTTATTGACAAACC acid transporter, y+ system), member 6TCCCCAAAAGAATATGCAATTGT (SLC7A6), mRNA/cds = (261, 1808) 2587 Table 3AHs.339840 NM_003992 4502884 Homo sapiens, clone MGC:16360 1AGCTGCCAGAAAGCACAGATTTGACC IMAGE:3927645, mRNA, completeCAAGCTATTTATATGTTATAAAGT cds/cds = (561, 731) 2588 Table 3A Hs.83426NM_003998 10835176 nuclear factor of kappa light 1AGCTGCTGCTGGATCACAGCTGCTTT polypeptide gene enhancer in B-cells 1CTGTTGTCATTGCTGTTGTCCCTC (p105) (NFKB1), mRNA/ cds = (397, 3303) 2589literature Hs.278443 NM_004001 4557021 Fc fragment of IgG, low affinityIIb, 1 GATGAGGCTGACAAAGTTGGGGCTG receptor for (CD32) (FCGR2B),AGAACACAATCACCTATTCACTTCT mRNA/cds = (0, 875) 2590 Table 3A Hs.12068NM_004003 4755131 carnitine acetyltransferase (CRAT), 1TCCTGCCCCCGCCCTGCTGTATGATA nuclear gene encoding mitochondrialTTAATGTGGAAGGTCATCAATAAA protein, transcript variant peroxisomal,mRNA/cds = (296, 2113) 2591 Table 3A Hs.169470 NM_004010 5032314dystrophin (muscular dystrophy, 1 AAACTGTAAATCATAATGTAACTGAA Duchenneand Becker types), includes GCATAAACATCACATGGCATGTTT DXS142, DXS164,DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272 (DMD), transcriptvariant Dp427p2, mRNA/cds = (702, 11390) 2592 Table 3A Hs.460 NM_0040244755127 activating transcription factor 3 (ATF3), 1ACAAGGACGCTGGCTACTGTCTATTA mRNA/cds = (164, 520)AAATTCTGATGTTTCTGTGAAATT 2593 Table 3A Hs.186120 NM_004031 4809287interferon regulatory factor 7 (IRF7), 1 CTTCCTTATGGAGCTGGAGCAGCCCtranscript variant d, mRNA/ GCCTAGAACCCAGTCTAATGAGAAC cds = (335, 1885)2594 Table 3A Hs.78637 NM_004034 4809278 annexin A7 (ANXA7), transcriptvariant 1 TGCATCTCATTTTGCCTAAATTGGTTC 2, mRNA/cds = (60, 1526)TGTATTCATAAACACTTTCCACA 2595 Table 3A Hs.217493 NM_004039 4757755annexin A2 (ANXA2), mRNA/ 1 AGTGAAGTCTATGATGTGAAACACTT cds = (49, 1088)TGCCTCCTGTGTACTGTGTCATAA 2596 Table 3A Hs.227817 NM_004049 14574570BCL2-related protein A1 (BCL2A1), 1 TTGATGATGTAACTTGACCTTCCAGA mRNA/cds= (183, 710) GTTATGGAAATTTTGTCCCCATGT 2597 Table 3A Hs.155935 NM_0040544757887 complement component 3a receptor 1 1 AGCTCACACGTTCCACCCACTGTCCC(C3AR1), mRNA/cds = (0, 1448) TCAAACAATGTCATTTCAGAAAGA 2598 Table 3AHs.153640 NM_004073 4758015 cytokine-inducible kinase (CNK), 1GGACCACTTTTATTTATTGTCAGACA mRNA/cds = (38, 1859)CTTATTTATTGGGATGTGAGCCCC 2599 Table 3A Hs.108080 NM_004078 4758085cysteine and glycine-rich protein I 1 GGGCTGTACCCAAGCTGATTTCTCAT(CSRP1), mRNA/cds = (54, 635) CTGGTCAATAAAGCTGTTTAGACC 2600 literatureHs.78394 NM_004092 12707569 enoyl Coenzyme A hydratase, short 1GCTCTGAGGGAAACGCTGTCTGCTG chain, 1, mitochondrial (ECHS1),CCTTCATACAGATGCTGATTAAAGT nuclear gene encoding mitochondrial protein,mRNA/cds = (71, 943) 2601 literature Hs.4756 NM_004111 6325465chromosome 11, BAC CIT-HSP-311e8 1 TTTTAGCTCAGGAAAATATGTCAGGC (BC269730)containing the hFEN1 TCAAACCACTTCTCAGGCAGTTTA gene/cds = (2644, 3786)2602 Table 3A Hs.171862 NM_004120 6996011 guanylate binding protein 2,interferon- 1 TTGTTGAACCATAAAGTTTGCAAAGT inducible (GBP2), mRNA/AAGGTTAAGTATGAGGTCAATGT cds = (156, 1931) 2603 Table 3A Hs.284265NM_004124 4758441 pRGR1 mRNA, partial cds/ 1 TGTGGTTTCAGTCTCTGCTAGTTCATcds = (0, 538) ATTGCATGTTTATTTTGGACAGTC 2604 Table 3A Hs.3069 NM_0041344758569 heat shock 70 kD protein 9B (mortalin- 1AGCAGAAATTTTGAAGCCAGAAGGAC 2) (HSPA9B), mRNA/cds = (29, 2068)AACATATGAAGCTTAGGAGTGAAG 2605 Table 3A Hs.80350 NM_004156 4758951protein phosphatase 2 (formerly 2A), 1 ACTGCTTCATCTCCTTTTGCGCTTATTcatalytic subunit, beta isoform TGGAAATTTTAGTTATAGTGTTT (PPP2CB),mRNA/cds = (21, 950) 2606 Table 3A Hs.180062 NM_004159 4758969proteasome (prosome, macropain) 1 GAGAGAGTACGGGCTCAGCAGCCAG subunit,beta type 8 (large AGGAGGCCGGTGAAGTGCATCTTCT multifunctional protease 7)(PSMB8), mRNA/cds = (220, 1038) 2607 Table 3A Hs.272493 NM_00416614589962 small inducible cytokine subfamily A 1CCCAGTCACCCTCTTGGAGCTTCCCT (Cys—Cys) member 15 (SCYA15),GCTTTGAATTAAAGACCACTCATG transcript variant 2, mRNA/ cds = (474, 815)2608 Table 3A Hs.272493 NM_004167 14602450 small inducible cytokinesubfamily A 1 CCCAGTCACCCTCTTGGAGCTTCCCT (Cys—Cys), member 15 (SCYA15),GCTTTGAATTAAAGACCACTCATG transcript variant 2, mRNA/ cds = (474, 815)2609 Table 3A Hs.469 NM_004168 4759079 succinate dehydrogenase complex,1 GGAGCGTGGCACTTACCTTTGTCCCT subunit A, flavoprotein (Fp) (SDHA),TGCTTCATTCTTGTGAGATGATAA nuclear gene encoding mitochondrial protein,mRNA/cds = (24, 2018) 2610 Table 3A Hs.75379 NM_004172 4759125 solutecarrier family 1 (glial high 1 GCATACACATGCACTCAGTGTGGACT affinityglutamate transporter), member GGGAAGCATTACTTTGTAGATGTA 3 (SLC1A3),nuclear gene encoding mitochondrial protein, mRNA/ cds = (178, 1806)2611 Table 3A Hs.172791 NM_004182 4759297 ubiquitously-expressedtranscript 1 AAGCCTCACCATTGACTTCTTCCCCC (UXT), mRNA/cds = (56, 529)CATCCTCAGACATTAAAGAGCCTG 2612 literature Hs.212680 NM_004195 4759245tumor necrosis factor receptor 1 CTGACCTCGGCCCAGCTTGGACTGC superfamily,member 18 (TNFRSF18), ACATCTGGCAGCTGAGGAGTCAGTG mRNA/cds = (0, 725) 2613Table 3A Hs.18720 NM_004208 4757731 programmed cell death 8 (apoptosis-1 GGAAGATCATTAAGGACGGTGAGCA inducing factor) (PDCD8), mRNA/GCATGAAGATCTCAATGAAGTAGCC cds = (42, 1883) 2614 Table 3A Hs.79197NM_004233 4757945 CD83 antigen (activated B 1TTACCTCTGTCTTGGCTTTCATGTTAT lymphocytes, immunoglobulinTAAACGTATGCATGTGAAGAAGG superfamily) (CD83), mRNA/ cds = (41, 858) 2615RG Hs.6566 NM_004237 11321608 thyroid hormone receptor interactor 13 1AGTTACTGGTCTCTTTCTGCCGAATG house- (TRIP13), mRNA/cds = (45, 1343)TTATGTTTTGCTTTTATCTCACAG keeping genes 2616 Table 3A Hs.85092 NM_00423910863904 thyroid hormone receptor interactor 11 1CACAAAGTGGCCTTTGGGGAGAAAG (TRIP11), mRNA/cds = (356, 6295)TCATGTATTTGTTCGCAATTATGCT 2617 Table 3A Hs.151787 NM_004247 4759279 U5snRNP-specific protein, 116 kD 1 ATTTACTCCAAGTCCTCTCCCCAGCT (U5-116 KD),mRNA/cds = (60, 2978) ACCACCAGTCCCTTACTCTGTTCT 2618 Table 3A Hs.184276NM_004252 4759139 solute carrier family 9 1 GCCCATCCCTGAGCCAGGTACCACC(sodium/hydrogen exchanger), isoform ATTGTAAGGAAACACTTTCAGAAAT 3regulatory factor 1 (SLC9A3R1), mRNA/cds = (212, 1288) 2619 literatureHs.31442 NM_004260 4759029 RecQ protein-like 4 (RECQL4), 1AGGACCGACGCTTCTGGAGAAAATAC mRNA/cds = (0, 3626) CTGCACCTGAGCTTCCATGCCCTG2620 Table 3A Hs.90606 NM_004261 4759095 15 kDa selenoprotein (SEP15),mRNA/ 1 TTCACAAAGATTTGCGTTAATGAAGA cds = (4, 492)CTACACAGAAAACCTTTCTAGGGA 2621 Table 3A Hs.15259 NM_004281 14043023BCL2-associated athanogene 3 1 ATACCTGACTTTAGAGAGAGTAAAAT (BAG3),mRNA/cds = (306, 2033) GTGCCAGGAGCCATAGGAATATCT 2622 Table 3A Hs.341182NM_004288 8670550 602417256F1 cDNA, 5′ end/ 1 ATGGAAAGATGTGGTCTGAGATGGGTclone = IMAGE:4538829/clone_end = GCTGCAAAGATCATAATAAAGTCA 5′ 2623 Table3A Hs.75393 NM_004300 4757713 acid phosphatase 1, soluble (ACP1), 1ACATCCAGAAAGAAGGACACTTGTAT transcript variant a, mRNA/GCTAGTCTATGGTCAGTTGAGGAA cds = (775, 1251) 2624 Table 3A Hs.274350NM_004301 4757717 BAF53 (BAF53A), mRNA/ 1 TTGACTAGTAAAAGTTACTGCCTAGT cds= (138, 1425) CTTTTTACCTTAGGCTTACAGAAT 2625 Table 3A Hs.109918 NM_0043104757769 ras homolog gene family, member H 1 TTGCCCAGGCCAGTTAGAAAATCCCT(ARHH), mRNA/cds = (579, 1154) TGGGGAACTGTGATGAATATTCCA 2626 Table 3AHs.75811 NM_004315 4757785 N-acylsphingosine amidohydrolase 1ATAATCACAGTTGTGTTCCTGACACT (acid ceramidase) (ASAH), mRNA/CAATAAACAGTCACTGGAAAGAGT cds = (17, 1204) 2627 literature Hs.234799NM_004327 11038638 breakpoint cluster region (BCR), 1TGACCGGATTCCCTCACTGTTGTATC transcript variant 1, mRNA/TTGAATAAACGCTGCTGCTTCATC cds = (488, 4303) 2628 db mining Hs.2534NM_004329 4757853 bone morphogenetic protein receptor, 1CCAAAGTTGGAGCTTCTATTGCCATG type IA (BMPR1A), mRNA/AACCATGCTTACAAAGAAAGCACT cds = (309, 1907) 2629 literature Hs.82794NM_004344 4757901 centrin, EF-hand protein, 2 (CETN2), 1GTGAACTCCTGCACTGGCATTTGGAT mRNA/cds = (47, 565) GTGTGTTAATGCTATTTGTTTTGT2630 Table 3A Hs.170019 NM_004350 4757917 runl-related transcriptionfactor 3 1 GCTGGGTGGAAACTGCTTTGCACTAT (RUNX3), mRNA/cds = (9, 1256)CGTTTGCTTGGTGTTTGTTTTTAA 2631 Table 3A Hs.84298 NM_004355 10835070 CD74antigen (invariant polypeptide of 1 GCTTGTTATCAGCTTTCAGGGCCATG majorhistocompatibility complex, class GTTCACATTAGAATAAAAGGTAGT IIantigen-associated) (CD74), mRNA/ cds = (7, 705) 2632 Table 3A Hs.75564NM_004357 4757941 CD151 antigen (CD151), mRNA/ 1CTTTGCCTTGCAGCCACATGGCCCCA cds = (84, 845) TCCCAGTTGGGGAAGCCAGGTGAG 2633Table 3A Hs.75887 NM_004371 6996002 coatomer protein complex, subunit 1TGCGGGTTATTGATTTGTTCTTTACAA alpha (COPA), mRNA/cds = (466,CTATTGTTCTCATATTTCTCACA 4140) 2634 Table 3A Hs.79194 NM_004379 4758053cAMP responsive element binding 1 AGTTATTAGTTCTGCTTTAGCTTTCCA protein 1(CREB1), mRNA/ ATATGCTGTATAGCCTTTGTCAT cds = (198, 7526) 2635 Table 3AHs.23598 NM_004380 4758055 CREB binding protein (Rubinstein- 1GCTGTTTTCAACATTGTATTTGGACTA Taybi syndrome) (CREBBP), mRNA/TGCATGTGTTTTTTCCCCATTGT cds = (198, 7526) 2636 Table 3A Hs.76053NM_004398 13514826 DEAD/H (Asp-Glu-Ala-Asp/His) box 1AAGTAAATGTACAGTGATTTGAAATA polypeptide 5 (RNA helicase, 68 kD)CAATAATGAAGGCAATGCATGGCC (DDX5), mRNA/cds = (170, 2014) 2637 Table 3AHs.155595 NM_004404 4758157 neural precursor cell expressed, 1CCCACACTGCTACACTTCTGATCCCC developmentally down-regulated 5TTTGGTTTTACTACCCAAATCTAA (NEDD5), mRNA/cds = (258, 1343) 2638 Table 3AHs.171695 NM_004417 7108342 dual specificity phosphatase 1 1TCTTAAGCAGGTTTGTTTTCAGCACT (DUSP1), mRNA/cds = (248, 1351)GATGGAAAATACCAGTGTTGGGTT 2639 Table 3A Hs.1183 NM_004418 12707563 dualspecificity phosphatase 2 1 GGGGTTGGAAACTTAGCACTTTATAT (DUSP2), mRNA/cds= (85, 1029) TTATACAGAACATTCAGGATTTGT 2640 Table 3A Hs.2128 NM_00441912707565 dual specificity phosphatase 5 1 ACCCGTGTGAATGTGAAGAAAAGCAG(DUSP5), mRNA/cds = (210, 1364) TATGTTACTGGTTGTTGTTGTTGT 2641 Table 3AHs.74088 NM_004430 4756251 early growth response 3 (EGR3), 1TTGCACTGTGAGCAAATGCTAATACA mRNA/cds = (357, 1520)GTAAATATATTGTGTTTGCTGACA 2642 Table 3A Hs.55921 NM_004446 4758293glutamyl-prolyl-tRNA synthetase 1 AAATGAAGTCACACAGGACAATTATT (EPRS),mRNA/cds = (58, 4380) CTTATGCCTAAGTTAACAGTGGAT 2643 Table 3A Hs.48876NM_004462 4758349 famasyl-diphosphate 1 GTCGCTGCATATGTGACTGTCATGAGfamesyltransferase 1 (FDFT1),mRNA/ ATCCTACTTAGTATGATCCTGGCT cds = (44,1297) 2644 Table 3A Hs.76362 NM_004492 4758485 general transcriptionfactor IIA, 2 1 AAGGACAAAAGTTGTTGCCTTCCTAA (12 kD subunit) (GTF2A2),mRNA/ GAACCTTCTTTAATAAACTCATTT cds = (141, 470) 2645 Table 3A Hs.103804NM_004501 14141160 heterogeneous nuclear 1 CTGCATTTTGATTCTGAAAAGAAAGCribonucleoprotein U (scaffold TGGCTTTGCCCATTTCTTATTAAA attachment factorA) (HNRPU), transcript variant 1, mRNA/ cds = (217, 2691) 2646 db miningHs.171545 NM_004504 7262381 HIV-1 Rev binding protein (HRB), 1ACCTGTCTGCATAATAAAGCTGATCA mRNA/cds = (243, 1931)TGTTTTGCTACAGTTTGCAGGTGA 2647 literature Hs.152983 NM_004507 4758575HUS1 (S. pombe) checkpoint homolog 1 TACTGGTAGATGTGCTCATTCTCCCT (HUS1),mRNA/cds = (60, 902) GAAACATACCCATCATATTGTCCT 2648 Table 3A Hs.38125NM_004510 4758587 interferon-induced protein 75, 52 kD 1AGGAAGCAATGTGGTTGGACCTGGTT (IFI75), mRNA/cds = (170, 1396)AAGGGAAAGGCTGATTACGGAAAT 2649 Table 3A Hs.75117 NM_004515 4758601interleukin enhancer binding factor 2, 1 AACTAATACTTTGCTGTTGAAATGTTG 45kD (ILF2), mRNA/cds = (39, 1259) TGAAATGTTAAGTGTCTGGAAAT 2650 Table 3AHs.6198 NM_004517 4758605 integrin-linked kinase (ILK), mRNA/ 1GAGCTTTGTCACTTGCCACATGGTGT cds = (156, 1514) CTTCCAACATGGGAGGGATCAGCC2651 db mining Hs.111301 NM_004530 11342665 matrix metalloproteinase 2(gelatinase 1 CCCTGTTCACTCTACTTAGCATGTCC A, 72 kD gelatinase, 72 kD typeIV CTACCGAGTCTCTTCTCCACTGGA collagenase) (MMP2), mRNA/ cds = (289, 2271)2652 Table 3A Hs.198271 NM_004544 4758767 NADH dehydrogenase(ubiquinone) 1 1 TGCACATTGTTTTTCTTCTGACTTCCA alpha subcomplex, 10 (42kD) GAAATAAAAGTGTTTCCATGGGA (NDUFA10), mRNA/cds = (21, 1088) 2653 Table3A Hs.173611 NM_004550 4758785 NADH dehydrogenase (ubiquinone) 1ACTAAAAAAGGAGAAATTATAATAAAT Fe S protein 2 (49 kD) (NADH-TAGCCGTCTTGCGCCCCTAGGCC coenzyme Q reductase) (NDUFS2), mRNA/cds = (6,1397) 2654 Table 3A Hs.80595 NM_004552 4758789 NADH dehydrogenase(ubiquinone) Fe 1 ACGACAAACCTCCTTGTCAAAGTGTG S protein 5 (15 kD)(NADH-coenzyme TAAAAATAAAGGATTGCTCCATCC Q reductase) (NDUFS5), mRNA/ cds= (71, 391) 2655 Table 3A Hs.91640 NM_004556 4758805 nuclear factor ofkappa light 1 CCACTGGGGAAGGGAAGTTTCAGTA polypeptide gene enhancer inB-cells ACATGACACTAAAATGGCAGAGACG inhibitor, epsilon (NFKBIE), mRNA/ cds= (33, 1535) 2656 Table 3A Hs.74497 NM_04559 4758829 nuclease sensitiveelement binding 1 AAAGATTGGAGCTGAAGACCTAAAGT protein 1 (NSEP1), mRNA/GCTTGCTTTTTGCCCGTTGACCAG cds = (234, 1202) 2657 Table 3A Hs.158225NM_004571 4758929 PBX/knotted 1 hoemobox 1 1 GAAGTCAGTGGGAAACACACAG(PKNOX1), mRNA/cds = (85, 1392) AAATTTATTTTAAAATCTTTCAGG AGCT 2658 Table3A Hs.7688 NM_004576 4758953 protein phosphatase 2 (formerly 2A), 1AGATGTATTAGAAGTCCTGACTTTCA regulatory subunit B (PR 52), betaAGTGTAATTTGCTTTGGAGGAGGA isoform (PPP2R2B), mRNA/ cds = (525, 1856) 2659literature Hs.240457 NM_004584 4759021 RAD9 (S. pombe) homolog (RAD9), 1CTGTGCAGAAGAGCTGCCAGGCAGT mRNA/cds = (76, 1251)GTCTTAGATGTGAGACGGAGGCCAT 2660 Table 3A Hs.75498 NM_004591 4759075 smallinducible cytokine subfamily A 1 ACATCATGGAGGGTTTAGTGCTTATC (Cys—Cys),member 20 (SCYA20), TAATTTGTGCCTCACTGGACTTGT mRNA/cds = (58, 348) 2661Table 3A Hs.30035 NM_004593 4759097 splicing factor,arginine/serine-rich 1 TTGCTTACCAAAGGAGGCCCAATTTC (transformer 2Drosophila homolog) 10 ACTCAAATGTTTTGAGAACTGTGT (SFRS10), mRNA/cds =(121, 987) 2662 Table 3A Hs.53125 NM_004597 7242206 small nuclearribonucleoprotein D2 1 TCACTCCTCTGTCCTATGAAGACCGC polypeptide (16.5 kD)(SNRPD2), TGCCATTGGTGTTGAGAATAATAA mRNA/cds = (30, 366) 2663 literatureHs.91175 NM_004618 10835217 topoisomerase (DNA) III alpha 1GTTAAGCCAGGACATCCAGAATTCAT (TOP3A), mRNA/cds = (177, 3182)TGCTTTAATAAAGAACCCAGGCCG 2664 Table 3A Hs.75066 NM_004822 4759269translin (TSN), mRNA/cds = (81, 767) 1 TCAGTTTTAACAAATGCTATTAAAGTGGAGAAGCACACTCTGGTCTTGGA 2665 db mining Hs.320 NM_004628 4759331xeroderma pigmentosum, 1 CTCACTGCCTCTTTGCAGTAGGGGAG complementationgroup C (XPC), AGAGCAGAGAAGTACAGGTCATCT mRNA/cds = (191, 2662) 2666literature Hs.8047 NM_004629 4759335 Fanconi anemia, complementation 1TTGACTTTGCTCGAGGCACCTTTTTT group G (FANCG), mRNA/CCTGTTTCTCCTTTTCTGTTGTCG cds = (492, 2360) 2667 Table 3A Hs.159627NM_004632 4756117 death associated protein 3 (DAP3), 1AAATGGGTTTCACTGTGAATGCGTGA mRNA/cds = (73, 1269)CAATAAGATATTCCCTTGTTCCTA 2668 Table 3A Hs.237955 NM_004637 13794266 mRNAfor RAB7 protein/ 1 AACGAATTTCCTGAACCTATCAAACT cds = (602, 1225)GGACAAGAATGACCGGGCCAAGGC 2669 Table 3A Hs.25911 NM_004638 4758107 HLA-Bassociated transcript 2 (BAT2), 1 CTTCCCCTGGTCCCCTGTCCCTGGG mRNA/cds =(101, 6529) GCTGTTTGTTAAAAAAGAGTAATAA 2670 Table 3A Hs.966 NM_0046454758023 coilin (COIL), mRNA/cds = (22, 1752) 1ACCGTGAAAATTGGTTTCATTTAACAA AAGATCAGATCCCTCCTTCAGCT 2671 Table 3AHs.77576 NM_004652 11641424 ubiquitin specific protease 9, x 1TTTCTTGTTACACCCACTGCACTCTG chromosome (Drosophila fat facetsCAACCAGTGTTGCCTGCCTCATGG related) (USP9X), transcript variant 1,mRNA/cds = (59, 7750) 2672 Table 3A Hs.80358 NM_004653 4759149 SMC(mouse) homolog, Y 1 GGGAAAAACAAGAATTTCATGACTCT chromosome (SMCY), mRNA/ACCTGTGGTCTATCTTTAATTTCA cds = (275, 4694) 2673 Table 3A Hs.121102NM_004665 4759313 vanin 2 (VNN2), mRNA/ 1 GCTGTGCCCTTGAAGAGAATAGTAAT cds= (11, 1573) GATGGGAATTTAGAGGTTTATGAC 2674 Table 3A Hs.6856 NM_0046744757789 ash2 (absent, small, or homeotic, 1 TCCAAGGAAATGGTAACCTGTTTCTGDrosophila, homolog)-like (ASH2L), AGAACACCTGAAATCAATGGCTAT mRNA/cds =(4, 1890) 2675 Table 3A Hs.155103 NM_004681 4758253 eukaryotictranslation initiation factor 1 TTCATTGTAATCCACTGTTTTGGCTTT 1A, Ychromosome (EIF1AY), mRNA/ CATGAACAAGTAAATTACAGTGT cds = (132, 588) 2676Table 3A Hs.54483 NM_004688 4758813 N-myc (and STAT) interactor (NMI), 1ACTTATTTCCATGTTTCTGAATCTTCT mRNA/cds = (280, 1203)TTGTTTCAAATGGTGCTGCATGT 2677 Table 3A Hs.5097 NM_004710 4759201synaptogyrin 2 (SYNGR2), mRNA/ 1 ATGCCCGGCCTGGGATGCTGTTTGG cds = (29,703) AGACGGAATAAATGTTTTCTCATTC 2678 Table 3A Hs.40323 NM_004725 4757879BUB3 (budding uninhibited by 1 TACTCTAAACCTGTTATTTCTGTGCTAbenzimidazoles 3, yeast) homolog ATAAACGAGATGCAGAACCCTTG (BUB3),mRNA/cds = (70, 1056) 2679 Table 3A Hs.77324 NM_004730 4759033eukaryotic translation termination 1 TGCAGAGAGATACTAAGCAGCAAAAT factor 1(ETF1), mRNA/ CTTGGTGTTGTGATGTACAGAAAT cds = (135, 1448) 2680 Table 3AHs.326159 NM_004735 4758689 leucine rich repeat (in FLII) interacting 1AGTCTTTGATCTTGAACCGATACTTTT protein 1 (LRRFIP1), mRNA/GGATCTCATTGTTGATATACCTG cds = (178, 2532) 2681 Table 3A Hs.333513NM_004757 4758265 small inducible cytokine subfamily E, 1TGGAATCAAATAAAATGCTTCCACTA member 1 (endothelial monocyte-CCAAAAGACATTAGAGAAAACCTT activating) (SCYE1), mRNA/ cds = (49, 987) 2682Table 3A Hs.9075 NM_004760 4758191 serine/threonine kinase 17a(apoptosis- 1 TGCCGAATACCTTAAAGTAACTAATTA inducing) (STK17A), mRNA/TCCTTACACACAAAAGGCTCAGT cds = (117, 1361) 2683 Table 3A Hs.170160NM_004761 4758531 RAB2, member RAS oncogene family- 1CTTTCCCAGGATCAAGGCCACAGGG like (RAB2L), mRNA/cds = (0, 2333)AGGAAGATTGCACGGGCACTGTTCT 2684 Table 3A Hs.1050 NM_004762 4758963pleckstrin homology. Sec7 and 1 CTTGTAAACTAGCGCCAAGGAACTGC coiled/coildomains 1 (cytohesin 1) AGCAAATAAACTCCAACTCTGCCC (PSCD1), transcriptvariant 1, mRNA/ cds = (69, 1265) 2685 Table 3A Hs.11482 NM_0047684759099 splicing factor, arginine/serine-rich 11 1TGTGCAGTAGAAACAAAAGTAGGCTA (SRFS11), mRNA/cds = (83, 1537)CAGTCTGTGCCATGTTGATGTACA 2686 Table 3A Hs.15589 NM_004774 4759265 PPARbinding protein (PPARBP), 1 AGGAGGGTTTAAATAGGGTTCAGAGA mRNA/cds = (235,4935) TCATAGGAATATTAGGAGTTACCT 2687 Table 3A Hs.26703 NM_004779 4758945CCR4-NOT transcription complex, 1 TGGTGGAAGTAAAAACTGGTAACTCA subunit 8(CNOT8), mRNA/ CTCAAGTGAATGAATGGTCTTGCA cds = (244, 1122) 2688 Table 3AHs.23965 NM_004790 4759041 solute carrier family 22 (organic anion 1GCAGGAAAGGGAAACAGACGCGACA transporter), member 6 (SLC22A6),GCAACAAGAGCACCAGAAGTATATG mRNA/cds = (0, 1652) 2689 Table 3A Hs.77965NM_004792 4758105 peptidyl-prolyl isomerase G (cyclophilin 1TCCATTCTGTTTCGGATTTTAAGTTTG G) (PPIG), mRNA/cds = (157, 2421)AGAGACTTGCTAATGAATCTCCT 2690 Table 3A Hs.28757 NM_004800 4758873transmembrane 9 superfamily member 1 CCTTCAGAAACACCGTAATTCTAAAT 2(TM9SF2), mRNA/cds = (133, 2124) AAACCTCTTCCCATACACCTTTCC 2691 Table 3AHs.49587 NM_004811 4758669 leupaxin (LPXN), mRNA/ 1CTGGACAACTTTGAGTACTGACATCA cds = (93, 1253) TTGATAAATAAACTGGCTTGTGGT2692 Table 3A Hs.168103 NM_004818 4759277 prp28, U5 snRNP 100 kd protein(U5- 1 CCCAGGGGATTTTTTAAGTAGATGGG 100K), mRNA/cds = (39, 2501)GGGACACGGTGAACTGGCTGTGTC 2693 Table 3A Hs.3628 NM_004834 4758523mitogen-activated protein kinase 1 ACTCCAAAATAAATCAAGGCTGCAAT kinasekinase kinase 4 (MAP4K4), GCAGCTGGTGCTGTTCAGATTCCA mRNA/cds = (79, 3576)2694 Table 3A Hs.102508 NM_004836 4758891 eukaryotic translationinitiation factor 2- 1 TGAAATCTTAAGTGTCTTATATGTAAT alpha kinase 3(EIF2AK3), mRNA/ CCTGTAGGTTGGTACTTCCCCCA cds = (72, 3419) 2695 Table 3AHs.227806 NM_004841 4758807 RAS protein activator like 2 (RASAL2), 1TGGGAGTCTTCTCTTTTAGACAGGGG mRNA/cds = (125, 3544)CTTTTTGTTTTTAACCCCAATTGT 2696 db mining Hs.78364 NM_004847 6680470allograft inflammatory factor 1 (AIF1), 1 TGACCCAGATATGGAAACAGAAGACAtranscript variant 2, mRNA/ AAATTGTAAGCCAGAGTCAACAAA cds = (453, 851)2697 Table 3A Hs.10649 NM_004848 4758579 basement membrane-induced gene1 AGGTTTCATCAGGTGGTTAAAGTCGT (ICB-1), mRNA/cds = (128, 982)CAAAGTTGTAAGTGACTAACCAAG 2698 Table 3A Hs.274472 NM_004850 6633807high-mobility group (nonhistone 1 ATGCTGTCAAAGTTACAGTTTACGCAchromosomal) protein 1 (HMG1), GGACATTCTTGCCGTATTCTCATG mRNA/cds = (52,699) 2699 Table 3A Hs.178710 NM_004859 4758011 clathrin, heavypolypeptide (Hc) 1 TGTGTGTTTACTAACCCTTCCCTGAG (CLTC), mRNA/cds = (172,5199) GCTTGTGTATGTTGGATATTGTGG 2700 Table 3A Hs.76507 NM_004862 4758913LPS-induced TNF-alpha factor (PIG7), 1 TCTGTAATCAAATGATTGGTGTCATTTmRNA/cds = (233, 919) TCCCATTTGCCAATGTAGTCTCA 2701 Table 3A Hs.59403NM_004863 4758667 serine palmitoyltransferase, long chain 1TGCCCAGCAGCCATCTTAATACATTA base subunit 2 (SPTLC2), mRNA/AACCAGTTTAAAAAATACCTTCCA cds = (188, 1876) 2702 Table 3A Hs.5409NM_004875 4759045 RNA polymerase I subunit (RPA40), 1GCCAGAGTTGCCAACCCCCGGCTGG mRNA/cds = (22, 1050)ATACCTTCAGCAGAGAAATCTTCCG 2703 Table 3A Hs.66371 NM_004876 4758513 zincfinger protein 254 (ZNF254), 1 AATCCATTAACACCTGCTCACATCTTA mRNA/cds =(134, 1195) CTCAAAATTGTAGAGTTCATAGT 2704 Table 3A Hs.75258 NM_0048934758495 H2A histone family, member Y 1 ATTTGCAATTTGGAATTTGTGTGAGTT(H2AFY), mRNA/cds = (173, 1288) GATTTAGTAAAATGTTAAACCGC 2705 Table 3AHs.80426 NM_004899 4757871 brain and reproductive organ- 1AAGTAAAGCCTCAGGAATGCCCACG expressed (TNFRSF1A modulator)CCTTTCTTCCAAAGCCTTTGTCTCT (BRE), mRNA/cds = (146, 1297) 2706 Table 3AHs.145696 NM_004902 4757925 splicing factor (CC1.3) (CC1.3), 1TCAAACAAATGACTTTCATATTGCAAC mRNA/cds = (149, 1723)AATCTTTGTAAGAACCACTCAAA 2707 Table 3A Hs.119 NM_004906 4758635 Wilms'tumor 1-associating protein 1 GGGGAATGTGTTCCTTCATTGTATTT (KIAA0105),mRNA/cds = (124, 579) GGGCCTTTTGTATTGCACTCTTGA 2708 Table 3A Hs.737NM_004907 4758313 Homo sapiens, Similar to kinesin 1TTGTTTACCTTTCGTGCGGTGGATTC family member 5B, clone MGC:15265TTTTTAACTCCGTCTACCTGGCGT IMAGE:4297793, mRNA, complete cds/cds = (424,1566) 2709 Table 3A Hs.288156 NM_004911 4758303 cDNA: FLJ21819 fis,clone HEP01185/ 1 GGGGTTTGTGCTATACACTGGGATGT cds = UNKNOWNCTAATTGCAGCAATAAAGCCTTTC 2710 Table 3A Hs.81964 NM_004922 4758833 SEC24(S. cerevisiae) related gene 1 ACCTGGGATGCCCCTGCTCTGGACC family, memberC (SEC24C), mRNA/ TCTCATTTCTCTTCATTGGTTTATT cds = (114, 3491) 2711 Table3A Hs.333417 NM_004930 4826658 capping protein (actin filament) muscle 1AGCCTGCTTCTGCCACACCTCGCTCT Z-line, beta (CAPZB), mRNA/CAGTCTCTCCACATTTCCATAGAG cds = (0, 818) 2712 Table 3A Hs.2299 NM_0049314826666 CD8 antigen, beta polypeptide 1 (p37) 1AAGTTTCTCAGCTCCCATTTCTACTCT (CD8B1), mRNA/cds = (50, 682)CCCATGGCTTCATGCTTCTTTCA 2713 Table 3A Hs.171872 NM_004941 4826689 DEAD/H(Asp-Glu-Ala-Asp/His) box 1 GAGCTACTGTGCTCATCTAAAGTGTT polypeptide 8(RNA helicase) (DDX8), TGCCCCACTTCCCACCCCGTCTCC mRNA/cds = (73, 3735)2714 Table 3A Hs.251064 NM_004965 4826757 high-mobility group(nonhistone 1 ATGTTAAGATTTGTGTACAAATTGAAA chromosomal) protein 14(HMG14), TGTCTGTACTGATCCTCAACCAA mRNA/cds = (150, 452) 2715 Table 3AHs.808 NM_004966 14141150 heterogeneous nuclear 1TCTGTTGATAGCTGGAGAACTTTAGT ribonucleoprotein F (HNRPF), mRNA/TTCAAGTACTACATTGTGAAAGCA cds = (323, 1570) 2716 literature Hs.115541NM_004972 13325062 Janus kinase 2 (a protein tyrosine 1TGAGGGGTTTCAGAATTTTGCATTGC kinase) (JAK2), mRNA/AGTCATAGAAGAGATTTATTTCCT cds = (494, 3892) 2717 Table 3A Hs.40154NM_004973 11863151 jumonji (mouse) homolog (JMJ), 1CCTTGGGAGGGAGACTTCATGTGGTT mRNA/cds = (244, 3984)TATTGCGAGTTTTTTGTTTACTTT 2718 Table 3A Hs.184050 NM_004985 4826811v-Ki-ras2 Kirsten rat sarcoma 2 viral 1 GTATGTTAATGCCAGTCACCAGCAGGoncogene homolog (KRAS2), mRNA/ CTATTTCAAGGTCAGAAGTAATGA cds = (192,758) 2719 Table 3A Hs.279946 NM_004990 14043021 methionine-tRNAsynthetase (MARS), 1 GCCCCTAAAGGCAAGAAGAAAA mRNA/cds = (23, 2725)AGTAAAAGACCTTGGCTCATAGAA AGTC 2720 Table 3A Hs.75103 NM_005005 6274549tyrosine 3-monooxygenase/tryptophan 1 AGTGAAATATGTTACAGAACATGCAC5-monooxygenase activation protein, TTGCCCTAATAAAAAATCAGTGAA zetapolypeptide (YWHAZ), mRNA/ cds = (84, 621) 2721 Table 3A Hs.8248NM_005006 4826855 NADH dehydrogenase (ubiquinone) Fe 1TGCAGATGCTCTTAAAAGCATTGATA S protein 1 (75 kD) (NADH-coenzymeACCTTTGTGACGAACATAAAGAGA Q reductase) (NDUFS1), mRNA/ cds = (46, 2229)2722 Table 3A Hs.182255 NM_005008 4826859 non-histone chromosome protein2 (S. 1 GCTAGTTCATGTGTTCTCCATTCTTGT cerevisiae)-like 1 (NHP2L1), mRNA/GAGCATCCTAATAAATCTGTTCC cds = (94, 480) 2723 Table 3A Hs.151134NM_005015 4826879 oxidase (cytochrome c) assembly 1- 1AACCCTCCCAATATCCCTAGCAGCAG like (OXA1L), mRNA/cds = (0, 1487)CAGCAAACCAAAGTCAAAGTATCC 2724 Table 3A Hs.75721 NM_005022 4826897profilin 1 (PFN1), mRNA/ 1 CACCTCCCCCTACCCATATCCCTCCC cds = (127, 549)GTGTGTGGTTGGAAAACTTTTGTT 2725 db mining Hs.100724 NM_005037 4826929peroxisome proliferative activated 1 GAGTCCTGAGCCACTGCCAACATTTCreceptor, gamma (PPARG), mRNA/ CCTTCTTCCAGTTGCACTATTCTG cds = (172,1608) 2726 literature Hs.180455 NM_005053 4826963 RAD23 (S. cerevisiae)homolog A 1 CCCCACCCCAGAACAGAACCGTGTC (RAD23A), mRNA/cds = (38, 1127)TCTGATAAAGGTTTTGAAGTGAATA 2727 Table 3A Hs.180610 NM_005066 4826997splicing factor proline/glutamine rich 1 CCCATTTCTTGTTTTTAAAAGACCAAC(polypyrimidine tract-binding protein- AAATCTCAAGCCCTATAAATGGCassociated) (SFPQ), mRNA/ cds = (85, 2208) 2728 Table 3A Hs.149923NM_005080 14110394 X-box binding protein 1 (XBP1), 1AGTGTAGCTTCTGAAAGGTGCTTTCT mRNA/cds = (48, 833) CCATTTATTTAAAACTACCCATGC2729 Table 3A Hs.1579 NM_005082 4827064 zinc finger protein 147(estrogen- 1 GAGTGCCCGATTCCTCTTAGAGAAAA responsive finger protein)(ZNF147), TCCATAGCCTTCAGATCTTGGTGT mRNA/cds = (39, 1931) 2730 Table 3AHs.82712 NM_005087 4826735 fragile X mental retardation, autosomal 1ACTTTGACACCTACTGTGTTATAAAAT homolog 1 (FXR1), mRNA/ATATCATCAGATGTGCCTTGAGA cds = (12, 1877) 2731 Table 3A Hs.21595NM_005088 10835221 DNA segment on chromosome X and 1AGCTGTAACGTTCGCGTTAGGAAAGA Y (unique) 155 expressed sequenceTGGTGTTTATTCCAGTTTGCATTT (DXYS155E), mRNA/cds = (166, 1323) 2732literature Hs.248197 NM_005092 4827033 tumor necrosis factor (ligand) 1TGATATTCAACTCTGAGCATCAGGTT superfamily, member 18 (TNFSF18),CTAAAAAATAATACATACTGGGGT mRNA/cds = (0, 533) 2733 Table 3A Hs.75243NM_005104 12408641 bromodomain-containing 2 (BRD2), 1GTCATCTCCCCATTTGGTCCCCTGGA mRNA/cds = (1701, 4106)CTGTCTTTGTTGATTCTAACTTGT 2734 Table 3A Hs.95220 NM_005109 4826877oxidative-stress responsive 1 (OSR1), 1 GAGAATAATGATGTACCAATAAGTGGmRNA/cds = (342, 1925) AGATTCCTCCTTATGATGTATGCT 2735 literatureHs.241382 NM_005118 4827031 tumor necrosis factor (ligand) 1ACAAGACAGACTCCACTCAAAATTTA superfamily, member 15 (TNFSF15),TATGAACACCACTAGATACTTCCT mRNA/cds = (1123, 1647) 2736 Table 3A Hs.11861NM_005121 4827043 thyroid hormone receptor-associated 1TCCATACCATTGTGTGTGGAGGATTT protein, 240 kDa subunit (TRAP240),ACAGCTAAGCTGTAGTTGCAGAGT mRNA/cds = (77, 6601) 2737 Table 3A Hs.3382NM_005134 4826933 protein phosphatase 4, regulatory 1ACACTTTTGATTGTTTTCTAGATGTCT subunit 1 (PPP4R1), mRNA/ACCAATAAATGCAATTTGTGACC cds = (93, 2894) 2738 Table 3A Hs.75981NM_005151 4827049 ubiquitin specific protease 14 (tRNA- 1ACTGTACAATTTCTGAAGATGGTTATT guanine transglycosylase) (USP14),AACACTGTGCTGTTAAGCATCCA mRNA/cds = (91, 1575) 2739 Table 3A Hs.152818NM_005154 4827053 ubiquitin specific protease 8 (USP8), 1TCAGTCCTTTCTTAGGGAAATGACAG mRNA/cds = (317, 3673)GGCAAAGCAATTTTTCTGTTGGCT 2740 Table 3A Hs.89399 NM_005176 6671590 ATPsynthase, H+ transporting, 1 AGTACAAGGCCCGAAGGGTAGTGAT mitochondrial F0complex, subunit c GGTGCTAAACTCAACATGGATTTGG (subunit 9), isoform 2(ATP5G2), mRNA/cds = (59, 484) 2741 Table 3A Hs.431 NM_005180 4885094murine leukemia viral (bmi-1) 1 CCCCAGTCTGCAAAAGAAGCACAATT oncogenehomolog (BMI1), mRNA/ CTATTGCTTTGTCTTATAGT cds = (479, 1459) 2742 Table3A Hs.838 NM_005191 4885122 CD80 antigen (CD28 antigen ligand 1, 1CTTCTTTTGCCATGTTTCCATTCTGCC B7-1 antigen) (CD80), mRNA/ATCTTGAATTGTCTTGTCAGCCA cds = (375, 1241) 2743 Table 3A Hs.247824NM_005214 4885166 cytotoxic T-lymphocyte-associated 1GGGTCTATGTGAAAATGCCCCCAACA protein 4 (CTLA4), mRNA/cds = (0,GAGCCAGAATGTGAAAAGCAATTT 671) 2744 literature Hs.211567 NM_0052154885174 deleted in colorectal carcinoma (DCC), 1CCTTCTTTCACAGGCATCAGGAATTG mRNA/cds = (0, 4343) TCAAATGATGATTATGAGTTCCCT2745 literature Hs.34789 NM_005216 4885176dolichyl-diphosphooligosaccharide- 1 CATCTTCAGCATCGTCTTCTTGCACA proteinglycosyltransferase (DDOST), TGAAGGAGAAGGAGAAGTCCGACT mRNA/cds = (0,1370) 2746 literature Hs.89296 NM_005238 4885216 excision repaircross-complementing 1 GGGAATGCTGCAAATGCCAAACAGCT rodent repairdeficiency, TTATGATTTCATTCACACCTCTTT complementation group 4 (ERCC4),mRNA/cds = (0, 2750) 2747 Table 3A Hs.129953 NM_005243 4885224 Ewingsarcoma breakpoint region 1 1 TTAAAAATGGTTGTTTAAGACTTTAAC (EWSR1),transcript variant EWS, AATGGGAACCCCTTGTGAGCATG mRNA/cds = (43, 2013)2748 Table 3A Hs.1422 NM_005248 4885234 Gardner-Rasheed feline sarcomaviral 1 GGGAGAAGTTTGCAGAGCACTTCCC (v-fgr) oncogene homolog (FGR),ACCTCTCCTGAATAGTGTGTATGTGT mRNA/cds = (147, 1736) 2749 Table 3A Hs.79022NM_005261 4885262 GTP-binding protein overexpressed in 1TGGTTGACCCTTGTATGTCACAGCTC skeletal muscle (GEM), mRNA/TGCTCTATTTATTATTATTTTGCA cds = (213, 1103) 2750 Table 3A Hs.73172NM_005263 4885266 growth factor independent 1 (GFI1), 1TGGGAAGGAAGGCTCTGTCTTCAACT mRNA/cds = (267, 1535)CTTTGACCCTCCATGTGTACCATA 2751 Table 3A Hs.237519 NM_005271 4885280yz35c09.s1 cDNA, 3′ end/ 1 GCATGGCTTAACCTGGTGATAAAAGC clone =IMAGE:285040/clone_end = AGTTATTAAAAGTCTACGTTTTCC 3′ 2752 Table 3AHs.239891 NM_005301 4885320 G protein-coupled receptor 35 1CTCCCCGTGCTAAGGCCCACAAAAG (GPR35), mRNA/cds = (0, 929)CCAGGACTCTCTGTGCGTGACCCTC 2753 Table 3A Hs.289101 NM_005313 4885358glucose regulated protein, 58 kD 1 AATTCAAGAAGAAAAACCCAAG (GRP58),mRNA/cds = (0, 1517) AAGAAGAAGAAGGCACAGGAGGAT CTCT 2754 literatureHs.89578 NM_005316 4885364 Homo sapiens, general transcription 1TCCCAGAGCTGATGCTATTGTACTTG factor I/H, polypeptide 1 (62 kDCACATTGGAGACTGAAAGGAAAGA subunit), clone MGC:8323 IMAGE: 2819217, mRNA,complete cds/cds = (169, 1815) 2755 literature Hs.136657 NM_0053204885376 H1 histone family, member 3 (H1F3), 1 GGGGAAGCCGAAGGTTACAAAGGCAmRNA/cds = (0, 665) AAGAAGGCAGCTCCGAAGAAAAAGT 2756 Table 3A Hs.14601NM_005335 4885404 hematopoietic cell-specific Lyn 1TCCCTGAAGAAATATCTGTGAACCTT substrate 1 (HCLS1), mRNA/CTTTCTGTTCAGTCCTAAAATTCG cds = (42, 1502) 2757 Table 3A Hs.132834NM_005337 4885410 hematopoietic protein 1 (HEM1), 1CCTCTCCGACCTTCATCACTATTCTTA mRNA/cds = (1582, 3423)GGATAATGCTGGCGGGCAGAGAT 2758 Table 3A Hs.193989 NM_005345 5579469 TARDNA binding protein (TARDBP), 1 ACTGCCATCTTACGACTATTTCTTCTT mRNA/cds =(88, 1332) TTTAATACACTTAACTCAGGCCA 2759 Table 3A Hs.274402 NM_0053465579470 heat shock 70 kD protein 1B 1 AGGGTGTTTCGTTCCCTTTAAATGAA(HSPA1B), mRNA/cds = (152, 2077) TCAACACTGCCACCTTCTGTACGA 2760 Table 3AHs.289088 NM_005348 13129149 heat shock 90 kD protein 1, alpha 1GACCCTACTGCTGATGATACCAGTGC (HSPCA), mRNA/cds = (60, 2258)TGCTGTAACTGAAGAAATGCCACC 2761 Table 3A Hs.1765 NM_005356 4885448lymphocyte-specific protein tyrosine 1 CATTTCCTGAGACCACCAGAGAGAG kinase(LCK), mRNA/cds = (51, 1580) GGGAGAAGCCTGGGATTGACAGAAG 2762 Table 3AHs.1765 NM_005356 4885448 lymphocyte-specific protein tyrosine 1CATTTCCTGAGACCACCAGAGAGAG kinase (LCK), mRNA/cds = (51, 1580)GGGAGAAGCCTGGGATTGACAGAAG 2763 db mining Hs.75862 NM_005359 4885456 MAD(mothers against 1 GCTAAGAAGCCTATAAGAGGAATTTC decapentaplegic,Drosophila) homolog TTTTCCTTCATTCATAGGGAAAGG 4 (MADH4), mRNA/cds = (128,1786) 2764 Table 3A Hs.297939 NM_005385 6631099 cathepsin B (CTSB),mRNA/ 1 ACTGACAGAGTGAACTACAGAAATAG cds = (177, 1196)CTTTTCTTCCTAAAGGGGATTGTT 2765 literature Hs.301862 NM_005395 4885552postmeiotic segregation increased 2- 1 CAGACAATGGATGTGGGGTAGAAGA like 9(PMS2L9), mRNA/cds = (0, 794) AGAAACTTTGAAGGCTTAATCTCT 2766 Table 3AHs.288757 NM_005402 4885568 v-ral simian leukemia viral oncogene 1AAAAGAAGAGGAAAAGTTTAGC homolog A (ras related) (RALA),CAAGAGAATCAGAGAAAGATGCTG mRNA/cds = (0, 629) CATT 2767 literatureHs.103982 NM_005409 14790145 small inducible cytokine subfamily B 1AGTGCACATATTTCATAACCAAATTAG (Cys-X-Cys), member 11 (SCYB11),CAGCACCGGTCTTAATTTGATGT mRNA/cds = (93, 377) 2768 Table 3A Hs.72988NM_005419 4885614 signal transducer and activator of 1TAGACCTCTTTTTCTTACCAGTCTCCT transcription 2, 113 kD (STAT2),CCCCTACTCTGCCCCCTAAGCTG mRNA/cds = (57, 2612) 2769 literature Hs.129727NM_005431 4885656 X-ray repair complementing defective 1AGCACAGTAAAAGTAAAGACTATTCT repair in Chinese hamster cells 2GTTTCTAGGCTGTTGAATCAAAGT (XRCC2), mRNA/cds = (86, 928) 2770 literatureHs.99742 NM_005432 12408644 X-ray repair complementing defective 1CATGGGCACAGTGGTGACCCCCTTG repair in Chinese hamster cells 3ATTCCCACCGTACAACCCCCTCCAC (XRCC3), mRNA/cds = (353, 1393) 2771literature Hs.75238 NM_005441 4885104 chromatin assembly factor 1,subunit B 1 CGTTATCCAGTGTGAAAATCAGTGAG (p60) (CHAF1B), mRNA/TCCTCCCTGGCATCCTCGTGAAAG cds = (62, 1741) 2772 Table 3A Hs.301704NM_005442 11321608 eomesodermin (Xenopus laevis) 1GCTGAAGAGTATAGTAAAGACACCTC homolog (EOMES), mRNA/AAAAGGCATGGGAGGGTATTATGC cds = (0, 2060) 2773 Table 3A Hs.169487NM_005461 4885446 Kreisler (mouse) maf-related leucine 1TTCAGACTGGTTTCTGTTTTTTGGTTA zipper homolog (KRML), mRNA/TTAAAATGGTTTCCTATTTTGCT cds = (73, 1044) 2774 Table 3A Hs.170311NM_005463 14110410 heterogeneous nuclear 1 TTTATGATTAGGTGACGAGTTGACATribonucleoprotein D-like (HNRPDL), TGAGATTGTCCTTTTCCCCTGATC transcriptvariant 1, mRNA/ cds = (580, 1642) 2775 literature Hs.24284 NM_00548411496991 ADP-ribosyltransferase (NAD+; 1 CCCCAACCAGGTCCGTATGCGGTACpoly(ADP-ribose) polymerase)-like 2 CTTTTAAAGGTTCAGTTTAATTTCC (ADPRTL2),mRNA/cds = (149, 1753) 2776 literature Hs.271742 NM_005485 11496992ADP-ribosyltransferase (NAD+; poly 1 TCCTGCAAGFGCTGGACTGTGATCTTC(ADP-ribose) polymerase)-like 3 AATCATCCTGCCCATCTCTGGTAC (ADPRTL3),mRNA/cds = (246, 1847) 2777 Table 3A Hs.180370 NM_005507 5031634 cofilin1 (non-muscle) (CFL1), mRNA/ 1 GGTCACGGCTACTCATGGAAGCAGG cds = (51, 551)ACCAGTAAGGGACCTTCCGATTAAAA 2778 literature Hs.184926 NM_005508 5031626chemokine (C—C motif) receptor 4 1 CCTTCTAACCTGAACTGATGGGTTTC (CCR4),mRNA/cds = (182, 1264) TCCAGAGGGAATTGCAGAGTACTG 2779 Table 3A Hs.77961NM_005514 5031742 major histocompatibility complex, class 1ATGTGTAGGAGGAAGAGTTCAGGTG I, B (HLA-B), mRNA/cds = (0, 1088)GAAAAGGAGGGAGCTACTCTCAGGC 2780 Table 3A Hs.334767 NM_005517 5031748hypothetical protein MGC5629 1 AACGATTGTCTGCCCATGTCCTGCCT (MGC5829),mRNA/cds = (285, 539) GAAATACCATGATTGTTTATGGAA 2781 Table 3A Hs.245710NM_005520 5031752 heterogeneous nuclear 1 TTCCTTTTAGGTATATTGCGCTAAGTribonucleoprotein H1 (H) (HNRPH1), GAAACTTGTCAAATAAATCCTCCT mRNA/cds =(72, 1421) 2782 Table 3A Hs.177559 NM_005534 5031782 interferon gammareceptor 2 1 GTCTTGACTTTGGCAAATGAGCCGGA (interferon gamma transducer 1)GCCCCTTGGGCAGGTCACACAACC (IFNGR2), mRNA/cds = (648, 1661) 2783literature Hs.121544 NM_005535 5031784 interleukin 12 receptor, beta 1 1GATACAGAGTTGTCCTTGGAGGATGG (IL12RB1), mRNA/cds = (64, 2052)AGACAGGTGCAAGGCCAAGATGTG 2784 Table 3A Hs.155939 NM_005541 5031798inositol polyphosphate-5-phosphatase, 1 TCCCATGATGGAAGTCTGCGTAACCA 145kD (INPP5D), mRNA/ ATAAATTGTGCCTTTCTCACTCAA cds = (140, 3706) 2785 Table3A Hs.56205 NM_005542 5031800 insulin induced gene 1 (INSIG1), 1TCTACATGTCTTGGGGGCGGGCTCA mRNA/cds = (414, 1247)AATTCTTCGAAAGTGGTTGGATTAA 2786 Table 3A Hs.211576 NM_005546 5031810IL2-inducible T-cell kinase (ITK), 1 ACCTGTTATCCTTTGTAGAGCACACA mRNA/cds= (2021, 3883) GAGTTAAAAGTTGAATATAGCAAT 2787 Table 3A Hs.23881 NM_0055565031842 keratin 7 (KRT7), mRNA/ 1 TGAGCTTCTCCAGCAGTGCGGGTCC cds = (56,1465) TGGGCTCCTGAAGGCTTATTCCATC 2788 Table 3A Hs.81915 NM_00556313518023 stathmin 1/oncoprotein 18 (STMN1), 1 GCATGTCCTCATCCTTTCCTGCCATAmRNA/cds = (91, 540) AAAGCTATGACACGAGAATCAGAA 2789 Table 3A Hs.2488NM_005565 7382491 lymphocyte cytosolic protein 2 (SH2 1ACCCCTCCCCATGAACACAAGGGTTT domain-containing leukocyte protein ofTATCCTTTCCTTTAAAAACAGTGT 76 kD) (LCP2), mRNA/cds = (207, 1808) 2790Table 3A Hs.314760 NM_005566 5031856 HOA7-1-F8 cDNA 1TGCAACCAACTATCCAAGTGTTATAC CAACTAAAACCCCCAATAAACCTT 2791 db miningHs.153883 NM_005585 5031898 Smad6 mRNA, complete cds/ 1ATGCCCAGACAAAAAGCTAATACCAG cds = (936, 2426) TCACTCGATAATAAAGTATTCGCA2792 literature Hs.20555 NM_005590 5031920 meiotic recombination (S.cerevisiae) 1 TGGCACTGAGAAACATGCAAGATACA 11 homolog A (MRE11A), mRNA/GGAAAAATGAAAATGTTACAAGCT cds = (170, 2296) 2793 Table 3A Hs.158164NM_005594 5031930 transporter 1, ATP-binding cassette, 1TCTCAAAGGAGTAACTGCAGCTTGGT sub-family B (MDR/TAP) (TAP1),TTGAAATTTGTACTGTTTCTATCA mRNA/cds = (30, 2456) 2794 Table 3A Hs.18069NM_005606 5031990 Homo sapiens, protease, cysteine, 1 1GTCAACCTTTGTGAGAAGCCGTATCC (legumain), clone MGC:15832ACTTCACAGGATAAAATTGTCCAT IMAGE:3507728, mRNA, complete cds/cds = (1124,2425) 2795 Table 3A Hs.256290 NM_005620 5032058 S100 calcium-bindingprotein A11 1 ATCTCCACAGCCCACCCATCCCCTGA (caligizzarin) (S100A11), mRNA/GCACACTAACCACCTCATGCAGGC cds = (120, 437) 2796 Table 3A Hs.8180NM_005625 5032082 syndecan binding protein (syntenin) 1TTTCCTGACTCCTCCTTGCAAACAAA (SDCBP), mRNA/cds = (148, 1044)ATGATAGTTGACACTTTATCCTGA 2797 Table 3A Hs.76122 NM_005626 5032088splicing factor, arginine/serine-rich 4 1 CCTGCAGTAACCCATAGGAAATAAAC(SFRS4), mRNA/cds = (47, 1531) TGTAGAGTTCCATATTCTGCGGCC 2798 Table 3AHs.296323 NM_005627 5032090 serum/glucocorticoid regulated kinase 1TAGAAAGGGTTTTTATGGACCAATGC (SGK), mRNA/cds = (42, 1337)CCCAGTTGTCAGTCAGAGCCGTTG 2799 Table 3A Hs.155188 NM_005642 14717406 TATAbox binding protein (TBP)- 1 TGTGATGACGTGAGATCAATAAGAAG associatedfactor, RNA polymerase II, AACCTAGTCTAGAGACAATGATGC F, 55 kD (TAF2F),mRNA/ cds = (740, 1789) 2800 literature Hs.100030 NM_005652 5032168telomeric repeat binding factor 2 1 GTGCTTGCTGTCTCTCCCGGACACCC (TERF2),mRNA/cds = (124, 1626) TTAAAGACTGTCTTTTTAGCAAAA 2801 Table 3A Hs.82173NM_005655 5032176 TGFB inducible early growth response 1AACATTGTTTTTGTATATTGGGTGTAG (TIEG), mRNA/cds = (123, 1565)ATTTCTGACATCAAAACTTGGAC 2802 literature Hs.170263 NM_005657 5032188tumor protein p53-binding protein, 1 1 TGTGTAACTGGATTCCTTGCATGGAT(TP53BP1), mRNA/cds = (173, 6091) CTTGTATATAGTTTTATTTGCTGA 2803 Table 3AHs.2134 NM_005658 5032192 TNF receptor-associated factor 1 1CAGGACCTCCAAGCCACTGAGCAAT (TRAF1), mRNA/cds = (75, 1325)GTATAACCCCAAAGGGAATTCAAAA 2804 Table 3A Hs.7381 NM_005662 5032220voltage-dependent anion channel 3 1 GATCTGACCCACCAGTTTGTACATCA (VDAC3),mRNA/cds = (99, 950) CGTCCTGCATGTCCCACACCATTT 2805 Table 3A Hs.155968NM_005667 5031824 zinc finger protein homologous to 1ACAATCTCTGTCCAGCACCTCTTGGT Zfp103 in mouse (ZFP103), mRNA/TAAATAATGTATGCTGTGAGACAT cds = (922, 2979) 2806 Table 3A Hs.172813NM_005678 13027652 PAK-interacting exchange factor beta 1TGCGTCTTGTGAAATTGTGTAGAGTG (P85SPR), mRNA/cds = (473, 2413)TTTGTGAGCTTTTTGTTCCCTCAT 2807 Table 3A Hs.30570 NM_005710 5031956polyglutamine binding protein 1 1 CTTCGGCCTCCCTGGCCCTGGGTTA (PQBP1),mRNA/cds = (257, 1054) AAATAAAAGCTTTCTGGTGATCCTG 2808 Table 3A Hs.82425NM_005717 5031592 actin related protein 2/3 complex, 1TGAGCTTGTGCTTAGTATTTACATTG subunit 5 (16 kD) (ARPC5), mRNA/GATGCCAGTTTTGTAATCACTGAC cds = (24, 479) 2809 Table 3A Hs.6895 NM_0057195031596 actin related protein 2/3 complex, 1 ATTTGAAATTTTCTGCAGCATTAAAGCsubunit 3 (21 kD) (ARPC3), mRNA/ TGGCGCTTAATAAGAATAAGTAA cds = (25, 561)2810 Table 3A Hs.10927 NM_005721 7262289 HSZ78330 cDNA/clone =2.49-(CEPH) 1 TCGCATTCTGTTTCTTGCTTTAAAAGA AGAGTAAAGACAAGAGTGTTGGA 2811Table 3A Hs.42915 NM_005722 5031570 ARP2 (actin-related protein 2,yeast) 1 CCTGCCAGTGTCAGAAAATCCTATTT homolog (ACTR2), mRNA/ATGAATCCTGTCGGTATTCCTTGG cds = (74, 1258) 2812 Table 3A Hs.173125NM_005729 5031986 peptidylprolyl isomerase F (cyclophilin 1CTGTCAGCCAAGGTGCCTGAAACGAT F) (PPIF), mRNA/cds = (83, 706)ACGTGTGCCCACTCCACTGTCACA 2813 Table 3A Hs.83583 NM_005731 5031598 actinrelated protein 2/3 complex, 1 GAAGCGGCTGGCAACTGAAGGCTGG subunit 2 (34kD) (ARPC2), mRNA/ AACACTTGCTACTGGATAATCGTAG cds = (84, 988) 2814literature Hs.41587 NM_005732 5032016 Rad50 (Rad50) mRNA, complete cds/1 TCGATCAGTGCTCAGAGATTGTGAAA cds = (388, 4326) TGCAGTGTTAGCTCCCTGGGATTC2815 Table 3A Hs.182591 NM_005739 6382080 RAS guanyl releasing protein 11 AGGACAAATCTTGTTGTATTAACAGC (calcium and DAG-regulated)AGGGTCACTTCTCATTTTCTTTGC (RASGRP1), mRNA/cds = (103, 2498) 2816 Table 3AHs.182429 NM_005742 5031972 protein disulfide isomerase-related 1AGTCGTATTCTGTCACATAATATTTTG protein (P5), mRNA/cds = (94, 1416)AAGAAAACTTGGCTGTCGAAACA 2817 Table 3A Hs.291904 NM_005745 10047078accessory proteins BAP31/BAP29 1 AGGAGGGTGGGTGGAACAGGTGGAC (DXS1357E),mRNA/cds = (136, 876) TGGAGTTTCTCTTGAGGGCAATAAA 2818 Table 3A Hs.291904NM_005745 10047078 accessory proteins BAP31/BAP29 1AGGAGGGTGGGTGGAACAGGTGGAC (DXS1357E), mRNA/cds = (138, 876)TGGAGTTTCTCTTGAGGGCAATAAA 2819 Table 3A Hs.239138 NM_005748 5031976pre-B-cell colony-enhancing factor 1 TGCACCTCAAGATTTTAAGGAGATAA (PBEF),mRNA/cds = (27, 1502) TGTTTTTAGAGAGAATTTCTGCTT 2820 Table 3A Hs.179608NM_005771 5032034 retinol dehydrogenase homolog 1GCTTATGGTCCCCAGCATTTACAGTA (RDHL), mRNA/cds = (7, 978)ACTTGTGAATGTTAAGTATCATCT 2821 Table 3A Hs.173993 NM_005777 5032032 RNAbinding motif protein 6 (RBM6), 1 CTTGTTTTGTTTGTCTCTCCTTTTCTT mRNA/cds =(133, 3504) TTGTTACTGTTCTTGCTGCTAGA 2822 Table 3A Hs.201675 NM_0057785032030 RNA binding motif protein 5 (RBM5), 1 TTTTGGAAGATTTTCAGTCTAGTTGCmRNA/cds = (148, 2595) CAAATCTGGCTCCTTTACAAAAGA 2823 Table 3A Hs.152720NM_005792 5031918 M-phase phosphoprotein 6 1 TCAAGAATAAAAATGCCTCTCCAGCC(MPHOSPH6), mRNA/cds = (32, 514) TTAAGTATTTACATGCTCCCAGGT 2824 Table 3AHs.179982 NM_005802 5032190 tumor protein p53-binding protein 1TCTGGAAATGTGTTATAAGCTAGGAG (TP53BPL), mRNA/cds = (540, 2987)AATCCCTTTGGACAGTCTTTATTT 2825 Table 3A Hs.143460 NM_005813 6563384protein kinase C, nu (PRKCN), mRNA/ 1 ATTTCCTATCACCATACTTTTCCATGT cds =(555, 3227) GAAAACCTGAGCCTATTTCTAGT 2826 Table 3A Hs.142023 NM_0058165032140 T cell activation, increased late 1 TGGCTGTTGCTTTGCTTCATGTGTATexpression (TACTILE), mRNA/ GGCTATTTGTATTTAACAAGACTT cds = (928, 2637)2827 Table 3A Hs.157144 NM_005819 5032130 syntaxin 6 (STX6), mRNA/cds =1 ATAGCCATCCTCTTTGCAGTCCTGTT (0, 767) GGTTGTGCTCATCCTCTTCCTAGT 2828Table 3A Hs.99491 NM_005825 5031822 RAS guanyl releasing protein 2 1AGGGCCAGGGCTGGTGTCCCTAAGG (calcium and DAG-regulated)TTGTACAGACTCTTGTGAATATTTG (RASGRP2), mRNA/cds = (253, 2082) 2829 Table3A Hs.15265 NM_005826 14141188 heterogeneous nuclear 1GCCGTGACAATTTGTTCTTTGATGTG ribonucleoprotein R (HNRPR), mRNA/ATTGTATTTCCAATTTCTTGTTCA cds = (90, 1991) 2830 Table 3A Hs.18192NM_005839 5032118 Ser/Arg-related nuclear matrix protein 1TGGTATATACAACTTTCAGAGCCTCT (plenty of prolines 101-like) (SRM160),TGTATTTGGAAGGCTGGAAGGGCC mRNA/cds = (5, 2467) 2831 Table 3A Hs.29117NM_005859 5032006 purine-rich element binding protein A 1GCTACTGCAGGGTGAGGAAGAAGGG (PURA), mRNA/cds = (59, 1027)GAAGAAGATTGATCAAACAGAATGA 2832 Table 3A Hs.23964 NM_005870 12056471sin3-associated polypeptide. 18 kD 1 TGTTTCAAGCCCTTCTGTAAAATATGA(SAP18), mRNA/cds = (573, 1034) AGAAAAGTCTCTTAGCATTCTGT 2833 Table 3AHs.22960 NM_005872 5031652 breast carcinoma amplified sequence 1TTCTAAACACATTCTTGATCACCAAAC 2 (BCAS2), mRNA/cds = (48, 725)AACTTCAGAAAGACAGTGACTGT 2834 Table 3A Hs.21756 NM_005875 5031710translation factor sui1 homolog 1 ATCTTTGTGAGCAATTATGCTCCCAA (GC20),mRNA/cds = (241, 582) ATCTAAGCAAGTAATAAAGAAGGG 2835 Table 3A Hs.21189NM_005880 7549807 DnaJ (Hsp40) homolog, subfamily A, 1TGTAAAGTTTGTACAATTTGTCCTGAA member 2 (DNAJA2), mRNA/GCTTTGTGTTTGGCTGCACCTGC cds = (52, 1290) 2836 Table 3A Hs.277721NM_005899 14110374 membrane component, chromosome 1ACAGTATAACTCCTGAATGCTACTTA 17, surface marker 2 (ovarianAATAAACCAGGATTCAAACTGCAA carcinoma antigen CA125) (M17S2), transcriptvariant 2, mRNA/ cds = (459, 3359) 2837 db mining Hs.82483 NM_0059015174510 MAD (mothers against 1 AGAAGCAGATTTTCCTGTAGAAAAACdecapentaplegic, Drosophila) homolog TAATTTTTCTGCCTTTTACCAAAA 2 (MADH2),mRNA/cds = (55, 1458) 2838 db mining Hs.288261 NM_005902 5174512 cDNA:FLJ23037 fis, clone LNG02036, 1 GAGCTTGCTCCAGATTCTGATGCATA highlysimilar to HSU88019 mad CGGCTATATTGGTTTATGTAGTCA protein homolog(hMAD-3) mRNA/ cds = UNKNOWN 2839 db mining Hs.100602 NM_005904 5174516MAD (mothers against 1 ATGGGTGTTATCACCTAGCTGAATGT decapentaplegic,Drosophila) homolog TTTCTAAAGGAGTTTATGTTCCA 7 (MADH7), mRNA/cds = (295,1575) 2840 Table 3A Hs.75375 NM_005917 5174538 malate dehydrogenase 1,NAD 1 ACGTGCTTCTTGGTACAGGTTTGTGA (soluble) (MDH1), mRNA/ATGACAGTTTATCGTCATGCTGTT cds = (55, 1059) 2841 Table 3A Hs.32353NM_005922 5803087 mitogen-activated protein kinase 1TGTTGTTGTTGGCAAGCTGCAGGTTT kinase kinase 4 (MAP3K4), transcriptGTAATGCAAAAGGCTGATTACTGA variant 1, mRNA/cds = (142, 4965) 2842 Table 3AHs.68583 NM_005932 5174566 mitochondrial intermediate peptidase 1TCATTGTTCGCTTCTGTAATTCTGAAA (MIPEP), nuclear gene encodingAACTTTAAACTGGTAGAACTTGG mitochondrial protein, mRNA/ cds = (74, 2215)2843 Table 3A Hs.211581 NM_005955 5174588 metal-regulatory transcriptionfactor 1 1 CCAGTGCTGTTTGGTGGTCTGCCTTC (MTF1), mRNA/cds = (83, 2344)TTTTTAATGGTATTTTCTTCCTCA 2844 Table 3A Hs.78103 NM_005969 5174612nucleosome assembly protein 1-like 4 1 GCCCCACCATTCATCCTGTCTGAAGG(NAP1L4), mRNA/cds = (149, 1278) TCCTGGGTTTGGTGTGACCGCTTG 2845 Table 3AHs.48029 NM_005985 5174686 snail 1 (drosophila homolog), zinc 1CCGACAGGTGGGCCTGGGAGGAAAA finger protein (SNAI1), mRNA/TGTTTACATTTTTAAAGGCACACTG cds = (61, 855) 2846 Table 3A Hs.12570NM_005993 8400735 tubulin-specific chaperone d (TBCD), 1GGGGTGGACGCCTCTGCCTTCACTT mRNA/cds = (109, 3667)GAACACAAATGTGCTTCCTATAAAA 2847 Table 3A Hs.1708 NM_005998 5174726chaperonin containing TCP1, subunit 3 1 GGCAGCCCCCAGTCCCTTTCTGTCC(gamma) (CCT3), mRNA/cds = (0, CAGCTCAGTTTTCCAAAAGACACTG 1634) 2848Table 3A Hs.3712 NM_006003 5174742 ubiquinol-cytochrome c reductase, 1CTGTTAAGCACTGTTATGCTCAGTCA Rieske iron-sulfur polypeptide 1TACACGCGAAAGGTACAATGTCTT (UQCRFS1), nuclear gene encoding mitochondrialprotein, mRNA/ cds = (90, 914) 2849 Table 3A Hs.73818 NM_006004 5174744ubiquinol-cytochrome c reductase 1 ATGGGTTTGGCTTGAGGCTGGTAGCT hingeprotein (UQCRH), mRNA/ TCTATGTAATTCGCAATGATTCCA cds = (36, 311) 2850Table 3A Hs.3776 NM_006007 5174754 zinc finger protein 216 (ZNF216), 1TTCAGTTTTGCTTTCAATTTTATGTAC mRNA/cds = (288, 929)CTTAGTTCTGAGTTAGACCTGCA 2851 Table 3A Hs.272897 NM_006009 5174732Tubulin, alpha, brain-specific (TUBA3), 1 AAGGATTATGAGGAGGTTGGTGTGCAmRNA/cds = (0, 1355) TTCTGTTGAAGGAGAGGGTGAGGA 2852 Table 3A Hs.75412NM_006010 5174392 arginine-rich, mutated in early stage 1TCCCTTCCTTCTGTTGCTGGTGTACT tumors (ARMET), mRNA/CTAGGACTTCAAAGTGTGTCTGGG cds = (132, 836) 2853 Table 3A Hs.43910NM_006016 5174406 CD164 antigen, sialomucin (CD164), 1AGTTCATTAAAAACTGCAAAACCAAT mRNA/cds = (79, 648) CTGTATCATGTACCAAACTGACTT2854 Table 3A Hs.137555 NM_006018 5174460 putative chemokine receptor,GTP- 1 TGCACGTTCCTCCTGGTTCCTTCGCT binding protein (HM74), mRNA/TGTGTTTCTGTACTTACCAAAAAT cds = (60, 1223) 2855 Table 3A Hs.46465NM_006019 5174620 T-cell, immune regulator 1 (TCIRG1), 1TGCCAGACCTCCTTCCTGACCTCTGA mRNA/cds = (57, 2546)GGCAGGAGAGGAATAAAGACGGTC 2856 literature Hs.54418 NM_006020 5174384alkylation repair, alkB homolog (ABH), 1 AGTCCCAAGGGTGTTTTGTTACTGTTmRNA/cds = (223, 1122) TTCTCCATGAATAAACTCACTTGA 2857 Table 3A Hs.43628NM_006021 5174494 deleted in lymphocytic leukemia, 2 1ATTAATGTCATTTCTGGAAGTGTGAA (DLEU2), mRNA/cds = (240, 494)AATGTTAATGTTCAACAAGCAACA 2858 Table 3A Hs.82043 NM_006023 5174422 D123gene product (D123), mRNA/ 1 GCGGGTGGGCCGAGCAGTGTGGACA cds = (280, 1290)TCAGCCACTTTTTATATTCATGTAC 2859 Table 3A Hs.997 NM_006025 5174622protease, serine, 22 (P11), mRNA/ 1 CCACTGAGAACTAAATGCTGTACCAC cds =(154, 1263) AGAGCCGGGTGTGAACTATGGTTT 2860 Table 3A Hs.109804 NM_0060265174448 H1 histone family, member X (H1FX), 1 AAACAATCGCTCCGGGCTCAGGGCTmRNA/cds = (101, 742) GCGCGGCTCTTCCCTTCATTCCATG 2861 Table 3A Hs.24594NM_006048 5174482 ubiquitination factor E4B (homologous 1TGTCCTCTGTTCAATTCCTAACGCAA to yeast UFD2) (UBE4B), mRNA/ACTACAATAAATGGTGACACACGT cds = (85, 3993) 2862 Table 3A Hs.274243NM_006054 5174654 receptor tyrosine kinase-like orphan 1AGCACCTAAGGAGCTTGAATCTTGGT receptor 1 (ROR1), mRNA/TCCTGTAAAATTTCAAATTGATGT cds = (375, 3188) 2863 Table 3A Hs.54452NM_006060 5174500 zinc finger protein, subfamily 1A, 1 1ACCAACACTGTCCCAAGGTGAAATGA (lkeros) (ZNFN1A1), mRNA/AGCAACAGAGAGGAAATTGTACAT cds = (168, 1727) 2864 Table 3A Hs.318501NM_006074 5174698 stimulated trans-acting factor (50 kDa) 1TGTCAGCCATTTCAATGTCTTGGGAA (STAF50). ACAATTTTTTGTTTTTGTTCTGTT 2865 Table3A Hs.8024 NM_006083 11038650 IK cytokine, down-regulator of HLA II 1AGAGCTTGATCGCCAGTGGAAGAAG (IK), mRNA/cds = (111, 1784)ATTAGTGCAATCATTGAGAAGAGGA 2866 Table 3A Hs.1706 NM_006084 5174474interferon-stimulated transcription 1 TTTCCCTCTTCCCTGACCTCCCAACT factor3, gamma (48 kD) (ISGF3G), CTAAAGCCAAGCACTTTATATTTT mRNA/cds = (34,1215) 2867 Table 3A Hs.5662 NM_006098 5174446 guanine nucleotide bindingprotein (G 1 GGCAGGTGACCATTGGCACACGCTA protein), beta polypeptide 2-like1 GAAGTTTATGGCAGAGCTTTACAAA (GNB2L1), mRNA/cds = (95, 1048) 2868 Table3A Hs.284142 NM_006134 8659558 chromosome 21 open reading frame 4 1CTGTTTGTAGATAGGTTTTTTATCTCT (C21orf4), mRNA/cds = (158, 634)CAGTACACATTGCCAAATGGAGT 2869 Table 3A Hs.1987 NM_006139 5453610 CD28antigen (Tp44) (CD28), mRNA/ 1 GCTCACCTATTTGGGTTAAGCATGCC cds = (222,884) AATTTAAAGAGACCAAGTGTATGT 2870 Table 3A Hs.82646 NM_006145 5453689heat shock 40 kD protein 1 (HSPF1), 1 TAGACTCATTGTAAGTTGCCACTGCCmRNA/cds = (40, 1062) AACATGAGACCAAAGTGTGTGACT 2871 Table 3A Hs.334851NM_006148 5453709 LIM and SH3 protein 1 (LASP1), 1CAAACCTTTCTGGCCTGTTATGATTC mRNA/cds = (75, 860) TGAACATTTGACTTGAACCACAAG2872 Table 3A Hs.40202 NM_006152 5453723 lymphoid-restricted membraneprotein 1 GGGAAAGTATAGCATGAAACCAGAG (LRMP), mRNA/cds = (574, 2241)GTTCTCAGAATGACCGTAAGATAGC 2873 Table 3A Hs.75512 NM_006156 5453759neural precursor cell expressed, 1 AGTCCTGTGTGCTTCCCTCTCTTATGdevelopmentally down-regulated 6 ACTGTGTCCCTGGTTGTCAATAAA (NEDD8),mRNA/cds = (99, 344) 2874 Table 3A Hs.79389 NM_006159 5453765 nel(chicken)-like 2 (NELL2), mRNA/ 1 ATCTTCAGAATCAGTTAGGTTCCTCA cds = (96,2546) CTGCAAGAAATAAAATGTCAGGCA 2875 Table 3A Hs.96149 NM_006162 5453771transcription factor (NF-ATc/B) mRNA/ 1 CTTCTGGCACCCCTGGGGTTCAATACcomplete cds/cds = (369, 2646) TGGAAGTGCCTTATTTAACCAGAC 2876 Table 3AHs.75643 NM_006163 5453773 nuclear factor (erythroid-derived 2), 1GGTCTTTAGCCTCCACCTTGTCTAAG 45 kD (NFE2), mRNA/cds = (273,CTTTGGTCTATAAAGTGCGCTACA 1394) 2877 Table 3A Hs.155396 NM_006164 5453775nuclear factor (erythroid-derived 2)-like 1 TGATGATATGACATCTGGCTAAAAAGNFE2L2), mRNA/cds = (39, AAATTATTGCAAAACTAACCACGA 1808) 2878 Table 3AHs.95262 NM_006165 5453777 nuclear factor related to kappa B 1TCCAAAGCAGTCTCCACTGTTGTTGT binding protein (NFRKB), mRNA/GACTACAGCTCCGTCTCCTAAACA cds = (2220, 5216) 2879 Table 3A Hs.15243NM_006170 5453791 nucleolar protein 1 (120 kD) (NOL1), 1ATTGTCACCAGGTTGGAACTCTTGCC mRNA/cds = (0, 2567) TCTGTGAGGATGCCTTCTCTACTG2880 Table 3A Hs.82120 NM_006186 5453821 nuclear receptor subfamily 4,group A, 1 TTTTCTTTGTATATTTCTAGTATGGCA member 2 (NR4A2), mRNA/CATGATATGAGTCACTGCCTTTT cds = (317, 2113) 2881 Table 3A Hs.41694NM_006190 5453829 origin recognition complex, subunit 2 1TGACCTTCATGATACCAGTGAGAAGC (yeast homolog)-like (ORC2L), mRNA/CAGGCTAGAGAAATAAAATCCTGA cds = (186, 1919) 2882 Table 3A Hs.2853NM_006196 14141164 poly(rC)-binding protein 1 (PCBP1), 1ACGGATTGGTTAAAAAATGCTTCATA mRNA/cds = (177, 1247)TTTGAAAAAGCTGGGAATTGCTGT 2883 Table 3A Hs.79709 NM_006224 5453907phosphotidylinositol transfer protein 1 GTCTCTCTCCATTGTGTTCCGATCCA(PITPN), mRNA/cds = (216, 1028) TTTCTGTGTGTTCCCCCAACCTTT 2884 Table 3AHs.89040 NM_006228 11079650 prepronociceptin (PNOC), mRNA/ 1GCCACTGCCATAACTTGTTTGTAAAA cds = (211, 741) GAGCTGTTCTTTTTGACTGATTGT2885 literature Hs.168846 NM_006231 5453925 polymerase (DNA directed),epsilon 1 GAACATTGCCCAGCACTACGGCATGT (POLE), mRNA/cds = (44, 6904)CGTACCTCCTGGAGACCCTGGAGT 2886 Table 3A Hs.155079 NM_006243 5453949protein phosphatase 2, regulatory 1 ATCTTCATTGGGGGATTGAGCAGCAT subunit B(B56), alpha isoform TTAATAAAGTCTATGTTTGTATTT (PPP2R5A), mRNA/cds =(571, 2031) 2887 Table 3A Hs.9247 NM_006251 5453963 protein kinase,AMP-activated, alpha 1 1 TTATAACCGAGGGCTGGCGTTTTGGA catalytic subunit(PRKAA1), mRNA/ ATCGAATTTCGACAGGGATTGGAA cds = (23, 1675) 2888 Table 3AHs.315366 NM_006255 5453971 protein kinase C, eta (PRKCH), mRNA/ 1TTCCCAGCATCAGCCTTAGAACAAGA cds = (166, 2214) ACCTTACCTTCAAGGAGCAAGTGA2889 Table 3A Hs.75348 NM_006263 5453989 proteasome (prosome, macropain)1 CCAGATTTTCCCCAAACTTGCTTCTG activator subunit 1 (PA28 alpha)TTGAGATTTTTCCCTCACCTTGCC (PSME1), mRNA/cds = (92, 841) 2890 Table 3AHs.81848 NM_006265 5453993 RAD21 (S. pombe) homolog (RAD21), 1AACCAAGGAGTTTTCCCCGTTTGTAA mRNA/cds = (184, 2079)AAAGACATTGTAGATAATTGAATG 2891 Table 3A Hs.199179 NM_006267 6382078 RANbinding protein 2 (RANBP2), 1 ACCATGTTCTTTCGTTAAAGATTTGCT mRNA/cds =(127, 9801) TTATACAAGATTGTTGCAGTACC 2892 Table 3A Hs.173159 NM_0062835454099 transforming, acidic coiled-coil 1 CACATCTGCTTCCACTGTGTTCCCACcontaining protein 1 (TACC1), mRNA/ GGGTGCCATGAAGTGTGTGAGGAG cds = (320,2737) 2893 Table 3A Hs.89657 NM_006284 5454105 TATA box binding protein(TBP)- 1 CGCACTACTTCACCTGAGCCACCCAA associated factor, RNA polymeraseII, CCTAAATGTACTTATCTGTCCCCA H, 30 kD (TAF2H), mRNA/ cds = (17, 673)2894 Table 3A Hs.116481 NM_001782 4502682 CD72 antigen (CD72), mRNA/ 1GGGCGGCCCGGAGCCAGCCAGGCA cds = (108, 1187) GTTTTATTGAAATCTTTTTAAATAAT2895 Table 3A Hs.18420 NM_006289 5454129 talin 1 (TLN1), mRNA/cds =(126, 1 CTCTCCAAGAGTATTATTAACGCTGC 7751) TGTACCTCGATCTGAATCTGCCGG 2896Table 3A Hs.211600 NM_006290 5454131 tumor necrosis factor,alpha-induced 1 TCCCTAATAGAAAGCCACCTATTCTTT protein 3 (TNFAIP3), mRNA/GTTGGATTTCTTCAAGTTTTTCT cds = (66, 2438) 2897 Table 3A Hs.101382NM_006291 5454133 tumor necrosis factor, alpha-induced 1AGTACTGCTTTTGTATGTATGTTGAAC protein 2 (TNFAIP2), mRNA/AGGATCCAGGTTTTTATAGCTTG cds = (131, 2095) 2898 Table 3A Hs.118910NM_006292 5454139 tumor susceptibility gene 101 1CACTTTCTATCCTCTGTAAACTTTTTG (TSG101), mRNA/cds = (90, 1262)TGCTGAATGTTGGGACTGCTAAA 2899 Table 3A Hs.131255 NM_006294 5454151ubiquinol-cytochrome c reductase 1 GAAGAATGGGCAAAGAAGTAATCATG bindingprotein (UQCRB), mRNA/ TAGTTGAAGTCTGTGGATGCAGCT cds = (32, 367) 2900Table 3A Hs.279841 NM_018062 8922359 hypothetical protein FLJ10335 1CAAAGGTTCTTGAGACTCTTGATATTT (FLJ10335), mRNA/cds = (33, 1160)CTGTCTTCTCCTTGTGCTTTCCT 2901 literature Hs.98493 NM_006297 5454171 X-rayrepair complementing defective 1 CCGATGGATCTACAGTTGCAATGAGA repair inChinese hamster cells 1 AGCAGAAGTTACTTCCTCACCAGC (XRCC1), mRNA/cds =(105, 2006) 2902 Table 3A Hs.293007 NM_006310 5453987 aminopeptidasepuromycin sensitive 1 TTCCTGCATAACTCAATCTGAACCAA (NPEPPS), mRNA/cds =(404, 3031) GGATTGTAGTTTAGTTTTCCTCCT 2903 Table 3A Hs.287994 NM_0063125454073 nuclear receptor co-repressor 2 1 GCAGGGTGGTGGTATTCTGTCATTTA(NCOR2), mRNA/cds = (1, 7554) CACACGTCGTTCTAATTAAAAAGC 2904 Table 3AHs.10842 NM_006325 6042206 RAN, member RAS oncogene family 1GCACTTTTTGTTTGAATGTTAGATGCT (RAN), mRNA/cds = (114, 764)TAGTGTGAAGTTGATACGCAAGC 2905 db mining Hs.12540 NM_006330 5453721lysophospholipase I (LYPLA1), mRNA/ 1 GCAAGAAATATTCCATTGAAATATTGT cds =(35, 727) GCTGTAACATGGGAAAGTGTAAA 2906 literature Hs.19400 NM_0063416006019 MAD2 (mitotic arrest deficient, yeast, 1GCCAACACTGTCTGTCTCAAATACTG homolog)-like 2 (MAD2L2), mRNA/TGCTGTGAGTTGTTTCAATAAAGG cds = (111, 746) 2907 Table 3A Hs.104019NM_006342 5454101 transforming, acidic coiled-coil 1GACCTCATCTCCAAGATGGAGAAGAT containing protein 3 (TACC3),CTGACCTCCACGGAGCCGCTGTCC mRNA/cds = (108, 2624) 2908 Table 3A Hs.43913NM_008346 5453889 PIBF1 gene product (PIBF1), 1CTTTACTAAAAAAGAAGCACCTGAGT mRNA/cds = (0, 2276) GGTCTAAGAAACAAAAGATGAAGA2909 Table 3A Hs.158196 NM_006354 5454103 Homo sapiens, Similar to 1GCCTGGAAGACTCTGAAGGAGCGTG transcriptional adaptor 3 (ADA3, yeastAGAGCATCCTGAAGCTGCTGGATGG homolog)-like (PCAF histone acetylasecomplex), clone MGC:3508 IMAGE:3009860, mRNA, complete cds/cds = (557,1666) 2910 Table 3A Hs.307099 NM_006356 5453558 clone 023e08 My032protein mRNA, 1 CAGGAGGAAGCTCTGGCCCTTGTATT complete cds/cds = (46, 459)ACACATTCTGGACATTAAAAATAA 2911 Table 3A Hs.69469 NM_006360 5453653dendritic cell protein (GA17), 1 GCCTTTTGAGTCTTTCCGATACCTGA mRNA/cds =(51, 1175) GTTTTTATGCTTATAATTTTTGTT 2912 Table 3A Hs.173497 NM_00636314591927 Sec23 (S. cerevisiae) homolog B 1 TTAAGCTGAGGATACAACCAGGAAAT(SEC23B), transcript variant 3, GCAACGGTGTCAGATTGTGTTCAA mRNA/cds =(112, 2415) 2913 Table 3A Hs.104125 NM_006367 10938021 adenylylcyclase-associated protein 1 TCTACCCATTTCCTGAGGCCTGTGGA (CAP), mRNA/cds= (62, 1489) AATAAACCTTTATGTACTTAAAGT 2914 Table 3A Hs.79089 NM_0063785454049 sema domain, immunoglobulin domain 1 AGCAATAAACTCTGGATGTTTGTGCG(lg), transmembrane domain (TM) and CGTGTGTGGACAGTCTTATCTTCC shortcytoplasmic domain, (semaphorin) 4D (SEMA4D), mRNA/cds = (87, 2675) 2915Table 3A Hs.279939 NM_008389 13699881 mitochondrial carrier homolog 1 1AGCTGTTGATGCTGGTTGGACAGGTT (MTCH1), nuclear gene encodingTGAGTCAAATTGTACTTTGCTCCA mitochondrial protein, mRNA/cds = (0, 1118)2916 Table 3A Hs.296585 NM_006392 5453793 nucleolar protein (KKE/D)repeat) 1 AGGTGACATTTCCCACCCTGTGCCCG (NOP56), mRNA/cds = (21, 1829)TGTTCCCAATAAAAACAAATTCAC 2917 Table 3A Hs.84153 NM_006400 13259506dynactin 2 (p50) (DCTN2), 1 CTGTGGCTGACTGTAATACTGTACAA mRNA/cds = (136,1358) CTGTTTCTGACCATTAAATGCTGT 2918 Table 3A Hs.80261 NM_006403 5453679enhancer of filamentation 1 (cas-like 1 ACATATGCAGACCTGACACTCAAGAGdocking; Crk-associated substrate TGGCTAGCTACACAGAGTCCATCT related)(HEF1), mRNA/cds = (163, 2667) 2919 Table 3A Hs.92384 NM_006407 7669496vitamin A responsive; cytoskeleton 1 TGACTTCACAGACATGGTCTAGAATC related(JWA), mRNA/cds = (89, 855) TGTACCCTTACCCACATATGAAGA 2920 Table 3AHs.139120 NM_006413 5454023 Homo sapiens, ribonuclease P (30kD), 1CCCAGTCTCTGTCAGCACTCCCTTCT clone MGC:12256 IMAGE:3827681,TCCCTTTTATAGTTCATCAGCCAC mRNA, complete cds/cds = (294, 1100) 2921 Table3A Hs.82921 NM_006416 5453620 solute carrier family 35 (CMP-sialic 1TGACTGAGTACCCCTTTAGTGAGTAC acid transporter), member 1CCCTTTAGTGCTATATTTGTGCCA (SLC35A1), mRNA/cds = (27, 1040) 2922 Table 3AHs.82316 NM_006417 5453743 interferon-induced, hepatitis C- 1TGCCTTTTGAGCAAATAGGGAATCTA associated microtubular aggregateAGGGAGGAAATTATCAACTGTGCA protein (44kD) (MTAP44), mRNA/cds = (0, 1334)2923 db mining Hs.100431 NM_006419 5453576 small inducible cytokine Bsubfamily 1 GCGGGGCCGGGGGGACTCTGGTATC (Cys-X-Cys motif), member 13(B-cell TAATTCTTTAATGATTCCTATAAAT chemoattractant) (SCYB13), mRNA/cds =(90, 419) 2924 Table 3A Hs.94631 NM_006421 6715588 brefeldin A-inhibitedguanine 1 ACAACTTTCTGTACAATATTGATTCCC nucleotide-exchange protein 1(BIG1), ATCTGGCATATTCTAATCAGGTT mRNA/cds = (141, 5690) 2925 Table 3AHs.108809 NM_006429 5453806 chaperonin containing TCP1, subunit 7 1TTTTACAAGGAAGGGGTAGTAATTGG (eta) (CCT7), mRNA/cds = (68, 1699)CCCACTCTCTTCTTACTGGAGGCT 2926 Table 3A Hs.119529 NM_006432 5453677epididymal secretory protein (19.5kD) 1 AACAACATTAACTTGTGGCCTCTTTCT(HE1), mRNA/cds = (10, 465) ACACCTGGAAATTTACTCTTGAA 2927 Table 3AHs.174195 NM_006435 10835237 interferon induced transmembrane 1ACAGCCGAGTCCTGCATCAGCCCTTT protein 2 (1-8D) (IFITM2),ATCCTCACACGCTTTTCTACAATG mRNA/cds = (279, 677) 2928 Table 3A Hs.77225NM_006437 11496990 ADP-ribosyltransferase (NAD+; poly 1GTCAAGGCTAAGTCAAATGAAACTGA (ADP-ribose) polymerase)-like 1ATTTTAAACTTTTTGCATGCTTCT (ADPRTL1), mRNA/cds = (106, 5280) 2929 Table 3AHs.118131 NM_006441 5453745 5,10-methenyltetrahydrofolate 1AAACGACATGAAGGTAGATGAAGTCC synthelase (5-formyltetrahydrofolateTTTACGAAGACTCGTCAACAGCTT cyclo-ligase) (MTHFS), mRNA/cds = (13, 624)2930 Table 3A Hs.340268 NM_006461 5453831 qy37e05.x1 cDNA, 3′ 1CCCAATACCAAGACCAACTGGCATAG end/clone = AGCCAACTGAGATAAATGCTATTTIMAGE:2014208/clone_end = 3′ 2931 Table 3A Hs.233936 NM_006471 5453739myosin, light polypeptide, regulatory, 1 GGGTCTATACAGAGTCAATATATTTTTnon-sarcomeric (20kD) (MLCB), TCAGAGAAAGTTAGTTCGGCTCG mRNA/cds = (114,629) 2932 Table 3A Hs.179526 NM_006472 5454161 upregulated by1,25-dihydroxyvitamin 1 CCAGAAAGTGTGGGCTGAAGATGGT D-3 (VDUP1),TGGTTTCATGTGGGGGTATTATGTA mRNA/cds = (221, 1396) 2933 Table 3A Hs.5509NM_006495 5729817 ecotropic viral integration site 2B 1TCCAACCTTGAGATCCAGTGTCAGGA (EVI2B), mRNA/cds = (0, 1346)GTTCTCTATTCCTCCCAACTCTGA 2934 literature Hs.155573 NM_006502 5729981polymerase (DNA directed), eta 1 TGGCACAGAAAAGGGACCAAGTTTAA (POLH),mRNA/cds = (237, 2378) AAAAGGGTTTTAAATGTAATGAGA 2935 db mining Hs.858NM_006509 5730006 v-rel avian reticuloendotheliosis viral 1GGGGTAGGTTGGTTGTTCAGAGTCTT oncogene homolog B (nuclear factor ofCCCAATAAAGATGAGTTTTTGAGC kappa light polypeptide gene enhancer inB-cells 3) (RELB), mRNA/cds = (144, 1883) 2936 Table 3A Hs.4888NM_006513 5730028 seryl-tRNA synthetase (SARS), 1TGGGCATAGGGACCCATCATTGATGA mRNA/cds = (75, 1619)CTGATGAAACCATGTAATAAAGCA 2937 Table 3A Hs.155040 NM_006526 5730123 zincfinger protein 217 (ZNF217), 1 ATTTTCCTACAGCCCTTTGTACTTCAA mRNA/cds =(271, 3417) AATATGTTTTTGTGTCCATCAGT 2938 Table 3A Hs.251636 NM_0065375730109 ubiquitin specific protease 3 (USP3), 1TCAGCACTAACTAAATAAATTTGTTGG mRNA/cds = (93, 1658)TTCAGTTGTACTTGTCCTGCAAA 2939 Table 3A Hs.86088 NM_006548 5729881 IGF-IImRNA-binding protein 1 (IMP- 1 AGAGGGTGGATCACACCTCAGTGGG 1), mRNA/cds =(9, 1742) AAGAAAAATAAAATTTCCTTCAGGT 2940 Table 3A Hs.119537 NM_0065595730026 GAP-associated tyrosine 1 TGTGTAAGTCTGCCTAAATAGGTAGCphosphoprotein p62 (Sam68) (SAM68), TTAAACTTATGTCAAAATGTCTGC mRNA/cds =(106, 1437) 2941 Table 3A Hs.59106 NM_006568 5729764 cell growthregulatory with ring finger 1 TCCTTTCTGCTTAGTGAATGAATACT domain (CGR19),GGAATCCATCTGTGTTGATACAAT mRNA/cds = (27, 1025) 2942 db mining Hs.270737NM_006573 5730096 tumor necrosis factor (ligand) 1GCAATACCAAGAGAAAATGCACAAAT superfamily, member 13b (TNFSF13B),ATCACTGGATGGAGATGTCACATT mRNA/cds = (0, 857) 2943 Table 3A Hs.4069NM_006582 13435376 glucocorticoid modulatory element 1TGGGGATCTCAGGGCCAGGAGTTAT binding protein 1 (GMEB1), transcriptGTTTTGATTTGGAATTTTAATTATT variant 1, mRNA/cds = (138, 1859) 2944 Table3A Hs.12820 NM_006590 5730024 SnRNP assembly defective 1 homolog 1CCAGTAACTTCGCTCTGTTAGAGGTG (SAD1), mRNA/cds = (492, 1466)GAGGATTTTCCTATGTTCCCCCCA 2945 literature Hs.241517 NM_006596 5729983 DNApolymerase theta (POLQ) 1 TGCTGAAAAGATTGTACTTTGTGATC mRNA, completecds/cds = (0, 8174) CCAATCAGAGGGATGGAGCTAATC 2946 Table 3A Hs.180414NM_006597 5729876 heat shock 70kD protein 8 (HSPA8), 1TCAGACTGCTGAGAAGGAAGAATTTG mRNA/cds = (83, 2023)AACATCAACAGAAAGAGCTGGAGA 2947 Table 3A Hs.154672 NM_006836 13699869methylene tetrahydrofolate 1 TGGGCAGCTTGGGTAAGTACGCAAC dehydrogenase(NAD+ dependent), TTACTTTTCCACCAAAGAACTGTCA methenyltetrahydrofolatecyclohydrolase (MTHFD2), nuclear gene encoding mitochondrial protein,mRNA/cds = (76, 1110) 2948 Table 3A Hs.38927 NM_006644 5729878 heatshock 105kD (HSP105B), 1 TGTGAAAGTGTGGAATGGAAGAAATG mRNA/cds = (313,2757) TCGATCCTGTTGTAACTGATTGTG 2949 Table 3A Hs.1845 NM_006674 5729965MHC class I region ORF (P5-1), 1 CTAATTTCAGTGCTTGTGCTTGGTTG mRNA/cds =(304, 735) TTCAGGGCCATTTCAGGTTTGGGT 2950 Table 3A Hs.76807 NM_0066965730052 major histocompatibility complex, class 1AGCTAGCAGATCGTAGCTAGTTTGTA II, DR alpha (HLA-DRA),TTGTCTTGTCAATTGTACAGACTT mRNA/cds = (26, 790) 2951 Table 3A Hs.5300NM_006698 5729737 bladder cancer associated protein 1ATGGGCCAGGCAGAGAACAGAACTG (BLCAP), mRNA/cds = (254, 517)GAGGCAGTCCATCTAGGGAATGGGA 2952 Table 3A Hs.75207 NM_006708 5729841glyoxalase I (GLO1), 1 GTTTCCTTTTTGGGTGAAATGGATTTA mRNA/cds = (87, 641)TGTGAGTGCTTTAAACAAATAGC 2953 Table 3A Hs.74861 NM_006713 5729967activated RNA polymerase II 1 GAACAATGGAGCCAGCTGAAGGAAC transcriptioncofactor 4 (PC4), AGATTTCTGACATAGATGACGCAGT mRNA/cds = (0, 383) 2954Table 3A Hs.195471 NM_006732 58030166-phosphofructo-2-kinase/fructose-2,6- 1 CGTCCCCTCTCCCCTTGGTTCTGCACbiphosphatase 3 (PFKFB3), TGTTGCCAATAAAAAGCTCTTAAA mRNA/cds = (114,1676) 2955 Table 3A Hs.75367 NM_006748 5803170 Src-like adapter (SLA), 1GAGCACCCAGAGGGATTTTTCAGTG mRNA/cds = (41, 871) GGAAGCATTACACTTTGCTAAATCA2956 Table 3A Hs.77837 NM_006759 13027637 UDP-glucose pyrophosphorylase2 1 AGCACAGATGGTGCAATACTTTCCTT (UGP2), mRNA/cds = (84, 1610)CTTTGAAGAGATCCCAAAGTTAGT 2957 Table 3A Hs.75462 NM_006783 5802987 BTGfamily, member 2 (BTG2), 1 TGGAAGAATGTACAGCTTATGGACAA mRNA/cds = (71,547) ATGTACACCTTTTTGTTACTTTAA 2958 Table 3A Hs.100555 NM_006773 13787205DEAD/H (Asp—Glu—Ala—Asp/His) 1 TTTTGGAGCAAAAACTATGGGTTGTA boxpolypeptide 18 (Myc-regulated) ATTTGAATAAAGTGTCACTAAGCA (DDX18),mRNA/cds = (71, 2063) 2959 Table 3A Hs.143604 NM_006777 10048402 Kaiso(ZNF-kaiso), 1 TTCAGCAGGAAAATGATTCAATTTTTA mRNA/cds = (0, 2018)AACAAAATGTAACAGATGGCAGT 2960 Table 3A Hs.33085 NM_006784 5803220 WDrepeat domain 3 (WDR3), 1 AAGTAGCCAAGCTAAGATGCCTGGCT mRNA/cds = (47,2878) GGGCTTCTGAGGAATTAATACACT 2961 Table 3A Hs.4943 NM_006787 10863906hepatocellular carcinoma associated 1 CTGACCGCCACTCTCACATTTGGGCTprotein; breast cancer associated gene CTTCGCTGGCCTTGGTGGAGCTGG 1(JCL-1), mRNA/cds = (69, 1889) 2962 Table 3A Hs.6353 NM_006791 5803101MORF-related gene 15 (MRG15), 1 TGCATTGTGTAGCTAGTTTTCTGGAA mRNA/cds =(131, 1102) AAGTCAATCTTTTAGGAATTGTTT 2963 Table 3A Hs.88764 NM_0068005803103 male-specific lethal-3 (Drosophila)-like 1ACAGCTATACTTTGTTGTGTAATGTTA 1 (MSL3L1), mRNA/cds = (105, 1670)TGGTTCCCTTTCTGTAAAATGTT 2964 Table 3A Hs.77897 NM_006802 5803166splicing factor 3a, subunit 3, 60kD 1 GACAGGATCCCCCAGAGACCCCATTT(SF3A3), mRNA/cds = (8, 1513) GCCTCTCAACACTCAGACCTTCAA 2965 Table 3AHs.272168 NM_006811 5803192 DNA sequence from clone RP1- 1TTTGGTTTAAAATGTAAGATAGGAAA 179M20 on chromosome 20 Contains aTGTTGGATATTTGAGGCCATGCT 3′ end of a novel gene similar to cellularretinaldehyde-binding protein, the TDE1 gene (Tumour differentiallyexpressed 1), the PKIG gene encoding protein kinase (cAMP-dependent,catalytic) inhibitor gamma, the 3′ end of the ADA gene encodingadenosine deaminase, 2 CpG islands, ESTs, STSs and GSSs/cds = (69, 1490)2966 Table 3A Hs.75969 NM_006813 5802981 proline-rich protein withnuclear 1 AATCTACATTTTCTTACCAGGAGCAG targeting signAl (B4-2),CATTGAGGTTTTTGAGCATAGTAC mRNA/cds = (113, 1096) 2967 Table 3A Hs.75841NM_006817 13124889 chromosome 12 open reading frame 8 1ACTAACCCACGATTCTGAGCCCTGAG (C12orf8), mRNA/cds = (11, 796)TATGCCTGGACATTGATGCTAACA 2968 Table 3A Hs.75612 NM_006819 5803180stress-induced-phosphoprotein 1 1 TTATTCTGCGTCCCCTTCTCCAATAAA(Hsp70/Hsp90-organizing protein) ACAAGCCAGTTGGGCGTGGTTAT (STIP1),mRNA/cds = (62, 1693) 2969 Table 3A Hs.75470 NM_006820 5803026hypothetical protein, expressed in 1 TCCTTCCCACTCTCTCCAACATCACAosteoblast (GS3688), TTCACTTTAAATTTTTCTGTATAT mRNA/cds = (241, 1482)2970 Table 3A Hs.74405 NM_006826 5803226 tyrosine3-monooxygenase/typtophan 1 AGTCCCAAAAAAGCCTTGTGAAAATG 5-monooxygenaseactivation protein, TTATGCCCTATGTAACAGCAGAGT theta-polypeptide (YWHAQ),mRNA/cds = (100, 837) 2971 Table 3A Hs.15591 NM_006833 5803095 COP9subunit 6 (MOV34 homolog, 34 1 AGGGGAGGGCACTACACTTCCTTGA kD)(MOV34-34KD), GAGAAACCGCTGTCATTAATAAAAG mRNA/cds = (43, 938) 2972 Table3A Hs.79933 NM_006835 5802991 cycline I (CCNI), mRNA/cds = 1AGGCTGTAGAAGGAAATATACCTTAA (0, 1133) CAGGCTGATTTGGAGTGACCCAGA 2973 Table3A Hs.278613 NM_006837 5803045 interferon, alpha-inductible protein 27 1ACCAGTTACCCAAAATCTGATTAGAA (IF127), mRNA/cds = (54, 422)GTATAAGGTGCTCTGAAGTGTCCT 2974 Table 3A Hs.78504 NM_006839 5803114 innermembrane protein, mitochondrial 1 TGAGGCTTGTGAGGCCAATCAAAATA (mitofilin)(IMMT), ATGTTTGTGATCTCTACTACTGTT mRNA/cds = (92, 2368) 2975 Table 3AHs.75916 NM_006842 5803154 splicing factor 3b, subunit 2, 145kD 1CAGTTCCCAAGGACTTGTCATTTCAT (SF3B2), mRNA/cds = (48, 2666)GTTCTTATTTTAGACCTGTTTTGT 2976 db mining Hs.105928 NM_006847 5803063leukocyte immunoglobulin-like 1 ACCACTAGAAGATTCCGGGAACGTTG receptor,subfamily B (with TM and GGAGTCACCTGATTCTGCAAAGAT ITIM domains), member3 (LILRB3), mRNA/cds = (49, 1944) 2977 Table 3A Hs.315463 NM_0068505803085 interleukin 24 (IL24), 1 GTCAAGCTGACCTTGCTGATGGTGAC mRNA/cds =(274, 894) ATTGCACCTGGATGTACTATCCAA 2978 Table 3A Hs.64639 NM_0068515803150 glioma pathogenesis-related protein 1 ACAGCTCAAGTACCCTAATTTAGTTC(RTVP1), mRNA/cds = (128, 928) TTTTGGACTAATACAATTCAGGAA 2979 db miningHs.113277 NM_006865 5803061 leukocyte immunoglobulin-like 1GATGACGCTGGGCACAGAGGGTCAG receptor, subfamily A (without TMGTCCTGTCAAGAGGAGCTGGGTGTC domain), member 3 (LILRA3), mRNA/cds = (62,1381) 2980 Table 3A Hs.82143 NM_006874 6857815 E74-like factor 2 (etsdomain 1 AACATCTCTCTTCTCCTTCCCAACTAC transcription factor) (ELF2),TGCATGAAGAAATTCTACTTCCA mRNA/cds = (121, 1722) 2981 Table 3A Hs.80205NM_006875 5803124 pim-2-oncogene (PIM2), 1 TTCCTGCCTGGATTATTTAAAAAGCCmRNA/cds = (185, 1189) ATGTGTGGAAACCCACTATTTAAT 2982 Table 3A Hs.177530NM_006886 5901895 ATP synthase, H+ transporting, 1TGCTACATTTCCAAGGTGAAGATGTG mitochondrial F1 complex, epsilonTGGGCACATGTTATGGCAGATTGA subunit (ATP5E), mRNA/cds = (91, 246) 2983Table 3A Hs.177656 NM_006888 5901911 calmodulin 1 (phosphorylase kinase,1 ACAACCATCAACATTGCTGTTCAAAG delta) (CALM1), AAATTACAGTTTACGTCCATTCCAmRNA/cds = (199, 648) 2984 Table 3A Hs.155410 NM_006899 5901981isocitrate dehydrogenase 3 (NAD+) 1 CCCACCCATAGGCCCTGTCCATACCC beta(IDH38), mRNA/cds = (79, 1236) ATGTAAGGTGTTCAATAAAGAACA 2985 Table 3AHs.118684 NM_006923 14141194 stromal cell-derived factor 2 (SDF2), 1ACTCTTCAGGAGCTTGGCATCATGGA mRNA/cds = (39, 674) CTGTTAATGTATGTGATTTTCCCC2986 Table 3A Hs.166975 NM_006925 5902077 splicing factor,arginino/serine-rich 5 1 GGTCAAGGGTGTCCTCCACTCTTTAA (SFRS5), mRNA/cds =(218, 541) CAGCTGCTGGACAGACACATTAGA 2987 Table 3A Hs.7594 NM_0069315902089 solute carrier family 2 (facilitated 1GCAACTTCATGTCAACTTTCTGGCTC glucose transpoter), member 3CTCAAACAGTAGGTTGGCAGTAAG (SLC2A3), mRNA/cds = (242, 1732) 2988 Table 3AHs.180139 NM_006937 5902097 SMT3 (suppressor of mil two 3, yeast) 1CCAAGTGGAGACGGGGATGGGGAAA homolog 2 (SMT3H2), AATACTGATTCTGTGGAAAATACCCmRNA/cds = (90, 377) 2989 Table 3A Hs.88948 NM_006938 5902101 smallnuclear ribonucleoprotein D1 1 TGTGTAATGTACCTGTCAGTGCCTCC polypeptide(16kD) (SNRPD1), TTTATTAAGGGGTTCTTTGAGAAT mRNA/cds = (150, 509) 2990Table 3A Hs.237825 NM_006947 5902123 signal recognition particle 72kD 1GCAGGGGCTCCAGCAACAAAAAAGA (SRP72), mRNA/cds = (0, 2015)AACAGCAACAGAAAAAGAAGAAAGG 2991 Table 3A Hs.108642 NM_006983 5902159 Homosapiens, zinc finger protein 22 1 AGACTCACTTACCCTCTTGGAAAGCT (KOX 15),clone MGC:9735 GGTACAGAAGGAAGTCTGTGGCTG IMAGE:3852749, mRNA, completecds/cds = (133, 807) 2992 Table 3A Hs.167741 NM_006994 6325463butyrophilin, subfamily 3, member A3 1 CCTGGTCATTGGTGGATGTTAAACCC(BTN3A3), mRNA/cds = (171, 1925) ATATTCCTTTCAACTGCTGCCTGC 2993 Table 3AHs.225951 NM_006999 6631114 topoisomerase-related function protein 1AATGAATTGGCCTGGCTACCACTGTG 4-1 (TRF4), mRNA/cds = (37, 1665)GTCGCGTGCTACAGGTTTGACAAA 2994 Table 3A Hs.97932 NM_007015 5901931chondromodulin 1 precursor (CHM-1), 1 TTGATTTGCCATAAGTCTTCCCTTGCTmRNA/cds = (0, 1004) TGCATCTTCCAAAGCTATTTCGA 2995 Table 3A Hs.93502NM_007020 5902143 U1-snRNP binding protein homolog 1AGTGAAGTTACAGTGGAAATGAGTGG (70kD) (U1SNRNPBP), transcriptAGGGGGATTGTCTTTCAACGCAGC variant 1, mRNA/cds = (213, 953) 2996 Table 3AHs.149443 NM_007022 5901883 putative tumor suppressor (101F6), 1GCTTGGTCATTATGAACCAGGTGAGC mRNA/cds = (0, 668) AATGCCTACCTATACCGCAAGAGG2997 literature Hs.41693 NM_007034 6631084 DnaJ-like heat shock protein40 1 AAGGCACTGAAAATATAAAAGGACTG (HLJ1), mRNA/cds = (176, 1189)GTAGTTTACTGATGTAGATGTGAA 2998 Table 3A Hs.87497 NM_007047 5901905butyrophilin, subfamily 3, member A2 1 GCAGAAAAGGGGAACTCATTTAGCTC(BTN3A2), mRNA/cds = (188, 1147) ACGAGTGGTCGAGTGAAGATTGAA 2999 Table 3AHs.169963 NM_007049 5921460 butyrophilin, subfamily 2, member A1 1TATCTTGAGACGCCTTACAAATGATG (BTN2A1), mRNA/cds = (210, 1793)GAGGATTCCAAAGAGTTTTTGTTT 3000 Table 3A Hs.164170 NM_007063 5902153vascular Rab-GAP/TBC-containing 1 AAAATGTTGTTGTGTACATACCATGC (VRP),mRNA/cds = (1117, 3810) TTTCAATGTTGGCTTCCAAGTTTT 3001 Table 3A Hs.21907NM_007067 5901961 histone acetyltransferase (HBOA), 1GGTAGAATGTGCTCTTCTATATCTAC mRNA/cds = (42, 1877)TCCTCAATAAAGCATGTTCTCTGC 3002 literature Hs.37181 NM_007068 5901995 DMC1(dosage suppressor of mck1, 1 CCACAAGAGGATTTAAGGGAGGAAT yeast homolog)meiosis-specific GTTTATAGGACACACACACAAAAGC homologous recombination(DMC1), mRNA/cds = (53, 1075) 3003 Table 3A Hs.109606 NM_007074 5902133coronin, actin-binding protein, 1A 1 CTCCAGCAGGGTCAGCCATTCACAC (CORO1A),mRNA/cds = (100, 1485) CCATCCACTCACCTCCCATTCCCAG 3004 Table 3A Hs.252574NM_007104 6325471 ribosomal protein L10a (RPL10A), 1AAACTGGCAGAATGTCCGGGCCTTAT mRNA/cds = (15, 668) ATACAAGAGCACCATGGGCAAGC3005 Table 3A Hs.29352 NM_007115 6005905 tumor necrosis factor,alpha-induced 1 AACACACAGTGTTTATGTTGGAATCT Protein 6 (TNFAIP6)TTTGGAACTCCTTTGATCTCACTG mRNA/cds = (68, 901) 3006 Table 3A Hs.301819NM_007145 6005965 zinc finger protein 146 (ZNF146), 1TGGGAGTGAGGATGGGAATGCTGTA mRNA/cds = (856, 1734)TCTGTGGAAGTCATGTTATACTGGA 3007 Table 3A Hs.260523 NM_007158 6005738neuroblastoma RAS viral (v-ras) 1 TGCTTAGATCACTGCAGCTTCTAGGA oncogenehomolog (NRAS), CCCGGTTTCTTTTACTGATTTAAA mRNA/cds = (253, 822) 3008Table 3A Hs.301637 NM_007187 6005977 zinc finger protein 258 (ZNF258), 1CTGAACTACCAAATAGCTGTGGGCTT mRNA/cds = (93, 2264)TCTGGAACTGCTGGCTGGGTTGCT 3009 Table 3A Hs.14963 NM_007192 6005756chromatin-specific transcription 1 GCTCTGTGACTTTAAGAGAAGAAGGG elongationfactor, 140 kDa subunit GGGAGGGGTCCCGGATTTTATGTT (FACTP140), mRNA/cds =(291, 3434) 3010 literature Hs.146329 NM_007194 6005849 protein kinaseChk2 (RAD53), 1 AGAAATGTCCTTCTTTCACTCTGCAT mRNA/cds = (0, 1631)CTTTCTTTTCTTTGAGTCGTTTTT 3011 literature Hs.271699 NM_007195 6005847polymerase (DNA directed) iota 1 TCCAGATAAAGCAAGAATAGTTGCAA (POLI),mRNA/cds = (64, 2211) GAAGTAAATTCTGGCACAAAGCGT 3012 literature Hs.251398NM_007205 6005917 three prime repair exonuclease 2 1CCCACAATGGCTTTGATTATGATTTC (TREX2), mRNA/cds = (0, 710)CCCCTGCTGTGTGCCGAGCTGCGG 3013 literature Hs.79086 NM_007208 6005861mitochondrial ribosomal protein L3 1 AAATTACAGAAACATGTTAAAGGCCG (MRPL3),mRNA/cds = (76, 1122) GACAAAGGAAAGACAATAAAATCA 3014 Table 3A Hs.182825NM_007209 6005859 ribosomal protein L35 (RPL35), 1GAAGTACGCGGTCAAGGCCTGAGGG mRNA/cds = (27, 398) GCGCATTGTCAATAAAGCACAGCTG3015 Table 3A Hs.151676 NM_007210 13124893 UDP-N-acetyl-alpha-D- 1TCTACAGCCATGTCCTATTCCTTGAT galactosamine:polypeptide N-CATCCAAAGCACCTGCAGAGTCCA acetylgalactosaminyltransferase 6 (GalNAc-T6)(GALNT6), mRNA/cds = (0, 1868) 3016 Table 3A Hs.28866 NM_007217 6005897programmed cell death 10 (PDCD10), 1 AATGTAGCTTAATCATAATCTCACACTmRNA/cds = (153, 791) GAAGATTTTGCATCACTTTTGCT 3017 Table 3A Hs.28285NM_007218 6005911 patched related protein translocated in 1TGATGATGATGTTCAAAGAGAAAGAA renal cancer (TRC8), ATGGAGTGATTCAGCACACAGGCGmRNA/cds = (0, 1994) 3018 Table 3A Hs.283646 NM_007220 6005722 carbonicanhydrase VB, mitochondrial 1 GCCACCAGCCAAGCAACCCCCTAAA (CA5B), nucleargene encoding ACATTCATATCTAGGCAGTATTTTG mitochondrial protein, mRNA/cds= (137, 1090) 3019 Table 3A Hs.94446 NM_007221 6005831polyamine-modulated factor 1 (PMF1), 1 GCCTTTACCATGTTCTCTCCACATCCmRNA/cds = (111, 608) GTAAATAAACTTCCTTCACTACAA 3020 literature Hs.334676NM_007248 6005752 three prime repair exonuclease 1 1CCACACCTGGCGAGTAGGCCAAGAA (TREX1), mRNA/cds = (256, 1170)GGAAAATCTGACGAATAAAGACCCC 3021 literature Hs.78016 NM_007254 6005835polynucleotide kinase 3′-phosphatase 1 GGGCTGAGCCCCGCCCAGCTCCCCT (PNKP),mRNA/cds = (0, 1565) CCACAATAAACGCTGTTTCTCCTTG 3022 Table 3A Hs.10958NM_007262 6005748 RNA-binding protein regulatory subunit 1TTTCTCAGCCTACAAATTGTGTCTATA (DJ-1), mRNA/cds = (20, 589)CATTTCTAAGCCTTGTTTGCAGA 3023 db mining Hs.10326 NM_007263 6005734coatomer protein complex, subunit 1 GAGCCCACCCCCAGCACCCCCATCT epsilon(COPE), mRNA/cds = (42, 968) GTTAATAAATATCTCAACTCCAAAA 3024 Table 3AHs.8813 NM_007269 6005885 syntaxin binding protein 3 (STXBP3), 1TGGAGTGATTTCACAGTGTGTACTGT mRNA/cds = (51, 1829)TTTGCCACATACTTCTAAAGAACA 3025 Table 3A Hs.8724 NM_007271 6005813 serinethreonine protein kinase (NDR), 1 CCCTTTGGAAATGGTGAAGGAACCAG mRNA/cds =(595, 1992) CCCAATAGAAGTACAGAGCCAGCT 3026 Table 3A Hs.7771 NM_0072736005853 B-cell associated protein (REA), 1 CTCCCTCAAGGCTGGGAGGAGATAAmRNA/cds = (9, 906) ACACCAACCCAGGAATTCTCAATAA 3027 Table 3A Hs.7719NM_007278 6005763 GABA(A) receptor-associated protein 1AGGGACTGAAATTGTGGGGGGAAGG (GABARAP), mRNA/cds = (104, 457)TAGGAGGCACATCAATAAAGAGGAA 3028 Table 3A Hs.1298 NM_007289 6042203membrane metallo-endopeptidase 1 TGGGGCAAAACCTTGCTAATTTTCTC (neutralendopeptidase, enkephalinase, AAAAGCATTTATCATTCTTGTTGC CALLA, CD10)(MME), transcript variant 2b, mRNA/cds = (228, 2480) 3029 literatureHs.194143 NM_007295 6552300 breast cancer 1, early onset (BRCA1), 1CCCCCAGTGTGCAAGGGCAGTGAAG transcript variant BRCA1b,ACTTGATTGTACAAAATACGTTTTG mRNA/cds = (397, 5988) 3030 Table 3A Hs.21486NM_007315 6274551 signal transducer and activator of 1AGATGGCGAGAACCTAAGTTTCAGTT transcription 1, 91kD (STAT1),GATTTTACAATTGAAATGACTAAA mRNA/cds = (196, 2448) 3031 Table 3A Hs.3260NM_007318 7549812 presenilin 1 (Alzheimer disease 3) 1TGTCAGACCTTCTTCCACAGCAAATG (PSEN1), transcript variant I-463,AGATGTATGCCCAAAGCGGTAGAA mRNA/cds = (553, 1944) 3032 Table 3A Hs.279611NM_007329 6633800 deleted in malignant brain tumors 1 1GTTGCAGGGCGAGGTCAAGAGAGTT (DMBT1), transcript variant 2,CTGACCTGGATGGCCCATAGACCTG mRNA/cds = (106, 7347) 3033 Table 3A Hs.74335NM_007355 6680306 heat shock 90kD protein 1, beta 1GACAGCAGGATTGGATGTTGTGTATT (HSPCB), mRNA/cds = (0, 2174)GTGGTTTATTTTATTTTCTTCATT 3034 Table 3A Hs.74085 NM_007360 6679051 DNAsegment on chromosome 12 1 AGTGCCTTCCCTGCCTGTGGGGGTC (unique) 2489expressed sequence ATGCTGCCACTTTTAATGGGTCCTC (D12S2489E), mRNA/cds =(338, 988) 3035 Table 3A Hs.172207 NM_007363 7657382non-POU-domain-containing, octamer- 1 TTTGGAGTTTTTCTGAAAAATGGAGC binding(NONO), AGTAATGCAGCATCAACCTATTAA mRNA/cds = (138, 1551) 3036 Table 3AHs.158135 NM_011086 6755061 mRNA for KIAA0981 protein, partial 1CAATGGACAAGTATTTCCTAATGGTA cds/cds = (0, 1737) CCAGACCACTGGACAGGCTTGGGT3037 Table 3A Hs.9754 NM_012068 12597624 activating transcription factor5 (ATF5), 1 GTGTTGGAGAGGGGCTGTGTCTGGG mRNA/cds = (319, 1167)TGAGGGATGGCGGGGTACTGATTTT 3038 Table 3A Hs.97199 NM_012072 11496985complement component C1q receptor 1 GTGCTTTGAGGGTCAGCCTTTAGGAA (C1QR),mRNA/cds = (148, 2106) GGTGCAGCTTTGTTGTCCTTTGAG 3039 Table 3A Hs.173334NM_012081 6912353 ELL-RELATED RNA POLYMERASE 1GGCTCACATCAAAAGGCTAATAGGTG II, ELONGATION FACTOR (ELL2),AATTTGACCAACAGCAAGCAGAGT mRNA/cds = (0, 1922) 3040 Table 3A Hs.1710NM_012089 9961243 ATP-binding cassette, sub-family B 1CAGAAAGCAAACAACACAATTA (MDR/TAP), member 10 (ABCB10),CAAGGTTGAATCTGAGGAAAATAA nuclear gene encoding mitochondrial TCCTprotein, mRNA/cds = (43, 2259) 3041 Table 3A Hs.342849 NM_012097 6912243xv24a05.x1 cDNA, 3′ 1 TCTCTCTGTGTTCTCTGTATTGTACTA end/close =ACCAACCTCCCAAATCGCTGAGC IMAGE:2814032/clone_end = 3′ 3042 Table 3AHs.33979 NM_012123 6912299 CGI-02 protein (CGI-02), 1CCTGGAATAAAACTCAACATGCAGAT mRNA/cds = (268, 2124)TTGCCTACTCATAGGGACTTTGCC 3043 Table 3A Hs.22857 NM_012124 6912303 chorddomain-containing protein 1 1 TGCCTCCCTGATGGAAAACTATATAA (CHP1),mRNA/cds = (84, 1082) AATTGTAGACTTAAAAGGTTTGTG 3044 Table 3A Hs.36794NM_012142 6912335 cyclin D-type binding-protein 1 1TTCATTGTAAAGATGTTGATGGTCTC (CCNDBP1), mRNA/cds = (87, 1172)AATAAAATGCTAACTTGCCAGTGA 3045 Table 3A Hs.83363 NM_012151 12056462coagulation factor VIII-associated 1 CGTCCGCACGGTACGTCTTCATGGG (intronictranscript) (FBA), AGTCATTTTATTCCTTACAGCTTCC mRNA/cds = (57, 1172) 3046Table 3A Hs.24178 NM_012155 6912355 microtubule-associated protein like1 TGGTGTTTGGTTTGGGGTGTTTTTTA echinoderm EMAP (EMAP-2),AGTTTTTTCTTTTATATCATCCAG 3047 Table 3A Hs.5912 NM_012179 7106310 F-boxonly protein 7 (FBXO7), 1 CTCCCTGCTCTTGGTTCTCCTCTAGA mRNA/cds = (205,1773) TTGAAGTTTGTTTTCTGATGCTGT 3048 Table 3A Hs.79381 NM_012198 6912387grancalcin, EF-hand calcium-binding 1 TGAAGACATAGTTCACCTAAAATGGC protein(GCA), mRNA/cds = (119, 772) ATCCTGCTCTGAATCTAGACTTTT 3049 Table 3AHs.14520 NM_012199 6912351 eukaryotic translation initiation factor 1CCCTTTGAGATTTGTGTTTGTGTCCT 2C, 1 (EIF2C1), GCTTTGAGCTGTACCTTGTCCAGTmRNA/cds = (213, 2786) 3050 Table 3A Hs.5734 NM_012215 11024697meningioma expressed antigen 5 1 TCCTGTAGAAAACGAACTGTAAAAGA(hyaluronidase) (MGEA5), CCATGCAAGAGGCAAAATAAAACT mRNA/cds = (395, 3145)3051 literature Hs.271353 NM_012222 6912519 mutY (E. coli) homolog(MUTYH), 1 CCAGTGACACCTCTGAAAGCCC mRNA/cds = (134, 1774)CCATTCCCTGAGAATCCTGTTGTT AGTA 3052 Table 3A Hs.26719 NM_012231 10092605PR domain containing 2, with ZNF 1 CCTGGTCAGTGGTGGTCTTCAAGAC domain(PRDM2), GACAGCTCTGTATCTGCCATGTGAA mRNA/cds = (855, 6014) 3053 Table 3AHs.44017 NM_012237 13775599 sirtuin (silent mating type information 1CCCACTTCCCATGCTGGATGGGCAG regulation 2, S. cerevisiae, homolog) 2AAGACATTGCTTATTGGAGACAAAT (SIRT2), transcript variant 1, mRNA/cds =(200, 1369) 3054 Table 3A Hs.31176 NM_012238 13775598 sirtuin (silentmating type information 1 TTACTGGCATATGTTTTGTAGACTGTT regulation 2, S.cerevisiae, homolog) 1 TAATGACTGGATATCTTCCTTCA (SIRT1), mRNA/cds = (53,2296) 3055 Table 3A Hs.22891 NM_012244 6912669 solute carrier family 7(cationic amino 1 AATGTAAGGTTGTTTTGGGGGATGGA acid transporter, y+system), member 8 GTTAGAACCTTAATGATAATTTCT (SLC7A8), mRNA/cds = (730,2337) 3056 Table 3A Hs.79008 NM_012245 6912675 SKI-INTERACTING PROTEIN 1TTTGGAGTGGGCAAAGTAACCTCTTG (SNW1), mRNA/cds = (27, 1637)CTTGGTGCAACTATTTGTTTCAAA 3057 Table 3A Hs.268555 NM_012255 6912743 5′-3′exoribonuclease 2 (XRN2), 1 GCTTATAAACACATTTGAGGAATAGG mRNA/cds = (68,2920) AGGTCCGGGTTTTCCATAATGGGT 3058 Table 3A Hs.10882 NM_012257 6912409HMG-box containing protein 1 (HBP1), 1 TCTTATCATTGCATACATTTTCTGGATmRNA/cds = (23, 1567) GCTTGAGCCATCAGATATCAGCT 3059 Table 3A Hs.23170NM_012280 7110660 homolog of yeast SPB1 (JM23), 1TGCAGTGGGAATTCTTGAGTGAGGTC mRNA/cds = (300, 1289)TTACCTCTTCTTTAAACCTCTTCA 3060 Table 3A Hs.173714 NM_012286 6912447MORF-related gene X (KIAA0026), 1 TGCATTATTGTGTAGCCACGGTTTTC mRNA/cds =(305, 1171) TGGAAAAGTTGATATTTTAGGAAT 3061 Table 3A Hs.18895 NM_0122906912719 tousled-like kinase 1 (TLK1), 1 ATTACATTGGAAGGGAGCTTTCAAGAmRNA/cds = (212, 2575) TGGTAGGATATTGACTAACTGAGC 3062 Table 3A Hs.30687NM_012296 6912459 GRB2-associated binding protein 2 1CATGGTACAGGCTTGGAGCTTGCAG (GAB2), mRNA/cds = (160, 2076)GTCCCTTTCTACTGTGGTGTTGGAG 3063 Table 3A Hs.120165 NM_012318 6912481leucine zipper-EF-hand containing 1 TGTGCAGGGACAGTTGGCTTCCAGAtransmembrane protein 1 (LETM1), GGTTTCAGCTTTCAGTTATTTGAGA mRNA/cds =(297, 2516) 3064 Table 3A Hs.234279 NM_012325 6912493microtubule-associated protein, RP/EB 1 AATTCCATTTTATTGGGAACCCATTTTfamily, member 1 (MAPRE1), CCACCTGGTCTTTCTTGACAGGG mRNA/cds = (64, 870)3065 Table 3A Hs.172740 NM_012326 10800411 microtubule-associatedprotein, RP/EB 1 AAATAAACTTGTGTGGTAAAAGTACA family, member 3 (MAPRE3),TGCCATGTGTCCCTCAACTGAAAA mRNA/cds = (153, 998) 3066 Table 3A Hs.18625NM_012332 6912517 Mitochondrial Acyl-CoA Thioesterase 1TTCAAGACAATTTTAATTGTGAACCTA (MT-ACT48), CCATGTTGCCTCCCATCTTCTGA mRNA/cds= (147, 1367) 3067 Table 3A Hs.215766 NM_012341 6912531 GTP-bindingprotein (NGB), 1 TTTGTAAGAGCTGGGAGCAAACACGT mRNA/cds = (23, 1924)TTATGAGTGTGTCGGAATCCCGTG 3068 Table 3A Hs.74420 NM_012381 6912561 originrecognition complex, subunit 3 1 CCCAAACAGGCATGTATCAAAACACC (yeasthomolog)-like (ORC3L), TGTGGAGTACTTTAGACTCCAACA mRNA/cds = (26, 2161)3069 Table 3A Hs.241531 NM_012392 6912581 PEF protein with a longN-terminal 1 TGGGGCCAAAAGTCCAGTGAAATTGT hydrophobic domain (peflin)(PEF), AAGCTTCAATAAAAGGATGAAACT mRNA/cds = (12, 866) 3070 Table 3AHs.21807 NM_012406 9055315 PR domain containing 4 (PRDM4), 1TGGGCTGGAGTAGAGGACTCTGGTG mRNA/cds = (122, 2527)GGAAGGTTTTGCTGCTAATGTATTT 3071 Table 3A Hs.79033 NM_012413 9257235glutaminyl-peptide cyclotransferase 1 AGCTAAACAGTACTTAAATAGCGGTT(glutaminyl cyclase) (QPCT), GGAACTAGGTAGCCTTTCGAATTT mRNA/cds = (11,1098) 3072 literature Hs.128501 NM_012415 6912621 RAD54, S. cerevisiae,homolog of, B 1 TGTCATTCATTTTTCAGAATATAACCA (RAD54B), mRNA/cds = (80,2812) CTCAAGCTACTGGCACATAGTGA 3073 Table 3A Hs.333212 NM_012417 6912623retinal degeneration B beta (RDGBB), 1 TCTGATAGAGAAAAAGACTGCTTTGTmRNA/cds = (0, 998) CACTCAAACATGTTCCTTCGACCT 3074 Table 3A Hs.151242NM_012423 14591905 serine (or cysteine) proteinase 1GGCATCGCCCATGCTCCTCACCTGTG inhibitor, clade G (C1 inhibitor),TTTTGTAATCAGAAATAAATTGCT member 1 (SERPING1), mRNA/cds = (60, 1562) 3075Table 3A Hs.334826 NM_012433 6912653 splicing factor 3b, subunit 1,155kD 1 TTTGATGTTAAACAGTAAATGCCAGT (SF3B1), mRNA/cds = (0, 3914)AGTGACCAAGAACACAGTGATTAT 3076 literature Hs.159737 NM_012444 6912679SPO11, meiotic protein covalently 1 CCTTTGCCTTTATACTTTAGGGGTCTT bound toDSB (S. cerevisiae)-like ACTCCATTAATTCATTTGTTACA (SPO11), mRNA/cds =(108, 1298) 3077 literature Hs.244613 NM_012448 6912687 signaltransducer and activator of 1 TGCACGTTATGGTGTTTCTCCCTCTC transcription5B (STAT5B), ACTGTCTGAGAGTTTAGTTGTAGC mRNA/cds = (146, 2509) 3078 Table3A Hs.109571 NM_012456 6912707 translocase of inner mitochondrial 1CTGTAGAGAGTCTTCAAGATCCCGGA membrane 10 (yeast) homologGTGGTAGCGCTGTCTCCTGGTGAA (TIMM10), mRNA/cds = (129, 401) 3079 Table 3AHs.7797 NM_012461 6912715 TERF1 (TRF1)-interacting nuclear 1TAGTAGGAATGAAGTGGAAGTCCAG factor 2 (TINF2), GCTTGGATTGCCTAACTACACTGCTmRNA/cds = (262, 1326) 3080 Table 3A Hs.105806 NM_012483 7108345granulysin (GNLY), transcript variant 1 GATCCAGAATCCACTCTCCAGTCTCC 519,mRNA/cds = (280, 669) CTCCCCTGACTCCCTCTGCTGTCC 3081 Table 3A Hs.199263NM_013233 7019542 Ste-20 related kinase (SPAK), 1ATTCCATTCTATTGTTTACACAACGAT mRNA/cds = (173, 1816)TACTCGAAGATGACTGCAAAGGT 3082 Table 3A Hs.283781 NM_013234 10801344muscle specific gene (M9), 1 AGCCAAGAAGAGAGCATTAAACCCAA mRNA/cds = (171,827) GAACATTGTGGAGAAGATTGACTT 3083 Table 3A Hs.13493 NM_013236 7106298like mouse brain protein E46 (E46L), 1 TATATTGTACTTACTGTGACAGCAGAmRNA/cds = (198, 1625) TAATAAACCAGTCTCTTGGAGGGC 3084 Table 3A Hs.279529NM_013237 7019508 px19-like protein (PX19), 1 CTTATTCTCCCATTGGGCAGCTGAGGmRNA/cds = (176, 835) ACCGAGGCACAGAGGTGCGGTGAC 3085 Table 3A Hs.126355NM_013252 10281668 C-type (calcium dependent, 1TCACTGTATACCACTGGAGTTTTCTG carbohydrate-recognition domain)GTTATCTCTCGTATAGCAAAATCT lectin, superfamily member 5 (CLECSF5),mRNA/cds = (197, 763) 3086 Table 3A Hs.169330 NM_013259 10047091neuronal protein (NP25), 1 GCTGCCACCTCCTGTTCATTTAGAAC mRNA/cds = (49,897) TATGCAAAGACTCCGCTTCCGTTT 3087 Table 3A Hs.136748 NM_013269 7019446lectin-like NK cell receptor (LLT1), 1 ACAGCAAAGCCCCAACTAATCTTTAGmRNA/cds = (13, 588) AAGCATATTGGAACTGATAACTCC 3088 Table 3A Hs.14805NM_013272 7706713 solute carrier family 21 (organic anion 1GCCAGCTTGGAGGATGGACATTTCTG transporter), member 11 (SLC21A11),GATACACATACACATACAAAACAG mRNA/cds = (193, 2325) 3089 literatureHs.129903 NM_013274 7019490 polymerase (DNA-directed), lambda 1GTCAACATCATCCGGCACCCTCTGG (POLL), mRNA/cds = (371, 2098)GGTAGGAGAACAGCCATTCCACATG 3090 Table 3A Hs.54642 NM_013283 11034824methionine adenosyltransferase II, 1 TCATATGTGTGGTTATACTCATAATAA beta(MAT2B), mRNA/cds = (0, 1004) TGGGCCTTGTAAGCCTTTTCACC 3091 literatureHs.252646 NM_013284 7019492 wm25f06.x1 cDNA, 3′ 1CTGCTTGACTCACCGGCTTCCTATTT end/clone = 1 GATGCACCCAGGCCCCCTTGTGGCIMAGE:2436995/clone_end = 3′ 3092 Table 3A Hs.75528 NM_013285 7019418nucleolar GTPase (HUMAUANTIG), 1 GGGACAGAAACACAAACGCAAA mRNA/cds = (79,2274) AAATTCAGACAAAAGCAGTAATGT TTAA 3093 Table 3A Hs.106260 NM_0133227019538 sorting nexin 10 (SNX10), 1 GCGATCCTCATCCCTTCAGCAATATG mRNA/cds= (128, 733) TATTTGAGTTCACACTATTTCTGT 3094 Table 3A Hs.289080 NM_0133267019454 colon cancer-associated protein Mic1 1TTTTGAACAGCGAAACCAGCGTTTGC (MIC1), mRNA/cds = (76, 1905)GAGGGAGCCCCAATTTCACACCAG 3095 literature Hs.283018 NM_013347 9558730replication protein A complex 34 kd 1 TTCCAAAAGAAAAACTAGTTGCAGTC subunithomolog Rpa4 (HSU24186), AGGGAGCCAGCGAAAAGACAAAAA mRNA/cds = (404, 1189)3096 Table 3A Hs.272409 NM_013351 7019548 T-box 21 (TBX21), 1ACTGAGAGTGGTGTCTGGATATATTC mRNA/cds = (211, 1818)CTTTTGTCTTCATCACTTTCTGAA 3097 Table 3A Hs.58636 NM_013352 7019520squamous cell carcinoma antigen 1 GCATGCATTCATTGGTTGTTCAATAA recognizedby T cell (SART-2), GTGAGATGATTACAGATAATACTG mRNA/cds = (149, 3025) 3098literature Hs.189138 NM_013368 7019514 RPA-binding trans-activator(RBT1), 1 CTGATTTCATAACCAGGCCGGACCAC mRNA/cds = (291, 881)GTGCAATAGGGTGGAAACCAAACT 3099 Table 3A Hs.138713 NM_013378 7019566 pre-Blymphocyte gene 3 (VPREB3), 1 GAAGACGACGCGGATTACTACTGCTC mRNA/cds = (42,413) TGTTGGCTACGGCTTTAGTCCCTA 3100 Table 3A Hs.279784 NM_013388 7019502protactin regulatory element binding 1 TGAACCTCAGCCCATTAGGCAGGAAA(PREB), mRNA/cds = (131, 1384) AGTTGATATTTAATAAACAAGGAA 3101 Table 3AHs.171825 NM_013390 7019554 basic helix-loop-helix domain 1CCAAGGCACTTGGTTTTTCTGTTTTAT containing, class B, 2 (BHLHB2),ATACTAATAATCAGGGCCTAAGT mRNA/cds = (196, 1434) 3102 Table 3A Hs.272736NM_013392 7019332 nuclear receptor binding protein 1GGGGGCCATTCGATTCGCCTCAGTT (NRBP), mRNA/cds = (112, 1719)GCTGCTGTAATAAAAGTCTACTTTT 3103 Table 3A Hs.7838 NM_013446 7305272makorin, ring finger protein, 1 1 ACTTTAAGAAAAAACAAATAATT (MKRN1),mRNA/cds = (122, 1570) GTTGCAGAGGTCTCTGTATTTTG CAGC 3104 Table 3AHs.8858 NM_013448 7304918 bromodomain adjacent to zinc finger 1CTGTACCAGTGCTGGCTGCAGGTATT domain, 1A (BAZ1A), AAGTCCAAGTTTATTAACTAGATAmRNA/cds = (115, 5139) 3105 Table 3A Hs.277401 NM_013449 7304920bromodomain adjacent to zinc finger 1 GCCACCTCTGTGTTCCTGTCATAGCA domain,2A (BAZ2A), AATATGGGACCATCACCAGCTTAC mRNA/cds = (739, 6375) 3106 Table3A Hs.234680 NM_013451 7305052 fer-1 (C. elegans)-like 3 (myoferlin) 1TCCTGAGGTGATATACTTCATATTTGT (FER1L3), mRNA/cds = (96, 6281)AATCAACTGAAAGAGCTGTGCAT 3107 literature Hs.100299 NM_013975 7710125ligase III, DNA, ATP-dependent 1 TGCTGGGTTTGCCATCTTTTTTTGT (LIG3),transcript variant alpha, TTTCTTTGAAAAGCAGCTTAGTT mRNA/cds = (323, 3091)ACCC 3108 Table 3A Hs.8262 NM_013995 7669502 lysosomal-associatedmembrane 1 CCACTAGTTGATGTATGGTATCTTTA protein 2 (LAMP2), transcriptvariant GATATTTGCCTGTCTGTTTGCTCA LAMP2b, mRNA/cds = (137, 1369) 3109Table 3A Hs.127649 NM_014007 7662099 KIAA0414 protein (KIAA0414), 1AATGGCCTACAACCAAGCTATTTGTC mRNA/cds = (1132, 2535)CCCTACTTTGAGTCTTAACTGTGG 3110 Table 3A Hs.301175 NM_014029 7661739HSPC022 protein (HSPC022), 1 ATCCTGAGCTGCACTTACCTGTGAGA mRNA/cds = (18,623) GTCTTCAAACTTTTAAACCTTGCC 3111 Table 3A Hs.11125 NM_014041 7661745HSPC033 protein (HSPC033), 1 TGCTCTGAGATGGGGAACAGAACAC mRNA/cds = (168,443) ACAAGTATGAAGTTTCTTTCAGGTG 3112 Table 3A Hs.182238 NM_014052 7661715GW128 protein (GW128) 1 AAGCACACCCGTGGTTGTGAAAATAGTATAGCAAAAAAGAAAAATCCCCCG 3113 Table 3A Hs.76640 NM_014059 7662650 RGC32protein (RGC32), 1 TGTTTACCTGCTTGCAGCATATTAGA mRNA/cds = (146, 499)ACAGACGATCCATGCTAATATTGT 3114 Table 3A Hs.279040 NM_014065 7661837 HT001protein (HT001), 1 AATCCTTACTTAAAATTCTTCCGTTAC mRNA/cds = (241, 1203)CACCCTTGAAACAATTAGCTTTT 3115 Table 3A Hs.5327 NM_014106 7662624 PRO1914protein (PRO1914), 1 ATAACAGTTCTATTTGGAATGATACC mRNA/cds = (1222, 1425)CACAACTCTACAAGCATCTTATCC 3116 Table 3A Hs.78961 NM_014110 13699255protein phosphatase 1, regulatory 1 AGAGATTTGTACATTTGTGTAATAGG(inhibitor) subunit 8 (PPP1R8), CCTTTTCATGCTTTATGTGTAGCT mRNA/cds =(935, 1318) 3117 Table 3A Hs.26102 NM_014112 7657658trichorhinophalangeal syndrome I gene 1 TCTTGGTGTATTTCTTATGCAAACAAT(TRPS1), mRNA/cds = (638, 4483) CTTCAGGCAGCAAAGATGTCTGT 3118 Table 3AHs.179898 NM_014153 7661761 HSPC055 protein (HSPC055), 1AACCTGTACTGTTGGTATTGTGTTAG mRNA/cds = (1400, 1903)TGTATGGACCAATACTGCCTGTAA 3119 Table 3A Hs.279474 NM_014160 8850222HSPC070 protein (HSPC070), 1 AATTGAGGGACCATCAGATAACTGTA mRNA/cds = (331,1581) TTTTGTCAGGTGCAATAAAAACAA 3120 Table 3A Hs.5232 NM_014165 7661785HSPC125 protein (HSPC125), 1 CTATGTGTACTCCTCATCCCTCCTGC mRNA/cds = (79,608) TGTATATTTTCTCATTTTTTGCGT 3121 Table 3A Hs.181112 NM_014168 7661787HSPC126 protein (HSPC126), 1 TTAAAAGTAACAAAAACTGCCA mRNA/cds = (25, 837)TTTGACAGTAAAGGCTCTTGGCTT CTGT 3122 Table 3A Hs.279761 NM_014169 7661793HSPC134 protein (HSPC134), 1 GCTCCCTTCTCTTTGATAGCAGTTAT mRNA/cds = (45,716) AATGCCCTTGTTCCCAATAAAACT 3123 Table 3A Hs.13645 NM_014174 7661803HSPC144 protein (HSPC144), 1 CTGAGATACTGCTGCTGGAATGGGC mRNA/cds = (446,1123) GAGACATTGCTGCAAAGAAGTCAAG 3124 Table 3A Hs.30026 NM_014188 7661831cDNA FLJ13048 fis, clone 1 CTGCGGCGTGTTAGGAATGACCTGG NT2RP3001399,weakly similar to AATTGTCAATAAACAGATGCTGCTG SSU72 PROTEIN/cds = (27,488) 3125 Table 3A Hs.121025 NM_014205 7656935 chromosome 11 openreading frame 5 1 AGCTCCCTAGCTGAACGGGTTACCCT (C11orf5), mRNA/cds = (45,1256) GGTCATTAATAAAGCTGTGACTGG 3126 Table 3A Hs.58685 NM_014207 7656964CD5 antigen (p56—62) (CD5), 1 CTCATCTAAAGACACCTTCCTTTCCA mRNA/cds = (72,1559) CTGGCTGTCAAGCCACAGGGCACC 3127 Table 3A Hs.70499 NM_014210 7657074ecotropic viral integration site 2A 1 GGCAGAATCCACACCAGCTTATCAAC(EVI2A), mRNA/cds = (219, 917) CAACACAGCTAATTTTAGAATAGG 3128 Table 3AHs.173902 NM_014225 7657474 protein phosphatase 2 (formerly 2A), 1GACAGGACAGTGACCTTGGGAGGAA regulatory subunit A (PR65), alphaGGGGCTACTCCGCCATCCTTAAAAG isoform (PPP2R1A), mRNA/cds = (138, 1907) 3129Table 3A Hs.273307 NM_014230 7657616 signal recognition particle 68kD 1GGACAAGTTGGAACAGAAGACCAAG (SRP68), mRNA/cds = (0, 1859)AGTGGCCTCACTGGATACATCAAGG 3130 Table 3A Hs.332724 NM_014232 7657674AV705126 cDNA, 5′ 1 CCCCAATTCTGTGGCGCATCCCAGATT end/clone =GTGAAAATGTACAATAAATGTGTA ADBCFB08/clone_end = 5′ 3131 Table 3A Hs.14084NM_014245 7657521 ring finger protein 7 (RNF7), 1TTCAGAGAACTTTTTGCATGCTTATG mRNA/cds = (53, 394) GTTGATCAGTTAAAAAAGAATGTT3132 Table 3A Hs.279919 NM_014248 7657507 ring-box 1 (RBX1), 1TGCTGTTTCTGTAGCCATATTGTATTC mRNA/cds = (6, 332) TGTGTCAAATAAAGTCCAGTTGG3133 Table 3A Hs.74711 NM_014280 7657610 splicing factor similar to dnaJ(SPF31), 1 ACGCCACCCAAACCTTTCACTTTCCA mRNA/cds = (7, 801)AAGAGCTAGCCGTCCTCCACCCAG 3134 Table 3A Hs.227823 NM_014287 10947030 pM5protein (PM5), 1 GCATCTGAGATCCTGTTGGAAACCAC mRNA/cds = (0, 3668)AGCAACCTGTATTCATTATTAGGA 3135 Table 3A Hs.54609 NM_014291 7657117glycine C-acetyltransferase (2-amino-3- 1 GGACGTGACCTGTGCTGAGGGCTGTketobutyrate coenzyme A ligase) GAGAATGTGAAACAACAGTGTGAAA (GCAT),mRNA/cds = (3, 1262) 3136 Table 3A Hs.10729 NM_014306 7657014hypothetical protein (HSPC117), 1 GCCATCAGATTGATCTTCTTCACACC mRNA/cds =(75, 1592) AAGCTCTGTTTACATTCCGAGAGG 3137 literature Hs.5212 NM_0143117657596 cDNA FLJ10927 fis, clone 1 CCTTTCCTCACAGGGACCAAGACAAA OVARC1000488/cds = UNKNOWN GCATGGGACATGAAATTAAGAGTG 3138 Table 3A Hs.278994NM_014313 7657594 Rhesus blood group, CcEe antigens 1AAGCATGATTCCCACAAGGACTAAGT (RHCE), mRNA/cds = (0, 1253)ATCAGTGATTTGTAATTTTCCTGT 3139 Table 3A Hs.20597 NM_014315 7657300 hostcell factor homolog (LCP), 1 ACCTGTTGGTTTTAATGTGCATGTGA mRNA/cds = (316,1536) ATGGCCTAGAGAACCTATTTTTGT 3140 Table 3A Hs.7256 NM_014319 7706606integral inner nuclear membrane 1 CCGACCAAGATCCCTCCCTGCAAGA protein(MAN1), CAGATGGGAATGTGTATAATAACTA mRNA/cds = (6, 2741) 3141 Table 3AHs.76556 NM_014330 9790902 protein phosphatase 1, regulatory 1GGGAGGCGTGGCTGAGACCAACTGG (inhibitor) subunit 15A (PPP1R15A),TTTGCCTATAATTTATTAACTATTT mRNA/cds = (240, 2264) 3142 Table 3A Hs.38738NM_014343 7858980 claudin 15 (CLDN15), 1 GGACGGTGTCCCCGCACGTTTGTATTmRNA/cds = (254, 940) GTGTATAAATACATTCATTAATAA 3143 Table 3A Hs.48433NM_014345 7657183 endocrine regulator (HRIHFB2436), 1ATCCTTTCCTCAACCTCCTCCTTTCC mRNA/cds = (621, 6920)CAATTAATTTCAACCATAGTACGA 3144 Table 3A Hs.17839 NM_014350 7657123TNF-induced protein (GG2-1), 1 GCCAGCTATGTCCTCTAGGAAATGAC mRNA/cds =(197, 769) AGACCCAACCACCAGCAATAAACA 3145 Table 3A Hs.283737 NM_0143667857047 AD-017 protein (LOC58830), 1 CTGTAAAAAGACAATTCATCTCATTGTmRNA/cds = (118, 1233) GAGTGGAAGTAGTTATCTGGAAT 3146 Table 3A Hs.97101NM_014373 7857135 putative G protein-coupled receptor 1GCATTTCAGAATGTGTCTTTTGAAGG (GPCR150), mRNA/cds = (321, 1337)GCTATACCAGTTATTAAATAGTGT 3147 literature Hs.279843 NM_014381 7857338mutl. (E. coli) homolog 3 (MLH3), 1 CCAGGGTTTCTGCACTGGTCCCCTCT mRNA/cds= (114, 4403) TTTCCCTTCAGTCTTCTTCACTTC 3148 Table 3A Hs.182470 NM_0143947657479 PTD010 protein (PTD010), 1 ACACTGCTACACCATTACTTTCTTGA mRNA/cds =(129, 1088) GACATTTGTAAGTCCTTTGATACA 3149 Table 3A Hs.128342 NM_0144067657252 potassium large conductance calcium- 1TGAATAACTAGTGATACCCTCAATAA activated channel, subfamily M, betaAACAGGGATTGCCAAGAAGGGAAC member 3-like (KCNMB3L), mRNA/cds = (243, 1918)3150 Table 3A Hs.27258 NM_014412 7656951 calcyclin binding protein(CACYBP), 1 ACCTTTAACATGTAAAGATGCTCACC mRNA/cds = (117, 603)TTGTTCAGAAGAGAATAAACCAGT 3151 Table 3A Hs.301956 NM_014415 7657702 zincfinger protein (ZNF-U69274), 1 TATGTCATAAACATGTAAATAAAAGAT mRNA/cds =(161, 3322) GTTGAATCTTGTTGAAAGCGCGG 3152 Table 3A Hs.14125 NM_0144547657436 p53 regulated PA26 nuclear protein 1 TTGTATTCTGGAAGCGTGAATTGCTT(PA26), mRNA/cds = (11, 1668) TTGAAGTCTGTCAGTATTACTGGT 3153 Table 3AHs.326248 NM_014456 7657448 cDNA:FLJ22071 fls, clone 1TTTGTAAGCGAAGGAGATGGAGGTC HEP11691/cds = UNKNOWNGTCTTAAACCAGAGAGCTACTGAAT 3154 Table 3A Hs.111632 NM_014463 7657314 Lsm3protein (LSM3), 1 ACTCACAACTTCTTAAGCTAAATGGT mRNA/cds = (29, 337)ATTTTCATTTTTCTCAAGCTCTCC 3155 Table 3A Hs.127011 NM_014464 7857644tubulointerstitial nephrilis antigen (TIN- 1 AGTTTAGCAATATGACATTCTTGGTGAG), mRNA/cds = (1, 1431) ACAGTGGAATCTTTGTCTCTTCAC 3156 Table 3AHs.300684 NM_014478 7656976 calcitonin gene-related peptide- 1GCCACTGACCTTGGCTCACCTTAGAG receptor component protein (CGRP-GAATTTCCTCGAGAACAACAGAGA RCP), mRNA/cds = (61, 507) 3157 literatureHs.154149 NM_014481 7856891 Homo sapiens, apurinic/apyrimidinic 1ACTTCTGTCTTTGCTGGAAAGTGTAT endonuclease (APEX nuclease)-like 2TTGTGCATAAATAAAGTCTGTGTA protein, clone MGc:1418 IMAGE:3139156, mRNA,complete cds/cds = (38, 1594) 3158 Table 3A Hs.120766 NM_014487 13384595nucleolar cysteine-rich protein 1 TTCTCTTTCTTCACAATGTATGTCCTC (HSA6591),mRNA/cds = (173, 1135) AGTGGTACCTATTATTGATGCCT 3159 Table 3A Hs.296433NM_014499 10092632 putative purinergic receptor (P2Y10), 1CTGTGACCCGCTCCCGCCTCATGAG mRNA/cds = (0, 1019) CAAGGAGAGTGGTTCATCAATGATT3160 Table 3A Hs.187660 NM_014504 7857495 putative Rab5 GDP/GTP exchange1 TGTAGGGTAAATGTGACTGGAATACA factor homologue (RABEX5), 1CCTTTGGAACGGAATTCTTTATCA mRNA/cds = (77, 1552) 3161 db mining Hs.278457NM_014512 7857276 killer cell immunoglobulin-like 1AGAACTTCCAAATGCTGAGCCCAGAT receptor, three domains, shortCCAAAGTTGTCTTCTGTCCACGAG cytoplasmic tall, 1 (KIR3DS1), mRNA/cds = (11,1174) 3162 Table 3A Hs.239720 NM_014515 7857384 CCR4-NOT transcriptioncomplex, 1 TGACAAATTAGAAGAACGGCCTCACC subunit 2 (CNOT2),TGCCATCCACCTTCAACTACAACC mRNA/cds = (115, 1737) 3163 Table 3A Hs.17667NM_014521 7657561 SH3-domain binding protein 4 1TGGATATTTTAACCTGTTAAGTGTGT (SH3BP4), GTGTGTTTTCTGTACCCAACCAGA 3164 Table3A Hs.275243 NM_014624 9845517 S100 calcium-binding protein A6 1TAAATAGGGAAGATGGAGACACCTCT (calcyclin) (S100A6),GGGGGTCCTCTCTGAGTCAAATCC mRNA/cds = (102, 374) 3165 Table 3A Hs.173288NM_014633 7661949 KIAA0155 gene product (KIAA0155), 1TGTGTTAGGTTGAATAAGGTGTGGAA mRNA/cds = (86, 3607) 3166 Table 3A Hs.170307NM_014636 7662069 Ral quanine nucleotide exchange 1GCAGTAACCACTGAACGTCAATCAGC factor RalGPS1A (RalGPS1A),CCTCCATGGGGTTCTTTCGATTTT mRNA/cds = (267, 1940) 3167 Table 3A Hs.323580NM_014644 11036643 cDNA FLJ10757 fis, clone 1 GTTTGAAGTTGTGACTCTCCTGCTACNT2RP3004578, highly similar to CAATTAAATAAAGCTTACTTTGCC mRNA forKIAA0477 protein/cds = UNKNOWN 3168 Table 3A Hs.166318 NM_014646 7662021lipin 2 (LPIN2), 1 TGCAAGATGAATGGCTAATATTTTGG mRNA/cds = (239, 2929)TGCAGTGTTTGATGTTCAAAACAA 3169 Table 3A Hs.323712 NM_014664 7662203KIAA0615 gene product (KIAA0615), 1 CTGCCTGTTCAGAACTGTTTAATAGC mRNA/cds= (237, 2927) AGTTACTCTTGAGTGTATTTACCT 3170 Table 3A Hs.132853 NM_0146667661967 KIAA0171 gene product (KIAA0171), 1 ATTCTAGAGTTTGGAATGCAAAATTAAmRNA/cds = (101, 1978) TTGTTTTACCCTCAAGCTGGGAA 3171 Table 3A Hs.155291NM_014670 7661849 KIAA0005 gene product (KIAA0005), 1TGGGGTGAATTTGTTAAAATGAGTAA mRNA/cds = (80, 1339)CTTTGATAAAGTTTTTCATGCACA 3172 Table 3A Hs.154332 NM_014874 7662001KIAA0212 gene product (KIAA0212), 1 AAAAGTATAGAGTTGGAAACTCTGGG mRNA/cds= (58, 2031) AAAACTTACGGAAATACACAAATG 3173 Table 3A Hs.151791 NM_0148797661899 KIAA0092 gene product (KIAA0092), 1 ATGTGTCAACCACCATTTCAGCTATTmRNA/cds = (53, 1477) AAAAACTCCTGTTATCTCCTTGTT 3174 Table 3A Hs.186840NM_014686 7662075 KIAA0355 gene product (KIAA0355), 1TACAATGCTTCCAAACTGGAACTCTA mRNA/cds = (838, 4050)CATTTTGTATCTTTTAAAGCTCCT 3175 Table 3A Hs.111894 NM_014713 13518239lysosomal-associated protein 1 GTGACTTGACTGTGGAAGATGATGGT transmembrane4 alpha (LAPTM4A), TGCATGTTTCTAGTTTGTATATGT mRNA/cds = (148, 849) 3176Table 3A Hs.181418 NM_014730 7661947 KIAA0152 gene product (KIAA0152), 1CCTTCCATGTCCCACCCCACTCCCAC mRNA/cds = (128, 1006)CAAAAAGTACAAAATCAGGATGTT 3177 Table 3A Hs.81892 NM_014736 7661905KIAA0101 gene product (KIAA0101), 1 TGGTGTTTGATTATTGGAATGGTGCC mRNA/cds= (61, 396) ATATTGTCACTCCTTCTACTTGCT 3178 Table 3A Hs.80905 NM_0147377661963 Ras association (RatGDS/AF-6) 1 ACAGGGCCTCAGCAAGGGAGCCATA domainfamily 2 (RASSF2), CATTTTTGTAACATTTTGATATGTT mRNA/cds = (196, 1176) 3179Table 3A Hs.108920 NM_014739 7661957 HT018 mRNA, complete 1GGCTAAACGATTCTTACTCAGTGTGA cds/cds = (451, 1179)TGTATAATGATGCAACAGGGACCC 3180 Table 3A Hs.79768 NM_014740 7661919KIAA0111 gene product (KIAA0111), 1 TAATGGGGTTTATATGGACTTTCTTCT mRNA/cds= (214, 1449) CATAAATGGCCTGCCGTCTCCCT 3181 Table 3A Hs.77724 NM_0147497662189 KIAA0586 gene product (KIAA0586), 1 ATACCTTCTGAACGGGAAGAGACAGCmRNA/cds = (274, 4875) CAGCACAGTGTTTATGCCACTGGT 3182 Table 3A Hs.77685NM_014752 7661907 KIAA0102 gene product (KIAA0102), 1TTCCACTAGTATATCCCTGTTGATTTG mRNA/cds = (307, 678)TTTGTGCCTTTTATTAACTGCCA 3183 Table 3A Hs.77329 NM_014754 7662646phosphatidylserine synthase 1 1 TCATCTGTGCCATGCTCTAGAACCTT (PTDSS1),mRNA/cds= (102, 1523) GACCTTGATAGTTCACCACGTCTG 3184 Table 3A Hs.76988NM_014757 13376996 mastermind (drosophila)-like 1 1ACTGCCCTTAACTCTGGTATACACCA (MAML1), mRNA/cds = (263, 3313)AAAAGAAATCTTTACTTTCCTTGT 3185 Table 3A Hs.75824 NM_014761 7661971KIAA0174 gene product (KIAA0174), 1 AGGCAGCCTTTCTTTAATGTTTTCAGT mRNA/cds= (63, 1157) TGGTTTGTATTTTGTAGCTCAGT 3186 Table 3A Hs.75574 NM_0147637661911 mitochondrial ribosomal protein L19 1 CCAGAATGGTCTTTAATGAGCATGGA(MRPL19), mRNA/cds = (34, 876) ACCTGAGCAAAGGGAATAGGTGGG 3187 Table 3AHs.75416 NM_014764 7661885 DAZ associated protein 2 (DAZAP2), 1TCTCTCTCTACACTGTGGTGCACTTA mRNA/cds = (69, 575) ACTTGTGGAATTTTTATACTAAAA3188 Table 3A Hs.74583 NM_014767 7662035 KIAA0275 gene product(KIAA0275), 1 ACTCAGCCTAAGGAAACAAGTACACT mRNA/cds = (316, 1590)CCACACATGCATAAAGGAAATCAA 3189 Table 3A Hs.52528 NM_014779 7662235KIAA0669 gene product (KIAA0669), 1 TGTCAAATAAAAGAGAACGAACAGGT mRNA/cds= (1016, 3358) AGTTTGGTGGAGCTGAGCTAGTGT 3190 Table 3A Hs.28020 NM_0148057662293 KIAA0766 gene product (KIAA0766), 1 TTTGCATCATGTAGTCATTGAGTGAGmRNA/cds = (116, 1939) GGGGAGATATAAGCCAAGGATTTT 3191 Table 3A Hs.23488NM_014814 7661913 KIAA0107 gene product (KIAA0107), 1GCTTACTTCACAATGTGCCCAGGTCA mRNA/cds = (25, 1194)GCTGTATAAAATAAATACTGCATT 3192 Table 3A Hs.279849 NM_014819 7662123KIAA0438 gene product (KIAA0438), 1 TGTAATGGTTGGTTTATTGTTCTATAA mRNA/cds= (117, 2243) CCCCAGCCCATCATTTTCTGTGT 3193 Table 3A Hs.17969 NM_0148277662231 KIAA0663 gene product (KIAA0663), 1 AGTCAATGTTTCGTGTTCCGCATTATTmRNA/cds = (213, 2645) TGAACCATTTGCCCTTACAGAAA 3194 Table 3A Hs.194035NM_014828 7662273 KIAA0737 gene product (KIAA0737), 1AGGGAGCAGTGCTTTTGGGTCCTAG mRNA/cds = (32, 1897)AACCTGTTGAGTTTCTAATGAATAT 3195 Table 3A Hs.173802 NM_014832 7662197KIAA0603 gene product (KIAA0603), 1 AATGACTTGTTATAGCTCAGTGTGCC mRNA/cds= (347, 4246) CTTGAATCCATACAGTTTCTTAAA 3196 Table 3A Hs.15087 NM_0148377662023 KIAA0250 gene product (KIAA0250), 1 TGTTTTGTTTTCTGGGTTTTGTTTTTTGTTTTTGTCTGTGCAAGACCTGC 3197 Table 3A Hs.7764 NM_014851 7662139 KIAA0469gene product (KIAA0469), 1 GGCTTCCATGTCCAGAATCCTGCTTA mRNA/cds = (184,1803) AGGTTTTAGGGTACCTTCAGTACT 3198 Table 3A Hs.6684 NM_014858 7662151KIAA0476 gene product (KIAA0476), 1 CCTGACCTGTGCAATAAGGATTGTTC mRNA/cds= (588, 4728) CCTGCGAAGTTTTGTTGGATGTAA 3199 Table 3A Hs.8338 NM_0148597662241 KIAA0672 gene product (KIAA0672), 1 GAGTCTGGGGTAAGGGTGGGGGTTGmRNA/cds = (300, 2756) AAAGTTGTTATCTTTAAATACATGT 3200 Table 3A Hs.5737NM_014864 7662149 KIAA0475 gene product (KIAA0475), 1TTGATCTGCCAAGGATTTCCTCTCAG mRNA/cds = (336, 1585)AGCTGTTGCACAGACAGAGATTGT 3201 Table 3A Hs.5094 NM_014868 7662652 ringfinger protein 10 (RNF10), 1 GGGGGTTTCCACAATGTGAGGGGGA mRNA/cds = (698,2983) ACCAAGAAAATTTTAAATACAGTGT 3202 Table 3A Hs.273397 NM_0148717662257 KIAA0710 gene product (KIAA0710), 1 TGCCTGTCCCAAGTTTTGTTCCATTTTmRNA/cds = (203, 3550) TTAAAAATTTGTTGTAAACTGCA 3203 Table 3A Hs.3085NM_014877 7661883 helicase KIAA0054 (KIAA0054), 1TATTGTTACATATGTTTGCATCAAGCT mRNA/cds = (145, 5973)AGCAGCCAAGAGGTTAATTGTGC 3204 Table 3A Hs.1528 NM_014882 7661881 KIAA0053gene product (KIAA0053), 1 AAACCAGAACAAGCAACAAACTGTAT mRNA/cds = (193,2109) TTATGCAAGCAAAATTGATGAGAA 3205 Table 3A Hs.8170 NM_014886 7662676hypothetical protein (YR-29), 1 TGATGTTTCTGAATACTACCAAACAG mRNA/cds =(82, 864) CCATACATGTCTGCAATGAAGAGA 3206 Table 3A Hs.23518 NM_0148877656970 hypothetical protein from BCRA2 1 TATCATCCTCCTTCTCAACCCATCTCregion (CG005), CCTAACCCCACATGCTTGCCAGTT mRNA/cds = (165, 1916) 3207Table 3A Hs.239189 NM_014905 7662327 glutaminase (GLS), 1TTCTGAAATTGGGAAACATTTATTTTA mRNA/cds = (19, 2028)AATGCAATCAGGTAGTGTTGCTT 3208 Table 3A Hs.131915 NM_014913 7662345KIAA0863 protein (KIAA0863), 1 GACTGAATTTGACATCTGGTATGCTG mRNA/cds =(185, 3580) GTATGTAGCTCAGACATCAAGAGT 3209 Table 3A Hs.110488 NM_0149187662433 KIAA0990 protein (KIAA0990), 1 TTGTACTTTTCAGAACCATTTTGTCTCmRNA/cds = (494, 2902) ATTATTCCTGTTTTAGCTGAAGA 3210 Table 3A Hs.104305NM_014922 14719827 death effector filament-forming Cad-4 1CTGGCTGTGTCACAGGGTGAGCCCC like apoptosis protein (DEFCAP),AAAATTGGGGTTCAGCGTGGGAGGC transcript variant B, mRNA/cds = (522, 4811)3211 Table 3A Hs.211576 NM_005546 5031810 IL2-inducible T-cell kinase(ITK), 1 AATGGTCCCCTGTGTTTGTAGAGAAC mRNA/cds = (2021, 3883)TCCCTTATACAGAGTTTTGGTTCT 3212 Table 3A Hs.70266 NM_014933 7662389 yeastSec31p homolog (KIAA0905), 1 TTCTTTCATGTCCTCCCTACTTCCTCA mRNA/cds = (53,3715) GTGTCAATCAGATTAAAGTGTGT 3213 Table 3A Hs.42959 NM_014939 7662447KIAA1012 protein (KIAA1012), 1 TTTGAACTTTGGTCATAGAGTCTTCAT mRNA/cds =(57, 4364) ATTTCAGTATTTGGTGGTCCCTA 3214 Table 3A Hs.24083 NM_0149507662437 KIAA0997 protein (KIAA0997), 1 ACCCTAGAGTTACTCTCTTTTGGGAAmRNA/cds = (282, 2196) CATAAGGAGGTATACAGAACTGCA 3215 Table 3A Hs.323346NM_014953 7662443 KIAA1008 protein (KIAA1008), 1TTGATGTGTCACAAAACATTACTCATT mRNA/cds = (93, 2879)TGATTTCCCCCACCCCCGCCAAC 3216 Table 3A Hs.10031 NM_014959 7662403KIAA0955 protein (KIAA0955), 1 TCAGGGCGTTTGAATGTGAATTAGGA mRNA/cds =(313, 1608) CCAGCGCAATGAATGCTCAAGTTG 3217 Table 3A Hs.227133 NM_0149777662237 KIAA0670 protein/acinus (KIAA0670), 1 AGTTCCCAGTCTCTTCTGTCCTGCAGmRNA/cds = (327, 4352) CCCTTGCCTCTTTCCCACAGGTTC 3218 Table 3A Hs.184827NM_014999 7661921 KIAA0118 protein (KIAA0118), 1GTAGAATCAGGCACTGCTCGCAGAA mRNA/cds = (255, 932)GGAACACAGATTGTAGAGATTAACA 3219 Table 3A Hs.184245 NM_015001 14790189SMART/HDAC1 associated repressor 1 TTTTCTCAGCGCAGTTTTGTTTTGTGT protein(SHARP), GTCCATTGGATTACAAACTTTAT mRNA/cds = (204, 11198) 3220 Table 3AHs.151411 NM_015057 7662379 KIAA0916 protein (KIAA0916), 1TGCCTCATTATCTTGCAGCTGTAAAC mRNA/cds = (146, 14071)ATATTGGAATGTACATGTCAATAA 3221 Table 3A Hs.132942 NM_015071 7662207GTPase regulator associated with the 1 GCCATAGCCTGAATCTTTTAGGGGTA focaladhesion kinase pp125(FAK); TTAAGGTCAGCCTCTCACTCTTCC KIAA0621 protein(KIAA0621), mRNA/cds = (423, 2667) 3222 Table 3A Hs.306117 NM_01512511056033 capicua protein (CIC) mRNA, 1 AGCCGCCTTCCAGGCCCGCTATGCAcomplete cds/cds = (40, 4866) GACATCTTTCCCTCCAAGGTTTGTC 3223 Table 3AHs.79337 NM_015148 8923825 KIAA0135 protein (KIAA0135), 1AGCAGCTTTCTTCAAGTCGCTCTTTA mRNA/cds = (1803, 3791)GCCCTTTGTGGTTAATCTCTCAGT 3224 Table 3A Hs.11000 NM_015344 7662509 MY047protein (MY047) 1 TGCACTGATACAACATTACCATTCTTC mRNA/cds = (84, 479)TATGGAAAGAAAACTTTTGATGA 3225 Table 3A Hs.287586 NM_015384 7661841 cDNAFLJ13648 fls, clone 1 ATAGAGGAGGAGGCACTTCAGGGGT PLACE1011340, weaklysimilar to GAGGCGGAGGAGGAGTCAACGTATT IDN3-B mRNA/cds = UNKNOWN 3226Table 3A Hs.105460 NM_015393 7661631 DKFZP564O0823 protein 1ATACCCACACAGCAACTGGTCCACTG (DKFZP564O0823), CTTTACTGTCTGTTGGATAATGGCmRNA/cds = (170, 904) 3227 Table 3A Hs.99843 NM_015400 7661691DKFZP586N0721 protein 1 AGATTTGTGTCCTCTCATTCCCTCTCT (DKFZP586N0721),TCCTCTTGTAAGTGCCCTTCTAA mRNA/cds = (726, 1151) 3228 Table 3A Hs.75884NM_015416 7661659 DKFZP588A011 protein 1 GCACTGTTTTTAAACCCAAGTAAAGA(DKFZP586A011), CTGCTTGAAACCTGTTGATGGAAA mRNA/cds = (330, 832) 3229Table 3A Hs.64595 NM_015423 7661649 aminoadipate-semlaldehyde 1AGATTTCCCCTCAGTTTCCATTGACTT dehydrogenase-phosphopantetheinylAGATCAGGTTACAGAGAAAGGCA transferase (AASDHPPT), mRNA/cds = (166, 1095)3230 Table 3A Hs.48320 NM_015435 13491169 mRNA for ring-IBR-ring domain1 AGATCGAGATCTTCAGTCCTCTGCTT containing protein Dorfin, completeCATCTGTGAGCTTGCCTTCAGTCA cds/cds = (317, 2833) 3231 Table 3A Hs.12305NM_015509 7661639 DKFZP566B183 protein 1 AGTGACTAAATACTGGGAACCTATTT(DKFZP566B183), TCTCAATCTTCCTCCATGTTGTGT mRNA/cds = (351, 749) 3232Table 3A Hs.6880 NM_015530 7661569 DKFZP434D156 protein 1TGGCACTCTGTGGCTCCTTGTAGTAT (DKFZP434D156), TATAGCTATACTGGGAAAGCATAGmRNA/cds = (230, 1384) 3233 Table 3A Hs.187991 NM_015626 7661595DKFZP564A122 protein 1 TTGGTGAGTTGCCAAAGAAGCAATAC (DKFZP564A122),AGCATATCTGCTTTTGCCTTCTGT mRNA/cds = (2570, 2908) 3234 Table 3A Hs.156764NM_015646 7661677 RAP1B, member of RAS oncogene 1AATTGACCAACCTAATGTTACAACTA family (RAP1B), CTTTGAGGTGGCCAAATGTAAACTmRNA/cds = (148, 702) 3235 Table 3A Hs.44563 NM_015697 7661549 Homosapiens, Similar to RIKEN 1 CTACTACGCTGCCCTGGGTGCTGTA cDNA 2310002F18gene, clone GGAGCCCATCTGACTCACCAGAAAT MGC:10413 IMAGE:3954787, mRNA/cds= (16, 1131) 3236 Table 3A Hs.5324 NM_015702 7661547 hypotheticalprotein (CL25022), 1 AAGGCCTCAGTTTTAATTATTTTCTTC mRNA/cds = (157, 1047)CCAAAATAAATCACACATTTGGT 3237 Table 3A Hs.110707 NM_015726 7657147 H326(H326), mRNA/cds = (176, 1969) 1 GGTGGGGTGATAGGGTGGGCTAAAAACCATGCACTCTGGAATTTGTTGTA 3238 Table 3A Hs.25674 NM_015832 7710144methyl-CpG binding domain protein 2 1 AGAGGCAGCTTCTAGACAGAGTTGCT (MBD2),transcript variant testis- TAATGAAAGGGTTTGTAATACTTT specific, mRNA/cds =(229, 1137) 3239 Table 3A Hs.278573 NM_015874 7706215 H-2K bindingfactor-2 (LOC51580), 1 GCTCAGTTCCATATTTCATCCGTGAA mRNA/cds = (238, 1500)AAACTTGCAATACGAGCAGTTTCA 3240 Table 3A Hs.104640 NM_015898 7705374 HIV-1inducer of short transcripts 1 CAACGGCCAGGAGAAGCACTTTAAG binding protien(FBI1), GACGAGGACGAGGACGAGGACGTGG mRNA/cds = (0, 1754) 3241 Table 3AHs.287414 NM_015906 7706235 transcriptional intermediary factor 1 1ATACAGCCCCGGCAGAAAACGCCTA gamma (TIF1GAMMA), transcriptAAGTCAGATGAGAGACCAGTACATA variant alpha, mRNA/cds = (84, 3467) 3242Table 3A Hs.145956 NM_015919 7706241 zinc finger protein mRNA, complete1 ACCAGAAACTTCAAATGTGTCACAAA cds/cds = (1073, 3133)AGATGAGCAGAACTATCCCGAGGT 3243 Table 3A Hs.279813 NM_015932 7705428hypothetical protein (HSPC014), 1 AAAGCGAAGTCATGGGAGAGCCACA mRNA/cds =(82, 507) CTTGATGGTGGAATATAAACTTGGT 3244 Table 3A Hs.171774 NM_0159337705430 hypothetical protein (HSPC016), 1 TCCCTGCCATAACATCTTTTGCCACGmRNA/cds = (38, 232) TATAGCTGGAATTAAGTGTTGTCT 3245 Table 3A Hs.119908NM_015934 7706253 nucleolar protein NOP5/NOP58 1CTGGTGACTCCACACTTCCAACCTGC (NOP5/NOP58), mRNA/cds = (0, 1589)TCTAAAAAACGCAAAATAGAACAG 3246 Table 3A Hs.84038 NM_015937 7706257 CGI-06protein (LOC51604), 1 TGTGTAGTGGATGGAGTTTACTGTTT mRNA/cds = (6, 1730)GTGGAATAAAAACGGCTGTTTCCG 3247 Table 3A Hs.5798 NM_015946 7705599 pelota(Drosophila) homolog (PELO), 1 ACAGGGATTTCTTATGTCTTTGGCTA mRNA/cds =(259, 1416) CACTAGATATTTTGTGATTGGCAA 3248 Table 3A Hs.7236 NM_0159537705715 eNOS interacting protein (LOC51070), 1 AGGCCTGAGTGTGTGCGGGAGACCAmRNA/cds = (44, 949) AATAAACCGGCTTGGGTGCGCAAAA 3249 Table 3A Hs.7104NM_015995 7706289 mRNA; cDNA DKFZp761P06121 1 AAGAAAGAAGAGAGAGAACTTG(from clone ATGCCAAGTCCACGAAAAAACAA DKFZp781P06121)/cds = UNKNOWN TTTTT3250 Table 3A Hs.6153 NM_016001 7705764 CGI-48 protein (LOC51096), 1GATCCAGCTGTGCTTAAGAGCCAGTA mRNA/cds = (107, 1872)ATGTCTTAATAAACATGTGGCAGC 3251 Table 3A Hs.7194 NM_016007 7706297 CGI-74protein 1 AAGCACTTGTTTTATTTTGTGTGTGGA GTATAAAGGCTACACCCTTATTG 3252 Table3A Hs.318725 NM_016018 7705782 CGI-72 protein (LOC51105), 1CCTTTTTCTACAGAATCATCAGGCAT mRNA/cds = (69, 1400)GGGTAAGGTGGCTAACGCTGAGAT 3253 Table 3A Hs.110803 NM_016039 7706321CGI-99 protein (LOC51637), 1 TGGGTATGTTCTAGAGATTTACCACC mRNA/cds = (161,895) ATTGCTTATTGCTTTTTTCTTTAA 3254 Table 3A Hs.286131 NM_016041 7705603CGI-101 protein (LOC51009), 1 TCTTCTTGATAGATGAGGCCATGGTG mRNA/cds = (6,635) TAAATGGAAGTTTCAGAGAGGACA 3255 Table 3A Hs.271614 NM_016049 7705615CGI-112 protein (LOC51016), 1 GTGGGTTGGTCCCACTAATGGAAATG mRNA/cds =(158, 784) GAAATGCCTGAGCCAGGCCAGCGG 3256 Table 3A Hs.283670 NM_0160587706334 CGI-119 protein (LOC51643), 1 AATCTATTCCTGCACCTGTTACGGTTmRNA/cds = (0, 776) TCTGGAAGCAGTTAATAAAAAGTA 3257 Table 3A Hs.181271NM_016057 7708338 CGI-120 protein (LOC51644), 1GCATGGAGTCAGGAGAAAACCACCTT mRNA/cds = (37, 570) CATAAACTGCTCTGTGCAAAGAGG3258 Table 3A Hs.27693 NM_016059 7706338 peptidylprolyl isomerase(cyclophilin)- 1 ACAAATGCCCCTGTTTATCAATAGGT like 1 (PPIL1), mRNA/cds =(227, 727) GACTACTTACTACACATGGAACCA 3259 Table 3A Hs.184542 NM_0160617706340 CGI-127 protein (LOC51646), 1 TGATTATATGCAGATTCCTAGTAGCAmRNA/cds = (125, 490) TGCCTTACCTACAGCACTATGTGC 3260 Table 3A Hs.32826NM_016063 7705623 CGI-130 protein (LOC51020), 1GGTCATTGAGCCTCAGGTAGGGAATA mRNA/cds = (63, 575) TATCAACCCGATTTCTTCCTCTCT3261 Table 3A Hs.5887 NM_016090 9994184 RNA binding motif protein 7(RBM7), 1 TTTCAAAGTGCCCAGACTGTGTACAA mRNA/cds = (21, 821)AGACACATGTAATGGAGATTGTAC 3262 Table 3A Hs.119503 NM_016091 7705432HSPC025 (HSPC025), 1 AGGACCGAAGTGTTTCAAGTGGATCT mRNA/cds = (33, 1727)CAGTAAAGGATCTTTGGAGCCAGA 3263 Table 3A Hs.7953 NM_016099 7705820 HSPC041protein (LOC51125), 1 AGTTTCACTGTCAGAGATATTGTAGG mRNA/cds = (141, 455)TGCTAATACTGGATTTCGTCTCAG 3264 Table 3A Hs.27023 NM_016108 7706370vesicle transport-related protein 1 AGTTAGAAGAGCAATATGTTTCCTTC (RA410),mRNA/cds = (7, 1929) TCTGTAACAGTGTCCTAACAGTGA 3265 db mining Hs.306603NM_016115 7705830 cDNA FLJ11517 fis, clone 1 AGCTGCCACTTCCCAGAAGCCTACATHEMBA 1002337/cds = UNKNOWN AATTATTTGCTCTATGAAGACGTT 3266 Table 3AHs.142295 NM_016123 7705840 putative protein kinase NY-REN-64 1GCCACTAATAACATTGGGCTAATATC antigen (LOC51135), TGCTGTGCTTCTCTGACAGGTAGTmRNA/cds = (49, 1431) 3267 Table 3A Hs.279921 NM_016127 7706384 HSPC035protein (LOC51669), 1 AGCATGCAGTTCTCTGTGAAATCTCA mRNA/cds = (18, 1035)AATATTGTTGTAATAGTCTGTTTC 3268 Table 3A Hs.102950 NM_016128 11559928 coatprotein gamma-cop (LOC51137), 1 TGAATCTATCCCCCAAGAAACCATCT mRNA/cds =(15, 2639) TATCCCTGTAATAAATCAGCATGT 3269 Table 3A Hs.272398 NM_0161357706730 transcription factor ets (TEL2), 1 GTGCTTCCAGGCGGCACTGACAGCCmRNA/cds = (75, 1100) TCAGTAACAATAAAAACAATGGTAG 3270 Table 3A Hs.108969NM_016145 7706664 PTD008 protein (PTD008), 1 GTCCATGTTTCTAGGGGTATTCATTTmRNA/cds = (233, 553) GCTTTCTCGTTGAAACCTGTTGTT 3271 Table 3A Hs.279901NM_016146 7706666 PTD009 protein (PTD009), 1 TAGGTCCATAAATGTTGTAATAAATATmRNA/cds = (257, 916) TCCTTTGATCTTGGTGTTTGCGT 3272 Table 3A Hs.306706NM_016154 7706872 cDNA:FLJ21192 fls, clone COL00107, 1GCTAGTACCTGTTATTTATTACCTGG highly similar to AF165522 ras-relatedAGGCCTGTCCAGCACCCACCCTAC GTP-binding protein 4b (RAB4B) mRNA/cds =UNKNOWN 3273 Table 3A Hs.279518 NM_016160 4502146 amytoid beta (AF)precursor-like 1 CCCACTATGCACAGATTAAACTTCAC protein 2 (APLP2),CTACAAACTCCTTAATATGATCTG mRNA/cds = (72, 2363) 3274 Table 3A Hs.75251NM_016166 7706636 DEAD/H (Asp—Glu—Ala—Asp/His) 1TGTGCTCTGTTTTACCTTACTCTGTTT box binding protein 1 (DDXBP1),AGAAAAGTATACAAGCGTGTTTT mRNA/cds = (96, 2051) 3275 Table 3A Hs.241578NM_018200 7706424 U6 snRNA-associated Sm-like protein 1TGAGTGTGTCTCTGGATTTTGACCCC LSm8 (LOC51691), TTATTGATTCATTGTAATATGTAAmRNA/cds = (82, 372) 3276 literature Hs.135756 NM_016218 7705343polymerase (DNA-directed) kappa 1 ACATTTGTAAGGGCTCTCAAAGATTC (POLK),mRNA/cds = (172, 2784) ACACATGCCTATATTATCATAAGA 3277 Table 3A Hs.7905NM_016224 7706705 SH3 and PX domain-containing protein 1TCCGCATCCATTATTTAAACCAGTGG SH3PX1 (SH3PX1), AAATTGTCTCTATTTTTGGAAAGTmRNA/cds = (43, 1830) 3278 Table 3A Hs.108636 NM_016227 7705321 membraneprotein CH1 (CH1), 1 ACGGAGCTGTAGTGCCATTAGAAACT mRNA/cds = (124, 4341)GTGAATTTCCAAATAAATCTGAAC 3279 Table 3A Hs.5741 NM_016230 7705898flavohemoprotein b5 + b5R 1 AGCCTTCAGTTTCTTAAATGAAATCAA (LOC51167),mRNA/cds = (6, 1469) ATGTTCCTTCAGTACAGGTAACT 3280 Table 3A Hs.127561NM_016239 7705900 myosin XVA (MYO15A), 1 CCAGACCCCCATCACTTGATGGGCCmRNA/cds = (338, 10930) ACACAAGTTTGAGAGTGGTACAAGG 3281 Table 3AHs.250646 NM_016252 10442821 baculovairl Iap repeat-containing 6 1TCAGGTTAAACCCAGCAGCAGCAAAG (BIRC6), mRNA/cds = (0, 14489)AACTCCCCAGTGACTTCCAGTTAT 3282 Table 3A Hs.107740 NM_016270 7706468Kruppel-like factor (LOC51713), 1 GGTGGGCATTTTTGGGCTACCTGGTT mRNA/cds =(84, 1151) CGTTTTTATAAGATTTTGCTGGGT 3283 Table 3A Hs.8148 NM_0162757706470 selenoprotein T (LOC51714), 1 AGTGCAATAATACTGTATAGCTTTCCmRNA/cds = (138, 629) CCCACCTCCCACAAAATCACCCAG 3284 Table 3A Hs.279588NM_018283 7706211 adrenal gland protein AD-004 1AATCATGTTGCAGAACCAGCAGGTGG (LOC51578), mRNA/cds = (341, 859)ATAGTATATAGGTTTATGCCTGGG 3285 Table 3A Hs.6406 NM_016289 7706480 MO25protein (LOC51719), 1 GGTGCAGCGTGTCAGACACAACATTC mRNA/cds = (53, 1078)ATGTTACTCTTACATTGGAATCTG 3286 literature Hs.182366 NM_016292 7706484heat shock protein 75 (TRAP1), 1 GGACTGACACCACAGATGACAGCCC mRNA/cds =(4, 2118) CACCTCCTTGAGCTTTATTTACCTA 3287 Table 3A Hs.14770 NM_0162937706486 bridging integrator 2 (BIN2), 1 ACGACCCATTTTGCAAGACTTAAAGCmRNA/cds = (38, 1735) CGGAAGAACACATTTTCAGATTGT 3288 Table 3A Hs.284164NM_016301 9994188 protein x 0004 (LOC51184), 1AGGAATTACTGTAACAAAATATGTAT mRNA/cds = (31, 885) GTCCGAAGGGAAAAAGCTGCAAGG3289 Table 3A Hs.102897 NM_016302 10047097 CGI-47 protein (LOC51095), 1TCCTGTGGAATCTGATATGTCTGGTA mRNA/cds = (131, 1348)GCATGTCATTGATGGGACATGAAG 3290 Table 3A Hs.284162 NM_016304 10047101 60Sribosomal protein L30 isolog 1 ATGGCACTAGGCAGCATTTGTATAGT (LOC51187),mRNA/cds = (143, 634) AACTAATGGCAAAAATTCATGGCT 3291 Table 3A Hs.334811NM_016312 7706500 Npw38-binding protien NpwBP 1ATTTGATTAAAATTATTTCCCACTGAC (LOC51729), mRNA/cds = (143, 2066)CTAAACTTTCAGTGATTTGTGGG 3292 literature Hs.110347 NM_016316 7706880 REV1(yeast homolog)-like (REV1L), 1 AAAGCAAGTGTTTTGTACATTTCTTTT mRNA/cds =(212, 3967) CAAAAAGTGCCAAATTTGTCAGT 3293 Table 3A Hs.83761 NM_0163257706506 zinc finger protein 274 (ZNF274), 1 AATCTGCACTGATATTACATCCACAGmRNA/cds = (401, 2266) TACCACAGTATTTATGTGTATGAA 3294 Table 3A Hs.16085NM_016334 7706703 putative G-protein coupled receptor 1ATGGTAGCTGAGCCAAACACGTAGG (SH120), mRNA/cds = (103, 1470)ATTTCCGTTTTAAGGTTCACATGGA 3295 Table 3A Hs.279918 NM_016391 7705450hypothetical protein (HSPC111), 1 AAGCCAGAACCTGCTGTTTTCAGGGT mRNA/cds =(62, 598) GGGTGATGTAAATATAGTGTGTAC 3296 Table 3A Hs.239720 NM_0163987705464 CCR4-NOT transcription complex, 1 TGACAAATTAGAAGAACGGCCTCACCsubunit 2 (CNOT2), TGCCATCCACCTTCAACTACAACC mRNA/cds = (115, 1737) 3297Table 3A Hs.334788 NM_016406 7705480 hypothetical protein FLJ14639 1TCTTTCTGGTTTCTGGAGATAACCCA (FLJ14639), mRNA/cds = (273, 689)TCAATAAAAGCTGCTTCCTCTGGT 3298 Table 3A Hs.98289 NM_016440 7705992 VRK3for vaccine related kinase 3 1 GGGACCCCTCCTACCCTTGACTCCTC (LOC51231),mRNA/cds = (118, 1542) TGTGCTTTGGTAATAAATTGTTTT 3299 Table 3A Hs.3059NM_016451 7705368 coatomer protein complex, subunit 1GTTCTGAATGCTGTCCTCAAAGTATA beta (COPB), mRNA/cds = (178, 3039)TAATGTTTCATGTACCAAGACCCT 3300 Table 3A Hs.172918 NM_016466 7706006hypothetical protein (LOC51239), 1 GACATCTGCTCCCTCCTCCTGCAACA mRNA/cds =(0, 527) CAGCCCAGCCCTGAAGGCCATCCG 3301 Table 3A Hs.171566 NM_0164687706010 hypothetical protein (LOC51241), 1 TGGGAAGATCCTGACCTCCTCCAAGmRNA/cds = (0, 320) GAAGAAATCCAGAAAGCCTTAAGAC 3302 Table 3A Hs.75798NM_016470 7705508 hypothetical protein (HSPC207), 1AGCCAGTGATCTCTCTGACTTTCAAT mRNA/cds = (0, 620) CAGTTTCCAAGCTTAACCAGGGCA3303 Table 3A Hs.55847 NM_016497 7706044 hypothetical protein(LOC51258), 1 AAACGCATCCGCTATCTCTACAAACA mRNA/cds = (0, 386)CTTTAACCGACATGGGAAGTTTCG 3304 Table 3A Hs.278429 NM_016520 7706556hepatocellular carcinoma-associated 1 TCCTCCAGCTGACAGAAAAATCCAGG antigen59 (LOC51759), ATGAGATCAGAAGGATACTGGTGT mRNA/cds = (27, 896) 3305 Table3A Hs.183125 NM_016523 7705573 killer cell lectin-like receptorsubfamily 1 TTCCAGGCTTTTGCTACTCTTCACTC F, member 1 (KLRF1),AGCTACAATAAACATCCTGAATGT mRNA/cds = (64, 759) 3306 Table 3A Hs.75425NM_016525 8394498 ubiquitin associated protein (UBAP), 1ACACCTAGTCATAGAAATCAGTCTCT mRNA/cds = (172, 1680)CTGGTTTGTTTTGTATTATGTTGT 3307 Table 3A Hs.239208 NM_016533 7706622ninjurin 2 (NINJ2), 1 CACTGCTTCCTTCTGCTCCAGGCCTC mRNA/cds = (56, 484)AATTTTCCCTTCTTGTAAAATGGA 3308 Table 3A Hs.10071 NM_016551 7706574 seventransmembrane protein 1 ACTTTCGGAGGGAGTTTATTATTGAG TM7SF3 (TM7SF3),TCTTTATCTGTGACAGTATTTGGA mRNA/cds = (37, 1749) 3309 Table 3A Hs.179152NM_018582 7706092 toll-like receptor 7 (LOC51264), 1ATAGAGAGGTAATTAAATTGCTGGAG mRNA/cds = (135, 3284)CCAACTATTTCACAACTTCTGTAA 3310 Table 3A Hs.18552 NM_016565 7706098 E2IG2protein (LOC51287), 1 GTTCCACCAGTATTTACCAGGAAAAC mRNA/cds = (131, 421)AAAGAATGTGTTAAGGGATGCTCC 3311 Table 3A Hs.267182 NM_016569 7706728 T-box3 (ulnar mammary syndrome) 1 TGCTATTTCCTATTTTCACCAAAATTG (TBX3),mRNA/cds = (116, 1908) GGGAAGGAGTGCCACTTTCCAGC 3312 Table 3A Hs.14896NM_016598 7706132 DHHC1 protein (LOC51304), 1 TGCTGCCACTTTTCAATTCTGTCAGTmRNA/cds = (214, 1197) GCTTCCACATGGAAACAAAATGCA 3313 Table 3A Hs.24125NM_016604 7706598 putative zinc finger protein 1TCACTTTCTGTATTTTAATTTTGTTGA (LOC51780), mRNA/cds = (744, 4997)AGGGCTGATTGGGATTTCCATGT 3314 Table 3A Hs.46847 NM_016614 7705261 TRAFand TNF receptor-associated 1 GCATGAAGAGACATAGCCTTTTAGTT protein(AD022), TTGCTAATTGTGAAATGGAAATGC mRNA/cds = (16, 1104) 3315 Table 3AHs.107139 NM_016619 7706157 hypothetical protein (LOC51316), 1TGTTGTCCCTGAACTTAGCTAAATGG mRNA/cds = (101, 448)TGCAACTTAGTTTCTCCTTGCTTT 3316 db mining Hs.106826 NM_016621 7706159 cDNAFLJ13196 fis, clone 1 TCATAGTGTCAGTGAGGTCCCGTGAG NT2RP3004426, weaklysimilar to TCTTTGTGAGTCCTTGTGTCATCG CHROMODOMAIN HELICASE-DNA-BINDINGPROTEIN 4/cds = (385, 2289) 3317 Table 3A Hs.92918 NM_016623 7705303hypothetical protien (BM-009), 1 GTGCGTAGAATATTACGTATGCATGT mRNA/cds =(385, 1047) TCATGTCTAAAGAATGGCTGTTGA 3318 Table 3A Hs.70333 NM_0166287706169 mRNA for KIAA1844 protein, partial 1 CGTGGTTGTGGGAGGGGAAAGAGGAcds/cds = (0, 1105) AACAGAGCTAGTCAGATGTGAATTG 3319 Table 3A Hs.71475NM_016630 13699804 acid cluster protein 33 (ACP33), 1GGACATTGGTTATTTTATGCTTTCTTG mRNA/cds = (176, 1102)GATATAACCATGATCAGAGTGCC 3320 Table 3A Hs.278027 NM_016733 8051617 LIMdomain kinase 2 (LIMK2), 1 GCAAGTGTAGGAGTGGTGGGCCTGA transcript variant2b, ACTGGGCCATTGATCAGACTAAATA mRNA/cds = (315, 2168) 3321 literatureHs.342801 NM_018734 9951919 paired box gene 5 (B-cell lineage 1AATCAGAAGAGCCTGGAAAAAG specific activator protein) (PAX5),ACCTAGCCCAACTTCCCTTGTGGG mRNA/cds = (448, 1623) AAAC 3322 Table 3AHs.324470 NM_016824 9943847 adducin 3 (gamma) (ADD3), transcript 1TCAACAAAGGGGATTTTGTACACATA variant 1, mRNA/cds = (31, 2151)ACATGGGTTATTTAGTTTAACTCT 3323 Table 3A Hs.77273 NM_016936 9055373 rashomolog gene family, member A 1 CTTTTGTGCAGCGACTATGTTGGTGT (ARHA),mRNA/cds = (151, 732) TAGGGGTGGTGTGGAGATTGTTAA 3324 Table 3A Hs.159565NM_018952 8393083 surface glycoprotein, lg superfamily 1ATTTATGCCTTAAATGTTTTCTTCCCC member (CDO), mRNA/cds = (0, 3722)ATTCCTTCCTCCCCCTCGGTAGG 3325 Table 3A Hs.9082 NM_017426 8393857nuceloporin p54 (NUP54), 1 TTTGTATTTGTGAACTCATCTGTGGG mRNA/cds = (25,1542) AGGAGTAAAGAAAATCCAAAAGCA 3326 Table 3A Hs.83551 NM_017459 9665258microfibrillar-associated protein 2 1 CCCCCGTGGGCATGGACCACCTTTAT(MFAP2), transcript variant 1, TTTATACAAAATTAAAAACAAGTT mRNA/cds = (114,685) 3327 Table 3A Hs.85100 NM_017491 9257256 WD repeat domain 1 (WDR1),1 ACTGTAAACTAATCTGTCATTGTTTTT transcript variant 1,ACCTTCCTTTTCTTTTTCAGTGC mRNA/cds = (202, 2022) 3328 Table 3A Hs.139262NM_017523 8923794 XIAP associated factor-1 1 TACTTGCTGTGGTGGTCTTGTGAAAG(HSXIAPAF1), mRNA/cds = (0, 953) GTGATGGGTTTTATTCGTTGGGCT 3329 Table 3AHs.119018 NM_017544 8923943 transcription factor NRF (NRF), 1AAAGAATTAGTGTATGCTTCCTGAAT mRNA/cds = (653, 1819)AAAAAGGAGCCAAAGTTGATCAGA 3330 Table 3A Hs.306195 NM_017601 8922168over-expressed breast tumor protein 1 AGGGGGTGATTTTTGCTCTTGTCCTG (OBTP),mRNA/cds = (0, 224) AGAAATAACAGTGCTGTTTTAAAA 3331 Table 3A Hs.32922NM_017632 8923039 hypothetical protein FLJ20036 1AGCTTAAGGTTTTAAAAATGTTGCCC (FLJ20036), mRNA/cds = (162, 1904)GTAATGTTGAACGTGTCTGTTAGA 3332 Table 3A Hs.246875 NM_017644 8923080hypothetical protein FLJ20059 1 GGATGCACGTACAGAATACATTCAGC (FLJ20059),mRNA/cds = (25, 1290) CGTCAGGTAATAACATGAAGCAGT 3333 Table 3A Hs.7942NM_017657 8923087 hypothetical protein FLJ20080 1GGACAGTTTCTATTGCTTTTCCTTTTT (FLJ20080), mRNA/cds = (315, 3044)TCCATCCCTTCCCTACCATCAAA 3334 Table 3A Hs.26389 NM_017748 8923268hypothetical protein FLJ20287 1 AGACTTACATTACTGCTTTAACGTGTA (FLJ20287),mRNA/cds = (131, 2920) TATCACTGGGCATCCCCAAGGGC 3335 Table 3A Hs.8928NM_017748 8923270 hypothetical protein FLJ20291 1GTCAGGTTAGGTCAAAGCCAGGGAG (FLJ20291), mRNA/cds = (117, 1394)TGACAGAATCTGGGAAATCAAACAA 3336 Table 3A Hs.7862 NM_017761 8923294hypothetical protein FLJ20312 1 CCTCTTGATGCCTAAGCAGGTAAGCA (FLJ20312),mRNA/cds = (133, 552) GATGCCTAAGCTGTATTTCTCCAA 3337 Table 3A Hs.126721NM_017762 8923296 hypothetical protein FLJ20313 1TGGATCTGTCAAACTAACACTTATGC (FLJ20313), mRNA/cds = (344, 1699)CTTTAGTCTCATTGTATGAGGTGT 3338 Table 3A Hs.306668 NM_017774 8923317 cDNAFLJ14089 fis, clone 1 ACCTGCCATCATTGGTCTTTACTAAG MAMMA1000257/cds =UNKNOWN TGAAGTGACTTCTTTCTTTAACAA 3339 Table 3A Hs.105461 NM_0177808923329 hypothetical protein FLJ20357 1 GCTGCCAACTGTAGTAATGATGCTTT(FLJ20357), mRNA/cds = (35, 2083) TAATAAAAGTGACCCATGATATGC 3340 Table 3AHs.6831 NM_017792 8923351 hypothetical protein FLJ20373 1ACTGTTGTCCCCCCACCCTTTTTTCC (FLJ20373), mRNA/cds = (268, 849)TTAAATAAAGTAAAAATGACACCC 3341 Table 3A Hs.283685 NM_017801 8923369hypothetical protein FLJ20396 1 TGTGAATACTGTGTAGCAGGATCTTG (FLJ20396),mRNA/cds = (107, 658) AGAGTCCTTGTTCTTACATAGGCA 3342 Table 3A Hs.14220NM_017827 8923420 hypothetical protein FLJ20450 1AAGAGGCTTCCATCCCTCCTTCCTTC (FLJ20450), mRNA/cds = (27, 1583)TTTCCTCCTACAGTGCTGAGCAAA 3343 Table 3A Hs.132071 NM_017830 8923426ovarian carcinoma immunoreactive 1 GTTGAATTGGGGTGGATGGGGGGAG antigen(OCIA), mRNA/cds = (167, 904) CAAGCATAATTTTTAAGTGTGAAGC 3344 Table 3AHs.5811 NM_017835 8923436 chromosome 21 open reading frame 1TCACCAGCTGATGACACTTCCAAAGA 59 (C21ORF59), GATTAGCTCACCTTTCTCCTAGGCmRNA/cds = (360, 776) 3345 Table 3A Hs.5080 NM_017840 8923447mitochondrial ribosomal protein L16 1 CCCACTGAAGTCTTTGGGTAGCTCTT(MRPL16), mRNA/cds = (111, 866) AAGCCATAACTAAGGAGCAGCATT 3346 Table 3AHs.39850 NM_017859 8923486 hypothetical protein FLJ20517 1AGTGACGAGGAGGAAGTGGCCTACA (FLJ20517), mRNA/cds = (44, 1690)CGGGTTAGCTGCCCAGTGAGCCATC 3347 Table 3A Hs.44344 NM_017867 8923502hypothetical protein FLJ20534 1 AACAGAAGTCAAGAGAACATAG (FLJ20534),mRNA/cds = (20, 1060) ACCAACTTGCTGCATGAGTAAGGT GGCT 3348 Table 3AHs.107213 NM_017892 8923548 hypothetical protein FLJ20585 1TTTTCCCTGCTATTGAGGAAGTATTTT (FLJ20585), mRNA/cds = (99, 746)GCCTTCCCTACTCACTGAGAAGT 3349 Table 3A Hs.55781 NM_017897 8923558hypothetical protein FLJ20604 1 CGGAACCAGAATTTGATCTCAACTAT (FLJ20604),mRNA/cds = (99, 1476) GTTCCACTAAAGGCACAGGAATGG 3350 Table 3A Hs.18791NM_017899 8923562 hypothetical protein FLJ20607 1CGCACCTTGTGTCTTGTAGGGTATGG (FLJ20607), mRNA/cds = (48, 698)TATGTGGGACTTCGCTGTTTTTAT 3351 Table 3A Hs.52184 NM_017903 8923570hypothetical protein FLJ20618 1 AGCAGTTATATTGCCCCTTGGTTTTTA (FLJ20618),mRNA/cds = (318, 725) TTCAGTTTAACTACTGTTTCCAA 3352 Table 3A Hs.49376NM_017917 8923599 hypothetical protein FLJ20644 1AGCAAAATCCTCAGAAATGGTCTAAA (FLJ20644), mRNA/cds = (276, 1637)TAAAACACTTGATATGCCTAGAGA 3353 Table 3A Hs.234149 NM_017918 8923601hypothetical protein FLJ20647 1 TGATTTTGCAACTTAGGATGTTTTTGA (FLJ20647),mRNA/cds = (90, 838) GTCCCATGGTTCATTTTGATTGT 3354 Table 3A Hs.180201NM_017924 8923614 hypothetical protein FLJ20671 1TTACCTGGATTCCATTGGCTGGTTTT (FLJ20671), mRNA/cds = (72, 494)ACCACTCCTATCAGATTGTAGTGT 3355 Table 3A Hs.48712 NM_017948 8923662hypothetical protein FLJ20736 1 CTCTTTGCCCTCTATCCTGAGTAACT (FLJ20736),mRNA/cds = (130, 1851) AATGGACATCTTCTCATGCAAGGT 3356 Table 3A Hs.279937NM_014980 7662439 KIAA1001 protein (KIAA1001), 1GCCACAGAATGGTCACCCAGCTTATT mRNA/cds = (458, 2035)TAGGTGTAGACAAGTATGACACAG 3357 Table 3A Hs.280978 NM_018114 8922464hypothetical protein FLJ10496 1 GCCACAGAGGCTCCAATACCTGGGA (FLJ10498),mRNA/cds = (13, 429) ATGTTCACAAAGTCATCAACTGGAA 3358 Table 3A Hs.55024NM_018053 8922341 hypothetical protein FLJ10307 1AGAATGTGTGTGCCTGTGGGTCTCTA (FLJ10307), mRNA/cds = (28, 462)CAAGTGACAGATGTGTTGTTTTCA 3359 Table 3A Hs.100895 NM_018099 8922433hypothetical protein FLJ10462 1 TCCAAATTGTTTCCTAACATTCTATTT (FLJ10462),mRNA/cds = (147, 1694) TATGCCTTTGCGTATTAAACGTG 3360 Table 3A Hs.4997NM_018107 8922449 hypothetical protein FLJ10482 1GCCTCTACTGTGGCCTCAACCCTGG (FLJ10482), mRNA/cds = (149, 1369)CAATTATAGCTACTCCCATCCCTTA 3361 Table 3A Hs.236844 NM_018169 8922572hypothetical protein FLJ10652 1 AACTGAACACAATTTTGGGACAACGT (FLJ10652),mRNA/cds = (50, 1141) TTAAACATTACTTTTCATACTTGA 3362 Table 3A Hs.66048NM_018174 8922582 chromosome 19 open reading frame 5 1CTGAGCCCAGCCCGCCTGTCCCTAG (c19orf5), mRNA/cds = (175, 2193)ATTCAGCCACATCAGAAATAAACTG 3363 Table 3A Hs.8083 NM_018210 8922653hypothetical protein FLJ10769 1 ACTGTGCCATGGACATTTTTCCTCTG (FLJ10769),mRNA/cds = (14, 1186) GGGAATTAACATCTAAATTCTGGT 3364 Table 3A Hs.59838NM_018227 8922683 hypothetical protein FLJ10808 1ACAACGCTCTTAGAGAATCCGTGAAT (FLJ10808), mRNA/cds = (180, 1559)GTGAACAGACAAATGTGGCTAACC 3365 Table 3A Hs.18851 NM_018253 8922730hypothetical protein FLJ10875 1 TAGGAGAATAAGAGTCTGGAGACTG (FLJ10875),mRNA/cds = (100, 2037) GGAGCCTTCACTTCGGCCTCCGATT 3366 Table 3A Hs.8739NM_018255 8922734 hypothetical protein FLJ10879 1TGCTGAGTGGTTACACTTTGCAAGCT (FLJ10879), mRNA/cds = (10, 2490)GTGGTGAAGATCACACTGTGAAGA 3367 Table 3A Hs.143954 NM_018270 8922763hypothetical protein FLJ10914 1 CCCAGTGCTGATGGAGATGCCACTTT (FLJ10914),mRNA/cds = (71, 685) CGTGTGACTGCGAACATTAAAGCA 3368 Table 3A Hs.6118NM_018285 8922793 mitochondrial ribosomal protein S4 1TGTTCAGGATCTCCTCCCTTGTTTAA (MRPS4), mRNA/cds = (47, 601)ATGTCAATAAATGCCCCAACTGCT 3369 Table 3A Hs.302981 NM_018295 8922813hypothetical protein FLJ11000 1 TTATTCATATATTCCTGTCCAAAGCCA (FLJ11000),mRNA/cds = (223, 780) CACTGAAAACAGAGGCAGAGACA 3370 Table 3A Hs.30822NM_018326 8922872 hypothetical protein FLJ11110 1AGGTCATCCACACACTTCTGCCCCCA (FLJ11110), mRNA/cds = (44, 1033)CTGCATTGAATTTTTTGCTTATGT 3371 Table 3A Hs.105216 NM_018331 8922883hypothetical protein FLJ11125 1 TTTTCGTTCTCCTCCTACCCCAGATC (FLJ11125),mRNA/cds = (203, 712) TCTACAAGGACATTGCCCCTAAGC 3372 Table 3A Hs.8033NM_018346 8922910 hypothetical protein FLJ11164 1GTGTTTGTAATTCTTCTTTGTCCTTTT (FLJ11164), mRNA/cds = (58, 1384)ACCTACAGAAATGGTCACATGGT 3373 Table 3A Hs.184465 NM_018370 8922957hypothetical protein FLJ11259 1 AGGATGTTTGTAGTGCTATAATATAG (FLJ11259),mRNA/cds = (87, 485) AATGGGATTTACTCTGCTTTACCA 3374 Table 3A Hs.11260NM_018371 8922959 hypothetical protein FLJ11264 1AGCTAATTATCTCTTTGAGTCCTTGCT (FLJ11264), mRNA/cds = (362, 1189)TCTGTTTGCTCACAGTAAGCTCA 3375 Table 3A Hs.26194 NM_018384 8922984hypothetical protein FLJ11296 1 TCCTACTTATTTAAGCTATTTGAGCTC (FLJ11296),mRNA/cds = (303, 1226) CGGGTCTCTTCTACCTGCATTCT 3376 literature Hs.266514NM_018394 8923000 hypothetical protein FLJ11342 1AGTGATTGCCACCTAAATCAGAAGAC (FLJ11342), mRNA/cds = (10, 930)GTTCTAAAGTCAGTAAGAAAGTGT 3377 Table 3A Hs.183856 NM_018399 9055235 VNN3protein (HSA238982), 1 CACGCTTAGGGCAGGGATCTGGGAA mRNA/cds = (45, 1550)ATTCCAGTGATCTCCTTTAGCAGAG 3378 Table 3A Hs.123090 NM_018450 8922086BRG1-Associated Factor 250a 1 TTTCTAATCGAGGTGTGAAAAAGTTC (BAF250a) mRNA,complete TAGGTTCAGTTGAAGTTCTGATGA cds/cds = (378, 7235) 3379 Table 3AHs.7731 NM_018453 8922092 uncharacterized bone marrow protein 1TCATTCTGTTTTTGATGAACATTTGGA BM036 (BM036), mRNA/cds = (95, 796)AACTGTCGGGCTTTTTATTAAAG 3380 Table 3A Hs.6375 NM_018471 8923807uncharacterized hypothalamus protein 1 CAATGCCCTGTGTTAAATTGTTTAAAA HT010(HT010), GTTTCCCTTTTCTTTTTTGCCAA mRNA/cds = (226, 1419) 3381 Table 3AHs.334370 NM_018476 8923715 brain expressed, X-linked 1 (BEX1), 1ACCTATTGCATGGAAAGATGCTCATT mRNA/cds = (171, 548)ATAGTGAAGTTAATAAAGCACCTT 3382 Table 3A Hs.274369 NM_018477 8923711uncharacterized hypothalamus protein 1 AGAGGACTATAGTGGAAGTGAAAGCA HARP11(HARP11), TTCTGTGTTTACTCTTTGCATTAA mRNA/cds = (80, 1333) 3383 db miningHs.10669 NM_018482 8923867 mRNA for KIAA1249 protein, partial 1TGAATTGCACTGTGAAAAGCACTCTT cds/cds = (0, 2850) CCCTCTCAGTTTTCGTTCATCCTG3384 Table 3A Hs.102652 NM_018489 8922080 hypothetical protein ASH1(ASH1), 1 CCATGGGGTCAGAAGGGCACGGTAG mRNA/cds = (309, 9218)TTCTTGCAATTATTTTTGTTTTACC 3385 Table 3A Hs.160271 NM_018490 8923700 Gprotein-coupled receptor 48 1 AATGTGGGAAGGATTTATTTACAGTG (GPR48),mRNA/cds = (444, 3299) TGTTGTAATTTTGTAAGGCCAACT 3386 Table 3A Hs.7535NM_018491 13236498 COBW-like protein (LOC55871), 1AGCTACTGTGACAGAAACAGAA mRNA/cds = (64, 1251) AAGCAGTGGACAACACGTTTCCAAGAAG 3387 Table 3A Hs.104741 NM_018492 8923876 PDZ-binding kinase;T-cell originated 1 TGCTCATGCTGACTTAAAACACTAGC protein kinase (TOPK),AGTAAAACGCTGTAAACTGTAACA mRNA/cds = (154, 1122) 3388 Table 3A Hs.283330NM_018507 8924082 hypothetical protein PRO1843 1TCCAATGCAGTCCCATTCTTTATGGC (PRO1843), mRNA/cds = (964, 1254)CTATAGTCTCACTCCCAACTACCC 3389 Table 3A Hs.186874 NM_018519 8924144hypothetical protein PRO2266 1 GGTGTCTGACTTAATGACTCCTGCTG (PRO2266),mRNA/cds = (258, 826) AAGTTGAATTGTGAGATGTTATCC 3390 Table 3A Hs.343477AF119911 7770258 PRO2975 mRNA, complete 1 CATTTGTCTGGAAATGCTGCCGGGAGcds/cds = UNKNOWN CCTATTGTGTAAATGTAGGTATTT 3391 Table 3A Hs.147644NM_018555 10092612 zinc finger protein 331:zinc finger 1GCGGGAAGGCATGTAACCACCTAAA protein 463 (ZNF381), CCATCTCCGAGAACATAGAGGATCmRNA/cds = (376, 1767) 3392 Table 3A Hs.300496 NM_018579 8924027mitochondria solute carrier protein 1 CAGGTCAACCCCCACCGGACCTACA (MSCP)mRNA, complete cds, ACCCGCAGTCCCACATCATCTCAGG alternatively spliced/cds= (44, 511) 3393 Table 3A Hs.300496 NM_018579 6924027 mitochondriasolute carrier protein 1 CAGGTCAACCCCCACCGGACCTACA (MSCP) mRNA, completecds, ACCCGCAGTCCCACATCATCTCAGG alternatively spliced/cds = (44, 511)3394 Table 3A Hs.52881 NM_018807 13699664 hypothetical protein PRO1853)1 TTTAGGGTTGTGACTGGCTTTGGTGC (PRO1653), mRNA/cds = (472, 771)AAATGTGTGCTCAAGCTAATAAGT 3395 Table 3A Hs.103657 NM_018823 8924137PRO2219 mRNA, complete 1 ACTTGTGTTTTGTTTGGGGGCTGGGA cds/cds = (823,1056) AATGTATTTTTACATTGTAGCCAA 3396 Table 3A Hs.241576 NM_018630 8924181hypothetical protein PRO2577 1 AACATTGTGCTCTAACAGTATGACTA (PRO2577),mRNA/cds = (491, 664) TTCTTTCCCCCACTCTTAAACAGT 3397 Table 3A Hs.283022NM_018643 8924261 triggering receptor expressed on 1CCAAGGGAGGAGGGAGGAGGTAAAA myeloid cells 1 (TREM1),GGCAGGGAGTTAATAACATGAATTA mRNA/cds = (47, 751) 3398 Table 3A Hs.14317NM_018646 8923941 nucleolar protein family A, member 3 1TACTCTTTGGCATCCAGTCTCTCGTG (H/ACA small nucleolar RNPs)GCGATTGATTATGCTTGTGTGAGG (NOLA3), mRNA/cds = (97, 291) 3399 Table 3AHs.195292 NM_018666 8924241 putative tumor antigen (SAGE), 1CCTTCCAGAAGCTACGAAAAAGGGA mRNA/cds = (167, 2881)GCTGTTTAAATTTAATAAATCTCTG 3400 Table 3A Hs.8117 NM_018695 8923908erbb2-interacting protein ERBIN 1 AAGTGCCATAGAAGACCAATAACTGT (ERBB2IP),mRNA/cds = (323, 4438) TTAGTTGAGGCTAGTCTGGAACCT 3401 Table 3A Hs.78825NM_018834 10047081 matrin 3 (MATR3), 1 TGGATTCAAGTTACTGAAGTGAATACmRNA/cds = (254, 2800) CAATAAAAAGAAAACCCTAGGCCA 3402 Table 3A Hs.44163NM_018838 10092656 13kDa differentiation-associated 1AGGAGTGGATCCCACCTTCAACACCT protein (LOC55967), TACAAGTAAAGACAATGAAGAACAmRNA/cds = (53, 490) 3403 Table 3A Hs.183842 NM_018955 11024713ubiquitin B (UBB), 1 CAGTAATAGCTGAACCTGTTCAAAAT mRNA/cds = (94, 783)GTTAATAAAGGTTTCGTTGCATGG 3404 db mining Hs.44234 NM_018965 9507202triggering receptor expressed on 1 AGGGAGTGGGGAGGTGGTAAGAACA myeloidcells 2 (TREM2), CCTGACAACTTCTGAATATTGGACA mRNA/cds = (94, 786) 3405Table 3A Hs.274428 NM_018975 9507032 TRF2-interacting talomeric RAP1 1AAAATTAGTGGATTGACTCCACTTTG protein (RAP1), TTGTGTTGTTTTCATTGTTGAAAAmRNA/cds = (136, 1034) 3406 Table 3A Hs.61053 NM_018986 9506676hypothetical protein (FLJ20356), 1 AATGGAGGCACGAACGCAGGGGCCA mRNA/cds =(91, 3285) AATAGCAATAAATGGGTTTTGTTTT 3407 Table 3A Hs.80618 NM_0189969506648 hypothetical protein (FLJ20015), 1 TGTTTTGATTGTTTTGCAAGGAAGAAmRNA/cds = (31, 522) AGACAATGGAATAACATACCTTCA 3408 Table 3A Hs.83954NM_019006 9506852 protein associated with PRK1 (AWP1), 1TCATTGCTGTCTACAGGTTTCTTTCA mRNA/cds = (244, 804)GATTATGTTCATGGGTTTGTGTGT 3409 Table 3A Hs.98324 NM_019044 9506632hypothetical protein (FLJ10996), 1 GAAAACAGACCTTGTGCTGAGGACAC mRNA/cds =(135, 857) GTCAATAAAAATTATACCTTCCCC 3410 db mining Hs.110746 NM_0190529506772 HCR (a-helix coiled-coil rod) 1 GGGATACCAGCTGAGTCTGAATTCTGhomologue) (HCR), CTCTAAATAAAGACGACTACAGAG mRNA/cds = (79, 2427) 3411Table 3A Hs.274248 NM_019059 9506858 hypothetical protein FLJ20758 1TGGCTCGGATAAGAGATGGGACATC (FLJ20758), mRNA/cds = (464, 1306)ATTCAGTCACTAGTTGGATGGCACA 3412 Table 3A Hs.124835 NM_019062 9506662hypothetical protein (FLJ20225), 1 AACTTGATGAAAGTATTGCAGTATTG mRNA/cds =(177, 860) ATGCCATTGTAGAATAGAACTGGA 3413 Table 3A Hs.30909 NM_01908111464998 KIAA0430 gene product (KIAA0430), 1 TTTGTGTGTTGGGACCAAACAGTTGTmRNA/cds = (0, 3599) CAATAAACTTTACAAGCGAGCATC 3414 Table 3A Hs.76807NM_019111 9506780 major histocompatibility complex, class 1CATGGGGCTCTCTTGTGTACTTATTG II, DR alpha (HLA-DRA),TTTAAGGTTTCCTCAAACTGTGAT mRNA/cds = (26, 790) 3415 Table 3A Hs.25951NM_019555 9506400 Rho guanine nucleotide exchange 1AGGTGGTCAATGAATGTTTTGATGAA factor (GEF) 3 (ARHGEF3),ATGAATGTTTTTGTATAATGGCCT mRNA/cds = (127, 1707) 3416 Table 3A Hs.278857NM_019597 14141155 heterogeneous nuclear 1 ACGGGACAATTTTAAGATGTAATACCribonucleoprotein H2 (H′) (HNRPH2), AATACTTTAGAAGTTTGGTCGTGT mRNA/cds =(78, 1427) 3417 Table 3A Hs.159523 NM_019604 9624976 class-IMHC-restricted T cell 1 ACAGCAAACTTTGGCATTTATGTGGA associated molecule(CRTAM), GCATTTCTCATTGTTGGAATCTGA mRNA/cds = (0, 1181) 3418 Table 3AHs.159523 NM_019604 9624976 class-I MHC-restricted T cell 1ACAGCAAACTTTGGCATTTATGTGGA associated molecule (CRTAM),GCATTTCTCATTGTTGGAATCTGA mRNA/cds = (0, 1181) 3419 Table 3A Hs.324743NM_019853 9790172 protein phosphatase 4 regulatory 1ACTTTTATGTAAAAAAGTGCACCTTTA subunit 2 (PPP4R2), GTTTTACAAGTAAAGCAGGTTGTmRNA/cds = (417, 1778) 3420 Table 3A NA NM_019997 9910435 Mus musculuscDNA sequence 1 TCTTAATAATAATGAAGACGACTTACC AB041581 (AB041581), mRNA.CTGTGGAATTGAACACACTGGTG 3421 Table 3A Hs.5392 NM_020122 10047127potassium channel modulatory factor 1 GCTGCTGTGTGTATTTATGAATATTAA(DKFZP434L1021), TGAATAAAAACTGCTTGGATGGT mRNA/cds = (53, 1198) 3422Table 3A Hs.8203 NM_020123 10047129 endomembrane protein emp70 1ACCGTGTAAAGTGGGGATGGGGTAA precursor isolog (LOC56889),AAGTGGTTAACGTACTGTTGGATCA mRNA/cds = (19, 1779) 3423 Table 3A Hs.236628NM_020135 9910349 putative helicase RUVBL (LOC56897), 1TAAATTTATTTATTTATGAAAAAACT mRNA/cds = (238, 1575)CGTGCCGAATTCTTGGCCTCGAG 3424 Table 3A Hs.110796 NM_020150 9910541GTP-binding protein SAR1 (SAR1) 1 GGGTTTCCGCTGGCTCTCCCAGTATA mRNA,complete cds/cds = (124, 720) TTGACTGATGTTTGGACGGTGAAA 3425 Table 3AHs.334775 NM_020151 9910251 Homo sapiens, Similar to RIKEN 1GTACAGTTACTCATGTCATTGTAATG cDNA 1200014H14 gene, cloneATTTCACTCCTAACTGTGACATTT IMAGE:3139657, mRNA partial cds/cds = (0, 523)3426 literature Hs.21320 NM_020165 14550404 postreplication repairprotein hRAD18p 1 ACTGAGTTGTCAGAAATTATGTCAAA (RAD18), mRNA/cds = (77,1564) ATGAAAACTGTTTGTTTCATGACA 3427 Table 3A Hs.6879 NM_020188 9910183DC13 protein (DC13), 1 ACCTGACTTCACCATGTTTATTCCCTT mRNA/cds = (175, 414)TGCCTACAACCAGTTAATATCTG 3428 Table 3A Hs.7045 NM_020194 9910247 GL004protein (GL004), 1 TCATGCGTGAACAATTTAAAAAACGA mRNA/cds = (72, 726)CAGAATAAGGTACAAATGTAGTGT 3429 literature Hs.9822 NM_020196 9910259 HCNPprotein; XPA-binding protein 2 1 CCCATCCCCCCTCCCCACCCCCATC (HCNP),CCCAATACAGCTACGTTTGTACATC 3430 Table 3A Hs.283611 NM_020217 9910199hypothetical protein DKFZp5471014 1 CCAACAAAATTGGGATCATCCAAACT(DKFZp5471014), GAGTCCATCTGGCTAATTCTAAAT mRNA/cds = (1774, 2166) 3431Table 3A Hs.79457 NM_017860 8923488 hypothetical protein FLJ20519 1TGACTGGAACTGAGAGTAAATTGGGA (FLJ20519), mRNA/cds = (74, 604)ATGTATGACCAATCTTAGACCCTG 3432 Table 3A Hs.4859 NM_020307 9945319 cyclinL ania-6a (LOC57018), 1 TGTTTAAATGATGGTGAATACTTTCTT mRNA/cds = (54,1834) AACACTGGTTTGTCTGCATGTGT 3433 Table 3A Hs.283728 NM_020357 9966826PEST-containing nuclear protein 1 ACCTAAGGTCAAGCTGGGAGAGAGA (pcnp),mRNA/cds = (18, 554) AATGACTGAGATGAATGTCTTTACT 3434 Table 3A Hs.322901NM_020368 9968798 disrupter of silencing 10 (SAS10), 1GCTTAGGGAAATTTCACAGTTCATTG mRNA/cds = (161, 1600)TGGAGTGTTAAACTTAGAACATGT 3435 Table 3A Hs.111988 NM_020382 9966854PR/SET domain containing protein 07 1 TGTTACAGGTTTCCAAGGTGGACTTG(SET07), mRNA/cds = (150, 1331) AACAGATGGCCTTATATTACCAAA 3436 Table 3AHs.12450 NM_020403 14589940 protocadherin 9 (PCDH9), 1TGTTACTGCTTTGCCAGTTCTACGTT mRNA/cds = (118, 3729)ATTTACAATTATTCAGCTCTTGCA 3437 Table 3A Hs.286233 NM_020414 14251213sperm autoantigenic protein 17 1 TTTCTGTATTGCAGTGTTTATAGGCTT (SPA17),mRNA/cds = (1210, 1665) CTTGTGTGTTAAACTTGATTTCA 3438 Table 3A Hs.287369NM_020525 10092624 interleukin 22 (IL22), 1 AACTAACCCCCTTTCCCTGCTAGAAAmRNA/cds = (71, 610) TAACAATTAGATGCCCCAAAGCGA 3439 Table 3A Hs.81328NM_020529 10092618 nuclear factor of kappa light 1GTTTGTGTTACCCTCCTGTAAATGGT polypeptide gene enhancer in B-cellsGTACATAATGTATTGTTGGTAATT inhibitor, alpha (NFKBIA), mRNA/cds = (94,1047) 3440 Table 3A Hs.78888 NM_020548 10140852 diazepam bindinginhibitor (GABA 1 GCTCACCATACGGCTCTAACAGATTA receptor modulator,acyl-Coenzyme A GGGGCTAAAACGATTACTGACTTT binding protein) (DBI),mRNA/cds = (0, 314) 3441 literature Hs.247302 NM_020648 10190663 twistedgastrulation (TSG), 1 CGGCTGATGGGACAGGAATTGAAGA mRNA/cds = (13, 684)AGAGAATTGACTCGTATGAACAGGA 3442 literature Hs.149342 NM_020661 10190699activation-induced cytidine deaminase 1 TGGTGCTACGAAGCCATTTCTCTTGA(AICDA), mRNA/cds = (76, 672) TTTTTAGTAAACTTTTATGACAGC 3443 Table 3AHs.295231 NM_020666 10190705 CLK4 mRNA, complete 1TGAGAAACTGTTTGACCTGGTTCGAA cds/cds = (153, 1514)GAATGTTAGAATATGATCCAACTC 3444 Table 3A Hs.105052 NM_020979 10280625adaptor protein with pleckstrin 1 GGTGGGACACGCCAAGCTCTTCAGT homology andsrc homology 2 domains GAAGACACGATGTTATTAAAAGCCT (APS), mRNA/cds = (127,2025) 3445 Table 3A Hs.104624 NM_020980 11038852 aquaporin 9 (AQP9), 1TGCTTTGAAGCTACCTGGATATTTCC mRNA/cds = (286, 1173)TATTTGAAATAAAATTGTTCGGTC 3446 Table 3A Hs.211563 NM_020993 10337612B-cell CLL/lymphoma 7A (BCL7A), 1 ATCGCCAAGAACCTGGTTAGAGGCAT mRNA/cds =(953, 1648) AAAGACCTTTTTTCACCGTTACCT 3447 Table 3A Hs.6574 NM_02100810337616 suppressin (nuclear deformed) 1 TGCTGCGACGCACATACATACGTGTTepidermal autoregulatory factor-1 GTGTCTGTCAATAAAGTGTAAATA(DEAF-1)-related) (SPN), mRNA/cds = (356, 2011) 3448 Table 3A Hs.178391NM_021029 10445222 ribosomal protein L44 (RPL44), 1TGGGAGGAGATAAGAAGAGAAAGGG mRNA/cds = (37, 357) CCAAGTGATCCAGTTCTAAGTGTCA3449 Table 3A Hs.28578 NM_021038 10518339 muscleblind (Drosophila)-like(MBNL), 1 TGCAGTAGTTGACTTTGCTGTATGGA mRNA/cds = (1414, 2526)AAAATAAAGTGAAATTGCCCTAAT 3450 literature Hs.51011 NM_021064 10800131 H2Ahistone family, member P 1 GCTAAATAAGGAATACTCATGCCAAG (H2AFP), mRNA/cds= (30, 422) ATCATCGAATTGTGCCTCCTCCCT 3451 Table 3A Hs.51299 NM_02107410835024 NADH dehydrogenase (ubiquinone) 1 ACCCAAGGGACCTGGATTTGGTGTACflavoprotein 2 (24kD) (NDUFV2), AAGCAGGCCTTTAATTTATATTGA mRNA/cds = (18,767) 3452 Table 3A Hs.63302 NM_021090 10835108 myotubularin relatedprotein 3 1 GGAGTCAGTCAGTGCTCCTATATTTT (MTMR3) TCATTTTTTGTCAAAGCAAGAAGT3453 Table 3A Hs.324406 NM_021104 10883874 ribosomal protein L41(RPL41), 1 TTTGTGGCCGAGTGTAACAACCATAT mRNA/cds = (83, 160)AATAAATCACCTCTTCCGCTGTTT 3454 Table 3A Hs.196282 NM_021105 10863876phospholipid scramblase 1 (PLSCR1), 1 TTCTACATGAAATGTTTAGCTCTTACAmRNA/cds = (256, 1212) CTCTATCCTTCCTAGAAAATGGT 3455 Table 3A Hs.75968NM_021109 11056080 thymosin, beta 4, X chromosome 1GGACGACAGTGAAATCTAGAGTAAAA (TMSB4X), mRNA/cds = (77, 211)CCAAGCTGGCCCAAGTGTCCTGCA 3456 Table 3A Hs.154890 NM_021122 12669908fatty-acid-Coenzyme A ligase,long- 1 TGTTTTGGGGTCTGTGAGAGTACATG chain 2(FACL2), TATTATATACAAGCACAACAGGGC mRNA/cds = (13, 2109) 3457 Table 3AHs.96 NM_021127 10863922 phorbol-12-myristate-13-acetate- 1AGGAACAGTTAGTTCTCATCTAGAAT induced protein 1 (PMAIP1),GAAAGTTCCATATATGCATTGGTG mRNA/cds = (173, 337) 3458 Table 3A Hs.71818NM_021128 14589958 polymerase (RNA) II (DNA directed) 1TGTGTGTGTATCCCATACCCCACTCT polypeptide L (7.6kD) (POLR2L),GGAAGGAACCATCCAGTAAAGGTC mRNA/cds = (21, 224) 3459 Table 3A Hs.184011NM_021129 11056043 pyrophosphatase (inorganic) (PP), 1GTGCAAGGGGAGCACATATTGGATG nuclear gene encoding mitochondrialTATATGTTACCATATGTTAGGAAAT protein, mRNA/cds = (77, 948) 3460 Table 3AHs.267690 NM_021130 10863926 mRNA for KIAA1228 protein, partial 1TTTCCTTGTTCCCTCCCATGCCTAGC cds/cds = (0, 2176) TGGATTGCAGAGTTAAGTTTATGA3461 literature Hs.84981 NM_021141 12408850 X-ray repair complementingdefective 1 ACCCAGTCACCTCTGTCTTCAGCACC repair in Chinese hamster cells 5CTCATAAGTCGTCACTAATACACA (double-strand-break rejoining; Ku autoantigen,80kD) (XRCC5), mRNA/cds = (33, 2231) 3462 Table 3A Hs.12743 NM_02115110863952 camitine O-octanoyltransferase 1 TGAATCACATTGTCAGAATTTTTTCCT(CROT), mRNA/cds = (136, 1974) CCTCGCTGTTCAATTTTGTAGTT 3463 Table 3AHs.7137 NM_021188 10863994 clones 23667 and 23775 zinc finger 1AGATGCCTTGTTGCTTTGAAGAAGGG protein (LOC57862), AGTGATGTCAATTCTCTTGTTACAmRNA/cds = (182, 1618) 3464 Table 3A Hs.8185 NM_021199 10864010 CGI-44protein; sulfide dehydrogenase 1 CCATGTGGGCTACTCATGATGGGCTT like (yeast)(CGI-44), GATTCTTTGGGAATAATAAAATGA mRNA/cds = (76, 1428) 3465 Table 3AHs.12152 NM_021203 14917112 APMCF1 protein (APMCF1), 1AAAAGTTCTCTGTAGATTTCTGAAGT mRNA/cds = (16, 831) GCATATTCATTGATGCCAAGAAAA3466 Table 3A Hs.25726 NM_021211 10864022 transposon-derived Buster1 1GGAGGAGTTTGCATGTCTCATGATAA transposese-like protein (LOC58486),CCAAATGTAAGATGAAAATAAAAG mRNA/cds = (468, 2549) 3467 Table 3A Hs.29417NM_021212 10864024 HCF-binding transcription factor 1TTGGTGACTTAGTGATTTTGTCATTTT Zhangfei (ZF), mRNA/cds = (457, 1275)TTACATCAACTTCATGGTCTTGT 3468 literature Hs.274363 NM_021257 10864064neuroglobin (NGB), 1 CGCCCGGCAGCCCCCATCCATCTGT mRNA/cds = (0, 455) 3469Table 3A Hs.19520 NM_021603 11125763 FXYD domain-containing iontransport 1 GTCTGTCTGTTGGCCTGTATCTGTT regulator 2 (FXYD2), transcriptvariant CACCTCATGCTTATAATAAAGCCGG b, mRNA/cds = (67, 261) 3470 Table 3AHs.104305 NM_021621 14719827 death effector filament-forming Ced-4- 1CTGGCTGTGTCACAGGGTGAGCCCC like apoptosis protein (DEFCAP),AAAATTGGGGTTCAGCGTGGGAGGC transcript variant B, mRNA/cds = (522, 4811)3471 Table 3A Hs.17757 NM_021622 11055985 pleckstrin homology domain- 1GCCGTCCTCAGTTACCTTTCATGAGG containing, family A (phosphoinositideCTTCTAGCCAAAGATGATAAAGGG binding specific) member 1 (PLEKHA1), mRNA/cds= (66, 1260) 3472 Table 3A Hs.106747 NM_021626 11055991 serinecarboxypeptidase 1 precursor 1 AGGATAAAATCATTGTCTCTGGAGGC protein(HSCP1), AATTTGGAAATTATTTCTGCTTCT mRNA/cds = (32, 1390) 3473 Table 3AHs.3826 NM_021633 11056005 cDNA FLJ14750 fis, clone 1CGGGTGATTACAGGCACCAGTGCAG NT2RP3002948, weakly similar toTGATGATTGTACTTATTTGACACAT RING CANAL PROTEIN/cds = (200, 1906) 3474Table 3A Hs.155418 NM_021643 11056053 GS3955 protein (GS3955), 1GCCTCTGGTGCTTTGTCCTGTATTTG mRNA/cds = (1225, 2256)GTTTAATGTTTTTGTCCTAATCTC 3475 Table 3A Hs.279681 NM_021644 14141158heterogeneous nuclear 1 TTGATGTGAATTCAGTTATTGAACTTG ribonucleoprotein H3(2H9) (HNRPH3), TTACTTGTTTTTGCCAGAAATGT transcript variant 2H9, mRNA/cds= (118, 1158) 3476 Table 3A Hs.174030 NM_021777 11496993 a disintegrinand metalloproteinase 1 AAGCTTCGAACTCAAAATCATGGAAA domain 28 (ADAM28),transcript variant GGTTTTAAGATTTGAGGTTGGTTT 1, mRNA/cds = (47, 2374)3477 Table 3A Hs.288906 NM_021818 11141888 WW Domain-Containing Gene 1CCCAGTTAGATATCAGTGAGTTTGAA (WW45), mRNA/cds = (215, 1366)TAACTGAAGAAATGTTGACAATGT 3478 Table 3A Hs.10724 NM_021821 11141894MDS023 protein (MDS023), 1 AAGTACACCTGTCAGCTGTTTCTTAC mRNA/cds = (335,1018) CACTTCGATGGTTGTGATTAATTT 3479 Table 3A Hs.154938 NM_02182511141900 hypothetical protein MDS025 1 TGTTTGCTTGAACAGTTGTGTAAATC(MDS025), mRNA/cds = (5, 769) ATACAGGATTTTGTGGGTATTGGT 3480 literatureHs.302003 NM_021922 11345453 Fanconi anemia, complementation 1TGACCTTCTGTGTTTTTGTTTCTGACT group E (FANCE), TGAATAATTTATCAATGGTGTTGmRNA/cds = (185, 1795) 3481 Table 3A Hs.7174 NM_021931 11345467hypothetical protein FLJ22759 1 CCAGGGCTGCTTTGCTGTGATGATGA (FLJ22759),mRNA/cds = (2, 2113) TTGCATTTCAACACATGCCAGATG 3482 Table 3A Hs.89751NM_021950 11386188 membrane-spanning 4-domains, 1GAGTTACCACACCCCATGAGGGAAG subfamily A, member 2 (Fe fragment ofCTCTAAATAGCCAACACCCATCTGT lgE, high affinity I, receptor for, betapolypeptide) (MS4A2), mRNA/cds = (90, 983) 3483 Table 3A Hs.2484NM_021966 11415027 T-cell leukemia/lymphoma 1A 1TTCTATCCTTGACTTAGATTCTGGTG (TCL1A), mRNA/cds = (45, 389)GAGAGAAGTGAGAATAGGCAGCCC 3484 Table 3A Hs.75569 NM_021975 11496238 v-relavian reticuloendotheliosis viral 1 TCTTGCTCTTTCTACTCTGAACTAATA oncogenehomolog A (nuclear factor of AAGCTGTTGCCAAGCTGGACGGC kappa lightpolypeptide gene enhancer in B-cells 3 (p65))) (RELA), mRNA/cds = (38,1651) 3485 literature Hs.245342 NM_021979 13676856 hypothetical proteinFLJ14642 1 TGCAAACAAATGCATAAATGCAAATG (FLJ14642), mRNA/cds = (23, 583)TAAAGTAAAGCTGAAATTGATCTC 3486 Table 3A Hs.326801 NM_021998 11527399 DNAsequence from PAC 75N13 on 1 ATGCTACTTGGGAGAAAACTCTCACT chromosomeXq21.1. Contains ZNF6 AACTGTCTCACCGGGTTTCAAAGC like gene, ESTs, STSs andCpG islands/cds = (567, 2882) 3487 Table 3A Hs.293970 NM_021999 11527401methylmalonate-semialdehyde 1 TGCAATGGAATATAAATATCACAAAG dehydrogenase(ALDH6A1), TTGTTTAACTAGACTGCGTGTTGT mRNA/cds = (42, 1649) 3488 Table 3AHs.82407 NM_022059 11545764 CXC chemokine ligand 16 (CXCL16), 1TTTCACCTCCTCAGTCCCTTGCCTAC mRNA/cds = (423, 1244)CCCAGTGAGAGTCTGATCTTGTTT 3489 Table 3A Hs.136164 NM_022117 11545834cutaneous T-cell lymphoma- 1 CGCCTCTCCCCGTGGACCCTGTTAAT associated tumorantigen se20-4 CCCAATAAAATTCTGAGCAAGTTC (SE20-4), mRNA/cds = (129, 2210)3490 Table 3A Hs.24633 NM_022136 11545870 SAM domain, SH3 domain and 1AGGATTCGCTGTTGAAACAAGTTGTC nuclear localisation signals, 1CAAGCAATGTTATATTCATTTTTA (SAMSN1), mRNA/cds = (82, 1203) 3491 Table 3AHs.184052 NM_022152 11545897 PP1201 protein (PP1201), 1GGAAGGGGGACAAGGGTCAGTCTGT mRNA/cds = (75, 1010)CGGGTGGGGGCAGAAATCAAATCAG 3492 Table 3A Hs.184052 NM_022152 11545897PP1201 protein (PP1201), 1 GGAAGGGGGACAAGGGTCAGTCTGT mRNA/cds = (75,1010) CGGGTGGGGGCAGAAATCAAATCAG 3493 literature Hs.294030 NM_02244713937360 topoisomerase-related function protein 1TTTTTCCCAGCTCGCCACAGAATGGA 4-2 (TRF4-2), mRNA/cds = (336, 869)TCATGAAGACTGACAACTGCAAAA 3494 Table 3A Hs.74899 NM_022451 11967984hypothetical protein FLJ12820 1 AGGAGTGGCCTAAGAAATGCGTGTTT (FLJ12820),mRNA/cds = (156, 1451) CAGTGACTAGATTATAAATATTCT 3495 Table 3A Hs.15220NM_022473 11968022 zinc finger protein 106 (ZFP106), 1AGCTGTGAACTTCGTAACTTTGTAAA mRNA/cds = (335, 5986)GCAAGATATAAAGCAAATACAAGA 3496 Table 3A Hs.27556 NM_022485 11968038hypothetical protein FLJ22405 1 AGGAGGGATCACCTGCACTGAGAAT (FLJ22405),mRNA/cds = (81, 1334) GAGGCAGTTTGACACAGATCACAAA 3497 Table 3A Hs.26367NM_022488 11968042 PC3-98 protein (PC3-96), 1TGTTCCACTACCAGCCTTACTTGTTTA mRNA/cds = (119, 586)ATAAAAATCAGTGCAAAGAGAAA 3498 Table 3A Hs.22353 NM_022494 11968052hypothetical protein FLJ21952 1 ACCTCAGATTTTGTTACCTGTCTTTTA (FLJ21952),mRNA/cds = (424, 1665) AAAATGCAGATTTTGTCAAATCA 3499 Table 3A Hs.23259NM_022496 11968056 hypothetical protein FLJ13433 1TTAACGGCTTCACTGGACAGTTTTCC (FLJ13433), mRNA/cds = (35, 1225)TTAGAAGGTAGTTTTGTGTGACTG 3500 Table 3A Hs.275885 NM_022551 14165467mRNA; cDNA DKFZp586A0618 (from 1 ACCGTGGGTGTGTCCAAGAAGAAATA cloneDKFZp586A0818)/cds = AGTCTGTAGGCCTTGTCTGTTAAT UNKNOWN 3501 Table 3AHs.161788 NM_022570 13384803 C-type (calcium dependent, 1CCAATGGATATTTCTGTATTACTAGG carbohydrate-recognition domain)GAGGCATTTACAGTCCTCTAATGT lectin, superfamily member 12 (CLECSF12),mRNA/cds = (71, 676) 3502 literature Hs.65328 NM_022725 12232378 Fanconianemia, complementation 1 TAGCTTTAGAAAATAACAGTTTGTGAA group F (FANCF),CTTACTTCCCTATATTTGCAGCT mRNA/cds = (13, 1137) 3503 Table 3A Hs.83809NM_022727 12232380 Hpall tiny fragments locus 9C 1CTTTGTGGACTAGCCAAGGCTGTGAG (HTF9C), mRNA/cds = (235, 1662)GGCCAGAATAAACAACTGCTCAAC 3504 Table 3A Hs.7503 NM_022738 12232392hypothetical protein FLJ14153 1 GCCGAGCAATGACCCTTTTCAATTTC (FLJ14153),mRNA/cds = (30, 1427) TTATTTCTGTGTTACTGAGGACCC 3505 Table 3A Hs.194477NM_022739 12232398 E3 ubiquitin ligase SMURF2 1GAAACATGTGGATTTGCTGTGGAATG (SMURF2), mRNA/cds = (8, 2254)ACAAGCTTCAAGGATTTACCCAGG 3506 Table 3A Hs.34516 NM_022766 12232440 mRNAfor KIAA1646 protein, partial 1 TTTGATCTGAAATGTTTGAGAAGACA cds/cds = (0,1446) CGAATAAAGTTACTTGGGCAGAAA 3507 Table 3A Hs.154057 NM_02279013027789 matrix metalloproteinase 19 (MMP19), 1TCCCATCAAAAAGGTATCAAATGCCT transcript variant rasi-3,TGGAAGCTCCCTGATCCTACAAAA mRNA/cds = (1642, 1899) 3508 Table 3A Hs.121849NM_022818 13699868 microtubule-associated proteins 1A/1B 1ATCTGACATTATTGTAACTACCGTGT light chain 3 (MAP1A/1BLC3),GATCAGTAAGATTCCTGTAAGAAA mRNA/cds = (84, 461) 3509 Table 3A Hs.148123NM_022894 12587626 hypothetical protein FLJ12972 1ACCTTGTACCATGGAAAACATGAAAA (FLJ12972), mRNA/cds = (168, 1076)GAGTCTTAGAAGTAAAGAACAACA 3510 Table 3A Hs.57987 NM_022898 12697634B-cell lymphoma/leukaemia 11B 1 AGCATGTGTCTGCCATTTCATTTGTA (BCL11B),mRNA/cds = (267, 2738) CGCTTGTTCAAAACCAAGTTTGTT 3511 Table 3A Hs.128003NM_022900 12597838 hypothetical protein FLJ21213 1TGAGCTGTATTACCATAAGTAGAATTT (FLJ21213), mRNA/cds = (74, 1042)TAAGTAAACTGGTGAATTTGGGC 3512 Table 3A Hs.194688 NM_023005 14670389bromodomain adjacent to zinc finger 1 GCCCCATTAAAGGGTGAACTTGTAAT domain,1B (BAZ1B), transcript variant AAATTGGAATTTCAAATAAACCTC 1, mRNA/cds =(352, 4803) 3513 Table 3A Hs.168232 NM_023079 12751494 hypotheticalprotein FLJ13855 1 TGCCCTAATCTTGAGTTGAGGAAATA (FLJ13855), mRNA/cds =(314, 1054) TATGCACAGGAGTCAAAGAGATGT 3514 db mining Hs.37026 NM_02401313128949 interferon, alpha 1 (IFNA1), 1 AACGTCATGTGCACCTTTACACTGTGmRNA/cds = (67, 636) GTTAGTGTAATAAAACATGTTCCT 3515 Table 3A Hs.302981NM_024033 8922813 hypothetical protein FLJ11000 1TTATTCATATATTCCTGTCCAAAGCCA (FLJ11000), mRNA/cds = (223, 780)CACTGAAAACAGAGGCAGAGACA 3516 Table 3A Hs.115960 NM_024036 13128987hypothetical protein MGC3103 1 GCAGCCACCCACTGGGAGTCTTGTTT (MGC3103),mRNA/cds = (10, 984) TTATTTATAATAAAATTGTTGGGG 3517 Table 3A Hs.7392NM_024045 13129005 nucleolar protein GU2 (GU2), 1ATCCACCAAAAATTAGGTCATCATAG mRNA/cds = (107, 2320)TTGAGGTATGTGTCTGCTATTTGC 3518 Table 3A Hs.103834 NM_024056 13129025hypothetical protein MGC5576 1 CCATTGGCTGGAACATGGATTGGGG (MGC5576),mRNA/cds = (51, 803) ATTTGATAGAAAAATAAACCCTGCT 3519 Table 3A Hs.115659NM_024061 13129035 hypothetical protein MGC5521 1GTTCCTTACTCTGTCCTTGATGGAGG (MGC5521), mRNA/cds = (163, 708)GGAGAAGGGAGGGCAAAGAAGTTA 3520 Table 3A Hs.267400 NM_024095 13129097hypothetical protein MGC5540 1 TGGTTTTCCTTTGGGGACGTGGTTAA (MGC5540),mRNA/cds = (77, 943) CGGTCCAGAAGAATCCCTTCTAGA 3521 Table 3A Hs.321130NM_024101 13129107 hypothetical protein MGC2771 1ACCCCTTTCACTCTTGGCTTTCTTATG (MGC2771), mRNA/cds = (184, 1986)TTGCTTTCATGAATGGAATGGAA 3522 Table 3A Hs.109701 NM_024292 13236509ubiquitin-like 5 (UBL5), 1 CCCATCCTCATCCCCCACACTGGGAT mRNA/cds = (65,286) AGATGCTTGTTTGTAAAAACTCAC 3523 Table 3A Hs.78768 NM_024298 13236521malignant cell expression-enhanced 1 TCAGGCCGCCTAGCTGCCCCTTTGCgene/tumor progression-enhanc CAGGTTAATAAAGCACTGACTTGTT (LENG4),mRNA/cds = (1101, 1700) 3524 Table 3A Hs.323193 NM_024334 13236586hypothetical protein MGC3222 1 AAGGATTTTAAATAACTGCCGACTTC (MGC3222),mRNA/cds = (149, 1351) AAAAGTGTTCTTAAAACGAAAGAT 3525 Table 3A Hs.15961NM_024348 13259513 dynactin 3 (p22) (DCTN3), transcript 1CACCCACCCTCCCCCCAATCAGTGTT variant, 2 mRNA/cds = (16, 546)CTTATTTCAGTGACAATAAACCAT 3526 Table 3A Hs.8121 NM_024408 13249343 Notch(Drosophila) homolog 2 1 ATAGCTGGTGACAAACAGATGGTTGC (NOTCH2), mRNA/cds =(12, 7427) TCAGGGACAAGGTGCCTTCCAATG 3527 db mining Hs.12315 NM_00455713375722 hypothetical protein FLJ11608 1 CATGGATATCATGTATCCTTCCTGGT(FLJ11608), mRNA/cds = (561, 1184) GCTCACACACCTGTCACCTTGTAA 3528 Table3A Hs.337561 NM_024567 13375737 hypothetical protein FLJ21616 1GCTGTGTGACTTAGTAGATAAAATAC (FLJ21616), mRNA/cds = (119, 1093)TGCCTTCTGCCTTTGGGACCATGA 3529 db mining Hs.236449 NM_024898 13376352hypothetical protein FLJ22757 1 ACTTCCATCTCAGCTAATGCACCCAC (FLJ22757),mRNA/cds = (92, 2473) CAGCTCAAACACACCAATAAAGCT 3530 literature Hs.72241NM_030662 13489053 mitogen-activated protein kinase 1GCTGCTGTGTGTGGTCTCAGAGGCT kinase 2 (MAP2K2), CTGCTTCCTTAGGTTACAAAACAAAmRNA/cds = (263, 1465) 3531 Table 3A Hs.196270 NM_030780 13540550 folatetransporter/carrier (LOC81034), 1 ATTTATCGTAAACATCCACGAGTGCT mRNA/cds =(128, 1075) GTTGCACTACCATCTATTTGTTGT 3532 Table 3A Hs.211458 NM_03078813540564 DC-specific transmembrane protein 1 CCCCACAATGGTCTCTTTTCTCCCTG(LOC81501), mRNA/cds = (51, 1463) CTCCCTTATTAAAGAACTCTTTCT 3533 cytokineHs.46468 NM_031409 14043039 chemokine (C—C motif) receptor 6 1CAGTGGTTCCCATTGATTCTCCCCAT arrays (CCR6), transcript variant 2,ATCTTTTTGCTCTCAGGCTCTGGC mRNA/cds = (551, 1675) 3534 Table 3A Hs.301183NM_031419 13899228 molecule possessing ankyrin repeats 1CTTGTATCTCTAAATATGGTGTGATAT induced by lipopolysaccharide (MAJL),GAACCAGTCCATTCACATTGGAA homolog of mouse (MAJL), mRNA/cds = (48, 2204)3535 Table 3A Hs.245798 NM_031435 13899258 hypothetical proteinDKFZp56410422 1 ACATAGATTTTCTGCCAACAAATCCT (DKFZP56410422),CTCTGCTGTTCACATTATCCTTTG mRNA/cds = (510, 1196) 3536 db mining Hs.238730NM_031437 13899264 hypothetical protein MGC10823 1CAGAGGTGGGAGTAACTGCTGGTAG (MGC10823), mRNA/cds = (63, 1235)TGCCTTCTTTGGTTGTGTTGCTCAG 3537 Table 3A Hs.103376 NM_031453 13899290hypothetical protein MGC11034 1 TTAGAACCAAAGTTATTCTTAATAAAA (MGC11034),mRNA/cds = (245, 640) ATCACCACATGCTTGGACCATGC 3538 Table 3A Hs.281397NM_031480 13899339 hypothetical protein AD034 (AD034), 1GCTCTTACACTTCGTCTTTAATGTTCT mRNA/cds = (195, 1880)TTTTGGAGTTAGGACCTCTCAGT 3539 RG Hs.334691 NM_032223 1419927 hypotheticalprotein FLJ22427 1 ACCTTGACATGGGTTGTCTAATAAAA house- (FLJ22427),mRNA/cds = (40, 2631) CTCGGACCCTTCTTGTGAAATCAA keeping genes 3540 Table3A NA R11456 764191 spleen 1NFLS cDNA clone 1 ATCCCAGTGCACAGTGAGTTGTATATIMAGE:129880 5′ similar to CACAAATAGGAGGCCACTTCAGGA 3541 RG Hs.170222R14692 768965 Na+/H+ exchanger NHE-1 isoform 1 GAAGCTGCTAGGGGAAGGACTGGCChouse- [human, heart, mRNA, 4516 nl]/cds = TGGCTCCAGAATGTTGTTGCCTTTTkeeping (577, 3024) genes 3542 Table 3A Hs.100896 R18757 772387yg17e04.r1 cDNA, 5′ 1 GGGAAGGAAAAGGGGTGTGGCAGCT end/clone =GGGAGCGTTTATTTATGTTCTTTCT IMAGE:32522/clone _end = 5′ 3543 RG Hs.82927AK025706 10438309 cDNA:FLJ22053 fis, clone HEP09502, 1GAGTGGTGTTCCCAGTGTGGCTCCC house- highly similar to HUMAMPO2 AMPAGAGCTTTGACCAGATTGTGATCCC keeping deaminase (AMPD2) genes mRNA/cds =UNKNOWN 3544 RG Hs.240013 R44202 822065 mRNA; cDNA DKFZp547A166 (from 1CTTTGCATTTAGGGACACAGCCCGGA house- clone DKFZp547A166)/cds =GCCGCAGAAGGTCAGCAGGGAGCA keeping UNKNOWN genes 3545 RG Hs.12163NM_003908 4503504 DNA sequence from clone RP1-64K7 1CATTGCCTACTTTAACACCTGTCAGA house- on chromosome 20q11.21-11.23.GAAACGTGATATGGGGTAAGGAGG keeping Contains the EIF2B2 gene for geneseukaryotic translation initiation factor 2 subunit 2 (beta, 38kD), aputative novel gene, the gene for heterogenous nuclear ribonucleoproteinRALY or autoantigen P542, an RPS2 (RPS4) (40S ribosomal protein S2)pseudogene, ESTs, STS, GSSs and two CpG islands/cds = (138, 1139) 3546RG Hs.26320 R56088 826194 mRNA for TRABID protein (TRABID) 1GCAATCTGGGAGCAGCACATTGTTGA house- gene)/cds = (406, 2532)TGGAGTCCAAGTGAGCACATTTCA keeping genes 3547 Table 3A Hs.208603 R64054835933 7f01d11.x1 cDNA, 3′ 1 CTCTCCTGGACTGTTGCAGTTGGGTG end/clone =TGGCTGATTTGAAATTGTGCTTCA IMAGE:3293397/clone_end = 3′ 3548 Table 3AHs.181400 R67739 840377 602650370T1 cDNA, 3′ 1TAACAAGAATTGCATTGAGGAAACAA end/clone = GGCTCCACAGGGCCAATCTTCTGGIMAGE:4761353/clone_end = 3′ 3549 Table 3A Hs.161043 R84314 942720602415728F1 cDNA, 5′ 1 AAGAAGTTACATCTTCAATGTCCAGG end/clone =GATGATCGTTTGAAGAGAACCTCT IMAGE:4523958/clone_end = 5′ 3550 Table 3A NAR85137 943543 brain N2b4HB55Y cDNA clone 1 AAAACATTGCCAGACCATTTAGTCCTIMAGE:180492 5′ CTTGGAAGGGCCTCTCCGGTGGGG 3551 Table 3A Hs.134025 R88126946939 UL-H-B12-agp-a-07-0-UL.s1 cDNA, 3′ 1 AGGGATAATAAGGTTAGCTGTTAACCend/clone = AAGCAACTGAGCTTTTAACCAAAG IMAGE:2724781/clone_end = 3′ 3552Table 3A Hs.85289 S53911 264768 CD34 antigen (CD34), 1CAAGACACTGTGGACTTGGTCACCAG mRNA/cds = (90, 1076)CTCCTCCCTTGTTCTCTAAGTTCC 3553 Table 3A Hs.246381 S57235 298664 CD68antigen (CD68), 1 TCTTTGACGGGGTTTTCCTTGCTCCT mRNA/cds = (15, 1079)GCCAGGATTAAAAGTCCATGAGTT 3554 Table 3A Hs.75258 S59049 299704 regulatorof G-protein signalling 1 1 CTTAAAGTATATGTTTTCAAATTGCCA (RGS1), mRNA/cds= (14, 604) TTGCTACTATTGCTTGTCGGTGT 3555 Table 3A Hs.279518 S60099300168 amyloid beta (A4) precursor-like 1 CTCCTGTCACCGGCCTTGTGACATTCprotein 2 (APLP2), ACTCAGAGAAGACCACACCAAGGA mRNA/cds = (72, 2363) 3556Table 3A Hs.300697 S62140 386156 mRNA for immunoglobulin lambda 1GTCGGACTATGTAATTGTAACTATAC heavy chain/cds = (65, 1498)CTCTGGTTCCCATTAAAAGTGACC 3557 Table 3A Hs.249247 S63912 399757heterogeneous nuclear 1 GCTAGTGTTTGAATATGCTCTCTTGTT ribonucleoprotein A3(HNRPA3), GCTCTAATTCTGTGCCTCCGTGC mRNA/cds = (30, 839) 3558 Table 3AHs.155924 S68271 545204 cAMP responsive element modulator 1AGAGGAACTTGAAACCTTGAAA (CREM), mRNA/cds = (0, 998)GACATTTGTTCTCCCAAAACTGAT TACT 3559 Table 3A Hs.89545 S71381 551546proteasome (prosome, macropain) 1 ACTGGGATATTGCCCACATGATCAGT subunit,beta type, 4 (PSMB4), GGCTTTGAATGAAATACAGATGCA mRNA/cds = (23, 817) 3560Table 3A Hs.179526 S73591 688298 upregulated by 1,25-dihydroxyvitamin 1CCAGAAAGTGTGGGCTGAAGATGGT D-3 (VDUP1), mRNA/cds = (221, 1396)TGGTTTCATGTGGGGGTATTATGTA 3561 Table 3A Hs.155396 S74017 693841 nuclearfactor (erythroid-derived 2)-like 1 TTTCTTAGGACACCATTTGGGCTAGT 2(NFE2L2), mRNA/cds = (39, 1808) TTCTGTGTAAGTGTAAATACTACA 3562 Table 3AHs.274401 S75463 833998 mRNA, cDNA DKFZp434P086 (from 1GAAGGGTTGGCCTGCCTGGCTGGGG clone DKFZp434P086); partialAGGTCAGTAAACTTTGAATAGTAAG cds/cds = (798, 1574) 3563 Table 3A Hs.73090S76638 243420 p50-NF-kappa B homolog (human 1 TTAACACCCCACACCCACCCCTCAGTperipheral blood T cells, mRNA, 3113 TGGGACAAATAAAGGATTCTCATG nt)/cds =250, 2952) 3564 Table 3A Hs.252136 S80990 1911529 ficolin(collagen/fibrinogen domain- 1 CAAGCCGCCACATGCCCACAACCTC containing) 1(FCN1), ACCAGAGGGAGAATTATGTTTCTAA mRNA/cds = (92, 1072) 3565 Table 3AHs.301497 T77017 694220 arginine-tRNA-protein transferase 1-1p 1GTGTATTGATCCAAGTAGTCAAAGTG (ATE1) mRNA, alternatively splicedTCTTAAAGGGCACCTATTTGTCCT product, partial cds/cds = (0, 1544) 3566 Table3A Hs.158183 T78173 696682 yd79c05.r1 cDNA, 5′ 1AGTGCTTTCCAAATGTGATTGTTCTG end/clone = GGTGATGGGACATATGGGCAGTTGIMAGE:114440/clone_end = 5′ 3567 Table 3A NA T80378 698887 1NIB cDNAclone IMAGE:24693 5′ 1 CGGGGGAATAGGAGGAAAAACATGGCATGGAACAAACCAACATAAAAGGT 3568 Table 3A NA T80854 703539 spleen 1NFLScDNA clone 1 ACTAATTCTGCTCTTTGGACAAGTGC IMAGE:108950 5′CTGACATCTGCTTCATTGGGTTTT 3569 Table 3A Hs.189744 T85880 714232qz25e11.x1 cDNA, 3′ 1 AGGAATAAAGTTAAGTATTTCCCACTT end/clone =GGAAATTGTACCACTCCTGGGGT IMAGE:2027948/clone_end = 3′ 3570 Table 3AHs.327 U00672 482802 interleukin 10 receptor, alpha 1CCTCTGCCAAAGTACTCTTAGGTGCC (IL10RA), mRNA/cds = (61, 1797)AGTCTGGTAACTGAACTCCCTCTG 3571 Table 3A Hs.184592 U00946 405048 proteinkinase, lysine deficient 1 1 GTCTGGTAAGCCGATGCTAATGGCA (PRKWNK1),mRNA/cds = (0, 7148) GAACCAATAGAAGTCCAAGGCACTA 3572 Table 3A Hs.278857U01923 460085 heterogeneous nuclear 1 ACGGGACAATTTTAAGATGTAATACCribonucleoprotein H2 (H′) (HNRPH2), AATACTTTAGAAGTTTGGTCGTGT mRNA/cds =(78, 1427) 3573 Table 3A Hs.303627 U02019 433343 heterogeneous nuclear 1CTCTCAGTTCCCAAGATGGCCCCACA ribonucleoprotein D (AU-rich elementTTCCCATTGTTTTCCCCAAGAGAA RNA-binding protein 1,37kD) (HNRPD), transcriptvariant 1, mRNA/cds = (285, 1352) 3574 Table 3A Hs.239138 U02020 404012pre-B-cell colony-enhancing factor 1 GGTTGTTGTATTGTACCAGTGAAATG (PBEF),mRNA/cds = (27, 1502) CCAAATTTGAAAGGCCTGTACTGC 3575 Table 3A Hs.172081U02882 433348 rolipram-sensitive 3′, 5′-cyclic AMP 1TTGTTTGCCATCTGTTGATCAGGAAC phosphodiesterase mRNA, completeTACTTCAGCTACTTGCATTTGATT cds/cds = (108, 1922) 3576 Table 3A Hs.75969U03105 476094 proline-rich protein with nuclear 1AATCTACATTTTCTTACCAGGAGCAG targeting signal (B4-2),CATTGAGGTTTTTGAGCATAGTAC mRNA/cds = (113, 1096) 3577 Table 3A Hs.89421U03644 476104 CBF1 interacting corepressor (CIR), 1ACAGAGAGCACCCAGGAGGTACACA mRNA/cds = (0, 1352) TACTAAAGTGACACAAAGAGAATGA3578 Table 3A Hs.154654 U03688 501030 cytochrome P450, subfamily I(dioxin- 1 TGTGTGCATAATAGCTACAGTGCATA inducible), polypeptide 1(glaucoma 3, GTTGTAGACAAAGTACATTCTGGG primary infantile) (CYP1B1),mRNA/cds = (372, 2003) 3579 Table 3A Hs.75546 U03851 433307 cappingprotein alpha mRNA, partial 1 AGCATGTTGTTTAATTTCTTTTTAAAA cds/cds = (16,870) ATCACTGTTGGGCTTTGAAAGCA 3580 Table 3A Hs.196384 U04636 496975prostaglandin-endoperoxide synthase 1 GCTGACAAAACCTGGGAATTTGGGTT 2(prostaglandin G/H synthase and GTGTATGCGAATGTTTCAGTGCCT cyclooxygenase)(PTGS2), mRNA/cds = (134, 1948) 3581 Table 3A Hs.118962 U05040 460151far upstream element (FUSE) binding 1 TCACTTTCCAAATGCCTGTTTTGTGCTprotein 1 (FUBP1), TTACAATAAATGATATGAAACCT mRNA/cds = (26, 1960) 3582Table 3A Hs.79630 U05259 452561 MB-1 gene, complete cds 1TTTATGCGTATTTAAGCCTTGGAAAC ACAGGGACTATCTTGTGGATTGGG 3583 Table 3AHs.177559 U05875 463549 interferon gamma receptor 2 1GTCTTGACTTTGGCAAATGAGCCGGA (interferon gamma transducer 1)GCCCCTTGGGCAGGTCACACAACC (IFNGR2), mRNA/cds = (648, 1661) 3584 Table 3AHs.1197 U07550 469170 heat shock 10kD protein 1 (chaperonin 1ACATCCAGTGTCTCCAAAATTGTTTC 10) (HSPE1), mRNA/cds = (41, 349)CTTGTACTGATATAAACACTTCCA 3585 Table 3A Hs.78909 U07802 984508 Tis11dgene, complete 1 GGTACAGTTGGAGCACTATATGTACT cds/cds = (291, 1739)CTCTGGACTACTTTGGACAGAAGT 3586 Table 3A Hs.173965 U08316 475587 ribosomalprotein S6 kinase, 90kD, 1 AAAATCACCTCAACAGCCCTGTGAAG polypeptide 3(RPS8KA3), TGACCTCAGTGAGATATTTGGATC mRNA/cds = (0, 2222) 3587 Table 3AHs.170171 U08626 551473 glutamine synthetase pseudogene 1TTAAAGTGCACCTTCCAAAATGTCTC CCATAAGTAGGTAAGACCAACCTG 3588 Table 3AHs.333513 U10117 498909 small inducible cytokine subfamily E. 1AATGATGAGTGTGTGGCTACATACAA member 1 (endothelial monocyte-AGGAGTTCCCTTTGAGGTGAAAGG activating) (SCYE1), mRNA/cds = (49, 987) 3589Table 3A Hs.40202 U10485 505685 lymphoid-restricted membrane protein 1GGGAAAGTATAGCATGAAACCAGAG (LRMP), mRNA/cds = (574, 2241)GTTCTCAGAATGACCGTAAGATAGC 3590 Table 3A Hs.79022 U10550 762886GTP-binding protein overexpressed in 1 TGGTTGACCCTTGTATGTCACAGCTCskeletal muscle (GEM), TGCTCTATTTATTATTATTTTGCA mRNA/cds = (213, 1103)3591 Table 3A Hs.194776 U11870 511804 interleukin B receptor, alpha(ILBRA), 1 TTGTCCACAAGTAAAAGGAAATCCTC mRNA/cds = (100, 1152)CTCCAGGGAGTCTCAGCTTCACCC 3592 Table 3A Hs.80561 U12767 924281 mitogeninduced nuclear orphan 1 CATTGCTCTTTAGTGTGTGTTAACCT receptor (MINOR)mRNA, complete GTGGTTTGAAAGAAATGCTCTTGT cds/cds = (209, 1972) 3593 Table3A Hs.184411 U13044 531892 albumin (ALB), mRNA/cds = (39, 1888) 1GTCTGGCTTAACTATTTTTGAAAATAT AACTGTTTCCCCTCTCTGCTGCT 3594 Table 3AHs.78915 U13045 531894 GA-binding protein transcription factor, 1AAAAGCAATTACCCTTAAAACTG beta subunit 1 (53kD) (GABPB1),TACTCTGGCCTACTTTTCTATTT transcript variant beta, TGCA mRNA/cds = (169,1356) 3595 Table 3A Hs.1162 U15085 557701 major histocompatibilitycomplex, class 1 GGCTCTCAGTGTGCCATAGAGGACA II, DM beta (HLA-DMB),GCAACTGGTGATTGTTTCAGAGAAA mRNA/cds = (233, 1024) 3596 Table 3A Hs.155596U15173 558843 BCL2/adenovirus E1B 19kD- 1 AAACTGTTTCTTTGGTGTCCTTTACATinteracting protein 2 (BNIP2), TGAAATAAATTGTGTTTGTGCCT mRNA/cds = (211,1155) 3597 Table 3A Hs.2128 U15932 9911129 dual specificity phosphatase5 1 ACCCGTGTGAATGTGAAGAAAAGCAG (DUSP5), mRNA/cds = (210, 1364)TATGTTACTGGTTGTTGTTGTTGT 3598 Table 3A Hs.64639 U16307 1100927 gliomapathogenesis-related protein 1 AGAGAGGGAACATCAAATGCTGGCA (RTVP1),mRNA/cds = (128, 928) CTATATACATACGATCAGCCTGATT 3599 Table 3A Hs.183105U17989 805094 nuclear autoantigen (GS2NA), 1 GTCTTCCGAGAAACTTTTCTGATCAGmRNA/cds = (204, 2345) TTTGCGAGTTTTGATGAGTTTTGT 3600 Table 3A Hs.155188U18062 842794 TATA box binding protein (TBP)- 1GCTGCTGTTGCTGCTTTGTGATGACG associated factor, RNA polymerase II,TGAGATCAATAAGAAGAACCTAGT F, 55kD (TAF2F), mRNA/cds = (740, 1789) 3601Table 3A Hs.2488 U20158 806765 lymphocyte cytosolic protein 2 (SH2 1AGGACTGAACTGAACCCCTCCCCATG domain-containing leukocyte protein ofAACACAAGGGTTTTATCCTTTCCT 76kD) (LCP2), mRNA/cds = (207, 1808) 3602 Table3A Hs.78913 U20350 665580 G protein-coupled receptor V28 1GATGTGGTAACTGTTAAATTGCTGTG mRNA, complete cds/cds = (87, 1154)TATCTGATAGCTCTTTGGCAGTCT 3603 Table 3A Hs.154230 U22897 984296 nucleardomain 10 protein (NDP52), 1 GATCAAAAGGGCTATGGGAAGGGCA mRNA/cds = (54,1394) GACCCCGCCAATGATTTCTCTTCAC 3604 Table 3A Hs.2437 U23028 806853eukaryotic initiation factor 2B-epsilon 1 GAACAGCTTTGTGCTCCGGCTTTCCCmRNA, partial cds/cds = (0, 1925) TCAGGGAACAGCAGAGAGCAGTTG 3605 Table 3AHs.93304 U24577 1314245 phospholipase A2, group VII (platelet- 1TCCAGGGACCAACATTAACACAACCA activating factor acetylhydrolase,ATCAACACATCATGTTACAGAACT plasma) (PLA2G7), mRNA/cds = (161, 1486) 3606Table 3A Hs.278625 U24578 1125049 RP1 and complement C4B precursor 1TATTAAAGGCTTTTGGCAGCAAAGTG (C4B) genes, TCAGTGTTGGCAGCGAAGTGTCAG 3607Table 3A Hs.3144 U26710 862406 Cas-Br-M (murine) ectropic retroviral 1TTCACAAGATGCTTTGAAGGTTCTGA transforming sequence b (CBLB),TTTTCAACTGATCAAACTAATGCA mRNA/cds = (322, 2634) 3608 Table 3A Hs.1724U29607 903981 interleukin 2 receptor, alpha (IL2RA), 1ACTAATTTGATGTTTACAGGTGGACA mRNA/cds = (159, 977)CACAAGGTGCAAATCAATGCGTAC 3609 Table 3A Hs.75981 U30888 940181 ubiquitinspecific protease 14 (tRNA- 1 ACTGTACAATTTCTGAAGATGGTTATT guaninetransglycosylase (USP14), AACACTGTGCTGTTAAGCATCCA mRNA/cds = (91, 1575)3610 Table 3A Hs.845 U31120 1045451 interleukin-13 (IL-13) precursorgene, 1 CTGTGTCTGGCACCACCCACACATCC complete cds ATGTCTCCCTCACAACCCAGGAGG3611 Table 3A Hs.64310 U32324 975336 interleukin 11 receptor, alpha 1CATGTATGTAGGTGCCTGGGAGTGT (IL11RA), mRNA/cds = (5, 1273)GTGTGGTCCTTGCTCTGGCCCTTTC 3612 Table 3A Hs.41724 U32659 1155222interleukin 17 (cytotoxic T-lymphocyte- 1 ATTCAATTCCAGAGTAGTTTCAAGTTTassociated serine esterase 8) (IL17), CACATCGTAACCATTTTCGCCCG mRNA/cds =(53, 520) 3613 Table 3A Hs.108327 U32986 1136227 damage-specific DNAbinding protein 1 TCTTCGGAAAGAAGAAGGTGGGAGG 1 (127kD) (DDB1),ATGTGAATTGTTAGTTTCTGAGTTT mRNA/cds = (109, 3531) 3614 Table 3A Hs.32970U33017 984968 signaling lymphocytic activation 1ATCAAGCCTCTGTGCCTCAGTTTCTC molecule (SLAM), TCTCAGGATAAAGAGTGAATAGAGmRNA/cds = (133, 1140) 3615 Table 3A Hs.2533 U34252 1049218 aldehydedehydrogenase 9 (gamma- 1 GCGATAGAGGAAATCTACTCCCTATC aminobutyraldehydedehydrogenase, TTGGGTCCTTGAACTACAGCCTGC E3 isozyme) (ALDH9), mRNA/cds =(377, 1858) 3616 Table 3A Hs.169476 U34995 1497857 Homo sapiens,glyceraldehyde-3- 1 CTAGGGAGCCGCACCTTGTCATGTAC phosphate dehydrogenase,clone CATCAATAAAGTACCCTGTGCTCA MGC:10926 IMAGE:3828129, mRNA, completecds/cds = (2306, 3313) 3617 Table 3A Hs.289107 U37547 1145292baculoviral IAP repeat-containing 2 1 TTTCTCCCCCTAGTTTGTGAGAAACA(BIRC2), mRNA/cds = (1159, 3015) TCTCAATAAAGTGCTTTCCAAAAA 3618 Table 3AHs.154057 U38320 2228241 matrix metalloproteinase 19 (MMP19), 1TCCCATCAAAAAGGTATCAAATGCCT transcript variant rasi-3,TGGAAGCTCCCTGATCCTACAAAA mRNA/cds = (1642, 1899) 3619 Table 3A Hs.151518U38847 1184691 TAR (HIV) RNA-binding protein 1 1TGCCAAAAGTTTGCCATGTGCCTTAA (TARBP1), mRNA/cds = (0, 4865)ACATATTACTATATATTTTCCCCT 3620 Table 3A Hs.75916 U41371 1173904 splicingfactor 3b, subunit 2, 145kD 1 CAGTTCCCAAGGACTTGTCATTTCAT (SF3B2),mRNA/cds = (48, 2666) GTTCTTATTTTAGACCTGTTTTGT 3621 Table 3A Hs.169531U41387 1230563 DEAD/H (Asp—Glu—Ala—Asp/His) 1 TTACCAAGAAGGACTTAAGGGAGTAAbox polypeptide 21 (DDX21), GGGGCGCAGATTAGCATTGCTCAA mRNA/cds = (265,2412) 3622 Table 3A Hs.57304 U41654 2058395 Ras-related GTP-bindingprotein 1 GATATGCACATCAAAGCCTTTACCAG (RAGA), mRNA/cds = (31, 972)TATCTTCCTGTATTCCGTATCAGA 3623 Table 3A Hs.167503 U43185 1151169 signaltransducer and activator of 1 CTCTGAGGCGTGAGGACTCGCAGTC transcription 5A(STAT5A), AGGGGCAGCTGACCATGGAAGATTG mRNA/cds = (640, 3024) 3624 Table 3AHs.54460 U46573 1280140 small inducible cytokine subfamily A 1CCTCTCTTCCTCCCTGGAATCTTGTA (Cys—Cys), member 11 (eolaxin)AAGGTCCTGGCAAAGATGATCAGT (SCYA11), mRNA/cds = (53, 346) 3625 Table 3AHs.279891 U46751 3077821 truncated calcium binding protein 1GCCTCCTGGTCTCTTCACCACTGTAG (LOC51149), mRNA/cds = (219, 695)TTCTCTCATTTCCAAACCATCAGC 3626 Table 3A Hs.155637 U47077 13570016DNA-dependent protein kinase 1 TTTTCCTTCTAACACTTGTATTTGGAG catalyticsubunit (DNA-PKcs) GCTCTTCTGTGATTTTGAGAAGT mRNA, complete cds/cds = (57,12443) 3627 Table 3A Hs.306359 U50078 4220427 clone 25038 mRNA 1TGAATTGCCTGTTCAGGGTTCCTTAT sequence/cds = UNKNOWNGCAGAGAAATAAAGCAGATTCAGG 3628 Table 3A Hs.173824 U51166 1378106thymine-DNA glycosylase (TDG), 1 GGACATCCACTAGAGTGGGTTTGAG mRNA/cds =(399, 1631) GATTTTCCAAGCGTGTAATAATGA 3629 Table 3A Hs.78993 U519031262925 IQ motif containing GTPase activating 1TTGCACGCAGAGCCTTTAAGTGACTA protein 2 (IQGAP2), AGGAACAACATAGATAGTGAGCATmRNA/cds = (222, 4949) 3630 Table 3A Hs.74170 U52054 1377850 602708243F1cDNA, 5′ 1 ACTTTAATCTGATCTTGTGTCTTAGAG end/clone =AAGCCCCCATACCTGGTAGAGCA IMAGE:4844914/clone_end = 5′ 3631 Table 3AHs.82132 U52682 1378108 interferon regulatory factor 4 (IRF4), 1TGTAGGAAAGGATGCTTCACAAACTG mRNA/cds = (105, 1460)AGGTAGATAATGCTATGCTGTCGT 3632 Table 3A Hs.82132 U52682 1378108interferon regulatory factor 4 (IRF4), 1 TGTAGGAAAGGATGCTTCACAAACTGmRNA/cds = (105, 1460 AGGTAGATAATGCTATGCTGTCGT 3633 Table 3A Hs.183556U53347 1478280 solute carrier family 1 (neutral amino 1CTGGGGAGAGGCTGAGGACAAATAC acid transporter), member 5 (SLC1A5),CTGCTGTCACTCCAGAGGACATTTT mRNA/cds = (590, 2215) 3634 Table 3A Hs.333527U53530 1314642 cDNA FLJ13685 fis, clone 1 CATTACTTGTGAGCTGCTGAACAAACPLACE2000039, highly similar to AAGTCAAGGTGAGCCCGGACATGG DYNEIN HEAVYCHAIN, CYTOSOLIC/cds = UNKNOWN 3635 Table 3A Hs.58189 U54559 2351379eukaryotic translation initiation factor 3, 1 AAGAAGTTAACATGAACTCTTGAAGTsubunit 3 (gamma, 40kD) (EIF3S3), CACACCAGGGCAACTCTTGGAAGA mRNA/cds =(5, 1063) 3636 Table 3A Hs.44585 U58334 1399804 tumor proteinp53-binding protein, 2 1 GAAACTTGCTACAGACTTACCCGTAA (TP538P2), mRNA/cds= (756, 3773) TATTTGTCAAGATCATAGCTGACT 3637 Table 3A Hs.169191 U589134204907 small inducible cytokine subfamily A 1 TGGACACACGGATCAAGACCAGGAA(Cys—Cys), member 23 (SCYA23), GAATTGAACTTGTCAAGGTGAAGGG mRNA/cds = (71,433) 3638 Table 3A Hs.11383 U59808 4097420 small inducible cytokinesubfamily A 1 TGCTAAATATGTTATTGTGGAAAGAT (Cys—Cys), member 13 (SCYA13),GAATGCAATAGTAGGACTGCTGAC mRNA/cds = (75, 371) 3639 Table 3A Hs.79089U60800 1663568 sema domain, immunoglobulin domain 1AGCAATAAACTCTGGATGTTTGTGCG (lg), transmembrane domain (TM) andCGTGTGTGGACAGTCTTATCTTCC short cytoplasmic domain, (semaphorin) 4D(SEMA4D), mRNA/cds = (87, 2875) 3640 Table 3A Hs.238648 U60805 1794210oncostatin M receptor (DSMR), 1 TCCTCTTTTCTTTCAAGAACTATATAT mRNA/cds =(367, 3306) AAATGACCTGTTTTCACGCGGCC 3641 Table 3A Hs.77256 U611451575348 enhancer of zeste (Drosophila) 1 AGCTGCAAAGTGTTTTGTACCAGTGAhomolog 2 (EZH2), ATTTTTGCAATAATGCAGTATGGT mRNA/cds = (57, 2297) 3642Table 3A Hs.30035 U61287 1418285 splicing factor, arginine/serine-rich 1TTGCTTACCAAAGGAGGCCCAATTTC (transformer 2 Drosophila homolog) 10ACTCAAATGTTTTGAGAACTGTGT (SFRS10), mRNA/cds = (121, 987) 3643 Table 3AHs.155935 U82027 1511643 complement component 3a receptor 1 1ACATAGTGAAAGTTTATAAGAGGATG (C3AR1), mRNA/cds = (0, 1448)AAGTGATATGGTGAGCAGCGGACT 3644 Table 3A Hs.177584 U62981 15190513-oxoacid CoA transferase (OXCT), 1 AACAGCCTTTCTGGCTGACCACATGG nucleargene encoding mitochondrial TTAAATGCATACCTTCCCAGTACT protein, mRNA/cds =(98, 1660) 3645 Table 3A Hs.75498 U64197 1778716 small induciblecytokine subfamily A 1 TGTGCCTCACCTGGACTTGTCCAATT (Cys—Cys), member 20(SCYA20), AATGAAGTTGATTCATATTGCATC mRNA/cds = (58, 348) 3646 Table 3AHs.73165 U64198 1685027 interleukine 12 receptor, beta 2 1CTATAGATGAAGACATAAAAGACACT (IL12RB2), mRNA/cds = (640, 3228)GGTAAACACCAATGTAAAAGGGCC 3647 Table 3A Hs.279939 U65590 1794218mitochondrial carrier homolog 1 1 AGCTGTTGATGCTGGTTGGACAGGTT (MTCH1),nuclear gene encoding TGAGTCAAATTGTACTTTGCTCCA mitochondrial protein,mRNA/cds = (0, 1118) 3648 Table 3A Hs.73172 U67369 1898891 growth factorindependent 1 (GFI1), 1 TGGGAAGGAAGGCTCTGTCTTCAACT mRNA/cds = (267,1535) CTTTGACCCTCCATGTGTACCATA 3649 Table 3A Hs.84264 U70439 1698782Homo sapiens, acidic protein rich in 1 GATTCTTGCTGTAGCGTGGATAGCTGleucines, clone MGC:8650 TGATTGGTGAGTCAACCGTCTGTG IMAGE:2961642, mRNA,complete cds/cds = (211, 966) 3650 Table 3A Hs.82116 U70451 1763090myleoid differentiation primary 1 TGGGCATTTTAAAGCCATCTCAAGAG responseprotein My088 mRNA, GCATCTTCTACATGTTTTGTACGC complete cds/cds = (32,922) 3651 Table 3A Hs.117005 U71383 2411474 sialic acid binding lg-likelectin 5 1 AAGTCAGGGACCACTTGCTGAAGCA (SIGLEC5), mRNA/cds = (142, 1797)CGAAGAGCCCTTGTGGCAATGTTAA 3652 Table 3A Hs.12045 U72514 2276395 Homosapiens, Similar to gene rich 1 GACTGCTGGAAGATGATCTTTCTGCA cluster, C2fgene, clone MGC:16358 CTGAGACTGTGGAGTTTGGGGAAG IMAGE:3927564, mRNA,complete cds/cds = (278, 733) 3653 Table 3A Hs.183684 U73824 1857236eukaryotic translation initiation factor 4 1 TTGTGGGTGTGAAACAAATGGTGAGAgamma, 2 (EIF4G2), ATTTGAATTGGTCCCTCCTATTAT mRNA/cds = (306, 3029) 3654Table 3A NA U75686 2801402 Poly(A)-binding protein, cytoplasmic 4 1AATTCCAGCTGAGCGCCGGTCGCTA (inducible form) CCATTACCGTTGGTCTTGGTGTCAA3655 Table 3A Hs.20191 U76248 2673967 hSIAH2 mRNA, complete 1CCCCAACCCTCAAATTAAAACTAGAA cds/cds = (526, 1500)CTATAGATCCACATGAACGCACGC 3656 Table 3A Hs.81361 U76713 1814273heterogeneous nuclear 1 AGCTTTTGAAATAAAATTTAAAAACCC ribonucleoproteinA/B (HNRPAB), CAAGCCTGGGTGAGTGTGGGAAA transcript variant 1, mRNA/cds =(224, 1219) 3657 Table 3A Hs.76507 U77396 1684871 LPS-induced TNF-alphafactor (PIG7), 1 TCTGTAATCAAATGATTGGTGTCATTT mRNA/cds = (233, 919)TCCCATTTGCCAATGTAGTCTCA 3658 Table 3A Hs.78103 U77456 1879778 nucleosomeassembly protein 1-like 4 1 GCCCCACCATTCATCCTGTCTGAAGG (NAP1L4),mRNA/cds = (149, 1276) TCCTGGGTTTGGTGTGACCGCTTG 3659 Table 3A Hs.80205U77735 1750275 pim-2 oncogene (PIM2), 1 TTCCTGCCTGGATTATTTAAAAAGCCmRNA/cds = (185, 1189) ATGTGTGGAAACCCACTATTTAAT 3660 Table 3A Hs.55481U78722 1699000 zinc finger protein 165 (ZNF165), 1AGCCTTCAGTCAGAGCTCAAACCTTA mRNA/cds = (567, 2024)GTCAACACCAGAGAATTCACATGA 3661 Table 3A Hs.71848 U79277 1710245 clone23548 mRNA 1 GAATTTTCAGTTTGTGCTTACATTTTC sequence/cds = UNKNOWNTAACATTGGATGTTTGCTTTGGC 3662 Table 3A Hs.173854 U80735 2565045 CAGF28mRNA, partial 1 TATGACTTTAAGAGCCCACATTAGGT cds/cds = (0, 2235)TTTATGATTCATTTGCCAGGTTTT 3663 Table 3A Hs.306094 U80743 2565060 mRNA forKIAA1818 protein, partial 1 GGCGTGCCGTTGAGGGGGAAAACGA cds/cds = (0,3473) AGCCCAGTATTTGCTACTGTTTTTC 3664 Table 3A Hs.181466 U81002 4580010cDNA FLJ14502 fis, clone 1 CTCTTGGGCATAAAATCTCAGAGGAA NT2RM1000244,highly similar to GCTACTTAGGACATCATCTTGGCC TRAF4 associated factor 1mRNA/cds = (UNKNOWN) 3665 Table 3A Hs.181002 U82828 2072424 non-lensbeta gamma-crystallin like 1 TCTACAGTAGCCTGTGCTGAACTGAT protein (AIM1)mRNA, parital CTCTTAAATAAACTTGCTTCTGGT cds/cds = (0, 4913) 3666 Table 3AHs.334457 U83115 2623760 Aac11 (aac11) mRNA, complete 1TTCTCAAGTTTGATACTGAGTTGACT cds/cds = (77, 1663) GTTCCCTTATCCCTCACCGTTCCC3667 Table 3A Hs.80420 U83857 1888522 small inducible cytokine subfamilyD 1 AGACTTTTCCAACCCTCATCACCAAC (Cys-X3-Cys), member 1 (fractalkine,GTCTGTGCCATTTTGTATTTTACT neurotactin) (SCYD1), mRNA/cds = (79, 1272)3668 Table 3A Hs.154685 U84487 2218086 phosphomannomutase 2 (PMM2), 1CCAGCGGCATCTTTCCTTGTCGAATG mRNA/cds = (48, 788) ATACTGTAATGACCTTCCAAAGTG3669 Table 3A Hs.50404 U85773 2388626 small inducible cytokine subfamilyA 1 TCTGGTCATTCAAGGATCCCCTCCCA (Cys—Cys), member 25 (SCYA25),AGGCTATGCTTTTCTATAACTTTT mRNA/cds = (0, 452) 3670 Table 3A Hs.162808U86453 2317893 phosphatidylinositol 3-kinase catalytic 1TGTGGGTTGAGACCAGCACTCTGTGA subunit p11Odella mRNA, completeAACCTTGAAATGAGAAGTAAAGGC cds/cds = (195, 3329) 3671 Table 3A Hs.74407U88602 1835785 nucleolar protein p40; homolog of 1TGAATACAAAGAACCAAGAAAA yeast EBNA1-binding protein (P40),AGGAATGAAGACTCGCAATTTCAC mRNA/cds = (142, 1082) GACA 3672 Table 3AHs.5181 U87954 4099505 proliferation-associated 2G4, 38kD 1CTGAATTTGGTTTTGGGAGGTGAGGC (PA2G4), mRNA/cds = (97, 1281)TTCCCAACCACGGAAGACTACTTT 3673 Table 3A Hs.173334 U88629 1946346ELL-RELATED RNA POLYMERASE 1 GGCTCACATCAAAAGGCTAATAGGTG II, ELONGATIONFACTOR (ELL2), AATTTGACCAACAGCAAGCAGAGT mRNA/cds = (0, 1922) 3674 Table3A Hs.169963 U90543 2062887 butyrophilin, subfamily 2, member A1 1GACGCCTTACAAATGATGGAGGATTC (BTN2A1), mRNA/cds = (210, 1793)CAAAGAGTTTTTGTTTATTTGGGT 3675 Table 3A Hs.167741 U90548 2062697butryophilin, subfamily 3, member A3 1 CCTGGTCATTGGTGGATGTTAAACCC(BTN3A3), mRNA/cds = (171, 1925) ATATTCCTTTCAACTGCTGCCTGC 3676 Table 3AHs.284283 U90552 2062705 butyrophilin (BTF5) mRNA, complete 1TGGTGGATGTTAAACCAATATTCCTTT cds/cds = (359, 1900)CAACTGCTGCCTGCTAGGGAAAA 3677 Table 3A Hs.83724 U90904 1913882 Homosapiens, clone IMAGE:3451448, 1 CAGCTCTGGAAATAGAAGACTAGG mRNA, partialcds/cds = (0, 901) GTTGTTTCTTAAATTTAGCTCATGT 3678 Table 3A Hs.279948U93243 6649661 HSPC205 mRNA, complete 1 TGACTTATGAGCTGTGACTCAACTGCcds/cds = (190, 681) TTCATTAAACATTCTGCATTGGGT 3679 Table 3A Hs.7811U94856 2055430 eukaryotic translation initiation factor 3, 1ACACTGAGATAGTCAGTTGTGTGTGA subunit 5 (epsilon, 47kD) (EIF3S5),CTCTAATAAACGGAGCCTACCTTT mRNA/cds = (8, 1079) 3680 Table 3A Hs.328248U98828 2343084 cDNA:FLJ22071 fis, clone 1 TTTGTAAGCGAAGGAGATGGAGGTCHEP11691/cds = UNKNOWN GTCTTAAACCAGAGAGCTACTGAAT 3681 Table 3A Hs.195175U97075 2253880 mRNA for CASH alpha 1 GGATGATAACACCCTATGCCCATTGTprotein/cds = (481, 1923) CCTGATCTGAAAATTCTTGGAAAT 3682 Table 3AHs.308026 V00522 32122 major histocompatibility complex, class 1CTTTGCCTAAACCCTATGGCCTCCTG II, DR beta 5 (HLA-DRB5),TGCATCTGTACTCACCCTGTACCA mRNA/cds = (29, 829) 3683 Table 3A Hs.25647V01512 29903 cellular oncogene c-fos (complete 1AAAAGCATTTAAGTTGAATGCGACCA sequence) ACCTTGTGCTCTTTTCATTCTGGA 3684 Table3A Hs.44189 W00466 1271875 yz99f01.r1 cDNA, 5′ 1CCTTGAGAAACACCCATCTCCACTCC end/clone = TAGACAAACCAATGAACATTAGTCIMAGE:291193/clone_end = 5′ 3685 Table 3A NA W00491 1271910 2NbHM cDNAclone IMAGE:291255 5′ 1 TCTTAAGGTGTGGCAGAGACAGGGT similar toATTTGGGATATACTTTTCAGACTCC 3686 Table 3A NA W02600 1274578 spleen 1NFLScDNA clone 1 AACAATAAAATATGGCTAGACTGGCC IMAGE:296099 5′TCTGGTTGCCTAAACAGAGCATCA 3687 Table 3A NA W03955 1275820 za62d04.rfcDNA, 5′ 1 CTTAACTGAGGGCTTGTCCTGGTTAT end/clone = IMAGE:297127/AAATGTCTGGGTGGGGGTGGGCAC 3688 Table 3A Hs.306117 W16552 1290934 capicuaprotein (CIC) mRNA, 1 AACTGTGAGGCAAATAAAATGCTTCT complete cds/cds = (40,4866) CAAACTGTGTGGCTCTTATGGGGT 3689 Table 3A Hs.17778 W19201 1295429neuropilin 2 (NRP2), 1 GTGGCTAAGTCATTGCAGGAACGGG mRNA/cds = (0, 2780)GCTGTGTTCTCTGCTGGGACAAAAC 3690 Table 3A Hs.235883 W19487 1295576602626774F1 cDNA, 5′ 1 ATTGCGACTGTATGGAGAAGAACTGT end/clone =TTGTCATTCAGTGCCGTGGGATAT IMAGE:4753483/clone_end = 5′ 3691 Table 3AHs.340717 W25068 1302933 we58c01.x1 cDNA, 3′ 1TTTATAGAACAATTCCTTTCTCTTCTC end/clonde = TTGAATGTGGCAGTCATTACTGCIMAGE:2345280/clone_end = 3′ 3692 Table 3A Hs.173334 W47229 1331889ELL-RELATED RNA POLYMERASE 1 TTGATTAGAGCAATGGGAAGCATACT II, ELONGATIONFACTOR (ELL2), GTGGCCTACCAGCATCTGGAAGTG mRNA/cds = (0, 1922) 3693 Table3A NA W56487 1358345 zc59c07 rf 1 TCAATTGAGGCCCCTTCCCTAAGATTSoares_parathyroid_tumor_NbHPA ACAACATTGATAACCTGTCCTTTT cDNA clone 3694Table 3A Hs.21812 W74397 1384683 AL562895 1 CAGCCCTCCGTCGCTTTTTATAAAACcDNA/clone = CS0DC021YO20- TTTGTGTGAGAAGAATATATTGAT (3-prime) 3695 Table3A Hs.163846 W79598 1390869 putative N6-DNA-methyltransferase 1ACTTCAGATCCTTTTGTGTTTAAATAA (N6AMT1), mRNA/cds = (29, 673)AGGAAAAGCTGCACATCCAAAAA 3696 Table 3A Hs.8294 W80882 1391906 KIAA0196gene product (KIAA0196), 1 AGCCTACCTCCTACCCCAGCTGTCTG mRNA/cds = (273,3752) TTGAGAGCAGTGCTGACCCCAGCA 3697 Table 3A Hs.303157 X00437 36748 mRNAfor T-cell specific 1 GAAGAGCTGCTCTCACCTCTCTGCAT protein/cds = (37, 975)CCCAATAGATATCCCCCTATGTGC 3698 Table 3A Hs.75514 X00737 35564 nucleosidephosphorylase (NP), 1 GGGCTCAGTTCTGCCTTATCTAAATC mRNA/cds = (109, 978)ACCAGAGACCAAACAAGGACTAAT 3699 Table 3A Hs.1724 X01057 33812interleukin-2 receptor 1 AAATACAAACATTCTAATTAAAGGCTTTGCAACACATGCCTTGTCTGTTT 3700 Table 3A Hs.95327 X01451 36774 CD3Dantigen, delta polypeptide (TIT3 1 GCCATTACCAACTGTACCTTCCCTTC complex)(CD3D), mRNA/cds = (0, 515) TTGCTCAGCCAATAAATATATCCT 3701 Table 3AHs.1103 X02812 37092 tranforming growth factor, beta 1 1CACCAGGAACCTGCTTTAGTGGGGG (TGFB1), mRNA/cds = (841, 2016)ATAGTGAAGAAGACAATAAAAGATA 3702 Table 3A Hs.1217 X02994 28379 adenosinedeaminase (ADA), 1 TGGGCATGGTTGAATCTGAAACCCTC mRNA/cds = (95, 1186)CTTCTGTGGCAACTTGTACTGAAA 3703 Table 3A Hs.2233 X03656 31687 gene forgranuloctye colony-stimulating 1 CTGGGGAGGAGGTCCAGGGAGGAG factor (G-CSF)GAGGAAAGTTCTCAAGTTCGTCTGAC 3704 Table 3A Hs.174142 X03663 29899 colonystimulating factor 1 receptor, 1 AACTAACAGTCACGCCGTGGGATGTC formerlyMcDonough feline sarcoma TCTGTCCACATTAAACTAACAGCA viral (v-fms) oncogenehomolog (CSF1R), mRNA/cds = (300, 3218) 3705 Table 3A Hs.14376 X0409828338 actin, gamma 1 (ACTG1), 1 GGTTTTCTACTGTTATGTGAGAACATT mRNA/cds =(74, 1201) AGGCCCCAGCAACACGTCATTGT 3706 Table 3A Hs.74451 X04106 35327calpain 4, small subunit (30K) 1 TTTGTCTATATTCTGCTCCCAGCCTG (CAPN4),mRNA/cds = (158, 964) CCAGGCCAGGAGGAAATAAACATG 3707 Table 3A Hs.198365X04327 29480 2,3-bisphosphoglycerate mutase 1 TTCCTCTTTGGCCACAAGAATAAGCA(BPGM), mRNA/cds = (110, 889) GCAAATAAACAACTATGGCTGTTG 3708 Table 3AHs.58685 X04391 37186 CD5 antigen (P56-62) (CD5), 1CTCATCTAAAGACACCTTCCTTTCCA mRNA/cds = (72, 1559)CTGGCTGTCAAGCCACAGGGCACC 3709 Table 3A Hs.93913 X04430 32673interleukine B (interferon, beta 2) (IL6), 1 GCAGTTTGAATATCCTTTGTTTCAGAmRNA/cds = (62, 700) GCCAGATCATTTCTTGGAAAGTGT 3710 Table 3A Hs.2253X04481 34627 complement component 2 (C2), 1 CCCTGGTTGACTTGACTCATGCTTGTmRNA/cds = (36, 2294) TTCACTTTCACATGGAATTTCCCA 3711 Table 3A Hs.2247X04688 33835 interleukin 5 (colony-stimulating factor, 1TCAGAGGGAAAGTAAATATTTCAGGC eosinophil) (IL5), mRNA/cds = (44, 448)ATACTGACACTTTGCCAGAAAGCA 3712 Table 3A Hs.79015 X05323 34742 MRC OX-2gene signal sequence 1 CACAAGGTAAAGAAACTCAATTCCCCTGCTTGGAGCCCAGCAAACACAAT 3713 Table 3A Hs.78225 X05908 34387 annexin A1(ANXA1), 1 TGTGGAGGAAACTAAACATTCCCTTG mRNA/cds = (74, 1114)ATGGTCTCAAGCTATGATCAGAAG 3714 Table 3A Hs.36972 X06180 29819 CD7 antigen(p41) (CD7), 1 GGAGGAGACCAGTCCCCCACCCAGC mRNA/cds = (0, 722)CGTACCAGAAATAAAGGCTTCTGTG 3715 Table 3A Hs.81665 X06182 34084 v-kitHardy-Zuckerman 4 feline 1 TGTGTAAATACATAAGCGGCGTAAGT sarcoma viraloncogene homolog (KIT), TTAAAGGATGTTGGTGTTCCACGT mRNA/cds = (21, 2951)3716 Table 3A Hs.173255 X06347 37540 small nuclear ribonucleoprotein 1CGCTGTTAGGCCGGAATTAAAGTGG polypeptide A (SNRPA),CTTTTTGAGGTTTGGTTTTTCACAA mRNA/cds = (125, 973) 3717 db mining Hs.2014X06557 37003 mRNA for T-cell receptor 1 GGGGTTTATGTCCTAACTGCTTTGTAdelta/cds = UNKNOWN TGCTGTTTTATAAAGGGATAGAAG 3718 Table 3A Hs.153003X06956 32014 serine/threonine kinase 16 (STK16), 1ACACCAACCTGCTTCCACTTTATTCTT mRNA/cds = (118, 1050)GTTTACACATTCTCCTGCTCCCA 3719 Table 3A Hs.77202 X07109 35492 proteinkinase C, beta 1 (PRKCB1), 1 AAGATGTTTGTGGAAATGTTCATTTGT mRNA/cds =(136, 2151) ATCTGGATCTCTGTTATGTGCCA 3720 Table 3A Hs.89751 X07203 29775membrane-spanning 4-domains, 1 GAGTTACCACACCCCATGAGGGAAG subfamily A,member 2 (Fc fragment of CTCTAAATAGCCAACACCCATCTGT IgE, high affinity I,receptor for; beta polypeptide) (MS4A2), mRNA/cds = (90, 983) 3721 Table3A Hs.77438 X07743 35517 pleckstrin (PLEK), 1 TTCCTGAAGCTGTTCCCACTCCCAGAmRNA/cds = (60, 1112) TGGTTTTATCAATAGCCTAGAGGT 3722 Table 3A Hs.318885X07834 36517 superoxide dismutase 2, mitochondrial 1TACTTTGGGGACTTGTAGGGATGCCT (SOD2), mRNA/cds = (4, 672)TTCTAGTCCTATTCTATTGCAGTT 3723 Table 3A Hs.78056 X12451 29714 cathepsin L(CTSL), 1 TCGAATCATTGAAGATCCGAGTGTGA mRNA/cds = (288, 1289)TTTGAATTCTGTGATATTTTCACA 3724 Table 3A Hs.193400 X12830 33845interleukin 6 receptor (IL6R), 1 ATATCCAATATTCGCTGTGTCAGCAT mRNA/cds =(437, 1843) AGAAGTAACTTACTTAGGTGTGGG 3725 Table 3A Hs.856 X13274 32691interferon, gamma (IFNG), 1 TTGTTGACAACTGTGACTGTACCCAA mRNA/cds = (108,608) ATGGAAAGTAACTCATTTGTTAAA 3726 Table 3A Hs.2299 X13444 29826 CD8antigen, beta polypeptide 1 (p37) 1 AAGTTTCTCAGCTCCCATTTCTACTCT (CD881),mRNA/cds = (50, 682) CCCATGGCTTCATGCTTCTTTCA 3727 Table 3A Hs.234489X13794 34314 lactate dehydrogenase B gene exon 1 1TCTCCATGTTGTCAAAATCATGCCGT and 2 (EC 1.1.1.27) TTATAGCTATTTTCACCTCAGTGG3728 literature Hs.89137 X13916 34338 low density lipoprotein-relatedprotein 1 GCCCCGTTTTGGGGACGTGAACGTTT 1 (alpha-2-macroglobulin receptor)TAATAATTTTTGCTGAATTCTTTA (LRP1), mRNA/cds = (466, 14100) 3729 Table 3AHs.82120 X14008 34433 nuclear receptor subfamily 4, group A, 1AGGTGGGCACAAGTATTACACATCAG member 2 (NR4A2), AAAATCCTGACAAAAGGGACACATmRNA/cds = (317, 2113) 3730 Table 3A Hs.77424 X14356 31331 Fc fragmentof IgG, high affinity Ia, 1 GTTCAACAACACCAGAACTGTGTGTC receptor for(CD64) (FCGR1A), TCATGGTATGTAACTCTTAAAGCA mRNA/cds = (0, 1124) 3731Table 3A Hs.87409 X14787 37464 thrombospondin 1 (THBS1), 1TTGACCTCCCATTTTTACTATTTGCCA mRNA/cds = (111, 3623)ATACCTTTTTCTAGGAATGTGCT 3732 Table 3A Hs.289088 X15183 32487 heat shock90kD protein 1, alpha 1 AAAGCTGTTCAAATACTCGAGCCCAG (HSPCA), mRNA/cds =(60, 2258) TCTTGTGGATGGAAATGTAGTGCT 3733 Table 3A Hs.339703 X16277 35137zv26f06.r1 cDNA, 5′ 1 CTTAAGTCTGACGGACCTGTCCTGTC end/clone =CAGGCCAGTGCCCAGGGAAGGTGT IMAGE:754787/clone_end = 5′ 3734 Table 3AHs.50964 X16354 37197 mRNA for transmembrane 1TTTCTAACCCTGACACGGACTGTGCA carcinoembryonic antigen BGPaTACTTTCCCTCATCCATGCTGTGC (formerly TM1-CEA)/cds = (72, 1652) 3735 Table3A Hs.154672 X16396 35070 methylene tetrahydrofolate 1CAGCAGCTGCCTGCTTTTCTGTGATG dehydrogenase (NAD+ dependent),TATGTATCCTGTTGACTTTTCCAG methenyltetrahydrofolate cyclohydrolase(MTHFD2), nuclear gene encoding mitochondrial protein, mRNA/cds = (76,1110) 3736 Table 3A Hs.14601 X16663 32054 hematopoietic cell-specificLyn 1 TCCCTGAAGAAATATCTGTGAACCTT substrate 1 (HCLS1),CTTTCTGTTCAGTCCTAAAATTCG mRNA/cds = (42, 1502) 3737 Table 3A Hs.176663X16883 31321 leukocyte IgG receptor (Fc-gamma-R) 1ATGGGAGTAATAAGAGCAGTGGCAG mRNA, complete cds/cds = (17, 718)CAGCATCTCTGAACATTTCTCTGGA 3738 Table 3A Hs.271986 X17033 33906 integrin,alpha 2 (CD49B, alpha 2 1 ACCCATTTCTACTTTTTGCACCTTATT subunit of VLA-2receptor) (ITGA2), TTCTCTGTTCCTGAGCCCCCACA mRNA/cds = (42, 3587) 3739Table 3A Hs.1908 X17042 32432 proteoglycan 1, secretory granule 1TGTGTTTGCAGAGCTAGTGGATGTGT (PRG1), mRNA/cds = (24, 500)TTGTCTACAAGTATGATTGCTGTT 3740 Table 3A Hs.342863 X17094 31477 Ig48108.x1cDNA, 3′ 1 GGCCCAGCATTGCTGGTTCTATTTAA end/clone =TGGACATGAGATAATGTTAGAGGT IMAGE:2112035/clone_end = 3′ 3741 Table 3AHs.198951 X51345 34014 jun B proto-oncogene (JUNB), 1TGAATATAATATATTTGTGTATTTAAC mRNA/cds = (253, 1296)AGGGAGGGGAAGAGGGGGCGATC 3742 Table 3A Hs.3288 X51757 35221 heat shock70kD protein 6 (HSP708′) 1 TGGCACTTTAACATTGCTTTCACCTAT (HSPA6), mRNA/cds= (0, 1931) ATTTTGTGTACTTTGTTACTTGC 3743 Table 3A Hs.76053 X52104 35219DEAD/H (Asp—Glu—Ala—Asp/His) 1 AGTAAATGTACAGTGATTTGAAATAC boxpolypeptide 5 (RNA helicase, 68kD) AATAATGAAGGCAATGCATGGCCT (DDX5),mRNA/cds = (170, 2014) 3744 Table 3A Hs.323098 X52142 30292cDNA:FLJ23458 fis, clone 1 CTTAATGTGACCTAGCAATAGGCATA HIS107327/cds =UNKNOWN GCTACGTGGCACTATATTCTGGCC 3745 literature Hs.99987 X52221 31215ERCC2 gene, exons 1 & 2 1 AGGAGCACCTCACAGATGCCAACCT (partial)/cds =UNKNOWN CAACCTGACCGTGGACGAGGGTGTC 3746 Table 3A Hs.278544 X52882 311380acetyl-Coenzyme A acetyltransferase 1 CCACGACTTCTGCCCATTCTCTCCAG 2(acetoacetyl Coenzyme A thiolase) TGTGTGTAACAGGGTCACAAGAAT (ACAT2),mRNA/cds = (37, 1230) 3747 Table 3A Hs.85266 X53587 33950 integrin, beta4 (ITGB4), 1 GGCCCAAACCTATTTGTAACCAAAGA mRNA/cds = (126, 5384)GCTGGGAGCAGCACAAGGACCCAG 3748 Table 3A Hs.117950 X53793 28383multifunctional polypeptide similar to 1 GCGAGCAAGCATTTTGAACACATGGASAICAR synthetase and AIR TTTCCTTGAAGCAGGCTGACAAGA carboxylase (ADE2H1),mRNA/cds = (24, 1301) 3749 Table 3A NA X53795 35832 R2 mRNA for aninducible membrane 1 TCGGATGGGCTGTTTAGATGTTATAT proteinAATCCACAAAAGGTTCATTGAGCT 3750 Table 3A Hs.105938 X53961 34415lactotransferrin (LTF), 1 GGATTGCCCATCCATCTGCTTACAAT mRNA/cds = (294,2429) TCCCTGCTGTCGTCTTAGCAAGAA 3751 Table 3A Hs.55921 X54326 31957glutamyl-prolyl-tRNA synthetase 1 AAAATGAAGTCACACAGGACAATTAT (EPRS),mRNA/cds = (58, 4380) TCTTATGCCTAAGTTAACAGTGGA 3752 Table 3A Hs.789X54489 34625 GRO1 oncogene (melanoma growth 1 GCCTTGTTTAATGGTAGTTTTACAGTstimulating activity, alpha) (GRO1), GTTTCTGGCTTAGAACAAAGGGGC mRNA/cds =(79, 402) 3753 Table 3A Hs.74085 X54870 35062 DNA segment on chromosome12 1 AGTGCCTTCCCTGCCTGTGGGGGTC (unique) 2489 expressed sequenceATGCTGCCACTTTTAATGGGTCCTC (D12S2489E), mRNA/cds = (338, 988) 3754 Table3A Hs.83758 X54942 29978 CDC28 protein kinase 2 (CKS2), 1TTCCAGTCAGTTTTTCTCTTAAGTGCC mRNA/cds = (95, 334) TGTTTGAGTTTACTGAAACAGTT3755 Table 3A Hs.283330 X56733 8924082 hypothetical protein PRO1843 1TCCAATGCAGTCCCATTCTTTATGGC (PRO1843), mRNA/cds = (964, 1254)CTATAGTCTCACTCCCAACTACCC 3756 Table 3A Hs.312670 X55740 23896 xn42c03.x1cDNA, 3′ 1 TGGTATAAGAAATGACTTTGAACCAC end/clone =TTTGCAATTGTAGATTCCCAACAA IMAGE:2696356/clone_end = 3′ 3757 Table 3AHs.85112 X57025 33007 IGF-I mRNA for insulin-like growth 1CCCCTGCTACTTTGAAACCAGAAAAT factor I/cds = (166, 627)AATGACTGGCCATTCGTTACATCT 3758 Table 3A Hs.279920 X57346 23113 tyrosine3-monooxygenase/tryptophan 1 TGATCTGTCCAGTGTCACTCTGTACC 5-monooxygenaseactivation protein, CTCAACATATATCCCTTGTGCGAT beta polypeptide (YWHAB),mRNA/cds = (372, 1112) 3759 Table 3A Hs.74405 X57347 32463 tyrosine3-monooxygenase/tryptophan 1 AAAAGCCTTGTGAAAATGTTATG 5-monooxygenaseactivation protein, CCCCTATGTAACAGCAGAGTAACA beta polypeptide (YWHAQ),TAAA mRNA/cds = (100, 837) 3760 Table 3A Hs.289110 X57809 33714rearranged immunoglobulin lambda 1 CCACCACGGGAGACTAGAGCTGCAG light chainmRNA/cds = (9, 710) GATCCCGGGGGAGGGGTCTCTCCTC 3761 Table 3A Hs.289110X57812 33723 rearranged immunoglobulin lambda 1CAGTGGAAGTCCCACAGAAGCTACA light chain mRNA/cds = (9, 710)GCTGCCAGGTCACGCATGAAGGGAG 3762 Table 3A Hs.302063 X58529 33480rearranged immunoglobulin mRNA for 1 CCCACACTGCTTTGCTGTGTATACGC mu heavychain enhancer and TTGTTGCCCTGAAATAAATATGCA constant region/cds =UNKNOWN 3763 Table 3A Hs.302063 X58529 33480 rearranged immunoglobulinmRNA for 1 CCCACACTGCTTTGCTGTGTATACGC mu heavy chain enhancer andTTGTTGCCCTGAAATAAATATGCA constant region/cds = UNKNOWN 3764 Table 3AHs.155101 X59066 28937 Homo sapiens ATP synthase, H+ 1ACAAATTTCTTGGCTGGATTTGAAGC transporting, mitochondrial F1 complex,TTAAACTCCTGTGGATTCACATCA alpha subunit, isoform 1, cardiac muscle 3765Table 3A Hs.83532 X59405 34508 H. sapiens, gene for Membrane 1AGAGACCAGTTTTCTCTGGAAGTTG cofactor protein/cds = UNKNOWNTTTAAATGACAGAAGCGTATATGA 3766 literature Hs.861 X60188 31220 ERK1 mRNAfor protein 1 CGCCCCTGCCACCTCCCTGACCCGT serine/threonine kinase/cds =(72, 1211) CTAATATATAAATATAGAGATGTGT 3767 Table 3A Hs.81634 X60221509290 ATP synthase, H+ transporting, 1 GCCAGTCAGATGTTTCTCATCCTTCTmitochondrial F0 complex, subunit b, TGCTCTGCCTTTGAGTTGTTCCGT isoform 1(ATP5F1), mRNA/cds = (32, 802) 3768 Table 3A Hs.44926 X60708 35335dipeptidylpeptidase IV (CD26, 1 AAATACTGATGTTCCTAGTGAAAGAG adenosinedeaminase complexing GCAGCTTGAAACTGAGATGTGAAC protein 2) (DPP4),mRNA/cds = (75, 2375) 3769 Table 3A Hs.81226 X60992 29817 CD6 mRNA for Tcell glycoprotein 1 AGAAGCTGCACTAGGCCCCGAGTCC CD6/cds = (120, 1526)CCATGTGTCTCCTTGAATTGATGAG 3770 Table 3A Hs.77054 X61123 29508 B-celltranslocation gene 1, anti- 1 AAGTCTTTTCCACAAACCACCATCTAT proliferative(BTG1), TTTGTGAACTTTGTTAGTCATCT mRNA/cds = (308, 823) 3771 Table 3AHs.76913 X61970 296739 proteasome (prosome, macropain) 1AAATTTTATTTCCAGCTCCTGTTCCTT subunit, alpha type, 5 (PSMA5),GGAAAATCTCCATTGTATGTGCA mRNA/cds = (21, 746) 3772 Table 3A Hs.276770X62466 29645 CDW52 antigen (CAMPATH-1 1 CCTGAAACAGCTGCCACCATCACTCGantigen) (CDW52), CAAGAGAATCCCCTCCATCTTTGG mRNA/cds = (24, 209) 3773Table 3A Hs.80684 X82534 32332 high-mobility group (nonhistone 1TTCTGTGTGTATGGTAGCACAGCAAA chromosomal) protein 2 (HMG2),CTTGTAGGAATTAGTATCAATAGT mRNA/cds = (190, 819) 3774 Table 3A Hs.172690X62535 30822 diacylglycerol kinase, alpha (80kD) 1ACACACATACACACACCCCAAAACAC (DGKA), mRNA/cds = (103, 2310)ATACATTGAAAGTGCCTCATCTGA 3775 Table 3A Hs.77522 X62744 36062 majorhistocompatibility complex, class 1 GATCTCCTCTTAGGGTAGAAGAAGTC II, DMalpha (HLA-DMA), TCTGGGACATCCCTGGGGTGTGTG mRNA/cds = (45, 830) 3776Table 3A Hs.296014 X63563 36121 polymerase (RNA) II (DNA directed) 1GGCTGCCGCAATAAAACCCAGATTTC polypeptide B (140kD) (POLR28),TTTGGTGCGAATGCCTTACGCATG mRNA/cds = (43, 3567) 3777 Table 3A Hs.82359X53717 28741 tumor necrosis factor receptor 1 TCATCATCTGGATTTAGGAATTGCTCsuperfamily, member 6 (TNFRSF6), TTGTCATACCCCCAAGTTTCTAAG mRNA/cds =(220, 1227) 3778 db mining Hs.2490 X65019 33792 caspase 1,apoptosis-related cysteine 1 TGCCCACCACTGAAAGAGTGACTTTG protease(interleukin 1, beta, ACAAGATGTTTCTACCTCTTCCCA convertase) (CASP1),mRNA/cds = (0, 1151) 3779 Table 3A Hs.75248 X68060 37230 topoisomerase(DNA) II beta (180kD) 1 TTTGATCAGGATTCAGATGTGGACAT (TOP28), mRNA/cds =(0, 4865) CTTCCCCTCAGACTTCCCTACTGA 3780 Table 3A Hs.652 X68550 37269tumor necrosis factor (ligand) 1 TCTACCTGCAGTCTCCATTGTTTCCA superfamily,member 5 (hyper-IgM GAGTGAACTTGTAATTATCTTGTT syndrome) (TNFSF5),mRNA/cds = (39, 824) 3781 Table 3A Hs.116774 X68742 33949 mRNA forintegrin, alpha 1 CGGATTGTTGCTGTTAATGCTGCTCA subunit/cds = UNKNOWNTTTTAGCACTGTGGAAGATTGGAT 3782 Table 3A Hs.77502 X68836 36326 Homosapiens, methionine 1 TAGAGATTGTGAAGAAGAATTTCGAT adenosyltransferase II,alpha, clone CTCCGCCCTGGGGTCATTGTCAGG MGC:4537 IMAGE:3010820, mRNA,complete cds/cds = (116, 1303) 3783 Table 3A Hs.192760 X69392 36114kinesin family member 5A (KIF5A), 1 CTCCTGTTGGGTAAGGGTGTTGAGTG mRNA/cds= (148, 3246) TGACTTGTGCTGAAAACCTGGTTC 3784 Table 3A Hs.83715 X698041015499 Sjogren syndrome antigen B 1 AAAAGGAAAACCGAATTAGGTCCACT(autoantigen La) (SSB), TCAATGTCCACCTGTGAGAAAGGA mRNA/cds = (72, 1298)3785 Table 3A Hs.309952 X69819 32627 mRNA; cDNA DKFZp434E0516 (from 1GGAAGAACCGTCCAGAGCTGAGTGA clone CGCTGGGATCCGGGATCAAAGTTGGDKFZp434E0516)/cds = UNKNOWN 3786 Table 3A Hs.170009 X70340 37069transforming growth factor, alpha 1 TGTGCATTGTTATTGAGTTGTACTGTA (TGFA),mRNA/cds = (31, 513) CCTTATTTGGAAGGATGAAGGAA 3787 Table 3A Hs.180610X70944 38457 splicing factor proline/glutamine rich 1CCCATTTCTTGTTTTTAAAAGACCAAC (polypyrlmidine tract-binding protein-AAATCTCAAGCCCTATAAATGGC associated) (SFPQ), mRNA/cds = (85, 2208) 3788Table 3A Hs.106876 X71490 313011 Homo sapiens, clone MGC:15351 1AGAAGCATGTCACTTTCATGTTCCTC IMAGE:4126712, mRNA, completeCCTAACTCCCTGACCTGAGAACCC cds/cds = (87, 1142) 3789 Table 3A Hs.251526NM_006273 13435401 gene for monocyte chemotactic protein 1GGATGCTCCTCCCTTCTCTACCTCAT 3 (MCP-3)/cds = (0, 329)GGGGGTATTGTATAAGTCCTTGCA 3790 Table 3A Hs.156110 X72475 441418cDNA:FLJ21321 fis, clone COL02335, 1 GCACCATCTGTCTTCATCTTCCGCCA highlysimilar to HSA010442 mRNA for TCTGATGAGCAGTTGAAATCTGGA immunoglobulinkappa light chain/cds = UNKNOWN 3791 Table 3A Hs.156110 X72475 441418cDNA:FLJ21321 fis, clone COL02335, 1 GCACCTCTGTCTTCATCTTCCGCCA highlysimilar to HSA010442 mRNA for TCTGATGAGCAGTTGAAATCTGGA immunoglobulinkappa light chain/cds = UNKNOWN 3792 Table 3A Hs.79081 X74008 402777protein phosphatase 1, catalytic 1 AAAAGAAATCTGTTTCAACAGATGAC subunit,gamma isoform (PPP1CC), CGTGTACAATACCGTGTGGTGAAA mRNA/cds = (154, 1125)3793 Table 3A Hs.331328 X74262 397375 intermediate filament proteinsyncoilin 1 GGCCTGTTACTCTCCATGACTAACTG (SYNCOILIN), mRNA/cds = (168,623) TGTAAGTGCTTAAAATGGAATAAA 3794 Table 3A Hs.1708 X74801 671526chaperonin containin TCP1, subunit 3 1 GGCAGCCCCCAGTCCCTTTCTGTCC (gamma)(CCT3), mRNA/cds = (0, 1634) CAGCTCAGTTTTCCAAAAGACACTG 3795 Table 3AHs.44313 X75042 402648 v-rel avian reticuloendotheliosis viral 1TCTTGATACCACCTATATAGATGCAG oncogene homolog (REL),CATTTTGTATTTGTCTAACTGGGG mRNA/cds = (177, 2036) 3796 Table 3A Hs.73965X75755 455418 splicing factor, arginine/serine-rich 2 1CGGGCCTTGCATATAAATAACGGAGC (SFRS2), mRNA/cds = (155, 820)ATACAGTGACCACATCTAGCTGAT 3797 Table 3A Hs.74637 X75861 456258 testisenhanced gene transcript 1 CTGTGCTTTTTGCTTGGGATAATGGA (TEGT), mRNA/cds =(40, 753) GTTTTTCTTTAGAAACAGTGCCAA 3798 Table 3A Hs.79362 X75918 415822p130 mRNA for 130K 1 TTGAGGGGATTAATATGAAAACTTAT protein/cds = (69, 3488)GACCTCTTCCTTTAGGAGGGAGTT 3799 Table 3A Hs.79362 X76061 416030 p130 mRNAfor 130K 1 TGTTAAAACCCCTATAGCCACCTTTT protein/cds = (69, 3488)GGGAATGTTTTAAATTCTCCAGTT 3800 Table 3A Hs.83347 X76302 431952angio-associated, migratory cell 1 TGGCAGGCGTCAACCCCATTTTATTT protein(AAMP), mRNA/cds = (0, 1358) GTCCTTATTCCTGTGGAAGCAGTA 3801 Table 3AHs.85226 X76488 434305 lipase A, lysosomal acid. cholesterol 1AATACACCTGCTTCACGTCCCTATGT esterase (Wolman disease) (LIPA),TGGGAAGTCCATATTTGTCTGCTT mRNA/cds = (40, 1239) 3802 Table 3A Hs.334648X76770 556782 PAP mRNA/cds = UNKNOWN 1 CAGGAAATGCAGCAACTTCAGGAAATGCAGCAACAAAAATACCTACTCCT 3803 Table 3A Hs.76136 X77584 453963thioredoxin (TXN), 1 AAACCCAGTTGCCATCTGCGTGACAA mRNA/cds = (63, 380)TAAAACATTAATGCTAACACTTTT 3804 Table 3A Hs.85155 X79067 483524 ERF-1 mRNA3′ 1 TGCTGTATTACTTCTGAAAAGACTGT end/cds = UNKNOWNGCAGTGTGTTAGTTGTTGGCTGAA 3805 Table 3A Hs.153221 X79201 531105 synovialsarcoma translocation, 1 GTGTATGAGAGAGAGAGTGTGTGTTT chromosome 18(SS18), GTGTGTTTCAAGGTCAGAACAGGT mRNA/cds = (3, 1176) 3806 Table 3AHs.179943 X79234 495125 ribosomal protein L11 (RPL11), 1TGGTTCCAGCAGAAGTATGATGGGAT mRNA/cds = (0, 538) CATCCTTCCTGGCAAATAAATTCC3807 Table 3A Hs.74576 X79353 695584 GDP dissociation inhibitor 1(GDI1), 1 TGTCCCCTTCCCCACCCTCTAGTGTA mRNA/cds = (80, 1423)TTTCACAGAAAACAAAACCTCCCA 3808 Table 3A Hs.7957 X79448 2326523 adenosinedeaminase, RNA-specific 1 AGTCCAGTTTTATGATTCTGCTTTTAT (ADAR), transcriptvariant ADAR-e, GTGTCCCTTGATAACAGTGACTT mRNA/cds = (187, 3867) 3809Table 3A Hs.249495 X79536 496897 heterogeneous nuclear 1AAACTCATCTGTCCAAGTTCGTGGCA ribonucleoprotein A1 (HNRPA1),GAAAGAACGTCCTTGTGAAGACC transcript variant 2, mRNA/cds = (104, 1222)3810 Table 3A Hs.151134 X80695 619490 oxidase (cytochrome c) assembly 1-1 AGAGCACTGGGTAGCCAAGTGATCTT like (OXA1L), mRNA/cds = (0, 1487)CCCATTCACAGAGTTAGTAAACCT 3811 Table 3A Hs.77897 X81789 551449 splicingfactor 3a, subunit 3, 60kD 1 CCCCCAGAGACCCCATTTGCCTCTCA (SF3A3),mRNA/cds = (8, 1513) ACACTCAGACCTTCAACTGTTTTT 3812 Table 3A Hs.318501X82200 899299 stimulated trans-acting factor (50 kDa) 1CCAGTGACACCCCATATTCATCACAA (STAF50), mRNA/cds = (122, 1450)AATTAAAGCAAGAAGTCCATAGTA 3813 Table 3A Hs.153961 X82206 563882 ARP1(actin-related protein 1, yeast) 1 TGACACCAAGACCCACCCCAATCCAG homolog A(centractin alpha) ACTTCACACAGTATTCTCCCCCAC (ACTR1A), mRNA/cds = (57,1187) 3814 Table 3A Hs.289103 X83300 603028 SMA4 mRNA/cds = (66, 488) 1GACTGCAAGTCACTCTTAGGGGCTGT ACTTCCTTAGTACTGGTAGCATTA 3815 Table 3AHs.160483 X85116 1161561 epb72 gene exon 1/cds = (61, 927) 1AACTGAGCATCACGAACCCTGTTTGG CAGACTGAGGTCACGATGGAGGGG 3816 Table 3AHs.24143 X86019 2760482 Wiskott-Aldrich syndrome protein 1TCCTCCATTGAAGAAGAATGTCAACA interacting protein (WASPIP),AGAAAGGAAAAATAGACAAACTGG mRNA/cds = (108, 1619) 3817 Table 3A Hs.75410X87949 1143491 mRNA for BiP 1 AAGTCTCGAATGTAATTGGAATCTTC protein/cds =(222, 2183) ACCTCAGAGTGGAGTTGAACTGCT 3818 Table 3A Hs.2007 X89102 887455tumor necrosis factor (ligand) 1 CCATCGGTGAAACTAACAGATAAGCA superfamilymember 6 (TNFSF6), AGAGAGATGTTTTGGGGACTCATT mRNA/cds = (157, 1002) 3819Table 3A Hs.180433 X89602 1150420 rTS beta protein (HSRTSBETA), 1ACAAAAATAGCTATATCAAGGGCTGG mRNA/cds = (17, 1267)CACCTAGACATTAAACTGTACTTT 3820 Table 3A Hs.13046 X91247 1237037thioredoxin reductase 1 (TXNRD1), 1 GTCCACCAGTCTCTGAAATTAGAACA mRNA/cds= (439, 1932) GTAGGCGGTATGAGATAATCAGGC 3821 Table 3A Hs.335328 X913481418768 predicted non coding cDNA 1 GAAATGTAGCTGGAGTCATCATTTAG(DGCR5)/cds = UNKNOWN CAGAGCACGGTGTCCCTGGGTTGG 3822 Table 3A Hs.2726X92518 1225979 mRNA for HMGI-C 1 GCCTCTGTGATCCCCATGTGTTTTGA protein/cds= (848, 1177) TTCCTGCTCTTTGTTACAGTTCCA 3823 Table 3A Hs.78335 X942321292887 microtubulo-associated protein, RP/EB 1AAAACAAGAAACAAATGTGCCCACCC family, member 2 (MAPRE2),CACTTTCCGCTTAACTGAAAAGCT mRNA/cds = (112, 1095) 3824 Table 3A Hs.75841X94910 3413292 chromosome 12 open reading frame 8 1GTAAAAAGGCTGTCTGTGATTTTCCA (C12orfB), mRNA/cds = (11, 796)GGGTTTGGTGGGGGTAGGGAGGGG 3825 Table 3A Hs.3416 X97324 1806039 adiposedifferentiation-related protein 1 CTGACTGAGTCTCAGAATGCTCAGGA (ADFP),mRNA/cds = (0, 1313) CCAAGGTGCAGAGATGGACAAGAG 3826 Table 3A Hs.100555X98743 1498228 DEAD/H (Asp—Glu—Ala—Asp/His) 1 AGCTTCTTGGGTTCCTAATTCCTGGTbox polypeptide 18 (Myc-regulated) GTTTAATAATTCTCTCCACGATCA (DDx18),mRNA/cds = (71, 2083) 3827 Table 3A Hs.139262 X99699 1869900 XIAPassociated factor-1 1 TACTTGCTGTGGTGGTCTTGTGAAAG (HSXIAPAF1), mRNA/cds =(0, 953) GTGATGGGTTTTATTCGTTGGGCT 3828 Table 3A Hs.170121 Y00062 34275protein tyrosine phosphatase receptor 1 ATTTCCAGTGAGCTTATCATGCTGTC type,C (PTPRC), TTTACATGGGGTTTTCAATTTTGC mRNA/cds = (66, 4000) 3829 Table 3AHs.51077 Y00093 35175 integrin, alpha X (antigen CD11C 1TGCAGCTCACCAGCCCCAGGGGCAG (p150), alpha polypeptide) (ITGAX),AAGAGACCCAACCACTTCCTATTTT mRNA/cds = (58, 3549) 3830 Table 3A Hs.169476Y00262 36048 Homo sapiens, glyceraldehyde-3- 1ACTTACCCAGATGTTGCTTTTGAAAA phosphate dehydrogenase, cloneGTTGAAATGTGTAATTGTTTTGGA MGC:10926 IMAGE:368129, mRNA, complete cds/cds= (2306, 3313) 3831 Table 3A Hs.76473 Y00285 33054 insulin-like growthfactor 2 receptor 1 TGTATATAGACTCTGGTGTTCTATTG (IGF2R), mRNA/cds = (147,7622) CTGAGAAGCAAACCGCCCTGCAGC 3832 Table 3A Hs.172182 Y00345 35569poly(A)-binding protein, cytoplasmic 1 1 ATGTCAGTTCTGTTTTAAGTAACAGAA(PABPC1), mRNA/cds = (502, 2403) TTGATAACTGAGCAAGGAAACGT 3833 Table 3AHs.180414 Y00371 32466 hsc70 gene for 71 kd heat shock 1TTGGAGCTAAGCTGCCACCTGGTTAA cognate protein TTAAGGTCCCAACAGTGAGTTGTG 3834Table 3A Hs.233950 Y00503 34038 serine protease inhibitor, Kunitz type 11 CTTTGGAGGGTGTCTTCTGGGTAGAG (SPINT1), mRNA/cds = (175, 1716)GGATGGGAAGGAAGGGACCCTTAC 3835 Table 3A Hs.75716 Y00630 35267 serine (orcysteine) proteinase 1 TGCCTTTAATTGTTCTCATAATGAAGA inhibitor, clade B(ovalbumin), member ATAAGTAGGTACCCTCCATGCCC 2 (SERPINB2), mRNA/cds =(72, 1319) 3836 Table 3A Hs.79368 Y07909 1542882 epithelial membraneprotein 1 (EMP1), 1 ATTTGCATTACTCTGGTGGATTGTTCT mRNA/cds = (218, 691)AGTACTGTATTGGGCTTCTTCGT 3837 Table 3A Hs.113503 Y08890 2253155 Homosapiens mRNA for Ran_GTP 1 TTTGGCTTAGTGTTTTCATTGCAAATT binding protein 5(RanBP5(Importin5) ATAATTGCTGTAGAGCCACACAC gene)/cds = (236, 3529) 3838Table 3A Hs.227817 Y09397 1694788 BCL2-related protein A1 (BCL2A1), 1TTGATGATGTAACTTGACCTTCCAGA mRNA/cds = (183, 710)GTTATGGAAATTTTGTCCCCATGT 3839 Table 3A Hs.43913 Y09631 3925684 PIBF1gene product (PIBF1), 1 AACAAAAGATGAAGACCTAGTGTTTT mRNA/cds = (0, 2276)GGATGGGAAGCACCTGTAGACCAT 3840 Table 3A Hs.44499 Y09703 4581462 pinin,desmosome associated protein 1 ACATGTGCAAATAAATGTGGCTTAGA (PNN),mRNA/cds = (30, 2261) CTTGTGTGACTGCTTAAGACTAAA 3841 Table 3A Hs.47007Y10256 1841433 mitogen-activated protein kinase 1TCTGGGTTGTAGAGAACTCTTTGTAA kinase kinase 14 (MAP3K14),GCAATAAAGTTTGGGGTGATGACA mRNA/cds = (232, 3075) 3842 Table 3A Hs.7879Y10313 2708510 interferon-related developmental 1CGAACCAAAGCTAGAAGCAAATGTCG regulator 1 (IFRD1), AGATAAGAGAGCAGATGTTGGAGAmRNA/cds = (219, 1580) 3843 Table 3A Hs.51957 Y11251 1848180 splicingfactor, arginine/serine-rich 2, 1 CACTCTTCACCTATTGTATGACCAAATinteracting protein (SFRS2IP), AAAGGTTATGCTGCTTGTTACGC mRNA/cds = (1210,4656) 3844 Table 3A Hs.129953 Y11289 2808510 Ewing sarcoma breakpointregion 1 1 TGCTAGGTGATGGAGTAGAAATGGAT (EWSR1), transcript variant EWS,TCCCTCTGGGAATGGTTTCTTGGT mRNA/cds = (43, 2013) 3845 Table 3A Hs.106019Y13247 2117158 protein phosphatase 1, regulatory 1TATGAAAACAGTGGATTGGTTGGGTT subunit 10 (PPP1R10),TTGTGCAGGGTCTTGGGTTAGAGC mRNA/cds = (539, 3361) 3846 Table 3A Hs.16530Y13710 2326515 small inducible cytokine subfamily A 1TGCATGGATCAATCAGTGTGATTAGC (Cys—Cys), member 18, pulmonary andTTTCTCAGCAGACATTGTGCCATA activation-regulated (SCYA16), mRNA/cds = (70,339) 3847 Table 3A Hs.17883 Y13936 2315201 protein phosphatase 1G(formerly 2C), 1 CTCATCACCGGTTCTGTGCCTGTGCT magnesium-dependent, gammaCTGTTGTGTTGGAGGGAAGGACTG isoform (PPM1G), mRNA/cds = (24, 1664) 3848Table 3A Hs.195175 Y14039 2653415 mRNA for CASH alpha 1GCAGCACACTCTGAGAAAGAAACTTA protein/cds = (481, 1923)TCCTCTCCTACACATAAGAAACCA 3849 Table 3A Hs.227913 Y15906 5327056API5-like (API5L1), 1 TGCAAGACACCTGTTTATCATCTTGTT mRNA/cds = (132, 1646)TAAATGTAAATGTCCCCTTATGC 3850 Table 3A Hs.85951 Y16414 2924334 exportin,tRNA (nuclear export 1 TCAACGCCAATATGTATTCTACAAAA receptor for tRNAs)(XPOT), GAGAATGGTTTTAGGCTCCAGTGT mRNA/cds = (0, 2888) 3851 Table 3AHs.271387 Y16645 2916795 mRNA for monocyte chemotactic 1TGGATCATCAAGGTGAAACACTTTGG protein-2/cds = (472, 771)TATTCTTTGGCAATCAGTGCTCCT 3852 Table 3A Hs.337737 Y17829 4128042 Homer,neuronal immediate early 1 GATACACTGTCTCTCTTCATAGGACT gene, 1B (SYN47),GTTTAGGCTCTGCATCAAGATTGC mRNA/cds = (75, 1139) 3853 Table 3A Hs.247792Z00013 33149 germline gene for the leader peptide 1AAGGCAGGGATCATGACACCTGAGG and variable region of a kappaAGTCTAGTTTATGGCTTCAGTTGGA immunoglobulin (subgroup V kappa I) 3854 Table3A Hs.173936 Z17227 393378 mRNA for transmembrane receptor 1ATGGATGGACTGATCTGAAAATCGAC protein/cds = (43, 1020)CTCAACTCAAGGGTGGTCAGCTCA 3855 Table 3A Hs.211577 Z22551 296163 kinectin1 (kinesin receptor) (KTN1), 1 TGCTAATGTAATCGGTTTTTGTAATG mRNA/cds =(83, 3985) GCGTCACAAATAAAAGGATGCTTA 3856 Table 3A Hs.82401 Z22578 397938CD69 antigen (p60, early T-cell 1 TGCAAGACATAGAATAGTGTTGGAAA activationantigen) (CD69), ATGTGCAATATGTGATGTGGCAAA mRNA/cds = (81, 680) 3857Table 3A Hs.74078 Z22970 312145 mRNA for M130 antigen cytoplasmic 1AAGTTTGTGAATGTGACTACTTAGTG variant 2/cds = (101, 3571)GTGTATATGAGACTTTCAAGGGAA 3858 Table 3A Hs.146381 Z23064 3256006 RNAbinding motif protein, X 1 CCATTTTGCCTTTCTGACATTTCCTTG chromosome(RBMX), GGAATCTGCAAGAACCTCCCCTT mRNA/cds = (11, 1186) 3859 Table 3AHs.225160 Z23090 433597 hypothetical protein FLJ13102 1CTGTGCCTCCCCCGCCACCTGTGTG (FLJ13102), mRNA/cds = (80, 1084)TTCTTTTGATACATTTATCTTCTGT 3860 Table 3A Hs.4934 Z24724 505034 polyA siteDNA/cds = UNKNOWN 1 TGTATATTTATGGTGGGAGGTGGTTG GGAACTTTTAACAAAATGGGGTGT3861 Table 3A Hs.2236 Z29067 479172 nek3 mRNA for protein 1TCCTTTGGAAACAGAATGAAGCAGAG kinase/cds = (0, 1379)GAAACTCTTAATACTTAAAATCGT 3862 Table 3A Hs.109918 Z35227 609016 rashomolog gene family, member H 1 TTGCCCAGGCCAGTTAGAAAATCCCT (ARHH),mRNA/cds = (579, 1154) TGGGGAACTGTGATGAATATTCCA 3863 Table 3A Hs.198427Z46378 587201 hexokinase 2 (HK2), 1 CTAGTCATAGAAATACCTCATTCGCC mRNA/cds= (1490, 4243) TGTGGGAAGAGAAGGGAAGCCTCT 3864 Table 3A Hs.171626 Z47087860989 transcription elongation factor B (SIII), 1ATGTGGTAAAACCCAGAAAGCATCCA polypeptide 1-like (TCEB1L),TCATGAATGCAAGATACTTTCAAT mRNA/cds = (101, 592) 3865 Table 3A Hs.180877Z46950 761715 clone PP781 unknown 1 TGCTTGATTAAGATGCCATAATAGTG mRNA/cds= (113, 523) CTGTATTTGCAGTGTGGGCTAAGA 3866 Table 3A Hs.83465 Z49995895841 homeo box D1 (HOXD1), 1 TCTTCTGTTTCATCCTGCGGTTCTGG mRNA/cds =(223, 1209) AACCAGATTTTGACTTGCGTGTCA 3867 Table 3A Hs.78683 Z724991545951 ubiquitin specific protease 7 (herpes 1CCTTCAGTTATACTTTCAATGACCTTT virus-associated) (USP7),TGTGCATCTGTTAAGGCAAAACA mRNA/cds = (199, 3507) 3868 Hs.51077 M81695487829 integrin, alpha X (antigen CD11C 1 ATGCATCTACCGCTCCTTGGGAAATA(p150), alpha polypeptide) (ITGAX), ATCTGAAAGGTCTAAAAATAAAAA mRNA/cds =(58, 3549) 3869 Table 3A Hs.113029 BF025727 10733439 ribosomal proteinS25 (RPS25), 1 CGCAAGAAGCAGGAAGAGGAAAGAG mRNA/cds = (63, 440)AAGAAAAGCACAACGGGGAAAGATA 3870 Table 3A Hs.150675 BF028489 10738201polymerase (RNA) II (DNA directed) 1 GTAGTGTGTTGCATCCCTCTCACCCTpolypeptide K (7.0kD) (POLR2K), CTGATCTTCGTCAGTCGTGTCATG mRNA/cds = (66,242) 3871 Table 3A Hs.74170 BF028896 10736608 602708243F1 cDNA, 5′ 1GAGGGAAACCCGGTAATAGGCTGGG end/clone = AGTAATCCACACACGTGCTAACATTIMAGE:4844914/clone_end = 5′ 3872 Table 3A Hs.199061 BF029654 10737366p300/CBP-associated factor (PCAF), 1 CACACACTGCTACGTGACGTACCACT mRNA/cds= (458, 2956) ACTGCCAGCGCAGCACTAGCTCAC 3873 Table 3A Hs.13268 BF02979610737508 602634117F1 cDNA, 5′ 1 GGATCGTGACACACCGGGTTACACA end/clone =CTTTCCACACCGTAATTCCATCAAT IMAGE:4779149/clone_end = 5′ 3874 Table 3AHs.149595 BF029894 10737606 601557058F1 cDNA, 5′ 1GGTTGCACCAAGGCTGCCTAGGAGA end/clone = AGTGCCTGACTGGACTACCCCGATCIMAGE:3827172/clone_end = 5′ 3875 Table 3A Hs.118303 BF030930 10738642601558648F1 cDNA, 5′ 1 TCTGCCATCTGTCTATTTCCCAATTTT end/clone =CCTTCTGACTGTTCCTTTCTCCT IMAGE:3828706/clone_end = 5′ 3876 Table 3AHs.337988 BF033741 10741453 Homo sapiens, clone MGC:17431 1CTGTGATATTTTGGTCATGGGCTGGT IMAGE:2984883, mRNA, completeCTGGTCGGTTTCCCATTTGTCTGG cds/cds = (1336, 1494) 3877 Table 3A Hs.144559BF036688 10744746 601459771F1 cDNA, 5′ 1 TACGACATTTGCGAAATTCGCTAAAAend/clone = ACAAGGGGGAGTTCACGCGGCCAT IMAGE:3863248/clone_end = 5′ 3878Table 3A Hs.39457 BF103848 10886287 602537152F1 cDNA, 5′ 1GCGCAGGTTACCGGAACCCAAGGTC end/clone = CTTTGAAATTCACAACTCTCTTTGGIMAGE:4656037/clone_end = 5′ 3879 Table 3A Hs.279009 BF105172 10887698matrix Gla protein (MGP), 1 AGCTGTGGAAAGGGCAACCTGTGGT mRNA/cds = (46,357) TTCTCTGTACTGGTGTTTAATGGGG 3880 Table 3A Hs.95388 BF107010 10889635602619064F1 cDNA, 5′ 1 CACAAACACCCGCCCGAGCAACCAC end/clone =AGACACAGGACACGACACCACACAC IMAGE:4733030/clone_end = 5′ 3881 Table 3AHs.171595 BF130300 10969340 HIV TAT specific factor 1 (HTATSF1), 1AAAGGGTTACTTTTCAAAACAGTCTC mRNA/cds = (57, 2321)CTTTCGACCGGGGTCAGGGTGGCC 3882 Table 3A Hs.129872 BF131060 10970089 spermassociated antigen 9 (SPAG9), 1 GGTGGACAGTATAAGGCGGTTAAGAT mRNA/cds =(110, 2410) CCGTTGATGGCGAAGGTGAGAATG 3883 Table 3A Hs.75428 BF13165410970694 superoxide dismutase 1, soluble 1 GACAGAGCGAGTAGACGGGAGGCGG(amyotrophic lateral sclerosis 1 (adult)) AGAAGGAAGAGGAGACGAGACGAGG(SOD1), mRNA/cds = (0, 464) 3884 Table 3A Hs.9614 BF131656 10970696nucleophosmin (nucleolar 1 CAAGACACAGAGGCAACGGAGAGAC phosphoprotein B23,numatrin) ACGCAGACAAGCAAGGCCACGGAAC (NPM1), mRNA/cds = (0, 884) 3885Table 3A NA BF184881 11063302 ESTs 1 AGGGATAGGATAATTACAGAGGTACTGAGACTCCTGGCGTGGGTGACTCT 3886 Table 3A Hs.160954 BF207290 11100876602759615F1 cDNA, 5′ 1 CCCATCATGAAAAAACGCCTTAGGAG end/clone =CCGAAGAAGAAAACCTCGGGAAAA IMAGE:4895042/clone_end = 5′ 3887 Table 3AHs.78064 BF214148 11107732 ribosomal protein L27a (RPL27A), 1GACACAGCGAGAGTCCAGGAACAGG mRNA/cds = (22, 468) CAGACAAGCGAGAAAGAGGAGAAGC3888 Table 3A Hs.169248 BF214508 11108094 601845758F1 cDNA, 5′ 1GTAGGAGGCGAGAAGGAAGAACAAG end/clone = GCACACCGAAGGAGCAAGACCAGACIMAGE:4076510/clone_end = 5′ 3889 Table 3A Hs.75968 BF217687 11111273thymosin, beta 4, X chromosome 1 CAAGAAGCAGAAGCAGCAACCAGAG (TMSB4X),mRNA/cds = (77, 211) ACAGAGAGACAAACGCAGAACAACA 3890 Table 3A Hs.111611BF219474 11113299 ribosomal protein L27 (RPL27), 1CAACAAGCAGACGAACAACAAC mRNA/cds = (17, 427) AAATATCAACGAGGCGCAGCAGCTCAAA 3891 Table 3A Hs.112318 BF237710 11151628 cDNA FLJ14633 fis, clone1 AACACACAAGAGAAACATAACCACTA NT2RP2000938/cds = UNKNOWNAATCACTACAAACACACACAGAAT 3892 Table 3A Hs.182937 BF242969 11158897peptidylprolyl isomerase A (cyclophilin 1 AAACGAATTCTTGCACTGAGAGTGTT A)(PPIA), mRNA/cds = (44, 541) CACAGCGCCACTTTCCTCCTCCTC 3893 Table 3AHs.171774 BF243010 11156938 hypothetical protein (HSPC016), 1CGAGAAGCAGAAGATGACAGCAGAG mRNA/cds = (38, 232) CGAAAGCAGAGAACGAACAGACAAG3894 Table 3A Hs.296251 BF243724 11157654 programmed cell death 4(neoplastic 1 TTGGATTTATTAAAGTCCCTTTGGAA transformation inhibitor)(PDCD4), GTCTTCTACCATTACTGTAGACCA mRNA/cds = (84, 1493) 3895 Table 3AHs.109697 BF244603 11158534 601862620F1 cDNA, 5′ 1TCACATACCCTATGCCGACTGAGTGG end/clone = AACGAGCCGACTATCACACAGAGCIMAGE:4080412/clone_end = 5′ 3896 Table 3A Hs.294110 BF245076 11159008601863910F1 cDNA, 5′ 1 CACATGCGCAATAAACCCCGGCGAAG end/clone =ACGCCACTCTGCGGCAAAGGACACA IMAGE:4082235/clone_end = 5′ 3897 Table 3AHs.182825 BF245224 11159156 ribosomal protein L35 (RPL35), 1CCGCAGACACGAAAGCACCAACCAC mRNA/cds = (27, 398) CGACCGCCACCAGAAGGAACAACAG3898 Table 3A Hs.199248 BF245892 11159734 prostagtandin E receptor 4(subtype 1 GGGCACTTAAATGGTCACCTGTGTAA EP4) (PTGER4),CAGTTTGGTGTAACTCCCAGTGAT mRNA/cds = (388, 1854) 3899 Table 3A Hs.108124BF303895 11250572 cDNA:FLJ23088 fis, clone 1 ACAACACGAAAACGAACAAGCALNG07026/cds = UNKNOWN AAGAAAGAAAACGGACACGAGCGA ACCA 3900 Table 3AHs.296251 BF303931 11250608 programmed cell death 4 (neoplastic 1TTGGATTTATTAAAGTCCCTTTGGAA transformation inhibitor) (PDCD4),GTCTTCTACCATTACTGTAGACCA mRNA/cds = (84, 1493) 3901 Table 3A NA BF30620411253289 cDNA clone IMAGE:4138980 5′ 1 CAGCCATGTCCATGACAACCAGAGCCTGGGAGGAGCTGGATGGCGGCCTG 3902 Table 3A Hs.5174 BF307213 11254322ribosomal protein S17 (RPS17), 1 AAACACACAGCAAGAACCACGA mRNA/cds = (25,432) AAAGAGCAACCCAAAATAGGAAAA GCGG 3903 Table 3A Hs.84883 BF30787111255039 mRNA for KIAA0864 protein, partial 1 ACAGCGTGGATATAAGGACCAAGAGcds/cds = (0, 3856) ACTAGGGCGCATACTATGATTCGCA 3904 Table 3A Hs.63906BF309911 11257388 hypothetical protein MGC14726 1ATGGACACGAGGACGGAACTGGGGG (MGC14726), mRNA/cds = (21, 653)TACTAGAACAACCCTTCTCTGAAAA 3905 Table 3A Hs.292457 BF310168 11257703 Homosapiens, clone MGC:16362 1 AGACCAAACGAGAAGGAGAAAAAGC IMAGE:3927795,mRNA, complete AAGACCACAAAAGACAACAACAGCG cds/cds = (498, 635) 3906 Table3A NA BF313856 11261925 601902261F1 5′ 1 AAAAAATCGGGCTTTTTCTGGGGGAAend/clone = AGGGAAGGGCGGGGAATGCTGGCC IMAGE:4134998 3907 Table 3A NABF315059 11263244 601899090F1 5′ 1 CTACAACAATACAGCACACAGCATAA end/clone= GCGCACAGGGCATAGACTAGGCAA IMAGE:4128334 3908 Table 3A Hs.99858 BF31515911263380 ribosomal protein L7a (RPL7a), 1 CAAGAGAGTGGAGACGAGTACGCGAmRNA/cds = (31, 831) GAACGCACGACACAGAGCGCAAGAA 3909 Table 3A Hs.268177BF339088 11285508 phospholpase C, gamma 1 (formerly 1TCTGCTGCCCTCTTAAGATCTGACTG subtype 148) (PLCG1),CCAAATAAATCATCCTCATGTCCT mRNA/cds = (76, 3948) 3910 Table 3A Hs.296317BF340402 11286776 mRNA for KIAA1789 protein, partial 1GATGAGAAACAACCACAAGGAAGAG cds/cds = (3466, 4899)GGCAGCGCCGGAGACCTACAGAAAG 3911 Table 3A Hs.116567 BF341330 11287821602013274F1 cDNA, 5′ 1 GCGGGGGCACTGGCTCTTCACATTT end/clone =GGTTGCGAGTTGCACACACCACAAC IMAGE:4149066/clone_end = 5′ 3912 Table 3AHs.2554 BF341359 11287850 sialyltransferase 1 (beta-galactoside 1GGGGGAAGCGGAAGGGTTGGATTGG alpha-2,6-sialytransferase) (SIAT1),GTGAAAAAAGAATTGTTCGTGTTTA mRNA/cds = (310, 1530) 3913 Table 3A Hs.28788BF341640 11288136 602016073F1 cDNA, 5′ 1 ATAATAGAGGAGAGATATTGTAAATAend/clone = GAGACTGGCAGCAGTTTCCACAAA IMAGE:4151706/clone_end = 5′ 3914Table 3A Hs.33905 BF342246 11289148 602041247F1 cDNA, 5′ 1AGTGGCAGGTGCAATTGTCGGTTCG end/clone = ATTTGTGTTCCCAACAGTCTGAAATIMAGE:4179250/clone_end = 5′ 3915 Table 3A Hs.127863 BF342439 11289452601898969F1 cDNA, 5′ 1 GAGCCCACGGGGAAGGGAACCCAGC end/clone =AACACGGAAATAAGTTGGACCGATC IMAGE:4128112/clone_end = 5′ 3916 Table 3AHs.205442 BF377518 11339543 601439689F1 cDNA, 5′ 1ACAACCTGAGAAATAATTCGGTCAAT end/clone = ACCAGACTCCAACATTCCTGATCTIMAGE:3924407/clone_end = 5′ 3917 Table 3A Hs.319825 BF380732 11389857602021477F1 cDNA, 5′ 1 GTCTATTACAAAGTAAAGAGAGTCAA end/clone =TTACTCCAGGAGGAGAATTGCAGG IMAGE:4156915/clone_end = 5′ 3918 Table 3AHs.5174 BF381953 11363256 ribosomal protein S17 (RPS17), 1ACCAGACACGGACACACACGAACAC mRNA/cds = (25, 432) AAGAAAACACAAAACAAGAGCAACC3919 Table 3A Hs.112237 BF525720 11613081 602321076F1 cDNA, 5′ 1CGGTTGGGTCCTCAAAATATGCCTGT end/clone = TTGGTTAACAAAAGCGGTTGTGAAIMAGE:4424130/clone_end = 5′ 3920 Table 3A Hs.136537 BF526066 11613527602071176F1 cDNA, 5′ 1 GATAAAGAAGGGGCGCGGGAAACAG end/clone =CGAGGGAAGGACGGGCTGGGAGAAC IMAGE:4214059/clone_end = 5′ 3921 Table 3AHs.274472 BF526421 11613784 high-mobility group (nonhistone 1ATCTCTGGCAATACTGTCTGATTACG chromosomal) protein 1 (HMG1),GGGGTGATGCCGACGGTTAAAAAC mRNA/cds = (52, 699) 3922 Table 3A Hs.334825BF530382 11617745 cDNA FLJ14752 fis, clone 1 GAACACAAAAAACCTCTTCTATAACGNT2RP3003071/cds = (205, 1446) GGGACACACGCCAAGGGGACAAGT 3923 Table 3AHs.255390 BF531016 11616379 602072345F1 cDNA, 5′ 1TTGGGTGCAACAACCAATACACTTAT end/clone = ACTTGGAAACCACGGGCCATATTAIMAGE:4215251/clone_end = 5′ 3924 Table 3A Hs.146426 BF569545 11642925pro-alpha-1 (V) collagen mRNA, 1 AGGAGGAACAAAAACCGCAGCGTGG completecds/cds = (229, 5745) ATTTCAAATTTCTGGAAGTAAGTCT 3925 Table 3A Hs.22265BF571362 11645074 pyruvate dehydrogenase phosphatase 1AAATTCGCGCACCCTTTGTTTTATTG (PDP), mRNA/cds = (131, 1855)CCCCGGTTACAAGGTTTTGAACTG 3926 Table 3A Hs.301183 BF572855 11646567molecule possessing ankyrin repeats 1 CGGGCCAGTATGAATGTAGGGTCAA inducedby lipopolysaccharide (MAIL), GGAACGCCGAGGGTTTCACAAAAGG homolog of mouse(MAIL), mRNA/cds = (48, 2204) 3927 Table 3A Hs.79530 BF663116 11937011M5-14 protein (LOC51300), 1 CTCAGTGTAGGGCAGAGAGGTCTAA mRNA/cds = (186,1043) CACCAACATAAGGTACTAGCAGTGT 3928 Table 3A Hs.11356 BF665055 11938950602119856F1 cDNA, 5′ 1 AGAATATATGTATTTTGAAAGGAAAG end/clone =GACTTGGGGATTTTTAACAGGGCA IMAGE:4276860/clone_end = 5′ 3929 Table 3AHs.3585 BF666961 11940856 602121608F1 cDNA, 5′ 1GAGACTCTCGTTGTCTCCTCTTCTGC end/clone = TCTCTTCTCTGTTGGAGGGGAGGAIMAGE:4278768/clone_end = 5′ 3930 Table 3A Hs.46877 BF667821 11941516PRO2000 protein (PRO2000), 1 AGGTTGTGGGGAGTATGTTTGGACCA mRNA/cds = (650,1738) AAAATTAAAATATTGTGGGAGGGA 3931 Table 3A Hs.343615 BF668050 11941945602621493F1 cDNA, 5′ 1 GACCTTACCTGGTGGTTTTGTGGTTT end/clone =GTTCTCCCGAAAAATGCGGGGTTT IMAGE:4755166/clone_end = 5′ 3932 Table 3AHs.12035 BF668230 11942125 602122419F1 cDNA, 5′ 1CACCCTGGGTTTTAAAGTGTGGGAGA end/clone = AAAGCGCCCGGAAGAAGGAAACAAIMAGE:4279300/clone_end = 5′ 3933 Table 3A Hs.324342 BF688584 11942479602123634F1 cDNA, 5′ 1 GAGGGGACCGGCCATCTGGGCAAGC end/clone =AGATATGCTAATTGGGAATTATAGG IMAGE:4280408/clone_end = 5′ 3934 Table 3AHs.285729 BF670567 11944559 602013364F1 cDNA 5′ 1ATGACTTGTGAATACCTGAGTTATAC end/clone = TTTCCCAACAGATGTGCCTAACACIMAGE:4149351/clone_end = 5′ 3935 Table 3A Hs.27590 BF671020 11944915histone acetyltransferase (MORF), 1 TGATAGCTCACTTAGTTAATTGTTTTG mRNA/cds= (315, 6536) AAGCAAATTTTTGGGTTGGATGGG 3936 Table 3A Hs.99858 BF67395111947846 ribosomal protein L7a (RPL7A), 1 GACACAGAAGAGAGACAGAAGAGAAmRNA/cds = (31, 831) ACGGTCGAGGAGAAGAAGCAGGAGC 3937 Table 3A Hs.96566BF673956 11947851 602137338F1 cDNA 5′ 1 AAAGACCAGAGACAGGGAGACACGGend/clone = CAGACAGAGCGCCCACAAAGAAGAG IMAGE:4274048/clone_end = 5′ 3938Table 3A Hs.181357 BF676042 11949937 laminin receptor 1 (87kD, ribosomal1 CAAGGCGACATGGGAGAGCGAGAAG protein SA) (LAMR1),GCTAGGAGGACGACAGACAAGGAAA mRNA/cds = (85, 972) 3939 Table 3A Hs.122408BF677944 11951839 602084766F1 cDNA 5′ 1 GAATTTTGGGGAGGTTACTGGTCGGend/clone = GGGAAATAACAGGGTTGGACAAACG IMAGE:4248905/clone_end = 5′ 3940Table 3A Hs.131887 BF676298 11952193 602415225F1 cDNA 5′ 1CTCCACATATGGGTAACACACTCGGT end/clone = CCTTACAAGCACCTAGTCACTTCCIMAGE:4523725/clone_end = 5′ 3941 Table 3A Hs.205319 BF679831 11953640602154415F1 cDNA 5′ 1 GGGACCAGACTGCTTTCTAAATGCAC end/clone =AGCTCTTTCACTATCAGAATGTGT IMAGE:4295595/clone_end = 5′ 3942 Table 3AHs.34549 BF680988 11954883 602620683F1 cDNA 5′ 1TGTGGTCACTTGGGAAATAAATTCCA end/clone = TCTGGCTTACCCAATGGGTGGTGGIMAGE:4746422/clone_end = 5′ 3943 Table 3A Hs.10702 BF684382 11969790hypothetical protein DKFZp761H221 1 CCACAGCCACAACACCAGACAAGCC(DKFZp761H221), GACCAACAGACAGATACAGACCACC mRNA/cds = (776, 1714) 3944Table 3A Hs.164675 BF689700 11975108 602186609F1 cDNA 5′ 1ACCACAGCAAGACAACAAGGACGAG end/clone = AAAGAGAACAGACAATGAGCAACGAIMAGE:4298402/clone_end = 5′ 3945 Table 3A Hs.71331 BF691178 11976586hypothetical protein MGC5350 1 ACTACTGCTTGCGTACCTCTCCGCTT (MGC5350),mRNA/cds = (189, 995) TCCCTCTCCTTACTATCGACCATA 3946 Table 3A Hs.173965BF691895 11977303 ribosomal protein S6 kinase, 90kD, 1TCCGTTTATATTAGCACTGTATCCCTT polypeptide 3 (RPS6KA3),GTGCCATCCAACATTTGTATGT mRNA/cds = (0, 2222) 3947 Table 3A Hs.233936BF694761 11980263 myosin, light polypeptide, regulatory, 1CGGGCGCAGGACAGTAGCAGAGAAG non-sarcomeric (20kD) (MLCB),AGAGGTGGAGAGCCGGACAACGCAG mRNA/cds = (114, 629) 3948 Table 3A Hs.318782BF696330 11981738 602808489F1 cDNA 5′ 1 CTTCAGTCATTATGGGCTCAGTTTCCend/clone = TCACTATTGGTTCCTCGCAAGGGA IMAGE:4940633/clone_end = 5′ 3949Table 3A Hs.103180 BF698884 11984292 602126455F1 cDNA 5′ 1AAGAGCAACAACGAGGCGAAGAGGA end/clone = AGGAGGAGGCAAGACAGAAGAGGAAIMAGE:4283340/clone_end = 5′ 3950 Table 3A Hs.252723 BF698920 11984328ribosomal protein L19 (RPL19), 1 GAGGAGCAACGACCAGAGAGACGAA mRNA/cds =(28, 618) CTGACATCAACCATAGAAGACGACA 3951 Table 3A Hs.323662 BF70050211985910 hypothetical protein MGC14595 1 AAGCATGAAGAAGACCTGGATGAGG(MGC14595), mRNA/cds = (101, 850) CTCAGGGAGGTTCCCCCAGTTTAAA 3952 Table3A Hs.253550 BF750565 12077241 RC1-BN0410-261000-014-(11 cDNA 1ATCAGTCAATCAGTCAGCTTCTCAGA GTAGCAATCCATGTGTCCAGAGGA 3953 Table 3AHs.10957 BF793378 12098432 602254823F1 cDNA 5′ 1AAATCCAATCCTTCGGAGAGGGAATG end/clone = GGCGGTATTAATTAAGGGAAGTCCIMAGE:4347076/clone_end = 5′ 3954 Table 3A Hs.293658 BF794089 12099143602255649F1 cDNA 5′ 1 ATGACAAGACAAGCCAGACGAAGAA end/clone =GACAAACAAGGGAGACACAGCAGAC IMAGE:4338732/clone_end = 5′ 3955 Table 3AHs.206761 BF794256 12099310 602255454F1 cDNA 5′ 1TGCGCCCCAATATTTGTGGAACAGCG end/clone = TTTTGTTCGAATAAAACGATCGGTIMAGE:4338949/clone_end = 5′ 3956 Table 3A Hs.246818 BF796642 12101696602259646F1 cDNA 5′ 1 CTCGAGGTGTAACTCAGGAAGGCCT end/clone =AGCGAATCCCGACTCGGATGGTGTC IMAGE:4343171/clone_end = 5′ 3957 Table 3AHs.54452 BF797348 12102402 zinc finger protein, subfamily 1A, 1 1TTCACCTACTCTGTTCTTTTCATCCAT (lkaros) (ZNFN1A1), CCCCTGAGTCAGTTGGTTGGAGGmRNA/cds = (188, 1727) 3958 Table 3A NA BF821451 12160669 RT0038 cDNA 1CTGTTGTCTGGAGTGTGGAGTCTCTT GTCTGGATTGTGGAGTCTCTTGTC 3959 Table 3A NABF889206 12280465 RC6-TN0073-041200-013-H02 1CAAGATGATGCTTGCTGTCTTTTTCCT cDNA/gb = BF889208 CTCGGCTACCCAGAATGGCATTTG3960 Table 3A Hs.38664 BF892532 12283991 IL0-MT0152-061100-501-e04 1AGTACTCATGACTTGAGAGACGTGGA cDNA CGGAGCCAGCTTCTACCTTGCTTG 3961 Table 3AHs.337534 BF965088 12332283 602268833F1 cDNA 5′ 1GGTCCGACCAATTAATGACTCCATGA end/clone = TCGGCCTCGGTTTTCACAAACCTTIMAGE:4356776/clone_end = 5′ 3962 Table 3A Hs.334691 BF965438 12332653hypothetical protein FLJ22427 1 AGACAAAGAGAGCATAAATATAGCTC (FLJ22427),mRNA/cds = (40, 2631) TACTCATGGGTACCATACCAGTGT 3963 Table 3A Hs.133864BF965766 12332981 602276890F1 cDNA 5′ 1 TTACATTTGTGGACCATGTTACAGTTAend/clone = AAGAAAAATCCTGTTTCAGTCCT IMAGE:4364495/clone_end = 5′ 3964Table 3A Hs.279681 BF965960 12333175 heterogeneous nuclear 1GCAGGTTATCGCAAGATGTCTTAGAG ribonucleOprotein H3 (2H9) (HNRPH3),TAGGGTTAAGGTTCTCAGTGACAC transcript variant 2H9, mRNA/cds = (118, 1158)3965 Table 3A Hs.5324 BF966028 12333243 hypothetical protein (CL25022),1 ATTTTTAAATGGCTTTACCAAACATTG mRNA/cds = (157, 1047)TCAGTACCTTTACGTGTTAGAAG 3966 Table 3A Hs.179902 BF966049 12333264transporter-like protein (CTL1), 1 CTTTCCACAGCAATTGTTTTGTACGA mRNA/cds=0 (0, 1964) GGGGCCTTACAGCGCGGTCCACTT 3967 Table 3A Hs.48320 BF96626912333484 mRNA for ring-IBR-ring domain 1 TTCTACAGCACGATGCCTGGATCTACcontaining protein Dorfin, complete TGACCTGTCAACCACGAATCTTGA cds/cds =(317, 2833) 3968 Table 3A Hs.171802 BF966361 12333576 RST31551 cDNA 1GAAACAGCAACAAGCAAACAGG ATCTCAGCATTACCAACAGCCAGC ACTA 3969 Table 3AHs.22790 BF968270 12335485 602269653F1 cDNA 5′ 1TGAGCCTGAACTTTTTTAGCAAATTAT end/clone = TATTCTCAGTTTCCATTACCTGTIMAGE:4357740/clone_end = 5′ 3970 Table 3A NA BF968628 12335843 cDNAclone IMAGE:4359351 5′ 1 CCTTCCAAAGCGGTCACCTGATAGGGAAGTCTTACGGCTAGGAAGTTACA 3971 Table 3A Hs.5064 BF968963 12336178602490910F1 cDNA 5′ 1 GAATGGTGGGGAGAAAAAAGGGGGG end/clone =CACAGTCATGATCGGCTCTTATAAT IMAGE:4619835/clone_end = 5′ 3972 Table 3AHs.24143 BF969990 12337205 Wiskott-Aldrich syndrome protein 1GTCACATAATCCGGGGACCCAAAGAA interacting protein (WASPIP),AGTTCTCCAGAGTGGTTTCACGAG mRNA/cds = (108, 1619) 3973 Table 3A Hs.23703BF970427 12337642 602272760F1 cDNA 5′ 1 ACAACAACACATCACGTAACCACAACend/clone = ACGCATAAACAGCAAATCATCCTA IMAGE:4360767/clone_end = 5′ 3974Table 3A Hs.102647 BF970875 12338090 602271535F1 cDNA 5′ 1CAGAACACCAACAAGCAGGGACGGA end/clone = AGCCGACCGAGCAAACAGCGAAGGGIMAGE:4359609/clone_end = 5′ 3975 Table 3A Hs.321477 BF970928 12338143602270204F1 cDNA 5′ 1 GTGGACGGCCTGGGAATGTGCCCCC end/clone =CGGTGTAACATCGAGCCCACAATGG IMAGE:4358425/clone_end = 5′ 3976 Table 3AHs.79101 BF971075 12338290 cyclin G1 (CCNG1), 1AGGATTAGGAGAGGGTCACAGAACA mRNA/cds = (187, 1074)GAAAGCAGATTACACTTGGGATGGA 3977 Table 3A Hs.33026 BF971984 12339199 mRNAfor FLJ00037 protein, partial 1 CTCTGTTTGTCTGGCCGCCTCCGTGA cds/cds =(3484, 3921) TCAAACCGTGTCGTCGGCGTGTTC 3978 Table 3A Hs.146550 BF97659012343805 DNA sequence from clone RP1-68O2 1 GGCTTGGACATTGCTCTCAAGAAGATon chromosome 22 Contains the 5′ end TAAGAACCCTGGAGGAACACTAGG of theAPOL2 gene for apolipoprotein L 2, the APOL gene for applipoprotein L,the MYH9 gene for nonmuscle type myosin heavy chain 9, ESTs, STSs andGSSs/cds = (0, 5882) 3979 Table 3A Hs.7905 BF981080 12383892 602310311F1cDNA 5′ 1 TGTACAGCTAAATTTCTCCAAAGCAC end/clone =TTTTTCAAAACCAAAAAAGAAAAA IMAGE:4401411/clone_end = 5′ 3980 Table 3AHs.182740 BF981263 12384075 ribosomal protein S11 (RPS11), 1TTTGCACACTGAACACTTACAGATGT mRNA/cds = (33, 509) GGCAGATGTGAAATTTGTCATCAA3981 Table 3A Hs.289721 BF981634 12384446 cDNA:FLJ22193 fis, clone 1ACAGAGAGTCACCCGCGAGTACGAA HRC01108/cds = UNKNOWNACAGGCACATTTTTAGAAACTCACA 3982 Table 3A Hs.83583 BG024761 12410861 actinrelated protein 2/3 complex, 1 AGGTTCTTACCACCACTTTTGTGCCC subunit 2 (34kD) (ARPC2), ATCTTTCCCTTCGTTCCCAATGTG mRNA/cds = (84, 986) 3983 Table 3AHs.1432 BG026279 12413729 protein kinase C substrate 80K-H 1CCGGGGTGGCCCTCTCAAATTTGGC (PRKCSH), mRNA/cds = (138, 1719)ATGGGGTCCTCTTTCAATGTTGTGG 3984 Table 3A Hs.279009 BG028577 12417672matrix Gla protein (MGP), 1 CACGAGCGGCTGGAGGACACCCATT mRNA/cds = (46,357) TTGTGCAGTGCCCGTCCGTCCCTTC 3985 Table 3A Hs.5122 BG028906 12418001602293015F1 cDNA 5′ 1 GCCCTATGGCGTTGTTAAACACGAGC end/clone =GTATGCTAGTAAGTATCATTCATA IMAGE:4387778/clone_end = 5′ 3986 Table 3AHs.143554 BG033028 12424903 Pur-beta (PURB) mRNA, complete 1GGTGTGTCTCGCGGCTGGCCCAGTC cds/cds = (13, 951) TATTCTCGGTGTTTATCTTCATCAC3987 Table 3A Hs.118787 BG033294 12425446 transforming growth factor,beta- 1 GACAACGGAAACTCTGTCTCTACCAC induced, 68kD (TGFB1),CATGTGACAGACGCGTTGATGCGT mRNA/cds = (47, 2098) 3988 Table 3A Hs.103902BG033732 12426494 602301101F1 cDNA 5′ 1 CAAGACACAAACAGCACGACTC end/clone= ACACAGAGAAAGCAACCATGCCGA IMAGE:4402465/clone_end = 5′ GGAG 3989 Table3A Hs.306155 BG033909 12426670 chorionic somatomammotropin 1CGCGTCGAACTTCGGGACATTCCCG hormone 1 (placental lactogen)TAAACCACAAACAGATAAAGAATTA (CSH); transcript variant 2, mRNA/cds = (116,886) 3990 Table 3A Hs.332404 BG033953 12426761 CDA02 protein (CDA02), 1GCGTAAAGTGATCAAAAGGCCCTGAA mRNA/cds = (2, 1831) GGGGAAAATGATAAAACCCGTGGT3991 Table 3A Hs.12396 BG034192 12427253 602302446F1 cDNA 5′ 1AGAGGAAGCGTGTGAATACAACAATC end/clone = TAAAAAGGAGGAGAGGTCGAGCACIMAGE:4403868/clone_end = 5′ 3992 Table 3A Hs.125819 BG034799 12428456putative dimethyldenosine 1 ACACATTCCCCATACCATTTCGTGTT transferase(HSA9761), ATTCACATTCCCCGTACCATTTCT mRNA/cds = (78, 1019) 3993 Table 3AHs.16488 BG035120 12428935 calreticul (CALR), 1TAAAAAGGGGGTGGCGGCTGTAGTA mRNA/cds = (68, 1321)AGGAGGAGCGAGTAATGTATAGCAC 3994 Table 3A Hs.17719 BG035218 12429131EBP50-PDZ interactor of 64 kD 1 CCATGAGCAGGCGCAACCATAACAG (EPI64)mRNA/cds = (24, 1550) TTAGAGACGGCACACAGCACGACAC 3995 Table 3A Hs.319825BG036101 12430901 602021477F1 cDNA 5′ 1 ACTCACGCAAGAGCAGGGGGACTATend/clone = AACAGAAATAAACAAGTAAATAAAT IMAGE:4156915/clone_end = 5′ 3996Table 3A Hs.192965 BG036938 12432665 602287708F1 cDNA 5′ 1TACACAGGCAGCTATGCGGATCATCA end/clone = GACGAGCACATATTCTAACAGAGAIMAGE:4375153/clone_end = 5′ 3997 Table 3A Hs.144924 BG037042 12432874serine/threonine protein kinase SSTK 1 CGTCGCCGTAGGACGCCTCCGTCGT (SSTK),mRNA/cds = (122, 943) CGTCTGGTCTGTCTCCTGCATCGAG 3998 Table 3A Hs.318893BG106948 12600794 602291361F1 cDNA 5′ 1 AAAGGCAAGAGTCCGGGGTGGCAGAend/clone = AGAGTGAAAAATGAAAGAGAGAAGG IMAGE:4386159/clone_end = 5′ 3999Table 3A Hs.109007 BG110599 12604105 602342214F1 cDNA 5′ 1TTCTGCCCAGAGTGTATTTGTGAAGA end/clone = GTCTCTTATATTATGTTTTGTGGAIMAGE:4452602/clone_end = 5′ 4000 Table 3A Hs.173737 BG110835 12604341ras-related C3 botiulinum toxin 1 GTGCGAATGTGGAGTGTTTTACATTG substrate 1(rho family, small GTP ATCTTTGCTAATGAATTAGCATCA binding protein Rac1)(RAC1), transcript variant Rac1b, mRNA/cds = (0, 635) 4001 Table 3AHs.323950 BG111212 12604718 zinc finger protein 6 (CMPX1) (ZNF6), 1CATTACGCATATTGGTAAGACGCAAA mRNA/cds = (1265, 3361)ATGAGACAGATCGACACTGGGACG 4002 Table 3A Hs.37908 BG111773 12605279601820448F1 cDNA 5′ 1 CACAACGGGTCTTAATGACGACGGAA end/clone =AGATACATCCATCGGTATGAACGC IMAGE:4052578/clone_end = 5′ 4003 Table 3AHs.74313 BG112085 12605591 mRNA for KIAA1265 protein, partial 1ACCAGCAATCCGCAGCAGAGTCATAA cds/cds = (68, 2573) GTGGGGTAGGTGATATGTACTAAC4004 Table 3A Hs.320972 BG112503 12606009 602282105F1 cDNA 5′ 1GAAAAAACAAGCTAACAAACAC end/clone = ACACGCCCACACCAACATGCCAGAIMAGE:4369633/clone_end = 5′ ACGC 4005 Table 3A Hs.7589 BG11250512606011 602282107F1 cDNA 5′ 1 TGAACATGGGTGGGTTTGATCACGAG end/clone =GATTCCGCTGAAAAGATTAGAGGG IMAGE:4369729/clone_end = 5′ 4006 Table 3A NABG118529 12612035 cDNA clone IMAGE:4443519 5′ 1CGCGTTCATAACGGCGTCGACTGTTC TTGTGCTGCTGTTATCTATACTAT 4007 Table 3A NABG121288 12614797 cDNA clone IMAGE:4450407 5′ 1GGGACCAGACTACACGGAATACCAG AGTTGAAGAAAATTAAGATTTAAGC 4008 Table 3AHs.285729 BG163237 12669951 602013384F1 cDNA 5′ 1TATACTGAGAGTGAAGGTCTGGGTGC end/clone = CAACTTGAGACAGGTGGTCTAGGAIMAGE:4149351/clone_end = 5′ 4009 Table 3A Hs.111554 BG164898 12671532ADP-ribosylation factor-like 7 (ARL7), 1 CCCCTGGTTTTCTCGTTCTGCCTCCTmRNA/cds = (14, 592) TTGGACCTGTGTTTGTTTTCTGCT 4010 Table 3A Hs.193482BG165998 12672701 cDNA FLJ11903 fis, clone 1 CCCTTAGAATGGTTACTGCCCTTGAAHEMBB1000030/cds = UNKNOWN TTAACTTGACACAACTTGGGTTGG 4011 Table 3A NABG166279 12672982 cDNA clone IMAGE:4455496 5′ 1CGAATAATCCCTATTTGATTACCTCA GAAAGTTTTGTCTTCCGCCAAGG 4012 Table 3AHs.87113 BG188139 12674842 602341526F1 cDNA 5′ 1TTGGACCCCAGGGTAAGGCGGATAT end/clone = TGGTTGGGACGTTCGGGGAGTGTATIMAGE:4449343/clone_end = 5′ 4013 Table 3A Hs.182695 BG170647 12677350mitochondrial ribosomal protein 63 1 AATTACGTTCGGAGGTATATAAAAAG (MRP63),mRNA/cds = (215, 523) GGATCGGCGCAGTGGATAGGGGGT 4014 Table 3A Hs.204959BG180098 12886801 hypothetical protein FLJ14886 1GGAGATCCACAGTGATCTCAGGCCC (FLJ14888), mRNA/cds = (111, 1169)TGGACCGGAAAAGGCAGCAAGATCA 4015 Table 3A NA BG249224 12759040 cDNA cloneIMAGE:4470038 5′ 1 AAGACGAGTACACCAAGACCAAAGA GCGCCAACGAGCACGACCGAGTGAA4016 Table 3A Hs.6682 BG254117 12763933 solute carrier family 7,(cationic amino 1 AACGCCGACTAGACGTCACAAAGACT acid transporter, y+system) member TAATAAGAAACACACTGATATCCA 11 (SLC7A11), mRNA/cds = (235,1740) 4017 Table 3A NA BG254292 12764108 cDNA clone IMAGE:4477042 5′ 1CGCAACATTATCCATTTAAACCCCTG CATAACCCATTACCAAAGCCCTCT 4018 Table 3AHs.30724 BG260954 12770770 602372582F1 cDNA 5′ 1GGCACCCCAATCCCCGGCAAAAACA end/clone = TTTGTTAACCTCTTGGGAATTTCTTIMAGE:4480647/clone_end = 5′ 4019 Table 3A Hs.217493 BG282346 13031273annexin A2 (ANXA2), 1 CTCGTCTGCACCGAGTCTCACAAAT mRNA/cds = (49, 1068)TTAGCATCTGGGTCTTGAGCATTA 4020 Table 3A Hs.71243 BG283002 13032445602406192F1 cDNA 5′ 1 CCCTCCGGGGTCTCTATACCCACAAC end/clone =CTTCTATCACTCAATCAGTTGGTA IMAGE:4518214/clone_end = 5′ 4021 Table 3AHs.322653 BG283132 13032707 602406784F1 cDNA 5′ 1 AACAAGATAGAGAGAAGACGAAend/clone = GATCGACACAGACAAACAACCACA IMAGE:4518957/clone_end = 5′ ACCG4022 Table 3A Hs.246818 BG283706 13033918 602259846F1 cDNA 5′ 1TGTTGGGACCCCTCATCTCACGGGTC end/clone = ATTTCCACCACTAAACGCCCTTTTIMAGE:4343171/clone_end = 5′ 4023 Table 3A Hs.151239 BG286500 13039430602382992F1 cDNA 5′ 1 CCCTGAAATCCTAAATTCCGTCACCC end/clone =CTCCAACATGACCATAAAAGTCCC IMAGE:4500527/clone_end = 5′ 4024 Table 3AHs.323950 BG286649 13039715 zinc finger protein 6 (CMPX1) (ZNF6), 1GACCACGTTATGTGCCTGACTTCGAG mRNA/cds = (1265, 3361)GACACCCTCTCTGGTTTGGTATTT 4025 Table 3A Hs.278428 BG286817 13040034progestin induced protein (DD5), 1 TCTCCTTTCAGTTCCTTTGTAGGATTT mRNA/cds= (33, 8432) CTGGCCTTGAGGATAGTCTTCA 4026 Table 3A NA BG288308 13043014cDNA clone IMAGE:45127006 5′ 1 TCTCATCAACATTTGACTCTCAGAAGAGCCTCCATTTGCCCTTTCTCTCT 4027 Table 3A Hs.115467 BG288391 13043387602388053F1 cDNA 5′ 1 GCAGAGCAGACCTTATTACGCACAAT end/clone =TGCCGGTAACATGTAACACCAGTT IMAGE:4517076/clone_end = 5′ 4028 Table 3AHs.11637 BG288429 13043463 602388093F1 cDNA 5′ 1ATTGGGCATGGTTGGTCCAATGCCTC end/clone = ACATGGCCGGGATAACAGGACGCAIMAGE:4517086/clone_end = 5′ 4029 Table 3A Hs.79101 BG288554 13043326cyclin G1 (CCNG1), 1 CAAAGGGTGTAATTCCACATTGACAC mRNA/cds = (187, 1074)TCCTGTCATGCGGTGGGGCGGGAAC 4030 Table 3A Hs.44577 BG288837 13044076602388170F1 cDNA 5′ 1 CTAGCTCACTAGTTGTGCCTATATGC end/clone =CACACCGGGGGACCCAACAAGGGT IMAGE:4517129/clone_end = 5′ 4031 Table 3AHs.173830 BG289048 13044499 602383668F1 cDNA 5′ 1ATACTGTGTGATTTGCCCTTGCTGTC end/clone = CAACCCTGTTCTTGCTGCCATTTAIMAGE:4512712/clone_end = 5′ 4032 Table 3A Hs.169363 BG289347 13045100GLE1 (yeast homolog)-like, RNA 1 GTGGCCTGAAGTGACCCATTCTATGA exportmediator (GLE1L), ATTGTTAATTAAGGTGCCAAAAA mRNA/cds = (87, 2066) 4033Table 3A Hs.79914 BG290141 13046637 lumican (LUM), mRNA/cds = (84, 1100)1 GGGTTTGAGACTTGGGTATGGAAACA GAACCGGAAATTGTGTGCTCTGGT 4034 Table 3AHs.125872 BG290577 13047679 sperm associated antigen 9 (SPAG9), 1ATTTCTATTATGGAATCCCTGGGGTT mRNA/cds = (110, 2410)CAGAATGTAACTTTGTACATGAGA 4035 Table 3A Hs.95835 BG291649 13049588RST8356 cDNA 1 GACAGTACACCTCAGGGAAGGGACA AACAAACACGATAAATCGACACACG 4036Table 3A Hs.289088 BG291970 13050316 heat shock 90kD protein 1, alpha 1TCAGACCCAGTCTTGTGGATGGAAAT (HSPCA), mRNA/cds = (60, 2258)GTAGTGCTCGAGTCACATTCTGCT 4037 Table 3A Hs.322804 BG311130 13112931ia55a08.yt cDNA, 5′ 1 TCCTGAGCCCCACACGCCCGAAGCA end/clone_end = 5′ATAAAGAGTCCACTGACTTCCAAAA 4038 Table 3A Hs.190219 BG326781 13133218602425659F1 cDNA 5′ 1 ACGAATATCGAATCTCCCACGCGGG end/clone =GGGTGAGACCCGAATCTGCGGCTGC IMAGE:4563471/clone_end = 5′ 4039 Table 3AHs.292457 BG339050 13145488 Homo sapiens, clone MGC:16362 1AGACACACGAGCAAAACGACGCAGC IMAGE 3927795, mRNA, completeAAGAATCAGATAGCATAGCAAACAT cds/cds = (498, 635) 4040 Table 3A Hs.170980BG387694 13281140 cell cycle progression 2 protein 1GCAGTGGGACGGAACGGGTGAAGCC (CPR2), mRNA/cds = (126, 1691)TGATGGCTGATGCGGCACGATCTTG 4041 Table 3A Hs.268175 BG391695 13285143 cDNAFLJ20673 fis, clone 1 CTTTAAATCTTAGATTGCTCCGCACA KAIA4464/cds = (104,1402) GATAAAGAGAACCAGGATTGGGGC 4042 Table 3A Hs.301226 BG396292 13289740mRNA for KIAA1085 protein, partial 1 TTTATTTGGGTACTTTTCCCCAACACA cds/cds= (0, 1755) AGTCCTTTTATCCCACCCTTGGG 4043 Table 3A Hs.58643 BG39756413291012 602438603F1 cDNA 5′ 1 AAAAGATCTCGGAAAATAGCATTTTG end/clone =TTAAAACCTTGGGGGGTAAAACCC IMAGE:4564968/clone_end = 5′ 4044 Table 3AHs.26670 BG403635 13297083 PAC clone RP3-515N1 from 22q11.2- 1AACCTTCATGCAAGTGGAGACGGGTA q22/cds = (0, 791) GGGGGTTCTATGGGGCATTGGTTG4045 Table 3A Hs.292457 BG424974 13331480 Homo sapiens, clone MGC:163621 TGTGAAAAGCTGATAAGAAAACCATC IMAGE:3927795, mRNA, completeCAGAAAAAGCTCTTCGTTTTACA cds/cds = (498, 635) 4046 Table 3A NA BG42740413334006 cDNA clone IMAGE:4612518 5′ 1 TCATTATAATTCTGTCCTAGGAAATCAAATTAGAACGCTCCACAAGCCGG 4047 Table 3A NA BG432194 13338700 cDNA cloneIMAGE:4610035 5′ 1 CGCAGAGCTGGGCCTTACAAATGGG TTCCAAATCGGGCTTCTCACTCAGG4048 Table 3A Hs.28491 BG434865 13341371 spermidine/spermine N1- 1TACAACTGTACCACACTGGGTTACTC acetyltransferase (SAT),TAGAAGTCTCTGGTCGGATCCTTC mRNA/cds = (165, 880) 4049 Table 3A Hs.281397BG438232 13344738 hypothetical protein AD034 (AD034), 1CATAGAGCACAAGAGACACATGGAC mRNA/cds = (195, 1880)CGGCACGCGACCCGACCCAAAGCGC 4050 Table 3A Hs.301226 BG468330 13400600 mRNAfor KIAA1085 protein, partial 1 TTTACCTCATTTATTTGGTACTTTCCC cds/cds =(0, 1755) CACACAGTCCTTTATCCACCTGG 4051 Table 3A Hs.334787 BG47322613405503 Homo sapiens, clone MGC:19556 1 CCATTTTTAGTGGGGGAGAAAACTGTIMAGE:4304831, mRNA, complete CACTGTGCTGGCGAAAGAGGTCCA cds/cds = (1505,1666) 4052 Table 3A Hs.292457 BG473813 13406090 Homo sapiens, cloneMGC:18362 1 CCGCACCGATTAACGGCCAGAGAAG IMAGE:3927795, mRNA, completeCAACAAGCAAATAAAAAGTGGGAAA cds/cds = (498, 635) 4053 Table 3A Hs.173737BG482796 13415077 ras-related C3 bolulinum toxin 1AACTTAACTCACTGGCGAGAATACAG substrate 1 (rho family, small GTPCGTGGGACCCTTCAGCCACTACAA binding protein Rac1) (RAC1), transcriptvariant Rac1b, mRNA/cds = (0, 635) 4054 Table 3A Hs.24054 BG48937513450885 hypothetical protein GL009 (GL009), 1AGGACTTAACGGGAATACGGGAATAA mRNA/cds = (77, 628) CTCCAATTACTTCATCTCTAGGGC4055 Table 3A Hs.166254 BG493253 13454765 hypothetical proteinDKFZp5661133 1 AAGGAGGTTGCTCACCAGTAGTGCTT (DKFZP5661133),GTTACCAAAATGTCACCAGGAGTT mRNA/cds = (133, 1353) 4056 Table 3A Hs.29131BG497765 13459262 nuclear receptor coactivator 2 1TGAATTAAGTGCATTATCAATTAACCT (NCOA2), mRNA/cds = (162, 4556)TATGGTGGTTGGAATAGTGATCA 4057 Table 3A Hs.172089 BG501063 13482580mRNA:cDNA DKFZp58612022 (from 1 AAACACACAGGAAAAGGGCAAAGGG cloneDKFZp58812022)/cds = GGCACCAGGAGAACCGGGAGACAAA UNKNOWN 4058 Table 3A NABG501895 13463412 cDNA clone IMAGE:4654344 5′ 1CGGAGAAACGGGGCCAAAAGGTTGC CGAGAGACCCGGCGAAAAGGACAGG 4059 Table 3AHs.279009 BG503693 13465210 matrix Gla protein (MGP), 1ACAAAGCATCAAACAGCAGGGAGCTA mRNA/cds = (46, 357) GTGGAGAGGTCTATTGTCCCAGTG4060 Table 3A Hs.86437 BG505271 13488788 602411368F1 cDNA 5′ 1GGGTGCATGCCAAGAAAGTATGGTT end/clone = GGAATTCCTGGTACACTGAAGTGGAIMAGE:4540096/clone_end = 5′ 4061 Table 3A Hs.237868 BG505379 13466896interleukin 7 receptor (IL7R), 1 ATGTTATCTTGGGAATTAGTGTCTTG mRNA/cds =(22, 1401) AGCCTCTGTCTGTTACCGTAGTTT 4062 Table 3A Hs.3280 BG50596113467478 caspase 6, apoptosis-related cystaine 1TGACCGAGTAAAAAACATCTATCAAT protease (CASP6), transcriptTACACAAATGAACAAGAATGTGAG variant alpha, mRNA/cds = (78, 959) 4063 Table3A Hs.293842 BG506472 13467989 601571679F1 cDNA 5′ 1ACAAGAAATGGTTGAGGCGAATATTG end/clone = GAAACACATGGGCTTAATGCTGAAIMAGE:3838675/clone_end = 5′ 4064 Table 3A Hs.111911 BG527060 13518597602540462F1 cDNA 5′ 1 GGTATTGATGCTTGGTTTTTCCTGCC end/clone =AGTCCGAAATTCCTGTATTTGTCA IMAGE:4671519/clone_end = 5′ 4065 Table 3AHs.12396 BG527658 13519195 602302446F1 cDNA 5′ 1TCATGCTACTTGTCCTGGTTTTGTCAT end/clone = TGATACTCTCATAGCCCTTTTGAIMAGE:4403868/clone_end = 5′ 4066 Table 3A NA BG531486 13523023 cDNAclone IMAGE:4899409 5′ 1 GCCTGGCGGACCGGCAGCCTATATGACGGACTTCCTCATTACTTACCACG 4067 Table 3A Hs.279009 BG532345 13523883matrix Gla protein (MGP), 1 AAACTGTTTGGAGAATTTAAGCACTC mRNA/cds = (46,357) TCTGATGGGGGACAACTCTATGGA 4068 Table 3A Hs.129872 BG532470 13524009sperm associated antigen 9 (SPAG9), 1 TCTTTGTGCAGATACGTTCACCACATmRNA/cds = (110, 2410) AAGTGTGAGCCATTTAAACCTGGT 4069 Table 3A Hs.343475BG533994 13525534 601558208T1 cDNA 3′ 1 CACCAAAGTGGAGACAAATACATGATend/clone = CTCAAAGATACACAGTACCTACTT IMAGE:3826392/clone_end = 3′ 4070Table 3A Hs.74647 BG536394 13527940 T-cell receptor active alpha-chain 1AATAATTGGTCTTTTAAACAAACACG mRNA from JM cell line, completeGAAGTTTGGTGGAATCGGTCATGT cds/cds = (138, 969) 4071 Table 3A Hs.343475BG536841 13528187 601556208T1 cDNA 3′ 1 TGTTCGTGCCTTCCTTCTGGGTTCCAend/clone = CAAAGGTGGGACCTTACTTATCTA IMAGE:3826392/clone_end = 3′ 4072Table 3A Hs.72988 BG537502 13529734 signal transducer and activator of 1AGGGAAAAACGCAGGGGGTTCAAAA transcription 2 113kD (STAT2),ACTCTCTCACTCTATGCAGTGTATA mRNA/cds = (57, 2612) 4073 Table 3A NABG538731 13530964 cDNA clone IMAGE:4691392 5′ 1AAGCAGCTCAATAGCAGCATAGAGGA TTAGATTAATGGAACAGCACTGCA 4074 Table 3AHs.124675 BG541679 13533912 602571258F1 cDNA 5′ 1ACATATACAAGGACACAGAGGAAAGG end/clone = CGGGAACAACGGGAAGAGGTTTTGIMAGE:4695805/clone_end = 5′ 4075 Table 3A NA BG542394 13534627 cDNAclone IMAGE:4696046 5′ 1 TGTGGCGATTAAGAGAGGTGAAGCATAACTGATTTGCAGGATATGGTTTG 4076 Table 3A Hs.198427 BG547561 13546239hexokinase 2 (HK2), 1 AAAAGCCAAAAGGTTTCATGTAGATT mRNA/cds = (1490, 4243)TTAGTTCACTAAAGGGTGCCCACA 4077 Table 3A Hs.83077 BG547627 13546292interleukin 18 (interferon-gamma- 1 GCAGAACTCTAATTGTACGGGGTCAC inducingfactor) (IL18), AGAGGCGTGATATGGTATCCCAAA mRNA/cds = (177, 756) 4078literature Hs.227656 XM_001289 14732543 xenotropic polytropic murine 1CTTAACCATACAGAATGATATAACTC leukemia virus receptor (X3)CTGTGCAATGAAGGTGATAACAGT mRNA, complete cds/cds = (165, 2255) 4079literature Hs.55468 XM_001939 11426048 H4 histone, family 2 1CTTCGGAGGCTAGGCCGCCGCTCCA GCTTTGCACGTTTCGATCCCAAAGG 4080 Table 3AHs.170171 XM_002068 14732456 mRNA; cDNA DKFZp434MO813 (from 1CAAAGTCAAATAACTCCTCATTGTAAA clone DKFZp434MO813); partialCAAACTGTGTAACTGCCCAAAGC cds/cds = (430, 768) 4081 literature Hs.181097XM_002135 11428074 tumor necrosis factor (ligand) 1CCAATCCCGATCCAAATCATAATTTG superfamily, member 4 (tax-TTCTTAAGTATACTGGGCAGGTCC transcriptionally activated glycoprotein1,34kD) (TNFSF4), mRNA/cds = (36, 587) 4082 Table 3A Hs.76913 XM_00215813839010 proteasome (prosome, macropain) 1 TCCAGCTCCTGTTCCTTGGAAAATCTsubunit, alpha type, 5 (PSMA5), CCATTGTATGTGCATTTTTTAAAT mRNA/cds = (21,746) 4083 Table 3A Hs.10927 XM_002269 13636009 HSZ78330 cDNA/clone =2.49-(CEPH) 1 AACTGATGCCTGCTAGTGCTTTCTGA TTACTCGCATTCTGTTTCTTGCTT 4084literature Hs.81424 XM_002513 13646509 ubiquitin-like 1 (sentrin)(UBL1), 1 TCAGGTTGAAGTCAAGATGACAGATA mRNA/cds = (66, 371)AGGTGAGAGTAATGACTACTCCAA 4085 Table 3A Hs.173912 XM_003189 14735115eukaryotic translation initiation factor 1 TCCTAGGTAGGGTTTAATCCCCAGTA4A, isoform 2 (EIF4A2), AAATTGCCATATTGCACATGTCTT mRNA/cds = (15, 1238)4086 Table 3A Hs.63668 XM_003304 14720715 toll-like receptor 2 (TLR2), 1AGCGGGAAGGATTTTGGGTAAATCTG mRNA/cds = (129, 2483)AGAGCTGCGATAAAGTCCTAGGTT 4087 Table 3A Hs.89714 XM_003507 14731038 smallinducible cytokine subfamily B 1 GAGGCCCTAGCATTTCTCCTTGGATA (Cys-X-Cys),member 5 (epithelial- GGGGACCAGAGAGAGCTTGGAATG derivedneutrophil-activating peptide 78) (SCYB5), mRNA/cds = (106, 450) 4088Table 3A Hs.66052 XM_003593 13646753 CD38 antigen (p45) (CD38), 1CTCCACAATAAGGTCAATGCCAGAGA mRNA/cds = (69, 971) CGGAAGCCTTTTTCCCCAAAGTCT4089 Table 3A Hs.251664 XM_004020 11417288 DNA for insulin-like growthfactor II 1 CCAATGTTTCTCTTTTGGCCCTATACA (IGF-2); axon 7 and additionalAAGGCAAGAAGGAAAGACCAAGA ORF/cds = (0, 233) 4090 Table 3A Hs.79197XM_004500 13631147 CD83 antigen (activated B 1TTTACCTCTGTCTTGGCTTTCATGTTA lymphocytes, immunoglobulinTTAAACGTATGCATGTGAAGAAG superfamily) (CD83), mRNA/cds = (41, 656) 4091db mining Hs.159651 XM_004585 14758499 tumor necrosis factor receptor 1GGGAAGTTGGTTTATAAGCCTTTGCC superfamily, member 21 (TNFRSF21),AGGTGTAACTGTTGTGAAATACCC mRNA/cds = (0, 1967) 4092 Table 3A Hs.279903XM_004611 14740071 Ras homolog enriched in brain 2 1CCCTCCCTTCAGATTATGTTAACTCT (RHEB2), mRNA/cds = (23, 577)GAGTCTGTCCAAATGAGTTCACTT 4093 Table 3A Hs.302981 XM_004720 14745195hypothetical protein FLJ11000 1 TTATTCATATATTCCTGTCCAAA (FLJ11000),mRNA/cds = (223, 780) GCCACACTGAAAACAGAGGCAGA GACA 4094 Table 3AHs.239138 XM_004839 13629023 pre-B-cell colony-enchancing factor 1TGCACCTCAAGATTTTAAGGAGATAA (PBEF), mRNA/cds = (27, 1502)TGTTTTTAGAGAGAATTTCTGCTT 4095 Table 3A Hs.79022 XM_005182 14746130GTP-binding protein overexpressed in 1 TATGGCCTTCAAGCTCAAGTCCAAATskeletal muscle (GEM), CCTGCCATGACCTCTCTGTACTCT mRNA/cds = (213, 1103)4096 Table 3A Hs.234842 XM_005543 13841011 aquaporin 3 (AQP3), 1TCCATCTGTGCATAAGGAGAGGAAAG mRNA/cds = (64, 942) TTCCAGGGTGTGTATGTTTTCAGG4097 Table 3A Hs.124029 XM_005693 14737168 inositolpolyphosphate-5-phosphatase, 1 GGACCATTCCGGAGCAGCCCCACAT 40kD (INPP5A),ACCTCACTGTCTCGTCTGTCTATGT mRNA/cds = (101, 1192) 4098 Table 3A Hs.326248XM_005698 13627052 cDNA; FLJ22071 fis, clone 1 TTTGTAAGCGAAGGAGATGGAGGTCHEP11691/cds = UNKNOWN GTCTTAAACCAGAGAGCTACTGAAT 4099 Table 3A Hs.287797XM_005799 13629831 mRNA for FLJ00043 protein, partial 1ACCACTGTATGTTTACTTCTCACCATT cds/cds = (0, 4246) TGAGTTGCCCATCTTGTTTCACA4100 Table 3A Hs.1395 XM_005883 14740090 early growth response 2(Krox-20 1 AAATCTATTCTAACGCAAAACCACTAA (Drosophila) homolog) (EGR2),CTGAAGTTCAGATAATGGATGGT mRNA/cds = (338, 1768) 4101 Table 3A Hs.1908XM_005980 14748566 proteoglycan 1, secretory granule 1TGTTATAAAAGAGGATTTTCCCACCTT (PRG1), mRNA/cds = (24, 500)GACACCAGGCAATGTAGTTAGCA 4102 db mining Hs.73958 XM_006283 14763523recombination activating gene 1 1 ACCAGGATGCAATGGATTTATTTGAT (RAG1),mRNA/cds = (124, 3255) TCAGGGGACCTGTATTTCCATGTC 4103 Table 3A Hs.146589XM_006741 14783662 mRNA for MOP-3, complete 1 AACAGAAACAGCTATGGCAACAGCATcds/cds = (0, 4178) CACCCTCAGAGCATCACCAACTTG 4104 db mining Hs.99954XM_006840 14763859 activin A receptor, type IB (ACVR1B), 1TATTTAACCTGAGTATAGTATTTAACG transcript variant 1,AAGCCTAGAAGCACGGCTGTGGG mRNA/cds = (39, 1556) 4105 Table 3A Hs.287369XM_006881 13650909 interleukin 22 (IL22), 1 AACTAACCCCTTTCCCTGCTAGAAAmRNA/cds = (71, 610) TAACAATTAGATGCCCCAAAGCGA 4106 literature Hs.159XM_006950 13652420 tumor necrosis factor receptor 1ATAGCAAGCTGAACTGTCCTAAGGCA superfamily, member 1A (TNFRSF1A),GGGGCGAGCACGGAACAATGGGGC mRNA/cds = (255, 1622) 4107 Table 3A Hs.159492XM_007156 12737945 sacsin (SACS) gene, complete 1TGACAGGTTCACTTCTGAGGTTGCTA cds/cds = (76, 11565)TGAGGGTGATGGAATGTACTGCCT 4108 Table 3A Hs.170133 XM_007189 14755876forkhead box O1A 1 TGTTTAAATGGCTTGGTGTCTTTCTTT (rhabdomyosarcoma)(FOXO1A), TCTAATTATGCAGAATAAGCTCT mRNA/cds = (385, 2352) 4109 Table 3AHs.87409 XM_007606 14749307 thrombospondin 1 (THBS1), 1TTGAAATTGGTGGCTTCATTCTAGAT mRNA/cds = (111, 3623)GTAGCTTGTGCAGATGTAGCAGGA 4110 Table 3A Hs.75415 XM_007650 14785206 cDNA;FLJ22810 fis, clone KAIA2933, 1 ACTTCTTATACATTTGATAAAGTAAGG highlysimilar to AB021288 mRNA for CATGGTTGTGGTTAATCTGGTTT beta2-microglobulin/cds = UNKNOWN 4111 Table 3A Hs.17279 XM_008062 13627121tyrosylprotein sulfotransferase 1 1 CATGAAGAAGCAAGACGAAAAC (TPST1),mRNA/cds = (81, 1193) ACACAGGAGGGAAAATCCTGGGAT TCTT 4112 Table 3AHs.5344 XM_008082 14779810 adaptor-related protein complex 1, 1GCCTGGCTTGGACCTTGGCATTCCGT gamma 1 subunit (AP1G1),TTGAATTCCTTCTAACTGGAACAT mRNA/cds = (28, 2505) 4113 Table 3A Hs.75703XM_008449 13852724 small inducible cytokine A4 1GTCCACTGTCACTGTTTCTCTGCTGT (homologous to mouse Mip-1b)TGCAAATACATGGTAACACATTT (SCYA4), mRNA/cds = (108, 386) 4114 literatureHs.79241 XM_008738 13846672 B-cell CLL/lymphoma 2 (BCL2), 1TTGTGTTGTTGGAAAAAGTCACATTG nuclear gene encoding mitochondrialCCATTAAACTTTCCTTGTCTGTCT protein, transcript variant alpha, mRNA/cds =(31, 750) 4115 db mining Hs.9731 XM_008901 11432998 nuclear factor ofkappa light 1 CAGTAGCGACAGCGACGGCGGAGAC polypeptide gene enhancer inB-cells GAGGGCGTGAGTCAGGAGGAGAGAC inhibitor, beta (NFKBIB), mRNA/cds =(0, 1016) 4116 db mining Hs.69747 XM_009101 11425196 fucosyltransferase1 (galactoside 2- 1 AGCTGCCACGGGTGAGAGAGCAGGAalpha-L-fucosyltransferase, Bombay GGTATGAATTAAAAGTCTACAGCAC phenotypeincluded) (FUT1), mRNA/cds = (103, 1200) 4117 db mining Hs.46328XM_009103 14760495 mRNA for 1 CTTTCCTCAAAATCTTTAAGCCAGAG alpha(1,2)fucosyltransferase, complete GCAGCCTTCCTGCCGGAGTGGACA cds/cds =(111, 1142) 4118 Table 3A Hs.84038 XM_009533 14771190 CGI-06 protein(LOC51604), 1 TCTGCCTCACGTGCACTGTGGTGGC mRNA/cds = (6, 1730)CGTGTGCTACGGCTCCTTCTACAAT 4119 Table 3A Hs.296585 XM_009574 14771391nucleolar protein (KKE/D repeat) 1 CCATAGCCCAAGGTGACATTTCCCAC (NOP56),mRNA/cds = (21, 1829) CCTGTGCCGTGTTCCCCAATAAAA 4120 Table 3A Hs.198298XM_009641 14770741 cDNA FLJ14219 fis, clone 1 GGGGTATCCAGAATTGGTTGTAAATANT2RP3003800, highly similar to CTTTGCATATTGTCTGATTAAACA Rattusnorvegicus tyrosine protein kinase pp60-c-src mRNA/cds = (501, 1256)4121 Table 3A Hs.334691 XM_009917 13648023 hypothetical protein FLJ224271 GAGGCTTTGCCTTGCCTGCATATTTG (FLJ22427), mRNA/cds = (40, 2631)TTTCGCTCTTACTCAGTTTGGGAA 4122 Table 3A Hs.278027 XM_009929 11417988 LIMdomain kinase 2 (LIMK2), 1 GCAAGTGTAGGAGTGGTGGGCCTGA transcript variant2b, ACTGGGCCATTGATCAGACTAAATA mRNA/cds = (315, 2168) 4123 Table 3AHs.32970 XM_010593 14727775 signaling lymphocytic activation 1TTGCAAAACCCAGAAGCTAAAAAGTC molecule (SLAM), AATAAACAGAAAGAATGATTTTGAmRNA/cds = (133, 1140) 4124 Table 3A Hs.155595 XM_010897 13837965 neuralprecursor cell expressed, 1 CCCACACTGCTACACTTCTGATCCCC developmentallydown-regulated 5 TTTGGTTTTACTACCCAAATCTAA (NEDD5), mRNA/cds = (258,1343) 4125 Table 3A NA XM_011080 14738482 T cell activation, increasedlate 1 AAAAGAAGCCCTAATAAACCACCCGG expression ATAATAACCCTGTCTACCATCTTT4126 Table 3A Hs.302014 XM_011062 13626304 interleukin 21 (IL21), 1GTGAAGATTCCTGAGGATCTAACTTG mRNA/cds = (46, 534) CAGTTGGACACTATGTTACATACT4127 Table 3A Hs.78687 XM_011714 14749491 neutral sphingomyelinase(N-SMase) 1 AGAAGGATTAGCAGTTCTTAGTAAGT activation associated factor(NSMAF), TTACTGTGTATAGGAACGGTTTGT mRNA/cds = (12, 2765) 4128 literatureHs.91390 XM_011844 14739654 poly (ADP-ribose) glycohydrolase 1CGGCTGCCTCTCTTGAGACCATCTGC (PARG), mRNA/cds = (166, 3096)CAATCACACAGTAACTATTCGGGT 4129 Table 3A Hs.76038 XM_011865 14737830isopentenyl-diphosphate delta 1 CCCAACTGAGGACCACTGTCTACAGA isomerase(ID11), mRNA/cds = (50, 738) GTCAGGAAATATTGTAGGGAGAA 4130 Table 3AHs.180450 XM_011914 13828205 ribosomal protein S24 (RPS24), 1CTGGCAAAAAGCCCGAAGGAGT transcript variant 1, AAAGGTGCTGCAATGATGTTAGCTGmRNA/cds = (37, 429) TGGC 4131 Table 3A Hs.154938 XM_012059 14771044hypothetical protein MDS025 1 TGTTTGCTTGAACAGTTGTGTAAATC (MDS025),mRNA/cds = (5, 769) ATACAGGATTTTGTGGGTATTGGT 4132 Table 3A Hs.1051XM_012328 14750596 granzyme B (granzyme 2, cytotoxic T- 1GGAGCCAAGTCCAGATTTACACTGG lumphocyte-associated serine esteraseGAGAGGTGCCAGCAACTGAATAAAT 1) (GZMB), mRNA/cds = (33, 776) 4133 Table 3AHs.251526 XM_012649 13833583 gene for monocyte chemotactic protein- 1GGATGCTCCTCCCTTCTCTACCTCAT 3 (MCP-3)/cds = (0, 329)GGGGGTATTGTATAAGTCCTTGCA 4134 db mining Hs.278454 AF285431 12741752killer cell immunoglobulin-like receptor, 1 TAACTTCAATGTAGTTTTCCATCCTTCtwo domains, long cytoplasmic tail, 2 AAATAAACATGTCTGCCCCCATG (KIR2DL2),mRNA/cds = (14, 1060) 4135 Table 3A Hs.334437 XM_015180 14778515hypothetical protein MGC4248 1 GAGTCCTTTTGATTTTTAACTTATTCC (MGC4248),mRNA/cds = (70, 720) CCATGTCCCTATACTCGTGTGC 4136 Table 3A Hs.137555XM_015921 1760439 putative chemokine receptor, GTP- 1TGCACGTTCCTCCTGGTTCCTTCGCT binding protein (HM74),TGTGTTTCTGTACTTACCAAAAAT mRNA/cds = (60, 1223) 4137 Table 3A Hs.164371XM_016136 13835810 cDNA FLJ1315 fis, clone 1 CAGCTTCAGCTAGGAGTTTGTAAGCANT2RP3003842/cds = UNKNOWN AGGACTTTGTGACACATTTGTCCC 4138 Table 3AHs.323463 XM_016481 14721648 mRNA for KIAA1693 protein, partial 1AATTGAAAAGTACCAAGAAGTG cds/cds = (0, 2707) GAAGAAGACCAAGACCCATCATGC CCCA4139 Table 3A Hs.15220 XM_016721 14784971 zinc finger protein 106(ZFP106), 1 ACTTCCTAGACACTTGTTTCTGAGAC mRNA/cds = (335, 5986)AGTTCTTTGCCTTCACTTCCCTGC 4140 Table 3A Hs.323463 XM_016972 14726508 mRNAfor KIAA1693 protein, partial 1 ACAACTGACCTGTCTCCTTCACATAG cds/cds = (0,2707) TCCATATCACCACAAATCACACAA 4141 Table 3A Hs.180946 XM_01849814723691 ribosomal protein L5 pseudogene 1 GCTCAGGAGCGGGGCTGCTGAGAGCTmRNA, complete cds/cds = UNKNOWN AAACCCAGCAATTTTCTATGATTTT 4142Literature Hs.194382 U67093 2072143 ataxia telangiectasia (ATM) gene, 1AAAGAAAGCCAGTATATTGGTTTGAA complete cds/cds = (795, 9965)ATATAGAGATGTGTCCCAATTTCA 4143 Literature Hs.184167 NM_006276 6857827splicing factor, arginine/serine-rich 7 1 ACTGGCAGGCTTATTTATCTGTTGCA(35kD) (SFRS7) mRNA/cds = (105, 490) CTTGGTTAGCTTTAATTGTTCTGT 4144Literature Hs.79037 NM_002156 4504520 Homo sapiens, heat shock 60kD 1AGCAGCCTTTCTGTGGAGAGTGAGAA protein 1 (chaperonin), cloneTAATTGTGTACAAAGTAGAGAAGT MGC:19755 IMAGE:3830225, mRNA, complete cds/cds= (1705, 3396) 4145 Literature Hs.206984 U15177 988207 cosmid CRI-JC2015at D10S289 in 1 CAACTGTGCTGGCCGGGAGGAGAGC 10sp13/cds = (0, 1214)AGAGACGCAGTCCTGCCCAGTGTAG 4146 Literature Hs.395 XM_002923 13643499chamokine (C—C motif) receptor 2 1 CACATGGCTAAAGAAGGTTTCAGAAA (CCR2),mRNA/cds = (39, 1163) GAAGTGGGGACAGAGCAGAACTTT 4147 Literature NANC_001807 13959823 mitochondrion, complete genome 1CCGACATCTGGTTCCTACTTCAGGGT CATAAAGCCTAAATAGCCCACACG 4148 LiteratureHs.32017 NM_020645 11034818 ASCL3 gene, CEGP 1 gene, C11orf14 1CTCATTTGTATTCAAGCCTTTAACAG gene, C11orf15 gene, C11orf16 geneGAGGGCAAAGAGGTGAGAATGTGT and C11orf17 gene/cds = (66, 791) 4149Literature Hs.74621 U29185 2865216 prion protein (p27-30) (Creutzfeld- 1GCACTGAATCGTTTCATGTAAGAATC Jakob disease, Gersimann-Strausler-CAAAGTGGACACCATTAACAGGTC Scheinker syndrome, fatal familial insomnia)(PRMP), mRNA/cds = (49, 810) 4150 Literature NA X04948 36891 T-cellreceptor alpha-chain HAP05 1 GCAGACACTGCTTCTTACTTCTGTGC V(e)3.1/J(a)PTACGGATGGGAACAGAGATGACAA 4151 Literature NA X92768 1054779 mRNA forT-cell receptor alpha (clone 1 GGGGAAACTGGAGGCTTCAAAACTAT XPBP531)CTTTGGAGCAGGAACAAGACTATT 4152 Literature Hs.75064 NM_003192 4507372tubulin-specific chaperone (TBCC), 1 GGGGAAGGAGGGTGATTATATTGCTT mRNA/cds= (23, 1063) TGTAATGGTTTGTGATACTTGAAA 4153 Literature Hs.99093 8G17951712686220 chromosome 19, cosmid 1 GTACGAATGGGAGGTCCTCGACACC R28379/cds =(0, 633) TGGGGAACTGCGGACTATGCGGCAG 4154 Literature Hs.77356 NM_0032344507456 transferrin receptor (p90, CD71) 1 TATCAGACTAGTGACAAGCTCCTGGT(TFRC), mRNA/cds = (263, 2545) CTTGAGATGTCTTCTCGTTAAGGAA 4155 LiteratureHs.194638 U89387 2253834 polymerase (RNA) II (DNA directed) 1TGACCTCCACCAAAGCCCATATAAGG polypeptide D (POLR2D),AGCGGAGTTGTTAAGGACTGAAGA mRNA/cds = (30, 458) 4156 Literature Hs.15220NM_022473 14764971 zinc finger protein 106 (ZFP106), 1TTTCTCCGGACTCATCAGTAAACCTG mRNA/cds = (335, 5986)TAGAAGTGTCGCTTTCCAGCCTTT 4157 Literature Hs.326248 NM_014456 7657448cDNA; FLJ22071 fis, clone 1 TTTGTAAGCGAAGGAGATGGAGGTC HEP11691/cds =UNKNOWN GTCTTAAACCAGAGAGCTACTGAAT 4158 Literature Hs.182447 BC00339413097278 heterogeneous nuclear 1 AAAGTTGATACTGTGGGTTATTTTTGTribonucleoprotein C (C1/C2) (HNRPC), GAACAGCCTGATGTTTGGGACCT transcriptvariant 1, mRNA/cds = (191, 1102) 4159 Literature Hs.31314 X72841 297903relinoblastoma-binding protein 7 1 AACTTTTACACTTTTTCCTTCCAACAC (RBBP7),mRNA/cds = (287, 1564) TTCTTGATTGGCTTTGCAGAAAT 4160 Literature Hs.177592NM_001003 4506668 ribosomal protein, large, P1 (RPLP1), 1ACAGCCAAGACTTAGGTTACAGGGCA ACGCACTACTGTTCAGCTTTGAAT 4161 LiteratureHs.81361 M65028 337450 heterogeneous nuclear 1ACGTGTCCTGATTTTGCCACAACCTG ribonucleoprotein A/B (HNRPAB),GATATTGAAGCTATCCAAGCTTTT transcript variant 1, mRNA/cds = (224, 1219)4162 Literature Hs.279939 BC004560 13528726 mitochondrial carrierhomolog 1 1 AGCTGTTGATGCTGGTTGGACAGGTT (MTCH1), nuclear gene encodingTGAGTCAAATTGTACTTTGCTCCA mitochondrial protein, mRNA/cds = (0, 1118)4163 Literature Hs.241567 NM_002897 8400725 RNA binding motif, singlestranded 1 ATAAGGTGCATAAAACCCTTAAATTC interacting protein 1 (RBMS1),ATCTAGTAGCTGTTCCCCCGAACA transcript variant MSSP-2, mRNA/cds = (265,1434) 4164 Literature NA BE874440 10323216 NIH_MGC_69 cDNA clone 1CCAATGACAGCCTACCTATTACCAAG IMAGE:3891187 5′, GGCTCCCCTACAACTCTGAACCTT4165 Literature Hs.1074 BC005913 13543508 surfactant,pulmonary-associated 1 GACAAACCCTGGAGAAATGGGAGCT protein C (SFTPC),TGGGGAGAGGATGGGAGTGGGCAGA mRNA/cds = (27, 620) 4166 Literature Hs.56205BC001880 12804864 insulin induced gene 1 (INSIG1), 1GTGTCAGTGCCCAAAGGAGGGAGGT mRNA/cds = (414, 1247)TGATGGTGCTTAACAAACATGAAGT 4167 Literature Hs.77356 BC001188 12654696transferrin receptor (p90, CD71) 1 TCATTGTATAAAAGCTGTTATGTGCAA (TFRC),mRNA/cds = (263, 2545) CAGTGTGGAGATTCCTTGTCTGA 4168 Literature Hs.194638BC002958 12804200 polymerase (RNA) II (DNA directed) 1TGACCTCCACCAAAGCCCATATAAGG polypeptide D (POLR2D),AGCGGAGTTGTTAAGGACTGAAGA mRNA/cds = (30, 458) 4169 Literature Hs.35406AA057484 1550124 602675161F1 cDNA, 5′ 1 TTGGCTTCATTACGAGAGAGAAACATend/clone = AACAGAGGCAGTGATGGTTTCAGA IMAGE:4797783/clone_end = 5′ 4170Literature Hs.74451 X04106 35327 calpain 4, small subunit (30K) 1TTTGTCTATATTCTGCTCCCAGCCTG (CAPN4), mRNA/cds = (158, 964)CCAGGCCAGGAGGAAATAAACATG 4171 Literature Hs.13231 H17596 883836od15d12.s1 1 AGCACATTGGGAGATACATGATAAAT cDNA/clone = IMAGE:1368023TTCTATCTGCAGTTGCTATTTGCA 4172 Literature Hs.74002 U40396 1117914 mRNAfor steroid receptor coactivator 1 GGCCCAGCAGAAGAGCCTCCTTCAG 1e/cds =(201, 4400) CAGCTACTGACTGAATAACCACTTT 4173 Literature NA X17403 59591CMV HCMVTRL2 = IRL2 1 AATAATAGATTAGCAGAAGGAATAATCCGTGCGACCGAGCTTGTGCTTCT 4174 Literature NA X17403 59591 CMV HCMVUL27 1ACATTCAAAAGTTTGAGCGTCTTCAT GTACGCCGTTTTCGGCCTCACGAG 4175 Literature NAX17403 59591 CMV HCMVUL106 1 ACGAACAGAAATCTCAAAAGACGCTGACCCGATAAGTACCGTCACGGAGA 4176 Literature NA X17403 59591 CMV HCMVTRL7 =IRL7 1 AGGAACCAGCAAGTCAACAAAA GACTAACAAAGAAAAACCATCTTG GAAT 4177Literature NA X17403 59591 CMV HCMVUL33 1 CCAACGACACATCCACAAAAATCCCCCATCGACTCTCACAATCGCATCAT 4178 Literature NA X17403 59591 CMV HCMVUL123 1CCTCTGGAGGCAAGAGCACCCACCC TATGGTGACTAGAAGCAAGGCTGAC 4179 Literature NAX17403 59591 CMV HCMVUL75 Glycoprotein H 1 GATGTCCGTCTACGCGCTATCGGCCATCATCGGCATCTATCTGCTCTACC 4180 Literature NA X17403 59591 CMV HCMVUS28 1TTCGTGGGCACCAAGTTTCGCAAGAA CTACACTGTCTGCTGGCCGAGTTT 4181 Literature NAX17403 59591 CMV HCMVUL21 1 GAGATCGACATCGTCATCGACCGACCTCCGCAGCAACCCCTACCCAATCC 4182 Literature NA X17403 59591 CMV HCMVUL54 1CTTTGAGCAGGTTCTCAAGGCTGTAA CTAACGTGCTGTCGCCCGTCTTTC 4183 Literature NAX17403 59591 CMV HCMVUL83 1 TCTTCTGGGACGCCAACGACATCTACCGCATCTTCGCCGAATTGGAAGGC 4184 Literature NA X17403 59591 CMV HCMVUL109 1AGAGAACAACAAACCACCACGACGA TGAAACAAAACGCTCAACCAAACA 4185 Literature NAX17403 59591 CMV HCMVUL113, spliced to 1 GAGAAAAGATTGTGCGATCTCCCCCTHCMVUL112 GGTTTCCAGCAGACTCTTGCCAGA 4186 Literature NA X17403 59591 CMVHCMVUL122 1 CATCTTCTCCACCAACCAGGGTGGGT TCATGCTGCCTATCTACGAGACGG 4187 dbmining Hs.164427 AI307795 4002399 tb28c03.x1 cDNA 3′ −1TCCCATGTTCCCTTTATTTGTCTTTTG end/clone = GTTCTGCTTTTTGGGAGATTTTTIMAGE:2055852/clone_end = 3′ 4188 Table 3A Hs.169168 AA977148 3154594oq24g08.s1 cDNA 3′ −1 TGGTGCGCTTTTGTGTGCGGTGGAG end/clone =GAGTTCCTAACCCTCGGCTTGTTTT IMAGE:1587326/clone_end = 3′ 4189 Table 3AHs.117333 AI023714 3238758 mRNA for KIAA1093 protein, partial −1GCCGTTGGTTGGCTTAAACTTGGTTT cds/cds = (179, 5362)CGTCACTTCGGGCACTTTGGTTTT 4190 Table 3A NA AI380955 4190797 lg18b08.x1cDNA, 3′ −1 CTGGCCTCCCCTGGCTCTTTAAGCTC end/clone =CCCTTTGGTTAAAAACTGGGTTTT IMAGE:2109111 4191 Table 3A Hs.93870 AA9760453151837 cDNA; FLJ22664 fis, clone −1 AAAAGGCCAAGGGTGTTGTTGGGGCHS108202/cds = UNKNOWN GTCTGTCTAATGTGGTGGGTCTTTT 4192 Table 3A Hs.332583AA788623 2874972 yc77a06.s1 cDNA 3′ −1 GCTGTAAATCTCTGTCTCATCATCCTTend/clone = CTCTTTTGTTTCCATAGCCTTTT IMAGE:21844/clone_end = 3′ 4193Table 3A Hs.71433 AA131524 1693030 zl31h02.s1 cDNA 3′ −1GTGTGTGCTGGCTGAGAAGCCACTG end/clone = TGAATTGATTCTTCTTCTGAAGTTTIMAGE:503571/clone_end = 3′ 4194 Table 3A Hs.309127 AI380687 4190540tg03e04.x1 cDNA 3′ −1 AATAAGGGTGTTGCCCTTTGTTCCCT end/clone =CACATAATCGTGAAAGGCTGCTTT IMAGE:2107710/clone_end = 3′ 4195 Table 3AHs.102630 AA808085 2877491 602440867F1 cDNA 5′ −1TTCCTCAGTCCCTGTTCATACCATCT end/clone = CTGCACCCACAATCACACTGATTTIMAGE:4556561/clone_end = 5′ 4196 Table 3A Hs.134473 AI074016 3400660oy66g02.x1 cDNA 3′ −1 GACCACAGATATGCACTCCTTACATT end/clone =AACCTCAGCCTTGATGTATCATTT IMAGE:1870834/clone_end = 3′ 4197 Table 3AHs.158653 AI370965 4149718 ta29b11.x1 cDNA 3′ −1CCCCCTGTTATGAAAAGGGTTAAACT end/clone = TGAACCCACCCATTTTAAAAATTTIMAGE:2045489/clone_end = 3′ 4198 Table 3A Hs.243029 AA424812 2106917UI-H-B14-aow-c-10-0-UI.s1 cDNA 3′ −1 TTATAGCTACCAGAAGCCACCAGGGCend/clone = CTTAGCCCAGCAGTAGAAACCTCT IMAGE:3086226/clone_end = 3′ 4199Table 3A Hs.188777 AA432384 2114747 zw76a09.s1 cDNA 3′ −1GATCAGTAGACACACCCCTCAATGCT end/clone = GCGAAGAAAATGAAGGCCACTCTTIMAGE:782104/clone_end = 3′ 4200 Table 3A Hs.132237 AI031656 3249868ow48e06.x1 cDNA 3′ −1 AGCAGACAATGGACAACTGTAGTTTT end/clone =TGAATTGACTTCTATAGCCATCTT IMAGE:1650082/clone_end = 3′ 4201 db miningHs.123445 AA813728 2882413 602623874F1 cDNA 5′ −1TCCACCACAGTGCATGATAATTCCGA end/clone = CAGAACGGCCTTTTATTTGTACCTIMAGE:4748515/clone_end = 5′ 4202 Table 3A Hs.143049 AI126688 3595202Homo sapiens, Similar to −1 TGTTCTCTGAACTGTCTGGATGAACC DKFZP727C091protein, clone GGTCAACGGCACTCATCATACCTT MGC:10677 IMAGE:3948445, mRNA,complete cds/cds = (79, 1530) 4203 Table 3A Hs.108327 AA701667 2704832damage-specific DNA binding protein −1 GCTTCACTCTGCTTTCTGTATAAAGG 1(127kD) (DDB1), GCAGTCTGTGGTCACGCAAGACTT mRNA/cds = (109, 3531) 4204Table 3A Hs.270264 AA813224 2464262 no19d06.s1 cDNA 3′ −1AGCAAAGACCAAATTCTCCTTGGGAA end/clone = GTGTGGGAGCAGGCTGACATTATTIMAGE:1101131/clone_end = 3′ 4205 Table 3A Hs.158978 AI380390 4190243UI-H-B12-ahi-a-03-0-UI.s1 cDNA 3′ −1 GTCCTTTGATAGCAGAACAAGAGGCTend/clone = CTGTGATCCTCTGGACCTCAGATT IMAGE:2726692/clone_end = 3′ 4206Table 3A Hs.204214 AA826926 2900923 EST389900 cDNA −1TCCACGACATGGTACAGCTCTTCACT TTTTCAGCTTTTTAAATGTCCATT 4207 Table 3AHs.326392 AA974839 3150631 son of sevenless (Drosophila) −1GACAAGGCAATGCTACTGATCACCTG homolog 1 (SOS1), AGGATAATGGTGAAGGACTTTTGTmRNA/cds = (0, 3998) 4208 Table 3A Hs.53542 AI084224 3422647chorea-ecanthocytosis (CHAC) −1 TCAATAGTTGTGAAATTCTTCTCAGG mRNA,complete cds/cds = (260, 2784) CTCCTTAAACCCTCGCTTTGTTGT 4209 Table 3AHs.173334 AA284232 1928532 ELL-RELATED RNA POLYMERASE −1AGGCTTACGTTTATCCAAAAGCATTT II, ELONGATION FACTOR (ELL2),CACCTTGCACATTACTGTTGTTGT mRNA/cds = (0, 1922) 4210 db mining Hs.86437AI300700 3960048 602411368F1 cDNA 5′ −1 ACAAGCATTTAGATCATAACATGGTAend/clone = AAGCCTATTACCAGCCAATGTTGT IMAGE:4540096/clone_end = 5′ 4211db mining Hs.61558 AI220970 3803173 hz63d07.x1 cDNA 3′ −1TGTTTTGGCATAGAGCTTTACTTAAAA end/clone = TGCTGCTTCATTTTACACATTGTIMAGE:3212653/clone_end = 3′ 4212 Table 3A Hs.239489 AA639796 2563575TIA1 cylotoxic granule-associated −1 TGGAGCTCAATTCTATGCAGTTGTGCRNA-binding protein (TIA1), transcript TGATATTTCATTAAGTCACTGTGT variant2, mRNA/cds = (185, 1345) 4213 Table 3A Hs.228795 AI094726 3433702qa08f05.x1 cDNA 3′ −1 TTTCCCCTTGGCCTGAGTTTTTATAAA end/clone =ATTTCCATTAATTGGGGCAGTGT IMAGE:1688177/clone_end = 3′ 4214 db miningHs.62699 AA740964 2779556 EST386140 cDNA −1 TGCAGCTAAATTCGAAGCTTTTGGTCTATATTGTTAATTGCCATTGCTGT 4215 Table 3A Hs.124675 AA858297 2948599ob13b08.s1 cDNA 3′ −1 GGATTTGGAAGATGCTTTCAGAAATA end/clone =TGGCATAGGTTTTTGTCGAAATGT IMAGE:1323543/clone_end = 3′ 4216 Table 3A NAAI281442 3919675 cDNA clone IMAGE:1967452 3′ −1AAAGAAAAATTCAGCCTGAACCCTAC CCTTATAAAACAGGTTAATTGGGT 4217 Table 3AHs.228817 AI199388 3751994 qs75e05.x1 cDNA 3′ −1TGTAAGTCCCATGCCCGAATTTGGAG end/clone = ATTTGGGTTTTTCTTTTCAGGGGTIMAGE:1943936/clone_end = 3′ 4218 Table 3A Hs.291003 AA504269 2240429hypothetical protein MGC4707 −1 CGGATTCCAAATTACTTAAAGCCTTTA (MGC4707),mRNA/cds = (72, 1067) TGGGAACACGGTAGATTGTAGGT 4219 Table 3A Hs.299416AA132448 1694015 zo20a03.s1 cDNA 3′ −1 GCCTTCTGGCCTCTGAGGCAAAGGTend/clone = CAGTGATACTGATGGGAGGGTAGGT IMAGE:587404/clone_end = 3′ 4220Table 3A Hs.6733 AI057025 3330814 phosphoinositide-specific −1GCTCAAGATCACCTCTTTGTCATCTT phospholipase C PLC-epsilon mRNA,GAACAATGTTTTTCTCTTCTAGGT complete cds/cds = (235, 7146) 4221 db miningHs.177712 AA251806 1886786 zs09c03.s1 cDNA 3′ −1TGTTTCCACTTCATGGGATATGACTC end/clone = CATCACAATGAAAATGGGTCCAGTIMAGE:684676/clone_end = 3′ 4222 Table 3A Hs.133175 AI51673 3307207oy77g06.x1 cDNA 3′ −1 TTGTGATTGTAAATCATGTATGTACAA end/clone =ATGCCATGAAAATTAAAGCCAGT IMAGE:1671898/clone_end = 3′ 4223 Table 3AHs.203041 AI271437 3890604 602417270F1 cDNA, 5′ −1TTTCCCTTATGCACCTTCCAGTCTTTG end/clone = GCAGGACATGATTTATGGACAGTIMAGE:4538737/clone_end = 5′ 4224 Table 3A Hs.56205 AA846378 2932518insulin induced gene 1 (INSIG1), −1 TGCACTCTACCAGATTTGAACATCTA mRNA/cds= (414, 1247) GTGAGGTTCACATTCATACTAAGT 4225 Table 3A NA AA873734 2969856Vanin 2 −1 TCAACTGCAGGGAATCTCCTAGGAAG CGGATAAATCTGGCAATTGGAAGT 4226Table 3A NA AA482019 2209697 cDNA clone IMAGE:746048 3′ −1ACCACCAGCTATTTGTAATTCCTTCTT CTAAGGCATAGTGAAAACTTGCT 4227 db miningHs.182594 AA806247 2875516 oc21f01.s1 cDNA, 3′ −1TCGCTTTCTAACTGATTCCATTCCAC end/clone = CATGTCAGATACTCCTGGGCTGCTIMAGE:1341529 4228 Table 3A Hs.210727 AI075288 3401879 oy69h10.x1 cDNA,3′ −1 CAGCAATGAGGGGATATTTTTGATGA end/clone = GCTGGAATATCCAATTGAACAGCTIMAGE:1671139/clone_end = 3′ 4229 Table 3A Hs.252300 AI383340 4196121tc76g05.x1 cDNA, 3′ −1 CCCCCTAAGTTAAAAGCTCTGTCTTT end/clone =TTGGGGTTTGCCCTATGTAAAGCT IMAGE:2070584/clone_end = 3′ 4230 Table 3AHs.191958 AI347054 4084260 immunoglobulin superfamily receptor −1GAAGCCTCTACTCTTGAGTCTCTTTC translocation associated 2 (IRTA2),ATTACTGGGGATGTAAATGTTCCT mRNA/cds = (158, 3091) 4231 Table 3A Hs.283410AI253134 3849663 602635144F1 cDNA, 5′ −1 ACACTTGATCTCTTCCTTATTTCTCTCend/clone = AGAAAACCTGTAGGATTGTGCCT IMAGE:4780090/clone_end = 5′ 4232Table 3A Hs.44189 AI361839 4113460 yz99f01.s1 cDNA, 3′ −1AGTAGATATTTTGCCGGTGTACTTGG end/clone = AATACCTTTCAGAAGCCAAACCCTIMAGE:291193/clone_end = 3′ 4233 Table 3A Hs.148288 AA908367 3047772og76c11.s1 cDNA, 3′ −1 AATTCCAATCCTGGTATATAGCACCT end/clone =GGTATTATGGGTACCAAAAACCCT IMAGE:1454228/clone_end = 3′ 4234 Table 3AHs.143534 AI095189 3434165 602466053F1 cDNA, 5′ −1ACTGCTCCAAATATCAACCCCATGTA end/clone = GGCAGGATGTTTGATCTTGGTACTIMAGE:4594260/clone_end = 5′ 4235 Table 3A Hs.23349 AI357493 4109114nab70e03.x1 cDNA, 3′ −1 TGTTGTTGGATACGTACTTAACTGGT end/clone =ATGCATCCCATGTCTTTGGGTACT IMAGE:3273292/clone_end = 3′ 4236 db miningHs.292235 AI057035 3330824 oy75b11.x1 cDNA, 3′ −1TTAGGATTGCTCAGTTTCATCAAGGT end/clone = TTGAAGGATAGGCAGGCTCTCACTIMAGE:1671645 4237 Table 3A Hs.337986 AA101212 1647866 Homo sapiens,clone MGC:17431 −1 GGCCAGTCTCTGTGTGTCTTAATCCC IMAGE:2984883, mRNA,complete 1 TTGTCCTTCATTAAAAGCAAAACT cds/cds = (1336, 1494) 4238 Table 3AHs.60088 AA004799 1448296 hypothetical protein MGC11314 −1GCATTCCCGGTCACTCCCTCCCTAAT (MGC11314), mRNA/cds = (221, 673)CTGAGCATCACTCAAGCTCTTTAT 4239 db mining Hs.177376 AA44590 2783354zb85a06.s1 cDNA, 3′ −1 CTGAATGCCAAGAGCTTCAAGAGTGT end/clone =GTGTAAATAAAGCCACACCTTTAT IMAGE:310354/clone_end = 3′ 4240 Table 3AHs.163787 AA627122 2540166 nq70g02.s1 cDNA, 3′ −1CCCGAGGAGGAAGACGAATCGTTAA end/clone = ACATCTGAAAGGGTCAGGTGAGTATIMAGE:1157714/clone_end = 3′ 4241 Table 3A Hs.332992 AA760848 2809778nz14f06.s1 cDNA, 3′ −1 CAAACTTGTTCTGAAGACAATTTCCA end/clone =AGGTTGTCAGCCATGTCACCATAT IMAGE:1287779/clone_end = 3′ 4242 Table 3AHs.129572 AA746320 2786306 ob08f01.s1 cDNA, 3′ −1TCAGGTTCGTGTTAAACGCTGTATGT end/clone = TAACTATGACTGGAATTCTGTGATIMAGE:1323097/clone_end = 3′ 4243 Table 3A Hs.233383 AA745714 2785700RC2-CT0434-310700-013-c08 cDNA −1 ATGGAGATCCAGAGACGTTGGTTTTCAAATGGAGCAAACAGCACTGTGAT 4244 Table 3A Hs.156601 AI146787 3874489qb83f02.x1 cDNA, 3′ −1 AGCTTTAGGCTGAGGGCATGGAAACT end/clone =GTTACGCTTTTCCTTTTATGTGAT IMAGE:1706715/clone_end = 3′ 4245 Table 3AHs.273775 AA527312 2269381 ng38a08.s1 cDNA, 3′ −1TCACTCCAGAATAGAAATTAGAGTAT end/clone = AGGTAGGCAGTCCAACCTCTGCATIMAGE:936854/clone_end = 3′ 4246 Table 3A Hs.159316 AI380278 4190131cDNA; FLJ21572 fis, clone −1 TCAGATGCCACACTTATGAGACCCTC COL06851/cds =UNKNOWN ATCCTTCTGCTCACTCTCTTCCAT 4247 Table 3A Hs.159424 AI3802554190106 602589478F1 cDNA, 5′ −1 CCCTGCCTTTACCTCTCTACTTGTAG end/clone =TGTTCTTTCAGAGCCTGCTCCCAT IMAGE:4723722/clone_end = 5′ 4248 Table 3AHs.114931 AA702108 2705221 zi85e01.s1 cDNA, 3′ −1CAAAACAAGATGTGCCAGGGCCTGG end/clone = GGGATGGGATAATTTCAGAGAGAATIMAGE:447576/clone_end = 3′ 4249 Table 3A Hs.179779 AI004582 3214092ribosomal protein L37 (RPL37), −1 ACCCAAGAGGGCAGCAGTTGTGTCA mRNA/cds =(28, 321) TCCAGTTCATCTTAAGAATTTCAAT 4250 Table 3A Hs.100555 AI3526904089896 DEAD/H (Asp—Glu—Ala—Asp/His) −1 GGGGTAGGAAGAGGATGGAATTGAG boxpolypeptide 18 (Myc-regulated) ATGTTTGAGCCTCATTTACATCAAT (DDX18),mRNA/cds = (71, 2083) 4251 Table 3A Hs.157213 AI351144 4088350qt23f10.x1 cDNA, 3′ −1 GCTCTCTGATGCTGGTGGCTGTTCCC end/clone =CCAGAATGGAAGCATTGATTAAAT IMAGE:1948459/clone_end = 3′ 4252 Table 3AHs.77399 AI337347 4074274 caudal type homeo box transcription −1GGGGAGAAGTGATATGGTGAAGGGA factor 2 (CDX2), AGTGGGGAGTATTTGAACACAGTTGmRNA/cds = (360, 1301) 4253 Table 3A Hs.128630 AI222805 3805008qp39c07.x1 cDNA, 3′ −1 CACCATGCCTCACTTTTAGCGCAGTG end/clone =TGATCCTACACAAATTGCCCTGTG IMAGE:1925388/clone_end = 3′ 4254 Table 3AHs.270341 AI270476 3889643 602307338F1 cDNA, 5′ −1TATGGTTTTTAGGCTATGCAGATATTC end/clone = TGTTGGTTTTTGAGACAGCTCTGIMAGE:4398848/clone_end = 5′ 4255 Table 3A Hs.190229 AA582958 2360318nn80d08.s1 cDNA, 3′ −1 CCTTCCTTTCTAAGGCATAAGTGCGA end/clone =CGTTCGCTGCTGTGCGTGGAACTG IMAGE:1090191/clone_end = 3′ 4256 Table 3AHs.170333 AI373163 4153029 qz13a07.x1 cDNA, 3′ −1GAGAGGAAGGCAGACAGGCAGCCAT end/clone = TTTAAGAGAGAAGAGCCAGACAATGIMAGE:2021364/clone_end = 3′ 4257 Table 3A Hs.158289 AI199223 3751829qi47c06.x1 cDNA, 3′ −1 GTTATCAAAGGTGGAATCGGAAACAC end/clone =CAGGCTCCTAGTGCCACGGAAATG IMAGE:1859626/clone_end = 3′ 4258 Table 3AHs.29282 AA748714 2788672 mitogen-activated protein kinase −1AAATGTGCCTATTGCTAGAGCTCCTC kinase kinase 3 (MAP3K3),CCTCTCAACACCCAGTTTCCTTGG mRNA/cds = (83, 1963) 4259 Table 3A Hs.230752AI025427 3241040 ow27g06.s1 cDNA, 3′ −1 CAATCGTCTTATCTCTACAGAGAGAAend/clone = GTGGAAAATTCTTTTTCAAGGGGG IMAGE:1648090/clone_end = 3′ 4260Table 3A Hs.131560 AI024984 3240597 ov39d11.x1 cDNA, 3′ −1CTATGGAAGGCAGTTGGTGGGCAAA end/clone = AGTCCGGTTTTTACGCTTTGAGGGGIMAGE:1839701/clone_end = 3′ 4261 Table 3A Hs.98306 AA418743 2080544mRNA for KIAA1862 protein, partial −1 GTCTGATCCTTAGACCGTCTCATCAC cds/cds= (0, 1874) AGCAACCCTAACTGCAGAGCAGGG 4262 Table 3A Hs.337307 AA7195372732636 zh40g12.s1 cDNA, 3′ −1 AATGGTAAGAAATGCCTTGTGTGGGT end/clone =GGCCCTCCAGTCCCCAGTCCAGGG IMAGE:414598/clone_end = 3′ 4263 Table 3A NAAA136584 1697794 fetal retina 937202 cDNA clone −1AACATATCCAGGGAGGACAAACTCTG IMAGE:565899 3′ GGCTGGACAATGTATCCACAAGGG 4264Table 3A Hs.339990 AI263141 3871344 qw90c01.x1 cDNA, 3′ −1GCCCATGGTCCTAGAATTAATTCCCC end/clone = TAAAAATTTTTGAAATAGGGGCGGIMAGE:1998338/clone_end = 3′ 4265 Table 3A Hs.309122 AI380449 4190302tg02f12.x1 cDNA, 3′ −1 GCCAACTGCTTAGAAGCCCAACACAA end/clone =CCCATCTGGTCTCTTGAATAAAGG IMAGE:2107631/clone_end = 3′ 4266 Table 3AHs.290535 AA719103 2732202 zh33d10.s1 cDNA, 3′ −1GAGCCCTTAAAATTACTGTATCTCCT end/clone = CTAAAGTGTGATTTAATGGCTGCGIMAGE:413875/clone_end = 3′ 4267 Table 3A Hs.188886 AA576947 2354421nm82b04.s1 cDNA, 3′ −1 CTTTTGCTGGAGACTCATCGCTTTGG end/clone =GAAGTGCATTTGCTTCGTCGTCCG IMAGE:1074703/clone_end = 3′ 4268 Table 3AHs.130232 AI089359 3428418 qb05h03.x1 cDNA, 3′ −1CCCAGTTCACAGTAGAGAGGTGGAG end/clone = CTTAGTACTTCCTGCTGCCCATTAGIMAGE:1695413/clone_end = 3′ 4269 Table 3A Hs.44828 AI384128 4196909EST389740 cDNA −1 CTGGGCTGTAGGTACTGCTGGGTCA CTGTTGCTATAAATGGTCACTGGAG4270 db mining Hs.184284 AI434146 4294137 ti36g07.x1 cDNA, 3′ −1CTTTAGATGTCCCACGTCCCTTCAAG end/clone = CACATGAAAGAGCTCACACTGGAGIMAGE:2132604/clone_end = 3′ 4271 Table 3A Hs.173720 AA534537 2278790nf80h10.s1 cDNA, 3′ −1 GACTCTGGAACTCGAGCGTGTGGCT end/clone =GCTGCGCCGACAGCTGAATCTAGAG IMAGE:926275/clone_end = 3′ 4272 Table 3AHs.120891 AA677952 2658474 zi14a06.s1 cDNA, 3′ −1CCTTAGAGATCGTGACCCTTCCTGCT end/clone = TGCCTCCCTGGTGGGCTCTTTCAGIMAGE:430738/clone_end = 3′ 4273 Table 3A Hs.142838 AI299573 3959158nucleolar protein interacting with the −1 AGAGTGAGAAGGCAGTTCCAGTTTTA FHAdomain of pKI-67 (NIFK), GCACAGATTTGTTTATGTGTTCAG mRNA/cds = (54, 935)4274 Table 3A Hs.8724 AI298509 3958245 serine threonine protein kinase(NDR), −1 TCTCAAGAGAGAACGCCACAGCAGA mRNA/cds = (595, 1992)GAGACCCAATCCGCCTAAGTTGCAG 4275 db mining Hs.204873 AI086035 3424458oy70h04.x1 cDNA, 3′ −1 AGGTTTGGGGAGGGGTCCCAGTCTG end/clone =CGATCCTTTCTCCCTCTTCGTGCAG IMAGE:1671223/clone_end = 3′ 4276 Table 3AHs.323950 AA916990 3056382 zinc finger protein 6 (CMPX1) (ZNF6), −1CCTCAGCTTCCAACTCTGATTCCAGG mRNA/cds = (1265, 3361)ACAGGATGGAAAACCTTTGGACAG 4277 Table 3A Hs.144114 AI074020 3400664oy66g06.x1 cDNA, 3′ −1 AATCCCTTGTACCATGTATACAAATG end/clone =AGACAAGTGAGCTTGACATTCAAG IMAGE:1670842/clone_end = 3′ 4278 Table 3AHs.235042 AI076222 3405400 oy65b09.x1 cDNA, 3′ −1GCTACAGCCCGGAACACAAAAGAAG end/clone = ACACCCATGCAAATACCATTAAAAGIMAGE:1670681/clone_end = 3′ 4279 Table 3A Hs.158975 AI380388 4190241tt96a03.x1 cDNA, 3′ −1 ATTAACCCTTTATTGCCCTAGCCAGT end/clone =GGGGTGGGAGGGAGAGATTGTTTC IMAGE:2107084/clone_end = 3′ 4280 Table 3A NAAI361642 4113263 qy86d04.x1 cDNA, 3′ −1 GTTATCCTTAGGCCAGGTCTCCCACCend/clone = TTTGAGCCGGACAAAACCAGAGTC IMAGE:2018887 4281 Table 3AHs.34549 AI123826 3539592 602620663F1 cDNA, 5′ −1TGCTGCTACAGTTGCAAAACACTGGA end/clone = GCTAGAGAAAATAAAGTACTGATCIMAGE:4746422/clone_end = 5′ 4282 Table 3A Hs.185062 AI085568 3423991oy68b05.x1 cDNA, 3′ −1 CGAGAGTCTTGCTGAGCCAGGACTT end/clone =GAGTGCCTCGAAGTTTTCAATGATC IMAGE:1670961/clone_end = 3′ 4283 Table 3AHs.180201 AA516406 2253788 hypothetical protein FLJ20671 −1ATCAGGAGAGGGAGATAATTAGTTGC (FLJ20671), mRNA/cds = (72, 494)TTCCTCCTTCACACTGTTTGAATC 4284 Table 3A Hs.54452 AI041828 3281022 zincfinger protein, subfamily 1A, 1 −1 TTGCCCTTTCCTCTCACTGCCTTTTAT (lkaros)(ZNFN1A1), AGCCAATATCAATGTCTCTTTGC mRNA/cds = (168, 1727) 4285 db miningHs.206654 AA705316 2715234 EST368531 cDNA −1 ATCCCTATTGCCAGACACATCATTCTCTCCATCCAGAAAGCCAACTTTGC 4286 Table 3A Hs.147040 AI187423 3738061ql31d04.x1 cDNA, 3′ −1 CTCTCTTCATCTTCTGATTGGGATTGT end/clone =GTCCAGTCCTCTGCTTCTTCTGC IMAGE:1751623/clone_end = 3′ 4287 Table 3AHs.105230 AA489227 2218829 aa57f07.s1 cDNA, 3′ −1GAGGGTTCTAGCAACTTAATCCCATT end/clone = AGCATGTTAGCTGAAGACTACTGCIMAGE:825061/clone_end = 3′ 4288 db mining Hs.309108 AI378046 4187899te67h12.x1 cDNA, 3′ −1 GTCCCAAGGGTCAGTATATTGGAGGA end/clone =AAGTAAAGGAGTGAATCAGACTGC IMAGE:2091815/clone_end = 3′ 4289 Table 3AHs.209203 AI343473 4080879 tb97a08.x1 cDNA, 3′ −1CTGGAATTACTAATGTGGAGGTGATC end/clone = TGAGAACTGGGAACAAAGTAGGGCIMAGE:2082262/clone_end = 3′ 4290 Table 3A Hs.158966 AI380236 4190089tf94b10.x1 cDNA, 3′ −1 TCCAGGGACTGACAAGAGTGAGTGG end/clone =TGTCAACCTAAAGAGAAACTCAGGC IMAGE:2106907/clone_end = 3′ 4291 Table 3AHs.50477 AA923567 3070876 Rab27a mRNA, complete −1CAGAACTCCATAGACAGCCTCACTTT cds/cds = (245, 910)GTGCTCGGGGGGCCTGTCCCAAGGC 4292 Table 3A Hs.133230 AA984890 3163415 Homosapiens, ribosomal protein S15, −1 GCACTTCTCCCGGTTCATCCCTCTCA cloneMGC:2295 IMAGE:3507983, AGTAATGGCTCAGCTAATAAAGGC mRNA, complete cds/cds= (14, 451) 4293 Table 3A Hs.165051 AI248204 3843601 qh64h11.x1 cDNA, 3′−1 TCCATCTCCTTTCTACTGTAGCGGAG end/clone = ACTACAAGTCCCAGGATGCCCCGCIMAGE:1849509/clone_end = 3′ 4294 Table 3A NA AA663244 2669135 schizobrain S11 cDNA clone −1 CCACATTCTTGCTGTCCACATCCTGC IMAGE:971252 3′TGGGTGAAATTGTGTTGAAGTAGC 4295 Table 3A NA AA826572 2898398 cDNA cloneIMAGE:1416447 3′ −1 TGACTGTCTTGGTAATTTTCTTCCTTG TTTTACTTCTGGAAACTGGGAGC4296 Table 3A Hs.11637 AI275205 3897479 602388093F1 cDNA, 5′ −1TGACTTTCAGGAATGTCAGCATTGAC end/clone = CTCTCCTTGCCACTGTTACTCAGCIMAGE:4517086/clone_end = 5′ 4297 Table 3A Hs.21812 AI131018 3601034AL562895 −1 AAGTTTGTGCAGCACATTCCTGAGTG cDNA/clone =TACGATATTGACCTGTAGCCCAGC CS0DC021YO20-(3-prime) 4298 Table 3A Hs.21812AI888714 5593878 AL562895 −1 AAGTTTGTGCAGCACATTCCTGAGTG cDNA/clone =TACGATATTGACCTGTAGCCCAGC CS0DC021YO20-(3-prime) 4299 Table 3A Hs.59459AA889552 3016431 ak20d12.s1 cDNA, 3′ −1 ACCAGACTTCAGGAAGAATAAAGGTCend/clone = GCCAACTCAATAAAACCACCAAGC IMAGE:1406519/clone_end = 3′ 4300Table 3A Hs.230805 AI087055 3425478 oy70c09.x1 cDNA, 3′ −1ACTTGCCACATAAACAGTTCCATCAT end/clone = AAAAACTCTTCCCCTTCTTGTTCCIMAGE:1671184/clone_end = 3′ 4301 Table 3A Hs.125608 AI380443 4190298tg02f04.x1 cDNA, 3′ −1 GCTTCCTTGAACCACCCAGAAATCCA end/clone =CTCAAATTTGGGGATTGTCATTCC IMAGE:2107615/clone_end = 3′ 4302 Table 3AHs.229385 AI354231 4094384 qv12c04.x1 cDNA, 3′ −1GGGGGTGATGGGTTAATTAAATAAGT end/clone = CCATTCCTGGGATTTGAGGGGGCCIMAGE:1981350/clone_end = 3′ 4303 Table 3A Hs.330928 AI371227 4149980601659234R1 cDNA, 3′ −1 ATGCCCCTCGTCCTAGAATTAATTCC end/clone =CCTAAAAATCTTTGAAATAGGGCC IMAGE:3895641/clone_end = 3′ 4304 db miningHs.141153 AI39639 3645611 tx43b11.x1 cDNA, 3′ −1TCAAACTAAGACCAGGGTTGAAAACT end/clone = ATGGCCCAGGGACCACTTCCAGCCIMAGE:2272317/clone_end = 3′ 4305 Table 3A Hs.134342 AI363001 4114622mRNA for LanC-like protein 2 (lancl2 −1 GACGCGCACACACCTTGAGTGACAGgene)/cds = (186, 1538) CGACCTCTTCTCTACAGGTTTTCCC 4306 Table 3AHs.226755 AA909983 3049273 RC1-UT0033-250800-022-h02 cDNA −1ATCCAAGCTTTAATTCTGCCATCTCA GAATGGTGATAAACCATTTCTCCC 4307 Table 3AHs.158894 AI378457 4188310 tc79d10.x1 cDNA, 3′ −1TACTTCATTGCTATTGTAAACCAAAAA end/clone = TAAAATTTGAAGCCCCCTGCCCCIMAGE:2072371/clone_end = 3′ 4308 Table 3A Hs.127327 AI084064 3422487EST390862 cDNA −1 CTTCATCACTCAGGAAACAGAAAAGG CTTCAGAAGGAGCGGCCATGCCCC4309 Table 3A Hs.295945 AW081320 6036472 xc30f12.x1 cDNA, 3′ −1AGAACCCGTATTCATAAAATTTAGAC end/clone = CAAAAAGGAAGGAATCGAACCCCCIMAGE:2585807/clone_end = 3′ 4310 Table 3A Hs.143410 AA825245 2898544oe59g09.s1 cDNA, 3′ −1 TTTTCTATTTTCATCTGTCATTTTCAC end/clone =TGCAGAGCGCACCTCCCGGACCC IMAGE:1415968/clone_end = 3′ 4311 db miningHs.228874 AI356505 4108126 qz22b04.x1 cDNA, 3′ −1AGACTGAAGGGGTTGAAAGACCCGT end/clone = AGACGCTCCTTTCCTCTTTTAGACCIMAGE:2027599/clone_end = 3′ 4312 Table 3A NA AI364936 4124625qz23c12.x1 cDNA, 3′ −1 CTCTGCGGCCCTAGAGTTAATCCCAT end/clone =CAGCCGAGGTGAGGCACCTGTTAC IMAGE:2027734 4313 Table 3A Hs.125892 AI3780324187885 ta67g08.x1 cDNA, 3′ −1 CCAATTCCGCAGTACAGAGCATTCAG end/clone =CAGGTAGTGGTGACCCTGGGTGAC IMAGE:2091806/clone_end = 3′ 4314 Table 3AHs.158943 AI379953 4189806 tc81a07.x1 cDNA, 3′ −1GGCTCCAGCCACCGGCAGCTCTGAA end/clone = AGAGTTTGAAGAATTTATTGTTCACIMAGE:2072532/clone_end = 3′ 4315 Table 3A Hs.108124 AI362793 4114414cDNA; FLJ23088 fis, clone −1 GCTCGCTACCAGAAATCCTACCGATA LNG07026/cds =UNKNOWN AGCCCATCGTGACTCAAAACTCAC 4316 db mining Hs.129332 AA9922993179055 ol53b06.s1 cDNA, 3′ −1 CACTGGAACACAACCCAGCCATGAAA end/clone =AGGAAGAAGCTCTGACTCAGGCAC IMAGE:1820467/clone_end = 3′ 4317 Table 3A NAAI318342 4034222 ta73c09.x1 3′ −1 CATCTCATGCGTAGCACTGATCAATG end/clone =TGCCCCAGGGTGTGTATTCGCCAC IMAGE:2049712 4318 Table 3A Hs.157447 AI0284783245787 EST388739 cDNA −1 CAATCAGAGCGCGAGTTACAAGCGCGGTGGAGTGGGGAAGCGAATGAAAC 4319 Table 3A Hs.205175 AA885473 2994550am10c12.s1 cDNA, 3′ −1 GACATTGCACATTTTTGAACCTGTCT end/clone =ACAGCAGCCTGGGTTGGTCACAAC IMAGE:1466422/clone_end = 3′ 4320 Table 3A NAAI370412 4149165 cDNA, clone −1 ACACTGGCAGAGTCCAGAAAAGCAG IMAGE:19875873′ CAGAAGAAAAATTCAGAGCAAAAAC 4321 Table 3A Hs.132594 AI346336 4083542qp50b04.x1 cDNA, 3′ −1 TTTAACGTGCTTCTGAGACAGCCACC end/clone =ACCGAAAGGCACCTTTAGCGGTTA IMAGE:1926415/clone_end = 3′ 4322 Table 3AHs.50252 AA984245 3162770 mitochondrial ribosomal protein L32 −1TCAGCCAACCTGAATCTGGTATCTTT (MRPL32), mRNA/cds = (46, 612)ACTTAAACACAGCAGTTGTAGTTA 4323 Table 3A NA AA744774 2783538 cDNA cloneIMAGE:1283731 3′ −1 AAAAGGAGACGATGTCAGGCAAACA CTCCTTACCCTGCCATTTCTAGTTA4324 db mining Hs.15200 AW190635 6465115 EST379783 cDNA −1TCACAATCAGTCTCAGATTCCCAGCA GCAGAGAGTGAATTGTATGTTGTA 4325 Table 3AHs.276766 AI380791 4190844 tg04b12.x1 cDNA, 3′ −1TAAAGACAATGCTATTTAAGTGCACA end/clone = GTTCCAGGGGCGCTTGTGGCTCTAIMAGE:2107775/clone_end = 3′ 4326 Table 3A NA AA573427 2347955 cDNAclone IMAGE:1028913 3′ −1 GAAGACCAAGTCTACGCCTGCAAGCTCTCAGACCGGGAACATCCACTCTA 4327 Table 3A Hs.127557 AA953396 3117543on63h10.s1 cDNA, 3′ −1 CTGAAGAGACAGAAAGGGAGACACC end/clone =AAAACTTTAATGGCAGTTATTCCTA IMAGE:1561411/clone_end = 3′ 4328 Table 3AHs.124391 AA831838 2904937 oc85h08.s1 cDNA, 3′ −1GCCGCCCCCATGAAGCCCTTTCTTAC end/clone = TGTAAGTGCTCAAGAACAAAGATAIMAGE:1358539/clone_end = 3′ 4329 Table 3A Hs.210943 AI823511 5444182wh54h10.x1 cDNA, 3′ −1 GCTAGCACGACTCTGCCTTGTTCCTT end/clone =TGGAGACAATTGTTATCATCAATA IMAGE:2384611/clone_end = 3′ 4330 Table 3A NAAA757952 2805815 zg49e07.s1 cDNA, 3′ −1 ATTGGGAATATAGATCATCAACAGACend/clone = ACAGCCCTGGACGCATAAATTTGA IMAGE:396708/ 4331 Table 3AHs.10056 AA576946 2354420 hypothetical protein FLJ14821 −1ACTAACGTATTTCATCATGGAAGGTC (FLJ14621), mRNA/cds = (525, 1307)CTGTGGTGATGGTTTTCCCTGGGA 4332 Table 3A Hs.132156 AI042377 3281571ox62c03.x1 cDNA, 3′ −1 AAGTAATAGCTCCCTGTTTGTGCCTT end/clone =GTTAGGGCTAGGGATGTTTAAGGA IMAGE:1660900/clone_end = 3′ 4333 Table 3AHs.173125 AI052431 3308422 peptidylprolyl isomerase F (cyclophilin −1AGCTCCTCCCCTTAGTGACCCCAAGT F) (PPIF), mRNA/cds = (83, 706)CTGTTTCCCTCAGCTGCATAAGGA 4334 Table 3A Hs.122983 AI081246 3418038oy67b06.x1 cDNA, 3′ −1 CCCTCAAATCTCCCAATCTACTCCAG end/clone =GGAAAAGACACTTCAAGTGAGAGA IMAGE:1670867/clone_end = 3′ 4335 db miningHs.85923 AA194310 1784006 zq04g12.s1 cDNA, 3′ −1ACATGCAAACAGTGACTTACTTAGTG end/clone = CTTCTGAAAAATTTCTGAGTCAGAIMAGE:628774/clone_end = 3′ 4336 Table 3A Hs.118659 AI052447 3308438oz07g04.x1 cDNA, 3′ −1 AATGCCCATTGGTAAGTCAACATTGT end/clone =TTTCCCTGAAAGTCCTGAGACAGA IMAGE:1674678/clone_end = 3′ 4337 Table 3AHs.231154 AA761571 2818898 oa30h07.s1 cDNA, 3′ −1CCATGTTTGCTGCTGCTGTTGAGTTT end/clone = CTGTGCTTTGGGAGTATAATAAGAIMAGE:1306525/clone_end = 3′ 4338 Table 3A Hs.57787 AW029440 5888196602381381F1 cDNA, 5′ −1 TGTGTTTGGTTGGGTGTAATGAGGAA end/clone =AATACCTGATAAAATGTCTGAAGA IMAGE:4498845/clone_end = 5′ 4339 Table 3AHs.57787 AA588755 2402486 602381381F1 cDNA, 5′ −1TGGATAAGTGAAGACAGTAATAACAT end/clone = TGAAGCAGTGAACCAGTGGAAAGAIMAGE:4498845/clone_end = 5′ 4340 Table 3A NA AA974991 3150783Soares_NFL_T_GBC_S1 −1 AGCACAAAAATGTTGAAGTATTAGGC cDNA cloneIMAGE:1560953 3′ CCAAGCTCCATGTTTGGTTAGTCA 4341 Table 3A Hs.127514AI028267 3245576 ow01d06.x1 cDNA, 3′ −1 CGTTTAACAATAATAAAGGTGACTGCend/clone = TTCATCTAAGGAATCCGAGCCGCA IMAGE:1645547/clone_end = 3′ 4342Table 3A Hs.88130 AI184553 3735191 qd60a05.x1 cDNA, 3′ −1GGGCATTCCACCGAAATTCTTGGGGA end/clone = AATTTAGTAGCCTTCATTTTAGCAIMAGE:1733840/clone_end = 3′ 4343 Table 3A Hs.158965 AI380220 4190073tf94a04.x1 cDNA, 3′ −1 TCCATGTTCTGTGCAAGAAGGAGACA end/clone =CATTTTCAGTTGAGGTTCCCAGCA IMAGE:2106894/clone_end = 3′ 4344 Table 3AHs.235823 AI379474 4189327 602631538F1 cDNA, 5′ −1AGCTCAACACTGTGGTAGGAAAATAG end/clone = CCACTAGAAAGAAAATAAAAAGCAIMAGE:4776728/clone_end = 5′ 4345 db mining Hs.229560 AI373169 4153035qz13b11.x1 cDNA, 3′ −1 GCATCTCCAGGGTTTAGCATCAGGAC end/clone =AGAGGATTAAGTAAATTCTTTCCA IMAGE:2021373/clone_end = 3′ 4346 Table 3AHs.146627 AI141004 3648461 oy68f02.x1 cDNA, 3′ −1GAGACTACAGAGCCTTAGCCCCTTTA end/clone = AAGCCCTTAAAGTTACTACTTCCAIMAGE:1671003/clone_end = 3′ 4347 Table 3A NA AA431959 2115667 cDNAclone IMAGE:782188 3′ −1 AGAGCAAGTCTCAGAAATAATGCTGTATCTACACTGTCATGTATTTGCCA 4348 db mining Hs.56156 AA257976 1894471601463367F1 cDNA, 5′ −1 TGGTTCTCTGATTTGTAATGAGCACC end/clone =TGGATATGTCAATTAAAATGCCCA IMAGE:3866512/clone_end = 5′ 4349 Table 3AHs.264298 AI380111 4189964 tf98a11.x1 cDNA, 3′ −1GCAAGACTGTTCAGTATTATGTTAGC end/clone = ATTGATATAAAAAGAAGCAGACCAIMAGE:2107292/clone_end = 3′ 4350 Table 3A Hs.40411 AI266255 3884413qx69f01.x1 cDNA, 3′ −1 AATGTTCCCAAAGGCCAAATTTGTTG end/clone =CCAGGTTTTATACGCAGGTCACCA IMAGE:2008617/clone_end = 3′ 4351 Table 3AHs.90753 AI223400 3805603 Tat-interacting protein (30kD) (TIP30), −1TGCCTATTGTGATTATCGCTATCACTA mRNA/cds = (98, 826) CATCCCCTGACTAAGGGAAACCA4352 Table 3A Hs.192427 AI380016 4189869 602296277F1 cDNA, 5′ −1ACAAAATTCACTGCAGGTCGGTGGAA end/clone = TGATAGAATGCATTTTAAATCACAIMAGE:4390770/clone_end = 5′ 4353 Table 3A NA AA524720 2265648 cDNAclone IMAGE:937468 3′ −1 GGACGGTTGGCTGAATGGCAACAGTGATGGAATATTTATATTTAGCCACA 4354 Table 3A Hs.92909 AA187234 1773460 NREBPmRNA, complete −1 ACATTGCACATTTAATAGCTGCACCA cds/cds = (49, 7209)GACACTAAGAGTTCCTCTCACACA 4355 Table 3A Hs.158877 AI378113 4187968tc80c12.x1 cDNA, 3′ −1 CGCTTGTCCTGTGAGTAGCTCGTCAC end/clone =CTGAGGCCTTGTCGTGAATATTAA IMAGE:2072470/clone_end = 3′ 4356 Table 3AHs.314941 AI039890 3279084 602381893F1 cDNA, 5′ −1TGGAGCAAACCACAGTTTCATGCCCA end/clone = TCGTCCTAGAATTAATTCCCCTAAIMAGE:4499447/clone_end = 5′ 4357 Table 3A Hs.157813 AI361761 4113382qz19a07.x1 cDNA, 3′ −1 GGGACAACACAGTGGATTTGAAATCT end/clone =GAAGGGGCATTGGTGGTACTGGAA IMAGE:2021940/clone_end = 3′ 4358 Table 3AHs.205079 AA742400 2784400 EST388750 cDNA −1 ACCTCCATATCTTCTCGTACTTGTTCCTGCTGGTCTCTTAGCTCTCCGAA 4359 Table 3A Hs.87908 AI381588 4194367Snf2-related CBP activator protein −1 CGAGGATGGTTTCCTGATAGCTTTCA(SRCAP), mRNA/cds = (210, 9125) AACACCTTTGCCATCTCTTCGCAA 4360 Table 3AHs.208854 AI766620 5233129 nab69e11.x1 cDNA, 3′ end −1ACTCCTGACAGCTCATCCTGCAAAAT /clone = IMAGE:3272949/clone_end = 3′TAAAATCCAAAATTTAAGTCGCAA 4361 Table 3A Hs.157556 AI356405 4108026qz26g04.x1 cDNA, 3′ end −1 GCTGGATCTCTGCCTAAAGTCACGGT /clone =IMAGE:2028054/clone_end 3′ AGGATGAGAAGTAGAAACGAGCAA 4362 Table 3AHs.182594 AA806222 2874997 wd43h11.x1 cDNA, 3′ end −1TCAGACCATAGGTGGGTGTTGTTTCT /clone = IMAGE:2330949/clone_end = 3′TTTAAGTGTGTGTACTGTGTCCAA 4363 Table 3A Hs.164168 AA806766 2880855ob58h11.s1 cDNA, 3′ end −1 TCATCTATGTAGCTTAATCTCATCGAC /clone =IMAGE:1335621/clone_end = 3′ GTTTCGGTTCATTTCCTGCACAA 4364 Table 3AHs.291129 AA581115 2358887 oe10d02.s1 cDNA −1 TTCCTTTTCCGCTAATCAAGAGTCCA/clone = IMAGE:1385475 GGGAGGTGGGAACAGCCTCAACAA 4365 Table 3A Hs.33757AI114852 8359997 HA1247 cDNA −1 CCGGCAGCTGTGTTTAGCCCCTCCAGATGGAAGTTTCACTTGAATGTAAA 4366 Table 3A Hs.121709 AA767883 2824475ai35b09.s1 cDNA, 3′ end −1 ACAAAGGAATGAAGCTTTATGACAGG /clone =1358969/clone_end = 3′ GCACGTGAAATGTTTATAGTGAA 4367 Table 3A NA AI3350044071831 tb21e09.x1 cDNA, 3′ end −1 ACTAAAGGTCACAACCCATTAACAAC /clone =IMAGE:2055016/clone_end = 3′ CATGAAATTGGTGTTGGGAAGAAA 4368 Table 3AHs.157815 AI361849 4113470 qz19h11.x1 cDNA, 3′ end −1TGCTCAGGAACCAAAAAGGATGTCT /clone = IMAGE:2022021/clone_end = 3′GCATGGAGGACAAAAAGGCACAAA 4369 Table 3A Hs.98903 AA913840 3053232602680377F1 cDNA, 5′ end −1 TGAGAACCGCGCACCCTACCCATCG /clone =IMAGE:4813147/clone_end = 5′ GCCACGTGACCAGTCCTTTTTAAAA 4370 Table 3AHs.292276 AI184710 3735348 qd64a01.x1 cDNA, 3′ end −1GTCTTTGGGTCAGTGTCATCATTCTC /clone = IMAGE:1734216/clone_end = 3′TTCAAGTCTGGGGCTTGGGGAAAA 4371 Table 3A Hs.143314 AI357640 4109261qy15b06.x1 cDNA, 3′ end −1 CTCCACACAGGAGAATCTCGGCGATT /clone =IMAGE:2012051/clone_end = 3′ TACACCCACAGGCTACGCAGAAAA 4372 Table 3AHs.259084 AI144328 3666137 hg02g06.x1 cDNA, 3′ end −1GCGCTGCTCCCAAAATCTATCTGCTG /clone = IMAGE:2944474/clone_end 3′TTTAATAGTTTTTACCTTTCAAA 4373 db mining Hs.327454 AI378123 4187976tc80e02.x1 cDNA, 3′ end −1 GGGTTCAGGGGGTTTTCCCTTTGCCC /cloneIMAGE:2072474/clone_end = 3′ GTTTGGCCCTGGGTTTAATAAAAA 4374 db miningHs.132775 AI028477 3245786 ti02c07.x1 cDNA, 3′ end −1CCAACTCCTCACAGGGCAGGCTAGC /clone = IMAGE:2129292/clone_end =GGGCACCAGGTCGCCGGGGAAGTG 3′ G 4375 db mining Hs.283392 AI052781 3308772oy78h07.x1 cDNA, 3′ end −1 CGGCTGAGAGCCCGGTAGGGCCCAG /clone =IMAGE:1671997/clone_end = GGGCCAAGCGCAGGCAGAGGCCGC 3′ G 4376 db miningHs.270564 AI361877 4113498 qz25d07.x1 cDNA, 3′ end −1CTTGGGGTCCAGGGCACAGCGGTGC /clone = IMAGE:2027917/clone_end = 3′CGGGGACACAGCAGTTCCGAGGGTC 4377 db mining Hs.110059 AA82600 2898912601763318F1 cDNA, 5′ end −1 AGTATGGTAATTAGAAAGCATGTTAG /clone =IMAGE:4026173/clone_end = 5′ AACATGTGGAAAAAGGGGGAAAAA 4378 Table 3A NAAI027844 3246543 cDNA clone IMAGE:1671612 3′ −1CATCAGTCCTCATCAGCTGAAGTGGC TTCCCAAGGATTTAAATAAATAGT 4379 Table 3AHs.229374 AI380491 4190344 602851994F1 cDNA, 5′ end −1AGACATTGACTACAGGGTAATTTCTA /clone = IMAGE:4993678/clone_end = 5′TGATTATATTATTTAGAAGTATGA 4380 Table 3A Hs.124344 H12462 877282MR1-GN0173-071100-009-g10 cDNA −1 CCAGTGAACTGTTAGCAACAATGCAGAAGAATCTGCATGTAATAAACTGA 4381 Table 3A Hs.144119 AI090305 3429384oy61b01.s1 cDNA, 3′ end −1 ACTTAAATGCCTTTTAATTTTTGTCGA /clone =IMAGE:1672201/clone_end = 3′ TGTAATAGTTTAATACCAGTAA 4382 Table 3AHs.333513 AI379735 4189588 small inducible cytokine subfamily E. −1TTTTTAATTCTAGCTTCTTTTTAAGA member 1 (endothelial monocycte-TTATTTGGGTACCTAATAAAGGA activating) (SCYE1), mRNA /cds = (49, 987) 4383Table 3A Hs.135339 AI051664 3307198 oy77f06.x1 cDNA, 3′ end −1CAAAGCCTCCACAGGAGACCCCACC /clone = IMAGE:1671875/clone_end = 3′CAGCAGCCCAGCCCCTACCCAGGAG 4384 db mining Hs.2186 AA182528 1766227 Homosapiens, eukaryolic translation 1 CGAGTGACATTGGCTGACATCACAGT elongationfactor 1 gamma, clone TGTCTGAACCTGTTGTGGCTCTAT MGC:4501 IMAGE:2964623,mRNA, complete cds/cds = (2278, 3231) 4385 db mining Hs.101370 AA2872601932959 AL583391 cDNA 1 TGAATTGCTTCAAAACCTCTTCCATCT /clone =CS0DL012YA12-(3-prime) CAGAAGACCAGACCCTGGGAACT 4386 Table 3A Hs.238514AA613460 2464498 xy5208.x1 cDNA, 3′ end 1 GCTGAAGTGGCAATAGAGAGAGTCT/clone = IMAGE:2856808/clone_end = 3′ GCTAGAAAGACGGAAGTCACCATCT 4387Table 3A NA AA665359 2880102 nt89f05.s1 NCI_CGAP_Pr12 cDNA 1TCTACTGACTATCCTAGAAATCGCTG clone IMAGE:1205697 similar toTCGCCTTAATCCAAGCCTACGTTT SW:ATP6_HUMAN P00846 ATP SYNTHASE A CH 4388 dbmining Hs.98507 AB011115 3043609 mRNA for KIAA0543 protein, partial 1GTGTGTGCTTAGCCAAATACAGTAAC cds/cds = (0, 3338) TGTGACTGGCCCAGGGATGTTCTC4389 db mining Hs.129268 AB037809 7243156 mRNA for KIAA1388 protein,partial 1 GTGAGTCCAATGTATGCTTTAGAAGT cds/cds = (572, 2371)AAAGACATTGACCGTCACAGACCA 4390 Table 3A Hs.296317 AB058692 14017794 mRNAfor KIAA1789 protein, partial 1 CTCAAGAAAAGACAGAAGAGAC cds/cds = (3466,4899) AGTGATTTGGGAGAGTCTACTCT AGGA 4391 Table 3A Hs.195175 AF0057752286146 mRNA for CASH alpha protein 1 ACCCTATGCCCATTGTCCTGATCTGA /cds =(481, 1923) AATTCTTGGAAATTGTTCCATGT 4392 db mining Hs.62187 AF0229132558890 GPI transamidase mRNA complete 1 TTCACAGTCTTCTATTGTTGGACCACcds/cds = (17, 1204) TTACATTGTACCAAATGTTTTCCT 4393 db mining Hs.248077AF044592 2852420 lymphocyte-predominant Hodgkin's 1ATTAAGCCCCCGTAGCCCATCCCGCA disease case #4 immunoglobulin heavyAGTTAGATACAGCTATGGTTAAGG chain gene, variable region 4394 db miningHs.248078 AF044595 2852426 lymphocyte-predominant Hodgkin's 1TTATATTGTAGTGGTGGTATTTGCTTT disease case #7 immunoglobulin heavyCCGCCTGTTGGCTACTTCGACCC chain gene, variable region 4395 Table 3AHs.25812 AF058896 3098674 Nijmegen breakage syndrome 1 1TTGTTCTCTGTCATGCCCACAATCCC (nibrin) (NBS1), mRNA/cds = (52, 2316)TTTCTAAGGAAGACTGCCCTACTA 4396 db mining Hs.300865 AF063725 3142513 cloneBCSynL38 immunoglobulin 1 ACTGAGGACGAGGCTGACTACTACT lambda light chainvariable region GTCAGTCTTATGATAGCACCTATCA mRNA, partial cds/cds = (0,116) 4397 db mining Hs.249208 AF063784 3135618 clone LBLG9 immunogobulinlambda 1 AGATGGAGGATGAAGCTGACTACTAC light chain variable region gene,partial TGTTACTCAAGAGACAGCAGTGGT cds/cds = (0, 289) 4398 db miningHs.293441 AF067420 3201899 SNC73 protein (SNC73) mRNA, 1CATGTCAATGTGTCTGTTGTCATGGC complete cds/cds = (395, 1549)GGAGGTGGACGGCACCTGCTACTG 4399 db mining Hs.293441 AF067420 3201899 SNC73protein (SNC73) mRNA, 1 GTCAATGTGTCTGTTGTCATGGCGGA complete cds/cds =(395, 1549) GGTGGACGGCACCTGCTACTGAGC 4400 db mining Hs.247721 AF0737053335589 clone mcg53-54 immunoglobulin 1 TCCAACCTCCAGTTTGAGGATGAGGClambda light chain variable region 4a TGATTATTACTGTGAGACCTGGGA mRNA,partial cds/cds = (0, 324) 4401 Table 3A Hs.22380 AF086431 3483776AL557896 cDNA 1 GACTACAACTGGCAATCCCAACTCCT /clone =CS0DJ003YD10-(5-prime) GGGCTAGGGCTTTTTCTACCTTTT 4402 db mining HS.283882AF103295 4838126 clone N97 immunoglobulin heavy 1TATTTCTGTGCGAGAGTTCCCCCTAA chain variable region mRNA, partialACATGGCGGAGGCTTCTTCTACAA cds/cds = (0, 377) 4403 Table 3A Hs.167827AF116909 4768835 clone HH419 unknown mRNA 1 TGGCTAGGAGACCTTGGGCAGTACC/cds = (189, 593) TACAGTCTTGCTGTTTCTGTTTCAT 4404 db mining Hs.149235AF119843 7770122 PR01085 mRNA, complete cds 1 GTGAGCTGAACAAATACATCATTTAA/cds = (539, 1582) ATCTATGCTGCACTTTGAGTTGCT 4405 db mining Hs.193053AF121255 6468774 protein translation initiation factor 2C2 1CCCGTGTGTTTACAGCATTTCCAGGT (EIF2C2) mRNA, partial cdsCCAGAGAGGTTGGCAGACAAGTGC /cds = (0, 1133) 4406 db mining Hs.247909AF127125 4337068 isolate 459 immunoglobulin lambda 1AGCTGTGGGATATAAGTAGTGGTCAT light chain variable region (IGL) gene,TATGTCTTCGGAGGTGGCACCACT partial cds/cds = (0, 265) 4407 db miningHs.204588 AF150138 5133574 AF150138 cDNA/clone = CBCBOG02 1GCCCTTTGAGAAAGACTTTGTTCCTG AACTGCTCCCTTCTCTTTTAGGGT 4408 db miningHs.205158 AF150141 5133577 AF150141 cDNA/clone = CBCBQD03 1GGTCTGGTTCTAGATCAGCCTTTTCA GTCTGCCCTGGCCTGGTCATTAAT 4409 db miningHs.205438 AF150373 5133809 AF150373 cDNA/clone = CBMACE02 1GAAAAACCTGGCTAGAGCAGAGCAC AGGATGTAAAAGGGTGGGGGAGAAC 4410 db miningHs.283929 AF161340 6841093 HSPC077 mRNA, partial cds 1GGTTATCTGAGCATAACAGGGACAG /cds = (0, 396) GGTGGGCCACAGGATACCTCTGAGG 4411db mining Hs.283931 AF181351 6841115 HSPC088 mRNA, partial cds 1ACAAGCAGGAGCACATCGCTCTTTTA /cds = (0, 305) TGAAGCCCTTCAACATTTAACGT 4412db mining Hs.326257 AF161360 6841133 602288541T1 cDNA, 3′ end 1CAGGGACACCACTTATCCTGCTTCCA /clone = IMAGE:4374059/clone_end = 3′CTATAGCATGAATCAGTGCTCTCT 4413 db mining Hs.283934 AF161365 6841143HSPC102 mRNA, partial cds 1 CATCGCACACGAATTTGAATCATCTG /cds = (0, 285)CTCTTTGGAATCGCCTACACCCTG 4414 db mining Hs.283935 AF161370 6841153HSPC107 mRNA, partial cds 1 TGTATGTAGGTGTCTGAGCTTCACAA /cds = (0, 473)GCCTTTTATAGTCCATTCAGCACT 4415 db mining Hs.283924 AF168811 5833844 clonecase06H1 immunoglobulin 1 CGACGACAACGGTGTATATTATTGTG heavy chainvariable region gene, CGAAAGATCGGGCAGATTTGACTT partial cds/cds = (0,322) 4416 db mining Hs.177461 AF174394 5802906 apoplotic-related proteinPCAR 1 CGGTGAGACTCAGTGAAAGCCATCA mRNA, partial cds/cds = (0, 439)GCAAAACTACAGTAATGCGGCACTA 4417 Table 3A Hs.160422 AF218032 10441993clone PP902 unknown mRNA 1 AAGTTAAACAAGACTCTGAAAGCCCT /cds = (693, 1706)AAATCAACTAGTCCGTCGGCTGCA 4418 db mining Hs.169992 AF308298 12060848serologically defined breast cancer 1 CTTGAGTGGTCCTCTTCTGCCTGCTG antigenNY-BR-84 mRNA, partial cds CTCATTTGTCTTGGGCAACCATTT /cds = (0, 721) 4419db mining Hs.170580 AI475577 4328822 tc92e07.y1 cDNA 5′ end 1CCCAGGAATATACAGTACTTCTGTAG /clone = IMAGE:2073636/clone_end = 5′TGTCCAGCCATTACTTAGCAAGGG 4420 Table 3A Hs.145668 AI793342 5341058 fmlc5cDNA/clone = CR6-21 1 TGCTCTGTCTGCTGGTTTGCATTGTTTCTGTCTGAGTTAAGAGACTGGCA 4421 Table 3A Hs.194382 AI904071 6494458 ataxiatelangiectasia (ATM) gene, 1 TTCTTTTCTCCGTTAGCCACGCAGCT complete cds/cds= (795, 9965) ACCTACTCCCGCTTCCGGTTCAAA 4422 db mining Hs.333140 AJ2250923090425 mRNA for single-chain antibody, 1 AAAACTCATCTCAGAAGAGGATCTGAcomplete cds (scFv2)/cds = (0, 806) ATGGGGCCGCACATCACCATCATC 4423 dbmining Hs.272356 AJ275371 7573002 partial IGVH3 gene for immunoglobulin1 GATGAACAGTCTGAGAGGCGAGGAC heavy chain V region, case 1, clone 16ACGGCCTTGTTTAACTGTGCGAGTC /cds = (0, 236) 4424 db mining Hs.272357AJ275374 7573008 >partial IGVH3 gene for 1 TACTACTTGCCAGGTCCAAGAACGGGimmunoglobulin heavy chain V region, GCGGGTCCTGTTATCATTATTACA 4425 dbmining Hs.272358 AJ275383 7573027 partial IGVH3 gene for immunoglobulin1 GCTGTGTTTTTCTGTGGGTGAAATAA heavy chain V region, case 1,AGGTTTCGGAGCCCGTTTTAGATA 4426 db mining Hs.272359 AJ275397 7573058partial IGVH1 gene for immunoglobulin 1 CATTTCTGTGCGAGAGTGAACAGGG heavychain V region, GACCCTAGAGGATTTCGTTGTGGGA 4427 db mining Hs.272360AJ275399 7573060 partial IGVL2 gene for immunoglobulin 1GGACTCCAGGCTGAGGACGAGGCTG lambda light chain V regionATTATTAGTGATGCTCATAAACAAG 4428 db mining Hs.272361 AJ275401 7573064partial IGVH3 gene for immunoglobulin 1 CTCTTATTGTGCGAGAGACCTCCCGG heavychain V region AACTGCCACTGAAGGTGGAGGCTA 4429 db mining Hs.272362AJ275405 7573073 partial IGVL1 gene for immunoglobulin 1CTCCCTGAGTATCTCGGGCCTCTAGC lambda light chain V regionCTGAGGACGAGGCTGATTATTATT 4430 db mining Hs.272364 AJ275413 7573089partial IGVH3 DP29 gene for 1 AAGAACTCACTGTATCTGCAAATGAA immunoglobulinheavy chain V region, CAGCCTGAAAACCGAGGACACGGC case 1, celll Mo VII116/cds = (0, 257) 4431 db mining Hs.272365 AJ275453 7573172 partialIGVH4 gene for immunoglobulin 1 CACGGCTGTGTTTAACTCTGCGACAT heavy chain Vregion GCGGGGGACTATGGTTCGGGGGAA 4432 db mining Hs.50102 AK002098 7023770mRNA for rapa-2 (rapa gene) 1 TCAGGGTGATTGAAGGACACATATTG /cds = (836,3742) AAGTACCTAGAATGCCAGAAAGTG 4433 db mining Hs.270247 AK02203910433357 cDNA FLJ11977 fis, clone 1 AACAAAACTGTGATTTATATCAAATAAHEMBB1001254/cds = UNKNOWN CAATGGCTTGGAGGGGGTATGGA 4434 db miningHs.156110 AK024974 10437403 cDNA:FLJ21321 fis, clone COL02335, 1TTTTCCACAGGGGACCTACCCCTATT highly similar to HSAD10442 mRNA forGCGGTCCTCCAGCTCATCTTTCAC immunoglobulin kappa light chain /cds = UNKNOWN4435 db mining Hs.156110 AK024974 10437403 cDNA:FLJ21321 fis, cloneCOL02335, 1 TTTTCCACAGGGGACCTACCCCTATT highly similar to HSA010442 mRNAfor GCGGTCCTCCAGCTCATCTTTCAC immunoglobulin kappa light chain /cds =UNKNOWN 4436 db mining Hs.156110 AK024974 10437403 cDNA:FLJ21321 fis,clone COL02335, 1 TTTTCCACAGGGGACCTACCCCTATT highly similar to HSA010442mRNA for GCGGTCCTCCAGCTCATCTTTCAC immunoglobulin kappa light chain /cds= UNKNOWN 4437 db mining Hs.323884 AK025398 10437905 cDNA:FLJ21745 fis,clone COLF5038 1 TGTGGCTGTACTTAACCTTCTCCAAC /cds = UNKNOWNATACATCCTGCATTACATGAATGG 4438 db mining Hs.1501 AK025488 10438019heparan sulfate proteoglycan (HSPG) 1 AAGCCTTTGAAGTGCCTCTGATTCTA coreprotein, 3′ end/cds = (0, 1193) TGTAACTTGTTGCAGACTGGTGTT 4439 db miningHs.267697 AK026199 10438971 cDNA:FLJ22546 fis, clone HS100290 1GCATTGACCTGGAAGGAGAGAAGAT /cds = UNKNOWN AGAGAGTGGAGGCTCTGAAGGAGAC 4440db mining Hs.287728 AK026793 10439729 cDNA:FLJ23140 fis, clone LNG090651 CAGTACAGGGCTGGCAAGCAGTGAT /cds = UNKNOWN CTCTCAGGTATATTTATCAATAATT4441 db mining Hs.104696 AK026832 10439779 mRNA for KIAA1324 protein,partial 1 CAAACCCTCCTTTCTGCTTGCCTCAA cds/cds = (0, 1743)ACCTGCCAAATATACCCACACTTT 4442 db mining Hs.24684 AK026917 10439889 mRNAfor KIAA1376 protein, partial 1 GGTGCTGAATATGTCCTTGTAGGCTC cds/cds =(143, 1456) TGTTTTAAGAAAACAATATGTGGG 4443 db mining Hs.152925 AK02726010440394 mRNA for KIAA1268 protein, partial 1 AGTGATTTGATTAACTCAGGGCAAGGcds/cds = (0, 3071) CTGAATATCAGAGTGTATCGCACT 4444 Table 3A Hs.301783AL049935 4884177 mRNA; cDNA DKFZp564O1116 (from 1GCTTCCACTGGAGGCTTGTATTGACC clone DKFZp584O1116) TTGTAACTATATGTTAATCTCGTG/cds = UNKNOWN 4445 db mining Hs.18368 AL080186 5262664 mRNA; cDFNADKFZp564BO769 (from 1 ATGCATGTTTACCAAAATGGCTGTTT clone DKFZp584B0769);partial cds ACAGTGCATTCAGTTCTGATATTT /cds = (0, 900) 4446 Table 3AHs.326292 AL134898 6603085 DNA sequence from clone RP5- 1ACATGACAGGTGTAATTAGTCTGCTG 1167H4 on chromosome 20 ContainsAGCCAGCTTTACCCAATGAAGGGC ESTs, STSs, GSSs and CpG islands. Contains anovel gene, the STK15 gene for serine/threonine kinase 15, the CSTF1gene for cleavage stimulation factor subunit 1 (50 kDa), a novel genesimilar to NEDD9 for neural precursor cell expresseddevelopmentally-down-regulated protein 9 (enhancer of filamentation 1,HEF1) (CRK-associated substrate- relateed protein, CAS-L) and a 60 Sribsomal protein, L39 (RPL39) pseudogene/cds = (44, 622) 4447 Table 3AHs.260024 AL136842 6807668 mRNA; cDNA DKEZp434A0530 (from 1AACAGCAACCAATAACGGATTGTAAA clone DKFZp434A0530); complete cdsGTGTAAAGGCACAGGTTACTCATG /cds = (968, 1732) 4448 db mining Hs.298358AL137406 6807955 mRNA; cDNA DKFZp434M162 (from 1CCATGCCAAGGAATGGAATTTCCATC clone DKFZp434M162) CTGAGCCAGTTCAGTTAGGTGTCA/cds = UNKNOWN 4449 db mining Hs.56265 AL137736 6808315 mRNA; cDNADKFZp586P2321 (from 1 CTAGAGTTCATCTCTGAGCTGTAAGG clone DKFZp586P2321)GTGACCAGGGGGCAGGGGGACGAT /cds = UNKNOWN 4450 Table 3A Hs.66151 AL1574387018513 mRNA; cDNA DKFZp434A115 (from 1 CAAGTAGACACCAGAGTCACTGTTTG cloneDKFZp434A115) GTTGGTGGGTGATAGTGGGGTCAC /cds = UNKNOWN 4451 Table 3AHs.106875 AL355722 7799110 EST from clone 35214, full insert 1TGTCACCCTTCCATGACGCCTCCTCT /cds = UNKNOWN GTGCATTTGAGTTCACTGTTTATG 4452db mining Hs.283849 AL359560 8655615 mRNA; cDNA DKFZp762F0616 (from 1GGTAACATGAGCTATGGCAGTCGGTT clone DKFZp762F0616) GTGAAACCACAGGAAGTGTATGGG/cds = UNKNOWN 4453 Table 3A Hs.23964 AL360135 8919158 sin3-associatedpolypeptide, 18 kD 1 CAAATCGGGCACCACCTCCTTCAGG (SAP18), mRNA/cds = (573,1034) GCGCATGAGACCATATTAATTCTA 4454 Table 3A Hs.10927 AL385373 9187358HSZ78330 cDNA/clone = 2.49-(CEPH) 1 CAGAACTGCTTTCCTATGTTTACCCAGGGGACCTCCTTTCAGATGAACTG 4455 db mining Hs.171118 AL583913 13093778 DNAsequence from clone RP11- 1 AGCAATAATATCTCTGTTTTCATTTCA 165F24 onchromosome 9. Contains GAACATTGTGCTGTCTGTCAGCA the 3′ end of the genefor a novel protein (similar to Drosophila CG6830 and CG11376, KIAA1058,rat TRG), an RPL12 (60 S ribosomal protein L12) pseudogene, ESTs, STSs,GSSs and a CpG island/cds = (0, 4617) 4456 Table 3A Hs.11806 AU12476310949479 7-dehydrocholesterol reductase 1 TTACAACTACATGATGGGCATCGAGT(DHCR7), mRNA/cds = (194, 1621) TTAACCCTTGGATCGGGAAGTGGG 4457 db miningHs.205435 AV740518 10858099 AV740518 cDNA, 5′ end 1AATGTTTGAGCTGACCAAGCTTCTGA /clone = CBDAGC01/clone_end = 5′GATTCTTAACAGAAAAAGCCATGT 4458 db mining Hs.204751 AV741208 10858789AF150335 cDNA/clone = CBLAQF05 1 ACGTCAGCTTAAAACTGGAAAGAAGTCTTCTGGTGTATACTGAGATTTGA 4459 db mining Hs.204932 AV743878 10861459AV743878 cDNA, 5′ end 1 GCCCAAAGGAGTAGCTCTCTGTTGTT /clone =CBLAOC04/clone_end = 5′ ACTGTTGTGCTCTTCATGGATAAA 4460 db miningHs.205159 AV744351 10861932 AF150295 cDNA/clone = CBLADB01 1GCAAAAAGCCCAAGAGCCTGAATTTA GACCAATCTATCATCTTCCTCCTC 4461 db miningHs.205789 AV758240 10914088 AV756240 cDNA, 5′ end 1TGGAGATGTGATAACAACTCCTTATC /clone = BMFAUH12/clone_end = 5′TCTTTGTTGGCTCATCTGAAGTGT 4462 db mining Hs.254948 AW291284 6697920UI-H-BI2-agi-h-10-0-UI.s1 cDNA, 3′ 1 CTTGCAGTAAAATGTAGCCCTTCCTCend/clone = IMAGE:2724714 CTGGTTGTGCAGGAGTGGCCCTCG /clone_end = 3′ 4463db mining Hs.250605 AW327360 6797855 dq02e11.x1 cDNA, 5′ end 1TTTCTTTAGCCCAAGAGTGGAGGCTA /clone = IMAGE:2846885/clone_end = 5′AGCTACTTACTTCCAAGCCTGGGT 4464 Table 3A Hs211194 AW362304 6866954CM3-CT0275-031199-031-a08 cDNA 1 AGGCAAAGGGAACTTGAAATTAGAAAACCCCAGAAACAGTCACAATGGCT 4465 Table 3A Hs.342300 AW389509 6894188xm47a06.x1 cDNA, 3′ end 1 AGGGTCCCTTCCATAGTCCTCCTGCA /clone =IMAGE:2687314/clone_end:3′ TCATTTTCCTCCAACTTGAATAAA 4466 Table 3AHs.202402 AW390251 6894910 CM4-ST0182-051099-021-b06 cDNA 1GCCAACCAGTTCAGAGTGTTCCCAAG GAATTGCCACCCTTACTCTTCAAA 4467 Table 3AHs.192123 AW838827 7932601 CM1-LT0059-280100-e02 cDNA 1ATCCCAGTCTCAAATTTCTTCATTTGG AACTGATATGTAGGCCCTCATCG 4468 Table 3AHs.194589 AW945338 8123293 AV703056 cDNA, 5′ end 1TCTCTCACTGTTATCATTTTTGCACAG /clone = ADBCAMB06/clone end = 5′GTGGTTTCAGCAGCTTGATGCCA 4469 Table 3A Hs.83724 BC000957 13111830 Homosapiens, clone IMAGE:3451448, 1 ATTGTCATTTAGACTTTGAACAGCTCT mRNA,partial cds/cds = (0, 901) GGGAAATAGAAGACTAGGGTTGT 4470 db miningHs.267690 BC001224 12654762 mRNA for KIAA1228 protein, partial 1TTTCCTTGTTCCCTCCCATGCCTAGC cds/cds = (0, 2176) TGGATTGCAGAGTTAAGTTTATGA4471 db mining Hs.76932 BC002332 12803062 Homo sapiens, Similar tohypothetical 1 GGATTCACCGTGGCCGACTCTTTTCC protein FLJ20419, cloneMGC:15417 CTGCTTTGGTTTGTTTGAAATCTA IMAGE:3942735, mRNA, complete cds/cds = (208, 918) 4472 Table 3A Hs.343272 BC002770 12803854 Homosapiens, clone IMAGE:3816574, 1 CCCTCCACACCATCCTCCCCGATTTA mRNA, partialcds/cds = (0, 640) AATATAGTCACTGCTACAAGTAAC 4473 db mining Hs.81221BC002792 12803890 Homo sapiens, clone MGC:3963 1TTCATCATTGCTTGCTTGCCTTCCTC IMAGE:3621362, mRNA, complete cdsCCTTCTGTCCGCTCTTACTCCCTC /cds (40, 402) 4474 db mining Hs.302063BC002963 12804210 rearranged immunoglobulin mRNA for 1GCAAACTAACCGTGTCAACGGGGTG mu heavy chain enhancer andAGATGTTGCATCTTATAAAATTAGA constant region/cds = UNKNOWN 4475 db miningHs.302063 BC002963 12804210 rearranged immunoglobulin mRNA for 1GCAAACTAACCGTGTCAACGGGGTG mu heavy chain enhancer andAGATGTTGCATCTTATAAAATTAGA constant region/cds = UNKNOWN 4476 db miningHs.302063 BC002963 12804210 rearranged immunoglobulin mRNA for 1GCAAACTAACCGTGTCAACGGGGTG mu heavy chain enhancer andAGATGTTGCATCTTATAAAATTAGA constant region/cds = UNKNOWN 4477 Table 3AHs.334787 BC003063 13937660 Homo sapiens, clone MGC:19556 1AGTATCTGCTTTCCAGGCTGAAGTGA IMAGE:4304831, mRNA, complete cdsTTCATTCATTATTCTAGTCCTGCT /cds = (1505, 1666) 4478 Table 3A Hs.334573BC006008 13937718 Homo sapiens, clone IMAGE:4285740, 1AAGCTGTCTTCTTTGTTGGACAATCA mRNA/cds = UNKNOWN GCCAGAATGATAAGCAAACCTGCA4479 db mining Hs.300697 BC006402 13623574 mRNA for immunoglobulinlambda 1 CTCTCGCGGTCGCACGAGGATGCTT heavy chain/cds = (65, 1498)GGCACGTACCCCCTGTACATACTTC 4480 db mining Hs.300697 BC006402 13623574mRNA for immunoglobulin lambda 1 CTCTCGCGGTCGCACGAGGATGCTT heavychain/cds = (65, 1498) GGCACGTACCCCCTGTACATACTTC 4481 db miningHs.300697 BC006402 13623574 mRNA for immunoglobulin lambda 1CTCTCGCGGTCGCACGAGGATGCTT heavv chain/cds (65, 1498)GGCACGTACCCCCTGTACATACTTC 4482 Table 3A Hs.155101 BC007299 13938338 mRNAfor KIAA1578 protein, partial 1 CTCCTGTGGATTCACATCAAATACCA cds/cds = (0,3608) GTTCAGTTTTGTCATTGTTCTAGT 4483 db mining Hs.184778 BC00758314043190 ribosomal protein L23a (RPL23A), 1 GGCTCCTGATTACGATGCTTTGGATGmRNA/cds = (23, 493) TTGCCAACAAAATTGGGATCATCT 4484 db mining Hs.250528BC007747 14043522 Homo sapiens, clone IMAGE:4098694, 1AACGCCAGCATTTTGTTAGAGGAGTT mRNA, partial cds/cds = (0, 2501)AGACTTGGAAAAGTTAAGGGAAGA 4485 Table 3A Hs.44155 BC008629 14250392 mRNA;cDNA DKFZp588G1517 (from 1 ATGGGGACTAAGGGATTAAGAGTGT cloneDKFZp588G1517); partial cds GAACTAAAAGGTAACATTTTCCACT /cds = (0, 2755)4486 Table 3A Hs.164280 BC008737 14250566 Homo sapiens, Similar tosolute carrier 1 ACTGGCGAGTATGTTCTATGTTGGGC family 25 (mitochondrialcarrier, CTCCTGCTGCAAAACAATAAACAG adenine nucleotide translocator),member 5, clone MGC:3042 IMAGE:3342722, mRNA, complete cds /cds = (88,984) 4487 Table 3A Hs.336425 BC009111 14318625 Homo sapiens, cloneMGC:17296 1 GCTGATTAACTGTATTCCCCTTTCCC IMAGE:3460701, mRNA, complete cdsCTATGGCTGCTGGTGTAAATAAAC /cds = (3250, 3498) 4488 db mining Hs.287797BC009469 14495714 mRNA for FLJ0043 protein, partial 1CCCAGGGTTTCATGTCTGAGGCCCTC cds/cds = (0, 4248) ACCAAGTGTGAGTGACAGTATAAA4489 literature Hs.287797 BC009469 14495714 mRNA for FLJ00043 protein,partial 1 CCCAGGGTTTCATGTCTGAGGCCCTC cds/cds = (0, 4248)ACCAAGTGTGAGTGACAGTATAAA 4490 db mining Hs.293842 BG506472 13467989601571679F1 cDNA, 5′ end 1 ACAAGAATGGTTGAGGCGAATATTG /clone =IMAGE:3838875/clone_end = 5′ GAACCACATGGGCTTAATGCTGAA 4491 db miningHs.224344 BG623174 13674545 602646078F1 cDNA, 5′ end 1ACACCTCTCTATTTTGAAGTCCCTAT /clone = IMAGE:4769802/clone_end = 5′GTGCCCTGTAATGTCTCGTTTTAA 4492 db mining Hs.127128 BI091076 14509406ok13e12.s1 cDNA, 3′ end 1 GGGAGAGCTCATGTCAGTGAATATAG /clone =IMAGE:1507726/clone_end = 3′ ATCATTCTGTTGATACCCTTCTTT 4493 db miningHs.330212 D20259 501358 HUMGS01233 cDNA, 3′ end 1TTGAAACTTGTAACTGAGATGCTGTA /clone = pm1527/clone_end = 3′GTTTTTTGCCATCTGTAGTGATGT 4494 db mining Hs.330467 D20413 501509HUMGS01387 cDNA, 3′ end 1 AAAGGGTTTTATCCACTGTCATTTCAA /clone =pm1535/clone_end = 3′ TTGGATAACATTTTGTCAAGTTT 4495 db mining Hs.330223D20542 501638 HUMGS01517 cDNA, 3′ end 1 TCGGAAAGAAGAAGTGGGAGGATGT /clone= pm1520/clone_end = 3′ GAATTTTAGTTCTGAGTTTACCAAA 4496 db miningHs.330255 D20847 504687 HUMGS01828 cDNA, 3′ end 1GATCGGGAACTGGCTCCGTTGTGCT /clone = mp1214/clone_end = 3′GAGGTCATCTTTGGTCATCAGCCTC 4497 db mining Hs.141296 D86979 6834000 mRNAfor KIAA0226 protein, partial 1 TGGTGCTTGTGCAGCCTGGCAGTTCA cds/cds = (0,3033) TTGTCATCTTTAATAAACTAAGGA 4498 db mining Hs.303450 H13491 878311yj15f02.r1 cDNA, 5′ end 1 AGAAGTACAAGATTTCGTTCTTCCTT /clone =IMAGE:148827/clone_end = 5′ CCATTAAAGTACAATCTCCCTGGG 4499 db miningHs.138563 H65914 1024654 601819705F1 cDNA, 5′ end 1TACAAGTGAAAGCTAAGATGAACACA /clone = IMAGE:4051657/clone_end = 5′TTTAAGTTAAATGGCAGCCTTGTT 4500 db mining Hs.73858 J05158 179935carboxypeptidase N mRNA, 3′ end 1 AAAAGGATGTGACAGAAGCAGAGAT /cds = (0,1810) GACCAGAAAGCACAGGGGCAGGGTT 4501 db mining Hs.69771 K01566 187721B-factor, properdin 1 GGGTTTTCTATAAGGGGTTTCCTGCTGAACAGGGGCGTGGGATTGAATTA 4502 literature Hs.278625 K02403 187768complement component 4B (C4B), 1 CCTGGGACCAGGGCATATTAAAGGC mRNA/cds =(51, 5285) TTTTGGCAGCAAAGTGTCAGTGTTG 4503 db mining Hs.132807 L29376561725 (clone 3.8-1) MHC class I mRNA 1 TTTGTGGCTTGGGGCTGCCTACTATAfragment/cds = UNKNOWN AACTATTGGGGGTTCGTCCATTTT 4504 db mining Hs.274509M16768 339399 T-cell receptor aberrantly rearranged 1TTTACACGCCCTGAAGCAGTCTTCTT gamma-chain mRNA from cell lineTGCTAGTTGAATTATGTGGTGTGT HPB-MLT/cds = UNKNOWN 4505 db mining Hs.247956M22005 188300 interleukin 2 gene, clone pATlaclL- 1AATTCCTGAACCGTTGGATCACCTTC 2C/2TT, complete cds, clone pATlaclL-TGTCAGTCCATCATCTCCACCCTG 2C/2TT/cds = (0, 404) 4506 db mining Hs.247923M31949 185254 Ig rearranged mu-chain V-region gene, 1CTTACGTTGGGACACCTAAATTCGCC subgroup VH-III, exon 1 and 2GCGTCTGTAGAAGGCAGATTCGAG 4507 db mining Hs.247930 M55420 185346 IgEchain, last 2 exons 1 AAAACCGTGTCTGTCCCTTCAACAGAGTCATCGAGGAGGGGTGGCTGCTA 4508 literature NA M73276 177970 Humanangiolensin I-converting 1 AAACTGCCGGGTCCCCATCTTCAAAA enzyme (ACE) gene,5′ flank GAGAGGAGGCCCTTTCTCCAGCTT 4509 Table 3A Hs.154365 M82882 180551cis-acting sequence/cds = UNKNOWN 1 CAAGAAAGCAACTTGAGCCTTGGGCTAATCTGGCTGAGTAGTCAGTTATA 4510 Table 3A Hs.171699 N31778 1152177yx70d02.r1 cDNA, 5′ end 1 TGTGTTCTTTGAGTTCCCCCTTTACC /clone =IMAGE:267075/clone_end = 5′ CAAAAGTAATTTGGGGACCAAAGT 4511 db miningHs.206035 N39815 1163360 yx93c06.r1 cDNA, 5′ end 1GGGAAGGCAATCTGATGGGGAAGTT /clone = IMAGE:269290/clone_end = 5′GGCAATTTCTGGTTTGGGTGATTTA 4512 db mining Hs.169401 NM_000041 4557324apolipoprotein E (APOE), mRNA 1 CCAGCCGTCCTCCTGGGGTGGACCC /cds = (60,1013) TAGTTTAATAAGATTCACCAAGTT 4513 literature Hs.38069 NM_0000664557390 complement component 8, beta 1 CATGCAAGGGCAAAAGGCAGTGCCApolypeptide (C8B), mRNA TGCAAGCTGTTTAAATAAAGATGT /cds = (27, 1802) 4514literature Hs.317585 NM_000088 14719828 cDNA:FLJ21026 fis, cloneCAE06812 1 AGGGGTGGGAGGAAGCAAAAGACTC /cds = (27, 677)TGTACCTATTTTGTATGTGTATAAT 4515 db mining Hs.1472 NM_000173 4504070glycoprotein Ib (platelet), alpha 1 TCAGGATGTGAGCACTCGTTGTGTCTpolypeptide (GP1BA), mRNA GGATGTTACAATATGGGTGGTTT /cds = (42, 1922) 4516literature Hs.180532 NM_000175 4504086 Homo sapiens, cloneIMAGE:4098234, 1 TGTTCACGTTGTTCACATCCCATGTA mRNA, partial cds/cds = (0,904) GAAAAACAAAGATGCCACGGAGGA 4517 db mining Hs.290070 NM_000177 4504164gelsolin (amyloidosis, Finnish type) 1 AGCCCTGCAAAAATTCAGAGTCCTTG (GSN),mRNA/cds = (14, 2362) CAAAATTGTCTAAAATGTCAGTGT 4518 literature Hs.227730NM_000210 1111111 integrin, alpha 8 (ITGA6), mRNA 1TGTCATCTCAAGTCAAGTCACTGGTC /cds = (146, 3387) TGTTTGCATTTGATACATTTTTGT4519 db mining Hs.90598 NM_000247 4557750 MHC class Ipolypeptide-related 1 GAGTGACCACAGGGATGGCACACAG sequence A (MICA), mRNACTCGGATTTCAGCCTCTGATGTCAG /cds = (39, 1190) 4520 db mining Hs.1817NM_000250 4557758 myeloperoxidase (MPO), nuclear gene 1GCCTGTTGCCCTTTCTGTACCATTTA encoding mitochondrial protein, mRNATTTGCTCCCAATGTTTATGATAAT /cds = (177, 414) 4521 db mining Hs.1817NM_000200 4567758 myeloperoxidase (MPO), nuclear gene 1GCCTGTTGCCCTTTCTGTACCATTTA encoding mitochondrial protein, mRNATTTGCTCCCAATGTTTATGATAAT /cds = (177, 2414) 4522 db mining Hs.75093NM_000302 4557836 procollagen-lysine, 2-oxoglutarate 5- 1TCCTGGATGCCTCTGAAGAGAGGGA dioxygenase (lysine hydroxylase,CAGACCGTCAGAAACTGGAGAGTTT Ehlers-Danios syndrome type VI) (PLOD),mRNA/cds = (200, 2383) 4523 db mining Hs.10712 NM_000314 4506248phosphatase and tensin homolog 1 ACTTAACCATATAAATGTGGAGGCTA (mutated inmultiple advanced cancers TCAACAAGAATGGGCCTGAAACA 1) (PTEN), mRNA/cds =(1034, 2245) 4524 Table 3A Hs.83848 NM_000365 4507844 triosephosphateisomerase 1 (TPI1), 1 GTGCCTCTGTGCTGTGTATGTGAACC mRNA/cds = (34, 783)ACCCATGTGAGGGAATAAACCTAG 4525 Table 3A Hs.78943 NM_000388 455366bleomycin hydrolase (BLMH), mRNA 1 AAACAGACCTAATGCTCCTTGTTCCT /cds =(78, 1445) AGAGTAGAGTGGAGGGAGGGTGGC 4526 literature Hs.285401 NM_0003954559497 colony stimulating factor 2 receptor, 1GAGATAGCCTTGCTCCGGCCCCCTT beta, low-affinity (granulocyte-GACCTTCAGCAAATCACTTCTCTCC macrophage) (CSF2RB), mRNA /cds = (26, 2721)4527 db mining Hs.283743 NM_000407 9945387 glycoprotein ib beta mRNA,complete 1 CTGCTGCGTCTCCCTTCCAAACTCTG cds/cds = (636, 1871)GTGCTGAATAAACCCTTCTGATCT 4528 db mining Hs.20019 NM_000410 4504376hemochromatosis (HFE), mRNA 1 CACTTGGCTGCATAAATGTGGTACAA /cds = (221,1267) CCATTCTGTCTTGAAGGGCAGGTG 4529 literature Hs.8966 NM_00049111038661 complement component 1, q 1 CAGCCAATGGACACAGTAGGGCTTGsubcomponent, beta polypeptide GTGAATGCTGCTGAGTGAATGAGTA (C1QB),mRNA/cds = (63, 824) 4530 db mining Hs.278430 NM_000500 14550408cytochrome P450, subfamily XXIA 1 TGCAGAGGATTGAGGCTTAATTCTGA (steroid21-hydroxylase, congenital GCTGGCCCTTTCCAGCCAATAAAT adrenalhyperplasia), polypetide 2 (CYP21A2), mRNA/cds = (118, 1605) 4531 dbmining Hs.502 NM_000544 9961245 transporter 2, ATP-binding cassette, 1TTGACCTTCCACTAGACCATGAGCAC sub-family B (MDR/TAP) (TAP2),CTGGGCGGAAAGCCATATATCTTA transcript variant 1, mRNA /cds = (96, 2207)4532 literature Hs.93210 NM_000562 4557388 complement component 8, alpha1 ACAAGCAGACACCTGAAACAATCAAC polypeptide (C8A), mRNAGCCCAATAAAACAAAGTAGGATGA /cds = (137, 1891) 4533 db mining Hs.68876NM_000564 10835130 interleukin 5 receptor, alpha (IL5RA), 1TGAGGAAGAAAGCATTTTGCATCAGC mRNA/cds = (249, 1511)CTGGAGTGAACCATGAACTTGGAT 4534 literature Hs.241053 NM_000573 10834973AL572804 cDNA 1 GGAATAAGGTGTTGCCTGGAATTTCT /clone =CSODI034YD15-(3-prime) GGTTTGTAAGGTGGTCACTGTTCT 4535 Table 3A Hs.89679NM_000586 10835148 interleukin 2 (IL2), mRNA 1TGAACAGATGGATTACCTTTTGTCAA /cds = (47, 517) AGCATCATCTCAACACTAACTTGA4536 literature Hs.78065 NM_000587 4557386 complement component 7 (C7),1 CCCAGAGTTTTCAGGGAGTACACAG mRNA/cds = (0, 2531)GTAGATTAGTTTGAAGCATTGACCT 4537 literature Hs.960 NM_000590 10834979interleukin 9 (IL9), mRNA 1 TTCCAGAAAGAAAAGATGAGAGGGAT /cds = (11, 445)GAGAGGCAAGATATGAAGATGAAA 4538 literature Hs.1285 NM_000606 4557392complement component 8, gamma 1 GGCTGCCCCAGAGGACAGTGGGTGG polypeptide(C8G), mRNA AGTGGTACCTACTTATTAAATGTCT /cds = (61, 669) 4539 literatureHs.167988 NM_0006151 0834989 neural cell adhesion molecule 1 1CCGAGCAAAGATCAAAATAAAAAGTG (NCAM1), mRNA/cds = (201, 2747)ACACAGCAGCTTCACCAGAGCATT 4540 Table 3A Hs.17483 NM_000816 10835166chromosome 12p13 sequence 1 TTTCCTTCAAGCCTAGCCCTTCTCTC /cds = (194,1570) ATTATTTCTCTCTGACCCTCTCCC 4541 db mining Hs.100007 NM_00063510835184 regulatory factor X, 2 (influences HLA 1GGGTCAGTGTTCAAGAAGGAAAGCA class II expression) (RFX2), mRNAGTTGTTGAAGCTACAGAAGCCCAGG /cds = (159, 2330) 4542 db mining Hs.25954NM_000640 10834991 interleukin 13 receptor, alpha 2 1TGAAGACTTTCGATATCAAGAGACAT (IL13RA2), mRNA/cds = (93, 1235)GGTATTGACTCAACAGTTTCCAGT 4543 db mining Hs.1721 NM_000641 10834993interleukin 11 (IL11), mRNA 1 GGACTGTCATTCAGGGAGGCTAAGG /cds = (63, 662)AGAGAGGCTTGCTTGGGATATAGAA 4544 db mining Hs.78712 NM_000688 4502024aminolevulinate, delta-, synthase 1 1 TCACTTAACCCCAGGCCATTATCATA(ALAS1), nuclear gene encoding TCCAGATGGTCTTCAGAGTTGTCT mitochondrialprotein, mRNA /cds = (76, 1998) 4545 db mining Hs.3003 NM_000733 4502670CD3E antigen, epsilon polypeptide 1 CCACTGGATGGTCATTTGGCATCTCC (TiT3complex) (CD3E), mRNA GTATATGTGCTCTGGCTCCTCAGC /cds = (54, 677) 4546Table 3A Hs.1349 NM_000758 4503076 colony stimulating factor 2(granulocyte 1 CTGGGCCACACTGACCCTGATACAG macrophage) (CSF2), mRNAGCATGGCAGAAGAATGGGAATATTT /cds = (8, 442) 4547 db mining Hs.1349NM_000758 4503078 colony stimulating factor 2 (granulocyte 1CTGGGCCACACTGACCCTGATACAG macrophage) (CSF2), mRNAGCATGGCAGAAGAATGGGAATATTT /cds = (8, 442) 4548 literature Hs.86958NM_000874 4504600 interleukin receptor ifnar2-1 (splice 1TGATAGCATTGGTCTTGACAAGCACC variant IFNAR2-1) mRNA, completeATAGTGACACTGAAATGGATTGGT cds/cds = (326, 1321) 4549 literature Hs.86474NM_000962 11386140 prostaglandin-endoperoxide synthase 1CTGAGGATGTAGAGAGAACAGGTGG 1 (prostaglandin G/H synthase andGCTGTATTCACGCCATTGGTTGGAA cyclooxygenase) (PTGS1), mRNA /cds = (5, 1804)4550 Table 3A Hs.180450 NM_001026 14918502 ribosomal protein S24(RPS24), 1 CTGGCAAAAAGCCGAAGGAGTAAAG transcript variant 1, mRNAGTGCTGCAATGATGTTAGCTGTGGC /cds = (37, 429) 4551 Table 3A Hs.113029NM_001028 14591916 ribosomal protein S25 (RPS25), 1TGGTCCAAAGGCAAAGTTCGGGACA mRNA/cds = (63, 440) AGCTCAATAACTTAGTCTTGTTTGA4552 literature Hs.161305 NM_001057 4507344 tachykinin receptor 2(TACR2), mRNA 1 CAACAGGTGTCACACTAAGGAGACTT /cds = (0, 1196)TGTTCATGGCTGGGGACACAGCCC 4553 literature Hs.1080 NM_001058 7669544tachykinin receptor 1 (TACR1), 1 GCATGGAAATTCCCTTCATCTGGAAC transcriptvariant long, mRNA CATCAGAAACACCCTCACACTGGG /cds = (210, 1433) 4554literature Hs.942 NM_001059 7669547 tachykinin receptor 3 (TACR3), mRNA1 GGCAGCTATGGTCAAATTGAGAAAGG /cds = (143, 1540).TAGTGTATAAATGTGACAAAGACA 4555 db mining Hs.86947 NM_001109 4557252 adisintegrin and metalloproteinase 1 GCTATCTTGTCTGGTTTTCTTGAGAC domain 8(ADAMB), mRNA CTCAGATGTGTGTTCAGCAGGGCT /cds = (9, 2483) 4556 literatureHs.1239 NM_001150 4502094 alanyl (membrane) aminopeptidase 1CCGCCCTGTACCCTCTTTCACCTTTC (aminopeptidase N, aminopeptidase M,CCTAAAGACCCTAAATCTGAGGAA microsomal aminopeptidase, CD13, p150) (ANPEP),mRNA /cds = (120, 3023) 4557 db mining Hs.507 NM_001264 4502758corneodesmosin (CDSN), mRNA 1 CATATGGGAGAAGGCCAGTGCCCAG /cds = (14,1603) GCATAGGGTTAGCTCAGTTTCCCTC 4558 Table 3A Hs.74441 NM_001273 4557452chromodomain helicase DNA binding 1 TTAATACCAGGAACCCAGCGGCTCTA protein 4(CHD4), mRNA GCCACTGAGCGGCTAAATGAAATA /cds = (89, 5827) 4559 db miningHs.5057 NM_001304 8051580 carboxypeptidase D (CPD), mRNA 1GTGGAGGGGTTTACCACCTTCCTAG /cds = (15, 4148) GTCGTTCAACCAGGTTTTGTGAGGA4560 db mining Hs.2246 NM_001308 4503010 carboxypeptidase N, polypeptide1, 1 GCAACCCTTCAGAAAGGCTTTGCTCC 50 kD (CPN1), mRNA/cds = (213, 1589)TGCTCTCAGATCAGATCAAGCATT 4561 db mining Hs.336918 NM_001356 4503258death-associated protein 6 (DAXX), 1 AACATTTGGAGGAAGGTGGGAAGCA mRNA/cds= (147, 2369) GATGACTGAGGAAGGGATGGACTAA 4562 Table 3A Hs.268036NM_001402 4503470 tRNA isopentenylpyrophosphate 1TGCCCAGAAAGCTCAGAAGGCTAAT transferase (IPT), mRNAGAATAzttATCCCTAATACCTGCCA /cds = (60, 1040) 4563 Table 3A Hs.129673NM_001416 4503528 eukaryotic translation initiation factor 1AGAGGACTCTTCGAGACATTGAGACC 4A, isoform 1 (EIF4A1), mRNATTCTACAACACCTCCATTGAGGAA /cds = (16, 1236) 4664 Table 3A Hs.99855NM_001462 4503780 formyl peptide receptor-like 1 (FPRL1), 1TGGGGTAAGTGGAGTTGGGAAATAC mRNA/cds = (772, 1827)AAGAAGAGAAAGACCAGTGGGGATT 4565 literature Hs.198252 NM_001504 4504098 Gprotein-coupled receptor 9 (GPR9), 1 AACTAAAACTTCATCTTCCCCAAGT mRNA/cds= (68, 1174) GCGGGGAGTACAAGGCATGGCGTA 4566 db mining Hs.113207 NM_0015054504090 G protein-coupled receptor 30 1 AAAACCTTCCCATAAAATGTAAGAAA(GPR30), mRNA/cds = (691, 1818) AGCTGATGAGGCTGGTGACGTTCA 4567 db miningHs.278589 NM_001518 14670355 general transcription factor II, i 1TGACATGGTAGCAGAAATAGGCCCTT (GTF2I), transcript variant 1, mRNATTATGTGTTGCTTCTATTTTACCT /cds = (370, 3368) 4568 db mining Hs.101840NM_001531 4504416 major histocompatibility complex, class 1GCCACAAAATGTTCTTTGTTCTTTGG I-like sequence (HLALS), mRNACTCCAAAAAGACTGTCAGCTTTCA /cds = (5, 1030) 4569 db mining Hs.81234NM_001542 4504626 mRNA for KIAA0466 protein, partial 1CTGAGGCTCTCCCTTTCTCTGTGATT cds/cds = (40, 3684) GGACAGTTGACAGCACCCAAACTC4570 db mining Hs.22111 NM_001555 4504624 mRNA for KIAA0364 gene,complete 1 CCCTGTAACTCCTCACTGTACTGATT cds/cds = (1144, 5127)TACTGGCGCATGAAATTCTATTAA 4571 Table 3A Hs285115 NM_001560 4504648interleukin 13 receptor, alpha 1 1 CTTGAGTAAAATAAATATTGTCTTTTT(IL13RA1), mRNA/cds = (43, 1326) GTATGTCAAGCGGGCCGCCACCG 4572 literatureHs.1211 NM_001811 6138970 acid phosphatase 5, tartrate resistant 1GGGAGGGAGGGAGGGAAAGCTTCCT (ACP5), mRNA/cds = (89, 1086)CCTAAATCAAGCATCTTTCTGTTAC 4573 literature Hs.10247 NM_001627 4502028mRNA for MEMD protein 1 TCACAGATGCATATAGACACACATAC /cds = (0, 1748)ATAATGGTACTCCCAACTGACAA 4574 db mining Hs.268571 NM_001645 5174774intergenic region between apoE and 1 GCTGAGGACTCCCGCCATGTGGCCC apoCIgene/cds = UNKNOWN CAGGTGCCACCAATAAAAATCCTAC 4575 db mining Hs.69771NM_001710 14550403 B-factor, properdin (BF), mRNA 1CAAGATGAGGATTTGGGTTTTCTATA /cds = (129, 2423) AGGGGTTTCCTGCTGGACAGGGGC4576 literature Hs.1281 NM_001735 4502506 complement component 5 (C5), 1AAACATGGCCTTTGCTTGAAAGAAAA mRNA/cds = (12, 5042)TACCAAGGAACAGGAAACTGATCA 4577 literature Hs.11763 NM_001771 4502650 CD22antigen (CD22), mRNA 1 GTTTGAGATGGACACACTGGTGTGGA /cds = (56, 2599)TTAACCTGCCAGGGAGACAGAGCT 4578 literature Hs.83731 NM_001772 4502654 CD33antigen (gp67) (CD33), mRNA 1 GGACCAAAGGCTGATTCTTGGAGATT /cds = (12,1106) TAACTCCCCACAGGCAATGGGTTT 4579 Table 3A Hs.340325 NM_001774 4502682yf59e04.s1 cDNA, 3′ end 1 AATATTTGTTTAATCCCCAGTTCGCCT /clone =IMAGE:26202/clone_end = 3′ GGAGCCCTCCGCCTTCACATTCC 4580 literatureHs.82685 NM_001777 4502672 CD47 antigen (Rh-related antigen, 1AAAGTAACTGGTTGTCACCTATGAGA integrin-associated signal transducer)CCCTTACGTGATTGTTAGTTAAGT (CD47), mRNA/cds = (106, 1077) 4581 literatureHs.264190 NM_001780 4502678 cDNA:FLJ22121 fis, clone HEP18876, 1CTCAGCCTCCTCATCTGGGGGAGTG highly similar to AF191298 vacuolarGAATAGTATCCTCCAGGTTTTTCAA sorting protein 35 (VPS35) mRNA /cds = UNKNOWN4582 literature Hs.3107 NM_001784 4502690 CD97 antigen (CD97), mRNA 1GGCAGGAGGTTCTCACTGTTGTGAA /cds = (70, 2298) GGTTGTAGACGTTGTGTAATGTGTT4583 Table 3A Hs.10029 NM_001814 4503140 cathepsin C (CTSC), mRNA 1AAGTGGGAATTTTCTGGAAGATGGTC /cds = (33, 1424) AGCTATGAAGTAATAGAGTTTGCT4584 db mining Hs.11 NM_01815 4502792 carcinoembryonic antigen-relatedcell 1 GCCTGTGGCCCACCTGGGGTCACTT adhesion molecule 3 (CEACAM3),GGAAAGGATCTGAATAAAGGGGACC mRNA/cds = (54, 692) 4585 db mining Hs.119140NM_001970 4503544 eukaryotic translation initiation factor 1AAATAACTGGCTCCCAGGGTGGCGG 5A (EIF5A), mRNA/cds = (43, 507)TGGTGGCAGCAGTGATCCTCTGAAC 4586 db mining Hs.99863 NM_001972 4503548elastase 2, neutrophil (ELA2), mRNA 1 TGCCCACACCCACACTCTCCAGCATC /cds =(38, 841) TGGCACAATAAACATTCTCTGTTT 4587 db mining Hs.99863 NM_0019724503548 elastase 2, neutrophil (ELA2), mRNA 1 TGCCCACACCCACACTCTCCAGCATC/cds = (38, 841) TGGCACAATAAACATTCTCTGTTT 4588 literature Hs.193122NM_002000 4503672 Fc fragment of IgA, receptor for 1GCACCCACCTTTCTGCACATAAGTTA (FCAR), mRNA/cds = (39, 902)TGGTTTTCCATCTTATCTGTCTTC 4589 db mining Hs.8917 NM_002001 4503674 Fcfragment of IgE, high affinity I, 1 AATTGTCAAACACAGCTTGCAATATA receptorfor, alpha polypeptide CATAGAAACGTCTGTGCTCAAGGA (FCER1A), mRNA/cds =(106, 879) 4590 db mining Hs.77252 NM_002012 4503718 fragile histidinetriad gene (FHIT), 1 TCCAGAAACATGACAAGGAGGACTTT mRNA/cds = (362, 805)CCTGCCTCTTGGAGATCAGAGGAG 4591 db mining Hs.108694 NM_002099 8051602glycophorin A (includes MN blood 1 TCATAGTTAAATTTGGTATTCGTGGG group)(GYPA), mRNA/cds = (55, 507) GGAAGAAATGACCATTTCCCTTGT 4592 literatureHs.342658 NM_002119 4504400 major histocompatibility complex, class 1ACACACATTCTTGCTCTACCCAAAGC II, DN alpha (HLA-DNA), mRNATCTGCCTGGCAGCACTAAATGCTT /cds = (76, 828) 4593 literature Hs.342658NM_002119 4504400 major histocompatibility complex, class 1ACACACATTCTTGCTCTACCCAAAGC II, DN beta (HLA-DNA), mRNATCTGGCTGGCAGCACTAAATGCTT /cds = (76, 828) 4594 db mining Hs.1802NM_002120 4504402 major histocompatibility complex, class 1GCAGTCTCCACAGTCTTCAGAAGACA II, DO beta (HLA-DOB), mRNAAATGCTCAGGTAGTCACTGTTTCC /cds = (56, 877) 4595 db mining Hs.279930NM_002124 4504410 major histocompatibility complex, class 1GCCTCCCGTGCATCTGTACTCACCCT II, DR beta 3 (HLA-DRB3), mRNAGTACGACAAACACATTACATTATT /cds = (35, 835) 4596 db mining Hs.73885NM_002127 4504414 HLA-G histocompatibility antigen, 1TTTCCTGTTCCAGAAAAGGGGCTGGG class I, G (HLA-G), mRNAATGTCTCCGTCTCTGTCTCAATT /cds = (5, 1021) 4597 db mining Hs.1521NM_002180 4504622 immunoglobulin mu binding protein 2 1CGGCCTTCTCCGGTGTCCTGTACCAA (IGHMBP2), mRNA/cds = (49, 3030)CTCTTCTATTTAAGAGAACCTCAG 4598 db mining Hs.173880 NM_002182 4504660interleukin 1 receptor accessory 1 GGGACGTTCCATGCCCAGGTTAACAA protein(IL1RAP), mRNA AGAACTGTGATATATAGAGTGTCT /cds = (206, 1918) 4599literature Hs.172689 NM_002183 13324709 interleukin 3 receptor, alpha(low 1 ATGGGAGATGCCTGTGTAATTTCGTC affinity) (IL3RA), mRNACGAAGCTGCCAGGAAGAAGAACAG /cds = (146, 1282) 4600 literature Hs.12503NM_002189 4504648 interleukin 15 receptor, alpha 1CCTCTCCATTGAAGGATTCAGGAAGA (IL15RA), mRNA/cds = (82, 885)AGAAAACTCAACTCAGTGCCATTT 4601 literature Hs.149609 NM_002205 4504750integrin, alpha 5 (fibronectin receptor, 1 CCTCACCTTGGCACCAGACACCCAGalpha polypeptide) (ITGA5), mRNA GACTTATTTAAACTCTGTTGCAAGT /cds = (23,3172) 4602 Table 3A Hs.149846 NM_002213 4504772 integrin, beta 5(ITGB5), mRNA 1 TGCAATGTGAGTTTCCTCTCCTGTC /cds = (29, 2419)CGTGTTTGTTTAGTACTTTTATAA 4603 db mining Hs.78465 NM_002228 7710122 v-junavian sarcoma virus 17 1 AGCAGGAATTGGTGGCAGATTTTACA oncogene homolog(JUN), mRNA AAGATGTATCCTTCCAATTTGGA /cds = (974, 1969) 4604 db miningHs.169824 NM_002258 4504878 killer cell lactin-like receptor subfamily 1TGGATCTGCCAAAAAGAACTAACACC B, member 1 (KLRB1), mRNATGTGAGAAATAAAGTGTATCCTGA /cds = (60, 737) 4605 db mining Hs.172195NM_002408 6031183 mannosyl (alpha-1,6-)-glycoprotein, 1TTCCTGTACTATTGTGTTTTGAGTGTG beta-1,2-N- TTTTGGAACCTTCATAGAACACAacetylglucosaminyltransferase (MGAT2), mRNA/cds = (489, 1832) 4606literature Hs.77367 NM_002416 4505186 monokine induced by gamma 1TGACCCACTTACCTTGCATCTCACAG interferon (MIG), mRNA/cds = (39, 416)GTAGACAGTATATAACTAACAACC 4607 Table 3A Hs.926 NM_002463 11342663myxovirus (influenza) resistance 2, 1 TTTCCCTGATTATGATGAGCTTCCATThomolog of murine (MX2), mRNA GTTCTGTTAAGTCTTGAAGAGGA /cds = (104, 2251)4608 db mining Hs.173084 NM_002470 11342671 myosin, heavy polypeptide 3,skeletal 1 CACGAGAGTGAAGAGTGAGCCAGCC muscle, embryonic (MYH3), mRNACTTCTGGAGCAGGAGCAGGACAGAA /cds = (84, 5906) 4609 db mining Hs.113973NM_002472 4505300 myosin, heavy polypeptide 6, skeletal 1AAGAAAGGCACAAAATGTGCTATTTT muscle, perinatal (MYH8), mRNATGGTCACTTGCTTTATGACGTTTA /cds = (73, 5886) 4610 db mining Hs.275163NM_002512 4505408 non-metastatic cells 2, protein 1GTCCCTGGACACAGCTCTTCATTCCA (NM23B) expressed in (NME2), nuclearTTGACTTAGAGGCAACAGGATTGA gene encoding mitochondrial protein, mRNA/cds =(72, 530) 4611 Table 3A Hs.85844 NM_002529 4585711 neurotrophic tyrosinekinase, receptor, 1 GTACCAGCTCTCCAACACGGAGGCA type 1 (NTRK1), mRNA/cds =(0, 2390) ATCGACTGCATCACGCAGGGACGTG 4612 db mining Hs.93728 NM_0025864505624 pre-B-cell leukemia transcription factor 1GGGGGCTAGTTCTCTCCTCACTTGTA 2 (PBX2), mRNA/cds = (0, 1292)AACTTGTGTAGTTTCACAGAAAAA 4613 db mining Hs.41639 NM_002598 4505854programmed cell death 2 (PDCD2), 1 ACAGAAGAATTTGTGTGGAAGCAGGA mRNA/cds =(29, 1063) TGTAACAGATACACCGTAAGGCA 4614 Table 3A Hs.181013 NM_0026294505152 phosphglycerate mutase 1 (brain) 1 CCCTGCCACATGGGTCCAGTGTTCAT(PGAM1), mRNA/cds = (31, 795) CTGAGCATAACTGTACTAAATCCT 4615 db miningHs.288579 NM_002644 11342673 polymeric immunoglobulin receptor 1CTTGAAGGAAGAGGGACCAGGGTGG (PIGR), mRMA/cds = (156, 2450)GAGAGCTGATTGCAGAAAGGAGAGA 4616 db mining Hs.261285 NM_002669 4505894pleiotropic regulator 1 (PRL1, 1 AAACCATTAAAGTATACAGAGAGGAT Arabidopsishomolog) (PLRG1), mRNA GACACAGCCACAGAAGAAACTCAT /cds = (0, 1544) 4617Table 3A Hs.79402 NM_002694 14702172 polymerase (RNA) II (DNA directed)1 AACATGCACAAAGCAGTTAATTAGGC peptide C (33 kD) (POLR2C),AGCCTGGAGAAAACCAGAGATCCA transcript variant gamma, mRNA /cds = (57, 884)4618 Table 3A Hs.77202 NM_002738 4506068 protein kinase C. beta 1(PRKCB1, 1 ACTTCCAGAAACTCATCAAATGAACA mRNA/cds = (138, 2151)GACAATGTCAAAACTACTGTGTCT 4619 literature Hs.180533 NM_002758 4506098mitogen-activated protein kinase 1 GCTTTATGGGTTTGGCTTGTTTTTCTT kinase 3(MAP2K3), mRNA GCATGGTTTGGAGCTGATCGCTT /cds = (337, 1293) 4620literature Hs.111825 NM_002758 14589899 mitogen-activated protein kinase1 TTCTTTCTTGGCCTCAAGTTCAATATG kinase 6 (MAP2KB), transcript variantGAGAGGATTGCTTCCCTGAATCC 1, mRNA/cds (340, 1344) 4621 db mining Hs.241561NM_002770 4506146 protease, serine, 2 (trysin 2) 1AACTATGTGGACTGGATTAAGGACAC (PRSS2), mRNA/cds = (6, 749)CATAGCTGCCAACAGCTAAAGCCC 4622 db mining Hs.928 NM_002777 7382457proteinase 3 (serine proteinase, 1 CCTGACTTCTTCACGCGGGTAGCCCTneutrophil, Weganer granulomatosis CTACGTGGACTGGATCCGTTCTAC autoantigen)(PRTN3), mRNA /cds = (48, 818) 4623 db mining Hs.78575 NM_00277811386146 prosaposin (variant Gaucher disease 1AGCCAGCAGGACATGAAGTTGCTATT and variant metachromaticAAATGGACTTCGTGATTTTTGTTT leukodystrophy) (PSAP), mRNA /cds = (38, 1612)4624 db mining Hs.250655 NM_002823 4506276 prothymosin, alpha (genesequence 1 TTTGGCCTGTTTTGATGTATGTGTGA 28) (PTMA), mRNA/cds = (155, 487)AACAATGTTGTCCAACAATAAACA 4625 db mining Hs.82547 NM_002888 4506424retinoic acid receptor responder 1 AACTTGTGCCACAAGAGTTACAATCA(tazarotene induced) 1 (RARRES1), AAGTGGTCTCCTTAGACTGAATTC mRNA/cds =(36, 722) 4626 db mining Hs.106061 NM_002904 14670267 RD RNA-bindingprotein (RDBP), 1 AAAGCCTTTAAAAACGGCTGTCAGGT mRNA/cds = (108, 1250)TTGATCTCAGTGTAACAACATGGC 4627 db mining Hs.139228 NM_002914 4506488replication factor C (activator 1) 2 1 GAAAATGCGCCTTAGGCTGAGCCAA (40 kD)(RFC2), mRNA CATGACTGTCCCCCAAACTCCAGTG /cds = (207, 1271) 4628 db miningHs.123638 NM_002918 4506492 regulatory factor X, 1 (influences HLA 1CCAGCTTCGGTTCCTTCCACCTCATC class II expression) (RFX1), mRNACGGCTGCTCTACGACGAGTACATG /cds = (93, 3032) 4629 db mining Hs.166019NM_002919 4506494 regulatory factor X, 3 (influences HLA 1AAGATTGGTGCTCCTGATAAAGCAAA class II expression) (RFX3), mRNAGGGCTAGGAATACAATGGAAAGGA /cds = (8, 2131) 4630 db mining Hs.21273NM_002920 15011897 transcription factor NYD-sp10 mRNA, 1TCATTGGTACACATTCTGTATGCTGC complete cds/cds = (109, 2034)TGTTTTCAAGTTGGCAAATTAAGC 4631 literature Hs.73839 NM_002935 4506550ribonuclease, RNase A family, 3 1 TATCAGCAACTGTCCTCATCAGTCTC (eosinophilcationic protein) (RNASE3), CATACCCCTTCAGCTTTCCTGAGC mRNA/cds = (63,545) 4632 Table 3A Hs.74267 NM_002948 4506602 60 S ribosomal protein L15(EC45) 1 GCAGCTTGGAGAAGGCGCAATACTC mRNA, complete cds/cds = (34, 648)CAGCTCCACCGTTACCGCTAATATA 4633 Table 3A Hs.74267 NM_0020948 4506602 60 Sribosomal protein L15 (EC45) 1 GCAGCTTGGAGAAGGCGCAATACTC mRNA, completecds/cds = (34, 648) CAGCTCCACCGTTACCGCTAATATA 4634 db mining Hs.74592NM_002971 4506790 special AT-rich sequence binding 1CGGAGCCTCAAACAAGCATTATACCT protein 1 (binds to nuclearTCTGTGATTATGATTTCCTCTCCT matrix/scaffold-associating DNA's) (SATB1),mRNA/cds = (214, 2505) 4635 Table 3A Hs.89714 NM_002994 4506848 smallinducible cytokine subfamily B 1 ATGTTTCTTGGGGAATATGTTAGAGA (Cys-X-Cys),member 5 (epithelial- ATTCCCTTACTCTTGATTGTGGGA derivedneutrophil-activating peptide 78) (SCYB5), mRNA/cds = (106, 450) 4636 dbmining Hs.82109 NM_002997 4506858 syndecan 1 (SDC1), mRNA 1AGAGTGATAGTCTTTTGCTTTTGGCA /cds = (205, 1137) AAACTCTACTTAATCCAATGGGTT4637 db mining Hs.301698 NM_003033 4506950 BAC 180I23 chromosome 8 map 1GCCTCTTGCTTGGCGTGATAACCCTG 8q24.3 beta-galactoside alpha 2,3-TCATCTTCCCAAGCTCATTTATG sialyltransferase (SIAT4A) gene, completesequence /cds = (12296, 13318) 4638 db mining Hs.78403 NM_003083 4507102small nuclear RNA activating complex, 1 TTCAACTGACCAGTCGTGGTTACTCCpolypeptide 2, 45 kD (SNAPC2), mRNA CTGCTGCCAGGTCCTTCCCCTTCC /cds = (24,1028) 4639 literature Hs.80738 NM_003123 4507180 gene for sialophorin(CD43) 1 GGCTGGCACCTCTCAACGTCTGTGG /cds = (159, 1361)ACTGAATGAATAAACCCTCCTCATC 4640 db mining Hs.81884 NM_003167 4507306sulfotransferase family, cytosolic, 2A, 1 TGGGAATAACGTCCAAAACACTCTGGdehydropiandrosterone (DHEA) - ATCTTATATGGAGAATGACATTGA preferring,member 1 (SULT2A1), mRNA/cds = (52, 909) 4641 literature Hs.7510NM_003188 4507360 DNA sequence from clone RP1- 1AGTACTGAACTCAGTTCCATCCGTAA 154G14 on chromosome 6q15-18.3,AATATGTAAAGGTAAGTGGCAGCT Contains the 3′ end of the MAP3K7 gene formitogen-activated protein kinase kinase kinase 7 (TGF-beta activatedkinase 1, TAK1), ESTs, STSs and GSSs/cds = (0, 1700) 4642 db miningHs.250841 NM_003290 4507850 tropomyosin 4 (TPM4), mRNA 1GCCCAACTTCATTTCCATACTTCAGG /cds = (50, 796) GAACAGCAAATTGAGGATTTACTT4643 Table 3A Hs.178551 NM_003316 10835036 ribosomal protein L8 (RPL8),mRNA 1 CCGTTGAATGAGTGTGTTTTGTACAT /cds = (43, 816)AACTTCAGATACTTGTGAACATGC 4644 Table 3A Hs.4248 NM_003371 4507870 vav 2oncogene (VAV2), mRNA 1 TTTCTTGGGAGAGTCACTCCAGCCCT /cds = (5, 2641)GAAGTCTGTCTCTAGCTCCTCTGT 4645 Table 3A Hs.89414 NM_003467 4503174chemokine (C-X-C motif), receptor 4 1 TCAGGAGTGGGTTGATTTCAGCACCT (fusin)(CXCR4), mRNA ACAGTGTACAGTCTTGTATTAAGT /cds = (88, 1146) 4646 Table 3AHs.100293 NM_003605 6006036 O-linked N-acetylglucosamine 1TTAGGAGTGATTACTAATTATCAAGG (GlcNAc) transferase (UDP-N-GCACAGTTGTGGTACTGTCATTGA acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) (OGT), mRNA/cds = (2039, 4801) 4647 dbmining Hs.24640 NM_003612 4504236 serna domain, immunoglobulin domain 1CGGACGGAAGGACGGAAAAAGCTCT (Ig), and GP1 membrane anchor,ATTTTTATGTTAGGCTTATTTCATG (sernaphorin) 7A (SEMA7A, mRNA /cds = (17,2017) 4648 db mining Hs.131814 NM_003747 4507612 TRF1-interactingankyrin-related ADP- 1 AGTCCCTGACAGCCTAGAAATAAGCT ribose polymerasemRNA, partial cds GTTTGTCTTCTATAAAGCATTGCT /cds = (0, 3264) 4649 dbmining Hs.321231 NM_003779 13929468 UDP-Gal:betaGlcNAc beta 1,4- 1GCATTTTCTGCCTATGCTGGAATAGC galactosyltransferase, polypeptide 3TCCCTCTTCTGGTCCTGGCTCAGG (84GALT3), mRNA/cds = (262, 1443) 4650 Table 3AHs.151481 NM_003797 14523051 embryonic ectoderm development 1AGTAAGGGCACGTAGAGCATTTAGAG (EED), mRNA/cds = (34, 1317)TTGTCTTTCAGCATTCAATCAGGC 4651 Table 3A Hs.103755 NM_003821 4506536receptor-interacting serine-threonine 1 TGGGTCTTCAGCCTTACCCGGAAATAkinase 2 (RIPK2), mRNA/cds = (0, 1622) CTTGTGGTTTCTAGATCACCATCT 4652 dbmining Hs.184376 NM_003825 4507096 Homo sapiens, synaptosomai- 1ACAAGGCTGACACCAACAGAGATCGT associated protein, 23 kD, cloneATTGATATTGCCAATGCCAGAGCA MGC:5155 IMAGE:3481227, mRNA, complete cds/cds= (73, 708) 4653 db mining Hs.158315 NM_003853 4504656 interleukin 18receptar accessory 1 AGCTACTTCTGCCTTATGGCTAGGGA protein (IL18RAP), mRNAACTGTCATGTCTACCATGTATTGT /cds = (463, 2282) 4654 db mining Hs.102865NM_003854 4504682 interleukin 1 receptor-like 2 (IL1RL2), 1TGACTTGTTTTGCTCCATGTCTCCTC mRNA/cds = (134, 1822)ATTCCTACACCTATTTTCTGCTGC 4655 db mining Hs.159301 NM_003855 4504654interleukin 18 receptor 1 (IL18R1), 1 CTGTGAAACCGTCAGTTCGGAAGGCTmRNA/cds = (24, 1649) GGTTAGAACATGTGGGAGCAACAT 4656 db mining Hs.35947NM_003925 4505120 methyl-CpG binding domain protein 4 1GCCTAGTGTGTGTGCTTTCTTAATGT (MBD4), mRNA/cds = (176, 1918)GTGTGCCAATGGTGGATCTTTGCT 4657 db mining Hs.287832 NM_003953 4506356myelin protein zero-like 1 (MPZL1), 1 ACCAAACTGGACTCTCGTGCAGAAAAmRNA/cds = (132, 941) TGTAGCCCATTACCACATGTAGCC 4658 Table 3A Hs.108371NM_003973 4506600 E2F transcription factor 4, p107/p130- 1GCACCTGCTCCAAAGGCATCTGGCA binding (E2F4), mRNA/cds = (62, 1303)AGAAAGCATAAGTGGCAATCATAA 4659 Table 3A Hs.155101 NM_004046 4757809 mRNAfor KIAA1578 protein, partial 1 CTCCTGTGGATTCACATCAAATACCA cds/cds = (0,3608) GTTCAGTTTTGTCATTGTTCTAGT 4660 Table 3A Hs.238990 NM_004064 4757961Homo sapiens, Similar to cyclin- 1 GCCAACAGAACAGAAGAAAATGTTTC dependentkinase inhibitor 18 (p27, AGACGGTTCCCCAATGCCGGTTC Kip1), clone MGC:5304IMAGE:3458141, mRNA, complete cds /cds = (377, 973) 4661 Table 3AHs.239760 NM_004077 4758075 Homo sapiens, clone MGC:19593 1CTCTAGAAAGGCCCAAGTCCATGAGC IMAGE:3542491, mRNA, complete cdsACAGAGGGTCTGATGAAGTTTGTG /cds = (118, 1518) 4662 db mining Hs.272537NM_004088 4758185 deoxynucleotidyltransferase, terminal 1AGACCAAGAGGATATTCCTCAAAGCA (DNTT), mRNA/cds = (0, 1532)GAAAGTGAAGAAGAAATTTTTGCG 4663 db mining Hs.75450 NM_004089 4758197 mRNAfor GILZ, complete cds 1 TGGAGAAGTTCCAGTCCTGTCTGAGC /cds = (233, 637)CCTGAAGAGCCAGCTCCCGAATCC 4664 db mining Hs.32981 NM_004186 4759089 sernadomain, immunoglobulin domain 1 GAAGTAGACTTTCTGTCCTCACACCG (Ig), shortbasic domain, secreted, AAGAACCCGAGTGAGCAGGAGGGA (sernaphorin) 3F(SEMA3F), mRNA /cds = (78, 2435) 4665 db mining Hs.444 NM_004197 4759179serine/threonine kinase 19 (STK19), 1 GTGGGATTTCTGGGGAGGCTGGTGAtranscript variant 2, mRNA AGGAGGGCAGGGTTCTTTTCTCTAC /cds = (128, 1234)4666 db mining Hs.74115 NM_004258 4758589 immunoglobulin superfamily,member 1 CTATAGCTTCATGACCGTAACATGTG 2 (IGSF2), mRNA/cds = (21, 3086)ACCTGTGTGCTGGCAGGACGACTC 4667 db mining Hs.25887 NM_004263 4759093 mRNA;cDNA DKFZp761O15121 1 ATGATCCCCATGTTGCAATATGGAGT (from cloneDKFZp761O15121); CTCTGCCCTGAGATCTTCCCCATC complete cds/cds = (111, 2423)4668 Table 3A Hs.184211 NM_004279 4758733 peptidase (mitochondrialprocessing) 1 TGGTCAGTCTTTGTTCTCTGAGAAAT beta (PMPCB), mRNA/cds = (13,1482) TATGTTGGAAGCAGCATACTTTCA 4669 db mining Hs.18142 NM_004313 4757779arrestin, beta 2 (ARRB2), mRNA 1 CCCCAAGATACACACTGGACCCTCTC /cds = (53,1282) TTGCTGAATGTGGGCATTAATTTT 4670 literature Hs.54457 NM_0443564757943 CD81 antigen (target of 1 TTCTAACACGTCGCCTTCAACTGTAAantiproliferative antibody 1) (CD81), TCACAACATCCTGACTCCGTCATT mRNA/cds= (238, 948) 4671 db mining Hs.42853 NM_004381 14577922 cAMP responsiveelement binding 1 TTTTTCATTTTGGAGCTAGTTACTGG protein-like 1 (CREBL1),mRNA GAGTAAGGGAGGGTGGGGTGGGGG /cds = (33, 2144) 4672 db mining Hs.318546NM_004390 475895 cDNA:FLJ22499 fis, clone 1 GGGACTGTCTTTTCTGTATTCGCTGTHRC11250, highly similar to HSCATHH TCAATAAACATTGAGTGAGCACCT mRNA forcathepsin H (EC 3.4.22.16) /cds = UNKNOWN 4673 literature Hs.318546NM_004390 4758095 cDNA:FLJ22499 fis, clone 1 GGGACTGTCTTTTCTGTATTCGCTGTHRC11250, highly similar to HSCATHH TCAATAAACATTGAGTGAGCACCT mRNA forcathepsin H (EC 3.4.22.16) /cds = UNKNOWN 4674 Table 3A Hs.124024NM_004416 4758201 deltex (Drosophila) homolog 1 (DTX1), 1AGAGAAGACTCATCTTCACTATCGGC mRNA/cds = (503, 2365)ACGTCCAACACCACGGGCGAGTCG 4675 Table 3A Hs.74088 NM_004430 4758251 earlygrowth response 3 (EGR3), 1 AAACCGAAATATTGAAATGGTGTAAT mRNA/cds = (357,1520) GTTGTACCATTTGCACTGTGAGCA 4676 db mining Hs.278611 NM_0044829945386 UDP-N-acetyl-alpha-D- 1 AGGTGGGGGAAAATGAATTTTGTATGgalactosamine:polypeptide N- CTGAATTTCTAAGCGCCTATTGTTacetylgalactosaminyltransferase 3 (GalNAc-T3) (GALNT3), mRNA /cds = (0,1901) 4677 db mining Hs.73734 NM_004488 4758459 glycoprotein V(platelet) (GP5), mRNA 1 GTGGATGTGGAGCAGGAGAGCTGGA /cds = (270, 1952)TCGTGGCATTTGTTTCTGGGTTCTG 4678 db mining Hs.182447 NM_004500 14110430heterogeneous nuclear 1 AAAGTTGATACTGTGGGATTTTTGTG ribonucleoprotein C(C1/C2) (HNRPC), AACAGCCTGATGTTTGGGACCTTT transcript variant 1, mRNA/cds = (191, 1102) 4679 db mining Hs.111085 NM_004505 4758563 ubiquitinspecific protease 6 (Tre-2 1 TGTGGTTGCCTCTATGTGCTGTTTTT oncogene)(USP6), mRNA CCTCATACAAGTAAACACAGAAAG /cds = (1696, 4056) 4680 Table 3AHs.76038 NM_004508 4758583 isopentenyl-diphospate delta 1CCCAACTGAGGACCACTGTCTACAGA isomerase (IDI1), mRNA/cds = (50, 736)GTCAGGAAATATTGTAGGGAGAAA 4681 db mining Hs.296281 NM_004514 4758599interleukin enhancer binding factor 1 1 TGTTTGTTTCTTTGTGTTGACTTTGTC(ILF1), mRNA/cds = (197, 2164) CCTGGCAAAATTTTCCACTCTGA 4682 db miningHs.172674 NM_004555 4758803 nuclear factor of activated T-cells, 1AGGTGACCTGGTTACTTAGCTAGGAT cytoplasmic, calcineurin-dependent 3TGGTGATTTGTACTGCTTTATGGT (NFATC3), mRNA/cds = (210, 3416) 4683 Table 3AHs.78920 NM_004581 4759015 Rab geranylgeranyltransferase, alpha 1CCCTACCCTTGCCCTTTAACTTATTG subunit (RABGGTA), mRNAGGACTGAATAAAGAATGGAGAGGC /cds = (274, 1977) 4684 db mining Hs.90957NM_004620 4759253 TNF receptor-associated factor 6 1GGGCTTTTGCTCTGGTGTATTTTATT (TRAF6), mRNA/cds = (221, 1789)GTCAGAAAGTCCAGACTCAAGAGT 4685 db mining Hs.25333 NM_0044833 4758597interleukin 1 receptor, type II (IL1R2), 1 TGGTCTGACTGTGCTATGGCCTCATCmRNA/cds = (61, 1257) ATCAAGACTTTCAATCCTATCCCA 4686 db mining Hs.82222NM_004636 4759091 serna domain, immunoglobulin domain 1GGGCGAGGCAGGCCGACTGTACTAA (Ig), short basic domain, secreted,AGTAACGCAATAAACGCATTATCAG (sernaphorin) 3B (SEMA3B), mRNA /cds = (235,2484) 4687 db mining Hs.332229 NM_004669 4758005 zh68e05.s1 cDNA, 3′ end1 GTACGCCGCTACCTGGACAGCGCGA /clone = IMAGE:417248/clone_end = 3′TGCAGGAGAAAGAGTTCAAATACAC 4688 Table 3A Hs.77324 NM_004730 4759033eukaryotic translation termination 1 TGCAGAGAGATACTAAGCAGCAAAAT factor 1(ETF1), mRNA CTTGGTGTTGTGATGTACAGAAAT /cds = (135, 1446) 4689 Table 3AHs.326159 NM_004735 4758689 leucine rich repeat (in FLII) interacting 1GGATAACAAGTAATGTCTGAAAGCA protein 1 (LRRFIP1), mRNATGAGGGGCTTTATTTGCCTTTACC /cds = (178, 2532) 4690 db mining Hs.107526NM_004776 13929470 UDP-Gal:betaGlcNAc beta 1,4- 1TGAGCTTGCTCTTACGTTTTAAGAGG galactosyltransferase, polypeptide 5TGCCAGGGGTACATTTTTGCACTG (B4GALT5), mRNA/cds = (112, 1278) 4691 Table 3AHs.49587 NM_004811 4758669 leupaxin (LPXN), mRNA 1ACTGGACAACTTTGAGTACTGACATC /cds = (93, 1253) ATTGATAAATAAACTGGCTTGTGG4692 db mining Hs.24395 NM_004887 4757869 NJAC protein (NJAC) mRNA, 1CGCAGGGTCTACGAAGAATAGGGTG complete cds/cds = (7, 306)AAAAACCTCAGAAGGGAAAACTCCA 4693 Table 3A Hs.145696 NM_004902 4757925splicing facfor (CC1.3) (CC1.3), mRNA 1 AGGTTTTGTCTGGTTGCATATAATCTT /cds= (149, 1723) TGCTCTTTTTAAGCTCTGTGAGC 4694 db mining Hs.129738 NM_0049774826787 potassium voltage-gated channel, 1 CCTTGCAGACCCCACCCCCTGCCTGShaw-related subfamily, member 3 CTCTCTTTCCCTACAACTAGGTCAG (KCNC3),mRNA/cds = (295, 2568) 4695 db mining Hs.279946 NM_004990 14043021methionine-tRNA synthease (MARS), 1 GCCCCTAAAGGCAAGAAGAAAA mRNA/cds =(23, 2725) AGTAAAAGACCTTGGCTCATAGAA AGTC 4696 db mining Hs.927 NM_0049974826841 myosin-binding protein H (MYBPH), 1 GGAGTTGCACTCTGGGTGGGAAGCAmRNA/cds = (28, 1458) CTCAATAAAGATGCGTGGTGTTAA 4697 Table 3A Hs.180610NM_005066 4826997 splicing factor proline/glutamine rich 1AGCTTTTGAAAAGTGGAAAGGTCATT (polyprimidine tract-binding protein-TTGTTGCATTTCCCCATTTCTTGT associated) (SFPQ), mRNA /cds = (85, 2208) 4698literature Hs.100001 NM_005074 4827009 solute carrier family 17 (sodium1 ACCTCCTTATTGAAGGGAAGAGGGAC phosphate), member 1 (SLC17A1),CAGCACATGAGGCTGAGGCTGAGG mRNA/cds = (12, 1415) 4699 db mining Hs.81737NM_005155 6325470 inactive palmitoyl-protein thioesterase- 1GGTATCTCCCACACAGCCTGGCACTC 2i (PPT2) mRNA, complete cdsCAACCGTACCCTTTATGAGACCTG /cds = (568, 1473) 4700 db mining Hs.179735NM_005167 4885066 ras homolog gene family, member C 1AAGGATGGTCACACACCAGCACTTTA (ARHC), mRNA/cds = (76, 657)TACACTTCTGGCTCACAGGAAAGT 4701 literature Hs.113222 NM_005201 13929430chemokine (C-C motif) receptor 8 1 ATCATCCTGCCAGCAGCACTCCTCCC (CCR8),mRNA/cds = (120, 1187) GTTCCTCCAGCGTAGACTACATTT 4702 db mining Hs.181128NM_005229 11496880 DNA sequence from PAC 212G6 on 1AGTGCTACACTCGTCTCCACTGTTTG chromosome Xp11.3-p11.4, ContainsTTTTACTTCCCCAAAATGGACCTT synapsin 1, brain protein 4.1, properdin,tyrosine kinase (ELK1) oncogene, ESTs, STS, GSS/cds = (9150, 10436) 4703Table 3A Hs.248109 NM_005238 4885218 v-ets avian erythroblatosis virusE26 1 ACGCTACTATTACGACAAAAACATCA oncogene homolog 1 (ETS1), mRNATCCACAAGACAGCGGGGAACGCT /cds = (278, 1603) 4704 Table 3A Hs.85146NM_005239 4865220 chromosome 21 derived BAC 1 TTTGAGAGGGTAGGAGGGTGGGAAGcontaining erythroblastosis virus GAAACAACCATGTCATTTCAGAAGT oncogenehomolog 2 protein (ets-2) gene, complete cds/cds = (290, 1699) 4705 dbmining Hs.129953 NM_005243 4885224 Ewing sarcoma breakpoint region 1 1CATGCTCAGTATCATTGTGGAGAACC (EWSR1), transcript variant EWS,AAGAGGGCCTCTTAACTGTAACAA mRNA/cds = (43, 2013) 4706 db mining Hs.289098NM_005265 4885270 kidney gamma-glutamyl 1 GACCGGCTTCCCCTGTGAGCAGCAGtranspeptidase type II mRNA, 3′ end AGCAGCAGAATAAATGAGGCCACTG /cds = (0,598) 4707 Table 3A Hs.181307 NM_005324 4885384 H3 histone, family 3A(H3F3A), mRNA 1 GAAGATACCCACCTGTGTGCCATCCA /cds = (374, 784)CGCTAAGAGAGTCACCATCATGCC 4708 Table 3A Hs.79334 NM_005384 4885516nuclear factor, interleukin 3 regulated 1 GTTATCACTCTGCCTGTGTATAGTCA(NFIL3), mRNA/cds = (213, 1601) GATAGTCCATGCGAAGGCTGTATA 4709 db miningHs.297939 NM_005385 6631099 cathepsin B (CTSB), mRNA 1ACTGACAGAGTGAACTACAGAAATAG /cds = (177, 1196) CTTTTCTTCCTAAGGGGATTGTT4710 db mining Hs.78824 NM_005424 4885630 tyrosine kinase withimmunoglobulin 1 TAAGCCAGCACTCACACCACTAACAT and epidermal growth factorhomology GCCCTGTTCAGCTACTCCCACTCC domains (TIE), mRNA/cds = (38, 3452)4711 Table 3A Hs.181195 NM_005494 4885494 Homo sapiens, MRJ gene for a 1GGATGTTTTCTAGTTGTGCATGAATG member of the DNAJ protein family,CTGGCAACTTAGTAAGTTTTGACA clone MGC:1152 IMAGE:3346070, mRNA, completecds/cds = (163, 1143) 4712 db mining Hs.153299 NM_015510 5031670 DOM-3(C. elegans) homolog Z 1 CCCAAATAGTAATGCTTTAGAGGGAG (DOM3Z), transcriptvariant 2, mRNA GCAGTCATATCTCTGTGTGCAGAT /cds = (129, 1319) 4713 dbmining Hs.77961 NM_005514 5031742 major histocompatibility complex,class 1 ATGTGTAGGAGGAAGAGTTCAGGTG I, B (HLA-B), mRNA/cds = (0, 1088)GAAAAGGAGGGAGCTACTCTCAGGC 4714 literature Hs.279853 NM_005516 5031744HSPC018 protein (HSPC018), mRNA 1 CCCCTTCCTCACACTGACCTGTGTTC /cds =(148, 651) CTTCCCTGTTCTCTTTTCTATTAA 4715 db mining Hs.60288 NM_0055275031788 heat shock 70 kD protein-like 1 1 AAACTCTACCAAGGAGGATGCACTGG(HSPA1L), mRNA/cds = (0, 1925) GCCTGCCTGCGGAACAGGGTATGT 4716 db miningHs.171776 NM_005536 8393607 inositol(myo)-1(or 4)- 1CCCTTGGCACGTAAACAGACTACTAG monophosphatase 1 (IMPA1), mRNAACTTATTGTAGGTTCGTTTGAGCT /cds = (98, 931) 4717 db mining Hs.102171NM_005545 5031808 immunoglobulin superfamily containing 1CAAAGGCCAGCCAGCTTGGGAGCAG leucine-rich repeat (ISLR), mRNACAGAGAAATAAACAGCATTTCTGAT /cds = (98,1384) 4718 literature Hs.150101NM_005561 7669500 lysosomal-associated membrane 1GTGAGATCGGTGCGTTCTCCTGATGT protein 1 (LAMP1), mRNATTTGCCGTGGCTTGGGGATTGTAC /cds = (190, 1440) 4719 db mining Hs.154970NM_005653 5032174 transcription factor CP2 (TFCP2), 1GAACTTTCAGGAAGAAGCATGTTTTA mRNA/cds = (508, 1860)TTCTGGACACAATGAAAGAAACCA 4720 Table 3A Hs.82173 NM_005655 5032176 TGFBinducible early growth response 1 TTGGGTGTAGATTTCTGACATCAAAA (TIEG),mRNA cds = (123, 1565) CTTGGACCCTTGAAAACAAAAGT 4721 db mining Hs.200600NM_005698 5032076 secretory carrier membrane protein 3 1CAACCCAGCTTCCCTCTGCTGTGCCA (SCAMP3), mRNA/cds = (96, 1139)CGGCTGTTGCTTCGGTTATTTAAA 4722 db mining Hs.157144 NM_005819 5032130syntaxin 6 (STXB), mRNA/cds = (0, 1 ATAGCCATCCTCTTTGCAGTCCTGTT 767)GGTTGTGCTCATCCTCTTCCTAGT 4723 db mining Hs.17704 NM_005844 5031730PERB11 family member in MHC class ACATGAGCTTCTACCTCCAGATGTGC I region(HCGIX), mRNA/cds = (37, 270) CAGGGTGCATCTCAATAAACTTGG 4724 db miningHs.135194 NM_005849 5031672 immunoglobulin superfamily, member 1ACTGAAAAGACAACTGGCTACA 6 (IGSF6), mRNA/cds = (44, 769)AAGAAGGATGTCAGAATGTAAGGA AACT 4725 db mining Hs.4953 NM_005895 5174440golgi autoantigen, golgin subfamily a, 3 1 AAGTTGTGGCTGTTCTTGGGAAAGGG(GOLGA3), mRNA/cds = (269, 4861) GTCACCGTGTCTGACAAAGTGTAA 4726 db miningHs.211580 NM_005931 5174564 MHC class I polypeptide-related 1CCCCTCGCCCCGTCACACCGTTATG sequence B (MICB), mRNACATTACTCTGTGTCTACTATTATGT /cds = (5, 1156) 4727 Table 3A Hs.68583NM_005932 5174566 mitochondrial intermediate peptidase 1GCTGTGAGAGCTTGTTTCTGATTGTT (MIPEP), nuclear gene encodingTCATTGTTCGCTTCTGTAATTCTG mitochondrial protein, mRNA /cds = (74, 2215)4728 Table 3A Hs.54452 NM_006060 5174500 zinc finger protein, subfamily1A, 1 1 ACCAACACTGTCCCAAGGTGAAATGA (Ikaros) (ZNFN1A1), mRNAAGCAACAGAGAGGAAATTGTACAT /cds = (168, 1727) 4729 db mining Hs.292276NM_006068 5174720 qd64a01.x1 cDNA, 3′ end 1 TGCTCAGTTTTTCAGCTCCTCTCCAC/clone = IMAGE:1734216/clone_end = 3′ TCTGCTTTCCCAAATGGATTCTGT 4730 dbmining Hs.131342 NM_006072 5174670 small inducible cytokine subfamily A1 ATATTCACTACCAAAAGAGGCAAGAA (Cys—Cys), member 26 (SCYA26),AGTCTGTACCCATCCAAGGAAAAA mRNA/cds = (0, 284) 4731 db mining Hs.2414NM_006080 5174672 serna domain, immunoglobulin domain 1GCTGCATTACCTCTAGAAACCTCAAA (Ig), short basic domain, secreted,CAAGTAGAAACTTGCCTAGACAAT (sernaphorin) 3A (SEMA3A), mRNA /cds = (15,2330) MHC binding factor, beta (MHCBFB), 1 TCCAAGTCGAAATCGCTGCTGAGGCT4732 db mining Hs.2654 NM_006081 5174562 mRNA/cds = (90, 1286)GAGATGAAGAAAGAAAAGTCCAAA 4733 literature Hs.125359 NM_006288 5454117Homo sapiens, clone MGC:846 1 CATCTCCTCCCAGAACGTCACAGTGC IMAGE:3507917,mRNA, complete cds TCAGAGACAAACTGGTCAAGTGTG /cds = (60, 545) 4734 dbmining Hs.23168 NM_006313 14149626 ubiquitin specific protease 15 1TTTGTCTGCACTTGAGTTCACTTGAG (USP15), mRNA/cds = (9, 2867)TTTACATTTGAAATGTGCATGTTT 4735 db mining Hs.171921 NM_006379 5454047serna domain, immunoglobulin domain 1 AGTTCCCTTTATTTCACATAAGCCCAA (Ig),short basic domain, secreted, ACTGATAGACAGTAACGGTGTTT (sernaphorin) 3C(SEMA3C), mRNA /cds = (562, 2817) 4736 db mining Hs.240534 NM_0064115453717 1-acylglycerol-3-phosphate O- 1 GGAGAGGGTGGGACCCAGTTTTGCGacyltransferase 1 (lysophosphatidic TGGTTGGTTTTTATTAATTATCTGG acidacyltrasferase, alpha) 4737 db mining Hs.181368 NM_006445 5453983 U5snRNP-specific protein (220 kD), 1 CCTCTTTCCCTCTGTCTGTGCCTGTG orthologat S. cerevisiae Prp8p (PRP8), TTGTTGACCTCCTGATGGCTTGTC mRNA/cds = (41,7048) 4738 db mining Hs.239506 NM_006561 5729815 mab-21 (C.elegans)-like 1 1 CTGATTCTTCTGTCCTCATTGTGAAC (MAB21L1), mRNA/cds = (818,1897) ATAACCGTGTAGTTGAAACAGTCA 4739 db mining Hs.34526 NM_006564 5730105G protein-coupled receptor (TYMSTR), 1 TTTCCAATGTCTGCCACACAAACGTAmRNA/cds = (81, 1109) TGTAAATGTATATACCCACACACA 4740 db mining Hs.86998NM_006599 572944 nuclear factor of activated T-cells 5, 1TCCTGAGAAACAACACATTTTTCCCC tonicity-resonsive (NFAT5), mRNAATGAACGGTGCTGTTCTGAAGTCT /cds = (318, 4913) 4741 db mining Hs.167751NM_006604 5730012 ret finger protein-like 3 (RFPL3), 1TATTGCCACCATCCAACTCATTGAGT mRNA/cds = (292, 1158)CTTATGGTTCACATCTTGTTTCCT 4742 db mining Hs.157427 NM_006605 5730010 retfinger protein-like 2 (RFPL2), 1 AGTCCTATGGTTCACATCTTGTTTCCT mRNA/cds =(292, 1158) ATAGAAATGTCCTGTATTCTGGG 4743 db mining Hs.74861 NM_0067135729967 activated RNA polymerase II 1 AAACCAGGAAGAAAAGGTATTTCTTTtranscription cofactor 4 (PC4), mRNA AAATCCAGAACAATGGAGCCAGCT /cds = (0,383) 4744 db mining Hs.75063 NM_006734 5803032 DNA sequence from clone67K17 on 1 AAGCAGTTGGACTTTCACAGCAGCAA chromosome 6q24.1-24.3, ContainsGGAATTATCTTCAAGCACAGAGGA the HIVEP2 (Schnurri-2) gene for HIV type 1Enhancer-binding Protein 2, and a possible pseudogene in an intron ofthis gene. Contains STSs and GSSs and an AAAT repeat polymorphism /cds =(545, 7885) 4745 db mining Hs.56328 NM_006737 5803051 killer cellimmunoglobuin-like receptor, 1 CTTCAGTGTAGCTCTCTCCTCTTCAA three domains,long cytoplasmic tail, 2 ATAAACATGTCTGCCCTCATGGTT (KIR3DL2), mRNA/cds =(2, 1369) 4746 db mining Hs.82210 NM_006766 5803097 zinc finger protein220 (ZNF220), 1 TTCTCTCGTGCAACCAGTTTGCCCAT mRNA/cds = (393, 6407)TCTCTTCCTATTACTTGCTCCAGG 4747 db mining Hs.57692 NM_006781 11321623chromosome 6 open reading frame 10 1 TGCTCTTCAGAAGTTTCACCCTTTTTA(C6orf10), mRNA/cds = (238, 1942) ATCTCTCAGCCACAAACCTCAGT 4748 db miningHs.84865 NM_006790 5803105 titin immunoglobulin domain protein 1ACGTTTACTGGTACTGCTTTCTAAATA (myotilin) (TTID), mRNACTGTTTTACCCGTTTTCTCTTGT /cds = (280, 1776) 4749 db mining Hs.170027NM_006880 6031173 mouse double minute 2, homolog of; 1GACAACCAATTCAAATGATTGTGCTA p53-binding protein (MDM2), transcriptACTTATTTCCCCTAGTTGACCTGT variant MDM2, mRNA/cds = (311, 1786) 4750literature Hs.27954 NM_006889 5901919 CD86 antigen (CD28 antigen ligand2, 1 GGCCAAGCCCAGCTTAATGGCTCAT B7-2 antigen) (CD86), mRNAGACCTGGAAATAAAATTTAGGACCA /cds = (147, 1118) 4751 Table 3A Hs.173737NM_006908 9845510 ras-related C3 botulinum toxin 1CTCAAGACAGTGTTTGACGAAGCGAT substrate 1 (rho family, small GTPCCGAGCAGTCCTCTGCCCGCCTCC binding protein Rac1) (RAC1), transcriptvariant RaC1b, mRNA /cds = (0, 635) 4752 db mining Hs.218354 NM_0069135902053 ring finger protein 5 (RNF5), mRNA 1 CTTTTTCACCACCGTCTTCAATGCCC/cds = (0, 542) ATGAGCCTTTCCGCCGGGGTACAG 4753 db mining Hs.153299NM_006929 13787218 DOM-3 (C. elegans) homolog Z 1ACATCGTATTTGCGGCCAGCCTCTAC (DOM3Z), transcript variant 2, mRNAACCCAGTGAATGCCCCATGTAAA /cds = (129, 1319) 4754 literature Hs.278721NM_006979 5901935 HLA class II region expressed gene 1TATTCCTTTTATATCACTGTGTTTGAA KE4 (HKE4), mRNA/cds = (326, 1615)TCGAGGGGGAGGGGTGGTAACCG 4755 Table 3A Hs.97437 NM_007018 5901923centrosomal protein 1 (CEP1), mRNA 1 ATGGGAATAGTTGCATATGGGAATTT /cds =(472, 3456) AAACCAACATGTGGCTGAGCCTTT 4756 db mining Hs.41716 NM_00703613259505 endothelial cell-specific molecule 1 1GGCCTTTGAATGTAAAGCTGCATAAG (ESM1), mRNA/cds = (68, 622)CTGTTAGGTTTTGTTTTAAAAGGA 4757 db mining Hs.155150 NM_007042 5902065ribonuclease P (14 kD) (RPP14), 1 CAGTTTGGCCTTATGCTTTATGCAGA mRNA/cds =(169, 543) CTTGAGTGTATGCAGGATTTCATT 4758 db mining Hs.81743 NM_0070535901909 natural killer cell receptor, 1 CAGACCAAGAGCACCACAGACTimmunoglobulin superfamily member ACAACTGCCCAGCTTCATCTAAAT (BY55),mRNA/cds = (215, 760) ACTT 4759 db mining Hs.43543 NM_007056 5902129suppressor of white apricot homolog 2 1 GTGGGTAAGGGGCTCAAGCTGTGAT(SWAP2), mRNA/cds = (143, 2122) GCTGCTGGTTTTATCTCTAGTGAAA 4760 db miningHs.247979 NM_007128 9507238 pre-B lymphocyte gene 1 (VPREB1), 1ACCCTCCCAGGTTCCTGCTGAGATAT mRNA/cds = (0, 437) TTCTCACAATCAGACAAGAGCCAG4761 literature Hs.41682 NM_007334 7669498 killer cell lectin-likereceptor subfamily 1 GGGCAGAGAAGGTGGAGAGTAAAGA D, member 1 (KLRD1),transcript CCCAACATTACTAACAATGATACAG variant 1, mRNA/cds = (260, 799)4762 Tabe 3A Hs.173334 NM_012081 6912353 ELL-RELATED RNA POLYMERASE 1GGCTCACATCAAAAGGCTAATAGGTG II, ELONGATION FACTOR (ELL2),AATTTGACCAACAGCAAGCAGAGT mRNA/cds = (0, 1922) 4763 db mining Hs.268555NM_012255 6912743 5′-3′ exoribonuclease 2 (XRN2), 1AACACATTTGAGGAATAGGAGGTCCG mRNA/cds = (68, 2920)GGTTTTCCATAATGGGTAAAATGG 4764 db mining Hs.258612 NM_012312 6912471killer cell immunoglobulin-like receptor, 1 GCTGTTCCACCTCCCTTCAGACTATCtwo domains, short cytoplasmic tail, 4 TTTCAGCCTTCTGCCAGCAGTAA(KIR2DS4), mRNA/cds = (46, 960) 4765 db mining Hs.212414 NM_0124316912649 serna domain, immunoglobulin domain 1 ACTATAAGTCATTTTGAGTGTTGGTG(Ig), short basic domain, secreted, TTAAGCATGAAACAAACAGCAGCT(sernaphorin) 3E (SEMA3E), mRNA /cds = (466, 2793) 4766 Table 3AHs.144519 NM_012468 10947106 T-cell leukemia/lymphoma 6 (TCL6), 1GCTATTCACAGTTCTGGGGAACAACC transcript variant TCL6a2, mRNAAAAGGAGGAGGAGGACAAAGGGAA /cds = (1767, 2192) 4767 db mining Hs.334729NM_013230 7019342 cDNA FLJ20161 fis, clone COL09252, 1AAGCTACTGTGTGTGTGAATGAACAC highly similar to L33930 CD24 signalTCTTGCTTTATTCCAGAATGCTGT transducer mRNA/cds = UNKNOWN 4768 db miningHs.278911 NM_013278 7019434 interleukin 17C (IL17C), mRNA 1CTATCCACAGAAGCTGGCCTTCGCC /cds = (0, 593) GAGTGCCTGTGCAGAGGCTGTATCG 4769db mining Hs.71979 NM_013371 7019574 interleukin 19 (IL19), mRNA 1GTCATATAGTCCATGTCTGTGATGTG /cds = (47, 580) AGCCAAGTGATATCCTGTAGTACA4770 db mining Hs.247362 NM_013974 7524353 dimethylarginine 1TCCACTGGGTGAATCCTCCCTCTCAG dimethylaminohydrolase 2 (DDAH2),AACCAATAAAATAGAATTGACCTT mRNA/cds = (276, 1133) 4771 Table 3A Hs.8360NM_014039 7662640 PTDO12 protein (PTD012), mRNA 1GAGTTTCTCTATCGCATTGGTCAACC /cds = (473, 1087) AAAAGAGACGCATTCCATTGGGCG4772 Table 3A Hs.6975 NM_014086 7662589 AF001542 cDNA 1TTCTCTGCATCTAGGCCATCATACTG /clone = alpha_est218/52C1CCAGGCTGGTTATGACTCAGAAGA 4773 db mining Hs.278944 NM_014148 7661751HSPC048 protein (HSPC048), mRNA 1 TGCGAAATTGTGGACTGTTGGACTGT /cds = (87,419) GATTCTAAGTGGGGGAAATAGGCT 4774 db mining Hs.278946 NM_014152 7661759HSPC054 protein (HSPC054), mRNA 1 GAACCTTTCTGAAACCAGTGGCAGCC /cds =(107, 397) CAAGTTAGAGCCCAGCATTAAGTC 4775 db mining Hs.278948 NM_0141637661781 HSPC073 protein (HSPC073), mRNA 1 CCAGAATCTTCTATTCCCACTTCCCA/cds = (278, 649) TTTCTCAAATCATTTGACCTGTCG 4776 db mining Hs.130101NM_014227 14140235 solute carrier family 5 (neutral amino 1CCTCCTGGCTGTGGTGGTCTTTATTC acid transporters, system A), member 4ACGGCTACTATGCCTGAACTCTAT (SLC5A4), mRNA/cds = (18, 1995) 4777 db miningHs.205736 NM_014260 7657161 HLA class II region expressed gene 1GAAATTAAGCGATACGAATCCCAGCT KE2 (HKE2), mRNA/cds = (0, 389)TCGGGATCTTGAGCGGCAGTCAGA 4778 db mining Hs.241385 NM_014271 7657231interleukin 1 receptor accessory 1 TCACAGTGACCACTACAGAGTACTAAprotein-like 1 (IL1RAPL1), mRNA GAAGAGAAGATCAAGGGCATGAAA /cds = (510,2600) 4779 Table 3A Hs.211973 NM_014285 7657527 Homo sapiens, Similar tohomolog of 1 TCTTAAAGCCAGAAATAATGGAGGAG yeast RRP4 (ribosomal RNAATTGTGATGGAAACACGCCAGAGG processing 4), 3′-5′-exoribonuclease, cloneMGC:2403 IMAGE:2821702, mRNA, complete cds/cds = (11, 892) 4780 dbmining Hs.129751 NM_014339 7657229 interleukin 17 receptor (IL17R), mRNA1 CTTTTCTTTGTGCAGCGGTCTGGTTA /cds = (32, 2632) TCGTCTATCCCCAGGGGAATCCAC4781 db mining Hs.296429 NM_014348 7657468 similar to rat integralmembrane 1 CCACGTTGGGGTCACTACTGGAGTG glycoprotein, POM121 (POM121L1),GATGGAGGCCCTTCACATTTCTGGG mRNA/cds = (0, 1286) 4782 db mining Hs.21814NM_014432 7657690 interleukin 20 receptor, alpha 1TGACCTTTCGTGATTATCCGCAAATG (IL20RA), mRNA/cds = (236, 1897)CAAACAGTTTCAGATCTAATGGTT 4783 db mining Hs.110040 NM_014443 7657227interleukin 17B (IL17B), mRNA 1 CAGTCATGGAGACCATCGCTGTGGG /cds = (41,583) CTGCACCTGCATCTTCTGAATCACC 4784 db mining Hs.76698 NM_014445 7657551mRNA; cDNA DKFZp434L, 1621 (from 1 AGGTTTCTTCATGAGTCATTCCAAGT cloneDKFZp434L1621); complete cds TTTCTAGTCCATACCACAGTGCCT /cds = (315, 515)4785 db mining Hs.326248 NM_014456 7657448 cDNA:FLJ22071 fis, cloneHEP11691 1 GAGGTCGTCTTAAACCAGAGAGCTAC /cds = UNKNOWNTGAATATAAGAACTCTTGCAGTCT 4786 db mining Hs.278441 NM_014634 7661861KIAA0015 gene product KIAA0015), 1 GCAGTCTCCCAAGGACCCACCATGC mRNA/cds =(106, 1470) AGAAGTGTCAATAAACCACAAGTTC 4787 db mining Hs.19056 NM_0148247662295 KIAA0769 gene product (KIAA0769), 1 GGAGGGAGCCTCTGTGCAGAATGTGCmRNA/cds = (239, 2293) TTTCTTTACAGTGGCTGTAAAAAGT 4788 db mining Hs.11711NM_014844 7662057 mRNA for KIAA0297 gene, partial cds 1GATGCTTTTAAAGTTGTAGCTTCGTG /cds = (0, 3815) CTTTGTACAGTTTTCTTTCTGGTT4789 db mining Hs.7724 NM_014963 7662409 KIAA0963 protein (KIAA0963),mRNA 1 AATATATGCAATTCTCCCTCCCCCAG /cds = (215, 4315)CCCTTCCCTGACCCCTAAGTTATT 4790 Table 3A Hs.31989 NM_015449 14149687DKFZP586G1722 protein 1 AATCTGCCAGGCTATGTGACAGTAGG (DKFZP586G1722), mRNAAAGGAATGGTTTCCCCTAACAAGC /cds = (210, 869) 4791 db mining Hs.30488NM_015453 14149489 DKFZP434F091 protein 1 AGCACATACATTGATAGATGGGGTGT(DKFZP434F091), mRNA GGGACCAACAAACCAAATTAAAAG /cds = (334, 1857) 4792Table 3A Hs.104640 NM_015898 7705374 HIV-1 inducer of short transcripts1 CAACGGCCAGGAGAAGCACTTTAAG binding protein (FBI1), mRNAGACGAGGACGAGGACGAGGACGTGG /cds = (0, 1754) 4793 db mining Hs.278428NM_015902 13435357 progestin induced protein (DD5), 1TTGTGGAAACTGTTTCAGCAAAGGTT mRNA/cds = (33, 8432)CTTGTATAGAGGGAATAGGGAATT 4794 db mining Hs.279583 NM_016025 7705788 Homosapiens, Similar to CGI-81 1 GGGGGAAGGAAGGCTTCAGACTTGG protein, cloneMGC:705 GGGAAGGGGAGATTATTGCAAATTG IMAGE:3350598, mRNA, complete cds /cds= (248, 1099) 4795 db mining Hs.179817 NM_016026 7705790 CGI-82 protein(LOC51109), mRNA 1 CTATGGAGGAATTGAGGGCAAGCAC /cds = (40, 996)CCAGGACTGATGAGGTCTTAACAA 4796 db mining Hs.236494 NM_016131 7705848RAB10, member RAS oncogene 1 ACACCAAACAGTTAAGTCCATTCTCT family (RAB10),mRNA/cds = (90, 692) GGTACTAGCTACAAATTCGGTTTC 4797 db mining Hs.115515NM_016184 7705337 C-type (calcium dependent, 1 TGCACACAGGGAGAGAACATGAGTCcarbohydrate-recognition domain) TCTCTTSSTTTTTSTCTGGTTGCTA lectin,superfamily member 6 (CLECSF6), mRNA/cds = (241, 954) 4798 Table 3AHs.7905 NM_016224 7706705 SH3 and PX domain-containing protein 1TTCAATGGAAAATGAGGGGTTTCTCC SH3PX1 (SH3PX1), mRNACCACTGATATTTTACATAGAGTCA /cds = (43, 1830) 4799 db mining Hs.66NM_016232 11136631 interleukin 1 receptor-like 1 (IL1RL1), 1GACCACATTGCCAATAAAAGzgTCCCT mRNA/cds = (0, 1670)GAATTCCAAATTCTGGAAGCACGT 4800 db mining Hs.180403 NM_016271 7706722STRIN protein (STRIN), mRNA 1 AGGCCCAAATCACAGAATAAGGACT /cds = (221,958) AAGAGTGGATTTGCTGACATTCCA 4801 Table 3A Hs.3059 NM_016451 7705388coatomer protein complex, subunit 1 GCTGTCCTCAAAGTATATAATGTTTCA beta(COPB), mRNA/cds = (178, 3039) TGTACCAAGACCCTTTTCACAGT 4802 Table 3AHs.321245 NM_016530 7706562 cDNA FLJ10249 fis, clone 1AAGGGTATTTGGTCTGGTTCATATGG HEMBB1000725, highly similar toTCAAATATTACTGCCTTGGTAGCA Rattus norvegicus GTPase Rab8b mRNA/cds =UNKNOWN 4803 db mining Hs.115897 NM_016580 14589925 protocadherin 12(PCDH12), mRNA 1 GGGGTGCCAGGAAATGCTCTCTGAC /cds = (1211, 4765)CTATCAATAAAGGAAAAGCAGTGAT 4804 db mining Hs.98309 NM_018584 7706701 SGRFprotein, interleukin 23 p19 1 TGGGAAGGGAAATTTGGGGATTATTT subunit (SGRF),mRNA/cds = (143, 712) ATCCTCCTGGGGACAGTTTGGGGA 4805 Table 3A Hs.273385NM_016592 7706588 guanine nucleotide binding protein (G 1GCCACAAAAGTTCCCTCTCACTTTCA protein), alpha stimulating activityGTAAAAATAAATAAAACAGCAGCA polypeptide 1 (GNAS1), mRNA /cds = (68, 1252)4806 db mining Hs.241567 NM_016838 1111111 RNA binding motif, singlestranded 1 ATAAGGTGCATAAAACCCTTAAATTC interacting protein 1 (RBMS1),ATCTAGTAGCTGTTCCCCCGAACA transcript variant MSSP-2, mRNA /cds = (265,1434) 4807 db mining Hs.272354 NM_01741611 225606 interleukin 1 receptoraccessory 1 GATACCCAGGAATTTCACAGGAACAG protein-like 2 (IL1RAPL2), mRNATTCTTTGCTGCCTTTATCCTCCAA /cds = (758, 2816) 4808 db mining Hs.105956NM_017436 8392829 globotriaosylceramide/CD77 synthase; 1CCCACCCTGCCGCCCGCATTATAAAC Gb3/CD77 synthase; alpha1,4-ACAGGAGAATAATCAATAGAATAA galactosyltransferase; 4-N-acetylglucosaminyltransferase (A14GALT), mRNA/cds = (133, 1194) 4809 dbmining Hs.283690 NM_017548 6923709 clone H41 unknown mRNA 1AAACCAGGCCCTTAAACTTCAGCTAG /cds = (323, 1099) ACAACCAATATGCTGTGCTTGAAA4810 db mining Hs.14512 NM_017583 8923748 DIPB protein (HSA249128), mRNA1 CCAGATCCACAGCAGGCACATATCTC /cds = (177, 1211) TCCAAGGGATGACCAGTTTTATGC4811 Table 3A Hs.288036 NM_017646 8923064 tRNA isopentenylpyrophosphate1 GGACTTGAAGACCAAAGACTTTGAAA transferase (IPT), mRNATTTGCGAGCTGCTCATGTGTGAGT /cds = (60, 1040) 4812 Table 3A Hs.106650NM_017866 8923499 Homo sapiens, Similar to hypothetical 1GAAACGGCATAAAGATGAGAAATGAG protein FLJ20533, clone MGC:3448CCTATTTGTTAGTGTTCGTGCCTA IMAGE:3831570, mRNA, complete cds /cds = (380,865) 4813 Table 3A Hs.272134 NM_018067 8922367 AL544307 cDNA 1CCTGCCCTCGCCTGGAATCAGTGTTA /clone = CS0DI019YG13-(5-prime)CTGCATCTGATTAAATGTCTCCAG 4814 Table 3A Hs 7187 NM_018187 8922608 mRNAfor KIAA1757 protein, partial 1 AATGAGTTGTGTTGAAGCCTCCGTCT cds/cds =(347, 4576) CCCATCCTTGCCTGTAGCCCGTAG 4815 db mining Hs.85752 NM_0184618923923 mRNA for KIAA1541 protein, partial 1 CAGAGTTGACGGACACTGCTCCCAAAcds/cds = (908, 2341) AGGTCATTACTCAGAATAATGTA 4816 db mining Hs.272373NM_018724 11036633 interleukin 20 (L20), mRNA 1GAACCTCAGGCAGCAGTTGTGAAGG /cds = (0, 530) CTTTGGGGGAACTAGACATTCTTCT 4817db mining Hs.110309 NM_018950 9665231 major histocompatibility complex,class 1 GGACTGAGAAGCAAGATATCAATGTA I, F (HLA-F), mRNA/cds = (0, 1088)GCAGAATTGCACTTGTGCCTCACG 4818 Table 3A Hs.225674 NM_018963 11321643 mRNAfor WDR9 protein (WDR9 1 CAATGGTTGCACCTTATGACCTTGAG gene), form B/cds =(79, 6888) GGAAAGCCAGTTCATTTAAGAGGA 4819 db mining Hs.278430 NM_01910514719824 cytochrome P450, subfamily XXIA 1 GGGGGAGGGGAGGGGTTCGTACAG(steroid 21-hydroxylase, congenital GAGCAATAAAGGAGAAACTGAGGTAC adrenalhyperplasia), polypetide 2 (CYP212), mRNA/cds = (118, 1805) 4820 dbmining Hs.278430 NM_019105 14719824 cytochrome P450, subfamily XXIA 1GGGGGAGGGGAGGGGTTCGTACAG (steroid 21-hydroxylase, congenitalGAGCAATAAAGGAGAAACTGAGGTAC adrenal hyperplasia), polypeptide 2(CYP21A2), mRNA/cds = (118, 1605) 4821 db mining Hs.159679 NM_0195989665235 kallikrein 12 (KLK12), mRNA 1 ACTTCTTGGAACTTTAACTCCTGCCA /cds =UNKNOWN GCCCTTCTAAGACCCACGAGCGGGG 4822 db mining Hs.247808 NM_0196029824966 butyrophilin-like 2 (MHC class II 1 TGTTCCATCAGCATCCCCTTTTTGGGassociated) (BTNL2), mRNA CGAGGAGAAAATCGCAACTTTTTC /cds = (0, 1387) 4823db mining Hs.36989 NM_019616 10518502 coagulation factor VII (serum 1CAGACTATTCCCCACCTGCTTCCCAG prothrombin conversion accelerator)CTTCACAATAAACGGCTGCGTCTC (F7), transcript variant 1, mRNA /cds = (51,1451) 4824 db mining Hs.36989 NM_019616 10518502 coagulation factor VII(serum 1 CAGACTATTCCCCACCTGCTTCCCAG prothrombin conversion accelerator)CTTCACAATAAACGGCTGCGTCTC (F7), transcript variant 1, mRNA /cds = (51,1451) 4825 db mining Hs.289095 NM_020056 11095446 majorhistocompatibility complex, class 1 GTCTGTGGGCCTCATGGGCATTGTG II, DQalpha 2 (HLA-DQA2), mRNA GTGGGCACTGTCTTCATCATCCAAG /cds = (0, 767) 4826db mining Hs.296552 NM_020070 13399297 DNA sequence from clone CTA-246H31 CTCCAAACAGAGCAACAACAAG on chromosome 22 Contains the geneTACGCGGCCAGCAGCTACCTGAGC for IGLL1 (immunoglobulin lambda-like CTGApolypeptide 1, pre-B-cell specific), a pseudogene similar to LRP5(Lipoprotein Receptor Related Protein), ESTs, Genomic markers (D22S414,D22S925, D22S926), CA repeats, STSs, GSSs and a CpG Island /cds = (0,438) 4827 Table 3A Hs.94395 NM_020324 10947128 ATP-binding cassette,sub-family D 1 CCAAAGTCCTCACTCAGACCAGTGCC (ALD), member 4 (ABCD4),transcript CCTCCAGTTCAGTTGTCTATGTAT variant 5, mRNA/cds = (51, 1544)4828 db mining Hs.105509 NM_020428 9966908 cDNA FLJ14613 fls, clone 1TGTCTTCCACCCTCAAGAAACTCTTG NT2RP1001113, highly similar to CTL2AACAAGACCAACAAGAAGGCAGCG gene/cds = UNKNOWN 4829 literature Hs.248158NM_020530 10092620 oncostatin M (OSM), mRNA 1 GCAGGACCAGACCCTCCAGGAAAGG/cds = (0, 758) CAAGAGACTCATGACCAGGGGACAG 4830 db mining Hs.105052NM_020979 10280625 adaptor protein with pleckstrin 1GGTGGGACACGCCAAGCTCTTCAGT homology and src homolog 2 domainsGAAGACACGATGTTATTAAAAGCCT (APS), mRNA/cds = (127, 2025) 4831 literatureHs.1510 NM_021068 10835102 interferon, alpha 4 (IFNA4), mRNA 1AGCTTGGTGTATACCTTGCAGGCACT /cds = (140, 709) AGTCCTTTACAGATGACAATGCTG4832 db mining Hs.76293 NM_021103 1063894 thymosin, beta 10 (TMSB10),mRNA 1 AGGAAGAGCCACCTGCAAGATGGAC /cds = (65, 199)ACGAGCCACAAGCTGCACTGTGAAC 4833 db mining Hs.3254 NM_021134 10863930mitochondrial ribosomal protein L23 1 GGGTGCAGCATGGCTCTAACAAGAG(MRPL23), mRNA/cds = (54, 515) AAGAGATCACAGAAACGTGAGGATC 4834 Table 3AHs.7137 NM_121188 10863994 clones 23667 and 23775 zinc finger 1TACATTCTCCCTTTAGCAACCTGAGT protein (LOC57862), mRNAAAGAGACTCTCTGCCACTGGGCTG /cds = (182, 1618) 4835 db mining Hs.11090NM_021201 11139298 high affinity immunoglobulin epsilon 1AACTCTTGGCCTCAGAGGAAGGAAAA receptor beta subunit (CFFM4), mRNAGCAACTCAACACTCATGGTCAAGT /cds = (148, 868) 4836 db mining Hs.241587NM_021246 10864054 megakaryocyte-enhanced gene 1AGGGAACAAGGGAGCAAGGGAACAA transcript 1 protein (MEGT1), mRNAGGGACATCTGAACATCTAATGTGAG /cds = (3, 1151) 4837 db mining Hs.110915NM_021258 10864066 interleukin 22 receptor (IL22R), mRNA 1GTGGCCCCTGGACGGGTACAATAAC /cds = (23, 1747) ACACTGTACTGATGTCACAACTTTG4838 db mining Hs.210546 NM_021798 11141868 interleukin 21 receptor(IL21R), mRNA 1 CCCCTACCCTGCCCCAATTCAATCCT /cds = (68, 1684)GCCAATAAATCCTGTCTTATTTGT 4839 Table 3A Hs.302014 NM_021803 11141874interleukin 21 (IL21), mRNA 1 ACACGGAAGTGAAGATTCCTGAGGAT /cds = (46,534) CTAACTTGCAGTTGGACACTATGT 4840 db mining Hs.82887 NM_021959 11388174protein phosphatase 1, regulatory 1 CGGTCCTTTTGCCATACACAGTTACA(inhibitor) subunit 11 (PPP1R11), GAGATCAGTCAAATCCATACCACC mRNA/cds =(199, 579) 4841 db mining Hs.79372 NM_021970 11415051 retinoid Xreceptor, beta (RXRB), 1 ATACCTGTGAGGACTGGTTGTCTCTC mRNA/cds = (179,1780) TTCGGTGCCCTTGAGTCTCTGAAT 4842 db mining Hs.293934 NM_02198311875206 major histocompatibility complex, class 1TCATCTACTTCAGGAATCAGAAAGGA II, DR beta 4 (HLA-DRB4), mRNACACTCTGGACTTCAGCCAACAGGT /cds = (58, 948) 4843 Table 3A Hs.96560NM_022086 11545798 Homo sapiens, Similar to hypothetical 1TGCTTCTTGAAATGGATTTAACAACA protein FLJ11656, clone MGC:5247,GCCAGGAGCTTCCTGTCAGTAACC mRNA, complete cds/cds = (149, 271) 4844 dbmining Hs.288316 NM_022107 11545816 chromosome 6 open reading frame 9 1CCCTCCCCACTGCTGCTGAGTCTGTC (C6orf9), mRNA/cds = (373, 855)TGATGTTTTGGTTGTGTGAATAAA 4845 db mining Hs.99134 NM_022110 11545622 DIR1protein (NG7), mRNA 1 AGGAGGAACTGGGGAAGGTGGTCAT /cds = (268, 879)TCAGGGGAAGAACCAGGATGCAGGG 4846 Table 3A Hs.24633 NM_022136 11545870 SAMdomain, SH3 domain and 1 TGGGAAAGTGTGAGTTAATATTGGAC nuclear localisationsignals, 1 ACATTTTATCCTGATCCACAGTGG (SAMSN1), mRNA/cds = (82, 1203) 4847literature Hs.247885 NM_022304 1111111 histamine receptor H2 (HRH2),mRNA 1 TTAAAAGGAGCACATTAAAATTCTCA /cds = (525, 1604)GAGGACTTGGCAAGGGCCGCACAG 4848 db mining Hs.271815 NM_022352 11641262caspase recruitment domain protein 9 1 GCACACGCCATCTGTGTAACTTCAGG(LOC84170), mRNA/cds = (146, 1246) ATCTGTTCTGTTTCACCATGTAAC 4849 dbmining Hs.294030 NM_022447 13937360 topoisomerase-related functionprotein 1 TTTTTCCCAGCTCGCCACAGAATGGA 4-2 (TRF4-2), mRNA/cds = (338, 869)TCATGAAGACTGACAACTGCAAAA 4850 Table 3A Hs.15220 NM_022473 11968022 zincfinger protein 106 (ZFP106), 1 AAGAGAAATATATGCCCTAGAGCTGC mRNA/cds =(335, 5966) TCCAGCACCCTTGGTTTCTGATTT 4851 db mining Hs.28921 NM_02248211968149 DNA sequence from clone RP3- 1 ACAGACAGACTCGATGCCCACACAG 322G13on chromosome 20p11.21- CTTCACTCTTTGAGCAACATGGAAT 12.3 Contains the genefor NTF2- related export protein (NXT1), a gene for a novel zinc fingerprotein with three isoforms, two isoforms for the 3′ part of a novelgene, a gene for a novel protein similar to mouse and bovinebeta-soluble NSF attachment protein (SNAP-beta), a novel gene similar tocystalin, another novel gene similar to cystalin 8 (CST8) with twoisoforms, ESTs, STSs, GSSs and CPG islands /cds = (0, 2135) 4852 Table3A Hs.161786 NM_022570 13384603 C-type (calcium dependent, 1GCACGGTGTGTTGCCACGATTTGACC carbohydrate-recognition domain)CTCAACTTCTAGCAGTATATCAGT lectin, superfamily member 12 (CLECSF12),mRNA/cds = (71, 676) 4853 db mining Hs.302036 NM_022789 12232484interleukin 17E (IL17E), mRNA 1 AGTGTAGTTACTAGTCTTTTGACATG /cds = (258,791) GATGATTCTGAGGAGGAAGCTGTT 4854 Table 3A Hs.302981 NM_024033 13162284hypothetical protein FLJ11000 1 TCACTGCCATACAGGTTTTCCAATAC (FLJ11000),mRNA/cds = (223, 780) ACAAGTGCTAGAAAATACACACAA 4855 db mining Hs.267194NM_024039 13128993 hypothetical protein MGC2488 1TTGCTTGCCCTCCATGTCTTCCTAAA (MGC2488), mRNA/cds = (553, 1170)GAGCAGAACTTGGAGTTTCTCCTT 4856 Table 3A Hs.250723 NM_024104 13129111hypothetical protein MGC2747 1 AGAATGAGCCTGAATGTTGGTGGTTT (MGC2747),mRNA/cds = (92, 247) TTGAAATCCTGACTTGGAGGTAA 4857 db mining Hs.71746NM_024663 13375916 hypothetical protein FLJ11583 1CCTCGGCCCTGACAAACGGGGATCT (FLJ11583), mRNA/cds = (371, 1606)TTTACCTCACTTTGCACTGATTAAT 4858 db mining Hs.94810 NM_024681 13489098hypothetical protein FLJ12242 1 TGGCTTGGCCTTCTCTTTGGTGATCC (FLJ12242),mRNA/cds = (185, 1057) CACCCCCAGCCATTTGCATTGCTG 4859 Table 3A Hs.180799NM_024835 13376244 C3HC4-type zinc-finger protein (LZK1), 1AATGTTTCTCTTCCTGTGAGACTTACT mRNA/cds = (47, 2140)AAAGCAACTTAGTGGCAAAAAGT 4860 db mining Hs.183171 NM_024838 13376250hypothetical protein FLJ22002 1 AGTACTTGAGTAGTCTCAATAGGAGT (FLJ22002),mRNA/cds = (115, 783) GTATTTGTAGACAGCAGTTTCCCT 4861 db mining Hs.212839NM_024879 13376250 mRNA for KIAA1714 protein, partial 1ACCCTAGATGAGCTGTCCTGCTCCAG cds/cds = (0, 3175) TAACATTCTTTTTCTAAAATCATT4862 db mining Hs.125034 NM_025085 13376839 mRNA for putativeN-acetyltransferase 1 AACTAGAAGATGTACTTCGACAGCAT /cds = (208, 2808)CCATTTTACTTCAAGGCAGCAAGA 4863 db mining Hs.3365937 NM_025222 13489105mRNA; cDNA DKFZp434C0814 (from 1 ATTTGAGTTCCTGTGTGTCCAAAACT cloneDKFZp434C0814) GAGGCACCATGTTCTTTGAAAACA /cds = UNKNOWN 4864 Table 3AHs.336937 NM_025222 13489105 mRNA; cDNA DKFZp434C0814 (from 1ATTTGAGTTCCTGTGTGTCCAAACT clone DKFZp434C0814) GAGGCACCATGTTCTTTGAAAACA/cds = UNKNOWN 4865 Table 3A Hs.338937 NM_025222 13489105 mRNA; cDNADKFZp434C0814 (from 1 ATTTGAGTTCCTGTGTGTCCAAAACT clone DKFZp434C08104)GAGGCACCATGTTCTTTGAAAACA /cds = UNKNOWN 4866 db mining Hs.247879NM_025280 13376871 G6B protein (G6B), mRNA 1 GTCCACAGCGGACCCTGCTGATGCC/cds = (0, 725) TCCACCATCTATGCAGTTGTAGTTT 4867 db mining Hs.241586NM_025261 13376873 G6C protein (G6C), mRNA 1 CAGGCTCCCATATGTACCCCATCCCC/cds = (54, 431) CATACTCACCTCTTTCCATTTTGA 4868 db mining Hs.118354NM_025263 13376877 CAT56 protein (CAT56), mRNA 1GTTGTATTGGCAAGAGGGAGGGGTG /cds = (284, 1025) AGAGCTGTTGGAGAACTGAGAATGA4869 db mining Hs.301920 NM_030651 13449284 chromosome 6 open readingframe 31 1 GTACCATCCTCACCGTAGTCATCATC (C6orf31), mRNA/cds = (0, 602)ATCGCCGCGCAGCACCACGAGAAC 4870 Table 3A Hs.196270 NM_030780 13540550folate transporter/carrier (LOC81034), 1 ATTTATCGTAAACATCCACGAGTGCTmRNA/cds = (128, 1075) GTTGCACTACCATCTATTTGTTGT 4871 db mining Hs.107149NM_030934 13569898 novel protein similar to archaeal, yeast 1ATCGCTGAATATGTTGATCAGTGATG and worn N2,N2-dimethylguanosineAGTTGGGCTTAATGCAAAGATCCT tRNA methyltransferase (C1ORF25), mRNA/cds =(194, 2395) 4872 literature Hs.225946 NM_031200 14043041 chemokine (C—Cmotif) receptor 9 1 AGGCTATTTACTTCCATGCTTCTCCTT (CCR9), transcriptvariant A, mRNA TTCTTACTCTATAGTGGCAACAT /cds = (157, 1268) 4873 dbmining Hs.25063 NM_031268 13775167 PRO0461 protein (PRO0461), mRNA 1GGGACCCCCACCCAGTGAGTCAACA /cds = (779, 970) TAGGCTCATGTCAAGTTTGAAAATA4874 Table 3A Hs.301183 NM_031419 13899228 molecule possessing ankyrinrepeats 1 TGGTGTGATATGAACCAGTCCATTCA induced by lipopolysaccharide(MAIL), CATTGGAAAAACTGATGGTTTTAA homolog of mouse (MAIL), mRNA /cds =(48, 2204) 4875 db mining Hs.283801 NM_032009 14196461 protocadheringamma subfamily A, 2 1 TTTTTATCAGCGCCTCAATCTCTACTC (PCDHGA2), transcriptvariant 1, GAAGAAGAAAGAGAAGAAACGTT mRNA/cds = (185, 2983) 4876 Table 3AHs.301104 NM_032236 14149943 602313002F1 cDNA, 5′ end 1CGCTGTCGCCTTAATCCAAGCCTACG /clone = IMAGE:4422480/clone_end = 5′TTTTCACACTTCTAGTAAGCCTCT 4877 Table 3A Hs.193669 NM_032270 14150008hypothetical protein DKFZp586J1119 1 CTGTCGGGCTCTGAAGCGAGCTGGT(DKFZp586J1119), mRNA TTAGTTGTAGAAGATGCTCTGTTTG /cds = (27, 2153) 4878db mining Hs.323682 NM_032334 14150117 hypothelical protein MGC14595 1AGAAGCAGAATGCAGAAGGAGAATG (MGC14595), mRNA/cds = (101, 850)AATCCTTTGGATACTTTCAAGGACA 4879 db mining Hs.106823 NM_032335 14150119mRNA for KIAA1823 protein, partial 1 TCTGGCACAGTCCAGCTCACAACAAC cds/cds= (52, 1185) ATCAAGAGCAGAATTTGGAGACTT 4880 db mining Hs.334639 NM_03238914150222 SH3 domain-containing protein 6511 1 GGGACTTGACTTTCTTTCTGGACTGT(LOC51165), mRNA/cds = (215, 1489) TTGTATTGAAACAAGTGGTGTCA 4881 dbmining Hs.248367 NM_032445 14192940 MEGF11 protein (MEGF11), mRNA 1AGCCTAAACATGTATACTGTGCATTTT /cds = (159, 3068) ATGGGTGACTTTGAAAGATCTGT4882 db mining Hs.69233 NM_032494 14210505 zinc finger protein(LOC64524), mRNA 1 AGACTGGTGATTTGGAGTAGTTTACA /cds = (92, 967)AGATTCCTCATTCAGAGTGCCCTC 4883 db mining Hs.28514 NM_032597 14211930testes development-related NYD-SP21 1 TTGCCTCCTCCAATCTGTGTTCTCAA(NYD-SP21), mRNA/cds = (76, 2115) CTGTGGTTGCCACCTCATTAACTT 4884 Table 3AHs.10056 NM_032811 14249499 hypothetical potein FLJ14621 1TGGAACATACCACATGTAGAAAGGTT (FLJ14621), mRNA/cds = (525, 1307)GAACTGGTTTTTCAGCTATAATGC 4885 Table 3A Hs.334788 NM_032815 14249507hypothetical protein FLJ14639 1 TCACTTAGCCTTTCTGGTTTCCCTTC (FLJ14639),mRNA/cds = (273, 689) CTGTGCATTGCCCATTTTCTCATG 4886 Table 3A Hs.11360NM_032839 14249551 hypothetical protein FLJ14784 1AGCCAAGAGGTATATCGATGATGGAA (FLJ14784), mRNA/cds = (133, 1569)ATTAGCCACATGTACACTACATTT 4887 db mining Hs.29206 NM_032895 14249657hypothetical protein MGC14376 1 CTTCACCGCCCTACTTCCACCTCCGC (MGC14376),mRNA/cds = (184, 255) CCAGCCTGTAATGTTTATATAAGC 4888 Table 3A Hs.154172R64548 836427 602575012F1 cDNA, 5′ end 1 CTTTCAGAGCCAGTTTGTCCAAGGCC/clone = IMAGE:4703258/clone_end = 5′ AGCATCCCGTCTGGGAGATGCACC 4889 dbmining Hs.159388 S74639 807023 AL560682 cDNA 1 GCCGTATATTACTGTGCGAGAGGGC/clone = CS0DL004YM19-(5-prime) CGGAGTGGTTACTCGGTATGGACGT 4890 Table 3AHs.172762 T75153 691915 16b3 cDNA 1 AGGCAAAAGCGCCTCACGCATTCTTGTTCCTTGTTTGCTTCTTCGGTTT 4891 Table 3A Hs.294092 T93822 726995 EST375308cDNA 1 TTAGAAAGAAAAGTCTTTTATTAGTAC TGTGTAGGGAAGGCTAAAGAAAT 4892 dbmining Hs.301385 U19885 642583 602462113F1 cDNA, 5′ end 1ACTGTGCGAAACGTACTGTATTACGA /clone = IMAGE:4575051/clone_end = 5′TTTTTGGAGTGGCCGAAGTAGTCC 4893 db mining Hs.318720 U33547 3320135 Homosapiens, clone MGC:12387 1 CAGACCCTGGTGATGCTGGAAACAG IMAGE:3933019,mRNA, complete cds TTCCTCGGAGTGGAGAGGTTTACAC /cds = (63, 863) 4894 dbmining Hs.267811 U62624 1575443 mRNA for HLA-C alpha chain 1GTCCAGCAACAGTGCCCAGGGCTCT (Cw*1701)/cds = (0, 1118)GATGAGTCTCTCATCGCTTGTAAAG 4895 db mining Hs.247987 U80113 1791068immunoglobulin heavy chain variable 1 GTGTATTACTGTGCGAGAGCCTTCCG region(V4-31) gene, partial cds CCATCCCGGAGTACGTCCAATATG /cds = (0, 356) 4896db mining Hs.289036 U80180 1791202 immnoglobulin heavy chain variable 1CCCGTCCCTCAAGAGTCGAGTCACC region (VH4) mRNA, VH4-59 allele,ATATCAGTAGACAAGTCCAAGAACC partial cds/cds = (0, 353) 4897 db miningHs.247898 U96393 2078365 partial mRNA for Ig lambda light chain 1GGCTCCAGGCTCAGGATGAGGCTGA variable region, clone MB91 (331 bp)TTATTACTGCTGCTCATATACAAGC /cds = (0, 330) 4898 db mining Hs.914 X0045736405 Homo sapiens, Similar to major 1 CCCTCACTGTCACCTTCCCGAGAATAhistocompatibility complex, class II, DR CCCTAAGACCAATAATACTTCAG alpha,clone MGC:14114 IMAGE:4309471, mRNA, complete cds /cds = (40, 822) 4899db mining Hs.296552 X03529 33351 DNA sequence from clone CTA-246H3 1TGAATGACTTCTATCTGGGAATCTTG on chromosome 22 Contains the geneACGGTGACCTGGAAGGCAGATGGT for IGLL1 (immunoglobulin lamba-likepolypeptide 1, pre-B-cell specific), a pseudogene similar to LRP5(Lipoprotein Receptor Related Protein.), ESTs, Genomic markers (D22S414,D22S925, D22S926), CA repeats, STSs, GSSs and a CpG island /cds = (0,438) 4900 literature Hs.287797 X07979 31441 mRNA for FLJ00043 protein,partial 1 ACCACTGTATGTTTACTTCTCACCATT cds/cds = (0, 4248)TGAGTTGCCCATCTTGTTTCACA 4901 db mining Hs.247804 X51887 37616 V108 geneencoding an 1 AGAACAGAGATGATTACACCTACGAA immunoglobulin kappa orphonGTCTGAGTTATGGTGTGAGTTGGA 4902 db mining Hs.81220 X58397 33615 CLL-12transcript of unrearranged 1 TTCATCATTGCTTGCTTGCCTTCCTC immunoglobulinV(H)5 gene CCTCCTGTCCGCTCTCACTCACTC /cds = (39, 425) 4903 Table 3AHs.275959 X60656 31134 eukaryotic translation elongation factor 1TGGATGTGGCTGCTTTCAACAAGATC 1 beta 2 (EEF1B2), mRNATAAAATCCATCCTGGATCATGGCA /cds = (235, 912) 4904 db mining Hs.90093X67643 2244651 mRNA for heat shock protein apg-2, 1TGAAGAACGACCAAAATTATTTGAAG complete cds/cds = (278, 2800)AACTAGGGAAACAGATCCAACAGT 4905 db mining Hs.300697 Y14737 2765424 mRNAfor immunoglobulin lambda 1 GTCTACATACTTCCCAGGCACCCAGC heavy chain/cds =(65, 1498) ATGGAAATAAAGCACCCACCACTG 4906 db mining Hs.300697 Y147372785424 mRNA for immunoglobulin lambda 1 ATACTTCCCAGGCACCCAGCATGGAAheavy chain/cds = (65, 1498) ATAAAGGACCCACCACTGCCCTGG 4907 db miningHs.181125 Y14738 2785426 Homo sapiens, clone MGC:12849 1CCCAAGGCATCAAGCCCTTCTCCCTG IMAGE:4308973, mRNA, complete cdsCACTCAATAAACCCTCAATAAATA /cds = (24, 725) 4908 Table 3A Hs.283770 Z0000833142 germline gene for the leader peptide 1 AAGGCAGAGATCTTGACACCTAAGGAand variable region of a kapppa GTCTAGTTTAGGGCTTTGGTTGGA immunoglobulin(subgroup V kappa I) 4909 db mining Hs.37089 Z00010 33146 germ linepseudogene for 1 GTTGACATTAGAAGCAGGATTCTCTG immunoglobulin kappa tightchain GTACTCCCTCAGAAAATAGAATGC leader peptide and variable region(subgroup V kapppa I) 4910 db mining Hs.148661 Z00022 33158 qg78c05.x1cDNA 3′ end 1 TTGGAGCGTTTTTGTGTTTGAGATATT /clone =IMAGE:1841288/clone_end = 3′ AGCTCAGGTCAATTCCAAAGAGT 4911 Table 1Hs.181297 AA010282 1471308 tc35a11.x1 cDNA, 3′ end 1GGTTGTGTCTCTGGTTTCCCCTTTTC /clone = IMAGE:2066588/clone_end = 3′CCCGTGGTTTTAATTTTTAAGAAC 4912 Table 1 Hs.189468 AA069335 1576904tm30a06.x1 cDNA, 3′ end 1 ACCATAGCAGACAGGGTCAGATGGA /clone =IMAGE:2158068/clone_end = 3′ ATATTAGCGGTTTAGGTGAAGAACC 4913 Table 1Hs.13659 AA115345 1670525 mRNA; cDNA DKFZp586F2423 (from 1ATCCACATTCTTACCTTTGGTAGTCA clone DKFZp586F2423) GGTTTGGCTACTTTGCAGCTCGCC/cds = UNKNOWN 4914 Table 1 Hs.182278 AA203528 1799239 Homo sapiens,calmodulin 2 1 TCTGTTACCACCTCTAAAATATTGGG (phosphorylase kinase, delta),clone GTGGAATAAAGCTGGGTTCTTGCA MGC:1447 IMAGE:3504793, mRNA, completecds/cds = (93, 542) 4915 Table 1 Hs.100651 AA251184 1886149 golgi SNAPreceptor complex member 1 AAGGATGAAGGACTGATGGAGGGCA 2 (GOSR2), mRNA/cds= (0, 838) GAGGAACTGGAGGCAGCAGGCACAA 4916 Table 1 NA AA252909 1885512zr76a03.r1 Soares_NhHMPu_S1 1 AGATGTCTGTATAAACAACCTTTGGG cDNA cloneIMAGE:669292 5′, mRNA TAGCAGGTGGTCAGTTAGGCAGGA sequence 4917 Table 1Hs.194480 AA258979 1894266 EST389427 cDNA 1 TGCTTGTCTTTTAAACACCTTCACAGATATCATTTGCACCTTGCCAAAGG 4918 Table 1 Hs.5241 AA280051 1921589 fatty acidbinding protein 1, liver 1 GGGTAGGCAGCTTGCACCCAGTTCT (FABP1), mRNA/cds =(42, 425) CCTTTATCTCAACTTATTGTCCTGG 4919 Table 2 Hs.23128 AA2823041925220 Homo sapiens, Similar to RIKEN 1 ACTTGGAACAGAAGAACTTCGGCAAC cDNA4931428D14 gene, clone GAGAACACTATCTCAAGCAGAAGA MGC:15407 IMAGE:4309813,mRNA, complete cds/cds = (123, 1151) 4920 Table 1 NA AA282774 1925825zt14g01.r1 NCI_CGAP_GC81 cDNA 1 GCGGTGTCCCTGAGTGAGGGCAAAG cloneIMAGE:713136 5′, mRNA TTGTAATAACACTTGTTCTCTCCTT sequence 4921 Table 1Hs.89072 AA283081 1926050 hypothetical protein MGC4618 1ACGGCGTTCTGAAATTTAGCACACTG (MGC4618), mRNA/cds = (107, 1821)GGAAGTCCACATGGTTCATCTGAA 4922 Table 1 Hs.291448 AA290921 1938772EST368168 cDNA 1 AATGAGATCACAGATGGTGACACTGA GCGGAAGGATGCAGTACCTCGGAG4923 Table 1 Hs.211866 AA290993 193898 wh99f02.x1 cDNA, 3′ end 1GGCTAGTGGTGTTCAGAGAAATACCA /clone = IMAGE:2388891/clone_end = 3′AAACGTGTTTTTATCATTGCTGGT 4924 Table 1 NA AA319163 1971490 EST21341Adrenal gland tumor cDNA 1 AGCTGCCTCAGGAGGTTCTTAACATA 5′ end, mRNAsequence TAGGAATGTAATTATCAGATTCAA 4925 Table 1 Hs.260238 AA3325531984806 hypothetical protein FLJ10842 1 AGGAAACCAAGCCCTCACAGGAAAG(FLJ10842), mRNA/cds = (39, 1307) AAAGCCTGATTCAAGAAAACAAAGT 4926 Table 1Hs.343557 AA401648 2058830 601500320F1 cDNA, 5′ end 1GCTGGGGCTGAGAGAGGGTCTGGGT /clone = IMAGE:3902237/clone_end = 5′TATCTCCTTCTGATCTTCAAAACAA 4927 Table 1 Hs.186674 AA402069 2056860qf56f06.x1 cDNA, 3′ end 1 TCATGGACACAAACTTTGGAGTATAA /clone =IMAGE:1754051/clone_end = 3′ GCGACATCCCTTAAGCAACAGGCT 4928 Table 1Hs.301985 AA412436 2071006 602435787F1 cDNA, 5′ end 1GCCATTTTCCCTCCAGAAACAAAACC /clone = IMAGE:4553684/clone_end = 5′AAGATAATTTATCCTGAACACGGT 4929 Table 1 Hs.9691 AA418765 2080566 cDNA;FLJ23249 fis, clone COL04196 1 TGTTTGTACCACTAGCATTCTTATGTC /cds =UNKNOWN TGTACTTGAACGTGTAGTTAGCA 4930 Table 1 Hs.24143 AA426506 2106769Wiskoff-Aldrich syndrome protein 1 AGGACCATAGGGAAGAGCCAGCCTT interactingprotein (WASPIP), mRNA GCCTTTTCTTATATGATTTTGTTTA /cds = (108, 1619) 4931Table 1 Hs.89519 AA429783 2112974 KIAA1046 protein (KIAA1046), mRNA 1CCTGGGTTGCCTTGTAATGAAAAGGG /cds = (577, 1782) AGATCGAGCCATTGTACCACCTTA4932 Table 1 NA AA457757 2180477 aa92c03.r1 Stratagene fatal retina 1AGCTGTTTAATTGAATTGGAATCGTT 937202 cDNA clone IMAGE:836756 5′,CCACTTGGAACCCAAGTTTGGAAA mRNA sequence 4933 Table 1 Hs.82772 AA4808762185996 collagen, type X1, alpha 1 (COL11A1), 1TCGTTCTACGTTATCTCATCTCCTTGT mRNA/cds = (161, 5581)TTTCAGTGTGCTTCAATAATGCA 4934 Table 1 Hs.13809 AA476568 2204779 mRNA forKIAA1525 protein, partial 1 TGTTTTTGCTTCCTCAGAAACTTTTTA cds/cds = (0,2922) TTGCATCTGCCATCCTTCATTGG 4935 Table 1 NA AL047171 5936355DKFZp586F2018_r1 588 (synonym: 1 TGCACTTACTCATTAGTTTTTAGTTTG hute1) cDNAclone DKFZp586F2018 AACTCTCCTGCGAGGTCTAATGT 5′, mRNA sequence 4936 Table1 Hs.77868 AL513780 12777274 ORF (LOC51035), mRNA 1TGGTTCTTCTGATGAGCAAGGGAACA /cds = (135, 1031) ACACTGAGAATGAGGAGGAGGAGT4937 Table 2 Hs.30120 AL533737 12797230 cDNA/clone = CS0DF00ZYH09-(5- 1AAGCAAGAGATTGTAAACCGGGTACA prime) GATCCAAGAGATGAGAGAGGACCC 4938 Table 1Hs.285401 AL540399 12870508 colony stimulating factor 2 receptor, 1CGTCTACTGCGGAAAAGTCAGGGGA beta, low affinity (granulocyte-AACTGCCAAACAAAGGAAAATGCCC macrophage) (CSF2RB), mRNA /cds = (26, 2721)4939 Table 1 NA AV689330 10291193 AV689330 GKC cDNA clone 1GTGTTTGACTTCACTGCTGCGAAATG GKCDJE03 5′, mRNA sequenceACTGTCTCCTGGCTAGTAGGATCT 4940 Table 1 Hs.90960 AV710415 10729044602563938F1 cDNA, 5′ end 1 ATGTGGGAGGGGCATGGCAGCTATG /clone =IMAGE:4688769/clone_end =5′ AAGGACCTCCTACCTCTGGTTTCTG 4941 Table 1Hs.237868 AV716565 10813717 interleukin 7 receptor (IL7R), mRNA 1CCAGCCTTTGCCTCTTCCTTCAATGT /cds = (22, 1401) GGTTTCCATGGGAATTTGCTTCAG4942 Table 1 Hs.127160 AV719938 10817090 AV659177 cDNA, 3′ end 1ACCTTGTAAGTGCCTAAGAAATGAGA /clone = GLCFUC08/clone_end = 3′CTACAAGCTCCATTTCAGCAGGAC 4943 Table 2 Hs.21536 AV720964 10818136yf69a03.s1 cDNA, 3′ end 1 GCCGAGATCTGCTCAGACTACATGG /clone =IMAGE:27414/clone_end = 3′ CTTCCACTATAGGGTTCTACAGTGT 4944 Table 1Hs.22003 AV730135 10839556 solute carrier family 6 1ATGTCTATAAATGGTGTCATAACTAG (neurotransmitter transporter, GABA),AGCACGGGCGTTATGTAAGTTTCT member 1 (SLC6A1), mRNA /cds = (234, 2033) 4945Table 1 Hs.339696 AV755367 10913215 ribosomal protein S12 (RPS12), 1TGAGTCGTATTACAATTCACTGGCCG mRNA/cds = (80, 478) TCGTTTTACAACGTCGTGACTGGG4946 Table 1 Hs.301553 AW021037 5874567 karyopherin alpha 6 (importinalpha 7) 1 ACATAGGCGAAGAAAACATGGCATTG (KPNA8), mRNA/cds = (55, 1685)AGTGTGCTGAGTCCAGACAAATGT 4947 Table 2 NA AW402007 6920693UI-HF-BK0-aao-g-02-0-UI.r1 1 GTGCAGTCCATCAGATCCAAGCCTGT NIH_MGC_38 cDNAclone CTCTTGAGGAACAACCGCGCAGAC IMAGE:3054530 5′, mRNA sequence 4948Table 1 NA AW499658 7111531 UI-HF-BR0p-ajj-c-07-0-UI.r1 1TGGTGGCAAATCTGATTTTTGGAAAC NIH_MGC_52 cDNA cloneGAGTATTGGAGGACTATAAAACAA IMAGE:3074677 5′, mRNA sequene 4949 Table 1 NAAW499828 7111870 UI-HF-BN0-ake-c-06-0-UI.r1 1 ACATTTCTTGTTGGCACTACAGCAACNIH_MGC_50 cDNA clone CACATACAGTACAGACAACCTCCA IMAGE:3076619 5′, mRNAsequence 4950 Table 1 Hs.145668 AW500534 7113240 fmfc5 cDNA/clone =CR6-21 1 CCTGGCACATGTTGTCTGGAGTCTGG CACACTGGTTATCAATAGCACATT 4951 Table1 Hs.120996 AW504293 7141960 serine/threonine kinase 17b (epoptosis- 1CTGTGGTCTGTTATATGAGAGAGATC inducing) (STK17B), mRNACTTTAACTAGAGCAAAGAGGGAGT /cds = (281, 1379) 4952 Table 1 Hs.194589AW945536 8123293 AV703056 cDNA, 5′ end 1 TCTCTCACTGTTATCATTTTTGCACAG/clone = ADBCMB06/clone_end = 5′ GTGGTTTCAGCAGCTTGATGCCA 4953 Table 1 NABE177661 8656813 RC1-HT0598-020300-011-h02 1 AATCACAGCAGTAACTCCCAGTAGGAHT0598 cDNA, mRNA sequence AAGATTCTCAAAGGAATAGTTCTT 4954 Table 2 NABE253336 9123402 601117146F1 NIH_MGC_16 cDNA 1 CCTGGCCTTCAAGAAGTCGTAGTGGclone IMAGE:3357826 5′, mRNA CTATTTTCTTTGGACAAAGTAAGA sequence 4955Table 1 Hs.343565 BE540808 9769453 601510248F1 cDNA, 5′ end 1ATAGACAGACGGAGGTCCTGATATCC /clone = IMAGE:3912034/clone end =5′ATGGGCCAACGGCTTGGATTATTC 4956 Table 2 NA BE569141 9812861 601338954F2NIH_MGC_53 cDNA 1 GATATTGGTAGTAAAGGGGTTACCTG clone IMAGE:3881180 5′,mRNA TGAACTTCCAAAATTCCTTGGGGC sequence 4957 Table 1 Hs.271272 BE73734810151340 DKFZp434K1715_rt cDNA, 5′ end 1 GGTGGAGAATCAAAACGACCCCGCA/clone = DKFZp434K1715/clone_end = 5′ AATAAACATGGCGATTTGGCTTGGG 4958Table 2 Hs.20225 BE792125 10213323 tuftelin-interacting protein (TIP39),1 GATATCAGACAGCATCGTCTCTGCGA mRNA/cds = (283, 2776)GCACAAAGATCTGTTTGCTGAGCA 4959 Table 1 Hs.31314 BE872245 10321021retinoblastoma-binding protein 7 1 ACATTTTATAAGGCATTTGTGTTAGCC (RBBP7),mRNA/cds = (287, 1584) ACTCAGTCATCTTTGGGTGCTGC 4960 Table 2 NA BE88489810333674 601506831F1 NIH_MGC_71 cDNA 1 ATCTGGAGTGGGACCCTTCAAACCAT cloneIMAGE:3908551 5′, mRNA GTCTGTGCTTATGCGGGAACAAT sequence 4961 Table 1Hs.250824 BE887846 10343176 cDNA:FLJ23435 fis, clone HRC12631 1AATTAACGGCCATCACACCCACGACT /cds = UNKNOWN GACGGTGATCAAACAAATTCACAG 4962Table 1 NA BE898691 10361375 601440131F1 NIH_MGC_71 cDNA 1GACAGTACTCCTAAGACCCCTGTGTG clone IMAGE:3925062 5′, mRNATGTCCCGATGAGATCATGACTGGG sequence 4963 Table 1 Hs.337986 BF03374110741453 Homo sapiens, clone MGC:17431 1 CTGTGATATTTTGGTCATGGGCTGGTIMAGE:2984883, mRNA, complete 1ds CTGGTCGGTTTCCCATTTGTCTGG /cds = (1336,1494) 4964 Table 1 Hs.268177 BF339088 11285508 phospholipase C, gamma 1(formerly 1 CTCATAGCATAGCCAGCATTCAGCAC subtype 148) (PLCG1), mRNAACACAAACCTACTGCCCACATTTG /cds = (76, 3948) 4965 Table 1 Hs.2554 BF34135911287850 sialytransferase 1 (beta-galactoside 1 CACATTTGAAGGCCAAAGGGAAalpa-2,6-sialytransferase) (SIAT1), AACGGGGGAAGCGGAAGGGTTGGA mRNA/cds =(310, 1530) TTGG 4966 Table 1 Hs.334825 BF530382 11617745 cDNA FLJ14752fis, clone 1 TACGACCACTGAGAAACGGGCCACC NT2RP3003071/cds = (205, 1446)CGGCACACGGATCTTGGAACACAAA 4967 Table 1 Hs.79530 BF683110 11937011 M5-14protein (LOC51300), mRNA 1 CTCAGTGTAGGGCAGAGAGGTCTAA /cds = (186, 1043)CACCAACATAAGGTACTAGCAGTGT 4968 Table 1 Hs46677 BF667621 11941516 PRO2000protein (PRO2000), mRNA 1 AGGTTGTGGGGAGTATGTTTGGACCA /cds = (650, 1738)AAAATTAAAATATTGTGGGAGGGA 4969 Table 1 Hs.27590 BF671020 11944915 histoneacetyltransferase (MORF), 1 TGATAGCTCACTTAGTTAATTGTTTTG mRNA/cds = (315,6538) AAGCAAATTTTGGGTTGGATGGG 4970 Table 1 Hs.71331 BF691178 11976586hypothetical protein MGC5350 1 ACTACTGCTTGCGTACCTCTCCGCTT (MGC5350),mRNA/cds = (189, 995) TCCCTCTCCTTACTATCGACCATA 4971 Table 1 Hs.337534BF985068 12332283 602268833F1 cDNA, 5′ end 1 GGTCCGACCAATTAATGACTCCATGA/clone = IMAGE:4356776/clone_end = 5′ TCGGCCTCGGTTTTCACAAACCTT 4972Table 1 Hs.334691 BF965438 12332653 hypothetical protein FLJ22427 1AGACAAAGAGAGCATAAATATAGCTC (FLJ22427), mRNA/cds = (40, 2631)TACTCATGGGTACCATACCAGTGT 4973 Table 1 Hs.279681 BF985960 12333175heterogeneous nuclear 1 GCAGGTTATCGCAAGATGTCTTAGAG ribonucleoprotein H3(2H9) (HNRPH3), TAGGGTTACGGTTCTCAGTGACAC transcript variant 2H9, mRNA/cds = (118, 1158) 4974 Table 1 Hs.5324 BF966028 12333243 hypotheticalprotein (CL25022), mRNA 1 AAATGGCTTTACCAAACATTGTCAGT /cds = (157, 1047)ACCTTTACGTGTTAGAAGGCATTT 4975 Table 1 Hs.179902 BF966049 12333264transporter-like protein (CTL1), mRNA 1 CTTTCCACAGCAATTGTTTTGTACGA /cds= (0, 1964) GGGGCCTTACAGCGCGGTCCACTT 4976 Table 1 Hs.109441 BF96984712337062 cDNA FLJ14235 fis, clone 1 CCCTACTTGATTAAAGATTGAGGTGGNT2RP4000187/cds = (82, 2172) AATTCTAGATGTGGTCATTCGTGT 4977 Table 2Hs.289721 BF981634 12384446 cDNA:FLJ22193 fis, clone HRC01108 1ACAGAGAGTCACCCGCGAGTACGAA /cds = UNKNOWN ACAGGCACATTTTTAGAAACTCACA 4978Table 1 Hs.125819 BG034799 12428456 putative dimethyladenosine 1AGAAATGGTACGGGGAATGTGAATAA transfease (HSA9761), mRNACACGAAATGGTATGGGGAAATGTG /cds = (76, 1019) 4979 Table 1 Hs.34908BG111773 12605279 6018204481F1 cDNA, 5′ end 1 CACAACGGGTCTTAATGACGACGGAA/clone = IMAGE:4052578/clone_end = 5′ AGATACATCCATCGGTATGAACGC 4980Table 1 NA 1BG118529 2612035 602348464F1 NIH_MGC_90 cDNA 1TGTTCTTGTGCTGCTGTTATCTATACT clone IMAGE:4443519 5′, mRNAATTTTTGTTCGTGCCTTCTGACT sequence 4981 Table 1 Hs.285729 BG16323712669951 602013364F1 cDNA, 5′ end 1 GTCTGGGTGCCAACTTGAGACAGGT /clone =IMAGE:4149351/clone_end = 5′ GGTCTAGGAAATTGCGGTAAGAGCG 4982 Table 2Hs.111554 BG164898 12671532 ADP-ribosylation factor-like 7 (ARL7), 1CCCCTGGTTTTCTCGTTCTGCCTCCT mRNA/cds = (14, 592) TTGGACCTGTGTTTGTTTTCTGCT4983 Table 1 Hs.193482 BG165998 12672701 cDNA FLJ11903 fis, clone 1CCCTTAGAATGGTTACTGCCCTTGAA HEMBB1000030/cds = UNKNOWNTTAACTTGACACAACTTGGGTTGG 4984 Table 1 Hs.83731 BG179257 12685889 CD33antigen (gp67) (CD33), mRNA 1 AGGCTGATTCTTGGAGATTTAACACC /cds = (12,1108) CCACAGGCAATGGGTTTATAGACA 4985 Table 1 Hs.278426 BG286817 13040034progestin induced protein (DD5), 1 TCTCCTTTCAGTTCCTTTGTAGGATTT mRNA/cds= (33, 8432) CTGGGCTTGAAGGATAGTCTTCA 4986 Table 1 Hs.173830 BG28904813044499 602383666F1 cDNA, 5′ end 1 ATACTGTGTGATTTGCCCTTGCTGTC /clone =IMAGE:4512712/clone_end = 5′ GAACCCTGTTCTTGCTGCCATTTA 4987 Table 1Hs.129872 BG290577 13047679 sperm associated antigen 9 (SPAG9), 1AGAATGTCCCACTTGCTGTCTCTTAG mRNA/cds = (110, 2410)AGGCTGAGCTTCATTTCTATGAGC 4988 Table 1 Hs.170980 BG387694 13281140 cellcycle progression 2 protein 1 CAACCTCTGGAGAGTGCCTACTGTTA (CPR2),mRNA/cds = (126, 1691) GAAGCTGAAGGGATGTCAAAGTCA 4989 Table 1 Hs.266175BG391695 13285143 cDNA FLJ20673 fis, clone KAJA4464 1CTTTAAATCTTAGATTGCTCCGCACA /cds = (104, 1402) GATAAAGAGAACCAGGATTGGGGC4990 Table 1 Hs.58643 BG397564 13291012 602438603F1 cDNA, 5′ end 1GCCTCAGTACAGAGGGGGCTCTGGA /clone = IMAGE:4564968/clone_end = 5′AGTGTTTGTTGACTGAATAACGGA 4991 Table 1 Hs.24054 BG489375 13450885hypothetical protein GL009 (GL009), 1 AGGACTTAACGGGAATACGGGAATAAmRNA/cds = (77, 628) CTCCAATTACTTCATCTCTAGGGC 4992 Table 1 Hs.29131BG497765 13459282 nuclear receptor coactivator 2 1TGCCTAAGAGCAAAGCATCCTCTGCG (NCOA2), mRNA/cds = (182, 4556)ACAAAAGAAAATTACTGTAGTGGC 4993 Table 2 Hs.172089 BG501063 13462580 mRNA;cDNA DKFZp586I2022 (from 1 AAACACACAGGAAAAGGGCAAGGG clone DKFZp586I2022)GGCACCAGGAGAACCGGGAGACAAA /cds = UNKNOWN 4994 Table 1 NA BG50189513463412 602548201F1 NIH_MGC_61 cDNA 1 GACATGGAGCCCCCGGAAAAGCGGG cloneIMAGE:4654344 5′, mRNA TCTGGACACCAAGTCGATGTGTGAG sequence 4995 Table 1Hs.3280 BG505961 13467478 caspaso 6, apoptosis-related cysteine 1ACAGAATCAGATTTTGCAGGTGTCCA protease (CASP6), transcript variantACCTATAGTGGCTAAGAATTATGT alpha, mRNA/cds = (78, 959) 4996 Table 1Hs.279009 BG532345 13523883 matrix Gla protein (MGP), mRNA 1AAACTGTTTGGAGAATTTAAGCACTC /cds = (46, 357) TCTGATGGGGGACAACTCTATGGA4997 Table 1 Hs.74647 BG536394 13527940 T-cell receptor activealpha-chain 1 AATAATTGGTCTTTTAAACAAACACG mRNA from JM cell line,complete cds GAAGTTTGGTGGAATCGGTCATGT /cds = (136, 969) 4998 Table 1 NABG542394 13534627 602571761F1 NIH_MGC_77 cDNA 1TGTGGCGATTAAGAGAGGTGAAGCAT clone IMAGE:4696046 5′, mRNAAACTGATTTGCAGGATATGGTTTG sequence 4999 Table 1 Hs.83077 BG54762713546292 interleukin 18 (interferon-gamma- 1 GCAGAACTCTAATTGTACGGGGTCACinducing factor) (IL18), mRNA AGAGGCGTGATATGGTATCCCAAA /cds = (177, 758)5000 Table 1 Hs.301497 BG566035 13573688 arginine-tRNA-proteintransferase 1-1p 1 TGGAGATCCTTCTACTTGGCTGCTGT (ATE1) mRNA, alternativelyspliced ATTCATGCATTATGTTGGTTTGAG product, partial cds/cds = (0, 1544)5001 Table 1 Hs.343475 BG566964 13574617 601556208T1 cDNA, 3′ end 1ATTTGTACCAAATCTTTGGGATTCATT /clone = IMAGE:3826392/clone_end = 3′GGCAAATAATTTCAGTGTGGTGT 5002 Table 1 Hs.11050 BG571068 13578721 mRNA;cDNA DKFZp4340118 (from 1 GGTTTTAGCAGTTCTTTAGCCCGTGG cloneDKFZp434C0118); partial cds TATTTCAGTGTTGGGTTTCATAGC /cds = (0, 1644)5003 Table 1 Hs.194110 BG571747 13579400 hypothetical protein PRO2730 1GGGAGCCATAAGAACGACTCCAAAAA (PR02730), mRNA/cds = (183, 596)GAGCCCCAAGGAGGACAAGGGGG 5004 Table 1 Hs.306155 BG572371 13580024chorionic somatornammotropin 1 TCAGGGTCTTGGATACTCAAGAGAAA hormone 1(placental lactogen) GGAGACTTGTGGTTAATGTTTGGA (CSH1), transcript variant2, mRNA /cds = (116, 886) 5005 Table 1 Hs.301756 BG573202 1358055 Homosapiens, clone MGC:17544 1 TCCTTAGCACACGAAAAAGCCCCTTC IMAGE:3482146,mRNA complete cds CCCTGGATTCATGTTTCTTATTTC /cds = (258, 894) 5006 Table1 Hs.79101 BG575739 13583392 cyclin G1 (CCNG1), mRNA 1AAGCAAGTAGACACCTTCATAACTAT /cds = (187, 1074) GAATGAAGCTGCTGAAGTAGTGTT5007 Table 1 Hs.172780 BG611117 13682488 602343016F1 cDNA, 5′ end 1TCCATTAAAGATCGCAAATGTTGAGG /clone = IMAGE:4453466/clone_end = 5′TCCTGTAGCCTGAAAACTCTCTGC 5008 Table 1 Hs.5064 BG614405 13885776602490910F1 cDNA, 5′ end 1 CTGATTCAAACAGGTTCCAACGTAA /clone =IMAGE:4619835/clone_end = 5′ ACGTTCACACTTCCACCATTTCCT 5009 Table 1Hs.86437 BG815272 13666643 602411368F1 cDNA, 5′ end 1TGATGTTGGTATGCTTGCCCTGTTAC /clone = IMAGE:4540098/clone_end = 5′TTATAGACAGTCTTTGTCATAGGC 5010 Table 1 Hs.111911 BG617515 13668888602540482F1 cDNA, 5′ end 1 GGTCTTTGTCCCAGTAGAGTTCATAG /clone =IMAGE:4671519/clone_end = 5′ TCTATTTAGTGTGCATGTTTTTCC 5111 Table 1Hs.326392 BG618351 13669722 son of sevenless (Drosophila) 1TTGTGTCCAAAAGTGTTAACGAAGAC homolog 1 (SOS1), mRNATACTTAACCCAATGATTGGCGCGA /cds = (0, 3998) 5012 Table 1 NA BG62231313673684 602646981F1 NIH_MGC_79 cDNA 1 ATGCGTGGATATTGAGAACTTAGGTG cloneIMAGE:4768413 5′, mRNA TCTAATGGGGAGGATTATTGCTGT sequence 5013 Table 1Hs.173334 BG674441 13905837 ELL-RELATED RNA POLYMERASE 1AAGCATTTCCATTTCAACGAGTTTGT II, ELONGATION FACTOR (ELL2),CAGCTTTATTAATGTTGGGCAAAA mRNA/cds = (0, 1922) 5014 Table 1 Hs.343615BG675211 13906607 602621493F1 cDNA, 5′ end 1 AAACCTACCACTTTAAGAAGACAGCG/clone = IMAGE:4755166/clone_end = 5′ ATGGGTAATTCTTTATTGGCAGGT 5015Table 1 Hs.250905 BG675766 13907162 hypothetical protein (LOC51234), 1ATTCAGCATTAGTTTCTCACATCTTCC mRNA/cds = (0, 551) CCCAGGTATCCCCAACAGAATTA5016 Table 1 NA BG676788 13908185 602623378F1 NCI_CGAP_Skn4 1ACACCTCTCTTAGGGCTCCATCAAAC cDNA clone IMAGE:4748322 5′, mRNAAGAACTTTTAGACTGAGTAACGCT sequence 5017 Table 1 Hs.21812 BG67690313908300 AL562895 cDNA 1 AAGTTTGTGCAGCACATTCCTGAGTG /clone =CS0DC021YO20-(3-prime) TACGATATTGACCTGTAGCCCAGC 5018 Table 2 Hs.171802BG678827 13910224 RST31551 cDNA 1 ACCATGAACAGTGTGTTGCTTCAGACTATTACAAAGAGAATGGGGCAGGT 5019 Table 1 Hs.12396 BG679427 13910824602302446F1 cDNA, 5′ end 1 TTTTTGAAAAGTATGTTTGGTAGAAAT /clone =IMAGE:4403866/clone_end = 5′ TAGTTGTATGCCCTCAGGACGGT 5020 Table 1Hs.4248 BG679662 13911059 vav 2 oncogene (VAV2), mRNA 1GAAATTAGTGTGAACATGTGGGAAGC /cds = (5, 2641) CCGATGCATGTGGGTCAGGGATCT5021 Table 1 Hs.182937 BG681320 13912717 peptidylpropyl isomerase A(cyclophilin 1 TCCCTGGGTGATACCATTCAATGTCT A) (PPIA), mRNA/cds = (44,541) TAATGTACTTGTGGCTCAGACCTG 5022 Table 1 NA BG682704 13914101602629666F1 NCI_CGAP_Skn4 1 CAGACAGCACAGCCTGAGGGTAGCA cDNA cloneIMAGE:4754273 5′, mRNA GCAGCCACCCATGTTCAGGTAAGTC sequence 5023 Table 2Hs.250465 BG707615 13984138 mRNA; cDNA DKFZp434E2023 (from 1GCCATGAGGTGGAGGACGTGGACCT clone DKFZp434E2023) GGAGCTGTTCAACATCTCGGTGCAG/cds = UNKNOWN 5024 Table 1 Hs.235883 BG708357 13985818 602628774F1cDNA, 5′ end 1 TCTGCACCCAAACAAATACCTTTTGA /clone =IMAGE:4753483/clone_end = 5′ GATTTCTTATAGGCATTCCTCTCG 5025 Table 1Hs.119960 BG709079 13987060 mRNA; cDNA DKFZp727G051 (from 1GAAGCTCTGCCGCAGCGCCAGGCAC clone DKFZp727G051); partial cdsTTCCTACACCACTACTACGTCCACG /cds = (0, 1423) 5026 Table 1 Hs.87908BG709315 13987530 Snf2-related CBP activator protein 1CAGCTCGGACCACCGCCACCTCCCT (SRCAP), mRNA/cds = (210, 9125)TTTTATTTACAGATCACCCAGTAAG 5027 Table 1 Hs.10056 BG720359 13999546hypothetical protein FLJ14621 1 GGTCCCCTCCTGGAGACTCCCTCAC (FLJ14621),mRNA/cds = (525, 1307) AAAATCTTTCCCCAAGCTGTTCCCC 5028 Table 1 Hs.6986BG723274 14002461 glucose transporter pseudogene 1TGAATGGGCGTTTATCTTAATGACCA /cds = UNKNOWN GTTATTGACCAAAGTGTACTCAGA 5029Table 1 Hs.181392 BG740787 14051440 major histocompatibility complex,class 1 AGCCTATTCCTATTCTCTAGCCTATTC I, E (HLA-E), mRNA/cds = (7, 1083)CTTACCACCTGTAATCTTGACCA 5030 Table 2 Hs.86543 BG743518 14054171602495247F1 cDNA, 5′ end 1 GCAATGGGCGGCCAACTATGAACCC /clone =IMAGE:4609330/clone_end = 5′ TACGTGGTGGTGGCACGAGACTGTC 5031 Table 1Hs.77202 BG743900 14054553 protein kinase C, beta 1 (PRKCB1), 1GCCTGGAGCTTGGCTTTGTATCCAAG mRNA/cds = (138, 2151)TGTATGGTTGCTTTGTCTAAGAGG 5032 Table 2 Hs.95835 BG747882 14058515 RST8356cDNA 1 AGGGAGACTCTCAGCCTTCAGCTTCC TAATTCTGTGTCTGTGACTTTCG 5033 Table 1Hs.204959 BG758589 14069222 hypothetical protein FLJ14886 1AGCCTACAAGCCACCTCGCCACTGT (FLJ14888), mRNA/cds = (111, 1169)GAACTTGTCGTCACTCTTGGATGTC 5034 Table 2 Hs.37617 BG760189 14070842602144947F1 cDNA, 5′ end 1 CCTGCTCACAGACCAGGAACTCTACA /clone =IMAGE:4308683/clone_end = 5′ AGCTGGACCCTGACCGGCAGTACC 5035 Table 1Hs.182447 BG766957 14077610 heterogeneous nuclear 1AGCAGTTCCACAGTGTTTCACACTAC ribonucleoprotein C (C1/C2) (HNRPC),AGGATTTAAATATTTTGCTCCAGA transcript variant 1, mRNA /cds = (191, 1102)5036 Table 2 Hs.301226 BG768471 14079124 mRNA for KIAA1085 protein,partial 1 CCTTTATCCACCTGGATTTTAGGGAC cds/cds = (0, 1755)AACACTGAAAACGAATAAGTCCA 5037 Table 2 Hs.301226 BG768471 14079124 mRNAfor KIAA1085 protein, partial 1 CCTTTATCCACCTGGATTTTAGGGAC cds/cds = (0,1755) AAACACTGAAAACGAATAAGTCCA 5038 Table 1 Hs.124675 BG772661 14083314ob13b08.s1 cDNA, 3′ end 1 CAGAGAACGAAGTCAAGTGCAGCG /clone =IMAGE:1323543/clone_end = 3′ AGTTGGGTGGAAGCTGATAGAGCAA 5039 Table 2Hs.301228 BG775621 14045938 mRNA for KIAA1085 protein, partial 1CCACAAACCATTCAGATCAGGCACTT cds/cds = (0, 1755) GCTGACCCTGGTTCTTAAGGACAC5040 Table 1 Hs.180450 BG820627 14168214 ribosomal protein S24 (RPS24),1 AAGAAACTATGTAGCATAGTGTCTTA transcript variant 1, mRNAACACCTCAGTAAAGTAAGCTGGCC /cds = (37, 429) 5041 Table 1 Hs.1432 BG91343014293906 protein kinase C substrate 80K-H 1 AGCAGGAGACAGCTTCCTGATCTAGA(PRKCSH), mRNA/cds = (136, 1719) TGTACAATTAGAGTTTAGGTTGGA 5042 Table 1Hs.247474 BG913498 14293974 hypothetical protein FLJ21032 1TGGAACTAGTCACAATTGAAGTTCTT (FLJ21032), mRNA/cds = (235, 1005)CATCCAGTAGGTGTTAACAGTGT 5043 Table 1 Hs.72988 BI086609 14504939 signaltransducer and activator of 1 CCCACACAAGTGCGCCACATAAATCT transcription2, 113 kD (STAT2), mRNA GCGAGACTCCACGACAACACAGGG /cds = (57, 2612) 5044Table 1 Hs.288036 BI086741 14505071 tRNA isopentenylpyrophosphate 1GCAAACAAGTTCTAAAGTTGTGGAGA transferase (IPT), mRNAAAAAGTGATGTGGTCAAGAGTTGA /cds = (60, 1040) 5045 Table 1 Hs.131887BI090806 14509136 602415255F1 cDNA, 5′ end 1 GCCAGAAAGAGAAACGTAAAAA/clone = IMAGE:4523725/clone_end = CAGATAGAGATTCTGCCTGTGCTT 5′ TGGT 5046Table 1 Hs.287797 BI091791 14510121 mRNA for FLJ00043 protein, partial 1GAGAGTTGCTGGTGTAAAATACGTTT cds/cds = (0, 4248) GAAATAGTTGATCTACAAAGGCCA5047 Table 1 Hs.146381 BI092128 14510458 RNA binding motif protein, X 1GGTTAACGCTTCTGTGAGGACCTTCT chromosome (RBMX), mRNAGGCTCTTGAGATACCCTAAATATT /cds = (11, 1186) 5048 Table 1 Hs.75249BI092568 14510898 mRNA for KIAA0069 gene, partial cds 1ACTTTCATTGGTAAATAAGCCTGTCTT /cds = (0, 680) CCTATCTGGATTTTTGGTGTGCA 5049Table 1 Hs.73965 BI093470 14511800 splicing factor, arginine/serine-rich2 1 CAGTTATTTAAAGGCTGACAACTGCC (SFRS2), mRNA/cds = (155, 820)TTCCAGACCCGCGCTGTATTAATA 5050 Table 1 Hs.104679 BI094249 14512579 Homosapiens, clone MGC:18216 1 TGGTGGGTACAGAAACATTGTCACAG IMAGE:4156235,mRNA, complete cds GGATCCTGGAACAGAGGAAGAGTT /cds = (2206, 2373) 5051Table 1 Hs.7905 BI193299 14648319 SH3 and PX domain-containing protein 1TTCTGACCTAATAATTACGGGAAATG SH3PX1 (SH3PX1), mRNAGAAAGTCTGGGCCAGCATCAATAA /cds = (43, 1830) 5052 Table 1 Hs.217493BI195901 14650921 annaxin A2 (ANXA2), mRNA 1 TGGGTCGGCAAAGCTATTATAACTTT/cds = (49, 1068) GAATGCTAACGGCATGTTTGACCT 5053 Table 1 Hs.33026BI198202 14653223 mRNA for FLJ00037 protein, partial 1GCTGTGTCCTTTCTGGCACAATCGGG cds/cds = (384, 3921)GATTCCATTCTTTAGACACTGGAA 5054 Table 1 Hs.179661 BI222978 14676422 Homosapiens, tubulin, beta 5, clone 1 TTGACAAAGATGACATCGCCCCAAGA MGC:4029IMAGE:3617988, mRNA, GCCAAAAATAAATGGGAATTGAAA complete cds/cds = (1705,3039) 5055 Table 1 Hs.23158 BI224666 14678110 600943902F1 cDNA, 5′ end 1GTAAAGATCAGAATACCAAGGCCAGC /clone = IMAGE:2966352/clone_end = 5′TAAGGCAACGACTCCCTCCCCAAA 5056 Table 1 Hs.218387 H03298 866231 tc88c11.x1cDNA, 3′ end 1 ATACGGGACAATAAAATCTGCCTTTT /clone =IMAGE:2073236/clone_end = 3′ GCTCTGGAGGGAGATACTACCTCT 5057 Table 1Hs.178703 H56344 1004988 AV716627 cDNA, 5′ end 1ATGCTGGTGTCATGTGACATTTGTTG /clone = DCBBCH05/clone_end = 5′AGTCTCGGGCATGTTCACGGTGGG 5058 Table 1 NA H57221 1010053 yr08e08.r1Soares fetal liver spleen 1 GGAAATTGTGCCAAAACCATGGAAAA 1NFLS cDNA cloneIMAGE:204710 5′, TATTACTGTGTGTGGGGTGTCTGT mRNA sequence 5059 Table 1Hs.74002 H81660 1059749 mRNA for steroid receptor coactivator 1TTTGTGTGTGAAATATAACATTGATTG 1e/cds = (201, 4400) AATTGCAGTTACATTTGGTTAGT5060 Table 1 Hs.5122 N31700 1152099 602293015F1 cDNA, 5′ end 1AACATTCTACATAGCACAGGAGCTTA /clone = IMAGE:4387778/clone_end = 5′AGAGTGGCATTATCTTCTCGCCTT 5061 Table 1 NA R11456 764191 yf46a09.r1 Soaresfetal liver spleen 1 TAAGGTTAGGCAATAACTTAGGGGTA 1NFLS cDNA cloneIMAGE:129880 5′ TATTCTCTTCCTGCATCCCAGTGC similar to gb|M87943|HUMAALU45062 Table 1 Hs.208603 R64054 835933 7f01d11.x1 cDNA, 3′ end 1TAAGGTGTTTGCTGGGGGATGTTGTG /clone = IMAGE:3293397/clone_end = 3′TGTATTAGGGGAGTGTTTCCCTTG 5063 Table 1 NA R85137 943543 yo41c07.r1 Soaresadult brain 1 AAAACATTGCCAGACCATTTAGTCCT N2b4HB55Y cDNA cloneCTTGGAAGGGCCTCTCCGGTGGGG IMAGE:180492 5′, mRNA sequence 5064 Table 1 NAT80378 698887 yd05c01.r1 Soares infant brain 1NIB 1CGGGGGAATAGGAGGAAAAACATGG cDNA clone IMAGE:24693 5′, mRNACATGGAACAACCAACATAAAAGGT sequence 5065 Table 1 NA T80854 703539yd22a08.r1 Soares fetal liver spleen 1 ACTGGTGTTGGTGCTTTTGTCTGTCA 1NFLScDNA clone IMAGE:108950 5′, TACCATAGTATTTTCAAAACTTCA mRNA sequence 5066Table 1 Hs.44189 W00466 1271875 yz99f01.s1 cDNA, 3′ end 1CCTTGAGAAACACCCATCTCCACTTC /clone = IMAGE:291193/clone_end = 3′CTAGACAAACCAATGAACATTAGT 5067 Table 1 Hs.306117 W18552 1290934 capicuaprotein (CIC) mRNA, 1 AACTGTGAGGCAAATAAAATGCTTCT complete cds/cds = (40,4868) CAAACTGTGTGGCTCTTATGGGGT 5068 Table 1 Hs.17778 W19201 1295429neuroplin 2 (NRP2), mRNA 1 CTAAGTCATTGCAGGAACGGGGCTG /cds = (0, 2780)TGTTCTCTGCTGGGACAAAACAGGA 5969 Table 1 Hs.340717 W25088 1302933we58c01.x1 cDNA, 3′ end 1 GCCGTTCTTTATAGAACAATTCCTTTC /clone =IMAGE:2345280/clone_end = 3′ TCTTCTCTTGAATGTGGCAGTCA 5070 Table 1Hs.8294 W80882 1391906 KIAA0196 gene product (KIAA0196), 1AGCCTACCTCCCTACCCCAAGCTGTC mRNA/cds = (273, 3752)TGTTGAGAGCAGTGCTGACCCCAG 5071 Table 1 Hs.133543 AA251316 1886279EST378950 cDNA −1 TTTCATAAACCCACTCCTTCCTCTTCA CCCACTTGCAATCCGCATGCTTC5072 Table 3A Hs.96487 AA524555 2265483 7q23106.s1 cDNA, 3′ end −1CAAGTTGGTTTAGTTATGTAACAACC /clone = IMAGE:3899226/clone_end = 3′TGACATGATGGAGGAAAACAACCT 5073 Table 3A NA AA628833 2541220 af37g04.s1 −1GACTCGTTACGCCGTAGTTTGTCCTA Soares_total_fetus_Nb2HF8_9w cDNATCTTGTTTATCAAATGAATTTCGT clone IMAGE:1033878 3′, mRNA sequence 5074 dbmining NA AA701193 2704358 zj80c03.s1 −1 AGCCGCCCAGCTACTTAATCCCTCAGSoarses_fetal_liver_spleen_1NFLS_S1 TAACATCTATCTAAATCTCCCATG cDNA cloneIMAGE:461188 3′ similar to gb:M11124 HLA C 5075 Table 3A Hs.307486AA729508 2750867 nx54a03.s1 cDNA −1 TGGCCTGTGCTTTTACCACACCGTCA /clone =IMAGE:1266028 AACCCTTGATCATTTCTGTAAACA 5076 Table 3A Hs.104157 AA7655692816807 EST380899 cDNA −1 ACATTCTCATAGTCCAGGGGCTCAACAACTTTGGCCTTTTCCAGCACCAC 5077 db mining Hs.220649 AA774984 2834318QV1-GN0320-051200-552-b08 cDNA −1 TCAGCAGTTGTGCCTTTTCTCACAGATCCAGCCGTCCTTCTCGCTGTCAC 5078 db mining Hs.192078 AA884466 2993996te30h04.x1 cDNA, 3′ end −1 TGCAAGCAATAAAATCTTGCTTTAATC /clone =IMAGE:2087479/clone_end = 3′ AGTAACCACTGTCTGACAGGACA 5079 db miningHs.194249 AA907080 3042540 HOA43-1-G6.R cDNA −1GGTCGTAGAGAAGACAGCAAGGGAG GGGATAAAACCCAGGAGGACTTAA 5080 Table 3AHs.143254 AA961072 3127626 EST388440 cDNA −1 GGCTCACGATGACAACCGCCTACGGAAAAACTCTAATTCCTAAACATCTA 5081 db mining Hs.163271 AF343666 13591717translocation associated fusion protein −1 GACAAGCCAGGTCAGCCCAGATTGCIRTA/IGA1 (IRTA1/IGHA1) mRNA, CAAAGCAGCACTTGCCTACACCAGC complete cds/cds= (136, 402) 5082 Table 3A Hs.46476 AI018105 3232624 EST386846 cDNA −1GGTTCCCTTGAAGCAGTGCCAACCTA AATCTACCTCAGGTAAGTAGTTAG 5083 Table 3AHs.238954 AI031624 3249836 602637935F1 cDNA, 5′ end −1GCTGACAGTATGGAGGCTAAAGGTG /clone = IMAGE:4765448/clone_end = 5′TGGAGGAACCAGGAGGAGATGAGTA 5084 db mining Hs.133261 AI052754 3308745oy78e01.x1 cDNA, 3′ end −1 CAAGTGTGCCGGGCAAGTTTGGGAA /clone =IMAGE:1671960/clone_end = 3′ GGTGAAGCAATCTGTGACTTAAATA 5085 db miningHs.292803 AI056470 3330336 oy77d03.x1 cDNA, 3′ end −1GAGCTACTCAAGGGGAAAAAAGGGC /clone = IMAGE:1671845/clone_end = 3′ATATAGTATGCTCTGGTAGTAAAAGT 5086 db mining Hs.6733 AI057025 3330814phosphoinosilide-specific −1 GCTCAAGATCACCTCTTTGTCATCTT phospholipase CPLC-epsilon mRNA, GAACAATGTTTTTCTCTTCTAGGT complete cds/cds = (235,7146) 5087 db mining Hs.133930 AI073993 3400637 oy66d03.x1 cDNA, 3′ end−1 TGGTGATAATAGAGATTGTTTCTGCC /clone = IMAGE:1670789/clone_end = 3′CTGGGGGTAGTTCAAGGATAACAC 5088 db mining Hs.133949 AI074528 3401172oy79d05.x1 cDNA, 3′ end −1 CTTCAGGTTTGGCCCAGCCCCTCCTT /clone =IMAGE:1672041/clone_end = 3′ GAAGACTCCTTCCATCCAGTCAAG 5089 db miningHs.134018 AI076071 3405249 oy80b11.x1 cDNA, 3′ end −1CCCAAGTGAAGTCAAAGTTACTGTGT /clone = IMAGE:1672125/clone_end = 3′GGTTGATAGGGAACATGGCTGGAT 5090 db mining NA AI081253 3418045 oy67c02.x1NCI_CGAP_CLL1 cDNA −1 ACCCGCAGACCAGATGGTTGAAAGG clone IMAGE:1670882 3′similar to AAAAATTAAAGCCTTCTTGGGGATT gb:X64707 BREAST BASIC CONSERVED PR5091 db mining Hs.134590 AI081258 3418050 oy67c11.x1 cDNA, 3′ end −1GGAGTTAGATCAACCTTATGGGGAAG /clone = IMAGE:1870900/clone_end = 3′GGAAAGGCAGGGCTTGTGACAATT 5092 Table 3A Hs.105621 AI084553 3422976HNC29-1-B1.R cDNA −1 GATGGCTGCTTGGTTGCTAAACCCAG ACAGGGTCCTTCCAGTGCATCTGC5093 db mining Hs.230775 AI085588 3424011 oy68d10.x1 cDNA, 3′ end −1CATTTGTGGGTGGAGGGTTTTGAATG /clone = IMAGE:1670995/clone_end = 3′TCCTCTTTCCATGTCAGGCAAAGG 5094 db mining Hs.146591 AI086023 3424446oy70f10.x1 cDNA, 3′ end −1 TTCTATGAAGGTTTCCCTGGACAAGA /clone =IMAGE:1671211/clone_end = 3′ AACTGCCAGAGAGCCCTTAGCTCA 5095 Table 3AHs.23158 AI097125 3446707 600943902F1 cDNA, 5′ end −1TGCTGAATGTACCTGAGTGTATGTAT /clone = IMAGE:2968352/clone_end = 5′TTAAAAGGACTCACATGGGCATCA 5096 db mining Hs.150708 AI122689 3538455oy79f03.x1 cDNA, 3′ end −1 TCTCAACCCTAATATTCATTGTTCCAT /clone =IMAGE:1672061/clone_end = 3′ GAGCATTGTCAGGTTTTGGATGG 5097 db miningHs.326995 AI144314 3668123 oy64f01.x1 cDNA, 3′ end −1ACAAGTGGAAGAGGAAGACAGAAGA /clone = IMAGE:1672537/clone_end = 3′ATGGGTCAGGGAGATGCAAGGATGG 5098 db mining NA AI144317 3666126 oy84f04.x1NCI_CGAP_CLL1 cDNA −1 TCCTTAGGGAAAAGAAGATTTTCAAA clone IMAGE:1872543 3′similar to CCCTTCGTTAGTTTCGGTAGGGCC gb:X64707 BREAST BASIC CONSERVED PR5099 db mining NA AI187859 3739068 qe7h05.x1 Soares_testis_NHT cDNA −1ACGCAATTTGTTCACATACATACACAT clone IMAGE:1738329 3′, mRNAGCAAATCCCAAAAGAAGGTTTTA sequence 5100 Table 3A Hs.121210 AI2046113757217 EST384285 cDNA −1 CCCAGCCCTCTATGTACCCGTGTCCCAGCCAGCAATAAATGCCATCTTGG 5101 db mining Hs.144814 AI220630 3802833RST44972 cDNA −1 AGCCTGGAATTCTAAGCAGCAGTTTC ACAATCTGTAATTGCACGTTTCTG5102 db mining Hs.126580 AI222355 3804558 602691805F1 cDNA, 5′ end −1TGGTTACTCATGTCCTCAAAGACGAC /clone = IMAGE:4824264/clone_end = 5′TCATGATGCTGGATATGAAGAACT 5103 Table 3A Hs.36475 AI243620 3839017EST372075 cDNA −1 AGGCAAAAGTCATTTCTTCCCTATATT TTGTCATGCTTATCTCCTGTCTC5104 db mining NA AI283168 3871371 qh49e10.x1 Soares_NFL_T_GBC_S1 −1GTATGAAGGCAAGAAAATTTCAGGGG cDNA clone IMAGE:1848042 3′, mRNAAAAACAAGTGGTTATTTTCTGGCC sequence 5105 Table 3A Hs.158501 AI2908453933819 7q71b07.x1 cDNA, 3′ end −1 GATACCCTCTTCCTAAGACTCATCGC /clone =IMAGE:3703644/clone_end = 3′ GTCTCTTCCAGCCTCCTCGCCCCA 5106 db miningHs.150175 AI301070 3960416 qo16d04.x1 cDNA, 3′ end −1TCTGTATGCTGTGGTCTCATCAGGAA /clone = IMAGE:1908679/clone_end = 3′CCTTTTCTCTGCACTGCATTTTTCC 5107 db mining NA AI356349 4107970 qz26d12.x1NCI_CGAP_CLL1 cDNA −1 AGAGCTGGTTCCAGAAGGTTCGGAT clone IMAGE:2028023 3′similar to GAGTCCTGAATGTTTATGTAGGGCA contains MER7.b2 MER7 repetitive et5108 db mining Hs.157560 AI356388 4108009 qz26e07.x1 cDNA, 3′ end 1TCCTTAGTCTCCTTCAATTTCCACACA /clone = IMAGE:2028036/clone_end = 3′CTGAACATGACATTTTACCCTTT 5109 db mining NA AI356470 4108091 qz27b11.x1NCI_CGAP_CLL1 cDNA −1 TTTTCTGTTTTCTGTTTTAAGAAAATC clone IMAGE:20280933′, mRNA TGGAACCGCAAGGCCGTCCCTTT sequence 5110 db mining Hs.157808AI381701 4113322 qz18e09.x1 cDNA, 3′ end −1 CCAAAGCCTTTGTTGTTTGGTGGCGA/clone = IMAGE:2021896/clone_end = 3′ GGCCCCTTTTTGAATGGGGTTTTT 5111 dbmining Hs.327396 AI381729 4113350 qz24a08.x1 cDNA, 3′ end −1TGCCGCCCCCAGGATTCTTTTAAGAA /clone = IMAGE:2027798/clone_end = 3′TAAAAAGAAATGAGTGTGGACATG 5112 db mining Hs.157811 AI361733 4113354qz24b02.x1 cDNA, 3′ end −1 CCTACGATATCCTTTTCAAATAGGGG /clone =IMAGE:2027787/clone_end = 3′ TGGGTCCAGCCCCCTTGTGCCCTG 5113 db miningHs.270193 AI361773 4113394 qz19c05.x1 cDNA, 3′ end −1CTGGGAGAAAGGTACTTTGGGTTAGT /clone = IMAGE:2021960/clone_end = 3′GGTAGGGATAGGGATGAACGGGAA 5114 db mining NA AI364677 4124366 qz05h09.x1NCI_CGAP_CLL1 cDNA −1 AGCATAATCCTAATGAGGAACTTTGT clone IMAGE:2020673 3′,mRNA CTGAAGTCTGAGGCTGAGTTACTT sequence 5115 db mining Hs.327411 AI3649264124615 qz23b07.x1 cDNA, 3′ end −1 TTTTGGAACCCTTAGCCCTGTGCAAA /cloneIMAGE:2027701/clone_end = 3′ TCAAAGGATGTGAGGGGAAAAAGG 5116 db miningHs.157279 AI364931 4124620 qz23c04.x1 cDNA, 3′ end −1ATTTCCCCTACGGATGGGACCAAGAA /clone = IMAGE:2027718/clone_end = 3′ACTGATGAGAACGGCCAAGTGTTT 5117 db mining Hs.157280 AI364944 4124633qz23d11.x1 cDNA, 3′ end −1 AACACCCGAAACCGTCTTCTGTGGCA /clone =IMAGE:2027733/clone_end = 3′ TTTGTCAGTTGAAAAAGAACACCT 5118 db miningHs.283433 AI365377 4125066 qz08a02.x1 cDNA, 3′ end −1CCAGTGGCTGGGATGGTGACAGTGA /clone = IMAGE:2020874/clone_end = 3′CATCCACAGTAAACAGATGAAATGT 5119 db mining Hs.304043 AI365414 41251037e97a03.x1 cDNA, 3′ end −1 GGATTTCAGAAACAGTTGCAGATATT /clone =IMAGE:3293068/clone_end = 3′ ATTGATTAGCTAGTTGGCAGTGGG 5120 db miningHs.80426 AI385418 4125107 brain and reproductive organ- −1CTTGTTCCCAGGCCAGCCCCACACA expressed (TNFRSF1A modulator)GTAGGCAGTCATTAAGTTTGGTGA (BRE), mRNA/cds = (146, 1297) 5121 db miningHs.157310 AI365460 4125149 qz09e06.x1 cDNA, 3′ end −1TTTTCCTTCAACTCTTGCGACTTTCTT /clone = IMAGE:2021026/clone_end = 3′GGTCTGCCTGTGTGGTTTTAATA 5122 db mining Hs.157311 AI365473 4125162qz09f09.x1 cDNA, 3′ end −1 TTCTGTTAATAGCAAACATTGCCTTTG /clone =IMAGE:2021033/clone_end = 3′ AGTGCTACTACTAAACCTGAGGC 5123 db mining NAAI367021 4136766 qz23h06.x1 NCI_CGAP_CLL1 cDNA −1TCTAGGGATCTGCCCGGCTCAAAATC clone IMAGE:2027771 3′ similar toCCAGGCCGTTAGGCTAAGTTGTTC contains MSR1.t1 MSR1 repetitive el 5124 dbmining Hs.296281 AI368512 4147265 interleukin enhancer binding factor 1−1 CGGACAAGGGCTGGCAGGTAAATGC (ILF1), mRNA/cds = (197, 2164)CTTCAGTTTGTTGTTAAATAGAGGC 5125 db mining Hs.327453 AI378055 4187908tc79e11.x1 cDNA, 3′ end −1 AGCCTTAGCCCCTTTAAAGCACTTAA/clone-IMAGE:2072396/clone_end = 3′ AGTTACTACTTCCAAATGTGATTT 5126 dbmining NA AI378091 4187944 tc80a09.x1 NCI_CGAP_CLL1 cDNA −1ACCTTGTCATTAACAGCTCACTTTGAT clone IMAGE:2072440 3′, mRNATGAACATCTACTCTGTGGCGGTT sequence 5127 db mining Hs.158876 AI3780954187948 tc80b01.x1 cDNA, 3′ end −1 TGGAACGGCTATTTGCCGGTTTAAAA /clone =IMAGE:2072425/clone_end = 3′ ACCAAAAACCCCGGTTTTTCCCAAA 5128 db miningHs.283438 AI378109 4187962 7f19bo3.x1 cDNA, 3′ end −1GTAAGGCAGACGAGAGAGGCGGAGG /clone = IMAGE:3295085/clone_end = 3′TCTCACAGTGAACCACAGGATCTGG 5129 db mining Hs.158956 AI380117 4189970tf98bo7.x1 cDNA, 3′ end −1 TTGCCTGCCATGCCCTTATAAGTGCC /clone =IMAGE:2107285/clone_end = 3′ CTTTAATGTCATAGCATGTAAAGG 5130 db miningHs.158967 AI380252 4190105 tf94d05.x1 cDNA, 3′ end −1GGGTTTGTGTCCCCATTTAGAATCTG /clone = IMAGE:2106921/clone_end = 3′ATGAAACGGTGGGCTTTCCTTCTT 5131 db mining Hs.158969 AI380263 4190136tf99g02.x1 cDNA, 3′ end −1 CAGAGCCTCCAGAATTATGTGAACTT /clone =IMAGE:2107442/clone_end = 3′ GTCTCAAAACATTCTCTAAATGGC 5132 db miningHs.158971 AI380329 4190182 tf94g05.x1 cDNA, 3′ end −1GAAAGGACCCGAGGGTTTGTATTTAA /clone = IMAGE:2106968/clone_end = ′3′AAAGCCTCCCCTGGGCCTCAAAAA 5133 db mining Hs.309122 AI380449 4190302tg02f12.x1 cDNA, 3′ end −1 GCCAACTGCTTAGAAGCCCAACACAA /clone =IMAGE:2107631/clone_end = 3′ CCCATCTGGTCTCTTGAATAAAGG 5134 db miningHs.302447 AI380514 4190367 tg01e02.x1 cDNA, 3′ end −1TGTCTAGAACAGACTGAGAGTGACAC /clone = IMAGE:2107514/clone_end = 3′GCATATTTGATTGTGAGGACAGTT 5135 db mining Hs.231261 AI380594 4190447tf95h06.x1 cDNA, 3′ end −1 GTTTGGCCCCCAAAGTGTTTAGGAGA /clone =IMAGE:2107067/clone_end = 3′ GCTTTCTCCCTAGATCGCCCTGTG 5136 db miningHs.158988 AI380719 4190572 tg03h03.x1 cDNA, 3′ end −1CCAGGAGGGCCAGAATTTGAAAATTC /clone = IMAGE:2107733/clone_end = 3′CTTGGGGTTGTTCTTTTTCCAAAA 5137 db mining Hs.159000 AI381037 4190890tg20h01.x1 cDNA, 3′ end −1 CAGTTTGAGCAAAAGCCTTTGAAATC /clone =IMAGE:2109381/clone_end = 3′ CAAGACTTTTCCCCTTGGGGTGCT 5138 db miningHs.159025 AI381601 4194382 td05g03.x1 cDNA, 3′ end −1CCAGTTGGTTTTTGGACTCCAAAGCC /clone = IMAGE:2074804/clone_end = 3′CAGGACCCTTCCAATCCTGCTTG 5139 db mining NA AI382670 4195451 qz05f05.x1NCI_CGAP_CLL1 cDNA −1 AGGCCCTTTTTCAAAGAAAAACC clone IMAGE:2020641 3′,mRNA CCTTTGGGGAAAAAGGGAAAGGGC sequence AAAA 5140 db mining Hs.192078AI383475 4196256 tc30h04.x1 cDNA, 3′ end −1 TTTTGCTTGCTGTCGGGAGAATAAAG/clone = IMAGE:2087479/clone_end = 3′ CAGGGAACCTTTATGTAGTGAAAA 5141 dbmining Hs.327467 AI383510 4196291 td03c10.x1 cDNA, 3′ end −1GGGTTTGGCCCGATTATATTAGGTTG /clone = IMAGE:2074578/clone_end = 3′GGTGGGGGAAAAATTTTATGGGGG 5142 db mining Hs.105125 AI383774 4196555602639120F1 cDNA, 5′ end −1 GTGAACTGGATCTTGAGGCCGTGCT /cloneIMAGE:4762804/clone_end = 5′ GGAAACCGGAAGGTACACTGCTTGG 5143 db mining NAAI383803 4196584 tc98f01.x1 NCI_CGAP_CLLI cDNA −1CAAAACTTGAGATAAGGTTAAAACTG clone IMAGE:2074201 3′ similar toTGCCCAGAGGAAAACTGGTAGTCT gb:J03626 URIDINE 5′- MONOPHOSPHATE 5144 dbmining NA AI384024 4196805 td05b02.x1 NCI_CGAP_CLL1 cDNA −1TGCAGCCAGATTGTTCCAAGGTTGCC clone IMAGE:2074731 3′ similar toAATTACCTAGTGGGTAAATTTCCC contains Alu repetitive element; con 5145 Table3A Hs.107622 AI391443 4217447 tf96e06.x1 cDNA, 3′ end −1AGTGCTTATCATGAAATGTGCTTCAC /clone = IMAGE:2107138/clone_end = 3′TGGTTCAGCTCTGTTGTTTCCTTA 5146 db mining Hs.160956 AI391451 4217455tf96f03.x1 cDNA, 3′ end −1 GTTATTTGGGAGACAAATGGACGGG /clone =IMAGE:2107133/clone_end = 3′ CAGGAAGATTGATGCTCCGCTGTTC 5147 Table 3AHs.160959 AI391500 4217504 602086202F1 cDNA, 5′ end −1AGCTGAAGGGCTTCAACTTTGCTTGG /clone = IMAGE:4250424/clone_end = 5′ATTTTTAATATTTTCCTTGCATA 5148 Table 3A NA AI392705 4222252 tg23b03.x1NCI_CGAP_CLL1 cDNA −1 TGCAGGCTCATTGTGCTCCTTCTTCT clone IMAGE:2109581 3′,mRNA GGGTTTCAATTGGATTTCAGTCCT sequence 5149 db mining Hs.160978 AI3927454222292 tg08b05.x1 cDNA, 3′ end −1 ATCTCTAATGAAGCCTAGGATCAGAT /clone =IMAGE:2108145/clone_end = 3′ TTGTGGCATACCAACAGCACATGT 5150 db miningHs.160981 AI392793 4222340 tg04g01.x1 cDNA, 3′ end −1CCACAAGGGTTAGTTTGGGCCTTAAA /clone = IMAGE:2107824/clone_end = 3′ACTGCCAAGGAGTTTCCAAGGATT 5151 db mining Hs.160982 AI392799 4222346tg04g09.x1 cDNA, 3′ end −1 CGCTTTATTCCCACGAAACCTAGGAC /clone =IMAGE:2107840/clone_end = 3′ AGTGGCCATCAAACCGAGCGCTTT 5152 Table 3AHs.189031 AI392805 4222352 tg04h03.x1 cDNA, 3′ end −1CCTGTTGTGGCTGGCTGCATAATAAT /clone = IMAGE:2107829/clone_end = 3′TTCCAGGAGGCTTTCGGAAATGTT 5153 Table 3A Hs.221014 AI392814 4222361MR2-HT1162-180101-007-d08 cDNA −1 CGGTCCAGTCGGCTGCTTCCATTCCCTGAAGAAGAGGCCCTAAAGTTAAA 5154 Table 3A Hs.168287 AI392830 4222377tg10b09.x1 cDNA, 3′ end −1 TTAGCCTCAAAGGGGTGGGAAAAG /clone =IMAGE:2108345/clone_end = 3′ CCCATACCTCCTGGGCCAGTCCTAG 5155 db miningHs.276774 AI392845 4222392 tg10d01.x1 cDNA, 3′ end −1CCTTAGAATTAAGTTGAATTTTCCTGC /clone = IMAGE:2108353/clone_end = 3′CTTGCTAAGCAAGACTTCCTGCA 5156 Table 3A Hs.159855 AI392893 4222440tg05d07.x1 cDNA, 3′ end −1 CAGCCACGGCCCCTCGCGTCTTCGC /clone =IMAGE:2107885/clone_end = 3′ GGCACGTTAAATTAATGCGGAAAAC 5157 db miningHs.327469 AI392990 4222537 tg22f02.x1 cDNA, 3′ end −1TTTTACCCAAATTTTAAAGGCCGGAT /clone = IMAGE:2109531/clone_end = 3′AAAAGGGTTTTTGTTTGGAAGGGA 5158 db mining Hs.230848 AI392999 4222546tg22f11.x1 cDNA, 3′ end −1 GGAGGTTAGGGCCTGAAGCTCAAAG /clone =IMAGE:2109549/clone_end = 3′ CTCCCCCTTTTTAATAGTTTTTCCC 5159 db mining NAAI393006 4222553 tg22g06.x1 cDNA, 3′ end −1 CCCCTTTGGGCCCCCCGGGTTTTCC/clone = IMAGE:2109562/clone_end = 3′ CTTTTTGGTTTCGGGTTGTTTTTTG 5160 dbmining Hs.228891 AI393017 4222564 tg22h05.x1 cDNA, 3′ end −1ACGTGGGCCTTTGGACCCCTTATAAG /clone = IMAGE:2109561/clone_end = 3′ATGGTCATAAGACCCCAAAACTGA 5161 db mining Hs.159706 AI393038 4222585tg25b07.x1 cDNA, 3′ end −1 ATGGCTATAAGGCCAAAAAAAGT /clone =IMAGE:2109781/clone_end = TTGGCGGCATGGGGGATTTTTTGC 3′ TCTT 5162 Table 3AHs.160273 AI393041 4222588 tg25b10.x1 cDNA, 3′ end −1AGAGACGGCCACCTGAGACCAATTA /clone = IMAGE:2109787/clone_end = 3′GAATATCCACACCAGTGGAAGAGAG 5163 Table 3A Hs.126265 AI393205 4222752 Homosapiens, Similar to RIKEN −1 GCCTCCCCAACCCCTGGCCTCAATTT cDNA 0610006H10gene, clone CCCTTTCTATAAAATGGAAGATGT MGC:9740 IMAGE:3853707, mRNA,complete cds/cds = (171, 1130) 5164 db mining Hs.159718 AI393217 4222764tg14c09.x1 cDNA, 3′ end −1 ACACCCAGCCAAAGAAAAGCATACCT /clone =IMAGE:2108752/clone_end = 3′ GAATCCAAGAGAGTATTTACACTG 5165 db miningHs.240635 AI393223 4222770 tg14d03.x1 cDNA, 3′ end −1CTCAGAGAAGAACAGTGTAGAA /clone = IMAGE:2108741/clone_end =ACCCGCGCTGTGTGAAGCGAGGTT 3′ GGGC 5166 Table 3A Hs.160401 AI3939064223453 tg05f08.x1 cDNA, 3′ end −1 ACTTTCCATTGTTGAGCTGGGGAGTT /clone =IMAGE:2107911/clone_end = 3′ GGATTTTGTCCATTTGTTTTTATG 5167 Table 3AHs.340891 AI393908 4223455 wt30d11.x1 cDNA, 3′ end −1TCCCAGTGATGATTCGCTCCCTTTGT /clone = IMAGE:2391765/clone_end = 3′TAATTACTCAGTGTTTCTTGTTTT 5168 Table 3A Hs.274851 AI393960 4223507tg11d04.x1 cDNA, 3′ end −1 TGCGTGCTGCTAATACTTAGGTACCC /clone =IMAGE:2108455/clone_end = 3′ ATAATAGGTCTTTACACTCAGTTT 5169 Table 3AHs.160405 AI393962 4223509 tg11d08.x1 cDNA, 3′ end −1CCTGACCTTGAGGCATTTTTGATTGT /clone = IMAGE:2108463/clone_end = 3′GCAGTTACCTAGGGTATGCTTGTG 5170 Table 3A Hs.76239 AI393970 4223517hypothetical protein FLJ20608 −1 GAGGACTGGGACCGTGATTCCACTA (FLJ20608),mRNA/cds = (81, 680) ACCGGAAACCGTCGCCTTTCGGGCC 5171 Table 3A Hs.160408AI393992 4223539 tg06c05.x1 cDNA, 3′ end −1 GGGGAAGTCAAGGAGACACACACGC/clone = IMAGE:2107976/clone_end = 3′ TCTTTCAACAGAATCAGCTCTTAAT 5172Table 3A Hs.244666 AI394001 4223548 tg06d04.x1 cDNA, 3′ end −1AACTAGATCCTGCCTTAGAAAACCTT /clone = IMAGE:2107975/clone_end = 3′TTGCCATGAATGACAAATTCATGT 5173 db mining Hs.160410 AI394009 4223556tg11e02.x1 cDNA, 3′ end −1 TGTCAGCATCTGGAATAGTGTAAGTA /clone =IMAGE:2108474/clone_end = 3′ TGCAGTGGAGGAAATCTCATCCTT 5174 db miningHs.160423 AI394303 4223850 tg09g11.x1 cDNA, 3′ end −1TTAACAGGACCTCTGGGCCACCAAG /clone = IMAGE:2108324/clone_end = 3′GAGAAAGGGCTGGGGAAGCCAACAG 5175 Table 3A Hs.159678 AI394671 4224218tg24a07.x1 cDNA, 3′ end −1 GTTCTGTGATAGTTTGTTTCCCCTCAT /clone =IMAGE:2109684/clone_end = 3′ CTCCCTCACCTCTGCCTGGGTTG 5176 db miningHs.228337 AI394690 4224237 tg24c06.x1 cDNA, 3′ end −1GGCCCCTCCTTTTGCTGGAGAGTTT /clone = IMAGE:2109706/clone_end = 3′TTATAAACTGGAGCCCGATTTCAT 5177 db mining Hs.159682 AI394730 4224277tg24g04.x1 cDNA, 3′ end −1 GGGCTTTTTCTTCCCCTAATCAGGGT /clone =IMAGE:2109750/clone_end = 3′ GACCTGGGCCTTTTGGGCAGGATC 5178 db miningHs.159683 AI394733 4224280 tg24g09.x1 cDNA, 3′ end −1AAGGAGGGGAGTGAATGATATTGCT /clone = IMAGE:2109760/clone_end = 3′GTCATTTCTCAGCAAATCATAGTGA 5179 db mining Hs.177146 AI399977 4243064tg92e06.x1 cDNA, 3′ end −1 TAAATTCTCTGTGGGAAAAAGCCTG /clone =IMAGE:2116258/clone_end = 3′ CCAATAAAATGGGGGTTTTTGGGC 5180 Table 3AHs.225567 AI400714 4243801 tg93g12.x1 cDNA, 3′ end −1ACAGACTAAGCTGGTTTGGTGGATTC /clone = IMAGE:2116390/clone_end = 3′ATCTTTCACTTATGAAGAAAGCAG 5181 db mining NA AI400725 4243812 tg93h12.x1NCI_CGAP_CLL1 cDNA −1 CCCAAAGCCTGGGGGGTTTGGCCCA clone IMAGE:2116391 3′similar to AACCTTCCCCCTGGTTTTTATAAAA contains TAR1.t1 MER22 repetitive e5182 db mining Hs.224409 AI400798 4243883 IL3-ET0114-011100-330-F11 cDNA−1 ACTGCTTTCAAGAAAGTGGGACCAGT GGCATTGTAGCCACCATAATCACT 5183 db miningHs.174778 AI400826 4243913 th10g11.x1 cDNA, 3′ end −1GCCCTTGGCAAATGATTTGAGACCCC /clone = IMAGE:2117924/clone_end = 3′ endTTTTGAAAACCATGTAGGATGAAT 5184 db mining Hs.270294 AI401001 4244088tm29d11.x1 cDNA, 3′ end −1 CACACAGCAGTGGCTTGGGGATGAG /clone =IMAGE:2158005/clone_end = 3′ GAAGGAAGGGAGAATCTCAACGGAG 5185 db miningHs.224178 AI401179 4244286 tg26g11.x1 cDNA, 3′ end −1TTTTTCTGTGAGTTAGGGGCATGGAG /clone = IMAGE:2109956/clone_end = 3′GCGGCAGTGTTGGGAGCTGGAGCC 5186 db mining Hs.175338 AI401184 42442717o18b08.x1 cDNA, 3′ end −1 AGTTGGCTCTAGTTTAAAGATATAAAT /clone =IMAGE:3574239/clone_end = 3′ ACGTACCTCACTTAAACCCCATGT 5187 db miningHs.327913 AI401303 4244390 tg92d01.x1 cDNA, 3′ end −1CTTCAGGCCCAAGTTCAACGGGTTAA /clone = IMAGE:2116225/clone_end = 3′AGAGGTCCGCTCCCAAATTATTCT 5188 db mining Hs.159693 AI417000 4260504th02f02.x1 cDNA, 3′ end −1 GTCCCAGTAGCCCCATTTCAGGGCTT /clone =IMAGE:2117115/clone_end = 3′ GCTAGTTACATGGGTTTGTGTTTA 5189 Table 3AHs.79968 AI419082 4265013 splicing factor 30, survival of motor −1GGATGTGTGATGTTTATATGGGAGAA neuron-related (SPF30), mRNACAAAAAGCTGATGTATAGCCCTGT /cds = (0, 716) 5190 Table 3A Hs.131067AI421806 4267737 yf85b05.s1 cDNA, 3′ end −1 CAATTTCCACCTCTAAGGGGGTCGG/clone = IMAGE:231057/clone_end = 3′ GAAAGGCACGCTGAGGGTGAATATG 5191Table 3A Hs.159103 AI431873 4306229 tc97d09.x1 cDNA, 3′ end −1GCTTTCAAATGAATTTCAGGGCTTTC /clone = IMAGE:2074097/clone_end = 3′TTTGAAGCAGTCTTGTAAAGTTGT 5192 Table 3A Hs.254006 AI432340 4309500tg54e06.x1 cDNA, 3′ end −1 TCCTTTCTGGATACCAGGAATCACTT /clone =IMAGE:2112610/clone_end = 3′ AAAAATCTGTGTATAATGCCCCCA 5193 db miningHs.283442 AI435240 4301796 ti02a80.x1 cDNA, 3′ end −1AAACAGGGAACGACAGGAAAAAGAT /clone = IMAGE:2129270/clone_end = 3′GACCGTGATACACTCTGCTAAAAGC 5194 db mining Hs.327548 AI435268 4301992ti02d10.x1 cDNA, 3′ end −1 CCCCCCCGGCTTCCCCCTTTTTTCCC /clone =IMAGE:2129299/clone_end = 3′ CGCCCGTTTTTTTGGGGGAATGGG 5195 Table 3A NAAI436418 4281540 ti01h02.x1 NCI_CGAP_CLL1 cDNA −1GGCCATGCCGGGCCAGCCCCACCTG clone IMAGE:2129235 3′ similar toAAGCTCAGTGAAAGCTGATTAAAAA SW:SYB2_HUMAN P19065 SYNAPTOBREVIN 5196 Table3A Hs.165703 AI438561 4282683 ti03b03.x1 cDNA, 3′ end −1CGCAGGACTCTAAAGATCCAAGCTCA /clone = IMAGE:2129357/clone_end = 3′CAAAACACTCCAAATCCACCTCGA 5197 Table 3A Hs.111377 AI436587 4282890AL562032 cDNA −1 AACTTTACTTCTGTTCTTGGCAGGAC /clone =CS0DL003YA06-(3-prime) ATGGAGAGAGGGAGGGATTCCAAA 5198 db mining Hs.283443AI436589 4282906 7f34g01.x1 cDNA, 3′ end −1 GGGTGATAATTGAGGGTGCCGCTGG/clone = IMAGE:3296592/clone_end = 3′ GAAGGTCCGAGAATGGGTTTTCATG 5199Table 3A Hs.257066 AI438957 4300957 UI-H-BI3-aka-h-10-0-UI.s1 cDNA, 3′−1 GTTCATTGCTGTTCAGAGTGTTGCTG end/clone = IMAGE:2733930CTGTGGTGCTATAAATGCTCCCAG /clone_end = 3′ 5200 db mining Hs.165701AI438979 4301111 tc89d11.x1 cDNA, 3′ end −1 TATTCCACCAGTGAGCTACACTCCCG/clone = IMAGE:2073333/clone_end = 3′ GCCCCTTTAGTGTTGTTTGTAAAC 5201 dbmining Hs.165702 AI438980 4301118 tc89d12.x1 cDNA 3′ end −1CCGTGTTGTGGCAAAATGGTCCCTG /clone = IMAGE:2073335/clone_end = 3′GAGTTTTTGACCCTGTGTTTAAAGA 5202 db mining Hs.327566 AI439020 4301397tc89e05.x1 cDNA, 3′ end −1 TTTTTTGGGGCCGAAAACCCCCAATG /clone =IMAGE:2073344/clone_end = 3′ AGGGGGATTAAAGCTGTTTTCCCC 5203 db miningHs.327567 AI439044 4301565 tc89h03.x1 cDNA 3′ end −1GGGGTTGTCCTTTTCCCACCCTGATG /clone = IMAGE:2073365/clone_end = 3′GGGAATTTATGGATGGGTTTCCTT 5204 db mining Hs.165704 AI439060 4301677tc84f07.x1 cDNA, 3′ end −1 AAATGAGTGACCAAAACACTTCTGTA /clone =IMAGE:2072869/clone_end = 3′ CCACTTCTGTGAGCTGAGGTCCAG 5205 Table 3AHs.165681 AI439580 4305318 QV3-DT0043-211299-044-d03 cDNA −1AGGAACCTAAAGAAACTGCCAAGTGT AGATAAGCATTGAGTATGTTACCC 5206 db mining NAAI439601 4305465 tc85d10.x1 NCI_CGAP_CLL1 cDNA −1GGTTGTCCAGTTTTCGGTTTTTAACG clone IMAGE:2072947 3′, mRNACCCCCCATAGGGGATTTGGCCCCC sequence 5207 Table 3A Hs.192463 AI4396334305688 7q86c05.x1 cDNA, 3′ end −1 GTTTTGGAATCAGGAATGATTTTTCTA /clone =IMAGE:3705201/clone_end = 3′ AGCCTGACATCAGATGTCTGACA 5208 db miningHs.165732 AI439643 4305758 tc91e06.x1 cDNA, 3′ end −1GAAATTCTCCCCTTTTCCCCTCTCCTT /clone = IMAGE:2073538/clone_end = 3′CCCTTCTGCTGACCTGTTCTCAG 5209 Table 3A Hs.255490 AI439645 4305772tc91e08.x1 cDNA, 3′ end −1 CACAGAGGGAGTGTGCAGGGCCAGA /clone =IMAGE:2073542/clone_end = 3′ TTTCATCCTGGGGCCACGCTGAAAT 5210 Table 3AHs.9614 AI440234 4281195 Nucleophosmin (probe bad, mutations, −1TGATAGGACATAGTAGTACGGGTGGT wrong clone used) (nucleolarCAGACATGAAAATGGTGGGGAGCC phosphoprotein B23, nurnatrin) 5211 Table 3AHs.309279 AI440337 4282020 tc88b03.x1 cDNA, 3′ end −1CAATACCTACCCCCAGTGGCAGCCG /clone = IMAGE:2073197/clone_end = 3′CCTGCTCCTCATGACCCAAGTAAGT 5212 Table 3A Hs.89104 AI440491 4300600602590917F1 cDNA, 5′ end −1 TGTTTTAACAACTCTTCTCAACATTTT /clone =IMAGE:4717348/clone_end = 5′ GTCCAGGTTATTCCCTGTAACCA 5213 Table 3AHs.59844 AI440512 4300747 tc83f09.x1 cDNA, 3′ end −1TAAGTGTCAGGTTTGTGGGGAAGGTT /clone = IMAGE:2072777/clone_end = 3′ATTCTTGCCTTGTGTATTTTGTCC 5214 Table 3A Hs.327610 AI452611 4286566tj27g07.x1 cDNA, 3′ end −1 CAAACCCCTATCCCCCATTCTCCTCC /clone =IMAGE:2142760/clone_end = 3′ TATCCCTCAACCCCGACATCATTA 5215 Table 3AHs.121973 AI458739 4311318 602428025F1 cDNA, 5′ end −1CCTGCAACAGCTAAGGCCAAGCCAA /clone = IMAGE:4547239/clone_end = 5′ACTTACCGTGGACTCAAACACTTTG 5216 Table 3A Hs.86437 AI469584 4331674602411368F1 cDNA, 5′ end −1 TGAATTTGGAGTCCCTGGCACATAAA /clone =IMAGE:4540098/clone_end = 5′ TCTACCTTCAAATCAGAGGTCCTT 5217 Table 3AHs.149095 AI471868 4333956 ti67d04.x1 cDNA, 3′ end −1TCCCACCCCTTTTCTACTGAATTTGT /clone = IMAGE:2137063/clone_end = 3′GGGGATCCTATAATAAAAGTGAAT 5218 Table 3A Hs.303682 AI472078 4334168tj85h03.x1 cDNA, 3′ end −1 ACTACCAGAGCCCTAGGACTTCTGAG /clone =IMAGE:2148341/clone_end = 3′ CACATTTAGAAAATACCAGAGGCA 5219 db miningHs.170772 AI472328 4334416 tj87c09.x1 cDNA, 3′ end −1CATGTCAGAGTTCTTAACAGAAAGCA /clone = IMAGE:2148496/clone_end = 3′AAGGTTTCCAACAGCACTTGCATT 5220 Table 3A Hs.78746 AI474074 4327119cAMP-specific phosphodiesterase 8A −1 ATGAAATCTCATGGGGCCAAACTGCA (PDE8A)mRNA, partial cds CATCAGCTACTGCTACCTTCTTGC /cds = (0, 2141) 5221 dbmining NA AI475527 4328572 tc85g07.x1 NCI_CGAP_CLL1 cDNA −1CCCTGTGGCAACTTGTGGGTACGGTT clone IMAGE:2072988 3′, mRNATAACTGGACCACGCTGAGCTTCTG sequence 5222 db mining Hs.292501 AI756114328656 7f03g08.x1 cDNA, 3′ end −1 AGAAATAGTGTTTCTCGGAAGCTCAG /clone =IMAGE:3293630/clone_end = 3′ TTTGGAGCTGACTGCACACGTTGC 5223 Table 3AHs.300759 AI475653 4328698 ribosomal protein L36 (RPL36), mRNA −1GTTGCTGGCTGCCCTCCCCTGCACT /cds = (145, 482) CTCCCTGAAATAAAGAACAGCTTGG5224 db mining Hs.300759 AI475653 4328698 ribosomal protein L36 (RPL36),mRNA −1 GTTGCTGGCTGCCCTCCCCTGCACT /cds = (145, 482)CTCCCTGAAATAAAGAACAGCTTGG 5225 Table 3A NA AI475668 4326711 tc93c06.x1NCI_CGAP_CLL1 cDNA −1 ACGTGTCAGACACAATCCTGAGCCTT clone IMAGE:207310 3′,mRNA CTACAAGTGTTCCCTCTTACTCCT sequence 5226 db mining NA AI4756784328723 tc93d10.x1 NCI_CGAP_CLL1 cDNA −1 AAGCCCTGTTTACCCAGGTTTTTCTTclone IMAGE:2073715 3′ similar to AAGGCGAGAAGGTTTAGGGTGGTG gb:M92287G1/S-SPECIFIC CYCLIN D3 ( 5227 Table 3A Hs.105678 AI475680 4328725tc93d12.x1 cDNA, 3′ end −1 GAGAAAGCTCCCAGTCTGTCTTTCCC /clone =IMAGE:2073719/clone_end = 3′ AACATCCCTTCAGTTTCAATAAGC 5228 db miningHs.170338 AI475882 4328727 tc93e03.x1 cDNA, 3′ end −1TTCAGGTGAGTGTGCCTGGAGGTGG /clone = IMAGE:2073724/clone_end = 3′AGAACTATGGTTTTGATAACTTGGC 5229 Table 3A Hs.236030 AI475694 4328739SWI/SNF related, matrix associated, −1 AAGGTGCCATGTATTGAAAGTGTGCG actindependent regulator of chromatin, TCAAAGAACATAAATATCAGTGGA subfamily c.member 2 (SMARCC2), mRNA/cds = (22, 3663) 5230 db mining NA AI4757354328780 tc86g02.x1 NCI_CGAP_CLL1 cDNA −1 TGTAATTATTTTCTGTATGTTCAAGAAclone IMAGE:2073074 3′, mRNA GGTAAAGGAAAGGACAGCTATGGGA sequence 5231 dbmining Hs.327640 AI475806 4328851 tc94g03.x1 cDNA, 3′ end −1ATTTATTTGGGGTTGGTCCCCCCTTT /clone = IMAGE:2073844/clone_end = 3′GGGCCCCCCGGGTTTTCCCTTTTTT 5232 db mining Hs.170586 AI475815 4328860tc94h02.x1 cDNA, 3′ end −1 AACCATAAAAGGCCCGTTTGGTTAGT /clone =IMAGE:2073843/clone_end = 3′ TTTCCCTGTTTCCTGGTTTGGGCT 5233 Table 3AHs.105052 AI475827 4328872 adaptor protein with pleckstrin −1TTATGGGGTAACTCACTTTGGGCGGC homolog and src homology 2 domainsACGAAGAACTCCAGGCGGAAGCGT (APS), mRNA/cds = (127, 2025) 5234 db miningHs.258864 AI475833 4328878 tc87b01.x1 cDNA, 3′ end −1TCTCTCCCCATCCCAAGTCATCCAGC /clone = IMAGE:2073097/clone_end = 3′CCTTTTTCCTACCCTCAATAAACC 5235 Table 3A Hs.170587 AI475884 4328929tc95c12.x1 cDNA, 3′ end −1 CCCCCTGATGGACTTCAAATATGTCT /clone =IMAGE:2073910/clone_end = 3′ CATCAACTACAGTATTAAATGCCA 5236 Table 3AHs.170588 AI475905 4328950 tc95f06.x1 cDNA, 3′ end −1CGAGAATGCCTAGGGAAACCAGCTA /clone = IMAGE:2073923/clone_end = 3′CGCTTACAAGCCAGCTACGCAGCCC 5237 db mining Hs.170589 AI475909 4328954tc95f10.x1 cDNA, 3′ end −1 GGAAACATTGGCCTGGGGGTGTCCC /clone =IMAGE:2073931/clone_end = 3′ CCAAAAGGGGGCCGTTTTTAAAGGG 5238 db mining NAAI475926 4328971 tc95h10.x1 NCI_CGAP_CLL1 cDNA −1TGGGTTGACATTGTTCGCACGGGGT clone IMAGE:2073955 3′ similar toGTTTCTTATATTAAAAAGACTCACT gb:M59849 FIBRILLARIN (HUMAN):, mRN 5239 Table3A NA AI478558 4371782 tm53e03.x1 NCI_CGAP_Kid11 cDNA −1CTTTCCACAAAATAATCGATAACCTTG clone IMAGE:2161852 3′, mRNAGGGGATTGTTTTATGGCTTGACA sequence 5240 db mining NA AI479016 4372184tm29h05.x1 NCI_CGAP_CLL1 cDNA −1 CCGCCTTGGGGAGACAGGTCTTGAT cloneIMAGE:2158041 3′ similar to TGTCTTTTTCCCAGTGAACATTGTT gb:X58141_ma1ERYTHROCYTE ADDUCIN 5241 Table 3A Hs.170784 AI479022 4372190 tm30a05.x1cDNA, 3′ end −1 TCCCAGACTTTCAGGAAAGTAACTGT /clone =IMAGE:2158064/clone_end = 3′ AGCACTGTTAATATCACAACAACA 5242 db miningHs.187200 AI479029 4372197 tm30b08.x1 cDNA, 3′ end −1TTTTAGCTGGGAGTGGGGGGACTAT /clone = IMAGE:2158067/clone_end = 3′GGGGAATAACTTTCCTTCATTTAAT 5243 Table 3A Hs.337139 AI479075 4372243tm30h01.x1 cDNA, 3′ end −1 ACATGTGTGTGTTTTCCATGAGGCAC /clone =IMAGE:2158129/clone_end = 3′ TGCTTTTTATGCATTTCCCTCCCC 5244 db mining NAAI479094 4372262 tm31b02.x1 NCI_CGAP_CLL1 cDNA −1CTGTATTTGAAGTCAGCAGGGCTCAG clone IMAGE:2158155 3′ similar toCAGGATTTGACCGACAGTTACCTC contains TAR1.t1 MER22 repetitive e 5245 dbmining Hs.185498 AI479659 4372827 tm32h04.x1 cDNA, 3′ end −1TGGTTTATAGATGCACTTCCTTTCATA /clone = IMAGE:2158327/clone_end = 3′GGCAGTCCCTGGCACTTTCTTGC 5246 Table 3A Hs.170909 AI492034 4393037tg06f12.x1 cDNA, 3′ end −1 AGGAGCTGGTATTATTGGAGGGTATT /clone =IMAGE:2108015/clone_end = 3′ ATAGATCCAGTGTATTGTGACTGT 5247 db mining NAAI492041 4393044 tg06g08.x1 NCI_CGAP_CLL1 cDNA −1GCAGTAGTGCTAAGGCGTCTTTTGTA clone IMAGE:2108030 3′ similar toGGCTTTAGATTTTGTCGTTATGGC gb:L23320 ACTIVATOR 1 140 KD SUBUNI 5248 Table3A Hs.119923 AI492068 4393069 tg12b03.x1 cDNA, 3′ end −1GCTTGTCAGAACAGAAGATATTTCCA /clone = IMAGE:2108525/clone_end = 3′CCCTGCCTAGTAGATGTGTTTCAG 5249 db mining Hs.327698 AI492127 4393130tg07d04.x1 cDNA, 3′ end −1 CCCCCGTTTTAGGTTAGGGCCTTGG /clone =IMAGE:2108071/clone_end = 3′ GCAGGGGTTTGCCCCCTGTTACCCC 5250 db miningHs.170912 AI492164 4393167 tg12h01.x1 cDNA, 3′ end −1TTGGTTTTATTTATCCAAAACTGAGCC /clone = IMAGE:2108593/clone_end = 3′TTCTCATAGGCTTTACACCCGGA 5251 Table 3A Hs.341634 AI492181 4393184wt85e01.x1 cDNA, 3′ end −1 GGCAGGCTCTAGCCACCCTGTCGGT /clone =IMAGE:2514264/clone_end = 3′ TCCCAATAAGCCATTTATTGAATAA 5252 Table 3AHs.276903 AI492640 4393643 qz18a06.x1 cDNA, 3′ end −1TTTTTGACCAGTCTACATTTCGTATCT /clone = IMAGE:2021842/clone_end = 3′GTGGGATCTGCATTTGTGAATTC 5253 db mining Hs.170933 AI492648 4393651qz18b06.x1 cDNA, 3′ end −1 TCTGGACAATGTTGATGCTAACCTTG /clone =IMAGE:2021843/clone_end = 3′ ATGATATCCATCCCTATTACTGGG 5254 db mining NAAI492653 4393656 qz18c02.x1 NCI_CGAP_CLL1 cDNA −1 AGGACATGAAGGTCTGAAAAAGclone IMAGE:2021858 3′ similar to AAACAGGAAAATACAGACATCCCC contains Alurepetitive element;, m GCTT 5255 Table 3A Hs.170331 AI492865 4393888th78a05.x1 cDNA, 3′ end −1 AAGTCAAGGAACCCTCTCGGGTCTCT /clone =IMAGE:2124752/clone_end = 3′ GAGATCCAGGCCAACAGTAACAG 5256 db miningHs.327702 AI193426 4394429 tg91a07.x1 cDNA, 3′ end −1AGGGGGCTTTAAAATTTAAAAATTGC /clone = IMAGE:2116116/clone_end = 3′CTTTTGTTTTAAAAAAGGCCCATGT 5257 Table 3A Hs.276907 AI493726 4394729qz12f08.x1 cDNA, 3′ end −1 CCCCCTCCCACCCAAAGAAAAAGAAA /clone =IMAGE:2021319/clone_end = 3′ TGGTAACTACCTGGACAAAACATT 5258 db miningHs.342652 AI493740 4394743 yi60c05.r1 cDNA, 5′ end −1CCCTTGGCTCTTATTGTTCTTGCTGG /clone = IMAGE:143824/clone_end = 5′TGTGGTATGTTCCCGGCTGAAAAA 5259 db mining NA AI494343 4395346 qz14a10.x1cDNA, 3′ end −1 TTCCCCTTTTTTCCCCCTTTTTTAAAA /clone =IMAGE:2021466/clone_end = 3′ AGCCCCTTTTTTAAATGGGGCGC 5260 db miningHs.283456 AI494542 4395545 7f12b08.x1 cDNA, 3′ end −1AAGGACAGCTTGCTTGCTGATGAACA /clone = IMAGE:3294423/clone_end = 3′CTTCCACAGTCTTTTGAGCTAAGT 5261 Table 3A Hs.171009 AI494612 4395615RST42450 cDNA −1 ACATGAGAATTAACCATGTCCAGTAG TTAAGTTCATTTTCCTACAGTGTGC5262 Table 3A Hs.342008 AI498316 4390298 UI-H-BI1-aeq-b-02-UI.s1 cDNA,3′ −1 GCCAGAATGGTACAGAGTGGAGGGT end/clone = IMAGE:2720186GTTCTGCTAATGACTTCAGAGAAGT /clone_end = 3′ 5263 Table 3A Hs.169541AI523598 4437733 th08g11.x1 cDNA, 3′ end −1 GCACAACTTCTGGGAATCTAGTGGCT/clone = IMAGE:2117732/clone_end = 3′ GTATGTTAAGCATCGGTAAAAGA 5264 dbmining Hs.171098 AI523617 4437752 tg95b03.x1 cDNA, 3′ end −1AAAAAGGCCCCTTGTTTGTTGGTTTT /clone = IMAGE:2116493/clone_end = 3′TGGCCCGTTGGGGAAAATGCCTGT 5265 db mining Hs.264120 AI523641 4437776601436078F1 cDNA, 5′ end −1 TTTAGGAGCTGACCATACATGATGAG /clone =IMAGE:3921187/clone_end = 5′ TGATACAGCCTGTACTTTGCTCAT 5266 Table 3AHs.309484 AI523766 4437901 tg94f07.x1 cDNA, 3′ end −1GGTTTCCCACGAACGGGAGGCTGCT /clone = IMAGE:2116453/clone_end = 3′GAAGAGTCAAAGCCTGGGCAGACTC 5267 db mining NA AI523780 4437915 tg94h09.x1NCI_CGAP_CLL1 cDNA −1 CAGGTCATGAGTATTCCAAGCTCAGG clone IMAGE:2116481 3′similar to TGGTGAGTCCTCCTCACCGGGATG gb:M15059 LOW AFFINITY IMMUNOGLOBUL5268 db mining Hs.171108 AI523790 4437925 tg96b01.x1 cDNA, 3′ end −1AAAGGGAAACTGGCTCTGGCACCAC /clone = IMAGE:2116585/clone_end = 3′CTACTGGAGACCAAACTTCACCAAA 5269 Table 3A Hs.194054 AI523854 4437989HA0669 cDNA −1 GACAAAATAGTTACCTATGCTTTCCTT CTGGCACCCCGAATGTACGCAGG 5270Table 3A Hs.228926 AI523873 4438008 tg97c12.x1 cDNA, 3′ end −1ATCTGACCTGAGGGAGATCACAATG /clone = IMAGE:2116726/clone_end = 3′CCTTCTGTATTGGGTGGTAATGAT 5271 db mining Hs.207993 AI523884 4438019tg97e12.x1 cDNA, 3′ end −1 TCCGTTGTAACACATCTAATGTGAAC /clone =IMAGE:2116750/clone_end = 3′ GCATTATAAACATGGACCTGTACT 5272 db mining NAAI523904 4438039 tg97h03.x1 NCI_CGAP_CLL1 cDNA −1ACATAACTATTCCGTTGATGAATAGC clone IMAGE:2116757 3′ similar toATCAGGACTTAAATGGTGACCTTGT SW:MKK2_HUMAN P49137 MAP KINASE-ACT 5273 dbmining Hs.337129 AI523973 4438108 tg98h03.x1 cDNA, 3′ end −1AACGGGTTTGGGTTTGGGGGGGTTT /clone = IMAGE:2116853/clone_end = 3′GTTCTTTTTATTGAATCCATTTAAGT 5274 db mining Hs.340482 AI523988 4438123tg99b05.x1 cDNA, 3′ end −1 TATAGGAGATGGGATACTCATTCCCG /clone =IMAGE:2116881/clone_end = 3′ CTGCTATTGATAAGGTCGGAGGCG 5275 db miningHs.283457 AI523989 4438124 7f27b07.x1 cDNA, 3′ end −1CAGAACGTCCTCAAGGACACACTCCT /clone = IMAGE:3295861/clone_end = 3′CCCTCGGGCCTCACTCTGGAGCAC 5276 db mining Hs.229405 AI524004 4438139tg99d01.x1 cDNA, 3′ end −1 CTGGACATGTTGTTTCCATGTTCAGT /clone =IMAGE:2116897/clone_end = 3′ CCCTTCCCGGTTTTTGGGTGTTTT 5277 db miningHs.283458 AI524006 4438141 tg99d05.x1 cDNA, 3′ end −1AAAGTAGCCATCCTGAGTCTCCAGGG /clone = IMAGE:2116905/clone_end = 3′TGATGAGCGGACTTGGGTGTGGAT 5278 db mining Hs.327719 Al524013 4438148tg99e03.x1 cDNA, 3′ end −1 CCTTCCATCTCATCGGTGGCCTCTCA /clone =IMAGE:2116924/clone_end = 3′ CTGTGGCTCACTGTTTAACACATG 5279 Table 3AHs.252359 AI524022 4438157 tg99f02.x1 cDNA, 3′ end −1TGTTCAAGGTCACATAGTTTAGGTAA /clone = IMAGE:2116923/clone_end = 3′GAAGCTCAAACCTGAGTTTTAGGT 5280 Table 3A Hs.192524 AI524039 4438174tg99h02.x1 cDNA, 3′ end −1 CACCTGATTCCCCCTCTTGCCCACAG /clone =IMAGE:2116947/clone_end = 3′ GACTCTGCTGTTGTTTTCATTCTG 5281 db miningHs.283459 AI524048 4438181 th01a01.x1 cDNA, 3′ end −1TCTCGTGAGGTGATGTGGTGCTGCA /clone = IMAGE:2116968/clone_end = 3′GACTTAAGCTATCTGCCTTGAAGAT 5282 db mining Hs.171119 AI524139 4438274th09f04.x1 cDNA, 3′ end −1 AACAAGCCTGGAATAATGCCCCCAAA /clone =IMAGE:2117791/clone_end = 3′ GATTGAGTGGAAATCGCCCCTTTTT 5283 db mining NAAI524156 4438291 th09h01.x1 NCI_CGAP_CLL1 cDNA −1GAGGACCAGATGGCCCAGGAGGAAG clone IMAGE:2117809 3′ similar toTGGATGCTTTCTTGGTAGGGAATGG contains Alu repetitive element; con 5284Table 3A Hs.171122 AI524202 4438337 th10d11.x1 cDNA, 3′ end −1CCTCCTGCTAGAAGACAGATTTCTTC /clone = IMAGE:2117877/clone_end = 3′CTTGGCTGACAGGCTGAATTAAGC 5285 db mining Hs.171123 AI524214 4438349th11b04.x1 cDNA, 3′ end −1 AATTTCCAAAAACAAAACAAAA /clone =IMAGE:2117935/clone_end = CAAGCAGGTTTCATGGAGCCCGAG 3′ TCCA 5286 dbmining Hs.171124 AI524233 4438368 th11d04.x1 cDNA, 3′ end −1CCTTTATGCAAGTTGTAAGGGGTTGA /clone = IMAGE:2117959/clone_end = 3′CCAGTAAAGAGGAAGTTTTGCCCC 5287 Table 3A Hs.174193 AI524263 4438398th11g07.x1 cDNA, 3′ end −1 AGTATTAGCTACAAACAAGCCTTGTT /clone =IMAGE:2118012/clone_end = 3′ TCCTCTTGGCTGTCAGGCACTGCT 5288 db miningHs.230874 AI524266 4438401 th11g12.x1 cDNA, 3′ end −1AAGCCCCAGTAAGGTGTTCAGGACT /clone = IMAGE:2118022/clone_end = 3′GGTAAACGACTGTCCTCAAGTAAGG 5289 Table 3A Hs.12315 AI524824 4438759hypothetical protein FJ11608 −1 TGGTTCAGGTAGTAAATGCTTTTGGT (FLJ11608),mRNA/cds = (561, 1184) CACATCAGAACTCTAGATCTGGGG 5290 db mining Hs.327722AI524626 4438761 td11c03.x1 cDNA, 3′ end −1 GCCTGGGCTGTTTTTGCTATATGTAA/clone = IMAGE:2075332/clone_end = 3′ ATAAAGCCCTTGGGTCTTTATTTT 5291 dbmining Hs.231512 AI524700 4438835 th12c05.x1 cDNA, 3′ end −1GGAGGTTAGGAAGCCCTTTTAAAGTA /clone = IMAGE:2118058/clone_end = 3′CAAACCCCCGGCATGGGGAATTTT 5292 db mining Hs.171140 AI524720 4438855th12e10.x1 cDNA, 3′ end −1 AACGGGAGTGATCGGGAAGTGAACA /clone =IMAGE:2118090/clone_end = 3′ GTTTCATCATCTGCTGCTGCTATTC 5293 db miningHs.292520 AI524724 4438859 th12f03.x1 cDNA, 3′ end −1CTGGTATGTTGCTTTGTAGGGGAAAA /clone = IMAGE:21118077/clone_end = 3′ACTAATTTTGTTGGGTCAGGGACA 5294 db mining Hs.283462 AI538419 4452554td06a02.x1 cDNA, 3′ end −1 CCGGACAAGCCATTTGATGTTCTAGT /clone =IMAGE:2074826/clone_end = 3′ TTGCAATTACTCCACGCAAAGTGG 5295 db miningHs.231292 AI538420 4452555 td06a03.x1 cDNA, 3′ end −1TTTGGGCATCAACTTCAACAACTACT /clone = IMAGE:2074828/clone_end = 3′ACCAGGACGCCTGAGGGTGCTTTT 5296 db mining Hs.171216 AI538445 4452580td06d02.x1 cDNA, 3′ end −1 TCGAAGAAAGTACCTGTAAATGTAGA /clone =IMAGE:2074851/clone_end = 3′ GTAATTGCGAAGCTGTCAGGAATA 5297 Table 3AHs.203784 AI538474 4452609 td06h08.x1 cDNA, 3′ end −1TCCTAGACCCTGCATTGTGAAATGGG /clone = IMAGE:2074911/clone_end = 3′GCTTGAATTTTAGTTCTGAATTTT 5298 Table 3A Hs.306024 AI538546 4452681FK506-binding protein 3 (25 kD) −1 CTAAAGCAGTGTCTGACCTGGATTTG (FKBP3),mRNA/cds = (23, 697) CTGCCAATTTGTAAGCTTTCATGA 5299 Table 3A Hs.192534AI538554 4452689 EST384032 cDNA −1 GGAGCTGAGCAGGGATGCAAAACCATCCAGTCTGTAAGATTCACAGAGAC 5300 db mining Hs.171260 AI540044 4457417td08e06.x1 cDNA, 3′ end −1 AAACGGTGTTTGAGCTGCTTTGGGAA /clone =IMAGE:2075074/clone_end = 3′ AACCCATGTTGCAGATTTTCAGGT 5301 db miningHs.283463 AI540109 4457482 7f10e03.x1 cDNA, 3′ end −1CAGAGCTGTGTTTCCTCAACAAGTGT /clone = IMAGE:3294268/clone_end = 3′GCGAGCGGTCGTGTGCGCCATGAG 5302 Table 3A Hs.171261 AI540125 4457498MR1-BN0212-280600-001 cDNA −1 AAATCGCTTCTGTATTGTTAATAGCAATATATGACCTCTGCTGTCCTCCT 5303 db mining NA AI540130 4457503 td09g11.x1NCI_CGAP_CLL1 cDNA −1 GAAGGATAATTTCGAACCCTTGCAT clone IMAGE:2075204 3′similar to AGTTTCGGTATGGGCCGTGCCAAC gb:X64707 BREAST BASIC CONSERVED PR5304 Table 3A Hs.171264 AI540161 4457534 td10c10.x1 cDNA, 3′ end −1CCCTCTTGAACTGCACTGCCTAAGAA /clone = IMAGE:2075250/clone_end = 3′ATGTTGGTTGCATGGAGACATATT 5305 Table 3A Hs.222188 AI540165 4457538td10d05.x1 cDNA, 3′ end −1 TCTGCCTTATTTGGCTTGGAAGAGAA /clone =IMAGE:2075241/clone_end = 3′ ACCGATAAACACTCCCGTGCTAGT 5306 Table 3AHs.170935 AI540204 4457577 MYE6493a cDNA −1 AAACAGCAGAAAAGTAATTTCTGGTGAACTGATGAGAATTCCCTATTGCA 5307 db mining Hs327797 AI540784 4458157tc87e06.x1 cDNA, 3′ end −1 AGGTTGTTTTGGAAAAATTATTTGTTT /clone =IMAGE:2073158/clone_end = 3′ TGTCCTAAGGGGTCCTGCCCACC 5308 db miningHs.327798 AI540789 4458162 tc87f03.x1 cDNA, 3′ end −1CCTCCGGAACGTTTTTAAAAAGGAAA /clone = IMAGE:2073149/clone_end = 3′AAGCCCGGGTTTTCCCTTGGGAAAAA 5309 Table 3A Hs.170577 AI540813 4458186602574255F1 cDNA, 5′ end −1 CAGACCTGTGGGCTGATTCCAGACT /clone =IMAGE:4702644/clone_end = 5′ GAGAGTTGAAGTTTTGTGTGCATCA 5310 Table 3AHs.173182 AI554733 4487096 tn27f08.x1 cDNA, 3′ end −1ACCAAGTTTGAATTTGTCAAATCCCA /clone = IMAGE:2168871/clone_end = 3′AGTCAATCCAGGATGTTCATTTCT 5311 Table 3A Hs.282963 AI557431 4489794602583968F1 cDNA, 5′ end −1 AGTGATCTGCCTTTCAGCAACTGTCT /clone =IMAGE:4711721/clone_end = 5′ TATTTTGGTTCTTTGAAACTGTGA 5312 db miningHs.104679 AI559444 4509649 Homo sapiens, clone MGC:18216 −1TTTGAATGGCTGAAGCTAAGGCAACG IMAGE:4156235, mRNA, complete cdsTTAGTTTCTCCTTACTCTGCTTTT /cds = (2206, 2373) 5313 db mining Hs.118392AI560581 4510902 RST42486 cDNA −1 ACCTTTGTGATTCTGTCTAGTGAAAATGGGACATTTTTAATAGTGCCAGA 5314 Table 3A NA AI560651 4510992 tq60f01.x1NCI_CGAP_Ut1 cDNA −1 GAACTTGCCCCTAAACTGGGTTAAT clone IMAGE:2213209 3′similar to GGACCCTGTTGAGTTTTCTGGACA gb:M36072 60 S RIBOSOMAL PROTEIN L7A5315 db mining Hs.327874 AI568374 4531748 th13e03.x1 cDNA, 3′ end −1TAAATTGGGCAAAGTTTTTTATGGAAT /clone = IMAGE:211118172/clone_(—)TTCCGGGGCAAGGTTTTGGGGGC end =3′ 5316 Table 3A Hs.340517 AI568459 4531833tn39e07.x1 cDNA, 3′ end −1 AAATCTCATTTGCAAGTTCTCCCATTA /clone =IMAGE:2170020/clone_end = 3′ AGCAAGGGAGTAGTTTACTAGGA 5317 Table 3AHs.143951 AI568622 4531996 tn41e10.x1 cDNA, 3′ end −1AAGAAAGGCCCATAACAGATGGCAAA /clone = IMAGE:2170218/clone_end = 3′ATAGAGGATTGGTGAGGGATATGC 5318 db mining Hs.75969 AI568695 4532069proline-rich protein with nuclear −1 AAAACCATTCCAGCTTAATGCCTTTAAtargeting signal (B4-2), mRNA TTTTAATGCCAACAAAATTGGGG /cds = (113, 1096)5319 Table 3A NA AI568725 4532009 th15a01.x1 NCI_CGAP_CLL1 cDNA −1TGCAACCTTCTTAAAATGTGGGCTAC clone IMAGE:2118312 3′, mRNATGGAGATCATGCCACTGCACTCCA sequence 5320 Table 3A Hs.159014 AI5687514532125 th15d09.x1 cDNA, 3′ end −1 AGCTCAGATGGGTCCCCAAAAGAGG /clone =IMAGE:2118353/clone_end = 3′ CATAGGAAAGCGCGACCTCACTGCC 5321 db miningHs.174242 AI568753 4532127 tn15e04.x1 cDNA, 3′ end −1CAAATAAAAAGGCTGGGGCCAAAGG /clone = IMAGE:2118366/clone_end = 3′TGGGCACCAAAAGTCCTCCTATGTG 5322 Table 3A NA AI568755 4532129 th15f03.x1NCI_CGAP_CLL1 cDNA −1 TGCAGCTCCCATTTCCTGAGCGTCTA clone IMAGE:2118365 3′,mRNA CCAGGTACTAGGAGAACTCTTACA sequence 5323 db mining Hs.327876 AI5687714532145 th15h04.x1 cDNA, 3′ end −1 ATTATCCTTTTCCCCAGGAAGCCCTC /clone =IMAGE:2118391/clone_end = 3′ GGCCCCCAAAAAGGGAAACAGTTT 5324 db miningHs.179070 AI568773 4532147 th15h09.x1 cDNA, 3′ end −1CATGAGCCCAGGGGTTTCATGACAAA /clone = IMAGE:2118401/clone_end = 3′CATTACTAGCATGTTCAACTGCCC 5325 Table 3A NA AI569898 4533272 tr57c12.x1NCI_CGAP_Pan1 cDNA −1 GCCCGGTTTATGGAAAAACCAGGAC clone IMAGE:2222422 3′similar to CAGTTTATGTTTGGGGTTTTGGGAA gbD16234 PROBABLE PROTEIN DISULFID5326 Table 3A Hs.92448 AI570295 4533669 EST390664 cDNA −1GCTTGGTACTGTCATAGTGATTACAA ATTTCATGGAATGCGAAGAGCAAC 5327 Table 3AHs.5637 AI570531 4533905 602998983F1 cDNA, 5′ end −1TTTTCTCCCCTCTCTTCCCCTTCCAC /clone = IMAGE:5141013/clone_end = 5′GAACTGCAATACCAGTAACCTTGG 5328 Table 3A Hs.14623 AI571519 4534893interferon, gamma-inducible protein 30 −1 AGCCCAGATACACAAAATTCCACCC(IF130), mRNA/cds = (40, 951) CATGATCAAGAATCCTGCTCCACT 5329 db miningHs.8882 AI572757 4536131 tu43c07.x1 cDNA, 3′ end −1CATGTGTTGACTCTGTAATGGATTTAT /clone = IMAGE:2253804/clone_end = 3′GTAGCCCACTTCAGTCTGCAAAT 5330 Table 3A Hs.230430 AI579979 4564355tq45a01.x1 cDNA, 3′ end −1 AGGGGTGTCCCTTTTCCCCTTCATGT /clone =IMAGE:2211720/clone_end = 3′ AAAATTCTAACTGGGGCTACCAGT 5331 Table 3A NAAI581199 4565575 ti94h10.x1 NCI_CGAP_Co14 cDNA −1TCTACTGACTATCCTAGAAATCGCTG clone IMAGE:2154787 3′ similar toTCGCCTTAATCCCAAGCCTACGTTT SW:ATP6_HUMAN P00846 ATP SYNTHASE A 5332 Table3A Hs.327922 AI581383 4565759 to71c02.x1 cDNA, 3′ end −1TGAAGAAACTGCCCTTTCTGTGATGT /clone = IMAGE:2183714/clone_end = 3′TTTTGAATACTACCCAACAGCCAA 5333 Table 3A Hs.229918 AI581732 4567629ar74f03.x1 cDNA, 3′ end −1 CTTCCTAGCCCTAAGTTTGGCCTTTG /clone =IMAGE:2128349/clone_end = 3′ GGTGGCTCCAAAAAGGATTAGGTT 5334 Table 3AHs.292553 AI582954 4566851 tr98e07.x1 cDNA, 3′ end −1TCCCCCTCGTTTTGTAGGGTTTGTAC /clone = IMAGE:2227140/clone_end = 3′ATAATAAAACAATGGGGTGGGGCC 5335 Table 3A Hs.340925 AI590337 4599385wh96a06.x1 cDNA, 3′ end −1 TGTTAAGTGTGAGGTTTTCTGAACCC /clone =IMAGE:2388562/clone_end = 3′ TTAGCAGAAGGACTTTTAATGTTT 5336 Table 3AHs.101617 AI597917 4606976 601513709F1 cDNA, 5′ end −1AGTTCCACTGCTGTTCCTCTTACCTT /clone = IMAGE:3914786/clone_end = 5′GATTAATGCCTATGCATGTACTT 5337 db mining Hs.13646 AI611245 4620412601287348F1 cDNA, 5′ end −1 AGTTCTGTTGTGTAATCTGGTGCTGG /clone =IMAGE:3621754/clone_end = 5′ TTCCCTGGGCATATGTATTCTGTG 5338 Table 3A NAAI619574 4628700 ty50c09.x1 NCI_CGAP_Ut2 cDNA −1CCCCCTTGCTTGGTTTTAAGTAGGTA clone IMAGE:2282512 3′ similar toTGGAATGTTATTATAGGCCATAGT gb:M23613 NUCLEOLAR PHOSPHOPROTEIN B 5339 dbmining Hs.340564 AI625119 4650050 is47b12.x1 cDNA, 3′ end −1TCAGTGTAAACCATAATTAGGCCGTGA /clone = IMAGE:2231711/clone_end = 3′GTTTTTGCTCTTACTCCCAGGTTT 5340 Table 3A Hs.188385 AI625368 4650299ts37c10.x1 cDNA, 3′ end −1 TGTAAACTTGTTTTAACAACTCTTTTC /clone =IMAGE:2230770/clone_end = 3′ AACATTTTGGCCGGGGTATTCCC 5341 Table 3AHs.278554 AI627495 4664295 chromobox homolog 3 (Drosophila −1TGCTGAAAGTGGTCCCAAAGGGGTA HP1 gamma) (CBX3), mRNACTAGTTTTTAAGCTCCCAACTCCCC /cds = (111, 662) 5342 Table 3A Hs.171262AI628993 4665693 ty95h02.x1 cDNA, 3′ end −1 TTCCCAGTTGCCACAGACCGTTTATA/clone = IMAGE:2286867/clone_end = 3′ TGAAGAAATGCTAAAGAAGTTCCC 5343Table 3A NA AI628930 4665730 ty40d03.x1 NCI_CGAP_Ut2 cDNA −1TCTACTGACTATCCTAGAAATCGCTG clone IMAGE:2281541 3′ similiar toTCGCCTTAATCCAAGCCTACGTTT SW:ATP6_HUMAN P00846 ATP SYNTHASE A 5344 dbmining Hs.264154 AI630176 4681506 ad06a03.r1 cDNA/clone = ad06a03- −1AGTTCTAAAGCCGGGAATTCCTAAGG (random) ATATACTAAATGAGATTATGTGTGG 5345 Table3A Hs.340604 AI631850 4683180 wa36h07.x1 cDNA, 3′ end −1GCCTGGGGGAGGAGAAGTCCCTTCC /clone = IMAGE:2300221/clone_end = 3′CATTCCAGCTCGATCAATCTTGCTG 5346 Table 3A Hs.256729 AI634652 4685982wx27c05.x1 cDNA, 3′ end −1 GGAGTAGAGAGAGTCTTGCTACATGC /clone =IMAGE:2544872/clone_end = 3′ GGGAACTAGAATTACATCACTGCG 5347 Table 3AHs.319825 AI634972 4686302 602021477F1 cDNA, 5′ end −1AAGAAGTTTCATTGATATCCACTGGT /clone = IMAGE:4156915/clone_end = 5′CACATCATACCTGTCTATAGGGCA 5348 Table 3A Hs.176920 AI638800 4691034tt32e01.x1 cDNA, 3′ end −1 TGCTTCAAGCACAGGATTTATGGAAT /clone =IMAGE:2242488/clone_end = 3′ AGTTGGCAAATTAAACAACATGCT 5349 Table 3AHs.197028 AI650871 4734850 602643870F1 cDNA, 5′ end −1CGGCAGCCTTATGGAATGAGTTTCTT /clone = IMAGE:4774817/clone_end = 5′GTCATGAATGTTGTCCCCAAAGCT 5350 Table 3A Hs.4283 AI651212 4735191602621616F1 cDNA, 5′ end −1 ACAGTTACTTTGGAGCTGCTAGACTG /clone =IMAGE:4755315/clone_end = 5′ GTTTTCTGTGTTGGTAAATTGCCT 5351 db miningHs.203064 AI651922 4735901 hy16b12.x1 cDNA, 3′ end −1TGTGAAGAATCCCTACCATTAATACC /clone = IMAGE:3191471/clone_end = 3′CTGGGTGGGATAAATAAAAATGGG 5352 Table 3A Hs.195378 AI653766 4737745ty01b06.x1 cDNA, 3′ end −1 CCCAAAATTTGTTTAAAGTTCCGACTT /clone =IMAGE:2277779/clone_end = 3′ CCAAAAGGGGCCAATAAAAAGGG 5353 db miningHs.111941 AI660405 4763975 qd92a04.x1 cDNA, 3′ end −1CACCGCCTCTGCCTCCGCCTCTTCCA /clone = IMAGE:1736910/clone_end = 3′CTGGAGAGCCCGAGGTCAAAAGGTC 5354 Table 3A Hs.200442 AI669591 4834365tw34b09.x1 cDNA, 3′ end −1 CCCTCACCTAGCAGTACTACCACAAT /clone =IMAGE:2261561/clone_end = 3′ AATGCTATCATGGTGCCAGGGAAT 5355 Table 3AHs.101150 AI672433 4852164 Homo sapiens, clone IMAGE:4054156, −1TCTCCTTCCCCATTGGGCCGCCTTTA mRNA, partial cds/cds = (0, 526)TCAATTGCCTGTTTTGTTTTGTTT 5356 Table 3A Hs.341178 AI676004 4888186xa30a04.x1 cDNA, 3′ end −1 TTTTTATCTTTCTTGGTGGGGGTGTG /clone =IMAGE:2568270/clone_end = 3′ GTGGTGGTGAAGAGGACCTAAAAA 5357 Table 3AHs.324507 AI676099 4888261 hypothetical protein FLJ20986 −1CGCCAGAGGTCAGAACATGTCTATTT (FLJ20986), mRNA/cds = (182, 2056)TGAATTGGATCGTTACAAATGAGC 5358 Table 3A Hs.178784 AI681868 4892050602587746F1 cDNA, 5′ end −1 GCAGGCACTGACATTTTTGAGCAAAG /clone =IMAGE:4716442/clone_end = 5′ ACGTGATGTTATGAGATAAATATC 5359 Table 3AHs.90744 AI684022 4895316 proteasome (prosome, macropain) −1TTCTGACACGATTACACAACGAGGCT 265 subunit, non-ATPase, 11TTAATGCCATTTGGGTAGGTGAGC (PSMD11), mRNA/cds = (0, 1268) 5360 db miningHs.328323 AI684369 4695663 tc96e09.x1 cDNA, 3′ end −1TTTTAAAGGGGAGGGGCCGGGGTTT /clone = IMAGE:2074024/clone_end = 3′GGTCCCCGGTCCCAAAGGTAAAAGTT 5361 Table 3A Hs.58774 AI684437 4895731 Homosapiens, Similar to zinc finger −1 GAGTGAGAAGAGGCTTTTAAGGACCA protein175, clone MGC:12651 TGTGAAGAGGCTTTTAAACACTTT IMAGE:4301632, mRNA,complete cds /cds = (367, 522) 5362 db mining Hs.182817 AI684847 4896141602290551F1 cDNA, 5′ end −1 GGGTTGGGATAAACTGCTTAGATGTT /clone =IMAGE:4385293/clone_end = 5′ TGCCTACTTGTCCAGTGAAATTAC 5363 Table 3A NAAI688560 4899854 wd39f08.x1 Soarses_NFL_T_GBC_S1 −1ACTGAAAAGTTGAAAGACTTTTGCAG cDNA clone IMAGE:2330535 3′, mRNATGAACATTTATATAACTCCCCGCT sequence 5364 Table 3A Hs.201789 AI6931794970519 MR1-CI0181-081100-001-a01 cDNA −1 ATTCATAGGTAGTGCCCAGAGAGAGTACAAGCTCTGACTCATATGGCAGT 5365 literature Hs.202407 AI697497 49805397we14b06.x1 cDNA, 3′ end −1 ACATGTTACCTGGAGTAGCTGTGTCA /clone =IMAGE:2341043/clone_end = 3′ ACAGATTAATATGGAATGCTACTA 5366 Table 3AHs.177708 AI697756 4985658 602369210F1 cDNA, 5′ end −1TGGTTCCTGTGCTCACCATAGGGCTG /clone = IMAGE:4477370/clone_end = 5′GTGTACATTGGGCCATTAATAAAC 5367 Table 3A Hs.206854 AI700738 4988836EST388531 cDNA −1 ACAGATCCCTATTGCCAGACACATCA TTCTCTCCATCCAGAAAGCAAACA5368 Table 3A Hs.80887 AI701165 4989065 v-yes-1 Yamaguchi sarcoma viral−1 TCTGGGAAAGACATTTTTAAGCTGCT related oncogene homolog (LYN),GACTTCACCTGCAAAATCTAACAG mRNA/cds = (297, 1835) 5369 Table 3A Hs.102793AI707589 4997365 RST17769 cDNA −1 AGTCACGATAAACCTGGTCACCTGAAAATTGAATTGAGCCACTTCCTTG 5370 Table 3A Hs.30933 AI707809 4997585as28g09.x1 cDNA, 3′ end −1 AAACTGGCGGCCCAACAAAACAGTG /clone =IMAGE:2318560/clone_end = 3′ GGTTAAATGGGTCCCTGGGTGACAT 5371 Table 3AHs.107369 AI707896 4997672 as34a10.x1 cDNA, 3′ end −1AGTGTTTCCTCCACATCTAAAGAAAG /clone = IMAGE:2319066/clone_end = 3′CCCATTTTGAAACTGGATACTGCA 5372 Table 3A Hs.176430 AI708327 4998103at04c02.x1 cDNA, 3′ end −1 CCCAGGTGGCCCCTCTCCATCAGAT /clone =IMAGE:2354114/clone_end = 3′ GTTATTGCTCTTCCCCATTTATTTA 5373 Table 3AHs.300710 AI709236 4999012 RC-MT0059-200600-021-g05 cDNA −1AAGATGCCTAAGCGTTAACCAGGTGA AACAGGGGTGGGAGAGAGAAAGAA 5374 Table 3AHs.297184 AI720536 5037792 601502712F1 cDNA, 5′ end −1GTCATACACCTATCCCCCATTTTCCT /clone = IMAGE:3904539/clone_end = 5′CCTATCCCTCAACCCGGACATCAT 5375 Table 3A Hs.313929 AI733018 5054131oh60h01.x5 cDNA, 3′ end −1 GCAGGTGGCAGAATGGGGTGCATGA /clone =IMAGE:1471441/clone_end = 3′ AGGTTTCTGAAAATTAACACTGCTT 5376 Table 3AHs.310333 AI735206 5056730 at07f03.x1 cDNA, 3′ end −1ACAGAGAGGCAGCATTTGTTTTCCAG /clone = IMAGE:2354429/clone_end = 3′TTAAAATTTGACCTCACTGTGATT 5377 Table 3A Hs.277201 AI740667 5108955wg07b07.x1 cDNA, 3′ end −1 CCCCCTTTTGTTGTGGTTTTATATTGG /clone =IMAGE:2364373/clone_end = 3′ AACCCCCTTTTTCTTTGGAACTA 5378 Table 3AHs.204656 AI741246 5109534 wg26g09.x1 = 1 cDNA, 3′ end −1CTGACCCCTTCCTCACCCCTGCCAAC /clone = IMAGE:2366272/clone_end = 3′AGTGGTGGCATATATCACAAATGG 5379 Table 3A Hs.299883 AI742850 5111138hypothetical protein FLJ23399 −1 TGTTTTACCTCACTGTTGGACATACAT (FLJ23399),mRNA/cds = (282, 1789) TCCAAGCTTTTCAACTCTAGGAG 5380 Table 3A Hs.6187AI745230 5113518 wg10e05.x1 cDNA, 3′ end −1 CAGAACATGCCCAAAGAAGCCTATAT/clone = IMAGE:2364704/clone_end = 3′ CTTGCTGCTGGGAAATGTAAAGCA 5381Table 3A Hs.293842 AI748827 5127091 601571679F1 cDNA, 5′ end −1CAAACACCGGCAGTTGAAAGGAAAA /clone = IMAGE:3838675/clone_end = 5′GGACGGGGAATGTGATGGAAAAGAG 5382 Table 3A NA AI749435 5127699 at24b03.x1Barstead aorta HPLRB6 −1 CCCCCTCCCTGCCCCGGTGAGCTTT cDNA cloneIMAGE:2356015 3′ similar GGGGAACCCAAAAATTAGATTTTGC to gb:X55715 40SRIBOSOMAL PRO 5383 Table 3A Hs.204929 AI749444 5127708 at24c03.x1 cDNA,3′ end −1 CCCAAATCCAAGGACCAATGCTGTTG /clone = IMAGE:2356036/clone_end =3′ TAAACAAGGGGTAAAGGGCCTAAA 5384 Table 3A Hs.205071 AI760018 5175685wh83b02.x1 cDNA, 3′ end −1 ACTCCACCAAGACTGTGAACTCCACC /clone =IMAGE:2387307/clone_end = 3′ GGGGTAGGAAGCATATTTTACTCA 5385 Table 3AHs.160951 AI760020 5175687 wh83b05.x1 cDNA, 3′ end −1GAGAACTCGTTTCAAGGAACTCGATG /clone = IMAGE:2367313/clone_end = 3′TTTCCGGGGACCAAGCCCGCCCAG 5386 Table 3A Hs.340921 AI760026 5175693wh83c05.x1 cDNA, 3′ end −1 CCAGCGAATTTCCAGCTTTTGAAACT /clone =IMAGE:2367336/clone_end = 3′ CAGATTTCCTTTTGCGACCCAGGT 5387 Table 3AHs.26873 AI760224 5175891 wh62g06.x1 cDNA, 3′ end −1GATGCGCGGCAAGAATGTACCTGTA /clone = IMAGE:2385370/clone_end = 3′GATGTGTACATACCACAGTGCTGTA 5388 Table 3A Hs.14373 AI760353 5176020yx26h11.r1 cDNA, 5′ end −1 TTTATCTCAGAATCTTGATGAACTCTG /clone =IMAGE:282917/clone_end = 5′ AAATGACCCCTGATGGGGGCATG 5389 db miningHs.204598 AI760374 5176041 wh87d12.x1 cDNA, 3′ end −1GGCCCCCTGTCCTTACCTGTTTTCGG /clone = IMAGE:2387735/clone_end =3′CCCCCTTAATTTTTTAACCCCGGG 5390 db mining Hs.283496 AI760389 5176056wh87f08.x1 cDNA, 3′ end −1 GTCACAGTGTAGACACATGGTGCTTC /clone =IMAGE:2387751/clone_end = 3′ CATAGTGAGTAGAATATCCATTGT 5391 db miningHs.340927 AI760556 5176223 wi10d09.x1 cDNA, 3′ end −1GTGGCCTGGCCTGGCTCTCACAGAC /clone = IMAGE:2389841/clone_end = 3′CCAAGGCTTCCGTGTAGAATATGTC 5392 db mining Hs.205803 AI760674 5176341wh96b04.x1 cDNA, 3′ end −1 GGATTGTGGCAGGAACTGTTTCCCCT /clone =IMAGE:2388559/clone_end = 3′ CCCAGCCTTAAATTTTTCTGTGTT 5393 db miningHs.283497 AI760699 5176366 7f34c12.x1 cDNA, 3′ end −1AAACCCACACCTCAGTGAATTTAAAA /clone = IMAGE:3296566/clone_end = 3′GAGTAGATGTTTTAAAAGACCGGA 5394 db mining Hs.264654 AI760835 5176502wh96f11.x1 cDNA, 3′ end −1 TGCCATTTGGTATTTTTTCCTGAAACA /clone =IMAGE:2388621/clone_end = 3′ TTACATAATAAGAATGCAGCATGC 5395 Table 3A NAAI760901 5176568 wi09h06.x1 NCI_CGAP_CLL1 cDNA −1GCCTGAAACCATCCTGCCTTCTAGGA clone IMAGE:2389787 3′, mRNAAGACAGCAATTCTGGAAGAGCAAG sequence 5396 db mining Hs.230931 AI7609915176658 wh97b11.x1 cDNA, 3′ end −1 GGTGGTTCCCCAGCCCTTTTCCCTGG /clone =IMAGE:2388669/clone_end = 3′ CCCTGGGTTGGAAAATTTGTTTTC 5397 db miningHs.328494 AI761029 5178898 wi10d06.x1 cDNA, 3′ end −1AAAACCTTTCGCCCGGCTTAAATTT /clone = IMAGE:2389835/clone_end = 3′ACCGGGGTTTGGTTTTATTTGGTTT 5398 Table 3A Hs.98531 AI761058 5176725wi69b03.x1 cDNA, 3′ end −1 CTCCTTGGTGTCATGCAACTGAGGAA /clone =IMAGE:2398541/clone_end = 3′ CCTAATTGGCTGGGTGGGTTGTTC 5399 Table 3AHs.205452 AI761141 5178808 wh97g08.x1 cDNA, 3′ end −1GTTTGTAAAAGAACCTGCCACATTTG /clone = IMAGE:2388734/clone_end = 3′TTGAAAAGTTAGAGCCATCACAGC 5400 Table 3A NA AI761144 5176811 wh97h01.x1NCI_CGAP_CLL1 cDNA −1 CTCTTGGCTGCTGGCCTTTTGTTCTT clone IMAGE:2388721 3′,mRNA GTCATGGCTCATTAGCTCCCTAAA sequence 5401 db mining Hs.328495 AI7614685177135 wh98e07.x1 cDNA, 3′ end −1 CCAGGGGTTTTTAAATTTTCTGAAGTT /clone =IMAGE:2388804/clone_end = 3′ TTTGGGGCCATTTTGGTTGTTGG 5402 Table 3AHs.80887 AI761622 5177289 v-yes-1 Yamaguchi sarcoma viral −1CCCCGCTTGCCTTTTATTTCAGAACC related oncogene homolog (LYN),CCAAGTATTACCCAATATGTTACA mRNA/cds = (297, 1835) 5403 Table 3A Hs.289834AI761924 5177591 wg68h03.x1 cDNA, 3′ end −1 GCCGAAGCTCACAGAGGCTAAGTTA/clone = IMAGE:2370293/clone_end = 3′ CACGCTTAGGTGTTCTTATTCCTAC 5404Table 3A Hs.204610 AI762023 5177690 wh89f04.x1 cDNA, 3′ end −1AACCAGGTTTATGATGCTGTAATAAA /clone = IMAGE:2387935/clone_end = 3′CCATGGCATTAAAGAGGGCAAGAG 5405 db mining NA AI762158 5177823 wh90e05.x1NCI_CGAP_CLLI cDNA −1 GGGTTAAGGAGGGCCGCTCCAAAAT /clone = IMAGE:23880323′ similar to TTTCCTTTTTCCCAGGAAGCCCTTG gb:X64707 BREAST BASIC CONSERVEDPR 5406 db mining Hs.204771 AI762177 5177844 wh90g09.x1 cDNA, 3′ end −1ATGCTGTGAGTGGTACACATGGCTGA /clone = IMAGE:2388064/clone_end = 3′GGTTATGATCTGTTAAAATATGTA 5407 Table 3A Hs.205327 AI782557 5178224wh92f07.x1 cDNA, 3′ end −1 TTCATTAATTCCTCAACCCAATACTGT /clone =IMAGE:2388229/clone_end = 3′ CTGGCTTCCACCAACAGGAGCGG 5408 db miningHs.328503 AI762707 5178374 wh93d08.x1 cDNA 3′ end −1TGGTTTCTATTTTAAAAACCTGGGTTA /clone = IMAGE:2388299/clone_end = 3′GGCCAAGGTTTGGGGTTCGCCCT 5409 db mining Hs.204477 AI762719 5178386wh93e10.x1 cDNA, 3′ end −1 CAACATTGCCTACCAGTTGCAGTTCA /clone =IMAGE:2388330/clone_end = 3′ TTAGCCCCGTCCGCCCCAGCATTG 5410 db miningHs205815 AI762739 5178406 wh93g11.x1 cDNA, 3′ end −1CCTTTGGGGTGGGGGCTTTTTCCTTT /clone = IMAGE:2388356/clone_end = 3′TTGGCCGGTTCAATTAAGGTTTTT 5411 Table 3A NA AI762741 5178408 wh93h02.x1NCI_CGAP_CLL1 cDNA −1 CCCACTCCGGCTGTTTTAGAAGTTTT clone IMAGE:2388339 3′,mRNA CCCGAATCCGTGATCCCTTTACAA sequence 5412 db mining NA AI7627975178464 wi04c12.x1 NCI_CGAP_CLL1 cDNA −1 AATGGGCAAATTTTACCCAAAACTTAclone IMAGE:2389270 3′ similar to AGCTTGCCTATTCCGTTTGAGGCA TR:Q61655Q61655 EUKARYOTIC TRANSLA 5413 Table 3A Hs.333513 AI762870 5178537wi63c07.x1 cDNA, 3′ end −1 GAAGGAGAGGCACACACAAATACAC /clone =IMAGE:2397996/ ACACTCACACAAAACTCAACAACCA 5414 db mining Hs.204480AI762931 5178598 wh94e08.x1 cDNA, 3′ end −1 GGATACCCCCTTTATCCCGAGGGAAT/clone = IMAGE:2388422/clone_end = 3′ TTTTACCCTTTGGATGCCTTTAAA 5415 dbmining Hs.289836 AI762955 5178622 wh94g12.x1 cDNA, 3′ end −1CAAATTACAAACCTAAAAATACAGAA /clone = IMAGE:2388454/clone_end = 3′CATCAGCGGAGAAGACAGGAGAGC 5416 db mining Hs.277238 AI763079 5178748wh95a12.x1 cDNA, 3′ end −1 CTCCTCCCTTGGGTGGGACCTGGGT /clone =IMAGE:2388476/clone_end = 3′ TGGGGGTTTGATAGAAAAATTAACC 5417 Table 3AHs.173904 AI763121 5178788 wi06d12.x1 cDNA, 3′ end −1GGTTAAACTAGATCCCTGCAAGGCCA /clone = IMAGE:2389463/clone_end = 3′TCACCTCCATTCCAAGTTGTTACT 5418 Table 3A Hs.190453 AI763208 5178873wh95e09.x1 cDNA, 3′ end −1 AGTGGGTTATTTTAGATCTTTTCCTG /clone =IMAGE:2388520/clone_end = 3′ GGGTTCAGGTCACATAGCTTAACT 5419 db miningHs.283500 AI763225 5178892 UI-H-BW1-anj-a-06-0-UI.s1 cDNA, 3′ −1TGTTTGGGTATATTGTTTGGGTTTTG end/clone = IMAGE:3082282GGCACTAGGATGGGTGACTCAGGG /clone_end = 3′ 5420 Table 3A Hs.130059AI763262 5178929 wi66c04.x1 cDNA, 3′ end −1 GCCAGTGAATCTAGTTTTGGCTATTC/clone = IMAGE:2398278/clone_end = 3′ TGTATTTTGTCCAGTTTTTCCCAT 5421 dbmining Hs.328504 AI763414 5179081 wh92a11.x1 cDNA, 3′ end −1AACCATTTTCCCCCGGGAACCCGTTT /clone = IMAGE:2388168/clone_end = 3′TGCCTGGTTTCGGATTTTTTACCC 5422 Table 3A Hs.36137 AI765153 5231662hepalocyte nuclear factor 3, gamma −1 CCGGGAAGCGGGGTACTGGCTGTGT (HNF3G),mRNA/cds = (0, 1043) TTAATCATTAAAGGTACCGTGTCCG 5423 db mining Hs.340947AI766625 5233134 wi01f06.x1 cDNA, 3′ end −1 TTTTTCCCCCTCCCAAATTCACTGCAT/clone = IMAGE:2388995/clone_end = 3′ TACAGTTTTTGAAACAGAACGGG 5424 Table3A NA AI766638 5233147 wi02a10.x1 NCI_CGAP_CLL1 cDNA −1TACGAGAAGTCAGGAAGTTTTGAAAT clone IMAGE:2389050 3′, mRNAGGCAGTGACAGGAGACGGGGGAAG sequence 5425 db mining Hs.210276 AI7666585233165 wi02d04.x1 cDNA, 3′ end −1 AAGGGCAGGCAAATCAATTAAAATTA /clone =IMAGE:2389063/clone_end = 3′ GCCGTAACAACAACCTCGGGGGTG 5426 Table 3AHs.223935 AI766706 5233215 wl0g211.x1 cDNA, 3′ end −1AGTACACGGCCCTCAAAAGTTATATG /clone = IMAGE:2389124/clone_end = 3′TGCTGAATGTAACCTACTTAGCGA 5427 Table 3A Hs.89104 AI766963 5233472602590917F1 cDNA, 5′ end −1 TTGTTTTAACAACTCTTCTCAACATTT /clone =IMAGE:4717348/clone_end = 5′ TGTCCAGGTTATTCACTGTAACCA 5428 Table 3AHs.209511 AI768880 5235389 wh71e04.x1 cDNA, 3′ end −1CTTCTCCACCTCGGCCAGGTATAGG /clone = IMAGE:2386206/clone_end = 3′GCCAGCTTCTCGTCTCTGGGATCCG 5429 Table 3A Hs.203594 AI796317 5381780uncharacterized gastric protein ZA43P −1 GCCAGGTCATTGTATAGGGAGTAAGAmRNA, partial cds/cds = (0, 134) TGAAGGTGAATTTGCAGCTAGTTG 5430 Table 3AHs.230939 AI796419 5361882 wj17f02.x1 cDNA, 3′ end −1TGTGTTTTGTTTTTCTGGTCCCAGGG /clone = IMAGE:2403099/clone_end = 3′CACCGTTTGTTTTGTGAACTCCTC 5431 db mining Hs.291079 AI797561 5363033602437732F1 cDNA, 5′ end −1 CATGGCTCTAAAATTTGGAATTAACTT /clone =IMAGE:4555638/clone_end = 5′ CTCTTGCCTTAAGAGCTGCTTGT 5432 Table 3AHs.159577 AI797788 5383260 wh78b11.x1 cDNA, 3′ end −1GCTGGTGGGAAGTTGAGCCATGTTTA /clone = IMAGE:2386845/clone_end = 3′TCTCTAGTGGAATCCTTACCTTGT 5433 db mining Hs.207473 AI797813 5363370wh79c04.x1 cDNA, 3′ end −1 CATGTTTACACAAATTCCTTCAAAGC /clone =IMAGE:2386950/clone end = 3′ CCCTTAAACATGGGGCCGGGCCCC 5434 db miningHs.171110 AI797652 5363409 7e88g03.x1 cDNA, 3′ end −1ACCCTAATAGCTAGGCTGGGTATATT /clone = IMAGE:3292276/clone_end = 3TTCAAAGTGTAGCGAAACCCCACG 5435 db mining NA AI797901 5363296 wh78f12.x1NCI_CGAP_CLL1 cDNA −1 CAGTTGGCCTCCTACAATTGGGAATT clone IMAGE:2386895 3′similar to CTACCAAGCTCCAAGTTGACCTGG contains Alu repetitive element;. m5436 db mining Hs.226571 AI797916 5363311 DKFZp434G048_s1 cDNA, 3′ end−1 GGATTCCCGACAAAGGCTTGATGTGT /clone = DKFZp434G048/clone_end = 3′ACTTGAAGTGAGCAAAGGGTTTTG 5437 db mining Hs.223520 AI797988 5363460wh80a02.x1 cDNA, 3′ end −1 GGGTGGGAGACAGGCTAATCCTTTC /clone =IMAGE:2387018/clone_end = 3′ CCCTTGTTTTCCACGTCTTTATGAC 5438 db miningHs.207062 AI798027 5363499 wh80e09.x1 cDNA, 3′ end −1ACAACCTTCTTAATATATTAGAGACCC /clone = IMAGE:2387080/clone_end = 3′GCAGGAAACATTTAGTGGTGAAAC 5439 db mining Hs.341012 AI798028 5363500wh80f11.x1 cDNA, 3′ end −1 GTACATGTTTGTGTGCTAAATTGCTC /clone =IMAGE:2387085/clone_end = 3′ ATTTGGCAGTGATAGATTGAAAAAC 5440 db miningHs.229494 AI798100 5363583 wh81d01.x1 cDNA, 3′ end −1GGGGGTCAAAGAGGGTACAAATGTA /clone = IMAGE:2387137/clone_end = 3′TGGGGGTATATTGAATGCTAAACAT 5441 db mining Hs.328535 AI798101 536384wh81d02.x1 cDNA, 3′ end −1 GGGAGCCCGTTTTAGAAGGAAGGGC /clone =IMAGE:2387139/clone_end = 3′ AAAAGTAGGGTTTTTAACCCAAACG 5442 db miningHs.210307 AI798114 5363576 wh81c01.x1 cDNA, 3′ end −1TCCGTCCCATTCCCCCGGAAAACAAG /clone = IMAGE:2387138/clone_end = 3′GTTTTGAATTGGCCCGTAAAAGGG 5443 Table 3A Hs.209609 AI798144 5363816wh81g12.x1 cDNA, 3′ end −1 ACGTCCTTATACAATGCACTGTTTGA /clone =IMAGE:2387208/clone_end = 3′ TTTTTAACAATACCTGAAGGGCT 5444 Table 3AHs.158989 AI799909 5365381 602666595F1 cDNA, 5′ end −1 ACTCAATACTCGGGAAAGGCTTCACA /clone = IMAGE:4806358/clone_end = 5′TTTCTGGGACTCAGCATTATCCAA 5445 Table 3A Hs.135167 AI802181 5367664AV712376 cDNA, 5′ end −1 TTGAGAGGCAACACTTAAACACTAGG /clone =DCAAND12/clone_end = 5′ GCTACTGTGGCATCTATGTAGACA 5446 Table 3A Hs.195175AI802547 5368019 mRNA for CASH alpha protein −1AGCCCTTTCTTGTTGCTGTATGTTTA /cds = (481, 1923) GATGCTTTCCAATCTTTTGTTACT5447 Table 3A Hs.25648 AI803065 5368537 tumor necrosis factor receptor−1 GGGGTATGGTTTAGTAATATCCACCA superfamily, member 5 (TNFRSF5),GACCTTCCGATCCAGCAGTTTGGT mRNA/cds = (47, 880) 5446 Table 3A Hs.301209AI804629 5370101 myeloid/lymphoid or mixed-lineage −1AACAACAACAGCAAAATCCCCTTAGT leukemia (trithorax (Drosophila)GCGTAACTTGAAATTCCCTTCGGC homolog); translocated to, 10 (MLLT10),mRNA/cds = (183, 3266) 5449 db mining Hs.209261 AI805106 5391760tc90g10.x1 cDNA, 3′ end −1 TTGTAAGTGGGTGCATAAGAAGATCT /clone =IMAGE:2073474/clone_end = 3′ CTTCAATTAAATGCCCCCGCTGGT 5450 Table 3AHs.187698 AI805111 5391765 cytomegatovirus partial fusion receptor −1ATAATTAAGAAATCAGCCGTGTGCTT mRNA, partial cds/cds = (0, 1037)CTCACGTTTGGGCTCCGAGACGTG 5451 Table 3A Hs.167206 AI805131 5391785602727149F1 cDNA, 5′ end −1 GTCAGTCTCCTCACCTGCCTCTGCTC /clone =IMAGE:4868348/clone_end = 5′ CTCGCTTAGCCCATTGATTGCATC 5452 db mining NAAI805144 5391798 td11g08.x1 NCI_CGAP_CLL1 cDNA −1GGGAAGAAGCCCGTGCCCCCACCCA clone IMAGE:2075390 3′ similar toATAAATGTTGGTTTTGGCCCTGATG gb:L24038_ma1 A-RAF PROTO- ONCOGENE 5453 dbmining NA AI805257 5391750 tc90f09.x1 NCI_CGAP_CLL1 cDNA −1CAGAACTTCTGGCGAAGGCCATGTAA clone IMAGE:2073449 3′, mRNAGAACTACTCCAAGGAGGAAGAGGC sequence 5454 Table 3A NA AI807278 5393844wf38h03.x1 Soares_NFL_T_GBC_S1 −1 CTCTACCATAAGGCACTATCAGAGAC cDNA cloneIMAGE:2357909 3′ ,mRNA TGCTACTGGAGTGTATATTTGGTT sequence 5455 db miningNA AI808039 5394527 wf52h02.x1 Soares_NFL_T_GBC_S1 −1ACTGCTACAGCTTAACCATTGTTCCA cDNA clone IMAGE:2359251 3′ similarAGCTAATTAAATTACCTTTGGGGA to TR:Q62845 Q62845 NEURAL CELL 5456 Table 3AHs.87912 AI808931 5395497 EST379776 cDNA −1 CAATTGTGATTTGGAAGGTTTAACTGGGTCTGCCCAGATGTTTACGAATA 5457 db mining Hs.209989 AI809181 5395747wh75d05.x1 cDNA, 3′ end −1 TCCAAGCAAAAGTTATGCAATAAGAC /clone =IMAGE:2386569/clone_end = 3′ AGAATATAAAGTCTCCGAGAGCCT 5458 db miningHs.230485 AI809184 5395750 wh75d08.x1 cDNA, 3′ end −1GGGTGGGGTGGGGTGAGAGTGTGTG /clone = IMAGE:2386575/clone_end = 3′GAGTAAGGACCTTCAGAATTAATAT 5459 db mining Hs.292761 AI809305 5395871wh75g11.x1 cDNA, 3′ end −1 TGCAGTTCTTATTTTCTTTTGCCTGTG /clone =IMAGE:2386628/clone_end = 3′ ATAATTGCAAATCCGTCAATAGAA 5460 Table 3AHs.210385 AI809310 5395876 wh75h08.x1 cDNA, 3′ end −1TGCAAGTTTCTGAGACTGTGAAAAGT /clone = IMAGE:2386623/clone_end = 3′GTTTTGCTTCTTTTGTTACCCAAT 5461 db mining Hs.90463 AI809378 5395944wa27e12.x1 cDNA, 3′ end −1 TCCCAGCGAATGTGAATCATTTAGTG /clone =IMAGE:2299342/clone_end = 3′ TGCTACTCAAAATTAGGTGTCCAC 5462 Table 3AHs.257466 AI809475 5398041 UI-H-BI3-aid-e-08-0-UI.s1 cDNA, 3′ −1TAAGATGTAGGGGCCACCGGCCAGC end/clone = IMAGE:2736471AGTACCCAGGAATGACCACTATCAG /clone_end = 3′ 5463 db mining Hs.208153AI809564 5396130 wh76e01.x1 cDNA, 3′ end −1 ATAAATGAAAGCATACCAAGTGCTGT/clone = IMAGE:2386680/clone_end = 3′ CCATTCCATAGGTACAACTATGGA 5464 dbmining Hs.310486 AI809746 5396312 7e96g11.x1 cDNA, 3′ end −1CTGGTATTCTGAGGTCAGATGTAGGC /clone = IMAGE:3293060/clone_end = 3′TGTTGCTCGCTCCGGCTGGGTCTC 5465 Table 3A Hs.277293 AI811065 5397631tr03f05.x1 cDNA, 3′ end −1 CCATCGGGGGTATTGGGGTTTTGGG /clone =IMAGE:2217249/clone_end = 3′ CTGAATTTACTTGATTATTGGAAAA 5466 Table 3AHs.86693 AI817153 5436320 EST380760 cDNA −1 GCCAGATTGTGGCAGGTAAAGAGACAATGTAATTTGCACTCCCTATGATA 5467 Table 3A Hs.230492 AI818596 5437675wk74d04.x1 cDNA, 3′ end −1 TTTAAAAAGGAGGGAGGATTTCTGGG /clone =IMAGE:2421127/clone_end = 3′ TTAAAACTTTTATTTGGCCCCCAT 5468 Table 3AHs.229990 AI818777 5437856 wl11f10.x1 cDNA, 3′ end −1TAAAACCCAAGACTTCAGATTCAGCC /clone = IMAGE:2424819/clone_end = 3′GAATTGTGGTGTTTCACAAGGCCG 5469 Table 3A NA AI818951 5438030 wj89e12.x1NCI_CGAP_Lym12 cDNA −1 CTAAGCATGGGGAAGGGGGCAGAGT clone IMAGE:2410030 3′similar to GAGGACTGTGCCATTGATTAAAGTG WP:C11H1.7 CE18492; contains Alu r5470 Table 3A Hs.51039 AI823541 5444212 KIAA0078 gene product(KIAA0076), −1 GTACAGAAACATATTCCATGCTTTGA mRNA/cds = (86, 5182)AATAAAGGGAAGTGCTCTCCTGTT 5471 Table 3A Hs.211535 AI823649 5444320wi85g03.x1 cDNA, 3′ end −1 GAAGCCTTTTCTTTTCTGTTCACCCTC /clone =IMAGE:2400148/clone_end = 3′ ACCAAGAGCACAACTTAAATAGG 5472 Table 3AHs.304477 AI824522 5445193 tx71d03.x1 cDNA, 3′ end −1ACCGATCGTTTTTAGGATAATATGCA /clone = IMAGE:2275013/clone_end = 3′TGTTTCAAGTGGTATTGAAACCCCC 5473 db mining Hs.270624 AI825098 54458597b65e05.x1 cDNA, 3′ end −1 TGAGGGACAGGCTGCCTAAAGTCTAA /clone =IMAGE:3233120/clone_end = 3′ TTGGAGAGTTAACCTAATGTCTGT 5474 Table 3AHs.117906 AI825845 5446316 wb75b09.x1 cDNA, 3′ end −1CACCATCGTGGCTCTGAGAACTGAC /clone = IMAGE:2311481/clone_end = 3′GCCGTGAATGTTGACCTGAGTGCCG 5475 Table 3A Hs.229993 AI827451 5448122wt17d11.x1 cDNA, 3′ end −1 GGGGAGAGACCACCCTAGACATTTG /clone =IMAGE:2425173/clone_end = 3′ CATTTTTGTAAGTTAGCCAGCCAAT 5476 Table 3AHs.181400 AI827911 5448669 602650370T1 cDNA, 3′ end −1TGGATAAATCTGAGCAACTTTCTTCTT /clone = IMAGE:4761353/clone_end = 3′TGTGCTCCAGGAACCTACGCACT 5477 Table 3A Hs.342617 AI827950 5448708ha15h10.x1 cDNA, 3′ end −1 TGTGGGTTTTGATTGACATACTGTTG /clone =IMAGE:2873827/clone_end = 3′ TTCATGCTGAAGTTTGAGTGTCGT 5478 Table 3AHs.132238 AI829569 5450240 wf28e02.x1 cDNA, 3′ end −1GGTGTGCAGTCCGCCTGAAAGCCTT /clone = IMAGE:2356922/clone_end = 3 ′CCCTTTAGCTATTAGGAATTGAGTC 5479 db mining Hs.289878 AI831819 5452490wh84f12.x1 cDNA, 3′ end −1 ACATTGGAAAGAAACCCTACAACTGT /clone =IMAGE:2387471/clone_end = 3′ AATGAATATGAAAAGAATTGTCTAAAA 5480 Table 3AHs.341177 AI832038 5452709 wj99e02.x1 cDNA, 3′ end −1AAAACCGTTTTCCCCATACATAAAGA /clone = IMAGE:2410970/clone_end = 3′ACAGGGGTACTCCCGCCCTGATGG 5481 Table 3A Hs.210995 AI832182 5452853td13h11.x1 cDNA, 3′ end −1 TTTGGTGAAGTGAAAGAGAGAAGTTG /clone =IMAGE:2075589/clone_end = 3′ CTCTAAAAGGTTGGAAACCAGCCC 5482 Table 3AHs.249031 AI832183 5452854 wh80g09.x1 cDNA 3′ end −1TGGACTGTTGTAATGTTTTGCGTTAT /clone = IMAGE:2387104/clone_end = 3′CAAATGAAAACTGCCAAATGAGA 5483 Table 3A Hs.63908 AI85871 5512387hypothetical protein MGC14726 −1 GCTTTGAGTTTTGGGATGGTCACATG (MGC14726),mRNA/cds = (21, 653) ACACAATCCAGCACTTGAACCTGA 5484 Table 3A Hs.252259AI859076 5512692 ribosomal protein S3 (RPS3), mRNA −1AGAGCCATTCCCACAAAGTAAATGTG /cds = (22, 753) CAGTGCCCATGTTTCTTGTGTTTA5485 Table 3A NA AI860120 5513736 wh39e01.x1 NCI_CGAP_Kid11 cDNA −1GACTCTGAGAGAGAGCGACGGCCAT clone IMAGE:2383128 3′, mRNACATAGAACAGCGAAGGCAGTCGATC sequence 5486 db mining Hs.156811 AI8623325526439 hz33g10.x1 cDNA, 3′ end −1 ATCGATGAGAAGAGTCTGCAAAACAC /clone =IMAGE:3209826/clone_end = 3′ TTCATCCTCAGGACGTGCTGTCCT 5487 db miningHs.304508 AI882595 5526702 wh99g01.x1 cDNA, 3′ end −1ATATATTAAACCACAGGTATTAGAGA /clone = IMAGE2388912/clone_end = 3′CATGAATTGCACCCAACACAAGCT 5488 Table 3A NA AI862623 5526730 wh99h10.x1NCI_CGAP_CLL1 cDNA −1 ATTCATTCGGGTCTTCCTTTCTTCCG clone IMAGE:2388931 3′,mRNA CCCCCTTCCTTCCATTGGCACCTC sequence 5489 Table 3A Hs.181426 AI865425529523 EST367815 cDNA −1 TCAGTTTTGTGGAATCTGGTGTTTGCACTATAGGTTAAGAGTTGCCATTT 5490 Table 3A Hs.341208 AI855603 5529710wk47g03.x1 cDNA, 3′ end −1 TGTGTGGTGGGGGTGCTTTTGAGGTT /clone =IMAGE:2418580/clone_end = 3′ GGAGGAAAGTAGAGACAGCGAAAC 5491 Table 3AHs.9788 AI866194 5530301 hypothetical protein MGC10924 similar −1TGTGCTTTTTGCCCAAGTGGTAATTC to Nedd4 WW-binding protein 5ATCTTGGTTTGCTATGTTAAAACT (MGC10924), mRNA/cds = (104, 769) 5492 Table 3AHs.224760 AI224760 5548156 wm49b01.x1 cDNA, 3′ end −1CTTTGGGGACCTAAACCCCAGGTGG /clone = IMAGE:2439241/clone_end = 3′TCTCTTGGTGTTAATAATGCTGGAA 5493 Table 3A NA AI880542 5554591 at80h05.x1Barstead colon HPLRB7 −1 AAATCGCGGTCGCCTTAATCCAAGCC cDNA cloneIMAGE:2378381 3′ similar TAGGTTTTCACACTTTTAGTAAGC to SW:ATP6_HUMANP00846 ATP SY 5494 Table 3A Hs.220850 AI880607 5554856 ym91d11.r1 cDNA,5′ end −1 TGGGGCACTTTGAAAACTTCACAGGC /clone = IMAGE:166293/clone_end =5′ CCACTGCTGCTTGCTGAAATAAAA 5495 Table 3A Hs.89414 AI884548 5589712chemokine (C-X-C motif), receptor 4 −1 GACATTCATCTGTTTCCACTGAGTCT(fusin) (CXCR4), mRNA GAGTCTTCAAGTTTTCACTCCAGC /cds = (88, 1146) 5496Table 3A Hs.23096 AI884871 5589335 602254146F1 cDNA, 5′ end −1TGGCGAGGATAAATAGAGGCATTGTT /clone = IMAGE:4345626/clone_end = 5′TTTGCTACTTTGCATATCATTGGC 5497 db mining Hs.34650 AI885574 5590738602286784T1 cDNA, 3′ end −1 TGGCTCTCCTCTTTGTAATATACAGG /clone =IMAGE:4375724 clone_end = 3′ GTGAACTCTTTACTGATACACACA 5498 Table 3AHs.121572 AL886313 5591477 EST387650 cDNA −1 CCAGTGTCCTGCATGGGTGCTAGGCTGAATTATTTGTAATTGTGCTTAGG 5499 Table 3A Hs.213385 AI912585 5632440we11d07.x1 cDNA, 3′ end −1 ACCGTCTTTTGTGATTCCCTGGAAAC /clone =IMAGE:2340781/clone_end = 3′ CCTTAATTCAATAGTCCTGACTGA 5500 Table 3AHs.228486 AI917348 5637203 ts83d10.x1 cDNA, 3′ end −1AGCCCTGGGTAGCCAAGTGATTTTCC /clone = IMAGE:2237875/clone_end = 3′CATTCCCAAAGTTAGTAAACCTTT 5501 Table 3A Hs.179391 AI917642 5637497wi52d11.x1 cDNA, 3′ end −1 GCAGGAAAGATGGGGTGGTGGACTG /clone =IMAGE:2393877/clone_end = 3′ TTTTTGCCTACTTTTTGTTTTTGAA 5502 Table 3AHs.337286 AI922889 5858853 wn64g11.x1 cDNA, 3′ end −1CCCCCTGAAACTGGCATTTTGTAAAT /clone = IMAGE:2450276/clone_end = 3′GTGGTTTGACTATTTTTGTATGTT 5503 Table 3A Hs.212553 AI922921 5658885wn81c05.x1 cDNA, 3′ end −1 ACCTGGAGAATTCCCTAAGGCCAAAG /clone =IMAGE:2452232/clone_end = 3′ CAAGGTAACAGGGACTTCAGTTTT 5504 Table 3AHs.58643 AI926251 5662139 602438603F1 cDNA, 5′ end −1GCCTCAGTACAAAGGGGGCTTTGGA /clone = IMAGE:4564968/clone_end = 5′AGTGTTTGTTGGCTGAATAAAGGAA 5505 Table 3A Hs.40328 AI927454 5663418nab63b04.x1 CDNA, 3′ end −1 ACCCATGCCAATTGAAGAACGTGTTA /clone =IMAGE:3272383/clone_end = 3′ AAGATGAGGAGGAGAGATGTACCA 5506 db miningHs.154368 AI934956 5673826 ng40b06.s1 cDNA, 3′ end 1GCACATTCCTTCCTTATATCCTGGAA /clone = IMAGE:937235/clone_end = 3′GCACCCAGATATTCTTCATGTCCC 5507 Table 3A Hs.101370 AI936516 5675386AL583391 cDNA 1 TTAAGTCATCTGCTGAGCAGTGTGCT /clone =CS0DL012YA12-(3-prime) GTGTCAACCTCCTCCTAGGTAACC 5508 Table 3A Hs.180446A1948513 5740623 importin beta subunit mRNA, complete −1CAGGGTATCAGATATTGTGCCTTTTG cds/cds = (337, 2967)GTGCCAGGTTCAAAGTCAAGTGCC 5509 Table 3A Hs.71245 AI954490 5746809zl17f11.r1 cDNA, 5′ end −1 TGGTAATAGTGTTTGACTCCAGGGAA /clone =IMAGE:502221/clone_end = 5′ GAACAGATGGGTGCCAGAGTGAAA 5510 Table 3AHs.118820 AI955314 5747624 Homo sapiens, clone IMAGE:3357862, −1TCAAGTATACCATTTAAAATATTTCAT mRNA, partial cds/cds = (0, 325)CAGGCAGAGCCCTGACCAGGAAA 5511 db mining NA AI961962 5754664 wt40g09.x1NCI_CGAP_Pan1 cDNA −1 CTTTTCCGGTTGCCCGAGGATGCTTG clone IMAGE:2509984 3′similar to GGAAGGAACCCGTCTCCCTTCTTC gb:M87789 IG GAMMA-1 CHAIN C REGION5512 Table 3A Hs341528 AI962127 5754840 wx77f07.x1 cDNA, 3′ end −1TCCCCAAACCCCCTTAAAGGTTTTTA /clone = IMAGE:2549701/clone_end = 3′AATTGTTTCAAATCTGGGCAAGTT 5513 Table 3A Hs.37121 AI968387 5765205phospholipase C, beta 3 −1 GACTCGGAGAGCCAGGAGGAGAACA(phosphatidylinositol-specific) (PLCB3), CGCAGCTCTGAACTGGCTGAGCGAGmRNA/cds = (0, 3704) 5514 db mining Hs.13034 AI969716 5766534 hv63f09.s1CDNA, 3′ end −1 CTGTTGTGAATCATTTGTGTCCTTTTC /clone =IMAGE:3178121/clone_end = 3′ AACTGTCTTTCAGAGGAAAGGTA 5515 Table 3AHs.193247 AI978581 5803611 hypothetical protein DKFZp434A171 −1AAGAAGCAACCACAGCTAATTTTAGA (DKFZp434A171), mRNA ACATGCACTCTGACAGAAAAGACA/cds = (113, 2584) 5516 Table 3A Hs.153 AI984074 5811293 ribosomalprotein L7 (RPL7), mRNA −1 GCTTTTGAGGACCTTTCTGGAGGAAA /cds = (10, 756)GGAAAAGCCTGTTTTGGGGAGTCT 5517 Table 3A Hs.7557 AL042081 5421426FK506-binding protein 5 (FKBP5), −1 AGGCTGCATATGGATTGCCAAGTCAG mRNA/cds= (153, 1526) CATATGAGGAATTAAAGACATTGT 5518 Table 3A Hs.133262 AL0444985432716 DKFZp434I082_s1 cDNA, 3′ end −1 AAGACTAGAGCTACACTAGGCCACTA/clone = DKFZp434I082/clone_end = 3′ TCTTATTACACGACAGCACAACAT 5519 Table3A Hs.39911 AL138429 6855110 mRNA for FLJ00089 protein, partial −1TTAAGAACCCCAAAGATTAAAGGAAA cds/cds = (82, 1111) CAATGTTAAGGGCTTTTGTGAGGA5520 Table 3A Hs.89986 AL515381 12778874 cDNA/clone = CL0BB0172H06-(3-−1 CGGAAGTCGAAATCAAATCTATGCTT prime) TTAATTGAAACCGTGCCTGAAACG 5521 Table3A Hs.9096 AL520535 12784028 hypothetical protein FLJ20473 −1TCTTCACCAGGTTCAAGCTCCGTGGG (FLJ20473), mRNA/cds = (57, 1472)CCACACTGCTGCTGTGCCAAGAAG 5522 Table 3A Hs.13144 AL521097 12784590HSPC160 protein (HSPC160), mRNA −1 GATACACTGTCCAGCCCAGGTCCAG /cds = (53,514) GCCCTAGGTTCTTTACTCTAGCTAC 5523 Table 3A Hs.118142 AL522477 12785970AL522477 cDNA −1 TGGAATTTACTAAATTGTGAAATTAAC /clone =CS0DB008YK14-(3-prime) GTAACCGAAGCAACAACCGGCAA 5524 Table 3A Hs.295112AL528020 12791513 KIAA0616 gene product (KIAA0618), −1GCGGGAGGCTGGGACTTTCCATTAC mRNA/cds = (1041, 4040)AATAGAGACTTCATTCCTGTTGAG 5525 Table 3A Hs.26670 AL540260 12870241AL540260 cDNA −1 ACTCAGGTGGTGCTGGTGTTAGTGAT /clone =CS0DF032YF03-(3-prime) GCTGGAGAAGAGAATATTACTGGT 5526 Table 3A Hs.285013AL543900 12876379 putative HLA class II associated −1CAGGTTGCTTTCGTGTCCCTCTTCTG protein I (PHAP1), mRNAGTTGCTTTAGAAGTGACGTGTAAT /cds = (148, 897) 5527 Table 3A Hs.183232AL581892 12909772 hypothetical protein FLJ22638 −1AAACACAGCCCACCCCATTTCAGACC (FLJ22638), mRNA/cds = (12, 476)GCCTTCCTGAGGAGAAAATGACAG 5528 Table 3A Hs.21812 AL582895 12911771AL562895 cDNA −1 GCTAACTGGATAAAGTTTGTGCAGAC /clone =CS0DC021YO20-(3-prime) ATTCCTGAGTGTACGATATTGACC 5529 Table 3A Hs.21812AL582895 12911771 AL562895 cDNA −1 GCTAACTGGATAAAGTTTGTGCAGAC /clone =CS0DC021YO20-(3-prime) ATTCCTGAGTGTACGATATTGACC 5530 Table 3A Hs.181165AL565738 12917408 eukaryotic translation elongation factor −1AGCTGGCTTCACTGCTCAGGTGATTA 1 alpha 1 (EEF1A1), mRNATCCTGAACCACCAGGCCAAATAAG /cds = (53, 1441) 5531 Table 3A Hs.77393AL567986 12921892 famesyl diphosphate synthase −1AGTCAGGACTGTCTAGGTCAGGGAA (famesyl pyrophosphate synthetase,GCCAAGATGTCTGAAGAGAGAGGAA dimethylallyltransferase,geranyltranstransferase) (FDPS), mRNA/cds = (114, 1373) 5532 Table 3AHs.13256 AL570416 12928702 AL570416 cDNA −1 ATTCAACCAGTAATGGTACCTGAGGA/clone = CS0DI020Y05-(3-prime) ATTGAAATGGGTATTTGTTTCTGT 5533 Table 3AHs.180546 AL571386 12928631 AL571388 cDNA −1 AGTGGAGAGGCCCTGTTAGTTTACTT/clone = CS0DI009YL09-(3-prime) TTCATATTGAGTGATGCATGAGGT 5534 Table 3AHs.21732 AL573787 12933363 AL573787 cDNA −1 GCATTCTATTTAAAAAGGGAGTGGGG/clone = CS0DI055YM17-(3-prime) AGCAAATGAAAATTAAATGTGGGG 5535 Table 3AHs.23294 AL574514 12934790 hypothetical protein FLJ14393 −1TCACCAGGAAAACATGCTTGTGAATT (FLJ14393), mRNA/cds = (60, 1454)GTGCAGTAAAAGGTGGTAATGACT 5536 Table 3A Hs.181392 AL575666 12937052 majorhistocompatibility complex, class −1 CCTTTTCTCTCCCATGACCCTTTAACA I, E(HLA-E), mRNA/cds = (7, 1083) GCATCTGCTTCATTCCCCTCACC 5537 Table 3AHs.85258 AL575755 12937231 CD8 antigen, alpha polypeptide (p32) −1CTGAGAGCCCAAACTGCTGTCCCAAA (CD8A), mRNA/cds = (65, 772)CATGCACTTCCTTGCTTAAGGTAT 5538 Table 3A Hs.169610 AL576149 12938006 mRNAfor transmembrane −1 TGAGTGAACAAAGCTGTGAAACATTC glycoprotein (CD44 gene)TGCGTTTATGCAACTTCCTTGCCT /cds = (178, 2406) 5539 Table 3A Hs.174905AL577970 12941605 mRNA for KIAA0033 gene, partial cds −1CAAGAAGACAAGCATCTGTGGTGCG /cds = (0, 1008) GAGGCAAGCAGGCTAACTAGGAGTT5540 Table 3A Hs.5057 AL578975 12943566 AL578975 cDNA −1TTGGCCCAGTGTGATTGATTGCTTTA /clone = CS0DK012YN01-(3-prime)TCTTTGGTACTTTTACTTGAATGG 5541 Table 3A Hs.279555 AL582047 12949649AL582047 cDNA −1 CATCCAGCACTAATTTTCATGCATTTA /clone =CS0DL003YD01-(3-prime) TGAAAGGATGCCTGAGGACCCTT 5542 Table 3A Hs.198296AL582354 12950255 SWI/SNF related, matrix associated, −1AGCCTGAGGCAAATAAAATTCCAGTA actin dependent regulator of chromatin,ATTTCGAAGAATGGGTGTTGGCAA subfamily a, member 2 (SMARCA2), mRNA/cds =(297, 5015) 5543 Table 3A Hs.101370 AL583391 12952309 AL583391 cDNA −1AGGACCTTGACAAGCCGTTTGAGATG /clone = CS0DL012YA12-(3-prime)GAATGTAGGCCCTGATGTTATGCT 5544 Table 3A Hs.101370 AL583391 12952309AL583391 cDNA −1 AGGACCTTGACAAGCCGTTTGAGATG /clone =CS0DL012YA12-(3-prime) GAATGTAGGCCCTGATGTTATGCT 5545 Table 3A Hs.7187AU158636 11020157 mRNA for KIAA1757 protein, partial −1AGTGGAGTGTTTACACCTTGCTGTAA cds/cds = (347, 4576)CATTTGAACTTTCACAAGAGATGT 5546 Table 3A Hs.86671 AV648638 9869652602079785F2 cDNA, 5′ end −1 ATATCATATTATTTGATGCCATTAGGC /clone =IMAGE:4254068/clone_end = 5′ GGCCTGGATCACCAATTCTAAGT 5547 Table 3AHs.343475 AV648670 9869684 601556208T1 cDNA, 3′ end −1GCCACCAGACAGAAGGACCAGAGTT /clone = IMAGE:3826392/clone_end = 3′TCTGATTATAAACAATGATGCTGGG 5548 Table 3A Hs.2730 AV650434 9871446heterogeneous nuclear −1 TGTTGGTGAGCAATGTGCAGAGGCA ribonucleoprotein L(HNRPL), mRNA GAGCCGCTGAAGTATGGTTCCTGAG /cds = (28, 1704) 5549 Table 3AHs.312582 AV651615 9872629 601439711F1 cDNA, 5′ end −1GGCTGCTGTTGACTGAAATTCCTATC /clone = IMAGE:3924482/clone_end = 5′CTCAAATTACTCTAGACTGAAGCT 5550 Table 3A Hs.5897 AV653169 9874183 cDNAFLJ13388 fis, clone −1 CTTTTTAGTAGGCAAAGGTTCTTCTTC PLACE10011681/cds =UNKNOWN CTCCTCTTTTGGTGCAGGGACGC 5551 Table 3A NA AV664188 9875202AV654188 GLC cDNA clone −1 GCGTGTATGTGGGATGCCATAGGTG GLCDTC01 3′, mRNAsequence TGACTGTAGAGTCATTCTTCCTTCC 5552 Table 3A Hs.38218 AV6593589880372 602569369F1 cDNA, 5′ end −1 TGTAAGTTGACTTTCAAAAGTCTCTG /clone =IMAGE:4693744/clone_end = 5′ GAAACACTGGACTTTAGCTGGTCC 5553 Table 3AHs.133333 AV661783 9882797 AV661783 cDNA, 3′ end −1GAAGCGTGGCAGAGAACTATGGATC /clone = GLCGXE12/clone_end = 3′AGGCAGCCCCTCTCATCTTTACCAT 5554 Table 3A Hs.85844 AV700210 10302181neurotropic tyrosine kinase, receptor, −1 TTGGTCCAAACTCTGGAGCCTTGTGGtype 1 (NTRK1), mRNA/cds = (0, 2390) GAGAACATAGGGCATAACGTGTTT 5555 Table3A Hs.285173 AV700298 10302269 602632207F1 cDNA, 5′ end −1CCCTTCTTAGTAAAGAGACATCTTCT /clone = IMAGE:4777537/clone_end = 5′ACAGTAACCACAGAGAAGAAGTGG 5556 Table 3A Hs.238730 AV700542 10302513hypothetical protein MGC10823 −1 TGGACATAACCTGGGTCAGAAGAGAA (MGC10823),mRNA/cds = (63, 1235) ACTTTTGAAGCTACACGAACAAGC 5557 Table 3A Hs.284674AV700636 10302607 AV700636 cDNA, 3′ end −1 CGGCTCAAATAAACCTTTACCGGATT/clone = GKBAGH12/clone_end = 3′ TTTGGGGTTATGCCCACACCCTTG 5558 Table 3AHs.240077 AW002624 5849540 wu60d10.x1 cDNA, 3′ end −1GGACCACTAGTACTCCAGAACCATAA /clone = IMAGE:2524435/clone_end = 3′TATAACTAGACATGCCTGGAATGC 5559 Table 3A Hs.301704 AW002985 5849991eomesodermin (Xenopus laevis) −1 AACAAGCCATGTTTGCCCTAGTCCAG homolog(EOMES), mRNA GATTGCCTCACTTGAGACTTGCTA /cds = (0, 206O) 5660 Table 3A NAAW004905 5853768 wz82d03.x1 NCI_CGAP_Gas4 cDNA −1TCTACTGACTATCCTAGAAATCGCTG clone IMAGE:2565317 3′ similar toTCGCCTTAATCCAAGCCTACGTTT SW:ATP6_HUMAN P00848 ATP SYNTHASE A 5561 Table3A Hs.173280 AW005378 5854154 ws94a12.x1 cDNA, 3′ end −1GAGAAACTTCCGTGCATGAAGGTTTC /clone = IMAGE:2505598/clone_end = 3′CTCCTTGACTCGGCAGCAGCGGCC 5562 Table 3A Hs.233560 AW006045 5854823wz81b09.x1 cDNA, 3′ end −1 CCAAGTAGGTTTTAACTCTGGTATGG /clone =IMAGE:2565209/clone_end = 3′ TCTCGTGTTTTCATTTGTTGTGCA 5563 Table 3AHs.159643 AW006352 5855130 wt04d12.x1 cDNA, 3′ end −1GTTCCCACGGAGCTGACTTCTCCGG /clone = IMAGE:2506487/clone_end = 3′GGTGCCTGTGCCCTACATTAAACCC 5564 Table 3A Hs.231987 AW006867 5855845602320903F1 cDNA, 5′ end −1 CCGTAACTCCGACAACGCAGAACTT /clone =IMAGE:4424065/clone_end = 5′ CTTGAGGCTTTCTTCTTCTAAGGA 5565 db miningHs.157118 AW009081 5857859 ws76g10.x1 cDNA, 3′ end −1TCTGGACCCTGCTTGGGTTCACAGCA /clone = IMAGE:2503938/clone_end = 3′TTGGTGGAGGTAAGTAGTATTCTC 5566 Table 3A Hs.134272 AW009671 5858449ws85g09.x1 CDNA, 3′ end −1 GAAGAGGAAGCTCATCCGAAGTCTTC /clone =IMAGE:2504800/clone_end = 3′ CGACAGAGTGAGCCGTCATGCCCG 5567 db miningHs.131887 AW009730 5858508 602415255F1 cDNA, 5′ end −1AGTGTGTATTCTTGATGTTTATTGGCT /clone = IMAGE:4523725/clone_end = 5′CATGTGGACAGAAATGTACAGGG 5568 Table 3A Hs.232000 AW016002 5864759UI-H-B10p-abh-h-06-0-UI.s1 cDNA, 3′ −1 AGATGAGGCTGCTCTGAAGATTCAGTend/clone = IMAGE:2712035 AATTAGGATGGACAGTCAGCTACT /clone_end = 3′ 5569Table 3A Hs.233261 AW026667 5880120 wv15d09.x1 cDNA, 3′ end −1TGGGCTTTGGGGTTCAGTTTGTTACC /clone = IMAGE:2529617/clone_end = 3′TTTGGAGACTTATTTAATGAAACC 5570 Table 3A Hs.101340 AW026713 5880166EST380762 dnNA −1 CAGTGGTTCCTGAGAGAATCTTAGTT CAAAGGACTGCCCCCGCCAACCCC5571 Table 3A NA AW027160 5885916 wt72b08.x1 Soares_thymus_NHFTh −1ACCGCCAAAGCCAATCATCCACTTTC cDNA clone IMAGE:2512983 3′ similarAGTACTTACCTAACCAATCTCCCA to contains Alu repetitive eleme 5572 Table 3AHs.233564 AW027530 5888286 wv74c06.x1 cDNA, 3′ end −1CAGGATGTTATTGACAGGGTGGCCTT /clone = IMAGE:2535274/clone_end = 3′TGTGATTCCTCCGGTGGTGGCAGC 5573 Table 3A Hs.311783 AW043857 5904386wy61g04.x1 cDNA, 3′ end −1 GCCATTTCATTTGCTGTGTGGTTAGA /clone =IMAGE:2554998/clone_end = 3′ CTTCCAGGAGGCTGTTTAGCTCTA 5574 Table 3AHs.277672 AW050975 5913245 wz25f04.x1 cDNA, 3′ end −1CCTTTGTGAAAAGTCACCTGTGACTG /clone = IMAGE:2559103/clone_end = 3′TCAGGGGTATGCTATGGGCCTTTT 5575 db mining Hs.279068 AW063114 8887051TN0103 cDNA, 3′ end/clone_end = 3′ −1 GATCCACTTTGGGGTTCGGCGGCAGATTATTCCGCTGGTAGAGCCGGATG 5576 db mining Hs.279082 AW063120 8887169TN0257 cDNA, 3′ end/clone_end = 3′ −1 AATAAGGGACTCATTCATTATGCAGCAAATGTTCTTTGTTATTGGCTTGC 5577 db mining Hs.279083 AW063153 8887202TN0788 cDNA, 3′ end/clone_end = 3′ −1 CTTCATGGTCTCCAGCCAGGACTCCATCAGCGCCACGGCTTCATCCGAAC 5578 db mining Hs.279127 AW063155 8887204DP1003 cDNA, 3′ end/clone_end = 3′ −1 TTGATGCTCATCATCTGCTCGAGGTGATTGATGCCAGGTTGACGCACCAT 5579 db mining Hs.279104 AW063156 8887205TN0974 cDNA, 3′ end/clone_end = 3′ −1 TCCTTTGGATAAGGTCCAAAACCTGTAACACATGACCCTCAGAGCCCTTT 5580 db mining Hs.279085 AW063158 8887207TN0311 cDNA, 3′ end/clone_end = 3′ −1 CCCGGCGACTTCACCACCCGCTATCTGGGCACCAAAGACTATATCTAGAT 5581 db mining Hs.279086 AW063159 8887208TN0312 cDNA, 3′ end/clone_end = 3′ −1 CGCAATAGTCCTCGACAAGTCGCCAACCCTCCCACTTCGGTGGATCAGCT 5582 db mining Hs.279092 AW063191 8887240TN0359 cDNA, 3′ end/clone_end = 3′ −1 CGTCGGGTACCTCGCCGATAAAATCGCTGATGGCCTGGTCGATCCTGAAG 5583 db mining Hs.279093 AW063196 8887245TN0380 cDNA, 3′ end/clone_end = 3′ −1 ATCTTATCCCTCTGTTACTCAATGTGAGTGCATACTTTACATTGCCTACT 5584 db mining Hs.279102 AW063210 8887259 TN0377cDNA, 3′ end/clone_end = 3′ −1 GGTCCTTGAAGATGACGCGGATGATCGAGGTCTCTGCGCCGTAGGCGATG 5585 db mining Hs279067 AW063230 8887055TN0107 cDNA, 3′ end/clone_end = 3′ −1 ATGATGAAGCTGCTGTCCAACGCCTTCGTCTGCCAGTTTCTGCTGGTGTG 5586 db mining Hs.279069 AW063239 8887064TN0018 cDNA, 3′ end/clone_end = 3′ −1 TCCTTGCCAGAGCCTTCGGGTTCTACGATTTGATCGACGACGCTGGTGTC 5587 db mining Hs.279070 AW063242 8887067TN0138 cDNA, 3′ end/clone_end = 3′ −1 TCGAACATGGGCAGCTCCGTTTCAAGATGGCTCAAGACTAGCGGATTGGG 5588 db mining Hs.279071 AW663246 8887071TN0358 cDNA, 3′ end/clone_end = 3′ −1 AGTGATAGAGACCAAAGACTGCTTTTTAATTTTGTGGGGGAGGGGGTGGA 5589 db mining Hs.279072 AW063252 8887077TN0149 cDNA, 3′ end/clone_end = 3′ −1 CGGGTCACTCATGTTGGCTACTAACCCTTTTCGTGCGCCGGGCATTCTAG 5590 db mining Hs.279087 AW063267 8887092TN0331 cDNA, 3′ end/clone_end = 3′ −1 CTTGTCCTTGATCGCTTCCTTCTCTGCAAGGGAGAGCTTCTGGACCTTCA 5591 db mining Hs.279073 AW063271 8887096TN0158 cDNA, 3′ end/clone_end = 3′ −1 CTTGTTTGACATCAGCGCCATCTCGACAGCGTATTCCGCTATGACTGTTT 5592 db mining Hs.279074 AW063274 8887099TN0792 cDNA, 3′ end/clone_end = 3′ −1 CACGAAGCCTTCGATCAGTTGCAGCACGCGGCCAGAGCGGTCGATAGAAC 5593 db mining Hs.279122 AW063299 8887124TN0185 cDNA, 3′ end/clone_end = 3′ −1 CATTTTGCCATCTGCGAGCATCTGGGTATTGACATGATCCCCAGTGGAGC 5594 db mining Hs.279076 AW063319 8887144TN0230 cDNA, 3′ end/clone_end = 3′ −1 CACCAAGCTGGTCAACATCCAGGCGAATGGCTATTACGTGGATGAGATCA 5595 db mining Hs.279078 AW063325 8887150TN0238 cDNA, 3′ end/clone_end = 3′ −1 TTGCTGATACGGCCTTTGATCATGTTTTCAACGATGTTTTCCGGCTTGCC 5596 db mining Hs.279079 AW063327 8887152TN0238 cDNA, 3′ end/clone_end = 3′ −1 CCTCGACAAACTAAATGTTGATTTGAATTGGCCTGTTATCATCTTGATCAC 5597 db mining Hs.302423 AW063352 8887269TN0725 cDNA, 3′ end/clone_end = 3′ −1 GTTTCAGATCGGGCCGCTCCCGCCGGGTACCTATAGCGGAATCGAATTTC 5598 db mining Hs.279095 AW063358 8887295TN0979 cDNA, 3′ end/clone_end = 3′ −1 GAAAACAGAAATGATGCTCGGCACATTCTCGTCCAGCACCTCGGCAACGG 5599 db mining Hs.279096 AW063371 8887308TN0746 cDNA, 3′ end/clone_end = 3′ −1 AACTGTATTCGATCACCGTGGCGCTGATGGTGTCAGCAGTCGCCTTGTTC 5600 db mining Hs.279097 AW063372 8887309TN1085 cDNA, 3′ end/clone_end = 3′ −1 AGTTGACATATAACCCACTTTACATACATTCCAAAATTGCGAGTAGTGAGT 5601 db mining Hs.279075 AW063428 8887365TN0121 cDNA, 3′ end/clone_end = 3′ −1 ATATCGTACCGAGAAACTAGTGCGGATATCTGACCAGGTATGGCGGTTGG 5602 db mining Hs.279099 AW063436 8887373TN0922 cDNA, 3′ end/clone_end = 3′ −1 GTGGATGACCTGATCCAGGTCGGCCTGATCGGCCTGACTGATGAGCTGTC 5603 db mining Hs.279100 AW063458 8887395TN0949 cDNA, 3′ end/clone_end = 3′ −1 ATGATGACCAGATGCTCTGGCACCGTGTCGAGTTCGAGGATGCCGACATT 5604 db mining Hs.279103 AW063469 8887406TN0961 cDNA, 3′ end/clone_end = 3′ −1 GATCTGGGACGCATGGCCGAAGCTGAAAAGCTGGCTGTAGAAGACCTCGA 5605 db mining Hs.279101 AW063474 8887411TN0354 cDNA, 3′ end/clone_end = 3′ −1 AACATGGCAATATTTATTGGTCCTAATACTGTCACTGGCAAGGTTGGTGT 5606 db mining Hs.279821 AW063497 8887434 TN0113cDNA, 3′ end/clone_end = 3′ −1 GAGGCAGAGGTGTAGCGAGTCCAGGCTCTCTTCGAACGTTGCACCCGACG 5607 db mining Hs.279105 AW063509 8887446TN1012 cDNA, 3′ end/clone_end = 3′ −1 GTCCCACACGTTCGGCCCTGACTCTGCTGTGTTCGACGAGGACAATCTCG 5608 db mining Hs.279089 AW063534 8887471TN1054 cDNA, 3′ end/clone_end = 3′ −1 CATGACGTTGTGCTCGACACCCCAACAGATCACGTAATCAGCCTGGTGGA 5609 db mining Hs.279080 AW083546 8887483TN0243 cDNA, 3′ end/clone_end = 3′ −1 TAGGCTATAGAGATGTGAGGGATTATTATTAGTCACACCTCTAGTCATGCC 5610 db mining Hs.279108 AW063552 8887489TN1055 cDNA, 3′ end/clone_end = 3′ −1 GGCTGCCGGATGTGTAGGTCTTCCCATGTTGTGAAGTAACGGTGCTCCAC 5611 db mining Hs.279109 AW063556 8887493TN1059 cDNA, 3′ end/clone_end = 3′ −1 TGCCCTGTATAGTGTTGTAAAAATTAGAATGTTTCACCCAAACCATCTGG 5612 db mining Hs.279110 AW063561 8887498TN1066 cDNA, 3′ end/clone_end = 3′ −1 GTCTTTCGAATCGCTCTTTAGCTCGTGCGGGCTGTTGTCCCACTTGTTGG 5613 db mining Hs.279090 AW063572 8887509TN1079 cDNA, 3′ end/clone_end = 3′ −1 CTATGCGCTGCGCTACAAGCTGGACCTGTATTCGGACTTCAGCTACTACC 5614 db mining Hs.279111 AW063598 8887535DP0133 cDNA, 3′ end/clone_end = 3′ −1 TTCGAAGCGACGCTGCGTGCGCTGCTCGTCCAATTGCAGCATGGATAAGG 5615 db mining Hs.302424 AW063600 8887537DP0925 cDNA, 3′ end/clone_end = 3′ −1 CCTTCCGCTGTCCCTTCAGTAGCTGTTTCTGTTCCCTGACGCCCACTTCT 5616 db mining Hs.279124 AW063609 8887546DP0922 cDNA, 3′ end/clone_end = 3′ −1 CAATGCAGCGGCTGATGCAGATCACCCACGAGATGCAGGACGAAGGCGAG 5617 db mining Hs.279113 AW063830 8887567DP0154 cDNA, 3′ end/clone_end = 3′ −1 TCATTCAGTCTGAGTAGGAGGAAAGAGGACAGGTTGTTGGAGAGTTGGTT 5618 db mining Hs.279114 AW063635 8887572DP0774 cDNA, 3′ end/clone_end = 3′ −1 TAATTGCCGCTGAAGCAGAATCCTCGAAATGCGTCACCTTCGGATTGAC 5619 db mining Hs.279125 AW063652 8887589DP0189 cDNA, 3′ end/clone_end = 3′ −1 AAATGTGGTGACAAAGTACCAGCAAGAACTGGACTGTGTTTCTGGAGCCT 5620 db mining Hs.279116 AW063878 8887615DP0229 cDNA, 3′ end/clone_end = 3′ −1 GTTCATCGTCTCGCGTCGCAAGAAGTAAGGGCTAGGCCATGACTCGTTCG 5621 db mining Hs.279117 AW063709 8887648DP0338 cDNA, 3′ end/clone_end = 3′ −1 CTCTTGGCAGCCCTGCTCTCGTGGGTCAGCATCGTCGCGTGCTCCGGTGG 5622 db mining Hs.279118 AW063718 8887655DP0314 cDNA, 3′ end/clone_end = 3′ −1 GTGCTCGCTGAGCTGGTCCAGAAATCCGTCGACTGAGGCGATGGCGGCTG 5623 db mining Hs.279119 AW063746 8887683DP0347 cDNA, 3′ end/clone_end = 3′ −1 CATGAACAAGGGCCGGATCATCCTGATGCCCAACACACTGGACTTCGGTG 5624 db mining Hs.279123 AW063778 8887715DP0954 cDNA, 3′ end/clone_end = 3′ −1 CACCCGTTGTAGGCGACGAGCGTGAACGAAAACGTGTCGGACGGCTTGTA 5625 db mining Hs.279121 AW063780 8887717DP0388 cDNA, 3′ end/clone_end = 3′ −1 CATATGCGGCTGTGCCATAGCCGGATGTTCTTCGTGCGTGCCTACCCCCG 5626 db mining Hs.279123 AW063833 8887770DP0758 cDNA, 3′ end/clone_end = 3′ −1 TTCTTTCCGTCGCGCATCGGAATGCGAAACTCGTACTTCGTGTAGAACTC 5627 db mining Hs.279138 AW063909 8887846SP0953 cDNA, 3′ end/clone_end = 3′ −1 GCCAGGGGCTTTATCACTTCCATGGCCGCAGCGATGACCAGGTCAAGCTG 5628 db mining Hs.279126 AW063951 8887888DP0988 cDNA, 3′ end/clone_end = 3′ −1 CGCCGACCAAGCTTACCGACTTCTCGCCGATCTACTGCGACGAAGAAGGC 5629 db mining Hs.279174 AW063977 8887914DP1019 cDNA, 3′ end/clone_end = 3′ −1 GGTAGTGACGTGCTGAATGACGGTGCCGTCCATCATCGGGTCGGAGTAAG 5630 db mining Hs.279128 AW064020 8887957DP1073 cDNA, 3′ end/clone_end = 3′ −1 TTCAGGACTCGTTTCACGTAGGCAACGCTGTCTAAGTTCCCAAGGGATT 5631 db mining Hs.279130 AW064046 8887983 SP0153cDNA, 3′ end/clone_end = 3′ −1 CTCTTTACCCGGAAACAGGTTGGGGAGATGACACGCAGAAAATCATACGC 5632 db mining Hs.279084 AW064052 8887989SP0159 cDNA, 3′ end/clone_end = 3′ −1 CTTTGGATATATCGAGAAAGGCCAGGGCCTGAACAAGGAAAGCTTCCAGG 5633 db mining Hs.279825 AW064053 8887990SP0992 cDNA, 3′ end/clone_end = 3′ −1 AAGGCTGGTCAAGAATCTTGAGACGGAATTGCACAGTCTCGGCGTGATCC 5634 db mining Hs.279131 AW064060 8887997SP0636 cDNA, 3′ end/clone_end = 3′ −1 GATCGATTCGGGGGTGACATCGGCGCTGAGCACCATCACCGGAACATAAG 5635 db mining Hs.279135 AW064084 8888021SP0612 cDNA, 3′ end/clone_end = 3′ −1 CTGAGATCACCCTGAACACCGACAAGGACGAGATCGCAGTCTGCAACCTG 5636 db mining Hs.279136 AW064098 8888035SP0575 cDNA, 3′ end/clone_end = 3′ −1 CTGAAGGCTTTGGCGACAACCAGGTCTATCCGTTTGAATTGGCGAGAAC 5637 db mining Hs.302426 AW064100 8888037SP0684 cDNA, 3′ end/clone_end = 3′ −1 TCTTGTGCCAGCACGTCTTGCTGATAGCCGATGAATCGCGTCCCTTTGTC 5638 db mining Hs.279175 AW064121 8888058SP0554 cDNA, 3′ end/clone_end = 3′ −1 GAACTCCTCAAGGAAATAGTCCACCGCCTGCTGCTTGGACGCTGCCAGTT 5639 db mining Hs.279139 AW064129 8888068SP0696 cDNA, 3′ end/clone_end = 3′ −1 GTGACCTCGGGGTCCCCCTTGGTGAGGGTGCCGGTCTTGTCGAAGACGAC 5640 db mining Hs.279140 AW064138 8888073SP0570 cDNA, 3′ end/clone_end = 3′ −1 GTGTTCGGGCTTCATGTCGCCAACACCATCGGCACTGGCATCATCGATCC 5641 db mining Hs.279106 AW064157 8888094TN1014 cDNA, 3′ end/clone_end = 3′ −1 AGGTTGATTTCCACTTCCTCGGGAGGTTTCGCCACCTCTTCGCCTTTGAG 5642 db mining Hs.279141 AW064160 8888097SP0594 cDNA, 3′ end/clone_end = 3′ −1 GTTAGCTTCCACGCTTTATCTCCTGCTCTGAGTGTGTACCCGCGCTGCTC 5643 db mining Hs.279142 AW064161 8888098SP0595 cDNA, 3′ end/clone_end = 3′ −1 TTAAAGTGGTAAGGGAGGTTTCTACTCCTGGGGAAACATTAAGTACCTT 5644 db mining Hs.279143 AW064166 8888103 SP0605cDNA, 3′ end/clone_end = 3′ −1 CTTTCTCCGACTTCGAGATCTGCCCGTGGTCGAGATCGTGGTAGATGATG 5645 db mining Hs.279144 AW064175 8888112SP0615 cDNA, 3′ end/clone_end = 3′ −1 AACTGGATAGAGCACGAGCCTTCTAAGCTTGGAGTTGCAGGTTCGAATCC 5646 db mining Hs.279824 AW064185 8888122SP0630 cDNA, 3′ end/clone_end = 3′ −1 GAAGATCGGCGCAACGAAGACCGCTTCCACTTCATCAACTGGACCAAGAA 5647 Table 3A NA AW064187 8888124 (One singleEST, artifact ?) SP0632 −1 TGCTTCTGTGACAGATTAGCTTACAT KRIBB Human CD4intrathymic T-cell CTTACCACCTCACCGAGAAGAGCT cDNA library cDNA 3′, mRNAsequence 5648 db mining Hs.279146 AW064189 8888128 SP0634 cDNA, 3′end/clone_end = 3′ −1 AGCTCAAGAGCTTCCGCGACGTACCCAGCAAAGTAACGCTCGACGAATGC 5649 db mining Hs.279145 AW064194 8888131SP0633 cDNA, 3′ end/clone_end = 3′ −1 ATCGAAGACGTGATGCTGAACCTTTGGGCGAAGGCCGAGAAGGAAGGCAA 5650 db mining Hs.279147 AW064201 8888138SP0650 cDNA, 3′ end/clone_end = 3′ −1 CGATACCCTCACTAGACCTCGGATCGAATAAATCAGAGCGATCACATCG 5651 db mining Hs.279132 AW064208 8888145 SP0658cDNA, 3′ end/clone_end = 3′ −1 GGGGATACACACCCCACAAGCCTTCCTGCGGCTTCATCACGGTTACCACC 5652 db mining Hs.279148 AW064218 8888155SP0732 cDNA, 3′ end/clone_end = 3′ −1 GATCTTGGTGAGAAGCTCGGTCATGTAGAAGACCTCGCCCTGGGACACTA 5653 db mining Hs.279826 AW064223 8888160SP0676 cDNA, 3′ end/clone_end = 3′ −1 ATTTTATCGCCAGCTACGTCGGCATTGGTCAGGACGACCTGAAGGGGAAT 5654 db mining Hs.279149 AW064250 8888187SP1013 cDNA, 3′ end/clone_end = 3′ −1 TGATGCGGAGAGCGAGGTAGATCCCGGCGGAGTTTTCGTCGATGGGAAAG 5655 db mining Hs.279150 AW064255 8888192SP0105 cDNA, 3′ end/clone_end = 3′ −1 GTACACTTCCTGGATCTGATCCACGAGGTAACGAGCGAGAGTGGTGATAC 5656 db mining Hs.279134 AW064258 8888195SP0717 cDNA, 3′ end/clone_end = 3′ −1 GTGACTTCATGCTCGGGGTTGAGCTTGGCGTCCACCACCTTTTCCCACTC 5657 db mining Hs.279151 AW064272 8888209SP0130 cDNA, 3′ end/clone_end = 3′ −1 CCGGTGTCCTTGATCAGCTTCAGCAGTGGCTTGACGTAGATGCGGGTCGG 5658 db mining Hs.302427 AW064275 8888212SP1065 cDNA, 3′ end/clone_end = 3′ −1 CATCAGTGTTTCTCCTGCTGGGACTGTTGCATGTGGTGCATCACGGTTTG 5659 db mining Hs.279153 AW064284 8888221SP0755 cDNA, 3′ end/clone_end = 3′ −1 GCGAGGCGAAACATAGCTTCCATTGTGTCTTTTCTCCTTATGCGTCTTGC 5660 db mining Hs.279156 AW064319 8888256SP1055 cDNA, 3′ end/clone_end = 3′ −1 AATGAGACCCGCCGTCCCTGGAGATGAAGATGTCGTCCGACTCCGTCCAC 5661 db mining Hs.279157 AW064320 8888257SP0145 cDNA, 3′ end/clone_end = 3′ −1 CGGATGTTGTCGTTCCAGAACGAAGGATCGGCCTCTTGGGCCTGGATTTC 5662 db mining Hs.279164 AW064343 8888280SP0916 cDNA, 3′ end/clone_end = 3′ −1 GGCACCGACTTGGGCCTGAGAGAGGCGCAGGTCATCAATATAGAATCGGG 5663 db mining Hs.279159 AW064348 8888285SP1044 cDNA, 3′ end/clone_end = 3′ −1 CCATGCTGAACTTGGCCAGGTCCTTGACGGCGGTGTTTTCCGACAGCACC 5664 db mining Hs.279161 AW064375 8888312SP0115 cDNA, 3′ end/clone_end = 3′ −1 CGCGATGATCTCGTCCTTCGGCATGGCGATGCGCTATTCCTTCGACATGG 5665 db nining Hs.279182 AW064377 8888314SP1066 cDNA, 3′ end/clone_end = 3′ −1 GCCCATTGACCGTATCGCGTCATCTTGCTGGCATTTCTAAGAAAATACCG 5666 db mining Hs.279163 AW064378 8888315SP0966 cDNA, 3′ end/clone_end = 3′ −1 TGAACAGGGAAAAGCCAGGAAGATCTCCGGTTCCACGTCCAATTTGTAC 5667 db mining Hs.279168 AW064424 8888361SP1056 cDNA, 3′ end/clone_end = 3′ −1 CAAGAATGACGGAAAAATCCGTGAGCACAAGGCAAAGGCTTGCCGTGTGG 5668 db mining Hs.279165 AW064433 8888370SP1030 cDNA, 3′ end/clone_end = 3′ −1 GACTTGATCACAACCCGATCCGTAACGACGTATTGGAGCCACTCGAACAA 5669 db mining Hs.279166 AW064445 8888382SP1042 cDNA, 3′ end/clone_end = 3′ −1 CTTCTCGCCGTAACTTTTCCGCCGAGCACGCTACGCACGTAGGTGTTGTG 5670 db mining Hs.279823 AW064450 8888387SP1048 cDNA, 3′ end/clone_end = 3′ −1 TCGACTACGACTTCAACTTCCCCAAACGGTGGGAGAAGCGAGCTTGAGGC 5671 db mining Hs.279167 AW064452 8888389SP1069 cDNA, 3′ end/clone_end = 3′ −1 AAGTTGATCAGATCACGGGCCACGCCTGCAACCAGAGGCTTGTCATCGTC 5672 db mining Hs.279169 AW064468 8888405SP1067 cDNA, 3′ end/clone_end = 3′ −1 TGATCTGATTGTGAGGAGAGTGGAGAAGGTGGTATAGAAGCTGAAAGGGT 5673 db mining Hs.279155 AW064473 8888410SP1072 cDNA, 3′ end/clone_end = 3′ −1 CTTCATGCTCGAGAAGAAAATGCTCCGTGCCTCCGACGACGCCACCATCG 5674 db mining Hs.279170 AW064478 8888415SP1080 cDNA, 3′ end/clone_end = 3′ −1 CAGATGGTCACGAGACGCTTGTCCGTGATGTCTTCCGTCAGCGTGCAGAG 5675 db mining Hs.279171 AW064479 8888416SP0147 cDNA, 3′ end/clone_end = 3′ −1 TGATGGATTTGGAAAGTGTTATTCTGTTTGACTTCTCCCTGCTCTGCTCA 5676 db mining Hs.279158 AW064487 8888424SP1087 cDNA, 3′ end/clone_end = 3′ −1 TTGAACGGGTATAGCCACCAAGGCATTGGCTGCAAAGTCGGGCAAAACTT 5677 db mining Hs.330544 AW064490 8888427SP1090 cDNA, 3′ end/clone_end = 3′ −1 ACTGTGTATTGATGAGTATCTGATGCCTATAACATCTGTAGGAGGCTACA 5678 db mining Hs.279160 AW067725 8888472SP0110 cDNA, 3′ end/clone_end = 3′ −1 GTACGAAGGTGGCGATGATGCGTTCGATCACCTCGGGGATTTCCTCGGCG 5679 db mining Hs.279129 AW067742 8888489SP0150 cDNA, 3′ end/clone_end = 3′ −1 CGACCTTCGGCGTTTCCGCTTCGGAACCCGTGAAGGCGTTCTTCACTTTG 5680 db mining Hs.279133 AW067752 8888499SP0141 cDNA, 3′ end/clone_end = 3′ −1 ATTCGCTGGCAACATAATTACCAGACTCACATCGAACGAAGCTCGGTTCC 5681 db mining Hs.279154 AW067760 8888507SP0122 cDNA, 3′ end/clone_end = 3′ −1 TGTTCGTTGCCATCCTTGTCGAGGAACATCTCGCTTTCCAGTTCCCCCTG 5682 Table 3A Hs.89433 AW071894 8026892ATP-binding cassette, sub-family C −1 TTTGGGGGATCCTTTTGTAATGACTT(CFTR/MRP), member 1 (ABCC1), ACACTGGAAATGCGAACATTTGCA transcriptvariant 1, mRNA /cds = (196, 4791) 5683 Table 3A Hs.299581 AW0737076028705 xb01h03.x1 cDNA, 3′ end −1 GGACAAGGGGCACCCGGATTATATTT /clone =IMAGE:2575061/clone_end = 3′ CCCACCAATCCTAATCCTAAACCC 5684 db miningHs.243286 AW075809 6030807 xa85g05.x1 cDNA, 3′ end −1TGGAGCTTATTTTGGAGAACTGTCAC /clone = IMAGE:2573624/clone_end = 3′CATTTTATCCCAGTTGGCAATTTT 5685 db mining Hs.277714 AW075814 6030812xa85h03.x1 cDNA, 3′ end −1 ATTATGGGTAAGGCTTGGGCTTGTTC /clone =IMAGE:2573821/clone_end = 3′ CCACATGTTAACCAAATGGCCTCA 5686 db miningHs.244048 AW075894 6030892 xa81c04.x1 cDNA, 3′ end −1GGGAGGGCCAAAGAAATCTTTTTCCC /clone = IMAGE:2573190/clone_end = 3′GTTTCAATTATGTTCCCCAAAAA 5687 db mining Hs.329433 AW075905 6030903xa81d05.x1 cDNA, 3′ end −1 TTACCCCAAATGCTTTTGCCCCGGTGG /clone =IMAGE:2573193/clone_end = 3′ CCCAGTTTGTAAATTGGTTTGATT 5688 db miningHs.329434 AW075921 6030919 xa81f04.x1 cDNA, 3′ end −1CCCCCCTTGGCAGGTTAATTGGTGTT /clone = IMAGE:2573215/clone_end = 3′TAAGGAACCCTCCAGGGTGGGGGG 5689 db mining NA AW075929 6030927 xa81g05.x1NCI_CGAP_CML1 cDNA −1 CCCCCCAGTTTTAATGTTAGGGGGAA clone IMAGE:2673240 3′,mRNA GGGATTTAACCCCTTATTTAAAAAA sequence 5690 db mining Hs.265834AW075948 6030946 xa82b03.x1 cDNA, 3′ end −1 CTATCACCCTTGATATGAAATTCCAG/clone = IMAGE:2573281/clone_end = 3′ AATTTTCTGTGATACCACATGGCC 5691 dbmining Hs.277716 AW075986 6030984 xa82f05.x1 cDNA, 3′ end −1ACTCCGGGCCTTAATGGATTTGGCCT /clone = IMAGE:2573313/clone_end = 3′GTCCTCAAGAATGGTAATTATGAA 5692 db mining Hs.241982 AW076004 6031002xa82h04.x1 cDNA, 3′ end −1 ACGTGGTTTCAGTCCTTAGCACCGTG /clone =IMAGE:2573335/clone_end = 3′ GTATTGACATGACATCAGTTGCAA 5893 db miningHs.257711 AW076027 6031025 he31c12.x1 cDNA, 3′ end −1CACAACTTGCTGTTCACGTCTTTGGG /clone = IMAGE:2920630/clone_end = 3′GTGTTTTCCATTCCTAATAGATGG 5694 db mining Hs.277717 AW076038 6031036xa83d08.x1 cDNA, 3′ end −1 AACCCGTCCTCCATTATAATTACCTT /clone =IMAGE:2573391/clone_end = 3′ TCAAAGGGCAAGTCAAAAGTTGT 5695 db miningHs.241983 AW076068 6031068 xa84e02.x1 cDNA, 3′ end −1AAACAGCACAACATGAGTGTTTCCTA /clone = IMAGE:2573450/clone_end = 3′CCACATCAATTTTAATGAAGACAC 5696 db mining Hs.277718 AW076075 6031073xa84a10.x1 cDNA, 3′ end −1 CGGAATCGGGTTTCCATTGGACCCCA /clone =IMAGE:2573466/clone_end = 3′ AAAATTTCCCTTTGGGCTTCATGA 5697 db miningHs.242605 AW076083 6031081 xa84b10.x1 cDNA, 3′ end −1TGAGGATAGAAGCAGCCTTTTATATT /clone = IMAGE:2573467/clone_end = 3′TTTGTGTGGTAAAGCAAATTGGCA 5698 db mining Hs.329436 AW076127 6031125xa84g01.x1 cDNA, 3′ end −1 GGGGCAAATTTCAAGGGACCTCCCC /clone =IMAGE:2573520/clone_end = 3′ AAAGGGGGTGTTTTCCCTGGATGGG 5699 Table 3AHs.244816 AW078847 6033999 xb18g07.x1 cDNA, 3′ end −1AAACAGGAAGGGGGTTTGGGCCCTT /clone = IMAGE:2576700/clone_end = 3′TGATCAACTGGAACCTTTGGATCAAG 5700 Table 3A Hs.245616 AW080951 6036103xc28c10.x1 cDNA, 3′ end −1 ACTCTTTGTCTTTTTAAGACCCCTAAT /clone =IMAGE:2585588/clone_end = 3′ AGCCCTTTGTAACTTGATGGCTT 5701 Table 3AHs.176498 AW081098 6036250 xc29a12.x1 cDNA, 3′ end −1CCGGCTGCCTCCATCCCAGAAGAGT /clone = IMAGE:2585662/clone_end = 3′GCGCAGAGAATTAAATCTAGATATT 5702 Table 3A NA AW081232 6036384 xc22e08.x1NCI_CGAP_Co19 cDNA −1 GGGATGTAATACATATTTTTCCAAATA clone IMAGE:2585030 3′similar to AAATGCCTCATGGGCTTTGGGGC SW:RSIA_HUMAN P39027 40S RIBOSOMAL5703 Table 3A Hs.295945 AW081320 6036472 xc30f12.x1 cDNA, 3′ end −1AGAACCCGTATTCATAAAATTTAGAC /clone = IMAGE:2585807/clone_end = 3′CAAAAAGGAAGGAATCGAACCCCC 5704 Table 3A Hs.120219 AW081455 6036607xc31c07.x1 cDNA, 3′ end −1 AGTTAGTATACAGCCAGAACAGCCAA /clone =IMAGE:2585868/clone_end = 3′ GCCTCAATTCTTGTACCTTGTGTC 5705 Table 3AHs.277738 AW082714 6037888 xb61f07.x1 cDNA, 3′ end −1CCCTGATCCTCTGTAGGGAACTTCCT /clone = IMAGE:2580805/clone_end = 3′TTTCTCTAATCCTAGATCTTTTCA 5706 db mining NA AW088500 6044305 xd10a04.x1NCI_CGAP_Or23 cDNA −1 GAGGCATCAGAGGTTCAGGAGAGTT clone IMAGE:2593326 3′similar to ACAGGCAGCAGGTGCGGTATAATAT SW:BAT3_HUMAN P48379 LARGE PROLINE-5707 Table 3A Hs.243457 AW102836 6073449 xd38h12.x1 cDNA, 3′ end −1TTTGTTTCTTTGGGCCTGATTTGTATC /clone = IMAGE:2596103/clone_end = 3′TCTGGAAGGCATTAATTCTTGAA 5708 Table 3A Hs.341908 AW117189 6085773xd83f08.x1 cDNA, 3′ end −1 GCTTTGCCTCTCGGAGGAGTCAAAG /clone =IMAGE:2604231/clone_end = 3′ GGGCAGTAACTGTATGGGGTGAGAG 5709 Table 3AHs.3642 AW130007 6131612 RAB1, member RAS oncogene family −1GCTCCCGAATATTGTAATTTGTTGCC (RAB1), mRNA/cds = (50, 667)CCCTATGTACCCAACCCCCTGAAA 5710 Table 3A Hs.248367 AW131768 6133375 MEGF11protein (MEGF11), mRNA −1 AGGAAGTATGAGAGTTCTGAAACCCT /cds = (159, 3068)TGATAGAAACTGGAAGCCTGCCAT 5711 Table 3A Hs.203606 AW131782 6133389PM0-UT0103-300101-002-f12 cDNA −1 GACATAGGGTTGCAGTAGTGAGTGGGCATCTGTTCTCAGAAGGCAGTGCC 5712 Table 3A Hs.335449 AW136717 6140850UI-H-BI1-adm-a-03-0-UI.s1 cDNA, 3′ −1 TTCTGGCCTTGTTCACCTAGAAACGCend/clone = IMAGE:2717092 TATTTCCTGTGTTATGGTTCTGGC /clone_end = 3′ 5713Table 3A Hs.8121 AW137104 6141237 Notch (Drosophila) homolog 2 −1GCTCTGGGAAAGAGACAGGGAAGTC (NOTCH2), mRNA/cds = (12, 7427)TGGAATGGAAAAGAACACGATGAGA 5714 Table 3A Hs.12035 AW137149 6141282602122419F1 cDNA, 5′ end −1 GGGTTACATTTGAGTCTCTGTACCTG /clone =IMAGE:4279300/clone_end = 5′ CTTGGAAGAAATAAAAATACGTGT 5715 Table 3AHs.342003 AW138461 6142779 UI-H-BI1-edg-e-06-0-UI.s1 cDNA, 3′ −1CTGGGAATATGAAGCGAACGCCACA end/clone = IMAGE:2716882CACTAGAACGCGCCCTGGGAGCTGG /clone_end = 3′ 5716 Table 3A Hs.245138AW139918 6144636 UI-H-BI1-aee-d-05-0-UI.s1 cDNA, 3′ −1GCTGCTTTTGCCCATCCAGGTTTCCA end/clone = IMAGE:2719138CATCCTAATCTTTGCTTTTCTTGT /clone_end = 3′ 5717 Table 3A Hs.276718AW148618 6196514 601473284T1 cDNA, 3′ end −1 TGTAAATGTGGTTTGACTATTTCTGTA/clone = IMAGE:3876165/clone_end = 3′ TGTCCCCATCTATTGATGAGGGT 5718 Table3A Hs.89104 AW148765 6196661 602590917F1 cDNA, 5′ end −1TTGTTTTAACAACTCTTCTCAACATTT /clone = IMAGE:4717348/clone_end = 5′TGTCCAGGTTATTCACTGTAACCA 5719 Table 3A Hs.248857 AW150084 6198076xg36f03.x1 cDNA, 3′ end −1 ACATAAACTGTCCCTTTAGGAAGAAG /clone =IMAGE:2629661/clone_end = 3′ CCCAATGCCCGATTTTGCCCTTTA 5720 Table 3A NAAW150085 6196077 xg36f04.x1 NCI_CGAP_UI1 cDNA −1GGACAAGTGGCATCGGTACTATATTT clone IMAGE:2829663 3′ similar toCCCACCAATCCTAATCCTAATCCC gb:X65018 PULMONARY SURFACTANT-ASSOC 5721 Table3A Hs.265838 AW150944 6198842 xg42e09.x1 cDNA, 3′ end/clone = −1TATGTCCCTTTTTCTCCTCCCTTCCCC IMAGE: 2630248/clone_end = 3′ATTCCCTGGCATCATATTGGGAC 5722 Table 3A Hs.301104 AW151854 6199839602313002F1 cDNA, 5′ end/ −1 CGCTGTCGCCTTAATCCAAGCCTACG clone = IMAGE:4422480/ TTTTCACACTTCTAGTAAGCCTCT clone_end = 5′ 5723 Table 3A Hs.337727AW161820 6300853 au70h03.x1 cDNA, 3′ end/clone = −1TGTGGGCTTGGTATAAACCCTACTTT IMAGE: 2781653/clone_end = 3′GTGATTTGCTAAAGCACAGGATGT 5724 Table 3A Hs.299967 AW166001 6397526xf43e11.x1 cDNA, 3′ end/clone = −1 CCGCCTGAAACGGGCATTTTGTAAAT IMAGE:2620844/clone_end = 3′ GGGGTTTGACTATTTTTGTATGTC 5725 Table 3A Hs.81248AW166442 6397967 CUG triplet repeat, RNA-binding −1ACTGGCAAATGAAGCATACTGGCTTG protein 1 (CUGBP1), mRNA/cds =CAGGGACCTTCTGATTCAAGTACA (137, 1585) 5726 Table 3A Hs.169738 AW1723066438254 xj37a08x1 cDNA, 3′ end/clone = −1 GAATTCGATTTGAGATCTGAGGGCAGIMAGE: 2659382/clone_end = 3′ ACCCGAACCAGGAAAGCAACTCAG 5727 Table 3AHs.8991 AW172850 6438798 adaptor-related protein complex 1, −1AATGCACCAGGCTGCCACCTGCACC gamma 2 subunit (AP1G2),AGTGGTTGCTACATGGGATAAGAAA mRNA/cds = (45, 2402) 5728 Table 3A Hs.143525AW173163 6439111 xj84b08x1 cDNA, 3′ end/clone = −1TATGATAGGATTCTCCACAGTGGCTT IMAGE = 2663895/clone_end =CCGACTCAGGCTCCAATGGACCAA 3′ 5729 Table 3A Hs.38664 AW188135 6462571IL0-MT0152-061100-501-e04 −1 TGCTGTATGGGCAGGTTGTCTTATTA cDNATGTGATCAACAGATGTCCAGGAAC 5730 Table 3A NA AW188398 6462834 xj98c03.x1NCI_CGAP_Co18 −1 ACCTCCAAGAACATCTGCCTTTGTTG cDNA clone IMAGE: 26652523′, AACGTGTTTATTACCTGTCCACTC mRNA sequence 5731 Table 3A Hs.252989AW191929 6470628 xl77c10.x1 cDNA, 3′ end/clone = −1CCTTTTGCCCCTTAGCCCTTGGATAA IMAGE: 2680722/clone_end = 3′TCCGGCTGGGAATGGGGGTGAGGG 5732 Table 3A Hs.203755 AW194379 6473179xm08h07.x1 cDNA, 3′ end/clone = −1 CCCAAATAAGCTCTGTACTTCGGTTA IMAGE:2683645/clone_end = 3′ CCTATGTACCTGTTACCACTTTCA 5733 Table 3A Hs.253151AW195119 6474139 xn66b07.x1 cDNA, 3′ end/clone = −1GCCACATGTCCTATTCTCACACAGGT IMAGE: 2699413/clone_end = 3′GCTTTAATTTCAGCCCAGTCTCTA 5734 db mining Hs.253154 AW195169 6474211xn66h03.x1 cDNA, 3′ end/clone = −1 CTTGAAGGGGCTTTGTTGGGTTTTTG IMAGE:2699477/clone_end = 3′ GGGTTTTGGGTGGGACTCCCAAAG 5735 db mining Hs.330019AW195270 6474330 xn67c04.x1 cDNA, 3′ end/clone = −1GGGGTTTTAAAAATTTTCCCGATTTGA IMAGE: 2699528/clone_end = 3′AAATTAATTTTCCGTTGCCCCCCGG 5736 db mining Hs.253167 AW195284 6474352xn67d09.x1 cDNA, 3′ end/clone = −1 CCCCCTGGGGTTTTTGGGAATGAGG IMAGE:2699537/clone_end = 3′ TAAGGCTTTGAATTTGGTTTGATAT 5737 db miningHs.253168 AW195300 6474388 xn67112.x1 cDNA, 3′ end/clone = −1ACATGCTTAGAGCTGGAGGCTTGAAA IMAGE: 2699567/clone_end = 3′CCATAATCCCAATTAAGTGCTGTC 5738 db mining Hs.253169 AW195313 6474381xn67h05.x1 cDNA, 3′ end/clone = −1 TGTTTGTCCAGGAAAAGGAAGAGGG IMAGE:2699577/clone_end = 3′ GGAAATTAAAACCTTTCCGGTTAGT 5739 Table 3A Hs.253384AW204029 6503501 UI-H-BI1-aen-d-02-0-UI.s1 cDNA, −1GCACTGCTCCGTCTAGCTGTATGACC 3′ end/clone = IMAGE: 2719899/TTTGTTATGTTTCTTTTCTTCCGT clone_end = 3′ 5740 Table 3A Hs.253502 AW2058246505098 UI-H-BI1-afr-e-01-0-UI.s1 cDNA, −1 CTTCAATCTGGGCTGGGCACTCCAC 3′end/clone = IMAGE: 2722657/ GCACATAATCGTCACTCTCGGAGGA clone_end = 3′5741 Table 3A Hs.330058 AW206977 6506473 UI-H-BI1-afs-h-11-0-UI.s1 cDNA,−1 GCGGGAAGTGAAAGCGGAGGCTGGG 3′ end/clone = IMAGE: 2723180/ACAAGGGGAACTTACTGCTCAAAAA clone_end = 3′ 5742 Table 3A Hs.157315AW207701 6507197 UI-H-BI2-age-e-03-0-UI.s1 cDNA, −1AGTGGTGTGGTGGCAATAGGAAAAG 3′ end/clone = IMAGE: 2724172AAAAGATCAGGATGAGAAATTGCTT clone_end = 3′ 5743 db mining NA AW2361886568575 xn70e07.x1 NCI_CGAP_CML 1 −1 CCAAGGGCCTTTTGGGGTTGTTTCCT cDNAclone IMAGE: 2699844 3′, ATAACTTCAGTATTGTAAATTAGT mRNA sequence 5744 dbmining NA AW238203 6568592 xn70h07.x1 NCI_CGAP_CML 1 −1CATAAAGGGGCATTCCCCTAGCCGG cDNA clone IMAGE: 2699869 3′,TCCGGCCTTTTTCCAGTCCATCCTG mRNA sequence 5745 db mining Hs.330063AW236208 6568597 xn71a06.x1 cDNA, 3′ end/clone = −1AGGTTTAAGAAATTTCCCCTAAATCTT IMAGE: 2699890/clone_end = 3′GTTTGGTTGGTTGGGATGAAAAGT 5746 db mining Hs.253747 AW238262 6568641xn71g08.x1 cDNA, 3′ end/clone = −1 AATTGATCCCATTCTTGCTGAAGTAG IMAGE:2699966/clone_end = 3′ ACAGTGCCCTCAAGTGGAATTAAA 5747 db mining Hs.253748AW236271 6568880 xn72b03.x1 cDNA, 3′ end/clone = −1CTCCAATGCTGTTATCCCGGCTGGGT IMAGE: 2699981/clone_end = 3′CCTCACACTCCCCCAACAATCCCA 5748 db mining NA AW236345 6568734 xn73c12.x1NCI_CGAP_CML 1 −1 AGAATGCGCTATTTCCCTCAAAGCCC cDNA clone IMAGE: 27001183′ TGGCTGTAATAAAGAAGCCGATTT similar to contains element MER21 repetitivee 5749 Table 3A Hs.253820 AW237483 6569872 xm72e01.x1 cDNA, 3′ end/clone= −1 CTGAGGTCAGTGTGGTTTGGTGGAA IMAGE: 2689752/clone_end = 3′GGATTATGATATTTACAAGCTGAGT 5750 Table 3A Hs.342342 AW243795 6577635xo56f02.x1 cDNA, 3′ end/clone = −1 GGTCAATGTTTTGAAATTTGTGGAGC IMAGE:2707995/clone_end = 3′ AAACCCCAGTTTTATGCCCTTGGT 5751 Table 3A Hs.250591AW262077 6638893 xp19e09.x1 cDNA, 3′ end/clone = −1AGTTGGAAATTTAGAAATGTCCACT IMAGE: 2740840/clone_end = 3′GTAGGACGTGGAATATGGCGTCGA 5752 db mining Hs.250591 AW262272 6639088xp19e09.x1 cDNA, 3′ end/clone = −1 TTCACGTCCTAAAGTGTGGTAGACGC IMAGE:2740840/clone_end = 3′ GCCCGCGAATTTAGTAGTAGTAGG 5753 Table 3A Hs.277994AW262728 6639544 xq94a12.x1 cDNA, 3′ end/clone = −1GGACAAGTGGCATCCGTATTATATTT IMAGE: 2758270/clone_end = 3′CCCACCATTCCTATTCTTAATCCC 5754 db mining Hs.61345 AW262891 6639707 mRNAfor KIAA1154 protein, −1 GGTCTGCCTCAGTCTTCTACTCATCA partial cds/cds =(0, 676) GCACCACACTGTCAAAATGTTGGA 5755 Table 3A Hs.5662 AW264291 6641033guanine nucleotide binding protein −1 AGATGAATTGAAGCAAAAGTTTTCA (Gprotein), beta polypeptide 2- GTACCAGCAGCAAGGCAGACCCCC like 1 (GNB2L1),mRNA/cds = (95, 1048) 5756 Table 3A Hs.122656 AW274156 6681186hypothetical protein MGC14425 −1 TCACCTCCACCTCTGAGGGAGCAAC (MGC14425),mRNA/cds = (318, GAATACAAAGGTAGACCCCCAAAAG 686) 5757 Table 3A Hs.250600AW291304 6697940 UI-H-BI2-agk-a-02-0-UI.s1 cDNA, −1CCCCAGCCAGCACTTCCCTTTTCTGC 3′ end/clone = IMAGE: 2724386/GAGGGTTTTCTGTTTCTTTGATTA clone_end = 3′ 5758 Table 3A Hs.47325 AW2914586698021 UI-H-BI2-agh-c-02-0-UI.s1 cDNA, −1 AGAAAATTTGAACCCTACCCTTCTCC 3′end/clone = IMAGE: 2724099/ CATCCCACTTCTTACTCCATCCCG clone_end = 3′ 5759Table 3A Hs.170381 AW291507 6698143 UI-H-BI2-aga-g-11-0-UI.s1 cDNA, −1CTGTGGCATCATTCACACCACCAGCA 3′ end/clone = IMAGE: 2723900/GAGTCCCTTCCAAGAGGGGTCTGG clone_end = 3′ 5760 db mining Hs.255118AW292757 6699393 UI-H-BW0-aij-b-12-0-UI.s1 −1 CCGTGTTAAAACCAAAGTTTGGGATTcDNA, 3′ end/clone = IMAGE: TTTCGGGTATTCATTGGAAGTCAC 2729423/clone_end =3′ 5761 Table 3A Hs.255119 AW292772 6699408 UI-H-BW0-aij-d-03-0-UI.s1 −1CGAGAGCCTGGAAGCTTTGCACACTA cDNA, 3′ end/clone = IMAGE:CTGCCTGGAAGATCTGATTCTTTG 2729501/clone_end = 3′ 5762 db mining Hs.255123AW292814 6699450 UI-H-BW0-aij-h-02-0-UI.s1 −1TGTTTTAAAAGTGGGTTTATTTCAACC cDNA, 3′ end/clone = IMAGE:GCTTCACTCCCGGTTGGTGACCG 2729691/clone_end = 3′ 5763 db mining Hs.255129AW292855 6699491 UI-H-BW0-aif-d-03-0-UI.s1 −1 TCTTCTCTCAGTCTTCAGCAAGTAGCcDNA, 3′ end/clone = IMAGE: TTCTTTCAGAACTGCCTCCTCCCG 2729117/clone_end =3′ 5764 db mining Hs.255544 AW292873 6899509 UI-H-BW1-ame-e-09-0-UI.s1−1 GTTTTCTGCATCCCAAATGTCCTGGG cDNA, 3′ end/clone = IMAGE:GCATGTGTCCCTTCCTTGCTGACC 3069784/clone_end = 3′ 5765 db mining Hs.265134AW292900 6699536 UI-H-BW0-aig-a-05-0-UI.s1 −1TGTTATGATTCTCTCAATTTCATAAAG cDNA, 3′ end/clone = IMAGE:CTCTTCTGGCAGAGGAGACAGAT 2729000/clone_end = 3′ 5766 db mining Hs.255135AW292902 6699538 UI-H-BW0-aig-a-07-0-UI.s1 −1AAATGGATTACAATTTCCCTGACATTT cDNA, 3′ end/clone = IMAGE:GGGCATAAAACATCTGCCATCCT 2729004/clone_end = 3′ 5767 db mining Hs.256139AW292928 6699584 UI-H-BW0-aig-d-11-0-UI.s1 −1 TCCTCCTTCCAGAGACCTTTGCTTTAcDNA, 3′ end/clone = IMAGE: CTGCCATTTTTTCTGTGGGCTTTT 2729156/clone_end =3′ 5768 db mining Hs.255140 AW292941 6699577 UI-H-BW0-aig-f-10-0-UI.s1−1 AGGCATAGCAGTAGAATCTGTCAAAA cDNA, 3′ end/clone = IMAGE:AGGAGGCATGGAATGAAATGAACC 2729250/clone_end = 3′ 5769 db mining Hs.255142AW292960 6699598 UI-H-BW0-aih-a-02-0-UI.s1 −1 CTGACCCTCTCGCCCCTCCACCTGTGcDNA, 3′ end/clone = IMAGE: CTTCTGCCCTAGGATAACGCTGGG 2728995/clone_end =3′ 5770 db mining Hs.147728 AW292969 6699625 RST12623 cDNA −1GACCCAAAGAAAAGATCAAGAC CGCATGTAGCAAATGTAGCAAGGA GGCA 5771 db miningHs.255152 AW293001 6699637 UI-H-BW0-aih-d-12-0-UI.s1 −1CTAATTTCCCACTAAAAGGTCCAGAA cDNA, 3′ end/clone = IMAGE:AAATTGATGCCACCTGTAGTTTGG 2729159/clone_end = 3′ 5772 db mining NAAW293017 6699653 UI-H-BW0-aih-f-06-0-UI.s1 −1 GTAAAGTTCCAAGCGAGTGGAAGGTANCI_CGAP_Sub6 cDNA clone AATCACGACTGTGGCACCGGAGCC IMAGE: 2729243 3′,mRNA sequence 5773 db mining NA AW293143 6699779UI-H-BW0-aii-a-03-0-UI.s1 −1 GAAACTGAATGACCATGGAATGCTGA NCI_CGAP_Sub6cDNA clone AATTCCAAAAGAAAAACGTCGCGC IMAGE: 2729356 3′, mRNA sequence5774 db mining Hs.255172 AW293158 6699794 UI-H-BW0-aii-b-07-0-UI.s1 −1TCTCTCAGGTCGTCTTCAGAGTCCAT cDNA, 3′ end/clone = IMAGE:TCCCTTTGTCTTGATCTTTTCTCT 2729412/clone_end = 3′ 5775 Table 3A Hs.166975AW293159 6699795 splicing factor, arginine/serine-rich −1CTCCCATCATTCCCTCCCGAAAGCCA 5 (SFRS5), mRNA/cds = (218,TTTTGTTCAGTTGCTCATCCACGC 541) 5776 db mining Hs.255174 AW293172 6699808UI-H-BW0-aii-c-10-0-UI.s1 −1 GCCCTGCCCCCTACCCTTGCCCTTTA cDNA, 3′end/clone = IMAGE: AATTTTTGGGACTGAATAAAGAAT 2729466/clone_end = 3′ 5777Table 3A Hs.255178 AW293267 6899829 UI-H-BW0-aii-e-10-0-UI.s1 −1TGCAGGATAACTTGCTCATGAAAGGA cDNA, 3′ end/clone = IMAGE:AATGCCAGATTAAACCCCTTGCCA 2729582/clone_end = 3′ 5778 Table 3A Hs.75354AW293424 6700060 mRNA for KIAA0219 gene, partial −1GCCTTCCCTTCGTTCCTTTCCAGGCA cds/cds = (0, 7239) ATAATGACATCATTAGTGATGCAA5779 Table 3A Hs.255200 AW293428 6700062 UI-H-BI2-ahm-b-02-0-UI.s1 −1CGCCACGGCTCCAATCCCTATATGAG cDNA, 3′ end/clone = IMAGE:TGAGCAGTAGAATCACATAGGAAT 2727122/clone_end = 3′ 5780 Table 3A Hs.10041AW293461 6700097 602713308F1 cDNA, 5′ end/ −1 CCTAGAATCAGACTTTAAGCACAAGCclone = IMAGE: 4853618/ AGGGAGGGAAAGCACTTGAGCAGT clone_end = 5′ 5781 dbmining Hs.291317 AW293859 6700495 nx40e10.s1 cDNA, 3′ end/clone = −1GCACATGCAAAAACTCAGATGTGCAA IMAGE: 1258602/clone_end = 3′ATAACTGTTCCCTATTAACTACAA 5782 Table 3A Hs.255249 AW293895 6700531UI-H-BW0-ain-f-10-0-UI.s1 −1 GGTGCTCAAACTGTATTTTCTCCCTC cDNA, 3′end/clone = IMAGE: CCTCCCTCCTTCTTTCTTTCCAGA 2729995/clone_end = 3′ 5783db mining Hs.255251 AW293922 6700558 UI-H-BW0-aik-a-04-0-UI.s1 −1TTCTTCCACGGGATTTCTAATTCATTA cDNA, 3′ end/clone = IMAGE:AATAGGACCTCCACACCAGACCT 2729382/clone_end = 3′ 5784 db mining Hs.255253AW293949 6700585 UI-H-BW0-aik-c-10-0-UI.s1 −1 TATCCAGCCTGACTTCTTCATGCTGTcDNA, 3′ end/clone = IMAGE: ACTAGCCTTCCAATCCTTAACTAA 2729490/clone_end =3′ 5785 do mining Hs.255254 AW293950 6700588 UI-H-BW0-aik-c-11-0-UI.s1−1 TGGACATTGGGGGTCAAACCCTTTTG cDNA, 3′ end/clone = IMAGE:TTTAAATTTTCCCTTTCCCAGGGC 2729492/clone_end = 3′ 5786 Table 3A Hs.255255AW293955 670000591 UI-H-BW0-alk-d-05-0-UI.s1 −1GCTGTGCCACGGTCAGGTGGCTTCC cDNA, 3′ end/clone = IMAGE:AATCTGTACTCAATTGTTACTGTAC 2729526/clone_end = 3′ 5787 Table 3A Hs.190904AW294363 670000729 UI-H-BI2-ahg-b-05-0-UI.s1 −1TCAGAGATGCTGATGTCATATAAGTA cDNA, 3′ end/clone = IMAGE:GTTTCCCTGTCTGGCCTTGGATGT 2726720/clone_end = 3′ 5788 db mining Hs.255330AW294818 6701254 UI-H-BW0-ail-a-05-0-UI.s1 −1 GTATGACTGATGATAGCTGCGAATGAcDNA, 3′ end/clone = IMAGE: GGAGGAGGGAAGGGAAGGCTGGAG 2729385/clone_end =3′ 5789 db mining Hs.255333 AW294644 6701280 UI-H-BW0-ail-c-11-0-UI.s1−1 CCATTGCCCCGGTGTTTTGGTTTAAT cDNA, 3′ end/clone = IMAGE:TTTCCCAGGCTTATTTTAAAGGCC 2729493/clone_end = 3′ 5790 Table 3A Hs.255687AW294654 6701290 UI-H-BW0-ail-d-10-0-UI.s1 −1 AGGAAATTAAACATGAGCATGACATGcDNA, 3′ end/clone = IMAGE: ACCCCAACTCTCAAGAAATCCCCA 2729539/clone_end =3′ 5791 Table 3A Hs.255336 AW294081 6701317 UI-H-BW0-ail-g-10-0-UI.s1 −1ATCAGGTCCCCTACAAAATTAGCTAC cDNA, 3′ end/clone = IMAGE:TTTGGCCTTTCCTACAAAATTAGC 2729683/clone_end = 3′ 5792 db mining Hs.255337AW294692 6701328 UI-H-BW0-ail-h-11-0-UI.s1 −1TCATTCGTTTGCTTTCTCTGACTGACA cDNA, 3′ end/clone = IMAGE:GGCAGTAATGACTTCAATAAGCT 2729733/clone_end = 3′ 5793 Table 3A Hs.255339AW294695 6701331 UI-H-BW0-aim-e-02-0-UI.s1 −1 AGGGCCTGCTTCAGAGTTTGTTTCCTcDNA, 3′ end/clone = IMAGE: AAATAAAACAATGGCTCTCCCCGT 2729738/clone_end =3′ 5794 db mining Hs.255341 AW294697 67001333 UI-H-BW0-aim-a-04-0-UI.s1−1 CCCCCAACTTACATGGAAAAGGGATG cDNA, 3′ end/clone = IMAGE:GTTGCATTTCTGTGTCATATGCAT 2729742/clone_end = 3′ 5795 db mining Hs.342539AW294717 67001353 UI-H-BW0-ajl-g-03-0-UI.s1 −1 GCAGAGGGAAGAGGAAATGCTTTGAcDNA, 3′ end/clone = IMAGE: AGCCTTGCTAGTTATTTAATTAGTT 2732333/clone_end= 3′ 5796 db mining Hs.255347 AW294739 67001375UI-H-BW0-aim-f-07-0-UI.s1 −1 GACATAGTTGCAAAACACAATACTTA cDNA, 3′end/clone = IMAGE: ATACTTTTTCTGGAGGAGGGGGCC 2729988/clone_end = 3′ 5797db mining Hs.255354 AW294769 67001405 UI-H-BW0-ail-g-02-0-UI.s1 −1ACCCCTTTTCTTAATTTCTCAGGAGAA cDNA, 3′ end/clone = IMAGE:TGGCAGCTCCTTCTTTTGTCGTC 2729667/clone_end = 3′ 5798 db mining NAAW294812 6701448 UI-H-BI2-ahi-d-06-0-UI.s1 −1 CCTCCGGTGTCTTCGGAAGCACTGAANCI_CGAP_Sub4 cDNA clone GGGACATCTGGGGACCCTCACCTG IMAGE: 2726842 3′,mRNA sequence 5799 db mining Hs.255388 AW295071 6701707UI-H-BW0-ait-c-03-0-UI.s1 −1 ACTCTTTGACCAATAAATCACTGGAA cDNA, 3′end/clone = IMAGE: TAGAGGTTCCAGCATATTCTGAGA 2730245/clone_end = 3′ 5800Table 3A Hs.255389 AW295088 6701724 UI-H-BW0-ait-d-09-0-UI.s1 −1ATGCTTACACCCTGGATGAATAAAGT cDNA, 3′ end/clone = IMAGE:CTTTATTTACACCTCCACCTCCCC 2730305/clone_end = 3′ 5801 db mining Hs.255157AW295376 6702012 UI-H-BI2-ahv-f-03-0-UI.s1 cDNA, −1CTCTTCACAGGTCATAAGCCCCTCTG 3′ end/clone = IMAGE: 2728085/AGCGGCGACAGTCCTCGCATCCAG clone_end = 3′ 5802 db mining Hs.330175AW295597 6702233 UI-H-BW0-aip-a-10-0-UI.s1 −1 CAGCTCGACCTCAGTCCCCTTCAGAAcDNA, 3′ end/clone = IMAGE: ATAAGATGGCGGCTGCGCTGACAG 2729779/clone_end =3′ 5803 Table 3A Hs.255446 AW295610 6702246 UI-H-BW0-alp-c-03-0-UI.s1 −1TTTCAACGTGTACCTTTCCTGGGAAA cDNA, 3′ end/clone = IMAGE:CCATCTCAATAAACACATTTTGGT 2729861/clone_end = 3′ 5804 db mining Hs.255448AW295616 6702252 UI-H-BW0-alp-c-09-0-UI.s1 −1 GCTGGACACATGGGTTAAGAGGAGGcDNA, 3′ end/clone = IMAGE: AAAAGTAGGAAAGGAGGAGGGGAGA 2729873/clone_end= 3′ 5805 db mining Hs.255449 AW295629 6702288 UI-H-BW1-amu-a-09-0-UI.s1−1 GGCTGGGACCAGGGTTTTTCAAGCC cDNA, 3′ end/clone = IMAGE:ACCTTTTCCTGTCTCAGTTCAGAGA 3071128/clone_end = 3′ 5806 Table 3A Hs.255454AW295664 6702300 UI-H-BW0-aip-g-12-0-UI.s1 −1 CCCACTTTCACACATGACTCACACGAcDNA, 3′ end/clone = IMAGE: CTGAAGGAAAGAAAGGGCATCCTT 2730071/clone_end =3′ 5807 db mining Hs.255465 AW295689 6702305 UI-H-BW0-aip-h-06-0-UI.s1−1 AAGAAATTAAGGAAGGCAAGAG cDNA, 3′ end/clone = IMAGE:GGTAGGTGTTGGCCCATGGAAGTT 2730107/clone_end = 3′ TCCC 5808 db miningHs.255457 AW295888 6702324 UI-H-BW0-aiw-b-02-0-UI.s1 −1CTGGCAAATATTGCGGAAGATGTACT cDNA, 3′ end/clone = IMAGE:GAAATGTAATTGAAATGTAGCTGC 2730578/clone_end = 3′ 5809 db mining Hs.255459AW295711 6702347 UI-H-BW0-aiw-d-03-0-UI.s1 −1 AGCATAAGAGATACGAAGCTGATGGTcDNA, 3′ end/clone = IMAGE: AATTAACTTGTACCCCTTGAAGTG 2730676/clone_end =3′ 5810 db mining Hs.255462 AW295724 6702360 UI-H-BW0-aiw-e-08-0-UI.s1−1 AGTGTCAGACAATTAGATACTCTTTC cDNA, 3′ end/clone = IMAGE:CTGTCTTCAGGAGCCCATCTGGAA 2730734/clone_end = 3′ 5811 db mining Hs.255484AW295731 6702367 UI-H-BW0-aiw-f-05-0-UI.s1 −1 GAAGTGTAAACATGCCAACAGGGTTTcDNA, 3′ end/clone = IMAGE: ATATTTAGGTTCCAAGAGTTGCCA 2730776/clone_end =3′ 5812 Table 3A Hs.158814 AW295985 6702531 KIAA0377 gene product −1CTTCCCAAACTCCATTGTCTCATTCTC (KIAA0377), mRNA/cds = (126,ACTGCTTATGTTATTGCTCTTAT 4346) 5813 Table 3A Hs.255492 AW295005 6702641UI-H-BW0-aiu-b-01-0-UI.s1 −1 CCCACACAGCAGAGAAGTATCAGAAA cDNA, 3′end/clone = IMAGE: ACATAGAAACATGTGAAAATGCGC 2730552/clone_end = 3′ 5814db mining Hs.255495 AW296020 6702656 UI-H-BW0-aiu-c-07-0-UI.s1 −1AGGTTCAATTCATTTTCCTGAGATGTT cDNA, 3′ end/clone = IMAGE:TGGTTTATAAGATTTGAGGATGGT 2730612/clone_end = 3′ 5815 db mining Hs.255497AW296044 6702680 UI-H-BW0-aiu-e-10-0-UI.s1 −1 ATACTTACATGTGCTTGGATCCTGGGcDNA, 3′ end/clone = IMAGE: TGGGAGGCTTGGTTAGAAGTCACG 2730714/clone_end =3′ 5816 db mining Hs.255498 AW296054 6702690 UI-H-BW0-aiu-f-10-0-UI.s1−1 TGGGTCAGCGTGTTCAATTTTAAATA cDNA, 3′ end/clone = IMAGE:GGAATACACTAGCCTTACAACGGA 2730762/clone_end = 3′ 5817 db mining Hs.255499AW296058 6702694 UI-H-BW0-aiu-g-02-0-UI.s1 −1 TGTTCATCTTGATGTAATAGAGAAGGcDNA, 3′ end/clone = IMAGE: AAAGAGAGAGCATCCCTTTTCAGT 2730794/clone_end =3′ 5818 Table 3A Hs.255501 AW296063 6702699 UI-H-BW0-aiu-g-08-0-UI.s1 −1ACCAGTAACACAATGACGGCAAGCAC cDNA, 3′ end/clone = IMAGE:AGAGAAGGAAAAAGTCAGATCCCC 2730806/clone_end = 3′ 5819 db mining Hs.255502AW296066 6702702 UI-H-BW0-aiu-g-11-0-UI.s1 −1 ACTTGGAGCTAGAGAGCCACCCATCAcDNA, 3′ end/clone = IMAGE: TATGGAGGAGAAGTGGTCACTCTA 2730812/clone_end =3′ 5820 db mining Hs.34871 AW298352 6702988 zinc finger homeobox 1B −1TGCATGTGTGTTGTGTACTTGTCTGT (ZFHX1B), mRNA/cds = (444,TCTGTAAGATTGTCGGTGTTACAC 4088) 5821 db mining Hs.255543 AW298373 6703009UI-H-BW0-aio-c-10-0-UI.s1 −1 TTCCTGGCAGTAAAGAAAAGAA cDNA, 3′ end/clone =IMAGE: AGAAGATGTGAGTTATGAAGCATT 2729874/clone_end = 3′ GACT 5822 dbmining Hs.255548 AW298398 6703034 UI-H-BW0-aio-f-01-0-UI.s1 −1AAATAGGAATATAATCTGTCCACATC cDNA, 3′ end/clone = IMAGE:AAAGAATGGGAAGTCGAAGTGTACA 2730000/clone_end = 3′ 5823 db miningHs.255549 AW296404 6703040 UI-H-BW0-aio-f-08-0-UI.s1 −1GTTCCAAATGTTTTCCGCTAATAGTTT cDNA, 3′ end/clone = IMAGE:GTCCTAAAGCCTTTGCCATTCCT 2730014/clone_end = 3′ 5824 db mining Hs.255552AW298446 6703082 UI-H-BW0-aiq-b-07-0-UI.s1 −1 ACAGAGAAGGCTTATTTACGTTGGGAcDNA, 3′ end/clone = IMAGE: ATTACATTAAGGAAAAGTGGTGAC 2730160/clone_end =3′ 5825 Table 3A Hs.255554 AW296490 6703126 UI-H-BW0-aiq-f-08-0-UI.s1 −1CCTTCCTCCTATATCCTGCCTTGAAT cDNA, 3′ end/clone = IMAGE:AGGGATGTGATACCTTGAGCCATG 2730374/clone_end = 3′ 5826 db mining Hs.255558AW298504 6703140 UI-H-BW0-aiq-g-12-0-UI.s1 −1ATATTTGGGTCTCTGTTTAAGATTTCA cDNA, 3′ end/clone = IMAGE:TTGCCGTGGTAGGGAGAGTTCCA 2730430/clone_end = 3′ 5827 db mining Hs.255556AW298511 6703147 UI-H-BW0-aiq-h-08-0-UI.s1 −1 TGGATGCCATGATGACACCAATAAGCcDNA, 3′ end/clone = IMAGE: AACCCACAGATTAGGGGAAATACT 2730470/clone_end =3′ 5828 Table 3A Hs.255559 AW296532 6703168 UI-H-BW0-aiv-b-07-0-UI.s1 −1GGGGCTGGGAGCCACCAAAAGGGCC cDNA, 3′ end/clone = IMAGE:TGCTCTTCGGAGAAATGCTGAATTC 2730565/clone_end = 3′ 5829 Table 3A Hs.255560AW296545 6703181 UI-H-BW0-aiv-c-11-0-UI.s1 −1 AGGCATCTTGAAAGTTCCATAAAGACcDNA, 3′ end/clone = IMAGE: AGAAGTAAGGGTCATTCAGTCATT 2730621/clone_end =3′ 5830 db mining Hs.255561 AW296567 6703203 UI-H-BW0-aiv-f-04-0-UI.s1−1 AGCTAAAGCCACGGAACTCAATGAGA cDNA, 3′ end/clone = IMAGE:TTTATGCATGGAAGGAAACAGGTT 2730751/clone_end = 3′ 5831 db mining Hs.255569AW296695 6703331 UI-H-BW0-aix-c-06-0-UI.s1 −1 TGTTCTCTCTCGAACTCTGGAGCACAcDNA, 3′ end/clone = IMAGE: TCAGCTCTCTCTGCATAAACTGTT 2730635/clone_end =3′ 5832 db mining Hs.255572 AW296727 6703363 UI-H-BW0-aix-f-09-0-UI.s1−1 ATCTGGAGGATGGCAGTTTGAGAATT cDNA, 3′ end/clone = IMAGE:AGGACTAAGCCCGTCTCCCCTTTG 2730785/clone_end = 3′ 5833 Table 3A Hs.255573AW296730 6703386 UI-H-BW0-aix-f-12-0-UI.s1 −1 CATTAGCTCTCTAAACATTTGGCCTAcDNA, 3′ end/clone = IMAGE: AGGGATTCATAGGTGAAGCCTTTA 2730791/clone_end =3′ 5834 db mining Hs.255575 AW296758 6703394 UI-H-BW0-ajb-a-10-0-UI.s1−1 GGTAGGATTTATCCTTTTTCTTCATGTG cDNA, 3′ end/clone = IMAGE:CAACTGTATAAACTGGCAAAGCA 2730931/clone_end = 3′ 5835 db mining Hs.255577AW296773 6703409 UI-H-BW0-ajb-c-04-0-UI.s1 −1 AGTCTTATGGGACAGAGCAGCTCTCCcDNA, 3′ end/clone = IMAGE: AGTCTAGGATGGTAGAAGATTCTT 2731015/clone_end =3′ 5836 Table 3A Hs.255579 AW296797 6703433 UI-H-BW0-ajb-e-07-0-UI.s1 −1GAGTCTGTACCCCTTTCTAATAAACT cDNA, 3′ end/clone = IMAGE:GCTCTGGACACAATGAACCCTGAA 2731117/clone_end = 3′ 5837 db mining Hs.255550AW296802 6733438 UI-H-BW0-ajb-f-02-0-UI.s1 −1 CCATCGGCAAGCCTTGGTGGGTTCATcDNA, 3′ end/clone = IMAGE: ATTCAGTGGCATTAGGGATTAAGG 2731155/clone_end =3′ 5838 db mining Hs.255590 AW296914 6703550 UI-H-BW0-ajc-e-12-0-UI.s1−1 CCATTTCTTCTGGATCCTCTCCTAGTT cDNA, 3′ end/clone = IMAGE:GTCTTTGTGTGGACGCACAAGCG 2731294/clone_end = 3′ 5839 db mining Hs.255591AW296947 6703583 UI-H-BW0-ajc-e-05-0-UI.s1 −1 GATCCTTTGCTGACACTGGTTTCTCTcDNA, 3′ end/clone = IMAGE: CTTATTTTGCCCCGCCAATAAAAA 2731472/clone_end =3′ 5840 db mining Hs.255598 AW297024 6703660 UI-H-BW0-ajf-e-04-0-UI.s1−1 TCTGTCTGAAACTTCTTTTCTCTCTGA cDNA, 3′ end/clone = IMAGE:GAATTAAATTTTCCAATGGACCGT 2731495/clone_end = 3′ 5841 db mining Hs.255600AW297026 6703662 UI-H-BW0-ajf-e-06-0-UI.s1 −1 GATCTGTGTTTTCCTCCCAAAAGAAGcDNA, 3′ end/clone = IMAGE: ATCATCTTTCCAGAAAAAGAGGAT 2731499/clone_end =3′ 5842 db mining Hs.255601 AW297030 6703666 UI-H-BW0-ajf-e-10-0-UI.s1−1 TTCCATATGTCACTGTATCTGCCTGG cDNA, 3′ end/clone = IMAGE:CATTACCCCTTCTTAAAACACACA 2731507/clone_end = 3′ 5843 db mining Hs.288403AW297038 6703672 AV757131 cDNA, 5′ end/clone = −1GCTCACTACCACTTCTTCAAATCCAG BMFAKG04/clone_end = 5′CTAAAAGCATCACGGCCTCAATGA 5844 db mining Hs.255614 AW291182 6703808HNC68-1F10.R cDNA −1 GTCTGGTTGTTAGCTTTCCCGATCCT CCACACATTGGAAACCTAAGCATA5845 db mining Hs.255615 AW297175 6703811 UI-H-BW0-ajd-c-04-0-UI.s1 −1GGGCAATGGAGCCACAGACTCTCTA cDNA, 3′ end/clone = IMAGE:ACTTCAAGAGGTGTTTCATAGGTGT 2731375/clone_end = 3′ 5846 db miningHs.255618 AW297199 6703835 UI-H-BW0-ajd-e-07-0-UI.s1 −1AGCTGAGGTCAGACAAACCACAACAT cDNA, 3′ end/clone = IMAGE:ATATGCAGATTTATCAGCAATAAA 2731477/clone_end = 3′ 5847 db mining Hs.255617AW297201 6703637 7k38c02.x1 cDNA, 3′ end/clone = −1CCTGCCAGGGTTGTTCGGAAGTCGC IMAGE: 3477507/clone_end = 3′AGGTCCGAAAATCTCCTCCGCATAC 5848 db mining Hs.255621 AW297220 6703656UI-H-BW0-ajd-g-09-0-UI.s1 −1 CTTCTCTGAAATGGTACGCCTATACT cDNA, 3′end/clone = IMAGE: TGCATTTCTGAGAAGCCAAACAAA 2731577/clone_end = 3′ 5849db mining Hs.255622 AW297233 6703869 UI-H-BW0-aji-a-03-0-UI.s1 −1AGTTTTCTGGCTAAGTCACCTCTTAA cDNA, 3′ end/clone = IMAGE:GGAGATCCCTGTAAAATTCACCCT 2731684/clone_end = 3′ 5850 db mining NAAW297255 6703891 UI-H-BI2-ahi-d-06-0-UI.s1 −1 CAGATTAAAAACCCCATCCCGGCCCTNCI_CGAP_Sub6 cDNA clone CACCGAGGTGTTACAACTCTGTCC IMAGE: 2731782 3′,mRNA sequence 5851 db mining Hs.48820 AW297262 6703998 TAFII105 mRNA,partial/cds = (0, −1 AGCAAATTACTCTGCCTGGAAATAAA 2405)ATTCTGTCACTTCAAGCATCTCCT 5852 db mining Hs.255628 AW297265 6703901UI-H-BW0-aji-d-02-0-UI.s1 −1 TCCAGGCACTGTATAGGTGGCGAGG cDNA, 3′end/clone = IMAGE: ACACAATGATAGGCAAAGTAGTACA 2731826/clone_end = 3′ 5853db mining Hs.255630 AW297294 6703930 UI-H-BW0-aji-f-09-0-UI.s1 −1ACACACCCAAACCTCACACAGTGAAA cDNA, 3′ end/clone = IMAGE:GGCCACTTTCCTCACACAGTGAAA 2731936/clone_end = 3′ 5854 db mining Hs.255632AW297313 6703949 7k46h07.x1 cDNA, 3′ end/clone = −1TTGCTTCAGACTTTTAACAACAATCCT IMAGE: 3478525/clone_end = 3′AGAAGCCAGAAAACAATGAAGAAA 5855 db mining Hs.255633 AW297317 6703953UI-H-BW0-aji-h-12-0-UI.s1 −1 TTCTGTCAGGGCTTCAAAAGAGACTT cDNA, 3′end/clone = IMAGE: CCATAGTTTTGGGAACTGGAGTCA 2732038/clone_end = 3′ 5856db mining Hs.255634 AW297318 6703954 UI-H-BW0-air-a-01-0-UI.s1 −1GATATATTGAAGGTCAGAGGCAGAGC cDNA, 3′ end/clone = IMAGE:TAAACAGGTGATGCCACTGGGTCT 2730121/clone_end = 3′ 5857 db mining Hs.215635AW297328 6703964 UI-H-BW0-air-a-11-0-UI.s1 −1AGGCTCTTGTTGAGTATTCCTTTGATT cDNA, 3′ end/clone = IMAGE:CCTGCTTCTGTCTTTTTAAATCA 2730141/clone_end = 3′ 5858 Table 3A Hs.255637AW297339 6703975 UI-H-BW0-air-c-03-0-UI.s1 −1 ACACACCAAAAGAAATACAAGAGTCTcDNA, 3′ end/clone = IMAGE: TTTTCTGCCCTTGGGGAATCTGCA 2730221/clone_end =3′ 5859 db mining NA AW297356 6703992 UI-H-BW0-air-d-08-0-UI.s1 −1ACACCCAGCACCCACAGGGAAGAAA NCI_CGAP_Sub6 cDNA cloneTAATTCCACAGAGCTAAGTATTCCA IMAGE: 2730279 3′, mRNA sequence 5860 dbmining Hs.330185 AW297367 6104003 UI-H-BW0-air-f-01-0-UI.s1 −1TGTGCCTGTGTGCTCCAGCCTCTTCC cDNA, 3′ end/clone = IMAGE:TATGTGTGTAACTTCAATAAAACC 2730361/clone_end = 3′ 5861 db mining Hs.255644AW297374 6704010 UI-H-BW0-air-f-08-0-UI.s1 −1 ACCGAGTGTTACCGCAAGAGGTGTAAcDNA, 3′ end/clone = IMAGE: AAATCGAGGTTCATCTTTGCACAC 2730375/clone_end =3′ 5862 db mining Hs.255645 AW297384 6704020 UI-H-BW0-air-g-08-0-UI.s1−1 TCCTGATTCTCAAAGTACCCCCTTCC cDNA, 3′ end/clone = IMAGE:CTACAACTCTAACATGCTTTGTCT 2730423/clone_end = 3′ 5863 db mining Hs.255646AW297390 6704026 UI-H-BW0-air-h-05-0-UI.s1 −1 CCATGATTTTTCCAATGGACAAGCACcDNA, 3′ end/clone = IMAGE: TATTAACATGGGACTGTATTTCCT 2730485/clone_end =3′ 5864 Table 3A Hs.255647 AW297400 6704038 UI-H-BW0-ais-a-05-0-UI.s1 −1AATAGAACTGATAGCCCATGATGATT cDNA, 3′ end/clone = IMAGE:GGCTGGCAGGGTTAAGGAAGTGGG 2730152/clone_end = 3′ 5865 db mining Hs.255648AW297401 6704037 UI-H-BW0-ais-a-08-0-UI.s1 −1 TCCCAGGAGAGTCACATTTCTTTTTCcDNA, 3′ end/clone = IMAGE: ACTAAATAAGGAGGGGAAGAAAAA 2730154/clone_end =3′ 5866 db mining Hs.255649 AW297407 6704043 UI-H-BW0-ais-b-02-0-UI.s1−1 GGGTTACCTCACTTTCTAGGTTCCCA cDNA, 3′ end/clone = IMAGE:AGATTCCCAAGTTAAGGAAGCTTT 2730194/clone_end = 3′ 5867 db mining Hs.255650AW297411 6704047 UI-H-BW0-ais-b-07-0-UI.s1 −1 AAAGCGTCCAGTCCCCCTAACTCAAAcDNA, 3′ end/clone = IMAGE: CACAGAAACATAACAATTTTACAA 2730204/clone_end =3′ 5868 db mining Hs.255653 AW297426 6704062 UI-H-BW0-ais-c-12-0-UI.s1−1 CCCAGGGCTCCTCCACCTGAAAGAAT cDNA, 3′ end/clone = IMAGE:TGTCAGGGTTTCAGATCAGCTAAA 2730262/clone_end = 3′ 5869 db mining Hs.256657AW297443 6704079 UI-H-BW0-ais-e-09-0-UI.s1 −1 TGGCCTCCACCCATTAAACTGTCTTTcDNA, 3′ end/clone = IMAGE: GCCTAAGACAAATAATTCCCAGGA 2730352/clone_end =3′ 5870 Table 3A Hs.255661 AW297522 6704158 UI-H-BW0-aja-e-02-0-UI.s1 −1TGTACTCCTGATGCCTGAAAATCGTT cDNA, 3′ end/clone = IMAGE:AAGTGAAGACTTATCACATTACCG 2731108/clone_end = 3′ 5871 db mining Hs.255665AW297581 6704217 UI-H-BW0-ajg-b-08-0-UI.s1 −1 ATCCTTCAGATTGAGCTGGGTGTCAGcDNA, 3′ end/clone = IMAGE: CATTCAATTCCACAAGCCTACCTG 2731718/clone_end =3′ 5872 db mining Hs.255686 AW297590 6704226 RST6539 cDNA −1TGGATAAGCAATATGTTGGACTAGTA TGAAAATGGCATTCCCAGCAGTGA 5873 db miningHs.256672 AW297628 6704262 UI-H-BW0-ajg-f-12-0-UI.s1 −1TCACTAGCAGAATATAGTGGGCATGA cDNA, 3′ end/clone = IMAGE:CCAGTATCCTAGTAGAGCTGACCC 2731918/clone_end = 3′ 5874 db mining Hs.255673AW297030 6704272 UI-H-BW0-ajg-h-03-0-UI.s1 −1 AGTTTCTTTCTTACAATGCGGGTCTGcDNA, 3′ end/clone = IMAGE: AAATCCAGGGTTTCCACACCAGGG 2731996/clone_end =3′ 5875 db mining Hs.255674 AW297849 6704285 UI-H-BW0-ajh-a-05-0-UI.s1−1 CCAAATACTTAGTGTAGTTGACTTGT cDNA, 3′ end/clone = IMAGE:CTTGGGTTGCACTGTAAGGCAGAG 2731665/clone_end = 3′ 5876 db mining Hs.255675AW297651 6704267 UI-H-BW0-ajh-a-07-0-UI.s1 −1 CAAGAGTTTCCATGCGTCCAGTGATGcDNA, 3′ end/clone = IMAGE: ACCGGAATTAATCATGTATGGTGT 2731669/clone_end =3′ 5877 db mining Hs.255677 AW297664 6704300 UI-H-BW0-ajh-b-11-0-UI.s1−1 GTTTCTAACCCATAAGTGCCTCATAC cDNA, 3′ end/clone = IMAGE:ATACATTGCTAGTCTAAAGAGCTTT 2731725/clone_end = 3′ 5878 db miningHs.255679 AW297692 6704328 UI-H-BW0-ajh-e-05-0-UI.s1 −1ACCGGCTAATTTTGTAACTGGCTTGT cDNA, 3′ end/clone = IMAGE:TTGTAAAATAAATCCTTCCTGTGT 2731857/clone_end = 3′ 5879 db mining Hs.255881AW297694 6704330 UI-H-BW0-ajh-e-07-0-UI.s1 −1 TGGTGGGACTATGTGTTATTCTTGTAcDNA, 3′ end/clone = IMAGE: TACTTGCAGTGGGTAGATGTCACT 2731881/clone_end =3′ 5880 db mining Hs.255682 AW297698 6704334 UI-H-BW0-ajh-e-11-0-UI.s1−1 ACTTCCCTACCTCACAGGTTAGGATT cDNA, 3′ end/clone = IMAGE:CAAAGTGTGTATTCCCCCATTGTG 2731869/clone_end = 3′ 5881 db mining Hs.255688AW297728 6704364 UI-H-BW0-aiy-a-01-0-UI.s1 −1 GGGTGCTTTACAGGATTCTTGGAAATcDNA, 3′ end/clone = IMAGE: GTGTAGTGGATGCTGGCTCTAGGG 2730888/clone_end =3′ 5882 db mining Hs.255688 AW297749 6704385 UI-H-BW0-aiy-c-03-0-UI.s1−1 ACAGAAGCAGGGGGTCAGAAAGTTT cDNA, 3′ end/clone = IMAGE:CATAAAGGAGGTGTCTTGGAACAAA 2730988/clone_end = 3′ 5883 db miningHs.342530 AW297758 6704392 UI-H-BW0-aiy-d-01-0-UI.s1 −1CTATTGTGTGGGTTGCCTTGTCCTAC cDNA, 3′ end/clone = IMAGE:TCAACTTCAAATATTCACCACCCC 2731032/clone_end = 3′ 5884 db mining Hs.255691AW297780 6704416 UI-H-BW0-aiy-e-11-0-UI.s1 −1 CAGGTGTGCTTACTGGCAGGAACCGcDNA, 3′ end/clone = IMAGE: AGGGGATAAATAAAGATCACTGGAA 2731100/clone_end= 3′ 5885 db mining Hs.255692 AW297761 6704417 UI-H-BW0-aiy-e-12-0-UI.s1−1 ACCAGCCTTATGTGTGTGGGTATTCA cDNA, 3′ end/clone = IMAGE:ATACTCTGCACATTATATACTGTA 2731102/clone_end = 3′ 5886 db mining Hs.255693AW297785 6794421 UI-H-BW0-aiy-f-04-0-UI.s1 −1 GGGCATTTGTTACCCCCTCCTCACCAcDNA, 3′ end/clone = IMAGE: CCATCCCCATTAAAGGCTTCGGGG 2731134/clone_end =3′ 5887 Table 3A Hs.255695 AW297613 6704438 UI-H-BW0-aiy-g-09-0-UI.s1 −1CTGTATCTACAACTCCTGACTTCAGA cDNA, 3′ end/clone = IMAGE:TTTTTGCTTTCTTCAAAACAGCCT 2731192/clone_end = 3′ 5888 Table 3A Hs.255697AW297627 6704452 UI-H-BW0-aiy-h-11-0-UI.s1 −1AGCAAGACTTAACCACTAATTACTATT cDNA, 3′ end/clone = IMAGE:ATCTGACCCAGGACTCCGCC 2731244/clone_end = 3′ 5889 db mining Hs.255698AW297843 6704488 UI-H-BW0-aoa-c-05-0-UI.s1 −1 TGGATAGTTGCTCAATGTAGCAGTGAcDNA, 3′ end/clone = IMAGE: TGTTCTTGGGATTGCCAGCAGAGC 3083913/clone_end =3′ 5890 db mining Hs.326317 AW297929 6704565 yg18e06.s1 cDNA, 3′end/clone = −1 CCAACAGATTCGTGCTTACCCTGAGG IMAGE: 32551/clone_end = 3′TGAAGCCTCGTTTGAGAACCAAAT 5891 db mining Hs.255705 AW297949 6704565UI-H-BW0-ajn-d-11-0-UI.s1 −1 CAACCTTCTTGTTGAATTGATTTACTA cDNA, 3′end/clone = IMAGE: CTCATCAGGGTCATGCACAAGCA 2732229/clone_end = 3′ 5892db mining Hs.255706 AW297951 6704587 UI-H-BW0-ejn-e-01-0-UI.s1 −1ACATTCAAACTGCCAGAATATGACTG cDNA, 3′ end/clone = IMAGE:TAAAACAGCGAAGTGTTCTCTTGC 2732257/clone_end = 3′ 5893 db mining Hs.255708AW297970 6704600 UI-H-BW0-ajn-f-10-0-UI.s1 −1 TCTTCCTGGGAATGTGATGTGTTTTTcDNA, 3′ end/clone = IMAGE: CACTGGTTCTAATTCTGTCTTCCT 2732323/clone_end =3′ 5894 db mining Hs.255710 AW297974 6704610 UI-H-BW0-ajn-g-02-0-UI.s1−1 ACTTATTAATTCTCACCTCAGCCTCA cDNA, 3′ end/clone = IMAGE:GGGATGTATGTAGGGAAGGAGCAT 2732355/clone_end = 3′ 5895 db mining Hs.255713AW297994 6704830 UI-H-BW0-ajn-h-11-0-UI.s1 −1 ACATTCCTGTCATTAGTGAATAAGAAcDNA, 3′ end/clone = IMAGE: GCTGAGGTGTGACTAAGAAGACAA 2732421/clone_end =3′ 5896 db mining Hs.255717 AW298042 6704678 UI-H-BW0-ajp-e-07-0-UI.s1−1 CCTCCTTGATAAAATCAAGAACAGGT cDNA, 3′ end/clone = IMAGE:TAGATTAAAGCAGTAAATCCTAGACT 2732629/clone_end = 3′ 5697 db miningHs.330189 AW298048 6704684 UI-H-BW0-ejp-f-01-0-UI.s1 −1TCCTGGCCTTTGTGGGTTTTTAATTC cDNA, 3′ end/clone = IMAGE:CCTTTACCTTTTCCCTTTTTGGAT 2732665/clone_end = 3′ 5898 db mining Hs.255721AW298073 6704709 UI-H-BW0-ajp-h-05-0-UI.s1 −1 ACTGCTGCAACTACAATTCTCAGATAcDNA, 3′ end/clone = IMAGE: GTCCCATTTGTTTAAATCACGCAT 2732769/clone_end =3′ 5899 db mining Hs.342533 AW296095 6704731 UI-H-BW0-ajs-b-12-0-UI.s1−1 CCTTCCCTCTTGCCTGTAGGTTCTGT cDNA, 3′ end/clone = IMAGE:GGCTATAAACAAATCATAACTTTT 2732878/clone_end = 3′ 5900 db mining Hs.255725AW298100 6704742 UI-H-BW0-ajs-c-07-0-UI.s1 −1 TTAAATGCTTCCCTGGCTCTCCCTGGcDNA, 3′ end/clone = IMAGE: GTTTCAGTTTCTATCCATGCCCTG 2732916/clone_end =3′ 5901 db mining Hs.255726 AW298110 6704746 UI-H-BW0-ajs-c-11-0-UI.s1−1 TTGTTCTCCTCCCAAGTCTCTGGTTC cDNA, 3′ end/clone = IMAGE:TATTTGGCTTTTTCAGCTCTGTGC 2732924/clone_end = 3′ 5902 db mining Hs.255727AW298123 6704759 UI-H-BW0-ajs-e-01-0-UI.s1 −1 GCATTTCAGGGACACAAATGGGTcDNA, 3′ end/clone = IMAGE: CCATGGCAGAGACCAGTAATGCCA 2733000/clone_end =3′ GATA 5903 db mining Hs.255736 AW298201 6704837UI-H-BW0-ajt-d-08-0-UI.s1 −1 TTTTATCCCCGCTTTAACTTTGTTTGC cDNA, 3′end/clone = IMAGE: TTGGTACTTTTCTTGTGGTTACA 2732967/clone_end = 3′ 5904db mining NA AW298208 6704844 UI-H-BW0-ajl-e-05-0-UI.s1 −1CACGCACCCAACTCCCCACTGCTCCT NCI_CGAP_Sub6 cDNA cloneCTCCATCCAGATGTTCGTCCAGAG IMAGE: 2733009 3′, mRNA sequence 5905 db miningHs.255740 AW298234 6704870 UI-H-BW0-ajt-g-09-0-UI.s1 −1TTTGAGGGCAATTTAATGGTTAAGTG cDNA, 3′ end/clone = IMAGE:TAGGAAAATCCACTCTTACAGTGT 2733113/clone_end = 3′ 5906 db mining Hs.330191AW298238 6704874 UI-H-BW0-ajt-h-04-0-UI.s1 −1 GGCCTTTTGATTTTCCATTGGGGTCCcDNA, 3′ end/clone = IMAGE: CCCGCTTTCCCATTTTTGGTTTTT 2733151/clone_end =3′ 5907 db mining Hs.255743 AW298239 6704875 UI-H-BW0-ajt-h-05-0-UI.s1−1 GACAGTTTGGGGAAGGGATTGAAGG cDNA, 3′ end/clone = IMAGE:TCTGCGTCAAAGAGAACAGAAAACC 2733153/clone_end = 3′ 5908 db mining NAAW298271 6704994 UI-H-BW0-ajk-d-01-0-UI.s1 −1 AGGGGCCTTTTACCGGTTTGTTTTCCcDNA, 3′ end/clone = IMAGE: CTTAAATTTTTAAAGGAATTGAAT 2732184/clone_end =3′ 5909 db mining Hs.183669 AW298312 6705035 mRNA for KIAA1271 protein,−1 TCCTCTTTCTTGTCACTGTGAAGCGA partial cds/cds = (72, 1700)TGAATAAACCTGGGTGTAGATCCA 5910 db mining Hs.302681 AW298348 67049087j80e10.x1 cDNA, 3′ end/clone = −1 CCTAGAAATTATTATACAGGGATAAAT IMAGE:3392778/clone_end = 3′ GAGGCACTGAAGGTGGGAGAACC 5911 db mining Hs.255746AW298349 6704909 UI-H-BW0-ajj-c-10-0-UI.s1 −1 ACGACAAACTGCACAGTAAATATCACcDNA, 3′ end/clone = IMAGE: AAACACGGAAATACCACAGTGTCT 2731795/clone_end =3′ 5912 db mining Hs.255747 AW298355 6704915 UI-H-BW0-ajj-d-06-0-UI.s1−1 ACCATGACTTGGCAAAGAGTTTCAAG cDNA, 3′ end/clone = IMAGE:AGAGGGCATAATCAAAAGTAACCA 2731835/clone_end = 3′ 5913 db mining Hs.255749AW298388 6704948 UI-H-BW0-ajj-g-08-0-UI.s1 −1 GATTAATCAAGGGAAGAGCTTCAAGCcDNA, 3′ end/clone = IMAGE: AGAGCTCCTTAGGTTTTTCAAAAA 2731983/clone_end =3′ 5914 Table 3A Hs.313413 AW298430 6705068 802721745F1 cDNA, 5′ end/ −1GCTCAGGGGACAGCTATTCTTTTTCA clone = IMAGE: 4848506/AGAGCTCCTTAGGTTTTTCAAAA clone_end = 5′ 5915 db mining Hs.255762 AW2984376705073 UI-H-BW0-ajl-d-08-0-UI.s1 −1 TGAGAGCTTTCCTTCCTCCTACGATC cDNA, 3′end/clone = IMAGE: CAACCTGTCAAACATTTCCTACA 2732199/clone_end = 3′ 5916db mining Hs.255763 AW298445 6705081 UI-H-BW0-ajl-e-07-0-UI.s1 −1TGTGCCAACGCATGATTTCTTTGAGT cDNA, 3′ end/clone = IMAGE:AAATTTCTAAACGTCACAGAAGTT 2732245/clone_end = 3′ 5917 db mining Hs.255764AW298447 6705083 UI-H-BW0-ajl-e-09-0-UI.s1 −1 AGTCAACATGGAGCAAGTGAGCTAAGcDNA, 3′ end/clone = IMAGE: GAAGTAATGGAAACTGTTTGGAGA 2732249/clone_end =3′ 5918 db mining Hs.255766 AW298482 6705118 UI-H-BW0-ajl-h-11-0-UI.s1−1 AGCTCAGGTCTTCCCTCATCTGTTAG cDNA, 3′ end/clone = IMAGE:TTTCCTGGAGTCTGTTCTCATACT 2732397/clone_end = 3′ 5919 db mining Hs.255767AW298489 6705125 UI-H-BW0-ajm-a-08-0-UI.s1 −1 AAACATACTCCTCTTCACCAGCACTCcDNA, 3′ end/clone = IMAGE: AGACATTTGTATCCAGAGAAAGCT 2732078/clone_end =3′ 5920 db mining Hs.255768 AW298490 6705128 UI-H-BW0-ajm-a-09-0-UI.s1−1 AGTCTGCAATTGTTTAAGCCTGTGA cDNA, 3′ end/clone = IMAGE:TCTTTCTTTTCCCAGTTAAGAGTT 2732080/clone_end = 3′ 5921 db mining Hs.255769AW298494 6705130 UI-H-BW0-ajm-b-01-0-UI.s1 −1 TGTCCTCTCAACCCTACTTGTGGTTTcDNA, 3′ end/clone = IMAGE: TACACTGTTAATTACACTATTTGC 2732112/clone_end =3′ 5922 db mining Hs.132781 AW298502 6705138 class I cytokine receptor(WSX-1), −1 GTGTGTGTATGGTTGTTGGGCGTAG mRNA/cds = (138, 2048)GACAGGTTTCGGGGATGCGCGGTAC 5923 db mining Hs.255770 AW298503 6705139UI-H-BW0-ajm-b-12-0-UI.s1 −1 CTGTGCTTGACTATTGAAAACTTAGA cDNA, 3′end/clone = IMAGE: ATTGGGATGCCAAAGTTACTTCCT 2732134/clone_end = 3′ 5924db mining Hs.255772 AW298510 6705146 UI-H-BW0-ajm-c-11-0-UI.s1 −1GGTTGTATCAAAAGAACTCCACATCC cDNA, 3′ end/clone = IMAGE:ATATTGAATAAACTCCCACTAGCC 2732180/clone_end = 3′ 5925 db mining Hs.255777AW298559 6705195 UI-H-BW0-ajm-n-04-0-UI.s1 −1 GGCTGCCCAGATCTCGTGGGAAGAAcDNA, 3′ end/clone = IMAGE: GACCACAGGAGGACTCGGCTCAATG 2732406/clone_end= 3′ 5926 db mining Hs.255779 AW298607 6705243 UI-H-BW0-ajr-d-12-0-UI.s1−1 TGGAAAAATGATAGCAGCCAACTTGA cDNA, 3′ end/clone = IMAGE:CAGAAGAACCCAGCATACACATTC 2732615/clone_end = 3′ 5927 db mining Hs.255762AW298616 6705252 UI-H-BW0-ajr-e-10-0-UI.s1 −1 TTGGTTTTGGGGATTGGGAAGTCTTAcDNA, 3′ end/clone = IMAGE: AGCCAAATTGTCCCCGGTCTCCCC 2732659/clone_end =3′ 5928 db mining Hs.255783 AW298627 6705263 UI-H-BW0-ajr-f-10-0-UI.s1−1 GCCCTATATCTAGTGAGCAGGTTGTG cDNA, 3′ end/clone = IMAGE:GCAATCAGGAAGGGATTGATATTT 2732707/clone_end = 3′ 5929 db mining Hs.255784AW298832 6705268 UI-H-BW0-ajr-g-04-0-UI.s1 −1 TGCACGCAATGCTTGAAGTGTTCCCAcDNA, 3′ end/clone = IMAGE: GGTATTTAGTTTCAGGTAAATTTT 2732743/clone_end =3′ 5930 db mining Hs.255785 AW298647 6705283 UI-H-BW0-ajr-h-09-0-UI.s1−1 CTGTAGGTATGAGCTGCCAGGATCCA cDNA, 3′ end/clone = IMAGE:GGTGTGACTCGGGTATTTCTAGGG 2732801/clone_end = 3′ 5931 db mining Hs.255788AW298875 6705311 UI-H-BW0-ajo-c-03-0-UI.s1 −1 TCCCATTTGGGGGGTGGGCTGTTAAcDNA, 3′ end/clone = IMAGE: ATTTTGACTCCCTGTTTTAAACCC 2732524/clone_end =3′ 5932 db mining Hs.255794 AW298720 6705358 UI-H-BW0-ajo-g-07-0-UI.s1−1 CCACTTGCATCTCTTCTGGGGGTTCT cDNA, 3′ end/clone = IMAGE:TTCCTTTCTTTCCTGTTCTAAGGC 2732724/clone_end = 3′ 5933 db mining Hs.255797AW298752 6705388 UI-H-BW0-ajq-b-08-0-UI.s1 −1 TGGGTAATCAACACTCAACCATCAACcDNA, 3′ end/clone = IMAGE: AAACACTCTCTATTCCAGGCACTG 2732506/clone_end =3′ 5934 db mining Hs.255799 AW298806 6705442 RC4-MT0235-061200-011-a11−1 AGGAGAAATAATTAGAGTGGCACACT AGCATGATGGTAAACATTCTGTCA 5935 Table 3AHs.157396 AW300500 6710177 xs66c06.x1 cDNA, 3′ end/clone = −1AGGAGTTCAAGAAGCAGAGATTTCCA IMAGE: 2774602/clone_end = 3′GGTCCATGCACCAAAGCTCATGTG 5936 Table 3A Hs.262789 AW300888 6710545xk07d09.x1 cDNA, 3′ end/clone = −1 CTTGTCCTCTCCTGATCCAGGGCTCC IMAGE:2666033/clone_end = 3′ AGTGCCCATGTCCAGTGCCTTGGT 5937 db mining Hs.255880AW337887 6834513 he12d07.x1 cDNA, 3′ end/clone = −1GCATCTCCCCGCTGTCAGCCTCAGC IMAGE: 2918797/clone_end = 3′CCTCTCCTACCAAAATCTCTTTCGA 5938 Table 3A Hs.328348 AW338115 6834741tp39g05.x1 cDNA, 3′ end/clone = −1 GGCGTTTCCCATTGACCAGTTTGACC IMAGE:2190200/clone_end = 3′ CTGGTTTGAATAAAGAGAAGTGCG 5939 db mining Hs.255920AW339530 6836156 he13d09.x1 cDNA, 3′ end/clone = −1AGCCCATTGAAAACCTTGGCAAAATG IMAGE: 2918897/clone_end = 3′TCAGACCTTAAGACTTTCCACTAT 5940 Table 3A Hs.255927 AW339851 6836277he15g04.x1 cDNA, 3′ end/clone = −1 TCAGAGACAACGGAAGCTGAAAAATA IMAGE:2919126/clone_end = 3′ AGAGCTGAGAAAGGAAGAACTTTT 5941 Table 3A Hs.207995AW340421 6837047 hc96h02.x1 cDNA, 3′ end/clone = −1ATATACATACAAATCTAAGCTCCAAG IMAGE: 2907891/clone_end = 3′AAGCCTAAGAAAACCCCTTAGGGG 5942 Table 3A Hs.256031 AW341086 6837631xz92h04.x1 cDNA, 3′ end/clone = −1 GGGCAATTTACATCGGGACTCGTTTC IMAGE:2871703/clone_end = 3′ ATCTCTAGACCTTCACTTACCTGA 5943 Table 3A Hs.283867AW341449 6838075 arginyl aminopeptidase (amino- −1AGCTCTGGAGTGCCCCTCCCTCCAAA peptidase B) (RNPEP), mRNA/TAAAGTATTTTAAGCGAACACTGA cds = (9, 1982) 5944 Table 3A Hs.337986AW440517 6975823 Homo sapiens, clone MGC: 17431 −1GCCAGTCTCTATGTGTCTTAATCCCT IMAGE: 2984883, mRNA,TGTCCTTCATTAAAAGCAAAACTA complete cds/cds = (1338, 1494) 5945 db miningHs.256958 AW440813 6976044 he03b05.x1 cDNA, 3′ end/clone = −1CCCTCAGGCATAGAAATTGAATCTGA IMAGE: 2917905/clone_end = 3′AATGGCTGATGAATAAGCAAAGGC 5946 db mining Hs.313573 AW440817 6976048he03c02.x1 cDNA, 3′ end/clone = −1 CAGCCCTGCCTGAGTTTTTGACACCT IMAGE:2917922/clone_end = 3′ GCATCCCTCCCTGCCTCACCTCAC 5947 Table 3A Hs.256981AW440866 6976172 he05f02.x1 cDNA, 3′ end/clone = −1AGAGCAGGAGAAATCCTACTGCATTA IMAGE: 2918139/clone_end = 3′TTAATCTGAAAGCACAAGGACAGC 5948 Table 3A Hs.173730 AW440869 6976175Mediterranean faver (MEFV), −1 CTGTCTTGGTTTGTATGGGAAAATCT mRNA/cds =(41, 2386) GCGGGTTGTGGAATATTAGGTTCT 5949 Table 3A Hs.118448 AW4409856976271 HNC35-1-D12.R cDNA −1 TGGGATTATAGGGGGAGACAGGAGTTGTGGAATTACAGGAGAGGTTCACT 5950 db mining Hs.118446 AW440985 6976271HNC35-1-D12.R cDNA −1 TGGGATTATAGGGGGAGACAGGAGTTGTGGAATTACAGGAGAGGTTCACT 5951 Table 3A Hs.256971 AW440974 6976280he08e12.x1 cDNA, 3′ end/clone = −1 CTGAGAAAAGGAGTGTCTCTCTTCTG IMAGE:2918254/clone_end = 3′ CTCCCAAACTTCCAGTAGCTTCCA 5952 Table 3A Hs.342632AW444482 6988244 UI-H-BI3-akb-e-05-0-UI.s1 cDNA, −1TCGAGGTTCTTCCCAAGAAAAGCCCA 3′ end/clone = IMAGE:ATCTTATAAACTGTTACTTCCCCT 2733777/clone_end = 3′ 5953 Table 3A Hs.250AW444632 6988394 xanthene dehydrogenase (XDH), −1TGCAATGAGGCAGTGGGGTAAGGTT mRNA/cds = (81, 4082)AAATCCTCTAACCGTCTTTGAATCA 5954 Table 3A Hs.335815 AW444812 6986574UI-H-BI3-ajy-d-11-0-UI.s1 cDNA, −1 TGGCAACTTCAACTCCTTGATGGCGA 3′end/clone = IMAGE: TAATCTCTGGTATGAATATGAGCC 2733380/clone_end = 3′ 5955Table 3A Hs.99665 AW444899 6986661 UI-H-BI3-ajz-d-07-0-UI.s1 cDNA, −1TTGTGCTCCTGATACGACGTTGCCAC 3′ end/clone = IMAGE:AGTTAATCCGTTCTGATCTCTGCT 2733373/clone_end = 3′ 5956 Table 3A Hs.257283AW450350 6991126 UI-H-BI3-akn-c-01-0-UI.s1 cDNA, −1CAAGCCTAACTTTCCAACACTCCCGC 3′ end/clone = IMAGE:GACGCAACCCCTTCCCCTTTCCTC 2734825/clone_end = 3′ 5957 Table 3A Hs.313715AW450835 6991611 UI-H-BI3-alf-f-06-0-UI.s1 cDNA, −1CACGGTTAGAGTCACCAAACCTGTAT 3′ end/clone = IMAGE:TTCAGGGGACATCTTTCCAGCTCC 2736539/clone_end = 3′ 5958 Table 3A Hs.199014AW250874 6991850 601499703F cDNA, 5′ end/clone = −CCAAAGGCTCACTACCCCTGTGCGTT IMAGE: 3901440/clone_end = 5′GTCCAGCACACAGACACTATGTGC 5959 Table 3A Hs.342873 AW451293 6992069RC3-HT0230-130100-014-g06 −1 TGCTTGGGAAATTTGGTTTGTAAACC cDNATAAAATAGCCCTTATTTCTGGGGA 5960 Table 3A Hs.101370 AW452023 6992799AL583391 cDNA/clone = −1 CATCTGCTGAGCAGTGTGCTGTGTCACS0DL012YA12-(3-prime) ACCTCCTCCTAGGTCTCCTCTATG 5961 Table 3A Hs.342735AW452096 6992953 UI-H-BI3-alo-d-02-0-UI.s1 cDNA, −1CTTTCTGCCTGAAGCTGCCCCCATGA 3′ end/clone = IMAGE:CTCCCTTCTTTGTGCAAAAGCATG 3069196/clone_end = 3′ 5962 Table 3A NAAW452487 6993243 UI-H-BI3-als-e-09-0-UI.s1 −1 GAAATGAGTTGGTGTCTTCACAGAATNCI_CGAP_Sub5 cDNA clone GAGGATCCCCAGAGCCATCTTGCC IMAGE: 3068632 3′,mRNA sequence 5963 Table 3A Hs.257579 AW452513 6993289UI-H-BW1-ame-b-03-0-UI.s1 −1 GTCTCCCTCCCACTCTCTGCCTTACC cDNA, 3′end/clone = IMAGE: TGGTATCTATGACTCGACTGAAAT 3069628/clone_end = 3′ 5964db mining Hs.257581 AW452528 6993304 UI-H-BW1-ame-c-07-0-UI.s1 −1TGCGAGAGGAAGCAGAGACCACCT cDNA, 3′ end/clone = IMAGE:GAAACTCGGGTGCATTAAGTCCTTG 3069684/clone_end = 3′ 5965 db miningHs.257582 AW452545 6993321 UI-H-BW1-ame-d-12-0-UI.s1 −1TTAGCCACTGCTATTCTAGGTTCCTT cDNA, 3′ end/clone = IMAGE:GATGGAGCCCCACTCCCACGCCTA 3069742/clone_end = 3′ 5966 db mining Hs.257630AW452932 6993708 UI-H-BW1-amd-c-07-0-UI.s1 −1 ACCACCCAGAGGTTGCTGGCTTCCTTcDNA, 3′ end/clone = IMAGE: AATAAAGCTAACTTTCCTTTCACC 3069325/clone_end =3′ 5967 db mining Hs.257632 AW452953 6993729 UI-H-BW1-amd-e-04-0-UI.s1−1 AGGGGAGCCAGTGGTTTTTGGTCAT cDNA, 3′ end/clone = IMAGE:GGGAAGTGTTCTCATAAAATTCATT 3069415/clone_end = 3′ 5968 db miningHs.257633 AW452960 6993736 UI-H-BW1-amd-e-11-0-UI.s1 −1GCACCAGACTTCTGAACAGGCTGGG cDNA, 3′ end/clone = IMAGE:AGAGTGAGGCATAAACACATGAAAT 3069429/clone_end = 3′ 5969 db miningHs.257638 AW452985 6993761 UI-H-BW1-amd-g-12-0-UI.s1 −1ACACAGTACTTTGTTGAGATGTTGGC cDNA, 3′ end/clone = IMAGE:TTCTTGGTTTATGGCATGAATTCT 3069527/clone_end = 3′ 5970 Table 3A Hs.257640AW453021 6993797 UI-H-BW1-ama-c-02-0-UI.s1 −1 ACTTATCTTTTGCCACCCATGTTCCTcDNA, 3′ end/clone = IMAGE: GGATGCCTTGCCTTCCTCTTTCAT 3069290/clone_end =3′ 5971 db mining Hs.257644 AW453034 6993810 UI-H-BW1-ama-d-03-0-UI.s1−1 AAACAGGAAGCCTCTCATGAATTTGA cDNA, 3′ end/clone = IMAGE:CCAAGGAGCTACATTCGTTCTCTA 3069340/clone_end = 3′ 5972 db mining Hs.257645AW453039 6993815 UI-H-BW1-ama-d-08-0-UI.s1 −1 TGAGGAAGAGGAGATTTATTAAGCCCcDNA, 3′ end/clone = IMAGE: CTTCTTTTAGGCTAGGAGGTTTCC 3069350/clone_end =3′ 5973 Table 3A Hs.257648 AW453044 6993820 UI-H-BW1-ama-e-01-0-UI.s1 −1GGACACTGGCTTTTGTGCAGCTCTTC cDNA, 3′ end/clone = IMAGE:ATCACAGAGTCTGTTGAGCTACAA 3069384/clone_end = 3′ 5974 db mining Hs.257647AW453055 6993831 UI-H-BW1-ama-e-12-0-UI.s1 −1 ACAGTGATTTTCAACCAAGGGGCTTTcDNA, 3′ end/clone = IMAGE: TTCAAACTACATTCCTTAGCTCCC 3069408/clone_end =3′ 5975 Table 3A Hs.257667 AW467193 7037299 he07a04.x1 cDNA, 3′end/clone = −1 GGTGGTGGCTACAAGGGTGATTGCC 2918288/clone_end = 3′TTATGATAATTGACCGTGTCATAAT 5976 db mining Hs.257688 AW487208 703314he07c09.x1 cDNA, 3′ end/clone = −1 AGCTGGGAGGCCATTACTTTTTGTCT2918320/clone_end = 3′ GAGTCTTCTGGAGTTCTAGCAAAA 5977 db mining Hs.255877AW467312 703418 he09b01.x1 cDNA, 3′ end/clone = −1AGTTGCATTAAACTGAGCTTAGATGT 2918473/clone_end = 3′GTAAGTTTGCTAACGGATGGGTTT 5978 db mining Hs.257677 AW467338 7037444he09e07.x1 cDNA, 3′ end/clone = −1 CCTCTAAGGCATTTATTTACTGACAA2918532/clone_end = 3′ CATAAAATCTTGAACCCCAGGTCA 5979 db mining Hs.257679AW467385 7037491 he10d12.x1 cDNA, 3′ end/clone = −1TCACCTCCATCAACTTACTAGCACAT 2918815/clone_end = 3′AAAGGGTGGGATTTCATGTGTTGA 5980 Table 3A Hs.257880 AW487400 7037506he10f11.x1 cDNA, 3′ end/clone = −1 CTGGCAAAGGCATGGGTACAACCTG IMAGE:2918637/clone_end = 3′ CTCTGTGATCTACCTTCTGAACCAC 5981 db mining NAAW487421 7037527 he17b02.x1 NCI_CGAP_CML 1 −1ACACCTGTGGTATATTTGTATCATTCA cDNA clone IMAGE: 2919243 3′GTCTGGTTTCTCACCCTTCCTAA similar to contians Alu repetitive element; con5982 Table 3A NA AW487437 7037543 he17d05.x1 NCI_CGAP_CML 1 −1AACCCTCGTAAGGTTTCATCTTCCTT cDNA clone IMAGE: 2919273 3′GATTGCAAAATGAGTTTGTGTGAA mRNA sequence 5983 db mining NA AW4674457037551 he17e08.x1 NCI_CGAP_CML 1 −1 CCCGCTTCACCTTCCCTAAATAACTC cDNAclone IMAGE: 2919302 3′ GTTTGCAGGCTAATTCCATCAAAT similar to containselement MSR1 repetitive el 5984 db mining NA AW487448 7037554 he17l02.x1NCI_CGAP_CML 1 −1 ATTTTGCTCATTACCTGTCAGGAGAA cDNA clone IMAGE: 29192913′ AACCCTCCTTCCCCAGTCTCCACT similar to contians Alu repetitive element;con 5985 Table 3A Hs.257687 AW467501 7037607 he19e06.x1 cDNA, 3′end/clone = −1 ACCTACTGAATCTCCAGATTGCCAAG IMAGE: 2919490/clone_end = 3′TGAAACACAATGGTTGCCTCTTCA 5986 db mining Hs.257688 AW467571 7037677he21l02.x1 cDNA, 3′ end/clone = −1 TGCGAAAGCTAATTCCCTAGTATGAA IMAGE:2919675/clone_end = 3′ TAAACTTCAGACCTTGCTCTCCTT 5987 db mining Hs.257690AW467582 7037688 602497524F1 cDNA, 5′ end/ −1 AGCCTGAGGTGGGTGAAGAAAATACclone = IMAGE: 4611316/ CTGCTTTATACTGTTCTGGAAACTC clone_end = 5′ 5988 dbmining Hs.266387 AW467607 7037713 he22c05.x1 cDNA, 3′ end/clone = −1CTTTTCCCCTTCATGGTAGTTGCTGC IMAGE: 2919752/clone_end = 3′TTAAGTTTCTCTAACATGCCTGCA 5989 Table 3A Hs.257695 AW467746 7037776he23d05.x1 cDNA, 3′ end/clone = −1 TGAATGTGCAGATGCAGAACCCATTG IMAGE:2919849/clone_end = 3′ ATATGGAGGGCTGAGTGTCTGAAA 5990 Table 3A Hs.257705AW467863 7037969 he27c04.x1 cDNA, 3′ end/clone = −1TGTACTACTTATTTATGTGTAAACCAT IMAGE: 2920230/clone_end = 3′ACACAGGGCTAGAAAGGAAGGGAT 5991 Table 3A Hs.257706 AW467884 7037970he27c05.x1 cDNA, 3′ end/clone = −1 TGTAGAATTGCGGAGTAGAAAGACCC IMAGE:2920232/clone_end = 3′ TTGAAAGATCATTTGTCCTGTGGT 5992 Table 3A Hs.257709AW467992 7038098 he30b01.x1 cDNA, 3′ end/clone = −1GCTCAAGTTCCCAGCACCTGGGGAA IMAGE: 2920489/clone_end = 3′TTCTAAGCCTGAGGAAGACAAGGTG 5993 db mining Hs.257713 AW468139 7038245he32g11.x1 cDNA, 3′ end/clone = −1 TGTTTTTATGTCCTGAGCAAGCAAATT IMAGE:2920772/clone_end = 3′ GCTGCAATTAAAATCACCAATTT 5994 Table 3A Hs.257716AW468207 7038313 he34e12.x1 cDNA, 3′ end/clone = −1AGGCCTGATATTGAAAGCTTTTGATA IMAGE: 2920894/clone_end = 3′CTGAGATCCTATTAATCTCAGATGA 5995 db mining Hs.257719 AW468316 7038422he38a05.x1 cDNA, 3′ end/clone = −1 TGTTAGTTTGCTTTTGAAATTCTTTGG IMAGE:2921072/clone_end = 3′ AGGGTACTCTTCAGGGCTTCACA 5996 db mining Hs.278060AW488430 7038538 he37h10.x1 cDNA, 3′ end/clone = −1TAGTGATTATCTCCAGGAATCAAGTA IMAGE: 2921251/clone_end = 3′CAAACTTTGAAAAAAGACTGGAGGT 5997 Table 3A Hs.257727 AW488431 7038537he37h11.x1 cDNA, 3′ end/clone = −1 TTGTCCCAAGGGCTCAGACTGAAAG IMAGE:2921253/clone_end = 3′ AATGCAATGTGAGAGGTATGCCAC 5998 db mining Hs.330268AW468459 7038565 he38d05.x1 cDNA, 3′ end/clone = −1TCTGTGAAAATCTTTCTGCAAATGTCT IMAGE: 2921289/clone_end = 3′TTGCTTGCTTGTACTCACGTTTT 5999 db mining Hs.257738 AW468559 7038665he41a07.x1 cDNA, 3′ end/clone = −1 TGTCTTTAACGCACAGATGTTACTTC IMAGE:2921556/clone_end = 3′ AGCACCACAAGGACTGTTGATGGA 6000 Table 3A Hs.257743AW488621 7038727 he42e03.x1 cDNA, 3′ end/clone = −1CAGTCAGATGTTGGAATTGGGGGTA IMAGE: 2921692/clone_end = 3′GAGGGATTATAGAGTTGTGTGTGCT 6001 Table 3A Hs.122116 AW469546 7039652hd19e09.x1 cDNA, 3′ end/clone = −1 AAAGGAGGGACTATGGCATCAAACA IMAGE:2909992/clone_end = 3′ GCCTCTTCAGCACAGTGACACCATG 6002 Table 3A Hs.80618AW510795 7148873 hypothetical protein (FLJ20015), −1ACCCAGTTTGTGCATAGTTCATGATC mRNA/cds = (31, 522) CTCTATAAAACCAGCTTTTGTGGA6003 Table 3A Hs.193869 AW512498 7150576 hypothelical protein −1CTGTCGGGCTCTGAAGCGAGCTGGT DKFZp588J1119 TTAGTTGTAGAAGATGCTCTGTTTG(DKFZp588J1119), mRNA/cds = (27, 2153) 6004 Table 3A Hs.42915 AW5725387237271 ARP2 (actin-related protein 2, −1 TGGAATGGACTCTTAAAACAATGAAAyeast) homolog (ACTR2), mRNA/ GAGCATTTATCGTTTGTCCCTTGA cds = (74, 1258)6005 Table 3A Hs.342858 AW572930 7237663 hf17f07.x1 cDNA, 3′ end/clone =−1 TCACTACCTTCAATTGTTTACAAGGT IMAGE: 2932165/clone_end = 3′GGATATGGGCAGGCAACAGATACT 6006 Table 3A Hs.325991 AW573211 7237944602679187F1 cDNA, 5′ end/ −1 CTAGGCCGGATGGGCCAGAGAAGGA clone = IMAGE:4812093/ GAACCATGGCAGGAGCCGGAAGCAG clone_end = 5′ 6007 db miningHs.258933 AW589231 7276337 he27g09.x1 cDNA, 3′ end/clone = −1AAATGTTGAGCAACTGTTCAAAT IMAGE: 2920288/clone_end = 3′AACAGCACTAATTGTGTGTTCATT GGCT 6008 Table 3A Hs.304925 AW592876 7280068hg04d05.x1 cDNA, 3′ end/clone = −1 CTGGCACATCCAGGTTTTAGAGCAGG IMAGE:2944617/clone_end = 3′ CAGCCTGAGATTTCAAAAATGAGG 6009 Table 3A Hs.298654AW614181 7319367 hg77d03.x1 cDNA, 3′ end/clone = −1GGAGCGGAATACAGTAAAAGCACTG IMAGE: 2951621/clone_end = 3′GACTGACCTAAGAGTTTGTTTCTGC 6010 Table 3A Hs.259842 AW614193 7319379 cDNAFLJ11025 fis, clone −1 ACACCATTTCAGCGTTGGATCACAGA PLACE 1003968,moderately CAGCTCTTCCTTTATATCCCAGCA similar to 5′-AMP-ACTIVATED PROTEINKINASE, GAMMA-1 SUBUNIT/cds = (159, 1145) 6011 Table 3A Hs.342967AW629176 7375966 802819939F1 cDNA, 5′ end/ −1 CCACCTTGCTGCCTTTTGAAACACTCclone = IMAGE: 4745649/ AGGAAATATAGTTGGCTAAAACTG clone_end = 5′ 6012Table 3A Hs.140720 AW629485 7376275 FRAT2 mRNA, complete cds/ −1CACTTCGCAACGGAGTGTTTGAAATT cds = (129, 830) GTGGTGGTCCTGATTTATAGGATT6013 db mining Hs.175437 AW771958 7704007 hn88h09.x1 cDNA, 3′ end/clone= −1 GCTTTGGCAGATGGATTAACCTTGTT IMAGE: 3032897/clone_end = 3′CTTTTGGAGCCAGATCAATATCTA 6014 Table 3A Hs.151393 AW778854 7793457glutamate-cysteine ligase catalytic −1 AGAATGCCTGGTTTTCGTTTGCAATTsubunit (GCLC), mRNA/cds = (92, TGCTTGTGTAAATCAGGTTGTAAA 2005) 6015Table 3A Hs.109441 AW780057 7794660 cDNA FLJ14235 fis, clone −1TTCTGAACATTTTAGTCAAGCTACAAC NT2RP4000167/cds = (62, 2172)AGGTTTGGAAAACCTCTGTGGGG 6016 Table 3A Hs.343475 AW873028 8007081601556208T1 cDNA, 3′ end/ −1 TGCAAGTGGATGGTTTGGTATCACTG clone = IMAGE:3826392/ TAAATAAAAAGAGGGCCTGGGAAA clone_end = 3′ 6017 Table 3A Hs.166338AW873324 8007377 hl92e07.x1 cDNA, 3′ end/clone = −1GTGGCTTTTCTGTTGACGCCAAAGGT IMAGE: 3009396/clone_end = 3′TACTCCCTCTGCCTCACCATAAAA 6018 Table 3A Hs.90960 AW873326 8007379602563938F1 cDNA, 5′ end/ −1 ACCTCCTACGTCTGTTTTCTGGCTGT clone = IMAGE:4688769/ GGTGACTTGGGATTTTTAACCTTA clone_end = 5′ 6019 Table 3A Hs.120243BE044364 8361417 gamma-parvin (PARVG), mRNA/ −1ATCGTTGGATTATCTTTGAACCCCCT cds = (0, 995) TGTGTGGATCATTTTGAGCCGCCT 6020db mining Hs.157489 BE047166 8364219 602462536F1 cDNA, 5′ end/ −1AGCTCCAAAGTGGTTTGATGACCACA clone = IMAGE: 4575393/GGCTAAAATTCATAGTCTTAAAAT clone_end = 5′ 6021 Table 3A Hs.82316 BE0494398366494 interferon-induced, hepatitus C- −1 TCAGAAAGGAGAAAACACAGACassociated microtubular aggregate CAAAGAGAAGTATCTAAGACCAAA protein(44kD) (MTAP44), GGGA mRNA/cds = (0, 1334) 6022 Table 3A Hs.121587BE217848 8905166 602637362F1 cDNA, 5′ end/ −1 GCATCACGATTTGTCTACATAAGTCCclone = IMAGE: 4765191/ AGTTCATCTCGCGTTTGTTTTGGC clone_end = 5′ 6023Table 3A Hs.5734 BE218938 8906256 meningloma expressed antigen 5 −1ATACAGGGTTCCATCCAGAAAGCATT (hyaluronidase) (MGEA5), mRNA/CAGTCAGAGCAAGTTAAAGTCAGT cds = (395, 3145) 6024 Table 3A Hs.203772BE220869 8908187 FSHD region gene 1 (RFG1), −1AAGTGCCAGATTTTGATAATCACCAG mRNA/cds = (191, 967)CCTCTCATTCAACTCCTATGTTGC 6025 Table 3A Hs.73931 BE220959 8908277 majorhistocompatibility complex, −1 ACCCTTGGTCACTGGTGTTTCAAACA class II, DQbeta 1 (HLA-DQB1), TTCTGGCAAGTCACATCAATCAAG mRNA/cds = (57, 842) 6026Table 3A Hs.128675 BE222032 8909271 hr61g11.x1 cDNA, 3′ end/clone = −1AGCTCTGGAGCCTTTGCTTCCTCAAA IMAGE: 3133028/clone_end = 3′TACGAGCGGGAACTGCGTTGAGCG 6027 Table 3A Hs.167988 BE222301 8909619 neuralcell adhesion molecule 1 −1 AAGTTGTCCTGTGCTAAAGCAAGCGT (NCAM1), mRNA/cds= (201, GGGATGATCCTACCTACCTCTAGG 2747) 6028 Table 3A Hs.79914 BE2223928909710 lumican (LUM), mRNA/cds = −1 ATTTGGACAGATGCAGAAGGAACTGT (84,1100) TAGTGAGTCAAGACAAACACATCT 6029 Table 3A Hs.99237 BE326857 9200633hr65h06.x1 cDNA, 3′ end/clone = −1 CCCCTACCCCTGGAAAGTAATATACT IMAGE:3133403/clone_end = 3′ GAAGTCTCATCATACTGTTTTGGG 6030 Table 3A Hs.83623BE328818 9202594 nuclear receptor subfamily 1, −1TGTTTCGTAAATTAAATAGGTCTGGC group I, member 3 (NR1I3),CCAGAAGACCCACTCAATTGCCTT mRNA/cds = (272, 1318) 6031 Table 3A Hs.27774BE348809 9260662 602386841F1 cDNA, 5′ end/ −1 AGCTAGTGATGTTTTGTCCAAAGGAAclone = IMAGE: 4515730/ GATTCTGACAACAGCTTCAGCAGA clone_end = 5′ 6032Table 3A NA BE348955 9260808 hs91h01.x1 NCI_CGAP_Kid13 −1ACACAGACATATTGACCGCACACAAC cDNA clone IMAGE: 3144625 3′,ACTGAAATGGACTGACTTGAGAAA mRNA sequence 6033 Table 3A Hs.56156 BE3491489261067 601463367F1 cDNA, 5′ end/ −1 TGGTTCTCTGATTTGTAATGAGCACC clone =IMAGE: 3866512/ TGGATATGTCAATTAAAATGCCCA clone_end = 5′ 6034 Table 3AHs.315050 BE351010 9262791 hl22g04.x1 cDNA, 3′ end/clone = −1GGTCCATGTCACCGTGAGTACACCC IMAGE: 3147510/clone_end = 3′CTATGATTGGTTTGTTGTCAAGAAG 6035 Table 3A Hs.5027 BE379724 9325089601159415T1 cDNA, 3′ end/ −1 TGCTAGTTCAGGTCCTCCAGGCATTG clone = IMAGE:3511107/ ATTTGTACAGTTAAACTCCGAGTG clone_end = 3′ 6036 Table 3A Hs.86437BE464239 9510014 602411368F1 cDNA, 5′ end/ −1 ACAAGCATTTAGATCATAACATGGTAclone = IMAGE: 4540096/ AAGCCTATTACCAGCCAATGTTGT clone_end = 5′ 6037Table 3A Hs.127426 BE466500 9512198 Homo sapiens, Similar to homeo −1GGCCTACTGACCAAATTGTTGTGTTG box A9 clone MGC: 19648AGATGATATTTAACTTTTTGCCAA IMAGE: 2987818, mRNA, complete cds/cds = (62,880) 6038 Table 3A Hs.21812 BE467470 9513245 AL562895 cDNA/clone = −1AAGTTTGTGCAGCACATTCCTGAGTG CS0DC021YO20-(3-prime)TACGATATTGACCTGTAGCCCAGC 6039 Table 3A Hs.122575 BE502248 9704854endotheilial differentation, −1 CGATAGAATTGAAGCAGTCCACGGGlysophosphatidic acid G-protein- GAGGGGATGATACAAGGAGTAAACC coupledreceptor, 4 (EDG4), mRNA/cds = (6, 1061) 6040 Table 3A Hs.279522BE502919 9705327 hz81b08.x1 cDNA, 3′ end/clone = −1ATAGACTCCAAAGAGGCGTTAAGCAC IMAGE: 3214359/clone_end = 3′CTGGTTTTCCTTTGGCTCAGAAAA 6041 Table 3A Hs.197766 BE502992 9705400 clone23932 mRNA sequence/ −1 CTCAAACGAAATTGGGCAGGCCATTT cds = UNKNOWNGCGTGGTTTCTCTGGATAAGTTCC 6042 Table 3A Hs.61426 BE550944 9792636602329933F1 cDNA, 5′ end/ −1 GCACATGACAGTAAGCGAGGTTTTGG clone = IMAGE:4431248/ GTAAATATAGATGAGGATGCCTAT clone_end = 5′ 6043 Table 3A Hs.201792BE551203 9792895 7b55h12.x1 cDNA, 3′ end/clone = −1TCCCAGAGTAACTGACAGTATCAAAT IMAGE: 3232199/clone_end = 3′AGCAAGAGAGTTAGGATGAGGACT 6044 Table 3A Hs.122655 BE551867 9793559hypothetical protein MGC14425 −1 ACACAGGAACCGCTTACCCACCAGCT (MGC14425),mRNA/cds = (318, CTGCCCGCGTCTCTACCGCCATAG 686) 6045 Table 3A Hs.282091BE552131 9793823 hw29b05.x1 cDNA, 3′ end/clone = −1TTCTTCCAAGAGAATAACCCTATTAAA IMAGE: 3184305/clone_end = 3′GGCTAAAAATGGAAGCTCCCAGT 6046 Table 3A Hs.146381 BE613237 9894834 RNAbinding motif protein, X −1 ACTGACCTAGCAGATGTGTGGAAAAG chromosome(RBMX), mRNA/ GAATCAGATCTTGATTCTTCTGGG cds = (11, 1186) 6047 Table 3AHs.4310 BE614297 9895894 eukaryotic translation initiation −1ACAACTCAAGTGAAAAGATGTCTCCA factor 1A (EIF1A), mRNA/cds =GTTTCTGAAGATAACGCACGCTGA (207, 641) 6048 Table 3A Hs.198802 BE6216119892551 601493754T1 cDNA, 3′ end/ −1 CGCCGACTCGTTGAAAGTTTTGTTGT clone =IMAGE: 3895836/ GTAGTTGGTTTTCGTTGAGTTCTT clone_end = 3′ 6049 Table 3AHs.324481 BE646433 9970744 EEST 380617 cDNA −1CACCCACCTGGTAGGAAGGTCAATCT TATGCTCAGAAGTCCCACCCACCA 6050 db miningHs.283165 BE646441 9970752 7e86h06.x1 cDNA, 3′ end/clone = −1CAACTCCTTAAAGGGTTGAAGGTTGT IMAGE: 3292091/clone_end = 3′GACAATAACTGAGGGAACTGATGT 6051 Table 3A Hs.341573 BE6466470 9970781tc38c11.x1 cDNA, 3′ end/clone = −1 AAAACACTCCACCTAAAAGCAG IMAGE:2066900/clone_end = 3′ GAAAGATGGCAATTCTAAATAGCA GCTA 6052 db miningHs.283166 BE646492 9970803 7e87g01.x1 cDNA, 3′ end/clone = −1GGAGGTTTTGATCGTGACTTTATTTT IMAGE: 3292178/clone_end = 3′GAGATATTGTATCTTTGTTAGTATTGC 6053 Table 3A Hs.187872 BE646499 99708107e87h02.x1 cDNA, 3′ end/clone = −1 TTGTAAGGTTCCGGGGAACTGACTCA IMAGE:3292179/clone_end = 3′ ACATGGTTCTCCAACTCGAGGTTG 6054 db mining Hs.283167BE646510 9970821 7e88b08.x1 cDNA, 3′ end/clone = −1TGTGAGTGTTATAGGTTACAGTGGAT IMAGE: 3292215/clone_end = 3′TCCAAACTAGCCACAAGTGAAGCA 6055 db mining Hs.283168 BE646569 99708807e89c01.x1 cDNA, 3′ end/clone = −1 TCAGCCAGGAGGAAAAGCACTCTGAT IMAGE:3292320/clone_end = 3′ TATGAATTGAGCAGAAGGAAACAA 6056 db mining Hs.283169BE646617 9970928 7e91b07.x1 cDNA, 3′ end/clone = −1GTTCCCACTCGTTCTTGCCGGAGAAA IMAGE: 3292501/clone_end = 3′CCTGCCTTTTCAAGCATAATTCAA 6057 db mining Hs.225200 BE46840 99709517e91f08.x1 cDNA, 3′ end/clone = −1 GGGTCCAAGATTATTGATTAATTTGG IMAGE:3292551/clone_end = 3′ GCACCGCGAGAGCTCGAGTCCCCC 6058 Table 3A Hs.129192BE670584 10031125 7e36h08.x1 cDNA, 3′ end/clone = −1GACCACCTGTAAAGCAAGTCCTTTCA IMAGE: 3284607/clone_end = 3′AGTTTCACTGCACATCCCAAACCA 6059 Table 3A Hs.75703 BE670804 10031345 smallinducible cytokine A4 −1 TGGTCCACTGTCACTGTTTCTCTGCT (homologous to mouseMip-1b) GTTGCAAATACATGGATAACACAT (SCYA4), mRNA/cds = (108, 386) 6060Table 3A Hs.195374 BE671815 10032445 7a47c12.x1 cDNA, 3′ end/clone = −1AGACTCTGGAAAAGGAGGGTCGGAG IMAGE: 3221878/clone_end = 3′TATTAAACTGGCTGGGAATGAGAGG 6061 Table 3A NA BE672733 10033274 7b75g07.x1NCI_CGAP_Lu24 −1 TGAGAGCACACCATAAATTCACAGCA cDNA clone IMAGE: 3234108 3′GGAATAAACGAAGACACACGAGCA similar to TR: O99231 O99231 CYTOCHROME OXIDASE6062 Table 3A Hs.77542 BE673364 10033905 602629438F1 cDNA, 5′ end/ −1ACATTCTCTCATTTTGCTGAAGCTGAT clone = IMAGE: 4754432/TTGATTGGGTGTCTGTTTCTCGC clone_end = 5′ 6063 Table 3A Hs.66357 BE67375910034300 7d69d02.x1 cDNA, 3′ end/clone = −1 TGAGAAGGTAAAGTAGAAAGGGAAGIMAGE: 3278211/clone_end = 3′ ATGATGAGTGAACAATAAGCCTTGT 6064 db miningHs.283248 BE674662 10035284 7e93g03.x1 cDNA, 3′ end/clone = −1ACATTATTCCATGGGAATAAGTCATC IMAGE: 3292758/clone_end = 3′AGTGCAAAGGACTGTAAGGAGTGC 6065 Table 3A Hs.88845 BE674685 10035307AV733781 cDNA, 5′ end/ −1 CGCCGCTCCTGGAGACCTGATAACTT clone =cdAASF08/clone_end = 5′ AGGCTTGAAATAATTGACTTGTCT 6066 Table 3A Hs.171120BE674709 10035331 7e94105.x1 cDNA, 3′ end/clone = −1TGTATGTGCAATATGCTTATGGGTAA IMAGE: 3292833/clone_end = 3′TTATGGGCAAGAGAAATGGAAACA 6067 db mining Hs.283249 BE674713 100353357e94g02.x1 cDNA, 3′ end/clone = −1 ACCCCTTGGTAAAGCAGTTGTAAGAA IMAGE:3292850/clone_end = 3′ TTAAACAAGAGGAATTGCTCTTTC 6068 Table 3A Hs.167208BE674762 10035230 7e98d05.x1 cDNA, 3′ end/clone = −1AAATCAGGCCCCTTGCGCCATTCACA IMAGE: 3293193/clone_end = 3′AAAATCCTTGTGAGATGACTCAAG 6069 db mining Hs.283247 BE674807 100352757e93d11.x1 cDNA, 3′ end/clone = −1 AGGGCAGAGGTCCTTTGGGAGGGTA IMAGE:3292725/clone_end = 3′ AGCTCACAAAAACTCAGGGAGGCAG 6070 Table 3A Hs.174010BE674902 10035443 7e97a04.x1 cDNA, 3′ end/clone = −1TCATCTCCGCCAAGGTTCCCACTAGG IMAGE: 3293070/clone_end = 3′CAGGAAAGGATTTTTATCTAAAGT 6071 Table 3A Hs.174144 BE674951 100354927e97g10.x1 cDNA, 3′ end/clone = −1 CCACCCAAGTCGGAATCCGAGTGAA IMAGE:3293154/clone_end = 3′ ATAAATAGCATCGCCCGCCAACTAC 6072 Table 3A Hs.190065BE874984 10035505 7f11b09.x1 cDNA, 3′ end/clone = −1AGGCACACGATTGTCACCATTTCTCC IMAGE: 3294329/clone_end = 3′CTTTACAAGCTGTATAATCAGTAA 6073 Table 3A Hs.211826 BE875092 100356337f02d07.x1 cDNA, 3′ end/clone = −1 GCAACGTCTGAATGTAGTAATGTGAC IMAGE:3293485/clone_end = 3′ TCAGAGCTTCAAAGTAAGCATTCG 6074 db mining Hs.330706BE675125 10035668 IL3-UT0114-301100-357-H02 −1 GCCACCCCATCTGGGAGGCCCAGCAcDNA TCCAATTCAGTCGCCTTCAATGATT 6075 db mining Hs.283251 BE87518010035721 7f03h06.x1 cDNA, 3′ end/clone = −1 TGATAGACTGGATGCTGCTATGGTAAIMAGE: 3293827/clone_end = 3′ TCTGCCTCAGGAAAATGCCGGACT 6076 db miningHs.339281 BE675338 10035879 HNC29-1-D4.R cDNA −1TGGAGCCAAGAAGCCACTGACTCAA GAGGATTTCAAGCGAGAGCTGCTTG 6077 db miningHs.283253 BE675379 10035920 7f08b02.x1 cDNA, 3′ end/clone = −1CAACTTTTGTAACAGGGGACTTAGCC IMAGE: 3294027/clone_end = 3′GGGGGCAGGAGGGGTTCTTGAGAC 6078 db mining Hs.283254 BE675403 100359447f08d10.x1 cDNA, 3′ end/clone = −1 ACTTGAAGGCACATCTTCCTTTTGGT IMAGE:3294067/clone_end = 3′ TGTTTTCCATCTTCAAATTAAACT 6079 db mining Hs.283255BE675434 10035975 7f09a10.x1 cDNA, 3′ end/clone = −1TAAAAACTGACATGACATGAGATGGT IMAGE: 3294138/clone_end = 3′TTAAGTGTCAAACATAAGGGTCTTT 6080 db mining Hs.283256 BE675531 100360727f10h08.x1 cDNA, 3′ end/clone = −1 ACTGACATAAGCCCACTTCAGGTGTT IMAGE:3294303/clone_end = 3′ TGGAAGACACTAAAGAGAATCAGA 6081 db mining Hs.315345BE675610 10038151 7f12g09.x1 cDNA, 3′ end/clone = −1GCAGCTTTTTGCTGGCGGGGGTCTA IMAGE: 3294496/clone_end = 3′AATAAAGTAGCTTCCCCAAAAGAAA 6082 db mining Hs.180637 BE875718 100362597f14h04.x1 cDNA, 3′ end/clone = −1 ACCTGGTTATCTCGCAATGACCTAGC IMAGE:3294679/clone_end = 3′ TAACACAAATGCAACATCAGCCGG 6083 db mining Hs.283258BE675792 10036333 7f18b02.x1 cDNA, 3′ end/clone = −1TGATCAAAATGAAGATGCTCCAACCG IMAGE: 3294795/clone_end = 3′TATAAATGGCAGATGAAATAGACT 6084 db mining Hs.283259 BE675819 100363607f17d10.x1 cDNA, 3′ end/clone = −1 GCAGGAGAGAAATACCTTCTAATGGG IMAGE:3294931/clone_end = 3′ TGTGGACACTGGAGGAACTGTTAC 6085 db mining Hs.283261BE675957 10036498 7f19b06.x1 cDNA, 3′ end/clone = −1AGGGCACTGTTTGTTCCTTTAATATG IMAGE: 3295091/clone_end = 3′GAGAAATATCGCAAATAACTGGGA 6086 db mining NA BE676019 10036560 7f20c12.x1NCI_CGAP_CLL1 −1 TTGGCCTATGTTAATTTCTATTCTCAG cDNA clone IMAGE: 32952223′ TTCTTCTGTGCCCTTCCTCCTCT similar to contains Alu repetitive element; m6087 Table 3A Hs.170584 BE676049 10036590 7f21a03.x1 cDNA, 3′ end/clone= −1 GAACGTAAGCCCGACGCTAGGCAGT IMAGE: 3295276/clone_end = 3′GCTGTTAGAAAGTGATTTGGAAGAG 6088 Table 3A Hs.181015 BE676054 1003695signal transducer and activator of −1 ATCCCATTCTCCCTCTCAAGGCAGGGtranscription 6, interleukin-4 GTCATAGATCCTAAGCCATAAAAT induced (STAT6),mRNA/cds = (165, 2708) 6089 db mining Hs.283263 BE676154 100366957f24a12.x1 cDNA, 3′ end/clone = −1 TGCTGTAAAATGGCAGCTCCATAGGA IMAGE:3295582/clone_end = 3′ ACCTATTTTCCATAGGAACCTGCA 6090 db mining Hs.283264BE676173 10036714 7f24c12.x1 cDNA, 3′ end/clone = −1ACTGGAGAAAGGTGTCTTCCTGTCCT IMAGE: 3295606/clone_end = 3′TTCAGGGGCTCCTGCGGGGAATTC 6091 Table 3A Hs.134648 BE676210 100367517f25c05.x1 cDNA, 3′ end/clone = −1 ATTATATTTGTCCCTATCAGAATCCTC IMAGE:3295688/clone_end = 3′ GAATCCCTAGCAGCCAGTCCCTG 6092 db mining Hs.283266BE676275 10036816 7f26d04.x1 cDNA, 3′ end/clone = −1TGCTCACTGTCTTCTGGAAGAGACAA IMAGE: 3295783/clone_end = 3′GCACTTTCTTGAAATTCCTAAGCA 6093 Table 3A Hs.158714 BE676408 100369497f29b11.x1 cDNA, 3′ end/clone = −1 CAATCGGATCATTCTTCTCAACTTGG IMAGE:3296061/clone_end = 3′ GCGGCTCTTTCCTCCCTTCCTTCC 6094 Table 3A Hs.220929BE676472 10037003 cDNA FLJ14369 firs, clone −1 TGCTTTGGGCAGTAGCTGAAGCCGAHEMBA 1001174, highly similar AGTATGAACAGTCCATTTTGTTTCT toADP-RIBOSYLATION FACTOR-LIKE PROTEIN 5/cds = (207, 746) 6095 db miningHs.283268 BE676474 10037005 7f30c08.x1 cDNA, 3′ end/clone = −1CACAGTTGAGTAGGAGGTCATGAAGA IMAGE: 3296174/clone_end = 3′AGAAGAGATGATACCTGCCTTACC 6096 db mining Hs.283269 BE676528 100370697f31d12.x1 cDNA, 3′ end/clone = −1 TTTGTGTAGCAAATGTTCATTAATTGC IMAGE:3296279/clone_end = 3′ CTACTTTGTGCCAAATTCAGGCC 6097 Table 3A Hs.123254BE676541 10037082 AL572805 cDNA/clone = −1 TCCAGCATTGTATTGTCTATTGACACCS0DI034YHI06-(3-prime) ACAAAGTTTGAAAATAAAGGGGCA 6098 db miningHs.283505 BE676548 10037089 wh79f01.x1 cDNA, 3′ end/clone = −1CACCCACCAGACCGAGGATTCCAAAA IMAGE: 2386969/clone_end = 3′GGGGGCGAAGGCGGAGAGCAAAGG 6099 db mining Hs.283270 BE676813 100371547f33a08.x1 cDNA, 3′ end/clone = −1 TGGACTCTGTTTTCAAGAGGAAGAAA IMAGE:3296438/clone_end = 3′ CAACTGACAAATAAGTTGATGTCA 6100 db mining Hs.283271BE676614 10037155 7f33a10.x1 cDNA, 3′ end/clone = −1ATGTTGAAACTGGTTTTAACTTGTAAT IMAGE: 3298442/clone_end = 3′GGTGTGGCTGATGTTACCCGACC 6101 db mining Hs.283272 BE676667 100372087f34a07.x1 cDNA, 3′ end/clone = −1 ACACAGATTTGAAGTCTACTGTTCTA IMAGE:3296532/clone_end = 3′ AATGGCCTCTACTTCCTGCTGTCA 6102 db mining Hs.102165BE676737 10037278 7f37g03.x1 cDNA, 3′ end/clone = −1GGAACTTCTGCTTCCACTTACGATGA IMAGE: 3296884/clone_end = 3′AGGAACTTGTACTCAATCCATCCA 6103 db mining Hs.283276 BE676772 100373137f35d05.x1 cDNA, 3′ end/clone = −1 GAAGCCTTCCTGTGGTCATAACAAGT IMAGE:3298849/clone_end = 3′ CTCACACACCCCAAGGACTGATCT 6104 db mining Hs.86761BE738569 10152561 601572850F1 cDNA, 5′ end/ −1 GAGTCCAGCCTTTGAACCTGGCGCTclone = IMAGE: 3839581/ GAATCCTGACTTTACTGCTTATTCA clone_end = 5′ 6105Table 3A Hs.293842 BE748883 10162655 601571679F1 cDNA, 5′ end/ −1AAACTCATACATGCAGAAAATTTG clone = IMAGE: 3838675/ TCTTTGCTCGAAATGGTAATGCCclone_end = 5′ AAAA 6106 Table 3A Hs.293842 BE748663 10162655601571879F1 cDNA, 5′ end/ −1 AAACTCATACATGCAGAAAATTGTCTT clone = IMAGE:3838875/ TGCTCGAAATGGTAATGCCAAAA clone_end = 3′ 6107 Table 3A Hs.270293BE857296 10371182 7g27b01.x1 cDNA, 3′ end/clone = −1ACAAAAGTCATGGCTGTGAGGCTATC IMAGE: 3307657/clone_end = 3′ATTACCCTTTTACCAAAGTTGGAA 6108 Table 3A Hs.155935 BE858152 10373065complement component 3a −1 AGTTCTATTTCTATCCCAAACTAAGCT receptor 1(C3AR1), mRNA/cds = ATGTGAAATAAGAGAAGCTACTTTGT (0, 1448) 6109 Table 3AHs.294348 BE961923 11764299 601655335R1 cDNA, 3′ end/ −1ATCCCGATGGTGCCCACCGCTATTAA clone = IMAGE: 3845768/AGGTTCGTTGTTCCACGATTAAA clone_end = 3′ 6110 Table 3A Hs.5181 BE96258811765836 proliferation-associated 2G4, −1 ATGTCTCCATACCCATTACAATCTCC38kD (PA2G4), mRNA/cds = AGCATTCCCCCTCAAACCTAAAAA (97, 1281) 6111 Table3A Hs.314941 BE962883 11766238 602381893F1 cDNA, 5′ end/ −1GCCCGTATTTACCCTATAGCACCCCC clone = IMAGE: 4499447/TCTACCCCCTTTAGAGCCCAAAA clone_end = 5′ 6112 Table 3A Hs.301110 BE96319411766612 601656811R1 cDNA, 3′ end/ −1 ACATTTTCCTCCGCATAAGCCTGCGT clone =IMAGE: 3865731/ CAGATTAAAACACTGAACTGACAA clone_end = 3′ 6113 Table 3AHs.330887 BE963374 11788792 601857137R1 cDNA, 3′ end/ −1CCAAGCTGGTTTCAAGCCAACCCCAT clone = IMAGE: 3866193/GGCCTCCATGACTTTTTCCAAAAC clone_end = 3′ 6114 Table 3A Hs.334926 BE96355111755970 Homo sapiens, clone MCG: 8857 −1 TGATCAGGTGAACCGGAAGTCTCCAAIMAGE: 3868266, mRNA, TTTCTGAATGGATTATGTTTCTAA complete cds/cds = (62,133) 6115 Table 3A Hs.316047 BE963666 11767085 601656685R1 cDNA, 3′ end/−1 TGAGTACGTGACACTTGTTGTAGAAT clone = IMAGE: 3865820/AGTGGTGTTGAGCTATATTCTTGT clone_end = 3′ 6116 Table 3A Hs.294578 BE96381111767228 601657482R1 cDNA, 3′ end/ −1 GTGACCCTTGGCACCCGCTAGAAGTT clone =IMAGE: 3875846/ TATGGCCGAGCTTTACCAATTAAA clone_end = 3′ 6117 Table 3AHs.302585 BE964028 11767358 601657601R1 cDNA, 3′ end/ −1TGAACTCCAACTTTGACCAACCCATG clone = IMAGE: 3875617/AGACCCCTGTTATCCAAACTTTCT clone_end = 3′ 6118 db mining Hs.210628BE964051 11767519 601472729T1 cDNA, 3′ end/ −1CCCTCTACTATTTGGCTCCATAACTTA clone = IMAGE: 3875791/GGACCTGCCTTTCCCGGTTCCAG clone_end = 3′ 6119 Table 3A Hs.330588 BE96413411767602 601151626F1 cDNA, 5′ end/ −1 CCCGTATTTACCCTATAGCACCCCCT clone =IMAGE: 3507774/ CTACCCCCTTTAGAGCCCCAAAA clone_end = 5′ 6120 Table 3AHs.252259 BE964149 11767617 ribosomal protein S3 (RPS3), −1CCAACTTTCAGAACAGAAGGGTGGG mRNA/cds = (22, 753) AAACCAGAACCGCCTGCCATGCCCC6121 Table 3A Hs.184052 BE964596 11768078 PP1201 protein (PP1201), mRNA/−1 GCGCCAGAAATCCAATCCAGCCCAA cds = (75, 1010) GGATATAGTTAGGATTAATTACTTA6122 Table 3A Hs.288754 BE965319 11769559 601859229R1 cDNA, 3′ end/ −1CTGAGTTTTGGGTTTTCCACACGGG clone = IMAGE: 3895783/CCAAGATACCCGGCCTCTGCTGAG clone_end = 3′ 6123 Table 3A Hs.297190 BE96555411770044 601659486R1 cDNA, 3′ end/ −1 ATATCATTTCCACTTAGTATTATACCC clone= IMAGE: 3896204/ ACACCCACCCAAGAACAGGGTTT clone_end = 3′ 6124 Table 3AHs.108327 BF001438 10701713 damage-specific DNA binding −1ACAGCATGAGAAACTGTTAGTACGCA protein 1 (127kD) (DDB1),TACCTCAGTTCAAACCTTTAGGGA mRNA/cds = (109, 3531) 6125 Table 3A Hs.161075BF001821 10702098 7g93g02.x1 cDNA, 3′ end/clone = −1GCTTGCCCTAGCAGAGTCATACGGAA IMAGE: 3314068/clone_end = 3′TAATGGAAAACTCAACTTGTGTTC 6126 Table 3A NA BF056055 10809951 7k07h12.x1NCI_CGAP_GC6 −1 CACAATGCTGCCTCCTCTGTGGATGA cDNA clone IMAGE: 3443950 3′CTGATGGCAAGAGTCTGAATTGAA similar to contains element L1 repetitive eleme6127 Table 3A Hs.221695 BF058398 10812294 7k30d01.x1 cDNA, 3′ end/clone= −1 CCTCTCACTCTCAGACTCCAAGGGCC IMAGE: 3476785/clone_end = 3′AAGAAAAACTACGGACAGGAAGCC 6128 db mining Hs.255664 BF058429 108123257k30g11.x1 cDNA, 3′ end/clone = −1 GAGAGGAGGGGTCTCAGACGTTGGG IMAGE:3476949/clone_end = 3′ GGACACACTGCTGGGTGGGTGATTT 6129 Table 3A Hs.43857BF058599 10812495 mRNA for KIAA1247 protein, −1TAAGAAATCCCAATTTTCAGGAGTGG partial cds/cds = (285, 2942)TGGTGTCAATAAACGCTCTGTGGC 6130 Table 3A Hs.144583 BF059133 108113029 Homosapiens, clone IMAGE: −1 CGGCAGGGTGGCCTGTAACAATTTCA 3462401, mRNA,partial cds/cds = GTTTTCGCAGAACATTCAGGTATT (0, 153) 6131 db miningHs.257697 BF060727 10819637 AL533532 cDNA/clone = −1GGGGCTCCCTTCCCGGCTTTGTTTTC CS0DN004YJ14-(5-prime)TCTGGGAGATTTTATTTTACCTAA 6132 Table 3A Hs.193237 BF062295 108211937k76b11.x1 cDNA, 3′ end/clone = −1 GAAAGTGGAGGGAGTGGACGGGGAG IMAGE:3481293/clone_end = 3′ GAGACTAGCCAGAGAGGCTCATTAG 6133 Table 3A Hs.174215BF062628 10821538 7h62h05.x1 cDNA, 3′ end/clone = −1CTTCTCCCCTCTTGCCCTCTGTGGTC IMAGE: 3320601/clone_end = 3′TGTTTAAAACGAAAAGGTCGGAT 6134 db mining Hs.159013 BF063875 10822585hh82b10.x1 cDNA, 3′ end/clone = −1 GGACTTCTGAAATAGAGCTGGCTCCC IMAGE:2969275/clone_end = 3′ TGGGGTGACAATGTATATATGCAA 6135 Table 3A Hs.125887BF109873 10939563 hypothetical protein FLJ14464 −1CTGGGTGTCGTGGAAGATGACGAAG (FLJ14484), mRNA/cds = (69,ATGCTGGGCTGGCAGATGCAGTCCA 3146) 6136 Table 3A Hs.288443 BF11031210940002 7n38d08.x1 cDNA, 3′ end/clone = −1 ACCAGGGCTTAAAACCTCAATTTATGIMAGE: 3566854/clone_end = 3′ TTCATGACAGTGGGGATTTTTCTT 6137 Table 3AHs.250905 BF116224 10985700 hypothetical protein (LOC51234), −1ATTCTCCAACCACAAACAGCACTTCT mRNA/cds = (0, 551) AAACTAACTTTACTTTCTGCCCA6138 Table 3A Hs.318215 BF183507 11061818 60180999R1 cDNA, 3′ end/clone= −1 GATATAGTCTCCATACCCCATTACCA IMAGE: 4040470/clone_end = 3′TCTCCCAGCCATTCCCCCTCCAAC 6139 Table 3A Hs.96568 BF194880 11081165602137338F1 cDNA, 5′ end/ −1 TGATACTTTGGTTCTCTTTCCTGCTCA clone = IMAGE:4274048/ GGTCCCTTCATTTGTACTTTGGA clone_end = 5′ 6140 Table 3A Hs.232257BF195579 11082611 RST2302 cDNA −1 TAATACTGGAGGGGCTTGAAGAAGGCTGTCGTGTTTTGTCACCTGCTTTG 6141 Table 3A Hs.3353 BF197153 11085769beta-1,3-glucuronyltransferase 1 −1 GTCTTTCCCGTCTTTCTTCCTCACCTA(glucuronosyltransferase P) TGTAATTTCAGTAGTCTCTCAGC (B3GAT1), mRNA/cds =(175, 1179) 6142 Table 3A NA BF197762 11087169 7p91f02.x1 NCI_CGAP_Skn1−1 AGGAAGAGCCTGCACCTGTGGTGGA cDNA clone IMAGE: 3653139 3′,ACAATCAGGGAAAAGGAAGTCAAAA mRNA sequence 6143 Table 3A Hs.50785 BF22178011128957 SEC22, vesicle trafficking protein −1 TTGGAGCTTCTATAGGAGTGGAGAG(S. cerevisiae)-like 1 (SEC22L1), GGGCAGCTCATTGTTGAGAGTTGC mRNA/cds =(119, 766) 6144 Table 3A Hs.250811 BF432643 11444806 v-ral simianleukemia viral −1 TGATCTGACTGGAAAACAATCCTGTA oncogene homolog B (rasrelated; TCCCCTCCCAAAGAATCATGGGCT GTP binding protein) (RALB), mRNA/cds= (170, 790) 6145 Table 3A Hs.296356 BF433058 11445221 mRNA; cDNADKFZp434M162 −1 TCATCCCTTAAACACTCTGTGATGGG (from clone DKFZp434M162)/ATCTTCAGGATCATCTTTTGAAGT cds = UNKNOWN 6146 Table 3A Hs.76611 BF43335311445518 601435773F1 cDNA, 5′ end/ −1 TGCGTTTGGTTTAGGAATGTGCTTTT clone =IMAGE: 3920582/ GTACTTCCACTTGAATAAAGGTGT clone_end = 5′ 6147 Table 3AHs.178703 BF433657 11445848 AV716627 cDNA, 5′ end/clone = −1TGCTCAGGGCACATGCACACAGACAT DCBBCH05/clone_end = 5′TTATCTCTGCACTCACATTTTGTG 6148 Table 3A Hs.222833 BF435098 114473887p05g01.x1 cDNA, 3′ end/clone = −1 GGTTATTGCTGACACGCTGTCCTCTG IMAGE:3645097/clone_end = 3′ GCGACCTGTCGCTGGAGAGGTTGG 6149 Table 3A Hs.293478BF435821 11447923 hypothetical protein FKSG44 −1CGTTTTCTGAGCATCCGTTGTGCCTT (FKSG44), mRNA/cds = (126,AACATTTTCTGCTTGTCCTTTGGG 1520) 6150 db mining Hs.257641 BF43670411448943 7p07d12.x1 cDNA, 3′ end/clone = −1 CTTCTGAATGCCCGAGTCTTCTCTTTIMAGE: 3644999/clone_end = 3′ TGTGCTCACAAATGCCACCCAATC 6151 Table 3AHs.160980 BF437585 11449991 7p74d12.x1 cDNA, 3′ end/clone = −1TGCTTACAAGGGTGATTGACCTTGCC IMAGE: 3651526/clone_end = 3′TTACTCTTTATGTAAATTATGGCA 6152 db mining Hs.258513 BF437915 11450432AF150421 cDNA/clone = −1 CTGGCGTATTACCATTTTGATAGCCT CBNBCG12CTCTTCAGGCTAGATAAGCTGGGG 6153 Table 3A Hs.128594 BF445163 11510224nad21d12.x1 cDNA, 3′ end/clone = −1 CCCTGTATTATTGAAATGTCAGCATA IMAGE:3368191/clone_end = 3′ ATGACTGGAAGGTGAAATTGGTCC 6154 Table 3A Hs.174104BF445405 11510543 601438710F1 cDNA, 5′ end/ −1ACTGCTGTTGCATGAATAGATGATAC clone = IMAGE: 3923643/AAAGCAAGTGATGAGGTTGGTATG clone_end = 5′ 6155 Table 3A Hs.143389 BF44601711511155 7p18a11.x1 cDNA, 3′ end/clone = −1 TGGAAGAACAAATTCAGACATCATCAIMAGE: 3646004/clone_end = 3′ GTAAGTCTTTAGGGACACAGGGAA 6156 Table 3AHs.295726 BF447885 11513023 integrin, alpha V (vitronactin −1AGTGAAAACTGGTACAGTGTTCTGCT receptor, alpha polypeptide,TGATTTACAACATGTAACTTGTGA antigen CD51) (ITGAV), mRNA/ cds = (41, 3187)6157 Table 3A Hs.179528 BF475501 11548328 upregulated by 1,25-dihydroxy-−1 GCCAGAAAGTGTGGGCTGAAGATGG vitamin D-3 (VDUP1), mRNA/TTGGTTTCATGTTTTTGTATTATGT cds = (221, 1396) 6158 Table 3A Hs.181311BF478236 11549065 asparaginyl-tRNA synthetase −1TGTCCTCTGAACCTGAGTGAAGAAAT (NARS), mRNA/cds = (73, 1719)ATACTCTGTCCTTTGTACCTGCGT 6159 Table 3A Hs.179703 BF5077849 11591147tripartite motif protein 14 −1 CCATTTCCACTACATGCCTTTCCTAC (TRIM14),mRNA/cds = (10, CTTCCCTTCACAACCAATCAAGTG 1230) 6160 Table 3A Hs.159873BF508053 11591351 UI-H-BI4-apx-b-11-0-UI.s1 −1ACACTTCCCTGAATGTTGAAGAAGAT cDNA, 3′ end/clone = IMAGE:ATGCTATCCATGCAATCCTTGTCG 3088845/clone_end = 3′ 6161 Table 3A Hs.158999BF508694 11591992 UI-H-BI4-aop-f-09-0-UI.s1 −1ACTTGTGTTTGAACCACTTCTGCTTC cDNA, 3′ end/clone = IMAGE:CTCTTTAACCTGAGATGCACACGT 3085601/clone_end = 3′ 6162 Table 3A Hs.77542BF508702 11592000 602629438F1 cDNA, 5′ end/ −1ACATTCTCTCATTTTGCTGAAGCTGAT clone = IMAGE: 4754432/TTGATTGGGTGTCTGTTTCTCGC clone_end = 5′ 6163 Table 3A Hs.127311 BF50873111592029 AU185774 cDNA/clone = −1 TGACAGAATGAACTGGAAATGAAATC B02302-013CCACAGTTATGATCGTAGTAGAGT 6164 Table 3A Hs.144265 BF509758 11593056UI-H-BI4-apg-d-04-0-UI.s1 −1 AAGTACAGATGCCATCCCGGTGCTGT cDNA, 3′end/clone = IMAGE: GATCTTCCAGCCATTCTCCATTTC 3087390/clone_end = 3′ 6165Table 3A Hs.256931 BF510393 11593891 zb02d05.s1 cDNA, 3′ end/ −1ACTGCCAATCTGATTTAAAATTCTCCA clone = IMAGE: 300873/AGCTTAATTCTGTGCAACAAACA clone_end = 3′ 6166 Table 3A Hs.276341 BF51067011593968 UI-H-BI4-aof-b-08-0-UI.s1 −1 GCCTGTTGTTCTGTTTATCGCCCTAT cDNA,3′ end/clone = IMAGE: TTTACAAAACTGATTCTGACCTGG 3084615/clone_end = 3′6167 Table 3A Hs.248689 BF512500 11597602 UI-H-BI3-alw-h-10-0-UI.s1 −1AACTGGCATTGCTAAGCCCCAGAAAA cDNA, 3′ end/clone = IMAGE:ATGTATTTAGTGGAACAGATGAAA 3069162/clone_end = 3′ 6168 Table 3A Hs.136375BF513274 11598453 602544150F1 cDNA, 5′ end/ −1ACACTAGGTCCTTTTATACCTGTGCC clone = IMAGE: 4668332/TTTACGTTCGTTTTCCTGATTGCA clone_end = 5′ 6169 Table 3A Hs.300870 BF51360211598781 mRNA; cDNA DKFZp547M072 −1 AATACAGATTCATTTTATTTAAGCGTC (fromclone DKFZp547M072)/ CGTGGCACCGACAGGGACCCCAG cds = UNKNOWN 6170 Table 3AHs.255340 BF514247 11599426 UI-H-BW1-ani-h-09-0-UI.s1 −1AGTTCATCCCCTTTCAGAAGCTGTTT cDNA, 3′ end/clone = IMAGE:GCTCTTGGCTCATTAAACCTGTGA 3082601/clone_end = 3′ 6171 Table 3A Hs.283022BF514341 11599520 triggering recaptor expressed on −1GCCTCTTTTCCTGTATCACACAAGGG myeloid cells 1 (TREM1), mRNA/TCAGGGATGGTGGAGTAAAAGCTC cds = (47, 751) 6172 Table 3A Hs.83734 BF51553811600717 syntaxin 4A (placental) (STX4A), −1 TGTTAGGTGGCCTCTGCATACCTATGmRNA/cds = (66, 959) GGAACTCAGTGATGTAATGCAAAG 6173 Table 3A Hs.146065BF591040 11683364 AL580165 cDNA/clone = −1 CTGGGGCCGTAGCAAAAATCATGAAACS0DJ005YB18-(3-prime) AACACTTCAACGTGTCCTTTCAAT 6174 Table 3A Hs.30941BF592138 11684462 calcium channel, voltage- −1TGCCAAGTCAGCAGATTTGCTTTATG dependent, beta 2 subunitAATTACAGGGACTAGAAATGCCCA (CACNB2), mRNA/cds = (501, 2318) 6175 Table 3AHs.695 BF890338 11975746 cystalin B (stefin B) (CSTB), −1TTGCATGTCTCTTCCTAAATTTCATTG mRNA/cds = (96, 392) TGTTGATTTCTAATCCTTCCCGT6176 Table 3A Hs.142838 BF732404 12057407 nuclear protein interactingwith −1 AGAGTGAGAAGGCAGTTCCAGTTTTA the FHA domain of pIG-87GCACAGATTTGTTTATGTGTTCAG (NIFK), mRNA/cds = (54, 935) 6177 Table 3AHs.296317 BF938959 12356279 mRNA for KIAA1789 protein, −1GAAGTGACACTGACTGTATCTACCCTC partial cds/cds = (3466, 4899)TCCTTTTTCTTCATCAGGTGTTCCT 6178 Table 3A Hs.182937 BF939014 12356334peptidylpropyl isomerase A −1 TCCCTGGGTGATACCATTCAATGTCT (cyclophilin A)(PPIA), mRNA/ TAATGTACTTGTGGCTCAGACCTG cds = (44, 541) 6179 Table 3AHs.28138 BF940103 12357423 hypothetical protein MGC14158 −1AATTCCAAAGGAGTGATGTTGGAATA (MGC14156), mRNA/cds = (82,GTCCCTCTAAGGGAGAGAAATGCA 426) 6180 Table 3A Hs.133372 BF940291 12357611AF150127 cDNA/cds = −1 AGCCCCTCCACCCCACCCAGTACTTT CBCBGA01TACAATGTGTTATTAAAGACCCCT 6181 Table 3A Hs.304900 BF980139 12347354602288147F1 cDNA, 5′ end/ −1 CCATCCTTGAGAAATGTGGGCACCAA clone = IMAGE:4373983/ GTCCATAATCTCCATAAATCCAAT clone_end = 5′ 6182 Table 3A Hs.303214BG0546649 12511436 7045b01.x1 cDNA, 3′ end/ −1CGTTGCATTTTCACATTTGTGTGGCA clone = IMAGE: 3576912/GGACAAGCATGGGGCAAGAGGGAC clone_end = 5′ 6183 Table 3A Hs.8258 BG05496612512220 cDNA FLJ14737 fls, clone −1 TATGAGTTTATGCGTTTTCCCAGCCCNT2RP3002273, weakly similar to TCCGAATCACTGACTGGGGCGTTT SCD8PROTEIN/cds = (77, 1468) 6184 Table 3A Hs.179661 BG056668 12521375 Homosapiens, tubulin, beta 5, −1 TTGAAAAGATGACATCGCCCCAAGAG clone MGC: 4029IMAGE: CCAAAAATAAATGGGAATTGAAAA 3817988, mRNA, complete cds/ cds =(1705, 3039) 6185 Table 3A Hs.56205 BG057282 12522612 insulin inducedgene 1 (INSIG1), −1 TGCACTCTACCAGATTTGAACATCTA mRNA/cds = (414, 1247)GTGAGGTTCACATTCATACTAAGT 6186 Table 3A Hs.3709 BG057892 12523835 lowmolecular mass ubiquinone- −1 TGGTGATATCTGCTTAGATTTCCCTG binding protein(9.5kD) (QP-C), TATCTTTGCTGCCCTCCTTCAAGT mRNA/cds = (77, 358) 6187 Table3A Hs.5122 BG058599 12525258 602293015F1 cDNA, 5′ end/ −1AGTTGGAGCTATCTGTGCAGCAGTTT clone = IMAGE: 4387778/CTCTACAGTTGTGCATAAATGTTT clone_end = 5′ 6188 Table 3A Hs.89104 BG05873912525527 602590917F1 cDNA, 5′ end/ −1 CGTGGGAGGATGACAAAGAAGCATG clone =IMAGE: 4717348/ AGTCACCCTGCTGGATAAACTTAGA clone_end = 5′ 6189 Table 3AHs.166962 BG149747 12661777 phosphatidylinositol glycan, −1GTGGTTTGGTCAGCATACACACTTCT class F (PIGF), mRNA/cds = (67,CATTTCATTTGATGTACACAGCCA 726) 6190 Table 3A Hs.100293 BG149988 12662016O-linked N-acetylglucosamine −1 ACCTGGGATTTCATTTCTGCTGAAAG (GlcNAc)transferase (UDP-N- AAATAGGAAGAACAGGACTCACTT acetylglucosamine:polypeptide-N- acetylglucosaminyl transferase) (OGT), mRNA/cds = (2039,4801) 6191 Table 3A Hs.198427 BG150273 12662303 hexokinase 2 (HK2),mRNA/ −1 GGGTGTGATGAATAGCGAATCATCTC cds = (1490, 4243)AAATCCTTGAGCACTCAGTCTAGT 6192 Table 3A Hs.313810 BG150461 126624917k01d08.x1 cDNA, 3′ end/ −1 AGCTTTCACCACCTCGCAGTTGTAGA clone = IMAGE:3443006/ GATAGTCCCCGAAATATTATTCCA clone_end = 3′ 6193 Table 3A Hs.184456BG230563 12725596 hypothetical protein (LOC51249), −1GTGTGAAGTGACAGCCTTGTGTGTGA mRNA/cds = (0, 611) TGTTTTCTGCCTTCCCCAAGTTTG6194 Table 3A Hs.89104 GB231557 12726664 602590917F1 cDNA, 5′ end/ −1TTGTTTTAACAACTCTTCTCAACATTT clone = IMAGE: 4717348/TGTCCAGGTTATTCACTGTAACCA clone_end = 5′ 6195 Table 3A Hs.152925 BG23180512726934 mRNA for KIAA1268 protein, −1 TAAGTGGATTGGCAGACTCCTTGTTGpartial cds/cds = (0, 3071) CTTAAGAGTGGCTTTCTAGGCAGG 6196 Table 3AHs.89104 BG231961 12727100 602590917F1 cDNA, 5′ end/ −1TTGTTTTAACAACTCTTCTCAACATTT clone = IMAGE: 4717348/TGTCCAGGTTATTCACTGTAACCA clone_end = 5′ 6197 Table 3A Hs.337986 BG23594212749789 Homo sapiens, −1 GCCAGTCTCTATGTGTCTTAATCCCT clone MGC: 17431IMAGE: TGTCCTTCATTAAAAGCAAAACTA 2984883, mRNA, complete cds/ cds =(1336, 1494) 6198 Table 3A Hs.3353 BG236015 12749882beta-1,3-glucuronyltransferase 1 −1 GTCTTTCCCGTCTTTCTTCCTCACCTA(glucuronosyltransferase P) TGTAATTTCAGTAGTCTCTCAGC (B3GAT1), mRNA/cds =(175, 1179) 6199 Table 3A Hs.75703 BG238084 12749931 small induciblecytokine A4 −1 GGTCCACTCTCACTCTTTCTCTGCTG (homologous to mouse Mip-1b)TTGCAAATACATGGATAACACCGT (SCYA4), mRNA/cds = (108, 386) 6200 db miningHs.5146 D19756 500072 HUMGS00712 cDNA, 3′ end/ −1CATTCAGTATTTATTGGGAAGACTTG clone = mm0970/clone_end = 3′TCAAGCACCATGATAAGTGGTGGA 6201 db mining Hs.237971 D19770 500086hypothetical protein MGC5627 −1 AGAGGGGGAAGGACTTACATGACAT (MGC5627),mRNA/cds = (72, CCTACTGGGAATTTGCTAGAAACCA 584) 6202 db mining Hs.30709D20225 501322 HUMGS01199 cDNA, 3′ end/ −1 CTGGTGAAGCTGACTCCCCAGGTAAAclone = pm0880/clone_end = 3′ GAGATATCAGCTCTGCTTCAGACT 6203 db miningHs.30731 D20378 501474 HUMGS01352 cDNA, 3′ end/ −1TTGCTTCTTCCTGCTTTATAGAGTTCC clone = pm2943/clone_end = 3′CGTAAAATACCCTTCACCCTGGC 6204 db mining NA D20425 501521 HUMGS01399 Human−1 TCTGACCTCCGTGACGTTTATTACCA promyelocyte cDNA clone pm1261GCTGATGTCCCGTACACTGATTTCA 3′, mRNA sequence 6205 db mining Hs.229071D20458 501554 HUMGS01432 cDNA, 3′ end/ −1 GGGAAGGGTCAGCAACGATTTCTCAclone = pm1542/clone_end = 3′ CCAAATCACTACACAGACACAAAGG 6206 db miningHs.330221 D20465 501581 HUMGS01439 cDNA, 3′ end/ −1ACCACTAAATGGTTACACTACACCAA clone = pm2194/clone_end = 3′GACACTAAAATGGCAGGGAGCCCT 6207 db mining Hs.92440 D20522 501618HUMGS01497 cDNA, 3′ end/ −1 AAATTCAAATCACCCTTGATACCCAC clone =pm1507/clone_end = 3′ TTCTTTCTCCCACCCAAATCTGAT 6208 db mining Hs.90165D20538 501634 HUMGS01513 cDNA, 3′ end/ −1 ACCATATCGTGCAAAATGTAATATGGclone = pm1504/clone_end = 3′ AATTTCCAAACATCAATGAAGGGAT 6209 db miningHs.90171 D20572 501668 HUMGS01547 cDNA, 3′ end/ −1AATAAGTACCGTATATAAACACTTCTC clone = pm1503/clone_end = 3′TTTCTCTCCTCCACAATGGCACG 6210 db mining Hs.30766 D20726 504546 HUMGS01703cDNA, 3′ end/ −1 AGCATCACTCTTAGAAGAAGCAACTC clone = mp0664/clone_end =3′ CTTCCCTTGATTCTGTGTATTTGG 6211 db mining Hs.5816 D20846 504688HUMGS01827 cDNA, 3′ end/ −1 TCAACCCAGAATCTATAATGTATGAA clone =mp0825/clone_end = 3′ ATAAATTAATAGAGAACCCAACAGAT C 6212 db miningHs.30793 D20888 504708 HUMGS01869 cDNA, 3′ end/ −1AAGGTCTCCATCTAACAGGTAGAGCA clone = mp0838/clone_end = 3′GTTGGTGCAGATGAGATGAGCCTG 6213 Table 3A Hs.292590 D59502 960608602628588F1 cDNA, 5′ end/ −1 GGTGATGATACCACCTCCAATGAACA clone = IMAGE:4751396/ GGGAAGCAAGTTCATCAGTCAACA clone_end = 5′ 6214 Table 3A Hs.119274F13765 758015 RAS p21 protein activator (GTPase −1AGCTGTTGGGGCTGCACTGAGCTGC activating protein) 3 (Ins(1,3,4,5)-AATTTTTAACATGGATTTATAACTT P4-binding protein) (GAP1|P48P), mRNA/cds =(46, 2550) 6215 db mining Hs.238797 H07915 872737 602081681F1 cDNA, 5′end/ −1 AAGGAATTTGTTTTCCCTATCCTAACT clone = IMAGE: 4245999/CAGTAACAGAGGGTTTACTCCGA clone_end = 5′ 6216 db mining Hs.11307 H09541874363 RST29274 cDNA −1 CGCACACATTTTCTGTATGGACAAATCCTGGATTGGCTTCGTTATTTGGT 6217 Table 3A Hs.187908 H69141 1030426EST375312 cDNA −1 GGTAATGAAACAATCATCCAGTTAAC AATCAGCAAGGTTCTTCAGAGCCT6218 Table 3A Hs.117005 H71236 1043052 sialic acid binding lg-likelectin 5 −1 TGGAAGAGTGGACTGAAGAAAG (SIGLEC5), mRNA/cds = (142,AACTTATACTCTCCCTCCTCTAAAA 1797) TTGA 6219 Table 3A NA H78395 1056484yu12f03.x1 Soares fetal liver −1 TCCTGGGCTATTGGCTTTATGATATC spleen 1NFLScDNA clone TTTTGAGAAACAGGATTTTCACTT IMAGE: 233597 3′ similar to containsAlu repet 6220 Table 3A Hs.38864 H80108 1058197IL0-MT0152-061100-501-e04 −1 ACCTTTTAAGGATGTCTTATTTCCACC cDNACCAACTCTCCACTCCATTTTAGT 6221 Table 3A NA H92914 1099242 yl94g03.s1 −1GAACCTTCAAAACTGTCACTTTGAGT Soares_pineal_gland_N3HPGTCCAGAAGAGTCCTTCAGCATCTT cDNA clone IMAGE: 231988 3′, mRNA sequence 6222Table 3A Hs.2210 L40410 703109 thyroid receptor interactor (TRIP3) −1GTATTTGGGCTTCTCCAAGCAGATCA mRNA, 3′ end of cds/cds = (0,CGCAGACGACGGTGCTACATTTGA 458) 6223 Table 3A Hs.2200 L40557 705359perforin 1 (performing protein) −1 CAAGCATACTGGTTCTTTCCAAGCTC (PRF1),mRNA/cds = (0, 1667) ACTGTTCTCACCACACGGCCCCAC 6224 Table 3A Hs.198726M24069 181483 vasoactive intestinal peptide −1TCCATATCCATTTCTGACGTTGAACC receptor 1 (VIPR1), mRNA/cds =ATTTGACAGTGCCAAGGACTTTGG (56, 1543) 6225 Table 3A Hs.132911 N201901125145 MR2-OT0079-290500-007-b03 −1 AAGCCTGTTTTTCACTCTAAAAATTCA cDNAAGAGGACACGCTAAGAACGATCA 6226 Table 3A Hs.323950 N23307 1137457 zincfinger protein 6 (CMPX1) −1 CCTCAGCTTCCAACTCTGATTCCAGG (ZNF8), mRNA/cds= (1265, ACAGGATGGAAAACCTTTGGACAG 3361) 6227 db mining Hs.32250 N301521148872 yx81l03.s1 cDNA, 3′ end/clone = −1 AGTTGTGTTTGCTACTTTAGAAGCIMAGE: 268157/clone_end = 3′ AGTTGTGTTTGCTACTTTAGAAGC 6228 Table 3AHs.44512 N33584 1153983 yv21f11.s1 cDNA, 3′ end/clone = −1AACTCACGACAATTGCTACAAAACAC IMAGE: 243405/clone_end = 3′CAGGGAGGGGGCTTTTTGTGTTTTT 6229 Table 3A Hs.3353 N36787 1157929beta-1,3-glucuronyltransferase 1 −1 GTCTTTCCCGTCTTTCTTCCTCACCTA(glucuronosyltransferase P) TGTAATTTCAGTAGTCTCTCAGC (B3GAT1), mRNA/cds =(175, 1179) 6230 Table 3A Hs.38218 N39230 1162437 602569369F1 cDNA, 5′end/ −1 GCCCTGGTATGTATGCCTTTCTCTCC clone = IMAGE: 4693744/TACTGTCTAATAGCACCTCGTAAA clone_end = 5′ 6231 Table 3A Hs.236456 N498361191002 602287746T1 cDNA, 3′ end/ −1 AAGAAACCGTGGAAGATACTGGTTTA clone =IMAGE: 4375067/ TTTCAAATGAGCAGAGTATGTTGT clone_end = 3′ 6232 Table 3AHs.114453 N58052 1201942 601880526F1 cDNA, 5′ end/ −1CCACCTCTTCTGACATGAATGTAGCA clone = IMAGE: 4109119/TAAGTTAGCAATCGGTTCTTCCAA clone_end = 5′ 6233 Table 3A Hs.334731 N581361202026 Homo sapiens, clone IMAGE: −1 AGGTTCCCTTTCAAATAAAGATAAAG3448308, mRNA, partial cds/cds = (0, 2353) 6234 Table 3A Hs.205565N72600 1229704 za46f08.r1 cDNA, 5′ end/ −1 GGCTGGCCTCATTTTGAAAAGTTAGTclone = IMAGE: 295623/ ACAATTTTCTTCAGTGCTAACTTG clone_end = 5′ 6235Table 3A Hs.256931 N80578 1243279 zb02d05.s1 cDNA, 3′ end/ −1ACTCCAGAACGTCAGAAATGGTGTAG clone = IMAGE: 300873/CAGAATGAATTCTGTTATAAGGAA clone_end = 3′ 6236 Table 3A Hs.303018 N945111266820 zb80g04.s1 cDNA, 3′ end/ −1 CTGTTCGAAAGTTGGAGACTGCCTGT clone =IMAGE: 309942/ ACCCAGGTTGATAGTCAATTGTTT clone_end = 3′ 6237 db miningHs.118964 NM_017660 8923093 hypothetical protein FLJ20085 −1CCACCTTGAGCGCCTTCTTCTGGTTG (FLJ20085), mRNA/cds = (82,GTTGTCATGCAGTTCTCACACATG 655) 6238 Table 3A Hs.11594 R12665 765741yl40a04.s1 cDNA, 3′ end/ −1 ACCCTTCCCCTTTTTCATATCCTTTCT clone = IMAGE:129294/ TCAAAAATCTAAATGATGTGCCT clone_end = 3′ 6239 db mining Hs.108082R40823 821181 602068988F1 cDNA, 5′ end/ −1 AGTTCCAGGAGGTGGTTTTAAATATTclone = IMAGE: 4067972/ GGATGAAAACTTACAGGCTGTTTT clone_end = 5′ 6240 dbmining Hs.94881 R50838 812740 602387588F1 cDNA, 5′ end/ −1ACAATACATTTACAAAGCCATCTTTAC clone = IMAGE: 4516388/ATGCATTAAACGAGGGCTACAAC clone_end = 3′ 6241 Table 3A Hs.94881 R50838812740 602387588F1 cDNA, 5′ end/ −1 ACAATACATTTACAAAGCCATCTTTAC clone =IMAGE: 4518388/ ATGCATTAAACGAGGGCTACAAC clone_end = 5′ 6242 RG house-Hs.92004 R52541 814443 HSU55987 cDNA/clone = 39883 −1GGCCTGAAGAAGGAGATAAGTGTTC keeping CATTCGGCAACATAAGAGAAGTTAA genes 6243RG house- Hs.26766 R60313 831008 602270716F1 cDNA, 5′ end/ −1TCCATCCCAAAGGAGAGCTACTGTAC keeping clone = IMAGE: 4359027/TGACTGTACTTGTGGAATGCAGCG genes clone_end = 5′ 6244 db mining Hs.330530T25714 583034 ESTDIR309 cDNA, 3′ end/ −1 ACCCACCACTCTCAGGACCACCTGAAclone = CDDIRX9/clone_end = GGCAGAATAAACCGGATCCTGTTG 3′ 6245 db miningNA T25727 583047 ESTDIRX51 CD34 + −1 AAATTGTGTGAGAAGGCTGATAAACGDIRECTIONAL cDNA clone TCTGTGGTTTCTCCCTGTGCTATT CDDIRX51 3′, mRNAsequence 6246 db mining Hs.7569 T26893 587784 ESTDIR485 cDNA, 3′ end/ −1GCTGGGCTTCTGCAAAATTATAAAGT clone = CDDIR465/clone_end =TGCTTTATTAAATTCATACATGCGG 3′ 6247 db mining Hs.172822 T26903 587794ESTDIR551 cDNA, 3′ end/ −1 AGCTGATTCATTCATTCTATGTGTGC clone =CDDIR551/clone_end = CACTAAATAAAGAGATTGAGCAAGT 3′ 6248 Table 3AHs.185675 T98171 747516 QV2-EN0098-010201-603-a05 −1CTTGAAGCTGTGTTGGTGGCCTGTGA cDNA CCTTCCAATGCAATCTAGACTGTG 6249 Table 3AHs.58066 W72392 1382348 602389077F1 cDNA, 5′ end/ −1CTCATACACTTCTCAGCCTCAGCACC clone = IMAGE: 4517875/TAACCCTCACACAACACTCCAGTA clone_end = 5′ 6250 Table 3A NA W86427 1400194zh81c11.s1 −1 TGAGTATTGTTGTGGGGGCGGGTAT Soares_fetal_liv-GTCTGTATATAAATCTGTGCAGCCA er_spleen_1NFLS_S1 cDNA clone IMAGE: 4165643′, mRNA sequence 6251 Table 1 NA AA136584 1697794 zn95b02.s1 Stratagenefetal retinal −1 AACATATCCAGGGGAGGACAAAC 937202 cDNA clone IMAGE:TCTGGGCTGGACAATGTATCCACA 565899 3′, mRNA sequence AGGG 6252 Table 1 NAAA431959 2115667 zw77a03.s1 Soares_testis_NHT −1AGAGCAAGTCTCAGAAATAATGCTGT cDNA clone IMAGE: 782188 3′,ATCTACACTGTCATGTATTTGCCA mRNA sequence 6253 Table 1 NA AA482019 2209697zu98e04.s1 NCI_CGAP_GCB1 −1 ACCACCAGCTATTTGTAATTCCTTCTT cDNA cloneIMAGE: 746046 3′, CTAAGGCATAGTGAAAACTTGCT mRNA sequence 6254 Table 1 NAAA524720 2265848 ng42e03.s1 NCI_CGAP_Co3 −1 GGACGGTTGGCTGAATGGCAACAGTcDNA clone IMAGE: 937468 3′, GATGGAATATTTATATTTAGCCACA mRNA sequence6255 Table 1 Hs.57787 AA588755 2402488 602381381F1 cDNA, 5′ end/ −1AGGTTGTTATCAGGTGGCACAAATTA clone = IMAGE: 4498845/AATCCATCTTGAAGACTTCACACA clone_end = 5′ 6256 Table 1 NA AA628833 2541220af37g04.s1 −1 GACTCGTTACGCCGTAGTTTGTCCTA Soares_total_fetus_Nb2HF8_9wTCTTGTTTATCAAATGAATTTCGT cDNA clone IMAGE: 1033878 3′, mRNA sequence6257 Table 2 Hs.180669 AA633203 2556817 OS-4 protein (OS-4) mRNA, −1AGAGCTATGGGTGCTACAGGCTTGTC complete cds/cds = (305, 1158)TTTCTAAGTGACATATTCTTATCT 6258 Table 1 Hs.239489 AA639796 2563575 TIA1cytotoxic granule-associated −1 ACCCTTATAAACCAGAGCCCAGGAAA RNA-bindingprotein (TIA1), GACAGCTCGAGTGTATAATTCTCT transcript variant 2, mRNA/cds= (185, 1345) 6259 Table 1 Hs.29282 AA748714 2788872 mitogen-activatedprotein kinase −1 AGCTCCTCCCTCTCAACACCCAGTTT kinase kinase 3 (MAP3K3),CCTTGGGAGTTGTCATTAAAGGAA mRNA/cds = (83, 1983) 6260 Table 1 Hs.111554AA806222 2874972 ADP-ribosylation factor-like 7 −1GCTGTAATTCTCTGTCTCATCATCCTT (ARL7), mRNA/cds = (14, 592)CTCTTTTGTTTCCATAGCCTTTT 6261 Table 1 NA AA806766 2875516 ob91d04.s1NCI_CGAP_GCB1 −1 TCGCTTTCTAACTGATTCCATTCCAC cDNA clone IMAGE: 13387273′, CATGTCAGATACTCCTGGGCTGCT mRNA sequence 6262 Table 1 Hs.226755AA909983 3049273 RC1-UT0033-250800-022-h02 −1 ATCCAAGGTTTAATTCTGCCATCTCAcDNA GAATGGTGATAAACCATTTCTCCC 6263 Table 1 Hs.50252 AA984245 3162770milochondrial ribosomal protein −1 TCAGCCAACCTGAATCTGGTATCTTT L32(MRPL32), mRNA/cds = (46, ACTTAAACACAGCAGTTGTAGTTA 612) 6264 Table 1Hs.53542 AI084224 3422647 chorea-acanthocylosis (CHAC) −1TCAATAGTTGTGAAATTCTTCTCAGG mRNA, complete cds/cds = (260,CTCCTTAAACCCTCGCTTTGTTGT 9784) 6265 Table 1 Hs.135167 AI091533 3430592AV712376 cDNA, 5′ end/ −1 AGAGGCAACACTTAAACACTAGGGCT clone =DCAAND12/clone_end = ACTGTGGCATCTATGTAGACAGGA 5′ 6266 Table 1 Hs.11637AI275205 3897479 602388093F1 cDNA, 5′ end/ −1 TGACTTTCAGGAATGTCAGCATTGACclone = IMAGE: 4517086/ CTCTCCTTGCCACTGTTACTCAGC clone_end = 5′ 6267Table 1 Hs.8724 AI298509 3958245 serine threonine protein kinase −1TCTCAAGAGAGAACGCCACAGCAGA (NDR), mRNA/cds = (595, 1992)GAGACCCAATCCGCCTAAGTTGCAG 6268 Table 1 Hs.142838 AI299573 3959158nucleolar protein interacting with −1 AGAGTGAGAAGGCAGTTCCAGTTTTA the FHAdomain of pKi-67 GCACAGATTTGTTTATGTGTTCAG (NIFK), mRNA/cds = (54, 935)6269 Table 1 Hs.100555 AI352690 4089896 DEAD/H (Asp—Glu—Ala—Asp/ −1GGGGTAGGAAGAGGATGGAATTGAG His) box polypeptide 18 (Myc-ATGTTTGAGCCTCATTTACATCAAT regulated) (DDX18), mRNA/cds = (71, 2083) 6270Table 1 Hs.108124 AI362793 4114414 cDNA: FLJ23088 fls, clone −1GCTCGCTACCAGAAATCCTACCGATA LNG07026/cds = UNKNOWNAGCCCATCGTGACTCAAAACTCAC 6271 Table 1 Hs.134342 AI363001 4114622 mRNAfor LanC-like protein 2 −1 GACGCGCACACACCTTGAGTGACAG (lancl2 gene)/cds =(186, 1538) CGACCTCTTCTCTACAGGTTTTCCC 6272 Table 1 Hs.192427 AI3800164189889 602298277F1 cDNA, 5′ end/ −1 ACTTCCCCTTTAGGTATCCCTGGAGT clone =IMAGE: 4390770/ AATAATGACAACAAAATTCACTGC clone_end = 5′ 6273 Table 2Hs.158978 AI380390 4190243 UI-H-BI2-ahi-a-03-0-UI.s1 −1GTCCTTTGATAGCAGAACAAGAGGCT cDNA, 3′ end/clone = IMAGE:CTGTGATCCTCTGGACCTCAGATT 2726892/clone_end = 3′ 6274 Table 1 NA AI392705422252 tg23b03.x1 NCI_CGAP_CLL1 −1 TGCAGGCTCATTGTGCTCCTTCTTCT cDNA cloneIMAGE: 2109581 3′, GGGTTTCAATTGGATTTCAGTCCT mRNA sequence 6275 Table 1Hs.76239 AI393970 4223517 hypothetical protein FLJ20608 −1GAGGACTGGGACCGTGATTCCACTA (FLJ20608), mRNA/cds = (81,ACCGGAAACCGTCGCCTTTCGGGCC 880) 6276 Table 1 Hs.79988 AI419082 4265013splicing factor 30, survival of −1 GGATGTGTGATGTTTATATGGGAGAA motorneuron-related (SPF30), CAAAAAGCTGATGTATAGCCCTGT mRNA/cds = (0, 716)6277 Table 1 Hs.121973 AI458739 4311318 602428025F1 cDNA, 5′ end/ −1CCTGCAACAGCTAAGGCCAAGCCAA clone = IMAGE: 4547239/ACTTACCGTGGACTCAAACACTTTG clone_end = 5′ 6278 Table 1 Hs.342008 AI4983184390298 UI-H-BI1-aeq-b-02-0-UI.s1 −1 GCCAGAATGGTACAGAGTGGAGGGT cDNA, 3′end/clone = IMAGE: GTTCTGCTAATGACTTCAGAGAAGT 2720186/clone_end = 3′ 6279Table 1 Hs.194054 AI523854 4437989 HA0669 cDNA −1GACAAAATAGTTACCTATGCTTTCCTT CTGGCACCCCGAATGTACGCAGG 6280 Table 1Hs.14623 AI571519 4534893 interferon, gamma-inducible −1AAGCCCAGATACACAAAATTCCACCC protein 30 (IFI30), mRNA/cds =CATGATCAAGAATCCTGCTCCACT (40, 951) 6281 Table 1 Hs.278554 AI6274954664295 chromobox homolog 3 (Drosophila −1 TGCTGAAAGTGGTCCCAAAGGGGTA HP1gamma) (CBX3), mRNA/ CTAGTTTTTAAGCTCCCAACTCCCC cds = (111, 682) 6282Table 1 Hs.17132 AI633798 4885128 602326676F1 cDNA, 5′ end/ −1GCAACTGTTTTCTAGGACATGTTTAC clone = IMAGE: 4427970/TAGAACTACTTTAAGTATGCTGTGC clone_end = 5′ 6283 Table 1 Hs.4283 AI6512124735191 602621616F1 cDNA, 5′ end/ −1 ACAGTTACTTTGGAGCTGCTAGACTG clone =IMAGE: 4755315/ GTTTTCTGTGTTGGTAAATTGCCT clone_end = 5′ 6284 Table 1Hs.324507 AI678099 4888281 hypothetical protein FLJ20986 −1CGCCAGAGGTCAGAACATGTCTATTT (FLJ20988), mRNA/cds = (182,TGAATTGGATCGTTACAAATGAGC 2056) 6285 Table 1 Hs.90744 AI684022 4895316proteasome (prosome, macropain) −1 TTCTGACACGATTACACAACGAGGCT 26Ssubunit, non-ATPase, 11 TTAATGCCATTTGGGTAGGTGAGC (PMSD11), mRNA/cds =(0, 1268) 6286 Table 1 NA AI688560 4899854 wd39f08.x1 −1ACTGAAAAGTTGAAAGACTTTTGCAG Soares_NFL_T_GBC_S1 cDNATGAACATTTATATAACTCCCCCGCT clone IMAGE: 2330535 3′, mRNA sequence 6287Table 1 Hs.177708 AI697756 4985658 602369210F1 cDNA, 5′ end/ −1TGGTTCCTGTGCTCACCATAGGGCTG clone = IMAGE: 4477370/GTGTACATTGGGCCATTAATAAAC clone_end = 5′ 6288 Table 1 Hs.80887 AI7011654989065 v-yes-1 Yamaguchi saricoma −1 TCTGGGAAAGACATTTTTAAGCTGCT viralrelated oncogene homolog GACTTCACCTGCAAAATCTAACAG (LYN), mRNA/cds =(297, 1835) 6289 Table 1 Hs.299883 AI742850 5111138 hypothetical proteinFLJ23399 −1 TGTTTTACCCTCACTGTTGGACAT (FLJ23399), mRNA/cds = (282,ACATTCCAAGCTTTTCAACTCTA 1769) GGAG 6290 Table 1 Hs.14373 AI7603535176020 yx26h11.r1 cDNA, 5′ end/ −1 TTATCTCAGAATCTTGATGAACTCTG clone =IMAGE: 262917/ AAATGACCCCTGATGGGGGCATG clone_end = 5′ 6291 Table 1Hs.36137 AI785153 6231662 hepalocyte nuclear factor 3, −1CCGGGAAGCGGGGTACTGGCTGTGT gamma (HNF3G), mRNA/cds =TTAATCATTAAAGGTACCGTGTCCG (0, 1043) 6292 Table 1 Hs.195175 AI8025475368019 mRNA for CASH alpha protein/ −1 AGCCCTTTCTTGTTGCTGTATGTTTA cds =(481, 1923) GATGCTTTCCAATCTTTTGTTACT 6293 Table 1 Hs.24848 AI8030655288537 tumor necrosis factor receptor −1 GGGGTATGGTTTAGTAATATCCACCAsuperfamily, member 5 GACCTTCCGATCCAGCAGTTTGGT (TNFRSF5), mRNA/cds =(47, 880) 6294 Table 1 NA AI807278 5393844 wf38h03.x1 −1CTCTACCATAAGGCACTATCAGAGAC Soares_NFL_T_GBC_S1 cDNATGCTACTGGAGTGTATATTTGGTT clone IMAGE: 2357909 3′, mRNA sequence 6295Table 1 Hs.220850 AI880607 5554656 ym91d11.r1 cDNA, 5′ end/ −1TGGGGCACTTTGAAAACTTCACAGGC clone = IMAGE: 166293/CCACTGCTGCTTGCTGAAATAAAA clone_end = 5′ 6296 Table 1 Hs.23098 AI8846715589835 602254138F1 cDNA, 5′ end/ −1 TGGCGAGGATAAATAGAGGCATTGTT clone =IMAGE: 4346626/ TTTGCTACTTTGCATATCATTGGC clone_end = 5′ 6297 Table 1Hs.179391 AI917642 5637497 wi52d11.x1 cDNA, 3′ end/ −1GCAGGAAAGATGGGGTGGTGGACTG clone = IMAGE: 2393877/TTTTTGCCTACTTTTTGTTTTTGAA clone_end = 3′ 6298 Table 1 Hs.180446 AI9485135740823 importin beta subunit mRNA, −1 CAGGGTATCAGATATTGTGCCTTTTGcomplete cds/cds = (337, 2987) GTGCCAGGTTCAAAGTCAAGTGCC 6299 Table 1Hs.7557 AL042081 5421426 FK508-binding protein 5 (FKBP5), −1AGGCTGCATATGGATTGCCAAGTCAG mRNA/cds = (153, 1526)CATATGAGGAATTAAAGACATTGT 6300 Table 1 Hs.39911 AL138429 6855110 mRNA forFLJ00089 protein, −1 TTAAGAACCCCAAAGATTAAAGGAAA partial cds/cds = (62,1111) CAATGTTAAGGGCTTTTGTGAGGA 6301 Table 1 Hs.13144 AL521097 12784590HSPC160 protein (HSPC160), −1 GATACACTGTCCAGCCCAGGTCCAG mRNA/cds = (53,514) GCCCTAGGTTCTTTACTCTAGCTAC 6302 Table 1 Hs.26670 AL540260 12870241AL540260 cDNA/clone = −1 ACTCAGGTGGTGCTGGTGTTAGTGATCS0DF032YF03-(3-prime) GCTGGAGAAGAGAATATTACTGGT 6303 Table 1 Hs.183232AL561892 12909772 hypothetical protein FLJ22638 −1AAACACAGCCCACCCCATTTCAGACC (FLJ22638), mRNA/cds = (12,GCCTTCCTGAGGAGAAAATGACAG 476) 6304 Table 1 Hs.5057 AL578975 12943566AL578976 cDNA/clone = −1 TTGGCCCAGTGTGATTGATTGCTTTACS0DK012YN01-(3-prime) TCTTTGGTACTTTTACTTGAATGG 6305 Table 1 Hs.198296AL582354 12950255 SWI/SNF related, matrix −1 AGCCTGAGGCAAATAAAATTCCAGTAassociated, actin dependent ATTTCGAAGAATGGGTGTTGGCAA regulator ofchromatin, subfamily a, member 2 (SMARCA2), mRNA/cds = (297, 5015) 6306Table 1 Hs.101370 AL583391 12952309 AL583391 cDNA/clone = −1AGGACCTTGACAAGCCGTTTGAGATG CS0DL012YA12-(3-prime)GAATGTAGGCCCTGATGTTATGCT 6307 Table 1 Hs.38218 AV659358 9880372602589369F1 cDNA, 5′ end/ −1 TGTAAGTTGACTTTCAAAAGTCTCTG clone = IMAGE:4893744/ GAAACACTGGACTTTAGCTGGTCC clone_end = 5′ 6308 Table 1 Hs.301704AW002985 5849991 eomesodermin (Xanopus laevis) −1AACAAGCCATGTTTGCCCTAGTCCAG homolog (EOMES), mRNA/cds = (0, 2060) 6309Table 1 NA AW027160 5885918 wf72b08.x1 −1 ACCGCCAAAGCCAATCATCCACTTTCSoares_thymus_NHFTh cDNA AGTACTTACCTAACCAATCTCCCA clone IMAGE: 25129833′ similar to contains Alu repetitive eleme 6310 Table 1 Hs.89433AW071894 6026892 ATP-binding cassette, sub-family −1TTTGGGGGATCCTTTTGTAATGACTT C (CFTR/MRP), member 1ACACTGGAAATGCGAACATTTGCA (ABCC1), transcript variant 1, mRNA/cds = (196,4791) 6311 Table 1 Hs.335449 AW136717 6140850 UI-H-BI1-adm-a-03-0-UI.s1−1 TTCTGGCCTTGTTCACCTAGAAACGC cDNA, 3′ end/clone = IMAGE:TATTTCCTGTGTTATGGTTCTGGC 2717092/clone_end = 3′ 6312 Table 1 Hs.12035AW137149 8141282 602122419F1 cDNA, 5′ end/ −1 GGGTTACATTTGAGTCTCTGTACCTGclone = IMAGE: 4279300/ CTTGGAAGAAATAAAAATACGTGT clone_end = 5′ 6313Table 1 Hs.337727 AW161820 6300853 au70h03.x1 cDNA, 3′ end/ −1TGTGGGCTTGGTATAAACCCTACTTT clone = IMAGE: 2781653/GTGATTTGCTAAAGCACAGGATGT clone_end = 3′ 6314 Table 1 Hs.81248 AW1664426397987 CUG triplet repeat, RNA-binding −1 ACTGGCAAATGAAGCATACTGGCTTGprotein 1 (CUGBP1), mRNA/cds = CAGGGACCTTCTGATTCAAGTACA (137, 1585) 6315Table 1 Hs.166975 AW293159 6699795 splicing factor, arginine/serine-rich−1 CTCCCATCATTCCCTCCCGAAAGCCA 5 (SFRS5), mRNA/cds = (218,TTTTGTTCAGTTGCTCATCCACGC 541) 6316 Table 1 Hs.328348 AW338115 6834741lp39g05.x1 cDNA, 3′ end/ −1 GGCGTTTCCCATTGACCAGTTTGACC clone = IMAGE:2190200/ CTGGTTTGAATAAAGAGAAGTGCG clone_end = 3′ 6317 Table 1 Hs.337988AW440517 8975823 Homo sapiens, clone MGC: 17431 −1GCCAGTCTCTATGTGTCTTAATCCCT IMAGE: 2984883, mRNA,TGTCCTTCATTAAAAGCAAAACTA complete cds/cds = (1336, 1494) 6318 Table 1Hs.250 AW444632 8986394 xanthene dehydrogenase (XDH), −1TGCAATGAGGCAGTGGGGTAAGGTT mRNA/cds = (81, 4082)AAATCCTCTAACCGTCTTTGAATCA 6319 Table 2 Hs.335815 AW444812 8986574UI-H-BI3-ajy-d-11-0-UI.s1 −1 TGGCAACTTCAACTCCTTGATGGCGA cDNA, 3′end/clone = IMAGE: TAATCTCTGGTATGAATATGAGCC 2733380/clone_end = 3′ 6320Table 1 Hs.342873 AW451293 6992069 RC3-HT0230-130100-014-g06 −1TGCTTGGGAAATTTGGTTTGTAAACC cDNA TAAAATAGCCCTTATTTCTGGGGA 6321 Table 1Hs.342735 AW452096 6992953 UI-H-BI3-alo-d-02-0-UI.s1 −1CTTTCTGCCTGAAGCTGCCCCCATGA cDNA, 3′ end/clone = IMAGE:CTCCCTTCTTTGTGCAAAAGCATG 3068186/clone_end = 3′ 6322 Table 1 Hs.80618AW510795 7148873 hypothetical protein (FLJ20015), −1ACCCAGTTTGTGCATAGTTCATGATC mRNA/cds = (31, 522) CTCTATAAAACCAGCTTTTGTGGA6323 Table 1 Hs.259842 AW614193 7319379 cDNA FLJ11025 fls, clone −1ACACCATTTCAGCGTTGGATCACAGA PLACE 1003968, moderatelyCAGCTCTTCCTTTATATCCCAGCA similar to 5′-AMP-ACTIVATED PROTEIN KINASE,GAMMA-1 SUBUNIT/cds = (159, 1145) 6324 Table 1 Hs.334437 AW7787787793371 hypothetical protein MGC4248 −1 TGGCATAATGTTGGATTGAATCTACA(MGC4248), mRNA/cds = (70, TTTTGGCAGAAGTTAAACATTCCC 720) 6325 Table 1Hs.151393 AW778854 7793457 glutamate-cysteine ligase, catalytic −1AGAATGCCTGGTTTTCGTTTGCAATT subunit (GCLC), mRNA/cds = (92,TGCTTGTGTAAATCAGGTTGTAAA 2005) 6326 Table 1 Hs.120243 BE044384 8361417gamma-parvin (PARVG), mRNA/ −1 ATCGTTGGATTATCTTTGAACCCCCT cds = (0, 995)TGTGTGGATCATTTTGAGCCGCCT 6327 Table 1 Hs.5734 BE218938 8908256meningloma expressed antigen 5 −1 ATACAGGGTTCCATCCAGAAAGCATT(hyaluronidase) (MGEA5), mRNA/ CAGTCAGAGCAAGTTAAAGTCAGT cds = (395,3145) 6328 Table 1 Hs.167988 BE222301 8909619 neural cell adhesionmolecule 1 −1 AAGTTGTCCTGTGCTAAAGCAAGCGT (NCAM1), mRNA/cds = (201,GGGATGATCCTACCTACCTCTAGG 2747) 6329 Table 1 Hs.27774 BE348809 9260662602386841F1 cDNA, 5′ end/ −1 AGCTAGTGATGTTTTGTCCAAAGGAA clone = IMAGE:4515730/ GATTCTGACAACAGCTTCAGCAGA clone_end = 5′ 6330 Table 1 NABE348955 9260808 hs91h01.x1 NCI_CGAP_Kid13 −1 ACACAGACATATTGACCGCACACAACcDNA clone IMAGE: 3144625 3′, ACTGAAATGGACTGACTTGAGAAA mRNA sequence6331 Table 1 Hs.56156 BE349148 9261087 601463367F1 cDNA, 5′ end/ −1TGGTTCTCTGATTTGTAATGAGCACC clone = IMAGE: 3868512/TGGATATGTCAATTAAAATGCCCA clone_end = 5′ 6332 Table 1 Hs.127428 BE4665009512198 Homo sapiens, Similar to homeo −1 GGCCTACTGACCAAATTGTTGTGTTG boxA9 clone MGC: 19648 AGATGATATTTAACTTTTTGCCAA IMAGE: 2987818, mRNA,complete cds/cds = (62, 880) 6333 Table 1 Hs.122575 BE502248 9704854endotheilial differentation, −1 CGATAGAATTGAAGCAGTCCACGGGlysophosphatidic acid G-protein- GAGGGGATGATACAAGGAGTAAACC coupledreceptor, 4 (EDG4), mRNA/cds = (6, 1061) 6334 Table 1 Hs.197766 BE5029929705400 clone 23932 mRNA sequence/ −1 CTCAAACGAAATTGGGCAGGCCATTT cds =UNKNOWN GCGTGGTTTCTCTGGATAAGTTCC 6335 Table 1 Hs.61426 BE550944 9792636602329933F1 cDNA, 5′ end/ −1 GCACATGACAGTAAGCGAGGTTTTGG clone = IMAGE:4431248/ GTAAATATAGATGAGGATGCCTAT clone_end = 5′ 6336 Table 1 Hs.122655BE551867 9793559 hypothetical protein MGC14425 −1ACACAGGAACCGCTTACCCACCAGCT (MGC14425), mRNA/cds = (318,CTGCCCGCGTCTCTACCGCCATAG 686) 6337 Table 1 Hs.4310 BE614297 9895894eukaryotic translation initiation −1 ACAACTCAAGTGAAAAGATGTCTCCA factor1A (EIF1A), mRNA/cds = GTTTCTGAAGATAACGCACGCTGA (207, 641) 6338 Table 1Hs.341573 BE6466470 9970781 tc38c11.x1 cDNA, 3′ end/clone = −1AAAACACTCCACCTAAAAGCAG IMAGE: 2066900/clone_end = 3′GAAAGATGGCAATTCTAAATAGCA GCTA 6339 Table 1 Hs.88845 BE674685 10035307AV733781 cDNA, 5′ end/ −1 CGCCGCTCCTGGAGACCTGATAACTT clone =cdAASF08/clone_end = 5′ AGGCTTGAAATAATTGACTTGTCT 6340 Table 1 Hs.181015BE676054 1003695 signal transducer and activator of −1ATCCCATTCTCCCTCTCAAGGCAGGG transcription 6, interleukin-4GTCATAGATCCTAAGCCATAAAAT induced (STAT6), mRNA/cds = (165, 2708) 6341Table 1 Hs.108327 BF001438 10701713 damage-specific DNA binding −1ACAGCATGAGAAACTGTTAGTACGCA protein 1 (127kD) (DDB1),TACCTCAGTTCAAACCTTTAGGGA mRNA/cds = (109, 3531) 6342 Table 1 NA BF05605510809951 7k07h12.x1 NCI_CGAP_GC6 −1 CACAATGCTGCCTCCTCTGTGGATGA cDNAclone IMAGE: 3443950 3′ CTGATGGCAAGAGTCTGAATTGAA similar to containselement L1 repetitive eleme 6343 Table 1 Hs.43857 BF058599 10812495 mRNAfor KIAA1247 protein, −1 TAAGAAATCCCAATTTTCAGGAGTGG partial cds/cds =(285, 2942) TGGTGTCAATAAACGCTCTGTGGC 6344 Table 1 Hs.144583 BF059133108113029 Homo sapiens, clone IMAGE: −1 CGGCAGGGTGGCCTGTAACAATTTCA3462401, mRNA, partial cds/cds = GTTTTCGCAGAACATTCAGGTATT (0, 153) 6345Table 1 Hs.144519 BF061421 10820331 T-cell leukemia/lymphoma 6 −1GCTGGAGGGAGAGGCACTGGGGAAT (TCL6), transcript variant TCL6a2,TTTTCCTGGTGAATACTGAAGTTAC mRNA/cds = (1767, 2192) 6346 Table 1 Hs.96568BF194880 11081165 602137338F1 cDNA, 5′ end/ −1TGATACTTTGGTTCTCTTTCCTGCTCA clone = IMAGE: 4274048/GGTCCCTTCATTTGTACTTTGGA clone_end = 5′ 6347 Table 1 Hs.111583 BF19760811088855 602365742F1 cDNA, 5′ end/ −1 ACTGCCAGTGAAGACTGTAAAGACAG clone =IMAGE: 4473923/ AACACACTATTTTGGAGGGAGGAT clone_end = 5′ 6348 Table 2 NABF197762 11087169 7p91f02.x1 NCI_(—)CGAP_Skn1 −1AGGAAGAGCCTGCACCTGTGGTGGA cDNA clone IMAGE: 3653139 3′,ACAATCAGGGAAAAGGAAGTCAAAA mRNA sequence 6349 Table 2 Hs.50785 BF22178011128957 SEC22, vesicle trafficking protein −1TTTGGAGCTTCTATAGGAGTGGAGAG (S. cerevisiae)-like 1 (SEC22L1),GGGCAGCTCATTGTTGAGAGTTGC mRNA/cds = (119, 766) 6350 Table 1 Hs.250811BF432643 11444806 v-ral simian leukemia viral −1TGATCTGACTGGAAAACAATCCTGTA oncogene homolog B (ras related;TCCCCTCCCAAAGAATCATGGGCT GTP binding protein) (RALB), mRNA/cds = (170,790) 6351 Table 1 Hs.293478 BF435821 11447923 hypothetical proteinFKSG44 −1 CGTTTTCTGAGCATCCGTTGTGCCTT (FKSG44), mRNA/cds = (126,AACATTTTCTGCTTGTCCTTTGGG 1520) 6352 Table 1 Hs.174104 BF445405 11510543601438710F1 cDNA, 5′ end/ −1 ACTGCTGTTGCATGAATAGATGATAC clone = IMAGE:3923643/ AAAGCAAGTGATGAGGTTGGTATG clone_end = 5′ 6353 Table 1 Hs.295726BF447885 11513023 integrin, alpha V (vitronactin −1AGTGAAAACTGGTACAGTGTTCTGCT receptor, alpha polypeptide,TGATTTACAACATGTAACTTGTGA antigen CD51) (ITGAV), mRNA/ cds = (41, 3187)6354 Table 1 Hs.181311 BF478236 11549065 asparaginyl-tRNA synthetase −1TGTCCTCTGAACCTGAGTGAAGAAAT (NARS), mRNA/cds = (73, 1719)ATACTCTGTCCTTTGTACCTGCGT 6355 Table 1 Hs.179703 BF5077849 11591147tripartite motif protein 14 −1 CCATTTCCACTACATGCCTTTCCTAC (TRIM14),mRNA/cds = (10, CTTCCCTTCACAACCAATCAAGTG 1230) 6356 Table 1 Hs.300870BF513602 11598781 mRNA; cDNA DKFZp547M072 −1 AATACAGATTCATTTTATTTAAGCGTC(from clone DKFZp547M072)/ CGTGGCACCGACAGGGACCCCAG cds = UNKNOWN 6357Table 1 Hs.283022 BF514341 11599520 triggering recaptor expressed on −1GCCTCTTTTCCTGTATCACACAAGGG myeloid cells 1 (TREM1), mRNA/TCAGGGATGGTGGAGTAAAAGCTC cds = (47, 751) 6358 Table 1 Hs.146065 BF59104011683364 AL580165 cDNA/clone = −1 CTGGGGCCGTAGCAAAAATCATGAAACS0DJ005YB18-(3-prime) AACACTTCAACGTGTCCTTTCAAT 6359 Table 1 Hs.170577BF725383 12041294 602574255F1 cDNA, 5′ end/ −1 CAGACCTGTGGGCTGATTCCAGACTclone = IMAGE: 4702644/ GAGAGTTGAAGTTTTGTGTGCATCA clone_end = 5′ 6360Table 1 Hs.104640 BF726114 12042025 HIV-1 inducer of short transcripts−1 AAGGCAACCAACCACATTAGAAGTCT binding protein (FBI1), mRNA/TGGCACTTTGTAACGGAACGGGTA cds = (0, 1754) 6361 Table 1 Hs.296317 BF93895912356279 mRNA for KIAA1789 protein, −1 GAAGTGACACTGACTGTATCTACCCTCpartial cds/cds = (3466, 4899) TCCTTTTTCTTCATCAGGTGTTCCT 6362 Table 1Hs.28138 BF940103 12357423 hypothetical protein MGC14158 −1AATTCCAAAGGAGTGATGTTGGAATA (MGC14156), mRNA/cds = (82,GTCCCTCTAAGGGAGAGAAATGCA 426) 6363 Table 1 Hs.133372 BF940291 12357611AF150127 cDNA/cds = −1 AGCCCCTCCACCCCACCCAGTACTTT CBCBGA01TACAATGTGTTATTAAAGACCCCT 6364 Table 1 Hs.304900 BF980139 12347354602288147F1 cDNA, 5′ end/ −1 CCATCCTTGAGAAATGTGGGCACCAA clone = IMAGE:4373983/ GTCCATAATCTCCATAAATCCAAT clone_end = 5′ 6365 Table 1 Hs.8258BG054966 12512220 cDNA FLJ14737 fls, clone −1 TATGAGTTTATGCGTTTTCCCAGCCCNT2RP3002273, weakly similar to TCCGAATCACTGACTGGGGCGTTT SCD8PROTEIN/cds = (77, 1488) 6366 Table 1 Hs.5122 BG058599 12525258602293015F1 cDNA, 5′ end/ −1 AGTTGGAGCTATCTGTGCAGCAGTTT clone = IMAGE:4387778/ CTCTACAGTTGTGCATAAATGTTT clone_end = 5′ 6367 Table 2 Hs.89104BG058739 12525527 602590917F1 cDNA, 5′ end/ −1 CGTGGGAGGATGACAAAGAAGCATGclone = IMAGE: 4717348/ AGTCACCCTGCTGGATAAACTTAGA clone_end = 5′ 6368Table 1 Hs.166962 BG149747 12661777 phosphatidylinositol glycan, −1GTGGTTTGGTCAGCATACACACTTCT class F (PIGF), mRNA/cds = (67,CATTTCATTTGATGTACACAGCCA 726) 6369 Table 1 Hs.184456 BG230583 12725596hypothetical protein (LOC51249), −1 GTGTGAAGTGACAGCCTTGTGTGTGA mRNA/cds= (0, 611) TGTTTTCTGCCTTCCCCAAGTTTG 6370 Table 1 Hs.3353 BG23601512749882 beta-1,3-glucuronyltransferase 1 −1 GTCTTTCCCGTCTTTCTTCCTCACCTA(glucuronosyltransferase P) TGTAATTTCAGTAGTCTCTCAGC (B3GAT1), mRNA/cds =(175, 1179) 6371 Table 1 Hs.83623 BG654774 13792183 nuclear receptorsubfamily 1, −1 TGTTTCGTAAATTAAATAGGTCTGGC group I, member 3 (NR113),CCAGAAGACCCACTCAATTGCCTT mRNA/cds = (272, 1318) 6372 Table 1 Hs.109007BG655723 13793132 602342214F1 cDNA, 5′ end/ −1GTGGAAATCAGCACACAACCACAATG clone = IMAGE: 4452602/ACATTTAAGCACAGGATCATTATT clone_end = 5′ 6373 Table 1 Hs.14453 BG74491114055584 interferon consensus sequence −1 AGAATGGCAGACCTGTTTGCTGAAGTbinding protein 1 (ICSBP1), GTTCATAAGATAACAATAGGCTTG mRNA/cds = (47,1327) 6374 Table 1 Hs.2730 BI084548 14502878 heterogeneous nuclearribonucleo- −1 TGGGATTTTGTTTTTAAGTCATTTGGT protein L (HNRPL), mRNA/cds =TTGGGGAGGACCTTGTTTATTTT (28, 1704) 6375 Table 1 Hs.296356 BI08583214504182 mRNA; cDNA DKFZp434M162 −1 TGGACAAACTGACAGGGACTGCTTTG (fromclone DKFZp434M162)/ AAAGACAGGTACTCAGTTGAGTAT cds = UNKNOWN 6376 Table 1Hs.132911 N20190 1125145 MR2-OT0079-290500-007-b03 −1AAGCCTGTTTTTCACTCTAAAAATTCA cDNA AGAGGACACGCTAAGAACGATCA 6377 Table 1Hs.334731 N58136 1202026 Homo sapiens, clone IMAGE: −1AGGTTCCCTTTCAAATAAAGATAAAG 3448306, mRNA, partial cds/cds =AATTTGACTTGGGACACTGCCAGA (0, 2353) 6378 Table 1 Hs.303018 N94511 1266820zb80g04.s1 cDNA, 3′ end/ −1 CTGTTCGAAAGTTGGAGACTGCCTGT clone = IMAGE:309942/ ACCCAGGTTGATAGTCAATTGTTT clone_end = 3′ 6379 Table 1 NA W687081377588 zd35h04.s1 −1 AGCAGAGTTAAGTTTAAATTTCCATTCSoares_fetal_heart_NbHH19W TCACTAGTTTGTGACCTTTGCCA cDNA clone IMAGE:342679 3′, mRNA sequence 6380 Table 1 NA W88427 1400194 zh81c11.s1 −1TGAGTATTGTTGTGGGGGCGGGTAT Soares_fetal_liv- GTCTGTATATAAATCTGTGCAGCCAer_spleen_1NFLS_S1 cDNA clone IMAGE: 416564 3′, mRNA sequence 6381 Table3A NA 36G5 1 CCCTTGCAGATACATGAGACAGGCA GGGGCTGGAGTCTTGTTCCATCCTG 6382Table 3A NA 38F11 1 GAGTAGTTGTCTTTCCTGGCACTAAC GTTGAGCTCGTGTACGCACTGAAG6383 Table 1 NA 37G7 1 GAGTCCAATCTACACTCTAGTAGTGAAGACAGAAGAGTTGGCATACGAGT 6384 Table 1 NA 37G8 1GGCTGAACTTACTCATTAAGCCACAT AACTTCGAGTCAAGTTCCAGTCCA 6385 Table 3AHs.197345 thyroid autoantigen 70kD (Ku 1 GCTCTCAAGCCTCCTCCAATAAAGCTantigen) (G22P1), mRNA/cds = CTATCGGGAAACAAATGAACCAGT (17, 1846) 6386Table 1 NA 40E4 1 AGGAATGCACACATTGCTCCAGGATC ACTGTGAGGATTAAAGGAGATGGT6387 Table 3A NA 41E9 1 AGTAACGGAACAGTTCCCAGTACTCCTGGTTCCTAGGTGAGCAGGTGATG 6388 Table 3A Hs.169476 Homo sapiens,glyceraldehyde-3- 1 GGTGTGAACCATGAGAAGTTCGACAA phosphate dehydrogenase,clone CAGCCTCAAGATCATCAGCAATGA MGC: 10926 IMAGE: 3628129, mRNA, completecds/cds = (2306, 3313) 6389 Table 3A NA 47E5 1GGAGGTGTATAGGCTGGGATTTGAAA AGGAAAATAATCAGCGTGGTGCCA 6390 Table 2 NA47D11 1 CCTAGACACCTGCATCAGTCAAGGTC ATGGATATTGGGAAGACAGACAGC 6391 Table 1NA 50A11 1 TCCAGCAGATATAGGAAGCAGTGTAT CTAAACAGACAAATAAAAAGGCCT 6392Table 3A Hs.132906 DNA sequence from clone RP11- 1ATCTAGTGTACGAGACTTGGAGTCAG 404F10 on chromosome 1q23.1-GCAGTGAGACTGGTGGGGCACGGG 24.1. Contains the 5′ end of the SLAM gene forsignaling lymphocytic activation molecule a SET (SET translocation(myeloid leukemia-associated)) protein pseudogene, the CD48 gene forCD48 antigen (B-cell membrane protein), the gene for a novel LY9(lymphocyte antigen 9) like protein and the 5′ end of the LY9 gene.Contains ESTs, STSs and GSSs/cds = (41, 1048) 6393 Table 1 NA 52B9 1TGGTTTAATGGAAAATGCTCTGGAAA ATTCTTTTGCAACAGTTCATCGCT 6394 Table 1 NA 53B11 CACTAAAAGAGTGGGGAGGTGCAGC ACCTGGCTGGGGAACAAGAATATGG 6395 Table 1 NA53E3 1 AAACGAATCACGTGCCTCGAAAGGG ACATATATTGTTCCTTTAAGCATTT 6396 Table 1NA 53E10 1 AAGGGTTCAATTTCTTCTTTGGAAGG TGATGGTAAGGGTGTGGCTCCAGA 6397Table 2 NA 53G7 1 TGGACAATTCCAAGTCCAAGAGGACT GTCTACTTTCGACCTTGTGTGATT6398 Table 1 NA 54F4 1 TTGTGTTAACCTGTTGTCCACGCTAAGATACAAACTTCCCGGAGGAAAGT 6399 Table 1 NA 54G9 1TGTCACAGTGTTCTATTATTTGCCCG GTTCTTAAAGTGAGAGCATCCTGA 6400 Table 1 NA 59G11 ACAATGATATTGATGAGGCACCCAGT CTTTTCATTTACTCTGAGTGAAGT 6401 Table 1Hs.48320 mRNA for ring-IBR-ring domain 1 AGATCGAGATCTTCAGTCCTCTGCTTcontaining protein Dorfin, CATCTGTGAGCTTGCCTTCAGTCA complete cds/cds =(317, 2833) 6402 Table 1 NA 60G8 1 GGCCAGAGACCCTAAGCTGCTTAATACATTTATACCACATCCTTCTCAGC 6403 Table 2 NA 62C9 1CCCTTGGAATTACTTGTTCAACTTCTT TCTTTCCCACTAGACGGGGACTT 6404 Table 3A NA62F11 1 CTTTGTAGATGCAGAGAGAAGCTATA AGAAACCCCAGTACTTGCCGGGCG 6405 Table 1NA 63E1 1 ACTGCCACATCTGACTTTACAGAATA ACCAATGTAAGTTAAAATAGAGAAAC AG 6406Table 2 NA 65B1 1 AGTCTTGCGAGTCAACTCAGACTCAA ATGTAGAACTGGGAAGGACAGTGC6407 Table 2 NA 65d10 1 AGCACTGTGCAGATGGCTTTAGAAGATTCAGAACAGAAGCACAATCTGTT 6408 Table 2 NA 65D11 1AGCACTGTGCAGATGGCTTTGGAAGA TTCAGAACAGAAGCACAATCTGTT 6409 Table 2 NA65D12 1 CTATGGAGTCTTGGAGGACACTGGA GTCACCATGCTAACACTGTGCAGAT 6410 Table 1NA 68C9 1 CCCTGTCACCCTTCGTGGCCAGTGC CAGACAGTAACTAGTGGATGCTAAA 6411 Table1 NA 69F8 1 GAGAGAATAGGGTAGAGAGACCGGG ACTTGGGTAGAGATGACCGGGATTC 6412Table 1 NA 69H11 1 AGTGGAAGCTAGGAGAAATATCGAAT GTGTTAGGGACTTTGAAGTTACCA6413 Table 3A NA 70B6 1 CTGCATCTCTCTTTACTACCAGTGATTACAAAGTGGGGTTTGGTGGGAGT 6414 Table 3A Hs.17109 integral membrane protein2A 1 TCTCTGACTTCTTATTACCAAGGACA (ITM2A), mRNA/cds = (139, 930)CTCTATCTGTTGCCTCTTACTCTT 6415 Table 2 NA 72D4 1CAGTTCCCAGATGTGCGTGTTGTGGT CCCCAAGTATCACCTTCCAATTTC 6416 Table 3AHs.234279 microtubule-associated protein, 1 AACGACCCTGTATTGCAGAAGATTGTRP/EB family, member 1 AGACATTCTGTATGCCACAGATGA (MAPRE1), mRNA/cds =(64, 870) 6417 Table 2 NA 72D8 1 GGGTCCCGAGCCCTTCAAGAGCTAGATTTACTCAAGTTTGTTCCCTTGCC 6418 Table 1 NA 73C4 1CACTGAAGCCAAACCACAGAAGACTT TTGAGAATGAGGAGACAAATGAGT 6419 Table 1 NA 73H41 AGGTGAAAATTACTCTTCAGAAGATA GCAGAGTGGATAATGGCCCATCGA 6420 Table 2 NA73A7 1 TGCAGTGAGACTACATTTCTGTCTAA AGAAGATGTGTGAGTTCCGTCCTT 6421 Table 3AHs.174228 small inducible cytokine subfamily 1TCCAGCCAGCCAGCTCATTTCACTTT C, member 2 (SCYC2), mRNA/ACACCCTCATGGACTGGGATTATA cds = (0, 344) 6422 Table 3A Hs.3945 CGI-107protein (LOC51012), 1 TTTCATACATTGGAACTCCACCTGAC mRNA/cds = (84, 719)TTTGGACCAACCCCAGAACAGAGC 6423 Table 1 NA 75A2 1AGCACCGGAATACAAAAATGATACTA TGCTGCCCTCCTAGATCTCAGGGA 6424 Table 3AHs.249495 heterogeneous nuclear ribonucleo- 1 TGCCCATACACATGAGTATTTGTCTAprotein A1 (HNRPA1), transcript AAACATGTCTTCTTTGTAGCAGCT variant 2,mRNA/cds = (104, 1222) 6425 Table 2 NA 75B12 1GCAAATCTAAACTGCAGGAAAATTTT TGCACCCGAAGTATTCAGATCCCT 6426 Table 2Hs.205442 601439689F1 cDNA, 5′ end/ −1 GGCCCAGTGCTAATGTAACCAATGAT clone= IMAGE: 3924407/ GCCATGTCGATATTGGAAACCATA clone_end = 5′ 6427 Table 3ANA 101G7 1 GGGGAAGAACAAGATAATCTAGTGAC CTCACCACAGTCTATGCCCAGGCC 6428Table 3A Hs.179565 minichromosome maintenance 1AATTCAACTGAAGGCGAGGAATGTTG deficient (S. cerevisiae) 3GTGATGAAGCTGAGATCAGGACTC (MCM3), mRNA/cds = (44, 2470) 6429 Table 1Hs.119640 hBKLF for basic kruppel like 1 CACCTATATCGAAAGTTTGGGCTCATfactor (LOC51274), mRNA/ CTCCCATTGGTGGCAAAGACCTCC cds = (55, 1092) 6430Table 3A Hs.215595 guanine nucleotide binding protein 1TGGTGGAAAAGTGTGTCTGTCTGACA (G protein), beta polypeptide 1ATTACACTCAAGTTTACCTCTGGT (GNB1), mRNA/cds = (280, 1302) 6431 Table 1 NA105A10 1 ACGATAATACTGTTGGTTACTGCCAT AAATATTGGAAGCTAATGTAAAATGC A 6432Table 1 NA 107G11 1 TTCTCTTATAAAGGACAGCAAGTTTAA AATGGAGCAAGGAGCATTGGAAA6433 Table 1 NA 107H8 1 TGGCCAAAGAATAGAAGCTCTAGACCTTCCTTATTTCTATCGTGAAAACA 6434 Table 3A Hs.64239 DNA sequence from cloneRP5- 1 ACATGACCTGTGCAGTGTGTGGCTGT 1174N9 on chromosome 1p34.1-GAATTCTGTTGGCTTTGTATGAAA 35.3. Contains the gene for a novel proteinwith IBR domain, a (pseudo?) gene for a novel protein similar to MT1E(metallothionein 1E (functional)), ESTs, STSs, GSSs and two putative CpGislands/cds = (0, 2195) 6435 Table 1 NA 109H9 1TGACATAACTACCATCCCTGCAACTA ATGAACCCACCCTCACAGCTTCCT 6436 Table 3AHs.80261 enhancer of filamentation 1 (cas- 1 GAATGACATAAACCCCCTCCGGTCTGlike docking; Crk-associated AGGTCCGGCCTTCCAGCTTGTCTC substrate related)(HEF1), mRNA/ cds = (163, 2667) 6437 Table 3A Hs.1422 Gardner-Rasheedfeline sarcoma 1 GCCTTTCTCACTCCATCCCCACCCAA viral (v-fgr) oncogenehomolog AGTGCTCAGACCTTGTCTAGTTAT (FGR), mRNA/cds = (147, 1736) 6438Table 3A Hs.333114 AV713318 cDNA, 5′ end/clone = 1TCGTTTTACAACGTCGTGACTGGGAA DCAAAC09/clone_end = 5′AACCCTGGCGTTACCCAACTTAAT 6439 Table 1 NA 129A12 1TGTTTTGTTTTCTGAAACGAAATCCTG CTCTGTTGGCCCAGCTAGAACGC 6440 Table 1 NA129F10 1 CAGAAGCTGGATGACGTTGCTCCATC TTCACTCTGTTAATGAGACATGAT 6441 Table3A NA 137D4 1 CACATCTTCCATTCAGCCCTACCATG AAAACCGTACCTCGGGCGCGACCA 6442Table 1 NA 142F9 1 AATTTGCTTTAAATTGAGTTTCCTTGC CATTGCACACTCCTATCTTTCTG6443 Table 3A Hs.250655 prothymosin, alpha (gene sequence 1CAGATGACACGCGCTCTCCACCACC 28) (PTMA), mRNA/cds = (155,CAACCCAAACCATGAGAATTTGCAA 487) 6444 Table 3A Hs.249495 heterogeneousnuclear ribonucleo- 1 CCCATGCTGTTGATTGCTAAATGTAA protein A1 (HNRPA1),transcript CAGTCTGATCGTGACGCTGAATAA variant 2, mRNA/cds = (104, 1222)6445 Table 1 NA 149G2 1 GACACAGACAGACCAAGCTATAGTCAGACCTGGTTACACACATACACACA 6446 Table 1 NA 149A11 1TGGCAAAGATCACTGAAATTTAGGAC ACCAAAGCTAAAACCCCAAATGCT 6447 Table 3A NA151F11 1 GCTTGTGCTCGAGACCGCTTGCTATA GAAACGCTGAGCTGCTGGTTTATG 6448 Table1 NA 162E8 1 CTGGTTAAAAGCCCCATTACTGACCT TCGCCGCCACCACGCCTATCACTA 6449Table 3A Hs.334330 calmodulin 3 (phosphonylase 1GCATCCACCTCCTTCTCTGTCTCATG kinase, delta) (CALM3), mRNA/TGTGCTCTTCTTCTTTCTACAGTA cds = (123, 581) 6450 Table 1 NA 170F7 1TTAAATCTATCAAGAATTCATCCAAAT TGGTACCCTGCCGGGCCGCCTCG 6451 Table 2 NA170F9 1 AGTGCTGTATTGACTTTGCTCGGCAG TAGATGAAGCTATTCTGAACCCAA 6452 Table3A NA 177A3 1 TGCTGGACAAAGACAATGAGATGATT ATTGGTGGTGGGATGGCTGTTACC 6453Table 1 NA 331A3 1 GTGGAAAAGTCACTACCAGGCTGGC AGGGAATGGGGCAATCTATTCATAC6454 Table 1 NA 331A5 1 AAGGGACAGGGAGCGGGCACAAAATAAAACTTAGTTTGGTAGAAATTATA 6455 Table 3A NA 146C3 1TCAAAGCACTGGAGATGAGAGCCAG GATGGACCCGAAAAGAATTTTACAG 6456 Table 1 NA146D8 1 CAGGAACATGGCTGCAGCATATAAAA AGAATTGAATTCCATACTTTTGTTAAC CCT 6457Table 3A Hs.153 ribosomal protein L7 (RPL7), 1TTGCCATAACCACGCTTGTAGATTAG mRNA/cds = (10, 756) TTCATTTACTGACTTCAGATTGGG6458 Table 1 NA 158G6 1 TTACAGGCAACCGGAGCATCCAATCACCTTTCTCTAAGAGAGTACCTCGG 6459 Table 1 NA 158H6 1AAAAGCATCTTCGAGAGGGACTGTCA ATTCTCGACTATTTTCCAACCCGC 6460 Table 3AHs.119598 ribosomal protein L3 (RPL3), 1 AAGAAGGAGCTTAATGCCAGGAACAmRNA/cds = (6, 1217) GATTTTGCAGTTGGTGGGGTCTCAA 6461 Table 1 NA 158E9 1AGAGACACCTAAATTACAGATTTGTG AGCTGAGAGCTGGAGTTTTTCATT 6462 Table 3AHs.326249 ribosomal protein L22 (RPL22), 1 AACAGCAAAGAGAGTTACGAATTACGmRNA/cds = (51, 437) TTACTTCCAGATTAACCAGGACGA 6463 Table 3A Hs.297753vimentin (VIM), mRNA/cds = 1 AGCGCAAGATAGATTTGGAATAGGAA (122, 1522)TAAGCTCTAGTTCTTAACAACCGA 6464 Table 3A NA 155H10 1GCATGGACAAGATGCCAAGGCCCGG ATGCTTTAGGATGAAGTTCTTATCT 6465 Table 3AHs.108124 cDNA: FLJ23088 fls, clone 1 CCTCCAGTCACCATACACAGGTTACCLNG07026/cds = UNKNOWN AGTGTCGAACTTGATGAAATCAGT 6466 Table 1 NA 159F8 1CCAAACATCTGGACTTGTGACTGTAA AAGGGGAGGAGGTAGCCAATGATT 6467 Table 3A NA166F3 1 TTATGGTGGTCGGGGTGGGTGGTAG TTCAATGGGAGGTATGGGATTTATT 6468 Table 1NA 166F6 1 AGCTGTCTGGCTCAAAGATCTACATT CTGAAGTTGGCTGGAAATGTCTTG 6469Table 1 Hs.8121 Notch (Drosophila) homolog 2 1CTGGTTCCTACCAGTGCCAGTGCCTT (NOTCH2), mRNA/cds = (12,CAGGGCTTCACAGGCCAGTACCTC 7427) 6470 Table 2 Hs.25130 cDNA FLJ14923 fls,clone 1 TGACACAGACTGTTTCAATCTTGGAG PLACE1008244, weakly similar toCAGCGACTGACTTTGACAGAAGAT VEGETATIBLE INCOMPATI- BILITY PROTEINHET-E-1/cds = UNKNOWN 6471 Table 1 NA 188A9 1TGCTATTTAAAGCACCATGATAAATAT GAGGCCACTTGGAAATCCATCCA 6472 Table 1 NA171F11 1 GCAGGCGATGCTCTATAATCTAAAAT GTATCTCTCTTTCCCTAAGCTGAA 6473 Table3A NA 171G11 1 AAGTAAGACCACCTGTGAACTTGATC ATTATCTGGCGCACATAGGAAGAT 6474Table 1 NA 175D1 1 GCTGGGGCTGGGAATTGCGTGGGCT AATGTGTCATTTGACTTAAGAAACT6475 Table 1 NA 182H1 1 TTTGGGAAGAACCGATTGCTAAATTATGCCTAATTCATGTCAGAAGAGGG 6476 Table 3A NA 184B5 1AAGCAGTATACCATTTATATAGCAAA CAGCCAGTGGCCAGTTCACTGTAT 6477 Table 3A NA184D2 1 CTGCCCTTTGGTAGTGAGAGGACCA CGCCAATGATGCTTTTAAGTAACCT 6478 Table 1NA 184H1 1 CATTTCTTCATCTCTAAGGCACACTT GCTACCCCTCTTTGCTGACCCCAG 6479Table 1 NA 46D1 1 GCCTGCGTGTCTGTCTCAGTGTTTCC TGGTCCTCCTCTAAGTACTCTAAA6480 Table 1 NA 98C1 1 AATCCTAGACATGTGCTTGTCATTGCTCCCATGAAGGTAGTTTTCAAACA 6481 Table 1 NA 98C3 1ACCAATAGAGAAGAAGCTCTAGAAGA CAAAATCCCAAACCTTGGCACAAA 6482 Table 2Hs.205442 601439689F1 cDNA, 5′ end/ 1 GGCTTCAACAGAAACATCAAATGCCA clone =IMAGE: 3924407/ AGACCAGTGAGAGAGCGTCAAAAA clone_end = 5′ 6483 Table 1 NA98H4 1 GCAAGCCCACTAAAATAAACATCTAA CCAGCATCTTTCCCCCATTATAGG 6484 Table 1Hs.169363 GLE1 (yeast homolog)-like, RNA 1 ATGGATCTGTTCCTCTGTGCTAAATGexport mediator (GLE1L), mRNA/ TCTTGTGGCAGGGTGTGTTTGTGG cds = (87, 2068)6485 Table 3A NA 113F12 1 GCCGTAATGTCTCGGGATCTCTAATAATAGAGGAGGTGAGTTGTGGTGTC 6486 Table 1 Hs.30212 thyroid receptorinteracting protein 1 AGGCACTCCTCAACCAGTGTTCACTG 15 (TRIP15), mRNA/cds =(15, AATTCAACTGCTGAAATTGTAACA 1346) 6487 Table 3A NA 173A10 1AGAGAGGGTTTTAAGGGAGGGCTTG TGAATACTTGGGAGAATACGGAAGG 6488 Table 3AHs.334853 hypothetical protein FLJ23544 1 ATGAATTTGAAGACATGGTGGCTGAA(FLJ23544), mRNA/cds = (125, AAGCGGCTCATCCCAGATGGCTGT 517) 6489 Table 3AHs.20252 DNA sequence from clone RP4- 1 TTCCACAGATAGGTAAGCCAGGCGC 646B12on chromosome 1q42.11- GGCAAGATGAGACTGTATTCAGTTA 42.3. Contains an FTH1(femitin, heavy polypeptide 1) (FTHL6) pseudogene, the gene for a novelRas family protein, ESTs, STSs, GSSs and a putative CpG islands/ cds =(0, 776) 6490 Table 1 NA 174D1 1 TCTTGTCCTAGTCATTGTGGCAACCCCATCTGACACCTTGTGTAGTACCT 6491 Table 1 NA 45B9 1TTCTGGCAAGCTCTTGTCATGGTGTT CGACACTTCCTTCTGTCTTCTTGG 6492 Table 1 NA 45H81 TTTCAACATGGCTAGATCCATCAGAA ACTGAAGGCGGGGGAGAAAGCTCTC 6493 Table 1 NA111H6 1 GGTACTCAAAGGAAATTACTCTTTCT CTGGAACCCTGGCAGAAAGTTTTA 6494 Table 1NA 111E12 1 ATCCTTCCTACCTTTTATTATGAAAGT TTTGGTACCTGGCCCGGCGAGCG 6495Table 1 NA 111H11 1 ATTAAGGTTTTTAACATCTACTTTGGG TGATGGAGCCTTCAATGAAGTCA6496 Table 1 NA 112H3 1 GAAAGACTACGAATTTCGCTGGGAGGTAATAGGGAAGCCTTCCACATAAA 6497 Table 1 NA 112E9 1AAATGAGGTCAGCAATAACCTTGATT CGGTCCTCCACTGGCAACATTTTA 6498 Table 1 NA114G3 1 CTTCTCTCCCTGTAACCAGGCAGTGT GTGGGCGGGGCTCAGAACATATCT 6499 Table 1NA 117H6 1 GTTGCCCTGATCTGGAAATCCTGTTG CTTCTTCTGGGATGAAGGAACCTC 6500Table 1 NA 165E7 1 TAAGATAACCCACAGGCACTTCCTGT CATAAAGCCAACGACACAGACCAG6501 Table 1 NA 165E11 1 ATGGGAACAGGATGTTAAATACACACATACATACGCACACAAGCGTTGGG 6502 Table 1 NA 165F7 1CCTCTGCTATCACTAGAGAATGTAGA GAATGGAAATGGCTGCCTTTATGC 6503 Table 1 NA176A6 1 GATACAGATGTGATTATTCAGCCTCA AGGGGACTTCTCCATTGCGTAACG 6504 Table 1NA 176G2 1 TTATTGTTACCAATTAGAATCAGCAAT TCAACTGTGCGGTGATTTGGCCT 6505Table 1 NA 176E10 1 TCATCACTTGGGTTAACTAAAGGTTT GCGTATCACACAATTACACTACAA6506 Table 3A NA 176F11 1 TTCATAGTCAAACAAAAGGTAAGATCATGCATATACCCACGGCAACAAGG 6507 Table 1 Hs.232400 heterogeneous nuclearribonucleo- 1 CCCACCCCCTTCCCCTCCATGTGAAG protein A2/B1 (HNRPA2B1),ATTTGGGTGCTTAACATATCATTT transcript variant B1, mRNA/ cds = (169, 1230)6508 Table 1 NA 71F2 1 GGGAGACATGCTGATTCCACTCAAAGATCTCATAATAAACAGCTTTGGCC 6509 Table 1 Hs.172028 a disintegrin andmetalloproteinase 1 AAATAAATTTGGAATGGGACATTGTG domain 10 (ADAM10), mRNA/CTGTTTCACCTTCAATGCTGTTA cds = (469, 2715) 6510 Table 1 Hs.180610splicing factor proline/glutamine 1 AGAACAGTCTTGGGTTCAGGGGTGT rich(polypyrimidine tract-binding GATGCCAGAATGTATTTTCGTACCTprotein-associated) (SFPQ), mRNA/cds = (85, 2208) 6511 Table 1 NA 124G41 AAGGCGAAGTCAATCCCATCTCCCTG AACCCAACTGCCAGTAGGTAGTTC 6512 Table 1 NA123C8 1 AGTTAAACTGTTGGTGAGGTAGTGTG TCAGGTACTCTGTATATTAGCTCT 6513 Table 1NA 124F9 1 ACTGGATAAACAGAACGGATCAAAGA TAAAAGTATTCTTGTTGCCTGGGC 6514Table 3A NA 127A12 1 GTCCCTTAGGGGAGGGAGAGTTGTC CTCTTTGCCCACAGTCTACCCTCAG6515 Table 1 Hs.50180 601652275F1 cDNA, 5′ end/ 1ACTGGACTACTGAACTTTAGAATACT clone = IMAGE: 3935610/GTCCTAAGGAAATAGGTCTGGGCA clone_end = 5′ 6516 Table 1 NA 161E8 1CAAACAACAAAAGTGGCCTCCATCGC TGTGAGCCTCTCAAGGGACAGGGC 6517 Table 1 NA186E8 1 AAGGTGGCTGGCTTTTATGATACAGT GGTGGTAATGTAGCCCTTTTTGGT 6518 Table 2NA 191F6 1 TGCTCAATTGCCATACATGCACTATA GGCCGGGATAGAAAATCGTCAGCT 6519Table 3A NA 193G3 1 TTCAAGGATGTGACTGATATCTGGTG TGGTTTATTTTGTTTGTTTTGGGG6520 Table 1 NA 194C2 1 AGCTTTGGAAATTTGAACAAGGTGGGGACAAAATCAGGCAATAACAGACT 6521 db mining NA 458C6 1CACTTCCTGAGTGTTTCCTGAGAACA AAGGATCAGAGCTTCGGCTGTGAG 6522 Table 1 NA458E4 1 TTTTCCTTTTCGCTGACTTTCCCACTC ACTGTCTGTCTCTCATTTTCTCT 6523 Table 1NA 458G10 1 GCATGGGAATTGGCTGTCATCACTCA TAGCACGGTGTATAAACTCAAGGA 6524Table 1 NA 459B3 1 GTCCACTCAAGTTACCTGGCTGTCTA TCTTTTGGCTGACCCCTGAAGCGA6525 Table 1 NA 459D2 1 CTAAGTAAGCAAAGAGGCAGAGGGGAGGAGGGGAGTGTTTGGTACTGTCC 6526 Table 1 NA 459E6 1TGGTGCGGTGTTCATGATTATTATGC AGGGTGGAAGTTCAGTATTTGGTC 6527 Table 3AHs.20830 DNA sequence from cosmid 1 AGCACATTTGTGCAGAAAGGTTTTGC ICK0721Qon chromosome 6. AGGTATCTGAGGCACTGCTCACCT Contains a 60S RibosomalProtein L35A LIKE pseudogene, a gene coding for a 60S Ribosomal ProteinL12 LIKE protein in an intron of the HSET gene coding for a Kinesinrelated protein, the PHF1 (PHF2) gene coding for alternative spliceproducts PHD finger proteins 1 and 2, the gene coding for five differentalternatively spliced mRNAs coding for a protein similar to CYTA (CYCY)and identical to a polypeptide coded for by a known patented cDNA, andthe first two exons of the gene coding for the homolog of the ratsynaptic ras GTPase-activating protein p135 SynGAP. Contains threepredicted CpG islands, ESTs and an STS/cds = (163, 2184) 6528 Table 3ANA 460D5 1 AGAACAACACGGGATTGAAGTGGGA AGAGATGGGACCCTCATTGGATCTG 6529Table 1 NA 480B9 1 GGAACAATAGACCTCTTCACTAGCTC CCTGCTGTTTGATGGTTTGGTTGG6530 Table 3A NA 461A4 1 AGAGGATGACTTTGAGGTAAATGTTTACGATGCACGGTTTTAGGCGATGT 6531 Table 1 NA 461G8 1GTGTCCTGGGGAGTGAGGAGAGGTG GAGTAGACTCTGAGAGGAGTGAAAA 6532 Table 1 NA461D9 1 AGATCATGTCTGGATTGTGTTTCCTA TTACCTAGAGACGAACACAGATCT 6533 Table3A Hs.80788 chloride channel 7 (CLCN7), 1 GTGTCCCAGGACGAGCGGGAGTGCAmRNA/cds = (38, 2455) CCATGGACCTCTCCGAGTTCATGAA 6534 Table 1 NA 481H7 1TGTATGGCTTATAGCCAGAGATGAAA CAGAACCCAAGTTAATATTGCCAG 6535 Table 1Hs.333513 small inducible cytokine subfamily 1AGGTTTCAGAATCTGGGCCTTACCTT E, member 1 (endothelialTACAGGTTCAACAAAAGAATGGCA monocyle-activating) (SCYE1), mRNA/cds = (49,987) 6536 Table 1 NA 483A5 1 AAGATGAGGCGTAGCTCATGTACAAATGCAGCATTCTCATAAGTGCTTTA 6537 Table 1 NA 483B2 1AGATAGTGGTATTTGGGTGCTGGGCT TGTCTGAACTGAGGAGGTGGGTGC 6538 Table 1 NA483C5 1 CCTTGCACCAGAGACGACTGACATAT ATAGATGGGAGTCACTCATGCGCT 6539 Table3A Hs.40919 hypothetical protein FLJ14511 1 GGTGTAGCGTGAAGATCTGGACAGC(FLJ14511), mRNA/cds = (22, GCACTACGACCCGGGCCACTGTTTC 1272) 6540 Table 1NA 463H5 1 AGAAGCAAACCTGTGAAGCTACTATC GTTTATCATCAGTGTGAATGCACT 6541Table 1 NA 463A7 1 TAGTGATACAATTTGGGGTGCCAGAG GTTGGGGGTAAGGAATTTTGAAGC6542 Table 1 NA 463B10 1 GTGTGGCCTAAGGAACACCTCTTGTGGGGAGTAAGAGCCCAGCCCTTCCTC 6543 Table 1 NA 463C7 1AGATGCGGGCGCAAGCTTATGTCCT GTTATGAGGGTTTAAATTAGATTGG 6544 Table 1 NA463F10 1 TCATAACGCCCTTCAAAACATTGAAT AAAATCAGTGCAAAACATTGAGCA 6545 Table1 NA 464C2 1 TGAGAAAGGAGTTAGCAGAATATTAA CATACCGAGAAGCTGTTGTTAGCA 6546Table 1 NA 464C5 1 CTGGAGACTCAGGTCGCTTAAGTGG AGGGGACGGGCACAGCCATTCCTCC6547 Table 1 NA 464C10 1 AAAGACCTGCCACTTATTTTTGGCTCTCATCTGTACTCTTAAGTGTGTGT 6548 Table 1 NA 464D8 1AGACACAGCTGCAGAAAACTTATTCT TTTCAAGCATGCACAGTCACAAAA 6549 Table 1Hs.221695 7k30d01.x1 cDNA, 3′ end/ 1 CATTCAACAACACAAACCGAGCACCT clone =IMAGE: 3476765/ ACTGTGTGCCACGCCACAGACAAG clone_end = 3′ 6550 Table 1 NA464E7 1 CCTAGGAAACACAGGTCAAAGA AACACAGTCCAACATGTATTCAGA ATTC 6551 Table1 NA 464H12 1 AAACGCAATCTATTTTAGGTTTGAGAT TAGAAGCTGAGGCCAAGGACTCA 6552Table 2 NA 465B3 1 TCCTCCAGATGCATGGTCCGTGAAGA AATTTAATAGCAAAGACGAGAAGA6553 Table 1 NA 465G2 1 GGCTCTCATGCTTATGCCACACATCCTTGATTCTGCTTAGGAGTCTCTGG 6554 Table 1 NA 465H5 1AAGCCTGAGCTAACAAGAGCTGAGG ACAGTAGCTTATTCCTCTTTATGGG 6555 Table 1 NA465A12 1 TGGATGATGGGATTGGATAAGCATGT GGACTGGATTGTGTTACAAACTCT 6556 Table1 NA 465F7 1 TGCTGTTTCTAGGATTAACACGAAAT CATCACTTTGCCATATTTTGAGCT 6557Table 1 NA 465G8 1 GGCTCAGCACAAAAGAGAATTCGTAG CACTTTCATGTGAAAGCAGACCCA6558 Table 1 NA 465H10 1 GATATTAAGGTACTTTCAGTACAAATCTGGTGCTGTGAGTGGGCTCATCC 6559 Table 3A Hs.136309 DNA sequence from cloneRP4- 1 TCCAGTTTCTCATAAACAAATTCTTCT 612B15 on chromosome 1p22.2-ATCCTGGCATTTGGATTTGGGTT 31.1. Contains the (possibly pseudo) gene for anovel protein similar to 60S ribosomal protein L17 (RPL17), the gene forCGI-61, endophilin B1 and KIAA0491, ESTs, STSs, GSSs and two CpGislands/cds = (1011, 1406) 6560 Table 1 NA 515C12 1TCATGGTCATAGCTGTAACCTGTGTG AAATAGTAATCAGATCAAAAAGCG 6561 Table 1 NA515H10 1 ATATGTACCTGGAGGGCGGACGATC GAAATTACTAGTGAATTAGCGGCAG 6562 Table1 NA 55G3 1 TGCGAGTGTAATTTCTGTAAGGAGGG TATGGGATAATTAATAGCACGCCT 6563Table 1 NA 55F9 1 GCCCCCAGCATTCAATTCATTTTGTA CCCTTAGTTTAAAGAACTTCTCCC6564 Table 3A NA 99E7 1 AACTTTGCTTTCTGAAGGTTTTGGTGTACCTCGGGCGCGAACACGCTAAT 6565 Table 1 Hs.319825 602021477F1 cDNA, 5′end/ 1 ATTGACTCCACTTTGTGCCAAGCTCT clone = IMAGE: 4156915/GCGGGTAGGCATATTTCATATCTT clone_end = 5′ 6566 Table 1 Hs.17481 mRNA; cDNADKFZp434G2415 1 CAGTGGAGAAGCTGCACTGTCTCCG (from clone DKFZp434G2415)/GGCTTGTGTGATCCGATCTCTGTAC cds = UNKNOWN 6567 Table 1 NA 116C9 1AGCTTTGAAAGTAATGTCTAACCCTG CTGTCAGTTTATCACAAGTGCATT 6568 Table 1 NA128F5 1 AGCTTAATTGAATTGGAGGAGCACCG AACAGGCAGTTTCCTGAGCAGTGG 6569 Table 1NA 135F10 1 GCTCTCACTGATCTCTCTTCTCTATCT CTTTCTGCAGTTATACCAGCACT 6570Table 1 NA 189F3 1 TGAGAAGAGCTGTGAAGGCAGAGGC GGGGCAAGTGCAAAGGTCCTGACTT6571 Table 1 NA 189A8 1 AACTCCCTGTTCAGTTCAGTTGCTAATGATCTCAAGCTCTTCCCTGATTA 6572 Table 1 NA 195H12 1CAGCCTAATGCCTAACCACACAGATA CCATTGGTGGGCGACGTGACCCAG 6573 Table 1Hs.292457 Homo sapiens, clone MGC: 16362 1 CACCATCTTTTGCTCGGATACTAGCCIMAGE: 3927795, mRNA, CGCAATACCCACTCACCTACCACC complete cds/cds = (498,835) 6574 Table 3A NA 466C4 1 AGGGTCTCCACCTTACAGAAGTACATGAACAACCAGAGATAGCAGGGCTG 6575 Table 1 NA 466D1 1ACCAGGAAAAGTAAAAATCATAGTTG GTGTCTCTCGGGTTTCTCACCTTC 6576 Table 1 NA466G2 1 ATGTATGAGAGAGATTCGAGATGAGT TAAAGGAGGGGAAGGGAGGGGTGGT 6577 Table1 NA 466H5 1 CATGAGTATTGGCACTGGGGTTCAAG TTCCAGGGCAGAGCAGGATAAGAG 6578Table 1 NA 466B7 1 CTCCTGGGGCTGGAGTCCTGGTCTG CCTTCTGGGGACAGAGATTAGGTCG6579 Table 2 NA 466B10 1 TGGAACTTCAGTCAAAAACATCTGTACTTTGTACAGGACAAAGATTTGGC 6580 Table 1 NA 466C9 1ATAGAACTTGTTTTACCCTATGAG CCTTGCCTTGTATTTATTCACTG TGGC 6581 Table 1Hs.7187 mRNA for KIAA1757 protein, 1 ACATCTCTTGTGAAAGTTCAAATGTTA partialcds/cds = (347, 4576) CAGCAAGGTGTAAACACTCCACT 6582 Table 1 NA 121F1 1GGGTGAATTAATCGGGAGATGGGTA GTCAGGGCAAATGATGGGTGGGTTT 6583 Table 1 NA121A11 1 TGCAATTGTGGAGACAAATTGTTAGA GTTTAAATCCTGGCTCTGTTCCCT 6584 Table3A NA 121F8 1 GGACCTATGTCCTCAAGACATGGAAA CTACTAGTTCTGTCGTGCCAGGAG 6585Table 1 NA 178B2 1 AATTAAGGATGCCCTACCGACATCTA TCAGCATACCTGGAACAGGTTCGA6586 Table 3A NA 178B5 1 CGGCCAACCCAGGAGGGCAGGTGTTTTGGGCATCTGGTTTATAGTACCTC 6587 Table 1 NA 178F5 1GCTGGGGTGAAAACTTGAAGACTCA GACCTCAGTGGAAACAGATGAATGT 6588 Table 1 NA178C12 1 CCCCAGGCTCTGTGACGCTTGAAATT CTAATTAGCGCAGAAAAGGGCTAA 6589 Table1 NA 462A11 1 CCTGACTACGTGTTTTCCCCACAGAC ATCACACTGGTTCACCTCGTTGAA 6590Table 1 Hs.13231 od15d12.s1 cDNA/clone = 1 AATGGAAAGACACTTCTGTATACACTIMAGE: 1368023 GGAAATCTCAGGAAATTTCTTTTTTCC 6591 Table 1 NA 462D9 1GACAGTACAGTACCCTAAGAGCACTG AGGAGGGCCAGGGGACGTGAACTC 6592 Table 1 NA462E8 1 TTTCCTTGGAGATTTCAGGCATCTTA GGCCGGAAGGGACCTCGAAGGTGG 6593 Table 1NA 462F9 1 CTCCGCTTCTTTCACTCATTCGTTTAG TGTTTCTTTAAGCTTTGCCTTGT 6594Table 1 NA 462F11 1 TCCACATTTTGATCATGCATTTATGAA AGCCCTGGGTTTGTTATTGAGAA6595 Table 1 NA 462G12 1 GCTATCTTCTGCTGAATCAGCGTAATGCTGATATACACCCTATTTTCTGT 6596 Table 1 NA 462H9 1AAAAGAAAAGTTTTTCAACCCAGGGA ATTTATAGTGGGTGTCAGTCGAGA 6597 Table 1 NA472B1 1 AGGAGACGATGTAGGGGGAAGTGTG TTAGATTGTAATGGAGGGGTTTGGA 6598 Table 1NA 472C1 1 GCTCTTTCCCAGACCCAGCCGCCAG GTTCTCTGTAGAAGAAAATAAATGC 6599Table 1 NA 472E6 1 AAGGAGGAATGGGAATCTCAAGCTCA AGGGCACTCTCACTAATTGTGGGT6600 Table 1 NA 472F4 1 AAATAGCCACCTTCTCCCCATTTTCTGTCAGAACACACACTTTATATCCA 6601 Table 1 NA 472G2 1TTTGGTAAAAGAGATTGGAGGGGACA CCAGGGAAACCAGGATTTTCTGGC 6602 Table 1 NA472D7 1 AAGTGCTAAGGCATTCTCTAAACTAT CTTTCCAGCTCCGGGCGACAATGG 6603 Table 1NA 472G12 1 CCACTCTCTAAGTCAAGCGAGTCCTT CCTGCATACCTGTACTGGGTGCTG 6604Table 1 Hs.75354 mRNA for KIAA0219 gene, partial 1GGACTTTGCAGGCTTCATTCCCTGTC cds/cds = (0, 7239) TGTGTCTTTTCCTTCTGGTGTGTT6605 Table 2 NA 64G9 1 ATTTGCTGGCCAATCCTGCTGACTATGAATCTTTGGGGGCACTGAGTTAC 6606 Table 1 NA 467E5 1CTGGGGTACTGGGGAAAAGGAACTG GTATTGAGATTTTATATTTGGGGCG 6607 Table 1 NA467A8 1 TTGAGTAAGGCTCAGAGTTGCAGATG AGGTGCAGAGAACATCCTGTGACT 6608 Table 1NA 467C9 1 GGTCACAGAGAGAAATGGTAGCTGA AGAAGCAGGGCACGAGGGCTCTAAC 6609Table 3A NA 467F8 1 TTTCCGGTATATTCGTGTGGGTTGAC TTTTTGTGTGTGTGGTTGTGGTGG6610 Table 1 NA 468E6 1 GGATCTCTTGCTCCTCTCACCTGTGTGACAGACTACTAACAGCCCAACTG 6611 Table 1 NA 468B9 1ACAGTGTGGGACAGAAGAGTGCTCA GTGATTAAATGCCTGATAATAGATT 6612 Table 1 NA468E10 1 CTCTCTCGCAATTTACAACCGCTTTC AGTACCATTCACCGTCACTCCTCT 6613 Table1 NA 468F10 1 CTTTGGGGAGTGGAGTTGTTGTAGAT GGGGAGAGAATCAGAACAAGGAGA 6614Table 1 NA 468F11 1 CCTTACTGCTTACGGTCATCGGTCAT CAGCCCAACCCGCTTGGTTAGGTG6615 Table 1 NA 468G12 1 AGAGTATAATTTCCCCAGTGTGGAGTGGTTAGTGTTGCTAAAGAAGAGGT 6616 Table 1 NA 468H11 1CTGTGTCGTGTCTGCACTCACCTGG TCATGTGTTCTGTTGTGCGGTAGT 6617 Table 1 NA 469B61 AGGGGCAGAGAAGAATCCACACTCA CAAGAGATGACCAGGAGTAAAACTG 6618 Table 1 NA469D2 1 CCCAGCAGAGGCCAACAAGCAGCCA TACCCAAACTTCAGCCAAAATAAAA 6619 Table 1NA 469A10 1 TGTGCAAATACGGCAGAGAAGAAGTG CATGAGAAAGTGCTTTATAAGCTGT 6620Table 1 NA 469E12 1 CCAGCTTTTCCTTTGATGTTAGTTAG CAGTAAGTCACAGGTTTGAGCCCC6621 Table 1 NA 469F8 1 GGCACGCATCCTCATTCCTGCATGCTCTTAGAATATCTATCAATGATCAT 6622 Table 1 NA 469G8 1ACTTCTATACTCAGTGCGCTGTGGGT AACCAAGCAAGCAGGTTTGTTGTC 6623 Table 1 NA470B2 1 GCGGGATGGTGGGAAGACAGACACT GCCTTAGAGCATGAATAATTGAAGA 6624 Table 1Hs.118174 tetratricopeptide repeat domain 3 1 AGGTAGACTATTTAGCTGGAAGCATC(TTC3), mRNA/cds = (2082, CAAACAGGGGATTTTAAAAATACTCA 7460) 6625 Table 1NA 470C3 1 AAAATGTAGGTTAAAACTCTCACTTAA GAAGGAGAAGATCTGAGTAAACCCA 6626Table 1 NA 470D5 1 ACCTGAACAATGAATGAAGAAAGGAA GACTTGGTTCTTCTAGCTCTGGAC6627 Table 1 NA 470E1 1 CATGGCTCACAAGCTCTAACACTCCCCTCCCTCCAGATCCTAAGAAGAAG 6628 Table 1 NA 470E5 1TCTGAGCTTCACTTCAAGAACTGGTA GTCCAAAAGAACTGGTTCGTTCAG 6629 Table 1 NA470F3 1 ACTTCACTCACTTTTTAGCCTGTTCAT ATGAGCTTGTCAGTGCTTTTGTT 6630 Table 1NA 470G6 1 TGAGGAGGATGGGAGGCGCACAGGC AATTTAGCTAGATATAGAAAGAGAA 6631Table 1 NA 470B8 1 AGCTGATTTGGATTCTTGCGGTTTGC ATCGGTCTAATTTATCAAGTGTGT6632 Table 1 NA 470G10 1 TCCATCCTTGGAAGCTTGACAAGCATTCACACTACTGGCTCACCTACTAT 6633 Table 1 NA 471D6 1TAGCACTGTAGCCAGAGTCCCTGCTT GTACCAGGAAGCTGGGTGGTGGTT 6634 Table 1 NA471F1 1 TGGATAGCAGAATTACGTGTTTTGT GGATTGGGGAGGGAGGGGAGGAAA 6635 Table 1NA 471F4 1 GCACTCCTGGAACCTTCTCACTAATT CGGGGACCAGTTTTGTGAATGTTG 6636Table 1 NA 471F6 1 TTGCTGCGGATGACCTGACTGAGCC CTGGGAGACTGTGCTATAATCTCTC6637 Table 1 NA 471E9 1 AGAAGGAGGATCTGTTCTAAACATCTGCGAGGGGAGGACAAAGCATTGAA 6638 Table 1 NA 471E11 1CTGCATCTGAGTGAAGATGAACCTT TCTTTCCCAGCCCTGAGAGAGGGA 6639 Table 1 NA471H11 1 GTCTAGCTGGCAGGTGATGGATGAAT GGATGAGCTGGCAGACCAACAGAA 6640 Table1 NA 473E4 1 TGCATGGAAATGTTTCGAGTACGGGG AAAATAAGGGAGCCAAAACTGTGT 6641Table 1 NA 473F3 1 TTTTAAGGTGTGACTCAATTTACAGG CATTCTGTATTTTTGCGATTTGGT6642 Table 1 NA 473E11 1 ACCTTTGGGAGAAAGTCTTACAACTACATGAAATGCAGATTTATGGACTC 6643 Table 1 NA 476C1 1GAAGGGACAGAACAATCAACTGTGA GAGATGGGAAGAAAACTCAAATGGA 6644 Table 1 NA476D3 1 CTAGTTTGGGGACTTTCATTGGGCAC GTGAATCCAGGAGGGCTGAATTTT 6645 Table 1NA 476F5 1 GGCCCAGATTGTAGACAGCATAAAAA TAATTTTGGGCTTTTCCTGTTAAA 6646Table 1 NA 476G3 1 CTGGGCTTCTTGTGTGAGAAGCACC GCAGCCAAGAACAACCAGTGCAACT6647 Table 2 NA 476G4 1 GAAGGGGGATTCGGTGATGGGGGAAGCCAAGGGACAAGGGAAAAAGGAAA 6648 Table 1 NA 476A10 1AACCCAACCATGAAAAAGAAGA AGCTCTGGACTACGGCCAGGCGTG GGAG 6649 Table 1 NA476G8 1 TGGCTATTTGAGTTTTCTCTTACATGA AATGCCTGGCAACGTACACTGGC 6650 Table 1NA 476H10 1 TGAACTCTGATTTCCGCCGAAACTAG GAGGAAACACCCAAAAGAAGACGG 6651Table 2 NA 477E1 1 TTTGCTGGGACTAAAATCAAAACTGC ACTGCAGAGCAGGTGAGGGTTCAT6652 Table 1 NA 477E6 1 TGGAGAGTGTGTGTATTACCATTTTTTTACATTGCATCACATTTTACCATCTAT ATCT 6653 Table 2 NA 477A11 1TTTGAAGCCCCTCATAGAGAAGAGAC TGTACCATAAGAGAAGCCCACTCA 6654 Table 1 NA477D9 1 AACTCTCAGTCCATGAGCTTGATTAC TCCATTGTACCATTTGGAAGCCCA 6655 Table 1NA 477D10 1 GTGGGTAGCCATTAAGTGGTCTGGC ACAGAAAGGGACAAGTAGCTTCAAG 6656Table 2 NA 480A3 1 CTGGTGCTGAGTGGAGTCACAGTAA GGCTGTAGATGGAGCGCCCTGGGAA6657 Table 1 NA 480B5 1 TTTTGATGTGACCAGTCGTGCATGGCGGGGGACAGGAGCTTAGGGGGAAT 6658 Table 1 NA 480D2 1ATTATGCATGTCGAGGGGACAACTTT TATTAAACAGGAGGGGTGTGTCTT 6659 Table 1 NA480E2 1 TGGTCATGTTTCCCTCTTTACTCCAC GACAGTTTCATTATTGTAACCAGG 6660 Table 1NA 480E3 1 TTCTGTTGGTTATATGAATGGCAGTT ATTGTCTCCCAGTGTGTGGGTTCT 6661Table 1 NA 480F3 1 AGTCCTGGCAACTTTACCTGGGAATT GTCTGTAATCTTTAAGCAGTGGCG6662 Table 1 NA 480G4 1 AGGACTTATCTAGCTTTCACAGATTCAGAGTGCGTTTCAAACATCATTGT 6663 Table 1 NA 480C8 1TTTAACAGGCTTATCTAGGACATAGG CCCAAGAGGGGAGGAGGAGGAAGGC 6664 Table 1 NA480D9 1 CTCCAGGCCGAACGAGCCTCCACTC TGGATTAAGATCTGTCATCTTGACA 6665 Table 1NA 480E7 1 GCAGGACTTGTGGCAGGACTCAACG GGAGAGAAAGAGGCTGAAACATAAA 6666Table 1 NA 480E11 1 AAGAACATCCCAACTTTTCCGGTAGG CAAGTGTCAAGTCACCTGGACAAT6667 Table 1 NA 480F8 1 TCTGTGGCTTGTTGTGGGACCCCTGCGCCCTTTAAATTAGGGCATATTTTA 6668 Table 1 NA 487F11 1GCGCTAAAAACCTGGTGATTAAATGA CAAACAGAACGTGAGAAGAGATTT 6669 Table 3A NA499G1 1 TCCTGCACACAACAAATAAAGACAAG AATAAAGGGCCACCCATCAGTAGC 6670 Table 1NA 518F10 1 ATGTTGTTCAAATTAAACATCATACCA CATGGGGGCAGCTACCAATTTTT 6671Table 3A NA 524A12 1 TAATATGAAAAGCTGGAAAAGAATTA AGGGGTTGAGGAGACGTGCCGGGT6672 Table 1 NA 526B9 1 GTTACCCTGACGAATGCAGTCCTCGTGTGGAATGTCTATGCCCTCTTGAG 6673 Table 1 NA 583B5 1ACACCAGCAGTCATAGGGGAAAGGG GAATACAGTTAATTGGGTATTTGTT 6674 Table 1 NA583D6 1 ACTCCCTCCCATCTCTGGTCTTTAGT TGGAAGCAAGCTTTCGGACAACGG 6675 Table 1NA 583G8 1 TCCAACAAGGGTTACGGCAGAATTTA TGCGAAAGTCTTCTTTGGGCTAAA 6676Table 3A NA 584A1 1 TTGTTCTGCTCAGGCCAAGGATTGTT GTGTGCTCTGTATTTGCTGCTTTG6677 Table 1 NA 584D3 1 GGCCCGGCATGTCTTCGTTTTGTCAGTCCTCATCCAATCCATCTTCATAT 6678 Table 3A NA DNA sequence from clone RP4- 1GTGGGTTTTTAGACACCTGCAGCAAG 620E11 on chromosome 20q11.2-AAGAAATACTGACTGACTAGGCAT 12 Contains l 6679 Table 3A NA 591H9 1TTTTAAAGAAAAATCTATTATCTTGGA GCATGGATGGGGGAATGCGAAGG 6680 Table 3AHs.6179 DNA sequence from clone RP3- 1 CAGAAGAAACATGGCAAACTGCTCTG 434P1on chromosome 22 Contains TGCTTTCAAACCAAAGTGTTCCCC the KCNJ4 gene forinwardly rectifying potassium channel J4 (hippocampal inward rectifier,HIR, HRK1, HIRK2, KIR2.3), the KDELR3 gene for KDEL (Lys—Asp—Glu—Leu)endoplasmic reticulum protein retention receptor 3, the DDX17 gene forDEAD/H (Asp—Glu—Ala—Asp/His) box polypeptide 17 (72kD), ESTs, STSs, GSSsand slx putative CpG islands/cds = (307, 2259) 6681 Table 1 Hs.44577602388170F1 cDNA, 5′ end/ 1 GTTACTTAAGATCAGTATGTGTGGTG clone = IMAGE:4517129/ CATATGTGATTTCGACCATTCAGT clone_end = 5′ 6682 Table 3A Hs.108124cDNA: FLJ23088 fls, clone 1 GAGAATTTCCGTCTGATCTATGACAC LNG07026/cds =UNKNOWN CAAGGGTCGCTTTGCTGTACCTCG 6683 Table 1 NA 119F12 1CTGGGTTAATACTCACCAACTTTGAG AAGGTTGGTCTCTGCTCTTCTGTA 6684 Table 1 NA119G10 1 GGAAAGACAGGTGAGTGTGCCACAA CTACCTAACACATCAGCAAATCTGG 6685 Table1 NA 485A8 1 GTCACTTTAGCGAGCGGGAAAACAAT GGCGGAAAGGGAAAACCTGGAAAG 6686Table 1 NA 485D5 1 CGATAAGCTGTGGTGTTGGGAGTGA GAGATGTTACTTTGCGAATGTTCAA6687 Table 1 NA 489H9 1 AAAGGCTAGGTTTGCGAAAGCCCTTCTAAAACTATGCTTTGGTGGTTACT 6688 Table 2 NA 494B11 1CTGACCCTGCGGGGCGGAAGATAAA ACAAAAACGAGAAGAACAAGCAAGA 6689 Table 1 NA478E5 1 AAGATTGTAAAAATACATTTTAGGCTC AAGAGTTCCAGGGGTTTCAGAGC 6690 Table 1NA 478G6 1 TGCAAGCTGGCACCTTCACGTTTATT TTTAAAGGGCTTCACATCAAAGAT 6691Table 3A NA 478H3 1 AAACAAAGAAGGAAAATGAAGAGGG GGAAAAGATGAACATCAGGCTGGGT6692 Table 1 NA 478C7 1 TCCAAAGGATGTTCTGGTGTTGCAGCATGATTTCTGGTGTTAGTCTTTCT 6693 Table 1 NA 478G8 1TTTGTGGGTGCGTGAGAGGGGATTTA TACTCCTTGAGCCATATTTTGTGA 6694 Table 1 NA478H7 1 GGGTTCACAGCATGGGTGGAGGTAA GTAGTATTCTCATTGGTTGGTTAGT 6695 Table3A NA 479B4 1 GACAGTGAGAAGAATATGGAGTAGA GTCCTTTTGGTCTTTGAGGCGGTCA 6696Table 1 NA 479D2 1 AACAGCTGAAGAACAAGAAGGTGAG CTCTGAATGCGTCAGGTGGTCATTC6697 Table 1 NA 479G2 1 GGCTGACCAGTACAGGCTTGGGAATTTTATGGTTGGGTGGTTTCTACCAA 6698 Table 1 NA 479G3 1GGGGGAGCTATATTACTGATTAAAAC CACCATTTCTTCACCCAACTTATG 6699 Table 1 NA479G5 1 AAGTCTTGTATTATGAGGTACTGGGG CTCTGGGGGATATTGAGATGAGAA 6700 Table 1NA 479G6 1 AGTCCTGCTGAATCATTGGTTTATAG AAGACTATCTGGAGGGCCTGATAG 6701Table 1 NA 479H4 1 GGAGCTTCCAGTCTAATAGAAAAGAT GCACTTACGAATAGACTTTGGGTA6702 Table 1 NA 479H5 1 TCTGTGCTCTGTGGACCCGTCACCCTGAGCTCCTCAGTTGCTGAACCATC 6703 Table 1 NA 479H6 1TGCTGGCATGTGGATAGACTTTAGCA AATGGTAGTCATCTTCTAATTTCT 6704 Table 1 NA479G12 1 AATGGGAATCTTAAGGCCTCTCTGGA AAGGGTGTGAGGGGGTCGAGGGGG 6705 Table1 NA 479H12 1 TGCATATTGTCACTGACTGGCTAGGG TCTCTAAATTTATGAAACCTTACA 6706Table 1 NA 482A5 1 GTCAGCAACTAAAAAGGGAGATATAT CTTAGAGAGACTGGAATAAGCAACTC6707 Table 3A NA 483G5 1 GGAAGGACTCAAACTGGCCATAAAGGCAATACGGCATGTTCATTACACCA 6708 Table 1 NA 488C4 1TTTGTTGACTATGAAATAGTGGTCCT GGTTTTAACTCTTTGGGGTTCCCT 6709 Table 1 NA490F10 1 AATTATATTTTAGGCTGATGTGGGTG GTCTGTAATGCTCTCATTTACCCAC 6710 Table1 NA 493C2 1 CTGTGTTTCTGTATGGTATTGCATTTG TCCCGGCCTGTTGGGTTTGGTGG 6711Table 1 NA 58G4 1 TTCATGCTCATTAGGACATTGAACAA ATGGCAGAGTAAGAAAGTTTGGCC6712 Table 3A Hs.169370 DNA sequence from PAC 66H14 1GGGAATGGACTCATATGCAAGATTGC on chromosome 6q21-22. ContainsTGACTTCGGATTGGCCCGATTGAT FYN (P59-FYN, SYN, SLK) gene coding for twoisoforms. Contains ESTs and STSs/cds = (12, 1706) 6713 Table 1 NA 598H21 CAACACATGGGACGGGAAGGAAATC CTTCCGTGTGATTTTGTTAAAAATA 6714 Table 3A NAAA077131 1836605 7B08E10 Chromosome 7 Fetal 1 CAGCCACCTCCTCAGGTCAGACAAGBrain cDNA Library cDNA clone CCCAGCACCCCAAATACCACTATCTG 7B08E10, mRNAsequence 6715 Table 3A NA AA501725 2236692 ng18e12.s1 NCI_CGAP_Lip2 1GGCTTCCCTATTACCTCCCAGCGAAA cDNA clone IMAGE: 929806TTCGTAGTCTTTCTCTATGGAGTT similar to contains Alu repetitive element;mRNA 6716 Table 3A NA AA501934 2236901 nh56a10.s1 NCI_CGAP_Pr6 1TGCTGATGTGTTAGGTAGTTGTGGCA cDNA clone IMAGE: 956346,CACTCACCTGTCTTTCCTAAATGC mRNA sequence 6717 Table 3A NA AA579400 2357584nf33d05.s1 NCI_CGAP_(‘3)Pr1 1 TTCATGCTCAGCAAAACAACGTTTTA cDNA cloneIMAGE: 915561 GGATGGTGAGAGAAGACAAAGTAA similar to contains Alurepetitive element contains 6718 Table 3A NA AF249845 8099620 isolateSlddi 10 hypervariable 1 TATTAACCACTCACGGGAGCTCTCCA region I,mitochondrial sequence TGCATTTGGTATTTTCGTCTGGGG 6719 db mining Hs.277051AI630242 4681572 ad07c09.y1 cDNA/clone = 1 TTACCTGCTTTGCATGCTCTCCATCGad07c09-(random) TCAAAGTCTTCTGGAAACTTAGGC 6720 db mining Hs.277052AI630342 4681672 ad08g11.y1 cDNA/clone = 1 CCCCACCCCAACACATACAAACGTTTad08g11-(random) CCCACCAATCCTTGAACTGCAAAA 6721 db mining NA AI7322285053341 nf19e05.x5 NCI_CGAP_Pr1 1 TTCAAGGTCCCAATACCCAACTAACT cDNA cloneIMAGE: 914240 CGAAGGAAGAAATGGAAATCTATT similar to contains Alurepetitive element, mRNA s 6722 Table 3A Hs.197803 AW379049 6883708 mRNAfor KIAA0180 gene, partial 1 TGCACAGAACTCTTACTTACATGTCT cds/cds = (0,2413) CATCGAAACTCCAGAACACCGTCG 6723 Table 3A Hs.232000 AW380881 6885540UI-H-BI0p-abh-h-06-0-UI.s1 1 TGCATGTATCCCGGTAATTCAAATCC cDNA, 3′end/clone = IMAGE: AATTTCACAGCCACTGCTGAATAT 2712035/clone_end = 3′ 6724Table 3A Hs.325568 AW384988 6889647 602386081F1 cDNA, 5′ end/ 1TACAGGAAAATGAAACTAGACGGGTG clone = IMAGE: 4514972/GGGGACACTAGAATGAAAACCAGT clone_end = 5′ 6725 Table 3A NA AW8363897930363 PM0-LT0030-101299-001-f08 1 AGTTTCTGCTTTCAGTGACTGAGGCT LT0030cDNA, mRNA sequence TTGCTTTAACCTGGTGACTCCCAA 6726 Table 3A NA AW8377177931691 CM2-LT0042-281299-062-e11 1 TCCCACTTCAAGTTAAGCACCAAAGC LT0042cDNA, mRNA sequence AATCACTAATTCTGGAGCACAGGA 6727 Table 3A NA AW8378087931782 CM1-LT0042-100300-140-105 1 CATGGATGGGGGCAGTGGTGTTTCT LT0042cDNA, mRNA sequence AGTGTGTGAGGAAGCAGAGCAGATG 6728 Table 3A NA AW8424897936472 PM4-CN0032-050200-002-c11 1 TCACCACAGATGGGAAGATCGTTTCC CN0032cDNA, mRNA sequence TGAAAACAGTCTATAAATCACAGA 6729 Table 3A NA AW8466567942373 QV3-CT0195-011099-001-c09 1 CAGACGCTCCAGTGCTGCCGAGGTT CT0195cDNA, mRNA sequence AGTGTGTTTATTAGACCTGAAATGA 6730 Table 3A NA AW8564907952183 PM4-CT0290-271099-001-c04 1 CCCTTTAGGCCTCTTGCCCGAACAGT CT0290cDNA, mRNA sequence GAACACTAATAGATATCCTAAGCT 6731 Table 3A NA AW8913448055549 PM2-NT0079-030500-001-a04 1 ATGGGGATCATGTTTTATTTTTCTCTA NT0079cDNA, mRNA sequence TATAATGGGCCAGTGTGTTCCCA 6732 Table 3A NA BE0611158405765 QV0-BT0041-011199-039-f09 1 AGCTGTAGACCATAAGCCACCTTCAG BT0041cDNA, mRNA sequence GTAGTGGTTTGGGAAATCAAGCAA 6733 Table 3A NA BE0860768476469 PM2-BT0672-130400-008-h09 1 TGTACTTATGCTTGTCTTCTCTACCTG BT0672cDNA, mRNA sequence TGTACTTATGCTTGTCTTCTCTACCTG 6734 Table 3A NABE091932 8482364 IL2-BT0733-130400-068-C11 1 GGAGGGTGTGGGAAGCAAGAGAAGABT0733 cDNA, mRNA sequence ACATTCTGTTAGGGGCAGAGAAGAA 6735 Table 3AHs.173334 BE160822 8823543 ELL-RELATED RNA POLY- 1GCATCTCCAGCTTTCATAGTTACCCA MERASE II, ELONGATIONACTTGTAAACCAGAAGATGTGCTG FACTOR (ELL2), mRNA/cds = (0, 1922) 6736 Table3A NA BE163106 8625827 QV3-HT0457-060400-148-h10 1GGCCAGTGCCAGACGGTAGCTAGTT HT0457 cDNA, mRNA sequenceGGATGCTAAAGGTAGAATTTAGATA 6737 Table 3A Hs.301497 BE168334 8631159arginine-tRNA-protein transferase 1 GGCATTGTAGGGTTGACACCAGC 1-1p (ATE1)mRNA, alternatively AAAGACTCAGAGTGACTTGAGCAT spliced product, partialcds/cds = TGGA (0, 1544) 6738 Table 3A Hs.172780 BE176373 869102602343016F1 cDNA, 5′ end/ 1 AGCCCATTTGGATATGGCCCATCTTT clone = IMAGE:4453468/ ACCTAATGGCTACTATAGTGAGGT clone_end = 5′ 6739 Table 3A NABE177661 8656813 RC1-HT0598-020300-011-h02 1 AATCACAGCAGTAACTCCCAGTAGGAHT0598 cDNA, mRNA sequence AAGATTCTCAAAGGAATAGTTCTT 6740 Table 3A NABE178880 8658032 PM1-HT0609-060300-001-g03 1 AATGGTCAGGCACAGGTAGAATCAAAHT0609 cDNA, mRNA sequence GTCCTGTATGTATGTTCACACAGA 6741 Table 3A NABE247056 9098807 TCBAP1D6404 Pediatric pre-B 1 TACCTGAAGGTGTAGAGAGTGCCCGcell acute lymphoblastic leukemia CATCCAGCAAGGCCAACAGCTCCAC Baylor-HGSCproject = TCBA cDNA clone T 6742 Table 3A Hs.11050 BE763412 10193336mRNA; cDNA DKFZp434C0118 1 CTGTGTTTTTCCCAAAGCAACAATTTC (from cloneDKFZp434C0118); AAACAAAGTGAGAGCCACTGACA partial cds/cds = (0, 1644) 6743Table 3A NA BF330908 11301656 RC3-BT0333-310800-115-f11 1GACTCCGAGCTCAAGTCAGTCTGTAC BT0333 cDNA, mRNA sequenceCCCCAACCCCTAACCCACTGCATC 6744 Table 3A NA BF357523 11316597CM2-HT0945-150900-379-g06 1 TGTAACTGACTTTATGTATCACTCAAG HT0945 cDNA,mRNA sequence TCTTGCCTTTACTGAGTGCCTGA 6745 Table 3A NA BF364413 11326438RC6-NN1068-070600-011-B01 1 TCTCTCTAACCAAAACTGTAATCTTCA NN1088 cDNA,mRNA sequence GGACCAGCAAACTCAGCCCAAGG 6746 Table 3A NA BF373638 11335663MR0-FT0176-040900-202-g09 1 AACTCTTGGTTAAATGGGTTAATAGA FT0176 cDNA, mRNAsequence GGATTGGAACACTTTGTTTGCTGT 6747 Table 3A NA BF740663 12067339QV1-HB0031-071200-562-h04 1 AGAAGCAAACCTGTGAAGCTACTATC HB0031 cDNA, mRNAsequence GTTTATCATCAGTGTGAATGCACT 6748 Table 3A NA BF749089 12075765MR2-BN0388-051000-014-b04 1 GGACTAACTTCCACCTCCTCTGCTAC BN0386 cDNA, mRNAsequence TTCCAGCTGCTTCTAATCACACTT 6749 Table 3A NA BF758480 12106360MR4-CT0539-141100-003-d05 1 AGTCTTCCACCCAGCATAGGTATCAC CT0539 cDNA, mRNAsequence ACAACCAGCTCTGTTTTACTCCTG 6750 Table 3A NA BF773126 12121026CM3-IT0048-151200-568-f08 1 TTAGCTGGTACATTGTTCAGAGTTTA IT0048 cDNA, mRNAsequence CTGGGAGCCGGTAAGATAGTCACC 6751 Table 3A NA BF773393 12121293CM2-IT0039-191200-638-h02 1 AGCGTGATGCTTCCTCATGTCGGTGA IT0039 cDNA, mRNAsequence TTTTCTGTTGAGACATCTTCAAGC 6752 Table 3A NA NF805164 12134153QV1-CI0173-061100-456-f03 1 CAGGGTTAACAAAAGTATGGAATTCA CI0173 cDNA, mRNAsequence ATTCTTTTTATATGCTGCAGCCATGTT CCT 6753 Table 3A NA BF81859412156027 MR3-CI0184-201200-009-a04 1 TGTAATTGATTTCCGCATAAACGGTC CI0184cDNA, mRNA sequence ATTACTGGCACCTATGGCAGCACC 6754 Table 3A NA BF82773412171909 RC8-HN0025-041200-002-F08 1 GTGATCCACTTGGAGCTGCTACTGGT HN0025cDNA, mRNA sequence CCCATTGAGTCCTATAGTACTTCA 6755 Table 3A NA BF64516712201450 RC5-HT1035-271200-012-F08 1 TGCCATGAAATCTCTATTAATTCTCAG HT1035cDNA, mRNA sequence AAAGATCAAAGGAGGTCCCGTGT 6756 Table 3A NA BF86916712259297 IL5-ET0119-181000-181-b11 1 CCCACCTGGCAAATCCTCAAGTGTGA ET0119cDNA, mRNA sequence CCCTAGTCATCTTTCTCCTTTTGG 6757 Table 3A NA BF87557512265705 QV3-ET0100-111100-391-c02 1 GCTAAACAGAAAAGAACCTGAAGTAC ET0100cDNA, mRNA sequence AGTTCCCGTCTTCAAAGAAGATGC 6758 Table 3A NA BF87797912268109 MR0-ET0109-171100-001-b02 1 ATCCTCCTCCCCTGGGATGGCATAGA ET0109cDNA, mRNA sequence AGAGACTTTAAAACCAAATGAGCC 6759 Table 3A NA BF89704212288501 IL2-MT0179-271100-254-C11 1 GTCAGTAAGCTCTGCCTGCCAAGAAG MT0179cDNA, mRNA sequence ACACAGTGAGAGGTGTCCACAGTC 6760 Table 3A NA BF89828512289744 QV1-MT0229-281100-508-e11 1 GTTTCCACTTAGTTACTTCTTCCTACC MT0229cDNA, mRNA sequence TGCTGTGAAGCTCTGCACCCTGC 6761 Table 3A NA BF89948412290923 IL5-MT0211-011200-317-f03 1 AGAGTAATCCACATCCCAGGGACAGT MT0211cDNA, mRNA sequence CACAATGACCTACGGCTTTAGCTG 6762 Table 3A NA BF90442512295884 CM1-MT0245-211200-662-d02 1 GCAGGGCTACACCAAGTCCATTGATA MT0245cDNA, mRNA sequence TTTGGTCTGTAGGCTGCATTCTGG 6763 Table 3A NA BF90611412297573 IL3-MT0267-281200-425-A05 1 TCTTCTCTAAAATGCCCTCCTCTCCTT MT0267cDNA, mRNA sequence CCTTTTTCCAGACCTGGTTTAAA 6764 Table 3A NA BF92618712323197 CM2-NT0193-301100-562-c07 1 TCGCCATTTGGTAGTTCCACAGTGAC NT0193cDNA, mRNA sequence TGCTCTTCTATTTTACGAAGCCAC 6765 Table 3A NA BF92884412326772 QV3-NT0216-061200-517-g03 1 GTAGATTACTATGAGACCAGCAGCCT NT0218cDNA, mRNA sequence CTGCTCCCAGCCAGCTGTGGTGTG 6766 Table 3A NA BG00682012450388 RC4-GN0227-271100-011-d03 1 TTTCCTTTTCGCTGACTTTCTCACTCA GN0227cDNA, mRNA sequence CTGTCTGTCTCTCATTTTCTCCA 6767 Table 3A NA F11941708260 HSC33F051 normalized infant 1 TGGTAAGTTTCTGGCAGTGTGGAGAC braincDNA cDNA clone c-33f05, AGGGGAATAATCTCAACAGTAGGT mRNA sequence 6768Table 3A NA U46388 1236904 HSU46388 Human pancreatic 1CCATGGTGGTGCTTGACTTTGCTTTG cancer cell line Patu 8988t cDNAGGGCTTAATCCTAGTATCATTTGG clone xs425, mRNA sequence 6769 Table 3A NAU75805 1938265 HSU75805 Human cDNA clone 1 TCAGTGGGTGTTGGTTGTCCATTAGTf48, mRNA sequence TGAGACTTAGTTGTTGCTCTGGGA 6770 Table 3A NA W278581307658 36f10 Human retina cDNA 1 GGCTGGACAGCAGATGATTCAAATCT randomlyprimed sublibrary CAATACTACATGCCCATTCTGTGG cDNA, mRNA sequence 6771Table 3A NA 38G5 −1 CAGGATGGAACAAGACTCCAGCCCC TGCCTGTCTCATGTATCTGCAAGGG6772 Table 3A NA 38F11 −1 CTTCAGTGCGTACACGAGCTCAACGTTAGTGCCAGGAAAGACAACTACTC 6773 Table 1 NA 37G7 −1ACTCGTATGCCAACTCTTCTGTCTTC ACTACTAGAGTGTAGATTGGACTC 6774 Table 1 NA 37G8−1 TGGACTGGAACTTGACTCGAAGTTAT GTGGCTTAATGAGTAAGTTCAGCC 6775 Table 3AHs.197345 thyroid autoantigen 70kD (Ku −1 ACTGGTTCATTTGTTTCCCGATAGAGantigen) (G22P1), mRNA/cds = CTTTATTGGAGGAGGCTTGAGAGC (17, 1846) 6776Table 1 NA 40E4 −1 ACCATCTCCTTTAATCCTCACAGTGA TCCTGGAGCAATGTGTGCATTCCT6777 Table 3A NA 41E9 −1 CATCACCTGCTCACCTAGGAACCAGGAGTACTGGGAACTGTTCCGTTACT 6778 Table 3A Hs.169476 Homo sapiens,glyceraldehyde-3- −1 TCATTGCTGATGATCTTGAGGCTGTT phosphate dehydrogenase,clone GTCGAACTTCTCATGGTTCACACC MGC: 10926 IMAGE: 3628129, mRNA, completecds/cds = (2306, 3313) 6779 Table 3A NA 47E5 −1TGGCACCACGCTGATTATTTTCCTTTT CAAATCCCAGCCTATACACCTCC 6780 Table 2 NA46D11 −1 GCTGTCTGTCTTCCCAATATCCATGA CCTTGACTGATGCAGGTGTCTAGG 6781 Table1 NA 50A11 −1 AGGCCTTTTTATTTGTCTGTTTAGATA CACTGCTTCCTATATCTGCTGGA 6782Table 3A Hs.132906 DNA sequence from clone RP11- −1CCCGTGCCCCACCAGTCTCACTGCC 404F10 on chromosome 1q23.1-TGACTCCAAGTCTCGTACACTAGAT 24.1. Contains the 5′ end of the SLAM gene forsignaling lymphocytic activation molecule a SET (SET translocation(myeloid leukemia-associated)) protein pseudogene, the CD48 gene forCD48 antigen (B-cell membrane protein), the gene for a novel LY9(lymphocyte antigen 9) like protein and the 5′ end of the LY9 gene.Contains ESTs, STSs and GSSs/cds = (41, 1048) 6783 Table 1 NA 52B9 −1AGCGATGAACTGTTGCAAAAGAATTT TCCAGAGCATTTTCCATTAAACCA 6784 Table 1 NA 53B1−1 CCATATTCTTGTTCCCCAGCCAGGTG CTGCACCTCCCCACTCTTTTTAGTG 6785 Table 1 NA53E3 −1 AAATGCTTAAAGGAACAATATATGTC CCTTTTCGAGGCACGTGATTCGTTT 6786 Table1 NA 53E10 −1 TCTGGAGCCACACCCTTACCATCACC TTCCAAAGAAGAAATTGAACCCTT 6787Table 2 NA 53G7 −1 AATCACACAAGGTCGAAAGTAGACAG TCCTCTTGGACTTGGAATTGTCCA6788 Table 1 NA 54F4 −1 ACTTTCCTCCGGGAAGTTTGTATCTTAGCGTGGACAACAGGTTAACACAA 6789 Table 1 NA 54G9 −1TCAGGATGCTCTCACTTTAAGAACCG GGCAAATAATAGAACACTGTGACA 6790 Table 1 NA 59G1−1 ACTTCACTCAGAGTAAATGAAAAGAC TGGGTGCCTCATCAATATCATTGT 6791 Table 1Hs.48320 mRNA for ring-IBR-ring domain −1 TGACTGAAGGCAAGCTCACAGATGAAcontaining protein Dorfin, GCAGAGGACTGAAGATCTCGATCT complete cds/cds =(317, 2833) 6792 Table 1 NA 60G8 −1 GCTGAGAAGGATGTGGTATAAATGTATTAAGCAGCTTAGGGTCTCTGGCC 6793 Table 2 NA 62C9 −1AAGTCCCCGTCTAGTGGGAAAGAAA GAAGTTGAACAAGTAATTCCAAGGG 6794 Table 3A NA62F11 −1 CGCCCGGCAAGTACTGGGGTTTCTTA TAGCTTCTCTCTGCATCTACAAAG 6795 Table1 NA 63E1 −1 CTGTTTCTCTATTTTAACTTACATTGG TTATTCTGTAAAGTCAGATGTGGCAG 6796Table 2 NA 65B1 −1 GCACTGTCCTTCCCAGTTCTACATTT GAGTCTGAGTTGACTCGCAAGACT6797 Table 2 NA 65D10 −1 AACAGATTGTGCTTCTGTTCTGAATCTTCTAAAGCCATCTGCACAGTGCT 6798 Table 2 NA 65D11 −1AACAGATTGTGCTTCTGTTCTGAATC TTCCAAAGCCATCTGCACAGTGCT 6799 Table 2 NA65D12 −1 ATCTGCACAGTGTTAGCATGGTGACT CCAGTGTCCTCCAAGACTCCATAG 6800 Table1 NA 68C9 −1 TTTAGCATCCACTAGTTACTGTCTGG CACTGGCCACGAAGGGTGACAGGG 6801Table 1 NA 69F8 −1 GAATCCCGGTCATCTCTACCCAAGTC CCGGTCTCTCTACCCTATTCTCTC6802 Table 1 NA 69H11 −1 TGGTAACTTCAAAGTCCCTAACACATTCGATATTTCTCCTAGCTTCCACT 6803 Table 3A NA 70B6 −1ACTCCCACCAAACCCCACTTTGTAAT CACTGGTAGTAAAGAGAGATGCAG 6804 Table 3AHs.17109 integral membrane protein 2A −1 AAGAGTAAGAGGCAACAGATAGAGT(ITM2A), mRNA/cds = (139, 930) GTCCTTGGTAATAAGAAGTCAGAGA 6805 Table 2 NA72D4 −1 GAAATTGGAAGGTGATACTTGGGGAC CACAACACGCACATCTGGGAACTG 6806 Table3A Hs.234279 microtubule-associated protein, −1TCATCTGTGGCATACAGAATGTCTAC RP/EB family, member 1AATCTTCTGCAATACAGGGTCGTT (MAPRE1), mRNA/cds = (64, 870) 6807 Table 2 NA72D8 −1 GGCAAGGGAACAAACTTGAGTAAATC TAGCTCTTGAAGGGCTCGGGACCC 6808 Table 1NA 73C4 −1 ACTCATTTGTCTCCTCATTCTCAAAAG TCTTCTGTGGTTTGGCTTCAGTG 6809Table 1 NA 73H4 −1 TCGATGGGCCATTATCCACTCTGCTA TCTTCTGAAGAGTAATTTTCACCT6810 Table 2 NA 73A7 −1 AAGGACGGAACTCACACATCTTCTTTAGACAGAAATGTAGTCTCACTGCA 6811 Table 3A Hs.174228 small induciblecytokine subfamily −1 TATAATCCCAGTCCATGAGGGTGTAA C, member 2 (SCYC2),mRNA/ AGTGAAATGAGCTGGCTGGCTGGA cds = (0, 344) 6812 Table 3A Hs.3945CGI-107 protein (LOC51012), −1 GCTCTGTTCTGGGGTTGGTCCAAAGT mRNA/cds =(84, 719) CAGGTGGAGTTCCAATGTATGAAA 6813 Table 1 NA 75A2 −1TCCCTGAGATCTAGGAGGGCAGCAT AGTATCATTTTTGTATTCCGGTGCT 6814 Table 3AHs.249495 heterogeneous nuclear ribonucleo- −1AGCTGCTACAAAGAAGACATGTTTTA protein A1 (HNRPA1), transcriptGACAAATACTCATGTGTATGGGCA variant 2, mRNA/cds = (104, 1222) 6815 Table 2NA 75B12 −1 AGGGATCTGAATACTTCGGGTGCAAA AATTTTCCTGCAGTTTAGATTTGC 6816Table 2 Hs.205442 601439689F1 cDNA, 5′ end/ −1TATGGTTTCCAATATCGACATGGCAT clone = IMAGE: 3924407/CATTGGTTACATTAGCACTGGGCC clone_end = 5′ 6817 Table 3A NA 101G7 −1GGCCTGGGCATAGACTGTGGTGAGG TCACTAGATTATCTTGTTCTTCCCC 6818 Table 3AHs.179565 minichromosome maintenance −1 GAGTCCTGATCTCAGCTTCATCACCAdeficient (S. cerevisiae) 3 ACATTCCTCGCCTTCAGTTGAATT (MCM3), mRNA/cds =(44, 2470) 6819 Table 1 Hs.119640 hBKLF for basic kruppel like −1GGAGGTCTTTGCCACCAATGGGAGA factor (LOC51274), mRNA/TGAGCCCAAACTTTCGATATAGGTG cds = (55, 1092) 6820 Table 3A Hs.215595guanine nucleotide binding protein −1 ACCAGAGGTAAACTTGAGTGTAATTG (Gprotein), beta polypeptide 1 TCAGACAGACACACTTTTCCACCA (GNB1), mRNA/cds =(280, 1302) 6821 Table 1 NA 105A10 −1 TGCATTTTACATTAGCTTCCAATATTTATGGCAGTAACCAACAGTATTATCGT 6822 Table 1 NA 107G11 −1TTTCCAATGCTCCTTGCTCCATTTTAA ACTTGCTGTCCTTTATAAGAGAA 6823 Table 1 NA107H8 −1 TGTTTTCACGATAGAAATAAGGAAGG TCTAGAGCTTCTATTCTTTGGCCA 6824 Table3A Hs.64239 DNA sequence from clone RP5- −1 TTTCATACAAAGCCAACAGAATTCAC1174N9 on chromosome 1p34.1- AGCCACACACTGCACAGGTCATGT 35.3. Contains thegene for a novel protein with IBR domain, a (pseudo?) gene for a novelprotein similar to MT1E (metallothionein 1E (functional)), ESTs, STSs,GSSs and two putative CpG islands/cds = (0, 2195) 6825 Table 1 NA 109H9−1 AGGAAGCTGTGAGGGTGGGTTCATT AGTTGCAGGGATGGTAGTTATGTCA 6826 Table 3AHs.80261 enhancer of filamentation 1 (cas- −1 GAGACAAGCTGGAAGGCCGGACCTClike docking; Crk-associated AGACCGGAGGGGTTTATGTCATTC substrate related)(HEF1), mRNA/ cds = (163, 2667) 6827 Table 3A Hs.1422 Gardner-Rasheedfeline sarcoma −1 ATAACTAGACAAGGTCTGAGCACTTT viral (v-fgr) oncogenehomolog GGGTGGGGATGGAGTGAGAAAGGC (FGR), mRNA/cds = (147, 1736) 6828Table 3A Hs.333114 AV713318 cDNA, 5′ end/clone = −1ATTAAGTTGGGTAACGCCAGGGTTTT DCAAAC09/clone_end = 5′CCCAGTCACGACGTTGTAAAACGA 6829 Table 1 NA 129A12 −1GCGTTCTAGCTGGGCCAACAGAGCA GGATTTCGTTTCAGAAAACAAAACA 6830 Table 1 NA129F10 −1 ATCATGTCTCATTAACAGAGTGAAGA TGGAGCAACGTCATCCAGCTTCTG 6831 Table3A NA 137D4 −1 TGGTCGCGCCCGAGGTACGGTTTTC ATGGTAGGGCTGAATGGAAGATGTG 6832Table 1 NA 142F9 −1 CAGAAAGATAGGAGTGTGCAATGGC AAGGAAACTCAATTTAAAGCAAATT6833 Table 3A Hs.250655 prothymosin, alpha (gene sequence −1TTGCAAATTCTCATGGTTTGGGTTGG 28) GTGGTGGAGAGCGCGTGTCATCTG 6834 Table 3AHs.249495 heterogeneous nuclear ribonucleo- −1TTATTCAGCGTCACGATCAGACTGTT protein A1 (HNRPA1), transcriptACATTTAGCAATCAACAGCATGGG variant 2, mRNA/cds = (104, 1222) 6835 Table 1NA 149G2 −1 TGTGTGTATGTGTGTAACCAGGTCTG ACTATAGCTTGGTCTGTCTGTGTC 6836Table 1 NA 149A11 −1 AGCATTTGGGGTTTTAGCTTTGGTGT CCTAAATTTCAGTGATCTTTGCCA6837 Table 3A NA 151F11 −1 CATAAACCAGCAGCTCAGCGTTTCTATAGCAAGCGGTCTCGAGCACAAGC 6838 Table 1 NA 162E8 −1TAGTGATAGGCGTGGTGGCGGCGAA GGTCAGTAATGGGGCTTTTAACCAG 6839 Table 3AHs.334330 calmodulin 3 (phosphonylase −1 TACTGTAGAAAGAAGAAGAGCACACAkinase, delta) (CALM3), mRNA/ TGAGACAGAGAAGGAGGTGGATGC cds = (123, 581)6840 Table 1 NA 170F7 −1 CGAGGCGGCCCGGCAGGGTACCAATTTGGATGAATTCTTGATAGATTTAA 6841 Table 2 NA 170F9 −1TTGGGTTCAGAATAGCTTCATCTACT GCCGAGCAAAGTCAATACAGCACT 6842 Table 3A NA177A3 −1 GGTAACAGCCATCCCACCACCAATAA TCATCTCATTGTCTTTGTCCAGCA 6843 Table1 NA 331A3 −1 GTATGAATAGATTGCCCCATTCCCTG CCAGCCTGGTAGTGACTTTTCCAC 6844Table 1 NA 331A5 −1 TATAATTTCTACCAAACTAAGTTTTAT TTTGTGCCCGCTCCCTGTCCCTT6845 Table 3A NA 146C3 −1 CTGTAAAATTCTTTTCGGGTCCATCCTGGCTCTCATCTCCAGTGCTTTGA 6846 Table 1 NA 146D8 −1AGGGTTAACAAAAGTATGGAATTCAA TTCTTTTTATATGCTGCAGCCATGTTC CTG 6847 Table 3AHs.153 ribosomal protein L7 (RPL7), −1 CCCAATCTGAAGTCAGTAAATGAACTmRNA/cds = (10, 756) AATCTACAAGCGTGGTTATGGCAA 6848 Table 1 NA 158G6 −1CCGAGGTACTCTCTTAGAGAAAGGTG ATTGGATGCTCCGGTTGCCTGTAA 6849 Table 1 NA158H6 −1 GCGGGTTGGAAAATAGTCGAGAATTG ACAGTCCCTCTCGAAGATGCTTTT 6850 Table3A Hs.119598 ribosomal protein L3 (RPL3), −1 TTGAGACCCCACCAACTGCAAAATCTmRNA/cds = (6, 1217) GTTCCTGGCATTAAGCTCCTTCTT 6851 Table 3A NA 158G11 −1AATGAAAAACTCCAGCTCTCAGCTCA CAAATCTGTAATTTAGGTGTCTCT 6852 Table 3AHs.326249 ribosomal protein L22 (RPL22), −1 TCGTCCTGGTTAATCTGGAAGTAACGmRNA/cds = (51, 437) TAATTCGTAACTCTCTTTGCTGTT 6853 Table 3A Hs.297753vimentin (VIM), mRNA/cds = −1 TCGGTTGTTAAGAACTAGAGCTTATT (122, 1522)CCTATTCCAAATCTATCTTGCGCT 6854 Table 3A NA 155H10 −1AGATAAGAACTTCATCCTAAAGCATC CGGGCCTTGGCATCTTGTCCATGC 6855 Table 3AHs.108124 cDNA: FLJ23088 fls, clone −1 ACTGATTTCATCAAGTTCGACACTGGLNG07026/cds = UNKNOWN TAACCTGTGTATGGTGACTGGAGG 6856 Table 1 NA 159F8 −1AATCATTGGCTACCTCCTCCCCTTTT ACAGTCACAAGTCCAGATGTTTGG 6857 Table 3A NA166F3 −1 AATAAATCCCATACCTCCCATTGAAC TACCACCCACCCCGACCACCATAA 6858 Table1 NA 166F6 −1 CAAGACATTTCCAGCCAACTTCAGAA TGTAGATCTTTGAGCCAGACAGCT 6859Table 1 Hs.8121 Notch (Drosophila) homolog 2 −1GAGGTACTGGCCTGTGAAGCCCTGA (NOTCH2), mRNA/cds = (12,AGGCACTGGCACTGGTAGGAACCAG 7427) 6860 Table 2 Hs.25130 cDNA FLJ14923 fls,clone −1 ATCTTCTGTCAAAGTCAGTCGCTGCT PLACE1008244, weakly similar toCCAAGATTGAAACAGTCTGTGTCA VEGETATIBLE INCOMPATI- BILITY PROTEINHET-E-1/cds = UNKNOWN 6861 Table 1 NA 188A9 −1TGGATGGATTTCCAAGTGGCCTCATA TTTATCATGGTGCTTTAAATAGCA 6862 Table 1 NA171F11 −1 TTCAGCTTAGGGAAAGAGAGATACAT TTTAGATTATAGAGCATCGCCTGC 6863 Table3A NA 171G11 −1 ATCTTCCTATGTGCGCCAGATAATGA TCAAGTTCACAGGTGGTCTTACTT 6864Table 1 NA 175D1 −1 AGTTTCTTAAGTCAAATGACACATTAG CCCACGCAATTCCCAGCCCCAGC6865 Table 1 NA 182H1 −1 CCCTCTTCTGACATGAATTAGGCATAATTTAGCAATCGGTTCTTCCCAAA 6866 Table 3A NA 184B5 −1ATACAGTGAACTGGCCACTGGCTGTT TGCTATATAAATGGTATACTGCTT 6867 Table 3A NA184D2 −1 AGGTTACTTAAAAGCATCATTGGCGT GGTCCTCTCACTACCAAAGGGCAG 6868 Table1 NA 184H1 −1 CTGGGGTCAGCAAAGAGGGGTAGCA AGTGTGCCTTAGAGATGAAGAAATG 6869Table 1 NA 46D1 −1 TTTAGAGTACTTAGAGGAGGACCAGG AAACACTGAGACAGACACGCAGGC6870 Table 1 NA 98C1 −1 TGTTTGAAAACTACCTTCATGGGAGCAATGACAAGCACATGCTAGGATT 6871 Table 1 NA 98C3 −1TTTGTGCCAAGGTTTGGGATTTTGTC TTCTAGAGCTTCTTCTCTATTGGT 6872 Table 2Hs.205442 601439689F1 cDNA, 5′ end/ −1 TTTTGACGCTCTCTCACTGGTCTTG clone =IMAGE: 3924407/ GCATTTGATGTTTCTGTTGAAGCC clone_end = 5′ 6873 Table 1 NA98H4 −1 CCTATAATGGGGGAAAGATGCTGGTT AGATGTTTATTTTAGTGGGCTTGC 6874 Table 1Hs.169363 GLE1 (yeast homolog)-like, RNA −1 CCACAAACACACCCTGCCACAAGACAexport mediator (GLE1L), mRNA/ TTTAGCACAGAGGAACAGATCCAT cds = (87, 2068)6875 Table 3A NA 113F12 −1 GACACCACAACTCACCTCCTCTATTATTAGAGATCCCGAGACATTACGGC 6876 Table 1 Hs.30212 thyroid receptorinteracting protein −1 TGTTACAATTTCAGCAGTTGAATTCA 15 (TRIP15), mRNA/cds= (15, GTGAACACTGGTTGAGGAGTGCCT 1346) 6877 Table 3A NA 173A10 −1CCTTCCGTATTCTCCCAAGTATTCAC AAGCCCTCCCTTAAAACCCTCTCT 6878 Table 3AHs.334853 hypothetical protein FLJ23544 −1 ACAGCCATCTGGGATGAGCCGCTTTT(FLJ23544), mRNA/cds = (125, CAGCCACCATGTCTTCAAATTCAT 517) 6879 Table 3AHs.20252 DNA sequence from clone RP4- −1 TAACTGAATACAGTCTCATCTTGCCG646B12 on chromosome 1q42.11- CGCCTGGCTTACCTATCTGTGGAA 42.3. Contains anFTH1 (femitin, heavy polypeptide 1) (FTHL6) pseudogene, the gene for anovel Ras family protein, ESTs, STSs, GSSs and a putative CpG islands/cds = (0, 776) 6880 Table 1 NA 174D1 −1 AGGTACTACACAAGGTGTCAGATGGGGTTGCCACAATGACTAGGACAAGA 6881 Table 1 NA 45B9 −1CCAAGAAGACAGAAGGAAGTGTCGA ACACCATGACAAGAGCTTGCCAGAA 6882 Table 1 NA 45H8−1 GAGAGCTTTCTCCCCGCCTTCAGTTT CTGATGGATCTAGCCATGTTGAAA 6883 Table 1 NA111H6 −1 TAAAACTTTCTGCCAGGGTTCCAGAG AAAGAGTAATTTCCTTTGAGTACC 6884 Table1 NA 111E12 −1 CGCTCGCCGGGCCAGGTACCAAAAC TTTCATAATAAAAGGTAGGAAGGAT 6885Table 1 NA 111H11 −1 TGACTTCATTGAAGGCTCCATCACCC AAAGTAGATGTTAAAAACCTTAAT6886 Table 1 NA 112H3 −1 TTTATGTGGAAGGCTTCCCTATTACCTCCCAGCGAAATTCGTAGTCTTTC 6887 Table 1 NA 112E9 −1TAAAATGTTGCCAGTGGAGGACCGAA TCAAGGTTATTGCTGACCTCATTT 6888 Table 1 NA114G3 −1 AGATATGTTCTGAGCCCCGCCCACAC ACTGCCTGGTTACAGGGAGAGAAG 6889 Table1 NA 117H6 −1 GAGGTTCCTTCATCCCAGAAGAAGCA ACAGGATTTCCAGATCAGGGCAAC 6890Table 1 NA 165E7 −1 CTGGTCTGTGTCGTTGGCTTTATGAC AGGAAGTGCCTGTGGGTTATCTTA6891 Table 1 NA 165E11 −1 CCCAACGCTTGTGTGCGTATGTATGTGTGTATTTAACATCCTGTTCCCAT 6892 Table 1 NA 165F7 −1GCATAAAGGCAGCCATTTCCATTCTC TACATTCTCTAGTGATAGCAGAGG 6893 Table 1 NA176A6 −1 CGTTACGCAATGGAGAAGTCCCCTTG AGGCTGAATAATCACATCTGTATC 6894 Table1 NA 176G2 −1 AGGCCAAATCACCGCACAGTTGAATT GCTGATTCTAATTGGTAACAATAA 6895Table 1 NA 176E10 −1 TTGTAGTGTAATTGTGTGATACGCAA ACCTTTAGTTAACCCAAGTGATGA6896 Table 3A NA 176F11 −1 CCTTGTTGCCGTGGGTATATGCATGATCTTACCTTTTGTTTGACTATGAA 6897 Table 1 Hs.232400 heterogeneous nuclearribonucleo- −1 AAATGATATGTTAAGCACCCAAATCTT protein A2/B1 (HNRPA2B1),CACATGGAGGGGAAGGGGGTGGG transcript variant B1, mRNA/ cds = (169, 1230)6898 Table 1 NA 71F2 −1 GGCCAAAGCTGTTTATTATGAGATCTTTGAGTGGAATCAGCATGTCTCCC 6899 Table 1 Hs.172028 a disintegrin andmetalloproteinase −1 TTAACAGCATTGAAGGTGAAACAGCA domain 10 (ADAM10),mRNA/ CAATGTCCCATTCCAAATTTATTT cds = (469, 2715) 6900 Table 1 Hs.180610splicing factor proline/glutamine −1 AGGTACGAAAATACATTCTGGCATCA rich(polypyrimidine tract-binding CACCCTGAACCCAAGACTGTTCTprotein-associated) (SFPQ), mRNA/cds = (85, 2208) 6901 Table 1 NA 124G4−1 GAACTACCTACTGGCAGTTGGGTTCA GGGAGATGGGATTGACTTCGCCTT 6902 Table 1 NA123C8 −1 AGAGCTAATATACAGAGTACCTGACA CACTACCTCACCAACAGTTTAACT 6903 Table1 NA 124F9 −1 GCCCAGGCAACAAGAATACTTTTATC TTTGATCCGTTCTGTTTATCCAGT 6904Table 3A NA 127A12 −1 CTGAGGGTAGACTGTGGGCAAAGAGGACAACTCTCCCTCCCCTAAGGGAC 6905 Table 1 Hs.50180 601652275F1 cDNA, 5′end/ −1 TGCCCAGACCTATTTCCTTAGGACAG clone = IMAGE: 3935610/TATTCTAAAGTTCAGTAGTCCAGT clone_end = 5′ 6906 Table 1 NA 161E8 −1GCCCTGTCCCTTGAGAGGCTCACAG CGATGGAGGCCACTTTTGTTGTTTG 6907 Table 1 NA186E8 −1 ACCAAAAAGGGCTACATTACCACCAC TGTATCATAAAAGCCAGCCACCTT 6908 Table2 NA 191F6 −1 AGCTGACCATTTTCTATCCCGGCCTA TAGTGCATGTATGGCAATTGAGCA 6909Table 3A NA 193G3 −1 CCCCAAAACAAACAAAATAAACCACA CCAGATATCAGTCACATCCTTGAA6910 Table 1 NA 194C2 −1 AGTCTGTTATTGCCTGATTTTGTCCCCACCTTGTTCAAATTTCCAAAGCT 6911 db mining NA 458C6 −1CTCACAGCCGAAGCTCTGATCCTTTG TTCTCAGGAAACACTCAGGAAGTG 6912 Table 1 NA458E4 −1 AGAGAAAATGAGAGACAGACAGTGA GTGGGAAAGTCAGCGAAAAGGAAAA 6913 Table1 NA 458G10 −1 TCCTTGAGTTTATACACCGTGCTATG AGTGATGACAGCCAATTCCCATGC 6914Table 1 NA 459B3 −1 TCGCTTCAGGGGTCAGCCAAAAGATA GACAGCCAGGTAACTTGAGTGGAC6915 Table 1 NA 459D2 −1 GGACAGTACCAAACACTCCCCTCCTCCCCTCTGCCTCTTTGCTTACTTAG 6916 Table 1 NA 459E6 −1GACCAAATACTGAACTTCCACCCTGC ATAATAATCATGAACACCGCACCA 6917 Table 3AHs.20830 DNA sequence from cosmid −1 AGGTGAGCAGTGCCTCAGATACCTG ICK0721Qon chromosome 6. CAAAACCTTTCTGCACAAATGTGCT Contains a 60S RibosomalProtein L35A LIKE pseudogene, a gene coding for a 60S Ribosomal ProteinL12 LIKE protein in an intron of the HSET gene coding for a Kinesinrelated protein, the PHF1 (PHF2) gene coding for alternative spliceproducts PHD finger proteins 1 and 2, the gene coding for five differentalternatively spliced mRNAs coding for a protein similar to CYTA (CYCY)and identical to a polypeptide coded for by a known patented cDNA, andthe first two exons of the gene coding for the homolog of the ratsynaptic ras GTPase-activating protein p135 SynGAP. Contains threepredicted CpG islands, ESTs and an STS/cds = (163, 2184) 6918 Table 3ANA 460D5 −1 CAGATCCAATGAGGGTCCCATCTCTT CCCACTTCAATCCCGTGTTGTTCT 6919Table 1 NA 480B9 −1 CCAACCAAACCATCAAACAGCAGGGA GCTAGTGAAGAGGTCTATTGTTCC6920 Table 3A NA 461A4 −1 ACATCGCCTAAAACCGTGCATCGTAAACATTTACCCTCAAAGTCATCCTCT 6921 Table 1 NA 461G8 −1TTTTCACTCCTCTCAGAGTCTACTCC ACCTCTCCTCACTCCCCAGGACAC 6922 Table 1 NA461D9 −1 AGATCTGTGTTCGTCTCTAGGTAATA GGAAACACAATCCAGACATGATCT 6923 Table3A Hs.80788 chloride channel 7 (CLCN7), −1 TTCATGAACTCGGAGAGGTCCATGGTmRNA/cds = (38, 2455) GCACTCCCGCTCGTCCTGGGACAC 6924 Table 1 NA 481H7 −1CTGGCAATATTAACTTGGGTTCTGTT TCATCTCTGGCTATAAGCCATACA 6925 Table 1Hs.333513 small inducible cytokine subfamily −1TGCCATTCTTTTGTTGAACCTGTAAA E, member 1 (endothelialGGTAAGGCCCAGATTCTGAAACCT monocyle-activating) (SCYE1), mRNA/cds = (49,987) 6926 Table 1 NA 483A5 −1 TAAAGCACTTATGAGAATGCTGCATTTGTACATGAGCTACGCCTCATCTT 6927 Table 1 NA 483B2 −1GCACCCACCTCCTCAGTTCAGACAAG CCCAGCACCCAAATACCACTATCT 6928 Table 1 NA483C5 −1 AGCGCATGAGTGACTCCCATCTATAT ATGTCAGTCGTCTCTGGTGCAAGG 6929 Table3A Hs.40919 hypothetical protein FLJ14511 −1 GAAACAGTGGCCCGGGTCGTAGTGC(FLJ14511), mRNA/cds = (22, GCTGTCCAGATCTTCACGCTACACC 1272) 6930 Table 1NA 463H5 −1 AGTGCATTCACACTGATGATAAACGA TAGTAGCTTCACAGGTTTGCTTCT 6931Table 1 NA 463A7 −1 GCTTCAAAATTCCTTACCCCCAACCT CTGGCACCCCAAATTGTATCACTA6932 Table 1 NA 463B10 −1 GAGGAAGGGCTGGCTCTTACTCCCCACAAGAGGTGTTCCTTAGGCCACAC 6933 Table 1 NA 463C7 −1CCAATCTAATTTAAACCCTCATAACAG GACATAAGCTTGCGCCCGCATCT 6934 Table 1 NA463F10 −1 TGCTCAATGTTTTGCACTGATTTTATT CAATGTTTTGAAGGGCGTTATGA 6935 Table1 NA 464C2 −1 TGCTAACAACAGCTTCTCGGTATGTT AATATTCTGCTAACTCCTTTCTCA 6936Table 1 NA 464C5 −1 GGAGGAATGGCTGTGCCCGTCCCCT CCACTTAAGCGACCTGAGTCTCCAG6937 Table 1 NA 464C10 −1 ACACACACTTAAGAGTACAGTGAGAGCCAAAAATAAGTGGCAGGTCTTT 6938 Table 1 NA 464D8 −1TTTTGTGACTGTGCATGCTTGAAAAG AATAAGTTTTCTGCAGCTGTGTCT 6939 Table 1Hs.221695 7k30d01.x1 cDNA, 3′ end/ −1 CTTGTCTGTGGCGTGGCACACAGTA clone =IMAGE: 3476765/ GGTGCTCGGTTTGTGTTGTTGAATG clone_end = 3′ 6940 Table 1 NA464E7 −1 GAATTCTGAATACATGTTGGACTGTG TTTCTTTGACCTGTGTTTCCTAGG 6941 Table1 NA 464H12 −1 TGAGTCCTTGGCCTCAGCTTCTAATC TCAAACCTAAAATAGATTGCGTTT 6942Table 2 NA 465B3 −1 TCTTCTCGTCTTTGCTATTAAATTTCT TCACGGACCATGCATCTGGAGGA6943 Table 1 NA 465G2 −1 CCAGAGACTCCTAAGCAGAATCAAGGATGTGTGGCATAAGCATGAGAGCC 6944 Table 1 NA 465H5 −1CCCATAAAGAGGAATAAGCTACTGTC CTCAGCTCTTGTTAGCTCAGGCTT 6945 Table 1 NA465A12 −1 AGAGTTTGTAACACAATCCAGTCCAC ATGCTTATCCAATCCCATCATCCA 6946 Table1 NA 465F7 −1 AGCTCAAAATATGGCAAAGTGATGAT TTCGTGTTAATCCTAGAAACAGCA 6947Table 1 NA 465G8 −1 TGGGTCTGCTTTCACATGAAAGTGCT ACGAATTCTCTTTTGTGCTGAGCC6948 Table 1 NA 465H10 −1 GGATGAGCCCACTCACAGCACCAGATTTGTACTGAAAGTACCTTAATATC 6949 Table 3A Hs.136309 DNA sequence fromclone RP4- −1 AACCCAAATCCAAATGCCAGGATAGA 612B15 on chromosome 1p22.2-AGAATTTGTTTATGAGAAACTGGA 31.1. Contains the (possibly pseudo) gene for anovel protein similar to 60S ribosomal protein L17 (RPL17), the gene forCGI-61, endophilin B1 and KIAA0491, ESTs, STSs, GSSs and two CpGislands/cds = (1011, 1406) 6950 Table 1 NA 515C12 −1CGCTTTTTGATCTGATTACTATTTCAC ACAGGTTACAGCTATGACCATGA 6951 Table 1 NA515H10 −1 CTGCCGCTAATTCACTAGTAATTTCG ATCGTCCGCCCTCCAGGTACATAT 6952 Table1 NA 55G3 −1 AGGCGTGCTATTAATTATCCCATACC CTCCTTACAGAAATTACACTCGCA 6953Table 1 NA 55F9 −1 GGGAGAAGTTCTTTAAACTAAGGGTA CAAAATGAATTGAATGCTGGGGGC6954 Table 3A NA 99E7 −1 ATTAGCGTGTTCGCGCCCGAGGTACACCAAAACCTTCAGAAAGCAAAGTT 6955 Table 1 Hs.319825 103C4 −1AAGATATGAAATATGCCTACCGGCAG AGCTTGGCACAAAGTGGAGTCAAT 6956 Table 1Hs.17481 mRNA; cDNA DKFZp434G2415 −1 GTACAGAGATCGGATCACACAAGCC (fromclone DKFZp434G2415)/ CGGAGACAGTGCAGCTTCTCCACTG cds = UNKNOWN 6957 Table1 NA 116C9 −1 AATGCACTTGTGATAAACTGACAGCA GGGTTAGACATTACTTTCAAAGCT 6958Table 1 NA 128F5 −1 CCACTGCTCAGGAAACTGCCTGTTCG GTGCTCCTCCAATTCAATTAAGCT6959 Table 1 NA 135F10 −1 AGTGCTGGTATAACTGCAGAAAGAGATAGAGAAGAGAGATCAGTGAGAGC 6960 Table 1 NA 189F3 −1AAGTCAGGACCTTTGCACTTGCCCCG CCTCTGCCTTCACAGCTCTTCTCA 6961 Table 1 NA189A8 −1 TAATCAGGGAAGAGCTTGAGATCATT AGCAACTGAACTGAACAGGGAGTT 6962 Table1 NA 195H12 −1 CTGGGTCACGTCGCCCACCAATGGT ATCTGTGTGGTTAGGCATTAGGCTG 6963Table 1 Hs.292457 Homo sapiens, clone MGC: 16362 −1GGTGGTAGGTGAGTGGGTATTGCGG IMAGE: 3927795, mRNA,GCTAGTATCCGAGCAAAAGATGGTG complete cds/cds = (498, 835) 6964 Table 3A NA466C4 −1 CAGCCCTGCTATCTCTGGTTGTTCAT GTACTTCTGTAAGGTGGAGACCCT 6965 Table1 NA 466D1 −1 GAAGGTGAGAAACCCGAGAGACACC AACTATGATTTTTACTTTTCCTGGT 6966Table 1 NA 466G2 −1 ACCACCCCTCCCTTCCCTCCTTTAAC TCATCTCGAATCTCTCTCATACAT6967 Table 1 NA 466H5 −1 CTCTTATCCTGCTCTGCCCTGGAACTTGAACCCCAGTGCCAATACTCATG 6968 Table 1 NA 466B7 −1CGACCTAATCTCTGTCCCCAGAAGGC AGACCAGGACTCCAGCCCCCAGGAG 6969 Table 2 NA466B10 −1 GCCAAATCTTTGTCCTGTACAAAGTA CAGATGTTTTTGACTGAAGTTCCA 6970 Table1 NA 466C9 −1 GCCACAGTGAATAAATACAAGGCAAG GCTCATAGGTAAAACAAGTTCTAT 6971Table 1 Hs.7187 mRNA for KIAA1757 protein, −1 AGTGGAGTGTTTACACCTTGCTGTAApartial cds/cds = (347, 4576) CATTTGAACTTTCACAAGAGATGT 6972 Table 1 NA121F1 −1 AAACCCACCCATCATTTGCCCTGACT ACCCATCTCCCGATTAATTCACCC 6973 Table1 NA 121A11 −1 AGGGAACAGAGCCAGGATTTAAACTC TAACAATTTGTCTCCACAATTGCA 6974Table 3A NA 121F8 −1 CTCCTGGCACGACAGAACTAGTAGTT TCCATGTCTTGAGGACATAGGTCC6975 Table 1 NA 178B2 −1 TCGAACCTGTTCCAGGTATGCTGATAGATGTCGGTAGGGCATCCTTAATT 6976 Table 3A NA 178B5 −1GAGGTACTATAAACCAGATGCCCAAA ACACCTGCCCTCCTGGGTTGGCCCG 6977 Table 1 NA178F5 −1 ACATTCATCTGTTTCCACTGAGGTCT GAGTCTTCAAGTTTTCACCCCAGC 6978 Table1 NA 178C12 −1 TTAGCCCTTTTCTGCGCTAATTAGAAT TTCAAGCGTCACAGAGCCTGGGG 6979Table 1 NA 462A11 −1 TTCAACGAGGTGAACCAGTGTGATGT CTGTGGGGAAAACACGTAGTCAGG6980 Table 1 Hs.13231 od15d12.s1 cDNA/clone = −1GGAAAAAAGAAATTTCCTGAGATTTC IMAGE: 1368023 CAGTGTATACAGAAGTGTCTTTCCAT6981 Table 1 NA 462D9 −1 GAGTTCACGTGGGGTGGCCCTCCTCAGTGCTCTTAGGGTACTGTACTGTC 6982 Table 1 NA 462E8 −1CCACCTTCGAGGTCCCTTCCGGCCTA AGATGCCTGAAATCTCCAAGGAAA 6983 Table 1 NA462F9 −1 ACAAGGCAAAGCTTAAAGAAACACTA AACGAATGAGTGAAAGAAGCGGAG 6984 Table1 NA 462F11 −1 TTCTCAATAACAAACCCAGGGCTTTC ATAAATGCATGATCAAAATGTGGA 6985Table 1 NA 462G12 −1 ACAGAAAATAGGGTGTATATCAGCAT TACGCTGATTCAGCAGAAGATAGC6986 Table 1 NA 462H9 −1 TCTCGACTGACACCCACTATAAATTCCCTGGGTTGAAAAACTTTTCTTTT 6987 Table 1 NA 472B1 −1TCCAAACCCCTCCATTACAATCTAAC ACACTTCCCCCTACATCGTCTCCT 6988 Table 1 NA472C1 −1 GCATTTATTTTCTTCTACAGAGAACCT GGCGGCTGGGTCTGGGAAAGAGC 6989 Table1 NA 472E6 −1 ACCCACAATTAGTGAGAGTGCCCTTG AGCTTGAGATTCCCATTCCTCCTT 6990Table 1 NA 472F4 −1 TGGATATAAAGTGTGTGTTCTGACAG AAAATGGGGAGAAGGTGGCTATTT6991 Table 1 NA 472G2 −1 GCCAGAAAATCCTGGTTTCCCTGGTGTCCCCTCCAATCTCTTTTACCAAA 6992 Table 1 NA 472D7 −1CCATTGTCGCCCGGAGCTGGAAAGA TAGTTTAGAGAATGCCTTAGCACTT 6993 Table 1 NA472G12 −1 CAGCACCCAGTACAGGTATGCAGGA AGGACTCGCTTGACTTAGAGAGTGG 6994 Table1 Hs.75354 mRNA for KIAA0219 gene, partial −1 AACACACCAGAAGGAAAAGACAcds/cds = (0, 7239) CAGACAGGGAATGAAGCCTGCAAA GTCC 6995 Table 2 NA 64G9−1 GTAACTCAGTGCCCCCAAAGATTCAT AGTCAGCAGGATTGGCCAGCAAAT 6996 Table 1 NA467E5 −1 CGCCCCAAATATAAAATCTCAATACC AGTTCCTTTTCCCCAGTACCCCAG 6997 Table1 NA 467A8 −1 AGTCACAGGATGTTCTCTGCACCTCA TCTGCAACTCTGAGCCTTACTCAA 6998Table 1 NA 467C9 −1 GTTAGAGCCCTCGTGCCCTGCTTCTT CAGCTACCATTTCTCTCTGTGACC6999 Table 3A NA 467F8 −1 CCACCACAACCACACACACAAAAAGTCAACCCACACGAATATACCG GAAA 7000 Table 1 NA 468E6 −1CAGTTGGCTGTTAGTAGTCTGCAC ACAGGTGAGAGGAGCAAGAGATCC 7001 Table 1 NA 468B9−1 AATCTATTATCAGGCATTTAATCACTG AGCACTCTTCTGTCCCACACTGT 7002 Table 1 NA468E10 −1 AGAGGAGTGACGGTGAATGGTACTG AAAGCGGTTGTAAATTGCGAGAGAG 7003 Table1 NA 468F10 −1 TCTCCTTGTTCTGATTCTCTCCCCATC TACAACAACTCCACTCCCCAAAG 7004Table 1 NA 468F11 −1 CACCTAACCAAGCGGGTTGGGCTGA TGACCGATGACCGTAAGCAGTAAGG7005 Table 1 NA 468G12 −1 ACCTCTTCTTTAGCAACACTAACCACTCCACACTGGGGAAATTATACTCT 7006 Table 1 NA 468H11 −1ACTACCGCACAACAGAACACATGACC AGGTGAGTGCAGACACGACATCAG 7007 Table 1 NA469B6 −1 CAGTTTTACTCCTGGTCATCTCTTGT GAGTGTGGATTCTTCTCTGCCCCT 7008 Table1 NA 469D2 −1 TTTTATTTTGGCTGAAGTTTGGGTATG GCTGCTTGTTGGCCTCTGCTGGG 7009Table 1 NA 469A10 −1 ACAGCTTATAAAGCACTTTCTCATGC ACTTCTTCTCGCCGTATTTGCACA7010 Table 1 NA 469E12 −1 GGGGCTCAAACCTGTGACTTACTGCTAACTAACATCAAAGGAAAAGCTGG 7011 Table 1 NA 469F8 −1ATGATCATTGATAGATATTCTAAGAG CATGCAGGAATGAGGATGCGTGCC 7012 Table 1 NA469G8 −1 GACAACAAACCTGCTTGCTTGGTTAC CCACAGCGCACTGAGTATAGAAGT 7013 Table1 NA 470B2 −1 TCTTCAATTATTCATGCTCTAAGGCA GTGTCTGTCTTCCCACCATCCCGC 7014Table 1 Hs.118174 tetratricopeptide repeat domain 3 −1TGAGTATTTTTAAAATCCCCTGTTTGG (TTC3), mRNA/cds = (2082,ATGCTTCCAGCTAAATAGTCTACCT 7460) 7015 Table 1 NA 470C3 −1TGGGTTTACTCAGATCTTCTCCTTCTT AAGTGAGAGTTTTAACCTACATTTT 7016 Table 1 NA470D5 −1 GTCCAGAGCTAGAAGAACCAAGTCTT CCTTTCTTCATTCATTGTTCAGGT 7017 Table1 NA 470E1 −1 CTTCTTCTTAGGATCTGGAGGGAGGG GAGTGTTAGAGCTTGTGAGCCATG 7018Table 1 NA 470E5 −1 CTGAACGAACCAGTTCTTTTGGACTA CCAGTTCTTGAAGTGAAGCTCAGA7019 Table 1 NA 470F3 −1 AACAAAAGCACTGACAAGCTCATATGAACAGGCTAAAAAGTGAGTGAAGT 7020 Table 1 NA 470G6 −1TTCTCTTTCTATATCTAGCTAAATTGC CTGTGCGCCTCCCATCCTCCTCA 7021 Table 1 NA470B8 −1 ACACACTTGATAAATTAGACCGATGC AAACCGCAAGAATCCAAATCAGCT 7022 Table1 NA 470G10 −1 ATAGTAGGTGAGCCAGTAGTGTGAAT GCTTGTCAAGCTTCCAAGGATGGA 7023Table 1 NA 471D6 −1 AACCACCACCCAGCTTCCTGGTACAA GCAGGGACTCTGGCTACAGTGCTA7024 Table 1 NA 471F1 −1 TTTCCTCCCCTCCCTCCCCAATCCACAAAACACGTAATCTGACTATCCA 7025 Table 1 NA 471F4 −1CAACATTCACAAAACTGGTCCCCGAA TTAGTGAGAAGGTTCCAGGAGTGC 7026 Table 1 NA471F6 −1 GAGAGATTATAGCACAGTCTCCCAGG GCTCAGTCAGGTCATCCGCAGCAA 7027 Table1 NA 471E9 −1 TTCAATGCTTTGTCCTCCCCTCGCAG ATGTTTAGAACAGATCCTCCTTCT 7028Table 1 NA 471E11 −1 TCCCTCTCTCAGGGCTGGGAAAGAAA GGTTCATCTTCACTCAGATGCAAG7029 Table 1 NA 471H11 −1 TTCTGTTGGTCTGCCAGCTCATCCATTCATCCATCACCTGCCAGCTAGAC 7030 Table 1 NA 473E4 −1ACACAGTTTTGGCTCCCTTATTTTCC CCGTACTCGAAACATTTCCATGCA 7031 Table 1 NA473F3 −1 ACCAAATCGCAAAAATACAGAATGCC TGTAAATTGAGTCACACCTTAAAA 7032 Table1 NA 473E11 −1 GAGTCCATAAATCTGCATTTCATGTA GTTGTAAGACTTTCTCCCAAAGGT 7033Table 1 NA 476C1 −1 TCCATTTGAGTTTTCTTCCCATCTCTC ACAGTTGATTGTTCTGTCCCTTC7034 Table 1 NA 476D3 −1 AAAATTCAGCCCTCCTGGATTCACGTGCCCCAATGAAAGTCCCCAAACTAG 7035 Table 1 NA 476F5 −1TTTAACAGGAAAAGCCCAAAATTATTT TTATGCTGTCTACAATCTGGGCC 7036 Table 1 NA476G3 −1 AGTTGCACTGGTTGTTCTTGGCTGCG GTGCTTCTCACACAAGAAGCCCAG 7037 Table2 NA 476G4 −1 TTTCCTTTTTCCCTTGTCCCTTGGCTT CCCCCATCACCGAATCCCCCTTC 7038Table 1 NA 476A10 −1 CTCCCACGCCTGGCCGTAGTCCAGA GCTTCTTCTTTTTCATGGTTGGGTT7039 Table 1 NA 476G8 −1 GCCAGTGTACGTTGCCAGGCATTTCATGTAAGAGAAAACTCAAATAGCCA 7040 Table 1 NA 476H10 −1CCGTCTTCTTTTGGGTGTTTCCTCCT AGTTTCGGCGGAAATCAGAGTTCA 7041 Table 2 NA477E1 −1 ATGAACCCTCACCTGCTCTGCAGTGC AGTTTTGATTTTAGTCCCAGCAAA 7042 Table1 NA 477E6 −1 AGATATAGATGGTAAAATGTGATGCA ATGTAAAAAATGGTAATACACACACTCTCCA 7043 Table 2 NA 477A11 −1 TGAGTGGGCTTCTCTTATGGTACAGTCTCTTCTCTATGAGGGGCTTCAAA 7044 Table 1 NA 477D9 −1TGGGCTTCCAAATGGTACAATGGAGT AATCAAGCTCATGGACTGAGAGTT 7045 Table 1 NA477D10 −1 CTTGAAGCTACTTGTCCCTTTCTGTG CCAGACCACTTAATGGCTACCCAC 7046 Table2 NA 480A3 −1 TTCCCAGGGCGCTCCATCTACAGCCT TACTGTGACTCCACTCAGCACCAG 7047Table 1 NA 480B5 −1 ATTCCCCCTAAGCTCCTGTCCCCCGC CATGCACGACTGGTCACATCAAAA7048 Table 1 NA 480D2 −1 AAGACACACCCCTCCTGTTTAATAAAAGTTGTCCCCTCGACATGCATAAT 7049 Table 1 NA 480E2 −1CCTGGTTACAATAATGAAACTGTCGT GGAGTAAAGAGGGAAACATGACCA 7050 Table 1 NA480E3 −1 AGAACCCACACACTGGGAGACAATAA CTGCCATTCATATAACCAACAGAA 7051 Table1 NA 480F3 −1 CGCCACTGCTTAAAGATTACAGACAA TTCCCAGGTAAAGTTGCCAGGACT 7052Table 1 NA 480G4 −1 ACAATGATGTTTGAAACGCACTCTGA ATCTGTGAAAGCTAGATAAGTCCT7053 Table 1 NA 480C8 −1 GCCTTCCTCCTCCTCCCTCTTGGGCCTATGTCCTAGATAAGCCTGTTAAA 7054 Table 1 NA 480D9 −1TGTCAAGATGACAGATCTTAATCCAG AGTGGAGGCTCGTTCGGCCTGGAG 7055 Table 1 NA480E7 −1 TTTATGTTTCAGCCTCTTTCTCTCCCG TTGAGTCCTGCCACAAGTCCTGC 7056 Table1 NA 480E11 −1 ATTGTCCAGGTGACTTGACACTTGCC TACCGGAAAAGTTGGGATGTTCTT 7057Table 1 NA 480F8 −1 TAAAATATGCCCTAATTTAAAGGGCG CAGGGTCCCACAACAAGCCACAGA7058 Table 1 NA 487F11 −1 AAATCTCTTCTCACGTTCTGTTTGTCATTTAATCACCAGGTTTTTAGCGC 7059 Table 3A NA 499G1 −1GCTACTGATGGGTGGCCCTTTATTCT TGTCTTTATTTGTTGTGTGCAGGA 7060 Table 1 NA518F10 −1 AAAAATTGGTAGCTGCCCCCATGTGG TATGATGTTTAATTTGAACAACAT 7061 Table3A NA 524A12 −1 ACCCGGCACGTCTCCTCAACCCCTTA ATTCTTTTCCAGCTTTTCATATTA 7062Table 1 NA 526B9 −1 CTCAAGAGGGCATAGACATTCCACAC GAGGACTGCATTCGTCAGGGTAAC7063 Table 1 NA 583B5 −1 AACAAATACCCAATTAACTGTATTCCCCTTTCCCCTATGACTGCTGGTGT 7064 Table 1 NA 583D6 −1CCGTTGTCCGAAAGCTTGCTTCCAAC TAAAGACCAGAGATGGGAGGGAGT 7065 Table 1 NA583G8 −1 TTTAGCCCAAAGAAGACTTTCGCATA AATTCTGCCGTAACCCTTGTTGGA 7066 Table3A NA 584A1 −1 CAAAGCAGCAAATACAGAGCAC ACAACAATCCTTGGCCTGAGCAGA ACAA 7067Table 1 NA 584D3 −1 ATATGAAGATGGATTGGATGAGGACT GACAAAACGAAGACATGCCGGGCC7068 Table 3A NA DNA sequence from clone RP4- −1ATGCCTAGTCAGTCAGTATTTCTTCTT 620E11 on chromosome 20q11.2-GCTGCAGGTGTCTAAAAACCCAC 12 Contains l 7069 Table 3A NA 591H9 −1CCTTCGCATTCCCCCATCCATGCTCC AAGATAATAGATTTTTCTTTAAAA 7070 Table 3AHs.6179 DNA sequence from clone RP3- −1 GGGGAACACTTTGGTTTGAAAGCACA 434P1on chromosome 22 Contains GAGCAGTTTGCCATGTTTCTTCTG the KCNJ4 gene forinwardly rectifying potassium channel J4 (hippocampal inward rectifier,HIR, HRK1, HIRK2, KIR2.3), the KDELR3 gene for KDEL (Lys—Asp—Glu—Leu)endoplasmic reticulum protein retention receptor 3, the DDX17 gene forDEAD/H (Asp—Glu—Ala—Asp/His) box polypeptide 17 (72kD), ESTs, STSs, GSSsand slx putative CpG islands/cds = (307, 2259) 7071 Table 1 Hs.44577602388170F1 cDNA, 5′ end/ −1 ACTGAATGGTCGAAATCACATATGCA clone = IMAGE:4517129/ CCACACATACTGATCTTAAGTAAC clone_end = 5′ 7072 Table 3A Hs.108124cDNA: FLJ23088 fls, clone −1 CGAGGTACAGCAAAGCGACCCTTGG LNG07026/cds =UNKNOWN TGTCATAGATCAGACGGAAATTCTC 7073 Table 1 NA 119F12 −1TACAGAAGAGCAGAGACCAACCTTCT CAAAGTTGGTGAGTATTAACCCAG 7074 Table 1 NA119G10 −1 CCAGATTTGCTGATGTGTTAGGTAGT TGTGGCACACTCACCTGTCTTTCC 7075 Table1 NA 485A8 −1 CTTTCCAGGTTTTCCCTTTCCGCCAT TGTTTTCCCGCTCGCTAAAGTGAC 7076Table 1 NA 485D5 −1 TTGAACATTCGCAAAGTAACATCTCT CACTCCCAACACCACAGCTTATCG7077 Table 1 NA 489H9 −1 AGTAACCACCCAAAGCATAGTTTTAGAAGGGCTTTCGCAAACCTAGC CTTT 7078 Table 2 NA 494B11 −1TCTTGCTTGTTCTTCTCGTTTTTGTTT TATCTTCCGCCCGGCAGGGTCAG 7079 Table 1 NA478E5 −1 GCTCTGAAACCCCTGGAACTCTTGAG CCTAAAATGTATTTTTACAATCTT 7080 Table1 NA 478G6 −1 ATCTTTGATGTGAAGCCCTTTAAAAAT AAACGTGAAGGTGCCAGCTTGCA 7081Table 3A NA 478H3 −1 ACCCAGCCTGATGTTCATCTTTTCCC CCTCTTCATTTTCCTTCTTTGTTT7082 Table 1 NA 478C7 −1 AGAAAGACTAACACCAGAAATCATGCTGCAACACCAGAACATCCTTTGGA 7083 Table 1 NA 478G8 −1TCACAAAATATGGCTCAAGGAGTATA AATCCCCTCTCACGCACCCACAAA 7084 Table 1 NA478H7 −1 ACTAACCAACCAATGAGAATACTACT TACCTCCACCCATGCTGTGAACCC 7085 Table3A NA 479B4 −1 TGACCGCCTCAAAGACCAAAAGGACT CTACTCCATATTCTTCTCACTGTC 7086Table 1 NA 479D2 −1 GAATGACCACCTGACGCATTCAGAGC TCACCTTCTTGTTCTTCAGCTGTT7087 Table 1 NA 479G2 −1 TTGGTAGAAACCACCCAACCATAAAATTCCCAAGCCTGTACTGGTCAGCC 7088 Table 1 NA 479G3 −1CATAAGTTGGGTGAAGAAATGGTGGT TTTAATCAGTAATATAGCTCCCCC 7089 Table 1 NA479G5 −1 TTCTCATCTCAATATCCCCCAGAGCC CCAGTACCTCATAATACAAGACTT 7090 Table1 NA 479G6 −1 CTATCAGGCCCTCCAGATAGTCTTCT ATAAACCAATGATTCAGCAGGACT 7091Table 1 NA 479H4 −1 TACCCAAAGTCTATTCGTAAGTGCAT CTTTTCTATTAGACTGGAAGCTCC7092 Table 1 NA 479H5 −1 GATGGTTCAGCAACTGAGGAGCTCAGGGTGACGGGTCCACAGAGCACAGA 7093 Table 1 NA 479H6 −1AGAAATTAGAAGATGACTACCATTTG CTAAAGTCTATCCACATGCCAGCA 7094 Table 1 NA479G12 −1 CCCCCTCGACCCCCTCACACCCTTTC CAGAGAGGCCTTAAGATTCCCATT 7095 Table1 NA 479H12 −1 TGTAAGGTTTCATAAATTTAGAGACC CTAGCCCAGTCAGTGACAATATGCA 7096Table 1 NA 482A5 −1 GAGTTGCTTATTCCAGTCTCTCTAAGATATATCTCCCTTTTTAGTTGCTGAC 7097 Table 3A NA 483G5 −1TGGTGTAATGAACATGCCGTATTGCC TTTATGGCCAGTTTGAGTCCTTCC 7098 Table 1 NA488C4 −1 AGGGAACCCCAAAGAGTTAAAA CCAGGACCACTATTTCATAGTCAA CAAA 7099 Table1 NA 490F10 −1 GTGGTAAATGAGAGCATTACAGACCA CCCACATCAGCCTAAAATATAATT 7100Table 1 NA 493C2 −1 CCACCAAACCCAACAGGCCGGGACA AATGCAATACCATACAGAAACACAG7101 Table 1 NA 58G4 −1 GGCCAAACTTTCTTACTCTGCCATTTGTTCAATGTCCTAATGAGCCATGAA 7102 Table 3A Hs.169370 DNA sequence from PAC66H14 −1 ATCAATCGGGCCAATCCGAAGTCAGC on chromosome 6q21-22. ContainsAATCTTGCATATGAGTCCATTCCC FYN (P59-FYN, SYN, SLK) gene coding for twoisoforms. Contains ESTs and STSs/cds = (12, 1706) 7103 Table 1 NA 598H2−1 TATTTTTAACAAAATCACACGGAAGG ATTTCCTTCCCGTCCCATGTGTTG 7104 Table 3A NAAA077131 1836605 7B08E10 Chromosome 7 Fetal −1 CAGATAGTGGTATTTGGGTGCTGGGBrain cDNA Library cDNA clone CTTGTCTGACCTGAGGAGGTGGCTG 7B08E10, mRNAsequence 7105 Table 3A NA AA501725 2236692 ng18e12.s1 NCI_CGAP_Lip2 −1AACTCCATAGAGAAAGACTACGAATT cDNA clone IMAGE: 929806TCGCTGGGAGGTAATAGGGAAGCC similar to contains Alu repetitive element;mRNA 7106 Table 3A NA AA501934 2236901 nh56a10.s1 NCI_CGAP_Pr6 −1GCATTTAGGAAAGACAGGTGAGTGTG cDNA clone IMAGE: 956346,CCACAACTACCTAACACATCAGCA mRNA sequence 7107 Table 3A NA AA579400 2357584nf33d05.s1 NCI_CGAP_(‘3)Pr1 −1 TTACTTTGTCTTCTCTCACCATCCTAA cDNA cloneIMAGE: 915561 AACGTTGTTTTGCTGAGCATGAA similar to contains Alu repetitiveelement contains 7108 Table 3A NA AF249845 8099620 isolate Slddi 10hypervariable −1 CCCCAGACGAAAATACCAAATGCATG region I, mitochondrialsequence GAGAGCTCCCGTGAGTGGTTAATA 7109 db mining Hs.277051 AI6302424681572 ad07c09.y1 cDNA/clone = −1 GCCTAAGTTTCCAGAAGACTTTGACGad07c09-(random) ATGGAGAGCATGCAAAGCAGGTAA 7110 db mining Hs.277052AI630342 4681672 ad08g11.y1 cDNA/clone = −1 TTTTGCAGTTCAAGGATTGGTGGGAAad08g11-(random) ACGTTTGTATGTGTTGGGGTGGGG 7111 db mining NA AI7322285053341 nf19e05.x5 NCI_CGAP_Pr1 −1 AATAGATTTCCATTTCTTCCTTCGAGT cDNAclone IMAGE: 914240 TAGTTGGGTATTGGGACCTTGAA similar to contains Alurepetitive element, mRNA s 7112 Table 3A Hs.197803 AW379049 6883708RC3-HT0230-201199-013-c12 −1 CGACGGTGTTCTGGAGTTTCGATGAG HT0230 cDNA,mRNA sequence ACATGTAAGTAAGAGTTCTGTGCA 7113 Table 3A Hs.232000 AW3808816885540 UI-H-BI0p-abh-h-06-0-UI.s1 −1 ATATTCAGCAGTGGCTGTGAAATTGG cDNA,3′ end/clone = IMAGE: ATTTGAATTACCGGGATACATGCA 2712035/clone_end = 3′7114 Table 3A Hs.325568 AW384988 6889647 602386081F1 cDNA, 5′ end/ −1ACTGGTTTTCATTCTAGTGTCCCCCA clone = IMAGE: 4514972/CCCGTCTAGTTTCATTTTCCTGTA clone_end = 5′ 7115 Table 3A NA AW8363897930363 PM0-LT0030-101299-001-f08 −1 TTGGGAGTCACCAGGTTAAAGCAAAG LT0030cDNA, mRNA sequence CCTCAGTCACTGAAAGCAGAAACT 7116 Table 3A NA AW8377177931691 CM2-LT0042-281299-062-e11 −1 TCCTGTGCTCCAGAATTAGTGATTGC LT0042cDNA, mRNA sequence TTTGGTGCTTAACTTGAAGTGGGA 7117 Table 3A NA AW8378087931782 CM1-LT0042-100300-140-105 −1 CATCTGCTCTGCTTCCTCACACACTA LT0042cDNA, mRNA sequence GAAACACCACTGCCCCCATCCATG 7118 Table 3A NA AW8424897936472 PM4-CN0032-050200-002-c11 −1 TCTGTGATTTATAGACTGTTTTCAGGA CN0032cDNA, mRNA sequence AACGATCTTCCCATCTGTGGTGA 7119 Table 3A NA AW8466567942373 QV3-CT0195-011099-001-c09 −1 TCATTTCAGGTCTAATAAACACACTAA CT0195cDNA, mRNA sequence CCTCGGCAGCACTGGAGCGTCTG 7120 Table 3A NA AW8564907952183 PM4-CT0290-271099-001-c04 −1 AGCTTAGGATATCTATTAGTGTTCACT CT0290cDNA, mRNA sequence GTTCGGGCAAGAGGCCTAAAGGG 7121 Table 3A NA AW8913448055549 PM2-NT0079-030500-001-a04 −1 TGGGAACACACTGGCCCATTATATAG NT0079cDNA, mRNA sequence AGAAAAATAAAACATGATCCCCAT 7122 Table 3A NA BE0611158405765 QV0-BT0041-011199-039-f09 −1 TTGCTTGATTTCCCAAACCACTACCT BT0041cDNA, mRNA sequence GAAGGTGGCTTATGGTCTACAGCT 7123 Table 3A NA BE0860768476469 PM2-BT0672-130400-008-h09 −1 TTCCACCACTTCAAGACTGGGGGCA BT0672cDNA, mRNA sequence GGTAGAGAAGACAAGCATAAGTACA 7124 Table 3A NA BE0919328482364 IL2-BT0733-130400-068-C11 −1 TTCTTCTCTGCCCCTAACAGAATGTT BT0733cDNA, mRNA sequence CTTCTCTTGCTTCCCACACCCTCC 7125 Table 3A Hs.173334BE160822 8823543 ELL-RELATED RNA POLY- −1 CAGCACATCTTCTGGTTTACAAGTTGMERASE II, ELONGATION GGTAACTATGAAAGCTGGAGATGC FACTOR (ELL2), mRNA/cds =(0, 1922) 7126 Table 3A NA BE163106 8625827 QV3-HT0457-060400-148-h10 −1TATCTAAATTCTACCTTTAGCATCCAA HT0457 cDNA, mRNA sequenceCTAGCTACCGTCTGGCACTGGCC 7127 Table 3A Hs.301497 BE168334 8631159arginine-tRNA-protein transferase −1 TCCAATGCTCAAGTCACTCTGAGTCT 1-1p(ATE1) mRNA, alternatively TTGCTGGTGTCAACCTACAATGCC spliced product,partial cds/cds = (0, 1544) 7128 Table 3A Hs.172780 BE176373 869102602343016F1 cDNA, 5′ end/ −1 ACCTCACTATAGTAGCCATTAGGTAA clone = IMAGE:4453468/ AGATGGGCCATATCCAAATGGGCT clone_end = 5′ 7129 Table 3A NABE177661 8656813 RC1-HT0598-020300-011-h02 −1AAGAACTATTCCTTTGAGAATCTTTCC HT0598 cDNA, mRNA sequenceTACTGGGAGTTACTGCTGTGATT 7130 Table 3A NA BE178880 8658032PM1-HT0609-060300-001-g03 −1 TCTGTGTGAACATACATACAGGACTT HT0609 cDNA,mRNA sequence TGATTCTACCTGTGCCTGACCATT 7131 Table 3A NA BE247056 9098807TCBAP1D6404 Pediatric pre-B −1 GTGGAGCTGTTGGCCCTTGCTGGATG cell acutelymphoblastic leukemia CGGGCACTCTCTACACCTTCAGGTA Baylor-HGSC project =TCBA cDNA clone T 7132 Table 3A Hs.11050 BE763412 10193336 mRNA; cDNADKFZp434C0118 −1 TGTCAGTGGCTCTCACTTTGTTTGAA (from clone DKFZp434C0118);ATTGTTGCTTTGGGAAAAACACAG partial cds/cds = (0, 1644) 7133 Table 3A NABF330908 11301656 RC3-BT0333-310800-115-f11 −1 GATGCAGTGGGTTAGGGGTTGGGGGBT0333 cDNA, mRNA sequence TACAGACTGACTTGAGCTCGGAGTC 7134 Table 3A NABF357523 11316597 CM2-HT0945-150900-379-g06 −1TCAGGCACTCAGTAAAGGCAAGACTT HT0945 cDNA, mRNA sequenceGAGTGATACATAAAGTCAGTTACA 7135 Table 3A NA BF3644413 11326438RC6-NN1068-070600-011-B01 −1 CCTTGGGCTGAGTTTGCTGGTCCTGA NN1088 cDNA,mRNA sequence AGATTACAGTTTTGGTTAGAGAGA 7136 Table 3A NA BF37363811335663 MR0-FT0176-040900-202-g09 −1 ACAGCAAACAAAAGTGTTCCAAT FT0176cDNA, mRNA sequence CCTCTATTAACCCATTTAACCAAG AGTT 7137 Table 3A NABF740663 12067339 QV1-HB0031-071200-562-h04 −1AGTGCATTCACACTGATGATAAACGA HB0031 cDNA, mRNA sequenceTAGTAGCTTCACAGGTTTGCTTCT 7138 Table 3A NA BF749089 12075765MR2-BN0388-051000-014-b04 −1 AAGTGTGATTAGAAAGCAGCTGG BN0386 cDNA, mRNAsequence AAGTAGCAGAGGAGGTGGAAGTTA GTCC 7139 Table 3A NA BF75848012106360 MR4-CT0539-141100-003-d05 −1 CAGGAGTAAAACAGAGCTGGTTGTGT CT0539cDNA, mRNA sequence GATACCTATGCTGGGTGGAAGACT 7140 Table 3A NA BF77312612121026 CM3-IT0048-151200-568-f08 −1 GGTGACTATCTTACCGGCTCCCAGTA IT0048cDNA, mRNA sequence AACTCTGAACAATGTACCAGCTAA 7141 Table 3A NA BF77339312121293 CM2-IT0039-191200-638-h02 −1 GCTTGAAGATGTCTCAACAGAAAATC IT0039cDNA, mRNA sequence ACCGACATGAGGAAGCATCACGCT 7142 Table 3A NA NF80516412134153 QV1-CI0173-061100-456-f03 −1 AGGAACATGGCTGCAGCATATAAAAA CI0173cDNA, mRNA sequence GAATTGAATTCCATACTTTTGTTAACC CTG 7143 Table 3A NABF818594 12156027 MR3-CI0184-201200-009-a04 −1 GGTGCTGCCATAGGTGCCAGTAATGCI0184 cDNA, mRNA sequence ACCGTTTATGCGGAAATCAATTACA 7144 Table 3A NABF827734 12171909 RC8-HN0025-041200-002-F08 −1TGAAGTACTATAGGACTCAATGGGAC HN0025 cDNA, mRNA sequenceCAGTAGCAGCTCCAAGTGGATCAC 7145 Table 3A NA BF645167 12201450RC5-HT1035-271200-012-F08 −1 ACACGGGACCTCCTTTGATCTTTCTG HT1035 cDNA,mRNA sequence AGAATTAATAGAGATTTCATGGCA 7146 Table 3A NA BF86916712259297 IL5-ET0119-181000-181-b11 −1 CCAAAAGGAGAAAGATGACTAGGGT ET0119cDNA, mRNA sequence CACACTTGAGGATTTGCCAGGTGGG 7147 Table 3A NA BF87557512265705 QV3-ET0100-111100-391-c02 −1 GCATCTTCTTTGAAGACGGGAACTGT ET0100cDNA, mRNA sequence ACTTCAGGTTCTTTTCTGTTTAGC 7148 Table 3A NA BF87797912268109 MR0-ET0109-171100-001-b02 −1 GGCTCATTTGGTTTTAAAGTCTCTTCT ET0109cDNA, mRNA sequence ATGCCATCCCAGGGGAGGAGGAT 7149 Table 3A NA BF89704212288501 IL2-MT0179-271100-254-C11 −1 GACTGTGGACACCTCTCACTGTGTCT MT0179cDNA, mRNA sequence TCTTGGCAGGCAGAGCTTACTGAC 7150 Table 3A NA BF89828512289744 QV1-MT0229-281100-508-e11 −1 GCAGGGTGCAGAGCTTCACAGCAGG MT0229cDNA, mRNA sequence TAGGAAGAAGTAACTAAGTGGAAAC 7151 Table 3A NA BF89948412290923 IL5-MT0211-011200-317-f03 −1 CAGCTAAAGCCGTAGGTCATTGTGAC MT0211cDNA, mRNA sequence TGTCCCTGGGATGTGGATTACTCT 7152 Table 3A NA BF90442512295884 CM1-MT0245-211200-662-d02 −1 CCAGAATGCAGCCTACAGACCAAATA MT0245cDNA, mRNA sequence TCAATGGACTTGGTGTAGCCCTGC 7153 Table 3A NA BF90611412297573 IL3-MT0267-261200-425-A05 −1 TTTAAACCAGGTCTGGAAAAGGAAG MT0267cDNA, mRNA sequence GAGAGGAGGGCATTTTAGAGAAGA 7154 Table 3A NA BF92618712323197 CM2-NT0193-301100-562-c07 −1 GTGGCTTCGTAAAATAGAAGAGCAGT NT0193cDNA, mRNA sequence CACTGTGGAACTACCAAATGGCGA 7155 Table 3A NA BF92884412326772 QV3-NT0216-061200-517-g03 −1 CACACCACAGCTGGCTGGGAGCAGA NT0216cDNA, mRNA sequence GGCTGCTGGTCTCATAGTAATCTAC 7156 Table 3A NA BG00682012450388 RC4-GN0227-271100-011-d03 −1 TGGAGAAATGAGAGACAGACAGTG GN0227cDNA, mRNA sequence AGTGAGAAAGTCAGCGAAAAGGAAA 7157 Table 3A NA F11941707260 HSC33F051 normalized infant −1 ACCTACTGTTGAGATTATTCCCCTGT braincDNA cDNA clone c-33f05, CTCCACACTGCCAGAAACTTACCA mRNA sequence 7158Table 3A NA U46388 1236904 HSU46388 Human pancreatic −1CCAAATGATACTAGGATTAAGCCCCA cancer cell line Patu 8988t cDNAAAGCAAAGTCAAGCACCACCATGG clone xs425, mRNA sequence 7159 Table 3A NAU75805 1938265 HSU75805 Human cDNA clone −1 TCCCAGAGCAACAACTAAGTCTCAACf48, mRNA sequence TAATGGACAACCAACACCCACTGA 7160 Table 3A NA W278581307658 36f10 Human retina cDNA −1 CCACAGAATGGGCATGTAGTATTGAG randomlyprimed sublibrary ATTTGAATCATCTGCTGTCCAGCC cDNA, mRNA sequence 7161 dbmining Hs.681 nm_004146 10764846 NADH dehydrogenase 1ACCTCATCCGGCTGCTCAAGTGCAAG (ubiquinone) 1 beta subcomplex, 7CGTGACAGCTTCCCCAACTTCCTG (18kD, B18) (NDUFB7), mRNA/ cds = (22, 435)7162 db mining Hs.943 NM_004221 4758811 natural killer cell transcript 41 GACCTGGTGCTGTCGCCCTGGCATC (NK4), mRNA/cds = (59, 763)TTAATAAAACCTGCTTATACTTCCC 7163 db mining Hs.1063 NM_003093 4507126 smallnuclear ribonucleoprotein 1 GCATAAGGAAGACTTGCTCCCCTGTC polypeptide C(SNRPC), mRNA/ CTATGAAAGAGAATAGTTTTGGAG cds = (15, 494) 7164 db miningHs.1321 NM_000505 9981354 coagulation factor XII (Hageman 1GGGACTCATCTTTCCCTCCTTGGTGA factor) (F12), mRNA/cds = (49,TTCCGCAGTGAGAGAGTGGCTGGG 1896) 7165 db mining Hs.288856 NM_00390314110370 prefoldin 5 (PFDN5), mRNA/cds = 1 AGACTGGATCGCACACCTTTGCAACA(423, 926) GATGTGTTCTGATTCTCTGAACCT 7166 db mining Hs.1975 NM_03079413540575 hypothetical protein FLJ21007 1 AAGCAAATACCTTTTACAAGTGAAAG(FLJ21007), mRNA/cds = (257, GAAGAATTTTTCTTCTGCCGTCAA 2212) 7167 dbmining Hs.3804 NM_014045 13027587 DKFZP564C1940 protein 1GCAACAAATGCTTCTATTCCATAGCT (DKFZP564C1940), mRNA/cds =ACGGCATTGCTCAGTAAGTTGAGG (565, 1260) 7168 db mining Hs.3832 NM_03249314210503 clathrin-associated protein AP47 1 TCCGTGTAGAGGTTACAGCCTTTTAT(AP47), mRNA/cds = (76, 1347) GCTGTTGAGCTCCCAGGTACCAAA 7169 db miningHs.4113 NM_006821 5729723 S-adenosylhomocysteine 1GCCCACTTGGATTTATAGTATAGCCC hydrolase-like 1 (AHCYL1),TTCCTCGACTCCCACCAGACTTGC mRNA/cds = (47, 1549) 7170 db mining Hs.83848NM_000991 13904865 triosephosphate isomerase 1 1AAGAGCTCCTGAGCCCCCTGCCCCC (TPI1), mRNA/cds = (34, 783)AGAGCAATAAAGTCAGCTGGCTTTC 7171 db mining Hs.5076 AK025781 10438401 cDNA:FLJ22128 fls, clone 1 GCTCAACATGGAAAGAAGGTACAGAA HEP19543/cds = UNKNOWNAGTGATGTGTTCAAAACATTAGCA 7172 db mining Hs.5298 NM_015999 7705760 CGI-45protein (LOC51094), 1 TTATATACCCTGGTCCCATCTTTCTAG mRNA/cds = (182, 1294)GGCCTGGATCTGCTTATAGAGCA 7173 db mining Hs.5473 AW953785 8143488602659798F1 cDNA, 5′ end/ 1 GTTTACTCCGTCCCTATCACTGGTGT clone = IMAGE:4802950/ GGCTGTGGGCAAACCACTTATTGC clone_end = 5′ 7174 db mining Hs.5831NM_003254 4507508 tissue inhibitor of 1 GAACTGAAGCCTGCACAGTGTCCACmetalloproteinase 1 (erythroid CCTGTTCCCACTCCCATCTTTCTTC potentiatingactivity, collagenase inhibitor) TIMP1), mRNA/cds = (62, 685) 7175 dbmining Hs.5890 BF698885 11984293 hypothetical protein FLJ23306 1GAAGACCAAGAGAGACAACAGACGC (FLJ23306), mRNA/cds = (562,AGCAAACAGCCGAAGCACCAGACAA 930) 7176 db mining Hs.6211 NM_015846 7710138methyl-CpG binding domain 1 AATTCAGAAAATTGTTGGGAGGACAG protein 1 (MBD1),transcript CCCTTTTGTGAACCTTGTTTGGGG variant 1, mRNA/cds = (139, 1956)7177 db mining Hs.6285 AL080220 5262711 mRNA; cDNA DKFZp586P0123 1TTTACCCAGCTCTGAAGGTCATTGTT (from clone DKFZp586P0123);CTTGCCTGTGTTTGAATAAAATCA partial cds/cds = (0, 1067) 7178 db miningHs.6441 AL110197 5817115 mRNA; cDNA DKFZp586J021 1GTCTCTGATGCTTTGTATCATTCTTGA (from clone DKFZp586J021)/GCAATCGCTCGGTCCGTGGACAA cds = UNKNOWN 7179 db mining Hs.6459 NM_02453113375681 hypothetical protein FLJ11856 1 GGTAAGCCCCTGAGCCTGGGACCTA(FLJ11856), mRNA/cds = (239, CATGTGGTTTGCGTAATAAAACATT 1576) 7180 dbmining Hs.6618 AL524742 12768235 AL524742 cDNA/clone = 1TCTGGCTCTGACCGGTTGATGGCCTT CS0DC008YI07-(5-prime)GAGCGAATGAAATCATGAAATTGA 7181 db mining Hs.6650 NM_007259 6005775vacuolar protein sorting 45B 1 TGCCCTACATAGCAATTTTCTGTGGC (yeasthomolog) (VPS45B), ACTGAGAAACCATGTATGACCACA mRNA/cds = (33, 1745) 7182db mining Hs.6763 NM_015310 7662395 KIAA0942 protein (KIAA0942), 1GCAGTGTACTGTGTGCAATACCAAGG mRNA/cds = (52, 1658)GCATAGCTCCCTGTAATTTGGGAA 7183 db mining Hs.6780 NM_007284 6005845protein tyrosine kinase B-like 1 CTGAGACTAGGGTCCCAGCACAGCC (AB-relatedprotein) (PTK9L), CAGAACCTTTGGCCACAAGAAGTG mRNA/cds = (104, 1153) 7184db mining Hs.6817 NM_025200 13376793 putative oncogene protein 1TCGCCTTCCATGGTTTTTAAATGCAG hlc14-06-p (HLC14-08-P), mRNA/TAAATAACATTTCTGGATGAGACT cds = (51, 635) 7185 db mining Hs.7709 U794574205083 Homo sapiens, Similar to WW 1 GCTTTACCCCCGCAGGACATACACAG domainbinding protein 1 clone GAGCCTTTGATCTCATTAAAGAGA MGC: 15305 IMAGE:4309279 mRNA, complete cds/cds = (162, 971) 7186 db mining Hs.7740AF288741 14209837 oxysterol binding protein 2 1GGAATGTACCTCTCCCCAACACTGTT (OSBP2) mRNA, complete cds/TTGTTAGCGAGCACCTTTTGACCA cds = (112, 2748) 7187 db mining Hs.8108NM_(‘3)021080 10835268 disabled (Drosophila) homolog 1 1ACTCGCTCAGAAGAGGGAACTAAGC (DAB1), mRNA/cds = (785, 2426)ATTTTTGGCAACCAATGGGCAGATA 7188 db mining Hs.8109 NM_022743 12232400hypothetical protein FLJ21080 1 AGCTGTGTGAACCTCTCTTATTGGAA (FLJ21080),mRNA/cds = (127, ATTCTGTTCCGTGTTTGTGTAGGT 1236) 7189 db mining Hs.8207NM_020198 9910241 GK001 protein (GK001), mRNA/ 1AGTCCCATACATTTGGACCATGGCAG cds = (184, 1635) CTAATTTTGTAACTTAAGCATTCA7190 db mining Hs.226627 BC007375 13938462 leptin receptor short form(db) 1 CTGCCCCCTTCCTGGACTTCGTGCCT mRNA, complete cds/cds = (0, 2890TACTGAGTCTCTAAGACTTTTTCT

TABLE 8 SEQ ID Origin Unigene Locus GI Nominal Description Strand ProbeSequence 7191 db mining Hs.8768 NM_018243 8922711 hypothetical proteinFLJ10849 1 GGATAACATTTCTCATGAACCCACTG (FLJ10849), mRNA/cds = (93, 1382)CCCCTCTGCSTTTTCCTCACTGGT 7192 db mining Hs.8834 NM_006315 5454011 ringfinger protein 3 (RNF3), mRNA/ 1 CGCTTAAGAACATTGCCTCTGGGTGT cds = (114,857) CATGTGGACCAGACTTTCTGAATAG 7193 db mining Hs.9683 NM_006260 5453979protein-kinase, interferon-inducible 1 GGGTTCAATCCCTTCAGCTCAGGCG doublestranded RNA dependent GACCATTTAGATTTAAATTCCACTT inhibitor (PRKRI),mRNA/ cds = (690, 2204) 7194 db mining Hs.9825 NM_016062 7706342 CGI-128protein (LOC51647), mRNA/ 1 GCTCCTGCCAGGGCTGTTACCGTTGT cds = (35, 526)TTTCTTGAATCACTCACAATGAGA 7195 db mining Hs.10590 AL031685 9368423 DNAsequence from clone RP5- 1 AATCTGGCGAAACCTTCGTTTGAGGG 963K23 onchromosome 20q13.11- ACTGATGTGAGTGTATGTCCACCT 13.2 Contains a KRT18(Keratin type 1, Cylosketetal 18 (Cytokeratin 18, CK18, CYK18),pseudogene, a gene for a novel protein, the gene for spermatogenesisassociated protein PD1 (KIAA0757) and the 3′ end of the gene forKIAA0939 (novel Sodium/hydrogen exchanger family member). Contains ESTs,STSs, GSSs and four putative CpG islands/ cds = (2, 688) 7196 db miningHs.11485 NM_004832 4758483 glutathions-S transferase like: 1GACTATGGGCTCTGAAGGGGGCAGG glutathione transferase omegaAGTCAGCAATAAAGCTATGTCTGAT (GSTTLp28), mRNA/cds = (9, 734) 7197 db miningHs.11538 NM_005720 5031600 actin related protein 2/3 complex, 1AGGGAGGGGACAGATGGGGAGCTTT subunit 1A (41 kD) (ARPC18), mRNA/TCTTACCTATTCAACGAATACGTGC cds = (80, 1198) 7198 db mining Hs.12707AK023168 10434970 cDNA FLJ13106 fis, clone 1 ACCTTCTGAAAGCTCACAGTACACATNT2RP3002455, highly similar to TAGTATGTATAACTGGCTTTACCA mRNA forKIAA0678 protein/ cds = UNKNOWN 7199 db mining Hs.12785 AL031685 9368423DNA sequence from clone RP5- 1 TTTAAGGGAGTCAGGAATAGATGTAT 963K23 onchromosome 20q1311- GAACAGTCGTGTCACTGGATGCCT 13.2 Contains a KRT18(Keratin type 1, Cytoskeletal 18 (Cytokeratin 18, CK18, CYK18))pseudogene, a gene for a novel protein, the gene for spermatogenesisassociated protein PD1 (KIAA0757) and the 3′ end of the gene forKIAA0939 (novel Sodium/hydrogen exchanger family member). Contains ESTs,STSs, GSSs and four putative CpG islands/ cds = (0, 1313) 7200 db miningHs.13323 NM_022752 12232416 hypothetical protein FLJ22059 1CCCACCTTCCACCTCTTAGCACTGGT (FLJ22059), mRNA/cds = (783, 1967)GACCCCAAAAATGAAACCATCAAT 7201 db mining Hs.13659 AL080209 5262698Hypothetical protein DKFZp586F2423 1 AGACCAGCAGTGTTTAAATCTAAATACGTTGTGAGTCTGTTATCTGTCCT 7202 db mining Hs.14089 NM_013379 7019510dipeptidyl peptidase 7 (DPP7), mRNA/ 1 ACCTCGACCTCAGAGCCTCCCACCC cds =(0, 1478) AGAAGATCCTGCTTCCGTGGTTGAG 7203 db mining Hs.16488 NM_0043435921996 calreticulin (CALR), mRNA/ 1 GGGCAGTGGGTCCCACATTGGCTCA cds =(88, 1321) CACTGAGAATGTAAGAACTACAAAC 7204 db mining Hs.16580 NM_0183038922829 hypothetical protein FLJ11026 1 TGGCCTTAAGTTTTCTAATTCAAGCG(FLJ11026), mRNA/cds = (31, 2355) GGTTTTTGGAAAAATTTATGGTCT 7205 dbmining Hs.109438 AB028950 5689390 clone 24775 mRNA sequence/ 1TGCAGAGTTATAAGCCCCAAACAGGT cds = UNKNOWN CATGCTCCAATAAAAATGATTCTA 7206db mining Hs.18588 NM_014826 7662135 KIAA0451 gene product (KIAA0451), 1CCAAACAATGATGTGGATTCTTTTGC mRNA/cds = (1482, 2219)ACAGAAATATTTAAGGTGGGATGG 7207 db mining Hs.19575 NM_015941 7708261CGI-11 protein (LOC51606), mRNA/ 1 ACAAAAGTCAACTGTTGTCTCTTTTCA cds =(233, 1684) AACCAAATTGGGAGAATTGTTGC 7208 db mining Hs.20529 AK02546410437985 cDNA, FLJ21811 fis, clone HEP01037/ 1GCTGGGGACTCTAGCCTCTGTGTTCA cds = UNKNOWN TAAAGACATTAAGAAGTGGATGGA 7209db mining Hs.20725 NM_020963 14211539 Mov10 (Moloney leukemia virus 10,1 GGAGAATGACACATCAAGCTGCTAAC mouse) homolog (MOV10), mRNA/AATTGGGGGAAGGGGAAGGAAGAA cds = (70, 3081) 7210 db mining Hs.343590AB011104 3043587 601471579f1 cDNA, 5′ end/ 1 ACCTGGGTTTAATACAGCTCACATCAclone = IMAGE:3874747/clone_end = CTGAATGTTACACATGAGTTTAAA 5′ 7211 dbmining Hs.23449 NM_018842 10047119 insulin receptor tyrosine kinase 1CTTAAGGACGCCTTTGCCTGGCCCCT substrate (LOC55971), mRNA/TTATTACAGCCCAACACGGTAGGC cds = (333, 1553) 7212 db mining Hs.23990NM_017838 8923443 nucleolar protein family A, member 2 1TCCATCAGTGCCATTTCCTGTAGAAC (H/ACA small nucleolar RNPs)TAAAGGCTGTTCCAAGAATGTGGG (NOLA2), mRNA/cds = (66, 547) 7213 db miningHs.24024 NM_015376 7662333 KIAA0846 protein (KIAA0846), 1ATCTGTAAAGCACTCAGAAGGCAGCC mRNA/cds = (272, 2341)ATCCCTAGATGTTGGTTTCATGTA 7214 db mining Hs.334842 BC008330 14249901tubulin, alpha, uiquitous (K-ALPHA- 1 TGGTTAGATTGTTTTCACTTGGTGAT 1),mRNA/cds = (67, 1422) CATGTCTTTTCCATGTGTACCTGT 7215 db mining Hs.24641AK022982 10434687 cDNA FLJ12920 fis, clone 1 CATGTCCCTTGAAACATGATAGTTACNT2RP2004594/cds = (96, 2144) ATACACAGTTTTCTCTCCACACAT 7216 db miningHs.321105 NM_016462 7661683 cDNA: FLJ21737 fis, clone COLF3396/ 1AGGTTTCACATGAACCTGTTCTAGGC cds = UNKNOWN TGTGGACATTGGTGTGGAGAGGTT 7217db mining Hs.26802 NM_021158 11056039 protein kinase domains containing1 GACACTTGGGGTCCACAATCCCAGG protein similar to phosphoproteinTCCATACTCTAGGTTTTGGATACCA C8FW (LOC57761), mRNA/ cds = (294, 1370) 7218db mining Hs.26892 NM_018456 8922098 uncharacterized bone marrow protein1 AGAAATGATTTGCAGCTGAGTGAATC BM040 (BM040), mRNA/AGGAAGTGACAGTGATGACTGAAG cds = (257, 749) 7219 db mining Hs.27076NM_003729 4506588 RNA 3′-terminal phosphate cyclase 1TCCTGAGAGATGGACAATGAAATATC (RPC), mRNA/cds = (170, 1270)AGTTGGTGGATATGTGTGATAGCT 7220 db mining Hs.27445 NM_018209 7706428unknown (LOC51693), mRNA/ 1 CTTTCAGGGCAGGCAGCTGTGCATG cds = (58, 480)TTCTCTCAACTAAAGGTCTTGTGAG 7221 db mining Hs.27633 NM_015456 7661663DKFZP586B0519 protein 1 GCTGGACACACGGTGAGATTTTCTCG (DKFZP586B0519),mRNA/ TATGTAAATAAAAGGCAATTTGGT cds = (75, 1199) 7222 db mining Hs.28310BG260891 12770707 602372491F1 cDNA, 5′ end/ 1 CTCAACGAAAGGCTCACACTAACAGGclone = IMAGE:4480510/clone_end = GGAGGATTACAGCACCACAATACT 5′ 7223 dbmining Hs.28914 NM_000485 4502170 adenine phosphoribosyltransferase 1CCACACTGAACCCAATTACACACAGC (APRT), mRNA/cds = (71, 613)GGGAGAACGCAGTAAACAGCTTTC 7224 db mining Hs.29893 AL133426 6562628 mRNAfull length insert cDNA clone 1 AGGCCCTGGAAAATTTTGTGCTTCCA EUROIMAGE146397/ ACGTGGCCTTCAATTCTTGCTTTT cds = UNKNOWN 7225 db mining Hs.30120BF970068 12337281 802272333F1 cDAN, 5′ end/ 1 TATTAAGCTTGCCCAGGCTCCTGTTCclone = IMAGE:4360233/clone_end = ATGAAGGTTCCCCCAGCGGTGGCC 5′ 7226 dbmining Hs.30250 AF055376 3335147 short form transcription factor C-MAF 1GCTATACCACTGACTGTATTGAAAAC (c-mal) mRNA, complete cds/CAAAGTATTAAGAGGGGAAACGCC cds = (807, 1926) 7227 db mining Hs.30443AL138599 13276598 mRNA: cDNA DKFZp564G1816 (from 1TCGGGGTCAGTTAAGCCTCAGTATTC clone DKFZp5864G1816); completeTTAGCTTTTGTTGATTTTGGCACT cds/cds = (137, 3091) 7228 db mining Hs.31137NM_006504 5729992 protein tyrosine phosphatase, receptor 1ATGGTGCAAACCCTGGAACAGTATGA type, E (PTPRE), mRNA/ATTCTGCTACAAAGTGGTACAAGA cds = (51, 2153) 7229 db mining Hs.34114NM_000702 4502270 ATPase, Na+/K+ transporting, alpha 2 1AGAAGCAGCGAGTGCATGGGCTAAT (+)polypeptide (ATP1A2), mRNA/TATCATCAATCTTTATGTATTTGTT cds = (104, 3166) 7230 db mining Hs.35254NM_020119 9910221 hypothetical protein FLB6421 1GGAAATGTTGCTGTGGGGGATTCATT (FLB6421), mRNA/cds = (310, 792)GTAACTCTCCTTGTGAACTGCTCA 7231 db mining Hs.38735 BG149337 12661367nad26g06.x1 cDNA, 3 end/ 1 ATGCCAAATTCCTGACACGTGGCGTT clone =IMAGE:3365730/clone_end = TGAAAATACCATGGAACGTTTCCA 3′ 7232 db miningHs.41322 AI655467 4739446 tt13b01.x1 cDNA 3′ end/ 1ACATTCTGACTCCATCTGCGGCCTCA clone = IMAGE:2240617/clone_end =TTAAGGTGATAGAAACATACTAGG 3′ 7233 db mining Hs.42346 AY013295 11693027calcineurin-binding protein calsarcin-1 1 ATGATAATGTTGGCATCTGTGATAAAmRNA, complete cds/cds = (131, 925) CTATCAATGAGGCTCCCATCATGC 7234 dbmining Hs.42699 AW956580 8146278 EST368865 cDNA 1AGAGTCACATGTAGAAAAGCCTCCAG TATTAAGCTCCTGAATTCATTCCT 7235 db miningHs.44131 AB023191 4669591 mRNA for KIAA0974 protein, partial 1ATGGCAACAATGCTGACAGCAAGCA cds/cds = (0, 1697) GTAGATCCTCTGATTCCAATTACCA7236 db mining Hs.44441 BE295812 9179366 601176827F1 cDNA, 5′ end/ 1GGGAACCCTCATTAATTAGACAAGAA clone = IMAGE:3532039/clone_end =CACCAAGGCTATGACCACAGCAGC 5′ 7237 db mining Hs.46919 AY007155 9956067clone CDABP0095 mRNA sequence/ 1 GGCTCACCAGAGTACCCAGAAGAAT cds = UNKNOWNCAGTATGGAATTAGAGGACAGTGGC 7238 db mining Hs.56009 NM_006187 54538232′-5′-oligoadenylate synthetase 3 (100 1 ATTCCAGGCCCTCAGTCTTTGGCAAT kD)(OAS3), mRNA/cds = (34, 3297) GGCCACCCTGGTGTTGGCATATTG 7239 db miningHs.57843 W63785 1371386 zd30g09.s1 cDNA, 3′ end/ 1GCATACATAAAGGCAAAGAATGACAA clone = IMAGE:342208/clone_end = 3′AAGGCTTAATCCACCTAGAAGACA 7240 db mining Hs.58373 BF339746 11286202602034942F1 cDNA, 5′ end/ 1 ATATAGTGGGAGACAAAACACAGGAG clone =IMAGE:4182851/clone_end = GCGGGGGATATCATGTAGCAGAGC 5′ 7241 db miningHs.59238 NM_032139 14149802 hypothetical protien DKFZp434L0718 1TCTAATGTGCCTTGGATATGTGCCAA (DKFZP434L0718), mRNA/ATGATGGAMAGAAACAGTAAACT cds = (133, 3285) 7242 db mining Hs.62406NM_024660 13375912 hypothetical protein FLJ22573 1GCTTGGCTCATCTGGGGTTTGCTGG (FLJ22573), mRNA/cds = (99, 1166)GCTTAACACCCAATAAAGAACTTTG 7243 db mining Hs.63042 NM_018457 8922158DKFZp564J157 protein 1 CTGCGGTTTTGGAACCTTACCTCTCC (DKFZP564J157), mRNA/TCCTTAGCCCAATATGCTGTCTTG cds = (77, 523) 7244 db mining Hs.65648NM_005105 4826971 RNA binding motif protein 8A 1TCCAGGCCATTTTGCAGGGACTCTGA (RBM8A), mRNA/cds = (12, 536)AGTGACCTTTAGTAGTAATAGTCT 7245 db mining Hs.339868 NM_003974 4503356oh47h10s1 cDNA, 3′ end/ 1 TGGCAGCCAGGAACTGAGTATGACA clone =IMAGE:1469827/clone_end = ATGTTGTACTAAAGAAAGGCCCAAA 3′ 7246 db miningHs.75056 NM_003938 4501976 adaptor-related protein complex 3, 1AGAGAGAGACATATCACGCTGCTGTC delta 1 subunit (AP3D1), mRNA/ATGATTTTGTGTCAAGATGATCCA cds = (209, 3547) 7247 db mining Hs.75082NM_001665 4502218 ras homolog gene family, member G 1CTTCTGGGGACCTTTCCTACCCCCAT (rho G) (ARHG), mRNA/cds =CAGCATCAATAAAACCTCCTGTCT (129, 704) 7248 db mining Hs.75309 NM_0019614503482 eukaryctic translation elongation factor 1TAGATGATTTCTAGCAGGCAGGAAGT 2 (EEF2), mRNA/cds = (0, 2576)CCTGTGCGGTGTCACCATGAGCAC 7249 db mining Hs.75725 NM_003584 4507356transgelin 2 (TAGLN2), mRNA/ 1 CCATGGTCTGGGGCTTGAGGAAGAT cds = (73, 672)GAGTTTGTTGATTTAAATAAAGAAT 7250 db mining Hs.75770 NM_000321 4506434retinoblastoma 1 (including 1 AGGTCAAGGGCTTACTATTTCTGGGT osteosarcoma)(RB1), mRNA/ CTTTTGCTACTAAGTTCACATTAG cds = (138, 2924) 7251 db miningHs.75790 NM_002642 4505794 phosphalidylinositol glycan, class C 1TTTCTGGGGACCTCTTGAATTACATG (PIGC), mRNA/cds = (293, 1186)CTGTAACATATGAAGTGATGTGGT 7252 db mining Hs.76057 NM_000403 9945333galactose-4-epimerase, UDP-(GALE), 1 TGGCACAAAACCTCCTCCTCCCAGGC mRNA/cds= (76, 1122) ACTCATTTATATTGCTCTGAAAGA 7253 db mining Hs.76662 NM_03232714150105 hypothetical protein MGC2993 1 TGAGGTCACTGCCACTTCTCACATGC(MGC2993), mRNA/cds = (158, 1048) TGCTTAAGGGAGCACAAATAAAGG 7254 dbmining Hs.77266 NM_002826 13325074 quiescin Q6 (QSCN6), mRNA/ 1CACGCTACCCCCTGCCTTGGGAGGT cds = (75, 2318) GTGTGGAATAAATTATTTTTGTTAA7255 db mining Hs.77290 NM_006755 5803186 transaldolase 1 (TALDO1),mRNA/ 1 AATGCAGAGAATGGAAAGTAGCGCAT cds = (50, 1063)CCCTGAGGCTGGACTCCAGATCTG 7256 db mining Hs.77805 NM_001696 4502316ATPase, H+ transporting, lysosomal 1 GTGGCACACCACTCCTTCCAGCAGTA(vacuolar proton pump) 31 kD GTCGCTTTACTGTTACCTGTTTAG (ATP6E), mRNA/cds= (75, 755) 7257 db mining Hs.78592 NM_001414 4503502 eukaryotictranslation initiation factor 1 AGCAACAGTATTCTGCATGGTTCACT 2b, subunit 1(alpha, 26 kD) (EIF281), GCTTAAGAAAATGCCTTCTGGAAT mRNA/cds = (10, 927)7258 db mining Hs.78605 BC006159 13544048 Homo sapiens, cloneIMAGE:3635549, 1 AAACATGTCCCTGGAGAGTAGCCTGC mRNA, partial cds/cds = (0,891) TCCCACACTGTCACTGGATGTCAT 7259 db mining Hs.78890 AF171938 5852969NUMB isoform 1 (NUMB) mRNA, 1 CAGTTGCAGCCTCTTGACCTCGGATA completecds/cds = (270, 2225) ACAATAAGAGAGCTCATCTCATTT 7260 db mining Hs.79150NM_006430 5453604 chaperonin containing TCP1, subunit 4 1TGGGCTTGGTCTTCCAGTTGGCATTT (delta) (CCT4), mRNA/cds = (0, 1619)GCCTGAAGTTGTATTGAAACAATT 7261 db mining Hs.79259 NM_016404 7705476hypothetical protein (HSPC152), 1 TTCTGCCGTGTGTATCCCCAACCCTT mRNA/cds =(35, 412) GACCCAATGACACCAAACACAGTG 7262 db mining Hs.79358 NM_0067625803055 Lysosomal-associated multispanning 1 TGTGTGCGACAGGGAGGAAGTTTCAmembrane protein-5 (LAPTM5), ATAAAGCAACAACAAGCTTCAAGGA mRNA/cds = (75,863) 7263 db mining Hs.79572 NM_001909 4503142 cathepsin D (lysosomalaspartyl 1 CTCCCCTTGGGCGGCTGAGAGCCCC protease) (CTSD), mRNA/AGCTGACATGGAAATACAGTTGTTG cds = (2, 1240) 7264 db mining Hs.81337NM_009587 6806889 lectin, galactoside-binding, soluble, 9 1CTCCACCACCTGACCAGAGTGTTCTC (galectin 9) (LGALS9), transcriptTTCAGAGGACTGGCTCCTTTCCCA variant long, mRNA/cds = (56, 1123) 7265 dbmining Hs.82030 NM_004184 7710155 tryptophanyl-tRNA synthetase 1CTCTGCCCTCCTGTCACCCAGTAGAG (WARS), mRNA/cds = (187, 1502)TAAATAAACTTCCTTGGCTCCTAA 7266 db mining Hs.82396 NM_016816 80516202′,5′-oligoadenylate synthetase 1 (40- 1 AAATTCCAGCCTTGACTTTCTTCTGT 48kD) (OAS1), transcript variant E18, GGACCTGATGGGAGGGTAATGTCT mRNA/cds =(33, 1235) 7267 db mining Hs.82933 BC008739 14250568 Homo sapiens,protein x 013, clone 1 CTGTAGGCCAGGGTGGAATGAAGTC MGC:3073 IMAGE:3346340,mRNA, AGCTCCTTTTTATAGTTGAAATACA complete cds/cds = (101, 325) 7268 dbmining Hs.83753 NM_003091 4507124 small nuclear ribonucleoprotein 1TTGGCGGGCCATCCCAACAGGTGAT polypeptides B and B1 (SNRPB),GACCCCACAAGGAAGAGGTACTGTT mRNA/cds = (0, 695) 7269 db mining Hs.85838NM_004207 4759111 solute carrier family 16 1 GGAAGATGGAAATAAACCTGCGTGTG(monocarboxylic acid transporters), GGTGGAGTGTTCTCGTGCCGAATT member 3(SLC18A3), mRNA/ cds = (62, 1459) 7270 db mining Hs.306586 NM_0133419558756 clone HQ0688/cds = UNKNOWN 1 AGTGAGGACAATGTGGGTTGCTCCTTTTTGAATCTACAGATAATGCATGT 7271 db mining Hs.89497 NM_005573 5031876 laminB1 (LMNB1), mRNA 1 GAGGGTGGGGGAGGGAGGTGGAGG GAGGGAAGGGTTTCTCTATTAAAATG7272 db mining Hs.89525 NM_004494 4758515 heptoma-derived growth factor(high- 1 TGCTGACTGTAGCTTTGGAAGTTTAG mobility group protein 1-like)(HDGF), CTCTGAGAACCGTAGATGATTTCA mRNA/cds = (315, 1037) 7273 db miningHs.92208 NM_003815 11497001 a disintegrin and metalloproteinase 1GATTGAGGAAGGTCCGCACAGCCTG domain 15 (metargidin) (ADAM15),TCTCTGCTCAGTTGCAATAAACGTG mRNA/cds = (7, 2451) 7274 db mining Hs.103527NM_003975 4503632 SH2 domain protein 2A (SH2D2A), 1GATTCTTGTCTGGCTAATAAATCATCA mRNA/cds = (88, 1255)CCAACTGCCTTCTGCTACAGGGA 7275 db mining Hs.104679 BF347382 11294957 Homosapiens, clone MGC:18216 1 AGATTCTTAGGGCACGTTTGTTCCCC IMAGE:4156235,mRNA, complete TTGGAGGGTTTTCCACACGGAGTC cds/cds = (2208, 2373) 7276 dbmining Hs.105749 AB011125 3043629 mRNA for KIAA0553 protein, partial 1GCCATACTCTGGCTGCCTCTTTGCCT cds/cds = (0, 3289) TCCTAGGGGCATTTTCTTTAACTT7277 db mining Hs.105751 AL138761 8573811 DNA sequence from clone RO11-1 TGCCTCTTATCTACTTGAGAGCAACA 16H23 on chromosome 10. ContainsTGTCTTTTCAATCATGGGATTGAC the gene KIAA0204 (HSLK) for a protein kinase,the COL17A1 gene for collagen type XVII alpha 1 (BP180), ESTs andGSSs/cds = (0, 3557) 7278 db mining Hs.324406 AK026741 10439662ribosonal protein L41 (RPL41), mRNA/ 1 TGGACCTGTGACATTCTGGACTATTT cds =(83, 180) CTGTGTTTATTTGTGGGCGAGTGT 7279 db mining Hs.108371 NM_00195012669914 E2F transcription factor 4, p107/p130- 1TGAAGGTGTCTGTGACCTCTTTGATG binding (E2F4), mRNA/cds =TGCCTGTTCTCAACCTCTGACTGA (62, 1303) 7280 db mining Hs.109760 NM_0024914505360 NADH dehydrogenase (ubiquinone) 1 1 CCTGGAGTCCCTGAATAAAGATAAGAbeta subcomplex, 3 (12 kD, B12) AGCATCACTGAAGATAATACCTGG (NDUFB3),mRNA/cds = (252, 548) 7281 db mining Hs.109857 AF151783 14248494 MEG3(MEG3) mRNA, complete cds/ 1 TTGTCCCGAAGATTTGCGCCTTTAGT cds = (52, 2253)7282 db mining Hs.306417 NM_014714 7662193 cDNA FLJ10935 fis, clone 1CTGCTAGGTCTGCCCACCGGCCAC OVARC1000661/cds = (250, 938)CAACACTCCTGTAATTCCAATAAAG 7283 db mining Hs.114199 BG621594 13672965602617003F1 cDNA, 5′ end/ 1 TTAAAATACTGTCATTGGTTGGGAGG clone =IMAGE:4730858/clone_end = GGATTGCATTAAATGATTAGTCCA 5′ 7284 db miningHs.118786 BF131637 10970677 601820457F1 cDNA, 5′ end/ 1CTCACACACGCAGGCGACAGTCAGA clone = IMAGE:4052246/clone_end =ACAAACAGGAACAAAGCTACAACAC 5′ 7285 db mining Hs.122559 NM_024872 13376307hypothetical protein FLJ22570 1 TGAATAGTGTGCAGACTCACAGATAA (FLJ22570),mRNA/cds = (0, 1490) TAAAGCTCAGAGCAGCTCCCGGCA 7286 db mining Hs.123373AW963279 8153115 602853825F1 cDNA, 5′ end/ 1 CCCAGTGCTTCACGGAGTTAAAGGAAclone = IMAGE:4994982/clone_end = AGATCTGCTGGTAGTGTTTAGTCT 5′ 7287 dbmining Hs.125078 AF090094 4063829 clone IMAGE 172979/ 1CGAGCCGACCATGTCTTCATTTGCTT cds = UNKNOWN CCACAAGAACCGCGAGGACAGAGC 7288db mining Hs.130740 AK000315 7020316 cDNA FLJ20308 fis, clone HEP07264/1 TTTTCCCCCTTTAGTCTCCTGGCTTTT cds = (90, 1226) TCCTTTCCCTTCCCTTCTCCACT7289 db mining Hs.132955 AL132665 6137021 mRNA; cDNA DKFZp566E034 (from1 AACCCGTTGTGGAGATTATTGGAATT clone DKFZp586E034); complete cds/AACTGAGCCAAAGTGATTATGCAT cds = UNKNOWN 7290 db mining Hs.133230 BC00008512652672 Homo sapiens, ribosomal protein S15, 1GCCCCCGATCCTACACCCTGAGCCT clone MGC:2295 IMAGE:3507983,CAGAGCACTGCTACTTTTTAAAATA mRNA, complete cds/cds = (14, 451) 7291 dbmining Hs.142677 AK024108 10436406 cDNA FLJ14046 fis, clone 1AAGCGTCTCATGGAGTTCGGACTGGT HEMBA1006461/cds = UNKNOWNTGGGGTGATAATATTTGTTTCTTT 7292 db mining Hs.146170 NM_022842 12383093hypothetical protein FLJ22969 1 AAGCCAGGCTTTGGGATACAAGTTCT (FLJ22969),mRNA/cds = (274, 2223) TTCCTCTTCATTTGATGCCGTGCA 7293 db mining Hs.148550Z82215 3135984 DNA sequence from clone RP1-68O2 1AGCTGTCACCACTACAGTAAGCTGGT on chromosome 22 Contains the 5′ endTTACAGATGTTTTCCACTGAGCAT of the APOL2 gene for apolipoprotein L 2, theAPOL gene for apolipoprotein L, the MYH9 gene for nonmuscle type myosinheavy chain 9, ESTs, STSs and GSSs/cds = (0, 5882) 7294 db miningHs.149846 NM_002213 4504772 integrin, beta 5 (ITGB5), mRNA/ 1TGAAGGTACATCGTTTGCAAATGTGA cds = (29, 2419) GTTTCCTCTCCTGTCCGTGTTTGT7295 db mining Hs.151738 NM_004994 4828835 matrix metalloproteinase 9(gelatinase 1 GGATACAAACTGGTATTCTGTTCTGG B, 92 kD gelatinase, 92 kD typeIV AGGAAAGGGAGGAGTGGAGGTGGG collaenase) (MMP9), mRNA/ cds = (19, 2142)7296 db mining Hs.336451 NM_024519 13375657 Nucleoside disphosphatekinase type 6 1 CTGCCGCTGCCCAGCCACATCCCTT (inhibito of p53-inducedapoptosis- GGTTTTGTATTTTATTTACAGAGTT alpha) 7297 db mining Hs.154276NM_001186 4502352 BTB and CNC homology 1, basic 1TGCAGTAGACGATACAGGTTGCATGT leucine zipper transcription factor 1GGACACTCAGTCACATTAACAACT (BACH1), mRNA/cds = (118, 2328) 7298 db miningHs.155975 NM_005608 5032004 protein tyrosine phosphatase, receptor 1CCCCAACCACAGGCATCAGGCAACC type, C-associated proteinATTTGAAATAAAACTCCTTCAGCCT (PTPRCAP), mRNA/cds = (63, 683) 7299 db miningHs.159410 NM_014484 7657338 molybdopterin synthase sulfurylase 1GTACTGAGGTGACTGGTATAGTCTGA (MOCS3), mRNA/cds = (2, 1384)TGAGAAAGATGTGGATTGCCATAA 7300 db mining Hs.160999 AV648418 9869432AV648418 cDNA, 3′ end/ 1 CACTTGTTCAATCATGGAACTTTCTA clone =GLCBJC04/clone_end = 3′ GAACGCTGCCACTCTTCAAAGGCT 7301 db miningHs.164036 NM_002078 4504060 glucosamine (N-acetyl)-8-sulfatase 1TCATCACAGTGTGGTAAGGTTGCAAA (Sanfilippo disease IIID) (GNS),TTCAAAACATGTCACCCAAGCTCT mRNA/cds = (87, 1745) 7302 db mining Hs.164478NM_022461 11988002 hypothetical protein FLJ21939 similar 1ACAACCTGATCATTGAAGCCAACTTT to 5-azacytidine induced gene 2GTCCCAGCACATTCCTTAAGTCCT (FLJ21939), mRNA/cds = (379, 1557) 7303 dbmining Hs.169615 NM_023080 12751496 hypothetical protein FLJ20989 1ACTTGATTAGGCTCCGGTTTTCCTTT (FLJ20989), mRNA/cds = (52, 741)GGCTTCTGCTTTTCAGTGAATGGC 7304 db mining Hs.171811 AK023758 10435787 cDNAFLJ13696 fis, clone 1 TTGCAGACAAATTCCTCTGAGCTTAG PLACE2000140/cds =UNKNOWN CTAGGAGTTCATTATGCTTCCTGT 7305 db mining Hs.171992 NM_0028434506314 protein tyrosine phosphatase, receptor 1ACAGTAGCTTAGCATCAGAGGTTTGC type, J (PTPRJ), mRNA/TTCCTCAGTAACATTTCTGTTCTC cds = (349, 4362) 7306 db mining Hs.173373AB023148 4589505 mRNA for KIAA0931 protein, partial 1ATGTGAGCCAGAGCATGTTGCAGCAA cds/cds = (0, 2204) ATCTATTGTTTGTAAAAATAACAA7307 db mining Hs.173638 NM_030756 13540470 transcription factor 7-like2 (T-cell 1 TTTGTGCCATGTGGCTACATTAGTTG specific, HMG-box) (TCF7L2),mRNA/ ATGTTTATCGAGTTCATTGGTCAA cds = (307, 2097) 7308 db miningHs.177534 NM_007207 13518225 dual specificity phosphatase 10 1AGCCCAACCATTAAAAATTTAATACAA (DUSP10), mRNA/cds = (142, 1590)CTTGGTTTCTCCCCCTTTTTCCT 7309 db mining Hs.177592 NM_001003 4506668602791378F1 cDNA, 5′ end/ 1 GCAAAGAAAGAAGAATCCGAGGAGT clone =IMAGE:4896908/clone_end = CTGATGATGACATGGGCTTTGGTCT 5′ 7310 db miningHs.179661 BC008791 14250651 Homo sapiens, tubulin, beta5, clone 1TTGAAAAGATGACATCGCCCCAAGAG MGC:4029 IMGAE:3817988, mRNA,CCAAAAATAAATGGGAATTGAAAA complete cds/cds = (1705, 3039) 7311 db miningHs.179988 NM_005803 6552331 flotilin 1 (FLOT1), mRNA/ 1TTTTCCTGACCAAGACTGAGGGATGG cds = (164, 1447) GCTGGAGGTTTTCAACTTTGCCTAC7312 db mining Hs.180859 NM_016139 7705850 16.7 Kd protein (LOC51142),mRNA/ 1 TCTGGGACTGGGCAAATGTTTGTGTG cds = (81, 536)GCCTCCTTAAACTAGCTGTTATGT 7313 db mining Hs.181301 AK024855 10437263cDNA; FLJ21202 fis, clone COL00293/ 1 AACCTAAACGTATTTCACTAACTCTG cds =UNKNOWN GCTCCTTCTCCATAAAGCACATTT 7314 db mining Hs.181311 NM_0045397262387 asparaginyl-tRNA synthetase (NARS), 1 CCACCAAATGCATGTCATGTATTCTCmRNA/cds = (73, 1719) AATAGGCTGTATTCCCAGCAGTCA 7315 db mining Hs.181391AL390158 9388848 mRNA; cDNA DKFZp781G2113 (from 1TGTACAGGTAGCTAACTTTGTAAACG clone DKFZp781G2113)/cds = (0, 564)CTCTGTATTCCCTCTGCCCCCATG 7316 db mining Hs.182281 NM_016407 7705482hypothetical protein (HSPC164), 1 TCTCATCATTTCGAAGATAGCAGAGT mRNA/cds =(70, 990) CATAGTTGGGCACCCAGTGATTGG 7317 db mining Hs.183180 NM_01647613324711 anaphase promoting complex subunit 1 CAACAAGGTGGAAACAAGGGGTGGA11 (yeast APC11 homolog) GCTGCGTTTGTTTTGCCATCACTAT (ANAPC11), mRNA/cds =(0, 398) 7318 db mining Hs.183593 NM_006965 5902161 zinc finger protein24 (KOX 17) 1 GAGCATTCCTCAGGGGAGGTCACCT (ZNF24), mRNA/cds = (164, 1270)GTGAGGTTCCCAGAACTGTAGTTTT 7319 db mining Hs.184029 AL137509 6808164 Homosapiens, clone MGC:2764 1 TGCAGGTGTTGACAAGATCCGCCATC IMAGE:2958229,mRNA, complete TGTAATGTCCTTGGCACAATAAAA cds/cds = (70, 1785) 7320 dbmining Hs.187652 AA833892 2907491 od84g04.s1 cDNA/ 1AAGAGTCTGACTTCTCACTAGGAGCA clone = IMAGE:1372758TGTCTGTTGTACTTACTTCAAACA 7321 db mining Hs.188751 BG111636 1260514260228268F1 cDNA, 5′ end/ 1 CAAACACCAAACCAAGATAACACCGG clone =IMAGE:4369892/clone_end = AACGATAAACAGCAGAAACAGAGA 5′ 7322 db miningHs.193392 U46120 1164779 expressed unknown mRNA/ 1TGGGTTTGTCCAGTTCAGGCTAGATG cds = UNKNOWN TGCATCATGGCAGGAAGAAAGAAG 7323db mining Hs.195453 NM_001030 4506710 ribosomal protein S27 1AAGGATGTTCCTTCAGGAGGAAGCA (metallopanstimulin 1) (RPS27),GCACTAAAAGCACTCTGAGTCAAGA mRNA/cds = (35, 289) 7324 db mining Hs.196914D86978 1504025 mRNA for KIAA0223 gene, partial cds/ 1CGGAAGCCACCGTGTGGTTCTTTCAC cds = (0, 3498) AGGCACGTTTATTTTGCTGAAATA 7325db mining Hs.198281 NM_002654 4505838 pyruvate kinase, muscle (PKM2), 1CCTCCACTCAGCTGTCCTGCAGCCAA mRNA/cds = (109, 1704)CACTCCACCCTCCACCTTCCATTT 7326 db mining Hs.200317 AB037825 7243188 mRNAfor KIAA1404 protein, partial 1 TCCCTCCTTCCAGTGTTCCTTAGAAC cds/cds =(64, 5841) AGACATTTAGGTATCTCAGGTCCT 7327 db mining Hs.202613 BG28426213035032 802407238F1 cDNA, 5′ end/ 1 CAGCCGCAGCATCTAAACGAACAACA clone =IMAGE:4519449/clone_end = GAGGAGAACGACGAGGACAGAGTT 5′ 7328 db miningHs.210778 AL136679 12052881 mRNA; cDNA DKFZp584C1278 (from 1TCACTGGATTTCTGTGTCTTCACTAG clone DKFZp584C1278); complete cds/AACACCATTGTCATCTCATATTGA cds = (104, 1690) 7329 db mining Hs.211594NM_006503 5729990 proteasome (prosome, macropain) 1GCTTCTCTCGCACCCCCAGCACCTCT 28S subunit, ATPase, 4 (PSMC4),GTCCCAAAACCTCATTCCCTTTTT mRNA/cds = (12, 1268) 7330 db mining Hs.226307NM_004900 4758159 phorbolin (similar to apolipoprotein B 1AGCTGCTCACAGACACCAGCACAGC mRNA editing protein) (DJ742C19.2),AATGTGCTCCTGATCAAGTAGATTT mRNA/cds = (79, 651) 7331 db mining Hs.326048NM_008319 5453905 cDNA FLJ14188 fis, clone 1 ATGCTCATGTGGTGTCCCCACCGCCNT2RP2005726/cds = UNKNOWN CACTTGTTTGATGTCACTGACTGTC 7332 db miningHs.227835 NM_014972 14149656 KIAA1049 protein (KIAA1049), 1GCTGAGTGTGTCGCTCCCTGGTCCA mRNA/cds = (96, 2126)CTGTTTCTCCTATAAATGTAAATGG 7333 db mining Hs.231967 NM_014423 7656878 ALL1 fused gene from 5q31 1 TGCAGCACATTGATAAGATGGTTTCC (AF5Q31), mRNA/cds =(337, 3828) GTGAGCTATGATAAGATTGAAATT 7334 db mining Hs.232400 NM_03124314043071 heterogeneous nuclear 1 ATAAATATGCAGTGATATGGCAGAAGribonucleoprotein A2/B1 (HNRPA2B1), ACACCAGAGCAGATGCAGAGAGCC transcriptvariant B1, mRNA/ cds = (169, 1230) 7335 db mining Hs.236131 NM_02274013430859 homeodomain-interacting protein 1 TTGAACCGGGGAGTGGGAGGACGTAkinase 2 (HIPK2), mRNA/ GAGCAGAGAAGAGAACATTTTTAAA cds = (108, 3704) 7338db mining Hs.343558 AF090896 6690168 clone HQ0131 PRO0131 mRNA, 1TTTGCTCATTCTAAACTCAAGCTTTTA partial cds/cds = (0, 233)AGCCTCACAGGATTTACAGGGGT 7337 db mining Hs.238936 BG538032 13530264602563534F1 cDNA, 5′ end/ 1 GCCATAGGCTTACATGGGGCATACTC clone =IMAGE:4688193/clone_end = 5′ 7338 db mining Hs.241412 NM_030882 13582089apolipoprotein L, 2 (APOL2), mRNA/ 1 GGTCTCTCGCTCTGTCTTTCCAGCAT cds =(477, 1490) CCACTCTCCCTTGTCCTTCTGGGG 7339 db mining Hs.241471 AL1336426599293 mRNA; cDNA DKFZp58BG1721 (from 1 TCAGCACCAAGTCATGTTTAAAAGACclone DKFZp586G1721); partial cds/ CAGAGAGACAAGCATTTTGCCAAG cds = (0,669) 7340 db mining Hs.245188 NM_000362 9257248 tissue inhibitor ofmetalloproteinase 3 1 CGAACCCTGTCTAGAAGGAATGTATT (Sorsby fundusdystrophy, TGTTGCTAAATTTCGTAGCACTGT pseudoinflammatory) (TIMP3), mRNA/cds = (1183, 1818) 7341 db mining Hs.249170 NM_012476 7110734 ventralanterior homeobox 2 (VAX2), 1 CAAATGGCCTTGGTCCCGCAGCTTGT mRNA/cds = (32,904) GTGCGTGAGTGCAGTGTGAGTGTG 7342 db mining Hs.258551 NM_012100 6912247aspartyl aminopeptidase (DNPEP), 1 CTCTTGGAAAGACTTCTCTCCCATCC mRNA/cds =(151, 1578) CTTTGCACCTGAGAGGGGAAGTTC 7343 db mining Hs.259412 BG77237614083029 602722490F1 cDNA, 5′ end/ 1 GGCGCGGTGACCCACTTATGGGACT clone =IMAGE:4839143/clone_end = TGGCCTTTCTTTGTTGTTTGTTTAA 5′ 7344 db miningHs.259577 AW665292 7457838 hj02c11.x1 cDNA, 3′ end/ 1ACCCAGTTCATGATTACTTCTACTCTT clone = IMAGE:2980628/clone_end =AACACTCAATCCCCCTAATTAAACC 3′ 7345 db mining Hs.259679 AW956608 8146291EST388878 cDNA 1 TTCGATAAACAGCGTTGACTTGCTTG TACCACTTAAGAGTTGTGAGTGCT7346 db mining Hs.265827 NM_022873 13259549 interferon, alpha-inducibleprotein 1 TCCAGAACTTTGTCTATCACTCTCCC (clone IFI-6-16) (G1P3), transcriptCAACAACCTAGATGTGAAAACAGA variant 3, mRNA/cds = (107, 523) 7347 db miningHs.265891 AK001503 7022798 cDNA FLJ10641 fis, clone 1GGGATCTTTCAAATGGATAGTGAGTT NT2RP2005748/cds = UNKNOWNGCCTTTTCCTATAGGTGACAATCA 7348 db mining Hs.266456 AW768893 7700715hk65e11.x1 cDNA, 3′ end/ 1 AGAGCAAGCATTACAGAAAATAGGTC clone =IMAGE:3001580/clone_end = TGGAAGACAGGAAAAGGACAAAGA 3′ 7349 db miningHs.267368 NM_017842 8923451 hypothetical protein FLJ20489 1ATGTGTCCTGCCCCTCAGCTCTTTGC (FLJ20489), mRNA/cds = (482, 1201)CTTATCTGTGTCACTGTCACTTTA 7350 db mining Hs.267812 NM_003794 4507144sorting nexin 4 (SNX4), mRNA/ 1 TCCTGTGAATTGAATTTCTCTTCAATC cds = (0,1352) AAAGTGCCCCAAACAGAAGCACA 7351 db mining Hs.272027 NM_012177 6912365F-box only protein 5 (FBXO5), mRAN/ 1 AGGTCCCCTGCCTGGTACAAAGAAAA cds =(61, 1404) GCAAAAAGAATTTACGAAGATTGT 7352 ob mining Hs.272534 AL0800685262475 mRNA; cDNA DKFZp584J082 (from 1 GCCAGAAGCATAATTTACCAGAGACG cloneDKFZp564J082)/ AGAACAGGGTGTGGGAGAGAGGAA cds = UNKNOWN 7353 db miningHs.273415 NM_000034 4557304 aldolase A, fructose-bisphosphate 1TCTTTCTTCCCTCGTGACAGTGGTG (ALDOA), mRNA/cds = (187, 1261)GTGGTGTCGTCTGTGAATGCTAAG 7354 db mining Hs.273830 AK022804 10434416 cDNAFLJ12742 fis, clone 1 CAGTCAAACATTTTACCTTGTGCCTT NT2RP2000844/cds =UNKNOWN GGGTCACTCTGTGCCTTTTCTCCA 7355 db mining Hs.274287 AK0015087022805 cDNA FLJ10648 fis, clone 1 ACAGGAAACGGGCTTTCTCTGAATTGNT2RP2005773, highly similar to GTAAATGGGAAAGAAGTGAGCAAC pyrroline5-carboxylate reductase isoform mRNA/cds = UNKNOWN 7356 db miningHs.275163 NM_002512 4505408 non-metastalic cells 2, protein 1GTCCCTGGACACAGCTCTTCATTCCA (NM23B) expressedin (NME2), nuclearTTGACTTAGAGGCAACAGGATTGA gene encoding mitochondrial protein, mRNA/cds =(72, 530) 7357 db mining Hs.276818 AI435118 4300940 th95e09.x1 cDNA, 3′end/ 1 ACCCTCGCCACAAGATTCTGCAATCT clone = IMAGE:2126440/clone_end =CCTAAAGTACAGATGAGAAAGGAA 3′ 7358 db mining Hs.278582 AF135794 4574743AKT3 proein kinase mRNA, complete 1 TGCCAAGGGGTTAATGAAACAAATAG cds/cds =(0, 1439) CTGTTGACGTTTGCTCATTTAAGA 7359 db mining Hs.279535 AK02703510440049 cDNA; FLJ23382 fis, clone HEP16349/ 1CAGTGGCACACCTTAACCAGTCACTA cds = UNKNOWN ATTTTCACTGTTGTGAAAGTGATT 7360db mining Hs.283007 NM_006227 5453913 phospholipid transfer protein(PLTP), 1 CCCAGTGCCACAGAGAAGACGGGAT mRNA/cds = (87, 1588)TTGAAGCTGTACCCAAATTTAATTCC 7361 db mining Hs.283585 NM_005438 4885242FOS-like antigen-1 (FOSL1), mRNA/ 1 TGAGCCCTACTCCCTGCAGATGCCAC cds =(34, 849) CCTAGCCAATGTCTCCTCCCCTTC 7362 db mining Hs.284296 AK02664610439543 cDNA; FLJ22993 fis, clone KAT11914/ 1 GCAGGGAGGGGAGGATAAGTGGGATcds = UNKNOWN CTACCAATTGATTCTGGCAAAACAA 7363 db mining Hs.284892AF246229 10419514 AF246229 cDNA/clone = RB82 1GGCCACTACCTTTGTTGGAAACAAAG CATAAGGGAGTGAAAGTGTCTAAA 7364 db miningHs.284893 AF246230 10419515 AF246230 cDNA/clone = RB16 1GCTGGCCCGATCTCTCCCCACAGTT GCAAGAAGCATTTTCAAAGAATAGT 7365 db miningHs.285280 AK024885 10437298 cDNA; FLJ21232 fis, clone COL00752/ 1ATTGGGATGAAACTACTTTAGCAAAG cds = UNKNOWN TCCACAGATCAGAAACCAGACGGT 7366db mining Hs.288038 NM_006625 12056474 TLS-associated serine-arginineprotein 1 AGGAGACTGGGTCCTATAATTAGATT 1 (TASR1), mRNA/cds = (72, 623)ATTTTGAGGCAGACAGAGAGCTGT 7367 db mining Hs.288283 AK026008 10438707cDNA; FLJ22355 fis, clone HRC06344/ 1 AGCCTGCAAGGTTAGGACTTGAAGA cds =UNKNOWN GGGAAGGTATTTAATAACTGGGCGA 7368 db mining Hs.289043 AL13871912052956 mRNA; cDNA DKFZp566G0346 (from 1 TTAGTGCAGTTGGAATGAATGTGTATclone DKFZp566G0346); complete cds/ AGGTCAGAGGTCTTCGTGTTCACA cds = (278,790) 7369 db mining Hs.289087 AK024468 10440449 mRNA for FLJ00061protein, partial 1 TCACCTCTCAGTTGAAAGATTTCTTCT cds/cds = (0, 522)TTGAAAGGTCAAGACCGTGAACT 7370 db mining Hs.290494 BF475245 11544422 EST003 cDNA, 5′ end/clone_end = 5′ 1 AGTCTGGATGTAAGGCCTGCCTCAAAGAGACACTAATGGGAGGGAACAAA 7371 db mining Hs.290874 BE730505 10144599601562627F1 cDNA, 5′end/ 1 AAAGGAAGAAGCACGATGCAAACAG clone =IMAGE:3832302/clone_end = AAACAACACGACACAGAGTGAGCGA 5′ 7372 db miningHs.332403 NM_024113 13129129 hypothetical protein MGC4707 1ACTCCTTCAAGTCTTGACCCCTTTGT (MGC4707), mRNA/cds = (72, 1067)GTCTAATAGCTAAACAAACATGTG 7373 db mining Hs.292998 AW972292 8162138EST384381 cDNA 1 AACAATAGGAATAAGGTTACTTCAGC CTTAAGGGGCTTATCATACTGCTG7374 db mining Hs.293984 NM_032323 14150097 hypothetical proteinMGC13102 1 GACAGGGAAATCTGCCTACCAAGAG (MGC13102), mRNA/cds = (161, 1345)GGGTGTGTGTGTCTTTGTGCCCACA 7375 db mining Hs.295362 AK027385 14041993cDNA FLJ14459 fis, clone 1 AACAAGTCCATGACTCCCAAGGGTTT HEMBB1002409/cds =UNKNOWN AAGGACCAATGGTTCAGTGAGACA 7376 db mining Hs.297964 BF83604912187621 RC1-HT0975-161100-011-g07 cDNA 1 ACACTCATACTCATATGTACGTGCTCAGICGAACGGACTGCAGTCCGTTC 7377 db mining Hs.299329 AK000770 7021066 cDNAFLJ20763 fis, clone COL09911/ 1 TACTGCTATGGAATGAGACCACCACT cds = UNKNOWNTCTCCTGTTGTCCTTCCCAGCTTC 7378 db mining Hs.300631 AK022958 10434651 cDNAFLJ12896 fis, clone 1 TGCCAAGTGAGGACAAACTGCTAGG NT2RP2004194, weaklysimilar to CTGTATCCCATAATTTCAGGATGAG Rattus norvegicus Golgi SNARE GS15mRNA/cds = UNKNOWN 7379 db mining Hs.301417 M80899 178282 novel proteinAHNAK mRNA, partial 1 AAACCGACCGCCTGTAGGCTCCTGG sequence/cds = (0, 3835)AACTATACAGATAGGTAAAGAGTTC 7380 db mining Hs.301612 NM_005253 4885244FOS-like antigen 2 (FOSL2), mRNA/ 1 GACCAATCATCAGACTCCTTGAACTC cds = (3,983) CCCCACTCTGCTGGCTCTGTAACC 7381 db mining Hs.301636 NM_000287 4505728peroxisomal biogenesis factor 6 1 AGAGATCCAGGGCAAGTGGATTGA (PEX6),mRNA/cds = (70, 3012) GACAGCAGCAACAGCTCAAGAGATA 7382 db mining Hs.337774NM_004723 4758871 rho/rac guanine nucleotide exchange 1ATGTCCCTTTCTCCTCTCCCCTCTTC factor (GEF) 2 (ARHGEF2), mRNA/CTCTTACTGCTGTTCTCCCTTTCT cds = (112, 2988) 7383 db mining Hs.318568BF475243 11544420 EST 001 cDNA, 5′ end/clone_end = 5′ 1ACATCCATAGAACAATACATCAAAGT TGTTGAAGTGTTGCAGGGGAGGGC 7384 db miningHs.318569 BF475244 11544421 EST 002 cDNA, 5′ end/clone_end = 5′ 1AGCACTTACTGTCAGGCATTCAGAAT GTGAGCAATGACAATAATTTACCT 7385 db miningHs.321709 NM_002560 4505548 purinergic receptor P2X, ligand-gated 1AATCTGATTGAGTCTCCACTCCACAA ion channel, 4 (P2RX4), mRNA/GCACTCAGGGTTCCCCAGCAGCTC cds = (27, 1193) 7386 db mining Hs.322478D38491 559327 mRNA for KIAA0117 gene, partial cds/ 1AACCCAAGAAAAGAGTTGCTCTTACT cds = (0, 883) ATCTACTGCTGACTCTTGAACTTT 7387db mining Hs.323114 AK023846 10435906 cDNA FLJ13784 fis, clone 1TTCGTAGGTGGGCTTTTCCTATCAGA PLACE400593/cds = UNKNOWNGCTTGGCTCATAACCAAATAAAGT 7388 db mining Hs.323949 NM_002231 13259537kangai 1 (suppression of 1 AGGTGGGCTGGACTTCTACCTGCCC lumorigenicity 6,prostate; CD82 TCAAGGGTGTGTATATTGTATAGGG antigen (R2 leukocyte antigen,antigen detected by monoclonal and antibody IA4)) (KAI1), mRNA/cds =(181, 984) 7389 db mining Hs.324507 NM_024524 13375667 hypotheticalprotein FLJ02986 1 TGTGTCAGAATGGCACTAGTTCAGTT (FLJ20986), mRNA/cds =(182, 2056) TATGTCCCTTCTGATATAGTAGCT 7390 db mining Hs.326447 BC00485713436058 Homo sapiens, clone IMAGE:3690478, 1 CTATCAGCCCCAAGTGGAGCAGAACmRNA, partial cds/cds = (0, 71) AGAGGGATTTGGGAGGAATGTCCTC 7391 db miningHs.333558 BG577468 13592532 gu.seq cDNA 1 TGCTAAGGAGAGGGGCCATGAAGAGTTTTGTTGAGAACATCGTGTCTGAG 7392 db mining Hs.334303 BG642392 13777102gu.seq395250 cDNA 1 AGTCAGAACTTCAAGTCCCCATTAAA GGGGCTGGAAAATACAAGTACAGT7393 db mining Hs.334804 NM_000558 6715603 hemoglobin, alpha 1 (HBA1),mRNA/ 1 CTCCCCTTCCTGCACCCGTACCCCC cds = (37, 485)GTGGTCTTTGAATAAAGTCTGAGTG 7394 db mining Hs.334853 NM_032241 14149953hypothetical protein FLJ23544 1 CAGATGGTTGTGGGGTCAAGTACATC (FLJ23544),mRNA/cds = (125, 517) CCCAGTCGTGGCCCTTTGGACAAG 7395 db mining Hs.250655NM_032695 14249283 Prothymosin, alpha (gene sequence 1TTTTGGCCTGTTTGATGTATGTGTGA 28) AACAATGTTGTCCAACAATAAACA 7396 db miningHs.336689 AA493477 2223318 ESTs 1 AGCCTAGGTGACAGAGCAAGACTCCATTTCAAAAACAAAACAAAACAAAA 7397 db mining Hs.180450 BF791433 1206487ribosomal protein S24 (RPS24), 1 ACACTGAGAATACACGACATACACGC transciptvariant 1, mRNA/ ACGCACAAGACAACAACAGACAGC cds = (37, 429) 7398 Table 3ANA AA077131 1836605 7B08E10 Chromosome 7 Fetal Brain 1CAGCCACCTCCTCAGGTCAGACAAG cDNA Library cDNA clone 7B08E10,CCCAGCACCCAAATACCACTATCTG mRNA sequence 7399 Table 3A NA AA5017252236692 ng18e12.s1 NCI_CGAP_Lip2 cDNA 1 GGCTTCCCTATTACCTCCCAGCGAAA cloneIMAGE:929806 similar to TTCGTAGTCTTTCTCTATGGAGTT contains Alu repetitiveelement; mRNA 7400 Table 3A NA AA501934 2236901 nh56a10.s1 NCI_CGAp_Pr8cDNa 1 TGCTGATGTGTTAGGTAGTTGTGGCA clone IMAGE:956348, mRNACACTCACCTGTCTTTCCTAAATGC sequence 7401 Table 3A NA AA579400 2357584nf33d05.s1 NCI_CGAP_Pr1 cDNA 1 TTCATGCTCAGCAAAACAACGTTTTA cloneIMAGE:915561 similar to GGATGGTGAGAGAAGACAAAGTAA contains Alu repetitiveelement; contains 7402 Table 3A NA AF249845 8099620 isolate Siddi 10hypervariable region 1, 1 TATTAACCACTCACGGGAGCTCTCCA mitochondrialsequence TGCATTTGGTATTTTCGTCTGGGG 7403 db mining Hs.277051 AI6302424681572 ad07c09.y1 cDNA/clone = ad07c09- 1 TTACCTGCTTTGCATGCTCTCCATCG(random) TCAAAGTCTTCTGGAAACTTAGGC 7404 db mining Hs.277052 AI6303424681672 ad08g11.y1 cDNA/clone = ad08g11- 1 CCCCACCCCAACACATACAACGTTT(random) CCCACCAATCCTTGAACTGCAAAA 7405 db mining NA AI732228 5053341nf19e05.x5 NCI_CGAP_Pr1 cDNA 1 TTCAAGGTCCCAATACCCAACTAACT cloneIMAGE:914240 similar to CGAAGGAAGAAATGGAAATCTATT contains Alu repetitiveelement; mRNAs 7406 Table 3A Hs.197803 AW379049 6883708 mRNA forKIAA0160 gene, partial cds/ 1 TGCACAGAACTCTTACTTACATGTCT cds = (0, 2413)CATCGAAACTCCAGAACACCCGTCG 7407 Table 3A Hs.232000 AW380881 6885540UI-H-B10p-abh-h-06-0-UI.s1 cDNA, 3′ 1 TGCATGTATCCCGGTAATTCAAATCCend/clone = IMAGE:2712035/ AATTTCACAGCCACTGCTGAATAT clone_end = 3′ 7408Table 3A Hs.325568 AW384988 6889647 602386081F1 cDNA, 5′ end/ 1TACAGGAAAATGAAACTAGACGGGTG clone = IMAGE:4514972/clone_end =GGGGACACTAGAATGAAAACCAGT 5′ 7409 Table 3A NA AW836389 7930383PM0-LT0030-101299-001-f08 LT0030 1 AGTTTCTGCTTTCAGTGACTGAGGCT cDNA, mRNAsequence TTGCTTTAACCTGGTGACTCCCAA 7410 Table 3A NA AW837717 7931691CM2-LT0042-281299-062-e11 LT0042 1 TCCCACTTCAAGTTAAGCACCAAAGC cDNA, mRNAsequence AATCACTAATTCTGGAGCACAGGA 7411 Table 3A NA AW837808 7931782CM1-LT0042-100300-140-f05 LT0042 1 CATGGATGGGGGCAGTGGTGTTTCT cDNA, mRNAsequence AGTGTGTGAGGAAGCAGAGCAGATG 7412 Table 3A NA AW842489 7938472PM4-CN0032-050200-002-c11 1 TCACCACAGATGGGAAGATCGTTTCC CN0032 cDNA, mRNAsequence TGAAAACAGTCTATAAATCACAGA 7413 Table 3A NA AW846856 7942373QV3-CT0195-011099-001-c09 1 CAGACGCTCCAGTGCTGCCGAGGTT CT0195 cDNA, mRNAsequence AGTGTGTTTATTAGACCTGAAATGA 7414 Table 3A NA AW856490 7952183PM4-CT0290-271099-001-c04 1 CCCTTTAGGCCTCTTGCCCGAACAGT CT0290 cDNA, mRNAsequence GAACACTAATAGATATCCTAAGCT 7415 Table 3A NA AW891344 8055549PM2-NT0079-030500-001-a04 1 ATGGGGATCATGTTTTATTTTTCTCTA NT0079 cDNA,mRNA sequence TATAATGGGCCAGTGTGTTCCCA 7416 Table 3A NA BE061115 8405765QV0-BT0041-011199-039-f09 BT0041 1 AGCTGTAGACCATAAGCCACCTTCAG cDNA, mRNAsequence GTAGTGGTTTGGGAAATCAAGCAA 7417 Table 3A NA BE086076 8476469PM2-BT0672-130400-006-h09 1 TGTACTTATGCTTGTCTTCTCTACCTG BT0672 cDNA,mRNA sequence CCCCCAGTCTTGAAGTGGTGGAA 7418 Table 3A NA BE091932 8482384IL-2BT0733-130400-068-C11 BT0733 1 GGAGGGTGTGGGAAGCAAGAGAAGA cDNA, mRNAsequence ACATTCTGTTAGGGGCAGAGAAGAA 7419 Table 3A Hs.173334 BE1608228623543 ELL-RELATED RNA POLYMERASE 1 GCATCTCCAGCTTTCATAGTTACCCA II,ELONGATION FACTOR (ELL2), ACTTGTAAACCAGAAGATGTGCTG mRNA/cds = (0, 1922)7420 Table 3A NA BE163106 8625827 QV3-HT0457-060400-146-h10 1GGCCAGTGCCAGACGGTAGCTAGTT HT0457 cDNA, mRNA sequenceGGATGCTAAAGGTAGAATTTAGATA 7421 Table 3A Hs.301497 BE168334 8631159arginine-tRNA-protein transferase 1-1p 1 GGCATTGTAGGTTGACACCAGCAAAG(ATE1) mRNA, alternatively spliced ACTCAGAGTGACTTGAGCATTGGA product,partial cds/cds = (0, 1544) 7422 Table 3A Hs.172780 BE176373 8639102602343016F1 cDNA, 5′ end/ 1 AGCCCATTTGGATATGGCCCATCTTT clone =IMAGE:4453468/clone_end = ACCTAATGGCTACTATAGTGAGGT 5′ 7423 Table 3A NABE177661 8658813 RC1-HT0598-020300-011-h02 1 AATCACAGCAGTAACTCCCAGTAGGAHT0598 cDNA, mRNA sequence AAGATTCTCAAAGGAATAGTTCTT 7424 Table 3A NABE178880 8658032 PM1-HT0509-060300-001-g03 1 AATGGTCAGGCACAGGTAGAATCAAAHT0609 cDNA, mRNA sequence GTCCTGTATGTATGTTCACACAGA 7425 Table 3A NABE247056 9098807 TCBAP1D6404 Pediatric pre-B cell 1TACCTGAAGGTGTAGAGAGTGCCCG acute lymphoblastic leukemia Baylor-CATCCAGCAAGGCCAACAGCTCCAC HGSC project = TCBA cDNA clone T 7426 Table 3AHs.11050 BE763412 10193336 mRNA; cDNA DKFZp434C0118 (from 1CTGTGTTTTTCCCAAAGCAACAATTTC clone DKFZp434C0118); partial cds/AAACAATGAGAGCCACTGACA cds = (0, 1644) 7427 Table 3A NA BF330908 11301656RC3-BT0333-310800-115-f11 BT0333 1 GACTCCGAGCTCAAGTCAGTCTGTAC cDNA, mRNAsequence CCCCAACCCCTAACCCACTGCATC 7428 Table 3A NA bf357523 11316597CM2-HT0945-150900-379-g08 1 TGTAACTGACTTTATGTATCACTCAAG HT0945 cDNA,mRNA sequence TCTTGCCTTTACTGAGTGCCTGA 7429 Table 3A NA BF364413 11326438RC6-NN1068-070600-011-B01 1 TCTCTCTAACCAAAACTGTAATCTTCA NN1068 cDNA,mRNA sequence GGACCAGCAAACTCAGCCCAAGG 7430 Table 3A NA BF373638 11335663MR0-FT0176-040900-202-g09 FT0176 1 AACTCTTGGTTAAATGGGTTAATAGA cDNA, mRNAsequence GGATTGGAACACTTTGTTTGCTGT 7431 Table 3A NA BF740663 12067339QV1-HB0031-071200-582-h04 1 AGAAGCAAACCTGTGAAGCTACTATC HB0031 cDNA, mRNAsequence GTTTATCATCAGTGTGAATGCACT 7432 Table 3A NA BF749089 12075765MR2-BN0386-051000-014-b04 1 GGACTAACTTCCACCTCCTCTGCTAC BN0386 cDNA, mRNAsequence TTCCAGCTGCTTCTAATCACACTT 7433 Table 3A NA BF758480 12106380MR4-CT0539-141100-003-d05 1 AGTCTTCCACCCAGACAYAGGTA CT0539 cDNA, mRNAsequence TCACACACCAGCTCTGTTTTACT CCTG 7434 Table 3A NA BF773126 12121026CM3-IT0048-151200-568-f08 IT0048 1 TTAGCTGGTACATTGTTCAGAGTTTA cDNA, mRNAsequence CTGGGAGCCGGTAAGATAGTCACC 7435 Table 3A NA BF773393 12121293CM2-IT0039-191200-638-h02 IT0039 1 AGCGTGATGCTTCCTCATGTCGGTGA cDNA, mRNAsequence TTTTCTGTTGAGACATCTTCAAGC 7436 Table 3A NA BF805164 12134153QV1-C10173-061100-456-f03 CI0173 1 ACAAAAGTATGGAATTCAATTCTTTTT cDNA,mRNA sequence ATATGCTGCAGCCATGTTCCTGCCCT AGA 7437 Table 3A NA BF81859412156027 MR3-CI0184-201200-009-e04 CI0184 1 TGTAATTGATTTCCGCATAAACGGTCcDNA, mRNA sequence ATTACTGGCACCTATGGCAGCACC 7438 Table 3A NA BF82773412171909 RC5-HN0025-041200-022-F08 1 GTGATCCACTTGGAGCTGCTACTGGT HN0025cDNA, mRNA sequence CCCATTGAGTCCTATAGTACTTCA 7439 Table 3A NA BF84516712201450 RC5-HT1035-271200-012-F08 1 TGCCATGAAATCTCTATTAATTCTCAG HT1035cDNA, mRNA sequence AAAGATCAAAGGAGGTCCCGTGT 7740 Table 3A NA BF86916712259297 IL5-ET0119-181000-181-b11 ET0119 1 CCCACCTGGCAAATCCTCAAGTGTGAcDNA, mRNA sequence CCCTAGTCATCTTTCTCCTTTTGG 7441 Table 3A NA BF87557512255705 QV3-ET0100-111100-391-c02 ET0100 1 GCTAAACAGAAAAGAACCTGAAGTACcDNA, mRNA sequence AGTTCCCGTCTTCAAAGAAGATGC 7442 Table 3A NA BF87797912268109 MR0-ET0109-171100-001-b02 1 ATCCTCCTCCCCTGGGATGGCATAGA ET0109cDNA, mRNA sequence AGAGACTTTAAAACCAAATGAGCC 7443 Table 3A NA BF89704212288501 IL2-MT0179-271100-254-C11 MT0179 1 GTCAGTAAAGCTCTGCCTGCCAAcDNA, mRNA sequence GAAGACACAGTGAGAGGTGTCCAC AGTC 7444 Table 3A NABF898285 12289744 QV1-MT0229-281100-508-e11 1GTTTCCACTTAGTTACTTCTTCCTACC MT0229 cDNA, mRNA sequenceTGCTGTGAAGCTCTGCACCCTGC 7445 Table 3A NA BF899464 12290923IL5-MT0211-011200-317-f03 MT0211 1 AGAGTAATCCACATCCCAGGGACAGT cDNA, mRNAsequence CACAATGACCTACGGCTTTAGCTG 7446 Table 3A Hs.324473 BF90442512295884 40 kDa protein kinase related to rat 1GCAGGGCTACACCAAGTCCATTGATA ERK2/cds = (134, 1180)TTTGGTCTGTAGGCTGCATTCTGG 7447 Table 3A NA BF906114 12297573IL3-MT0267-281200-425-A05 MT0267 1 TCTTCTCTAAAATGCCCTCCTCTCCTT cDNA,mRNA sequence CCTTTTTCCAGACCTGGTTTAAA 7448 Table 3A Hs.104679 BF92618712323197 Homo sapiens, clone MGC-18218 1 TCGCCATTTGGTAGTTCCACAGTGACIMAGE:4156235, mRNA, complete TGCTCTTTCTATTTTACGAAGCCAC cds/cds = (2206,2373) 7449 Table 3A Hs.75703 BF928844 12326772 small inductible cytokineA4 1 GTAATTACTATGAGACCAGCAGCCT (homologous to mouse Mip-1b)CTGCTCCCAGCCAGCTGTGGTGTG (SCYA4), mRNA/cds = (108, 386) 7450 Table 3A NABG006820 12450386 RC4-GN0227-271100-011-d03 1TTTCCTTTTCGCTGACTTTCTCACTCA GN0227 cDNA, mRNA sequenceCTGTCTGTCTCTCATTTTCTCCA 7451 Table 3A NA F11941 706260 HSC33F051normalized infant brain 1 TGGTAAGTTTCTGGCAGTGTGGAGAC cDNA cDNA clonec-33f05, mRNA AGGGGAATAATCTCAACAGTAGGT sequence 7452 Table 3A NA U463881235904 HSU46388 Human pancreatic cancer 1 CCATGGTGGTGCTTGACTTTGCTTTGcell line Patu 8988t cDNA clone xs425, GGGCTTAATCCTAGTATCATTTGG mRNAsequence 7453 Table 3A NA U75805 1938265 HSU75805 Human cDNA clone f46,1 TCAGTGGGTGTTGGTTGTCCATTAGT mRNA sequence TGAGACTTAGTTGTTGCTCTGGGA 7454Table 3A NA W27656 1307658 36f10 Human retina cDNA randomly 1GGCTGGACAGCAGATGATTCAAATCT primed sublibrary cDNA, mRNACAATACTACATGCCCATTCTGTGG sequence 7455 literature NA X17403 59591 Humancytomegalovirus strain AD169 1 AATAATAGATTAGCAGAAGGAATAAT completegenome CCGTGCGACCGAGCTTGTGCTTCT 7456 literature NA X17404 59591 Humancytomegalovirus strain AD169 1 TTTTGCGAACTTTTAGGAACCAGCAA completegenome GTCAACAAAAGACTAACAAAGAAA 7457 literature Hs.2799 X17405 59591Cartilage linking protein 1 1 GAGATCGACATCGTCATCGACCGACCTCCGCAGCAACCCCTACCCAATCC 7458 literature Hs.2159 X17406 59591 mRNA forcartilege specific 1 ACATTCAAAAGTTTGAGCGTCTTCAT proteoglycanGTACGCCGTTTTCGGCCTCACGAG 7459 literature NA X17407 59591 Humancytomegalovirus strain AD169 1 CCAACGACACATCCACAAAAATCCCC completegenome CATCGACTCTCACAATCGCATCAT 7460 literature NA X17408 59591 Humancytomegalovirus strain AD169 1 CTTTGAGCAGGTTCTCAAGGCTGTAA completegenome CTAACGTGCTGTCGCCCGTCTTTC 7461 literature NA X17409 59591 Humancytomegalovirus strain AD169 1 GATGTCCGTCTACGCGCTATCGGCC complete genomeATCATCGGCATCTATCTGCTCTACC 7462 literature NA X17410 59591 Humancytomegalovirus strain AD169 1 TCTTCTGGGACGCCAACGACATCTAC completegenome CGCATCTTCGCCGAATTGGAAGGC 7463 literature NA X17411 59591 Humancytomegalovirus strain AD169 1 ACGAACAGAAATCTCAAAAGACGCTG completegenome ACCCGATAAGTACCGTCACGGAGA 7464 literature NA X17412 59591 Humancytomegalovirus strain AD169 1 AGAGAACAACAAACCACCACGACGA complete genomeTGAAACAAACGCTCAACCAAACA 7465 literature NA X17413 59591 Humancytomegalovirus strain AD169 1 CTGCATCGTCGTCGTCCTCCTCCTCT completegenome CGGAGATCGCGACGGAGAAACAAC 7466 literature NA X17414 59591 Humancytomegalovirus strain AD169 1 CTGAGCCTGGCCATCGAGGCAGCCA complete genomeTCCAGGACCTGAGGAACAAGTCTCA 7467 literature NA X17415 59591 Humancytomegalovirus strain AD169 1 CCTCTGGAGGCAAGAGCACCCACCC complete genomeTATGGTGACTAGAAGCAAHHCTGAC 7468 literature NA X17416 59591 Humancytomegalovirus strain AD169 1 TTCGTGGGCACCAAGTTTCGCAAGAA completegenome CTACACTGTCTGCTGGCCGAGTTT 7469 literature NA J01917 209811Adenovirus type 2, complete genome 1 CTGTGGAATGTATCGAGGACTTGCTTAACGAGTCTGGGCAACCTTTGGAC 7470 literature NA J01918 209811 Adenovirustype 2, complete genome 1 GCTGGCCTGCACCCGCGCTGAGTTTGGCTCTAGCGATGAAGATACAGATT 7471 literature NA J01919 209811 Adenovirustype 2, complete genome 1 GGGGCGGTTAGGCTGTCCTCCTTCTCGACTGACTCCATGATCTTTTTCTG 7472 literature NA J01920 209811 Adenovirustype 2, complete genome 1 TGTTTGCCTTATTATTATGTGGCTTATTTGTTGCCTAAAGCGCAGACGC 7473 literature Hs.250596 J01921 209811xy45f10.x1 cDNA, 3′ end/ 1 ACGGTGATCAATATAAGCTATGTGGT clone =IMAGE:2856139/clone_end = GGTGGGGCTATACTACTGAATGAA 3′ 7474 literature NAJ01922 209811 Adenovirus type 2, complete genome 1TTTCTGCCCTGAAGGCTTCCTCCCCT CCCAATGCGGTTTAAAACATAAAT 7475 literature NAJ01923 209811 Adenovirus type 2, complete genome 1GGCTTATGCCCATGTATCTGAACATC CAGAGTCACCTTTACCACGTCCTG 7476 literature NAJ01924 209811 Adenovirus type 2, complete genome 1CTACTGCCGTACAGCGAAAGCCGCC CCAACCCGCGAAACGAGGAGATATG 7477 Table 3A NAAA077131 1836605 7B08E10 Chromosome 7 Fetal Brain −1CAGATAGTGGTATTTGGGTGCTGGG cDNA Library cDNA clone 7B08E10,CTTGTCTGACCTGAGGAGGTGGCTG mRNA sequence 7478 Table 3A NA AA5017252236692 ng18e12.s1 NCI_CGAP_Lip2 cDNA −1 AACTCCATAGAGAAAGACTACGAATTclone IMAGE:929808 similar to TCGCTGGGAGGTAATAGGGAAGCC contains Alurepetitive element; mRNA 7479 Table 3A NA AA501934 226901 nh56a10.s1NCI_CGAP_Pr8 cDNA −1 GCATTTAGGAAAGACAGGTGAGTGTG clone IMAGE:958346, mRNACCACAACTACCTAACACATCAGCA sequence 7480 Table 3A NA AA579400 2357584nf33d05.s1 NCI_CGAP_Pr1 cDNA −1 TTACTTTGTCTTCTCTCACCATCCTAA cloneIMAGE:91581 similar to contains Alu repetitive element:contains 7481Table 3A NA AF249845 8099620 isolate Siddi 10 hypervariable region 1, −1CCCCAGACGAAAATACCAAATGCATG mitochondrial sequenceGAGAGCTCCCGTGAGTGGTTAATA 7482 db mining Hs.277051 AI630242 4881572ad07c09.y1 cDNA/clone = ad07c09- −1 GCCTAAGTTTCCAGAAGACTTTGACG (random)ATGGAGAGCATGCAAAGCAGGTAA 7483 db mining Hs.277052 AI830342 4681672ad08g11.y1 cDNA/clone = ad08g11- −1 TTTTGCAGTTCAAGGATTGGTGGGAA (random)ACGTTTGTATGTGTTGGGGTGGGG 7484 db mining NA AI732228 5053341 nf19e05.x5NCI_CGAP_Pr1 cDNA −1 AATAGATTTCCATTTCTTCCTTCGAGT clone IMAGE:91420similar to TAGTTGGGTATTGGGACCTTGAA contains Alu repetitive element; mRNAs 7485 Table 3A Hs.197803 AW379049 6883708 mRNA for KIAA0160 gene,partial cds/ −1 CGACGGTGTTCTGGAGTTTCGATGAG CDS = (0, 2413)ACATGTAAGTAAGAGTTCTGTGCA 7486 Table 3A Hs.232000 AW380881 6885540UI-H-B10p-abh-h-06-UI.s1 cDNA 3′ −1 ATATTCAGCAGTGGCTGTGAAATTGG end/clone= IMAGE:2712035/ ATTTGAATTACCGGGATACATGCA clone_end = 3′ 7487 Table 3AHs.325588 AW384988 6889647 602386081F1 cDNA 5′ end/ −1ACTGGTTTTCATTCTAGTGTCCCCCA clone = IMAGE:4514972/clone_end =CCCGTCTAGTTTCATTTTCCTGTA 5′ 7488 Table 3A NA AW836389 7930363PM0-LT0030-101299-001-f08 LT0030 −1 TTGGGAGTCACCAGGTTAAAGCAAAG cDNA,mRNA sequence 7489 Table 3A NA AW837717 7931691CM2-LT0042-2612990-062-e11 −1 TCCTGTGCTCCAGAATTAGTGATTGC LT0042 cDNA,mRNA sequence TTTGGTGCTTAACTTGAAGTGGGA 7490 Table 3A NA AW837608 7931782CM1-LT0042-100300-140-f05 LT0042 −1 CATCTGCTCTGCTTCCTCACACACTA cDNA,mRNA sequence GAAACACCACTGCCCCCATCCATG 7491 Table 3A NA AW842489 7936472PM4-CN0032-050200-002-c11 −1 TCTGTGATTTATAGACTGTTTTCAGGA CN0032 cDNA,mRNA sequence AACGATCTTCCCATCTGTGGTGA 7492 Table 3A NA AW848856 7942373QV3-CT0195-011099-001-c09 −1 TCATTTCAGGTCTAATAAACACACTAA CT0195 cDNA,mRNA sequence CCTCGGCAGCACTGGAGCGTCTG 7493 Table 3A NA AW856490 7952183PM4-CT0290-271099-001-c04 −1 AGCTTAGGATATCTATTAGTGTTCACT CT0290 cDNA,mRNA sequence GTTCGGGCAAGAGGCCTAAAGGG 7494 Table 3A NA AW891344 8055549PM2-NT0079-030500-001-a04 −1 TGGGAACACACTGGCCCATTATATAG NT0079 cDNA,mRNA sequence AGAAAAATAAAACATGATCCCCAT 7495 Table 3A NA BE061115 8405785QV0-BT0041-011199-039-f09 BT0041 −1 TTGCTTGATTTCCCAAACCACTACCT cDNA,mRNA sequence GAAGGTGGCTTATGGTCTACAGCT 7496 Table 3A NA BE086076 8476469PM2-BT0672-130400-008-h09 −1 TTCCACCACTTCAAGACTGGGGGCA BT0672 cDNA, mRNAsequence GGTAGAGAAGACAAGCATAAGTACA 7497 Table 3A NA BE091932 8482384IL2-BT0733-130400-068-C11 BT0733 −1 TTCTTCTCTGCCCCTAACAGAATGTT cDNA,mRNA sequence CTTCTCTTGCTTCCCACACCCTCC 7498 Table 3A Hs.173334 BE1608228623543 ELL-RELATED RNA POLYMERASE −1 CAGCACATCTTCTGGTTTACAAGTTG II,ELONGATION FACTOR (ELL2), GGTAACTATGAAAGCTGGAGATGC mRNA/cds = (0, 1922)7499 Table 3A NA BE163106 8825827 QV3-HT0457-050400-146-h10 −1TATCTAAATTCTACCTTTAGCATCCAA HT0457 cDNA, mRNA sequenceCTAGCTACCGTCTGGCACTGGCC 7500 Table 3A Hs.301497 BE168334 8631159arginine-tRNA-protein transferase 1-1p −1 TCCAATGCTCAAGTCACTCTGAGTCT(ATE1) mRNA, alternatively spliced, TTGCTGGTGTCAACCTACAATGCC product,partial cds/cds = (0, 1544) 7501 Table 3A Hs.172780 BE176373 8839102602343016F1 cDNA, 5′ end/ −1 ACCTCACTATAGTAGCCATTAGGTAA clone =IMAGE:4453466/clone_end = AGATGGGCCATATCCAAATGGGCT 5′ 7502 Table 3A NABE177681 8656813 RC1-HT0598-020300-011-h02 −1AAGAACTATTCCTTTGAGAATCTTTCC HT0598 cDNA, mRNA sequenceTACTGGGAGTTACTGCTGTGATT 7503 Table 3A NA BE178880 8658032PM1-HT0609-060300-001-g03 −1 TCTGTGTGAACATACATACAGGACTT HT0609 cDNA,mRNA sequence TGATTCTACCTGTGCCTGACCATT 7504 Table 3A Hs.88543 BE2470569098807 602495247F1 cDNA, 5′ end/ −1 GTGGAGCTGTTGGCCTTGCTGGATG clone =IMAGE:4609330/clone_end = CGGGCACTCTCTACACCTTCAGGTA 5′ 7505 Table 3AHs.11050 BE763412 10193336 mRNA; cDNA KDFZp434C0118 (from −1TGTCAGTGGCTCTCACTTTGTTTGAA clone DKFZp434C0228); partial cds/ATTGTTGCTTTGGGAAAAACACAG cds = (0, 1644) 7506 Table 3A NA BF33090811301656 RC3-BT0333-310800-115-f11 BT0333 −1 GATGCAGTGGGTTAGGGGTTGGGGGcDNA, mRNA sequence TACAGACTGACTTGAGCTCGGAGTC 7507 Table 3A NA BF35752311316597 CM2-HT0945-150900-379-g06 −1 TCAGGCACTCAGTAAAGGCAAGACTT HT0945cDNA, mRNA sequence GAGTGATACATAAAGTCAGTTACA 7508 Table 3A NA BF38441311326438 RC6-NN1068-070600-011-B01 −1 CCTTGGGCTGAGTTTGCTGGTCCTGA NN1068cDNA, mRNA sequence AGATTACAGTTTTGGTTAGAGAGA 7509 Table 3A NA BF37383811335663 MR0-FT0176-040900-202-g09 FT0173 −1 ACAGCAAACAAAGTGTTCCAATCCTCcDNA, mRNA sequence TATTAACCCATTTAACCAAGAGTT 7510 Table 3A NA BF74066312067339 QV1-HB0031-071200-582-h04 −1 AGTGCATTCACACTGATGATAAACGA HB0031cDNA, mRNA sequence TAGTAGCTTCACAGGTTTGCTTCT 7511 Table 3A NA BF74908912075765 MR2-BN0388-051000-014-b04 −1 AAGTGTGATTAGAAGCAGCTGGAAGT BN0386cDNA, mRNA sequence AGCAGAGGAGGTGGAAGTTAGTCC 7512 Table 3A NA BF75648012108380 MR4-CT0539-141100-003-d05 −1 CAGGAGTAAAACAGAGCTGGTTGTGT CT0539cDNA, mRNA sequence GATACCTATGCTGGGTGGAAGACT 7513 Table 3A NA BF77312612121026 CM3-IT0048-151200-568-f08 IT0048 −1 GGTGACTATCTTACCGGCTCCCAGTAcDNA, mRNA sequence AACTCTGAACAATGTACCAGCTAA 7514 Table 3A NA BF77339312121293 CM2-IT0039-191200-638-h02 IT0039 −1 GCTTGAAGATGTCTCAACAGAAAATCcDNA, mRNA sequence ACCGACATGAGGAAGCATCACGCT 7515 Table 3A NA BF80518412134153 QV1-CI0173-061100-456-f03 CI0173 −1 TCTAGGGCAGGAACATGGCTGCAGCcDNA, mRNA sequence ATATAAAAAGAATTGAATTCCATACTT TTGT 7516 Table 3A NABF818594 12156027 MR3-CI0184-201200-009-a04 CI0184 −1GGTGCTGCCATAGGTGCCAGTAATG cDNA, mRNA sequence ACCGTTTATGCGGAAATCAATTACA7517 Table 3A NA BF8277734 12171909 RC6-HN0025-041200-022-F08 −1TGAAGTACTATAGGACTCAATGGGAC HN0025 cDNA, mRNA sequenceCAGTAGCAGCTCCAAGTGGATCAC 7518 Table 3A NA BF845167 12201450RC5-HT1035-271200-012-F08 −1 ACACGGGACCTCCTTTGATCTTTCTG HT1035 cDNA,mRNA sequence AGAATTAATAGAGATTTCATGGCA 7519 Table 3A NA BF86916712259297 IL5-ET0119-181000-181-b11 ET0119 −1 CCAAAAGGAGAAAGATGACTAGGGTcDNA, mRNA sequence CACACTTGAGGATTTGCCAGGTGGG 7520 Table 3A NA BF87557512265705 QV3-ET0100-111100-391-c02 ET0100 −1 GCATCTTCTTTGAAGACGGGAACTGTcDNA, mRNA sequence ACTTCAGGTTCTTTTCTGTTTAGC 7521 Table 3A NA BF87797912268109 MR0-ET0109-171100-001-b02 −1 GGCTCATTTGGTTTTAAAGTCTCTTCT ET0109cDNA, mRNA sequence ATGCCATCCCAGGGGAGGAGGAT 7522 Table 3A NA BF89704212288501 IL2-MT0179-271100-254-C11 −1 GACTGTGGACACCTCTCACTGTGTCT MT0179cDNA, mRNA sequence TCTTGGCAGGCAGAGCTTACTGAC 7523 Table 3A NA BF89828512289744 QV1-MT0229-28100-508-e11 −1 GCAGGGTGCAGAGCTTCACAGCAGG MT0229cDNA, mRNA sequence TAGGAAGAAGTAACTAAGTGGAAAC 7524 Table 3A NA BF89946412290923 IL5-MT0211-011200-317-f03 MT0211 −1 CAGCTAAAGCCGTAGGTCATTGTGACcDNA, mRNA sequence TGTCCCTGGGATGTGGATTACTCT 7525 Table 3A Hs.324473BF904425 12295884 40 kDa protein kinase related to rat −1CCAGAATGCAGCCTACAGACCAAATA ERK2/cds = (134, 1180)TCAATGGACTTGGTGTAGCCCTGC 7526 Table 3A NA BF906114 12297573IL3-MT0267-281200-425-A05 MT0267 −1 TTTAAACCAGGTCTGGAAAAAGGAG cDNA, mRNAsequence GAGAGGAGGGCATTTTAGAGAAGA 7527 Table 3A Hs.104679 BF92618712323197 Homo sapiens, clone MGC:18216 −1 GTGGCTTCGTAAAATAGAAGAGCAGTIMAGE:4156235, mRNA, complete CACTGTGGAACTACCAAATGGCGA cds/cds = (2208,2373) 7528 Table 3A Hs.75703 BF928644 12326772 small inducible cytokineA4 −1 CACACCACAGCTGGCTGGGAGCAGA (homologous to mouse Mip-1b)GGCTGCTGGTCTCATAGTAATCTAC (SCYA4), mRNA/cds = (108, 386) 7529 Table 3ANA BG006820 12450386 RC4-GN0227-271100-001-d03 −1TGGAGAAAATGAGAGACAGACAGTG GN0227 cDNA, mRNA sequenceAGTGAGAAAGTCAGCGAAAAGGAAA 7530 Table 3A NA F11941 706260 HSC33F051normalized infant brain −1 ACCTACTGTTGAGATTATTCCCCTGT cDNA cDNA clonec-33f05, mRNA CTCCACACTGCCAGAAACTTACCA sequence 7531 Table 3A NA U463881236904 HSU46388 Human pancreatic cancer −1 CCAAATGATACTAGGATTAAGCCCCAcell line Palu 89881 cDNA clone xs425, AAGCAAAGTCAAGCACCACCATGG mRNAsequence 7532 Table 3A NA U75805 1938265 HSU75805 Human cDNA clone f48,−1 TCCCAGAGCAACAACTAAGTCTCAAC mRNA sequence TAATGGACAACCAACACCCACTGA7533 Table 3A NA W27658 1307658 38f10 Human retina cDNA randomly −1CCACAGAATGGGCATGTAGTATTGAG primed sublibrary cDNA, mRNAATTTGAATCATCTGCTGCCAGCC sequence 7534 literature Hs.99962 BC00592913543541 proteoglycan 2, bone marrow (natural 1TACTGGCGTCGAGCCCACTGCCTCA killer cell activator, eosinophil granuleGAAGACTTCCTTTCATCTGTTCCTA major basic protein) (PRG2), mRNA/ cds = (857,1525) 7535 literature Hs.46295 X14348 31182 eosinophil peroxidase (EPX),mRNA/ 1 GTTTCAAGGGACATCTTCAGAGCCAA cds = (0, 2147)CATCTACCCTCGGGGCTTTGTGAA 7536 literature Hs.1256 J05225 179078arylsulfatase B (ARSB), mRNA/ 1 CTACAGTTCTACCATAAACACTCAGT cds = (559,2160) CCCCGTGTACTTCCCTGCACAGGA 7537 literature Hs.728 M28129 556208ribonucleae, RNase A family, 2 (liver, 1 TAGTTGCATGTGACAACAGAGATCAAeosinophil-derived neurotoxin) CGACGAGACCCTCCACAGTATCCG (RNASE2),mRNA/cds = (71, 556) 7538 literature Hs.889 NM_001828 6325464Charol-Leyden crystal protein (CLC), 1 TTGACCATAGAATCAAGCCTGAGGCTmRNA/cds = (33, 461) GTGAAGATGGTGCAAGTGTGGAGA 7539 literature Hs.135626M69138 180539 chymase 1, mast cell (CMA1), mRNA/ 1CTGCTGTCTTCACCCGAATCTCCCAT cds = (0, 743) TACCGGCCCTGGATCAACCAGATC 7540literature Hs.334455 NM_003293 13699841 tryptase, alpha (TPS1), mRNA/ 1GTCACTGGAGGACCAACCCCTGCTG cds = (17, 844) 7541 literature NA NC_0013459625578 Human herpesvirus 4, complete 1 CATGCCATGCATATTTCAACTGGGCTgenome GTCTATTTTTGACACCAGCTTATT 7542 literature NA NC_001345 9625578Human herpesvirus 4, complete 1 GAGAAGCACCTCAACCTGGAGACAAT genomeTCTACTGTTCAAACAGCAGCAGCA 7543 literature NA NC_001345 9625578 Humanherpesvirus 4, complete 1 ACTTGTCAGGGCCATTCTCTCTCCGG genomeGCACTGGGTCACTAGGACTGTTTT 7544 literature NA NC_001345 9625578 Humanherpesvirus 4, complete 1 GACAGCGTCCTAGAAACCCTGGCGA genomeCCATTGCCTCCAGCGGGATAGAGTG 7545 literature NA NC_001345 9625578 Humanherpesvirus 4, complete 1 CATCCTCTGGAGCCTGACCTGTGATC genomeGTCGCATCATAGACCGCCAGTAGA 7546 literature NA NC_001345 9625578 Humanherpesvirus 4, complete 1 GCCTCCACACGACATCACACCATATA genomeCCGCAAGGAATATCAGGGATGCTG 7547 literature Hs.279852 BC004555 13528716 Gprotein-coupled receptor (G2A), 1 ACAGCCATCCTCCCCTTGAGAGTCAT mRNA/cds =(900, 2042) CAGAAAAATACATTAGGAAAATGT 7548 literature NA NC_0013459625578 Human herpesvirus 4, complete 1 ACCTTCGTCTTCTGAGTCTCATGCCTgenome CAAAACCTAGTTTGATAGACAGGA 7549 literature NA NC_001345 9625578Human herpesvirus 4, complete 1 AGATGGCTACCCTTCTGATTATGATC genomeCTTTCGTAGAAAATGCTCAAATCT 7550 literature NA NC_001345 9625578 Humanherpesvirus 4, complete 1 ATGCATCGCCGACAAGTCTTGAATTA genomeGGATTGTCGAAATTAGACAAAGAA 7551 literature NA NC_001345 9625578 Humanherpesvirus 4, complete 1 CGGGTGTGTTCAATCATCGACGGTGA genomeCAATCCTATCTCCATCTATAATCC 7552 literature NA NC_001345 9625578 Humanherpesvirus 4, complete 1 GAAGAGCGAAATGCAATCTTCTGCTT genomeCTTCAGTAGAGACTTTACAGTCTT 7553 literature NA NC_001345 9625578 Humanherpesvirus 4, complete 1 GCACATCCATCGCCCAAAGTGAAGTC genomeTGCAAGGATGCCATTTATTGGTTG 7554 literature NA NC_001345 9625578 Humanherpesvirus 4, complete 1 TCTCGGTTTACCTTTTTGCTGTTGTG genomeGTTCTTTGTTCTTGCTGGTTTGCT 7555 literature NA NC_001345 9625578 Humanherpesvirus 4, complete 1 TCTGAATACTCTACAAAACGCTCCTT genomeGTCTGCTCTTAAAACCATCTGTGT 7556 literature NA NC_001345 9625578 Humanherpesvirus 6, complete 1 TGAAGCTGACACCTGTGAAACTAACT genomeTAAACGCATGTTCTTCTGACTCAG 7557 literature NA NC_001345 9625578 Humanherpesvirus 6, complete 1 TTCTGTTTTGGGCCAGGAACCGTTCT genomeATAAATTGTTTTATTGACTACACG 7558 literature NA NC_001345 9625578 Humanherpesvirus 6, complete 1 TAACACCGTCCAAGAAATTTTGCCGT genomeTGTGTCCCCATACTTCTCTAGGGC 7559 literature NA NC_001345 9625578 Humanherpesvirus 6, complete 1 AGAAGAAGGATCAGATGGAGAGTTG genomeAAAACTTTAGCTGGTAAGTACATGA 7560 literature NA NC_001345 9625578 Humanherpesvirus 6, complete 1 CCGATACCGGCAAGATCTGTCGTCTG genomeGCAAACTCGTTTTCCACCTTATGG 7561 literature NA NC_001664 9628290 Humanherpesvirus 6, complete 1 CTGTGGGTCCCTCCCCCTCATCTGTT genomeATTCCCTTCCCCTCTGCCACCGAT 7562 db mining Hs.159568 AI382620 4195401qz04e10.x1 cDNa, 3′ end/ 1 ACTACATTTTAATTAAAGATTAATGGG clone =IMAGE:2020554/clone_end = CATATTAGAAGTTTCTCAAAGTTAGG 3′ CT 7563 dbmining Hs.129055 NM_002540 4505490 Homo sapiens. Similar to outer dense1 AAAAGGAGTGAGCTATCATCAGTGCT fiber of sperm tails 2, clone MGC:9034GTGAAATAAAAGTCTGGTGTGCCA IMAGE:3874501, mRNA, complete cds/cds = (656,2947) 7564 db mining Hs.12329 AB014597 3327207 mRNA for KIAA0697protein, partial 1 AAAGCCACCACTGTTCCCAGTCAGCA cds/cds = (0, 2906)TATACAAGCTCTTAATATTCTGTT 7565 db mining Hs.119177 NM_001659 4502202ADP-ribosylation factor 3 (ARF3), 1 AAATGTGGGATAACGCGATGACTGTG mRNA/cds= (311, 856) ACCCTGGTTGGAAATTAAACTTGT 7566 db mining Hs.12379 BC00337613097227 Homo sapiens, ELAV (embryonic 1 AACACAGAAACATTTGAGCATTGTATlethal, abnormal vision, Drosphila)-like TTCTCGCATCCCTTCTCGTGAGCG 1 (Huantigen R), clone MGC:5084 IMAGE:2901220, mRNA, complete cds/cds = (142,1122) 7567 db mining Hs.319886 AL589290 13243062 DKFZp451F1715_r1 cDNA,5′ end/ 1 AACCTATCAAAGCCTAGCCTAAGGGC clone = DKFZp451F1715/clone_end =TGCCATCTCTGTCTAAATTCTAGT 5′ 7568 db mining Hs.315597 NM_015960 7705727cDNA FLJ10280 fis, clone 1 AACTGCATGGTATGAATTCAGAGTGT HEMBB1001288,highly similar to GACTTAAGGGTCAATTCAAAGCAG CGI-32 protein mRNA/cds =UNKNOWN 7569 db mining Hs.110457 AF071594 3249714 MMSET type I (WHSC1)mRNA, 1 ACAGACTTTGTTAATGTAGGAAATCT complete cds/cds = (29, 1972)CTCCAAGTGGAAACGTGCTAACTT 7570 db mining Hs.144904 NM_006311 5454137nuclear receptor co-repressor 1 1 ACAGGCAATTCAGTGGACTATAATAA (NCOR1),mRNA/cds = (240, 7562) TAGTGGAGGGTTGAGATGTAGAGT 7571 db mining Hs.118064NM_022731 12232386 similar to rel nuclear ubiquitous casein 1ACAGGTCACAGTGGATTTCTTTTCAA kinase 2 (NUCKS), mRNA/ACTGACAATGTTTAGGTTTTAAGC cds = (68, 557) 7572 db mining Hs.337616NM_000753 4502924 phosphodiesterase 3B, cGMP- 1ACCTCAAGCAGATGAGATTCAGGTAA inhibited (PDE3B), mRNA/TTGAAGAGGCAGATGAAGAGGAAT cds = (0, 3338) 7573 db mining Hs.152049AW962287 8152099 EST374360 cDNA 1 ACCTTCTACACCACTGGAAAATAACATGGAGGTTTAGAGCCGTGCAAAAT 7574 db mining Hs.115325 NM_03929 4506374 RAB7,member RAS oncogene family- 1 ACTAAACTCTGAGGCCTGAAGTTCTG like 1(RAB7L1), mRNA/cds = TGATAGACCTTAAATAAGTGTCCT (40, 851) 7575 db miningHs.119178 AK024468 10440445 mRNA for FLJ00059 protein, partial 1ACTGGGGTGGTGATGTTTTCGTTCTG cds/cds = (2624, 4057)TTTTATTTTTCTAACTCTGCTGAC 7576 db mining Hs.183898 NM_000269 4557796ribosomal protein L29 (RPL29), 1 ACTTCATCATAATTTGGAGGGAAGCT mRNA/cds =(29, 508) CTTGGAGCTGTGAGTTCTCCCTGT 7577 db mining Hs.15787 AB0231664589541 mRNA for KIAA0949 protein, partial 1 AGAACGAGGAAGAGAACACAAGGAAcds/cds = (0, 2822) TGATTCAAGATCCACCTTGAGAGGA 7578 db mining Hs.108104NM_003347 4507788 ubiquitin-conjugating enzyme E2L3 1AGAGAATAGGCTTTCTAAGATGCTGC (UBE2L3), mRNA/cds = (15, 479)GATCCCGTTCTGCTGCCCGTAATA 7579 db mining Hs.163593 NM_000980 11415025ribosomal protein L18a (RPL18A), 1 AGCACAAGCCACGCTTCACCACCAA mRNA/cds =(19, 549) GAGGCCCAACACCTTCTTCTAGGTG 7580 db mining Hs.121044 L39061632997 transcription factor SL1 mRNA, partial 1AGGCCAATCACTGCTGACTAAGAATT cds/cds = (0, 1670) CATTATATTGGCTTAGTACACAGA7581 db mining Hs.309348 NM_032472 14277125 Ic93c11.x1 cDNA 3′ end/ 1AGGGAAGATTTCTGTATACTTGCTGG clone = IMAGE:2073716/clone_end =AGAGGAGGAATGTGTATAGTTACT 3′ 7582 db mining Hs.16493 AK027866 14042851cDNA FLJ14960 fis, clone 1 AGTTTTAATACCTTAAGCTTTTTCAAG PLACE4000192,weakly similar to ACCTAACTGCAGCCGCTTTGGGA ZINC FINGER PROTEIN 142/ cds =(114, 3659) 7583 db mining Hs.1342 NM_001882 4502982 cytochrome coxidase subunit Vb 1 ATGTGCTGTAAAGTTTCTTCTTTCCAG (COX5B), nuclear geneencoding TAAAGACTAGCCATTGCATTGGC mitochondrial protein, mRNA/ cds = (21,410) 7584 db mining Hs.111076 NM_005918 5174540 malate dehydrogenase 2,NAD 1 ATTGTGGGTGGCTCTGTGGGCGAT (mitochondrial) (MDH2), nuclear geneCAATAAAAGCCGTCCTTGATTTTAT encoding mitochondrial protein, mRNA/ cds =(86, 1102) 7585 db mining Hs.107476 NM_006476 5453560 ATP synthase, H+transporting, 1 ATTTGAGTGTTGTTGGACCATGTGTG mitochondrial F1F0, subunit gATCAGACTGCTATCTGAATAAAAT (ATP5JG), mRNA/cds = (73, 384) 7586 db miningHs.146354 NM_005809 5902725 peroxiredoxin 2 (PRDX2), mRNA/ 1CAAGCCCACCCAGCCGCACACAGGC cds = (89, 685) CTAGAGGTAACCAATAAAGTATTAG 7587db mining Hs.12124 NM_018127 11875212 elaC (E. coli) homolog 2 (ELAC2),1 CACCAGAGACAAGCAGAGTAACAGG mRNA/cds = (0, 2480)ATCAGTGGGTCTAAGTGTCCGAGAC 7588 db mining Hs.154023 AB011145 3043669 mRNAfor KIAA0573 protein, partial 1 CAGGAGGTAGGGATCTGGCTGAGAG cds/cds = (0,1356) GGAATAATCTGAGCAAAGGTATGAA 7589 db mining Hs.109051 NM_03128813775197 SH3BGRL3-like protein (SH3BGRL3), 1 CAGTCCCTCTCCCAGGAGGACCCTAmRNA/cds = (71, 352) GAGGCAATTAAATGATGTCCTGTTC 7590 db mining Hs.125307AA836204 2910523 od22g11.s1 cDNA/ 1 CATGAGAAGTATCTGCAATAACCCA clone =IMAGE:1368740 AGTCAACATTTAGGTTTGTGTACA 7591 db mining Hs.16803 NM_0180328922296 LUC7 (S. cerevisiae)-like (LUC7L), 1 CATGTTGAGTAGGAATAAATAAATCTmRNA/cds = (71, 1048) GATGCTGCCTCCTGAGGCTGCGGG 7592 db mining Hs.148580NM_001975 5803010 enolase 2, (gamma, neuronal) 1CCACCACCTCTGTGGCATTGAAATGA (ENO2), mRNA/cds = (222, 1526)GCACCTCCATTAAAGTCTGAATCA 7593 db mining Hs14169 AK027567 1402333 cDNAFLJ14681 fis, clone 1 CCATGCCGCCTCGTTGGATTGTCGG NT2RP2002710, weaklysimilar to AATGTAGACAGAAATGTACTGTTCT SH3-BINDING PROTEIN 3BP-1/ cds =(70, 2481) 7594 db mining Hs.118625 NM_000188 4504390 hexokinase 1(HK1), nuclear gene 1 CCCACCGCTTTGTGAGCCGTGTCGTA encoding mitochondrialprotein, mRNA/ TGACCTAGTAAACTTTGTACCAAT cds = (81, 2834) 7595 db miningHs.144505 NM_015653 13124762 DKFZP566F0546 protein 1CCCACGGGAGACTATTTCACACAATT (DKFZP566F0546), mRNA/TAATACAGGAAGTCGATAATGAGG cds = (377, 1308) 7596 db mining Hs.155751NM_004889 4757811 ATP synthase, H+ transporting, 1CCCTCCGTGAGGAACACAACTCAAT mitochondrial F0 complex, subunit 1,CGTTGCTGAATCCTTTCATATCCT isoform 2 (ATP5J2), mRNA/ cds = (27, 311) 7597db mining Hs.10267 NM_015367 7662505 ML1 protein (ML1), nuclear gene 1CCGTGTCTTTCCAGCCCTAAAGGAAG encoding mitochondrial protein, mRNA/GGCAGACCCGTGTCTTTCCATGCC cds = (71, 1231) 7598 db mining Hs.14632BC008013 14124973 Homo sapiens. Similar to CG12113 1CCTGAAGCACTTCACCTGGAATTGAT gene product, clone IMAGE:3532726,GTGTAGGCTTAAGGAGTATGTGAC mRNA, partial cds/cds = (0, 2372) 7599 dbmining Hs.125156 NM_001488 4503956 transcriptional adaptor 2 (ADA2,yeast, 1 CGCAGGCAAGAGCACTCATCAAGATA homolog)-like (TADAZL), mRNA/GATGTGAACAAAACCCGGAAAATC cds = (0, 1091) 7600 db mining Hs.159545NM_013308 7019400 platelet activating receptor homolog 1CGCTCAAAGGTCACTGAGACTTTTGC (H963), mRNA/cds = (219, 1178)CTCACCTAAAGAGACCAAGGCTCA 7601 db mining Hs.152936 NM_004068 4757993adaptor-related protein complex 2, mu 1 CGGCCTCAGTCCCTACTCTGCTTTGG 1subunit (AP2M1), mRNA/ GATAGTGTGAGCTTCATTTTGTAC cds = (135, 1442) 7602db mining Hs.110857 NM_016310 7706498 polymerase (RNA) III (DNAdirected) 1 CTAGTGTGTGCTTGCCTTGTCCCTCG polypeptide K (12.3 kDa)(POLR3K), GGGTAGATGCTTAGCTGGCAGTAT mRNA/cds = (39, 365) 7603 db miningHs.118666 NM_025207 13376805 hypothetical protein PP591 (PP591), 1CTTTCAGATTCCCTCTGGTCTCCGTC mRNA/cds = (820, 1704)CGAAACGTCTACCTCTTCCCAGGC 7604 db mining Hs.16390 AK024453 10440419 mRNAfor FLJ0045 protein, partial 1 GAAATTCACAGGCCAGGGCACATCTT cds/cds =(106, 924) TTATTTATTTCATTATGTTGGCCA 7605 db mining Hs.109302 AA8080182877424 nv64d09.s1 cDNA, 3′ end/ 1 GACTCCCTCAACACCCAAAACTCTA clone =IMAGE:1234577/clone_end = 3′ 7606 db mining Hs.111126 NM_004339 11038870pituitary tumor-transforming 1 1 GAGCAGCCACAAAACTGTAACCTCAA interactingprotein (PTTG1iP), mRNA/ GGAAACCATAAAGCTTGGAGTGCC cds = (210, 752) 7607db mining Hs.127376 NM_021645 11063982 KIAA0266 gene product (KIAA0266),1 GCAGCAAACAGAGGGTCAGTCACAG mRNA/cds = (733, 3033)GATGTTCTGACACACCATTGTAACT 7608 db mining Hs.108196 NM_016095 7706366HSPC037 protein (LOC51659), mRNA/ 1 GCCAACAATGCTGACCGGTGCTTATC cds =(78, 635) CTCTAAGCCCTGATCCACAATAAA 7609 db mining Hs.117487 AF0409652792365 unknown protein IT 12 mRNA, partial 1 GCCAGTGTAATTTCTGTCAACCACGGcds/cds = (0, 2622) ACGTTTGCCTTCATGTGTAGAATT 7610 db mining Hs.107882NM_018171 8922576 hypothetical protein FLJ10659 1GCCCAAGCACTAGTAGAGATGCGCG (FLJ10659), mRNA/cds = (38, 1000)ATACAGGTCTAGTTTCGGTAACTGT 7611 db mining Hs.147585 NM_024785 13376147hypothetical protein FLJ22746 1 GGCCAGATTTTGACTCCCAGATTCCT (FLJ22746),mRNA/cds = (266, 1072) TTACAAAACGCACTCATTCATTCA 7612 db mining Hs.153357NM_001084 4505890 procollagen-lysine, 2-oxoglutarate 5- 1GGGACTCCCCGCGTGATAAATTATTA dioxygenase 3 (PLOD3), mRNA/ATGTTCCGCAGTCTCACTCTGAAT cds = (216, 2432) 7613 db mining Hs.148495NM_002810 5292160 proteasome (prosome, macropain) 1GGGACTGCATGGGAAGCACGGAATA 26S Subunit, non-ATPase, 4 (ODMD4),TAGGGTTAGATGTGTGTTATCTGTA mRNA/cds = (62, 1195) 7614 db mining Hs.13144NM_014182 7661819 HSPC160 protein (HSPC160), mRNA/ 1GGGGTTCGTGTCTTTGGCATCAACAA cds = (53, 514) ATACTGAGGGATGGGTTTTGGGAC 7615db mining Hs.1189 NM_001949 12669913 E2F transcription factor (E2F3) 1GGGTGACCTGTTCTCTAGCTGTGATC mRNA, complete cds/cds = (66, 1463)TTACCACTTCAAATGGGTGTAATT 7616 db mining Hs.12284 BC001699 12804564 Homosapiens, clone IMAGE:2989556, 1 GGTGTGAACGGGCTGACTTGGTGAA mRNA, partialcds/cds = (0, 370) TTGGGCAACTCCTTATAGTGTTGTG 7617 db mining Hs.158380AI381581 4194362 td05e04.x1 cDNA, 3′ end/ 1 GTACCACTTGAATGATTTCAGTCAATTclone = IMAGE:2074782/clone_end = TTGAACCCCTTTGGAAAGAGGTG 3′ 7618 dbmining Hs.1390 BC000268 12653014 Homo sapiens, proteasome (prosome, 1GTGAAACCCCGTCTCTGCTAAAAATA macropain) subunit, beta type, 2, cloneCAAAAATTAGCTGGGCGTGGTGGC MGC:1664 IMAGE:3352313, mRNA, complete cds/cds= (58, 683) 7619 db mining Hs.115808 NM_002287 11231175leukocyte-associated tg-like receptor 1 1 GTTCTCTGGGTTGTGCTTTACTCCAC(LAIR1), transcript variant a, mRNA/ GCATCAATAAATAATTTTGAAGGC cds = (57,920) 7620 db mining Hs.119960 AL117477 5911950 mRNA; cDNA DKFZp727G051(from 1 TACTGCCAACTGACCTTATAACCCTC clone DKFZp727G051); partial cds/TGCACCTTCAAAAAGATTCATGGT cds = (0, 1423) 7621 db mining Hs.154073NM_005827 5032212 UDP-galactose transporter related 1TCAAACAGTGACATCTCTTGGGAAAA (UGTREL1), mRNA/cds = (87, 1055)TGGACTTAATAGGAATATGGGACT 7622 db mining Hs.11747 NM_017798 8923363hypothetical protein FLJ20391 1 TCACTTCCTCTGAACTGTTACTGCCT (FLJ20391),mRNA/cds = (9, 602) GAATGGAGTCCTGGACGACATTGG 7623 db mining Hs.10881AB011113 3043605 mRNA for KIAA0541 protein, partial 1TCCACTTAATAGACTCTATGTGTGCT cds/cds = (0, 3484) GAATGTTCCTGTGTACATATGTGT7624 db mining Hs.153850 AK024476 10440465 mRNA for FLJ00069 protein,partial 1 TCCCGCAGAGTGCAGAGACAGGAAG cds/cds = (2657, 4396)CTGGAGATGTCTTTATAAAGTCACA 7625 db mining Hs.247870 AL035694 4678462 DNAsequence from clone 33L1 on 1 TCTAGGACCCTAGGAAGCTTAACTCT chromosome6q14.1-15. Contains the GTCATCATCTCAAGTATCTGCACA gene for novel T-box(Brachyury) family protein. Contains ESTs, STSs, GSSs and two putativeCpG islands/ cds-(0, 1505) 7626 db mining Hs.324648 NM_003128 4507194cDNA FLJ13700 fis, clone 1 TCTTCCGCCATCTCCTCTGATAAACA PLACE2000216,highly similar to CGAGGTGTCTGCCAGCACCCAGAG SPECTRIN BETA CHAIN, BRAIN/cds = UNKNOWN 7627 db mining Hs.118722 NM_004480 4758407fucosyltransferase 8 (alpha (1, 6) 1 TGATATGTTGATCAGCCTTATGTGGAfucosyltransferase) (FUT8), mRNA/ AGAACTGTGATAAAAAGAGGAGCT cds = (716,2443) 7628 db mining NA AL134726 6602913 DKFZp547A1290_r1 cDNA, 5′ end/1 TGCAGTATTTTTCAAACTTCTGGTCG clone = DKFZp547A1290/clone_end = 5′ 7629db mining Hs.166887 NM_003915 4503012 copine I (CPNE1), mRNA/ 1TGCTGCTCTTGATCCCACCTTTGCTC cds = (156, 1769) CTGACAACCCTCATTCAATAAAGA7630 db mining Hs.146324 AK023182 10434993 cDNA FLJ13120 fis, clone 1TGGTTTGTTCATGGATGTATTCTAAG NT2RP3002882, highly similar to CGI-AGCTGAGAACAGGGCCTGGACACA 145 protein mRNA/cds = (176, 961) 7631 dbmining Hs.12438 AK026309 10439130 cDNA; FLJ22656 fis, clone HS107655/ 1TGTTCTGAATGTTGGTAGACCCTTCA cds = UNKNOWN TAGCTTTGTTACAATGAAACCTTG 7632db mining Hs.15164 NM_006333 5453582 nuclear DNA-binding protein (C1D),1 TGTTGATGGATGAATTTTGGCATGAT mRNA/cds = (117, 542)GACTGTACTCTCAATAAAGGCTGA 7633 db mining Hs.130743 AA642459 2567877ns30d01.s1 cDNA, 3′ end/ 1 TTCATCCTGTGAGTGCTGGGGAGGA clone =IMAGE:1185121/clone_end = 3′ 7634 db mining Hs.16492 NM_015497 13794264DKFZP546G2022 protein 1 TTCATTTTCCTGGGAAGTCAAGGTTA (DKFZP564G2022),mRNA/ CATCTTGCAGAGGTTGTTTTGAG cds = (42, 1709) 7635 db mining Hs.122552NM_016266 7705291 G-2 and S-phase expressed 1 1TTCTAAGCCCGAACCAAATCCTTTGCC (GTSE1), mRNA/cds = (70, 2232)TTGAAAGAACAGCCCTAAAGTGGT 7636 db mining Hs.312510 AI74807 6361196 HA2528cDNA 1 TTTGTTTGTTTGTTTCAGATAGGGTCT CCCTCTGTCACCCAGGCTGCAGT 7637 dbmining Hs.108258 NM_012090 10048480 actin cross-linking factor (ACF7), 1TTTTGTAAATCACGGACACCTCAATTA transcript varient 1, mRNA/GCAAGAACTGAGGGGAGGGCTTT cds = (51, 16343) 7638 db mining Hs.111092NM_024724 13376033 hypothetical protein FLJ22332 1CGGTGTGGAAAATGTTGTCCTTTGAG (FLJ2232), mRNA/cds = (275, 1255)TGGCAAGAATTAGAAAAATCTTCA 7639 db mining Hs.114311 NM_003504 4502712CDC45 (cell division cycle 45, 1 CTGAAAGCTGAGGATCGGAGCAAGT S.cerevisiae, homolog)-like (CDC45L), TTCTGGACGCACTTATTTCCCTCCT mRNA/cds =(24, 1724) 7640 db mining Hs.11081 NM_02541 13376853 UBXdomain-containing gene 1 1 GTTGGCCTCAGCCCTGTGGGTCTGT (UBXD1), mRNA/cds =(96, 1421) CTCATGCTCTCCCTGTTCCTCTCCC 7641 db mining Hs.100217 NM_0058925174400 formin-like (FMNL), mRNA/ 1 TAGCCATACTTAGCCTCAGCAGGAGC cds =(39, 1430) CTGGCCTGTAACTTATAAAGTGCA 7642 db mining Hs.12258 AL1377286808258 mRNA, cDNA DKFZp434B0920 (from 1 TGAGGGCTGTGCTGACCTTTGAGAG cloneDKFZp4348B0920)/ GATTTGAAATTGCTTCATATTGTGA cds = UNKNOWN 7643 db miningHs.155462 NM_005915 7427518 minichromosome maintenance 1TGTGTAAGAAAAGGCCATTACTTTT deficient (mis5, S. pombe) 6 (MCM6),AAGGTATGTGCTGTCCTATTGAGC mRNA/cds = (61, 2526) 7644 db mining Hs.165998NM_015640 7661625 PAI-1 mRNA-binding protein (PAI- 1TTGTTGGTAGGCACATCGTGTCAAGT RBP1), mRNA/cds = (85, 1248)GAAGTAGTTTTATAGGTATGGGTT 7645 db mining Hs.164207 NM_024805 13376184hypothetical protein FLJ21172 1 TTTCTAGCTTTTCCGTGTATCTAAACA (FLJ21172),mRNA/cds = (138, 1169) CAATTTGCTACACAAGTCACTGT 7646 db mining Hs.150275D87682 1663899 mRNA for KIAA0241 gene, partial cds/ 1ACTGTGGCACATGTTTTGATCAGAAA cds = (0, 1568) GGTAGTTCTCTTTGCTCTGGTAGT 7647db mining Hs.11039 NM_024102 13129109 hypothetical protein MGC2722 1CATCTTCTGCCCTGGTCCCCTTTCTC (MGC2722), mRNA/cds = (69, 1097)TTGATGTGGAAAGTCTGAATGCAG 7648 db mining Hs.102708 NM_015396 7661561DKFZP434A043 protein 1 CGCTCTAATACTGCATTCTGTTTCTC (DKFZP434A043), mRNA/CTTTTGTGCCCTGATTGTAATCCA cds = (697, 1425) 7649 db mining Hs.109646NM_002493 4505364 NADH dehydrogenase (ubiquinone) 1 1CTGGAGACTGGAGAAGTAATTCCACC beta subcomplex, 6 (17kD, B17)AATGAAAGATTTCCTGATCAACA (NDUFB8), mRNA/cds = (68, 454) 7650 db miningHs.142307 AL137273 6807710 mRNA; cDNA DKFZp43410714 (from 1TCAGTGTTTCGTTATTCCATATCAGTG clone DKFZp43410714)/cds = (0.412)GCTTTTACTGTCAAAGATTGTGT 7651 db mining Hs.16297 NM_005694 5031844 COX17(yeast) homolog, cytochrome c 1 TGCATGAGAGCCCTAGGATTTAAAAT oxidaseassembly protein (COX17), ATGAAATGGTGGTCTGCTGTGTGA mRNA/cds = (86, 277)7652 db mining Hs.11184 NM_017811 8923387 hypothetical protein FLJ204191 TGTGCTAAGCCTGATGAAATGTGCTC (FLJ20419), mRNA/cds = (191, 907)CTTCAATCTCCATGAAACCATCGT 7653 db mining Hs.12013 NM_002940 4506558ATP-binding cassette, sub-family E 1 AAATGATCTCCCTTTATTACCCTCCCA (OABP),member 1 (ABCE1), mRNA/ AAGGTTACCAGCGTTTGAATTTA cds = (117, 1918) 7654db mining Hs.155485 NM_005339 12545382 huntingtin interacting protein 2(HIP2), 1 ACACACTAATGTAACCATTTTATGAAG mRNA/cds = (77, 679)GTTGAAGTGGATTTATGCAGGCA 7655 db mining Hs.154573 AW955094 8144777EST367164 cDNA 1 ATCAGGAGAATGTCAAAGAAGTCCTT TATGTGGATTGCCCGAGCTTCTCT7656 db mining Hs.142157 AF080255 5733121 iodestar protein mRNA,complete cds/ 1 ATTGTGCCACTGTTTTCCAGCCTGGG cds = (30, 3518)CAATACAGTGAGACCCTGTCTCAA 7657 db mining Hs.1191 AK025679 10438273 cDNA;FLJ22026 fis, clone HEP08537/ 1 CGTCAAAGTCAATCCCAAAACAGATA cds = UNKNOWNAGCCCTATGAGGATGTCAGCATCA 7658 db mining Hs.13340 NM_003642 4504340histone acetyltransferase 1 (HAT1), 1 ACGACTTGCTCAAGAGTAAAGATTATmRNA/cds = (38, 1295) ACTGCTCTGTACAGGAAGCTTGCA 7659 db mining Hs.108110NM_014034 7681591 DKFZP547E2110 protein 1 TGTTGAGGAAAGGAAAAGGGCATTTG(DKFZP547E2110), mRNA/ TCTAAACATGGATTCTGAGTTGTA cds = (192, 806) 7660 dbmining Hs.123295 AA833793 2908561 od61g07.s1 cDNA/ 1GTGGATGAGTAGGGAGTGGGCGAGA clone = IMAGE:1372476CAGGGACGAGATGAGCAGGGTCAAG 7661 db mining Hs.126565 AB020688 420210 mRNAfor KIAA0861 protein, partial 1 GGTGTTCGTGTTAGTGCCAAGATTGC cds/cds = (0,2948) TTCGTTGTAGAGAGAGTTCGTTCC 7662 db mining Hs.155174 AB007892 2887434KIAA0432 mRNA, complete cds/ 1 ACTAGAGTCCAGGTAATAGTAGTGGA cds = (0,2251) GATATGTGGAGAGACATGATAGGT 7663 db mining Hs.116445 AA648776 2575205ns24d11.s1 cDNA, 3′ end/ 1 TTCCTGTGTGAGATTTCTCGCCATTC clone =IMAGE:1184565/clone_end = CTCAATTCAACAAATATGCCTTTT 3′ 7664 db miningHs.124933 AA825303 2898805 oc67e04.s1 cDNA, 3′ end/ 1TATACTTTGATCCCTCAGCAAGTTGT clone = IMAGE:1354782/clone_end =CCTCACTGTTGTGTGAACCTGTTT 3′ 7665 db mining Hs.313267 AW295641 6702277UI-H-BW0-aip-e-12-0-UI.s1 cDNA, 3′ 1 TTTCCTGAATACTTTATGACAACTGAGend/clone = IMAGE:2729975/ TTTGCCGGGTAGAGTGGCCGTTT clone_end = 3′ 7666db mining Hs.313203 AW293882 6700518 UI-H-BW0-ain-e-07-0-UI.s1 cDNA, 3′1 AAACTAGAATTCCGGTTTCCCAAGGT end/clone = IMAGE:2729941/GGCTTATGACAACCAGAATCCTTT clone_end = 3′ 7667 db mining Hs.105488AA521017 2261560 aa70f05.s1 cDNA, 3′ end/ 1 GGCTTCCCGCCTGTGCAGTCATTTGTclone = IMAGE:826305/clone_end = ATGTGTTTTATATATTGGAGTGTT 3′ 7668 dbmining Hs.125802 AA06833 2876049 oc29b10.s1 cDNA, 3′ end/ 1ACAAAATATAAGGGTGTGACTTTGGAT clone = IMAGE:1351099/clone_end =CCTGACTCAAACCAACCAGCTGTT 3′ 7669 db mining Hs.313274 AW295745 6702381UI-H-BW0-aiw-g-10-UI.s1 cDNA, 3′ 1 TCAAAATCCGTTACTCTTTCCACAACA end/clone= IMAGE:2730834/ ATTGAGGGTAATGGTGTTCAGTT clone_end = 3′ 7670 db miningHs.320376 BF512113 11597325 UI-H-BW1-ami-h-04-0-UI.s1 cDNA, 3′ 1GCCATTCCGGGCTTCTCTATTTGAAAA end/clone = IMAGE:3070302/CAGTTACCATATTCCCCCTCAGTT clone_end = 3′ 7671 db mining Hs.315341BE675056 10035597 7f02/10.x1 cDNA, 3′ end/ 1 ATTTGGTAGAGACGGGGTTTCACCTTclone = IMAGE:3293419/clone_end = ATTGCCCAGGCCATCATGTATCTT 3′ 7672 dbmining Hs.320407 BF512394 11597660 UI-H-BW1-amc-f-01-0-UI.s1 cDNA, 3′ 1TGTCATTTGCCCTTTCCCCCATATAT end/clone = IMAGE:3069456/GTAGAATTGGGTCTTTTTCAACTT clone_end = 3′ 7673 db mining Hs.313347AW297156 6703802 UI-H-BW0-ajd-b-05-0-UI.s1 cDNA, 3′ 1AACAGGGAGAGACTACACACAA end/clone = IMAGE:2731329/GCCAACCTCAATCTCATCTTTATGC clone_end = 3′ CATT 7674 db mining Hs.123298AA809468 2878874 ob85a10.s1 cDNA, 3′ end/ 1 TCTTCTTTTTGATGTGAATTACTCTTGclone = IMAGE:1338138/clone_end = AAATGCCGGAGAAGGGACAAATT 3′ 7675 dbmining Hs.320416 BF512570 11597749 UI-H-BW1-amf-e-12-0-UI.s1 cDNA, 3′ 1AGATAGAGTCATATTCTATTTAGCTTG end/clone = IMAGE:3069791/GGACATGGCAGGTACTCAGTTGT clone_end = 3′ 7676 db mining Hs.309262 AI4405324300887 CM4-NT0290-150101-684-e05 cDNA 1 AGCCTTTTTGGGAGTGAGGGTTTATATGATGTCTGATTCTGTAATACTGT 7677 db mining Hs.313338 AW297010 6703646UI-H-BW0-ejf-d-01-0-UI.s1 cDNA, 3′ 1 GCAGCCCTGAGCCTGGAATAGATACTend/clone = IMAGE:2731441/ TTTTGGTCTTTTGGTTGTAGATGT clone_end = 3′ 7678db mining Hs.315325 BE646400 9970711 7e66c01.x1 cDNA, 3′ end/ 1CCCTCCCTATCTTTTTATGGGTAATTT clone = IMAGE:3292032/clone_end =GATTATACACGGTGCTTGAATGT 3′ 7679 db mining Hs.313172 AW293016 6699652UI-H-BW0-aih-f-04-0-UI.s1 cDNA, 3′ 1 TATGTCTTCTTACCCCAGCACCCCTAend/clone = IMAGE:2729239/ ATTTAAAATACAGATCCCTGAGGT clone_end = 3′ 7680db mining Hs.313361 AW297413 5704049 UI-H-BW0-ais-b-09-0-UI.s1 cDNA, 3′1 AAAACCTTGACAGTTCATTTCACCAA end/clone = IMAGE:2730208/GCACCTATCAGGTATTTGGCAGGT clone_end = 3′ 7681 db mining Hs.313365AW297482 6704118 UI-H-BW0-aja-a-05-0-UI.s1 cDNA, 3′ 1AGTGCCCATGCTGTTTCAGATGCTCT end/clone = IMAGE:2730920/TCTAGCTCCTGGAGATACATCAGT clone_end = 3′ 7682 db mining Hs.313558AW297377 6704013 UI-H-BW0-eir-f-11-0-UI.s1 cDNA, 3′ 1TGAGCTTCTGCTAGTAATTCCTTCAG end/clone = IMAGE:2730381/GGGATTTCCTCCATGGCCGTAAGT clone_end = 3′ 7683 db mining Hs.320474BF513180 11598359 UI-H-BW1-amj-d-06-0-UI.s1 cDNA, 3′ 1GAGGGTGTCTGCTAATGATTTCCGAA end/clone = IMAGE:3070115/AAGTTCTTCAAAACACTCCGAAGT clone_end = 3′ 7684 db mining Hs.313382AW297707 6704343 UI-H-BW0-ajh-f-10-0-UI.s1 cDNA, 3′ 1ACCAGTGTCATGAGTTTTGACAAGAG end/clone = IMAGE:2731915/ACAAAAGGAAAGGGTGGGAGAAGT clone_end = 3′ 7685 db mining Hs.125779AA810831 2880442 oa78d09.s1 cDNA, 3′ end/ 1 GCTGGTTGTTGCCTTTCAAGACAGCCclone = IMAGE:1318193/clone_end = AACTACCATTTATTCAACAGAAGT 3′ 7686 dbmining Hs.313389 AW297882 6704507 UI-H-BW0-aju-e-07-0-UI.s1 cDNA, 3′ 1AGTCTGTCTATTCTCTTCTCTTTAGCT end/clone = IMAGE:2733038/CTGTCTGTTGCTCAAATTCAAGT clone_end = 3′ 7687 db mining Hs.313391 AW2979056704541 UI-H-BW0-eju-h-11-0-UI.s1 cDNA, 3′ 1 GCCAAGGTGAGTCAAAACACTGCTCTend/clone = IMAGE:2733188/ TCAGAAAGCAATTATTTGAAAAGT clone_end = 3′ 7688db mining Hs.309446 AI492055 4393058 tg12a01.x1 cDNA, 3′ end 1CATTGTCCCTCCCGCTGTGCTCTCAG clone = IMAGE:2108520/clone_end =GCAATAAATGATTTGATTATTTCT 3′ 7689 db mining Hs.313311 AW296433 6703069UI-H-BWD-aiq-a-05-0-UI.s1 cDNA, 3′ 1 GGTCAGAAACAGGCCCACAGAGACT end/clone= IMAGE:2730128/ CTGGAGGGTTCTTCCTTTGTGTTCT clone_end = 3′ 7690 db miningHs.319887 BF507608 11590906 UI-H-BW1-ana-e-05-0-UI.s1 cDNA, 3′ 1TTCAACTGCTTTGGCACTGCCATGGG end/clone = IMAGE:3071720/TACCTGAGGATAAGAGAGATGTCT clone_end = 3′ 7691 db mining Hs.225237AW293790 6700426 UI-H-B12-ahp-e-06-0-UI.s1 cDNA, 3′ 1GGGTTGACTAAATGCACATGGGCTTA end/clone = IMAGE:2727635/TCTTTACCTCTTCCAGAAATGTCT clone_end = 3′ 7692 db mining Hs.313383AW297459 6704095 UI-H-BW0-ais-g-03-0-UI.s1 cDNA, 3′ 1TGCATGACCAGAAACACTGCCTGATA end/clone = IMAGE:2730436/CAGTAAGCAGAGGTAGCTGTCTCT clone_end = 3′ 7693 db mining Hs.320367BF512169 11597272 UI-H-BW1-ami-c-10-0-UI.s1 cDNA, 3′ 1ACCTGCCAGCCAGCCCACAACTATAA end/clone = IMAGE:3070074/ACTGTGTGACACCCAAATTTATCT clone_end = 3′ 7694 db mining Hs.320440BF512733 15597912 UI-H-BW1-amm-d-04-0-UI.s1 cDNA, 1GGTTTCTGAGGTGATTCTAATATGCA 3′ end/clone = IMAGE:3070494/GTCATGGTTAAGAACCTGTGATCT clone_end = 3′ 7695 db mining Hs.313374AW297607 6704243 UI-H-BW0-ajg-e-04-0-UI.s1 cDNA, 3′ 1AAGCCTTGGACCAGCTTCCCGTTTCT end/clone = IMAGE:2731854/CTCTTGTCTCCTGCCAAAAGATCT clone_end = 3′ 7696 db mining Hs.313355AW297325 6703961 UI-H-BW0-air-a-08-0-UI.s1 cDNA, 3′ 1ACCCAAAGGATGGTGTCTCCTGTCCC end/clone = IMAGE:2730135/AGTTGAAAAGGTTTCTACCTAGCT clone_end = 3′ 7697 db mining Hs.320420BF512599 11597778 UI-H-BW1-anf-h-07-0-UI.s1 cDNA, 1TGGTTGAATACGCAGGAACACCCACA 3′ end/clone = IMAGE:3069925/GTACCCAGGGACTAATAAATAGCT clone_end = 3′ 7698 db mining Hs.118899AA243283 1874126 zs13g11.s1 cDNA, 3′ end/ 1 TTAGGGCAGTGGAGAATCAGGGTGTclone = IMAGE:685124/clone_end = ATCTAATAAATTCCTTCATGGAGCT 3′ 7699 dbmining Hs.105226 AA489212 2218814 aa57d11.s1 cDNA, 3′ end/ 1GCAGATGTCTGCGTCATGGTTTATTA clone = IMAGE:825045/clone_end =CTCCTGTGTTCGTTTCAAGGAGCT 3′ 7700 db mining Hs.297505 BF514865 11600044UI-H-BW1-anj-f-12-0-UI.s1 cDNA, 3′ 1 TGTCTGTATTTGGAGTCCAGTAGTACend/clone = IMAGE:3082534/ ACTGAAAATAATCCCGTAAAAGCT clone_end = 3′ 7701db mining Hs.320492 BF513340 11598519 UI-H-BW1-amk-b-10-0-UI.s1 cDNA, 3′1 CTCCCTTCCCACCATACACACACTCC end/clone = IMAGE:3070050/CAGCTCATTTTGATTCCTTTTCCT clone_end = 3′ 7702 db mining Hs.304837AW292802 6699438 UI-H-BW0-aij-f-12-0-UI.s1 cDNA, 3′ 1GGTGAAATTGACTGGGTTCCTCTCCC end/clone = IMAGE:2729615/ACCTCTCTTTCCGTAGCAATTCCT clone_end = 3′ 7703 db mining Hs.24656 BF50776211591060 KIAA0907 protein (KIAA0907), 1 ACTAATTCCCGTGTCTGGCCCTGAACmRNA/cds = (26, 1720) ATGAAGATATAATGGACGATCCCT 7704 db mining Hs.320460BF512975 11598154 UI-H-BW1-amh-b-06-0-UI.s1 cDNA, 3′ 1TTAAAGGCTCAAACCTACCTCAGACA end/clone = IMAGE:3069559CTGCTCTACCCATCCCCATCCCCT clone_end = 3′ 7705 db mining Hs.313384AW297745 6704381 UI-H-BW0-aiy-b-10-0-UI.s1 cDNA, 3′ 1CCCTTTGTGAGAAGAAGCAGGTTTCC end/clone = IMAGE:2730954/TTTCCTATGGATTGATGTGACCCT clone_end = 3′ 7706 db mining Hs.105105AA419402 2079198 zu99a12.s1 cDNA, 3′ end/ 1 TTCTACCCATCACACAGATTCTTCCAclone = IMAGE:746110/clone_end = CTTAATAAAATCCATCACCTACCT 3′ 7707 dbmining Hs.123180 AA805419 2874169 oc13g03.s1 cDNA, 3′ end/ 1TCATTACTGTTGTGAAGGCTCTTCAA clone = IMAGE:1340788/clone_end =GAGAGAAAGATGAAGCTGAAACCT 3′ 7708 db mining Hs.297396 BF515183 11600450UI-H-BW1-ani-c-01-0-UI.s1 cDNA, 3′ 1 GCTGTCCGTGAAAGCACTCTCAAGTCend/clone = IMAGE:30827728/ AGGAACTGAACTAAGAACTTTACT clone_end = 3′ 7709db mining Hs.334992 AI084211 3422634 RST20881 cDNA 1CTCCTGTAATCCCAGCACTGGAGCTT GCAGTGAGCCAAGATCATGCCACT 7710 db miningHs.313273 AW295743 6702379 UI-H-BW0-aiw-g-08-0-UI.s1 cDNA, 3′ 1TTGGTCACCACACCTGGGTGTCTGAA end/clone = IMAGE:2730830/TGTCTTGTCCTTCTAAAGGTAACT clone_end = 3′ 7711 db mining Hs.319891BF507631 11590929 UI-H-BW1-and-h-01-0-UI.s2 cDNA, 3′ 1GCAACAATTCTTTGGAAAGTGACTCT end/clone = IMAGE:3071856CTAGGGTGCGGAGAATGGTGTGAT clone_end = 3′ 7712 db mining Hs.320422BF512614 11597793 UI-H-BW1-amg-a-12-0-UI.s1 cDNA, 3′ 1TCATCTCTGTAGGTCTTCCTAATCCTA end/clone = IMAGE:3069822TGCGGAGCCAAATATAGACGGAT clone_end = 3′ 7713 db mining Hs.319872 BF50741411590721 UI-H-BW1-amz-a-11-0-UI.s2 cDNA, 3′ 1 CTTTGTATTTCAAAGAAAGTAGCCCCend/clone = IMAGE:3071517/ TTGGCTCTGATATTAGTTGCAGAT clone_end = 3′ 7714db mining Hs.264120 AI523841 4437776 601435078F1 cDNA, 5′ end/ 1TTTAGGAGCTGACCATACATGATGAG clone = IMAGE:3921187/clone_end =TGATACAGCCTGTACTTTGCTCAT 5′ 7715 db mining Hs.105284 AA491263 2220436aa49d04.s1 cDNA, 3′ end/ 1 ACTGGGATGAGATGAGATTCAAGGCA clone =IMAGE:824283/clone_end = CTTTTGGAGGGTGTAGCTAGCCAT 3′ 7716 db miningHs.124376 AA831043 2904142 oc58h02.s1 cDNA, 3′ end/ 1AGGCTGTTGCTGCACGGGCTTTTCAA clone = IMAGE:1353939/clone_end =AAGCGACTCATTATGAAGAAGAAT 3′ 7717 db mining Hs.309144 AI384035 4196816td05c02.x1 cDNA, 3′ end/ 1 GCACTCCAGCCTGGGCAACAAGAGC clone =IMAGE:2074754/clone_end = GAAACTCTGCCTCCAATAAATAAAT 3′ 7718 db miningHs.301325 BF514004 11599183 UI-H-BW1-amv-e-04-0-UI.s1 cDNA, 3′ 1CGGGCGGTGGCGGCTGCCTGGGAG end/clone = IMAGE:3071311/AAGATGAATCTTTCATGAGTGATTTG clone_end = 3′ 7719 db mining Hs.319904BF507742 11591040 UI-H-BW1-anc-f-02-0-UI.s2 cDNA, 3′ 1GATGGAACTCAAGGTGCTTTACGCTT end/clone = IMAGE:3072122/TCCTCAGTCTTACCAGGAGGCTTG clone_end = 3′ 7720 db mining Hs.320092AI392740 4222287 tg23f02.x1 cDNA, 3′ end/ 1 ACCAACCCTATGGACAACTTGATCTTclone = IMAGE:2109267/clone_end = GAACTTCTAGCTTTCAGACCTGTG 3′ 7721 dbmining Hs.313371 AW297578 6704214 UI-H-BW0-aig-b-03-UI.s1 cDNA, 3′ 1AATGTAGCTGACATTGGAGCCACCGC end/clone = IMAGE:2731708/CCATAGAAGAAGGCTAAAACTGTG clone_end = 3′ 7722 db mining Hs.320444BF512784 11597963 UI-H-BW1-amm-h-10-0-UI.s1 cDNA, 1CTTCACTGACGATCTGAGACACTAGG 3′ end/clone = IMAGE:3070698/CAGGTTGGAAAGGGTGGAGTGGTG clone_end = 3′ 7723 db mining Hs.320473BF513155 11598334 UI-H-BW1-amj-b-03-0-UI.s1 cDNA, 3′ 1GCCCCTGGTGGTTGGAAAAGTGTTCT end/clone = IMAGE:3070013/GAATCCAATAAAAGGAAAGCGGTG clone_end = 3′ 7724 db mining Hs.320419BF512597 11597776 UI-H-BW1-amf-h-05-0-UI.s1 cDNA, 3′ 1CAACAGTGGCAAGAGTAGCCAGCCC end/clone = IMAGE:3089921/ATAGGACGGAATGAAAATCAAGGTG clone_end = 3′ 7725 db mining Hs.320365BF512157 11597260 UI-H-BW1-ami-b-20-0-UI.s1 cDNA, 3′ 1CATCCTTAGATGCCAGTCTTCACTTT end/clone = IMAGE:3070026/GGGTATTTTCCTGCCTCCTCAGTG clone_end = 3′ 7726 db mining Hs.299471BF513893 1599072 UI-H-BW1-aq-d-02-0-UI.s1 cDNA, 3′ 1ACCAACAGTACCGTTATTGCCACCAC end/clone = IMAGE:3070874/AAGTAAACCAGTCCCTCACTTCTG clone_end = 3′ 7727 db mining Hs.313368AW297544 6704180 UI-H-BW0-aja-g-01-0-UI.s1 cDNA, 3′ 1AGGCTAAATCAGAGCTTTCCTCCCCA end/clone = IMAGE:2731200/GATAAAGGAAATTTTCCCTCCCTG clone_end = 3′ 7728 db mining Hs.105170AA481410 2210962 zv02g12.s1 cDNA, 3′ end/ 1 AACTTCCAGAGGCAGGAGATTAGACAclone = IMAGE:746374/clone_end = GGGATGACAGTTAAGGGGTTACTG 3′ 7729 dbmining Hs.313251 AW295130 6701766 UI-H-BW0-alt-h-08-0-UI.s1 cDNA, 3′ 1ACCTCTTCGTTGTATTTTACCTTTCAC end/clone = IMAGE:2730495/TTACAAACAAGCTCATGCCACTG clone_end = 3′ 7730 db mining Hs.297392 BF51420111599380 UI-H-BW1-ani-d-05-0-UI.s1 cDNA, 3′ 1 GATCAAAACAAGGTCCTTGACTTTTTend/clone = IMAGE:3082401/ GCAGGGGCAGCCTGGCAATCAATG clone_end = 3′ 7731db mining Hs.122417 AA761212 2810142 nz20c03.s1 cDNA, 3′ end/ 1CCTAAATGTTGTCCCTCAGAGATGCA clone = IMAGE:1288324/clone_end =CAGATGTATATGGGTAAGGAAATG 3′ 7732 db mining Hs.297469 BF512785 11597964UI-H-BW1-amm-h-11-0-UI.s1 cDNA, 1 CCAACCATAGTCATGAAGCTGCTTCT 3′end/clone = IMAGE = 3070700/ GTTCCCAATGCAATCCCATTGTGG clone_end = 3′7733 db mining Hs.313275 AW295750 6702386 UI-H-BW0-aiw-h-03-0-UI.s1cDNA, 3′ 1 GCTTTTCAATGCTTCCGAAACTGAGT end/clone = IMAGE:2730868/GCTAACAGGGGCAATTAGTGCTGG clone_end = 3′ 7734 db mining Hs.313173AW293031 6899667 UI-H-BW0-aih-g-10-0-UI.s1 cDNA, 3′ 1AGTTCTTGTAACAGTTAAAACTTTCTT end/clone = IMAGE:2729299/GCCAGCTCTCAGGTTATCACTGG clone_end = 3′ 7735 db mining Hs.320386 BF51229511597474 UI-H-BW0-amb-e-03-0-UI.s1 cDNA, 3′ 1 GTGTGTAAATGAGTGTCAGATCTTTTend/clone = IMAGE:3069389/ CTTGAAAACAGGTTTGGATTGGGG clone_end = 3′ 7736db mining Hs.320429 BF512664 11597843 UI-H-BW1-amg-f-03-0-UI.s1 cDNA, 3′1 AGGGTCCACAAGGAGAATATTTTCTT end/clone = IMAGE:3069844/AAAGTAACTCCCTGATTTGCGGGG clone_end = 3′ 7737 db mining Hs.123352AA811133 2880744 oa98b10.s1 cDNA, 3′ end/ 1 GCTCCCCTATGCCTGTGTAGCAGAATclone = IMAGE:1320283/clone_end = CTAAAAGATAATCATGTGAACGGG 3′ 7738 dbmining Hs.320389 BF512323 11597502 UI-H-BW1-amb-g-09-0-UI.s1 cDNA, 3′ 1TTGTCTTGTTTCTTTTATCTCCCCTAT end/clone = IMAGE:3069497/GTTTCATCTTAGTGCAGGCAGGG clone_end = 3′ 7739 db mining Hs.120563 AA7411182779708 nz04f08.s1 cDNA, 3′ end/ 1 ACAGTTGCCTTTGAGATTCCTGTATTT clone =IMAGE:1286823/clone_end = CTGCATGAATAAATCCATAAGGG 3′ 7740 db miningHs.320373 BF512098 11597310 UI-H-BW1-ami-f-12-0-UI.s1 cDNA, 3′ 1GTCCTTGGAAGGTAACACTTGTGATT end/clone = IMAGE:3070222/GGAACCACTCTTCAAGCTGAACGG clone_end = 3′ 7741 db mining Hs.320490BF513327 11598508 UI-H-BW1-amk-a-07-0-UI.s1 cDNA, 3′ 1ATTCATTCATTCATTCAACAAGCACTT end/clone = IMAGE:3069996AAAAACAATGCCTGTGTGCCAGG clone_end = 3′ 7742 db mining Hs.313290 AW2960746702710 UI-H-BW0-aiu-h-07-0-UI.s1 cDNA, 3′ 1 CACACCCAGCCCCATTCACAAAGGACend/clone = IMAGE:2730852/ TATAAAATCTACACCCCAGTCACG clone_end = 3′ 7743db mining Hs.320390 BF512330 11597509 UI-H-BW1-amb-h-05-0-UL.s1 cDNA, 1GGCATAGTAGTGCTAAACAGAGGTG 3′ end/clone = IMAGE:3069537/GAAGTAGTGAAGGGAGTTTTGAACG clone_end = 3′ 7744 db mining Hs.297397BF507606 11590904 UI-H-BW1-ana-e-02-0-UI.s2 cDNA, 1CTAGTCCTGCCCCCACCTCCCCAAGT 3′ end/clone = IMAGE:3071714/ATTACCCCTCCTAAGTCCTGCTAG clone_end = 3′ 7745 db mining Hs.309256AI373161 4153027 qz13a01.x1 cDNA, 3′ end/ 1 AGATAAGCAGGATAAACAAGACAGGTclone = IMAGE:2021352/clone_end = TGGATTGTGATCAGCTCTATGGAG 3′ 7746 dbmining Hs.343303 BF13322 11598501 UI-H-BW1-amk-a-02-0-UI.s1 cDNA, 1GATGGCTAGGACAAGATGATTTACAA 3′ end/clone = IMAGE:3069986/GAGCGTGGCGGGAGGGACGGCGAG clone_end = 3′ 7747 db mining Hs.301870BF507614 11590912 UI-H-BW1-ana-f-03-0-UI.s2 cDNA, 1CCGTGTCTGGAATTGTGTGTCTTACTT 3′ end/clone = IMAGE:3071764/CTAAAGGTGCACATACTTCATAAG clone_end = 3′ 7748 db mining Hs.300479AW452510 6993286 UI-H-BW1-ame-a-12-0-UI.s1 cDNA, 1GTATCTCTGCACCTCACTACTACCCT 3′ end/clone = IMAGE:3069598/TCACTCCTTGGAGACCTGGGCAAG clone_end = 3′ 7749 db mining Hs.320387BF512301 11597480 UI-H-BW1-amb-e-09-0-UI.s1 cDNA, 1AACACACCACCAAACATTCTTCCCAT 3′ end/clone = IMAGE:3069401/CCTTCTTCACCAACCAGCTACAAG clone_end = 3′ 7750 db mining Hs.122854AA292626 1940611 zs57h08.r1 cDNA, 5′ end/ 1 ACAATTGGAGTTGGGGCTGTCACCACclone = IMAGE:701631/clone_end = CTGAAGTGTGTCAACCACAGAAAG 5′ 7751 dbmining Hs.300488 AW453029 6993805 UI-H-BW1-ama-c-10-0-UI.s1 cDNA, 1TTAGGGCAAAAGTCCTAGTGGCGGC 3′ end/clone = IMAGE:3069306/AGCTTTCTTGTCTAGACCCTGGTTC clone_end = 3′ 7752 db mining Hs.335081AI380942 4190801 tg18c08.x1 cDNA, 3′ end/ 1 AGTGATGCTTGCCTTTTCGCTTTCCTclone = IMAGE:2109134/clone_end = AAAGATGTCATTTGAAAACAAGTC 3′ 7753 dbmining Hs.313822 AW452916 6993692 UI-H-BW1-amd-b-02-0-UI.s1 cDNA, 1CCCAGCTTCATTAATGTGAATGGTGG 3′ end/clone = IMAGE:3069267/CAGACACCTCTAGCTATAGAGCTC clone_end = 3′ 7754 db mining Hs.309486AI523959 4438094 tg98f09.x1 cDNA, 3′ end/ 1 GAGCCAAGATTGGGCCACTGCACTCclone = IMAGE:2115841/clone_end = CAGCCTGGGTGACAGAGTGAGACTC 3′ 7755 dbmining Hs.303926 AI084223 3422646 oy72g05.x1 cDNA, 3′ end/ 1GAGCCGAGATTGCATCACTGCACTCC clone = IMAGE:1571416/clone_end =AGCCTGGTCAACAGAGCGAGACTC 3′ 7756 db mining Hs.313170 AW292942 6699578UI-H-BW0-aig-f-11-0-UI.s1 cDNA, 1 TTCAGTCATGCAGCAACATCCGCTTA 3′end/clone = IMAGE:2729252/ ATGCCTCCTAAGTGCAGAACACTC clone_end = 3′ 7757db mining Hs.313795 AW452553 6993329 UI-H-BW1-ame-e-11-0-UI.s1 cDNA, 1GGTCCTCTTCTCTCTACTCTCCCTAG 3′ end/clone = IMAGE:3069788/TAACTAACCACCAAAGCCTAAATC clone_end = 3′ 7758 db mining Hs.319883BF507567 11590865 UI-H-BW1-amr-h-08-0-UI.s1 cDNA, 1TTGTTTGTTTGTTTATTTATTTATTTG 3′ end/clone = IMAGE:3071079/AGGCAGCGTCTTGCTCTGTTGC clone_end = 3′ 7759 db mining Hs.320476 BF51318711598365 UI-H-BW1-amj-e-02-0-UI.s1 cDNA, 1 TGCCATCTTTACATCTAATCAAGAGG 3′end/clone = IMAGE:3070155/ TAGAGCTTCCCCTGGTGTTCCTGC clone_end = 3′ 7760db mining Hs.313828 AW453000 6993776 UI-H-BW1-ama-a-05-0-UI.s1 cDNA, 1TGCTCTGCTCTTCCCAAATCAAGGAA 3′ end/clone = IMAGE:3069200/TGTAGATCTTGCTAACAGAACTGC clone_end = 3′ 7761 db mining Hs.120251AA731388 2753542 nz86f07.s1 cDNA, 3′ end/ 1 TGGCACCAACTTACACTTCCAGAAGAclone = IMAGE:1302373/clone_end = GAGTGGTTCAGGAAATTACTATGC 3′ 7762 dbmining Hs.313392 AW297908 6704544 UI-H-BW0-ajn-a-04-0-UI.s1 cDNA, 1AACTTTGGGAAGTGAGACTCTGTCTT 3′ end/clone = IMAGE:2732071/GGGTTTTTGATAATAAATGTGGGC clone_end = 3′ 7763 db mining Hs.343320BF512697 11597876 UI-H-BW1-amm-a-02-0-UI.s1 cDNA, 1CCGAGAAAGTACGGCTGGAGCGGAC 3′ end/clone = IMAGE:3070348/TGGGGAGACGGAAATATTGAGTCGC clone_end = 3′ 7764 db mining Hs.304178AI540182 4457555 td10f04.x1 cDNA, 3′ end/ 1 CGAAGAAAGAATTGGATGCAGAATTGclone = IMAGE:2075263/clone_end = TTGCCTAACCTGGGTGACAAGAGC 3′ 7765 dbmining Hs.320425 BF512629 11597808 UI-H-BW1-amg-c-03-0-UI.s1 cDNA, 1AGTGCCTGTGATTCCACCCCCTTACC 3′ end/clone = IMAGE:3069700/TCCCACTCAAGTGACAATGTAAGC clone_end = 3′ 7766 db mining Hs.313236AW294711 6701347 UI-H-BW0-aim-b-12-0-UI.s1 cDNA, 1AGAAAGTTAGGAGTCGGCAACCTTAA 3′ end/clone = IMAGE:2729806/GGAGGAGTTTCCTATCATCTCTCC clone_end = 3′ 7767 db mining Hs.313379AW297666 6704302 UI-H-BW0-ajh-c-02-0-UI.s1 cDNA, 1TGTCACAAAGATGAAGCAAGGTGGCT 3′ end/clone = IMAGE:2731755/CAGGGAACGTGCTCAGAAACCTCC clone_end = 3′ 7768 db mining Hs.123341AA810927 2880538 oa77d07.s1 cDNA, 3′ end/ 1 GCAAAGTGAAAGTTTTCCCTTTGGCCclone = IMAGE:1318285/clone_end = CTAAAATATGAAAGCAAAGCATCC 3′ 7769 dbmining Hs.313208 AW293991 6700627 UI-H-BW0-aik-h-08-0-UI.s1 cDNA, 1CCCTGTCCATCTTTTCCTGTTCCTATC 3′ end/clone = IMAGE:2729726/CAGCCTTCCCTCTCCTTTTTGCC clone_end = 3′ 7770 db mining Hs.123344 AA8110242880635 ca82g05.s1 cDNA, 3′ end/ 1 CCACGGAGGGCTCCCCATCTAAAGG clone =IMAGE:1318808/clone_end = GAGTTTAATAAACAAAGGAATGGCC 3′ 7771 db miningHs.320450 BF512839 11598018 UI-H-BW1-amu-e-10-0-UI.s1 cDNA, 1CAATTGGTACATTCTCGGCAAACCCT 3′ end/clone = IMAGE:3071322/TGCCCACAATTTCCTCAGGAAGCC clone_end = 3′ 7772 db mining Hs.313359AW297549 6704185 UI-H-BW0-aja-g-08-0-UI.s1 cDNA, 1AGGGTGTCCCTGTGATTTTTAAATTC 3′ end/clone = IMAGE:2731214/ACTATCTAGCTGTCCCTATCCCCC clone_end = 3′ 7773 db mining Hs.297527BF515924 11501103 UI-H-BW1-aoa-e-01-0-UI.s1 cDNA, 1CTTATATTATGTTTTCTCTGTGACAAG 3′ end/clone = IMAGE:3084001/CACCTCACCTCCCAACCCACCCC clone_end = 3′ 7774 db mining Hs.297513 BF51549811600677 UI-H-BW1-ann-g-04-0-UI.s1 cDNA, 1 GAGAATTCAAATTAAATGCAGAGTCC 3′end/clone = IMAGE:3082950/ TAGGCCCACCCTGGCATACCACCC clone_end = 3′ 7775db mining Hs.105218 AA488881 2218483 aa55f06.s1 cDNA, 3′ end/ 1ACAACCAATGCCTCACACTTAAGCTC clone = IMAGE:824867/clone_end =CTAGAAGTCACTAGGGACCAGACC 3′ 7776 db mining Hs.309447 AI492062 4393085tg12a11.x1 cDNA, 3′ end/ 1 GCCCTCACCAGAATTCAATCATGCTG clone =IMAGE:2108540/clone_end = GCACCTTATCTTGGACTTTCAACC 3′ 7777 db miningHs.309483 AI523758 4437893 tg94e10.x1 cDNA, 3′ end/ 1AGGGTAAGAGTTCCAGACCTGACTG clone = IMAGE:2116458/clone_end =GACAATAAAGTGAGACTGTCTCTAC 3′ 7778 db mining Hs.343333 BF515310 11600412UI-H-BW1-ank-g-09-0-UI.s1 cDNA, 1 CTCCGTCTGCCGCCTCCGTAGCCAC 3′ end/clone= IMAGE:3082577/ AGCGACTTTGGAAGTGATATTTGAC clone_end = 3′ 7779 db miningHs.309687 AI401187 4244274 tg26h10.x1 cDNA, 3′ end/ 1CCCTGGAGAAGGAGGGTGATTTATTT clone = IMAGE:2109955/clone_end =TCAACTTTCTGATTTACCACCGAC 3′ 7780 db mining Hs.314730 AI523958 4438093tg98f08.x1 cDNA, 3′ end/ 1 GATTGTTTGAGCCTGGGAGTTCCACA clone =IMAGE:2116839/clone_end = CCAGCCTGGGCTACATAGGGAGAC 3′ 7781 db miningHs.313337 AW297006 6703842 UI-H-BW0-ajf-c-09-0-UI.s1 cDNA, 1CTGCTCTAGACTGAGCACAGCCACTG 3′ end/clone = IMAGE:2731409/ACAGGTGACCTTCAGAATCCTCAC clone_end = 3′ 7782 db mining Hs.116455AA649141 2575570 ns32g12.s1 cDNA, 3′ end/ 1 ACCCCTGCTTTACTGTGACAGACATAclone = IMAGE:1185382/clone_end = TAGTTTGTCATACATAAAACCCAC 3′ 7783 dbmining Hs.123313 AA810089 2879495 od12f12.s1 cDNA, 3′ end/ 1ACCTAACAGAAATTTGGATTCGGGTT clone = IMAGE:1367758/clone_end =GTCTAAATACACCCTGGTGGGTTA 3′ 7784 db mining Hs.319668 BF507353 11590660UI-H-BW1-amx-c-04-0-UI.s1 cDNA, 1 GCCTTTCCCACCAACAGTTTATGTGA 3′end/clone = IMAGE:3071239/ TTCCCTGCCCTACCCTTACCATTA clone_end = 3′ 7785db mining Hs.123342 AA811005 2880618 oa73g11.s1 cDNA, 3′ end/ 1TCCCATTGCATGTCCCGTATATTGAA clone = IMAGE:1317956/clone_end =AGCTGCCTCTACTTCTCTCTGGTA 3′ 7786 db mining Hs.313288 AW296061 6702697UI-H-BW0-aiu-g-06-0-UI.s1 cDNA, 1 GGCAGGGGATGAACCAGATAATTTTCC 3′end/clone = IMAGE:2730802/ AGCCCTTCTTGGTAGCTCTTCGTA clone_end = 3′ 7787db mining Hs.308998 AI358553 4108174 qz27h12.x1 cDNA, 3+ end/ 1GCTTAGGAGTTTGGGACCAGCCTGG clone = IMAGE:2028167/clone_end =GTAACATAGTGAAACCCTGTCTCTA 3′ 7788 db mining Hs.313328 AW296796 6703432UI-H-BW0-ajb-e-06-0-UI.s1 cDNA, 1 TTGCAGCTATTTTCAAGTTGTAAGAAA 3′end/clone = IMAGE:2731115/ TGAACTTGCAACACATAGGGCTA clone_end = 3′ 7789db mining Hs.320462 BF512988 11598185 UI-H-BW1-amh-c-06-0-UI.s1 cDNA, 1TCTCTTGCCACAGGGATTTCCTCCAA 3′ end/clone = IMAGE:3069707/GCTGGAATCACCATTTCCTTCCTA clone_end = 3′ 7790 db mining Hs.297514BF516300 11601479 UI-H-BW1-anz-e-06-0-UI.s1 cDNA, 1CCCACCCACCAGTAGGTTGTGATTCA 3′ end/clone = IMAGE:3084010/ACTGAACCATTTCAGGAGCACCTA clone_end = 3′ 7791 db mining Hs.124358AA803650 2903749 oc52g02.s1 cDNA, 3′ end/ 1 GAACCCAGCTAAGCCACACCCAGATTclone = IMAGE:135362/clone_end = CTGACCCAGGGATACTCTGAAATA 3′ 7792 dbmining Hs.313345 AW297163 6703789 UI-H-BW0-ajd-a-04-0-UI.s1 cDNA, 1GTGTGTGCTGGCGTGCCTTATAGGT 3′ end/clone = IMAGE:2731279/GTGCGTGTTTCCCTGTCAGTTTTGA clone_end = 3′ 7793 db mining Hs.320484BF513248 11598425 UI-H-BW1-amo-b-06-0-UI.s1 cDNA, 1AGGAAAACTCAGAAATAATTTCTGCC 3′ end/clone = IMAGE:3070426/CCCTGGATTCTCTAAGATTTGTGA clone_end = 3′ 7794 db mining Hs.105130AA482030 2209708 zu98g04.s1 cDNA, 3′ end/ 1 GTGGAAAGAATCCTACAACGAACACTclone = IMAGE:746070/clone_end = ATTAAAGTCTGCACCTAGATCTGA 3′ 7795 dbmining Hs.104176 AA214530 1813155 zr92a06.s1 cDNA, 3′ end/ 1GGCCTAGGTTCCAGCATTCAGTCATC clone = IMAGE:683122/clone_end =AAGTCTTGTTACAGAAATAAATGA 3′ 7796 db mining Hs.121118 AA721101 2737236nz67a0.s1 cDNA, 3 end/ 1 CCCCATTTGGAGTCTAGTCAAAACAG clone =IMAGE:1300488/clone_end = CAGCTTCTTTGAGTTACCATTGGA 3′ 7797 db miningHs.313313 AW296455 6703091 UI-H-BW0-aiq-c-05-0-UI.s1 cDNA, 1AAGGCTTGTAACTGTAGGCCCTTGTA 3′ end/clone = IMAGE:2730224/CTACACTGTGCTATACCTGGTAGA clone_end = 3′ 7798 db mining Hs.335116AI524072 4438207 th01d07.x1 cDNA, 3′ end/ 1 CACTTTGGGAGGCAGAGGTGAGCAGclone = IMAGE:2117005/clone_end = ATCACTTGAGGCCAGGAGTTTGAGA 3′ 7799 dbmining Hs.309130 AI382229 4195010 td04d04.x1 cDNA, 3′ end/ 1GGATCACTTGAAGCCAGCAGTTTGAG clone = IMAGE:2074663/clone_end =ACCAGCCTGGGCAATAAAATGAGA 3′ 7800 db mining Hs.297504 BF514819 11599998UI-H-BW1-anj-b-10-0-UI.s1 cDNA, 1 TCAGTTGTGATGGGATTTCTTGATGG 3′end/clone = IMAGE:3082338/ ATGAGATGTGTCGTGTGACAGAGA clone_end = 3′ 7801db mining Hs.297473 BF513074 11598253 UI-H-BW1-amn-c-03-0-UI.s1 cDNA, 1CCTCCTAGAACTGGAACCAAGACTGC 3′ end/clone = IMAGE:3070445/TCCATCAGAGTTAAAGGTGTAAGA clone_end = 3′ 7802 db mining Hs.313168AW292924 6699560 UI-H-BW0-aig-d-05-0-UI.s1 cDNA, 1GCTCACCCTTGCACCTCCTTCCCAAA 3′ end/clone = IMAGE:2729144/TCTGCTGTCACATTTTCTCAAAGA clone_end = 3′ 7803 db mining Hs.319885BF507583 11590881 UI-H-BW1-ana-b-03-0-UI.s2 cDNA, 1TTCCTGTCTCCATGTTGTGGTCAAGA 3′ end/clone = IMAGE:3071572/TTGCCATTTGCTTCCTGAGTTTCA clone_end = 3′ 7804 db mining Hs.320411BF512514 11597693 UI-H-BW1-amc-h-10-0-UI.s1 cDNA, 1CTGGTTCTAGTGCAGTCTCCTCACTT 3′ end/clone = IMAGE:3069570/TCCTGGTGTTTGGTTTATCTTTTCA clone_end = 3′ 7805 db mining Hs.116501AA651832 2583484 ns40b05.s1 cDNA, 3′ end/ 1 TGACATGATTACCTGACTGATGTTTCclone-IMAGE:1188065/clone_end = TCCTCCATTAGACTGAATGCTTCA 3′ 7806 dbmining Hs.320438 BF512719 11597898 UI-H-BW1-amm-c-01-0-UI.s1 cDNA, 1TGGCAAAAAGCCTAACACTGACTCAT 3′ end/clone = IMAGE:3070440/CCCATTCTATCAGCACAAACTTCA clone_end = 3′ 7807 db mining Hs.319888BF507612 11590910 UI-H-BW1-ana-e-12-0-UI.s2 cDNA, 1GTTTACAAGGGATACTAGTTCCTGGA 3′ end/clone = IMAGE:3071734/GGGACGAAGGAGGCTCTGTTTGCA clone_end = 3′ 7808 db mining Hs.250726AW298545 6705181 UI-H-BW0-ajm-g-01-0-UI.s1 cDNA, 1TCCTCAACTCGGAGATTCCTGTATGG 3′ end/clone = IMAGE:2732352/AGAGAATCAATTTCATATATTTGCA clone_end = 3′ 7809 db mining Hs.120738AA749236 2789194 nx99c09.s1 cDNA, 3′ end/ 1 ACATTTCTTAGGTGTGTGTAGTGGclone = IMAGE:1270384/clone_end = TGAAGGAAAATAGTGGAAGATGTC 3′ TGCA 7810db mining Hs.320404 BF512350 11597616 UI-H-BW1-amc-b-01-0-UI.s1 cDNA, 1TCAGGAGGCTTGAAAAGACTCAAGGT 3′ end/clone = IMAGE:3069264/TTCTACACTATGGGAAATAAGGCA clone_end = 3′ 7811 db mining Hs.319880BF507510 11590808 UI-H-BW1-amr-c-04-0-UI.s1 cDNA, 1GTTTTCACTTGTCATACTAACTATTGT 3′ end/clone = IMAGE:3070831/TTTTCTCCCCCATGCCAAGAGCA clone_end = 3′ 7812 db mining Hs.320371 BF51209111597303 UI-H-BW1-ami-f-05-0-UI.s1 cDNA, 1 AGCCAAGGGAGCATATTATTCTCTTA 3′end/clone = IMAGE:3070208/ TTTTAAACCTCTCCGTAGGCAGCA clone_end = 3′ 7813db mining Hs.307837 AI052783 3308774 oy78h09.x1 cDNA, e′ end/ 1AGAAGGACCCCTGGTTGAGAACCAC clone = IMAGE:1872001/clone_end =GGTTGTATAGAAAGGAATTGAAGCA 3′ 7814 db mining Hs.124383 AA831706 2904805oc85b04.s1 cDNA, 3′ end/ 1 TTGACTGCCATAGCCAAGAGTTAATA clone =IMAGE:1356463/clone_end = TAGTTGCGTTTTCTTAAGGAAGCA 3′ 7815 db miningHs.123304 AA809672 2879078 nz99b08.s1 cDNA, 3′ end/ 1CTTACTGTGTCTTTTAGGTTTTGT clone = IMAGE:1303575/clone_end =TGCTTTCTGTCTGTATGCTATGT 3′ TCCA 7816 db mining Hs.123368 AA8115392881150 ob45d08.s1 cDNA, 3′ end/ 1 TGCAGTTAGGAGTGTGGACACTCTGC clone =IMAGE:1334319/clone_end = CCATCTCCATTGAATTAAATTCCA 3′ 7817 db miningHs.313178 AW293164 6699800 UI-H-BW0-aii-c-01-0-UI.s1 cDNA, 1ACTTGGGTTCTATCCCCACGATAACT 3′ end/clone = IMAGE:2729448/TGTTATGTATATGCCAATATCCCA clone_end = 3′ 7818 db mining Hs.313171AW292976 8699812 UI-H-BW0-aih-b-08-0-UI.s1 cDNA, 1AGCTAGAAAATGTCCCTTTTTCTTCTT 3′ end/clone:IMAGE:2729055TGGAGGTCTTTAACCAAGGCCCA clone_end = 3′ 7819 db mining Hs.343308 BF50888611592184 UI-H-B14-aos-a-03-0-UI.s1 cDNA, 1 ATCACCAATCTTATTTAGCACTGTGG 3′end/clone = IMAGE:3085732/ ATGCCGTTTTGCAAATGTCACCCA clone_end = 3′ 7820db mining Hs.320468 BF513104 11598283 UI-H-BW1-amn-e-10-0-UI.s1 cDNA, 1TGACTTAAGGTTGGAATATCTCCTAC 3′ end/clone = IMAGE:3070555/TACTCCCCTGTCCTCCTTGGACCA clone_end = 3′ 7821 db mining Hs.120585AA743221 2782727 ny21c06.s1 cDNA, 3′ end/ 1 TGTGGTTTGCAATGGTTTACTGATGAclone = IMAGE:1272394/clone_end = GACAGCAAAAATGAGACAGGACCA 3′ 7822 dbmining Hs.297468 BF513126 11598305 UI-H-BW1-amn-g-09-0-UI.s1 cDNA, 1TGGCGAGCCAGTCTCTGGATGGGAT 3′ end/clone = IMAGE:3070649/TCTGATCAACAGAAGTTCTCATACA clone_end = 3′ 7823 db mining Hs.313205AW293932 67000568 UI-H-BW0-aik-b-02-0-UI.s1 cDNA, 1TGCCCATCCTTTGCTGTTTTTCTCTTT 3′ end/clone = IMAGE:2729426/CAGTCATGGCCTATTTGGAGACA clone_end = 3′ 7824 db mining Hs.343329 BF51564611500825 UI-H-BW1-anu-d-06-0-UI.s1 cDNA, 1 CTCAACCTTGGCCCTAAACTAACAGT 3′end/clone = IMAGE:3083555/ GACAGGGAGTTCCCCAGCCTCAC clone_end = 3′ 7825db mining Hs.319906 BF507755 11591053 UI-H-BW1-anc-g-07-UI.s2 cDNA, 1TCCTGACCGTTGACAGAGAGCTTTTA 3′ end/clone = IMAGE:3072180/CAGAAGTCTTAGGCAGTACACACA clone_end = 3′ 7826 db mining Hs.320465BF513053 11598232 UI-H-BW1-amn-a-05-0-UI.s1 cDNA, 1AGTGTGTGGCACCCAGGATCACTG 3′ end/clone = IMAGE:3070355/TATGAGAATTTTCCTGAACAACAACA clone_end = 3′ 7827 db mining Hs.320430BF512667 11597846 UI-H-BW1-amg-f-08-0-UI.s1 cDNA, 1GCTGTAAGTCCCTTCCTTACTCATCT 3′ end/clone = IMAGE:3069850/TCCCTCTCAAATACAACAACAACA clone_end = 3′ 7828 db mining Hs.120718AA748539 2788497 ny05h12.s1 cDNA, 3′ end/ 1 GCCAGTTGGCACCATTTATGAAACAC3′ end/clone = IMAGE:1270919/clone_end = ACCACCTTGTAACCACTGAATTAA 3′7829 db mining Hs.320472 BF513154 11598333 UI-H-BW1-amj-b-02-0-UL.s1cDNA, 1 TCAACCTAGCACAGTGCCTGGCTGAT 3′ end/clone = IMAGE:3070011/AGGTGTTGAATATTTCCACTCTAA clone_end = 3′ 7830 db mining Hs.319899BF507695 11590993 UI-H-BW1-anb-h-05-0-UI.s2 cDNA, 1GCAACCCTCTGCCCCTGCAAAGAGAT 3′ end/clone = IMAGE:3071885/ATTGTGACAAAGATATTCACTGAA clone_end = 3′ 7631 db mining Hs.124932AA825273 2898575 oc67a02.s1 cDNA, 3′ end/ 1 TAACATTCCTGGCACAGTCCCTGGCAclone = IMAGE:1354730/clone_end = TAGGGTAGATAATAAATGGTGGAA 3′ 7832 dbmining Hs.313354 AW297308 6703944 UI-H-BW0-aji-h-03-0-UI.s1 cDNA, 1TCTCTAACCATCAAGGAAGGTCAAGG 3′ end/clone = IMAGE:2732020/GCCATGTATCTCTTTTAGGGAGAA clone_end = 3′ 7833 db mining Hs.127178AA938725 3096753 oc10g07.s1 cDNA, 3′ end/ 1 TTCCACAAACTCAGGTGTGCAAGAAAclone = IMAGE:1340508/clone_end = CAATGCATTACTTTATTTTCAGAA 3′ 7834 dbmining Hs.320445 BF512786 11597965 UI-H-BW1-amm-h-12-0-UI.s1 cDNA, 1CAGGAGTTTGAGACCAGCCTGGGCA 3′ end/clone = IMAGE:3070702/ACATAGTAAGTCTCCATCTCTTCAA clone_end = 3′ 7835 db mining Hs.319902BF507708 11591006 UI-H-BW1-and-b-02-UI.s2 cDNA, 1TCCCTAGTCCTGGAGACTCGGGAACT 3′ end/clone = IMAGE:3071930/AAAACAATCAATTCCCCTGAGCAA clone_end = 3′ 7836 db mining Hs.104348AA251338 1886301 zs08a06.s1 cDNA, 3′ end/ 1 TCCTCTTCATTGGAGACCCCTCCCTGclone = IMAGE:684562/clone_end = TCACAGCACAATGTGGGTAATAAA 3′ 7837 dbmining Hs.320442 BF512761 11597940 UI-H-BW1-amm-f-08-0-UI.s1 cDNA, 1CAGAACAAGGCCCACAGTGTGAAAG 3′ end/clone = IMAGE:3070598/GTGCTGCTGAACAAAGATAAATAAA clone_end = 3′ 7838 db mining Hs.320470BF513152 11598331 UI-H-BW1-amj-a-12-0-UI.s1 cDNA, 1GAGTCAGCAACAGTGGTCCTCTTGCC 3′ end/clone = IMAGE:3069983/TTGGTTGATGCTTTTGAACTGAAA clone_end = 3′ 7839 db mining Hs.300359BF516423 11601602 UI-H-BW1-aob-h-05-0-UI.s1 cDNA, 1TAAGGATGTATCCCTATGGGCAGGAA 3′ end/clone = IMAGE:3084512/ACCCAATTCTAAGAAACTTACAAA clone_end = 3′ 7840 db mining Hs.309152AI392970 4222517 tg22d05.s1 cDNA, 3′ end/ 1 GCCACTGCACTCCAGCCTGGGCAACclone = IMAGE:2109513/clone_end = AGAGCGAGACCTTGACTCTTTAAAA 3′ 7841 dbmining Hs.122448 AA761767 2810697 nz31e08.s1 cDNA, 3′ end/ 1CACAACACCCAAAAGGCTGCATTGCA clone = IMAGE:1289414/clone_end =TAACATGTATTTGTTGAATGAAAA 3′ 7842 db mining Hs.319874 BF507452 11590750UI-H-BW1-amz-e-06-0-UI.s2 cDNA, 1 GGGGTCCTTGCTCACAGAGCTCCCA 3′ end/clone= IMAGE:3071699/ AGATGGTGGTGGGCCACTTCCAAAA clone_end = 3′ 7843 db miningHs.104177 AA214542 1813167 zr92b09.s1 cDNA, 3′ end/ 1TCCCTCTATAGGTAAAAGACCTGTTT clone = IMAGE:683129/clone_end =GTCTGAAATGTGTGGAACCTGTCT 3′ 7844 db mining Hs.104182 AA521405 2261948aa68c0.s1 cDNA, 3′ end/ 1 GCTGCCGTGTCTTTTGGCATTTTCAG clone =IMAGE:826090/clone_end = CATGACTATATGTTTTTGTAATGT 3′ 7845 db miningHs.255522 AW296182 6702818 UI-H-B12-aia-c-01-0-UI.s1 cDNA, 1CCGAAGGCCCGTGTGGCGCTTCTCC 3′ end/clone = IMAGE:2728680/TATTCTGTAGAGTGGTAGTTTGTTT clone_end = 3′ 7846 db mining Hs.124926AA765668 2816906 ca04f02.s1 cDNA, 3′ end/ 1 AAAGAGGTAAACGCAAGTTCTCTCTTclone = IMAGE:1303995/clone_end = GTAGGTCGGGCTACAGGTGACTTT 3′ 7847 dbmining Hs.320388 BF512314 11597493 UI-H-BW1-amb-f-11-0-UI.s1 cDNA, 1TGGTTCTCAGCCTGGGTGAACAGAG 3′ end/clone = IMAGE:3069453/AAGGGGTCTAATTTGGTCTTTTGTT clone_end = 3′ 7848 db mining Hs.123161AA807319 2876895 oc38b01.s1 cDNA, 3′ end/ 1 TGTTCTTGGCACCCTGCACTGTCAGGclone = IMAGE:1351945/clone_end = CTATATCATTTCTGTTTGTTTCTT 3′ 7849 dbmining Hs.120608 AA743877 2783228 ny25b04.s1 cDNA, 3′ end/ 1TCTCATTTTCTTTTCCTAGCTGTGATG clone = IMAGE:1272751/clone_end =CAAAGTGTCAGTGGTCCCATCTT 3′ 7850 db mining Hs.120554 AA741010 2779602ny99a10.s1 cDNA, 3′ end/ 1 TGTCCAACCTTCCTTTTGCTACAAAC clone =IMAGE:1286394/clone_end = AAAGAATGCCTAGGGATTCAACTT 3′ 7851 db miningHs.330148 BE676227 10036768 xm80f05.x1 cDNA, 3′ end/ 1CAAGTGGCCTTGGTGTTTAAATCTTG clone = IMAGE:2690529/clone_end =CCCTAAATTGTAACTCACATGATT 3′ 7852 db mining Hs.120259 AA731522 2753678nw59h09.s1 cDNA, 3′ end/ 1 ACCAACCAGTGGTGTGCTGGAGCTG clone =IMAGE:1250945/clone_end = TCTCATACTATCTTGAGAGTCCATT 3′ 7853 db miningHs.124333 AA829233 2902332 od05a10.s1 cDNA, 3′ end/ 1AGCACTTGCTTTGTTCCAGACATTGT clone = IMAGE:1358298/clone_end =CCTTAGCTCCTTTCTTGTGTAATT 3′ 7854 db mining Hs.124281 AA825840 2899152od59d02.s1 cDNA, 3′ end/ 1 TGCAGCAAAAATTGAATTTCATAGGC clone =IMAGE:132227/clone_end = CATTCAGTGTTCTCTGCGATAATT 3′ 7855 db miningHs.120716 AA748500 2788458 ny01h10.s1 cDNA, 3′ end/ 1CCAGGAATGGAAATACGCCAACCCA clone = IMAGE:1270531/clone_end =GGTTAGGCACCTCTATTGCAGAATT 3′ 7856 db mining Hs.320428 BF512663 11597842UI-H-BW1-amg-f-02-0-UI.s1 cDNA, 1 AGGAAATTGGTTGAAGTCGTTTTTCT 3′end/clone = IMAGE:3089642/ CTTGTTAGTCTCATGTTAAGCTGT clone_end = 3′ 7857db mining Hs.123593 AA814828 2884424 ob73d07.s1 cDNA, 3′ end/ 1TCGCCTGGGGAGATTTAAAATCTAA clone = IMAGE:1337005/clone_end =GTCGCTGGAAGTCCCTTTGTATGT 3′ 7858 db mining Hs.120214 AA730985 2752189nw67a04.s1 cDNA, 3′ end/ 1 ACCTGTAGGAAGGGTTTGTGAATATT clone =IMAGE:1251630/clone_end = CTGTTGCTCTGAATTATTAGCGGT 3′ 7859 db miningHs.123365 AA811469 2881080 ob83c11.s1 cDNA, 3′ end/ 1TGAGAGGATCTTGAGACATTCTTGTG clone = IMAGE:1337972/clone_end =TTATTTGCCCTCTATGTTTTAGGT 3′ 7860 db mining Hs.127156 AA938155 3096266oc10a09.s1 cDNA, 3′ end/ 1 TCCCAAGCATGAGACAAGTACCACCA clone =IMAGE:130440/clone_end = GTGGTTCAGGAGATGATTTTAGGT 3′ 7861 db miningHs.320488 BF513278 11598455 UI-H-BW1-amo-e-01-0-UI.s1 cDNA, 1ACAAGACAGCAGCCTTCCCGAAATGT 3′ end/clone = IMAGE:3070560/CACTACTAAGAATTATTCAGAGGT clone_end = 3′ 7862 db mining Hs.343330BF514718 11599897 UI-H-BW1 = ans-a-12-0-UI.s1 cDNA, 1GCTGCCCAAACTTCCATTTATTTACC 3′ end/clone = IMAGE:3083063/CTCCAAACATCACTTCCTTCCTCT clone_end = 3′ 7863 db mining Hs.123584AA814349 2883945 nz06h06.s1 cDNA, 3′ end/ 1 ACATTTGCCAATGCACTTGATGTAAAclone = IMAGE:1287035/clone_end = GTTGTTGAGGATGTTGACTCTCCT 3′ 7864 dbmining Hs.123376 AA811751 2881362 nb80e12.s1 cDNA, 3′ end/ 1TCCCCCTTCCTAACACCAATTTGGGA clone = IMAGE:1337710/clone_end =ACATCACTACTTGTATATTATCCT 3′ 7865 db mining Hs.122860 AA766374 2817612oa36b03.s1 cDNA, 3′ end/ 1 TCAAGACCCTTAGAGTAAGTTAACTC clone =IMAGE:1307021/clone_end = CCAAGGAAATGTAGTTAGTTCCCT 3′ 7866 db miningHs.105268 AA490812 2219985 aa49e05.s1 cDNA, 3′ end/ 1AACCCACAATCCAACTCCCTTGATGA clone = IMAGE:824288/clone_end =GGATGATCATTAACAACAATCACT 3′ 7867 db mining Hs.297485 BF512677 11597856UI-H-BW-amg-g-04-0-UI.s1 cDNA, 1 TTTGAAGCCTCTGGTACTTCCCCTTC 3′ end/clone= IMAGE:3069894/ CCAAACCAGTCACAGGAAACACT clone_end = 3′ 7868 db miningHs.127167 AA938326 3096437 oc11c08.s1 cDNA, 3′ end/ 1TTGGAGGTTAACAGTATTCCTTTGAG clone = IMAGE:1340558/clone_end =TGGTGTGATTAAAGGTGCTTTTAT 3′ 7869 db mining Hs.123361 AA811359 2880970ob82a07.s1 cDNA, 3′ end/ 1 CCACCTCCAGAACTGCCTATCTAAC clone =IMAGE:1337844/clone_end = TCATCTGTGGTGATGGAATGCTAT 3′ 7870 db miningHs.105282 AA491247 2220420 aa49b01.s1 cDNA, 3′ end/ 1AGTGGCTCTCTGCTGTTAGCATGGTT clone = IMAGE:824233/clone_end =ACTAATCTTTTGGTTACTTTTCAT 3′ 7871 db mining Hs.320385 BF512292 11597471UI-H-BW-amb-d-12-0-UI.s1 cDNA, 1 TGACCTCAGTGTCTACTTCAGCAGAA 3′ end/clone= IMAGE:3089359/ CCTGTGGGTATATGCCTACCTCAT clone_end = 3′ 7872 db miningHs.105506 AA521196 2261739 aa74c04.s1 cDNA, 3′ end/ 1AAGGAGAACTGTCAACTGAATCTCAA clone = IMAGE:826662/clone_end =ATGCAGTCAAATGAAGAGAGGCAT 3′ 7873 db mining Hs.124928 AA765759 2816997ao07h05.s1 cDNA, 3′ end/ 1 TTCAAGTCATTATAGGTTTGGGCATA clone =IMAGE:1304313/clone_end = CAGGGTTAACCTTGTGATGTACAT 3′ 7874 db miningHs.320488 BF513286 11598465 UI-H-BW1-amo-e-11-0-UI.s1 cDNA, 1AGCAGAACAACATGTGTTTGACACTT 3′ end/clone = IMAGE:3070580/TTCCTTCTCTGTAATGAGGTACAT clone_end = 3′ 7875 db mining Hs.122891AA767601 2818816 ao45h09.s1 cDNA, 3′ end/ 1 TGCCTGTGTGGGTCAAAGGAATCATCclone = IMAGE:1307969/clone_end = TATGCTAATGTATTTGAGCCAAAT 3′ 7876 dbmining Hs.116435 AA848285 2574714 ns20d12.s1 cDNA, 3′ end/ 1ACCGAAAGCAGCATTTTCAATGTTTA clone = IMAGE:1184183/clone_end =ATTAAATCGATGCAGGAAATTGTG 3′ 7877 db mining Hs.300303 AW292760 6699396UI-H-BW0-aij-c-03-0-UI.s1 cDNA, 1 GTCCCTGGCCCTTCACTCTTCGTCCA 3′end/clone = IMAGE:2729453/ GGCTCTCTGACCTCTTTCCCTCTG clone_end = 3′ 7878db mining Hs.123154 AA688058 2674964 nv58c04.s1 cDNA, 3′ end/ 1TGTCCGCTGTTTTACCTCACTGCTCC clone = IMAGE:1233990/clone_end =TGTTTATGCCCTTAACTTCTGCTG 3′ 7879 db mining Hs.320489 BF513296 11598475UI-H-BW1-amo-f-11-0-UI.s1 cDNa, 1 GCACAAGACCTCACTTGGAACAAGTA 3′end/clone = IMAGE:3070628/ CCAGGCAGAAGAGAGCATTACCTG clone_end = 3′ 7880db mining Hs.124353 AA830448 2903547 oc51d05.s1 cDNA, 3′ end/ 1TTTCATATCTTGGCAGTTGGATGCGG clone = IMAGE:1353225/clone_end =TAAGAGCCACAGAGAAACCACCTG 3′ 7881 db mining Hs.122824 AA765319 2616557ao01f11.s1 cDNA, 3′ end/ 1 AGGACCCTTTTCCCATATTTCTGGCT clone =IMAGE:1303725/clone_end = ATATACAAGGATATCCAGACACTG 3′ 7882 db miningHs.124317 AA827178 2901175 ob53g04.s1 cDNA, 3′ end/ 1ACCAGGCCTAGAATTTAGGTTCTAGG clone = IMAGE:1335126/clone_end =TGTAAACTATTGGCCTATCAGATG 3′ 7883 db mining Hs.300373 AW297820 6704445UI-H-BW0-aiy-h-04-0-UI.s1 cDNA, 1 GTGCATTTTAGCAACAGACTTCCAGG 3′end/clone = IMAGE:2731230/ TTTCCAGCGCGGGCCAGGAAGGGG clone_end = 3′ 7884db mining Hs.320464 BF513050 11598229 UI-H-BW1-amn-a-03-0-UI.s1 cDNA, 1CTGTCATGCACCACCTCATCCCCTCC 3′ end/clone = IMAGE:3070349/TTCAGGGCCAGGGACAGTCCCTAG clone_end = 3′ 7885 db mining Hs.313366AW297537 6704173 UI-H-BW0-aja-f-05-0-UI.s1 cDNA, 1AGAGGAGGAGGGGGTAGAATGAATT 3′ end/clone = IMAGE:2731160/TCATTTAAAGCTCAACCTAGTTCAG clone_end = 3′ 7886 db mining Hs.320427BF512648 11597827 UI-H-BW1-amg-d-19-0-UI.s1 cDNA, 1CAGTCTCCCAGCTTTCTTGGCCTCCT 3′ end/clone = IMAGE:3069762/CTGCCAACTGGATGCAAGGCTCAG clone_end = 3′ 7887 db mining Hs.252840AW015143 5883960 UI-H-B10p-abb-e-07-0-UI.s1 cDNA, 1TGGAGAGAAGGTTCGGGAAGACGAG 3′ end/clone = IMAGE:2711149/GGGGCTGGGAGGTTTGGAAAGACAG clone_end = 3′ 7888 db mining Hs.313161AW292801 6699437 UI-H-BW0-aij-f-11-0-UI.s1 cDNA, 1CTGAAATGGGGGAAGGTGGGTTATG end/clone = IMAGE:2729613/ACAAAGTTCATGGAGAGGCCTGAAG clone_end = 3′ 7889 db mining Hs.309124AI380478 4190331 tf95a09.x1 cDNA, 3′ end/ 1 TAAAGCGGTACGGGATTCCGCACCCclone = IMAGE:2107000/clone_end = TACTCCAGCAAGAAAGAGCCTGAAG 3′ 7890 dbmining Hs.120562 AA741096 2779688 ny99g07.s1 cDNA, 3′ end/ 1AGCATTCATTCCTCCAAACACACTCC clone = IMAGE:1286460/clone_end =CAGGGTTAGGTCTCTTACCTCTGC 3′ 7891 db mining Hs.105530 AA521450 2261993aa69d11.s1 cDNA, 3′ end/ 1 GGTGTTGAATATTTATACGGATTGGC clone =IMAGE:826197/clone_end = ATCATAAGATACCGCGATACCTGC 3′ 7892 db miningHs.123194 AA805997 2874747 oc18g05.s1 cDNA, 3′ end/ 1ACCTTAGTCTAACTGCCTTCTGTAAA clone = IMAGE:1341272/clone_end =GTGGGTTGCTATAGTCTTTAAGCC 3′ 7893 db mining Hs.122833 AA765597 2816835ao08a10.s1 cDNA, 3′ end/ 1 TGAGGTTTGGATGGTGGCAGGTAAAA clone =IMAGE:1304346/clone_end = CAGAAAGGCAAGATGTCATCTGAC 3′ 7894 db miningHs.313827 AW452984 5993760 UI-H-BW1-amd-g-11-UI.s1 cDNA, 1TGGAGCTGCTACATAATTATTTCAGG 3′ end/clone = IMAGE:3069525/TCTCAAAGCTTCCAAGAAGTGGAC clone_end = 3′ 7895 db mining Hs.122383AA789140 2849260 aa66g10.s1 cDNA, 3′ end/ 1 AGACGGAACCTGAGATGTTGGATGTTclone = IMAGE:825954/clone_end = GTTGATCTTAGCAAACAGACTTTA 3′ 7896 dbmining Hs.120226 AA731687 2752576 nw58f05.s1 cDNA, 3′ end/ 1AGATCTGTAATCTTTGGCAAATGGAA clone = IMAGE:1250817/clone_end =CTCACCTGCAACGATACCTACTTA 3′ 7897 db mining Hs.120288 AA731998 2753949nw61b04.s1 cDNA, 3′ end/ 1 GAGGACTTCCATTCCCCATTTCCCGC clone =IMAGE:1251055/clone_end = ATACCTGCTGTTCTGTCTGAATTA 3′ 7898 db miningHs.123168 AA804519 2873850 ns28a11.s1 cDNA, 3′ end/ 1AGCTCACACCTGTTCCTTCATGGGTC clone = IMAGE:1184924/clone_end =AGTTCCTTTCATTTTCACTTTTGA 3′ 7899 db mining Hs.124369 AA830835 2903934oc54b06.s1 cDNA, 3′ end/ 1 AGCTGCTGCTTCTCTTTCAGTTGCAA clone =IMAGE:135491/clone_end = ATGCAAACCTGTTATAATCTTTGA 3′ 7900 db miningHs.122482 AA767335 2818350 nz65h02.s1 cDNA, 3′ end/ 1TCAATATCTGTGTGTCTTTTCATGAGT clone = IMAGE:1300371/clone_end =GGCTGTTACTTGTGAAGAATTGA 3′ 7901 db mining Hs.313287 AW296059 6702695UI.H.BW0-aiu-g-03-0-UI.s1 cDNA, 1 TGAGTGGACTGAGGAATGAATAGAAA 3′end/clone = IMAGE:2730796/ ACGTGGATATATGTAGAAAGCTGA clone_end = 3′ 7902db mining Hs.120705 AA748015 2787973 nx87c05.s1 cDNA, 3′ end/ 1ACCAGCCCCTGGGAATGTTATGAGCA clone = IMAGE:1269224/clone_end =AATGATACTCCATGAGTAAAATGA 3′ 7903 db mining Hs.320495 BF513385 11598564UI-H-BW1 = amk-f-10-0-UI.s1 cDNa, 1 TCGTGTGAGTGTGAGAGACATGTTCA 3′end/clone = IMAGE:3070242/ TTGTGAAAAGATACTCCTAGTGGA clone_end = 3′ 7904db mining Hs.121104 AA721020 2737155 nx89f11.s1 cDNA, 3′ end/ 1TTTGTCAAATGCCTGTTCACCATCTG clone = IMAGE:1269453/clone_end =TGGAAGTCATTATATGATTCAGGA 3′ 7905 db mining Hs.124297 AA827809 2900172od08c04.s1 cDNA, 3′ end/ 1 ACACTTTTCTTCTAAGGAGAGCTTTCT clone =IMAGE:1387334/clone_end = TAGGCATTTCAAAGAACTTTCGA 3′ 7906 db miningHs.320372 BF512096 11597308 UI-H-BW1-ami-f-10-0-UI.s1 cDNA, 1ACCAAATGAGTACCATCTGTTGAACA 3′ end/clone = IMAGE:3070218/CAGGGTGGCGATCCAAGTGTTTCA clone_end = 3′ 7907 HUVEC Hs.92381 AB0079563413930 mRNA, chromosome 1 1 ACCTGACTTCCACGATAAAATGGAGA cDNA transcriptKIAA0487/cds = TGAGTGCAGGGGTGAGTGTATAGT UNKNOWN 7908 HUVEC Hs.24950AB008109 2554613 regulator of G-protein signalling 5 1TGCAGATTTATACTCCTGACGTGTCT cDNA (RGS5), mRNA/cds = (81, 626)CATTCACAGCTAAATAATAGGCCA 7909 HUVEC Hs.306193 AB011087 3043553hypothetical protein (LQFBS-1), 1 ACCCTCGCCCTTTCCCTCCGGTTCAG cDNAmRNA/cds = (0, 743) TACCTATTGTTTCTCCTTTCAAAT 7910 HUVEC Hs.154919AB014525 3327063 mRNA for KIAA0625 protein, partial 1AAGAGGAAATGGCAGAATTAAAAGCA cDNA cds/cds = (0, 2377)GAAACAAGAAGATGGACATGGATT 7911 HUVEC Hs.153026 AB014540 3327093 mRNA forKIAA0640 protein, partial 1 AAGAGTGTTTGAGTGCTTGTCATCAG cDNA cds/cds =(0, 1812) GTGTTTTCCTTAATAAGTAGGGAT 7912 HUVEC Hs.24439 AB014546 3327105ring finger protein (C3HC4 type) 8 1 CTGCTGTCCACTTTCCTTCAGGCTCT cDNA(RNF8), mRNA/cds = (112, 1569) GTGAATACTTCAACCTGCTGTGAT 7913 HUVECHs.155829 AB014576 3327185 mRNA for KIAA0676 protein, partial 1TTCCTTGGATTCATTTCACTTGGCTA cDNA cds/cds = (0, 3789)GAAATTACACTGTGCTCAATGCCT 7914 HUVEC Hs.93675 AB022718 4204189 decidualprotein induced by 1 AGGTCTCTGCCACCTCCTTCTCTGTG cDNA progesterone(DEPP), mRNA/ AGCTGTCAGTCAGGTTATTCTCT cds = (218, 856) 7915 HUVECHs.104305 AB023143 4589483 death effector filament-forming Ced-4- 1GAATAGGAGGGACATGGAACCATTTG cDNA like apoptosis protein (DEFCAP),CCTCTGGCTGTGTCACAGGGTGAG transcript variant B, mRNA/ cds = (522, 4811)7916 HUVEC Hs.103329 AB023187 14133228 KIAA0970 protein (KIAA0970), 1CCTGTTTAAGAAAGTGAAATGTTATG cDNA mRNA/cds = (334, 2667)GTCTCCCCTCTTCCAATGAGCTTA 7917 HUVEC Hs.155182 AB017848 5689408 KIAA1036protein (KIAA1036), 1 TTTCACTTTCACACTTCATCTCATTCC cDNA mRNA/cds = (385,1482) TGTTGTCACTTTCCCCGAAACGA 7918 HUVEC Hs.129218 AB028997 5689484 DNAsequence from clone RP11- 1 TCTGGATCAATAGCTTCCCCTCTAGG cDNA 154E8 onchromosome 10. Contains GTCTACTGATGAGTCAAATCTAAA the gene KIAA1074, the3′ end of the YME1L1 gene for YME1 (S. cerevisiae)-like 1, ESTs, STSs,GSSs and a CpG island/cds = (166, 5298) 7919 HUVEC Hs.8383 AB0322556663499 bromodomain adjacent to zinc finger 1 TTTATCTACTGTGTGTTGTGGTGGCCcDNA domain, 2B (BAZ2B), mRNA/ TGTTGGAGGCAAATAGATCAGATT cds = (366,6284) 7920 HUVEC Hs.15165 AB037755 7243048 novel retinal pigmentepithellal gene 1 GACATTTTTGTAGGATGCCTGACGAG cDNA (NORPEG), mRNA/cds =(111, 3053) GTGTAGCCTTTTATCTTGTTTCCG 7921 HUVEC Hs.82113 AB04911310257384 dUTP pyrophosphatase (OUT), mRNA/ 1 CCCAGTTTGTGGAAGCACAGGCAAGcDNA cds = (29, 523) AGTGTTCTTTTCTGGTGATTCTCCA 7922 HUVEC Hs.8180AF000652 2795862 syndecan binding protein (syntenin) 1TGTTCCTTTTCCTGACTCCTCCTTGC cDNA (SDCBP), mRNA/cds = (148, 1044)AAACAAAATGATAGTTGACACTTT 7923 HUVEC Hs.147918 AF000982 2580549 DEAD/H(Asp-Glu-Ala-Asp/His) box 1 GTGACTTGTACATTCAGCAATAGCAT cDNA polypeptide3 (DDX3), transcript TTGAGCAAGTTTTATCAGCAAGCA variant 2, mRNA/cds =(856, 2844) 7924 HUVEC Hs.75056 AF002163 2290769 adaptor-related proteincomplex 3, 1 TTGCTATCGACATTCCCGTATAAAGA cDNA delta 1 subunit (AP3D1),mRNA/ GAGAGACATATCACGCTGCTGTCA cds = (209, 3547) 7925 HUVEC Hs.42915AF006082 2282029 ARP2 (actin-related protein 2, yeast) 1CCRFCCAGTGTCAGAAAATCCTATTT cDNA homolog (ACTR2), mRNA/ATGAATCCTGTCGGTATTCCTTGG cds = (74, 1258) 7926 HUVEC Hs.11538 AF0060842282033 actin related protein 2/3 complex, 1 AGGGAGGGGACAGATGGGGAGCTTTcDNA subunit 1A (41 kD) (ARPC1B), mRNA/ TCTTACCTATTCAAGGAATACGTGC CDS =(80, 1198) 7927 HUVEC Hs.6895 AF006086 2282037 actin related protein 2/3complex, 1 TCAAGAATTTGGGTGGGAGAAAAGAA cDNA subunit 3 (21 kD) (ARPC3),mRNA/ AGTGGGTTATCAAAGGGTGATTTGA cds = (25, 561) 7928 HUVEC Hs.286027AF010313 6468761 etoposide-induced mRNA (PIG8), 1TGTGATTAGGTTGTTTTCCTGTCATTT cDNA mRNA/cds = (72, 1151)TTGAGAGACTAAAATTGTGGGGG 7929 HUVEC Hs.79150 AF026291 2559007 chaperonincontaining TCP1, subunit 4 1 TGGGCTTGGTCTTCCAGTTGGCATTT cDNA (delta)(CCT4), mRNA/cds = (0, 1619) GCCTGAAGTTGTATTGAAACAATT 7930 HUVECHs.81452 AF030555 3158350 fatty-acid-Coenzyme A ligase, long- 1AACAAGATGAGAACAGATAAAGATTG cDNA chain 4 (FACL4), transcript variant 2,TGTGGTGTTTTGGATTTGGAGAGA mRNA/cds = (506, 2641) 7931 HUVEC Hs.139851AF035752 2665791 caveolin 2 (CAV2), mRNA/ 1 TGTAGCTCCCACAAGGTAAACTTCATcDNA cds = (20, 508) TGGTAAGATTGCACTGTTCTGATT 7932 HUVEC Hs.194709AF037364 14030860 paraneoplastic antigen MA1 (PNMA1), 1TCACTCCCCCATTTCACTTCTTTGTCA cDNA mRNA/cds = (664, 1725)GAGAATAGTTCTTGTTCATACTG 7933 HUVEC Hs.79516 AF039656 2773159 brainacid-soluble protein 1 (BASP1), 1 TGGGAGTGACAAACATTCTCTCATCC mRNA/cds =(52, 735) TACTTAGCCTACCTAGATTTCTCA 7934 HUVEC Hs.29417 AF039942 4730926HCF-binding transcription factor 1 AATGGAAGGATTAGTATGGCCTATTT cDNAZhangfei (ZF), mRNA/cds = TTAAAGCTGCTTTGTTAGGTTCCT (457, 1275) 7935HUVEC Hs.26232 AF044414 6136293 mannosidase, alpha, class 2C, 1CCCCAGCCTAAAGCAGGGATCAGTC cDNA member 1 (MAN2C1), mRNA/TTTTCTTGTGGAATAAATCCTTGGA cds = (56, 3244) 7936 HUVEC Hs.3776 AF0620723668065 zinc finger protein 216 (ZNF216), 1 TGTGGTAATGCCTGTTTTCATCTGTAcDNA mRNA/cds = (288, 929) AATAGTTAAGTATGTACACGAGGC 7937 HUVEC Hs.74034AF070648 3283922 clone 24651 mRNA sequence/ 1 AGATGCTTAGTCCCTCATGCAAATCAcDNA cds = UNKNOWN ATTACTGGTCCAAAAGATTGCTGA 7938 HUVEC Hs.274230AF074331 5052074 PAPS synthetase-2 (PAPSS2) mRNA, 1AAAACTGCTCTTCTGCTCTAGTACCA cDNA complete cds/cds = (63, 1907)TGCTTAGTGCAAATGATTATTTCT 7939 HUVEC Hs.12540 AF081281 3415122lysophospholipase (LYPLA1), mRNA/ 1 AGCTATTAGGATCTTCAACCCAGGTA cDNA cds= (35, 727) ACAGGAATAATTCTGTGGTTTCAT 7940 HUVEC Hs.159629 AF0921315138911 myosin IXB (MYO9B), mRNA/ 1 TCCTGCGTCTATCCATGTGGAATGCT cDNA cds= (0, 6068) GGACAATAAAGCGAGTGCTGCCCA 7941 HUVEC Hs.273385 AF1052537532779 guanine nucleotide binding protein (G 1GCCACAAAAGTTCCCTCTCACTTTCA cDNA protein), alpha stimulating activityGTAAAAATAAATAAAACAGCAGCA polypeptide 1 (GNAS1), mRNA/ cds = (68, 1252)7942 HUVEC Hs.2934 AF107045 5006419 ribonucleotide reductase M1 1ACTGCTTTGACTGGTGGGTCTCTAGA cDNA polypeptide (RRM1), mRNA/AGCAAAACTGAGTGATAACTCATG cds = (187, 2565) 7943 HUVEC Hs.158237 AF1123456650627 integrin alpha 10 subunit (ITGA10) 1 GGCATTGTCTCTGTTTCCCAGTGGGGcDNA mRNA, complete cds/cds = (76, 3579) TGGACAGTATATCAGATGGTCAGA 7944HUVEC Hs.183698 AF116627 7959755 ribosomal protein L29 (RPL29), 1CCCTGGGCTACCATCTGCATGGGGC cDNA mRNA/cds = (29, 508)TGGGGTCCTCCTGTGCTATTTTGTAC 7945 HUVEC Hs.2186 AF119852 7770136 Homosapiens, eukaryctic translation 1 TCAAGTGAACATCTCTTGCCATCACC cDNAelongation factor 1 gamma, clone TAGCTGCCTGCACCTGCCCTTCAG MGC:4501IMAGE:2964623, mRNA, complete cds/cds = (2278, 3231) 7946 HUVEC Hs.22900AF134891 7381111 nuclear factor (erythroid-derived 2)-like 1TCTTGGCAGCCATCCTTTTTAAGAGT cDNA 3 (NFE2L3), mRNA/cds = (492, 1694)AAGTTGGTTACTTCAAAAAGAGCA 7947 HUVEC Hs.108258 AF141968 6273777 actincross-linking factor (ACF7), 1 AGCTAAAGAGAGGGAACCTCATCTAA cDNAtranscript variant 1, mRNA/ GTAACATTTGCACATGATACAGCA cds = (51, 16343)7948 HUVEC Hs.11158 AF151072 7106885 hypothetical protein (LOC51255), 1GCTGAGTGCTGGCCCTCTGCGTCTT cDNA mRNA/cds = (0, 461)CCTTATTAACCTTGAATCCTCATTA 7949 HUVEC Hs.179573 AF193556 6907041collagen, type 1, alpha 2 (COL1A2), 1 TGAATGATCAGAACTGACATTTAATTC cDNAmRNA/cds = (139, 4239) ATGTTTGTCTCGCCATGCTTCTT 7950 HUVEC Hs.41135AF205940 8547214 endomucin-2 (LOC51705), mRNA/ 1TCCGGGCCAAGAATTTTTATCCATGA cDNA cds = (78, 863) AGACTTTCCTACTTTTCTCGGTGT7951 HUVEC Hs.142908 AF219119 7158848 E2F-like protein (LOC51270), mRNA/1 GCAGAGTTCATTGTTGCCCCTTAACA cDNA cds = (278, 979)GTTTTTCCTGAGTTTACTGAAGAA 7952 HUVEC Hs.154721 AF261088 9802307 aconitase1, soluble (ACO1), mRNA/ 1 TTATCAAGCAGAGACCTTTGTTGGGA cDNA cds = (107,2776) GGCGGTTTGGGAGAACACATTTCT 7953 HUVEC Hs.78288 AF261089 8802309calpain 2, (m/ll) large subunit 1 GGGTATGCTGCCTCTGTAAATTCATG cDNA(CAPN2), mRNA/cds = (142, 2244) TATTCAAAGGAAAAGACACCTTGC 7954 HUVECHs.152707 AJ001259 2769253 glioblastoma amplified sequence 1TTGTCTGCCCCACAATCAAGAATGTA cDNA (GBAS), mRNA/cds = (8, 868)TGTGTAAAGTGTGAATAAATCTCA 7955 HUVEC Hs.5097 AJ002308 2959871synaplogyrin 2 (SYNGR2), mRNA/ 1 ATGCCCGGCCTGGGATGCTGTTTGG cDNA cds =(29, 703) AGACGGAATAAATGTTTTCTCATTC 7956 HUVEC Hs.143323 AJ2437066572290 mRNA for RB-binding protein 1 AGCAGTTTGTGATATAGCAGAGGTTT cDNA(rbbo2h1a gene)/cds = (757, 5802) AAATGTACCCTCCCCTTTTATGCA 7957 HUVECHs.1197 NM_002157 4504522 Heat shock 10 kD protein 1 (chaperonin 1TGATGCTGCCCATTCCACTGAAGTTC cDNA 10) TGAAATCTTTCGTCATGTAAATAA 7958 HUVECHs.79037 BC010112 14603308 Homo sapiens, heat shock 60 kD 1AGCAGCCTTTCTGTGGAGAGTGAGAA cDNA protein 1 (chaperonin), cloneTAATTGTGTACAAAGTAGAGAAGT MGC:19755 IMAGE:3630225, mRNA, complete cds/cds= (1705, 3396) 7959 HUVEC Hs.279860 AJ400717 7573518 tumor protein,translationally-controlled 1 CATCTGAAGTGTGGAGCCTTACCCAT cDNA 1 (TPT1),mRNA/cds = (94, 612) TTCATCACCTACAACGGAAGTAGT 7960 HUVEC Hs.165563AK024508 10440535 DNA sequence form clone RP4- 1GCCAGGCTGGTTCCGCATGGTGATC cDNA 591C20 on chromosome 20. ContainsTCCGTCTTGTATGTCTGAATGTTGG ESTs, STSs, GSSs and CpG islands. Contains anovel gene for a protein similar to NG26, the TPD52L2 gene for twoisoforms of tumor protein D52-like protein 2, a gene for a novel DnaJdomain protein similar to mouse and bovine cysteine string protein withtwo isoforms, a gene for a novel phosphoribulokinase with threeisoforms, the KIAA1196 gene and the 5′ part of the TOM gene for aputative mitochondrial outer membrane protein import receptor similar toyeast pre- mRNA splicing factors Prp1/Zer1 and Prp6/cds = (0, 503) 7961HUVEC Hs.91146 AL050147 4884153 protein kinase D2 mRNA, complete 1CTATTTCCAAGGCCCCTCCCTGTTTC cDNA cds/cds = (39, 2675)CCCAGCAATTAAAACGGACTCATC 7962 HUVEC Hs.66762 AL050367 4914600 mRNA, cDNADKFZp584A026 (from 1 AAAGTGCCAGAATGACTCTTCTGTGC cDNA cloneDKFZp564A026)/ ATTCTTCTTAAAGAGCTGCTTGGT cds = UNKNOWN 7963 HUVECHs.165998 AL080119 5262550 PAI-1 mRNA-binding protein (PAI- 1TTGTTGGTAGGCACATCGTGTCAAGT cDNA RBP1), mRNA/cds = (85, 1248)GAAGTAGTTTTATAGGTATGGGTT 7964 HUVEC Hs.111801 AL096723 5419856 mRNA;cDNA DKFZp564H2023 (from 1 AGTCCTGTATCATCCATACTTGTACTA cDNA cloneDKFZp584H2023)/ CCTTGTCCTATGAAGCTCTGAGA cds = UNKNOWN 7965 HUVECHs.89434 AL110225 5817161 drebrin 1 (DBN1), mRNA/ 1TTGGCCGCTTCCCTACCCACAGGGC cDNA cds = (97, 2046)CTGACTTTTACAGCTTTTCTCTTTT 7966 HUVEC Hs.7527 AL110239 5817182 smallfragment nuclease 1 TATGACACAGCAGCTCCTTTGTAAGT cDNA (DKFZP588E144),mRNA/ ACCAGGTCATGTCCATCCCTTGGT cds = (77, 790) 7967 HUVEC Hs.187991AL110269 5817043 DKFZP564A122 protein 1 TTGGTGAGTTGCCAAAGAAGCAATAC cDNA(DKFZP564A122), mRNA/ AGCATATCTGCTTTTGCCTTCTGT cds = (2570, 2908) 7968HUVEC Hs.25882 AL117665 5912262 mRNA; cDNA DKFZp586M1824 (from 1TGCATAGATGACCTTTGGATTATTGG cDNA clone DKFZp586M1824); partial cds/ACTCTGACTATTGGGACCCTAAAT cds = (0, 3671) 7969 HUVEC Hs.17428 AL1330106453416 RBP1-like protein (BCAA), transcript 1 TGGACGCCCTAAGAAACAGAGAcDNA variant 2, mRNA/cds = (468, 4143) AAACAGAAATAACAACCAGGAACT GCTT7970 HUVEC Hs.278242 AL137300 6807762 Homo sapiens, clone MGC:3214 1CAATAGCTTGTGGGTCTGTGAAGACT cDNA IMAGE:3502820, mRNA complete cds/GCGGTGTTTGAGTTTCTCACACCC cds = (2066, 3421) 7971 HUVEC Hs.7378 AL1376636807784 mRNA; cDNA DKFZp434G227 (from 1 TGCACTGTACTCTCTTCATAGGATTG cDNAclone DKFZp434G227)/ TAAAGGTGTTCTAATCCAATTGCA cds = UNKNOWN 7972 HUVECHs.61289 AL157424 7018453 mRNA; cDNA DKFZp761E1512 (from 1TGAAGTCATTTCATTGGGAAGGAAAG cDNA clone DKFZp761E1512)/CTGCCAAAGATTATTGGGGGACTAG cds = UNKNOWN 7973 HUVEC Hs.240013 AL3901489388882 mRNA; cDNA DKFZp547A166 (from 1 TTTCATCTGGCCCACCCTCCTTAGAC cDNAclone DKFZp547A166)/ TCTCCTCCCTTCAAGAGTTGGAGC cds = UNKNOWN 7974 HUVECHs.22629 AW887820 8049833 602281231F1 cDNA, 5′ end/ 1GTGTAGAATTCGGATCCAGTCATCTC cDNA clone = IMAGE:4368943/clone_end =ACAGAACTTTCCACTAGGGTGCCA 5′ 7975 HUVEC Hs.333414 BE562833 9806553hypothetical protein MGC14151 1 CGGACCCCAGTTTCTTGTACCAAGGG cDNA(MGC14151), mRNA/cds = (108, 485) GGAAACATGCGGGGACCCCAATGG 7976 HUVEC NABE612847 9894444 601452239F1 NH_MGC_68 cDNA 1 TAAAGATGTCCGGGTACACTTCGCCAcDNA clone IMAGE:3856304 5′, mRNA AGGGTTAGCGTCTTTGGGCATTTC sequence 7977HUVEC Hs.86412 BE876332 10325018 chromosome 9 open reading frame 5 1AACACAACACTAAAACCGAACA cDNA (C9orf5), mRNA/cds = (32, 2767)CACACGTACTAACACACCCACGAC CCAA 7978 HUVEC Hs.285814 BE906689 10400012sprouly (Drosophila) homolog 4 1 CCTTCTGGTTCTGCTTTTGACCAGA cDNA (SPRY4),mRNA/cds = (205, 525) TTTTTGTGCCCCTCTGTTACTGTG 7979 HUVEC Hs.113029BF025727 10733439 ribosomal protein S25 (RPS25), 1GATATACGAAACACACCACTGGACGA cDNA mRNA/cds = (63, 440)TGCGAAAAACGAGACGACATAAGC 7980 HUVEC Hs.263339 BF107006 10889631602377929F1 cDNA, 5′ end/ 1 TGGACAGGCATGAAAGGTTACAAATG cDNA clone =IMAGE:4508646/clone_end = GGAGAAAACTCACACACGTTATGT 5′ 7981 HUVECHs.182426 BF204683 11098269 601887521F1 cDNA, 5′ end/ 1GCAGGAGAGCGAGAGAGGAGAAGAA cDNA clone = IMAGE:4110052/clone_end =GAGGCAGGAGGGAGAAAGAGCGTAC 5′ 7982 HUVEC Hs.75968 BF217687 11111273thymosin, beta 4, X chromosome 1 CAAGAAGCAGAAGCAGCAACCAGAG cDNA(TMSB4X), mRNA/cds = (77, 211) ACAGAGAGACAAACGCAGAACAACA 7983 HUVECHs.112318 BF237710 11151828 cDNA FLJ4633 fis, clone 1AGAGGAAAGAATAGGACCAGTGCCG cDNA NT2RP2000938/cds = UNKNOWNAGGTATAGGGAGGAGGGCATACTAA 7984 HUVEC Hs.293981 BF247088 11162147 Homosapiens, clone MGC:16393 1 TCGGAGTAAGGGCGATTGTCTCGTTA cDNAIMAGE:3939021, mRNA, complete GGTAATACATCATCTTCGTGCATA cds/cds = (506,1900) 7985 HUVEC Hs.157850 BF303931 11250608 Homo sapiens, cloneMGC:15545 1 AGACAAGACGAGCAACGACAACCAC cDNA IMAGE:3050745, mRNA, completeAGCAGCTCCATACACTCTGCCTCTC cds/cds = (1045, 1623) 7986 HUVEC Hs.217493D00017 219909 annexin A2 (ANXA2), mRNA/ 1 AGTGAAGTCTATGATGTGAAACACTTcDNA cds = (49, 1068) TGCCTCCTGTGTACTGTGTCATAA 7987 HUVEC Hs.76549D00099 219941 mRNA for Na, K-ATPase alpha- 1 TCACAAGACAGTCATCAGAACCAGTAcDNA subunit, complete cds/cds = (318, 3389) AATATCCGTCTGCCAGTTCGATCA7988 HUVEC Hs.330716 D10522 219893 cDNA FLJ4368 fis, clone 1AAACTCCTGCTTAAGGTGTTCTAATTT cDNA HEMBA 1001122/cds = UNKNOWNTCTGTGAGCACACTAAAAGCGAA 7989 HUVEC Hs.75929 D21255 575578 mRNA forO8-cadherin-2, complete 1 CGTGCCAGATATAACTGTCTTGTTTC cDNA cds/cds =(476, 2557) AGTGAGAGACGCCCTATTTCTATG 7990 HUVEC Hs.178710 D21260 434760clathrin, heavy polypeptide (Hc) 1 TCCCTGAGGCTTGTGTATGTTGGATA cDNA(CLTC), mRNA/cds = (172, 5199) TTGTGGTGTTTTAGATCACTGAGT 7991 HUVECHs.334822 D23660 432358 Homo sapiens. Similar to ribosomal 1CAGAGAAGAAACCTACTACAGAGGA cDNA protein L4, clone MGC:2968GAAGAAGCCTGCTGCATAAACTCTT IMAGE:3139805, mRNA, complete cds/cds = (1616,2617) 7992 HUVEC Hs.262823 D28500 7678803 hypothetical protein FLJ103261 TCAGAACATAGATATGTATTCAGCTT cDNA (FLJ10326), mRNA/cds = (2, 2296)GTCTTCAAATACGGCCAAGCAGAA 7993 HUVEC Hs.151761 D43947 603948 KIAA0100gene product (KIAA0100), 1 TTGGGGTCAAGTGAAAGGGTAGGGG cDNA mRNA/cds =(329, 6607) GATAGTCCTGATCAAGTGTGATAAA 7994 HUVEC Hs.699 D50525 1167502peptidylprolyl isomerase B (cyclophilin 1 CAGCAAATCCATCTGAACTGTGGAGGcDNA B) (PPIB), mRNA/cds = (21, 671) AGAAGCTCTCTTTACTGAGGGTGC 7995 HUVECHs.278607 D50911 6633996 mRNA; cDNA DKFZp434N0735 (from 1CCTTCTCTTCATGTGTGTAAATCTGTA cDNA clone DKFZp434N0735); partial cds/ATATACCATTCTCTGTGGCCTGT cds = (0, 1577) 7996 HUVEC Hs.57729 D509221469188 Ketch-like ECH associated protein 1 1 GGATGGCACTTCCCCACCGGGATGGAcDNA (KIAA0132), mRNA/cds = (112, 1986) CAGTTATTTTGTTGATAAGTAACCC 7997HUVEC Hs.240770 D59253 1060898 Homo sapiens, nuclear cap binding 1TGAGTCAGTGTCTTTACTGAGCTGGA cDNA protein subunit 2, 20 kD, cloneAGCCTCTGAAAGTTATTAAAGGCA MGC:4991 IMAGE:3458927, mRNA, complete cds/cds= (26, 496) 7998 HUVEC Hs.155595 D83878 981447 neural precursor cellexpressed, 1 CCCACACTGCTACACTTCTGATCCCC cDNA developmentallydown-regulated 5 TTTGGTTTTACTACCCAAATCTAA (NEDD5), mRNA/cds = (258,1343) 7999 HUVEC Hs.80712 D86957 1503987 septin 2 (SEP2) mRNA, partialcds/ 1 GTGGCTTGCTAGTCTGTTACGTTAAC cDNA cds = (0, 1527)ATGCTTTTCTAAAATTGCTTCACG 8000 HUVEC Hs.75822 D86970 1504013 mRNA forKIAA0216 gene, complete 1 TTGTACTCACTGGGCTGTGCTCTCCC cDNA cds/cds =(484, 5229) CTGTTTACCCGATGTATGGAAATA 8001 HUVEC Hs.170311 D89678 3128539heterogeneous nuclear 1 TTTATGATTAGGTGACGAGTTGACAT cDNAribonucleoprotein D-like (HNRPDL), TGAGATTGTCCTTTTCCCCTGATC transcriptvariant 1, mRNA/ cds = (580, 1842) 8002 HUVEC Hs.83213 J02874 178348fatty acid binding protein 4, adipocyte 1 TTGTTGTTTTCCCTGATTTAGCAAGCAcDNA (FABP4), mRNA/cds = (47, 445) AGTAATTTTCTCCCAAGCTGATT 8003 HUVECHs.177766 J03473 337423 ADP-ribosyltransferase (NAD+; poly 1TTAGAAACAAAAAGAGCTTTCCTTCT cDNA (ADP-ribose) polymerase) (ADPRT),CCAGGAATACTGAACATGGGAGCT mRNA/cds = (159, 3203) 8004 HUVEC Hs.155560L10284 186522 calnexin (CANX), mRNA/ 1 CCATTGTTGTCAAATGCCCAGTGTCC cDNAcds = (89, 1887) ATCAGATGTGTTCCTCCATTTTCT 8005 HUVEC Hs.75693 L13977431320 prolylcarboxypeptidase 1 GATGTCTGGTGCCCAATCCCAGGAA cDNA(anglotensinase C) (PRCP), mRNA/ GTGAGAGCCATTTCTTTTGTACTGG cds = (29,1519) 8006 HUVEC Hs.539 L31610 1220380 ribosomal protein S29 (RPS29), 1AGTTGGACTAAATGCTCTTCCTTCAG cDNA mRNA/cds = (30, 200)AGGATTATCCGGGGCATCTACTCA 8007 HUVEC Hs.1742 L33075 536843 IQ motifcontaining GTPase activating 1 TGAATTTACTTCCTCCCAAGAGTTTG cDNA protein 1(IQGAP1), mRNA/ GACTGCCCGTCAGATTGTTTCTGC cds = (467, 5440) 8008 HUVECHs.180446 L38951 893287 Importin beta subunit mRNA, complete 1AAACACATACACACAAAACAGC cDNA cds/cds = (337, 2967)AAACTTCAGGTAACTATTTTGGAT TGCA 8009 HUVEC Hs.79572 M11233 181179cathepsin D (lysosomal aspartyl 1 CTGAGGATGAGCTGGAAGGAGTGAG cDNAprotease) (CTSD), mRNA/ AGGGGACAAAACCCACCTTGTTGGA cds = (2 1240) 8010HUVEC Hs.273415 M11580 178350 aldolase A, fructose-bisphosphate 1TCTTTCTTCCCTCGTGACAGTGGTGT cDNA (ALDOA), mRNA/cds = (167, 1261)GTGGTGTCGTCTGTGAATGCTAAG 8011 HUVEC Hs.254105 M14328 182113 anolase 1,(alpha) (ENO1), mRNA/ 1 GCTAGATCCCCGGTGGTTTTGTGCTC cDNA cds = (94, 1398)AAAATAAAAAGCCTCAGTGACCCA 8012 HUVEC Hs.237519 M20867 183059 yz35c09.s1cDnA, 3′ end/ 1 GCATGGCTTAACCTGGTGATAAAAGC cDNA clone =IMAGE:285040/clone_end = AGTTATTAAAAGTCTACGTTTTCC 3′ 8013 HUVEC Hs.1239M22324 178535 alanyl (membrane) aminopeptidase 1CCGCCCTGTACCCTCTTTCACCTTTC cDNA (aminopeptidase N, aminopeptidase M,CCTAAAGACCCTAAATCTGAGGAA microsomal aminopeptidase, CD13, p150) (ANPEP),mRNA/ cds = (120, 3023) 8014 HUVEC Hs.118126 M22960 190282 protectiveprotein for beta- 1 GGACAGCCCACAGGGAGGTGGTGGA cDNA galactosidase(galactoslaidosis) CGGACTGTAATTGATAGATTGATTA (PPGB), mRNA/cds = (6,1448) 8015 HUVEC Hs.198281 M26252 338826 pyruvate kinase, muscle (PKM2),1 ATTGAAGCCGACTCTGGCCCTGGCC cDNA mRNA/cds = (109, 1704)CTTACTTGCTTCTCTAGCTCTCTAG 8016 HUVEC Hs.2050 M31166 339991pentaxin-related gene, rapidly induced 1 ACTAGACTTTATGCCATGGTGCTTTC cDNAby IL-1 beta (PTX3), mRNA/ AGTTTAATGCTGTGTCTCTGTCAG cds = (87, 1212)8017 HUVEC Hs.99853 M59849 182591 fibrillarin (FBL), mRNA/cds = 1GAGCCATATGAAAGAGACCATGCCGT cDNA (59, 1024) GGTCGTGGGAGTGTACAGGCCACC 8018HUVEC Hs.283473 M64098 183891 hypothetical protein PRO2900 1ATAACAGACTCCAGCTCCTGGTCCAC cDNA (PRO2900), mRNA/cds = (271, 501)CCGGCATGTCAGTCAGCACTCTGG 8019 HUVEC Hs.211573 M85289 184426 heparansulfate proleoglycan 2 1 CTGGCCTCTGTGTCCTAGAAGGGAC cDNA (perlecan)(HSPG2), mRNA/ CCTCCTGTGGTCTTTGTCTTGATTT cds = (40, 13221) 8020 HUVECHs.75103 M86400 189952 tyrosine 3-monooxygenase/tryptophen 1CCCAAAGCTCACTTTACAAAATATTTC cDNA 5-monooxygenase activation protein,CTCAGTACTTTGCAGAAAACACC zeta polypeptide (YWHAZ), mRNA/ cds = (84, 821)8021 HUVEC Hs.59271 M98982 338262 U2(RNU2) small nuclear RNA auxillary 1ATGTCTGCTAGAAAGTGTTGTAGTTG cDNA factor 1 (non-standard symbol)ATTGACCAAACCAGTTCATAAGGG cDNA (U2AF1), mRNA/cds = (38, 760) 8022 HUVECHs.110802 NM_000552 9257255 von Willebrand factor (VWF), mRNA/ 1CTCTGCATGTTCTGCTCTTGTGCCCT cDNA cds = (310, 8751)TCTGAGCCCACAATAAAGGCTGAG 8023 HUVEC Hs.274466 NM_001403 4503472eukaryotic translation elongation factor 1 TGCATCGTAAAACCTTTCAGAAGGAAcDNA 1 alpha 1-like 14 (EEF1A1L14), AGGAGAATGTTTTGTGGACACGTT mRNA/cds =(620, 1816) 8024 HUVEC Hs.279518 NM_001642 4502146 amyloid beta (A4)precursor-like 1 AGCCCTATTCATGTCTCTACCCACTA cDNA protein 2 (APLP2),mRNA/ TGCACAGATTAAACTTCACCTACA cds = (72, 2363) 8025 HUVEC Hs.76224NM_004105 9865261 EGF-containing fibulin-like 1AGTGACAGTGAACTTAAGCAAATTAC cDNA extracellular matrix protein 1CCTCCTACCCAATTCTATGGAATA (EFEMP1), transcript variant 1, mRNA/ cds =(149, 1630) 8026 HUVEC Hs.19545 NM_012193 6912383 frizzled (Drosophila)homolog 4 1 ACACATGCCCTGAATGAATTGCTAAA cDNA (FZD4), mRNA/cds = (306,1919) TTTCAAAGGAAATGGACCCTGCTT 8027 HUVEC Hs.87125 NM_014600 7657055EH-domain containing 3 (EHD3), 1 GCCACTGAACCAATCACTTTGTATGC cDNAmRNA/cds = (285, 1892) TATGCTCCTACTGTGATGGAAAAC 8028 HUVEC Hs.119503NM_016091 7705432 HSPC025 (HSPC025), mRNA/ 1 AGGACCGAAGTGTTTCAAGTGGATCTcDNA cds = (33, 1727) CAGTAAAGGATCTTTGGAGCCAGA 8029 HUVEC Hs.7905NM_016224 7706705 SH3 and PX domain-containing protein 1TTCAATGGAAAATGAGGGGTTTCTCC cDNA SH3PX1 (SH3PX1), mRNA/CCACTGATATTTTACATAGAGTCA cds = (43, 1830) 8030 HUVEC Hs.283722 NM_0201519910251 GTT1 protein (GTT1), mRNA/ 1 GCTCCATGTTCTGACTTAGGGCAATT cDNA cds= (553, 1440) TGATTCTGCACTTGGGGTCTGTCT 8031 HUVEC Hs.286233 NM_02041414251213 sperm autoantigenic protein 17 1 GCAGCAGCTTAATTTTTCTGTATTGCcDNA (SPA17), mRNA/cds = (1210, 1685) AGTGTTTATAGGCTTCTTGTGTGT 8032HUVEC Hs.272822 S56985 298485 RuvB (E. coli homolog)-like 1 1ACCTCCCACTTTGTCTGTACATACTG cDNA (RUBVL1), mRNA/cds = (76, 1446)GCCTCTGTGATTACATAGATCAGC 8033 HUVEC Hs.279518 S60099 300168 amyloid beta(A4) precursor-like 1 AGCCCTATTCATGTCTCTACCCACTA cDNA protein 2 (APLP2),mRNA/ TGCACAGATTAAACTTCACCTACA cds = (72, 2383) 8034 HUVEC Hs.194662S80582 1245968 calporin 3, acidic (CNN3), mRNA/ 1ACATGGAAGACTAAACTCATGCTTAT cDNA cds = (83, 1072)TGCTAAATGTGGTCTTTGCCAACT 8035 HUVEC Hs.76869 U08021 494988 nicotinamideN-methyltransferase 1 AGACCCCTGTGATGCCTGTGACCTCA cDNA (NNMT), mRNA/cds =(117, 911) ATTAAAGCAATTCCTTTGACCTGT 8036 HUVEC Hs.89657 U13991 582076TATA box binding protein (TBP)- 1 CGCACTACTTCACCTGAGCCACCCAA cDNAassociated factor, RNA polymerase II, CCTAAATGTACTTATCTGTCCCCA h, 30 kD(TAF2H), mRNA/ cds = (17, 673) 8037 HUVEC Hs.1516 U20982 695253insulin-like growth factor binding 1 CTGTAGACTCAGTGCCAGCCCAC cDNAprotein 4 (IGFBP4) gene promoter and AGCTTCAGAGATTGTGCTCACATG completeGTAT 8038 HUVEC Hs.183648 U22816 930342 protein tyrosine phosphate,receptor 1 TGACAAAGGATTTTACGTTTATAAAAT cDNA type, I polypeptide (PTPRF),interacting TATGACAGAAGCCATGTGCCCCG protein (liprin), alpha 1 (PPFIA1),mRNA/cds = (229, 3837) 8039 HUVEC Hs.83383 U25182 799380 thioredoxinperoxidase (antioxidant 1 GTCTGCCCTGCTGGCTGGAAACCTG cDNA enzyme)(ADE372), mRNA/ GTAGTGAAACAATAATCCCAGATCC cds = (43, 828) 8040 HUVECHs.75888 U30255 984324 phosphogluconate dehydrogenase 1CTCGTCATACAATGCCTGATGGGCTC cDNA (PGD), mRNA/cds = (6, 1457)CTGCTACCCTCCACGTCTCCACAG 8041 HUVEC Hs.169478 U34995 1497857 Homosapiens, glyceraldehyde-3- 1 CTAGGGAGCCGCACCTTATCATGTAC cDNA phosphatedehydrogenase, clone CATCAATAAAGTACCCTGTGCTCA MCG:10926 IMAGE:3828129,mRNA, complete cds/cds = (2308, 3313) 8042 HUVEC Hs.192023 U390671718194 eukaryolic translation initiation factor 3, 1TCCGTATCCATTACTTCGACCCACAG cDNA subunit 2 (beta, 36 kD) (EIF3S2),TACTTTGAATTTGAGTTTGAGGCT mRNA/cds = (17, 994) 8043 HUVEC Hs.155637U47077 13570016 DNA-dependent protein kinase 1CCAGTCCTCCACACCCAAACTGTTTC cDNA catalytic subunit (DNA-PKcs) mRNA,TGATTGGCTTTTAGCTTTTTGTTG complete cds/cds = (57, 12443) 8044 HUVECHs.285313 U51869 2745959 core promoter element binding protein 1CTGTTGTCTCTCTGAGGCTGCCAGTT cDNA (COPEB), mRNA/cds = (117, 968)GTTGTGTGTTACCGATGCCAGAAG 8045 HUVEC Hs.184270 U56637 1336098 cappingprotein (actin filament) muscle 1 AATATAGTCAAGCAAGTTTGTTCCAG cDNAZ-line, alpha 1 (CAPZA1), mRNA/ GTGACCCATTGAGCTGTGTATGCA cds = (0, 860)8046 HUVEC Hs.75064 U61234 1465773 tubulin-specific chaperone c (TBCC),1 TTTGCTATTTTCGTCATGCCTTTGAGA cDNA mRNA/cds = (23, 1063)CTGAGTCTTACTCCGTCCCCCAG 8047 HUVEC Hs.183684 U73824 1857236 eukaryotictranslation initiation factor 4 1 TTGTGGGTGTGAAACAAATGGTGAGA cDNA gamma,2 (EIF4G2), mRNA/ ATTTGAATTGGTCCCTCCTATTAT cds = (306, 3029) 8048 HUVECHs.165283 U89278 1877500 early development regulator 2 1CAGGAAGGAGGTAGGCACCTTTCTG cDNA (homolog of polyhomeotic 2) (EDR2),AGCTTATTCTATTCCCCACCCACAC mRNA/cds = (8, 1309) 8049 HUVEC Hs.334703W29012 1308969 Homo sapiens, clone IMAGE:3875338, 1GGGAGCCATCCCTCTCTACCAAGGT cDNA mRNA, partial cds/cds = (0, 930)GGCAATGATGGAGGGAACTTGCATG 8050 HUVEC Hs.287820 X02761 31396 mRNA forfibronectin (FN precursor)/ 1 TGGCCCGCAATACTGTAGGAACAAG cDNA cds = (0,6987) CATGATCTTGTTACTGTGATATTTT 8051 HUVEC Hs.14378 X04098 28338 actin,gamma 1 (ACTG1), mRNA/ 1 GGTTTTCTACTGTTATGTGAGAACATT cDNA cds = (74,1201) AGGCCCCAGCAACACGTCATTGT 8052 HUVEC Hs.290070 X04412 35447 gelsolin(amyloidosis, Finnish type) 1 AGCCCTGCAAAAATTCAGAGTCCTTG cDNA (GSN),mRNA/cds = (14, 2362) CAAAATTGTCTAAAATGTCAGTGT 8053 HUVEC Hs.79088X06323 34753 mitochondrial ribosomal protein L3 1TGGGGACTATAGTGCAACCTATTTGG cDNA (MRPL3), mRNA/cds = (78, 1122)GTAAAGAAACCATTTGCTAAAATG 8054 HUVEC Hs.287797 X07979 31441 mRNA forFLJ00043 protein, partial 1 ACCACTGTATGTTTACTTCTCACCATT cDNA cds/cds =(0, 4248) TGAGTTGCCCATCTTGTTTCACA 8055 HUVEC Hs.87409 X14787 37464thrombospandin 1 (THBS1), mRNA/ 1 TTGACCTCCCATTTTTACTATTTGCCA cDNAcds/cds = (111, 3623) ATACCTTTTTCTAGGAATGTGCT 8056 HUVEC Hs.82202 X5377734198 ribosomal protein L17 (RPL17), 1 GAGGAGGTTGCCCAGAAGAAAAAGA cDNAmRNA/cds = (286, 840) TATCCCAGAAGAAACTGAAGAAACA 8057 HUVEC Hs.233936X54304 34755 myosin, light polypeptide, regulatory, 1AACCTACCAGCCCTTCTCCCCCAATA cDNA non-sarcomeric (20 kD) (MLCB),ACTGTGGGTCTATACAGAGTCAAT mRNA/cds = (114, 629) 8058 HUVEC Hs.74405X57347 32463 tyrosine 3-monooxygenase/tryptophan 1AGAGAGTTGGACCACTATTGTGTGTT cDNA 5-monooxygenase activation protein,GCTAATCATTGACTGTAGTCCCAA theta polypeptide (YWHAQ), mRNA/ cds = (100,837) 8059 HUVEC Hs.77813 X59960 402620 sphingomyelin phosphodiesterase1, 1 CCCTGTACTGCTGCTGCGACCTGATG cDNA acid lysosomal (acidCTGCCAGTCTGTTAAAATAAAGAT sphingomyelinase) (SMPD1), mRNA/ cds = (0,1889) 8060 HUVEC Hs.172690 X62535 30822 diacylglycerol kinase, alpha (80kD) 1 ACACACATACACACACACCCCAAA cDNA (DGKA), mRNA/cds = (103, 2310)ACACATACATTGAAAGTGCCTCAT CTGA 8061 HUVEC Hs.272822 X63527 36127 RuvB (E.coli homolog)-like 1 1 ACCTCCCACTTTGTCTGTACATACTG cDNA (RUVBL1),mRNA/cds = (78, 1446) GCCTCTGTGATTACATAGATCAGC 8062 HUVEC Hs.119529X67698 37476 epididymal secretory protein (19.5 kD) 1AACAACATTAACTTGTGGCCTCTTTCT cDNA (HE1), mRNA/cds = (10, 465)ACACCTGGAAATTTACTCTTGAA 8063 HUVEC Hs.211579 X68264 433891 MUC18 geneexons 1&2/ 1 TCTCTGCTCAATCTCTGCTTGGCTCC cDNA cds = (26, 1966)AAGGACCTGGGATCTCCTGGTACG 8064 HUVEC Hs.75061 X70326 38434 macrophagemyrisloylated alanine-rich 1 TGTCTTACTCAAGTTCAAACCTCCAG cDNA C kinasesubstrate (MACMARCKS), CCTGTGAATCAACTGTGTCTCTTT mRNA/cds = (13, 800)8065 HUVEC Hs.31314 X72841 297903 retinoblastoma-binding protein 7 1AACTTTTACACTTTTTCCTTCCAACAC cDNA (RBBP7), mRNA/cds = (287, 1564)TTCTTGATTGGCTTTGCAGAAAT 8066 HUVEC Hs.79088 X78869 469884reticulocalbin, 2, EF-hand calcium 1 TGGTGAGTGGAATTTGACATTGTCCA cDNAbinding domain (RCN2), mRNA/ AACCTTTTTCATTTTTGAGTGATT cds = (66, 1019)8067 HUVEC Hs.7957 X79448 2326523 adenosine deaminase, RNA-specific 1GAGTGAGGAAGACCCCCAAGCATAG cDNA (ADAR), transcript variant ADAR-a,ACTCGGGTACTGTGATGATGGCTGC mRNA/cds = (187, 3867) 8068 HUVEC Hs.76206X79981 599833 cadherin 5, type 2, VE-cadherin 1TGGCAAAGCCCCTCACACTGCAAGG cDNA (vascular epithelium) (CDH5), mRNA/GATTGTAGATAACACTGACTTGTTT cds = (120, 2474) 8069 HUVEC Hs.172182 Y0034535569 poly(A)-binding protein, cytoplasmic 1 1GGAAAGGAAACTTTGAACCTTATGTA cDNA (PABPC1), mRNA/cds = (502, 2403)CCGAGCAAATGCCAGGTCTAGCAA 8070 HUVEC Hs.180414 Y00371 32466 hsc70 genefor 71 kd heat shock 1 AGTTAAGATTATTCAGAAGGTCGGGG cDNA cognate proteinATTGGAGCTAAGCTGCCACCTGGT 8071 HUVEC Hs.75216 Y00815 34266 proteintyrosine phosphatase, receptor 1 TTACCTTGTGGATGCTAGTGCTGTAG cDNA type F(PTPRF), mRNA/ AGTTCACTGTTGTACACAGTCTGT cds = (370, 6083) 8072 HUVECHs.65114 Y07604 1945761 keratin 18 (KRT18), mRNA/ 1GGGGTCTTCACATTATCATAACCTCT cDNA cds = (51, 1343)CCTCTAAAGGGGAGGCATTAAAAT 8073 HUVEC Hs.113503 Y08890 2253155 Homosapiens mRNA for Ran_GTP 1 TTTCCTTGTGCAATTCAGACTTAAGC cDNA bindingprotein 5 (RanBP5(importin5) ATCGAGTTTTTACCATCTTCCACT gene)/cds = (236,3529) 8074 HUVEC Hs.44499 Y09703 4581462 pinin, desmosome associatedprotein 1 ACATGTGCAAATAAATGTGGCTTAGA cDNA (PNN), mRNA/cds = (30, 2261)CTTGTGTGACTGCTTAAGACTAAA 8075 HUVEC Hs.8867 Y11307 2791897cysteine-rich, angiogenic inducer, 61 1 AAATGTAGCTTTTGGGGAGGGAGGG cDNA(CYR61), mRNA/cds = (80, 1225) GAAATGTAATACTGGAATAATTTGT 8076 HUVECHs.90061 Y12711 6759555 progesterone receptor membrane 1ACCCACTGCAAAAGTAGTAGTCAAGT cDNA component 1 (PGRMC1), mRNA/GTCTAGGTCTTTGATATTGCTCTT cds = (78, 665) 8077 HUVEC Hs.101033 Y143916562622 Pseudoautosomal GTP-binding protein 1 GCCTGCTGTGAACTGCTTTCCCTCGGcDNA like (PGPL), mRNA/cds = (329, 1540) AATGTTTCCGTAACAGGACATTAA 8078HUVEC Hs.24322 Y15286 2584788 ATPase, H+ transporting, lysosomal 1GAAGAGCCATCTCAACAGAATCGCAC cDNA (vacuolar proton pump) 9 kD (ATP6H),CAAACTATACTTTCAGGATGAATT mRNA/cds = (82, 307) 8079 HUVEC Hs.291904Z31696 479156 accessory proteins BAP31/BAP29 1 AGGAGGGTGGGTGGAACAGGTGGACcDNA (DXS1357E), mRNA/cds = (136, 878) TGGAGTTTCTCTTGAGGGCAATAAA 8080HUVEC Hs.180877 Z48950 761715 clone PP781 unknown mRNA/ 1TGCTTGATTAAGATGCCATAATAGTG cDNA cds = (113, 523)CTGTATTTGCAGTGTGGGCTAAGA 8081 HUVEC Hs.289101 Z49835 860985 glucoseregulated protein, 58 kD 1 TTGGGGGAAATGTTGTGGGGGTGGG cDNA (GRP58),mRNA/cds = (0, 1517) GTTGAGTTGGGGGTATTTTCTAATT 8082 HUVEC Hs.10340AK000452 7020548 hypothetical protein FLJ20445 1AGCATGGTAAACCTGGGTTTTTGTTCA cDNA (FLJ20445), mRNA/cds = (334, 1170)TATTTTCTCCAGACAGAAATGCAA 8083 HUVEC Hs.194676 AK001313 7022490 tumornecrosis factor receptor 1 GGTCTCTTTGACTAATCACCAAAAAG cDNA superfamily,member 6b, decoy CAACCAACTTAGCCAGTTTTATTT (TNFRSF6B), transcript variant2, mRNA/cds = (827, 4488) 8084 HUVEC Hs.808 AK001364 7022577heteroganeous nuclear 1 GCCCTTGATGCTGGAGTCACATCTGT cDNAribonucleoprotein F (HNRPF), mRNA/ TGATAGCTGGAGAACTTTAGTTTC cds = (323,1570) 8085 HUVEC Hs.15978 AK002211 7023952 cDNA FLJ11349 fis, clone 1GCCGATTCCAAGCGAGGGATTTAATC cDNA PLACE4000650, weakly similar toCTTACATTTTTGCCCATTTGGCTC TUBERIN/cds = UNKNOWN 8086 HUVEC Hs.29692AK021498 10432693 cDNA FLJ11436 fis, clone 1 TTCCCTGGACAGTTTGATGTGCTTATcDNA HEMBA1001213/cds = UNKNOWN GGTTGAGATTTATAATCTGCTTGT 8087 HUVECHs.109672 AK023900 10435975 Homo sapiens. Similar to 1GGCGGTGACTGCCCCAGACTTGGTT cDNA sialytransferase 7 ((alpha-N-TTGTAATGATTTGTACAGGAATAAA acetylneuraminyl 2,3-betagalactosyl-1,3)-N-acetyl galactosaminide alpha- 2,6-slaytransferase) F, cloneMGC:14252 IMAGE:4128833, mRNA, complete cds/cds = (128, 1129) 8088 HUVECHs.25635 AK024039 10436304 cDNA FLJ13977 fis, clone 1TGACCATTTGGAGGGGCGGGGCCTC cDNA Y79AA1001603, weakly similar toCTAGAAGAACCTTCTTAGACAATGG POLYPEPTIDE N- ACETYLGALACTOSAMINYL-TRANSFERASE (EC 2.4.1.41)/cds = (418, 1791) 8089 HUVEC Hs.288967AK024167 10438481 cDNA FLJ14105 fis, clone 1 CAGTCCTCACACCAGCCAAGGTCACAcDNA MAMMA1001202/cds = UNKNOWN GGCAAGAGCAAGAAGAGAAACTGA 8090 HUVECHs.25001 AK024230 10436557 cDNA FLJ14168 fis, clone 1CCTCAGTGATGGAATATCATGAATGT cDNA NT2RP2001440, highly similar toGAGTCATTATGTAGCTGTCGTACA mRNA for 14-3-3gamma/ cds = UNKNOWN 8091 HUVECHs.6101 AK025006 10437439 hypothetical protein MGC3716 1ACACACAACTTCAGCTTTGCATCACG cDNA (MGC3178), mRNA/cds = (81, 1055)AGTCTTGTATTCCAAGAAAATCAA 8092 HUVEC Hs.322680 AK025200 10437664 cDNA;FLJ21547 fis, clone COL08206/ 1 GGAATTTCGCACCAGAGGACCCACC cDNA cds =UNKNOWN ACGTCCTCGCTTCGACATCTTGAAC 8093 HUVEC Hs.288061 AK025375 10437878actin, beta (ACTB), mRNA/ 1 GGAGGCAGCCAGGGCTTACCTGTAC cDNA cds = (73,1200) ACTGACTTGAGACCAGTTGAATAAA 8094 HUVEC Hs.288869 AK025842 10438480nuclear receptor subfamily 2, group F, 1 CAGAGAAAGAAAAGGCAAAAGACTG cDNAmember 2 (NR2F2), mRNA/ GTTTGTTTGCTTAATTTCCTTCTGT cds = (342, 1588) 8095HUVEC Hs.251653 AK026594 10439481 tubulin beta, 2 (TUBB2), mRNA/ 1GAAAGCAGGGAAGCAGTGTGAACTC cDNA cds = (0, 1337) TTTATTCACTCCCAGCCTGTCCTGT8096 HUVEC Hs.334842 AK026632 10439528 tubulin, alpha, ubiquitous(K-ALPHA- 1 TGGTTAGATTGTTTTCACTTGGTGAT cDNA 1), mRNA/cds = (67, 1422)CATGTCTTTTCCATGTGTACCTGT 8097 HUVEC Hs.288036 AK026650 10439548 tRNAisopentenylpyrophosphate 1 TGCATCGTAAAACCTTCAGAAGGAAA cDNA transferase(IPT), mRNA/ GGAGAATGTTTTGTGGACCACTTT cds = (60, 1040) 8098 HUVECHs.324406 AK026741 10439662 ribosomal protein L41 (RPL41), 1TGGACCTGTGACATTCTGGACTATTT cDNA mRNA/cds = (83, 160)CTGTGTTTATTTGTGGCCGAGTGT 8099 HUVEC Hs.274388 AK026775 10439706 MSTP032protein (MSTP032), mRNA/ 1 TGCAACTAGCAACTCATCTTCGGAAG cDNA cds = (68,319) ACACAGCCAGGAGAATGAAGTAGA 8100 HUVEC Hs.289071 AK027187 10440255cDNA; FLJ22245 fis, clone HRC02612/ 1 GACTTCCTCTCTGCGAGCTTCTACT cDNA cds= UNKNOWN TCTAAGTCTGAATCCAGTCAGAAA 8101 HUVEC Hs.334788 BG38565813278634 hypothetical protein FLJ14639 1 GTTTCTCTTTGGTTTTCCAGATTTTCTcDNA (FLJ14639), mRNA/cds = (273, 689) TTAGAACGGTGACTGACCCTCCT 8102HUVEC NA NC_002090 9507429 many cloning vectors, kanamycin 1CTGAGCAATAACTAGCATAACCCCTT cDNA resistance, geneGGGGCCTCTAAACGGGTCTTGAGG 8103 HUVEC NA IJ07360 478289 Human DXS1178locus dinucleotide 1 TGCCCATTTCACATTGCTCATTACTCA cDNA repeatpolymorphism sequence TGCAAATTTCTTCTTGCTAACCT 8104 HUVEC Hs.230165AA449779 316529 zx09e02.s1 cDNA, 3′ end/ 1 ACCCACCATTGGTAAAATATTCAGGGcDNA clone = IMAGE:785978/clone_end = GAACTTGGTTTAAAAGTTTATGCT 3′ 8105HUVEC NA AI000459 3191013 c107c08.s1 NCI_CGAP_GC3 cDNA 1GTCAAATAAGGTTGTTCTTTCCTTGAA cDNA clone IMAGE:1914158 3′ similar toGGACAGCACCCATGCCACAGCAC gb:700361 60S RIBOSOMAL PROTEIN (HUM 8106 HUVECHs.172922 AI06204 3230540 ot83f03.s1 cDNA, 3′ end/ 1CTGGAAAAACATCACATGGTTGAGTC cDNA clone = IMAGE:1823389/clone_end =AAGGATGAAAAGTCAAACTACCT 3′ 8107 HUVEC Hs.96457 AI081571 3418383ox59h10.s1 cDNA, 3′ end/ 1 ATCCATCCAATAAACACAGCAACACC cDNA clone =IMAGE:1660675/clone_end = CTATGCTACTGACCAAGCAAAGCT 3′ 8108 HUVEC NAAI082318 3419110 ox72c08.x1 Soares_NhHMPu_S1 1TAGTTAGAGTCCAAGACATGGTTCCT cDNA cDNA clone IMAGE:1661870 3′CCCCCTTTGTCTGTACATCCTGGC similar to gb:X63527 60S RIBOSOMAL PROTEIN 8109HUVEC Hs.145222 AI187426 3738064 qf31d08.x1 cDNA, 3′ end/ 1CAGCCTGCCTGCTTGCCATTTTTCTT cDNA clone = IMAGE:1751631/clone_end =CCCCTTCCATTTTTCTAACCTCAG 3′ 8110 HUVEC Hs.273194 AI285483 3923716ty56b02.x1 cDNA, 3′ end/ 1 ACTTCCTCCCCCTCCCCCTAGCATTA cDNA clone =IMAGE:2283051/clone_end = CTTATATGATATGTTTCCATACCC 3′ 8111 HUVECHs.238797 AI307808 4002412 602081661F1 cDNA, 5′ end/ 1AAGGAATTTGTTTTCCCTATCCTAACT cDNA clone = IMAGE:4245999/clone_end =CAGTAACAGAGGGTTTACTCCGA 3′ 8112 HUVEC Hs.135872 AW028193 5886949wv61h08.x1 cDNA, 3′ end/ 1 TTTGCATCCCGAGTTTTGTATTCCAA cDNA clone =IMAGE:2534079/clone_end = GAAAATCAAAGGGGGCCAATTTGT 3′ 8113 HUVECHs.244816 AW078847 603399 xb18g07.x1 cDNA, 3′ end/ 1AAACAGGAAGGGGGTTTGGGCCCTT cDNA clone = IMAGE:2576700/clone_end =TGATCAACTGGAACCTTTGGATCAAG 3′ 8114 HUVEC Hs.249863 AW162315 6301348au66d07.x1 cDNA, 3′ end/ 1 AAAAACGGTTTATGGGGGTAGGGAAA cDNA clone =IMAGE:2781229/clone_end = CAGGCCGAAAAGAACGTGGAGAAA 3′ 8115 HUVECHs.329930 AW170757 6402282 xj4207.x1 cDNA, 3′ end/ 1GGGGACTCAGGCCCCCGCTGGGGGT cDNA clone = IMAGE:2658180/clone_end =CCCACATAGGGTTTTTATCCAAAAA 3′ 8116 HUVEC Hs.23349 AW237511 6569900nab70e03.x1 cDNA, 3′ end/ 1 TGTTGTTGGATACGTACTTAACTGGT cDNA clone =IMAGE:3273292/clone_end = ATGCATCCCATGTCTTTGGGTACT 3′ 8117 HUVEC NABE672733 10033274 7b75g07.x1 NCI_CGAP_Lu24 cDNA 1TGAGAGCACACCATAAATTCACAGCA cDNA clone IMAGE:3234108 3′ similar toGGAATAAACGAAGACACACGAGCA TR:O99231 O99231 CYTOCHROME OXIDASE 8118 HUVECHs.288443 BF110312 10940002 7n36d08.x1 cDNA, 3′ end 1ACCAGGGCTTAAAACCTCAATTTATG cDNA clone = IMAGE:3566654/clone_end =TTCATGACAGTGGGGATTTTTCTT 3′ 8119 HUVEC Hs.111301 J03210 180670 matrixmetalloproteinase 2 (gelatinase 1 AGCCATAGAAGGTGTTCAGGTATTGC cDNA A, 72kD gelatinase, 72 kD type IV ACTGCCAACTCTTTGTCCGTTTTG collagenase)(MMP2), mRNA/ cds = (289, 2271) 8120 HUVEC Hs.82085 M14083 189566 serine(or cysteine) proteinase 1 CCATGCCCTTGTCATCAATCTTGAAT cDNA inhibitor,clade E (nexin, plasminogen CCCATAGCTGCTTGAATCTGCTGC activator inhibitortype 1), member 1 (SERPINE1), mRNA/cds = (75, 1283) 8121 HUVEC Hs.80120Y10343 2292903 UDP-N-acetyl-alpha-D- 1 TTAAGAATGTGGCAGAAATGTATGCT cDNAgalactosamine:polypeptide N- GAGGTAGCCCAGTCAATCCTTATTacetylgalactosaminyltransferase 1 (FalNAc-T1) (GALNT1), mRNA/ cds = (31,1710) 8122 HUVEC Hs.10340 AK000452 7020548 hypothetical protein FLJ204451 ATCAGTAGCAAAACAAACCCAGCAAC cDNA (FLJ20445), mRNA/cds = (334, 1170)TTCTGTCCAGCATCTGCTGTAGGG 8123 HUVEC Hs.73742 AK001313 7022490 cDNAFLJ10451 fis, clone 1 CCCATCTAACTAGCACACGAACCTTC cDNA NT2RP1000959,highly similar to CACGAGGACGCCTGGCGAGAGAAG acidic ribosomalphosphoprotein PD mRNA/cds = UNKNOWN 8124 HUVEC Hs.808 AK001364 7022577heterogeneous nuclear 1 GAACTTGGCAGTTGTAGCAGAGGCA cDNA ribonucleoproteinF (HNRPF), mRNA/ GTTGAGGCTTGTTGACCATCACCAT cds = (323, 1570) 8125 HUVECHs.15978 AK002211 7023952 cDNA FLJ11349 fis, clone 1CGCTCTCTCCTGCACAGCACCACCAC cDNA PLACE4000650, weakly similar toCAACAGTCTGGATGATTTTAGGCA TUBERIN/cds = UNKNOWN 8126 HUVEC Hs.29692AK021498 10432693 cDNA FLJ11436 fis, clone 1 TTTTGGGAAGAAAACCCTATGCATCTcDNA HEMBA1001213/cds = UNKNOWN GAAATACAATTGGCAATGGAAGCT 8127 HUVECHs.109672 AK023900 10435975 Homo sapiens. Similar to 1CTCTTTGTTGCTACTCATTTCTCTCCG cDNA sialytransferase 7 ((alpha-N-GCGTCTGCTGAGGGGTAGGTGTC acetylneuraminyl 2,3-betagalactosyl-1,3)-N-acetyl galactosaminide alpha- 2,6-sialytransferase) F, cloneMGC:14252 IMAGE:4128833, mRNA, complete cds/cds = (126, 1129) 8128 HUVECHs.25835 AK024039 10436304 cDNA FLJ13977 fis, clone 1CACCTTCCTCTTGGTTACCCAGAAGA cDNA Y79AA1001603, weakly similar toACAGCAGCACCGTGATCCAGAGCA POLYPEPTIDE N- ACETYLGALACTOSAMINYL-TRANSFERASE (EC 2.4.1.41)/cds = (418, 1791) 8129 HUVEC Hs.288967AK024167 10436481 cDNA FLJ14105 fis, clone 1 CTGTACATCTGCATCCCAGCAAAGAGcDNA MAMMA1001202/cds = UNKNOWN CAGCAGGGACAGGAGGGAGGAGAG 8130 HUVECHs.25001 AK024230 10438557 cDNA FLJ14168 fis, clone 1CACAGACAGAAGGTTTCGTTCCTCAT cDNA NT2RP2001440, highly similar toTCGACAGTGGCTCATTCAGCTCTG mRNA for 14-3-3gamma/ cds = UNKNOWN 8131 HUVECHs.6101 AK025006 10437439 hypothetical protein MGC3178 1TCAAGATTGGCAATTCACTGTGCCCA cDNA (MGC3178), mRNA/cds = (81, 1055)TTAAACCACTCAGTAGCTCAGCCT 8132 HUVEC Hs.322680 AK025200 10437664 cDNA;FLJ21547 fis, clone COL08206/ 1 AGTTGTCCTGAGAGTTTTACACTTGT cDNA cds =UNKNOWN GAGAAAATACTGGCAGCTTTGATT 8133 HUVEC Hs.288061 AK025375 10437878actin, beta (ACTB), mRNA/ 1 CACATAGGAATCCTTCTGACCCATGC cDNA cds = (73,1200) CCACCATACACGCCCTGGTGCCTGG 8134 HUVEC Hs.288869 AK025842 10438480nuclear receptor subfamily 2, group F, 1 AACAGGAACCTTTATCTCTTTGTGAG cDNAmember 2 (NR2F2), mRNA/ GCGATTTGCATTCTCCACACAGGC cds = (342, 1586) 8135HUVEC Hs.251653 AK026594 10439481 tubulin, beta, 2 (TUBB2), mRNA/ 1GTACTTGCCGCCGGTGGCCTCATTG cDNA cds = (0, 1337) AGTACACGTTGATGCGTTCCAGCT8136 HUVEC Hs.278242 AK026632 10439528 Homo sapiens, clone MGC:3214 1ATAGTGGCTAGGGATTAGGAGGCGA cDNA IMAGE:3502620, mRNA, completeAGGCGACAGGAGCAGACACCGGGTC cds/cds = (2066, 3421) 8137 HUVEC Hs.181165AK026850 10439548 eukaryotic translation elongation factor 1CATTTTGGCTTTTAGGGGTAGTTTTC cDNA 1 alpha 1 (EEF1A1), mRNA/ACGACACCTGTGTTCTGGCGGCAA cds = (53, 1441) 8138 HUVEC Hs.108124 AK02674110439662 cDNA; FLJ23088 fis, clone LNG07026/ 1 CCCTGGTTCAGGAATTAAGGGGACAcDNA cds = UNKNOWN GACTTGAATAAGAAACAAAACAAAA 8139 HUVEC Hs.274368AK026775 10439706 MSTP032 protein (MSTP032), mRNA/ 1ACAGTAGAGAATTTGAGTACACAGGG cDNA cds = (88, 319) TATGGAGAGTAGGGCACAAAATGT8140 HUVEC Hs.241507 AK027187 10440255 cDNA; FLJ23534 fis, cloneLNG06974, 1 GAACAGCCTCGTCTTTCCCCGAATGC cDNA highly similar to HUMRPS6ACAGGCAGGATGACGATGAACGTGG ribosomal protein S6 mRNA/cds = UNKNOWN 8141HUVEC Hs.334788 BG392671 13286119 hypothetical protein FLJ14639 1GACCTCCAGAATTTCCTCATCGCTGT cDNA (FLJ14639), mRNA/cds = (273, 689)CGGTGACCAAGTCCACAGACACTA 8142 HUVEC NA NC_002090 9507429 many cloningvectors, kanamycin 1 TCTTGCCATCCTATGGAACTGCCTCG cDNA resistance, geneGTGAGTTTTCTCCTTCATTACAGA 8143 HUVEC NA U07360 476289 Human DXS1178 locusdinucleotide 1 TGTTACTCCTTCAAGCCCCTGAATCA cDNA repeat polymorphismsequence CTATAGCCACGACTCTCCAACTGA

TABLE 9 Viral genomes were used to design oligonucleotides for themicroarrays. The accession numbers for the viral genomes used are given,along with the gene name and location of the region used foroligonucleotide design. Virus Gene Name Genome Location Adenovirus, E1a1226 . . . 1542 type 2 E1b_1 3270 . . . 3503 Accession E2a_2complement(24089 . . . 25885) #J01917 E3-1 27609 . . . 29792 E4 (lastexon complement(33193 . . . 32802) at 3′-end) IX 3576 . . . 4034 Iva2complement(4081 . . . 5417) DNA Polymerase complement(5187 . . . 5418)Cytomega- HCMVTRL2 1893 . . . 2240 lovirus (IRL2) (CMV) HCMVTRL7complement(6595 . . . 6843) Accession (IRL7) #X17403 HCMVUL21complement(26497 . . . 27024) HCMVUL27 complement(32831 . . . 34657)HCMVUL33 43251 . . . 44423 HCMVUL54 complement(76903 . . . 80631)HCMVUL75 complement(107901 . . . 110132) HCMVUL83 complement(119352 . .. 121037) HCMVUL106 complement(154947 . . . 155324) HCMVUL109complement(157514 . . . 157810) HCMVUL113 161503 . . . 162800 HCMVUL122complement(169364 . . . 170599) HCMVUL123 complement(171006 . . .172225) (last exon at 3′-end) HCMVUS28 219200 . . . 220171 Epstein- Exonin EBNA-1 RNA 67477 . . . 67649 Barr virus Exon in EBNA-1 RNA 98364 . .. 98730 (EBV) BRLF1 complement(103366 . . . 105183) Accession BZLF1(first of complement(102655 . . . 103155) # 3 exons) NC_001345 BMLF1complement(82743 . . . 84059) BALF2 complement(161384 . . . 164770)Human U16/U17 complement(26259 . . . 27349) Herpesvirus U89complement(133091 . . . 135610) 6 (HHV6) U90 complement(135664 . . .135948) Accession U86 complement(125989 . . . 128136) # U83 123528 . . .123821 NC_001664 U22 complement(33739 . . . 34347) DR2 (DR2L) 791 . . .2653 DR7 (DR7L) 5629 . . . 6720 U95 142941 . . . 146306 U94complement(141394 . . . 142866) U39 complement(59588 . . . 62080) U42complement(69054 . . . 70598) U81 complement(121810 . . . 122577) U91136485 . . . 136829

TABLE 10A Lupus gene expression markers SEQ Oligo/ ID SEQ ID SourceUnigene Acc GI (Acc) Name Strand SAM FDR CART 41 cDNA Hs.166120NM_004031 4809287 8845 interferon regulatory factor 7 (IRF7) 1 1.1 NAT-cells 328 Tabel 3A NA NA NA 8846 53G7 1 NA surrogate 668 Table 3AHs.169895 NM_004223 4759281 8847 ubiquitin-conjugating enzyme E2L 6 11.6 NA 855 Table 3A Hs.135187 NM_030930 13569892 8848 unc93 (C. elegans)homolog B 1 1.1 NA 981 Table 3A Hs.17448 AK023680 10435678 8849 cDNAFLJ13618 fis 1 1.6 NA 1001 Table 3A Hs.85155 NM_004926 15812179 8850zinc finger protein 36, C3H type-like 1 1 NA Model II (5 gene) 3rdSplitter 1003 Table 3A Hs.24115 AK024240 10436567 8851 cDNA FLJ14178 fis1 NA Model II (5 gene) Secondary Splitter 1025 Table 3A Hs.12293NM_024556 13375720 8852 hypothetical protein FLJ21103 1 NA Model II (3gene) Secondary Splitter 1035 Table 3A Hs.166254 NM_030938 20070348 8853VMP1 ortholog of rat vacuole protein 1 1 NA surrogate 1227 Table 3AHs.322456 NM_032039 14042969 8854 hypothetical protein DKFZp761D0211 1NA surrogate 1341 Table 3A Hs.181165 AV756188 10914036 8855 eukaryotictranslation elongation factor 1 1.6 NA 1390 Table 3A Hs.238990 NM_00406417978497 8856 EST IMAGE:3458141, 1 1.1 NA Similar to p27, Kip1, 1436Table 3A Hs.288061 NM_001101 5016088 8857 actin, beta (ACTB) 1 NA ModelI (3 gene) Secondary Splitter 1535 Table 3A Hs.356755 BE868389 103171658858 tripartite motif protein 14 (TRIM14) 1 1.6 NA 1750 Table 3AHs.198253 NM_002122 18426974 8859 HLA-DQA1 1 1.1 NA 2102 Table 3AHs.301921 NM_001295 4502630 8860 chemokine (C-C motif) 1 1.6 NA receptor1 (CCR1) 2331 Table 3A Hs.172182 NM_002568 4505574 8861 poly(A)-bindingprotein, cytoplasmic 1 1 1.6 NA 2386 Table 3A Hs.63489 NM_00283118104988 8862 protein tyrosine phosphatase, PTPN6 1 1.6 NA 2412 Table 3AHs.79411 NM_002946 4506584 8863 replication protein A2 1 1.1 Model I (2gene) Primary Splitter 2560 literature Hs.1524 NM_003811 4507608 8864TNF (ligand) superfamily, 1 1.6 NA member 9 (TNFSF9) 2648 Table 3AHs.38125 NM_080424 17986253 8865 SP110 nuclear body protein 1 1.6 ModelI (2 gene) Primary Splitter 2895 Table 3A Hs.18420 NM_006289 167532328866 talin 1 (TLN1) 1 1.1 NA 3249 Table 3A Hs.7104 NM_015995 77062898867 cDNA DKFZp761P06121 1 NA surrogate 3305 Table 3A Hs.183125NM_016523 7705573 8868 killer cell lectin-like receptor 1 1.6 NAsubfamily F 3541 literature Hs.170222 R14692 768965 8869 Na+/H+exchanger NHE-1 isoform 1 1.6 NA 3692 Table 3A Hs.173334 W47229 13318698870 ELL-RELATED RNA 1 1.1 NA POLYMERASE II 3701 Table 3A Hs.1103NM_000660 10863872 8871 transforming growth factor, 1 1.6 NA beta 1(TGFB1) 3741 Table 3A Hs.198951 NM_002229 4504808 8872 jun Bproto-oncogene (JUNB) 1 1.1 NA 3825 Table 3A Hs.3416 NM_001122 45572608873 adipose differentiation-related 1 1.1 NA protein (ADFP) 3827 Table3A Hs.139262 NM_017523 8923794 8874 XIAP associated factor-1 1 2.67 NA(HSXIAPAF1) 3832 Table 3A Hs.172182 NM_002568 4505574 8875poly(A)-binding protein, cytoplasmic 1 1 1.6 NA 4149 Literature Hs.74621NM_000311 4506112 8876 prion protein (p27-30) (PRNP) 1 1.6 NA 4400 dbmining NA AF073705 3335589 8877 immunoglobulin lambda light chain 1 1.1NA variable region 4a 4601 literature Hs.149609 NM_002205 4504750 8878Integrin, alpha 5 (fibronectin receptor) 1 1.6 NA 4604 db miningHs.169824 NM_002258 4504878 8879 killer cell lectin-like receptor 1 1.1NA subfamily B, member 1 4631 literature Hs.73839 NM_002935 4506550 8880ribonuclease, RNase A family, 3 1 1.1 NA 4637 db mining Hs.301698NM_003033 4506950 8881 beta-galactoside alpha-2,3- 1 NA NAsialyltransferase (SIAT4A) 5067 Table 3B Hs.356291 W16552 1290934 8882capicua protein (CIC) mRNA 1 0 Model II (1 gene) Primary Splitter 5074db mining NA AA701193 2704358 8883 EST Soares_fetal_liver_spleen −1 1.6NA IMAGE: 461188 3′ 5468 Table 3A Hs.229990 AI818777 5437856 8884 ESTIMAGE: 2424619 −1 1.6 NA 5531 Table 3A Hs.77393 AL567986 12921892 8885famesyl diphosphate synthase −1 1.6 NA 5607 db mining Hs.279105 AW0635098887446 8886 TN1012 cDNA −1 1.6 NA 6382 Table 3A Hs.179665 NM_07846717978494 8887 cyclin-dependent kinase 1 1.6 NA inhibitor 1A (p21, Cip1)6956 Table 3B NA BM852711 19209110 8888 ESTT (Negative stand probe 1 1.1NA to Hs.17481) 7238 db mining Hs.56009 NM_006187 5453823 88892′-5′-oligoadenylate synthetase 3 1 1.1 NA 7330 db mining Hs.226307NM_004900 4758159 8890 phorbolin 1 0.25 NA 7641 db mining Hs.100217NM_005892 5174400 8891 formin-like (FMNL) 1 1.6 NA 8015 HUVEC Hs.198281NM_002654 4505838 8892 pyruvate kinase, muscle (PKM2) 1 1.6 NA cDNA 8095HUVEC Hs.251653 NM_006088 20127490 8893 tubulin, beta, 2 (TUBB2) 1 1.6NA cDNA

TABLE 10B PCR Primers for lupus marker genes SEQ ID PRIMER SET 1 Tm SEQID Primer Set 2 Tm SEQ ID 41 FORWARD GAAGAGCCTGGTCCTGGTGA 62.74 8894TGACGACATCGAGTGCTTCC 62.41 8895 REVERSE AGAGGCTGAGGCTGCTGCTA 62.82 8896CAGCTCTAGGTGGGCTGCTC 62.56 8897 328 FORWARD GCCCAAGGGTGAAAACTGTG 62.778898 TGGGTCTGCTGCTGTCTGTC 62.67 8899 REVERSE TCCGTCGTTGACTTGTGTCC 62.158900 AGGACGGGGATGGACGTATC 63.32 8901 668 FORWARD TACATTCCCCAGAGCCAAGG62.28 8902 GCCTGCTTGCAGGAAATGAA 63.63 8903 REVERSE GCCTGCAAGGTGACCTGTCT62.79 8904 CTCCCACCCATATGCTCCAC 62.63 8905 855 FORWARDTACATTCCCCAGAGCCAAGG 62.28 8906 GCCTGCTTGCAGGAAATGAA 63.63 8907 REVERSEGCCTGCAAGGTGACCTGTCT 62.79 8908 CTCCCACCCATATGCTCCAC 62.63 8909 981FORWARD CCGTAATCTTAAAGAGAAAATCTTTGGA 62.24 8910CCCGTAATCTTAAAGAGAAAATCTTTGG 63.41 8911 REVERSETCACTCAGAAATGGAACTTTTACCTG 61.95 8912 TCACTCAGAAATGGAACTTTTACCTGT 62.558913 1001 FORWARD TGGATTCCAGGTCTGGAGTTTT 62.09 8914 CACGTGCCCATCTCAAGACA63.3 8915 REVERSE CGACGGTAGTGACCAGCAAG 61.84 8916ATGTGTGTGTGCCAGTTCTGTTT 61.82 8917 1003 FORWARD GCCTCTCAACTGAGCAGTAAAGGT62.42 8918 GCAGTAAAGGTAAGGAGAGCTCAATC 62.1 8919 REVERSETGAAGTCTCAAGTGGGCATGA 61.79 8920 TGAAGTCTCAAGTGGGCATGA 61.79 8921 1025FORWARD AACCCACTCCCCAGGCTAGA 63.2 8922 GCCGCCTGTTCAAGTTCAAG 63.16 8923REVERSE ATCCAGACCCCGAGTCCTTC 62.71 8924 CACATTGGTGTGCTGTGTGG 62.16 89251035 FORWARD ATGGCAGCCTTGCCTAATCC 63.58 8926 TGCATGAGAGAGCCACTACCA 61.958927 REVERSE TATGCAGCAGCCCAGTTTCA 62.83 8928 AGGTAGGCCAATCCCAGAGG 62.628929 1227 FORWARD ACCTCTGTGCCTTGCTGCTC 63.06 8930 ATCCCAAGGAACTGGCTGTG62.4 8931 REVERSE ATCAGGCTGCTTTGGCTACG 62.72 8932 GCCTCTTCAGGGACAGAGCA63.01 8933 1341 FORWARD AAGGATTGATCGCCGTTTTG 62.22 8934CTGAACCATCCAGGCCAAAT 62.17 8935 REVERSE TGGGCCTGACAAGAACCATT 62.76 8936ACGGCGATCAATCCTTTCCT 63.1 8937 1390 FORWARD TGGCATGTTTTGTGCATTTGT 62.278938 AAGCCAAAGTGGCATGTTTTG 62.27 8939 REVERSE CTTGGCTCAGTATGCAACCTTTT61.81 8940 GGCTCAGTATGCAACCTTTTAAGC 62.48 8941 1436 FORWARDGCCGAGGACTTTGATTGCAC 63.04 8942 GAACGGTGAAGGTGACAGCA 62.29 8943 REVERSEGAAGTGGGGTGGCTTTTAGGA 62.55 8944 AATCAAAGTCCTCGGCCACA 62.89 8945 1535FORWARD TCCACACCATGGGCAGAAC 63.02 8946 CAGGGCCTGGGTTTGAATAA 62.08 8947REVERSE GGCCCTGCAATTATTCAAACC 62.69 8948 TTGATTGCTGAATGGGAGAGG 62.418949 1750 FORWARD CCCTTGGTGTCTGGAAGCAC 63.01 8950 TTAGGTAGCTGGGCGGCTTA62.06 8951 REVERSE GTCTGTGCCTTGGGGTTGTC 62.89 8952 GGTGCTTCCAGACACCAAGG63.01 8953 2102 FORWARD AGGAAGCAGGGTTGGTTTCC 62.63 8954CCCAGAGCCAATCAGTAGCC 62.07 8955 REVERSE CCAAGATGGCAGTCGGAACT 62.53 8956TGTTCCCCAGGATTCCAAGA 62.71 8957 2331 FORWARD GGCTGCCCAGAAAGCAGTTA 62.78958 AAAGAGGCTGCCCAGAAAGC 63.13 8959 REVERSE TTCTTCGGTGAAGCACAAGTTTC62.83 8960 TGAAGCACAAGTTTCTTTTCATGG 62.63 8961 2386 FORWARDAAGTGAGCGGTGCTGTCCTC 62.92 8962 AGCGGTCAGCAGACAAGGAG 63.04 8963 REVERSETGGGGCACTCCTAGGTTCAG 62.51 8964 AATGCTTCCACAGGGTCAGG 62.4 8965 2412FORWARD TGGCCTCTGCCTGTTTTCAT 63.02 8966 AGGACCAGGGCGTTATAGGC 62.56 8967REVERSE CGTCATGGCAAGTGTGTCAA 61.78 8968 ATGCCACACAACCAAAGTCG 61.81 89692560 FORWARD GGGTCCCTGCTGCTTTCTCT 63.11 8970 GGCGTCCATCTTCACACTGA 62.278971 REVERSE TCCAACTTGGGGAAGGAGTG 62.36 8972 ACCCGGAAGAGTCCCAAGAC 62.728973 2648 FORWARD AGCATCCCCACCTCAGGATT 63.08 8974 TTACGGTGAGCCCTTTCAGG62.43 8975 REVERSE GTGTCTGGGTTTGGGTCCTG 62.74 8976 GCATGTCTCGCACAAACCAT62.09 8977 2895 FORWARD CCAAGTGCCTTCATGCCCTA 63.37 8978TCTGCCTTCAGAGCTTCGAGA 62.79 8979 REVERSE CGGCAGATTCAGATCGAGGT 62.65 8980CAGCCCAGAAGGCTTTGGTA 62.56 8981 3249 FORWARD CTGGCAGGACTGCAACAAGA 62.558982 GCTCCCTCAGCGACTACAGC 62.58 8983 REVERSE CAGATGGGGCAGCTGAACTT 62.668984 AGGAAAGGCCAGGGACTCAC 62.85 8985 3305 FORWARD TCCCTCCATCATCGACACTG62.09 8986 GTCTAGCCTCAGAGTAACCCCTGTT 62.42 8987 REVERSETTGGCATAAAATAAGCGACGAA 61.72 8988 TTGGCATAAAATAAGCGACGAA 61.72 8989 3541FORWARD CTGCTGACCCACCAAGGTCT 62.64 8990 GAGCAGGGGTGGTTTCTACG 61.96 8991REVERSE CCCGCAGCTCTGAGTAAGGA 62.9 8992 TCCTTCCCCTAGCAGCTTCC 62.98 89933692 FORWARD TGGTTGCCTTAAGGTGTTTGC 62.27 8994 ACATTAAATCCGCCCTGCAA 62.588995 REVERSE GCCACAGTATGCTTCCCATTG 62.7 8996 TGCTCTAATCAAGTGGGAAGCAG62.93 8997 3701 FORWARD TTGACTTCCGCAAGGACCTC 62.65 8998GCCTTTCCTGCTTCTCATGG 62.19 8999 REVERSE TCCAGGCTCCAAATGTAGGG 62.28 9000CTCCGTGGAGCTGAAGCAAT 62.79 9001 3741 FORWARD TCCACCTCGACGTTTACAAGC 62.489002 CCTGCCCCTTTACGGACAC 62.76 9003 REVERSE CCCTCTTCCCCTCCCTGTTA 62.599004 GCCGGAGTCCAGTGTGGT 62.21 9005 3825 FORWARD ACCCTCCTGTCCAACATCCA62.73 9006 TGTTAACAACACGCCCCTCA 62.45 9007 REVERSE CAGCATTGCGGAACACTGAG62.95 9008 TGTCCATCTCTGCACCTTGG 62.26 9009 3827 FORWARDTTTTGATGTCAGAGCCCAAGC 62.57 9010 TCAGTGTGGCATCCTGCTTC 62.41 9011 REVERSEGAAGCAGGATGCCACACTGA 62.41 9012 TGAAGCTAACCACCGGCATT 62.81 9013 3832FORWARD TGGCATGTTGTTGGAGATTGA 62.43 9014 GGCTGCCCAGAAAGCAGTTA 62.7 9015REVERSE TGGGCAGCCTCTTTAGCTTG 62.81 9016 TTCTTCGGTGAAGCACAAGTTTC 62.839017 4149 FORWARD AAACCCTTTTGCGTGGTCCT 63 9018 TTAATATGTGGGAAACCCTTTTGC62.25 9019 REVERSE CCTGTTAATGGTGTCCACTTTGG 62.7 9020CCTGTTAATGGTGTCCACTTTGG 62.7 9021 4400 FORWARD ACATCATCGCATGGCATCAG63.06 9022 ACAACAAGGGGAGCGGAGTT 63.23 9023 REVERSE AACTCCGCTCCCCTTGTTGT63.23 9024 TCAGCCTCATCCTCAAACTGG 62.65 9025 4601 FORWARDCAGCTCCAAGGGGAATCAGA 62.61 9026 AGCCAGGAATTTCCCAGGAC 62.62 9027 REVERSECTGGATCTGCCTGGATTGGT 62.38 9028 ACAGTGGGCTCCCCTTTCTC 62.85 9029 4604FORWARD GGCAGCAACTCCGAGAGAAA 62.91 9030 TGCAGTGTGGACATTCAACAGA 62.719031 REVERSE GCAGGCTGGATTCTTTGGTG 63.02 9032 TCTCGGAGTTGCTGCCAATA 61.859033 4631 FORWARD CTCACAGGAGCCACAGCTCA 62.79 9034 CCACGGTATCCTGTGGTTCC62.51 9035 REVERSE CACCCATAAGCCCCAACAGA 63.12 9036 TGATTGAGGAGCTTGGCAGA62.03 9037 4637 FORWARD ATGCTGCCCTTCTTTTGCAC 62.59 9038GGCAAGCTTGGGAATGAATG 62.78 9039 REVERSE GGAGCCTCTGGTGGCTCATA 62.65 9040TGCTGGAGGTAATCGCCACT 63.04 9041 5067 FORWARD TCGACATGGTGAGGTAGAGCA 61.819042 TTTGGTGACAGTGAGCTTGAGG 62.69 9043 REVERSE TGTTCTGGCAGCACCTCAAG62.55 9044 TGGATGGCCGTTTAGAGAGAA 61.99 9045 5074 FORWARDGGCTTAACCCAGGCATCCTC 63.1 9046 TGTCTGGAAGCCACAACTGG 62.27 9047 REVERSEGAGGCCTGCTTCCAGTTGTG 63.27 9048 GGGTTTTCTGTGGCCCTCTT 62.63 9049 5468FORWARD CCCACTTCCCCATGTTTGTC 62.5 9050 TAAAACAGCCCAGCGCTCAC 63.65 9051REVERSE CGGCAGATCCCTGAAATGAC 62.88 9052 GCTGGAAACCTGGCAGTGAT 62.55 90535531 FORWARD CCATGGGGTCTTGCCCTAC 62.62 9054 TGCTCCTTCTCGCCATCAAT 63.149055 REVERSE AGGCTGGACCATCAGTCAGG 62.62 9056 AGGAAGCAGCCAGGAAGATG 61.829057 5607 FORWARD AAACTCGGCATGTCCTCCAG 62.53 9058 CGGTCAGATCGTTGCGTAGA62.33 9059 REVERSE CAAGGATGAGGACGGTGCTT 62.53 9060 TGGGCTTAGCCTTGATCCAC62.43 9061 6382 FORWARD TGGGGCTGGGAGTAGTTGTC 62.4 9062CATCCCTCCCCAGTTCATTG 62.6 9063 REVERSE GGAAGGTGTTTGGGGTCAGA 62.25 9064GTGGCATGCCCTGTCCATA 62.91 9065 6956 FORWARD TCTTGGAGATTCGAGCAGCA 62.179066 AGGCAGCAGTGCAAGTGACA 63.23 9067 REVERSE CTGCGACCAGAGTCAGTGGA 62.659068 TGGCTATTGCTGGCCTCCTA 63.03 9069 7238 FORWARD CTCTGCCAAGTTGTCCAGCA62.55 9070 GGACCCCAAACTCCACCTCT 62.59 9071 REVERSE AGGTACCCAACTGCGACCTG62.43 9072 TGGACAACTTGGCAGAGCAG 62.55 9073 7330 FORWARDCCTGGGTTGAGCAGCAGAAT 62.66 9074 CAGCCCTGGGATGGACTAGA 62.5 9075 REVERSEAGCACATTGCTTTGCTGGTG 62.36 9076 AGGCCCATCCTTCAGTTTCC 62.62 9077 7641FORWARD CAGGCTGAGGCTCAAGGAAG 62.53 9078 CCTCCGACCTCTCGCTGTAG 62.41 9079REVERSE CCAAGAGGAGGATGCACCAG 63.11 9080 GCTGAGGACCACCTTCCTTG 62.15 90818015 FORWARD CCCTGGCCCTTACTTGCTTC 63.22 9082 GCAAGAGGGTGACAGCTTCC 62.39083 REVERSE GGTGGAGGGTGGAGTGTTTG 62.74 9084 GCTGTTTCTTGACCCCAAGC 62.099085

TABLE 10 C Surrogates for lupus gene expression markers SEQ Hierarchical(Oligo) Clustering ID Acc Name CART Surogates Surrogates 41 NM_004031interferon regulatory factor 7 (IRF7) 328 unknown 53G7 668 AF061736ubiquitin-conjugating enzyme E2L 6 855 AJ271326 unc93 (C. elegans)homolog B 171 981 AK023680 cDNA FLJ13618 fis 1001 NM_004926 zinc fingerprotein 36, C3H type-like 1 1015, 1019, 1036, 1037, 1013, 2401, 209,8004, 578 1003 AK024240 cDNA FLJ14178 fis 10, 100, 1005, 1004, 1001 60741025 AK024756 hypothetical protein FLJ21103 103, 1041, 1042, 1046, 10031035 NM_030938 VMP1 ortholog of rat vacuole protein 1 1227 NM_032039hypothetical protein DKFZp761D0211 1341 AV756188 eukaryotic translationelongation factor 1390 AY004255 EST IMAGE:3458141, Similar to p27, Kip1,1436 NM_001101 actin, beta (ACTB) 5067, 7330, 3692, 1052 1635 BE868389tripartite motif protein 14 (TRIM14) 1750 M11124 HLA-DQA1 1770, 17692102 NM_001295 chemokine (C-C motif) receptor 1 (CCR1) 2331 NM_002568poly(A)-binding protein, cytoplasmic 1 3832 2386 NM_002831 proteintyrosine phosphatase, PTPN6 2412 NM_002946 replication protein A2 855,7330, 2331, 2895, 3741, 3692 2560 NM_003811 TNF (ligand) superfamily,member 9 (TNFSF9) 2648 NM_080424 SP110 nuclear body protein 2412, 855,7330, 2331, 2895, 3328, 824, 2969, 371, 8016, 7238, 3827, 4 2895NM_006289 talin 1 (TLN1) 8095, 2386 3249 NM_015995 cDNA DKFZp761P061213305 NM_016523 killer cell lectin-like receptor subfamily F 3541 R14692Na⁺/H⁺ exchanger NHE-1 isoform 3692 W47229 ELL-RELATED RNA POLYMERASE II3701 X02812 transforming growth factor, beta 1 (TGFB1) 3741 X51345 jun Bproto-oncogene (JUNB) 3825 X97324 adipose differentiation-relatedprotein (ADFP) 3827 X99699 XIAP associated factor-1 (HSXIAPAF1) 3832Y00345 poly(A)-binding protein, cytoplasmic 1 2331 4149 NM_000311 prionprotein (p27-30) (PRNP) 4444 4400 AF073705 immunoglobulin lambda lightchain variable region 4a 4601 NM_002205 integrin, alpha 5 (fibronectinreceptor) 4604 NM_002258 killer cell lectin-like receptor subfamily B,member 1 1991 4631 NM_002935 ribonuclease, RNase A family, 3 4637NM_003033 beta-galactoside alpha-2,3-sialyltransferase (SIAT4A) 5067W16552 capicua protein (CIC) mRNA 328, 2412, 1227, 3249, 2331, 7242 5074AA701193 EST Soares_fetal_liver_spleen IMAGE:461188 3′ 5468 AI818777 ESTIMAGE:2424619 5531 AL567986 farnesyl diphosphate synthase 5607 AW063509TN1012 cDNA 6382 NM_078467 cyclin-dependent kinase inhibitor 1A (p21,Cip1) 6956 BM852711 ESTT (Negative stand probe to Hs.17481) 5278 7238NM_006187 2′-5′-oligoadenylate synthetase 3 3328, 824, 2969, 371, 8016,1785, 3827, 41 7330 NM_004900 phorbolin 7641 NM_005892 formin-like(FMNL) 8015 M26252 pyruvate kinase, muscle (PKM2) 8095 AK026594 tubulin,beta, 2 (TUBB2)

TABLE 11 Kits for discovery of, or application of diagnostic gene setsA. Contents of kit for discovery of diagnostic gene sets usingmicroarrays 1. Sterile, endotoxin and RNAse free blood collection tubes2. Alcohol swabs, tourniquet, blood collection set 3. -PBS (phosphatebuffer saline; needed when method of example 8 is used to derivedmononuclear RNA) 4. Cell lysis buffer 5. RNA isolation kit 6. Substratesfor labeling of RNA (may vary for various expression profilingtechniques) For fluorescence microarray expression profiling: Reversetranscriptase and 10x RT buffer T7(dT)24 primer (primer with T7 promoterat 5′ end) DTT Deoxynucleotides 100 mM each RNAse inhibitor 2^(nd)strand cDNA buffer DNA polymerase Rnase H T7 RNA polymeraseRibonucleotides In Vitro transcription buffer Cy3 and Cy5 labeledribonucleotides 7. Microarrays containing candidate gene libraries 8.Cover slips for slides 9. Hybridization chambers 10. Software packagefor identification of diagnostic gene set from data Contains statisticalmethods. Allows alteration in desired sensitivity and specificity ofgene set. Software facilitates access to and data analysis by centrallylocated database server. 11. Password and account number to accesscentral database server. 12. Kit User Manual B. Contents of kit forapplication of diagnostic gene sets using microarrays 1. Sterile,endotoxin and RNAse free blood collection tubes 2. Alcohol swabs,tourniquet, blood collection set 3. -PBS (phosphate buffer saline;needed when method of example 7 is used to derived mononuclear RNA) 4.Cell lysis buffer 5. RNA isolation kit 6. Substrates for labeling of RNA(may vary for various expression profiling techniques) For fluorescencemicroarray expression profiling: Reverse transcriptase and 10x RT bufferT7(dT)24 primer (primer with T7 promoter at 5′ end) DTT Deoxynucleotides100 mM each RNAse inhibitor 2^(nd) strand cDNA buffer DNA polymeraseRnase H T7 RNA polymerase Ribonucleotides In Vitro transcription bufferCy3 and Cy5 labeled ribonucleotides 7. Microarrays containing candidategene libraries 8. Cover slips for slides 9. Hybridization chambers 10.Software package for identification of diagnostic geng set from dataContains statistical methods. Allows alteration in desired sensitivityand specificity of gene set. Software facilitates access to and dataanalysis by centrally located database server. 11. Password and accountnumber to access central database server. 12. Kit User Manual C.Contents of kit for application of diagnostic gene sets using Real-timeRT-PCR 1. Sterile, endotoxin and RNAse free blood collection tubes 2.Alcohol swabs, tourniquet, blood collection set 3. -PBS (phosphatebuffer saline; needed when method of example 7 is used to derivedmononuclear RNA) 4. Cell lysis buffer 5. RNA isolation kit 6. Substratesfor real time RT-PCR (may vary for various real-time PCR techniques:poly dT primers, random hexamer primers Reverse Transcriptase and RTbuffer DTT Deoxynucleotides 100 mM RNase H primer pairs for diagnosticand control gene set 10x PCR reaction buffer Taq DNA polymeraseFluorescent probes for diagnostic and control gene set (alternatively,fluorescent dye that binds to only double stranded DNA) reaction tubeswith or without barcode for sample tracking 96-well plates with barcodefor sample identification, one barcode for entire set, or individualbarcode per reaction tube in plate 7. Software package foridentification of diagnostic gene set from data Contains statisticalmethods. Allows alteration in desired sensitivity and specificity ofgene set. Software facilitates access to and data analysis by centrallylocated database server 8. Password and account number to access centraldatabase server. 9. Kit User Manual

1. A method of diagnosing or monitoring an autoimmune or chronicinflammatory disease in a patient, comprising detecting the expressionlevel of a gene in said patient to diagnose or monitor said autoimmuneor chronic inflammatory disease in said patient wherein said genecomprises the nucleotide consisting sequence of SEQ ID NO:
 7238. 2. Themethod of claim 1 wherein said chronic inflammatory disease is systemiclupus erythematosus (SLE).
 3. The method of claim 1 wherein saidexpression level is detected by measuring the RNA level expressed bysaid gene.
 4. The method of claim 3 further comprising isolating RNAfrom said patient prior to detecting the RNA level expressed by saidgene.
 5. The method of claim 4 wherein said RNA level is detected byPCR.
 6. The method of claim 4 wherein said RNA level is detected byhybridization.
 7. The method of claim 4 wherein said RNA level isdetected by hybridization to an oligonucleotide.
 8. The method of claim7 wherein the nucleotide sequence comprises DNA, RNA, cDNA, PNA, genomicDNA, or synthetic oligonucleotides.
 9. The method of claim 1 whereinsaid expression is detecting by measuring protein levels of said gene.